data_1krw_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1krw _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 1.581 ' HB3' ' CG ' ' A' ' 3' ' ' ARG . 0.0 OUTLIER . . . . . 2 N--CA 1.274 -9.244 0 CA-C-O 124.789 2.233 . . . . 0.0 114.498 . . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.45 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . 79.76 87.59 0.54 Allowed Glycine 1 C--N 1.149 -9.831 1 O-C-N 113.565 -5.709 . . . . 0.0 112.665 -179.864 . . . . . . . . 4 3 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 1.668 HD13 ' CG1' ' A' ' 5' ' ' ILE . 0.7 OUTLIER -112.7 113.3 43.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 O-C-N 122.59 -0.359 . . . . 0.0 111.365 -179.679 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 1.038 HG12 ' CB ' ' A' ' 6' ' ' VAL . 7.1 p -107.71 125.39 64.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.676 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.486 ' CD1' ' CG2' ' A' ' 31' ' ' THR . 31.4 m0 -114.44 134.13 55.23 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.03 0.443 . . . . 0.0 110.374 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 1.006 HG23 ' CB ' ' A' ' 8' ' ' VAL . 0.3 OUTLIER -122.29 143.83 33.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.653 -178.405 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 1.224 HG12 ' CB ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -123.81 109.65 23.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.038 0.447 . . . . 0.0 110.321 178.901 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.497 ' O ' ' N ' ' A' ' 12' ' ' ASP . 5.8 t0 -164.55 -177.24 4.72 Favored 'General case' 1 C--O 0.895 -17.579 0 CA-C-O 125.923 2.773 . . . . 0.0 111.103 -179.075 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 1.303 ' OD2' ' CB ' ' A' ' 11' ' ' ASP . 0.7 OUTLIER -44.89 -10.47 0.01 OUTLIER 'General case' 2 C--N 1.074 -11.412 3 O-C-N 104.073 -11.642 . . . . 0.0 112.854 -178.827 . . . . . . . . 5 4 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.497 ' N ' ' O ' ' A' ' 10' ' ' ASP . 2.6 t70 76.01 -147.53 0.03 OUTLIER 'General case' 1 C--O 1.13 -5.215 0 O-C-N 117.905 -2.997 . . . . 0.0 111.76 179.803 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 1.103 ' HG ' ' CB ' ' A' ' 13' ' ' SER . 8.2 t 22.05 -85.74 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.777 0 C-N-CA 126.371 1.868 . . . . 0.0 114.676 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.87 -56.92 14.9 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 120.925 0.393 . . . . 0.0 111.514 -179.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.998 HD11 ' CG1' ' A' ' 15' ' ' ILE . 24.0 mm -65.09 -24.99 36.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-O 120.823 0.344 . . . . 0.0 111.141 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 1.53 ' HE ' ' CZ ' ' A' ' 16' ' ' ARG . 1.8 ttt180 -72.29 -50.2 28.84 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.291 0.567 . . . . 0.0 111.201 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 72.1 t90 -60.33 -43.24 96.6 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 1.029 HG13 ' CB ' ' A' ' 18' ' ' VAL . 3.2 t -65.84 -48.05 83.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -178.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 1.603 HD23 ' CG ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -81.15 -29.29 34.76 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -178.093 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 1.327 ' OE1' ' CG ' ' A' ' 20' ' ' GLU . 12.9 pt-20 -67.13 -59.33 3.54 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -178.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 1.202 ' NE ' ' CG ' ' A' ' 21' ' ' ARG . 11.8 mmt180 -59.2 -51.27 70.73 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.821 -179.09 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.995 ' HB1' ' CA ' ' A' ' 22' ' ' ALA . . . -57.64 -46.11 84.6 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.91 0.386 . . . . 0.0 111.83 -179.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 1.556 HD22 ' CG ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -72.2 -26.46 62.06 Favored 'General case' 0 C--N 1.311 -1.109 0 CA-C-O 121.225 0.536 . . . . 0.0 110.408 179.577 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.983 ' HB3' ' CA ' ' A' ' 24' ' ' ALA . . . -67.09 -34.62 78.03 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.93 -26.14 68.63 Favored Glycine 0 N--CA 1.44 -1.073 0 C-N-CA 120.247 -0.978 . . . . 0.0 111.032 178.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.999 ' HB2' ' CA ' ' A' ' 26' ' ' ALA . . . -77.21 -15.71 59.37 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 120.802 0.334 . . . . 0.0 110.939 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.3 26.23 10.32 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.514 -0.851 . . . . 0.0 114.143 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 1.021 HD12 ' CG ' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -126.18 168.74 13.64 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 117.982 0.891 . . . . 0.0 112.238 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.994 HG21 ' CB ' ' A' ' 29' ' ' THR . 53.7 m -91.85 115.3 27.95 Favored 'General case' 0 C--O 1.211 -0.953 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.627 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 1.482 ' HG ' ' CB ' ' A' ' 30' ' ' CYS . 49.1 t -110.81 113.55 26.23 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.008 0.433 . . . . 0.0 112.083 -179.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 1.108 ' HG1' ' CB ' ' A' ' 31' ' ' THR . 2.7 t -122.48 146.22 47.59 Favored 'General case' 0 C--O 1.219 -0.509 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.999 HG22 ' CB ' ' A' ' 32' ' ' THR . 60.3 p -119.52 162.57 18.68 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.315 0.579 . . . . 0.0 112.258 -178.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.775 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 3.0 m-85 -133.65 173.54 11.4 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.371 -0.832 . . . . 0.0 111.7 -178.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 1.295 ' HG3' ' CD ' ' A' ' 34' ' ' GLU . 17.1 pt-20 -62.55 -47.03 85.66 Favored 'General case' 1 C--O 1.149 -4.211 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -177.98 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 1.587 HD21 ' CB ' ' A' ' 35' ' ' ASN . 0.0 OUTLIER -161.25 -61.73 0.05 Allowed 'General case' 1 C--O 0.886 -18.048 0 O-C-N 118.598 -2.564 . . . . 0.0 112.277 -179.252 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.617 ' HA3' ' CD2' ' A' ' 65' ' ' LEU . . . -163.39 -43.95 0.02 OUTLIER Glycine 1 C--N 1.066 -14.464 3 O-C-N 103.777 -11.827 . . . . 0.0 113.315 -179.399 . . . . . . . . 4 3 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.413 ' HA ' ' CD1' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -60.43 -33.31 72.35 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 122.208 -0.584 . . . . 0.0 111.358 -179.359 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 1.386 ' HG2' ' CD ' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -57.1 -55.27 36.91 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.384 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 1.071 HG23 ' CB ' ' A' ' 39' ' ' VAL . 21.5 t -53.44 -37.62 30.42 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.289 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.816 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 1.001 HD21 ' CG ' ' A' ' 40' ' ' LEU . 18.5 mt -56.42 -44.72 80.66 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.681 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.989 ' HB3' ' CA ' ' A' ' 41' ' ' ALA . . . -68.39 -48.77 63.84 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.212 0.529 . . . . 0.0 111.218 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.979 ' HB1' ' CA ' ' A' ' 42' ' ' ALA . . . -64.64 -31.77 73.14 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.913 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 1.038 HD12 ' CG ' ' A' ' 43' ' ' LEU . 12.9 mt -64.4 -24.93 67.8 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.515 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.978 ' HB1' ' CA ' ' A' ' 44' ' ' ALA . . . -57.35 -18.72 18.65 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.66 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 1.512 ' HG ' ' CB ' ' A' ' 45' ' ' SER . 0.1 OUTLIER -123.39 0.11 8.84 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.653 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 1.591 ' HZ3' ' CE ' ' A' ' 46' ' ' LYS . 0.3 OUTLIER -162.4 160.38 26.36 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-O 120.779 0.323 . . . . 0.0 111.55 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 1.123 ' HG1' ' CB ' ' A' ' 47' ' ' THR . 97.3 m -138.91 114.7 8.57 Favored Pre-proline 0 N--CA 1.448 -0.556 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.447 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.414 ' HG3' ' HB2' ' A' ' 7' ' ' TRP . 68.4 Cg_endo -75.29 159.58 40.15 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.441 2.094 . . . . 0.0 111.599 179.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -75.26 -26.53 58.88 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.803 0.335 . . . . 0.0 111.108 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.996 HG13 ' CB ' ' A' ' 50' ' ' VAL . 7.1 p -146.04 133.52 15.26 Favored 'Isoleucine or valine' 1 C--O 1.079 -7.92 0 CA-C-O 122.88 1.324 . . . . 0.0 110.861 -179.652 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 1.013 HD13 ' CG ' ' A' ' 51' ' ' LEU . 18.2 tp -120.02 134.45 55.25 Favored 'General case' 1 C--N 1.203 -5.766 1 O-C-N 114.859 -4.901 . . . . 0.0 111.649 -179.262 . . . . . . . . 4 3 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 1.023 HD21 ' CG ' ' A' ' 52' ' ' LEU . 0.6 OUTLIER -119.15 122.13 41.32 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 122.824 0.45 . . . . 0.0 110.232 179.676 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 1.342 ' HG ' ' CB ' ' A' ' 53' ' ' SER . 0.5 OUTLIER -115.96 136.59 52.9 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.273 0.559 . . . . 0.0 112.169 -179.541 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 1.282 ' O ' ' CA ' ' A' ' 55' ' ' ILE . 10.3 t70 -80.96 -2.32 47.27 Favored 'General case' 1 C--O 0.48 -39.423 1 CA-C-O 162.772 20.32 . . . . 0.0 112.03 -179.978 . . . . . . . . 4 3 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 1.466 HD13 ' CG1' ' A' ' 55' ' ' ILE . 14.7 tt 32.72 97.83 0.0 OUTLIER 'Isoleucine or valine' 2 C--N 0.776 -24.364 3 O-C-N 28.812 -58.68 . . . . 0.0 111.483 -179.326 . . . . . . . . 4 3 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 1.601 ' HG2' ' CD ' ' A' ' 56' ' ' ARG 0.266 0.3 OUTLIER -158.85 47.77 0.33 Allowed 'General case' 3 C--N 1.154 -7.898 1 O-C-N 112.899 -6.125 . . . . 0.0 117.447 -179.837 . . . . . . . . 6 4 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 1.716 ' HE1' ' SD ' ' A' ' 57' ' ' MET 0.684 11.2 ttt 88.93 28.48 0.0 OUTLIER Pre-proline 3 N--CA 1.257 -10.121 1 N-CA-C 139.177 10.436 . . . . 0.0 139.177 179.064 . . . . . . . . 5 3 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.36 -101.48 0.0 OUTLIER 'Trans proline' 3 C--O 0.983 -12.226 0 O-C-N 125.966 2.561 . . . . 0.0 112.862 178.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -98.25 -53.3 1.27 Allowed Glycine 4 C--O 0.965 -16.705 0 CA-C-N 125.744 3.884 . . . . 0.0 112.79 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 1.764 ' HE1' ' SD ' ' A' ' 60' ' ' MET . 0.0 OUTLIER -118.1 63.28 0.76 Allowed 'General case' 1 C--N 1.163 -7.537 2 O-C-N 113.5 -5.706 . . . . 0.0 109.958 178.763 . . . . . . . . 5 4 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 1.246 ' OD1' ' CB ' ' A' ' 61' ' ' ASP . 0.3 OUTLIER 62.99 -42.67 0.19 Allowed 'General case' 1 C--O 1.044 -9.721 0 CA-C-O 122.324 1.059 . . . . 0.0 112.137 -179.756 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.762 ' HA3' HG13 ' A' ' 55' ' ' ILE . . . 165.91 -30.87 0.21 Allowed Glycine 1 C--N 1.185 -7.814 1 O-C-N 114.55 -5.094 . . . . 0.0 111.417 -179.713 . . . . . . . . 4 3 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 1.097 HD11 ' CG ' ' A' ' 63' ' ' LEU . 2.2 mp -67.01 -19.19 65.66 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-O 120.852 0.358 . . . . 0.0 110.193 179.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.25 -37.49 64.74 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-O 121.183 0.516 . . . . 0.0 110.498 178.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 1.593 HD11 ' CB ' ' A' ' 65' ' ' LEU . 1.2 mt -58.33 -44.32 88.61 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.736 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 1.659 HD12 ' CD2' ' A' ' 66' ' ' LEU . 20.4 mt -55.88 -45.44 78.57 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.08 0.467 . . . . 0.0 110.619 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 1.646 ' HE2' ' CD ' ' A' ' 67' ' ' LYS . 3.2 mttt -53.34 -48.41 68.53 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.856 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 1.448 ' OE1' ' CG ' ' A' ' 68' ' ' GLN . 11.8 mm-40 -66.4 -34.55 78.21 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.963 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 1.299 HD11 ' CG1' ' A' ' 69' ' ' ILE . 98.4 mt -61.34 -41.78 91.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.727 -179.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 1.579 ' HE3' ' CD ' ' A' ' 70' ' ' LYS . 17.4 pttt -71.51 -28.1 63.66 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.669 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.755 ' NE2' ' HA ' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -72.84 -38.05 67.23 Favored 'General case' 0 C--O 1.213 -0.848 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.763 -179.441 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 1.531 ' HE ' ' CD ' ' A' ' 72' ' ' ARG . 70.7 mtt-85 -97.14 -41.65 8.22 Favored 'General case' 0 C--O 1.173 -2.949 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -179.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 1.56 ' HD2' ' CE1' ' A' ' 73' ' ' HIS . 0.0 OUTLIER -108.39 139.38 20.72 Favored Pre-proline 1 C--O 1.001 -11.985 0 CA-C-O 124.121 1.915 . . . . 0.0 112.683 -179.053 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.601 ' O ' ' CG ' ' A' ' 75' ' ' MET 0.337 8.3 Cg_endo -74.0 -36.37 3.51 Favored 'Trans proline' 4 C--O 0.774 -22.703 3 C-N-CA 128.145 5.896 . . . . 0.0 123.185 -179.942 . . . . . . . . 5 3 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 1.641 ' HE2' ' SD ' ' A' ' 75' ' ' MET . 47.5 mtt -159.83 31.21 0.18 Allowed 'General case' 2 C--N 0.983 -15.339 3 O-C-N 101.657 -13.152 . . . . 0.0 115.154 -179.923 . . . . . . . . 4 3 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 1.513 HD11 ' CG ' ' A' ' 76' ' ' LEU . 1.5 tt -64.24 118.77 49.98 Favored Pre-proline 0 C--N 1.306 -1.316 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.621 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.455 ' HA ' ' O ' ' A' ' 97' ' ' GLY . 3.4 Cg_exo -63.44 125.1 14.94 Favored 'Trans proline' 0 C--O 1.212 -0.808 0 C-N-CA 122.809 2.339 . . . . 0.0 112.31 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.993 HG12 ' CB ' ' A' ' 78' ' ' VAL . 4.3 t -119.32 145.15 25.88 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-O 120.997 0.427 . . . . 0.0 111.321 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 1.046 HD12 ' CG1' ' A' ' 79' ' ' ILE . 2.0 mt -125.71 113.08 33.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.618 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 1.404 HD11 ' CG1' ' A' ' 80' ' ' ILE . 15.9 mm -98.69 141.77 15.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.604 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 1.722 ' HE2' ' SD ' ' A' ' 81' ' ' MET . 2.2 ptm -73.64 -41.0 63.33 Favored 'General case' 0 C--O 1.165 -3.381 0 CA-C-N 116.081 -0.509 . . . . 0.0 112.232 -179.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 1.013 HG22 ' CB ' ' A' ' 82' ' ' THR . 7.0 m -135.42 155.39 50.64 Favored 'General case' 0 C--N 1.29 -2.019 0 O-C-N 120.435 -1.416 . . . . 0.0 111.818 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 1.027 ' HB3' ' CA ' ' A' ' 83' ' ' ALA . . . -118.55 20.93 12.82 Favored 'General case' 1 C--O 0.955 -14.412 0 CA-C-O 121.331 0.586 . . . . 0.0 111.748 -179.667 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 1.633 ' HD2' ' CE1' ' A' ' 84' ' ' HIS 0.257 0.0 OUTLIER -25.71 -163.74 0.0 OUTLIER 'General case' 3 C--O 0.554 -35.513 2 O-C-N 111.277 -7.14 . . . . 0.0 118.378 -179.582 . . . . . . . . 6 4 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 1.509 ' HB3' ' CA ' ' A' ' 85' ' ' SER 0.46 0.2 OUTLIER -32.87 6.71 0.0 OUTLIER 'General case' 4 C--O 0.302 -48.796 5 O-C-N 90.034 -20.417 . . . . 0.0 127.013 -178.286 . . . . . . . . 6 4 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 1.354 ' OD2' ' CB ' ' A' ' 86' ' ' ASP . 0.5 OUTLIER -148.27 44.23 1.05 Allowed 'General case' 2 C--N 0.866 -20.424 3 O-C-N 41.666 -50.646 . . . . 0.0 115.159 178.086 . . . . . . . . 5 4 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 1.605 HD13 ' CG ' ' A' ' 87' ' ' LEU . 0.2 OUTLIER -48.95 -22.44 0.85 Allowed 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.967 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -48.11 -49.37 32.22 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -179.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 1.029 ' HB3' ' CA ' ' A' ' 89' ' ' ALA . . . -67.14 -21.19 65.84 Favored 'General case' 0 C--N 1.317 -0.807 0 O-C-N 122.371 -0.206 . . . . 0.0 111.081 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 1.004 ' HB3' ' CA ' ' A' ' 90' ' ' ALA . . . -70.73 -42.14 70.94 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-O 121.282 0.563 . . . . 0.0 111.013 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 1.014 HG12 ' CB ' ' A' ' 91' ' ' VAL . 5.5 t -62.67 -46.06 97.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 CA-C-O 121.702 0.763 . . . . 0.0 111.725 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 1.562 ' HG ' ' CB ' ' A' ' 92' ' ' SER . 0.7 OUTLIER -61.37 -24.65 66.64 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.177 0.513 . . . . 0.0 110.267 178.954 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.987 ' HB1' ' CA ' ' A' ' 93' ' ' ALA . . . -64.51 -47.81 77.5 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-O 121.809 0.814 . . . . 0.0 110.948 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 1.507 ' CZ ' ' CD1' ' A' ' 94' ' ' TYR . 12.3 m-85 -58.17 -28.33 64.66 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-O 122.211 1.005 . . . . 0.0 110.829 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 1.531 ' HG2' ' CB ' ' A' ' 95' ' ' GLN . 0.0 OUTLIER -74.13 -38.11 63.89 Favored 'General case' 0 C--N 1.286 -2.188 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.523 179.91 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 1.484 HE21 ' CD ' ' A' ' 96' ' ' GLN . 7.6 pt20 -84.74 -12.44 53.75 Favored 'General case' 0 C--O 1.16 -3.634 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.263 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.455 ' O ' ' HA ' ' A' ' 77' ' ' PRO . . . 131.51 20.14 1.13 Allowed Glycine 2 C--O 0.905 -20.412 1 CA-C-O 128.143 4.19 . . . . 0.0 116.333 179.562 . . . . . . . . 4 3 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.998 ' HB1' ' CA ' ' A' ' 98' ' ' ALA . . . -77.62 145.55 36.69 Favored 'General case' 1 C--N 1.022 -13.635 3 O-C-N 102.124 -12.398 . . . . 0.0 110.88 179.427 . . . . . . . . 4 3 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.509 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 17.8 t80 -77.5 -53.7 7.3 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.707 -0.224 . . . . 0.0 111.433 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 1.14 ' CG ' ' CA ' ' A' ' 100' ' ' ASP . 2.9 t0 173.07 -167.3 0.03 OUTLIER 'General case' 0 C--O 1.221 -0.43 0 CA-C-O 120.882 0.372 . . . . 0.0 111.654 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.418 ' CD2' ' HB ' ' A' ' 80' ' ' ILE . 4.3 m-85 -132.42 152.82 51.33 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.365 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 1.174 HD13 ' CG ' ' A' ' 102' ' ' LEU . 0.9 OUTLIER -103.17 124.29 38.88 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-O 121.25 0.548 . . . . 0.0 110.903 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -68.19 -84.64 0.01 OUTLIER 'Trans proline' 1 C--O 1.101 -6.348 0 C-N-CA 122.104 1.869 . . . . 0.0 113.151 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 1.598 ' HD3' ' CE ' ' A' ' 104' ' ' LYS . 14.1 mttt -106.62 -58.03 0.06 OUTLIER Pre-proline 1 C--N 1.184 -6.62 1 O-C-N 115.977 -4.202 . . . . 0.0 111.964 -179.604 . . . . . . . . 4 3 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -57.49 160.29 14.38 Favored 'Trans proline' 0 CA--C 1.508 -0.81 0 C-N-CA 122.342 2.028 . . . . 0.0 112.748 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 1.319 ' HE2' ' CE1' ' A' ' 106' ' ' PHE . 3.0 t80 -166.73 -105.57 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.859 0 O-C-N 123.463 0.477 . . . . 0.0 111.131 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.564 ' O ' ' O ' ' A' ' 106' ' ' PHE . 2.9 p30 42.49 -179.44 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.861 0.362 . . . . 0.0 111.375 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 1.071 HD13 ' CG1' ' A' ' 108' ' ' ILE . 0.9 OUTLIER -67.63 -42.85 86.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.071 0.462 . . . . 0.0 111.594 -179.848 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 1.408 ' OD1' ' CB ' ' A' ' 109' ' ' ASP . 0.2 OUTLIER -49.76 -57.84 6.53 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.61 -179.407 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 1.097 ' OE1' ' CG ' ' A' ' 110' ' ' GLU . 5.2 mm-40 -76.99 -31.97 56.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.574 0.226 . . . . 0.0 111.542 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.4 ' CB ' ' O ' ' A' ' 107' ' ' ASP . . . -67.62 -59.52 3.28 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.845 0.355 . . . . 0.0 110.171 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.983 HG12 ' CB ' ' A' ' 112' ' ' VAL . 48.2 t -59.3 -31.44 46.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.423 0.63 . . . . 0.0 110.473 178.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.98 ' HB2' ' CB ' ' A' ' 113' ' ' ALA . . . -63.43 -46.36 86.65 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.067 179.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 1.042 HD13 ' CG ' ' A' ' 114' ' ' LEU . 29.4 tp -75.37 -22.4 57.55 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.992 -1.004 . . . . 0.0 111.802 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.995 HG13 ' CB ' ' A' ' 115' ' ' VAL . 4.2 p -79.26 -43.78 23.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.641 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 1.129 ' OE2' ' CG ' ' A' ' 116' ' ' GLU . 48.9 mt-10 -65.05 -44.69 88.22 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.949 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 1.514 ' CB ' ' CD ' ' A' ' 117' ' ' ARG . 0.0 OUTLIER -61.07 -24.73 66.44 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.859 179.772 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.509 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -71.27 -45.81 62.32 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.954 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 1.011 HD12 ' CG1' ' A' ' 119' ' ' ILE . 4.7 mt -69.67 -31.57 49.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.257 0.551 . . . . 0.0 111.034 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 1.495 ' HG ' ' CB ' ' A' ' 120' ' ' SER . 4.4 t -70.33 -47.38 61.32 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.32 -0.854 . . . . 0.0 111.086 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 19.4 m80 . . . . . 0 C--N 1.314 -0.964 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.059 -179.834 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.416 ' HB3' ' CD1' ' A' ' 5' ' ' ILE . 0.1 OUTLIER . . . . . 0 CA--C 1.531 0.216 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 52.06 78.72 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.795 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.416 ' CD1' ' HB3' ' A' ' 3' ' ' ARG . 3.6 mp -110.88 112.35 40.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.75 0.31 . . . . 0.0 110.831 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.552 ' O ' ' HA ' ' A' ' 30' ' ' CYS . 7.2 p -107.59 123.43 62.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.7 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.522 ' HB2' ' HG3' ' A' ' 48' ' ' PRO . 30.7 m0 -114.35 131.71 56.45 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.995 0.426 . . . . 0.0 110.924 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.3 OUTLIER -113.95 146.88 17.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.909 -179.588 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.65 HG12 ' HA2' ' A' ' 36' ' ' GLY . 0.0 OUTLIER -130.42 105.89 12.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.951 0.405 . . . . 0.0 110.099 179.377 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.427 ' C ' ' H ' ' A' ' 12' ' ' ASP . 1.0 OUTLIER -161.33 -155.14 0.39 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.822 -179.068 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -69.58 12.15 0.21 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.427 ' H ' ' C ' ' A' ' 10' ' ' ASP . 2.7 p30 46.94 -152.4 0.08 Allowed 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.4 t 38.02 -91.51 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.9 t -54.87 -60.15 3.76 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.727 0.299 . . . . 0.0 110.785 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.4 mm -63.28 -24.46 35.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.727 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.548 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 0.0 OUTLIER -71.57 -55.16 8.34 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.618 -179.598 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.414 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 86.3 t90 -61.15 -41.49 96.84 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -179.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.412 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 6.3 t -65.35 -44.56 94.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -178.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.412 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 26.5 mt -83.8 -25.68 30.21 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -178.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.571 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 18.8 pt-20 -67.7 -57.96 5.46 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -179.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.509 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 1.9 mmt-85 -65.47 -47.78 74.91 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.857 -0.611 . . . . 0.0 112.044 -178.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' A' ' 18' ' ' VAL . . . -54.41 -60.08 3.82 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 120.901 0.381 . . . . 0.0 111.317 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.49 ' CD2' ' CD1' ' A' ' 28' ' ' LEU . 3.3 mt -63.25 -29.14 70.53 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.01 179.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.26 -36.1 82.53 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.7 -24.9 71.48 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.247 -0.978 . . . . 0.0 111.086 178.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.404 ' CB ' HD11 ' A' ' 28' ' ' LEU . . . -77.48 -15.52 59.26 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 120.6 0.238 . . . . 0.0 111.241 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.5 25.88 8.46 Favored Glycine 0 CA--C 1.522 0.505 0 C-N-CA 120.791 -0.719 . . . . 0.0 113.887 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.49 ' CD1' ' CD2' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -124.64 171.13 10.3 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 117.691 0.745 . . . . 0.0 111.996 -179.83 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 32.4 m -99.12 106.45 18.66 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.371 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.571 ' HB3' ' HA ' ' A' ' 20' ' ' GLU . 48.7 t -103.15 113.39 26.82 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -178.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.498 ' CG2' ' CD1' ' A' ' 7' ' ' TRP . 2.6 t -120.73 149.04 43.14 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.548 ' CG2' ' HA ' ' A' ' 16' ' ' ARG . 32.7 p -119.8 166.12 13.68 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.318 0.58 . . . . 0.0 112.336 -178.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.653 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 3.9 m-85 -135.6 173.92 11.19 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.414 -178.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.635 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 2.6 pp20? -62.08 -43.21 99.34 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -177.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -166.07 -62.99 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.65 ' HA2' HG12 ' A' ' 9' ' ' VAL . . . -157.73 -48.87 0.01 OUTLIER Glycine 0 C--N 1.318 -0.466 0 C-N-CA 120.517 -0.849 . . . . 0.0 113.429 -178.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.717 ' HA ' HD12 ' A' ' 40' ' ' LEU . 0.4 OUTLIER -60.85 -24.51 65.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.975 0.417 . . . . 0.0 111.435 -179.072 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.653 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -60.25 -59.02 6.08 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.262 -179.866 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.66 HG11 ' HG ' ' A' ' 43' ' ' LEU . 4.7 t -52.49 -35.35 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 C-N-CA 120.431 -0.508 . . . . 0.0 111.135 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.717 HD12 ' HA ' ' A' ' 37' ' ' ASN . 19.5 mt -56.02 -42.37 76.37 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.03 0.443 . . . . 0.0 110.976 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.76 -47.47 21.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.2 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.16 -36.49 83.8 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.783 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.66 ' HG ' HG11 ' A' ' 39' ' ' VAL . 12.7 mt -59.81 -20.72 58.53 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.135 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.71 -16.79 52.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.501 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -120.68 -5.91 9.69 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -179.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.478 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.1 OUTLIER -162.9 160.77 25.33 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.865 0.364 . . . . 0.0 111.325 -179.746 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 96.5 m -138.61 115.08 8.86 Favored Pre-proline 0 N--CA 1.453 -0.302 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.535 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.522 ' HG3' ' HB2' ' A' ' 7' ' ' TRP . 65.9 Cg_endo -73.46 157.02 49.72 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.595 2.197 . . . . 0.0 111.471 178.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -77.0 -22.95 52.32 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.25 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.491 ' CG2' HD11 ' A' ' 79' ' ' ILE . 7.1 p -150.7 98.19 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-O 120.783 0.325 . . . . 0.0 111.46 -179.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.459 ' HB3' ' O ' ' A' ' 77' ' ' PRO . 29.1 tp -86.63 138.27 31.81 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.893 0.377 . . . . 0.0 111.435 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.526 ' O ' HG21 ' A' ' 9' ' ' VAL . 0.4 OUTLIER -123.29 113.93 19.53 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.663 179.49 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.429 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -116.54 154.6 30.14 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.322 0.582 . . . . 0.0 112.132 -179.384 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.1 p30 -83.39 -169.7 2.68 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.738 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.626 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 0.9 OUTLIER -158.15 65.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.15 0.5 . . . . 0.0 111.307 178.988 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 29.4 ptt180 -177.18 65.07 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.232 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.58 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . 2.2 tpt -161.97 -64.44 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.696 179.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.58 ' HD3' ' HB3' ' A' ' 57' ' ' MET . 42.0 Cg_endo -65.99 -173.15 0.31 Allowed 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.265 1.977 . . . . 0.0 112.913 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.95 -67.03 2.41 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.233 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.558 ' O ' ' N ' ' A' ' 62' ' ' GLY . 0.0 OUTLIER -76.98 55.31 1.1 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.063 0.459 . . . . 0.0 110.344 179.457 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.461 ' O ' ' HD2' ' A' ' 58' ' ' PRO . 1.0 OUTLIER 42.41 -77.8 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.711 -179.739 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.716 ' O ' ' HG ' ' A' ' 65' ' ' LEU . . . -135.34 -30.6 0.34 Allowed Glycine 0 C--O 1.225 -0.419 0 C-N-CA 120.367 -0.92 . . . . 0.0 113.224 -179.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.582 HD11 ' HB3' ' A' ' 86' ' ' ASP . 0.2 OUTLIER -67.75 -12.54 60.77 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.619 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.5 ' HB1' ' HB2' ' A' ' 60' ' ' MET . . . -56.34 -56.79 16.79 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-O 121.056 0.455 . . . . 0.0 110.116 178.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.716 ' HG ' ' O ' ' A' ' 62' ' ' GLY . 3.1 pp -54.78 -42.3 71.58 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.498 179.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.54 ' HG ' HD11 ' A' ' 65' ' ' LEU . 28.8 mt -48.19 -52.62 20.05 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.005 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.751 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 34.5 tttp -54.58 -43.13 71.85 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.09 0.472 . . . . 0.0 110.711 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.685 ' HB2' HD13 ' A' ' 40' ' ' LEU . 34.4 mm-40 -64.75 -28.4 69.55 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.615 179.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.494 HD12 HD13 ' A' ' 65' ' ' LEU . 96.2 mt -63.83 -40.45 89.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.726 -179.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.751 ' HG2' ' O ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -75.22 -25.38 58.11 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.893 -179.187 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.22 -50.8 70.31 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.209 -0.45 . . . . 0.0 112.175 -179.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 14.2 mtt-85 -96.26 -45.32 6.88 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -178.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.493 ' NE2' HD11 ' A' ' 43' ' ' LEU . 1.8 m-70 -91.41 130.3 40.01 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.198 -178.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_exo -56.76 -70.77 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.54 2.16 . . . . 0.0 113.099 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.7 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 2.1 mpt? -133.74 46.88 2.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.932 0.396 . . . . 0.0 111.412 -179.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.482 HD21 ' HD2' ' A' ' 48' ' ' PRO . 2.8 tm? -64.31 110.61 4.15 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.53 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.459 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 38.0 Cg_exo -58.49 131.58 43.46 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.624 2.216 . . . . 0.0 112.168 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.614 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 2.8 t -131.34 151.93 36.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.107 0.479 . . . . 0.0 111.431 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.491 HD11 ' CG2' ' A' ' 50' ' ' VAL . 4.0 mt -134.08 115.58 21.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.952 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.532 ' CG2' ' HB ' ' A' ' 55' ' ' ILE . 26.4 mm -93.68 141.95 14.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.525 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 7.7 ptm -71.99 -35.44 69.49 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -178.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.546 ' H ' HG23 ' A' ' 55' ' ' ILE . 4.1 m -147.31 149.4 32.76 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -179.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -108.64 83.31 1.75 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.798 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.421 ' CE1' HG23 ' A' ' 82' ' ' THR . 14.0 m-70 -66.87 -159.34 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.669 -179.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.457 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 0.4 OUTLIER -80.46 78.98 7.13 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-O 121.079 0.466 . . . . 0.0 112.152 -178.455 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.582 ' HB3' HD11 ' A' ' 63' ' ' LEU . 13.7 t70 175.74 26.6 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.777 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 13.3 mt -45.73 -22.96 0.21 Allowed 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -47.98 -46.9 33.14 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.61 0.243 . . . . 0.0 111.325 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.495 ' HB2' ' CB ' ' A' ' 63' ' ' LEU . . . -74.05 -22.04 59.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.334 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.483 ' HB2' ' CD2' ' A' ' 63' ' ' LEU . . . -65.41 -40.89 93.94 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.182 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.618 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 6.6 t -65.26 -40.06 87.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.933 -179.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.454 ' O ' ' HG3' ' A' ' 95' ' ' GLN . 19.5 m -63.42 -16.49 60.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.124 0.488 . . . . 0.0 109.903 178.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.768 ' O ' ' HG3' ' A' ' 96' ' ' GLN . . . -75.94 -55.01 6.02 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 121.503 0.668 . . . . 0.0 111.062 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.618 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 3.6 m-85 -57.38 -34.69 69.11 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.291 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.454 ' HG3' ' O ' ' A' ' 92' ' ' SER . 2.3 pp0? -77.19 -35.2 55.97 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.119 -179.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.768 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 1.9 pp0? -77.65 -18.41 56.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.096 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 147.37 -27.61 1.52 Allowed Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.987 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.614 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -41.95 152.7 0.07 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.563 0.181 . . . . 0.0 111.378 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.515 ' O ' ' HB2' ' A' ' 100' ' ' ASP . 59.6 t80 -85.63 -53.58 5.07 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 121.084 -0.246 . . . . 0.0 111.544 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.515 ' HB2' ' O ' ' A' ' 99' ' ' PHE . 1.0 OUTLIER 170.79 -176.19 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.009 0.433 . . . . 0.0 111.243 -179.717 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.531 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 3.9 m-85 -112.04 152.71 27.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.333 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.614 HD22 ' O ' ' A' ' 105' ' ' PRO . 6.5 tp -104.64 139.62 20.28 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.09 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -66.51 -164.29 0.08 OUTLIER 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.779 2.32 . . . . 0.0 113.1 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.471 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 85.6 mttt -46.37 -59.71 4.61 Favored Pre-proline 0 CA--C 1.533 0.315 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.779 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.614 ' O ' HD22 ' A' ' 102' ' ' LEU . 8.4 Cg_endo -50.74 164.4 0.57 Allowed 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.699 2.266 . . . . 0.0 112.157 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.624 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 86.7 t80 -162.16 -99.93 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.665 -0.243 . . . . 0.0 110.914 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.586 ' O ' ' O ' ' A' ' 106' ' ' PHE . 2.9 p-10 40.06 -177.2 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.977 0.418 . . . . 0.0 111.562 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.418 HG22 HG22 ' A' ' 112' ' ' VAL . 0.8 OUTLIER -67.76 -43.52 86.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.106 0.479 . . . . 0.0 111.024 179.474 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.524 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 8.1 t70 -49.42 -59.07 4.06 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.896 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.624 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 21.4 mm-40 -76.95 -27.51 54.83 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 111.841 0.312 . . . . 0.0 111.841 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.407 ' CB ' ' O ' ' A' ' 107' ' ' ASP . . . -71.01 -59.59 2.7 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 179.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.692 ' O ' HG12 ' A' ' 115' ' ' VAL . 53.6 t -59.61 -30.67 45.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.348 0.595 . . . . 0.0 110.271 178.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.524 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -63.61 -46.3 86.41 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.928 179.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.422 ' HA ' ' HG2' ' A' ' 117' ' ' ARG . 53.8 tp -74.86 -23.16 58.38 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.695 -179.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.692 HG12 ' O ' ' A' ' 112' ' ' VAL . 2.8 p -79.53 -42.38 22.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.997 -0.281 . . . . 0.0 111.547 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.563 ' HA ' HD13 ' A' ' 119' ' ' ILE . 47.6 mt-10 -63.71 -43.6 96.08 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.088 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.422 ' HG2' ' HA ' ' A' ' 114' ' ' LEU . 0.4 OUTLIER -64.35 -23.97 67.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.862 0.363 . . . . 0.0 110.739 179.638 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.449 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -71.35 -45.12 63.71 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.835 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.563 HD13 ' HA ' ' A' ' 116' ' ' GLU . 6.4 mt -62.71 -31.66 52.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.217 0.532 . . . . 0.0 110.709 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 9.2 m -71.19 -54.85 9.55 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.87 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 1.7 m80 . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.912 179.983 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 3' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.979 0.419 . . . . 0.0 111.173 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -82.64 86.03 1.48 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.557 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.6 mm -111.81 112.76 41.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.864 0.364 . . . . 0.0 111.157 -179.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.564 ' CG1' HD22 ' A' ' 23' ' ' LEU . 7.3 p -108.77 124.87 65.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.902 0.382 . . . . 0.0 110.521 179.205 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.552 ' NE1' HG22 ' A' ' 31' ' ' THR . 22.5 m0 -115.17 135.87 53.72 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.965 0.412 . . . . 0.0 110.637 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.742 ' O ' ' HA ' ' A' ' 32' ' ' THR . 1.3 t -126.22 146.04 32.69 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.332 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.431 -178.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.454 ' CG2' ' CG2' ' A' ' 39' ' ' VAL . 45.2 t -120.6 112.62 36.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 177.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -161.65 -158.21 0.54 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.96 -178.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -76.31 19.25 0.25 Allowed 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.506 ' HA ' ' HG1' ' A' ' 32' ' ' THR . 2.6 p30 46.25 -156.2 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 179.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.433 ' OG ' ' N ' ' A' ' 14' ' ' SER . 76.7 p 35.83 -95.09 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.433 ' N ' ' OG ' ' A' ' 13' ' ' SER . 0.3 OUTLIER -52.77 -62.04 1.91 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.911 -178.969 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 18.4 mm -63.93 -23.88 34.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.977 0.418 . . . . 0.0 111.063 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.483 ' HG3' ' OG1' ' A' ' 32' ' ' THR . 3.0 ttt-85 -75.95 -50.84 13.81 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.906 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.447 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 44.8 t90 -58.91 -37.41 76.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.188 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.425 ' CG1' HG12 ' A' ' 108' ' ' ILE . 11.2 t -69.39 -43.92 80.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.3 tp -84.03 -27.34 28.42 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.416 -178.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.65 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 12.8 pt-20 -67.82 -60.98 2.1 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.624 -0.431 . . . . 0.0 111.845 -179.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.457 ' N ' ' CG ' ' A' ' 20' ' ' GLU . 3.9 mmt-85 -59.65 -52.19 66.59 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.805 -179.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.07 -52.36 64.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.982 0.42 . . . . 0.0 111.316 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.739 HD13 ' CD1' ' A' ' 28' ' ' LEU . 1.8 tp -68.06 -24.98 65.13 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.342 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.444 ' HB1' ' O ' ' A' ' 20' ' ' GLU . . . -68.13 -35.61 78.38 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.229 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.87 -25.98 68.35 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.411 -0.9 . . . . 0.0 111.244 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.15 -15.78 59.39 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 120.675 0.274 . . . . 0.0 111.07 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.96 26.59 8.33 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.457 -0.878 . . . . 0.0 114.28 178.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.739 ' CD1' HD13 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -126.51 170.85 11.59 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 117.938 0.869 . . . . 0.0 111.897 -179.913 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.477 ' O ' HG11 ' A' ' 6' ' ' VAL . 35.2 m -99.8 104.95 16.67 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.091 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.65 ' HB3' ' HA ' ' A' ' 20' ' ' GLU . 51.5 t -100.1 111.52 23.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.582 -179.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.552 HG22 ' NE1' ' A' ' 7' ' ' TRP . 2.6 t -124.06 147.39 47.9 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.742 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 65.7 p -116.95 166.11 12.55 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -178.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.849 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 5.0 m-85 -135.66 170.3 16.18 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.002 -178.039 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.897 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 2.1 pp20? -68.96 -54.13 16.99 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -179.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.437 ' HB2' ' OE2' ' A' ' 34' ' ' GLU . 14.0 m120 -155.81 -178.65 7.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.898 0.38 . . . . 0.0 110.8 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.528 ' O ' ' HG ' ' A' ' 40' ' ' LEU . . . -50.98 -16.39 1.81 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.89 -0.671 . . . . 0.0 114.1 -178.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.474 ' HA ' HD12 ' A' ' 40' ' ' LEU . 0.4 OUTLIER -85.54 -36.33 20.54 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 117.766 0.783 . . . . 0.0 112.131 -179.262 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.897 ' HB2' ' HG3' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -55.37 -62.07 1.92 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -178.444 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.606 HG11 HD11 ' A' ' 51' ' ' LEU . 48.6 t -49.06 -32.23 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.999 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.528 ' HG ' ' O ' ' A' ' 36' ' ' GLY . 30.5 mt -59.9 -41.03 90.77 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.031 0.443 . . . . 0.0 110.209 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.53 -48.32 78.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.185 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.11 -29.65 64.29 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.829 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.625 ' HB3' ' CE1' ' A' ' 73' ' ' HIS . 5.9 mt -61.51 -33.52 73.94 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.017 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.56 -19.45 15.85 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.617 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.8 m -125.47 2.58 7.67 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.476 ' HD2' ' CZ2' ' A' ' 7' ' ' TRP . 0.1 OUTLIER -161.9 166.18 26.6 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 120.832 0.349 . . . . 0.0 111.165 179.966 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 85.1 m -138.41 114.78 8.96 Favored Pre-proline 0 N--CA 1.453 -0.289 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.999 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.47 ' HB3' ' CG ' ' A' ' 7' ' ' TRP . 61.2 Cg_endo -71.09 148.16 55.89 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.283 1.989 . . . . 0.0 111.886 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -74.21 -30.34 62.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.758 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.438 HG13 ' CG1' ' A' ' 119' ' ' ILE . 7.3 p -146.88 101.36 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.841 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.606 HD11 HG11 ' A' ' 39' ' ' VAL . 13.8 tp -85.46 125.6 33.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.08 0.467 . . . . 0.0 111.343 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.591 ' O ' ' HA ' ' A' ' 8' ' ' VAL . 1.2 tt -120.64 120.26 35.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.823 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.532 ' HB2' HD23 ' A' ' 65' ' ' LEU . 8.1 t -118.38 130.2 55.86 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.067 0.461 . . . . 0.0 111.106 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.401 ' HA ' ' HG2' ' A' ' 81' ' ' MET . 24.5 t70 -83.24 15.19 3.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.805 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.676 HG13 ' O ' ' A' ' 61' ' ' ASP . 3.5 tt 33.51 93.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 120.766 0.317 . . . . 0.0 111.813 -179.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.9 tpt180 -104.7 34.1 3.3 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.356 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.531 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER 53.14 47.35 4.04 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.674 179.08 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.732 ' HD2' ' O ' ' A' ' 61' ' ' ASP . 21.0 Cg_endo -61.26 -74.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.096 1.864 . . . . 0.0 111.272 178.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -117.01 -80.94 0.81 Allowed Glycine 0 C--N 1.332 0.306 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 178.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.563 ' O ' ' N ' ' A' ' 62' ' ' GLY . 0.0 OUTLIER -85.6 56.27 3.89 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 177.781 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.732 ' O ' ' HD2' ' A' ' 58' ' ' PRO . 4.1 p30 55.92 -62.88 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.224 -0.898 . . . . 0.0 112.106 -178.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 60' ' ' MET . . . -155.47 -35.97 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 121.147 -0.549 . . . . 0.0 112.276 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.734 ' HA ' HD13 ' A' ' 66' ' ' LEU . 0.3 OUTLIER -61.38 -22.0 64.57 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.73 0.3 . . . . 0.0 111.085 -179.802 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.414 ' HB3' ' HB2' ' A' ' 60' ' ' MET . . . -54.91 -42.76 72.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.092 0.473 . . . . 0.0 111.135 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.703 ' HG ' HD13 ' A' ' 69' ' ' ILE . 7.4 tp -52.96 -43.85 66.69 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.252 -179.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.734 HD13 ' HA ' ' A' ' 63' ' ' LEU . 2.9 mt -59.93 -43.83 94.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.912 0.387 . . . . 0.0 110.862 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.413 ' HG3' ' HE3' ' A' ' 70' ' ' LYS . 4.1 tttt -53.07 -54.92 28.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.775 -179.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 66.2 mm-40 -61.18 -44.66 96.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.911 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.703 HD13 ' HG ' ' A' ' 65' ' ' LEU . 22.7 mt -56.92 -54.18 33.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.287 0.565 . . . . 0.0 111.409 -178.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.449 ' HB3' ' CB ' ' A' ' 96' ' ' GLN . 11.0 pttt -57.45 -23.7 51.32 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.496 -179.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.65 -51.96 50.32 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.722 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 75.0 mtt-85 -100.37 -7.19 24.68 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.379 -178.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.625 ' CE1' ' HB3' ' A' ' 43' ' ' LEU . 71.6 m-70 -125.52 139.09 33.14 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-O 120.896 0.379 . . . . 0.0 112.015 -179.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -68.86 -62.33 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.95 2.433 . . . . 0.0 113.417 -179.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.722 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 1.8 mtt -136.06 49.0 2.14 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.574 ' HB3' HG22 ' A' ' 69' ' ' ILE . 0.9 OUTLIER -68.26 108.49 2.85 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.014 178.916 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.507 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 18.1 Cg_endo -59.42 132.32 45.6 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.419 2.079 . . . . 0.0 112.336 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.415 HG12 HD12 ' A' ' 80' ' ' ILE . 3.3 t -129.48 136.24 59.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.738 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.443 ' CG2' HD22 ' A' ' 114' ' ' LEU . 1.9 mt -127.61 110.89 23.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.934 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.607 HG13 ' CZ ' ' A' ' 101' ' ' TYR . 15.2 mm -99.79 147.53 7.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.538 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.485 ' HG3' ' N ' ' A' ' 82' ' ' THR . 0.3 OUTLIER -81.66 -34.58 30.69 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.261 -179.767 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.485 ' N ' ' HG3' ' A' ' 81' ' ' MET . 21.6 m -133.79 148.28 51.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.517 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.534 ' HA ' ' CE2' ' A' ' 101' ' ' TYR . . . -99.94 -25.82 14.2 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.41 ' CE1' HG22 ' A' ' 82' ' ' THR . 3.3 m-70 46.77 -158.87 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.764 -0.198 . . . . 0.0 110.913 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 94.0 p -80.25 175.44 10.64 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.977 0.417 . . . . 0.0 111.469 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.433 ' O ' HD23 ' A' ' 63' ' ' LEU . 0.7 OUTLIER 62.89 32.46 15.72 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.989 -179.897 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.576 ' HA ' HD23 ' A' ' 63' ' ' LEU . 1.9 mt -49.05 -21.66 0.75 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.414 -179.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -48.39 -41.36 28.75 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.806 0.298 . . . . 0.0 111.806 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.16 -23.79 66.53 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.594 ' HB3' HD21 ' A' ' 63' ' ' LEU . . . -77.3 -26.86 52.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.819 0.342 . . . . 0.0 110.726 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.513 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 6.3 t -68.22 -39.21 80.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.936 0.398 . . . . 0.0 110.073 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 30.9 m -68.55 -20.54 64.55 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.742 178.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.635 ' HB2' ' CB ' ' A' ' 98' ' ' ALA . . . -67.41 -42.99 82.33 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.668 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.513 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 12.5 m-85 -62.39 -25.79 68.12 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.18 -41.13 42.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.282 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.722 ' O ' ' HA ' ' A' ' 75' ' ' MET . 0.0 OUTLIER -76.06 -16.91 59.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.206 -179.876 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 119.16 17.63 4.87 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.461 -0.876 . . . . 0.0 113.652 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.635 ' CB ' ' HB2' ' A' ' 93' ' ' ALA . . . -64.43 165.05 10.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 117.141 0.47 . . . . 0.0 110.811 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.482 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 13.9 t80 -87.16 -54.42 4.32 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.456 ' HB3' ' O ' ' A' ' 99' ' ' PHE . 9.5 p30 167.77 -164.55 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.782 0.325 . . . . 0.0 110.887 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.607 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 5.6 m-85 -138.63 153.19 48.6 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.755 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.695 HD13 HD23 ' A' ' 114' ' ' LEU . 0.8 OUTLIER -103.25 122.34 45.57 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.074 179.863 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -70.13 -69.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.078 1.852 . . . . 0.0 112.501 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.595 ' H ' ' HD2' ' A' ' 105' ' ' PRO . 0.9 OUTLIER -119.07 -60.42 0.03 OUTLIER Pre-proline 0 CA--C 1.533 0.301 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.901 -179.637 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.595 ' HD2' ' H ' ' A' ' 104' ' ' LYS . 11.7 Cg_endo -54.12 160.53 6.17 Favored 'Trans proline' 0 C--N 1.35 0.605 0 C-N-CA 122.214 1.943 . . . . 0.0 112.513 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.632 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 50.5 t80 -170.8 -102.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.551 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.628 ' O ' ' HB1' ' A' ' 111' ' ' ALA . 2.3 p-10 43.26 178.46 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.558 0.218 . . . . 0.0 111.052 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.425 HG12 ' CG1' ' A' ' 18' ' ' VAL . 0.8 OUTLIER -67.82 -44.13 85.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.231 0.539 . . . . 0.0 111.217 179.852 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.586 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 1.5 t70 -49.42 -58.78 4.52 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.703 -179.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.632 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 6.4 mm-40 -74.17 -30.41 62.23 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 111.771 0.285 . . . . 0.0 111.771 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.628 ' HB1' ' O ' ' A' ' 107' ' ' ASP . . . -68.76 -62.05 1.55 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.817 0.341 . . . . 0.0 110.331 179.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.628 ' O ' HG12 ' A' ' 115' ' ' VAL . 44.0 t -57.84 -31.56 40.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.477 0.656 . . . . 0.0 110.716 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.586 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -64.0 -44.3 93.06 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.848 179.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.726 ' HA ' ' HD3' ' A' ' 117' ' ' ARG . 10.0 tp -78.33 -23.01 47.23 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.778 -179.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.628 HG12 ' O ' ' A' ' 112' ' ' VAL . 4.8 p -79.45 -41.77 22.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.026 0.441 . . . . 0.0 111.47 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -59.65 -47.76 84.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.274 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.726 ' HD3' ' HA ' ' A' ' 114' ' ' LEU . 0.8 OUTLIER -59.24 -23.96 62.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.44 -179.531 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.482 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -71.03 -39.34 72.39 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.105 0.478 . . . . 0.0 111.0 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.502 HD13 HD21 ' A' ' 28' ' ' LEU . 4.6 mt -76.95 -30.95 18.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.728 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.4 t -67.44 -41.15 85.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.602 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 17.5 m80 . . . . . 0 C--O 1.233 0.198 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.979 179.992 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.453 -0.288 0 CA-C-O 120.905 0.383 . . . . 0.0 111.079 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.435 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . 53.65 82.76 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.536 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.8 mp -108.4 112.38 40.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.713 0.292 . . . . 0.0 111.545 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.562 HG11 ' O ' ' A' ' 29' ' ' THR . 7.5 p -106.64 123.37 61.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.974 0.416 . . . . 0.0 110.911 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.538 ' NE1' HG21 ' A' ' 31' ' ' THR . 28.6 m0 -114.53 136.94 52.47 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.363 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.531 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.0 OUTLIER -129.68 141.49 46.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.478 -178.408 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.765 HG13 ' N ' ' A' ' 36' ' ' GLY . 0.2 OUTLIER -119.45 104.83 16.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 178.673 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.554 ' HB3' HG13 ' A' ' 15' ' ' ILE . 8.3 t0 -172.42 114.98 0.31 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.387 0.613 . . . . 0.0 111.401 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.659 ' O ' ' HB2' ' A' ' 12' ' ' ASP . 0.4 OUTLIER 49.75 -87.46 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.761 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.659 ' HB2' ' O ' ' A' ' 11' ' ' ASP . 22.9 t0 168.01 -125.72 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.51 0 O-C-N 123.041 0.213 . . . . 0.0 110.842 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.467 ' HA ' ' HB3' ' A' ' 16' ' ' ARG . 72.7 m -41.36 -43.58 2.54 Favored 'General case' 0 C--N 1.342 0.275 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.0 m -52.9 -62.4 1.67 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.65 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.554 HG13 ' HB3' ' A' ' 10' ' ' ASP . 21.8 mm -72.33 -20.08 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.617 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.73 ' HG2' ' HG3' ' A' ' 20' ' ' GLU . 3.0 tmm_? -72.38 -30.97 65.16 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-O 121.529 0.681 . . . . 0.0 110.244 178.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.624 ' O ' ' HB2' ' A' ' 21' ' ' ARG . 41.2 t90 -72.16 -58.07 3.73 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.886 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.503 HG12 HG12 ' A' ' 108' ' ' ILE . 0.8 OUTLIER -60.68 -62.24 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 -177.467 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.511 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -68.81 -49.52 57.84 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 114.29 1.218 . . . . 0.0 114.29 -176.818 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.73 ' HG3' ' HG2' ' A' ' 16' ' ' ARG . 1.5 mm-40 -67.87 -61.23 1.97 Allowed 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -177.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.624 ' HB2' ' O ' ' A' ' 17' ' ' TRP . 8.5 mmt180 -48.61 -44.22 36.92 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.327 -177.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.22 -28.6 62.26 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.878 0.37 . . . . 0.0 110.887 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.704 HD12 ' CD1' ' A' ' 28' ' ' LEU . 5.0 tp -80.93 -23.35 38.93 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.406 179.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' A' ' 20' ' ' GLU . . . -69.31 -35.14 75.68 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.87 -27.08 66.22 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.202 -0.999 . . . . 0.0 110.84 178.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.68 -15.86 58.89 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.623 0.249 . . . . 0.0 111.071 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.75 26.71 11.31 Favored Glycine 0 CA--C 1.522 0.47 0 C-N-CA 120.548 -0.834 . . . . 0.0 114.732 178.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.704 ' CD1' HD12 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -117.77 166.36 12.54 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 118.548 1.174 . . . . 0.0 112.007 -179.887 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.562 ' O ' HG11 ' A' ' 6' ' ' VAL . 88.5 m -84.73 104.66 14.89 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.776 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.504 ' HB2' ' HA ' ' A' ' 20' ' ' GLU . 2.8 p -106.29 109.31 21.2 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.956 -178.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.538 HG21 ' NE1' ' A' ' 7' ' ' TRP . 2.7 t -125.26 152.46 44.58 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.558 ' CG2' ' HA ' ' A' ' 16' ' ' ARG . 64.7 p -122.9 164.16 18.97 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.392 0.615 . . . . 0.0 112.597 -178.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.884 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 26.3 m-85 -135.93 172.95 12.26 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.025 -0.989 . . . . 0.0 112.033 -177.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.442 ' HG2' ' H ' ' A' ' 35' ' ' ASN . 5.3 pt-20 -63.26 -50.92 68.27 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.318 0.858 . . . . 0.0 113.318 -177.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.662 ' C ' HG13 ' A' ' 9' ' ' VAL . 10.5 m-20 -168.75 -26.06 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -179.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.765 ' N ' HG13 ' A' ' 9' ' ' VAL . . . 174.29 -61.62 0.12 Allowed Glycine 0 N--CA 1.453 -0.191 0 C-N-CA 120.115 -1.041 . . . . 0.0 113.029 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.771 ' HA ' HD12 ' A' ' 40' ' ' LEU . 0.5 OUTLIER -51.93 -28.38 16.3 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.69 0.281 . . . . 0.0 111.24 -179.536 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.884 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.7 OUTLIER -58.83 -58.34 9.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.67 179.245 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.656 HG23 HG11 ' A' ' 9' ' ' VAL . 7.7 t -50.74 -38.16 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 120.619 -0.433 . . . . 0.0 111.339 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.771 HD12 ' HA ' ' A' ' 37' ' ' ASN . 17.5 mt -53.81 -43.88 69.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.394 -179.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.89 -48.94 62.13 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.546 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.63 -35.28 78.63 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.37 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.648 ' HG ' HG11 ' A' ' 39' ' ' VAL . 14.2 mt -60.2 -26.31 66.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.076 0.465 . . . . 0.0 110.909 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.06 -20.46 25.01 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.302 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.3 m -123.08 4.67 9.28 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 112.146 0.425 . . . . 0.0 112.146 -179.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.522 ' HB3' ' CH2' ' A' ' 7' ' ' TRP . 0.0 OUTLIER -164.51 158.99 18.83 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.893 0.378 . . . . 0.0 111.273 -179.768 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.401 HG21 ' CD2' ' A' ' 76' ' ' LEU . 90.8 m -138.23 112.14 8.64 Favored Pre-proline 0 N--CA 1.452 -0.347 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.688 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.567 ' HD2' HD21 ' A' ' 76' ' ' LEU . 73.9 Cg_endo -73.58 156.21 49.57 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.703 2.268 . . . . 0.0 111.477 178.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -78.47 -22.92 46.8 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.174 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.454 ' CG2' HD12 ' A' ' 79' ' ' ILE . 7.3 p -150.58 96.66 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-O 120.663 0.268 . . . . 0.0 111.542 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.48 HD11 ' CB ' ' A' ' 7' ' ' TRP . 27.7 tp -87.09 145.8 26.31 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 121.123 0.487 . . . . 0.0 111.367 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.657 ' HG ' ' HB ' ' A' ' 79' ' ' ILE . 0.6 OUTLIER -131.36 114.18 14.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.323 179.637 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.672 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 35.3 t -115.32 144.52 43.64 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.62 0.724 . . . . 0.0 112.126 -179.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -83.14 168.36 16.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.395 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.545 HG13 ' O ' ' A' ' 61' ' ' ASP . 3.6 tt -142.58 87.6 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.721 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.5 ptm85 -118.51 36.22 4.48 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.541 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.657 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 1.2 ttt 64.46 46.3 0.59 Allowed Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.099 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.554 ' HD2' ' O ' ' A' ' 61' ' ' ASP . 27.0 Cg_endo -64.23 -74.81 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.024 1.816 . . . . 0.0 110.769 178.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -111.84 -85.58 1.53 Allowed Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 109.981 -1.247 . . . . 0.0 109.981 177.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.501 ' HB3' ' CB ' ' A' ' 64' ' ' ALA . 0.5 OUTLIER -87.72 58.65 5.0 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 177.408 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.657 ' HA ' ' HA ' ' A' ' 57' ' ' MET . 0.2 OUTLIER 62.54 -42.69 0.18 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.993 -179.5 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.467 ' HA3' HD12 ' A' ' 55' ' ' ILE . . . 171.31 -29.52 0.12 Allowed Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 111.494 -0.642 . . . . 0.0 111.494 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.579 HD21 ' N ' ' A' ' 90' ' ' ALA . 0.5 OUTLIER -72.46 -17.48 61.77 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 120.992 -0.283 . . . . 0.0 110.452 179.427 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.501 ' CB ' ' HB3' ' A' ' 60' ' ' MET . . . -53.94 -29.25 41.65 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 121.103 0.478 . . . . 0.0 110.54 178.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.497 HD12 ' HA3' ' A' ' 36' ' ' GLY . 1.4 mm? -66.77 -24.22 66.18 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.24 -179.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.48 HD12 ' O ' ' A' ' 89' ' ' ALA . 3.7 mt -77.73 -46.5 21.59 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.668 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 1.7 mtpt -46.09 -51.92 12.99 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.501 178.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.656 ' CB ' HD13 ' A' ' 40' ' ' LEU . 2.6 mp0 -64.42 -48.44 75.35 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.241 0.543 . . . . 0.0 110.335 178.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.519 ' HA ' ' CD2' ' A' ' 73' ' ' HIS . 4.2 mm -54.71 -39.05 45.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.665 -179.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.668 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -78.14 -30.58 49.34 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.199 -178.97 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.404 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -75.35 -40.93 57.69 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.825 -178.638 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.88 -46.31 9.52 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -179.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.528 ' CD2' HD11 ' A' ' 43' ' ' LEU . 1.2 m-70 -103.69 142.87 25.49 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.95 -178.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.29 -71.17 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.733 2.289 . . . . 0.0 113.272 -179.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 13.8 mtt -140.28 47.08 1.8 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.884 0.373 . . . . 0.0 110.805 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.567 HD21 ' HD2' ' A' ' 48' ' ' PRO . 3.1 tm? -59.31 110.31 2.6 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.684 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -63.02 116.51 3.62 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 123.086 2.524 . . . . 0.0 113.427 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.928 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 3.3 t -118.56 152.43 20.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.652 179.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.657 ' HB ' ' HG ' ' A' ' 52' ' ' LEU . 3.6 mt -132.25 114.28 23.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.548 -0.297 . . . . 0.0 110.572 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.672 ' HA ' ' O ' ' A' ' 53' ' ' SER . 11.6 mm -95.59 142.5 13.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.133 0.492 . . . . 0.0 111.788 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.453 ' CB ' ' CE1' ' A' ' 106' ' ' PHE . 2.8 ptt? -66.65 -28.74 68.71 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.308 -179.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.435 ' O ' HG22 ' A' ' 80' ' ' ILE . 5.0 m -147.07 167.78 23.21 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.43 0.157 . . . . 0.0 111.293 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.527 ' HB1' ' CD2' ' A' ' 101' ' ' TYR . . . -122.3 61.94 0.97 Allowed 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -179.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.406 ' CE1' HG22 ' A' ' 82' ' ' THR . 4.2 m-70 -73.16 162.87 28.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.824 0.345 . . . . 0.0 110.851 179.029 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.406 ' HB2' ' CB ' ' A' ' 61' ' ' ASP . 8.3 t 63.8 -167.41 0.21 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.124 0.488 . . . . 0.0 112.151 178.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.453 ' O ' HD22 ' A' ' 63' ' ' LEU . 16.6 p-10 -56.06 92.44 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.493 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.439 ' HG ' ' HB2' ' A' ' 83' ' ' ALA . 0.6 OUTLIER -47.76 -20.46 0.29 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.997 179.343 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -47.45 -45.98 26.28 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -178.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.48 ' O ' HD12 ' A' ' 66' ' ' LEU . . . -63.93 -25.73 68.27 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.786 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.579 ' N ' HD21 ' A' ' 63' ' ' LEU . . . -72.54 -48.79 37.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.768 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.637 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 3.4 t -63.48 -53.62 42.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.086 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 92.4 p -57.28 -23.94 51.65 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 178.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.575 ' C ' ' HB2' ' A' ' 98' ' ' ALA . . . -57.57 -53.77 54.37 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.438 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.677 ' CE1' ' HA ' ' A' ' 100' ' ' ASP . 5.9 m-85 -51.13 -33.16 25.41 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.764 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.91 -39.37 56.43 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.447 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.563 ' HB2' ' HB2' ' A' ' 70' ' ' LYS . 6.5 pt20 -94.39 5.8 50.67 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.063 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 93' ' ' ALA . . . 123.1 80.32 0.5 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.55 -0.834 . . . . 0.0 113.019 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.928 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -168.57 135.82 2.0 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.979 0.418 . . . . 0.0 111.27 179.185 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.471 ' HB3' HG12 ' A' ' 79' ' ' ILE . 38.5 t80 -75.84 -53.44 8.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.534 -179.354 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.677 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 1.0 OUTLIER 177.7 -172.84 0.12 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.177 0.513 . . . . 0.0 112.005 -179.535 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.527 ' CD2' ' HB1' ' A' ' 83' ' ' ALA . 3.2 m-85 -130.19 153.46 48.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.387 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.683 HD22 ' HA ' ' A' ' 106' ' ' PHE . 1.9 mp -103.97 118.38 57.3 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.62 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -73.24 -71.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 121.93 1.753 . . . . 0.0 111.895 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.596 ' H ' ' HD2' ' A' ' 105' ' ' PRO . 9.6 tttm -108.55 -58.66 0.05 OUTLIER Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.623 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.596 ' HD2' ' H ' ' A' ' 104' ' ' LYS . 15.6 Cg_endo -57.51 152.53 47.05 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.3 2.0 . . . . 0.0 113.014 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.683 ' HA ' HD22 ' A' ' 102' ' ' LEU . 14.9 t80 -163.22 -118.38 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.176 179.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.558 ' O ' ' O ' ' A' ' 106' ' ' PHE . 2.9 p30 42.5 -179.46 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 118.164 0.438 . . . . 0.0 111.486 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.503 HG12 HG12 ' A' ' 18' ' ' VAL . 1.0 OUTLIER -67.86 -40.92 84.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.516 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.496 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 30.8 t0 -49.18 -58.64 4.65 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.495 -179.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.537 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 74.9 mm-40 -77.87 -32.17 51.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.694 0.283 . . . . 0.0 111.371 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.409 ' CB ' ' O ' ' A' ' 107' ' ' ASP . . . -64.88 -62.5 1.52 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.931 0.396 . . . . 0.0 109.978 179.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.622 ' O ' HG13 ' A' ' 115' ' ' VAL . 47.0 t -58.4 -31.32 42.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.496 0.665 . . . . 0.0 110.802 179.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.505 ' O ' ' HG2' ' A' ' 117' ' ' ARG . . . -63.46 -45.97 88.38 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.196 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.499 HD23 HG21 ' A' ' 79' ' ' ILE . 5.5 tp -76.76 -22.47 53.74 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.786 -1.097 . . . . 0.0 112.169 -179.052 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.622 HG13 ' O ' ' A' ' 112' ' ' VAL . 4.7 p -79.28 -46.44 23.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.321 -0.552 . . . . 0.0 111.595 -179.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -64.35 -47.89 77.62 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.746 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.505 ' HG2' ' O ' ' A' ' 113' ' ' ALA . 2.8 ptp180 -60.46 -27.93 67.92 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.14 0.495 . . . . 0.0 110.404 179.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.436 ' HA ' ' CZ ' ' A' ' 99' ' ' PHE . . . -66.77 -47.02 73.47 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.792 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.429 ' CG1' HG12 ' A' ' 50' ' ' VAL . 4.4 mt -70.26 -30.69 44.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.689 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 10.5 t -66.72 -43.83 83.23 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.21 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 13.0 m80 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.147 -179.853 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.554 ' HG2' HD11 ' A' ' 5' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.469 0.492 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.42 ' C ' HD11 ' A' ' 5' ' ' ILE . . . 98.49 92.92 1.99 Allowed Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.242 179.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.554 HD11 ' HG2' ' A' ' 3' ' ' ARG . 5.0 mm -126.04 112.48 30.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.074 0.464 . . . . 0.0 111.754 -179.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.82 HG12 ' HA ' ' A' ' 30' ' ' CYS . 14.3 p -109.93 128.69 65.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.684 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.578 ' HB2' ' HG3' ' A' ' 48' ' ' PRO . 26.4 m0 -117.32 126.31 52.49 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.962 0.41 . . . . 0.0 110.112 179.09 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.593 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.5 OUTLIER -116.66 145.82 21.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.814 -178.105 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.937 HG11 ' HB2' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -124.52 111.1 27.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.919 0.39 . . . . 0.0 110.649 179.24 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -161.32 -159.15 0.62 Allowed 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.976 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -66.99 -0.64 3.29 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.474 ' O ' ' N ' ' A' ' 14' ' ' SER . 0.4 OUTLIER 68.08 -158.51 0.2 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 121.415 -0.114 . . . . 0.0 111.033 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 t 33.52 -86.46 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.474 ' N ' ' O ' ' A' ' 12' ' ' ASP . 37.6 t -54.21 -63.9 1.0 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.741 0.305 . . . . 0.0 111.324 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.0 mm -61.44 -28.15 43.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.012 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.494 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 2.7 ttm180 -73.29 -43.58 60.69 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.211 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 55.1 t90 -67.77 -40.75 84.0 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.965 -179.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.4 t -70.01 -39.27 77.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -178.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 16.2 mt -84.38 -27.72 27.47 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -178.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.595 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 24.5 pt-20 -67.44 -57.65 6.16 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.032 0.444 . . . . 0.0 111.655 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.453 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 0.7 OUTLIER -60.85 -52.49 64.85 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.937 -179.284 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.57 -43.85 84.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.866 0.365 . . . . 0.0 111.4 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.778 ' CD1' HG13 ' A' ' 6' ' ' VAL . 2.5 tm? -70.69 -31.78 68.79 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.331 0.586 . . . . 0.0 110.306 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.38 -34.22 77.67 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.16 -26.08 68.89 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.391 -0.909 . . . . 0.0 111.111 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.62 -15.56 59.13 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 120.751 0.31 . . . . 0.0 110.74 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.36 26.2 10.3 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.822 -0.704 . . . . 0.0 113.903 179.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.531 ' HB2' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -133.37 171.28 14.27 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 117.752 0.776 . . . . 0.0 111.902 179.705 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.486 ' O ' HG12 ' A' ' 6' ' ' VAL . 16.0 m -94.13 128.22 40.42 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.95 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.82 ' HA ' HG12 ' A' ' 6' ' ' VAL . 50.9 t -121.96 113.65 19.89 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 121.331 0.586 . . . . 0.0 111.477 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.523 HG23 ' CE1' ' A' ' 33' ' ' PHE . 2.7 t -117.8 151.86 36.49 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.594 178.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.593 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 40.2 p -124.35 164.46 19.58 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.219 0.533 . . . . 0.0 111.773 -179.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.937 ' HB2' HG11 ' A' ' 9' ' ' VAL . 2.3 m-85 -133.06 174.43 10.37 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.505 -178.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -61.49 -40.7 95.54 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 -176.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.438 ' C ' HG12 ' A' ' 9' ' ' VAL . 1.4 m120 -170.96 -38.39 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 119.073 0.851 . . . . 0.0 112.589 -179.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.482 ' HA2' HG13 ' A' ' 9' ' ' VAL . . . -178.77 -61.12 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.841 -179.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.56 ' HA ' HD13 ' A' ' 40' ' ' LEU . 13.0 m120 -50.74 -33.39 22.91 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 111.621 0.23 . . . . 0.0 111.621 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.829 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -57.7 -50.05 74.48 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.639 -0.425 . . . . 0.0 111.182 -179.98 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.61 HG21 ' CD1' ' A' ' 33' ' ' PHE . 5.5 t -62.44 -38.68 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 C-N-CA 119.93 -0.708 . . . . 0.0 110.442 179.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.611 HD11 ' HB2' ' A' ' 68' ' ' GLN . 12.9 mt -56.78 -42.16 78.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.524 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.35 -48.15 36.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.31 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.81 -28.41 69.84 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.364 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.744 HD12 ' NE2' ' A' ' 73' ' ' HIS . 8.4 mt -69.38 -24.12 63.83 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.083 -179.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.36 -17.69 5.32 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.266 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -123.97 0.61 8.57 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.503 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.1 OUTLIER -161.96 155.57 21.2 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.912 0.387 . . . . 0.0 111.348 179.913 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 91.0 m -139.05 114.7 8.46 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.212 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.578 ' HG3' ' HB2' ' A' ' 7' ' ' TRP . 73.8 Cg_endo -76.19 166.1 28.36 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.41 2.073 . . . . 0.0 110.965 178.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -74.14 -21.92 59.66 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.681 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.781 HG11 HG23 ' A' ' 6' ' ' VAL . 7.4 p -146.7 168.45 5.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.23 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.43 ' HA ' ' O ' ' A' ' 7' ' ' TRP . 13.5 tp -152.92 120.43 5.97 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.0 0.429 . . . . 0.0 111.53 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.506 ' HG ' ' HB ' ' A' ' 79' ' ' ILE . 0.3 OUTLIER -105.89 122.19 45.62 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.217 179.815 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.531 ' HB3' HD21 ' A' ' 65' ' ' LEU . 36.4 m -113.68 138.13 50.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.089 0.471 . . . . 0.0 112.021 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.521 ' O ' ' CG2' ' A' ' 55' ' ' ILE . 45.8 p-10 -78.23 -12.77 60.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.594 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.546 HG22 ' O ' ' A' ' 55' ' ' ILE . 5.3 tt 50.62 82.31 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-O 121.387 0.613 . . . . 0.0 111.867 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.748 ' C ' ' HD2' ' A' ' 58' ' ' PRO . 1.0 OUTLIER 175.93 145.8 0.08 Allowed 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.708 179.273 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.529 ' CB ' ' O ' ' A' ' 56' ' ' ARG . 14.1 ttt 96.52 -52.12 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.766 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 178.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.748 ' HD2' ' C ' ' A' ' 56' ' ' ARG . 20.4 Cg_endo -58.58 175.83 0.51 Allowed 'Trans proline' 0 C--N 1.35 0.643 0 CA-C-N 121.147 1.445 . . . . 0.0 112.286 -178.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -42.17 -74.46 0.17 Allowed Glycine 0 C--N 1.335 0.522 0 C-N-CA 121.126 -0.559 . . . . 0.0 112.501 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.582 ' H ' ' HB3' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -69.46 56.22 0.12 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.773 0.32 . . . . 0.0 110.597 179.221 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 56.75 -80.37 0.01 OUTLIER 'General case' 0 C--O 1.231 0.111 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.735 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.483 ' HA3' ' C ' ' A' ' 55' ' ' ILE . . . -137.1 -34.46 0.2 Allowed Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.655 -0.783 . . . . 0.0 113.007 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.544 ' CD1' HD12 ' A' ' 55' ' ' ILE . 5.2 mp -63.28 -15.76 58.2 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.864 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.588 ' HB2' ' HB2' ' A' ' 58' ' ' PRO . . . -53.82 -48.61 69.72 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 120.929 0.395 . . . . 0.0 111.355 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.531 HD21 ' HB3' ' A' ' 53' ' ' SER . 4.0 pp -51.42 -39.36 57.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.065 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.581 ' O ' ' HB ' ' A' ' 69' ' ' ILE . 5.1 mp -57.65 -47.98 80.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.912 0.387 . . . . 0.0 110.216 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.726 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 0.2 OUTLIER -49.98 -44.43 50.93 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.192 0.52 . . . . 0.0 110.097 178.954 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.611 ' HB2' HD11 ' A' ' 40' ' ' LEU . 11.6 mm100 -65.6 -26.42 67.83 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.262 179.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.849 HG12 ' CE1' ' A' ' 73' ' ' HIS . 94.0 mt -64.02 -39.62 86.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.486 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.726 ' HG2' ' O ' ' A' ' 67' ' ' LYS . 12.1 pttp -74.1 -27.22 60.78 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.893 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -85.85 -33.66 21.24 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.044 -179.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -106.54 -35.11 7.16 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -178.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.849 ' CE1' HG12 ' A' ' 69' ' ' ILE . 0.3 OUTLIER -99.44 136.07 20.49 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.891 -179.326 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -92.94 100.6 0.16 Allowed 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.953 2.435 . . . . 0.0 112.537 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.543 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 1.8 mtt 52.44 26.22 4.04 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.662 179.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.428 HD22 ' HB2' ' A' ' 51' ' ' LEU . 12.9 tp -69.79 112.66 13.01 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.815 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.4 125.41 18.82 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.353 2.035 . . . . 0.0 112.09 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.458 HG21 HD12 ' A' ' 69' ' ' ILE . 3.7 t -118.25 148.52 21.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.934 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.506 ' HB ' ' HG ' ' A' ' 52' ' ' LEU . 2.0 mt -127.82 114.14 34.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.617 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.612 HG13 ' CZ ' ' A' ' 101' ' ' TYR . 13.2 mm -99.54 143.49 13.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.984 0.421 . . . . 0.0 111.804 -179.045 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.416 ' HG3' ' N ' ' A' ' 82' ' ' THR . 18.6 ptm -86.56 -39.71 15.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.067 -178.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.593 ' O ' HG21 ' A' ' 80' ' ' ILE . 2.7 m -122.65 166.53 14.74 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.209 -179.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.42 ' H ' HG21 ' A' ' 82' ' ' THR . . . -138.99 -28.33 0.8 Allowed 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.472 ' CE1' HD13 ' A' ' 55' ' ' ILE . 3.5 p-80 38.19 -160.97 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 122.928 0.491 . . . . 0.0 111.863 -179.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 27.4 t -82.66 42.05 0.75 Allowed 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -178.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.463 ' O ' HD21 ' A' ' 63' ' ' LEU . 6.7 m-20 -132.84 15.98 4.28 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.718 0.294 . . . . 0.0 110.773 179.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.409 HD21 ' CB ' ' A' ' 90' ' ' ALA . 1.4 mt -44.74 -21.78 0.06 Allowed 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.291 -0.413 . . . . 0.0 112.006 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -47.94 -50.35 27.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.771 0.319 . . . . 0.0 111.028 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.7 -21.19 62.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.986 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.559 ' HB2' ' CE1' ' A' ' 101' ' ' TYR . . . -64.38 -33.22 75.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.861 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.617 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 3.1 t -66.15 -42.89 92.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.428 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.582 ' O ' ' HG3' ' A' ' 95' ' ' GLN . 14.9 m -60.43 -19.42 56.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.035 0.445 . . . . 0.0 110.073 178.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.729 ' O ' ' HG3' ' A' ' 96' ' ' GLN . . . -75.76 -53.93 7.73 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.62 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.617 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 5.6 m-85 -57.01 -33.19 66.91 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.148 0.499 . . . . 0.0 110.838 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.582 ' HG3' ' O ' ' A' ' 92' ' ' SER . 2.2 pp0? -76.95 -31.25 56.48 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.031 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.729 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 2.0 pp0? -83.09 -18.5 39.36 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.829 -0.349 . . . . 0.0 111.032 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 133.06 4.71 3.24 Favored Glycine 0 C--N 1.335 0.501 0 C-N-CA 120.231 -0.985 . . . . 0.0 114.315 178.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.486 ' HB2' ' C ' ' A' ' 93' ' ' ALA . . . -58.03 158.34 6.87 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 117.85 0.825 . . . . 0.0 111.278 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.507 ' CD2' ' HB1' ' A' ' 118' ' ' ALA . 10.4 t80 -85.11 -53.73 5.08 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.481 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 177.02 -163.69 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.807 0.337 . . . . 0.0 111.297 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.612 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 5.9 m-85 -138.82 152.65 48.04 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.464 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.449 HD22 ' HA ' ' A' ' 106' ' ' PHE . 2.7 mp -104.25 122.19 44.9 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.939 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -66.38 -74.68 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.168 1.912 . . . . 0.0 112.395 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.596 ' H ' ' HD2' ' A' ' 105' ' ' PRO . 1.1 mtpm? -114.88 -60.81 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.808 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.596 ' HD2' ' H ' ' A' ' 104' ' ' LYS . 14.4 Cg_endo -56.55 163.22 7.15 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.368 2.046 . . . . 0.0 112.574 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.66 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 41.9 t80 -170.2 -99.94 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.562 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.541 ' O ' ' O ' ' A' ' 106' ' ' PHE . 1.0 OUTLIER 41.47 -175.67 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.812 0.339 . . . . 0.0 111.096 -179.575 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.469 HG23 HG22 ' A' ' 112' ' ' VAL . 1.0 OUTLIER -68.01 -40.3 82.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.011 0.434 . . . . 0.0 111.62 179.909 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.613 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 55.2 m-20 -51.85 -58.83 5.31 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.573 -179.052 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.66 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 6.8 mm-40 -75.08 -31.42 61.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.646 0.26 . . . . 0.0 111.417 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -69.91 -61.73 1.66 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.47 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.706 ' O ' HG13 ' A' ' 115' ' ' VAL . 54.4 t -57.31 -30.61 35.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.444 0.64 . . . . 0.0 110.298 178.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.613 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -65.12 -49.22 70.79 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.727 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.462 ' CD2' HG23 ' A' ' 79' ' ' ILE . 13.0 tp -71.71 -21.23 61.8 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.958 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.706 HG13 ' O ' ' A' ' 112' ' ' VAL . 4.3 p -79.43 -47.53 22.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 C-N-CA 120.446 -0.501 . . . . 0.0 111.497 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.419 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 45.3 mt-10 -66.15 -45.08 82.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.578 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.458 ' HG3' ' O ' ' A' ' 113' ' ' ALA . 0.0 OUTLIER -60.65 -24.41 65.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.583 179.501 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.507 ' HB1' ' CD2' ' A' ' 99' ' ' PHE . . . -71.26 -48.8 48.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.968 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.47 HD13 HG13 ' A' ' 50' ' ' VAL . 4.3 mt -68.49 -31.07 49.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.233 0.54 . . . . 0.0 110.755 179.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -75.7 -54.38 7.06 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.155 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 17.9 m80 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.112 -179.717 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.422 ' HB3' HD13 ' A' ' 5' ' ' ILE . 15.1 ttt180 . . . . . 0 CA--C 1.532 0.279 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 51.39 73.83 0.35 Allowed Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.992 -0.623 . . . . 0.0 113.444 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.485 ' HB ' ' HA ' ' A' ' 48' ' ' PRO . 2.9 mp -105.17 112.76 40.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.749 0.309 . . . . 0.0 111.055 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.588 HG12 ' HA ' ' A' ' 30' ' ' CYS . 6.9 p -105.6 125.61 60.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.251 178.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.538 ' NE1' HG22 ' A' ' 31' ' ' THR . 31.4 m0 -115.74 132.01 56.76 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.09 0.472 . . . . 0.0 110.282 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.735 ' O ' ' HA ' ' A' ' 32' ' ' THR . 46.6 t -118.8 145.86 24.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.664 -178.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.898 HG11 ' HB2' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -127.35 118.01 48.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.806 0.336 . . . . 0.0 110.559 179.782 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -163.48 -159.43 0.52 Allowed 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.775 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.94 -0.09 4.0 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 65.61 -158.33 0.27 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.495 0.188 . . . . 0.0 110.904 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.44 ' HB3' ' H ' ' A' ' 14' ' ' SER . 1.3 t 35.43 -90.93 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.44 ' H ' ' HB3' ' A' ' 13' ' ' SER . 2.1 t -58.39 -54.87 42.17 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.708 0.289 . . . . 0.0 111.321 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.7 mm -64.83 -25.14 37.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.941 0.4 . . . . 0.0 111.15 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.584 ' HA ' HG22 ' A' ' 32' ' ' THR . 4.1 ttp180 -75.65 -53.27 8.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.257 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.541 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 86.7 t90 -57.25 -40.45 77.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.84 0.352 . . . . 0.0 111.51 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.554 HG13 HG12 ' A' ' 108' ' ' ILE . 18.9 t -66.43 -47.95 82.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 112.154 0.428 . . . . 0.0 112.154 -178.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.605 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 2.1 tp -80.54 -29.16 37.15 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -178.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.541 ' HG2' ' HA ' ' A' ' 17' ' ' TRP . 1.3 pp20? -62.46 -60.31 3.73 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.468 -0.493 . . . . 0.0 112.026 -179.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.0 mmm180 -58.93 -47.51 84.81 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.696 0.284 . . . . 0.0 111.679 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.87 -34.37 77.24 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -178.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.796 ' CD2' HD12 ' A' ' 28' ' ' LEU . 0.4 OUTLIER -81.82 -26.74 34.07 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.627 179.553 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.41 -34.25 74.21 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 177.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.68 -24.15 69.47 Favored Glycine 0 N--CA 1.443 -0.897 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 177.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.498 ' CB ' HD13 ' A' ' 28' ' ' LEU . . . -76.95 -15.3 59.7 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.589 -0.306 . . . . 0.0 110.275 178.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 94.1 26.65 13.79 Favored Glycine 0 C--N 1.337 0.633 0 C-N-CA 120.812 -0.709 . . . . 0.0 114.293 178.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.796 HD12 ' CD2' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -133.87 166.67 22.13 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-N 118.215 1.007 . . . . 0.0 112.784 -179.609 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 60.1 m -85.65 118.17 24.99 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.051 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.588 ' HA ' HG12 ' A' ' 6' ' ' VAL . 1.7 p -116.68 117.13 28.97 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.967 -0.56 . . . . 0.0 112.208 -178.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.558 HG23 ' CE1' ' A' ' 33' ' ' PHE . 2.8 t -125.11 133.24 52.93 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.735 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 77.1 p -107.64 164.28 12.36 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.159 0.504 . . . . 0.0 111.659 -178.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.898 ' HB2' HG11 ' A' ' 9' ' ' VAL . 2.9 m-85 -134.94 174.33 10.71 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.879 -177.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.639 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 2.5 pp20? -63.18 -34.76 78.32 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -176.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.612 ' C ' HG12 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -171.04 -55.83 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 118.947 0.794 . . . . 0.0 112.799 -179.273 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.573 ' O ' ' HG ' ' A' ' 40' ' ' LEU . . . -170.43 -43.77 0.03 OUTLIER Glycine 0 C--N 1.316 -0.58 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.57 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.676 ' HA ' ' CD1' ' A' ' 40' ' ' LEU . 1.5 t-20 -62.98 -26.07 68.67 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 120.985 0.421 . . . . 0.0 110.714 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.818 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -62.02 -57.64 10.88 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.269 179.819 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.696 HG13 ' HG ' ' A' ' 43' ' ' LEU . 21.2 t -55.51 -32.22 29.71 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 C-N-CA 120.116 -0.634 . . . . 0.0 111.233 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.808 HD12 ' CB ' ' A' ' 68' ' ' GLN . 11.2 mt -58.83 -46.47 87.6 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.773 0.32 . . . . 0.0 110.652 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.27 -48.93 63.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.177 0.513 . . . . 0.0 110.794 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.55 -33.61 75.28 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.716 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.696 ' HG ' HG13 ' A' ' 39' ' ' VAL . 15.0 mt -63.23 -27.68 69.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.531 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.99 -18.41 45.68 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.299 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.2 m -115.06 -4.77 12.49 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.454 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.1 OUTLIER -165.64 161.98 18.62 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.885 0.374 . . . . 0.0 111.081 179.951 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 54.0 m -138.86 111.77 8.14 Favored Pre-proline 0 N--CA 1.45 -0.43 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.354 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.533 ' HD2' HD12 ' A' ' 76' ' ' LEU . 66.1 Cg_endo -73.3 164.37 35.41 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.162 1.908 . . . . 0.0 111.329 178.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -77.76 -22.1 50.74 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.151 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.631 ' HA ' ' HG2' ' A' ' 77' ' ' PRO . 9.8 p -145.15 164.41 12.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.655 HD22 HG11 ' A' ' 39' ' ' VAL . 11.6 tp -152.67 111.37 3.76 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 121.139 0.495 . . . . 0.0 112.008 -178.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.464 HD22 ' O ' ' A' ' 79' ' ' ILE . 1.4 tt -97.7 119.98 37.25 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.759 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.712 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 0.3 OUTLIER -125.47 137.96 53.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.435 0.636 . . . . 0.0 112.63 -178.758 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.468 ' HA ' ' HG2' ' A' ' 81' ' ' MET . 0.8 OUTLIER -83.14 177.37 8.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.172 179.319 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.773 HG12 ' HA3' ' A' ' 62' ' ' GLY . 0.0 OUTLIER -154.73 105.41 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.195 0.522 . . . . 0.0 110.807 178.978 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.56 36.77 3.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.152 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.499 ' N ' ' CD ' ' A' ' 58' ' ' PRO . 0.5 OUTLIER 66.42 41.55 0.27 Allowed Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 179.042 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.499 ' CD ' ' N ' ' A' ' 57' ' ' MET . 58.1 Cg_endo -68.81 -90.57 0.0 OUTLIER 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 122.042 1.828 . . . . 0.0 111.0 178.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -87.66 -91.46 1.03 Allowed Glycine 0 C--N 1.335 0.488 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.597 ' HB3' ' CB ' ' A' ' 64' ' ' ALA . 34.6 tpp -87.56 64.85 8.31 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 177.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.478 ' O ' HG12 ' A' ' 55' ' ' ILE . 0.2 OUTLIER 67.61 -20.71 0.12 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.695 -179.291 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.773 ' HA3' HG12 ' A' ' 55' ' ' ILE . . . 133.01 -32.33 2.77 Favored Glycine 0 N--CA 1.446 -0.69 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 -179.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.606 ' HA ' ' CD1' ' A' ' 66' ' ' LEU . 5.4 mp -68.27 -13.86 62.57 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 120.862 0.363 . . . . 0.0 110.332 179.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.597 ' CB ' ' HB3' ' A' ' 60' ' ' MET . . . -53.17 -36.22 60.67 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.558 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.502 HD11 ' N ' ' A' ' 66' ' ' LEU . 3.8 pp -59.73 -40.68 88.86 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 121.1 -0.24 . . . . 0.0 111.222 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.606 ' CD1' ' HA ' ' A' ' 63' ' ' LEU . 4.8 mp -60.38 -43.01 97.02 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-O 121.124 0.488 . . . . 0.0 110.226 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.567 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -54.62 -44.23 72.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.202 -179.749 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.808 ' CB ' HD12 ' A' ' 40' ' ' LEU . 8.6 mm-40 -71.92 -43.51 65.19 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.44 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.4 HD12 ' HA ' ' A' ' 66' ' ' LEU . 16.8 mt -60.95 -35.38 64.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-O 121.033 0.444 . . . . 0.0 110.973 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.567 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -72.75 -29.81 63.63 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.013 -179.826 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.46 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -76.37 -36.68 58.02 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.631 -179.67 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.16 -26.14 21.44 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.926 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.651 ' NE2' ' HB3' ' A' ' 43' ' ' LEU . 31.9 m-70 -153.35 82.9 4.65 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.733 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.724 ' HA ' ' HB2' ' A' ' 96' ' ' GLN . 59.2 Cg_endo -73.47 39.08 0.46 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.583 2.189 . . . . 0.0 112.869 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.41 ' HG2' ' C ' ' A' ' 74' ' ' PRO . 1.5 mmm -141.92 -32.09 0.53 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.971 0.415 . . . . 0.0 111.689 -179.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.533 HD12 ' HD2' ' A' ' 48' ' ' PRO . 0.3 OUTLIER -61.29 124.37 80.28 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.805 -179.44 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.631 ' HG2' ' HA ' ' A' ' 50' ' ' VAL . 57.6 Cg_endo -71.2 126.31 12.25 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.32 2.013 . . . . 0.0 112.239 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.526 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 9.5 t -106.93 140.21 25.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.301 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.466 HG23 HD23 ' A' ' 114' ' ' LEU . 2.6 mt -127.13 110.08 22.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.614 179.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.712 ' HA ' ' O ' ' A' ' 53' ' ' SER . 13.5 mm -103.88 148.04 9.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.923 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.499 ' HB2' ' CE1' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -69.83 -73.3 0.16 Allowed 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.715 179.647 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.424 ' O ' HG23 ' A' ' 55' ' ' ILE . 3.9 m -105.31 162.8 13.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.949 0.404 . . . . 0.0 110.996 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.454 ' CB ' ' HG ' ' A' ' 87' ' ' LEU . . . -111.93 -22.22 11.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.621 -179.182 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 44.39 -163.0 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 120.605 0.241 . . . . 0.0 111.359 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 47.9 t -81.54 29.2 0.38 Allowed 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.411 ' O ' HD21 ' A' ' 63' ' ' LEU . 0.4 OUTLIER -128.51 24.77 5.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.708 0.29 . . . . 0.0 110.865 179.624 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.454 ' HG ' ' CB ' ' A' ' 83' ' ' ALA . 1.7 mt -50.32 -23.77 2.53 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.456 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -48.09 -56.95 6.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.71 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.535 ' HB3' ' HB3' ' A' ' 63' ' ' LEU . . . -59.57 -22.18 61.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.582 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.511 ' HB3' ' CE1' ' A' ' 101' ' ' TYR . . . -71.02 -35.57 72.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.998 0.428 . . . . 0.0 110.143 179.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.638 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 13.7 t -60.03 -44.65 95.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.464 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 49.0 m -60.97 -34.69 75.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.005 0.431 . . . . 0.0 110.491 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.737 ' O ' ' HG3' ' A' ' 96' ' ' GLN . . . -59.63 -42.28 92.37 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.019 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.638 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 11.0 m-85 -55.49 -24.24 30.4 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.317 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.595 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -75.74 -40.78 54.86 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.912 179.336 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.737 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 5.3 pp0? -77.1 -17.87 58.38 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.903 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.461 ' O ' ' HA ' ' A' ' 77' ' ' PRO . . . 123.36 18.09 3.13 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.761 -0.733 . . . . 0.0 113.335 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.653 ' HB1' ' C ' ' A' ' 93' ' ' ALA . . . -48.92 141.03 8.11 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 117.283 0.541 . . . . 0.0 110.911 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.555 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 27.1 t80 -75.72 -53.43 8.53 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.965 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.468 ' OD1' HD23 ' A' ' 114' ' ' LEU . 1.7 p30 167.57 -171.27 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.953 0.406 . . . . 0.0 111.502 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.511 ' CE1' ' HB3' ' A' ' 90' ' ' ALA . 5.3 m-85 -131.0 153.71 48.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.583 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.64 HD23 ' HA ' ' A' ' 106' ' ' PHE . 1.6 tp -102.27 123.4 43.32 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.663 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -72.82 -78.08 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 121.981 1.788 . . . . 0.0 112.766 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.424 ' O ' ' CD2' ' A' ' 106' ' ' PHE . 2.4 tmtm? -108.28 -54.19 0.06 OUTLIER Pre-proline 0 CA--C 1.531 0.247 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.437 ' O ' ' CG ' ' A' ' 106' ' ' PHE . 52.6 Cg_exo -55.49 154.54 24.22 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.275 1.983 . . . . 0.0 112.508 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.64 ' HA ' HD23 ' A' ' 102' ' ' LEU . 59.9 m-85 -160.43 -119.14 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.9 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.494 ' O ' ' O ' ' A' ' 106' ' ' PHE . 2.6 p30 47.71 174.94 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 120.835 0.35 . . . . 0.0 111.142 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.554 HG12 HG13 ' A' ' 18' ' ' VAL . 1.1 mp -67.11 -44.5 87.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.027 0.442 . . . . 0.0 111.461 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.733 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 0.8 OUTLIER -49.23 -53.92 19.19 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.554 -179.384 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.605 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 3.2 mm-40 -82.47 -34.61 28.01 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 -179.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.427 ' HB1' ' O ' ' A' ' 107' ' ' ASP . . . -69.4 -57.35 5.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.807 0.337 . . . . 0.0 110.2 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.705 ' O ' HG11 ' A' ' 115' ' ' VAL . 46.4 t -59.92 -30.84 46.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.294 0.569 . . . . 0.0 110.481 178.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.733 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -62.07 -46.16 90.32 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.522 0.677 . . . . 0.0 109.997 178.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.47 ' HA ' ' HG2' ' A' ' 117' ' ' ARG . 13.9 tp -72.8 -26.69 61.6 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 114.691 -1.14 . . . . 0.0 111.585 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.705 HG11 ' O ' ' A' ' 112' ' ' VAL . 4.7 p -79.21 -43.03 23.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.833 0.349 . . . . 0.0 111.895 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -65.84 -45.68 81.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.786 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.47 ' HG2' ' HA ' ' A' ' 114' ' ' LEU . 6.6 ptp180 -59.19 -26.2 64.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.67 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.555 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -68.72 -42.17 78.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.978 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.471 HD11 HD21 ' A' ' 28' ' ' LEU . 5.0 mt -75.68 -30.94 22.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.88 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 10.3 t -70.6 -51.31 29.11 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.903 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 17.1 m80 . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.073 -179.885 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.407 ' HB3' HD13 ' A' ' 5' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.22 0 CA-C-O 121.005 0.431 . . . . 0.0 111.406 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 55.93 85.57 0.03 OUTLIER Glycine 0 C--N 1.319 -0.405 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.386 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.63 ' HB ' ' HA ' ' A' ' 48' ' ' PRO . 3.1 mp -108.5 114.87 47.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.668 0.271 . . . . 0.0 111.115 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.503 ' CG1' ' CD2' ' A' ' 23' ' ' LEU . 7.4 p -107.33 114.8 47.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.051 0.453 . . . . 0.0 111.067 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.823 ' CD1' HG21 ' A' ' 31' ' ' THR . 38.7 m0 -107.95 147.39 31.11 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.009 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.513 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.1 OUTLIER -137.42 146.1 28.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.353 -178.752 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 1.017 HG11 ' HB2' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -120.61 104.78 15.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.035 0.445 . . . . 0.0 110.786 179.1 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.522 ' HB3' HG13 ' A' ' 15' ' ' ILE . 0.8 OUTLIER -174.1 118.05 0.24 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.812 -179.801 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.571 ' O ' ' HB2' ' A' ' 12' ' ' ASP . 0.2 OUTLIER 41.96 -87.28 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.232 -0.895 . . . . 0.0 112.033 -179.541 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.571 ' HB2' ' O ' ' A' ' 11' ' ' ASP . 24.4 t70 160.07 -100.79 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 122.734 0.414 . . . . 0.0 111.048 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.6 p -36.77 -76.51 0.02 OUTLIER 'General case' 0 C--O 1.231 0.096 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -179.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 44.0 t -52.76 -37.97 60.29 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.322 -177.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.522 HG13 ' HB3' ' A' ' 10' ' ' ASP . 19.3 mm -78.72 -22.88 13.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.163 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.594 ' O ' ' HB2' ' A' ' 20' ' ' GLU . 3.8 ttm-85 -77.18 -31.37 55.39 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.243 0.544 . . . . 0.0 110.277 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.577 ' HA ' ' HG3' ' A' ' 21' ' ' ARG . 79.7 t90 -72.12 -60.49 2.21 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -54.59 -62.04 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -176.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.494 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -77.11 -46.49 23.37 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 -176.177 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.594 ' HB2' ' O ' ' A' ' 16' ' ' ARG . 4.7 mm-40 -68.01 -61.38 1.89 Allowed 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 113.456 0.909 . . . . 0.0 113.456 -177.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.577 ' HG3' ' HA ' ' A' ' 17' ' ' TRP . 2.4 mmt180 -48.74 -43.96 38.02 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.098 -177.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.41 -26.98 61.2 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.781 0.324 . . . . 0.0 111.045 179.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.778 HD13 ' CD1' ' A' ' 28' ' ' LEU . 5.9 tp -82.27 -24.66 34.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.288 0.566 . . . . 0.0 110.198 179.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.407 ' N ' ' O ' ' A' ' 20' ' ' GLU . . . -68.36 -36.11 78.73 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.29 -25.17 68.13 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.256 -0.973 . . . . 0.0 110.749 178.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.41 ' CB ' HD12 ' A' ' 28' ' ' LEU . . . -76.76 -15.83 59.65 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 120.627 0.251 . . . . 0.0 110.885 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.06 26.58 9.46 Favored Glycine 0 CA--C 1.523 0.547 0 C-N-CA 120.482 -0.866 . . . . 0.0 114.559 178.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.778 ' CD1' HD13 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -120.76 166.98 12.98 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 118.227 1.014 . . . . 0.0 111.93 -179.93 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.466 ' O ' HG11 ' A' ' 6' ' ' VAL . 87.2 m -86.52 104.27 15.82 Favored 'General case' 0 CA--C 1.522 -0.097 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.491 ' HB2' ' HB3' ' A' ' 20' ' ' GLU . 4.2 p -105.31 110.33 22.65 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.914 -178.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.823 HG21 ' CD1' ' A' ' 7' ' ' TRP . 2.8 t -127.16 153.4 46.09 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.513 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 58.8 p -125.77 163.76 22.16 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.145 0.498 . . . . 0.0 111.923 -179.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 1.017 ' HB2' HG11 ' A' ' 9' ' ' VAL . 9.4 m-85 -136.09 173.4 11.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.482 -178.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.0 -42.51 99.87 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -177.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.699 ' C ' HG12 ' A' ' 9' ' ' VAL . 1.0 OUTLIER -170.92 -35.05 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 118.66 0.664 . . . . 0.0 112.343 -179.653 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.569 ' N ' HG12 ' A' ' 9' ' ' VAL . . . 176.71 -54.12 0.11 Allowed Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.231 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.419 ' HA ' ' CD1' ' A' ' 40' ' ' LEU . 27.5 m120 -51.31 -31.34 21.23 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.688 0.28 . . . . 0.0 111.328 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.778 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -65.15 -51.6 60.21 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.951 -0.3 . . . . 0.0 111.084 179.471 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.561 HG22 ' CG2' ' A' ' 9' ' ' VAL . 21.5 t -55.34 -33.95 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 120.277 -0.569 . . . . 0.0 111.722 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.518 HD13 ' CB ' ' A' ' 68' ' ' GLN . 13.3 mt -59.79 -47.85 84.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.692 0.282 . . . . 0.0 111.402 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.23 -47.36 79.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.268 0.556 . . . . 0.0 111.03 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.52 -40.06 96.04 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.025 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.569 HD13 ' CD2' ' A' ' 73' ' ' HIS . 17.9 mt -59.44 -26.12 64.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.433 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.74 -21.55 7.44 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.337 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.2 m -126.15 4.72 7.13 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -161.36 155.68 22.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.772 0.32 . . . . 0.0 110.968 179.946 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.407 HG21 ' CD2' ' A' ' 76' ' ' LEU . 89.8 m -138.56 112.05 8.39 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.448 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.63 ' HA ' ' HB ' ' A' ' 5' ' ' ILE . 71.7 Cg_endo -77.34 163.25 30.24 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.007 1.805 . . . . 0.0 111.444 178.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.465 ' O ' ' HG2' ' A' ' 77' ' ' PRO . 1.7 m-20 -75.74 -23.17 56.0 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.361 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.596 HG21 HD12 ' A' ' 79' ' ' ILE . 7.3 p -145.83 158.59 12.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 C-N-CA 121.16 -0.216 . . . . 0.0 110.83 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.547 ' HA ' ' O ' ' A' ' 7' ' ' TRP . 12.8 tp -152.86 115.69 4.55 Favored 'General case' 0 C--N 1.333 -0.115 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.554 ' HG ' ' HB ' ' A' ' 79' ' ' ILE . 0.8 OUTLIER -101.77 117.14 34.24 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.593 178.446 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.45 ' HB3' ' CD1' ' A' ' 65' ' ' LEU . 71.9 m -114.22 151.75 32.31 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.95 0.405 . . . . 0.0 112.022 -178.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -82.66 175.5 10.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.435 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.787 HG23 ' HG3' ' A' ' 81' ' ' MET . 3.2 tt -151.38 67.69 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.136 0 CA-C-O 121.343 0.592 . . . . 0.0 111.705 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 177.6 51.66 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.283 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.579 ' HB3' ' CD ' ' A' ' 58' ' ' PRO . 3.1 ttt -159.8 -62.48 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.3 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.503 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.579 ' CD ' ' HB3' ' A' ' 57' ' ' MET . 33.3 Cg_endo -61.64 -165.41 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.307 2.005 . . . . 0.0 112.546 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.45 -80.97 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.976 -0.63 . . . . 0.0 112.909 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.583 ' O ' ' N ' ' A' ' 62' ' ' GLY . 0.0 OUTLIER -77.03 55.57 1.14 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.794 0.33 . . . . 0.0 111.277 -179.629 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.551 ' HB3' HG13 ' A' ' 55' ' ' ILE . 0.8 OUTLIER 56.77 -68.93 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.574 179.4 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.62 ' O ' ' HG ' ' A' ' 65' ' ' LEU . . . -153.05 -34.34 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.817 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.586 HD22 ' HB1' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -62.17 -19.8 63.46 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 122.56 -0.377 . . . . 0.0 110.05 179.732 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.494 ' CB ' ' HB2' ' A' ' 60' ' ' MET . . . -54.3 -36.7 63.97 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 121.437 0.636 . . . . 0.0 109.975 178.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.62 ' HG ' ' O ' ' A' ' 62' ' ' GLY . 10.9 mt -60.14 -56.79 17.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.034 -0.984 . . . . 0.0 110.605 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.521 HD22 ' HB ' ' A' ' 78' ' ' VAL . 9.6 mt -46.17 -43.77 15.41 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.552 179.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.454 ' HZ1' ' HB2' ' A' ' 92' ' ' SER . 0.6 OUTLIER -52.07 -55.45 20.66 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.252 178.68 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.518 ' CB ' HD13 ' A' ' 40' ' ' LEU . 42.5 mm-40 -68.49 -34.74 76.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.863 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.53 -36.7 78.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.562 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.401 ' HB2' ' HB3' ' A' ' 96' ' ' GLN . 11.9 pttt -78.19 -26.82 47.72 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.06 -0.518 . . . . 0.0 112.338 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -67.77 -48.67 65.71 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -178.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.8 mmm180 -91.68 -42.55 10.1 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -178.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.569 ' CD2' HD13 ' A' ' 43' ' ' LEU . 3.3 m-70 -90.98 149.24 39.74 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.442 -178.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -73.6 -77.51 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.599 2.199 . . . . 0.0 113.187 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.709 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 1.3 mtt -125.76 44.56 2.8 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.743 0.306 . . . . 0.0 111.711 -179.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.519 HD23 ' HD2' ' A' ' 48' ' ' PRO . 1.0 OUTLIER -60.27 109.51 2.08 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.414 179.414 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.465 ' HG2' ' O ' ' A' ' 49' ' ' ASP . 32.9 Cg_exo -60.74 115.37 2.64 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.525 2.15 . . . . 0.0 112.051 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.521 ' HB ' HD22 ' A' ' 66' ' ' LEU . 5.0 t -115.47 151.91 17.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.14 0 CA-C-O 121.075 0.464 . . . . 0.0 111.345 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.596 HD12 HG21 ' A' ' 50' ' ' VAL . 2.1 mt -138.41 112.82 8.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.569 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.623 ' CG2' ' HB ' ' A' ' 55' ' ' ILE . 16.6 mm -95.03 142.07 14.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.018 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.787 ' HG3' HG23 ' A' ' 55' ' ' ILE . 1.4 ppp? -71.59 -27.24 63.0 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -178.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.553 ' O ' HG23 ' A' ' 80' ' ' ILE . 5.4 m -147.22 164.45 33.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.652 0.263 . . . . 0.0 110.77 179.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.483 ' CB ' ' HG ' ' A' ' 87' ' ' LEU . . . -129.18 37.26 4.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.769 0.318 . . . . 0.0 111.65 -179.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.43 ' O ' ' HB3' ' A' ' 85' ' ' SER . 0.6 OUTLIER -85.83 -172.91 4.34 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.72 179.794 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.43 ' HB3' ' O ' ' A' ' 84' ' ' HIS . 29.7 t 68.7 -79.6 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.384 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -141.49 80.2 1.72 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.928 0.394 . . . . 0.0 111.268 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.483 ' HG ' ' CB ' ' A' ' 83' ' ' ALA . 0.5 OUTLIER -55.94 -21.82 22.83 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.604 179.912 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -48.29 -50.32 30.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.67 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.453 ' HB3' ' HB2' ' A' ' 63' ' ' LEU . . . -57.6 -20.1 30.38 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.731 0.3 . . . . 0.0 111.741 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.586 ' HB1' HD22 ' A' ' 63' ' ' LEU . . . -73.75 -26.02 60.46 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.964 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.586 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 12.2 t -64.84 -50.64 74.27 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.485 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.454 ' HB2' ' HZ1' ' A' ' 67' ' ' LYS . 3.8 m -62.44 -23.63 66.98 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.97 0.414 . . . . 0.0 110.149 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.573 ' O ' ' HG3' ' A' ' 96' ' ' GLN . . . -62.27 -38.37 89.03 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 121.291 0.567 . . . . 0.0 109.935 178.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.586 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 9.1 m-85 -68.15 -23.06 64.83 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.547 178.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.425 ' HB3' ' O ' ' A' ' 92' ' ' SER . 0.0 OUTLIER -77.25 -38.37 51.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.855 179.38 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.709 ' O ' ' HA ' ' A' ' 75' ' ' MET . 1.5 pp0? -80.61 -19.01 46.39 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 120.949 -0.301 . . . . 0.0 111.31 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 117.99 31.42 1.59 Allowed Glycine 0 CA--C 1.52 0.388 0 C-N-CA 120.584 -0.817 . . . . 0.0 113.344 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.49 ' HB2' ' HB2' ' A' ' 93' ' ' ALA . . . -67.33 151.34 47.64 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 122.833 -0.216 . . . . 0.0 110.774 179.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.512 ' CZ ' ' HA ' ' A' ' 118' ' ' ALA . 14.2 t80 -76.84 -53.83 7.39 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 121.094 -0.242 . . . . 0.0 111.324 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.477 ' HB2' ' O ' ' A' ' 99' ' ' PHE . 4.4 t0 171.08 -168.7 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.312 0.577 . . . . 0.0 111.39 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.541 ' CE1' ' HB2' ' A' ' 90' ' ' ALA . 3.7 m-85 -133.79 152.36 51.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.016 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.692 HD22 ' HA ' ' A' ' 106' ' ' PHE . 1.5 mp -105.22 118.97 54.55 Favored Pre-proline 0 C--N 1.329 -0.314 0 C-N-CA 121.11 -0.236 . . . . 0.0 111.11 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -81.18 -76.31 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.399 2.066 . . . . 0.0 112.508 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.479 ' H ' ' HD2' ' A' ' 105' ' ' PRO . 1.3 mtpp -99.31 -62.07 0.1 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.603 -0.272 . . . . 0.0 111.682 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.479 ' HD2' ' H ' ' A' ' 104' ' ' LYS . 19.5 Cg_endo -59.03 149.56 78.87 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.186 1.924 . . . . 0.0 112.361 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.692 ' HA ' HD22 ' A' ' 102' ' ' LEU . 48.4 t80 -160.35 -111.79 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.89 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.629 ' O ' ' O ' ' A' ' 106' ' ' PHE . 2.8 p30 39.07 179.4 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.99 0.424 . . . . 0.0 111.921 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.46 HG21 HG21 ' A' ' 112' ' ' VAL . 0.7 OUTLIER -67.6 -42.57 86.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.85 0.357 . . . . 0.0 111.776 -179.403 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.556 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 3.9 m-20 -49.55 -58.42 5.24 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.364 -179.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.636 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 13.8 mm-40 -73.96 -35.35 64.52 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.771 0.319 . . . . 0.0 111.08 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.54 -56.18 15.74 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.924 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.611 ' O ' HG11 ' A' ' 115' ' ' VAL . 52.8 t -63.89 -31.92 55.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.494 0.664 . . . . 0.0 110.598 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.556 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -62.7 -45.46 92.66 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.281 179.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.509 HD21 ' CG2' ' A' ' 79' ' ' ILE . 13.8 tp -78.15 -22.43 48.76 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.727 -1.124 . . . . 0.0 111.995 -178.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.611 HG11 ' O ' ' A' ' 112' ' ' VAL . 6.2 p -79.6 -47.34 22.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 C-N-CA 120.351 -0.54 . . . . 0.0 111.348 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -63.22 -43.43 98.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.762 0.315 . . . . 0.0 110.775 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 68.4 mtt180 -60.38 -24.99 65.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.008 0.432 . . . . 0.0 110.505 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.512 ' HA ' ' CZ ' ' A' ' 99' ' ' PHE . . . -68.9 -45.4 71.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.739 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.437 HD13 HG11 ' A' ' 50' ' ' VAL . 4.9 mt -73.86 -32.02 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-O 121.16 0.505 . . . . 0.0 110.706 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 29.6 t -75.47 -48.51 22.34 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.247 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.254 0 CA-C-O 121.027 0.441 . . . . 0.0 111.125 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.436 ' HB3' ' CD1' ' A' ' 5' ' ' ILE . 0.1 OUTLIER . . . . . 0 CA--C 1.529 0.144 0 CA-C-O 120.852 0.358 . . . . 0.0 111.044 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 67.32 73.02 0.7 Allowed Glycine 0 CA--C 1.517 0.179 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.067 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.436 ' CD1' ' HB3' ' A' ' 3' ' ' ARG . 3.4 mp -112.03 112.91 42.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.747 0.308 . . . . 0.0 111.447 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.564 ' O ' ' HA ' ' A' ' 30' ' ' CYS . 5.6 p -107.54 130.51 59.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.074 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.538 ' CD1' ' CG2' ' A' ' 31' ' ' THR . 36.7 m0 -114.61 140.48 48.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.46 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.634 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.9 OUTLIER -123.34 134.99 64.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.806 0.336 . . . . 0.0 111.683 -178.636 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.516 HG11 ' HB2' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -119.82 109.19 25.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 120.881 0.372 . . . . 0.0 110.729 179.557 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -162.29 -157.94 0.49 Allowed 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.855 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -66.1 -2.13 3.85 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -179.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.409 ' O ' ' N ' ' A' ' 14' ' ' SER . 0.6 OUTLIER 66.81 -153.33 0.22 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 121.235 -0.186 . . . . 0.0 111.05 179.253 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.7 t 33.94 -89.83 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.409 ' N ' ' O ' ' A' ' 12' ' ' ASP . 3.6 m -55.18 -55.91 25.86 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.827 0.346 . . . . 0.0 111.125 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 27.6 mm -65.83 -25.58 36.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.372 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.618 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 14.0 ttp180 -69.84 -55.64 9.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.467 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.435 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 71.2 t90 -58.39 -39.62 80.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.763 -179.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.547 HG13 ' CD1' ' A' ' 108' ' ' ILE . 12.3 t -65.67 -49.28 78.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.417 HD23 HD13 ' A' ' 108' ' ' ILE . 0.3 OUTLIER -82.99 -25.21 32.47 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -178.109 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.646 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 23.1 pt-20 -67.41 -59.94 2.98 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.607 -0.437 . . . . 0.0 112.061 -179.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.49 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 3.6 mmt85 -67.7 -49.71 61.31 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -179.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.0 -57.33 10.74 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 120.905 0.383 . . . . 0.0 111.657 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.639 HD12 ' CD1' ' A' ' 28' ' ' LEU . 2.1 tp -65.34 -22.94 66.88 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.363 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.62 ' HB3' ' O ' ' A' ' 20' ' ' GLU . . . -69.4 -37.32 77.44 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.44 -24.73 66.11 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.456 -0.878 . . . . 0.0 111.404 178.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.45 -15.43 59.33 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 120.668 0.27 . . . . 0.0 111.01 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.65 26.58 8.0 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 120.6 -0.809 . . . . 0.0 114.069 178.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.639 ' CD1' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -128.97 171.85 11.94 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 117.764 0.782 . . . . 0.0 111.852 179.931 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.476 ' O ' HG13 ' A' ' 6' ' ' VAL . 23.7 m -99.78 105.56 17.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.333 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.646 ' HB3' ' HA ' ' A' ' 20' ' ' GLU . 7.2 t -102.68 114.68 29.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.856 -179.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.599 HG22 ' CE1' ' A' ' 33' ' ' PHE . 2.5 t -115.01 156.95 24.15 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.634 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 28.3 p -131.15 163.43 27.72 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.918 0.39 . . . . 0.0 111.894 -179.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.599 ' CE1' HG22 ' A' ' 31' ' ' THR . 35.4 m-85 -136.02 174.7 10.32 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -178.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.75 ' HG2' ' CD ' ' A' ' 38' ' ' GLU . 1.6 pt-20 -59.31 -39.56 83.46 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -176.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.528 ' N ' ' HG2' ' A' ' 34' ' ' GLU . 44.8 m-20 -168.22 -67.04 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.992 0.425 . . . . 0.0 111.352 -178.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.423 ' HA2' ' CG1' ' A' ' 9' ' ' VAL . . . -160.82 -35.22 0.02 OUTLIER Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.327 -0.939 . . . . 0.0 114.165 -179.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.733 ' HA ' HD13 ' A' ' 40' ' ' LEU . 4.7 m120 -61.45 -35.35 77.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 117.34 0.57 . . . . 0.0 112.088 -178.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.75 ' CD ' ' HG2' ' A' ' 34' ' ' GLU . 1.4 mp0 -51.79 -61.73 2.07 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.589 HG11 ' HG ' ' A' ' 43' ' ' LEU . 94.2 t -45.84 -31.05 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-O 121.286 0.565 . . . . 0.0 110.745 -179.133 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.733 HD13 ' HA ' ' A' ' 37' ' ' ASN . 10.1 mt -64.52 -43.87 92.66 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.039 179.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -82.5 -47.94 11.61 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.337 0.589 . . . . 0.0 110.703 178.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.34 -37.78 65.3 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.568 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.589 ' HG ' HG11 ' A' ' 39' ' ' VAL . 37.3 mt -67.39 -22.99 65.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.843 0.354 . . . . 0.0 111.523 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.35 -18.07 3.69 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.752 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.7 m -119.92 -5.9 10.07 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.531 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.1 OUTLIER -165.71 162.65 18.85 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.041 0.448 . . . . 0.0 111.702 -179.889 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 100.0 m -139.38 119.5 9.37 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.139 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.45 ' HD2' HD22 ' A' ' 43' ' ' LEU . 91.1 Cg_endo -80.41 165.62 20.72 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.403 2.069 . . . . 0.0 111.101 178.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -74.25 -25.37 59.59 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.967 -0.293 . . . . 0.0 110.992 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.468 HG13 ' CG2' ' A' ' 6' ' ' VAL . 8.9 p -145.02 162.46 13.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.177 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.417 ' N ' HG21 ' A' ' 50' ' ' VAL . 20.5 tp -152.91 126.67 8.88 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.177 0.513 . . . . 0.0 111.913 -179.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.536 ' HB3' HG11 ' A' ' 8' ' ' VAL . 0.4 OUTLIER -104.49 114.66 29.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.27 179.275 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.667 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 1.7 t -110.79 139.03 46.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.167 0.508 . . . . 0.0 111.627 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 32.1 p-10 -82.8 -173.65 4.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.639 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.55 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 16.3 tt -161.46 170.7 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.175 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.494 ' N ' HG12 ' A' ' 55' ' ' ILE . 13.9 ptt85 58.55 43.25 19.53 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-O 121.526 0.679 . . . . 0.0 110.246 -178.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.497 ' CB ' ' CD ' ' A' ' 58' ' ' PRO . 6.3 mtm -151.67 -67.89 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.393 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.497 ' CD ' ' CB ' ' A' ' 57' ' ' MET . 27.2 Cg_endo -59.76 -163.29 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.87 2.38 . . . . 0.0 112.847 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -52.8 -87.52 0.01 OUTLIER Glycine 0 C--N 1.332 0.352 0 CA-C-N 115.964 -0.562 . . . . 0.0 113.258 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.529 ' O ' ' N ' ' A' ' 62' ' ' GLY . 0.0 OUTLIER -76.39 61.17 1.66 Allowed 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.093 0.473 . . . . 0.0 110.466 -179.934 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.485 ' O ' ' HD2' ' A' ' 58' ' ' PRO . 6.9 m-20 60.8 -65.67 0.06 Allowed 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.944 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.55 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -165.05 -32.88 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.631 HD12 ' HB3' ' A' ' 86' ' ' ASP . 0.9 OUTLIER -64.06 -13.25 45.86 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 120.54 0.21 . . . . 0.0 110.481 179.398 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.417 ' HB3' ' HB2' ' A' ' 60' ' ' MET . . . -53.68 -31.55 48.19 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 121.054 0.455 . . . . 0.0 110.164 179.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.0 mp -62.64 -53.11 59.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.914 178.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.473 HD23 ' HA ' ' A' ' 63' ' ' LEU . 3.5 mm? -45.71 -45.82 14.56 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.861 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.683 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 27.1 mttt -59.15 -54.3 48.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.993 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.646 ' HB2' HD11 ' A' ' 40' ' ' LEU . 28.4 mm100 -64.34 -27.78 69.26 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.903 0.382 . . . . 0.0 110.34 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.523 ' HA ' ' CD2' ' A' ' 73' ' ' HIS . 41.4 mt -65.0 -36.74 78.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.853 -179.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.683 ' HG2' ' O ' ' A' ' 67' ' ' LYS . 6.5 pttt -75.72 -28.83 58.72 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.546 -179.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -69.14 -30.57 68.84 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.797 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.22 -56.96 2.31 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -179.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.566 ' CE1' ' HB2' ' A' ' 43' ' ' LEU . 1.3 m-70 -81.31 151.81 69.79 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-O 120.983 0.421 . . . . 0.0 111.817 -178.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -74.07 -80.99 0.01 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.377 2.051 . . . . 0.0 112.823 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.458 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 4.7 mtt -135.71 49.01 2.17 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 120.936 0.398 . . . . 0.0 111.73 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.429 ' CD1' HD22 ' A' ' 43' ' ' LEU . 0.7 OUTLIER -64.76 115.94 24.96 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.007 179.605 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -55.61 116.95 3.52 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.376 2.051 . . . . 0.0 112.214 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.467 HG22 HD13 ' A' ' 66' ' ' LEU . 4.1 t -110.68 144.23 19.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.089 0.471 . . . . 0.0 111.365 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.7 mt -128.59 111.36 23.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.427 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.667 ' HA ' ' O ' ' A' ' 53' ' ' SER . 31.1 mm -96.89 141.6 15.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.929 0.395 . . . . 0.0 111.611 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.406 ' CG ' HG22 ' A' ' 55' ' ' ILE . 21.8 ptm -72.67 -31.25 64.92 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -178.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.569 ' HA ' ' O ' ' A' ' 102' ' ' LEU . 7.1 m -146.36 169.17 19.4 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.511 -179.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.413 ' CB ' ' HG ' ' A' ' 87' ' ' LEU . . . -141.86 -22.31 0.71 Allowed 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.479 ' HE1' HG12 ' A' ' 55' ' ' ILE . 1.9 p-80 35.6 -102.74 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.1 p -120.99 -11.95 8.83 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -178.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.631 ' HB3' HD12 ' A' ' 63' ' ' LEU . 5.8 m-20 -82.09 18.25 1.41 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.839 0.352 . . . . 0.0 111.265 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.413 ' HG ' ' CB ' ' A' ' 83' ' ' ALA . 3.0 mt -50.69 -20.47 1.24 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.961 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -46.88 -53.79 11.37 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -178.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.403 ' HB3' HD22 ' A' ' 63' ' ' LEU . . . -65.7 -20.59 66.34 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.737 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.452 ' HB3' HD21 ' A' ' 63' ' ' LEU . . . -68.16 -40.47 82.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.225 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.673 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 4.3 t -57.31 -46.34 85.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.183 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.625 ' O ' ' NE2' ' A' ' 95' ' ' GLN . 12.8 m -62.23 -44.64 96.1 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.232 0.539 . . . . 0.0 109.827 179.248 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.444 ' HB3' ' HB2' ' A' ' 98' ' ' ALA . . . -47.48 -42.37 22.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.02 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.673 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 16.4 m-85 -56.19 -25.96 49.03 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.24 179.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.625 ' NE2' ' O ' ' A' ' 92' ' ' SER . 0.0 OUTLIER -71.35 -45.54 62.68 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.287 -179.916 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.629 ' HG3' ' HB3' ' A' ' 70' ' ' LYS . 75.5 mm-40 -74.23 -18.08 60.79 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.11 -179.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 119.86 32.56 1.18 Allowed Glycine 0 N--CA 1.453 -0.186 0 C-N-CA 120.311 -0.947 . . . . 0.0 113.163 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.444 ' HB2' ' HB3' ' A' ' 93' ' ' ALA . . . -64.43 145.81 55.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.819 0.309 . . . . 0.0 110.225 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.532 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 10.9 t80 -77.17 -53.93 7.13 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.197 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.401 ' HB2' ' O ' ' A' ' 99' ' ' PHE . 0.2 OUTLIER 173.18 -166.86 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.208 0.528 . . . . 0.0 111.728 179.7 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.629 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 5.3 m-85 -142.43 150.59 40.8 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.119 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.569 ' O ' ' HA ' ' A' ' 82' ' ' THR . 2.4 mp -104.87 119.53 53.08 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.234 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -69.25 -75.24 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.02 1.813 . . . . 0.0 112.194 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.552 ' H ' ' HD2' ' A' ' 105' ' ' PRO . 1.8 tttm -106.44 -60.0 0.05 OUTLIER Pre-proline 0 CA--C 1.533 0.293 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.552 ' HD2' ' H ' ' A' ' 104' ' ' LYS . 18.0 Cg_endo -59.72 156.73 36.02 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.263 1.975 . . . . 0.0 112.735 -179.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.608 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 24.0 t80 -166.94 -105.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.123 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.54 ' O ' ' O ' ' A' ' 106' ' ' PHE . 3.3 p30 42.79 -178.03 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.86 0.362 . . . . 0.0 111.155 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.547 ' CD1' HG13 ' A' ' 18' ' ' VAL . 0.9 OUTLIER -67.88 -40.89 84.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.137 0.494 . . . . 0.0 111.583 179.922 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -49.98 -58.62 5.08 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.721 -179.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.608 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 5.0 mm-40 -76.61 -31.59 57.54 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.74 0.305 . . . . 0.0 111.241 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.96 -61.58 1.97 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.901 0.381 . . . . 0.0 110.127 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.683 ' O ' HG12 ' A' ' 115' ' ' VAL . 46.5 t -59.1 -30.71 44.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.483 0.659 . . . . 0.0 110.792 179.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -64.53 -45.33 87.68 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.799 179.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.42 HD13 ' CE2' ' A' ' 99' ' ' PHE . 33.5 tp -77.38 -20.98 53.91 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.689 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.683 HG12 ' O ' ' A' ' 112' ' ' VAL . 4.1 p -79.4 -44.31 23.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.659 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.518 ' HA ' HD13 ' A' ' 119' ' ' ILE . 58.4 mt-10 -60.35 -44.91 95.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.894 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 21.8 mmm180 -62.26 -23.86 66.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.248 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.532 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -74.48 -42.69 58.57 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.63 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.518 HD13 ' HA ' ' A' ' 116' ' ' GLU . 6.3 mt -65.09 -31.29 53.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.13 0.49 . . . . 0.0 110.922 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 2.8 m -68.83 -49.34 59.29 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.995 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 31.8 m80 . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.143 -179.861 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.513 ' HB3' HD11 ' A' ' 5' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.518 -0.26 0 CA-C-O 121.149 0.5 . . . . 0.0 111.447 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.419 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . 71.11 76.7 0.55 Allowed Glycine 0 C--N 1.317 -0.5 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.704 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.513 HD11 ' HB3' ' A' ' 3' ' ' ARG . 2.4 mp -111.27 114.48 47.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.795 0.331 . . . . 0.0 111.267 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.571 ' O ' ' HA ' ' A' ' 30' ' ' CYS . 9.0 p -108.07 121.46 61.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.322 179.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.517 ' NE1' HG21 ' A' ' 31' ' ' THR . 27.4 m0 -111.55 133.32 53.9 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.912 0.387 . . . . 0.0 110.547 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.699 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.0 OUTLIER -124.89 149.15 29.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.149 -178.598 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.937 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -127.91 105.25 13.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 177.824 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.569 ' HB3' HG22 ' A' ' 15' ' ' ILE . 36.3 t0 -166.6 67.69 0.1 Allowed 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 120.952 0.406 . . . . 0.0 111.955 -179.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 20.6 t70 61.15 6.52 1.32 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.467 ' HA ' ' OG1' ' A' ' 32' ' ' THR . 4.5 p-10 44.28 -147.83 0.08 Allowed 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.41 ' HB3' ' H ' ' A' ' 14' ' ' SER . 1.7 t 36.05 -93.56 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 179.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.41 ' H ' ' HB3' ' A' ' 13' ' ' SER . 29.1 t -53.83 -65.66 0.53 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.652 0.263 . . . . 0.0 110.974 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.569 HG22 ' HB3' ' A' ' 10' ' ' ASP . 17.2 mm -60.57 -20.63 21.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.301 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.533 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 23.8 ttm-85 -69.74 -58.33 4.03 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 120.862 0.363 . . . . 0.0 110.848 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.457 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 49.8 t90 -51.5 -39.62 57.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.093 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.489 HG11 ' CD1' ' A' ' 108' ' ' ILE . 11.7 t -63.64 -51.59 68.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -178.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.667 HD22 HG11 ' A' ' 8' ' ' VAL . 6.2 tp -84.37 -24.97 29.46 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 -178.006 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.613 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 11.9 pt-20 -66.45 -59.86 3.27 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.416 -0.514 . . . . 0.0 111.565 -178.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.508 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 5.7 mmm180 -58.54 -52.78 64.19 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.848 -179.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.07 -47.92 77.05 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.81 0.338 . . . . 0.0 111.805 -179.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.771 HD11 ' CD1' ' A' ' 28' ' ' LEU . 1.7 tp -72.97 -24.65 60.81 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.126 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.5 ' HB2' ' O ' ' A' ' 20' ' ' GLU . . . -68.96 -34.27 75.05 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.37 -27.76 69.91 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.324 -0.941 . . . . 0.0 111.107 178.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.87 -16.0 59.54 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 120.605 0.241 . . . . 0.0 111.07 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.07 26.54 8.81 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 120.461 -0.876 . . . . 0.0 114.281 178.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.771 ' CD1' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -123.27 169.27 11.47 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 117.946 0.873 . . . . 0.0 111.653 179.756 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.442 ' O ' HG13 ' A' ' 6' ' ' VAL . 54.0 m -96.42 105.69 17.8 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.004 179.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.613 ' HB3' ' HA ' ' A' ' 20' ' ' GLU . 41.8 t -103.6 110.37 22.4 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.979 -179.103 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.517 HG21 ' NE1' ' A' ' 7' ' ' TRP . 2.6 t -117.37 154.16 31.78 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.699 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 29.1 p -126.11 165.56 18.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.301 0.572 . . . . 0.0 112.071 -179.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.937 ' HB2' HG13 ' A' ' 9' ' ' VAL . 16.2 m-85 -136.04 174.76 10.26 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.863 -178.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.757 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 2.3 pp20? -60.6 -49.19 78.53 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -176.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.728 ' C ' HG11 ' A' ' 9' ' ' VAL . 7.3 m-20 -165.56 -29.29 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -179.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.57 ' N ' HG11 ' A' ' 9' ' ' VAL . . . 174.92 -56.85 0.12 Allowed Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.448 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.594 ' HA ' HD13 ' A' ' 40' ' ' LEU . 1.2 t-20 -55.07 -30.59 59.96 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.674 0.273 . . . . 0.0 111.283 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.792 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -60.16 -55.66 31.11 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.709 179.796 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.656 HG21 HG12 ' A' ' 9' ' ' VAL . 5.5 t -50.9 -45.08 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.097 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.733 ' HB3' ' HD2' ' A' ' 72' ' ' ARG . 29.2 mt -52.1 -42.97 63.67 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.246 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.86 -50.78 67.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.202 0.525 . . . . 0.0 111.441 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.44 -29.36 65.93 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.766 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.836 HD13 ' NE2' ' A' ' 73' ' ' HIS . 5.6 mt -64.28 -25.44 68.05 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.8 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.9 -18.28 31.81 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.168 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 41.1 t -124.4 3.38 8.42 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 112.143 0.424 . . . . 0.0 112.143 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.43 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.4 OUTLIER -162.74 159.01 23.68 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-O 120.958 0.409 . . . . 0.0 111.497 179.924 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 98.4 m -138.62 115.48 8.94 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.459 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.572 ' HD2' HD22 ' A' ' 76' ' ' LEU . 72.7 Cg_endo -73.75 165.7 31.6 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.486 2.124 . . . . 0.0 111.363 178.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -76.72 -29.23 56.14 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 121.033 -0.267 . . . . 0.0 110.712 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.604 ' CG2' HD11 ' A' ' 79' ' ' ILE . 8.4 p -148.35 108.34 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.571 ' HB2' HD23 ' A' ' 76' ' ' LEU . 15.0 tp -86.99 136.92 32.75 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.889 0.376 . . . . 0.0 111.241 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.569 ' HB3' HG12 ' A' ' 8' ' ' VAL . 1.8 tt -124.2 124.17 41.88 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.099 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.565 ' HB2' ' CD1' ' A' ' 80' ' ' ILE . 67.0 m -110.94 136.61 49.7 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.045 0.45 . . . . 0.0 111.999 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.445 ' O ' ' HG2' ' A' ' 81' ' ' MET . 33.7 t70 -82.88 -12.91 57.02 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.209 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.827 HG13 ' HA3' ' A' ' 62' ' ' GLY . 6.5 tt 42.25 69.59 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-O 120.732 0.301 . . . . 0.0 111.502 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -112.06 44.85 1.34 Allowed 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.49 ' N ' ' CD ' ' A' ' 58' ' ' PRO . 0.5 OUTLIER 59.75 44.91 1.02 Allowed Pre-proline 0 N--CA 1.465 0.321 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 178.663 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.49 ' CD ' ' N ' ' A' ' 57' ' ' MET . 36.3 Cg_endo -65.08 -75.6 0.02 OUTLIER 'Trans proline' 0 CA--C 1.532 0.391 0 C-N-CA 122.579 2.186 . . . . 0.0 112.391 178.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -112.37 -27.67 3.81 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.074 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.619 ' N ' ' HB1' ' A' ' 64' ' ' ALA . 7.9 tpt -156.11 68.49 0.62 Allowed 'General case' 0 C--O 1.236 0.387 0 CA-C-O 120.981 0.419 . . . . 0.0 109.955 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.612 ' O ' HG13 ' A' ' 55' ' ' ILE . 0.4 OUTLIER 69.22 -26.43 0.15 Allowed 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.931 -179.709 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.827 ' HA3' HG13 ' A' ' 55' ' ' ILE . . . 139.32 -26.09 2.71 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -179.024 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.578 ' O ' ' HB2' ' A' ' 66' ' ' LEU . 3.1 mp -74.23 -15.14 61.0 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.619 ' HB1' ' N ' ' A' ' 60' ' ' MET . . . -53.74 -44.88 70.3 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.838 178.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.709 ' HG ' ' O ' ' A' ' 62' ' ' GLY . 4.0 pp -58.6 -36.64 74.33 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.289 179.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.578 ' HB2' ' O ' ' A' ' 63' ' ' LEU . 14.8 mt -55.75 -48.59 74.99 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.019 0.438 . . . . 0.0 110.402 179.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.539 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 12.6 tptt -53.23 -44.05 67.78 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.936 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.465 ' CB ' HD12 ' A' ' 40' ' ' LEU . 9.2 mm100 -67.08 -27.72 67.59 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.963 0.411 . . . . 0.0 110.704 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.701 HG12 ' CE1' ' A' ' 73' ' ' HIS . 96.8 mt -64.55 -38.13 81.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.527 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.539 ' HG2' ' O ' ' A' ' 67' ' ' LYS . 2.7 ptmt -74.97 -29.42 60.91 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.915 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.432 ' NE2' ' HG3' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -86.25 -30.61 22.21 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.735 -179.939 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.733 ' HD2' ' HB3' ' A' ' 40' ' ' LEU . 28.6 mtt85 -90.45 -68.01 0.81 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.856 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.836 ' NE2' HD13 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -88.04 144.63 34.86 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.629 -179.722 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -55.79 -67.49 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.603 2.202 . . . . 0.0 112.893 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.405 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 0.2 OUTLIER -146.89 40.13 1.06 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.934 0.397 . . . . 0.0 111.089 -179.554 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.644 ' HB3' ' HD1' ' A' ' 73' ' ' HIS . 22.7 tp -63.75 129.43 93.77 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.037 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.516 ' HA ' ' O ' ' A' ' 97' ' ' GLY . 58.2 Cg_endo -71.58 134.91 25.15 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.413 2.075 . . . . 0.0 112.278 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.612 HG21 HD13 ' A' ' 69' ' ' ILE . 5.5 t -123.95 148.57 28.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.944 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.604 HD11 ' CG2' ' A' ' 50' ' ' VAL . 2.2 mt -126.63 114.49 38.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.201 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.685 HG13 ' CZ ' ' A' ' 101' ' ' TYR . 9.7 mm -97.87 139.38 20.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.957 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.445 ' HG2' ' O ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -75.94 -30.76 58.8 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 112.357 0.502 . . . . 0.0 112.357 -178.882 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.566 ' O ' HG21 ' A' ' 80' ' ' ILE . 16.8 m -147.59 157.22 43.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.753 0.311 . . . . 0.0 111.574 -179.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -118.99 0.22 11.28 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.611 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.512 ' CE1' ' CD1' ' A' ' 55' ' ' ILE . 0.1 OUTLIER 25.75 -94.85 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 -179.168 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 16.1 m -136.89 -23.09 1.19 Allowed 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -178.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.561 ' O ' HD23 ' A' ' 63' ' ' LEU . 0.3 OUTLIER -78.66 28.39 0.2 Allowed 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -179.285 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.418 HD22 ' HB2' ' A' ' 90' ' ' ALA . 0.5 OUTLIER -46.84 -21.95 0.26 Allowed 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.887 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -48.11 -53.17 17.48 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.886 0.374 . . . . 0.0 111.264 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.436 ' HB1' ' CB ' ' A' ' 63' ' ' LEU . . . -64.05 -20.31 65.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.331 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.571 ' HB1' ' CE1' ' A' ' 101' ' ' TYR . . . -68.87 -33.89 74.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.837 0.351 . . . . 0.0 110.514 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.635 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 2.8 t -63.94 -46.61 93.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.81 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.591 ' O ' ' HG3' ' A' ' 95' ' ' GLN . 52.5 p -62.04 -16.89 55.19 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 178.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.729 ' O ' ' HG3' ' A' ' 96' ' ' GLN . . . -75.57 -52.14 11.29 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.408 0.623 . . . . 0.0 111.827 179.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.635 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 7.3 m-85 -57.9 -32.66 67.95 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.839 -179.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.591 ' HG3' ' O ' ' A' ' 92' ' ' SER . 2.1 pp0? -77.28 -32.06 55.23 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.247 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.729 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 3.3 pp0? -83.02 -15.95 49.05 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 121.13 -0.228 . . . . 0.0 111.295 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.516 ' O ' ' HA ' ' A' ' 77' ' ' PRO . . . 130.27 7.73 3.49 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.357 -0.925 . . . . 0.0 114.015 178.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.497 ' HB2' ' HB2' ' A' ' 93' ' ' ALA . . . -56.96 153.22 11.55 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 117.475 0.638 . . . . 0.0 111.138 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.551 ' CZ ' ' HA ' ' A' ' 118' ' ' ALA . 23.9 t80 -82.12 -53.65 5.92 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.336 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.544 ' HB3' ' O ' ' A' ' 99' ' ' PHE . 13.6 p-10 172.67 -161.49 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.311 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.685 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 4.6 m-85 -141.89 153.67 44.57 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.564 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.649 HD23 ' HA ' ' A' ' 106' ' ' PHE . 1.3 mp -102.32 120.01 54.62 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.71 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_exo -55.98 -69.19 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.478 2.118 . . . . 0.0 112.593 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.675 ' HB2' ' HD3' ' A' ' 105' ' ' PRO . 7.0 mmtt -128.42 -59.57 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.421 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.675 ' HD3' ' HB2' ' A' ' 104' ' ' LYS . 51.1 Cg_exo -54.16 161.56 5.04 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 121.74 1.627 . . . . 0.0 112.012 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.65 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 23.1 t80 -166.95 -105.6 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.653 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.484 ' O ' ' O ' ' A' ' 106' ' ' PHE . 2.8 p30 43.89 -175.57 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.778 0.323 . . . . 0.0 110.967 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.624 HG21 HG22 ' A' ' 112' ' ' VAL . 1.0 OUTLIER -67.86 -42.39 85.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 120.994 0.426 . . . . 0.0 111.416 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.624 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 26.3 t70 -49.12 -59.04 3.98 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.697 -179.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.65 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 7.0 mm-40 -76.16 -32.96 59.34 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.682 0.277 . . . . 0.0 111.376 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.419 ' CB ' ' O ' ' A' ' 107' ' ' ASP . . . -66.54 -59.37 3.7 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.486 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.656 ' O ' HG11 ' A' ' 115' ' ' VAL . 35.9 t -59.53 -31.37 46.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.444 0.64 . . . . 0.0 110.715 178.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.624 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -63.1 -44.8 94.69 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.096 179.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.489 ' CD2' HG23 ' A' ' 79' ' ' ILE . 36.0 tp -79.33 -21.26 46.13 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.86 -1.064 . . . . 0.0 112.072 -179.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.656 HG11 ' O ' ' A' ' 112' ' ' VAL . 6.0 p -79.2 -45.15 24.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.548 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -65.72 -45.4 82.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.693 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 42.8 mtp180 -60.03 -24.8 64.81 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.668 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.551 ' HA ' ' CZ ' ' A' ' 99' ' ' PHE . . . -72.27 -48.91 38.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.918 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.479 HD12 HG12 ' A' ' 50' ' ' VAL . 4.8 mt -65.27 -31.2 52.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.137 0.494 . . . . 0.0 110.75 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.3 t -72.24 -58.39 3.45 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.855 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 26.5 m80 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.885 -179.899 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 21.0 ptt180 . . . . . 0 N--CA 1.456 -0.141 0 CA-C-O 120.688 0.28 . . . . 0.0 111.001 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.548 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . 89.33 88.77 1.23 Allowed Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.097 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.8 mp -99.3 113.14 33.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 120.819 0.342 . . . . 0.0 111.297 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.566 HG12 ' O ' ' A' ' 29' ' ' THR . 6.2 p -105.69 123.41 60.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.061 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.538 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 31.4 m0 -115.08 127.91 55.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.633 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.624 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -112.86 143.02 23.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.401 -178.977 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.708 HG11 ' HB2' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -122.98 111.14 28.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.194 0.521 . . . . 0.0 110.633 179.367 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.414 ' HA ' ' OD2' ' A' ' 54' ' ' ASP . 3.9 t0 -161.43 -158.87 0.59 Allowed 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.188 -178.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.51 -2.25 4.49 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' A' ' 14' ' ' SER . 1.4 t0 67.76 -156.77 0.21 Allowed 'General case' 0 CA--C 1.531 0.233 0 O-C-N 122.381 -0.2 . . . . 0.0 110.833 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.412 ' HB3' ' H ' ' A' ' 14' ' ' SER . 3.3 t 34.66 -90.6 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.413 ' N ' ' O ' ' A' ' 12' ' ' ASP . 26.8 t -54.36 -61.15 2.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.741 0.305 . . . . 0.0 111.089 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 30.4 mm -61.75 -22.84 29.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.96 0.41 . . . . 0.0 110.754 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.891 ' HA ' HG21 ' A' ' 32' ' ' THR . 41.6 ttt180 -75.64 -54.85 6.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.634 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 83.4 t90 -58.65 -38.39 78.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.691 0.282 . . . . 0.0 111.595 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.438 ' CG1' HG12 ' A' ' 108' ' ' ILE . 3.6 t -69.52 -45.03 79.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -178.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.66 -26.69 29.67 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -178.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.599 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 10.9 pt-20 -67.74 -60.43 2.54 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -179.126 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.533 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 2.3 mmt-85 -60.71 -52.89 63.2 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -178.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.49 -50.4 65.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.948 0.404 . . . . 0.0 111.567 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.625 HD11 ' CD1' ' A' ' 28' ' ' LEU . 1.0 OUTLIER -70.4 -27.67 64.48 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.352 179.807 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.599 ' HB1' ' O ' ' A' ' 20' ' ' GLU . . . -67.56 -34.75 77.68 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.16 -26.45 69.26 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.417 -0.897 . . . . 0.0 111.038 178.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.414 ' CB ' HD12 ' A' ' 28' ' ' LEU . . . -77.26 -15.39 59.48 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.655 -0.273 . . . . 0.0 111.039 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.21 26.41 10.22 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.606 -0.807 . . . . 0.0 114.217 178.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.625 ' CD1' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -124.68 170.68 10.74 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 117.87 0.835 . . . . 0.0 111.775 179.722 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.566 ' O ' HG12 ' A' ' 6' ' ' VAL . 50.6 m -94.3 105.8 17.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.078 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.468 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 46.7 t -106.29 110.33 22.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.992 -178.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.524 HG22 ' CE1' ' A' ' 33' ' ' PHE . 2.8 t -118.73 153.05 35.03 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.891 HG21 ' HA ' ' A' ' 16' ' ' ARG . 20.5 p -126.43 157.12 39.42 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.558 0.694 . . . . 0.0 112.134 -179.214 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.774 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 1.0 OUTLIER -127.0 174.29 8.98 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.707 -1.133 . . . . 0.0 111.184 -178.73 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.643 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 3.0 pp20? -61.37 -34.23 74.97 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -177.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -176.92 -37.52 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.631 ' HA2' HG13 ' A' ' 9' ' ' VAL . . . 173.47 -47.02 0.16 Allowed Glycine 0 C--N 1.318 -0.438 0 C-N-CA 120.32 -0.943 . . . . 0.0 112.884 -179.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.531 ' HA ' HD11 ' A' ' 40' ' ' LEU . 0.8 OUTLIER -59.62 -29.66 68.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.154 0.502 . . . . 0.0 111.071 -179.765 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.774 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -62.97 -53.58 51.86 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.708 -179.525 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.449 ' CG2' ' CG1' ' A' ' 9' ' ' VAL . 21.3 t -50.08 -37.2 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 C-N-CA 120.349 -0.54 . . . . 0.0 110.661 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.531 HD11 ' HA ' ' A' ' 37' ' ' ASN . 12.6 mt -55.65 -48.13 75.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.479 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.01 -50.17 69.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.107 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.4 -34.6 77.07 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.726 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.552 ' HA ' ' O ' ' A' ' 46' ' ' LYS . 21.1 mt -59.23 -23.5 62.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.421 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.02 -17.8 28.6 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.826 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.5 t -128.52 3.08 5.59 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.552 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.2 OUTLIER -167.44 161.25 13.87 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.909 0.385 . . . . 0.0 111.216 179.895 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 90.4 m -138.96 111.74 8.06 Favored Pre-proline 0 N--CA 1.45 -0.457 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.201 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.477 ' HG2' HD21 ' A' ' 76' ' ' LEU . 43.3 Cg_endo -71.38 158.68 53.66 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.084 1.856 . . . . 0.0 111.276 179.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.441 ' O ' ' HG2' ' A' ' 77' ' ' PRO . 1.7 m-20 -74.24 -24.15 59.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.466 -179.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.52 HG13 ' HA ' ' A' ' 6' ' ' VAL . 7.6 p -145.98 166.47 8.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.582 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.538 ' HA ' ' O ' ' A' ' 7' ' ' TRP . 10.0 tp -152.96 137.36 16.68 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.985 0.422 . . . . 0.0 111.43 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.489 ' HG ' ' HB ' ' A' ' 79' ' ' ILE . 1.1 tt -121.9 119.21 30.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.713 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.411 ' HB2' ' CD1' ' A' ' 80' ' ' ILE . 0.6 OUTLIER -115.08 138.21 51.13 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.905 0.383 . . . . 0.0 111.408 -179.723 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.461 ' O ' ' CG2' ' A' ' 55' ' ' ILE . 2.9 p30 -82.27 -4.04 56.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 0.0 112.058 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.898 HG13 ' HA3' ' A' ' 62' ' ' GLY . 7.1 tt 50.47 169.4 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-O 120.953 0.406 . . . . 0.0 111.923 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.457 ' H ' ' HA3' ' A' ' 62' ' ' GLY . 8.2 ttt85 67.43 77.93 0.25 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.901 0.382 . . . . 0.0 110.696 -179.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.562 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . 7.5 tpt -163.14 -61.24 0.01 OUTLIER Pre-proline 0 CA--C 1.537 0.479 0 CA-C-N 116.081 -0.509 . . . . 0.0 112.063 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.72 ' HG3' ' HG ' ' A' ' 65' ' ' LEU . 94.3 Cg_endo -71.96 -164.58 0.17 Allowed 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.975 2.45 . . . . 0.0 113.47 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.64 -65.48 3.13 Favored Glycine 0 C--N 1.335 0.525 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.241 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.467 ' O ' ' N ' ' A' ' 62' ' ' GLY . 5.2 ttt -70.19 60.42 0.19 Allowed 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.082 0.468 . . . . 0.0 110.013 179.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 58.3 -81.79 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.558 -0.747 . . . . 0.0 109.812 -179.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.898 ' HA3' HG13 ' A' ' 55' ' ' ILE . . . -145.38 -28.96 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.593 179.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.53 ' HG ' ' HH ' ' A' ' 101' ' ' TYR . 4.0 mp -59.75 -18.85 46.27 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.497 ' HB1' ' HB2' ' A' ' 58' ' ' PRO . . . -55.63 -37.1 67.75 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 178.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.72 ' HG ' ' HG3' ' A' ' 58' ' ' PRO . 32.4 mt -60.76 -49.14 78.69 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.522 HD12 HD12 ' A' ' 80' ' ' ILE . 9.4 mp -51.1 -51.47 53.06 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.98 179.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.544 ' HA ' ' CE ' ' A' ' 70' ' ' LYS . 6.4 mtpm? -44.63 -49.43 10.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.851 179.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.479 ' HB3' HD13 ' A' ' 40' ' ' LEU . 60.8 mm-40 -68.22 -26.51 65.75 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.375 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.616 ' CG2' ' HD2' ' A' ' 73' ' ' HIS . 63.3 mt -63.89 -54.18 34.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.012 0.434 . . . . 0.0 111.119 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.785 ' HA ' ' CD2' ' A' ' 73' ' ' HIS . 0.0 OUTLIER -62.43 -28.35 69.74 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.16 -178.94 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -64.82 -22.48 67.0 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.179 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.72 -11.68 9.36 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.005 0.742 . . . . 0.0 113.005 -179.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.785 ' CD2' ' HA ' ' A' ' 70' ' ' LYS . 1.6 p80 -109.55 160.61 27.19 Favored Pre-proline 0 N--CA 1.465 0.321 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -179.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.455 ' O ' ' HG2' ' A' ' 75' ' ' MET . 60.6 Cg_endo -87.71 -59.45 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.976 2.451 . . . . 0.0 111.42 178.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.552 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 5.8 mmt -151.24 51.33 0.84 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.9 178.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.542 ' CD1' HD22 ' A' ' 43' ' ' LEU . 0.4 OUTLIER -76.66 123.25 87.58 Favored Pre-proline 0 N--CA 1.456 -0.135 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -179.147 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.441 ' HG2' ' O ' ' A' ' 49' ' ' ASP . 20.2 Cg_exo -64.72 138.07 56.88 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.189 1.926 . . . . 0.0 111.729 178.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.538 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 3.0 t -126.13 119.69 54.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.482 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.489 ' HB ' ' HG ' ' A' ' 52' ' ' LEU . 1.5 mp -109.83 110.22 31.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.863 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.729 HG23 ' HB ' ' A' ' 55' ' ' ILE . 37.0 mm -100.53 148.49 6.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.296 -178.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.544 ' N ' HG21 ' A' ' 80' ' ' ILE . 13.0 ptm -81.98 -35.32 29.07 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.61 -179.11 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.413 ' N ' ' HG3' ' A' ' 81' ' ' MET . 8.2 m -146.59 151.84 37.96 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.626 0.251 . . . . 0.0 111.138 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.409 ' O ' ' C ' ' A' ' 84' ' ' HIS . . . -117.03 10.24 13.9 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 111.803 0.297 . . . . 0.0 111.803 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.466 ' HE1' HD11 ' A' ' 63' ' ' LEU . 0.1 OUTLIER 25.84 -92.38 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -179.385 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 55.3 m -149.64 39.62 0.8 Allowed 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.527 ' HB3' ' CD1' ' A' ' 63' ' ' LEU . 0.4 OUTLIER -137.72 36.68 2.42 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.125 0.488 . . . . 0.0 110.349 179.236 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 7.9 mt -50.33 -20.86 1.19 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.993 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -47.69 -58.76 3.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.624 0.25 . . . . 0.0 111.434 -179.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.481 ' HB2' HD21 ' A' ' 63' ' ' LEU . . . -69.74 -19.64 63.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.892 0.377 . . . . 0.0 110.651 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.521 ' HB2' ' CE1' ' A' ' 101' ' ' TYR . . . -69.25 -46.42 67.35 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.878 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.64 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 3.5 t -67.0 -52.92 38.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 C-N-CA 120.474 -0.491 . . . . 0.0 111.297 -179.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.584 ' O ' ' HB3' ' A' ' 95' ' ' GLN . 24.4 m -60.21 -27.08 66.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.137 0.494 . . . . 0.0 109.786 178.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.577 ' HA ' ' OE1' ' A' ' 96' ' ' GLN . . . -60.72 -41.81 96.01 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.056 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.64 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 3.9 m-85 -67.73 -27.33 66.7 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.967 179.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.584 ' HB3' ' O ' ' A' ' 92' ' ' SER . 0.2 OUTLIER -60.92 -40.89 94.88 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.807 -179.192 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.577 ' OE1' ' HA ' ' A' ' 93' ' ' ALA . 0.0 OUTLIER -100.37 -19.3 16.35 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -179.565 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.441 ' O ' ' C ' ' A' ' 98' ' ' ALA . . . -176.01 -57.67 0.06 OUTLIER Glycine 0 C--N 1.335 0.474 0 C-N-CA 119.22 -1.467 . . . . 0.0 114.824 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.561 ' O ' ' HA ' ' A' ' 94' ' ' TYR . . . -29.1 139.37 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 117.32 0.56 . . . . 0.0 112.36 -178.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -84.78 -53.38 5.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.45 -179.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.44 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 7.9 p-10 -177.8 -164.65 0.09 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.747 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.692 ' CE2' HG22 ' A' ' 80' ' ' ILE . 4.1 m-85 -138.3 153.02 49.03 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.081 0.467 . . . . 0.0 111.004 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.74 HD21 ' HA ' ' A' ' 106' ' ' PHE . 3.2 mp -102.98 119.08 56.54 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.714 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -64.69 -66.84 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.537 2.158 . . . . 0.0 112.272 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.628 ' H ' ' HD2' ' A' ' 105' ' ' PRO . 5.6 mttp -119.81 -58.85 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.135 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.628 ' HD2' ' H ' ' A' ' 104' ' ' LYS . 11.9 Cg_endo -55.02 163.5 4.22 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.127 1.885 . . . . 0.0 112.347 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.74 ' HA ' HD21 ' A' ' 102' ' ' LEU . 39.9 t80 -172.08 -106.34 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.659 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.551 ' O ' ' O ' ' A' ' 106' ' ' PHE . 4.7 p-10 43.09 -179.94 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.744 0.307 . . . . 0.0 111.089 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.438 HG12 ' CG1' ' A' ' 18' ' ' VAL . 0.9 OUTLIER -67.87 -43.44 85.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -179.355 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.5 ' HB2' ' OD2' ' A' ' 107' ' ' ASP . 7.0 m-20 -49.82 -58.68 4.88 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.45 -179.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.604 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 6.1 mm-40 -74.46 -31.79 62.36 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.759 0.314 . . . . 0.0 111.318 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.419 ' CB ' ' O ' ' A' ' 107' ' ' ASP . . . -66.48 -61.18 2.13 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.336 179.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.654 ' O ' HG11 ' A' ' 115' ' ' VAL . 50.2 t -59.07 -31.51 45.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.5 0.667 . . . . 0.0 110.332 179.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.415 ' HB1' ' O ' ' A' ' 109' ' ' ASP . . . -64.24 -45.27 88.88 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.722 179.088 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.561 HD13 ' HD3' ' A' ' 117' ' ' ARG . 23.5 tp -74.89 -24.14 58.49 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.835 -1.075 . . . . 0.0 111.901 -179.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.654 HG11 ' O ' ' A' ' 112' ' ' VAL . 4.0 p -79.29 -43.83 23.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.668 -179.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -65.65 -43.76 88.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.114 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.561 ' HD3' HD13 ' A' ' 114' ' ' LEU . 7.8 ptm180 -63.27 -23.72 67.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.787 0.327 . . . . 0.0 110.844 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.38 -46.64 59.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.693 179.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.458 HD11 HG11 ' A' ' 50' ' ' VAL . 4.5 mt -68.62 -32.09 53.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.878 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 36.8 t -65.44 -41.89 93.0 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.492 -0.777 . . . . 0.0 110.819 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 2.4 m80 . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.785 179.947 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.528 0.116 0 CA-C-O 120.684 0.278 . . . . 0.0 111.222 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 89.3 94.39 1.11 Allowed Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.576 -0.821 . . . . 0.0 111.728 -179.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.8 mp -105.71 116.27 49.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.018 0.437 . . . . 0.0 111.451 -179.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.567 HG13 ' HG ' ' A' ' 23' ' ' LEU . 7.6 p -107.19 131.32 57.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.77 179.16 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.532 ' CD1' ' CG2' ' A' ' 31' ' ' THR . 39.5 m0 -117.44 142.2 47.43 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.132 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.72 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -134.18 145.37 33.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.011 0.434 . . . . 0.0 111.558 -178.421 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.977 HG13 ' HB2' ' A' ' 33' ' ' PHE . 3.1 m -131.39 105.93 11.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.262 178.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.414 ' O ' ' CG1' ' A' ' 15' ' ' ILE . 53.7 t0 -166.46 66.98 0.1 Allowed 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 121.148 0.499 . . . . 0.0 111.845 -179.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.2 t70 74.85 -9.11 1.41 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 178.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.7 t70 59.45 -154.36 0.37 Allowed 'General case' 0 CA--C 1.534 0.357 0 O-C-N 122.275 -0.266 . . . . 0.0 110.955 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 t 34.83 -91.01 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.483 ' O ' HG21 ' A' ' 18' ' ' VAL . 1.5 m -54.57 -65.98 0.48 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.513 0.197 . . . . 0.0 111.234 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.414 ' CG1' ' O ' ' A' ' 10' ' ' ASP . 40.2 mm -60.44 -20.58 21.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.771 0.319 . . . . 0.0 111.089 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.493 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 27.1 ttt180 -70.32 -57.81 4.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.238 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.462 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 50.1 t90 -53.9 -39.68 66.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.69 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.498 HG12 HG12 ' A' ' 108' ' ' ILE . 14.5 t -62.28 -54.82 29.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 113.018 0.748 . . . . 0.0 113.018 -178.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.441 ' CD1' HG22 ' A' ' 112' ' ' VAL . 7.8 tp -82.84 -22.4 34.1 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -177.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.579 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 22.8 pt-20 -67.75 -57.69 5.9 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.499 -178.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.514 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 0.1 OUTLIER -63.34 -49.83 72.37 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.93 -179.48 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.15 -47.5 83.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.84 0.353 . . . . 0.0 111.675 -179.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.733 HD13 ' CD1' ' A' ' 28' ' ' LEU . 2.4 tp -71.04 -25.28 62.59 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.259 179.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.08 -33.71 75.04 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.34 -25.04 71.06 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.475 -0.869 . . . . 0.0 111.028 178.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.423 ' CB ' HD12 ' A' ' 28' ' ' LEU . . . -76.68 -15.66 59.74 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 120.585 0.231 . . . . 0.0 110.78 179.197 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.14 26.41 9.55 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.68 -0.771 . . . . 0.0 113.825 179.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.733 ' CD1' HD13 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -123.94 168.12 13.22 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 117.848 0.824 . . . . 0.0 111.689 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.406 ' O ' HG12 ' A' ' 6' ' ' VAL . 73.5 m -94.75 105.66 17.61 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.627 179.085 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.579 ' HB3' ' HA ' ' A' ' 20' ' ' GLU . 10.8 t -100.77 112.44 24.85 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -178.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.54 HG22 ' CE1' ' A' ' 33' ' ' PHE . 2.5 t -120.21 144.75 47.56 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.335 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.72 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 43.6 p -121.53 157.96 29.54 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -178.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.977 ' HB2' HG13 ' A' ' 9' ' ' VAL . 0.4 OUTLIER -136.16 174.24 10.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.893 -1.049 . . . . 0.0 111.304 -179.882 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.571 ' HG2' ' N ' ' A' ' 35' ' ' ASN . 0.0 OUTLIER -63.19 -32.97 74.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.658 -179.294 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.571 ' N ' ' HG2' ' A' ' 34' ' ' GLU . 1.7 t-20 -178.61 179.0 0.77 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.356 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.485 ' O ' ' HG ' ' A' ' 40' ' ' LEU . . . -52.03 -19.93 5.94 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.646 -0.788 . . . . 0.0 113.058 -179.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -69.12 -50.9 43.85 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -179.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.631 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 3.9 tt0 -51.98 -51.7 55.5 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.055 -179.329 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.488 HG12 ' CD1' ' A' ' 43' ' ' LEU . 82.8 t -51.42 -32.7 13.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.133 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 36' ' ' GLY . 18.9 mt -58.3 -47.26 84.24 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.121 0.486 . . . . 0.0 110.065 179.167 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.47 -49.47 48.21 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.938 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.89 -32.08 71.55 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.206 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.583 ' HA ' ' O ' ' A' ' 46' ' ' LYS . 18.7 mt -68.78 -25.12 64.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.989 -179.294 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.31 -20.45 7.19 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.905 -179.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 28.6 t -124.8 4.92 8.1 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.583 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -167.69 155.73 9.02 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.972 0.415 . . . . 0.0 111.173 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.435 ' HA ' ' CD2' ' A' ' 43' ' ' LEU . 93.9 m -138.95 116.58 8.91 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.902 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.543 ' HD2' HD22 ' A' ' 43' ' ' LEU . 73.2 Cg_endo -77.92 163.0 28.95 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 121.988 1.792 . . . . 0.0 111.313 179.221 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -73.79 -21.0 60.31 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.818 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.524 HG11 ' CG2' ' A' ' 6' ' ' VAL . 5.5 p -147.63 161.42 7.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.715 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.75 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 26.8 tp -152.93 131.15 11.98 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 121.196 0.522 . . . . 0.0 111.947 -179.286 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.638 ' HG ' ' HB ' ' A' ' 79' ' ' ILE . 1.0 OUTLIER -114.45 118.18 33.07 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.447 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.784 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 3.8 m -117.26 144.37 44.91 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -178.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -82.98 179.15 7.85 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.559 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.713 HG13 ' HA3' ' A' ' 62' ' ' GLY . 9.0 tt -154.61 67.47 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.398 179.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.74 38.51 2.24 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.729 -179.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.534 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER 65.35 47.14 0.56 Allowed Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 178.947 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 62' ' ' GLY . 40.9 Cg_endo -68.18 -78.16 0.01 OUTLIER 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 122.387 2.058 . . . . 0.0 111.967 178.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -106.45 -27.71 5.43 Favored Glycine 0 C--N 1.335 0.496 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.126 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.618 ' HB3' ' CB ' ' A' ' 64' ' ' ALA . 2.2 tpt -159.51 67.97 0.41 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.885 0.374 . . . . 0.0 109.997 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.534 ' HA ' ' HA ' ' A' ' 57' ' ' MET . 0.2 OUTLIER 71.42 -29.12 0.19 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.338 -179.561 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.713 ' HA3' HG13 ' A' ' 55' ' ' ILE . . . 140.07 -28.45 2.49 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 -179.376 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.475 ' HA ' ' CD2' ' A' ' 66' ' ' LEU . 0.9 OUTLIER -72.74 -14.01 61.46 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 115.425 -0.387 . . . . 0.0 109.991 178.452 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.618 ' CB ' ' HB3' ' A' ' 60' ' ' MET . . . -53.38 -52.45 59.26 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-O 121.118 0.485 . . . . 0.0 110.428 178.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.611 HD11 HD23 ' A' ' 66' ' ' LEU . 3.5 pp -57.36 -33.23 67.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.121 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.611 HD23 HD11 ' A' ' 65' ' ' LEU . 3.9 mm? -59.36 -50.43 74.0 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.925 0.393 . . . . 0.0 110.766 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.518 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 6.9 mttt -54.54 -40.87 69.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.985 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.419 ' HB3' HD12 ' A' ' 40' ' ' LEU . 11.0 mm100 -65.84 -27.96 68.63 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.066 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.521 HG13 ' O ' ' A' ' 65' ' ' LEU . 87.9 mt -64.76 -53.94 36.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.8 -179.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.518 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.5 OUTLIER -64.7 -24.93 67.73 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.847 -179.099 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.86 -51.7 63.42 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -178.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.94 -26.4 15.59 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.201 -0.454 . . . . 0.0 112.176 -178.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.504 ' CE1' ' HB3' ' A' ' 43' ' ' LEU . 3.6 m-70 -110.3 139.34 21.37 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-O 120.706 0.289 . . . . 0.0 111.039 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.447 ' C ' ' HG3' ' A' ' 75' ' ' MET . 48.6 Cg_exo -54.24 -76.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.639 2.226 . . . . 0.0 112.937 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.538 ' HB3' ' HA2' ' A' ' 97' ' ' GLY . 2.8 mtm -144.14 54.34 1.29 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.845 0.355 . . . . 0.0 110.743 -179.407 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.411 ' CD1' HD11 ' A' ' 43' ' ' LEU . 1.9 tt -63.83 115.68 20.78 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.725 -179.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -56.72 118.04 4.81 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.497 2.131 . . . . 0.0 112.546 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.868 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 2.8 t -124.99 146.58 30.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.126 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.638 ' HB ' ' HG ' ' A' ' 52' ' ' LEU . 2.3 mp -128.07 116.23 41.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 179.271 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.784 ' HA ' ' O ' ' A' ' 53' ' ' SER . 18.0 mm -95.34 142.59 13.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.979 0.419 . . . . 0.0 112.086 -178.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.525 ' CB ' ' CE1' ' A' ' 106' ' ' PHE . 1.7 ptt? -66.46 -32.38 73.71 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.609 -178.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.549 ' HA ' ' O ' ' A' ' 102' ' ' LEU . 4.3 m -148.1 169.99 18.78 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.581 0.229 . . . . 0.0 111.362 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.512 ' HB3' HD23 ' A' ' 87' ' ' LEU . . . -144.69 56.06 1.27 Allowed 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 14.8 p80 -99.17 176.36 5.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.092 0.472 . . . . 0.0 111.897 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.4 t 67.44 -78.68 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.972 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.427 ' O ' HD21 ' A' ' 63' ' ' LEU . 0.8 OUTLIER -120.4 70.18 0.88 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.894 0.378 . . . . 0.0 111.277 -179.358 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.611 ' O ' ' HB2' ' A' ' 90' ' ' ALA . 3.0 tm? -54.93 -22.37 14.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.985 179.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -51.46 -56.26 14.28 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.756 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.423 ' HB2' HD21 ' A' ' 63' ' ' LEU . . . -59.47 -20.51 55.8 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.715 0.293 . . . . 0.0 111.147 -179.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.611 ' HB2' ' O ' ' A' ' 87' ' ' LEU . . . -69.13 -62.17 1.49 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.973 0.416 . . . . 0.0 110.776 179.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.598 HG22 HD13 ' A' ' 87' ' ' LEU . 8.4 t -53.62 -44.48 57.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.831 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.59 ' HA ' ' CG ' ' A' ' 95' ' ' GLN . 1.7 m -60.25 -25.24 65.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.17 0.51 . . . . 0.0 109.686 178.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.542 ' C ' ' HB1' ' A' ' 98' ' ' ALA . . . -75.88 -49.5 17.74 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.573 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.525 ' HA ' ' HB1' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -73.31 -29.25 62.57 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.038 -179.139 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.59 ' CG ' ' HA ' ' A' ' 92' ' ' SER . 2.1 pp0? -77.27 -37.61 52.58 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.547 178.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.542 ' HG2' ' O ' ' A' ' 93' ' ' ALA . 10.3 pt20 -73.47 -17.23 61.26 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.053 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.538 ' HA2' ' HB3' ' A' ' 75' ' ' MET . . . 165.16 -33.08 0.25 Allowed Glycine 0 C--N 1.335 0.473 0 C-N-CA 120.047 -1.073 . . . . 0.0 113.762 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.868 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -58.4 155.64 11.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 117.549 0.674 . . . . 0.0 111.218 -179.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.502 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 23.8 t80 -69.2 -53.88 17.7 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.735 -178.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.44 ' HB3' ' O ' ' A' ' 99' ' ' PHE . 17.1 p-10 178.99 -160.25 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 120.922 0.391 . . . . 0.0 111.084 -179.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.592 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 3.5 m-85 -135.98 153.36 51.42 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.986 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.699 HD23 ' HA ' ' A' ' 106' ' ' PHE . 1.4 tp -103.74 118.98 56.06 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.826 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -71.68 -75.38 0.01 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.034 1.823 . . . . 0.0 112.278 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.427 ' CB ' ' HD3' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -108.94 -57.03 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.503 -179.962 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.469 ' HB3' ' HG3' ' A' ' 110' ' ' GLU . 56.0 Cg_exo -52.31 154.15 11.8 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.295 1.996 . . . . 0.0 112.61 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.699 ' HA ' HD23 ' A' ' 102' ' ' LEU . 31.2 t80 -164.44 -116.52 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.197 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.55 ' O ' ' O ' ' A' ' 106' ' ' PHE . 2.9 p30 43.22 179.48 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.967 0.413 . . . . 0.0 111.449 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.498 HG12 HG12 ' A' ' 18' ' ' VAL . 0.8 OUTLIER -67.99 -43.75 85.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.892 0.377 . . . . 0.0 111.803 -179.617 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.473 ' HB2' ' OD1' ' A' ' 107' ' ' ASP . 4.2 m-20 -49.23 -58.28 5.31 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.567 -179.091 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.583 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 6.7 mm-40 -76.01 -32.02 59.2 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.591 0.234 . . . . 0.0 111.231 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.433 ' CB ' ' O ' ' A' ' 107' ' ' ASP . . . -66.21 -57.46 7.53 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.336 179.295 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.693 ' HA ' HG11 ' A' ' 115' ' ' VAL . 47.8 t -62.01 -33.52 58.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.362 0.601 . . . . 0.0 110.653 179.129 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.24 -46.26 89.63 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.551 179.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.509 HD21 ' CD1' ' A' ' 102' ' ' LEU . 37.9 tp -75.83 -21.98 56.75 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.96 -1.018 . . . . 0.0 112.205 -179.107 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.693 HG11 ' HA ' ' A' ' 112' ' ' VAL . 7.2 p -79.18 -41.44 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 C-N-CA 120.447 -0.501 . . . . 0.0 111.994 -179.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.468 ' N ' HG13 ' A' ' 115' ' ' VAL . 46.5 mt-10 -66.35 -42.95 87.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.825 0.345 . . . . 0.0 110.736 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.9 mtt180 -61.0 -23.86 65.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.385 179.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.502 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -72.17 -48.45 43.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.079 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.506 HD11 HG13 ' A' ' 50' ' ' VAL . 4.5 mt -69.63 -31.31 48.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.076 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 36.3 t -71.96 -50.84 25.52 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.165 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.134 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.536 ' O ' ' HG3' ' A' ' 3' ' ' ARG . 10.2 tpt85 . . . . . 0 N--CA 1.455 -0.224 0 CA-C-O 120.768 0.318 . . . . 0.0 110.776 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.515 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . 68.16 63.06 3.8 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.773 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.473 ' CD1' ' HB3' ' A' ' 3' ' ' ARG . 3.8 mp -101.73 115.02 42.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.767 0.318 . . . . 0.0 110.839 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.513 HG11 ' CD2' ' A' ' 23' ' ' LEU . 7.3 p -105.66 126.41 60.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.327 179.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.593 ' CD1' HG21 ' A' ' 31' ' ' THR . 21.6 m0 -116.63 126.31 53.05 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.669 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.547 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -112.02 148.26 15.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.236 -179.056 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.773 HG11 ' C ' ' A' ' 35' ' ' ASN . 0.2 OUTLIER -130.79 113.36 24.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 120.885 0.374 . . . . 0.0 110.379 178.736 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -161.4 -156.63 0.45 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.798 -179.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -67.24 0.78 2.52 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.411 ' O ' ' N ' ' A' ' 14' ' ' SER . 0.1 OUTLIER 65.38 -158.68 0.28 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.509 0.195 . . . . 0.0 110.783 179.717 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.42 ' HB3' ' H ' ' A' ' 14' ' ' SER . 1.3 t 34.62 -90.51 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 179.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.42 ' H ' ' HB3' ' A' ' 13' ' ' SER . 0.4 OUTLIER -53.87 -57.56 10.5 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.824 0.345 . . . . 0.0 111.114 -179.702 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 22.4 mm -65.2 -24.5 35.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.89 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.6 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 14.7 ttm-85 -71.1 -58.18 3.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.165 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.446 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 57.9 t90 -54.43 -37.3 64.96 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -179.141 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.539 HG11 HG12 ' A' ' 108' ' ' ILE . 8.2 t -67.84 -47.08 80.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -178.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.548 HD22 ' CD1' ' A' ' 108' ' ' ILE . 0.2 OUTLIER -84.25 -27.63 27.78 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -178.636 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.483 ' HG3' ' N ' ' A' ' 21' ' ' ARG . 12.1 pt-20 -66.75 -59.77 3.27 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.846 -179.138 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.483 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 4.0 mmm180 -67.0 -47.7 70.68 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.846 -179.156 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.67 -54.53 45.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.917 0.389 . . . . 0.0 111.456 -179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.762 HD13 ' CD1' ' A' ' 28' ' ' LEU . 2.2 tp -67.68 -23.49 65.31 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.065 179.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.22 -36.31 77.1 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.89 -25.73 68.1 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.427 -0.892 . . . . 0.0 110.982 178.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.404 ' HB2' HD12 ' A' ' 28' ' ' LEU . . . -76.81 -16.11 59.54 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 120.665 0.269 . . . . 0.0 111.067 179.491 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.71 26.59 8.46 Favored Glycine 0 CA--C 1.522 0.514 0 C-N-CA 120.289 -0.958 . . . . 0.0 114.158 178.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.762 ' CD1' HD13 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -127.21 170.38 12.49 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 117.994 0.897 . . . . 0.0 111.805 179.942 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.478 ' O ' HG13 ' A' ' 6' ' ' VAL . 52.9 m -95.46 105.51 17.48 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.432 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.509 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 40.7 t -106.34 113.36 26.83 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.221 0.534 . . . . 0.0 111.948 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.636 HG23 ' CE1' ' A' ' 33' ' ' PHE . 2.8 t -116.85 156.43 27.31 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.6 ' CG2' ' HA ' ' A' ' 16' ' ' ARG . 28.9 p -127.04 158.44 36.95 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.358 0.599 . . . . 0.0 111.684 -179.347 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.806 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 17.0 m-85 -128.44 174.24 9.51 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.735 -178.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.469 ' HG3' ' ND2' ' A' ' 35' ' ' ASN . 1.6 pt-20 -63.3 -37.6 87.87 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.577 0.955 . . . . 0.0 113.577 -177.103 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.773 ' C ' HG11 ' A' ' 9' ' ' VAL . 18.0 p30 -174.92 -41.02 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 118.766 0.712 . . . . 0.0 112.696 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.723 ' N ' HG11 ' A' ' 9' ' ' VAL . . . -178.57 -47.07 0.07 OUTLIER Glycine 0 C--N 1.321 -0.271 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.738 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.517 ' HA ' HD13 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -61.25 -29.94 70.15 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.616 0.246 . . . . 0.0 111.353 -179.525 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.806 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 3.1 tt0 -59.98 -51.34 70.07 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 121.089 -0.245 . . . . 0.0 111.597 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.583 HG12 ' HG ' ' A' ' 43' ' ' LEU . 19.5 t -52.37 -41.13 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 C-N-CA 120.584 -0.446 . . . . 0.0 111.461 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.602 HD11 HE21 ' A' ' 68' ' ' GLN . 7.1 mt -54.7 -46.74 74.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.97 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.91 -49.17 71.48 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.425 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.431 ' HB1' ' HE2' ' A' ' 33' ' ' PHE . . . -66.31 -32.7 74.26 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.881 179.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.671 ' HB3' ' HE2' ' A' ' 73' ' ' HIS . 8.3 mt -60.7 -25.02 66.11 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.086 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.4 -16.84 50.57 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.779 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.3 m -125.72 -0.97 7.37 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.46 ' HD2' ' CZ2' ' A' ' 7' ' ' TRP . 0.0 OUTLIER -160.95 162.07 31.83 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.905 0.383 . . . . 0.0 111.024 179.834 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.457 HG21 HD22 ' A' ' 76' ' ' LEU . 57.8 m -138.42 116.0 9.21 Favored Pre-proline 0 N--CA 1.451 -0.414 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.134 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.487 ' HB3' ' CG ' ' A' ' 7' ' ' TRP . 70.9 Cg_endo -74.76 149.24 37.59 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 121.97 1.78 . . . . 0.0 111.881 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -73.73 -24.89 59.96 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.706 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.518 HG22 ' CG2' ' A' ' 115' ' ' VAL . 7.6 p -147.53 101.83 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.983 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.52 HD13 ' CG1' ' A' ' 39' ' ' VAL . 18.0 tp -87.13 134.48 33.51 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.116 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.548 ' O ' HG21 ' A' ' 9' ' ' VAL . 1.3 tt -121.73 122.54 39.77 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.333 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.562 ' HB3' HD23 ' A' ' 65' ' ' LEU . 2.2 m -123.67 125.51 44.92 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.416 0.627 . . . . 0.0 112.473 -178.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.619 ' HA ' ' HG2' ' A' ' 81' ' ' MET . 1.2 m-20 -83.18 107.14 15.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.78 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.958 HG23 ' HG3' ' A' ' 81' ' ' MET . 4.9 tt -69.99 116.41 11.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.955 179.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.22 58.13 0.46 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.036 0.446 . . . . 0.0 111.883 -179.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.456 ' N ' ' CD ' ' A' ' 58' ' ' PRO . 9.6 ptp 47.07 46.17 3.27 Favored Pre-proline 0 CA--C 1.537 0.473 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 178.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.596 ' CG ' ' HA2' ' A' ' 62' ' ' GLY . 50.3 Cg_endo -69.81 -81.94 0.01 OUTLIER 'Trans proline' 0 CA--C 1.533 0.475 0 C-N-CA 122.89 2.393 . . . . 0.0 111.885 178.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.403 ' H ' ' HG2' ' A' ' 58' ' ' PRO . . . -105.85 -25.68 6.41 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.088 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.554 ' N ' ' HB3' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -161.57 71.75 0.38 Allowed 'General case' 0 C--O 1.235 0.321 0 CA-C-O 120.985 0.421 . . . . 0.0 110.126 179.498 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.532 ' O ' HG13 ' A' ' 55' ' ' ILE . 0.2 OUTLIER 69.49 -25.77 0.15 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.886 -179.805 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.958 ' HA3' HG13 ' A' ' 55' ' ' ILE . . . 136.68 -26.34 3.04 Favored Glycine 0 CA--C 1.502 -0.737 0 N-CA-C 111.639 -0.584 . . . . 0.0 111.639 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.554 ' CB ' ' HB3' ' A' ' 89' ' ' ALA . 4.0 mp -78.26 -14.0 59.62 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-O 121.051 0.453 . . . . 0.0 109.977 178.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.554 ' HB3' ' N ' ' A' ' 60' ' ' MET . . . -53.83 -44.51 70.31 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.031 179.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.562 HD23 ' HB3' ' A' ' 53' ' ' SER . 3.1 pp -57.98 -32.35 67.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.041 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.523 HD22 HD13 ' A' ' 80' ' ' ILE . 7.1 mp -62.93 -44.99 94.58 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.365 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.516 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 30.2 tttt -56.16 -44.62 79.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.756 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.602 HE21 HD11 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -66.26 -39.96 89.83 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.662 -179.869 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.549 HG23 ' HB3' ' A' ' 76' ' ' LEU . 10.4 mt -65.03 -32.65 59.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.816 -179.564 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.516 ' HG2' ' O ' ' A' ' 67' ' ' LYS . 16.0 pttt -76.16 -29.04 57.57 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.966 0.413 . . . . 0.0 111.108 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.18 -44.01 89.82 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.382 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 79.3 mtt-85 -87.57 -23.09 24.43 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.735 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.713 ' CB ' ' HB2' ' A' ' 76' ' ' LEU . 88.7 m-70 -143.28 92.57 6.67 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.972 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.465 ' O ' ' O ' ' A' ' 96' ' ' GLN . 23.0 Cg_exo -64.86 6.11 0.39 Allowed 'Trans proline' 0 CA--C 1.531 0.343 0 C-N-CA 122.657 2.238 . . . . 0.0 113.123 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.584 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -143.35 14.08 1.81 Allowed 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.666 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.713 ' HB2' ' CB ' ' A' ' 73' ' ' HIS . 0.8 OUTLIER -75.53 113.06 22.64 Favored Pre-proline 0 C--N 1.332 -0.188 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -179.512 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.822 ' HB2' ' HD1' ' A' ' 99' ' ' PHE . 37.9 Cg_endo -67.5 116.66 4.35 Favored 'Trans proline' 0 CA--C 1.533 0.458 0 C-N-CA 122.546 2.164 . . . . 0.0 112.423 179.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.424 ' C ' ' HB2' ' A' ' 99' ' ' PHE . 3.6 t -115.05 136.61 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 120.921 0.391 . . . . 0.0 111.719 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.585 HG22 HD22 ' A' ' 114' ' ' LEU . 2.3 mt -110.37 116.54 52.62 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.207 0 CA-C-O 121.143 0.497 . . . . 0.0 110.956 179.04 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.623 HD11 ' O ' ' A' ' 100' ' ' ASP . 1.6 mp -98.77 134.26 38.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.385 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.958 ' HG3' HG23 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -73.61 -24.93 60.1 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -178.089 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.543 ' O ' HG23 ' A' ' 80' ' ' ILE . 3.9 m -147.38 159.21 43.95 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.154 0.502 . . . . 0.0 112.327 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.433 ' CB ' ' CD2' ' A' ' 101' ' ' TYR . . . -138.03 68.58 1.4 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.61 179.115 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -68.2 -141.87 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.067 -179.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.2 p -80.44 79.23 7.07 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-O 120.927 0.394 . . . . 0.0 111.558 -179.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.542 ' O ' HD21 ' A' ' 63' ' ' LEU . 2.1 t70 179.53 29.06 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.926 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.423 ' O ' HG21 ' A' ' 91' ' ' VAL . 0.3 OUTLIER -54.15 -21.41 8.66 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.653 -179.966 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -47.25 -54.45 10.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.741 0.305 . . . . 0.0 111.59 -179.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.554 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -69.6 -22.3 63.51 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.145 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.503 ' HB3' ' CD2' ' A' ' 63' ' ' LEU . . . -75.11 -42.14 57.07 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.792 0.329 . . . . 0.0 110.34 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.681 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 19.5 t -62.56 -52.8 55.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.034 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.3 p -57.39 -33.55 67.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.62 0.724 . . . . 0.0 109.833 179.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.613 ' HA ' ' CD ' ' A' ' 96' ' ' GLN . . . -57.56 -39.95 77.84 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.482 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.681 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 18.8 m-85 -60.67 -21.12 62.49 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.237 179.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.627 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -74.01 -43.83 56.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.312 179.715 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.627 ' N ' ' HG2' ' A' ' 95' ' ' GLN . 3.8 pm0 -80.33 -12.4 59.6 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.48 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.542 ' O ' ' HA ' ' A' ' 77' ' ' PRO . . . 117.17 38.38 0.87 Allowed Glycine 0 C--O 1.228 -0.25 0 C-N-CA 119.972 -1.109 . . . . 0.0 114.045 178.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.549 ' HB2' ' C ' ' A' ' 93' ' ' ALA . . . -63.04 146.36 53.4 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 117.319 0.559 . . . . 0.0 110.772 179.162 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.822 ' HD1' ' HB2' ' A' ' 77' ' ' PRO . 1.3 t80 -71.75 -54.35 10.51 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.167 179.405 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.623 ' O ' HD11 ' A' ' 80' ' ' ILE . 2.9 p30 166.79 -166.87 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.711 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.563 ' CZ ' HG12 ' A' ' 80' ' ' ILE . 4.8 m-85 -143.21 145.95 33.24 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.38 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.522 ' CD2' ' HA ' ' A' ' 106' ' ' PHE . 6.4 mp -102.26 119.76 55.45 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.625 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -58.53 -66.27 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.343 2.029 . . . . 0.0 112.593 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.625 ' H ' ' HD2' ' A' ' 105' ' ' PRO . 8.8 mtpp -124.5 -60.68 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.465 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.625 ' HD2' ' H ' ' A' ' 104' ' ' LYS . 16.7 Cg_endo -57.13 159.24 15.65 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.077 1.851 . . . . 0.0 112.422 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.616 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 29.1 t80 -170.62 -104.34 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.382 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.538 ' O ' ' O ' ' A' ' 106' ' ' PHE . 3.3 p30 42.85 -177.58 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.542 0.211 . . . . 0.0 110.833 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.548 ' CD1' HD22 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -67.93 -42.67 85.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.994 0.426 . . . . 0.0 111.681 -179.716 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.496 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 1.7 m-20 -49.03 -57.46 6.51 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.54 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.616 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 5.5 mm-40 -77.0 -32.28 57.09 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 121.047 -0.261 . . . . 0.0 111.699 -179.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' A' ' 107' ' ' ASP . . . -66.6 -62.59 1.38 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.077 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.784 ' O ' HG13 ' A' ' 115' ' ' VAL . 42.6 t -57.64 -30.37 36.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 121.31 0.576 . . . . 0.0 110.816 178.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.496 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -63.94 -47.04 82.06 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.412 0.625 . . . . 0.0 110.203 179.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.585 HD22 HG22 ' A' ' 79' ' ' ILE . 4.8 tp -72.63 -22.38 60.95 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.487 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.784 HG13 ' O ' ' A' ' 112' ' ' VAL . 9.9 p -79.56 -49.57 19.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 120.437 -0.505 . . . . 0.0 111.843 -179.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.409 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 7.5 mt-10 -65.47 -54.74 24.05 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.766 0.317 . . . . 0.0 111.092 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 27.7 mtp85 -57.21 -26.47 60.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.188 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.529 ' HB2' ' CZ ' ' A' ' 99' ' ' PHE . . . -73.3 -48.99 29.98 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.479 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.2 mt -63.52 -30.88 50.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.218 0.533 . . . . 0.0 110.469 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 46.4 t -73.13 -48.92 31.42 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.099 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 25.4 m80 . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.271 -179.881 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.473 ' CG ' ' H ' ' A' ' 4' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.132 0 CA-C-O 121.05 0.453 . . . . 0.0 111.285 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.574 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . 167.93 89.78 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.701 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.462 HD13 ' HB ' ' A' ' 29' ' ' THR . 23.0 mm -117.74 112.76 40.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.768 0.318 . . . . 0.0 111.496 -179.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.732 HG13 ' HA ' ' A' ' 30' ' ' CYS . 12.2 p -105.26 128.36 59.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.054 178.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.774 ' CD1' HG21 ' A' ' 31' ' ' THR . 24.9 m0 -116.89 129.9 56.36 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.119 0.485 . . . . 0.0 110.009 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.648 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.9 OUTLIER -121.72 149.43 24.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.341 -177.681 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.941 HG11 ' HB2' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -125.31 113.41 35.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.555 178.973 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.444 ' OD2' ' OD2' ' A' ' 54' ' ' ASP . 2.3 t0 -164.78 -159.15 0.44 Allowed 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.14 -179.309 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -67.29 1.1 2.34 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -179.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.406 ' O ' ' N ' ' A' ' 14' ' ' SER . 14.7 t0 65.89 -158.33 0.27 Allowed 'General case' 0 CA--C 1.534 0.33 0 O-C-N 122.233 -0.292 . . . . 0.0 110.995 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.1 t 31.92 -89.84 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 179.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.406 ' N ' ' O ' ' A' ' 12' ' ' ASP . 3.5 t -53.72 -56.14 20.01 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.656 0.265 . . . . 0.0 111.468 -179.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.406 HG21 ' CB ' ' A' ' 10' ' ' ASP . 24.5 mm -66.51 -25.0 34.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.923 0.392 . . . . 0.0 111.048 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.616 ' HA ' HG21 ' A' ' 32' ' ' THR . 3.2 tmm_? -77.99 -44.48 26.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.777 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.43 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 82.3 t90 -64.49 -39.79 94.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.67 -179.128 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.645 HG12 HG12 ' A' ' 108' ' ' ILE . 6.3 t -69.14 -43.12 81.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 112.748 0.648 . . . . 0.0 112.748 -179.024 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.454 ' CD2' HG11 ' A' ' 8' ' ' VAL . 1.5 tp -84.53 -22.62 30.09 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -178.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.618 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 17.6 pt-20 -67.71 -57.11 6.93 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.099 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.474 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 5.8 mmt180 -63.22 -49.91 72.32 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.597 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.41 -56.3 20.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.154 0.502 . . . . 0.0 111.147 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.67 ' HG ' HG12 ' A' ' 6' ' ' VAL . 2.0 tm? -66.01 -28.21 68.7 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.537 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.26 -34.23 76.98 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.24 -26.73 66.43 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.379 -0.915 . . . . 0.0 111.366 178.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.442 ' HB1' HD12 ' A' ' 28' ' ' LEU . . . -76.84 -15.76 59.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.822 0.344 . . . . 0.0 110.919 179.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.25 25.5 10.21 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.797 -0.716 . . . . 0.0 113.596 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.574 ' HB3' ' O ' ' A' ' 4' ' ' GLY . 0.0 OUTLIER -130.74 171.67 12.84 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 117.762 0.781 . . . . 0.0 111.648 179.689 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.477 ' O ' HG11 ' A' ' 6' ' ' VAL . 32.1 m -94.35 130.71 40.55 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.175 -179.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.732 ' HA ' HG13 ' A' ' 6' ' ' VAL . 48.9 t -123.69 115.65 21.78 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 121.272 0.558 . . . . 0.0 111.83 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.774 HG21 ' CD1' ' A' ' 7' ' ' TRP . 2.9 t -117.44 156.5 27.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.597 178.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.648 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 55.5 p -132.53 151.41 51.93 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.142 0.496 . . . . 0.0 112.054 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.941 ' HB2' HG11 ' A' ' 9' ' ' VAL . 2.0 m-85 -125.46 174.42 8.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.228 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.615 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -61.66 -107.63 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.652 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.447 ' H ' ' CG ' ' A' ' 34' ' ' GLU . 0.6 OUTLIER -80.35 -69.84 0.57 Allowed 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.029 0.442 . . . . 0.0 112.038 -178.545 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.683 ' HA2' HG13 ' A' ' 9' ' ' VAL . . . -167.42 -36.56 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.484 -0.865 . . . . 0.0 113.543 -179.155 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.477 ' HA ' HD12 ' A' ' 40' ' ' LEU . 12.4 m120 -61.91 -30.0 70.59 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 116.999 0.399 . . . . 0.0 110.594 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.81 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -53.64 -56.86 13.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.624 179.225 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.584 HG22 HG13 ' A' ' 9' ' ' VAL . 2.9 t -51.75 -46.74 39.51 Favored 'Isoleucine or valine' 0 C--N 1.342 0.254 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.44 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.518 HD13 ' HB2' ' A' ' 68' ' ' GLN . 23.6 mt -55.23 -42.87 73.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.008 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.47 -49.65 72.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.159 0.504 . . . . 0.0 111.231 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.44 -26.4 63.63 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.05 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.707 HD13 ' NE2' ' A' ' 73' ' ' HIS . 6.5 mt -63.99 -21.3 66.43 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.445 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.72 -16.83 29.98 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.111 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.5 m -121.58 1.25 10.04 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -165.9 159.74 16.15 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.888 0.375 . . . . 0.0 111.367 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 90.8 m -138.58 111.84 8.34 Favored Pre-proline 0 N--CA 1.45 -0.441 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.422 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.709 ' HD2' HD11 ' A' ' 76' ' ' LEU . 51.8 Cg_endo -67.94 154.12 73.62 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.688 2.258 . . . . 0.0 111.891 179.041 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -74.66 -26.07 59.62 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.466 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.516 ' CG2' HD13 ' A' ' 79' ' ' ILE . 7.2 p -146.28 101.66 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.229 -178.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.618 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 19.5 tp -86.85 137.11 32.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.985 0.421 . . . . 0.0 111.427 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.564 ' HB3' HG12 ' A' ' 8' ' ' VAL . 1.9 tt -126.85 127.55 45.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.145 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -126.22 129.21 48.51 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.343 0.592 . . . . 0.0 111.474 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.444 ' OD2' ' OD2' ' A' ' 10' ' ' ASP . 0.5 OUTLIER -79.02 -0.24 30.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.324 -179.212 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.695 HG13 ' HA3' ' A' ' 62' ' ' GLY . 11.9 tt 36.82 94.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-O 120.89 0.376 . . . . 0.0 111.579 -179.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.8 mtt180 -118.84 40.51 3.25 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.775 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.581 ' HG2' ' HA ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER 59.59 46.19 1.33 Allowed Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 179.239 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.463 ' CD ' ' N ' ' A' ' 57' ' ' MET . 27.5 Cg_endo -61.9 -79.76 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.162 1.908 . . . . 0.0 111.23 178.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -106.35 -82.68 1.55 Allowed Glycine 0 C--N 1.332 0.343 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 178.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.696 ' H ' ' HB1' ' A' ' 64' ' ' ALA . 17.0 tpp -87.57 59.36 5.42 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 177.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.581 ' HA ' ' HG2' ' A' ' 57' ' ' MET . 0.1 OUTLIER 63.54 -16.05 0.07 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.021 -0.99 . . . . 0.0 111.851 -178.656 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.695 ' HA3' HG13 ' A' ' 55' ' ' ILE . . . 135.98 -30.95 2.69 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 -178.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.57 HD22 ' O ' ' A' ' 86' ' ' ASP . 1.9 tp -56.33 -30.17 62.26 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 178.117 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.696 ' HB1' ' H ' ' A' ' 60' ' ' MET . . . -53.69 -38.32 64.1 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.213 178.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.634 ' O ' HG13 ' A' ' 69' ' ' ILE . 1.7 tp -51.41 -50.04 60.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.368 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.732 HD11 ' OH ' ' A' ' 101' ' ' TYR . 81.3 mt -52.8 -42.87 65.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.141 179.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 31.3 mttm -58.47 -46.88 85.72 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.4 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.518 ' HB2' HD13 ' A' ' 40' ' ' LEU . 16.7 mm100 -65.0 -31.68 73.03 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.778 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.634 HG13 ' O ' ' A' ' 65' ' ' LEU . 88.7 mt -60.06 -45.72 95.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.728 -179.373 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.456 ' HG3' ' N ' ' A' ' 71' ' ' GLN . 0.4 OUTLIER -68.94 -29.5 67.75 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.536 -179.864 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.456 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 7.6 mt-30 -83.98 -33.21 24.63 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.565 -179.251 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.449 ' HB2' ' CD2' ' A' ' 73' ' ' HIS . 3.2 mtp85 -90.5 -65.26 1.03 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.18 -178.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.707 ' NE2' HD13 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -96.31 159.62 31.58 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.394 -178.956 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -96.44 101.2 0.09 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 123.489 2.793 . . . . 0.0 113.619 -179.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 6.8 mtt 57.04 24.2 9.29 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 177.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.709 HD11 ' HD2' ' A' ' 48' ' ' PRO . 2.2 tt -60.22 112.31 5.29 Favored Pre-proline 0 C--N 1.325 -0.487 0 C-N-CA 120.934 -0.307 . . . . 0.0 111.327 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.61 116.0 2.99 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.432 2.088 . . . . 0.0 112.153 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.886 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 19.0 t -115.06 145.14 21.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.985 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.516 HD13 ' CG2' ' A' ' 50' ' ' VAL . 1.8 mp -118.79 110.99 31.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.982 0.42 . . . . 0.0 111.031 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.526 ' HB ' ' CZ ' ' A' ' 101' ' ' TYR . 21.6 mm -103.3 146.72 10.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.578 -179.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.436 ' O ' ' HB2' ' A' ' 102' ' ' LEU . 7.2 ttt -69.06 -78.61 0.07 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.967 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.454 ' O ' HD13 ' A' ' 55' ' ' ILE . 4.0 m -106.62 159.08 16.47 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.118 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.478 ' HA ' ' CE2' ' A' ' 101' ' ' TYR . . . -87.52 -17.59 31.72 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.895 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.478 ' CD2' HG12 ' A' ' 55' ' ' ILE . 3.8 m-70 48.33 -89.63 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.409 ' N ' ' O ' ' A' ' 83' ' ' ALA . 4.7 m -81.83 -169.97 2.61 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.834 0.35 . . . . 0.0 111.087 -179.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.57 ' O ' HD22 ' A' ' 63' ' ' LEU . 24.7 m-20 -40.86 108.62 0.09 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.166 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.3 mt -48.15 -20.99 0.41 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.398 178.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -47.74 -43.58 27.24 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -178.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.556 ' HB2' ' HG ' ' A' ' 63' ' ' LEU . . . -74.1 -21.33 59.94 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 120.243 -0.583 . . . . 0.0 109.912 179.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.693 ' HA ' ' CD1' ' A' ' 66' ' ' LEU . . . -77.55 -58.91 3.01 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.615 178.239 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.742 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 18.3 t -58.25 -56.75 14.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.561 -179.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 57.6 p -52.79 -27.58 18.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.069 0.462 . . . . 0.0 110.696 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.493 ' C ' ' HB3' ' A' ' 98' ' ' ALA . . . -58.36 -46.08 86.97 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.003 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.742 ' CE2' ' HA ' ' A' ' 91' ' ' VAL . 5.5 m-85 -48.68 -27.95 3.22 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.767 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.6 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -76.91 -39.61 50.27 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.704 -179.903 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.6 ' N ' ' HG2' ' A' ' 95' ' ' GLN . 7.7 pt20 -100.14 5.33 44.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.979 -178.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 127.98 79.25 0.26 Allowed Glycine 0 CA--C 1.519 0.323 0 C-N-CA 120.101 -1.047 . . . . 0.0 113.178 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.886 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -171.62 127.04 0.63 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.008 0.432 . . . . 0.0 110.477 179.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.436 ' N ' ' O ' ' A' ' 78' ' ' VAL . 13.6 t80 -70.14 -53.73 16.0 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -178.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.681 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 0.1 OUTLIER 179.04 -170.48 0.12 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.011 0.434 . . . . 0.0 111.729 -179.291 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.732 ' OH ' HD11 ' A' ' 66' ' ' LEU . 3.0 m-85 -135.01 153.6 52.02 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.476 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.459 HD22 ' HA ' ' A' ' 106' ' ' PHE . 7.4 mp -102.19 123.76 42.21 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-O 120.768 0.318 . . . . 0.0 111.09 -179.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -69.71 -56.62 0.14 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.434 2.089 . . . . 0.0 112.475 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.657 ' HB3' ' HD3' ' A' ' 105' ' ' PRO . 1.8 ttmp? -133.52 -56.14 0.02 OUTLIER Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.474 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.657 ' HD3' ' HB3' ' A' ' 104' ' ' LYS . 45.1 Cg_exo -57.52 160.03 15.12 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 121.765 1.644 . . . . 0.0 111.758 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.634 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 62.9 t80 -165.85 -105.52 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.186 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.6 ' O ' ' O ' ' A' ' 106' ' ' PHE . 3.1 p30 41.65 178.63 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.959 0.409 . . . . 0.0 111.321 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.645 HG12 HG12 ' A' ' 18' ' ' VAL . 0.9 OUTLIER -67.89 -41.04 84.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.124 179.659 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.551 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 33.7 t0 -49.18 -58.54 4.83 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.602 -179.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.634 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 10.3 mm-40 -76.33 -32.6 58.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.711 0.291 . . . . 0.0 111.402 -179.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.85 -60.07 3.23 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.815 0.34 . . . . 0.0 110.407 179.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.627 ' O ' HG13 ' A' ' 115' ' ' VAL . 47.1 t -59.63 -30.79 45.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.576 0.703 . . . . 0.0 110.468 178.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.551 ' HB3' ' O ' ' A' ' 109' ' ' ASP . . . -63.66 -45.51 89.83 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.011 178.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.498 ' CD2' HG23 ' A' ' 79' ' ' ILE . 34.1 tp -77.35 -22.7 51.42 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.604 -179.344 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.627 HG13 ' O ' ' A' ' 112' ' ' VAL . 5.3 p -79.39 -40.98 22.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 120.467 -0.493 . . . . 0.0 111.412 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -67.19 -48.59 67.47 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.963 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.442 ' HE ' ' HA ' ' A' ' 114' ' ' LEU . 0.9 OUTLIER -58.93 -23.28 61.19 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.808 179.948 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.417 ' HA ' ' CZ ' ' A' ' 99' ' ' PHE . . . -72.43 -44.39 62.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.169 179.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.438 HG12 HG12 ' A' ' 50' ' ' VAL . 4.8 mt -72.18 -32.05 41.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.283 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 2.3 t -71.9 -47.2 54.33 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.805 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 . . . . . 0 C--N 1.327 -0.393 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.08 179.875 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.453 ' HG3' HD13 ' A' ' 5' ' ' ILE . 15.2 ptt180 . . . . . 0 CA--C 1.52 -0.2 0 CA-C-O 121.224 0.535 . . . . 0.0 110.691 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.449 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . 101.45 112.79 3.59 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.836 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.453 HD13 ' HG3' ' A' ' 3' ' ' ARG . 8.7 mm -124.97 112.89 33.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.809 0.338 . . . . 0.0 111.576 -178.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.758 HG11 ' CD1' ' A' ' 23' ' ' LEU . 8.0 p -106.47 125.52 62.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.17 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.636 ' CH2' ' HG2' ' A' ' 46' ' ' LYS . 29.1 m0 -117.13 123.46 46.81 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.627 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.0 OUTLIER -116.97 137.83 49.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.329 -177.237 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.879 HG12 ' HB2' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -121.25 104.98 15.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.967 178.695 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.444 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 3.7 t70 -168.1 72.49 0.1 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.984 0.421 . . . . 0.0 111.87 -179.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 63.95 2.59 1.42 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 179.015 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.7 p30 44.83 -149.63 0.07 Allowed 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.423 ' O ' ' HB3' ' A' ' 16' ' ' ARG . 1.4 t 34.85 -92.17 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 179.56 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.422 ' O ' HG23 ' A' ' 18' ' ' VAL . 2.9 t -53.81 -66.06 0.46 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.776 0.322 . . . . 0.0 110.56 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.487 ' CG2' HD12 ' A' ' 19' ' ' LEU . 35.0 mm -60.98 -20.51 22.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.924 179.349 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.52 ' HG3' ' OG1' ' A' ' 32' ' ' THR . 2.0 ttt180 -69.86 -58.03 4.36 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.255 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.462 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 36.8 t90 -59.43 -41.24 89.11 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.048 -0.523 . . . . 0.0 112.273 -179.117 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 14' ' ' SER . 2.7 t -67.14 -42.19 87.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -178.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.53 HD11 HG12 ' A' ' 8' ' ' VAL . 24.0 mt -84.13 -26.85 28.58 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -178.407 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.532 ' HG3' ' N ' ' A' ' 21' ' ' ARG . 21.2 pt-20 -67.5 -58.71 4.25 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.036 0.446 . . . . 0.0 112.029 -178.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.532 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 0.9 OUTLIER -50.71 -53.53 30.59 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.168 -179.154 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.01 -50.25 67.04 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -179.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.758 ' CD1' HG11 ' A' ' 6' ' ' VAL . 3.0 tm? -70.09 -30.62 67.89 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.421 0.629 . . . . 0.0 110.336 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.77 -32.53 73.88 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.64 -27.94 70.64 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 110.701 -0.959 . . . . 0.0 110.701 177.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.66 -15.75 59.73 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 120.625 0.25 . . . . 0.0 110.5 179.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.51 26.33 12.19 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.533 -0.842 . . . . 0.0 114.271 178.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.531 ' HB2' HD13 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -125.41 165.78 17.78 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 118.257 1.028 . . . . 0.0 112.3 179.729 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.59 ' O ' HG13 ' A' ' 6' ' ' VAL . 91.8 m -75.06 125.95 30.01 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.783 -179.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.645 ' HA ' HG13 ' A' ' 6' ' ' VAL . 4.2 p -125.77 110.4 13.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.697 -179.447 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.607 HG23 ' NE1' ' A' ' 7' ' ' TRP . 2.6 t -125.46 149.71 47.98 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.627 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 53.1 p -126.95 161.36 28.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.529 0.68 . . . . 0.0 112.734 -179.254 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.879 ' HB2' HG12 ' A' ' 9' ' ' VAL . 0.7 OUTLIER -135.23 173.37 11.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.595 -179.714 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.583 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -59.3 -103.11 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.885 -178.234 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.511 ' OD1' ' HD3' ' A' ' 58' ' ' PRO . 0.2 OUTLIER -88.93 -71.44 0.6 Allowed 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.103 0.478 . . . . 0.0 111.814 -179.076 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.494 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . -163.45 -34.74 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.638 -0.71 . . . . 0.0 113.069 -178.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.405 ' HA ' ' CD1' ' A' ' 40' ' ' LEU . 28.1 m120 -58.43 -32.51 68.76 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 121.223 0.535 . . . . 0.0 110.11 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.719 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -54.67 -61.79 2.08 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.24 179.542 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.574 HG23 HG11 ' A' ' 9' ' ' VAL . 4.4 t -50.05 -32.51 8.56 Favored 'Isoleucine or valine' 0 C--N 1.342 0.282 0 C-N-CA 120.329 -0.549 . . . . 0.0 110.926 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.56 HD13 ' HB3' ' A' ' 68' ' ' GLN . 22.6 mt -58.49 -44.73 89.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.839 0.352 . . . . 0.0 110.56 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.33 -49.39 77.79 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.228 0.537 . . . . 0.0 110.348 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.69 -31.79 72.0 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.156 178.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.61 HD22 ' HD3' ' A' ' 48' ' ' PRO . 10.2 mt -63.65 -25.82 68.39 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.706 179.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.503 ' HA ' ' HD3' ' A' ' 72' ' ' ARG . . . -59.34 -24.25 63.19 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.155 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -128.61 9.35 5.97 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.636 ' HG2' ' CH2' ' A' ' 7' ' ' TRP . 25.2 tptt -146.02 162.46 37.81 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 121.365 0.602 . . . . 0.0 111.878 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.56 ' H ' ' HG3' ' A' ' 46' ' ' LYS . 95.2 m -138.92 110.47 7.89 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.072 177.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.61 ' HD3' HD22 ' A' ' 43' ' ' LEU . 87.2 Cg_endo -80.65 148.38 17.94 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 122.433 2.089 . . . . 0.0 111.735 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -74.46 -30.79 62.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.946 0.403 . . . . 0.0 110.966 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.586 HG11 HG23 ' A' ' 6' ' ' VAL . 6.7 p -149.84 94.12 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.554 -179.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.454 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 27.0 tp -86.79 141.02 29.14 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.627 -179.218 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.836 ' HG ' ' HB ' ' A' ' 79' ' ' ILE . 0.2 OUTLIER -122.01 114.77 21.41 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.193 179.951 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.639 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -107.71 143.58 36.02 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.405 0.621 . . . . 0.0 112.086 -179.599 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 30.2 p30 -83.06 -177.66 6.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.02 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.745 HG21 ' HG3' ' A' ' 81' ' ' MET . 3.5 tt -159.13 160.85 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.885 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.446 ' H ' HG13 ' A' ' 55' ' ' ILE . 0.1 OUTLIER 78.01 51.95 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.007 0.432 . . . . 0.0 110.499 -179.207 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.493 ' CB ' ' CD ' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -163.39 -65.24 0.01 OUTLIER Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.95 179.892 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.596 ' HD2' ' O ' ' A' ' 61' ' ' ASP . 37.6 Cg_endo -65.44 -163.46 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.115 2.544 . . . . 0.0 112.933 -179.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -52.81 -89.89 0.01 OUTLIER Glycine 0 C--N 1.332 0.315 0 CA-C-N 115.974 -0.557 . . . . 0.0 113.0 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.502 ' O ' ' N ' ' A' ' 62' ' ' GLY . 2.6 tpp -72.52 57.38 0.39 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.774 0.321 . . . . 0.0 110.77 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.596 ' O ' ' HD2' ' A' ' 58' ' ' PRO . 0.1 OUTLIER 59.67 -74.34 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.067 179.948 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.548 ' O ' HD23 ' A' ' 65' ' ' LEU . . . -152.65 -30.1 0.04 OUTLIER Glycine 0 C--N 1.321 -0.264 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.502 -179.361 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.767 HD11 ' HB3' ' A' ' 86' ' ' ASP . 0.3 OUTLIER -66.14 -22.17 66.37 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.742 0.306 . . . . 0.0 110.874 179.912 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.407 ' CB ' ' CB ' ' A' ' 60' ' ' MET . . . -54.95 -30.21 58.41 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.349 0.595 . . . . 0.0 109.923 179.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.548 HD23 ' O ' ' A' ' 62' ' ' GLY . 2.7 mm? -66.07 -45.29 81.83 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.998 179.309 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.615 HD12 ' OH ' ' A' ' 101' ' ' TYR . 10.2 mt -51.81 -44.22 63.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.509 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.424 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 2.8 ttmm -55.14 -44.54 75.17 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.474 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.56 ' HB3' HD13 ' A' ' 40' ' ' LEU . 51.0 mm-40 -70.6 -43.91 68.38 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.191 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 56.2 mt -60.68 -36.2 69.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 121.057 0.456 . . . . 0.0 111.431 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.52 ' HB3' ' CD ' ' A' ' 96' ' ' GLN . 16.2 pttp -73.07 -27.0 61.47 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.285 -179.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -65.08 -39.07 92.67 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.237 0.541 . . . . 0.0 110.663 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.503 ' HD3' ' HA ' ' A' ' 44' ' ' ALA . 15.4 mtt-85 -94.42 -24.76 17.21 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.21 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.525 ' CB ' ' HB2' ' A' ' 76' ' ' LEU . 83.1 m-70 -140.47 101.59 6.7 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.138 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -77.03 11.48 2.02 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.596 2.198 . . . . 0.0 113.702 -179.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.674 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 5.9 mtt -147.64 12.95 1.03 Allowed 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.567 HD22 ' HD2' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -76.24 110.53 11.49 Favored Pre-proline 0 N--CA 1.462 0.164 0 CA-C-O 120.583 0.23 . . . . 0.0 111.576 179.881 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.415 ' HD3' ' O ' ' A' ' 75' ' ' MET . 35.4 Cg_exo -62.57 128.22 22.89 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.478 2.119 . . . . 0.0 111.906 179.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.511 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 4.3 t -125.1 152.66 31.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.059 0.456 . . . . 0.0 111.48 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.836 ' HB ' ' HG ' ' A' ' 52' ' ' LEU . 1.9 mt -134.17 112.09 15.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.483 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.639 ' HA ' ' O ' ' A' ' 53' ' ' SER . 16.6 mm -94.83 138.03 21.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.383 -179.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.745 ' HG3' HG21 ' A' ' 55' ' ' ILE . 0.2 OUTLIER -68.43 -31.41 70.72 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -178.936 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.506 ' O ' HG22 ' A' ' 55' ' ' ILE . 91.4 m -146.83 153.93 40.76 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.607 0.241 . . . . 0.0 110.713 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.475 ' HA ' ' CE2' ' A' ' 101' ' ' TYR . . . -106.23 -33.1 7.92 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -179.219 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 45.88 -166.64 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.727 0.298 . . . . 0.0 111.52 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -80.32 79.51 6.89 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.725 -179.066 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.767 ' HB3' HD11 ' A' ' 63' ' ' LEU . 0.1 OUTLIER -179.22 28.61 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.831 179.197 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.595 HD11 ' HB1' ' A' ' 90' ' ' ALA . 0.5 OUTLIER -49.23 -20.8 0.67 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 112.088 -179.985 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -47.68 -54.94 10.59 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 -179.103 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.495 ' HB3' ' HB2' ' A' ' 63' ' ' LEU . . . -70.68 -21.49 62.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.851 0.358 . . . . 0.0 111.247 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.595 ' HB1' HD11 ' A' ' 87' ' ' LEU . . . -69.69 -41.95 74.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.654 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.633 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 3.4 t -62.07 -46.24 96.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.898 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.465 ' O ' ' HB3' ' A' ' 95' ' ' GLN . 38.5 m -65.14 -21.96 66.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.039 0.447 . . . . 0.0 109.834 179.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.566 ' HB3' ' O ' ' A' ' 90' ' ' ALA . . . -66.0 -39.33 90.2 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.296 0.57 . . . . 0.0 109.687 179.049 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.633 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 8.9 m-85 -69.89 -22.7 63.21 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.639 178.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.465 ' HB3' ' O ' ' A' ' 92' ' ' SER . 0.3 OUTLIER -69.39 -44.31 71.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.906 179.555 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.674 ' O ' ' HA ' ' A' ' 75' ' ' MET . 2.3 pt20 -75.68 -17.95 59.79 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.668 179.12 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 125.24 16.87 2.8 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.368 -0.92 . . . . 0.0 113.939 178.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.511 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -55.47 151.23 10.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 117.413 0.607 . . . . 0.0 110.79 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.551 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 14.3 t80 -77.07 -53.55 7.66 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.269 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 169.92 -166.0 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.0 0.428 . . . . 0.0 111.656 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.638 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 3.4 m-85 -133.4 153.35 51.68 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.086 -179.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.697 HD21 ' HA ' ' A' ' 106' ' ' PHE . 1.0 OUTLIER -103.42 118.64 57.19 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.887 179.943 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -73.7 -72.94 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.089 1.859 . . . . 0.0 112.444 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.459 ' CB ' ' HD3' ' A' ' 105' ' ' PRO . 2.2 tttt -111.38 -57.98 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.663 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.459 ' HD3' ' CB ' ' A' ' 104' ' ' LYS . 51.8 Cg_exo -54.45 153.35 23.18 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.165 1.91 . . . . 0.0 112.524 -179.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.697 ' HA ' HD21 ' A' ' 102' ' ' LEU . 41.1 t80 -163.54 -113.15 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.431 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.573 ' O ' ' O ' ' A' ' 106' ' ' PHE . 3.1 p30 42.6 178.3 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 118.122 0.419 . . . . 0.0 111.591 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.533 HG21 HG21 ' A' ' 112' ' ' VAL . 0.8 OUTLIER -67.78 -43.1 86.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.113 0.482 . . . . 0.0 111.272 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.443 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 0.4 OUTLIER -49.04 -58.11 5.46 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.594 -179.548 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.636 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 36.5 mm-40 -76.98 -33.29 57.64 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.757 0.313 . . . . 0.0 111.371 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.428 ' CB ' ' O ' ' A' ' 107' ' ' ASP . . . -64.41 -59.13 4.72 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.116 179.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.64 ' HA ' HG13 ' A' ' 115' ' ' VAL . 48.3 t -60.74 -32.0 50.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.514 179.108 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.443 ' HB3' ' O ' ' A' ' 109' ' ' ASP . . . -62.51 -46.08 90.07 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.09 179.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.521 HD23 HG23 ' A' ' 79' ' ' ILE . 20.6 tp -76.09 -21.12 57.06 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.835 -1.075 . . . . 0.0 111.907 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.64 HG13 ' HA ' ' A' ' 112' ' ' VAL . 3.7 p -78.92 -37.98 20.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.477 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.556 ' HA ' HD12 ' A' ' 119' ' ' ILE . 35.7 mt-10 -68.67 -38.73 80.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.966 0.413 . . . . 0.0 110.735 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.1 mmm180 -63.54 -27.52 69.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.091 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.551 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -69.42 -44.57 71.08 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.064 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.556 HD12 ' HA ' ' A' ' 116' ' ' GLU . 6.5 mt -62.81 -31.95 54.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.16 0.505 . . . . 0.0 110.699 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 9.1 t -75.13 -49.54 19.25 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.868 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 18.1 m80 . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.137 179.855 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.459 ' O ' ' HG3' ' A' ' 3' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.272 0 CA-C-O 120.721 0.296 . . . . 0.0 111.594 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.506 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . 56.7 79.9 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.653 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.416 ' CD1' ' HB3' ' A' ' 3' ' ' ARG . 3.1 mp -116.71 112.18 38.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.697 0.285 . . . . 0.0 110.654 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.543 ' CG2' HG13 ' A' ' 50' ' ' VAL . 6.5 p -108.79 129.35 63.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.826 0.346 . . . . 0.0 110.929 179.242 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.569 ' CD1' HG21 ' A' ' 31' ' ' THR . 33.5 m0 -116.27 139.27 50.56 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.391 179.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.581 ' O ' ' HD1' ' A' ' 33' ' ' PHE . 0.4 OUTLIER -122.59 146.96 27.02 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.303 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.51 -178.352 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.87 HG12 ' HB2' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -129.12 109.33 18.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 120.92 0.391 . . . . 0.0 110.973 179.368 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.427 ' OD1' ' HB3' ' A' ' 54' ' ' ASP . 6.5 t0 -162.16 -158.19 0.51 Allowed 'General case' 0 CA--C 1.53 0.212 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.693 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -66.37 -2.73 4.81 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -179.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.6 t0 66.87 -144.31 0.15 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 121.296 -0.162 . . . . 0.0 110.628 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.411 ' OG ' ' N ' ' A' ' 14' ' ' SER . 53.1 p 33.48 -101.83 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 179.262 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.411 ' N ' ' OG ' ' A' ' 13' ' ' SER . 1.5 m -54.4 -49.5 69.77 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.675 0.274 . . . . 0.0 111.312 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.9 mm -62.97 -24.6 36.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.929 0.395 . . . . 0.0 111.11 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.496 ' HG3' HG21 ' A' ' 32' ' ' THR . 25.2 ttt180 -74.71 -55.09 6.23 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.022 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.428 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 14.6 t90 -56.3 -42.46 77.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.881 -0.6 . . . . 0.0 112.444 -178.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.402 ' CG1' HG12 ' A' ' 108' ' ' ILE . 5.3 t -66.53 -45.3 89.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -178.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.57 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 1.2 mp -83.77 -25.24 30.65 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -178.371 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.516 ' HG3' ' N ' ' A' ' 21' ' ' ARG . 14.8 pt-20 -66.58 -58.87 4.29 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.422 -0.511 . . . . 0.0 111.546 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.516 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -65.76 -51.23 60.88 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.121 -179.073 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.25 -45.27 80.1 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -178.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.57 ' HB2' ' O ' ' A' ' 19' ' ' LEU . 0.4 OUTLIER -74.88 -25.25 58.82 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.95 0.405 . . . . 0.0 110.63 179.688 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.404 ' HB1' ' O ' ' A' ' 20' ' ' GLU . . . -68.87 -34.22 75.08 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 177.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.69 -23.49 68.98 Favored Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 178.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.67 -15.73 58.98 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 120.805 0.336 . . . . 0.0 110.6 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.52 25.08 11.22 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.832 -0.699 . . . . 0.0 113.982 178.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.509 ' CD1' HD23 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -132.07 165.18 24.59 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 117.811 0.805 . . . . 0.0 112.562 179.694 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.499 ' O ' HG12 ' A' ' 6' ' ' VAL . 29.5 m -87.67 108.86 19.29 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.004 -179.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.513 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 42.2 t -106.63 111.71 24.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.031 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.569 HG21 ' CD1' ' A' ' 7' ' ' TRP . 2.4 t -118.04 154.99 31.11 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.04 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.496 HG21 ' HG3' ' A' ' 16' ' ' ARG . 38.5 p -124.37 164.51 19.51 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.123 0.487 . . . . 0.0 111.879 -179.129 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.87 ' HB2' HG12 ' A' ' 9' ' ' VAL . 2.3 m-85 -130.19 172.31 11.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.592 -178.236 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.621 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 3.0 pp20? -63.53 -44.87 92.98 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -177.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.624 ' C ' HG13 ' A' ' 9' ' ' VAL . 1.4 t30 -160.78 -58.2 0.05 Allowed 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -179.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.581 ' HA2' HG13 ' A' ' 9' ' ' VAL . . . -164.99 -43.47 0.02 OUTLIER Glycine 0 C--N 1.319 -0.382 0 C-N-CA 120.371 -0.919 . . . . 0.0 113.431 -179.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.745 ' HA ' HD11 ' A' ' 40' ' ' LEU . 11.2 m120 -67.4 -26.87 66.65 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -178.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.711 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 12.2 tt0 -58.92 -50.51 73.77 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.744 -0.382 . . . . 0.0 111.411 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.634 HG11 ' HG ' ' A' ' 43' ' ' LEU . 10.1 t -61.15 -35.46 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 C-N-CA 120.122 -0.631 . . . . 0.0 111.236 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.745 HD11 ' HA ' ' A' ' 37' ' ' ASN . 31.0 mt -56.94 -41.11 77.66 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.027 0.442 . . . . 0.0 110.728 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -77.53 -47.53 19.29 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.025 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.71 -36.38 80.77 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.069 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.634 ' HG ' HG11 ' A' ' 39' ' ' VAL . 16.0 mt -63.34 -22.98 67.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.031 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.17 -19.61 14.29 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.677 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -124.21 2.59 8.54 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -162.41 155.26 19.78 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.801 0.334 . . . . 0.0 110.862 179.965 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.463 HG21 ' CD2' ' A' ' 76' ' ' LEU . 98.6 m -138.97 112.84 8.23 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.573 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.536 ' HD2' HD21 ' A' ' 43' ' ' LEU . 72.4 Cg_endo -79.1 161.82 26.26 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.085 1.857 . . . . 0.0 111.436 178.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -73.98 -22.57 59.57 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.701 0.286 . . . . 0.0 111.294 -179.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.545 ' HA ' ' HG2' ' A' ' 77' ' ' PRO . 7.1 p -144.97 161.34 13.7 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.231 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.547 ' HB2' HD11 ' A' ' 76' ' ' LEU . 22.6 tp -152.87 133.19 13.59 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.164 0.507 . . . . 0.0 111.913 -178.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.428 ' O ' HG22 ' A' ' 9' ' ' VAL . 0.5 OUTLIER -111.86 115.54 29.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.265 179.983 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.568 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 2.1 m -110.98 138.57 47.22 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.124 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.427 ' HB3' ' OD1' ' A' ' 10' ' ' ASP . 15.4 p-10 -83.03 179.68 7.69 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.781 179.196 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.668 HG13 ' O ' ' A' ' 61' ' ' ASP . 1.0 OUTLIER -154.06 96.85 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.153 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -138.96 40.17 2.14 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.797 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.464 ' N ' ' CD ' ' A' ' 58' ' ' PRO . 0.0 OUTLIER 67.52 47.29 0.41 Allowed Pre-proline 0 CA--C 1.533 0.304 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 179.018 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 62' ' ' GLY . 37.5 Cg_endo -69.27 -76.45 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.309 2.006 . . . . 0.0 111.86 178.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -112.39 -25.25 4.74 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 121.069 -0.586 . . . . 0.0 111.928 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.519 ' C ' ' H ' ' A' ' 62' ' ' GLY . 1.0 OUTLIER -159.62 68.02 0.4 Allowed 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.261 0.553 . . . . 0.0 109.991 179.517 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.668 ' O ' HG13 ' A' ' 55' ' ' ILE . 0.1 OUTLIER 69.9 -29.21 0.18 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.862 -179.719 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.519 ' H ' ' C ' ' A' ' 60' ' ' MET . . . 142.58 -29.25 2.14 Favored Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.519 ' CD2' ' HB2' ' A' ' 90' ' ' ALA . 1.1 mp -70.24 -19.17 63.15 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 178.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.515 ' HB3' ' N ' ' A' ' 60' ' ' MET . . . -53.59 -32.18 49.93 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.532 179.068 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.1 tt -57.79 -46.14 85.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.315 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.479 ' HA ' HD12 ' A' ' 69' ' ' ILE . 6.5 mt -57.82 -44.68 86.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.948 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.411 ' O ' ' CG ' ' A' ' 70' ' ' LYS . 20.8 ttmt -52.76 -53.23 51.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.371 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.528 ' HB2' HD12 ' A' ' 40' ' ' LEU . 86.5 mm-40 -59.64 -34.6 73.01 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.923 0.392 . . . . 0.0 111.483 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.529 HD11 ' CG2' ' A' ' 78' ' ' VAL . 86.5 mt -61.57 -33.36 56.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.773 -178.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.521 ' HB3' ' CB ' ' A' ' 96' ' ' GLN . 0.2 OUTLIER -78.01 -29.44 49.55 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.999 0.428 . . . . 0.0 111.718 179.932 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.447 ' NE2' ' HA ' ' A' ' 68' ' ' GLN . 2.6 mt-30 -65.63 -48.23 72.91 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.152 -178.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.3 mtp85 -93.38 -55.94 3.11 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.97 -178.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.498 ' CD2' HD11 ' A' ' 43' ' ' LEU . 1.6 m-70 -84.25 152.82 62.04 Favored Pre-proline 0 C--N 1.319 -0.76 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.543 -178.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -69.85 -76.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.618 2.212 . . . . 0.0 112.882 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.649 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 6.6 mtm -138.71 53.49 1.77 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.185 0.517 . . . . 0.0 111.338 -179.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.552 ' O ' HG22 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -63.7 112.23 6.84 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.081 179.576 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.545 ' HG2' ' HA ' ' A' ' 50' ' ' VAL . 17.3 Cg_endo -57.19 122.73 12.32 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.188 1.925 . . . . 0.0 111.377 179.22 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.552 HG22 ' O ' ' A' ' 76' ' ' LEU . 3.9 t -119.54 152.03 22.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.167 0.508 . . . . 0.0 111.894 -178.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.412 ' O ' HD23 ' A' ' 52' ' ' LEU . 3.3 mt -131.6 113.74 23.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.363 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.568 ' HA ' ' O ' ' A' ' 53' ' ' SER . 2.4 mp -96.26 132.48 40.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.952 0.406 . . . . 0.0 110.829 -179.548 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.494 ' HB2' ' CE1' ' A' ' 106' ' ' PHE . 3.7 ptp -70.2 -24.65 63.15 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -177.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.407 ' HB ' ' CG2' ' A' ' 55' ' ' ILE . 12.0 m -146.96 160.16 42.69 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.974 0.416 . . . . 0.0 111.753 -179.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -142.32 57.84 1.46 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.56 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.471 ' H ' ' CD2' ' A' ' 84' ' ' HIS . 0.1 OUTLIER -75.34 -95.73 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.364 -179.896 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 6.9 t -89.87 173.01 8.47 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-O 121.109 0.48 . . . . 0.0 111.914 -179.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.518 ' O ' HD23 ' A' ' 63' ' ' LEU . 8.0 m-20 58.01 17.77 4.64 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.653 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.9 mt -48.8 -24.12 1.31 Allowed 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -48.01 -45.64 32.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.8 0.333 . . . . 0.0 111.062 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.44 ' HB1' ' HB2' ' A' ' 63' ' ' LEU . . . -65.99 -20.27 66.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.426 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.519 ' HB2' ' CD2' ' A' ' 63' ' ' LEU . . . -63.25 -44.86 93.97 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.845 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.55 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 5.6 t -59.41 -46.24 92.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.307 -179.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 98.4 p -62.87 -20.09 64.78 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.232 179.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.645 ' O ' ' HG3' ' A' ' 96' ' ' GLN . . . -65.05 -44.49 88.85 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 121.147 0.499 . . . . 0.0 110.367 179.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.55 ' CE2' ' HA ' ' A' ' 91' ' ' VAL . 8.5 m-85 -61.82 -25.13 67.32 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.696 178.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -76.55 -38.81 54.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.324 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.649 ' O ' ' HA ' ' A' ' 75' ' ' MET . 1.6 pp0? -78.85 -18.22 54.36 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.42 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 125.92 1.92 7.37 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 120.444 -0.884 . . . . 0.0 113.663 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.408 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -53.43 151.59 5.48 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 117.419 0.61 . . . . 0.0 110.699 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.512 ' CE2' HD13 ' A' ' 114' ' ' LEU . 11.4 t80 -79.63 -53.9 6.4 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 121.018 -0.273 . . . . 0.0 111.303 -179.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.409 ' O ' HD11 ' A' ' 80' ' ' ILE . 0.4 OUTLIER 175.04 -166.95 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.036 0.446 . . . . 0.0 111.594 179.787 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.515 ' CZ ' HG12 ' A' ' 80' ' ' ILE . 3.0 m-85 -133.95 153.53 51.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.034 -178.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.668 HD23 ' HA ' ' A' ' 106' ' ' PHE . 1.8 mp -103.62 118.83 56.54 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.197 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 102' ' ' LEU . 8.0 Cg_exo -70.63 -68.43 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.436 2.091 . . . . 0.0 111.97 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.625 ' H ' ' HD2' ' A' ' 105' ' ' PRO . 0.5 OUTLIER -117.92 -59.24 0.03 OUTLIER Pre-proline 0 CA--C 1.531 0.239 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -179.858 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.625 ' HD2' ' H ' ' A' ' 104' ' ' LYS . 13.0 Cg_endo -55.42 157.57 14.5 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.113 1.875 . . . . 0.0 112.44 -179.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.668 ' HA ' HD23 ' A' ' 102' ' ' LEU . 22.4 t80 -165.6 -111.01 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.434 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.548 ' O ' ' O ' ' A' ' 106' ' ' PHE . 3.0 p30 43.74 178.74 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.907 0.384 . . . . 0.0 111.257 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.439 HG22 HG22 ' A' ' 112' ' ' VAL . 0.9 OUTLIER -68.02 -42.88 85.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.979 0.418 . . . . 0.0 111.575 -179.643 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.426 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 78.8 m-20 -49.26 -58.35 5.2 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.413 -179.381 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.57 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 62.9 mm-40 -76.4 -32.26 58.43 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.678 0.275 . . . . 0.0 111.43 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.401 ' CB ' ' O ' ' A' ' 107' ' ' ASP . . . -64.92 -60.8 2.65 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.001 0.429 . . . . 0.0 109.946 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.67 ' O ' HG11 ' A' ' 115' ' ' VAL . 48.3 t -59.46 -31.27 46.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.413 0.625 . . . . 0.0 110.537 178.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.426 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -63.23 -45.07 93.35 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.01 179.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.587 HD23 ' CD1' ' A' ' 102' ' ' LEU . 55.7 tp -76.28 -23.44 54.41 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.703 -1.135 . . . . 0.0 111.782 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.67 HG11 ' O ' ' A' ' 112' ' ' VAL . 4.0 p -79.2 -41.25 22.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.801 0.334 . . . . 0.0 111.548 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.453 ' HA ' HD11 ' A' ' 119' ' ' ILE . 95.1 mt-10 -65.33 -44.48 87.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.181 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.433 ' HG2' ' HA ' ' A' ' 114' ' ' LEU . 6.5 ptp180 -62.29 -25.42 67.84 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.933 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.476 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -71.28 -44.56 64.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.088 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.486 HD12 HG12 ' A' ' 50' ' ' VAL . 4.8 mt -68.6 -30.8 48.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.252 0.548 . . . . 0.0 110.688 179.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 21.7 t -71.24 -45.03 64.16 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.212 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 30.1 m80 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.024 -179.753 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.53 0.188 0 N-CA-C 111.561 0.208 . . . . 0.0 111.561 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 84.4 86.33 0.9 Allowed Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.833 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.461 ' HB ' ' HA ' ' A' ' 48' ' ' PRO . 3.6 mp -110.56 112.75 41.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.102 0.477 . . . . 0.0 111.245 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.61 ' CG2' HD12 ' A' ' 23' ' ' LEU . 5.6 p -108.82 120.96 61.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.913 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.766 ' CD1' HG21 ' A' ' 31' ' ' THR . 31.4 m0 -112.32 141.74 45.67 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.117 0.484 . . . . 0.0 111.484 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.654 ' O ' ' HA ' ' A' ' 32' ' ' THR . 1.6 t -128.3 143.01 42.31 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.306 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.975 -178.261 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.842 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -120.95 110.69 28.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.456 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.555 ' HA ' ' HB3' ' A' ' 54' ' ' ASP . 4.5 p30 -161.3 -160.75 0.75 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.904 0.383 . . . . 0.0 111.67 -178.463 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -66.23 -3.28 5.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.681 -179.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 65.31 -155.91 0.28 Allowed 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 120.511 0.196 . . . . 0.0 110.927 179.439 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.444 ' OG ' ' N ' ' A' ' 14' ' ' SER . 64.0 p 33.56 -96.89 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 179.349 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.444 ' N ' ' OG ' ' A' ' 13' ' ' SER . 40.4 t -52.93 -57.41 10.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.535 -179.516 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.4 mm -64.61 -26.36 40.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.937 0.398 . . . . 0.0 111.182 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.49 ' HG3' HG23 ' A' ' 32' ' ' THR . 9.8 ttt180 -73.43 -49.29 27.7 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.447 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.417 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 87.0 t90 -63.4 -39.83 95.57 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -179.087 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.448 HG13 HG12 ' A' ' 108' ' ' ILE . 3.2 t -67.03 -42.87 89.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 112.133 0.419 . . . . 0.0 112.133 -178.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.559 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -84.12 -30.52 25.87 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -178.696 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.529 ' HG3' ' N ' ' A' ' 21' ' ' ARG . 17.2 pt-20 -64.09 -60.03 3.73 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -178.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.529 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 5.5 mmm180 -53.76 -52.59 59.72 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -178.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.17 -29.23 70.21 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -178.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.791 ' CD2' HD11 ' A' ' 28' ' ' LEU . 0.4 OUTLIER -85.32 -29.88 24.16 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.146 0.498 . . . . 0.0 110.088 179.175 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.38 -32.06 73.5 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 177.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.55 -25.16 72.7 Favored Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 177.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.482 ' CB ' HD12 ' A' ' 28' ' ' LEU . . . -77.11 -15.18 59.65 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.572 -0.314 . . . . 0.0 110.588 179.007 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.96 26.48 14.49 Favored Glycine 0 C--N 1.336 0.577 0 C-N-CA 120.959 -0.639 . . . . 0.0 114.28 178.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.791 HD11 ' CD2' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -127.25 161.28 28.94 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 117.889 0.845 . . . . 0.0 112.874 -179.303 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 99.4 m -75.98 116.85 17.1 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.973 179.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 2.0 p -111.18 109.31 19.3 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -178.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.766 HG21 ' CD1' ' A' ' 7' ' ' TRP . 2.8 t -130.21 138.23 50.46 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 178.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.654 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 81.5 p -115.32 160.59 19.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.498 0.666 . . . . 0.0 112.652 -178.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.842 ' HB2' HG13 ' A' ' 9' ' ' VAL . 1.4 m-85 -135.84 173.87 11.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.179 -179.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.658 ' HG2' ' HG3' ' A' ' 38' ' ' GLU . 0.1 OUTLIER -62.27 -105.45 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.939 -179.028 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.431 ' H ' ' CG ' ' A' ' 34' ' ' GLU . 14.2 m120 -86.45 -71.7 0.53 Allowed 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.319 0.581 . . . . 0.0 111.257 -179.313 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.691 ' HA2' HG12 ' A' ' 9' ' ' VAL . . . -159.76 -40.71 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.222 -0.899 . . . . 0.0 112.548 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.905 ' HA ' HD13 ' A' ' 40' ' ' LEU . 7.4 m120 -52.46 -30.08 27.97 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.726 0.298 . . . . 0.0 111.173 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.833 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -58.79 -58.0 10.52 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.417 179.526 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.518 ' CG1' HD13 ' A' ' 43' ' ' LEU . 6.0 t -54.58 -43.49 65.05 Favored 'Isoleucine or valine' 0 C--N 1.341 0.207 0 C-N-CA 120.24 -0.584 . . . . 0.0 111.295 -179.385 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.905 HD13 ' HA ' ' A' ' 37' ' ' ASN . 7.6 mt -53.37 -49.01 68.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.975 0.417 . . . . 0.0 110.564 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.73 -49.89 73.84 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.98 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.77 -28.05 67.28 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.838 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.518 HD13 ' CG1' ' A' ' 39' ' ' VAL . 5.9 mt -69.77 -26.11 64.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.631 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.22 -20.15 10.04 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.562 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 29.6 t -125.61 -0.27 7.47 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.478 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -154.3 155.66 35.56 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 120.761 0.315 . . . . 0.0 110.589 179.893 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.473 ' CG2' HD11 ' A' ' 76' ' ' LEU . 53.2 m -138.54 112.39 8.46 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.011 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.461 ' HA ' ' HB ' ' A' ' 5' ' ' ILE . 59.2 Cg_endo -77.98 161.77 29.62 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.031 1.82 . . . . 0.0 111.511 179.333 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -73.72 -23.76 59.82 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.175 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.511 HG11 HD11 ' A' ' 119' ' ' ILE . 7.8 p -145.35 167.32 9.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.914 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.422 HD23 HG13 ' A' ' 39' ' ' VAL . 11.3 tp -152.84 131.01 11.94 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.003 0.43 . . . . 0.0 111.833 -179.356 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.572 ' HB3' HG13 ' A' ' 8' ' ' VAL . 0.4 OUTLIER -113.84 128.21 56.31 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.243 179.695 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.2 m -105.69 134.23 49.15 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.835 0.35 . . . . 0.0 111.262 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.555 ' HB3' ' HA ' ' A' ' 10' ' ' ASP . 16.5 p-10 -72.75 -29.79 63.61 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.683 -179.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.989 HG12 ' HA3' ' A' ' 62' ' ' GLY . 0.0 OUTLIER 49.08 97.22 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.549 179.572 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 39.8 tpt85 -157.36 57.16 0.51 Allowed 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.452 ' N ' ' CD ' ' A' ' 58' ' ' PRO . 0.0 OUTLIER 61.21 46.59 1.08 Allowed Pre-proline 0 N--CA 1.47 0.54 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 178.476 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.61 ' CD ' ' HA2' ' A' ' 62' ' ' GLY . 39.0 Cg_endo -70.37 -75.46 0.01 OUTLIER 'Trans proline' 0 CA--C 1.53 0.301 0 C-N-CA 122.458 2.105 . . . . 0.0 111.522 178.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -119.19 -21.23 3.8 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.216 -0.516 . . . . 0.0 112.101 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.47 ' N ' ' HB2' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -159.95 67.78 0.38 Allowed 'General case' 0 C--O 1.236 0.393 0 CA-C-O 120.981 0.419 . . . . 0.0 110.177 179.748 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 72.93 -30.9 0.22 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.309 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.989 ' HA3' HG12 ' A' ' 55' ' ' ILE . . . 140.74 -24.2 2.61 Favored Glycine 0 CA--C 1.503 -0.679 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -179.124 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.792 HD22 ' HB1' ' A' ' 90' ' ' ALA . 3.1 mp -74.34 -23.67 59.07 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.47 ' HB2' ' N ' ' A' ' 60' ' ' MET . . . -53.96 -30.01 45.11 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.3 178.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.514 ' HA ' ' NE2' ' A' ' 68' ' ' GLN . 10.4 mt -58.48 -40.47 82.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.198 179.36 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.513 HD11 ' OH ' ' A' ' 101' ' ' TYR . 28.5 mt -63.51 -42.11 98.49 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.319 179.492 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.722 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 15.9 mttm -52.89 -42.2 65.07 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.152 179.088 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.622 ' CB ' HD11 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -71.54 -44.99 63.59 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.911 179.777 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.414 HG22 ' NE2' ' A' ' 73' ' ' HIS . 21.8 mt -56.1 -37.35 48.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.197 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.722 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -74.85 -28.17 60.57 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.892 179.885 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.56 -31.78 67.38 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.401 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.5 mtt-85 -91.73 -64.46 1.11 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.331 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.454 ' NE2' ' CD1' ' A' ' 43' ' ' LEU . 0.4 OUTLIER -125.06 76.22 67.34 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.996 179.718 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.431 ' HB3' ' O ' ' A' ' 70' ' ' LYS . 51.2 Cg_endo -69.59 60.82 1.62 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.528 2.152 . . . . 0.0 112.422 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 33.1 mtt -157.28 -35.45 0.08 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.534 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.561 ' HG ' ' HD2' ' A' ' 77' ' ' PRO . 0.6 OUTLIER -61.52 145.98 90.43 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.877 -179.44 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.561 ' HD2' ' HG ' ' A' ' 76' ' ' LEU . 94.9 Cg_endo -82.88 115.43 2.4 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.739 2.292 . . . . 0.0 112.697 179.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.643 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 3.2 t -98.92 139.16 21.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.685 179.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.522 ' HB ' ' HG ' ' A' ' 52' ' ' LEU . 2.0 mp -122.15 112.13 33.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.698 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.51 ' CG2' ' HB ' ' A' ' 55' ' ' ILE . 2.2 mp -98.32 134.6 36.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.135 0.493 . . . . 0.0 111.279 -179.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.515 ' HA ' ' HB2' ' A' ' 102' ' ' LEU . 4.7 ptm -87.23 -9.13 55.89 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -178.201 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.539 ' N ' HG22 ' A' ' 55' ' ' ILE . 19.0 m -149.02 136.78 20.51 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.642 0.258 . . . . 0.0 111.566 -179.197 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -123.0 82.27 1.97 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.834 0.35 . . . . 0.0 111.275 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -67.34 -166.32 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.574 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.35 80.53 6.78 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.022 0.439 . . . . 0.0 111.91 -179.06 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.537 ' O ' HD23 ' A' ' 63' ' ' LEU . 27.0 t0 -178.15 28.38 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.945 179.2 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -44.99 -23.1 0.12 Allowed 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -47.94 -44.04 29.76 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.569 ' HB2' ' CB ' ' A' ' 63' ' ' LEU . . . -73.38 -22.23 60.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.674 0.273 . . . . 0.0 111.595 -179.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.792 ' HB1' HD22 ' A' ' 63' ' ' LEU . . . -68.88 -39.66 79.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.972 0.415 . . . . 0.0 110.169 179.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.627 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 2.4 t -54.15 -39.93 44.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.207 -179.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.53 ' O ' ' HG3' ' A' ' 95' ' ' GLN . 85.5 p -63.09 -19.74 64.71 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.257 0.551 . . . . 0.0 109.745 178.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.748 ' O ' ' HG3' ' A' ' 96' ' ' GLN . . . -75.9 -55.43 5.62 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.204 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.627 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 4.4 m-85 -56.82 -33.61 66.91 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.921 -179.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.53 ' HG3' ' O ' ' A' ' 92' ' ' SER . 2.1 pp0? -75.46 -28.94 59.47 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.863 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.748 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 0.7 OUTLIER -87.03 -9.1 56.35 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 116.695 -0.23 . . . . 0.0 110.888 178.9 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 77' ' ' PRO . . . 121.58 6.7 8.56 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 120.407 -0.902 . . . . 0.0 113.774 179.238 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.643 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -55.3 157.38 3.67 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 117.213 0.507 . . . . 0.0 111.466 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.474 ' CD2' ' HB2' ' A' ' 118' ' ' ALA . 5.2 t80 -86.25 -53.89 4.77 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.584 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.479 ' O ' HD11 ' A' ' 80' ' ' ILE . 0.2 OUTLIER 170.19 -162.43 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.876 0.37 . . . . 0.0 111.867 -179.936 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.513 ' OH ' HD11 ' A' ' 66' ' ' LEU . 2.2 m-85 -134.61 153.26 52.05 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.567 -178.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.515 ' HB2' ' HA ' ' A' ' 81' ' ' MET . 1.0 OUTLIER -102.65 119.52 55.64 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.168 -179.905 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -65.18 -70.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.474 2.116 . . . . 0.0 112.553 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.586 ' H ' ' HD2' ' A' ' 105' ' ' PRO . 0.5 OUTLIER -123.63 -62.1 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.908 -179.611 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.586 ' HD2' ' H ' ' A' ' 104' ' ' LYS . 9.2 Cg_endo -50.12 163.56 0.57 Allowed 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.314 2.009 . . . . 0.0 112.367 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.594 ' O ' ' O ' ' A' ' 107' ' ' ASP . 58.9 t80 -171.71 -102.44 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.257 179.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.594 ' O ' ' O ' ' A' ' 106' ' ' PHE . 3.4 p30 43.14 178.39 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 117.792 0.269 . . . . 0.0 110.865 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.448 HG12 HG13 ' A' ' 18' ' ' VAL . 0.9 OUTLIER -67.91 -43.1 86.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 120.432 -0.507 . . . . 0.0 111.792 -179.738 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.497 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 32.7 t70 -49.62 -58.65 4.84 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.913 -179.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.587 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 3.7 mm-40 -74.81 -30.37 61.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.635 0.255 . . . . 0.0 111.6 -179.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -68.61 -62.53 1.35 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.279 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.604 ' O ' HG13 ' A' ' 115' ' ' VAL . 49.0 t -55.96 -31.35 30.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.559 0.695 . . . . 0.0 110.163 178.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.497 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -64.38 -46.68 82.29 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.327 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.507 ' CD2' HG21 ' A' ' 79' ' ' ILE . 19.6 tp -76.96 -21.2 55.12 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.996 -179.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.604 HG13 ' O ' ' A' ' 112' ' ' VAL . 4.7 p -79.4 -47.98 21.62 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 C-N-CA 120.401 -0.519 . . . . 0.0 111.715 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -64.38 -41.89 96.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.871 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.425 ' HG2' ' O ' ' A' ' 113' ' ' ALA . 20.1 mmm180 -61.77 -23.71 66.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.768 179.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.474 ' HB2' ' CD2' ' A' ' 99' ' ' PHE . . . -72.02 -49.34 37.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.941 179.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.511 HD11 HG11 ' A' ' 50' ' ' VAL . 3.9 mt -71.11 -31.66 45.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.16 0.505 . . . . 0.0 110.696 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.91 -48.63 52.59 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.122 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.297 -179.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.486 ' HG2' HD12 ' A' ' 5' ' ' ILE . 2.9 ptm180 . . . . . 0 N--CA 1.468 0.462 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 104.24 91.14 2.2 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.616 179.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.486 HD12 ' HG2' ' A' ' 3' ' ' ARG . 5.9 mm -118.73 112.23 37.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.908 0.385 . . . . 0.0 111.188 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 30' ' ' CYS . 4.4 p -114.98 117.17 54.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.428 179.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.673 ' CH2' ' HG2' ' A' ' 46' ' ' LYS . 25.7 m0 -107.31 133.89 51.19 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.031 0.443 . . . . 0.0 110.442 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.739 HG12 ' HB3' ' A' ' 52' ' ' LEU . 1.8 t -122.01 148.8 25.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.382 -177.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.795 HG12 ' HB2' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -126.16 112.0 28.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.991 178.037 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.416 ' O ' ' O ' ' A' ' 33' ' ' PHE . 8.7 t0 -161.42 -161.79 0.83 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.648 -178.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -66.36 -2.22 4.27 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -179.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 68.77 -153.23 0.16 Allowed 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 120.566 0.222 . . . . 0.0 110.711 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.41 ' OG ' ' N ' ' A' ' 14' ' ' SER . 62.5 p 33.66 -97.87 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 179.301 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.41 ' N ' ' OG ' ' A' ' 13' ' ' SER . 0.3 OUTLIER -52.85 -52.1 58.5 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 111.608 0.225 . . . . 0.0 111.608 -179.417 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 20.1 mm -64.24 -30.56 50.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.866 0.365 . . . . 0.0 111.215 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.593 ' HG3' HG22 ' A' ' 32' ' ' THR . 47.3 ttp180 -72.83 -41.77 64.49 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.961 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.502 ' O ' ' HD2' ' A' ' 21' ' ' ARG . 57.3 t90 -65.11 -53.51 44.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.999 -179.229 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.442 ' O ' HG12 ' A' ' 108' ' ' ILE . 2.1 t -60.24 -43.16 92.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -178.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.449 ' HA ' HD13 ' A' ' 19' ' ' LEU . 12.0 tp -82.44 -27.64 31.8 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -177.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.628 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 12.2 pt-20 -67.1 -62.3 1.5 Allowed 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 119.917 -0.713 . . . . 0.0 112.062 -178.461 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.674 ' HD2' ' H ' ' A' ' 21' ' ' ARG . 1.3 mpt_? -54.83 -49.16 71.73 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -179.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.408 ' HB3' HG23 ' A' ' 112' ' ' VAL . . . -52.87 -60.11 3.68 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.52 -179.45 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.477 ' CD2' ' CD1' ' A' ' 28' ' ' LEU . 2.6 mt -64.82 -27.36 68.83 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.081 0.467 . . . . 0.0 109.78 179.317 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.34 -34.92 79.26 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.78 -25.34 71.76 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.302 -0.952 . . . . 0.0 111.225 178.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.8 -15.42 59.74 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 120.681 0.277 . . . . 0.0 111.076 179.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.81 26.4 8.53 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.547 -0.835 . . . . 0.0 114.023 178.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.477 ' CD1' ' CD2' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -125.83 172.45 9.85 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 117.73 0.765 . . . . 0.0 112.158 -179.632 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.427 ' O ' HG11 ' A' ' 6' ' ' VAL . 23.5 m -99.01 105.77 17.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.193 179.298 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.628 ' HB3' ' HA ' ' A' ' 20' ' ' GLU . 11.4 t -100.86 111.31 23.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.066 -179.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.65 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.9 t -120.18 156.52 30.94 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.596 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 64.3 p -129.97 161.83 30.04 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.278 0.561 . . . . 0.0 112.04 -179.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.795 ' HB2' HG12 ' A' ' 9' ' ' VAL . 3.8 m-85 -129.42 173.99 10.04 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.572 -178.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.67 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 2.3 pp20? -60.04 -51.59 68.98 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -177.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.506 ' OD1' ' HB3' ' A' ' 58' ' ' PRO . 0.7 OUTLIER -150.59 -71.74 0.17 Allowed 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -178.454 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.59 ' O ' ' HG ' ' A' ' 40' ' ' LEU . . . -153.39 -42.41 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.4 -0.905 . . . . 0.0 113.709 -178.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.554 ' HA ' HD13 ' A' ' 40' ' ' LEU . 0.5 OUTLIER -67.59 -30.77 70.46 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-O 120.852 0.358 . . . . 0.0 111.361 -178.956 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.737 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -51.87 -59.85 3.85 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.751 179.86 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.551 ' CG2' HG12 ' A' ' 9' ' ' VAL . 0.8 OUTLIER -55.4 -41.51 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 C-N-CA 119.804 -0.759 . . . . 0.0 110.083 -179.637 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.59 ' HG ' ' O ' ' A' ' 36' ' ' GLY . 6.7 mt -53.32 -41.56 65.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.308 0.575 . . . . 0.0 109.845 179.078 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.48 -48.15 76.3 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.711 179.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.95 -26.75 63.31 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.894 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.549 HD11 ' NE2' ' A' ' 73' ' ' HIS . 1.1 mt -69.94 -22.46 63.18 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.564 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.48 -22.12 11.9 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.981 0.419 . . . . 0.0 110.847 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -130.48 2.45 4.58 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.612 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.673 ' HG2' ' CH2' ' A' ' 7' ' ' TRP . 1.3 tptp -138.05 161.48 36.63 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 121.523 0.678 . . . . 0.0 111.962 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.554 ' H ' ' HG3' ' A' ' 46' ' ' LYS . 51.1 m -139.38 111.25 7.7 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.674 178.06 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.512 ' HD2' HD23 ' A' ' 76' ' ' LEU . 73.2 Cg_endo -80.84 153.31 19.61 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.301 2.001 . . . . 0.0 111.305 179.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -74.44 -30.93 62.09 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.057 -179.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.522 HG22 HD13 ' A' ' 79' ' ' ILE . 9.0 p -150.95 103.71 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-O 120.892 0.377 . . . . 0.0 111.534 -179.44 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.691 ' HB2' HD21 ' A' ' 76' ' ' LEU . 11.1 tp -87.63 131.23 34.5 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -179.14 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.739 ' HB3' HG12 ' A' ' 8' ' ' VAL . 0.4 OUTLIER -115.17 127.42 55.54 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.446 179.524 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.481 ' CB ' HD13 ' A' ' 80' ' ' ILE . 0.6 OUTLIER -108.48 136.55 47.92 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 120.846 0.355 . . . . 0.0 110.972 179.969 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.428 ' O ' HG23 ' A' ' 55' ' ' ILE . 25.5 p-10 -79.54 -21.33 45.32 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -178.385 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.553 HG13 ' HA3' ' A' ' 62' ' ' GLY . 0.7 OUTLIER 44.81 86.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -179.666 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.411 ' O ' ' HG3' ' A' ' 56' ' ' ARG . 4.9 ptt85 -147.83 56.54 1.08 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 120.925 0.393 . . . . 0.0 111.832 179.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.454 ' N ' ' HD3' ' A' ' 58' ' ' PRO . 6.0 ttt 62.55 50.26 1.43 Allowed Pre-proline 0 N--CA 1.465 0.315 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 178.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 62' ' ' GLY . 45.2 Cg_endo -77.09 -77.01 0.01 OUTLIER 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 122.421 2.081 . . . . 0.0 111.749 178.397 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -118.04 -21.15 4.25 Favored Glycine 0 C--N 1.332 0.359 0 N-CA-C 111.798 -0.521 . . . . 0.0 111.798 179.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.503 ' N ' ' HB1' ' A' ' 64' ' ' ALA . 5.1 ttt -161.3 67.61 0.3 Allowed 'General case' 0 C--O 1.236 0.351 0 CA-C-O 120.978 0.418 . . . . 0.0 110.415 179.393 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.419 ' OD1' ' CE1' ' A' ' 84' ' ' HIS . 0.2 OUTLIER 69.79 -23.07 0.16 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.484 179.543 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.569 ' N ' ' HD2' ' A' ' 58' ' ' PRO . . . 136.36 -29.58 2.79 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 -178.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.612 ' HA ' ' CD1' ' A' ' 66' ' ' LEU . 4.1 mp -71.56 -21.93 61.82 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.465 -0.368 . . . . 0.0 110.225 179.285 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.503 ' HB1' ' N ' ' A' ' 60' ' ' MET . . . -53.74 -33.48 55.83 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.952 179.054 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.408 ' CG ' ' HA3' ' A' ' 36' ' ' GLY . 6.4 mp -56.99 -48.44 78.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.106 0.479 . . . . 0.0 110.76 179.692 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.612 ' CD1' ' HA ' ' A' ' 63' ' ' LEU . 4.9 mp -55.69 -40.3 72.18 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.763 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.658 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 0.1 OUTLIER -53.85 -48.07 70.34 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.9 179.286 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.559 ' HB2' HD11 ' A' ' 40' ' ' LEU . 13.1 mm-40 -71.39 -29.88 65.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.698 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.608 ' HA ' ' CE1' ' A' ' 73' ' ' HIS . 37.6 mt -62.72 -40.76 89.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.665 -179.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.658 ' HG2' ' O ' ' A' ' 67' ' ' LYS . 23.9 pttt -74.68 -29.58 61.27 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.475 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -85.88 -38.17 18.36 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -178.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 22.0 mtt-85 -95.33 -27.24 15.56 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -178.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.608 ' CE1' ' HA ' ' A' ' 69' ' ' ILE . 0.2 OUTLIER -107.52 134.85 19.83 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.699 -0.228 . . . . 0.0 111.131 -179.107 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.561 ' O ' ' HG2' ' A' ' 75' ' ' MET . 23.6 Cg_exo -63.66 79.88 0.14 Allowed 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.657 2.238 . . . . 0.0 112.587 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.561 ' HG2' ' O ' ' A' ' 74' ' ' PRO . 0.0 OUTLIER 50.69 43.19 27.93 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 121.558 0.694 . . . . 0.0 110.795 179.742 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.691 HD21 ' HB2' ' A' ' 51' ' ' LEU . 5.8 tp -68.24 137.08 91.47 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.678 -179.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.551 ' HD2' ' HG ' ' A' ' 76' ' ' LEU . 47.3 Cg_endo -67.34 125.09 12.92 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.495 2.13 . . . . 0.0 111.951 179.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.493 HG13 ' HG ' ' A' ' 66' ' ' LEU . 3.8 t -110.92 143.53 20.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.09 0.472 . . . . 0.0 111.614 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.522 HD13 HG22 ' A' ' 50' ' ' VAL . 2.3 mp -132.97 113.19 19.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.338 179.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.618 HG13 ' CZ ' ' A' ' 101' ' ' TYR . 13.0 mm -101.22 142.21 16.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.326 -179.211 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.483 ' O ' ' HB3' ' A' ' 102' ' ' LEU . 11.4 ptm -82.79 -21.23 34.64 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -178.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.581 ' O ' HG23 ' A' ' 80' ' ' ILE . 3.0 m -147.65 158.05 43.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.637 0.256 . . . . 0.0 111.22 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -138.53 66.43 1.43 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.571 -179.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.419 ' CE1' ' OD1' ' A' ' 61' ' ' ASP . 16.1 p80 -99.24 120.62 39.84 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 120.898 0.38 . . . . 0.0 111.578 -179.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 55.77 165.83 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.752 179.385 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.423 ' O ' HD22 ' A' ' 63' ' ' LEU . 1.0 OUTLIER 52.89 26.86 4.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.079 -179.817 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.423 ' HA ' HD22 ' A' ' 63' ' ' LEU . 0.1 OUTLIER -54.82 -23.72 19.62 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.352 -179.961 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -50.63 -35.93 32.85 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.829 -179.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.419 ' HB1' ' CB ' ' A' ' 63' ' ' LEU . . . -69.56 -23.32 63.55 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.798 0.333 . . . . 0.0 111.447 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.427 ' HB3' ' CE1' ' A' ' 101' ' ' TYR . . . -72.12 -30.63 65.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.209 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.647 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 5.5 t -66.67 -46.72 85.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.365 -179.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.6 m -58.12 -37.81 75.3 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.482 0.658 . . . . 0.0 110.093 179.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.557 ' CB ' HD23 ' A' ' 66' ' ' LEU . . . -56.89 -41.53 78.25 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.319 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.647 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 12.4 m-85 -59.03 -22.31 60.48 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.212 179.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.541 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -74.76 -39.76 61.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.518 -179.999 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.541 ' N ' ' HG2' ' A' ' 95' ' ' GLN . 4.8 pt20 -79.18 -11.12 59.97 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.376 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 108.05 32.15 3.37 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.336 -0.935 . . . . 0.0 112.91 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.545 ' HB2' ' HB2' ' A' ' 93' ' ' ALA . . . -61.07 145.76 49.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.756 0.278 . . . . 0.0 110.566 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.52 ' O ' ' HB3' ' A' ' 100' ' ' ASP . 9.2 t80 -71.08 -53.87 13.11 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.548 -179.387 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.52 ' HB3' ' O ' ' A' ' 99' ' ' PHE . 2.8 p30 166.82 -166.4 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.185 0.517 . . . . 0.0 111.498 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.618 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 4.8 m-85 -133.95 152.42 51.85 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.99 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.532 HD22 ' HA ' ' A' ' 106' ' ' PHE . 1.0 OUTLIER -104.72 119.02 54.94 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.258 179.584 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -67.84 -67.52 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.306 2.004 . . . . 0.0 112.448 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.586 ' H ' ' HD2' ' A' ' 105' ' ' PRO . 4.9 mttt -121.76 -61.95 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.969 -179.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.586 ' HD2' ' H ' ' A' ' 104' ' ' LYS . 9.7 Cg_endo -50.29 159.76 1.81 Allowed 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.42 2.08 . . . . 0.0 112.279 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.605 ' O ' ' O ' ' A' ' 107' ' ' ASP . 47.8 t80 -169.74 -105.83 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.414 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.605 ' O ' ' O ' ' A' ' 106' ' ' PHE . 2.7 p30 43.1 175.38 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.033 0.444 . . . . 0.0 111.447 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.473 HG21 HG21 ' A' ' 112' ' ' VAL . 0.9 OUTLIER -67.62 -41.07 85.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.09 0.472 . . . . 0.0 111.288 179.956 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.527 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 0.3 OUTLIER -50.01 -58.21 5.96 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.596 -179.707 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.581 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 58.4 mm-40 -77.32 -32.05 55.01 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -179.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.461 ' HB2' ' O ' ' A' ' 107' ' ' ASP . . . -67.33 -58.44 4.79 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.858 0.361 . . . . 0.0 110.237 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.716 ' O ' HG11 ' A' ' 115' ' ' VAL . 51.8 t -60.89 -32.46 52.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.488 0.661 . . . . 0.0 110.189 179.176 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.527 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -62.07 -44.8 95.9 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.567 0.699 . . . . 0.0 109.911 178.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.471 ' CD2' HG22 ' A' ' 79' ' ' ILE . 6.1 tp -74.97 -23.7 58.32 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.588 -179.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.716 HG11 ' O ' ' A' ' 112' ' ' VAL . 2.7 p -79.57 -42.75 23.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.832 0.348 . . . . 0.0 111.736 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.443 ' HG3' ' O ' ' A' ' 112' ' ' VAL . 31.6 mt-10 -60.31 -51.92 67.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.298 -179.394 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.407 ' NE ' ' HA ' ' A' ' 114' ' ' LEU . 0.1 OUTLIER -57.25 -23.88 51.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.852 0.358 . . . . 0.0 110.979 -179.993 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.473 ' CB ' ' CE1' ' A' ' 99' ' ' PHE . . . -70.39 -45.58 65.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.814 179.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 4.7 mt -77.22 -34.11 20.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.464 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.9 m -65.18 -47.06 78.29 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.969 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 11.1 m80 . . . . . 0 C--N 1.327 -0.391 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.986 -179.995 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.529 0.141 0 CA-C-O 120.498 0.19 . . . . 0.0 111.387 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.468 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . 84.89 85.81 0.95 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.79 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.7 mp -101.01 113.11 36.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.933 0.397 . . . . 0.0 111.218 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.661 ' O ' ' HA ' ' A' ' 30' ' ' CYS . 5.9 p -105.44 120.18 55.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.281 179.648 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.607 ' NE1' HG23 ' A' ' 31' ' ' THR . 26.3 m0 -112.21 139.8 47.45 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.915 0.388 . . . . 0.0 110.512 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.855 HG12 ' HB3' ' A' ' 52' ' ' LEU . 0.2 OUTLIER -126.94 148.83 31.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.749 -178.765 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.735 HG12 ' HB2' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -127.01 114.61 38.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.002 0.429 . . . . 0.0 109.995 179.023 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.937 ' HB3' HG13 ' A' ' 15' ' ' ILE . 9.1 t0 -171.05 -150.24 0.07 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.426 -178.306 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -66.49 -3.37 6.08 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.511 ' O ' ' N ' ' A' ' 16' ' ' ARG . 2.3 t0 69.19 -79.52 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 178.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -40.83 -78.35 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -178.327 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.505 ' O ' HG22 ' A' ' 18' ' ' VAL . 1.7 t -52.61 -32.6 42.44 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.669 -178.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.937 HG13 ' HB3' ' A' ' 10' ' ' ASP . 23.2 mm -77.53 -28.69 16.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.892 -179.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.592 ' HA ' ' HG3' ' A' ' 20' ' ' GLU . 14.1 ttt180 -58.35 -44.69 88.89 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.307 0.575 . . . . 0.0 110.176 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.729 ' O ' ' HB2' ' A' ' 21' ' ' ARG . 38.4 t90 -71.95 -62.22 1.5 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.766 -179.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.505 HG22 ' O ' ' A' ' 14' ' ' SER . 0.5 OUTLIER -59.17 -60.89 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 -177.056 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.722 ' CD1' HG11 ' A' ' 8' ' ' VAL . 13.9 mt -70.67 -51.49 27.42 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -175.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.592 ' HG3' ' HA ' ' A' ' 16' ' ' ARG . 5.1 mt-10 -67.62 -61.66 1.79 Allowed 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -178.316 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.729 ' HB2' ' O ' ' A' ' 17' ' ' TRP . 0.0 OUTLIER -49.99 -44.45 50.97 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.058 -178.202 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.82 -37.37 76.2 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.672 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.594 ' HB2' ' O ' ' A' ' 19' ' ' LEU . 3.0 mt -75.22 -27.1 59.42 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 178.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.409 ' N ' ' O ' ' A' ' 20' ' ' GLU . . . -63.72 -35.65 81.28 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.94 -26.2 69.97 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.171 -1.014 . . . . 0.0 110.993 178.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.467 ' CB ' HD13 ' A' ' 28' ' ' LEU . . . -76.85 -15.53 59.68 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 120.565 0.221 . . . . 0.0 110.923 179.345 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.13 26.71 9.97 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 120.636 -0.792 . . . . 0.0 113.955 179.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.499 ' CD1' ' CD2' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -123.72 168.87 12.12 Favored 'General case' 0 N--CA 1.456 -0.125 0 CA-C-N 117.707 0.754 . . . . 0.0 111.788 -179.983 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 58.2 m -96.44 113.52 25.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.918 179.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.661 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 3.1 t -112.05 117.51 32.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.093 0.473 . . . . 0.0 112.195 -179.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.607 HG23 ' NE1' ' A' ' 7' ' ' TRP . 3.3 t -123.57 139.85 53.59 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.169 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 76.8 p -112.5 161.42 16.76 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.129 0.49 . . . . 0.0 111.388 -178.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.74 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 3.7 m-85 -131.28 174.08 10.41 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.806 -177.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.703 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 3.2 pp20? -63.19 -39.04 93.5 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -177.219 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -164.2 -57.61 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.301 0 C-N-CA 119.755 -0.778 . . . . 0.0 113.049 -178.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.683 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . -169.07 -44.42 0.03 OUTLIER Glycine 0 C--N 1.318 -0.471 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.64 -178.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.508 ' N ' HD21 ' A' ' 65' ' ' LEU . 0.5 OUTLIER -64.88 -30.43 71.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.995 0.426 . . . . 0.0 110.96 -179.329 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.74 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -54.34 -52.84 60.29 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.551 -179.945 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.529 HG23 HG11 ' A' ' 9' ' ' VAL . 11.5 t -48.76 -38.77 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-O 121.017 0.437 . . . . 0.0 111.1 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.57 HD11 ' HB2' ' A' ' 68' ' ' GLN . 15.9 mt -61.82 -42.14 98.65 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.564 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.41 -49.45 73.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.19 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.86 -31.86 66.89 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.542 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.569 HD11 ' NE2' ' A' ' 73' ' ' HIS . 5.7 mt -59.88 -24.02 63.93 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.297 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.36 -19.32 34.53 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.439 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.5 t -121.52 0.88 10.03 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.451 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 3.6 tttt -165.37 164.39 19.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.944 0.402 . . . . 0.0 111.367 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.528 ' HA ' HD21 ' A' ' 43' ' ' LEU . 85.9 m -138.79 116.83 9.09 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.948 179.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.546 ' HD2' HD23 ' A' ' 43' ' ' LEU . 40.0 Cg_endo -74.82 156.06 43.8 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 121.796 1.664 . . . . 0.0 111.466 179.25 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -74.05 -30.84 62.6 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.079 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.518 HG22 HD13 ' A' ' 79' ' ' ILE . 14.9 p -149.49 106.27 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 CA-C-O 120.737 0.303 . . . . 0.0 111.699 -179.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.453 HD21 HG11 ' A' ' 39' ' ' VAL . 20.5 tp -87.07 155.32 20.19 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.937 0.399 . . . . 0.0 111.201 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.855 ' HB3' HG12 ' A' ' 8' ' ' VAL . 2.4 tt -137.16 119.6 15.85 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.197 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.518 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 0.6 OUTLIER -111.86 128.44 56.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.781 0.324 . . . . 0.0 111.378 -179.662 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.06 -2.9 56.55 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.463 HD11 ' CE1' ' A' ' 84' ' ' HIS . 3.0 tt 41.97 91.13 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-O 120.805 0.336 . . . . 0.0 111.698 179.409 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.4 ttt85 -117.56 40.17 3.14 Favored 'General case' 0 N--CA 1.461 0.111 0 N-CA-C 111.96 0.355 . . . . 0.0 111.96 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.592 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER 56.81 44.11 1.3 Allowed Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 179.042 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.478 ' CD ' ' N ' ' A' ' 57' ' ' MET . 30.1 Cg_endo -63.29 -80.81 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 121.959 1.773 . . . . 0.0 111.02 178.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -102.42 -86.6 1.95 Allowed Glycine 0 C--N 1.334 0.43 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 178.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.787 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -87.82 60.97 6.18 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 177.228 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.592 ' HA ' ' HA ' ' A' ' 57' ' ' MET . 0.1 OUTLIER 65.57 -28.2 0.11 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.65 -1.159 . . . . 0.0 112.447 -179.494 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.562 ' H ' ' C ' ' A' ' 60' ' ' MET . . . 152.15 -35.19 0.84 Allowed Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 110.946 -0.861 . . . . 0.0 110.946 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.425 ' CB ' ' HB1' ' A' ' 89' ' ' ALA . 1.0 OUTLIER -64.07 -21.43 66.52 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 178.878 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.787 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -53.56 -38.43 63.86 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 120.969 0.414 . . . . 0.0 110.389 179.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.572 ' O ' HG13 ' A' ' 69' ' ' ILE . 0.2 OUTLIER -55.03 -44.99 75.14 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.781 179.836 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.573 HD11 ' HB3' ' A' ' 93' ' ' ALA . 5.8 mt -54.5 -42.5 70.85 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.503 179.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.605 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 21.6 tttt -57.77 -43.47 85.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.704 179.451 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.57 ' HB2' HD11 ' A' ' 40' ' ' LEU . 8.2 mm100 -69.51 -27.78 65.47 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.851 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.572 HG13 ' O ' ' A' ' 65' ' ' LEU . 96.7 mt -64.58 -36.85 78.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.96 -179.083 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.605 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -78.15 -31.62 49.84 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.512 -179.52 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -63.72 -44.53 93.32 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.076 -178.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.2 mtt85 -96.42 -50.93 4.56 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.857 -179.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.569 ' NE2' HD11 ' A' ' 43' ' ' LEU . 0.3 OUTLIER -95.77 156.38 37.4 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.834 -179.326 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -66.28 -73.29 0.02 OUTLIER 'Trans proline' 0 CA--C 1.528 0.209 0 C-N-CA 122.538 2.159 . . . . 0.0 112.682 -179.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 7.3 mtt -145.16 55.52 1.22 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.7 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.536 HD23 HD23 ' A' ' 43' ' ' LEU . 22.5 tp -61.9 111.21 4.11 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.111 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -60.35 134.25 54.2 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.379 2.053 . . . . 0.0 112.387 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.742 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 5.1 t -131.43 152.93 38.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.25 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.661 ' HB ' ' HG ' ' A' ' 52' ' ' LEU . 1.1 mt -126.8 113.2 31.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.721 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.518 ' HA ' ' O ' ' A' ' 53' ' ' SER . 9.5 mm -101.86 134.9 41.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -178.051 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.539 ' HB2' ' CD1' ' A' ' 106' ' ' PHE . 2.4 ptt? -69.16 -34.01 74.3 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.271 -0.877 . . . . 0.0 112.216 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 7.3 m -139.16 150.72 45.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.752 0.311 . . . . 0.0 111.348 -179.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.541 ' CB ' ' CD2' ' A' ' 101' ' ' TYR . . . -121.06 70.58 0.92 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.731 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.463 ' CE1' HD11 ' A' ' 55' ' ' ILE . 2.6 p80 -98.94 -179.27 4.22 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.193 179.174 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 63.99 -161.42 0.29 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.769 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.41 88.74 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.924 0.392 . . . . 0.0 111.377 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.425 HD22 ' HB1' ' A' ' 83' ' ' ALA . 0.3 OUTLIER -51.85 -24.0 5.56 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.465 179.804 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -48.84 -36.36 16.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.008 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.425 ' HB1' ' CB ' ' A' ' 63' ' ' LEU . . . -72.84 -19.84 61.24 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.219 -179.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.459 ' HB1' ' CE1' ' A' ' 101' ' ' TYR . . . -68.93 -52.37 29.97 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.984 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.598 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 9.4 t -66.33 -44.94 90.72 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.19 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.845 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.662 ' O ' ' HG3' ' A' ' 95' ' ' GLN . 3.3 m -61.08 -14.54 24.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.889 0.376 . . . . 0.0 110.035 178.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.573 ' HB3' HD11 ' A' ' 66' ' ' LEU . . . -75.15 -61.74 1.79 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.113 0.482 . . . . 0.0 111.066 179.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.598 ' CE2' ' HA ' ' A' ' 91' ' ' VAL . 4.7 m-85 -44.84 -36.14 3.12 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.384 -178.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.662 ' HG3' ' O ' ' A' ' 92' ' ' SER . 1.7 pp0? -76.25 -37.01 58.21 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.959 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.498 ' HB2' ' HB3' ' A' ' 70' ' ' LYS . 10.3 pt20 -100.12 11.19 39.93 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -179.318 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 93' ' ' ALA . . . 122.21 79.0 0.48 Allowed Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.187 -1.006 . . . . 0.0 113.449 179.598 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.742 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -169.14 142.49 2.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.731 0.301 . . . . 0.0 110.637 178.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.503 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 3.3 t80 -84.49 -53.15 5.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.585 -178.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.577 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 0.4 OUTLIER 178.83 -165.58 0.05 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.139 0.495 . . . . 0.0 111.61 179.984 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.541 ' CD2' ' CB ' ' A' ' 83' ' ' ALA . 3.5 m-85 -136.38 153.73 51.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.458 -179.209 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.53 ' HG ' ' HB3' ' A' ' 106' ' ' PHE . 0.4 OUTLIER -101.9 118.85 58.5 Favored Pre-proline 0 C--N 1.327 -0.372 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 179.059 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.401 ' C ' ' HG3' ' A' ' 104' ' ' LYS . 61.5 Cg_exo -51.28 -42.49 53.97 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.58 2.187 . . . . 0.0 112.466 -179.211 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.603 ' HB2' ' HD3' ' A' ' 105' ' ' PRO . 40.3 mttp -156.07 -54.11 0.02 OUTLIER Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.173 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.603 ' HD3' ' HB2' ' A' ' 104' ' ' LYS . 98.1 Cg_endo -80.97 163.78 20.31 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.262 1.975 . . . . 0.0 112.229 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.672 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 0.5 OUTLIER -169.89 -75.88 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.487 178.928 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.547 ' O ' ' CB ' ' A' ' 111' ' ' ALA . 3.1 p30 37.32 -166.49 0.0 OUTLIER 'General case' 0 C--O 1.225 -0.189 0 CA-C-N 116.682 -0.235 . . . . 0.0 110.41 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.468 HD11 ' HG ' ' A' ' 19' ' ' LEU . 1.1 mp -67.85 -44.8 85.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 C-N-CA 120.11 -0.636 . . . . 0.0 111.366 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.76 ' O ' ' HB1' ' A' ' 113' ' ' ALA . 2.6 m-20 -53.58 -58.06 8.52 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.666 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.672 ' HB2' ' HA ' ' A' ' 106' ' ' PHE . 3.1 mm-40 -79.2 -28.04 42.58 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -178.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.547 ' CB ' ' O ' ' A' ' 107' ' ' ASP . . . -78.31 -55.09 5.52 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.349 -0.541 . . . . 0.0 110.084 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.789 ' O ' HG11 ' A' ' 115' ' ' VAL . 60.4 t -58.57 -29.51 39.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-O 121.549 0.69 . . . . 0.0 109.881 178.311 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.76 ' HB1' ' O ' ' A' ' 109' ' ' ASP . . . -64.82 -47.97 76.09 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.718 178.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.582 HD21 ' CG2' ' A' ' 79' ' ' ILE . 10.6 tp -73.83 -20.66 60.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.455 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.789 HG11 ' O ' ' A' ' 112' ' ' VAL . 2.6 p -78.52 -43.42 26.27 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-O 120.735 0.302 . . . . 0.0 111.526 -179.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.482 ' HA ' HD12 ' A' ' 119' ' ' ILE . 35.7 mt-10 -66.2 -41.92 89.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.209 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 28.4 mtp-105 -61.18 -25.64 67.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.646 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.51 ' HB2' HG23 ' A' ' 50' ' ' VAL . . . -73.01 -40.44 65.18 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.305 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.482 HD12 ' HA ' ' A' ' 116' ' ' GLU . 3.8 mt -75.42 -30.51 22.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 121.125 0.488 . . . . 0.0 110.658 179.117 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 91.5 p -67.35 -43.32 81.78 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.567 -179.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 17.8 m80 . . . . . 0 C--N 1.328 -0.359 0 CA-C-O 121.006 0.431 . . . . 0.0 110.943 -179.823 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.529 0.161 0 CA-C-O 120.589 0.233 . . . . 0.0 111.475 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 90.27 81.57 1.37 Allowed Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.942 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.6 mp -103.3 112.32 36.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.96 0.41 . . . . 0.0 111.26 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.594 HG13 ' CD2' ' A' ' 23' ' ' LEU . 4.3 p -106.92 126.64 62.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.1 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.518 ' CD1' ' CG2' ' A' ' 31' ' ' THR . 40.6 m0 -112.82 136.46 52.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.896 0.379 . . . . 0.0 110.444 179.512 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.656 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.1 OUTLIER -125.95 138.81 53.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.336 -178.658 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 1.019 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -115.6 105.59 18.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.988 0.423 . . . . 0.0 110.217 178.58 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.652 ' HB3' HG21 ' A' ' 15' ' ' ILE . 10.2 t0 -173.09 117.12 0.29 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.226 -179.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.594 ' O ' ' HB2' ' A' ' 12' ' ' ASP . 0.1 OUTLIER 47.67 -86.4 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.787 179.826 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.594 ' HB2' ' O ' ' A' ' 11' ' ' ASP . 15.4 t0 170.91 -133.31 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.676 -0.238 . . . . 0.0 110.824 -179.57 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 75.0 m -40.89 -42.03 1.74 Allowed 'General case' 0 C--N 1.341 0.234 0 CA-C-O 121.072 0.463 . . . . 0.0 112.117 -179.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.434 ' O ' HG23 ' A' ' 18' ' ' VAL . 27.6 m -53.18 -63.51 1.12 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.675 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.652 HG21 ' HB3' ' A' ' 10' ' ' ASP . 15.1 mm -70.46 -20.61 22.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.871 0.367 . . . . 0.0 110.667 179.488 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.489 ' HB2' ' OG1' ' A' ' 32' ' ' THR . 3.4 ttt180 -69.77 -55.56 9.53 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.846 179.282 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.49 ' O ' ' HG3' ' A' ' 20' ' ' GLU . 89.6 t90 -53.58 -45.09 69.84 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.708 -179.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 14' ' ' SER . 3.1 t -65.58 -45.13 93.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -178.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.66 -26.93 29.45 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -177.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.52 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 1.0 OUTLIER -66.61 -60.92 2.28 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -179.063 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 31.1 mmm-85 -52.77 -63.21 1.22 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.734 0.302 . . . . 0.0 111.802 -179.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -49.75 -54.69 17.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.046 0.45 . . . . 0.0 111.554 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.649 HD13 ' CD1' ' A' ' 28' ' ' LEU . 9.3 tp -66.36 -19.43 65.8 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.183 179.316 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.52 ' HB2' ' O ' ' A' ' 20' ' ' GLU . . . -70.32 -35.85 73.91 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.13 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -57.59 -27.83 59.09 Favored Glycine 0 C--N 1.335 0.527 0 C-N-CA 120.51 -0.852 . . . . 0.0 111.035 178.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.438 ' CB ' HD13 ' A' ' 28' ' ' LEU . . . -77.98 -15.8 58.66 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 120.716 0.293 . . . . 0.0 110.495 178.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.94 26.61 14.17 Favored Glycine 0 C--N 1.337 0.609 0 C-N-CA 120.637 -0.792 . . . . 0.0 114.501 178.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.649 ' CD1' HD13 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -116.06 164.94 13.71 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 118.32 1.06 . . . . 0.0 112.23 -179.779 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.445 ' O ' HG12 ' A' ' 6' ' ' VAL . 27.0 m -94.4 118.56 31.81 Favored 'General case' 0 CA--C 1.521 -0.149 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.484 179.053 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.535 ' SG ' ' HB3' ' A' ' 23' ' ' LEU . 3.0 m -108.46 118.61 37.23 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -178.323 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.611 HG21 ' CE1' ' A' ' 33' ' ' PHE . 2.7 t -122.79 139.76 53.65 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.047 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.656 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 69.0 p -115.01 161.63 18.08 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -177.496 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 1.019 ' HB2' HG13 ' A' ' 9' ' ' VAL . 12.1 m-85 -136.27 174.88 10.13 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 114.868 -1.06 . . . . 0.0 111.834 -178.316 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.429 ' HG2' ' H ' ' A' ' 35' ' ' ASN . 3.6 pt-20 -62.0 -46.94 87.02 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -177.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.529 ' C ' HG11 ' A' ' 9' ' ' VAL . 0.5 OUTLIER -168.41 -27.97 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 118.58 0.627 . . . . 0.0 112.687 -179.573 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.519 ' HA2' HG12 ' A' ' 9' ' ' VAL . . . 171.91 -59.66 0.16 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.402 -0.904 . . . . 0.0 112.754 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.597 ' HA ' HD11 ' A' ' 40' ' ' LEU . 6.5 m120 -48.1 -34.52 9.86 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 120.845 0.355 . . . . 0.0 110.979 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.882 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 5.2 tt0 -60.25 -55.65 31.12 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.382 179.082 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.593 HG23 HG12 ' A' ' 9' ' ' VAL . 6.2 t -53.93 -44.22 60.56 Favored 'Isoleucine or valine' 0 C--N 1.345 0.401 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.459 179.126 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.597 HD11 ' HA ' ' A' ' 37' ' ' ASN . 21.0 mt -57.51 -42.68 83.27 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.877 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.53 -50.13 40.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.075 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.55 -27.58 69.35 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.639 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.764 HD13 ' NE2' ' A' ' 73' ' ' HIS . 6.1 mt -67.71 -23.53 65.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.556 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.39 -16.71 15.83 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.182 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -117.43 -3.39 11.4 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.824 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.33 163.06 15.16 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.984 0.421 . . . . 0.0 111.73 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 66.3 m -139.11 112.47 8.08 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.522 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.509 ' HD2' ' CD1' ' A' ' 76' ' ' LEU . 66.6 Cg_endo -72.52 165.49 32.56 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.179 1.92 . . . . 0.0 111.548 178.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -74.09 -24.34 59.47 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 121.132 -0.227 . . . . 0.0 111.26 -179.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.512 HG12 ' HA ' ' A' ' 6' ' ' VAL . 7.2 p -145.15 166.45 11.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.43 ' HB2' HD21 ' A' ' 76' ' ' LEU . 19.6 tp -152.91 132.55 13.07 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 121.06 0.457 . . . . 0.0 111.368 -179.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.62 HD22 ' O ' ' A' ' 79' ' ' ILE . 0.9 OUTLIER -116.52 139.33 50.6 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.795 -179.878 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.509 ' HB2' ' CD1' ' A' ' 80' ' ' ILE . 8.1 m -127.1 128.44 46.23 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.978 0.418 . . . . 0.0 111.384 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.439 ' O ' HG21 ' A' ' 55' ' ' ILE . 44.6 t0 -69.48 -16.65 63.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.587 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.677 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 2.5 tt 43.79 72.58 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.109 -0.496 . . . . 0.0 112.262 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 177.46 61.82 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.695 179.245 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.577 ' HB3' ' CD ' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -162.0 -64.25 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.698 179.964 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.577 ' CD ' ' HB3' ' A' ' 57' ' ' MET . 36.4 Cg_endo -63.02 -165.6 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.694 2.263 . . . . 0.0 113.228 -179.496 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.79 -67.32 2.13 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.656 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.589 ' HB2' ' HB2' ' A' ' 64' ' ' ALA . 0.2 OUTLIER -79.95 51.23 1.31 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.941 0.4 . . . . 0.0 110.762 179.809 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.477 ' O ' ' HD2' ' A' ' 58' ' ' PRO . 0.1 OUTLIER 54.42 -74.56 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.407 179.643 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.677 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -144.14 -34.84 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.456 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.521 HD22 ' O ' ' A' ' 86' ' ' ASP . 0.5 OUTLIER -54.05 -23.55 14.07 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.654 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.589 ' HB2' ' HB2' ' A' ' 60' ' ' MET . . . -54.22 -36.48 63.54 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.795 178.183 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.518 ' CD1' ' HG3' ' A' ' 58' ' ' PRO . 9.9 mp -59.47 -55.54 33.34 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.306 179.29 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.421 ' CD1' ' HB3' ' A' ' 93' ' ' ALA . 17.0 mt -44.24 -42.53 6.63 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.666 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.47 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 11.3 mttp -57.93 -47.19 83.59 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.037 179.159 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.491 ' HB2' HD12 ' A' ' 40' ' ' LEU . 10.6 mm100 -68.02 -30.33 69.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.375 179.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.659 HG22 ' CE1' ' A' ' 73' ' ' HIS . 77.9 mt -65.21 -45.11 94.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.222 -179.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.47 ' HG2' ' O ' ' A' ' 67' ' ' LYS . 8.9 ptmt -64.81 -29.31 70.27 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.961 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -72.72 -36.51 67.8 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.093 0.473 . . . . 0.0 110.928 179.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.44 -70.96 0.7 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.556 -179.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.764 ' NE2' HD13 ' A' ' 43' ' ' LEU . 2.2 p80 -117.83 78.0 12.11 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.59 -179.197 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.448 ' HA ' ' OE1' ' A' ' 96' ' ' GLN . 72.4 Cg_endo -76.46 56.27 5.02 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.536 2.157 . . . . 0.0 112.563 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 38.2 mtt -154.8 -43.02 0.09 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.093 0.473 . . . . 0.0 111.457 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.621 ' HB2' ' HD1' ' A' ' 73' ' ' HIS . 1.0 OUTLIER -53.08 125.11 40.2 Favored Pre-proline 0 C--N 1.32 -0.679 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.614 -179.941 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.535 ' HD2' HD23 ' A' ' 76' ' ' LEU . 24.8 Cg_exo -61.82 129.65 28.37 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.428 2.085 . . . . 0.0 112.871 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 5.2 t -110.2 138.87 36.1 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.78 179.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.62 ' O ' HD22 ' A' ' 52' ' ' LEU . 1.7 mt -123.8 113.2 36.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.545 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.543 HG13 ' CZ ' ' A' ' 101' ' ' TYR . 15.1 mm -101.08 145.87 10.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.299 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.567 ' HG3' ' CG2' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -80.5 -30.11 37.33 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.242 -0.435 . . . . 0.0 112.029 -179.038 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.436 HG21 ' ND1' ' A' ' 84' ' ' HIS . 4.8 m -147.44 146.48 29.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.836 0.35 . . . . 0.0 111.354 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.56 ' O ' ' HG ' ' A' ' 87' ' ' LEU . . . -112.67 47.94 1.05 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.351 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.436 ' ND1' HG21 ' A' ' 82' ' ' THR . 0.7 OUTLIER -98.49 -175.19 3.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.721 0.296 . . . . 0.0 110.743 179.816 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.415 ' HB2' ' O ' ' A' ' 84' ' ' HIS . 45.9 m 71.6 -78.39 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.793 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.521 ' O ' HD22 ' A' ' 63' ' ' LEU . 7.6 m-20 -138.99 68.1 1.38 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.64 0.257 . . . . 0.0 111.633 -179.327 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.56 ' HG ' ' O ' ' A' ' 83' ' ' ALA . 0.4 OUTLIER -45.69 -23.82 0.29 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.898 179.467 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -48.54 -46.13 38.42 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -179.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.455 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -65.07 -20.04 66.29 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.809 0.338 . . . . 0.0 111.622 -179.379 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.541 ' HB2' ' CE1' ' A' ' 101' ' ' TYR . . . -68.84 -36.11 77.77 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.055 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.641 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 8.2 t -63.07 -41.2 91.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.063 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 44.5 m -63.31 -35.26 79.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.224 0.535 . . . . 0.0 110.306 179.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.529 ' O ' ' HG3' ' A' ' 96' ' ' GLN . . . -57.78 -39.57 77.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.998 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.641 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 10.7 m-85 -63.24 -20.95 65.9 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.379 179.249 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.603 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -74.23 -41.37 61.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.723 -179.808 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.603 ' N ' ' HG2' ' A' ' 95' ' ' GLN . 1.0 OUTLIER -78.59 -18.47 54.53 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.494 -179.332 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 122.01 29.47 1.36 Allowed Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.789 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.504 ' HB1' ' HB1' ' A' ' 93' ' ' ALA . . . -64.1 143.32 57.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.762 0.281 . . . . 0.0 110.809 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.443 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 18.9 t80 -71.49 -53.96 12.19 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.249 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 168.21 -164.96 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.16 0.505 . . . . 0.0 111.124 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.543 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 3.3 m-85 -130.67 150.96 51.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.259 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.6 HD23 ' HA ' ' A' ' 106' ' ' PHE . 5.6 tp -102.87 135.56 19.42 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.986 -179.427 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -78.96 -152.87 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.426 2.084 . . . . 0.0 111.904 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.505 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 5.7 mtpt -43.05 -56.55 6.2 Favored Pre-proline 0 CA--C 1.533 0.322 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.505 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 13.2 Cg_endo -56.71 163.39 7.21 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.565 2.177 . . . . 0.0 112.282 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.6 ' HA ' HD23 ' A' ' 102' ' ' LEU . 45.5 t80 -171.92 -105.03 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.892 179.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.521 ' O ' ' O ' ' A' ' 106' ' ' PHE . 4.6 p-10 43.75 -179.08 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.98 0.419 . . . . 0.0 111.039 -179.421 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.405 HG23 HG23 ' A' ' 112' ' ' VAL . 0.9 OUTLIER -67.84 -41.13 84.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 120.969 0.414 . . . . 0.0 111.533 -179.852 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.497 ' O ' ' HB1' ' A' ' 113' ' ' ALA . 12.7 t70 -50.6 -58.56 5.54 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.623 -179.496 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.587 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 36.3 mm-40 -77.1 -30.89 55.51 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.663 0.268 . . . . 0.0 111.64 -179.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.403 ' CB ' ' O ' ' A' ' 107' ' ' ASP . . . -68.46 -61.13 1.97 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.018 0.437 . . . . 0.0 110.283 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.638 ' O ' HG12 ' A' ' 115' ' ' VAL . 58.1 t -57.63 -30.51 37.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.587 0.708 . . . . 0.0 110.25 178.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.497 ' HB1' ' O ' ' A' ' 109' ' ' ASP . . . -63.86 -46.33 85.48 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.191 179.207 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.528 ' HA ' ' HG2' ' A' ' 117' ' ' ARG . 35.6 tp -74.66 -22.87 58.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.085 -179.316 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.638 HG12 ' O ' ' A' ' 112' ' ' VAL . 4.8 p -79.39 -46.44 23.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 120.442 -0.503 . . . . 0.0 111.639 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -63.82 -45.29 90.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.963 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.528 ' HG2' ' HA ' ' A' ' 114' ' ' LEU . 0.0 OUTLIER -59.09 -27.06 65.19 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.956 0.408 . . . . 0.0 110.796 179.741 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.443 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -67.93 -47.64 68.17 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.629 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.416 HD13 ' CD2' ' A' ' 28' ' ' LEU . 4.5 mt -74.15 -31.17 28.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.819 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.0 t -69.64 -42.05 74.77 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.974 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 1.3 m80 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.976 179.963 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.52 -0.192 0 CA-C-O 121.225 0.536 . . . . 0.0 110.764 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.516 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . 61.74 87.99 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.507 -0.769 . . . . 0.0 112.49 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.7 mp -111.0 112.34 40.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.848 0.356 . . . . 0.0 111.514 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.644 HG23 HD12 ' A' ' 23' ' ' LEU . 2.8 p -107.83 126.21 64.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.309 178.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.642 ' HB2' ' HG3' ' A' ' 48' ' ' PRO . 27.2 m0 -114.11 140.21 48.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.846 0.355 . . . . 0.0 110.181 179.17 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.517 HG22 ' CD2' ' A' ' 19' ' ' LEU . 1.1 t -123.73 147.71 28.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.36 -178.378 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.831 HG11 ' HB2' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -130.93 112.03 21.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.094 0.473 . . . . 0.0 110.446 179.146 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -161.64 -158.64 0.57 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.711 -178.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -66.87 -1.85 4.47 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.349 0.499 . . . . 0.0 112.349 -179.464 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.424 ' O ' ' N ' ' A' ' 14' ' ' SER . 0.2 OUTLIER 69.43 -157.97 0.16 Allowed 'General case' 0 CA--C 1.532 0.254 0 O-C-N 122.443 -0.16 . . . . 0.0 110.875 179.912 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.6 t 34.06 -88.96 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 179.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.424 ' N ' ' O ' ' A' ' 12' ' ' ASP . 3.6 m -53.02 -63.38 1.16 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.809 0.338 . . . . 0.0 111.216 -179.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.8 mm -61.46 -25.67 37.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.984 0.421 . . . . 0.0 110.89 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.512 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 30.8 ttt180 -71.42 -55.64 7.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.591 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.431 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 30.1 t90 -58.63 -41.1 85.17 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -179.193 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.436 HG11 HG12 ' A' ' 108' ' ' ILE . 2.5 t -65.26 -49.12 80.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -178.297 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.592 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 9.7 tp -82.64 -24.79 33.63 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -178.348 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.533 ' HG3' ' N ' ' A' ' 21' ' ' ARG . 10.7 pt-20 -65.75 -57.6 7.63 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.721 -179.368 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.533 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 1.2 mmt-85 -67.12 -48.99 66.44 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.063 -179.192 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.11 -40.57 81.54 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -178.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.669 ' CD2' HD13 ' A' ' 28' ' ' LEU . 0.2 OUTLIER -77.37 -25.13 50.68 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.225 0.536 . . . . 0.0 110.053 179.217 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.03 -34.24 77.63 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.97 -23.61 71.21 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 177.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.54 ' CB ' HD11 ' A' ' 28' ' ' LEU . . . -76.71 -15.4 59.79 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 120.87 0.366 . . . . 0.0 110.471 179.032 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.87 26.27 11.86 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 120.945 -0.645 . . . . 0.0 113.815 178.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.669 HD13 ' CD2' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -132.78 169.09 17.22 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 117.534 0.667 . . . . 0.0 112.384 -179.371 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 32.9 m -89.84 109.1 20.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.75 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.515 ' HA ' HG11 ' A' ' 6' ' ' VAL . 47.3 t -107.48 110.55 22.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.076 0.465 . . . . 0.0 111.585 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.51 ' CG2' ' CD1' ' A' ' 7' ' ' TRP . 2.7 t -118.96 153.45 34.61 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.512 ' CG2' ' HA ' ' A' ' 16' ' ' ARG . 34.5 p -125.35 162.79 24.0 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.301 0.572 . . . . 0.0 111.945 -179.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.831 ' HB2' HG11 ' A' ' 9' ' ' VAL . 1.1 m-85 -129.3 174.22 9.8 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.431 -178.264 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.44 ' HG2' ' N ' ' A' ' 35' ' ' ASN . 0.6 OUTLIER -61.6 -37.14 82.81 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 -177.299 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.44 ' N ' ' HG2' ' A' ' 34' ' ' GLU . 5.1 m120 -169.85 -56.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 118.443 0.565 . . . . 0.0 112.133 -179.474 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.551 ' HA2' HG13 ' A' ' 9' ' ' VAL . . . -164.7 -58.53 0.02 OUTLIER Glycine 0 C--N 1.318 -0.432 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.951 -179.175 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.603 ' HA ' HD11 ' A' ' 40' ' ' LEU . 0.4 OUTLIER -48.79 -34.98 13.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.687 0.28 . . . . 0.0 111.742 -179.456 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.703 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -55.33 -54.05 48.4 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.509 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.571 HG11 ' HG ' ' A' ' 43' ' ' LEU . 39.0 t -58.65 -42.53 85.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.569 179.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.603 HD11 ' HA ' ' A' ' 37' ' ' ASN . 4.0 mt -51.24 -45.47 62.01 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.794 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.64 -47.31 40.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.301 0.572 . . . . 0.0 110.867 179.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.81 -31.04 70.45 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.132 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.571 ' HG ' HG11 ' A' ' 39' ' ' VAL . 11.7 mt -68.68 -20.67 64.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.763 -179.553 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.77 -18.4 12.55 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.511 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.7 t -122.69 -0.46 9.13 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -164.22 157.15 17.56 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.064 0.459 . . . . 0.0 111.603 179.918 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.408 ' HA ' ' CD2' ' A' ' 43' ' ' LEU . 96.2 m -139.03 115.99 8.72 Favored Pre-proline 0 N--CA 1.45 -0.433 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.143 179.543 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.642 ' HG3' ' HB2' ' A' ' 7' ' ' TRP . 58.5 Cg_endo -72.24 165.08 33.68 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.267 1.978 . . . . 0.0 111.167 178.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -75.28 -27.09 59.23 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.966 -0.294 . . . . 0.0 111.267 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.454 ' CG2' HD12 ' A' ' 79' ' ' ILE . 7.2 p -148.79 104.9 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.553 -179.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.58 ' HB2' HD23 ' A' ' 76' ' ' LEU . 21.2 tp -86.52 132.04 34.02 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -179.125 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -114.82 123.19 48.56 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.289 179.044 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.685 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 0.5 OUTLIER -125.76 139.65 53.34 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 121.447 0.641 . . . . 0.0 112.254 -179.238 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.22 -170.05 2.84 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.231 178.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.594 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 3.6 tt -155.02 91.13 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.932 0.396 . . . . 0.0 111.048 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.424 ' HB3' ' O ' ' A' ' 55' ' ' ILE . 9.7 ptm180 172.73 47.02 0.0 OUTLIER 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.133 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.586 ' HB3' ' CD ' ' A' ' 58' ' ' PRO . 2.8 tpt -158.41 -64.29 0.02 OUTLIER Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.586 ' CD ' ' HB3' ' A' ' 57' ' ' MET . 11.9 Cg_endo -54.66 176.05 0.13 Allowed 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.368 2.045 . . . . 0.0 112.643 -179.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -52.37 -59.62 8.78 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.21 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.591 ' O ' ' N ' ' A' ' 62' ' ' GLY . 0.0 OUTLIER -82.55 52.26 2.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.552 0.215 . . . . 0.0 110.51 179.369 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 56.3 -71.81 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.143 0.497 . . . . 0.0 111.17 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.594 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -148.01 -36.16 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.641 -0.708 . . . . 0.0 111.753 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.532 HD23 ' O ' ' A' ' 86' ' ' ASP . 3.0 mp -53.17 -24.16 10.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.779 0.324 . . . . 0.0 110.408 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -56.92 -33.89 67.42 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.003 178.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.462 ' HB2' ' O ' ' A' ' 62' ' ' GLY . 0.2 OUTLIER -59.79 -35.86 75.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.429 179.39 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.63 HD23 HG13 ' A' ' 80' ' ' ILE . 3.3 mm? -63.67 -43.52 96.44 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.056 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.2 mmpt? -52.9 -50.62 63.55 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.325 179.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.578 ' HB2' HD12 ' A' ' 40' ' ' LEU . 12.2 mm100 -62.7 -38.46 90.49 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.517 179.16 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.654 HG12 ' CE1' ' A' ' 73' ' ' HIS . 18.5 mt -54.74 -46.09 73.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.645 -179.062 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.412 ' HB3' ' CD ' ' A' ' 96' ' ' GLN . 0.3 OUTLIER -69.61 -25.94 64.2 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.793 -179.27 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -85.62 -39.73 17.01 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -179.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.435 HH21 ' HB2' ' A' ' 40' ' ' LEU . 2.1 mtm180 -102.32 -40.9 6.54 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -178.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.654 ' CE1' HG12 ' A' ' 69' ' ' ILE . 0.5 OUTLIER -85.64 136.87 36.56 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.214 -178.962 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.604 ' O ' ' HG2' ' A' ' 75' ' ' MET . 17.2 Cg_exo -67.08 70.41 0.55 Allowed 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.509 2.139 . . . . 0.0 112.219 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.614 ' HB2' ' O ' ' A' ' 96' ' ' GLN . 0.2 OUTLIER 50.5 33.9 8.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.062 0.458 . . . . 0.0 111.114 179.843 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.58 HD23 ' HB2' ' A' ' 51' ' ' LEU . 20.7 tp -67.23 131.79 93.47 Favored Pre-proline 0 C--O 1.233 0.216 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.299 -179.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -63.66 127.32 19.45 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.383 2.055 . . . . 0.0 112.052 179.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.542 ' CG2' HG21 ' A' ' 69' ' ' ILE . 5.7 t -118.28 147.79 21.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.428 -179.423 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.497 ' CG2' HD21 ' A' ' 114' ' ' LEU . 2.0 mp -122.78 113.22 37.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.161 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.685 ' HA ' ' O ' ' A' ' 53' ' ' SER . 22.3 mm -99.31 144.22 12.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.568 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.545 ' O ' ' HB2' ' A' ' 102' ' ' LEU . 7.7 ttt -67.73 -67.22 0.48 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.47 -179.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.516 ' H ' ' CG2' ' A' ' 55' ' ' ILE . 3.7 m -106.45 169.65 8.39 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.524 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.464 ' O ' ' O ' ' A' ' 84' ' ' HIS . . . -124.22 -2.84 8.05 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -179.135 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.464 ' O ' ' O ' ' A' ' 83' ' ' ALA . 33.1 m170 31.23 -160.63 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 179.064 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 24.9 m -81.09 -22.58 39.05 Favored 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -178.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.532 ' O ' HD23 ' A' ' 63' ' ' LEU . 67.4 m-20 -79.81 21.6 0.53 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 120.549 0.214 . . . . 0.0 111.324 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.64 HD22 ' HB2' ' A' ' 90' ' ' ALA . 3.1 tm? -43.68 -24.37 0.12 Allowed 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -49.03 -38.2 22.93 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.4 -22.94 61.8 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -179.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.64 ' HB2' HD22 ' A' ' 87' ' ' LEU . . . -73.45 -29.82 62.8 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.878 0.37 . . . . 0.0 110.476 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.626 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 3.0 t -61.74 -45.6 98.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.177 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.511 ' O ' ' HB3' ' A' ' 95' ' ' GLN . 83.7 p -67.46 -22.25 65.49 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 178.299 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.544 ' HB2' ' O ' ' A' ' 90' ' ' ALA . . . -64.49 -39.73 94.34 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.306 0.574 . . . . 0.0 109.793 178.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.626 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 9.6 m-85 -69.19 -23.93 63.98 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.719 178.552 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.511 ' HB3' ' O ' ' A' ' 92' ' ' SER . 0.3 OUTLIER -67.59 -46.45 72.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.388 -179.949 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.614 ' O ' ' HB2' ' A' ' 75' ' ' MET . 4.5 pm0 -76.17 -18.14 59.24 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.751 179.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 117.7 33.9 1.24 Allowed Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.387 -0.911 . . . . 0.0 113.601 178.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.434 ' HB1' ' HB1' ' A' ' 93' ' ' ALA . . . -62.6 155.92 24.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.957 0.379 . . . . 0.0 110.553 179.339 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.458 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 15.4 t80 -76.45 -53.69 7.77 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.032 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 168.46 -166.99 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.241 0.543 . . . . 0.0 111.799 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.51 ' CE2' ' HB ' ' A' ' 80' ' ' ILE . 3.2 m-85 -136.07 153.23 51.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.888 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.653 HD21 ' HA ' ' A' ' 106' ' ' PHE . 5.8 mp -102.22 120.26 54.05 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 120.595 0.236 . . . . 0.0 110.565 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -61.71 -67.33 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.116 1.877 . . . . 0.0 112.334 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.684 ' HB3' ' HD3' ' A' ' 105' ' ' PRO . 3.1 tttm -126.57 -53.04 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.074 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.684 ' HD3' ' HB3' ' A' ' 104' ' ' LYS . 31.8 Cg_exo -58.85 164.02 10.43 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.293 1.995 . . . . 0.0 112.311 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.681 ' O ' ' O ' ' A' ' 107' ' ' ASP . 74.2 t80 -169.38 -97.45 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.943 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.681 ' O ' ' O ' ' A' ' 106' ' ' PHE . 0.3 OUTLIER 37.53 177.3 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.26 0.553 . . . . 0.0 112.356 179.344 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.513 HG21 HG23 ' A' ' 112' ' ' VAL . 0.5 OUTLIER -68.18 -48.22 74.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.899 0.38 . . . . 0.0 111.998 -179.75 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.431 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 4.9 p-10 -49.52 -58.7 4.71 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.913 -179.017 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.604 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 6.2 mm-40 -70.15 -30.75 67.99 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.811 0.339 . . . . 0.0 111.079 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -68.12 -62.17 1.52 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.063 179.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.56 ' HA ' HG12 ' A' ' 115' ' ' VAL . 38.7 t -56.01 -34.24 37.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.36 0.6 . . . . 0.0 110.682 178.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' A' ' 109' ' ' ASP . . . -60.12 -45.9 91.43 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.389 179.556 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.497 HD21 ' CG2' ' A' ' 79' ' ' ILE . 5.2 tp -78.5 -21.52 48.82 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.56 -179.505 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.56 HG12 ' HA ' ' A' ' 112' ' ' VAL . 1.3 p -77.98 -36.34 21.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.613 -179.413 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.499 ' N ' HG11 ' A' ' 115' ' ' VAL . 2.9 mm-40 -68.39 -41.08 81.03 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.098 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 5.6 mmt85 -60.47 -24.85 65.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.273 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.458 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -71.3 -43.33 67.3 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.937 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.406 ' CD1' HD23 ' A' ' 28' ' ' LEU . 4.9 mt -73.57 -31.98 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.175 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 33.5 t -64.57 -42.32 95.72 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.947 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 14.5 m80 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.92 -179.941 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.492 ' HG3' HD13 ' A' ' 5' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.955 0.407 . . . . 0.0 111.231 . . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 96.22 102.27 1.99 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.012 -179.915 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.602 ' HB ' ' HA ' ' A' ' 48' ' ' PRO . 7.4 mm -114.13 114.14 45.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.956 0.408 . . . . 0.0 111.737 -179.382 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.57 HG13 ' CD1' ' A' ' 23' ' ' LEU . 3.5 p -114.07 119.81 62.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.128 178.751 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.565 ' NE1' HG22 ' A' ' 31' ' ' THR . 39.0 m0 -112.46 143.74 43.09 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.009 0.433 . . . . 0.0 110.698 -179.806 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.644 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -129.3 136.91 58.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.539 -178.807 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.816 HG23 ' HA ' ' A' ' 53' ' ' SER . 3.0 m -115.64 110.09 30.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.625 178.947 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.515 ' OD1' ' HB ' ' A' ' 15' ' ' ILE . 1.9 p30 -164.05 -159.11 0.47 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.186 -178.052 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -66.45 -3.02 5.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.832 -179.619 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 66.41 -152.09 0.22 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.473 0.177 . . . . 0.0 111.271 179.359 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.41 ' OG ' ' N ' ' A' ' 14' ' ' SER . 72.0 p 34.89 -95.33 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 178.831 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.513 ' O ' HG21 ' A' ' 18' ' ' VAL . 8.2 t -52.79 -60.57 3.1 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.748 -178.984 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.515 ' HB ' ' OD1' ' A' ' 10' ' ' ASP . 9.9 mm -60.54 -24.99 33.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.684 0.278 . . . . 0.0 110.955 -179.781 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.42 ' CD ' ' OE1' ' A' ' 20' ' ' GLU . 3.2 ttm-85 -71.48 -51.89 21.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.794 0.331 . . . . 0.0 110.594 179.494 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 40.8 t90 -59.3 -38.44 80.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.824 -179.516 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.755 HG13 HG12 ' A' ' 108' ' ' ILE . 18.1 t -65.65 -54.18 30.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -178.717 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.663 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -76.18 -26.43 56.19 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -178.235 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.613 ' HA ' ' CB ' ' A' ' 30' ' ' CYS . 10.7 pt-20 -67.82 -60.69 2.32 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.56 -0.456 . . . . 0.0 112.109 -178.874 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.48 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 4.5 mmm180 -57.89 -55.94 28.44 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.921 -179.098 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.44 -50.09 65.99 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -179.198 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.663 ' HB2' ' O ' ' A' ' 19' ' ' LEU . 5.2 mt -69.44 -29.0 66.6 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.131 0.491 . . . . 0.0 110.16 179.532 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.1 -35.01 75.86 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.422 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.04 -28.09 69.92 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.048 -1.073 . . . . 0.0 110.462 177.762 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.53 -15.99 57.96 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 120.578 0.228 . . . . 0.0 110.88 179.173 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.86 27.11 13.09 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 120.482 -0.866 . . . . 0.0 114.491 178.665 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.499 ' CD1' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -118.04 167.53 11.37 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 118.407 1.104 . . . . 0.0 112.105 -179.921 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 98.7 m -88.28 117.23 27.04 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.941 179.223 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.613 ' CB ' ' HA ' ' A' ' 20' ' ' GLU . 3.1 m -108.96 110.19 21.43 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.661 -178.907 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.565 HG22 ' NE1' ' A' ' 7' ' ' TRP . 2.7 t -130.22 135.61 48.33 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 178.484 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.644 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 29.8 p -111.09 164.8 12.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.262 0.553 . . . . 0.0 111.915 -179.054 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.76 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 3.7 m-85 -136.39 172.17 13.41 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.302 -178.204 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.577 ' HG2' ' N ' ' A' ' 35' ' ' ASN . 0.1 OUTLIER -63.4 -32.63 74.12 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 121.445 0.64 . . . . 0.0 109.917 179.202 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.577 ' N ' ' HG2' ' A' ' 34' ' ' GLU . 8.1 t-20 179.81 170.2 1.14 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.994 -179.81 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.555 ' HA3' ' CG ' ' A' ' 65' ' ' LEU . . . -43.43 -29.9 1.23 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.788 -0.72 . . . . 0.0 113.629 -179.238 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.457 ' HA ' ' HG ' ' A' ' 40' ' ' LEU . 0.4 OUTLIER -58.88 -51.48 69.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.737 0.304 . . . . 0.0 111.525 -179.48 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.76 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -51.91 -48.72 64.04 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.909 -0.316 . . . . 0.0 111.289 -179.531 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.592 HG23 ' CE1' ' A' ' 33' ' ' PHE . 79.5 t -60.7 -27.4 40.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.113 179.808 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' A' ' 36' ' ' GLY . 33.9 mt -57.39 -46.88 82.96 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.222 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.31 -48.69 49.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.098 179.569 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.67 -31.6 68.34 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.832 179.818 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.566 ' HA ' ' O ' ' A' ' 46' ' ' LYS . 16.1 mt -70.02 -25.03 63.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.485 -179.936 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.24 -19.6 14.68 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.913 -179.36 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.8 2.13 8.13 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -179.663 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.566 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -163.65 155.6 17.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.793 0.33 . . . . 0.0 110.733 179.712 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.449 HG21 ' CD2' ' A' ' 76' ' ' LEU . 87.4 m -139.09 112.71 8.12 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.466 179.92 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.602 ' HA ' ' HB ' ' A' ' 5' ' ' ILE . 94.7 Cg_endo -78.22 165.59 25.57 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.063 1.842 . . . . 0.0 110.914 178.538 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.62 ' OD2' HG12 ' A' ' 119' ' ' ILE . 4.8 p-10 -74.59 -59.58 2.67 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.659 -179.733 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.517 HG21 HG23 ' A' ' 115' ' ' VAL . 10.0 p -101.91 164.85 2.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.926 179.558 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.621 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 14.5 tp -153.45 143.04 21.82 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 120.733 0.301 . . . . 0.0 111.072 -179.765 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.585 ' HG ' ' HB ' ' A' ' 79' ' ' ILE . 0.2 OUTLIER -129.17 142.15 50.96 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.631 -0.258 . . . . 0.0 110.783 -179.922 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.816 ' HA ' HG23 ' A' ' 9' ' ' VAL . 3.0 m -129.48 137.05 50.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.005 0.431 . . . . 0.0 111.494 -179.864 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.446 ' O ' ' CG2' ' A' ' 55' ' ' ILE . 20.7 p-10 -77.87 -18.03 56.68 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.745 -178.712 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.58 HG13 ' HA3' ' A' ' 62' ' ' GLY . 0.7 OUTLIER 45.28 91.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-O 120.823 0.344 . . . . 0.0 111.255 -179.779 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.0 49.66 2.25 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -179.108 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.451 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 1.1 ttt 57.01 51.01 4.99 Favored Pre-proline 0 N--CA 1.466 0.364 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 178.715 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.588 ' HD2' ' N ' ' A' ' 62' ' ' GLY . 42.8 Cg_endo -69.26 -78.87 0.01 OUTLIER 'Trans proline' 0 CA--C 1.533 0.428 0 C-N-CA 122.75 2.3 . . . . 0.0 112.102 178.685 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.401 ' H ' ' HG2' ' A' ' 58' ' ' PRO . . . -112.2 -20.81 6.51 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 121.262 -0.494 . . . . 0.0 112.09 179.603 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.528 ' C ' ' H ' ' A' ' 62' ' ' GLY . 0.8 OUTLIER -159.99 66.38 0.36 Allowed 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.084 0.469 . . . . 0.0 110.266 179.725 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.451 ' HA ' ' HA ' ' A' ' 57' ' ' MET . 0.9 OUTLIER 68.29 -23.56 0.13 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.321 179.746 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.588 ' N ' ' HD2' ' A' ' 58' ' ' PRO . . . 140.21 -31.67 2.24 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 111.286 -0.726 . . . . 0.0 111.286 -179.604 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.585 HD23 ' N ' ' A' ' 90' ' ' ALA . 2.4 mp -66.74 -28.23 68.25 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 178.92 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.517 ' HB2' ' N ' ' A' ' 60' ' ' MET . . . -53.79 -28.72 36.67 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.352 0.596 . . . . 0.0 109.791 178.074 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.555 ' CG ' ' HA3' ' A' ' 36' ' ' GLY . 4.9 tt -51.67 -57.06 10.27 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.343 179.243 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.586 HD21 ' HB1' ' A' ' 98' ' ' ALA . 1.9 mt -55.76 -40.99 73.34 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.746 -1.116 . . . . 0.0 110.692 179.91 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.502 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -47.72 -49.11 28.97 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 120.792 0.33 . . . . 0.0 111.039 179.197 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.42 ' HB2' HD11 ' A' ' 40' ' ' LEU . 2.7 mm-40 -69.22 -32.21 71.3 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.028 0.442 . . . . 0.0 110.831 -179.948 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.468 HD12 HG23 ' A' ' 78' ' ' VAL . 81.3 mt -60.75 -40.85 86.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.535 -179.222 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.502 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -74.61 -27.9 60.67 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.767 -179.666 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.0 -41.95 67.02 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.674 -178.925 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -94.84 -26.42 16.21 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.377 -0.374 . . . . 0.0 112.007 -179.15 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.495 ' CD2' HD12 ' A' ' 43' ' ' LEU . 1.3 m-70 -124.52 168.45 13.08 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-O 120.749 0.309 . . . . 0.0 111.173 -179.421 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.443 ' HD2' ' HB3' ' A' ' 73' ' ' HIS . 35.5 Cg_endo -69.6 -83.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.339 2.026 . . . . 0.0 112.723 -179.373 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.426 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 8.0 mtm -146.71 55.44 1.13 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.734 0.302 . . . . 0.0 111.406 -179.626 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.524 HD13 ' HD2' ' A' ' 77' ' ' PRO . 0.1 OUTLIER -57.22 111.09 2.96 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.427 179.811 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.524 ' HD2' HD13 ' A' ' 76' ' ' LEU . 38.6 Cg_exo -58.68 115.62 2.67 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.264 1.976 . . . . 0.0 112.593 179.841 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.905 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 5.0 t -117.59 145.96 22.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.951 179.622 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.585 ' HB ' ' HG ' ' A' ' 52' ' ' LEU . 1.6 mp -117.52 112.61 39.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 179.147 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.76 HG13 ' CZ ' ' A' ' 101' ' ' TYR . 16.5 mm -93.7 130.65 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -178.205 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.637 ' HB2' ' CD2' ' A' ' 106' ' ' PHE . 6.7 ptm -72.43 -29.8 64.03 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.693 -179.968 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.543 ' O ' HG21 ' A' ' 55' ' ' ILE . 5.3 m -135.6 138.3 42.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.386 -179.433 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.562 ' HA ' ' CE2' ' A' ' 101' ' ' TYR . . . -89.71 -27.05 20.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.574 179.957 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.416 ' CE1' HG22 ' A' ' 82' ' ' THR . 3.2 m-70 44.72 -159.74 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.286 179.609 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.6 t -81.41 164.31 22.18 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.937 0.399 . . . . 0.0 111.415 -179.529 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.405 ' O ' HD21 ' A' ' 63' ' ' LEU . 0.2 OUTLIER 72.07 31.24 2.01 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.746 179.99 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.1 mt -45.8 -21.84 0.15 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.793 -0.639 . . . . 0.0 112.502 -179.812 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -48.11 -44.23 31.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.617 0.246 . . . . 0.0 111.042 -179.657 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.447 ' O ' ' HB1' ' A' ' 93' ' ' ALA . . . -67.25 -20.55 65.68 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.191 179.902 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.585 ' N ' HD23 ' A' ' 63' ' ' LEU . . . -62.35 -50.5 71.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.886 -179.777 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.575 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 6.3 t -67.72 -45.47 84.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.41 179.587 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.658 ' O ' ' HG3' ' A' ' 95' ' ' GLN . 9.8 m -61.56 -14.07 26.83 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.088 0.471 . . . . 0.0 109.835 178.24 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.584 ' C ' ' HB3' ' A' ' 98' ' ' ALA . . . -75.66 -53.25 8.86 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.399 179.724 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.647 ' CE1' ' HA ' ' A' ' 100' ' ' ASP . 4.8 m-85 -55.81 -34.78 65.66 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.142 -178.805 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.658 ' HG3' ' O ' ' A' ' 92' ' ' SER . 1.8 pp0? -74.37 -34.14 63.26 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.242 -179.755 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.482 ' HB2' ' CB ' ' A' ' 70' ' ' LYS . 9.3 pt20 -100.29 11.29 39.75 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.141 -179.344 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 119.43 78.26 0.56 Allowed Glycine 0 C--N 1.334 0.441 0 C-N-CA 120.314 -0.946 . . . . 0.0 113.474 179.79 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.905 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -169.04 134.89 1.66 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.08 0.467 . . . . 0.0 111.623 178.966 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.548 ' CZ ' ' HA ' ' A' ' 118' ' ' ALA . 3.5 t80 -74.96 -52.53 10.94 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.237 -179.673 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.647 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 0.9 OUTLIER 179.15 -167.71 0.08 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.247 0.546 . . . . 0.0 111.955 -179.831 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.76 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 4.9 m-85 -136.04 153.17 51.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.275 -179.685 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.544 ' HG ' ' CB ' ' A' ' 106' ' ' PHE . 1.7 mm? -102.82 120.7 51.81 Favored Pre-proline 0 C--N 1.329 -0.299 0 C-N-CA 121.081 -0.247 . . . . 0.0 110.83 179.51 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -66.26 -78.7 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.318 2.012 . . . . 0.0 112.395 -179.838 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.611 ' HB3' ' HD3' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -108.81 -58.18 0.05 OUTLIER Pre-proline 0 C--O 1.232 0.175 0 C-N-CA 121.185 -0.206 . . . . 0.0 111.425 179.949 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.611 ' HD3' ' HB3' ' A' ' 104' ' ' LYS . 77.0 Cg_endo -79.07 163.03 25.79 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 121.693 1.595 . . . . 0.0 110.726 178.933 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.706 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 0.9 OUTLIER 177.58 -91.38 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 121.3 -0.16 . . . . 0.0 111.262 179.936 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.511 ' O ' ' CB ' ' A' ' 111' ' ' ALA . 2.7 p30 44.04 -165.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 -179.442 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.755 HG12 HG13 ' A' ' 18' ' ' VAL . 1.0 OUTLIER -66.67 -43.83 90.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 120.744 -0.383 . . . . 0.0 111.528 -179.727 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.44 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 8.6 t70 -48.84 -58.33 4.98 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.192 -179.684 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.706 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 5.2 mm-40 -78.23 -32.61 49.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.552 -179.68 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.511 ' CB ' ' O ' ' A' ' 107' ' ' ASP . . . -65.92 -59.58 3.7 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 179.398 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.759 ' O ' HG12 ' A' ' 115' ' ' VAL . 56.0 t -59.58 -29.85 43.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.452 0.644 . . . . 0.0 110.195 178.877 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.44 ' HB3' ' O ' ' A' ' 109' ' ' ASP . . . -66.49 -46.76 75.23 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.566 178.759 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.554 HD21 ' CG2' ' A' ' 79' ' ' ILE . 15.2 tp -74.81 -20.76 59.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.205 179.859 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.759 HG12 ' O ' ' A' ' 112' ' ' VAL . 5.5 p -79.31 -48.43 21.17 Favored 'Isoleucine or valine' 0 C--O 1.231 0.088 0 CA-C-O 120.841 0.353 . . . . 0.0 111.44 179.985 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.593 ' HA ' HD13 ' A' ' 119' ' ' ILE . 35.6 mt-10 -63.5 -38.13 89.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.938 -179.967 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 13.6 mmt180 -65.24 -24.88 67.45 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.901 179.761 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.548 ' HA ' ' CZ ' ' A' ' 99' ' ' PHE . . . -74.42 -39.63 62.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.222 179.935 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.62 HG12 ' OD2' ' A' ' 49' ' ' ASP . 4.9 mt -71.74 -30.67 38.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.135 0.493 . . . . 0.0 110.72 179.873 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 24.3 t -67.71 -35.77 79.38 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.02 179.823 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 25.9 m80 . . . . . 0 C--N 1.33 -0.263 0 CA-C-O 120.897 0.38 . . . . 0.0 111.161 -179.804 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.446 ' HG3' HD13 ' A' ' 5' ' ' ILE . 10.2 ptt-85 . . . . . 0 C--O 1.231 0.121 0 CA-C-O 121.039 0.447 . . . . 0.0 111.828 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 98.85 102.12 2.31 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.964 -0.636 . . . . 0.0 111.879 -179.301 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.446 HD13 ' HG3' ' A' ' 3' ' ' ARG . 8.4 mm -111.12 112.78 42.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.887 0.375 . . . . 0.0 111.351 -179.393 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.591 ' O ' ' HA ' ' A' ' 30' ' ' CYS . 7.7 p -109.06 123.47 64.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.818 179.459 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.517 ' CD1' ' CG2' ' A' ' 31' ' ' THR . 40.5 m0 -113.68 133.7 55.17 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.686 -179.798 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.628 HG13 ' HB3' ' A' ' 52' ' ' LEU . 0.6 OUTLIER -119.43 145.79 25.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.997 0.427 . . . . 0.0 111.965 -179.106 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.9 HG11 ' HB2' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -123.96 110.63 26.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.095 0.474 . . . . 0.0 110.985 178.999 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.408 ' CB ' HG23 ' A' ' 15' ' ' ILE . 5.0 t0 -161.17 -163.45 1.02 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.78 -179.549 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -66.66 -1.73 4.08 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -178.788 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.529 ' O ' ' N ' ' A' ' 14' ' ' SER . 1.2 t70 65.24 -141.85 0.21 Allowed 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 121.027 -0.269 . . . . 0.0 110.61 179.338 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 35.29 -82.21 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 179.07 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.529 ' N ' ' O ' ' A' ' 12' ' ' ASP . 1.8 m -80.17 -44.4 19.91 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -178.71 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.466 HD13 HG21 ' A' ' 15' ' ' ILE . 27.3 mm -65.24 -33.74 65.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 -178.773 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.503 ' HB3' ' OG1' ' A' ' 32' ' ' THR . 2.4 ppt_? -72.42 -55.27 7.32 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.881 -179.279 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.422 ' N ' ' HD2' ' A' ' 16' ' ' ARG . 81.4 t90 -48.12 -41.95 27.89 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -178.9 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -73.11 -57.48 6.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.137 0.494 . . . . 0.0 112.252 -178.557 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.578 HD22 HG12 ' A' ' 8' ' ' VAL . 7.3 mp -65.02 -30.94 71.95 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.573 -0.739 . . . . 0.0 112.567 -177.912 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.509 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 19.9 pt-20 -67.77 -59.18 3.51 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.877 0.37 . . . . 0.0 111.484 -179.63 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.459 ' N ' ' CG ' ' A' ' 20' ' ' GLU . 6.2 mmm180 -56.9 -51.45 69.06 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.586 -179.623 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.47 -43.56 93.23 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 120.876 0.37 . . . . 0.0 111.589 -179.355 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.576 HD11 ' CD1' ' A' ' 28' ' ' LEU . 2.1 tp -74.09 -24.58 59.5 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.214 179.634 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.47 -35.16 75.34 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.357 178.374 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.9 -26.09 69.81 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.522 -0.847 . . . . 0.0 111.283 178.656 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.68 -16.15 59.6 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 120.677 0.275 . . . . 0.0 111.246 179.636 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.46 26.65 8.05 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 120.45 -0.881 . . . . 0.0 114.374 178.748 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.576 ' CD1' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -125.72 170.83 11.16 Favored 'General case' 0 C--O 1.231 0.079 0 CA-C-N 118.28 1.04 . . . . 0.0 112.018 179.943 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.421 ' HB ' HD11 ' A' ' 5' ' ' ILE . 31.5 m -99.25 105.96 18.05 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.807 179.954 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.591 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 4.7 t -98.29 117.1 31.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.583 -179.675 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.531 HG22 ' CE1' ' A' ' 33' ' ' PHE . 2.2 t -126.66 130.92 51.37 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 178.401 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.542 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 60.4 p -103.26 164.51 11.59 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -177.713 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.9 ' HB2' HG11 ' A' ' 9' ' ' VAL . 3.4 m-85 -135.92 174.48 10.56 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.936 -178.057 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.722 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 2.9 pp20? -61.36 -40.13 93.16 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -177.561 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.443 ' C ' HG12 ' A' ' 9' ' ' VAL . 1.4 t-20 -168.31 -46.66 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -179.165 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.508 ' HA2' HG13 ' A' ' 9' ' ' VAL . . . -176.73 -47.48 0.06 OUTLIER Glycine 0 C--N 1.32 -0.318 0 C-N-CA 120.178 -1.011 . . . . 0.0 113.628 -178.907 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.493 ' HA ' HD11 ' A' ' 40' ' ' LEU . 0.6 OUTLIER -65.77 -27.94 68.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.896 0.379 . . . . 0.0 111.168 -179.2 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.722 ' HB2' ' HG3' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -58.62 -53.39 58.84 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.052 179.997 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.605 ' C ' HD13 ' A' ' 43' ' ' LEU . 8.2 t -51.94 -49.01 39.38 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.145 0 C-N-CA 120.39 -0.524 . . . . 0.0 109.925 179.683 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.528 HD13 ' HB3' ' A' ' 68' ' ' GLN . 22.3 mt -48.18 -42.55 30.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.08 179.879 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.62 -49.57 62.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.232 0.539 . . . . 0.0 110.862 179.576 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.14 -26.41 68.8 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.712 179.552 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.622 HD11 ' CE1' ' A' ' 73' ' ' HIS . 1.3 mt -69.7 -27.12 64.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.465 -178.918 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.46 -21.04 1.31 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.84 -179.556 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 29.9 t -126.09 6.56 7.2 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -179.435 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.524 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.3 OUTLIER -166.44 156.44 11.9 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.974 0.416 . . . . 0.0 111.451 179.969 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 98.2 m -139.09 112.51 8.1 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.22 179.616 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.569 ' HD2' HD22 ' A' ' 43' ' ' LEU . 57.7 Cg_endo -71.82 165.13 33.48 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 121.873 1.716 . . . . 0.0 111.027 178.974 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -76.43 -22.66 54.38 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.691 -0.403 . . . . 0.0 111.232 -179.795 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.552 HG11 ' HA ' ' A' ' 6' ' ' VAL . 9.1 p -145.55 165.48 10.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 116.679 -0.237 . . . . 0.0 111.222 -179.666 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 12.1 tp -152.69 136.31 16.07 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.999 0.428 . . . . 0.0 111.561 -179.353 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.628 ' HB3' HG13 ' A' ' 8' ' ' VAL . 0.6 OUTLIER -122.85 117.29 25.28 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.509 -179.991 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.442 ' HB2' ' CD1' ' A' ' 80' ' ' ILE . 3.3 m -105.76 134.53 48.73 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.232 0.539 . . . . 0.0 111.705 -179.667 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.487 ' C ' HG22 ' A' ' 55' ' ' ILE . 34.2 t70 -83.08 16.04 2.55 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -178.938 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.65 HG13 ' O ' ' A' ' 61' ' ' ASP . 1.1 tt 31.53 -107.75 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 179.434 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.478 ' N ' ' CG1' ' A' ' 55' ' ' ILE . 3.5 ttt180 54.16 43.42 30.67 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 179.618 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.515 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 1.0 OUTLIER 48.25 63.78 9.73 Favored Pre-proline 0 N--CA 1.468 0.44 0 N-CA-C 113.472 0.915 . . . . 0.0 113.472 178.694 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.575 ' HD2' ' N ' ' A' ' 62' ' ' GLY . 55.9 Cg_endo -73.86 -78.23 0.01 OUTLIER 'Trans proline' 0 CA--C 1.533 0.434 0 C-N-CA 122.419 2.079 . . . . 0.0 111.248 177.948 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.411 ' H ' ' HG2' ' A' ' 58' ' ' PRO . . . -109.61 -28.55 4.23 Favored Glycine 0 C--N 1.335 0.477 0 C-N-CA 121.127 -0.559 . . . . 0.0 112.16 179.068 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.638 ' HB3' ' CB ' ' A' ' 64' ' ' ALA . 0.4 OUTLIER -152.42 65.19 0.82 Allowed 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.173 0.511 . . . . 0.0 110.048 179.544 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.65 ' O ' HG13 ' A' ' 55' ' ' ILE . 0.4 OUTLIER 68.07 -25.29 0.13 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.184 -0.917 . . . . 0.0 112.161 -179.788 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.575 ' N ' ' HD2' ' A' ' 58' ' ' PRO . . . 141.84 -31.92 2.06 Favored Glycine 0 CA--C 1.502 -0.728 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 179.981 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.587 HD22 ' O ' ' A' ' 86' ' ' ASP . 1.2 mp -70.61 -16.75 62.87 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 115.068 -0.566 . . . . 0.0 110.044 179.124 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.638 ' CB ' ' HB3' ' A' ' 60' ' ' MET . . . -53.5 -39.26 64.45 Favored 'General case' 0 CA--C 1.522 -0.098 0 CA-C-O 121.312 0.577 . . . . 0.0 109.768 178.115 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.573 ' HB3' HD11 ' A' ' 69' ' ' ILE . 6.8 mt -62.3 -39.18 92.13 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.885 179.755 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.465 HD21 HD12 ' A' ' 80' ' ' ILE . 1.2 mm? -59.02 -44.12 91.68 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.272 0.558 . . . . 0.0 109.804 179.165 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.611 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -57.98 -43.7 86.7 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.729 179.474 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.528 ' HB3' HD13 ' A' ' 40' ' ' LEU . 30.3 mm100 -73.93 -38.41 64.28 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.659 179.692 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.573 HD11 ' HB3' ' A' ' 65' ' ' LEU . 17.1 mt -63.5 -36.0 74.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.364 -179.247 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.611 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -75.41 -26.64 58.57 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.056 -179.57 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.486 ' NE2' ' HG3' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -86.21 -32.62 21.09 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.603 -179.351 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.486 ' HG3' ' NE2' ' A' ' 71' ' ' GLN . 0.6 OUTLIER -95.41 -23.44 17.15 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.154 0.428 . . . . 0.0 112.154 -179.692 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.622 ' CE1' HD11 ' A' ' 43' ' ' LEU . 0.2 OUTLIER -111.11 135.23 20.9 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-O 120.673 0.273 . . . . 0.0 111.667 -179.07 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -59.76 -54.41 2.43 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.41 2.073 . . . . 0.0 112.082 179.116 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.436 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 22.2 mtt -156.47 36.74 0.32 Allowed 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.227 -179.9 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.574 ' HB2' ' HB3' ' A' ' 73' ' ' HIS . 0.7 OUTLIER -71.13 121.79 85.18 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.379 -179.891 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.485 ' HD2' HD22 ' A' ' 76' ' ' LEU . 15.7 Cg_exo -68.58 121.86 8.8 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.586 2.19 . . . . 0.0 112.762 -179.708 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.738 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 11.4 t -99.21 141.02 17.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.843 179.302 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.522 ' HB ' ' HG ' ' A' ' 52' ' ' LEU . 2.4 mt -127.07 110.67 23.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.945 179.853 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.531 ' HB ' ' CD2' ' A' ' 101' ' ' TYR . 5.4 mm -101.17 142.12 16.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.104 -179.926 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.602 ' O ' ' HE1' ' A' ' 106' ' ' PHE . 26.5 ptm -66.66 -56.51 10.3 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.943 179.607 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.416 ' OG1' ' CZ ' ' A' ' 106' ' ' PHE . 2.8 m -131.06 152.21 50.6 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 121.771 -0.581 . . . . 0.0 112.152 -179.809 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.506 ' CB ' ' CD2' ' A' ' 101' ' ' TYR . . . -116.71 46.18 1.68 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.825 -179.796 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 17.1 p80 -77.23 56.65 1.33 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.666 0.269 . . . . 0.0 111.192 -179.98 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.436 ' HB2' ' CD1' ' A' ' 63' ' ' LEU . 0.7 OUTLIER -159.64 -160.63 0.84 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 121.046 0.45 . . . . 0.0 111.67 -179.642 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.587 ' O ' HD22 ' A' ' 63' ' ' LEU . 0.5 OUTLIER -66.79 90.05 0.17 Allowed 'General case' 0 CA--C 1.528 0.097 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.834 179.559 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.424 HD13 HG21 ' A' ' 91' ' ' VAL . 0.2 OUTLIER -44.44 -21.29 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -179.965 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -48.12 -53.66 15.87 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -178.975 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.46 -22.04 66.2 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.642 0.258 . . . . 0.0 111.446 -179.648 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.537 ' N ' HD21 ' A' ' 63' ' ' LEU . . . -76.97 -42.91 37.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.754 0.311 . . . . 0.0 110.965 -179.865 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.56 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 13.6 t -64.69 -41.17 91.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.234 179.79 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 19.8 m -61.06 -36.08 78.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.922 179.0 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.488 ' O ' ' HG3' ' A' ' 96' ' ' GLN . . . -55.76 -45.44 78.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.644 179.622 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.56 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 7.4 m-85 -55.16 -25.02 29.53 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.525 179.507 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.59 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -72.19 -40.77 67.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.337 179.688 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.59 ' N ' ' HG2' ' A' ' 95' ' ' GLN . 1.6 pt20 -76.03 -18.13 59.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.547 -179.6 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 134.32 -8.78 4.71 Favored Glycine 0 CA--C 1.521 0.45 0 C-N-CA 120.318 -0.944 . . . . 0.0 113.508 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.738 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -43.67 143.92 0.91 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 117.268 0.534 . . . . 0.0 111.505 -179.817 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.433 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 39.5 t80 -80.73 -54.63 5.46 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 121.049 -0.26 . . . . 0.0 111.232 -179.59 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 166.71 -168.23 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.06 0.457 . . . . 0.0 111.546 179.582 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.531 ' CD2' ' HB ' ' A' ' 80' ' ' ILE . 9.2 m-85 -118.3 152.63 35.41 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.654 178.948 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.589 ' O ' ' O ' ' A' ' 81' ' ' MET . 19.6 tp -102.58 144.63 29.01 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-O 120.926 0.394 . . . . 0.0 111.5 -178.411 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.476 ' HD2' ' CD1' ' A' ' 102' ' ' LEU . 79.2 Cg_endo -80.22 -160.56 0.13 Allowed 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.513 2.142 . . . . 0.0 113.01 -179.399 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.492 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -42.15 -54.03 7.96 Favored Pre-proline 0 CA--C 1.534 0.347 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -179.165 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.492 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 18.2 Cg_endo -59.19 156.71 33.42 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.033 1.822 . . . . 0.0 112.39 -179.287 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.675 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 60.2 m-85 -157.36 -109.45 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.156 -179.924 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.505 ' O ' ' O ' ' A' ' 106' ' ' PHE . 2.6 p30 44.75 -179.48 0.0 OUTLIER 'General case' 0 C--O 1.227 -0.119 0 CA-C-O 121.336 0.588 . . . . 0.0 111.248 -179.579 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.528 HD12 ' HA ' ' A' ' 19' ' ' LEU . 0.5 OUTLIER -64.06 -53.64 41.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-O 121.473 0.654 . . . . 0.0 112.324 -179.788 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.723 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 1.0 OUTLIER -49.16 -52.91 23.54 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 114.947 -1.024 . . . . 0.0 111.961 -178.014 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.675 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 2.0 mm-40 -81.51 -27.78 34.32 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -179.13 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.44 ' CB ' ' O ' ' A' ' 107' ' ' ASP . . . -76.39 -55.39 5.59 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.252 179.933 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.615 ' O ' HG12 ' A' ' 115' ' ' VAL . 61.8 t -59.01 -30.47 43.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.502 0.668 . . . . 0.0 110.061 178.55 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.723 ' HB3' ' O ' ' A' ' 109' ' ' ASP . . . -62.04 -46.61 88.4 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.492 -0.777 . . . . 0.0 110.587 179.345 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.619 ' HA ' ' HD3' ' A' ' 117' ' ' ARG . 21.5 tp -71.36 -26.71 62.92 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.108 -0.951 . . . . 0.0 112.127 -178.764 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.615 HG12 ' O ' ' A' ' 112' ' ' VAL . 4.3 p -79.35 -40.04 21.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.886 0.374 . . . . 0.0 111.57 -179.805 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -67.31 -43.97 80.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.282 -179.448 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.619 ' HD3' ' HA ' ' A' ' 114' ' ' LEU . 6.7 ptm180 -60.09 -23.64 63.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.64 0.257 . . . . 0.0 110.827 179.807 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.433 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -72.16 -50.11 30.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.763 179.203 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.402 HD12 HG12 ' A' ' 50' ' ' VAL . 3.9 mt -69.65 -34.52 61.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.274 0.559 . . . . 0.0 110.649 179.554 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.3 t -63.49 -38.93 93.04 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.002 -179.958 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.075 -179.907 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.456 -0.154 0 CA-C-O 120.95 0.405 . . . . 0.0 110.942 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.498 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . 56.54 85.94 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.05 -179.534 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.5 mp -116.81 117.62 56.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.74 0.305 . . . . 0.0 111.565 -179.292 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.774 HG11 ' HG ' ' A' ' 23' ' ' LEU . 5.4 p -104.95 129.22 57.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.722 179.414 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.561 ' CD1' HG22 ' A' ' 31' ' ' THR . 28.2 m0 -116.38 130.49 56.8 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.789 179.248 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.502 ' O ' ' HD1' ' A' ' 33' ' ' PHE . 1.6 t -114.43 135.71 53.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.503 -177.919 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.629 HG12 ' CG2' ' A' ' 39' ' ' VAL . 0.0 OUTLIER -121.0 106.39 18.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.329 -0.396 . . . . 0.0 109.999 179.43 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.402 ' O ' ' O ' ' A' ' 34' ' ' GLU . 2.9 p30 -161.17 -160.85 0.76 Allowed 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.215 -177.887 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -66.3 -2.77 4.76 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -178.663 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 67.69 -150.12 0.16 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 121.199 -0.201 . . . . 0.0 111.177 179.268 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.435 ' OG ' ' N ' ' A' ' 14' ' ' SER . 60.1 p 34.78 -97.72 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 179.205 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.435 ' N ' ' OG ' ' A' ' 13' ' ' SER . 12.5 t -53.17 -57.43 10.49 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.686 -0.234 . . . . 0.0 111.598 -179.069 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.6 mm -61.37 -25.1 35.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.78 0.324 . . . . 0.0 111.546 -179.854 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.438 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 5.8 ttm180 -70.89 -54.54 11.07 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.103 179.919 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.405 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 84.7 t90 -60.79 -43.57 97.95 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -179.03 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.6 t -64.73 -46.15 93.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.67 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.474 HD11 HG13 ' A' ' 108' ' ' ILE . 11.9 tp -84.13 -23.16 30.8 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -178.198 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.487 ' HG3' ' N ' ' A' ' 21' ' ' ARG . 15.1 pt-20 -67.46 -58.85 4.01 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.194 -0.602 . . . . 0.0 111.321 -179.277 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.487 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 3.1 mmm180 -59.73 -50.42 73.9 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.689 -179.396 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.29 -48.48 71.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.881 0.372 . . . . 0.0 111.713 -179.343 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.774 ' HG ' HG11 ' A' ' 6' ' ' VAL . 2.4 tm? -70.06 -30.27 67.48 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.393 0.616 . . . . 0.0 110.516 179.972 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.09 -31.94 72.77 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 178.298 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.31 -28.34 70.78 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 178.029 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.26 -15.67 59.35 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 120.82 0.343 . . . . 0.0 110.711 179.159 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 94.71 26.4 13.24 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.729 -0.748 . . . . 0.0 114.373 178.552 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.498 ' HB3' ' O ' ' A' ' 4' ' ' GLY . 0.0 OUTLIER -126.12 166.32 17.23 Favored 'General case' 0 C--N 1.334 -0.066 0 CA-C-N 118.27 1.035 . . . . 0.0 112.379 179.892 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.661 ' O ' HG13 ' A' ' 6' ' ' VAL . 93.4 m -81.34 127.47 32.78 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.591 -179.745 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.463 ' HA ' HG13 ' A' ' 6' ' ' VAL . 2.4 p -123.61 116.75 23.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.935 -178.947 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.561 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.4 t -129.12 133.46 47.65 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.396 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.464 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 44.1 p -105.92 162.73 13.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.209 0.528 . . . . 0.0 112.114 -178.393 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.774 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 1.2 m-85 -131.56 172.22 12.49 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.775 -178.017 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.683 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 2.9 pp20? -63.55 -42.57 98.36 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -178.786 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -166.3 -59.76 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.224 0.535 . . . . 0.0 111.707 -178.983 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.579 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . -162.98 -53.34 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.463 -0.79 . . . . 0.0 112.501 -179.485 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.655 ' HA ' HD13 ' A' ' 40' ' ' LEU . 0.8 OUTLIER -49.39 -28.4 5.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.996 0.427 . . . . 0.0 111.299 -179.817 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.774 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 2.1 tp10 -62.0 -56.74 15.94 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.253 179.919 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.725 HG13 ' HG ' ' A' ' 43' ' ' LEU . 38.6 t -60.52 -31.89 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.102 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.542 179.398 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.715 HD12 ' HB3' ' A' ' 68' ' ' GLN . 46.2 mt -55.21 -43.85 74.82 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.305 179.183 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -80.79 -48.71 12.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.142 -179.892 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.73 -30.94 64.05 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.317 -179.762 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.725 ' HG ' HG13 ' A' ' 39' ' ' VAL . 27.4 mt -64.26 -23.56 67.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.909 0.385 . . . . 0.0 111.323 179.986 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.95 -15.5 32.05 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.587 -179.911 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 31.4 t -119.47 -7.51 10.16 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.519 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.44 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -164.61 163.17 21.83 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.891 0.377 . . . . 0.0 111.413 -179.866 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 51.8 m -138.48 113.61 8.71 Favored Pre-proline 0 N--CA 1.452 -0.331 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.264 179.855 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.494 ' HG3' ' HB2' ' A' ' 7' ' ' TRP . 57.1 Cg_endo -71.14 149.06 57.5 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.546 2.164 . . . . 0.0 111.672 179.228 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -74.07 -22.88 59.34 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.185 -179.743 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.436 ' CG2' HG22 ' A' ' 115' ' ' VAL . 6.3 p -149.02 98.23 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.751 -179.349 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.49 HD13 ' HB2' ' A' ' 7' ' ' TRP . 38.9 tp -87.13 144.48 26.84 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.902 0.382 . . . . 0.0 111.863 -179.276 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -124.29 115.06 20.41 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.69 179.65 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.692 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 0.6 OUTLIER -115.23 134.03 55.5 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 121.567 0.699 . . . . 0.0 112.02 -179.337 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.08 -176.91 6.57 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.756 179.695 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.802 HG12 ' HA3' ' A' ' 62' ' ' GLY . 0.0 OUTLIER -149.17 108.62 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.492 179.623 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.448 ' O ' ' HG3' ' A' ' 57' ' ' MET . 0.1 OUTLIER -161.3 73.62 0.45 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.827 -179.463 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.448 ' HG3' ' O ' ' A' ' 56' ' ' ARG . 1.8 ptt? 38.85 51.45 3.14 Favored Pre-proline 0 CA--C 1.535 0.382 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 178.536 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.52 ' CG ' ' HA2' ' A' ' 62' ' ' GLY . 54.4 Cg_endo -76.4 -73.04 0.01 OUTLIER 'Trans proline' 0 CA--C 1.529 0.243 0 C-N-CA 122.215 1.944 . . . . 0.0 111.658 178.365 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.402 ' H ' ' HG2' ' A' ' 58' ' ' PRO . . . -117.7 -27.06 2.65 Favored Glycine 0 CA--C 1.52 0.385 0 N-CA-C 111.835 -0.506 . . . . 0.0 111.835 179.172 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.617 ' HB3' ' CB ' ' A' ' 64' ' ' ALA . 4.4 tpt -159.44 69.6 0.45 Allowed 'General case' 0 C--O 1.236 0.358 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.318 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.442 ' O ' HG12 ' A' ' 55' ' ' ILE . 0.2 OUTLIER 68.82 -25.76 0.14 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.406 -0.816 . . . . 0.0 112.327 -179.951 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.802 ' HA3' HG12 ' A' ' 55' ' ' ILE . . . 142.13 -30.7 2.12 Favored Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -179.723 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.444 HD23 ' HB1' ' A' ' 89' ' ' ALA . 3.3 mp -71.76 -21.36 61.75 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.456 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.617 ' CB ' ' HB3' ' A' ' 60' ' ' MET . . . -53.68 -42.38 67.88 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.008 0.433 . . . . 0.0 110.461 179.007 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.546 ' O ' HG13 ' A' ' 69' ' ' ILE . 15.9 mt -51.54 -50.28 60.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.134 179.5 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.792 HD13 HG13 ' A' ' 80' ' ' ILE . 17.2 mt -52.12 -56.78 12.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.542 179.632 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.531 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 28.4 mttp -41.19 -47.68 3.34 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.669 -179.277 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.715 ' HB3' HD12 ' A' ' 40' ' ' LEU . 60.1 mm-40 -69.27 -35.9 76.54 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.278 -179.547 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.713 HG21 ' HE2' ' A' ' 73' ' ' HIS . 59.0 mt -54.07 -46.45 66.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.08 179.881 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.583 ' HA ' ' CE1' ' A' ' 73' ' ' HIS . 0.0 OUTLIER -70.96 -26.72 63.29 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -179.619 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -61.87 -30.23 70.72 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.218 -178.839 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.43 ' HD3' ' HB3' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -90.2 -59.73 2.11 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.405 0.621 . . . . 0.0 111.409 179.669 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.713 ' HE2' HG21 ' A' ' 69' ' ' ILE . 3.8 p80 -81.22 172.52 9.55 Favored Pre-proline 0 C--N 1.318 -0.779 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.557 -179.183 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.468 ' HD2' ' HB2' ' A' ' 73' ' ' HIS . 73.4 Cg_endo -87.33 -52.8 0.03 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.948 2.432 . . . . 0.0 112.073 179.015 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.629 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 28.7 mtt -157.48 49.51 0.43 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.071 179.213 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.622 ' H ' ' ND1' ' A' ' 73' ' ' HIS . 2.1 tt -64.94 114.0 13.21 Favored Pre-proline 0 N--CA 1.454 -0.247 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.978 179.886 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -64.71 115.45 3.24 Favored 'Trans proline' 0 CA--C 1.528 0.206 0 C-N-CA 122.389 2.06 . . . . 0.0 112.635 -179.796 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.943 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 5.3 t -115.51 154.45 16.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.104 179.909 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.428 HD12 ' CG2' ' A' ' 50' ' ' VAL . 1.9 mp -120.86 117.38 52.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.492 178.972 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.792 HG13 HD13 ' A' ' 66' ' ' LEU . 9.4 mm -99.04 150.21 5.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.098 0.475 . . . . 0.0 111.841 -179.409 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.536 ' HB3' HG21 ' A' ' 55' ' ' ILE . 53.5 ttp -67.59 -52.75 34.83 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.835 -179.129 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.0 m -143.91 146.85 33.28 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 122.306 -0.246 . . . . 0.0 111.584 -179.234 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.483 ' CB ' ' CD2' ' A' ' 101' ' ' TYR . . . -113.98 57.86 0.69 Allowed 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.37 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.471 ' CE1' ' CD1' ' A' ' 55' ' ' ILE . 10.6 p-80 -99.21 -176.6 3.35 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.946 -0.302 . . . . 0.0 110.952 179.392 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' A' ' 84' ' ' HIS . 20.8 p 71.09 -61.16 0.49 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.603 -179.709 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -154.01 85.64 1.16 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -179.096 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.42 ' O ' ' HB2' ' A' ' 90' ' ' ALA . 0.7 OUTLIER -52.73 -20.8 3.42 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.487 179.33 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -47.83 -57.09 6.07 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.607 -0.269 . . . . 0.0 111.664 -178.972 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.444 ' HB1' HD23 ' A' ' 63' ' ' LEU . . . -64.21 -19.94 65.69 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.725 0.297 . . . . 0.0 111.209 -179.968 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.505 ' CB ' ' CE1' ' A' ' 101' ' ' TYR . . . -77.26 -46.4 23.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.696 -179.696 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.612 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 6.6 t -62.64 -49.14 84.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 120.985 -0.286 . . . . 0.0 111.141 -179.7 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 52.5 p -56.51 -25.6 51.97 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.216 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.549 ' C ' ' HB3' ' A' ' 98' ' ' ALA . . . -60.08 -52.89 63.43 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.924 179.791 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.612 ' CE2' ' HA ' ' A' ' 91' ' ' VAL . 2.8 m-85 -55.78 -31.2 62.4 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.459 0.647 . . . . 0.0 109.917 179.771 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.12 -42.07 39.43 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.922 -1.036 . . . . 0.0 110.995 -179.967 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.629 ' O ' ' HA ' ' A' ' 75' ' ' MET . 7.3 pt20 -85.2 -18.15 34.94 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.785 -179.421 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 93' ' ' ALA . . . 140.29 85.32 0.1 Allowed Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.114 -179.101 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.943 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -168.26 123.81 0.99 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.157 0.503 . . . . 0.0 111.918 179.946 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -58.16 -52.77 64.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.773 -179.931 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.568 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 0.2 OUTLIER 170.12 -172.53 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 121.197 0.522 . . . . 0.0 111.675 -179.873 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.51 ' CD2' ' HB ' ' A' ' 80' ' ' ILE . 7.9 m-85 -113.38 153.57 28.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.263 179.621 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.672 HD21 ' O ' ' A' ' 105' ' ' PRO . 7.9 tp -102.3 144.97 29.66 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.827 -179.195 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.533 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 18.5 Cg_exo -66.69 -157.06 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.739 2.293 . . . . 0.0 112.838 -179.043 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.48 ' HB3' ' HD3' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -56.13 -55.08 45.62 Favored Pre-proline 0 CA--C 1.531 0.218 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.859 -179.246 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.672 ' O ' HD21 ' A' ' 102' ' ' LEU . 54.1 Cg_exo -52.31 164.23 1.37 Allowed 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.349 2.032 . . . . 0.0 111.923 179.695 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.611 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 57.6 t80 -158.2 -106.93 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.707 -0.224 . . . . 0.0 110.588 179.865 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.541 ' O ' ' O ' ' A' ' 106' ' ' PHE . 3.1 p30 42.37 -176.82 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.937 0.398 . . . . 0.0 111.041 -179.791 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.584 HG23 HG21 ' A' ' 112' ' ' VAL . 0.7 OUTLIER -68.0 -40.73 83.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.224 0.535 . . . . 0.0 111.155 -179.969 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.496 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 8.3 t0 -50.62 -58.88 4.79 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.919 -179.316 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.611 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 9.6 mm-40 -76.41 -30.36 57.42 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 111.725 0.268 . . . . 0.0 111.725 -179.366 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.478 ' HB1' ' O ' ' A' ' 107' ' ' ASP . . . -69.77 -55.63 9.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.928 0.394 . . . . 0.0 110.322 179.332 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.884 ' HA ' HG11 ' A' ' 115' ' ' VAL . 48.1 t -61.2 -33.61 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-O 121.357 0.598 . . . . 0.0 110.364 179.332 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.496 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -61.63 -47.14 86.75 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.618 179.723 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.417 ' CD2' ' HB2' ' A' ' 102' ' ' LEU . 55.4 tp -75.6 -21.43 57.8 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.632 -179.58 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.884 HG11 ' HA ' ' A' ' 112' ' ' VAL . 2.9 p -79.4 -38.8 20.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.776 -0.37 . . . . 0.0 111.836 -179.639 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.605 ' N ' HG13 ' A' ' 115' ' ' VAL . 36.7 mt-10 -68.44 -38.5 81.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.846 0.355 . . . . 0.0 110.773 179.997 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -64.21 -24.91 67.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.951 0.405 . . . . 0.0 110.367 179.531 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -70.62 -49.54 46.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.717 179.544 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 4.7 mt -70.36 -32.66 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-O 121.271 0.558 . . . . 0.0 110.965 179.759 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 15.1 m -70.01 -44.06 70.07 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.262 -179.786 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 11.2 m80 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.181 -179.841 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.802 0.335 . . . . 0.0 111.093 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.451 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . 88.46 97.78 0.97 Allowed Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.426 -0.892 . . . . 0.0 111.074 -179.257 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.451 HD12 ' HB ' ' A' ' 29' ' ' THR . 4.9 mm -121.77 112.49 35.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 120.689 0.28 . . . . 0.0 111.361 -179.032 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.635 HG21 HG11 ' A' ' 50' ' ' VAL . 10.6 p -105.56 127.0 60.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.229 0.538 . . . . 0.0 110.657 179.101 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.606 ' NE1' HG22 ' A' ' 31' ' ' THR . 34.3 m0 -114.53 125.6 53.98 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.868 179.746 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.658 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -115.65 136.55 52.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.691 -177.956 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.545 ' CG2' ' HA ' ' A' ' 53' ' ' SER . 18.0 m -115.25 110.68 32.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.224 0.535 . . . . 0.0 110.746 179.062 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -162.22 -158.6 0.53 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.381 -179.166 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -67.83 -0.19 3.97 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.614 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 68.78 -154.07 0.16 Allowed 'General case' 0 CA--C 1.532 0.265 0 O-C-N 122.313 -0.242 . . . . 0.0 111.02 179.553 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.438 ' OG ' ' N ' ' A' ' 14' ' ' SER . 74.8 p 33.01 -96.37 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 179.219 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.438 ' N ' ' OG ' ' A' ' 13' ' ' SER . 4.4 t -53.06 -57.27 10.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.629 0.252 . . . . 0.0 111.599 -179.197 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 31.0 mm -61.41 -26.15 38.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.849 0.357 . . . . 0.0 111.078 179.931 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.444 ' HG3' HG21 ' A' ' 32' ' ' THR . 53.8 ttt180 -77.06 -44.27 31.31 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.708 179.803 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.434 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 70.2 t90 -64.23 -40.44 96.04 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.979 -179.275 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.5 t -70.48 -37.57 70.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.0 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.452 HD13 ' O ' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -84.26 -29.32 26.56 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.969 -179.171 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.537 ' HA ' ' SG ' ' A' ' 30' ' ' CYS . 24.9 pt-20 -67.53 -60.36 2.62 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.913 -178.906 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.445 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 5.7 mmt85 -58.11 -54.09 50.85 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.189 -0.459 . . . . 0.0 112.008 -179.588 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.56 -53.96 47.65 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.108 0.48 . . . . 0.0 111.343 -179.574 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.614 ' HG ' HG12 ' A' ' 6' ' ' VAL . 2.5 tm? -66.32 -27.98 68.32 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.582 0.706 . . . . 0.0 110.451 179.52 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.1 -34.55 77.86 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.527 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.53 -26.78 64.99 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.296 -0.954 . . . . 0.0 110.946 178.039 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.405 ' HB1' HD12 ' A' ' 28' ' ' LEU . . . -77.27 -16.22 59.09 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 120.701 0.286 . . . . 0.0 110.805 179.104 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.49 23.68 13.72 Favored Glycine 0 CA--C 1.521 0.419 0 C-N-CA 120.675 -0.774 . . . . 0.0 114.247 178.615 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.601 ' HB2' HD13 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -123.81 166.64 15.25 Favored 'General case' 0 CA--C 1.527 0.076 0 CA-C-N 118.107 0.954 . . . . 0.0 111.935 -179.802 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.451 ' HB ' HD12 ' A' ' 5' ' ' ILE . 97.6 m -84.83 138.54 32.5 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.027 -179.777 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.612 ' HA ' HG13 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -126.85 116.43 20.85 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.073 0.463 . . . . 0.0 111.694 -179.544 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.606 HG22 ' NE1' ' A' ' 7' ' ' TRP . 2.4 t -128.77 132.43 47.9 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.409 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.658 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 45.8 p -108.51 165.09 11.79 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.267 0.556 . . . . 0.0 111.749 -178.335 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.765 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 3.2 m-85 -135.06 172.09 13.51 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.196 -177.89 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.55 ' HG2' ' N ' ' A' ' 35' ' ' ASN . 0.0 OUTLIER -63.31 -32.67 74.15 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.797 -179.837 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.55 ' N ' ' HG2' ' A' ' 34' ' ' GLU . 50.1 p-10 -179.47 179.49 0.61 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.264 -179.434 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.609 ' O ' ' HG ' ' A' ' 40' ' ' LEU . . . -55.16 -10.2 2.48 Favored Glycine 0 CA--C 1.521 0.438 0 C-N-CA 120.709 -0.758 . . . . 0.0 114.011 -179.438 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.799 ' HA ' HD13 ' A' ' 40' ' ' LEU . 3.3 m120 -84.55 -44.57 13.44 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 117.727 0.763 . . . . 0.0 112.501 -179.315 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.765 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 6.6 tt0 -51.74 -58.72 5.6 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -179.271 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.702 HG11 HD12 ' A' ' 51' ' ' LEU . 55.1 t -47.55 -38.13 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 121.017 0.437 . . . . 0.0 111.173 -179.594 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.799 HD13 ' HA ' ' A' ' 37' ' ' ASN . 20.6 mt -57.03 -41.84 79.36 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.429 -179.956 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.87 -48.09 40.43 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.277 0.56 . . . . 0.0 110.177 178.911 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.48 -28.66 69.45 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.135 179.386 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.619 HD23 ' CE1' ' A' ' 73' ' ' HIS . 15.1 mt -65.56 -24.94 67.22 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.88 -179.412 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.64 -16.0 14.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.843 -179.471 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -125.68 -1.57 7.35 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.712 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.529 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -163.42 159.89 22.81 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.917 0.389 . . . . 0.0 111.419 179.822 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.508 ' CG2' HD21 ' A' ' 76' ' ' LEU . 83.1 m -139.08 116.03 8.7 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.297 -179.929 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.488 ' CD ' HD21 ' A' ' 43' ' ' LEU . 77.3 Cg_endo -77.42 163.21 30.09 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.056 1.837 . . . . 0.0 111.511 179.084 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -74.23 -22.17 59.46 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.973 -0.291 . . . . 0.0 111.33 -179.744 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.648 HG13 HD12 ' A' ' 119' ' ' ILE . 8.3 p -147.7 169.42 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.477 -179.562 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.702 HD12 HG11 ' A' ' 39' ' ' VAL . 10.0 tp -152.93 129.85 11.0 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 120.958 0.409 . . . . 0.0 111.318 -179.075 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.555 ' HG ' ' HB ' ' A' ' 79' ' ' ILE . 0.2 OUTLIER -115.69 126.76 54.52 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.78 179.789 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.62 ' HB2' HD21 ' A' ' 65' ' ' LEU . 0.2 OUTLIER -119.3 126.43 51.43 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -178.727 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -83.21 101.9 11.54 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.643 177.803 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.632 HG13 ' HA3' ' A' ' 62' ' ' GLY . 2.2 tt -68.79 93.03 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.665 -179.505 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.438 ' NH2' ' HB3' ' A' ' 35' ' ' ASN . 6.8 ptt85 -135.46 59.05 1.74 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.48 -179.446 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.5 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 24.6 ptm 41.04 48.94 2.98 Favored Pre-proline 0 N--CA 1.467 0.381 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 179.746 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 62' ' ' GLY . 43.5 Cg_endo -70.49 -80.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.267 1.978 . . . . 0.0 111.999 178.943 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -107.27 -23.72 6.85 Favored Glycine 0 N--CA 1.449 -0.441 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 179.359 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.543 ' N ' ' HB2' ' A' ' 64' ' ' ALA . 8.8 tpt -162.88 69.1 0.23 Allowed 'General case' 0 C--O 1.236 0.36 0 CA-C-O 120.923 0.392 . . . . 0.0 110.447 179.816 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.5 ' HA ' ' HA ' ' A' ' 57' ' ' MET . 0.3 OUTLIER 68.56 -26.46 0.14 Allowed 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.246 179.834 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.632 ' HA3' HG13 ' A' ' 55' ' ' ILE . . . 140.62 -29.58 2.36 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -179.441 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.476 HD22 ' O ' ' A' ' 86' ' ' ASP . 2.2 mp -75.62 -12.19 60.16 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.649 -0.275 . . . . 0.0 110.428 179.088 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.543 ' HB2' ' N ' ' A' ' 60' ' ' MET . . . -53.67 -26.9 24.7 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-O 120.925 0.393 . . . . 0.0 110.455 179.155 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.62 HD21 ' HB2' ' A' ' 53' ' ' SER . 0.2 OUTLIER -59.11 -62.15 2.1 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.954 -0.567 . . . . 0.0 109.714 178.982 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.496 HD13 ' HB2' ' A' ' 93' ' ' ALA . 7.9 mt -43.56 -43.39 5.55 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.243 179.513 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.417 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 19.4 mttt -54.0 -58.0 8.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.004 0.43 . . . . 0.0 111.225 179.507 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.697 ' HB2' HD11 ' A' ' 40' ' ' LEU . 21.5 mm-40 -62.07 -28.73 69.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.035 -179.846 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.624 HG21 ' CD2' ' A' ' 73' ' ' HIS . 77.0 mt -63.11 -42.02 95.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.029 0.442 . . . . 0.0 111.294 -179.846 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.589 ' HA ' ' HA ' ' A' ' 74' ' ' PRO . 0.1 OUTLIER -67.64 -29.25 68.51 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.573 -179.773 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.442 ' NE2' ' HA ' ' A' ' 68' ' ' GLN . 9.8 mt-30 -68.51 -40.61 80.76 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.036 179.527 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 52.0 mtt-85 -93.26 -76.22 0.48 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.743 -179.963 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.647 ' CE1' ' HG ' ' A' ' 76' ' ' LEU . 0.5 OUTLIER -114.5 79.18 5.28 Favored Pre-proline 0 C--N 1.318 -0.781 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.88 179.707 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.589 ' HA ' ' HA ' ' A' ' 70' ' ' LYS . 56.9 Cg_endo -70.87 50.28 1.07 Allowed 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.734 2.289 . . . . 0.0 113.131 -179.708 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.542 ' HG3' ' O ' ' A' ' 74' ' ' PRO . 2.8 mtp -150.65 -36.88 0.14 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.145 0.497 . . . . 0.0 110.82 179.716 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.647 ' HG ' ' CE1' ' A' ' 73' ' ' HIS . 0.2 OUTLIER -48.7 117.46 6.17 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.629 -179.831 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.433 ' HA ' ' O ' ' A' ' 97' ' ' GLY . 31.5 Cg_endo -64.5 134.37 41.11 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.046 1.831 . . . . 0.0 111.627 179.051 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.571 HG22 HD13 ' A' ' 69' ' ' ILE . 5.8 t -122.15 143.62 34.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.932 0.396 . . . . 0.0 111.262 -179.56 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.555 ' HB ' ' HG ' ' A' ' 52' ' ' LEU . 1.6 mt -124.01 110.67 26.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.925 -180.0 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.454 HD11 ' HB3' ' A' ' 53' ' ' SER . 6.3 mm -99.01 148.28 6.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.586 -179.199 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.434 ' O ' ' HB2' ' A' ' 102' ' ' LEU . 62.2 ttp -76.21 -60.42 2.34 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.813 -0.631 . . . . 0.0 112.322 -179.211 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.624 ' HB ' ' CG2' ' A' ' 55' ' ' ILE . 40.9 m -109.76 151.57 26.78 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.31 -178.516 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.535 ' CB ' ' CD2' ' A' ' 101' ' ' TYR . . . -136.09 -3.7 2.21 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -179.377 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.575 ' H ' ' CD2' ' A' ' 84' ' ' HIS . 1.0 OUTLIER -71.49 35.41 0.06 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -178.982 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.415 ' H ' ' C ' ' A' ' 83' ' ' ALA . 80.2 p -159.79 102.16 1.49 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.698 0.285 . . . . 0.0 111.184 179.447 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.476 ' O ' HD22 ' A' ' 63' ' ' LEU . 0.7 OUTLIER 67.64 35.37 4.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.911 179.762 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.516 HD21 ' HB1' ' A' ' 90' ' ' ALA . 0.5 OUTLIER -46.52 -22.53 0.28 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.108 -0.496 . . . . 0.0 112.078 -179.931 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -47.98 -50.3 27.84 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 -179.498 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.407 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . . . -60.77 -21.02 62.63 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.649 0.261 . . . . 0.0 111.661 -179.601 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.57 ' HB3' ' CE1' ' A' ' 101' ' ' TYR . . . -70.29 -34.03 72.27 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.886 0.374 . . . . 0.0 110.711 179.625 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.584 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 4.5 t -61.75 -49.84 82.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.386 -179.961 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.444 ' O ' ' NE2' ' A' ' 95' ' ' GLN . 17.6 m -59.72 -22.51 62.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.063 0.459 . . . . 0.0 110.037 179.209 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.53 ' CB ' ' HB3' ' A' ' 98' ' ' ALA . . . -65.14 -50.85 64.43 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.526 179.419 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.584 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 9.8 m-85 -54.92 -24.48 23.82 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.089 179.146 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.444 ' NE2' ' O ' ' A' ' 92' ' ' SER . 0.0 OUTLIER -76.51 -30.58 57.25 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.991 179.254 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.518 ' HG2' ' HA ' ' A' ' 93' ' ' ALA . 1.7 pt20 -91.14 -18.31 24.69 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.93 179.403 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.433 ' O ' ' HA ' ' A' ' 77' ' ' PRO . . . 127.85 14.72 2.49 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.059 -1.067 . . . . 0.0 114.016 179.283 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.53 ' HB3' ' CB ' ' A' ' 93' ' ' ALA . . . -55.46 144.52 25.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 117.457 0.629 . . . . 0.0 110.785 179.569 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.566 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 12.3 t80 -78.49 -54.46 6.13 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.337 -179.548 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.524 ' HB3' ' O ' ' A' ' 99' ' ' PHE . 10.3 p-10 173.62 -165.26 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 121.065 0.46 . . . . 0.0 111.528 179.96 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.57 ' CE1' ' HB3' ' A' ' 90' ' ' ALA . 5.3 m-85 -138.78 153.8 48.45 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.097 -179.832 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.791 HD23 ' HA ' ' A' ' 106' ' ' PHE . 5.5 mp -103.0 127.9 28.87 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 120.662 0.267 . . . . 0.0 111.288 -179.918 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -77.84 -74.6 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 121.962 1.775 . . . . 0.0 112.252 179.593 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.597 ' H ' ' HD2' ' A' ' 105' ' ' PRO . 0.2 OUTLIER -107.77 -55.91 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 -179.661 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.597 ' HD2' ' H ' ' A' ' 104' ' ' LYS . 34.0 Cg_endo -64.44 160.01 41.42 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 121.909 1.739 . . . . 0.0 112.729 -179.5 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.791 ' HA ' HD23 ' A' ' 102' ' ' LEU . 47.5 t80 -166.21 -106.51 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.089 -179.929 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.686 ' O ' ' HB1' ' A' ' 111' ' ' ALA . 2.4 p30 42.98 177.47 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.859 0.361 . . . . 0.0 111.414 -179.888 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.455 HG22 HG21 ' A' ' 112' ' ' VAL . 0.9 OUTLIER -68.06 -42.37 85.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.001 0.429 . . . . 0.0 111.401 -179.624 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.494 ' HB2' ' OD1' ' A' ' 107' ' ' ASP . 6.1 m-20 -49.08 -58.27 5.22 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.521 -179.826 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.672 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 8.1 mm-40 -74.76 -35.6 62.58 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.646 0.26 . . . . 0.0 111.602 -179.675 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.686 ' HB1' ' O ' ' A' ' 107' ' ' ASP . . . -65.77 -56.15 13.51 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.692 179.693 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.764 ' HA ' HG11 ' A' ' 115' ' ' VAL . 54.7 t -62.1 -33.92 60.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.341 0.591 . . . . 0.0 110.585 179.364 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.489 ' HB3' ' O ' ' A' ' 109' ' ' ASP . . . -61.84 -46.45 89.44 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.427 179.19 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.583 HD22 HD12 ' A' ' 102' ' ' LEU . 36.3 tp -74.67 -23.66 58.68 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.837 -179.216 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.764 HG11 ' HA ' ' A' ' 112' ' ' VAL . 6.4 p -79.49 -43.12 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.586 -179.901 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.495 ' N ' HG13 ' A' ' 115' ' ' VAL . 13.3 mt-10 -62.73 -47.31 84.15 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.056 -179.695 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.557 ' HD2' HD12 ' A' ' 114' ' ' LEU . 6.4 ptp180 -60.05 -23.6 63.87 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.735 179.507 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.566 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -74.63 -48.15 28.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.121 179.998 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.648 HD12 HG13 ' A' ' 50' ' ' VAL . 3.8 mt -68.76 -32.69 55.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.173 0.511 . . . . 0.0 110.738 179.697 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.5 t -68.95 -55.06 12.12 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.239 -179.763 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 6.4 m80 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.519 -179.612 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.316 0 CA-C-O 120.797 0.332 . . . . 0.0 111.319 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.445 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . 78.02 101.28 0.2 Allowed Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.809 -179.473 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.4 mp -118.72 113.24 41.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.913 0.387 . . . . 0.0 111.509 -179.419 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.768 HG13 ' HA ' ' A' ' 30' ' ' CYS . 11.6 p -105.97 128.33 60.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.675 179.297 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.616 ' CD1' HG21 ' A' ' 31' ' ' THR . 31.2 m0 -114.69 132.86 56.27 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.742 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.549 HG11 ' HB3' ' A' ' 52' ' ' LEU . 0.2 OUTLIER -123.86 141.6 43.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.066 0.46 . . . . 0.0 111.594 -178.06 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.596 ' HB ' ' C ' ' A' ' 35' ' ' ASN . 29.1 m -123.92 111.28 28.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.301 0.572 . . . . 0.0 111.005 179.474 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -161.38 -157.81 0.53 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.475 -179.557 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -72.0 9.12 1.01 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.987 0.365 . . . . 0.0 111.987 -179.929 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.532 ' O ' ' N ' ' A' ' 14' ' ' SER . 3.4 p30 47.8 -136.69 0.91 Allowed 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 179.662 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.518 ' N ' ' HG2' ' A' ' 16' ' ' ARG . 1.5 t 36.32 -84.44 0.0 OUTLIER 'General case' 0 C--O 1.236 0.348 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -179.584 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.532 ' N ' ' O ' ' A' ' 12' ' ' ASP . 35.6 t -77.8 -43.82 29.37 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.205 -0.452 . . . . 0.0 112.135 -179.21 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 27.4 mm -63.97 -34.34 67.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -178.893 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.606 ' HG3' ' H ' ' A' ' 17' ' ' TRP . 6.1 ptp180 -67.85 -52.69 33.76 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.789 -179.44 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.606 ' H ' ' HG3' ' A' ' 16' ' ' ARG . 28.4 t90 -54.85 -41.92 71.36 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.326 -178.782 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.5 t -67.55 -49.16 73.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -178.542 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.47 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 6.7 mt -79.72 -26.9 40.7 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.777 -178.112 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.595 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 19.3 pt-20 -66.8 -57.99 5.95 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.506 -0.477 . . . . 0.0 111.411 -179.604 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.461 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 3.4 mmt-85 -60.79 -54.46 44.88 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.927 -179.463 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.86 -33.29 68.52 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -179.055 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.67 ' CD1' HG11 ' A' ' 6' ' ' VAL . 2.7 tm? -76.01 -30.36 58.47 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.494 0.664 . . . . 0.0 110.308 179.602 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.61 -33.3 75.61 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.28 178.401 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.18 -26.15 68.98 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.198 178.607 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.25 -15.57 58.65 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 120.752 0.311 . . . . 0.0 110.823 179.371 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.98 26.06 10.74 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.647 -0.787 . . . . 0.0 113.596 179.211 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.598 ' HB2' HD13 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -132.77 170.89 14.62 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 117.571 0.685 . . . . 0.0 111.742 179.854 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.5 m -95.76 137.6 34.59 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.63 -179.438 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.768 ' HA ' HG13 ' A' ' 6' ' ' VAL . 10.9 t -125.38 119.86 29.47 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.088 0.471 . . . . 0.0 111.501 -179.569 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.621 HG23 ' CE1' ' A' ' 33' ' ' PHE . 2.5 t -125.95 132.27 52.11 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.833 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.537 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 69.9 p -103.4 164.11 11.85 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 -177.23 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.633 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 6.0 m-85 -134.41 172.96 12.18 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.59 -178.384 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.418 ' HG2' ' N ' ' A' ' 35' ' ' ASN . 0.5 OUTLIER -62.28 -34.83 77.32 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -177.175 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.596 ' C ' ' HB ' ' A' ' 9' ' ' VAL . 22.0 p30 -176.68 -26.44 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 179.622 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.459 ' N ' ' HB ' ' A' ' 9' ' ' VAL . . . 161.82 -56.64 0.3 Allowed Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.037 -1.077 . . . . 0.0 113.123 179.649 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.495 ' N ' HD13 ' A' ' 65' ' ' LEU . 0.7 OUTLIER -50.02 -34.03 19.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.12 0.486 . . . . 0.0 110.673 -179.764 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.633 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -54.22 -52.08 62.42 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.454 179.803 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.575 HG21 ' CG ' ' A' ' 33' ' ' PHE . 56.1 t -57.61 -40.98 78.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.036 -179.829 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.431 HD11 ' HA ' ' A' ' 37' ' ' ASN . 19.2 mt -53.12 -40.69 64.37 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.092 0.472 . . . . 0.0 110.426 179.459 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -77.25 -48.71 16.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.044 179.449 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.69 -25.15 67.22 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.763 179.67 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.569 ' HG ' HG11 ' A' ' 39' ' ' VAL . 9.3 mt -68.35 -22.05 64.7 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.036 -179.54 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.06 -17.09 36.84 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.737 -179.641 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.8 t -121.96 -3.48 9.12 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -179.611 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.495 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -162.71 159.02 23.78 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.038 0.447 . . . . 0.0 111.34 179.643 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.423 ' HA ' ' CD2' ' A' ' 43' ' ' LEU . 98.2 m -139.23 113.96 8.22 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.442 179.703 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.46 ' HG3' ' HB2' ' A' ' 7' ' ' TRP . 72.0 Cg_endo -75.7 161.64 36.42 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.049 1.832 . . . . 0.0 111.291 178.92 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.417 ' O ' ' HG2' ' A' ' 77' ' ' PRO . 1.2 m-20 -73.69 -21.15 60.34 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.649 0.261 . . . . 0.0 110.956 -179.869 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.481 HG11 ' HA ' ' A' ' 6' ' ' VAL . 7.5 p -148.75 166.7 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.347 179.958 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.526 HD12 ' O ' ' A' ' 7' ' ' TRP . 18.8 tp -153.02 130.78 11.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.736 0.303 . . . . 0.0 111.158 -179.467 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.549 ' HB3' HG11 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -112.31 121.44 44.9 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.531 -179.934 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.51 ' HA ' ' CG2' ' A' ' 9' ' ' VAL . 3.2 m -106.23 130.83 54.02 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.928 0.394 . . . . 0.0 111.488 -179.695 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.402 ' O ' ' CG2' ' A' ' 55' ' ' ILE . 35.4 t70 -73.78 -22.67 59.76 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.586 -179.803 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.763 HG12 ' HA3' ' A' ' 62' ' ' GLY . 0.0 OUTLIER 44.04 99.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 121.185 0.517 . . . . 0.0 111.832 -179.782 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -142.58 43.99 1.62 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.585 -179.57 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.525 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER 58.81 48.13 2.2 Favored Pre-proline 0 CA--C 1.532 0.264 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 179.296 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.545 ' HD2' ' N ' ' A' ' 62' ' ' GLY . 41.1 Cg_endo -68.06 -79.16 0.01 OUTLIER 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 122.327 2.018 . . . . 0.0 111.969 178.914 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -107.83 -25.15 6.04 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.331 179.478 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.526 ' C ' ' H ' ' A' ' 62' ' ' GLY . 0.3 OUTLIER -158.72 65.03 0.42 Allowed 'General case' 0 C--O 1.236 0.368 0 CA-C-O 120.962 0.41 . . . . 0.0 110.454 179.813 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.525 ' HA ' ' HA ' ' A' ' 57' ' ' MET . 0.2 OUTLIER 70.36 -21.24 0.19 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.961 179.998 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.763 ' HA3' HG12 ' A' ' 55' ' ' ILE . . . 130.76 -30.0 3.47 Favored Glycine 0 N--CA 1.446 -0.674 0 N-CA-C 110.146 -1.182 . . . . 0.0 110.146 -178.847 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.607 HD13 ' HB3' ' A' ' 86' ' ' ASP . 0.8 OUTLIER -70.54 -15.99 62.83 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.007 -0.596 . . . . 0.0 109.732 178.675 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.455 ' HB3' ' N ' ' A' ' 60' ' ' MET . . . -53.54 -32.08 49.15 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-O 120.906 0.384 . . . . 0.0 110.259 179.706 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.495 HD13 ' N ' ' A' ' 37' ' ' ASN . 0.1 OUTLIER -61.24 -43.38 98.97 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.311 179.027 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.596 ' HG ' ' CB ' ' A' ' 93' ' ' ALA . 3.1 mm? -57.69 -45.45 85.62 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.052 -179.493 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -55.55 -47.69 75.96 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.234 0.54 . . . . 0.0 110.361 179.15 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.425 ' HG2' ' O ' ' A' ' 64' ' ' ALA . 34.7 mm-40 -60.04 -29.74 68.73 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.503 179.62 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.555 ' HA ' ' CD2' ' A' ' 73' ' ' HIS . 59.4 mt -57.19 -48.98 81.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.224 0.535 . . . . 0.0 111.155 -179.705 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.523 ' HB3' ' CG ' ' A' ' 96' ' ' GLN . 7.6 pttt -63.02 -33.57 75.7 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.004 -179.232 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.487 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 4.4 mt-30 -72.73 -32.94 66.08 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.913 -179.478 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.2 mtt180 -108.87 -65.71 1.11 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -178.627 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.555 ' CD2' ' HA ' ' A' ' 69' ' ' ILE . 0.8 OUTLIER -82.12 169.04 19.84 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.679 -178.677 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -84.67 -68.99 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.885 2.39 . . . . 0.0 113.116 -179.579 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.418 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 69.7 mtm -150.98 45.83 0.84 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.823 0.344 . . . . 0.0 110.786 -179.8 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.433 HD11 ' HD2' ' A' ' 48' ' ' PRO . 25.3 tp -56.77 114.8 8.6 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.231 -179.589 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.417 ' HG2' ' O ' ' A' ' 49' ' ' ASP . 19.6 Cg_endo -59.87 123.14 12.62 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.236 1.957 . . . . 0.0 112.011 179.531 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.851 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 4.6 t -124.59 153.07 31.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.843 -179.743 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.501 ' CD1' HG22 ' A' ' 115' ' ' VAL . 1.7 mt -128.45 114.39 33.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.94 179.939 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.567 HG13 ' CZ ' ' A' ' 101' ' ' TYR . 13.7 mm -93.83 141.01 15.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.889 -179.865 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.558 ' HA ' ' HB3' ' A' ' 102' ' ' LEU . 0.3 OUTLIER -80.26 -33.04 38.17 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.573 -179.334 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.46 ' N ' ' HG3' ' A' ' 81' ' ' MET . 19.8 m -147.83 144.92 28.5 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 120.96 0.41 . . . . 0.0 111.724 -179.244 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.474 ' HA ' ' CE2' ' A' ' 101' ' ' TYR . . . -86.92 -26.19 24.03 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.39 179.661 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 46.87 44.5 14.49 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.766 179.549 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 38.8 m 53.4 85.89 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.576 179.286 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.607 ' HB3' HD13 ' A' ' 63' ' ' LEU . 0.2 OUTLIER 177.03 35.71 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.825 179.822 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -49.12 -21.87 0.83 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.949 -179.509 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -47.7 -61.08 2.11 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.48 0.181 . . . . 0.0 111.422 -179.503 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.0 -20.03 60.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.824 0.345 . . . . 0.0 110.698 179.375 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.425 ' HB1' ' CE1' ' A' ' 101' ' ' TYR . . . -62.38 -47.57 83.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.345 -179.963 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.554 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 6.6 t -67.26 -41.05 86.16 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 C-N-CA 120.704 -0.399 . . . . 0.0 110.52 179.819 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.492 ' O ' ' HG3' ' A' ' 95' ' ' GLN . 39.7 m -62.19 -15.83 49.0 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.387 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.596 ' CB ' ' HG ' ' A' ' 66' ' ' LEU . . . -75.87 -64.0 1.18 Allowed 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 120.988 0.423 . . . . 0.0 111.625 179.904 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.625 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 3.9 m-85 -41.7 -44.35 3.14 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.782 -178.431 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.578 ' NE2' ' HG3' ' A' ' 96' ' ' GLN . 0.2 OUTLIER -69.97 -48.46 58.17 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.23 179.563 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.578 ' HG3' ' NE2' ' A' ' 95' ' ' GLN . 59.5 mt-30 -75.92 -9.83 58.93 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.292 -0.413 . . . . 0.0 112.106 -179.831 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 93' ' ' ALA . . . 133.48 80.64 0.16 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.063 -179.553 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.851 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -168.5 133.82 1.73 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.093 0.473 . . . . 0.0 111.309 -179.903 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.427 ' CG ' ' HB1' ' A' ' 118' ' ' ALA . 50.4 t80 -73.33 -53.37 10.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.773 -179.777 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.516 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 1.7 t0 175.84 -171.05 0.07 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.016 0.436 . . . . 0.0 111.404 -179.817 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.567 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 6.7 m-85 -114.35 152.88 30.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.233 179.328 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.683 HD22 ' O ' ' A' ' 105' ' ' PRO . 5.9 tp -105.52 137.32 19.26 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.142 -179.032 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.467 ' HD2' HD12 ' A' ' 102' ' ' LEU . 36.7 Cg_endo -65.23 -161.5 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.933 2.422 . . . . 0.0 112.726 -179.545 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.433 ' CB ' ' HD3' ' A' ' 105' ' ' PRO . 0.3 OUTLIER -48.89 -59.25 6.61 Favored Pre-proline 0 CA--C 1.531 0.223 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.819 -179.478 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.683 ' O ' HD22 ' A' ' 102' ' ' LEU . 73.8 Cg_exo -48.49 164.27 0.22 Allowed 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.44 2.093 . . . . 0.0 111.868 179.776 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.625 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 64.8 t80 -161.74 -102.42 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.706 -0.224 . . . . 0.0 110.719 179.844 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.583 ' O ' ' O ' ' A' ' 106' ' ' PHE . 2.6 p-10 42.09 179.3 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.915 0.388 . . . . 0.0 111.318 -179.983 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.513 HG23 HG23 ' A' ' 112' ' ' VAL . 1.0 OUTLIER -67.66 -42.29 86.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.084 0.468 . . . . 0.0 111.346 179.863 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.663 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 3.4 t0 -51.86 -58.77 5.49 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.594 -179.36 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.625 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 3.3 mm-40 -75.62 -27.7 58.55 Favored 'General case' 0 C--N 1.333 -0.124 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -179.476 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.419 ' CB ' ' O ' ' A' ' 107' ' ' ASP . . . -73.82 -62.52 1.47 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.925 0.393 . . . . 0.0 110.256 179.519 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.65 ' O ' HG12 ' A' ' 115' ' ' VAL . 49.3 t -55.63 -29.86 25.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.484 0.659 . . . . 0.0 110.256 179.021 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.663 ' HB3' ' O ' ' A' ' 109' ' ' ASP . . . -63.46 -50.96 67.65 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.731 179.172 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.407 ' HG ' HG21 ' A' ' 79' ' ' ILE . 53.7 tp -72.4 -20.69 61.39 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.395 -0.82 . . . . 0.0 112.273 -179.705 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.65 HG12 ' O ' ' A' ' 112' ' ' VAL . 2.9 p -79.36 -47.67 22.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.686 -179.338 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.416 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 26.0 mt-10 -64.24 -42.8 96.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.855 0.36 . . . . 0.0 110.652 179.98 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.522 ' HG3' ' O ' ' A' ' 113' ' ' ALA . 40.5 mtt85 -63.36 -23.68 67.52 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.924 0.392 . . . . 0.0 110.551 179.224 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.427 ' HB1' ' CG ' ' A' ' 99' ' ' PHE . . . -70.16 -48.76 55.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.663 179.446 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.403 HG12 ' HB ' ' A' ' 50' ' ' VAL . 4.9 mt -68.1 -31.95 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.039 179.892 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 9.2 p -74.04 -49.05 25.91 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.382 -179.725 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 1.6 m80 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.312 -179.551 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.491 ' HG2' HD11 ' A' ' 5' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.341 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 . . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.443 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . 104.84 103.46 2.86 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.444 179.41 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.491 HD11 ' HG2' ' A' ' 3' ' ' ARG . 7.5 mm -127.56 112.7 28.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 120.904 0.383 . . . . 0.0 111.813 -179.546 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.738 HG13 ' HA ' ' A' ' 30' ' ' CYS . 7.9 p -107.07 135.16 46.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.144 179.642 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.616 ' CG ' ' HB3' ' A' ' 48' ' ' PRO . 24.2 m0 -120.26 125.89 49.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.014 0.435 . . . . 0.0 110.657 179.447 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.731 HG13 ' HB3' ' A' ' 52' ' ' LEU . 0.5 OUTLIER -114.56 146.64 18.79 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.288 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.46 -178.365 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.746 HG12 ' HB2' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -124.7 110.8 25.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.821 0.343 . . . . 0.0 110.582 179.243 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.421 ' CB ' HG23 ' A' ' 15' ' ' ILE . 3.8 t0 -161.49 -161.18 0.77 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.228 -179.231 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.24 -0.23 3.29 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -179.487 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.436 ' O ' ' N ' ' A' ' 14' ' ' SER . 0.8 OUTLIER 69.51 -157.72 0.16 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.5 0.19 . . . . 0.0 110.894 179.896 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.6 t 34.54 -88.61 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 113.002 0.741 . . . . 0.0 113.002 179.51 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.436 ' N ' ' O ' ' A' ' 12' ' ' ASP . 28.4 t -56.07 -58.99 5.6 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.719 0.295 . . . . 0.0 111.235 -179.699 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.421 HG23 ' CB ' ' A' ' 10' ' ' ASP . 20.5 mm -65.77 -24.46 34.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.262 -179.821 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.464 ' HG3' HG23 ' A' ' 32' ' ' THR . 20.2 ttt-85 -78.39 -41.15 34.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.023 179.819 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.409 ' HA ' ' CD ' ' A' ' 20' ' ' GLU . 84.1 t90 -65.7 -40.17 91.99 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.541 -179.351 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.606 HG11 HG12 ' A' ' 108' ' ' ILE . 3.5 t -69.37 -38.17 76.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -178.93 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.43 HD21 HD13 ' A' ' 108' ' ' ILE . 0.2 OUTLIER -84.39 -29.29 26.33 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -178.962 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.732 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 24.4 pt-20 -67.87 -59.01 3.62 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -179.29 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.45 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 9.8 mmt180 -64.65 -51.69 61.23 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.885 -178.904 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.23 -44.43 79.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.103 0.478 . . . . 0.0 111.521 -179.384 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.717 ' CD1' HG11 ' A' ' 6' ' ' VAL . 2.1 tm? -72.04 -27.85 62.98 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.188 179.523 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.54 -33.63 76.11 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.29 178.397 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.18 -28.65 69.45 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.498 -0.858 . . . . 0.0 111.16 178.772 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.84 -15.35 59.74 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 120.717 0.294 . . . . 0.0 110.947 179.412 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.49 26.08 11.36 Favored Glycine 0 C--N 1.334 0.422 0 C-N-CA 120.7 -0.762 . . . . 0.0 113.657 179.001 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.479 ' HB2' HD13 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -131.5 172.65 11.96 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 117.528 0.664 . . . . 0.0 111.583 179.625 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.462 ' HB ' HD12 ' A' ' 5' ' ' ILE . 16.6 m -96.62 138.08 34.73 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.43 -179.256 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.738 ' HA ' HG13 ' A' ' 6' ' ' VAL . 8.5 t -127.61 117.5 22.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.884 179.972 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.583 HG22 ' CE1' ' A' ' 33' ' ' PHE . 2.8 t -122.08 142.77 50.02 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.275 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.691 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 66.7 p -118.26 159.81 22.7 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.181 0.515 . . . . 0.0 112.165 -178.889 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.859 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 0.2 OUTLIER -135.1 171.92 13.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.823 -179.007 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.677 ' HG2' ' N ' ' A' ' 35' ' ' ASN . 0.0 OUTLIER -64.17 -43.53 94.84 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.212 -179.532 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.677 ' N ' ' HG2' ' A' ' 34' ' ' GLU . 29.3 p30 -173.1 178.89 2.37 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.104 0.478 . . . . 0.0 110.988 -179.018 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.59 ' HA3' ' HB3' ' A' ' 65' ' ' LEU . . . -43.05 -32.21 1.46 Allowed Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.46 -0.791 . . . . 0.0 113.825 -179.47 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.623 ' HA ' HD13 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -72.67 -45.68 57.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.945 0.373 . . . . 0.0 111.613 -178.966 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.859 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -52.2 -54.47 30.5 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 -179.836 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.54 HG23 HG11 ' A' ' 9' ' ' VAL . 3.5 t -48.86 -36.26 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.32 -179.438 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.623 HD13 ' HA ' ' A' ' 37' ' ' ASN . 7.0 mt -62.62 -49.6 74.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.838 0.351 . . . . 0.0 110.532 179.85 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -54.35 -50.39 67.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.32 -179.488 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.531 ' CB ' ' HE2' ' A' ' 33' ' ' PHE . . . -70.77 -33.46 70.78 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.258 179.953 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.559 ' HA ' ' O ' ' A' ' 46' ' ' LYS . 16.0 mt -61.19 -27.12 68.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.307 -179.821 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.79 -17.99 4.2 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.618 -179.583 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 23.9 t -120.85 -3.39 9.7 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -179.635 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.559 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.4 OUTLIER -167.66 165.38 14.37 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.883 0.373 . . . . 0.0 111.47 -179.73 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 59.3 m -139.18 128.14 13.94 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.221 179.585 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.616 ' HB3' ' CG ' ' A' ' 7' ' ' TRP . 74.1 Cg_endo -78.06 159.66 30.33 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.38 2.053 . . . . 0.0 111.904 179.195 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -75.42 -31.37 60.35 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.622 179.847 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.593 HG22 HG23 ' A' ' 115' ' ' VAL . 13.5 p -149.68 111.82 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.446 -179.435 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.445 HD21 HG13 ' A' ' 39' ' ' VAL . 15.3 tp -87.13 150.2 24.14 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.925 0.393 . . . . 0.0 111.949 -179.656 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.731 ' HB3' HG13 ' A' ' 8' ' ' VAL . 1.4 tt -138.75 118.13 12.83 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.743 179.539 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.498 ' N ' HD23 ' A' ' 52' ' ' LEU . 3.2 m -112.42 135.16 53.46 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 121.038 0.447 . . . . 0.0 111.286 179.756 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.523 ' O ' HG21 ' A' ' 55' ' ' ILE . 25.7 t0 -77.36 -8.01 56.99 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -178.705 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.968 HG12 ' HA3' ' A' ' 62' ' ' GLY . 0.0 OUTLIER 37.61 100.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 179.908 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.3 ptt85 -146.03 44.0 1.24 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.501 179.68 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.502 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 37.7 ttp 65.27 49.37 0.72 Allowed Pre-proline 0 CA--C 1.532 0.285 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 178.894 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' A' ' 62' ' ' GLY . 57.5 Cg_endo -72.05 -84.54 0.0 OUTLIER 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 122.757 2.305 . . . . 0.0 112.116 178.711 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -100.33 -29.33 6.76 Favored Glycine 0 C--N 1.337 0.636 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.433 179.696 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.571 ' HB3' ' CB ' ' A' ' 64' ' ' ALA . 0.7 OUTLIER -157.23 69.4 0.57 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.907 0.384 . . . . 0.0 110.114 179.496 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.502 ' HA ' ' HA ' ' A' ' 57' ' ' MET . 0.2 OUTLIER 68.56 -22.96 0.13 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.964 -179.694 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.968 ' HA3' HG12 ' A' ' 55' ' ' ILE . . . 136.69 -26.63 3.01 Favored Glycine 0 CA--C 1.498 -0.997 0 C-N-CA 120.981 -0.628 . . . . 0.0 111.682 -179.838 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.551 ' HA ' HD13 ' A' ' 66' ' ' LEU . 1.0 OUTLIER -75.95 -17.56 59.69 Favored 'General case' 0 N--CA 1.44 -0.971 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.157 179.221 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.571 ' CB ' ' HB3' ' A' ' 60' ' ' MET . . . -53.47 -38.34 63.51 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 121.002 0.429 . . . . 0.0 110.601 179.085 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.59 ' HB3' ' HA3' ' A' ' 36' ' ' GLY . 3.8 pp -58.76 -36.94 75.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.197 -179.795 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.551 HD13 ' HA ' ' A' ' 63' ' ' LEU . 9.6 mt -62.7 -43.73 98.04 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.835 0.35 . . . . 0.0 110.308 179.586 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.488 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 0.4 OUTLIER -52.9 -59.75 4.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.499 179.563 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.514 ' CB ' HD11 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -55.86 -38.19 69.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.023 0.44 . . . . 0.0 111.146 179.422 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.437 ' HA ' ' CD2' ' A' ' 73' ' ' HIS . 6.7 mm -61.56 -36.74 75.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.218 -178.738 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.584 ' HB2' ' HB2' ' A' ' 96' ' ' GLN . 1.1 pttt -78.44 -24.86 45.87 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.247 -0.433 . . . . 0.0 112.084 -179.613 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.49 ' NE2' ' HG3' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -80.57 -30.03 37.01 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.694 -178.251 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.49 ' HG3' ' NE2' ' A' ' 71' ' ' GLN . 27.5 mtt180 -103.9 -21.78 13.59 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -179.684 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.551 ' NE2' HD11 ' A' ' 43' ' ' LEU . 1.9 m-70 -128.67 156.24 77.77 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-O 120.776 0.322 . . . . 0.0 111.255 -178.935 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -95.25 100.88 0.11 Allowed 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 123.214 2.609 . . . . 0.0 113.687 -178.88 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.458 ' HA ' ' CA ' ' A' ' 97' ' ' GLY . 3.9 mtt 55.53 38.57 30.4 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.261 178.169 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.539 ' O ' HG22 ' A' ' 78' ' ' VAL . 1.4 tt -60.52 114.19 9.51 Favored Pre-proline 0 C--N 1.325 -0.483 0 C-N-CA 121.143 -0.223 . . . . 0.0 110.867 179.602 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -55.87 129.94 37.65 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.532 2.155 . . . . 0.0 112.848 -179.948 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.601 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 4.4 t -137.59 147.06 26.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.286 179.55 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.587 ' HB ' ' HG ' ' A' ' 52' ' ' LEU . 2.0 mt -122.47 111.07 28.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.212 179.563 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.63 HG22 ' CE2' ' A' ' 101' ' ' TYR . 8.6 mm -99.2 142.13 15.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 120.996 0.426 . . . . 0.0 111.839 -178.903 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.626 ' O ' ' HB2' ' A' ' 102' ' ' LEU . 13.8 ttt -70.72 -75.73 0.12 Allowed 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.631 -179.42 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.472 ' H ' ' CG2' ' A' ' 55' ' ' ILE . 3.0 m -105.65 147.39 28.54 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.089 0.471 . . . . 0.0 111.542 -178.936 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.538 ' O ' ' HG ' ' A' ' 87' ' ' LEU . . . -116.29 59.12 0.74 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.902 179.941 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 21.1 p80 -99.07 135.28 40.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.913 0.387 . . . . 0.0 111.561 -179.674 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.432 ' HB3' ' CG ' ' A' ' 61' ' ' ASP . 9.5 t 62.85 134.11 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.648 179.183 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.43 ' O ' HD23 ' A' ' 63' ' ' LEU . 1.8 t70 55.49 36.65 27.57 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.128 179.65 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' A' ' 83' ' ' ALA . 0.5 OUTLIER -53.48 -24.27 12.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.566 -179.901 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -49.5 -47.46 48.63 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.96 0.41 . . . . 0.0 111.357 -179.782 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.512 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -62.66 -19.74 64.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.258 -179.888 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.507 ' HB1' HD22 ' A' ' 63' ' ' LEU . . . -72.09 -57.49 4.22 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.775 0.321 . . . . 0.0 110.972 179.527 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.677 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 3.5 t -59.95 -52.45 60.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.299 -179.55 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 89.9 p -58.44 -22.25 53.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.01 0.434 . . . . 0.0 109.98 178.975 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.507 ' O ' ' N ' ' A' ' 97' ' ' GLY . . . -59.92 -48.81 80.17 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.365 179.154 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.677 ' CE2' ' HA ' ' A' ' 91' ' ' VAL . 2.8 m-85 -57.62 -30.89 65.72 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.186 -180.0 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.77 -36.37 59.85 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.306 -179.911 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.584 ' HB2' ' HB2' ' A' ' 70' ' ' LYS . 11.8 pt20 -100.18 0.88 41.34 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.526 -178.98 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 93' ' ' ALA . . . 128.4 81.32 0.31 Allowed Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.347 -0.93 . . . . 0.0 113.323 179.955 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.601 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -169.7 136.04 1.56 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.778 0.323 . . . . 0.0 110.26 179.162 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.515 ' CZ ' ' HA ' ' A' ' 118' ' ' ALA . 32.0 t80 -74.97 -53.32 9.16 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.976 -0.29 . . . . 0.0 111.325 -179.449 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.613 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 2.4 t70 179.82 -172.76 0.2 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.265 0.555 . . . . 0.0 111.924 -179.756 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.63 ' CE2' HG22 ' A' ' 80' ' ' ILE . 3.1 m-85 -128.36 154.1 46.34 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.811 179.986 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.626 ' HB2' ' O ' ' A' ' 81' ' ' MET . 9.0 mp -102.04 123.58 43.07 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-O 120.719 0.295 . . . . 0.0 110.614 179.958 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -68.62 -66.8 0.03 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.19 1.927 . . . . 0.0 112.337 -179.753 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.641 ' H ' ' HD2' ' A' ' 105' ' ' PRO . 0.7 OUTLIER -119.4 -58.39 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.244 -0.434 . . . . 0.0 112.117 -179.535 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.641 ' HD2' ' H ' ' A' ' 104' ' ' LYS . 17.8 Cg_endo -59.5 163.1 13.43 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.255 1.97 . . . . 0.0 112.697 -179.501 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.593 ' O ' ' O ' ' A' ' 107' ' ' ASP . 38.9 t80 -166.86 -108.61 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.223 179.609 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.594 ' O ' ' HB2' ' A' ' 111' ' ' ALA . 3.1 p30 43.04 176.57 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.896 0.379 . . . . 0.0 111.274 -179.975 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.606 HG12 HG11 ' A' ' 18' ' ' VAL . 1.0 OUTLIER -67.7 -39.41 82.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 121.903 -0.498 . . . . 0.0 111.278 -179.82 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.462 ' O ' ' HB1' ' A' ' 113' ' ' ALA . 4.4 t70 -49.82 -58.47 5.3 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.246 -179.75 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.581 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 3.4 mm-40 -77.61 -34.32 53.42 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 111.709 0.263 . . . . 0.0 111.709 -179.76 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.594 ' HB2' ' O ' ' A' ' 107' ' ' ASP . . . -64.39 -59.56 4.21 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 179.328 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.758 ' O ' HG13 ' A' ' 115' ' ' VAL . 55.8 t -59.54 -30.27 44.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.466 0.65 . . . . 0.0 110.506 178.86 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.462 ' HB1' ' O ' ' A' ' 109' ' ' ASP . . . -65.37 -47.55 76.0 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.158 179.367 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.542 HD22 HD12 ' A' ' 102' ' ' LEU . 23.6 tp -73.51 -21.33 60.43 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.551 -179.627 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.758 HG13 ' O ' ' A' ' 112' ' ' VAL . 5.7 p -79.44 -47.08 22.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.779 0.323 . . . . 0.0 111.679 -179.838 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.578 ' HA ' HD12 ' A' ' 119' ' ' ILE . 31.8 mt-10 -67.88 -46.8 70.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.88 -179.786 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 55.8 mtp180 -61.01 -24.2 65.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.091 0.472 . . . . 0.0 110.567 179.392 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.515 ' HA ' ' CZ ' ' A' ' 99' ' ' PHE . . . -71.16 -47.4 57.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.97 179.625 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.585 HD13 HG12 ' A' ' 50' ' ' VAL . 4.6 mt -62.94 -31.17 51.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.127 -179.95 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.0 t -74.55 -51.0 15.86 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.422 -179.387 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 20.5 m80 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.394 -179.464 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 1.747 ' H1 ' ' SD ' ' A' ' 1' ' ' MET 1.51 3.9 mtm . . . . . 3 N--CA 0.345 -55.692 2 N-CA-C 162.743 19.164 . . . . 0.0 162.743 . . . . . . . . . 4 2 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 1.625 HE21 ' CG ' ' A' ' 2' ' ' GLN 0.586 2.3 mt-30 -124.41 111.4 15.7 Favored 'General case' 4 C--N 0.591 -32.401 5 O-C-N 76.631 -28.793 . . . . 0.0 122.754 179.739 . . . . . . . . 5 3 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 1.581 ' HB3' ' CG ' ' A' ' 3' ' ' ARG . 0.0 OUTLIER -46.67 -29.08 1.7 Allowed 'General case' 3 C--N 0.87 -20.26 3 O-C-N 94.922 -17.361 . . . . 0.0 114.498 -179.438 . . . . . . . . 5 4 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.45 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . 79.76 87.59 0.54 Allowed Glycine 1 C--N 1.149 -9.831 1 O-C-N 113.565 -5.709 . . . . 0.0 112.665 -179.864 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 1.668 HD13 ' CG1' ' A' ' 5' ' ' ILE . 0.7 OUTLIER -112.7 113.3 43.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 O-C-N 122.59 -0.359 . . . . 0.0 111.365 -179.679 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 1.038 HG12 ' CB ' ' A' ' 6' ' ' VAL . 7.1 p -107.71 125.39 64.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.676 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.486 ' CD1' ' CG2' ' A' ' 31' ' ' THR . 31.4 m0 -114.44 134.13 55.23 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.03 0.443 . . . . 0.0 110.374 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 1.006 HG23 ' CB ' ' A' ' 8' ' ' VAL . 0.3 OUTLIER -122.29 143.83 33.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.653 -178.405 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 1.224 HG12 ' CB ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -123.81 109.65 23.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.038 0.447 . . . . 0.0 110.321 178.901 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.497 ' O ' ' N ' ' A' ' 12' ' ' ASP . 5.8 t0 -164.55 -177.24 4.72 Favored 'General case' 1 C--O 0.895 -17.579 0 CA-C-O 125.923 2.773 . . . . 0.0 111.103 -179.075 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 1.303 ' OD2' ' CB ' ' A' ' 11' ' ' ASP . 0.7 OUTLIER -44.89 -10.47 0.01 OUTLIER 'General case' 2 C--N 1.074 -11.412 3 O-C-N 104.073 -11.642 . . . . 0.0 112.854 -178.827 . . . . . . . . 5 4 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.497 ' N ' ' O ' ' A' ' 10' ' ' ASP . 2.6 t70 76.01 -147.53 0.03 OUTLIER 'General case' 1 C--O 1.13 -5.215 0 O-C-N 117.905 -2.997 . . . . 0.0 111.76 179.803 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 1.103 ' HG ' ' CB ' ' A' ' 13' ' ' SER . 8.2 t 22.05 -85.74 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.777 0 C-N-CA 126.371 1.868 . . . . 0.0 114.676 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.87 -56.92 14.9 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 120.925 0.393 . . . . 0.0 111.514 -179.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.998 HD11 ' CG1' ' A' ' 15' ' ' ILE . 24.0 mm -65.09 -24.99 36.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-O 120.823 0.344 . . . . 0.0 111.141 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 1.53 ' HE ' ' CZ ' ' A' ' 16' ' ' ARG . 1.8 ttt180 -72.29 -50.2 28.84 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.291 0.567 . . . . 0.0 111.201 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 72.1 t90 -60.33 -43.24 96.6 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 1.029 HG13 ' CB ' ' A' ' 18' ' ' VAL . 3.2 t -65.84 -48.05 83.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -178.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 1.603 HD23 ' CG ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -81.15 -29.29 34.76 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -178.093 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 1.327 ' OE1' ' CG ' ' A' ' 20' ' ' GLU . 12.9 pt-20 -67.13 -59.33 3.54 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -178.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 1.202 ' NE ' ' CG ' ' A' ' 21' ' ' ARG . 11.8 mmt180 -59.2 -51.27 70.73 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.821 -179.09 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.995 ' HB1' ' CA ' ' A' ' 22' ' ' ALA . . . -57.64 -46.11 84.6 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.91 0.386 . . . . 0.0 111.83 -179.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 1.556 HD22 ' CG ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -72.2 -26.46 62.06 Favored 'General case' 0 C--N 1.311 -1.109 0 CA-C-O 121.225 0.536 . . . . 0.0 110.408 179.577 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.983 ' HB3' ' CA ' ' A' ' 24' ' ' ALA . . . -67.09 -34.62 78.03 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.93 -26.14 68.63 Favored Glycine 0 N--CA 1.44 -1.073 0 C-N-CA 120.247 -0.978 . . . . 0.0 111.032 178.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.999 ' HB2' ' CA ' ' A' ' 26' ' ' ALA . . . -77.21 -15.71 59.37 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 120.802 0.334 . . . . 0.0 110.939 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.3 26.23 10.32 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.514 -0.851 . . . . 0.0 114.143 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 1.021 HD12 ' CG ' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -126.18 168.74 13.64 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 117.982 0.891 . . . . 0.0 112.238 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.994 HG21 ' CB ' ' A' ' 29' ' ' THR . 53.7 m -91.85 115.3 27.95 Favored 'General case' 0 C--O 1.211 -0.953 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.627 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 1.482 ' HG ' ' CB ' ' A' ' 30' ' ' CYS . 49.1 t -110.81 113.55 26.23 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.008 0.433 . . . . 0.0 112.083 -179.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 1.108 ' HG1' ' CB ' ' A' ' 31' ' ' THR . 2.7 t -122.48 146.22 47.59 Favored 'General case' 0 C--O 1.219 -0.509 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.999 HG22 ' CB ' ' A' ' 32' ' ' THR . 60.3 p -119.52 162.57 18.68 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.315 0.579 . . . . 0.0 112.258 -178.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.775 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 3.0 m-85 -133.65 173.54 11.4 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.371 -0.832 . . . . 0.0 111.7 -178.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 1.295 ' HG3' ' CD ' ' A' ' 34' ' ' GLU . 17.1 pt-20 -62.55 -47.03 85.66 Favored 'General case' 1 C--O 1.149 -4.211 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -177.98 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 1.587 HD21 ' CB ' ' A' ' 35' ' ' ASN . 0.0 OUTLIER -161.25 -61.73 0.05 Allowed 'General case' 1 C--O 0.886 -18.048 0 O-C-N 118.598 -2.564 . . . . 0.0 112.277 -179.252 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.617 ' HA3' ' CD2' ' A' ' 65' ' ' LEU . . . -163.39 -43.95 0.02 OUTLIER Glycine 1 C--N 1.066 -14.464 3 O-C-N 103.777 -11.827 . . . . 0.0 113.315 -179.399 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.413 ' HA ' ' CD1' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -60.43 -33.31 72.35 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 122.208 -0.584 . . . . 0.0 111.358 -179.359 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 1.386 ' HG2' ' CD ' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -57.1 -55.27 36.91 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.384 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 1.071 HG23 ' CB ' ' A' ' 39' ' ' VAL . 21.5 t -53.44 -37.62 30.42 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.289 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.816 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 1.001 HD21 ' CG ' ' A' ' 40' ' ' LEU . 18.5 mt -56.42 -44.72 80.66 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.681 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.989 ' HB3' ' CA ' ' A' ' 41' ' ' ALA . . . -68.39 -48.77 63.84 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.212 0.529 . . . . 0.0 111.218 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.979 ' HB1' ' CA ' ' A' ' 42' ' ' ALA . . . -64.64 -31.77 73.14 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.913 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 1.038 HD12 ' CG ' ' A' ' 43' ' ' LEU . 12.9 mt -64.4 -24.93 67.8 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.515 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.978 ' HB1' ' CA ' ' A' ' 44' ' ' ALA . . . -57.35 -18.72 18.65 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.66 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 1.512 ' HG ' ' CB ' ' A' ' 45' ' ' SER . 0.1 OUTLIER -123.39 0.11 8.84 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.653 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 1.591 ' HZ3' ' CE ' ' A' ' 46' ' ' LYS . 0.3 OUTLIER -162.4 160.38 26.36 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-O 120.779 0.323 . . . . 0.0 111.55 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 1.123 ' HG1' ' CB ' ' A' ' 47' ' ' THR . 97.3 m -138.91 114.7 8.57 Favored Pre-proline 0 N--CA 1.448 -0.556 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.447 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.414 ' HG3' ' HB2' ' A' ' 7' ' ' TRP . 68.4 Cg_endo -75.29 159.58 40.15 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.441 2.094 . . . . 0.0 111.599 179.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -75.26 -26.53 58.88 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.803 0.335 . . . . 0.0 111.108 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.996 HG13 ' CB ' ' A' ' 50' ' ' VAL . 7.1 p -146.04 133.52 15.26 Favored 'Isoleucine or valine' 1 C--O 1.079 -7.92 0 CA-C-O 122.88 1.324 . . . . 0.0 110.861 -179.652 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 1.013 HD13 ' CG ' ' A' ' 51' ' ' LEU . 18.2 tp -120.02 134.45 55.25 Favored 'General case' 1 C--N 1.203 -5.766 1 O-C-N 114.859 -4.901 . . . . 0.0 111.649 -179.262 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 1.023 HD21 ' CG ' ' A' ' 52' ' ' LEU . 0.6 OUTLIER -119.15 122.13 41.32 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 122.824 0.45 . . . . 0.0 110.232 179.676 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 1.342 ' HG ' ' CB ' ' A' ' 53' ' ' SER . 0.5 OUTLIER -115.96 136.59 52.9 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.273 0.559 . . . . 0.0 112.169 -179.541 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 1.282 ' O ' ' CA ' ' A' ' 55' ' ' ILE . 10.3 t70 -80.96 -2.32 47.27 Favored 'General case' 1 C--O 0.48 -39.423 1 CA-C-O 162.772 20.32 . . . . 0.0 112.03 -179.978 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 1.466 HD13 ' CG1' ' A' ' 55' ' ' ILE . 14.7 tt 32.72 97.83 0.0 OUTLIER 'Isoleucine or valine' 2 C--N 0.776 -24.364 3 O-C-N 28.812 -58.68 . . . . 0.0 111.483 -179.326 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 1.601 ' HG2' ' CD ' ' A' ' 56' ' ' ARG 0.266 0.3 OUTLIER -158.85 47.77 0.33 Allowed 'General case' 3 C--N 1.154 -7.898 1 O-C-N 112.899 -6.125 . . . . 0.0 117.447 -179.837 . . . . . . . . 6 4 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 1.716 ' HE1' ' SD ' ' A' ' 57' ' ' MET 0.684 11.2 ttt 88.93 28.48 0.0 OUTLIER Pre-proline 3 N--CA 1.257 -10.121 1 N-CA-C 139.177 10.436 . . . . 0.0 139.177 179.064 . . . . . . . . 5 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.36 -101.48 0.0 OUTLIER 'Trans proline' 3 C--O 0.983 -12.226 0 O-C-N 125.966 2.561 . . . . 0.0 112.862 178.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -98.25 -53.3 1.27 Allowed Glycine 4 C--O 0.965 -16.705 0 CA-C-N 125.744 3.884 . . . . 0.0 112.79 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 1.764 ' HE1' ' SD ' ' A' ' 60' ' ' MET . 0.0 OUTLIER -118.1 63.28 0.76 Allowed 'General case' 1 C--N 1.163 -7.537 2 O-C-N 113.5 -5.706 . . . . 0.0 109.958 178.763 . . . . . . . . 5 4 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 1.246 ' OD1' ' CB ' ' A' ' 61' ' ' ASP . 0.3 OUTLIER 62.99 -42.67 0.19 Allowed 'General case' 1 C--O 1.044 -9.721 0 CA-C-O 122.324 1.059 . . . . 0.0 112.137 -179.756 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.762 ' HA3' HG13 ' A' ' 55' ' ' ILE . . . 165.91 -30.87 0.21 Allowed Glycine 1 C--N 1.185 -7.814 1 O-C-N 114.55 -5.094 . . . . 0.0 111.417 -179.713 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 1.097 HD11 ' CG ' ' A' ' 63' ' ' LEU . 2.2 mp -67.01 -19.19 65.66 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-O 120.852 0.358 . . . . 0.0 110.193 179.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.25 -37.49 64.74 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-O 121.183 0.516 . . . . 0.0 110.498 178.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 1.593 HD11 ' CB ' ' A' ' 65' ' ' LEU . 1.2 mt -58.33 -44.32 88.61 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.736 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 1.659 HD12 ' CD2' ' A' ' 66' ' ' LEU . 20.4 mt -55.88 -45.44 78.57 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.08 0.467 . . . . 0.0 110.619 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 1.646 ' HE2' ' CD ' ' A' ' 67' ' ' LYS . 3.2 mttt -53.34 -48.41 68.53 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.856 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 1.448 ' OE1' ' CG ' ' A' ' 68' ' ' GLN . 11.8 mm-40 -66.4 -34.55 78.21 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.963 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 1.299 HD11 ' CG1' ' A' ' 69' ' ' ILE . 98.4 mt -61.34 -41.78 91.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.727 -179.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 1.579 ' HE3' ' CD ' ' A' ' 70' ' ' LYS . 17.4 pttt -71.51 -28.1 63.66 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.669 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.755 ' NE2' ' HA ' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -72.84 -38.05 67.23 Favored 'General case' 0 C--O 1.213 -0.848 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.763 -179.441 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 1.531 ' HE ' ' CD ' ' A' ' 72' ' ' ARG . 70.7 mtt-85 -97.14 -41.65 8.22 Favored 'General case' 0 C--O 1.173 -2.949 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -179.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 1.56 ' HD2' ' CE1' ' A' ' 73' ' ' HIS . 0.0 OUTLIER -108.39 139.38 20.72 Favored Pre-proline 1 C--O 1.001 -11.985 0 CA-C-O 124.121 1.915 . . . . 0.0 112.683 -179.053 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.601 ' O ' ' CG ' ' A' ' 75' ' ' MET 0.337 8.3 Cg_endo -74.0 -36.37 3.51 Favored 'Trans proline' 4 C--O 0.774 -22.703 3 C-N-CA 128.145 5.896 . . . . 0.0 123.185 -179.942 . . . . . . . . 5 3 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 1.641 ' HE2' ' SD ' ' A' ' 75' ' ' MET . 47.5 mtt -159.83 31.21 0.18 Allowed 'General case' 2 C--N 0.983 -15.339 3 O-C-N 101.657 -13.152 . . . . 0.0 115.154 -179.923 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 1.513 HD11 ' CG ' ' A' ' 76' ' ' LEU . 1.5 tt -64.24 118.77 49.98 Favored Pre-proline 0 C--N 1.306 -1.316 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.621 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.455 ' HA ' ' O ' ' A' ' 97' ' ' GLY . 3.4 Cg_exo -63.44 125.1 14.94 Favored 'Trans proline' 0 C--O 1.212 -0.808 0 C-N-CA 122.809 2.339 . . . . 0.0 112.31 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.993 HG12 ' CB ' ' A' ' 78' ' ' VAL . 4.3 t -119.32 145.15 25.88 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-O 120.997 0.427 . . . . 0.0 111.321 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 1.046 HD12 ' CG1' ' A' ' 79' ' ' ILE . 2.0 mt -125.71 113.08 33.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.618 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 1.404 HD11 ' CG1' ' A' ' 80' ' ' ILE . 15.9 mm -98.69 141.77 15.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.604 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 1.722 ' HE2' ' SD ' ' A' ' 81' ' ' MET . 2.2 ptm -73.64 -41.0 63.33 Favored 'General case' 0 C--O 1.165 -3.381 0 CA-C-N 116.081 -0.509 . . . . 0.0 112.232 -179.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 1.013 HG22 ' CB ' ' A' ' 82' ' ' THR . 7.0 m -135.42 155.39 50.64 Favored 'General case' 0 C--N 1.29 -2.019 0 O-C-N 120.435 -1.416 . . . . 0.0 111.818 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 1.027 ' HB3' ' CA ' ' A' ' 83' ' ' ALA . . . -118.55 20.93 12.82 Favored 'General case' 1 C--O 0.955 -14.412 0 CA-C-O 121.331 0.586 . . . . 0.0 111.748 -179.667 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 1.633 ' HD2' ' CE1' ' A' ' 84' ' ' HIS 0.257 0.0 OUTLIER -25.71 -163.74 0.0 OUTLIER 'General case' 3 C--O 0.554 -35.513 2 O-C-N 111.277 -7.14 . . . . 0.0 118.378 -179.582 . . . . . . . . 6 4 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 1.509 ' HB3' ' CA ' ' A' ' 85' ' ' SER 0.46 0.2 OUTLIER -32.87 6.71 0.0 OUTLIER 'General case' 4 C--O 0.302 -48.796 5 O-C-N 90.034 -20.417 . . . . 0.0 127.013 -178.286 . . . . . . . . 6 4 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 1.354 ' OD2' ' CB ' ' A' ' 86' ' ' ASP . 0.5 OUTLIER -148.27 44.23 1.05 Allowed 'General case' 2 C--N 0.866 -20.424 3 O-C-N 41.666 -50.646 . . . . 0.0 115.159 178.086 . . . . . . . . 5 4 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 1.605 HD13 ' CG ' ' A' ' 87' ' ' LEU . 0.2 OUTLIER -48.95 -22.44 0.85 Allowed 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.967 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -48.11 -49.37 32.22 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -179.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 1.029 ' HB3' ' CA ' ' A' ' 89' ' ' ALA . . . -67.14 -21.19 65.84 Favored 'General case' 0 C--N 1.317 -0.807 0 O-C-N 122.371 -0.206 . . . . 0.0 111.081 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 1.004 ' HB3' ' CA ' ' A' ' 90' ' ' ALA . . . -70.73 -42.14 70.94 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-O 121.282 0.563 . . . . 0.0 111.013 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 1.014 HG12 ' CB ' ' A' ' 91' ' ' VAL . 5.5 t -62.67 -46.06 97.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 CA-C-O 121.702 0.763 . . . . 0.0 111.725 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 1.562 ' HG ' ' CB ' ' A' ' 92' ' ' SER . 0.7 OUTLIER -61.37 -24.65 66.64 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.177 0.513 . . . . 0.0 110.267 178.954 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.987 ' HB1' ' CA ' ' A' ' 93' ' ' ALA . . . -64.51 -47.81 77.5 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-O 121.809 0.814 . . . . 0.0 110.948 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 1.507 ' CZ ' ' CD1' ' A' ' 94' ' ' TYR . 12.3 m-85 -58.17 -28.33 64.66 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-O 122.211 1.005 . . . . 0.0 110.829 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 1.531 ' HG2' ' CB ' ' A' ' 95' ' ' GLN . 0.0 OUTLIER -74.13 -38.11 63.89 Favored 'General case' 0 C--N 1.286 -2.188 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.523 179.91 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 1.484 HE21 ' CD ' ' A' ' 96' ' ' GLN . 7.6 pt20 -84.74 -12.44 53.75 Favored 'General case' 0 C--O 1.16 -3.634 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.263 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.455 ' O ' ' HA ' ' A' ' 77' ' ' PRO . . . 131.51 20.14 1.13 Allowed Glycine 2 C--O 0.905 -20.412 1 CA-C-O 128.143 4.19 . . . . 0.0 116.333 179.562 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.998 ' HB1' ' CA ' ' A' ' 98' ' ' ALA . . . -77.62 145.55 36.69 Favored 'General case' 1 C--N 1.022 -13.635 3 O-C-N 102.124 -12.398 . . . . 0.0 110.88 179.427 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.509 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 17.8 t80 -77.5 -53.7 7.3 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.707 -0.224 . . . . 0.0 111.433 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 1.14 ' CG ' ' CA ' ' A' ' 100' ' ' ASP . 2.9 t0 173.07 -167.3 0.03 OUTLIER 'General case' 0 C--O 1.221 -0.43 0 CA-C-O 120.882 0.372 . . . . 0.0 111.654 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.418 ' CD2' ' HB ' ' A' ' 80' ' ' ILE . 4.3 m-85 -132.42 152.82 51.33 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.365 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 1.174 HD13 ' CG ' ' A' ' 102' ' ' LEU . 0.9 OUTLIER -103.17 124.29 38.88 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-O 121.25 0.548 . . . . 0.0 110.903 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -68.19 -84.64 0.01 OUTLIER 'Trans proline' 1 C--O 1.101 -6.348 0 C-N-CA 122.104 1.869 . . . . 0.0 113.151 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 1.598 ' HD3' ' CE ' ' A' ' 104' ' ' LYS . 14.1 mttt -106.62 -58.03 0.06 OUTLIER Pre-proline 1 C--N 1.184 -6.62 1 O-C-N 115.977 -4.202 . . . . 0.0 111.964 -179.604 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -57.49 160.29 14.38 Favored 'Trans proline' 0 CA--C 1.508 -0.81 0 C-N-CA 122.342 2.028 . . . . 0.0 112.748 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 1.319 ' HE2' ' CE1' ' A' ' 106' ' ' PHE . 3.0 t80 -166.73 -105.57 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.859 0 O-C-N 123.463 0.477 . . . . 0.0 111.131 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.564 ' O ' ' O ' ' A' ' 106' ' ' PHE . 2.9 p30 42.49 -179.44 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.861 0.362 . . . . 0.0 111.375 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 1.071 HD13 ' CG1' ' A' ' 108' ' ' ILE . 0.9 OUTLIER -67.63 -42.85 86.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.071 0.462 . . . . 0.0 111.594 -179.848 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 1.408 ' OD1' ' CB ' ' A' ' 109' ' ' ASP . 0.2 OUTLIER -49.76 -57.84 6.53 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.61 -179.407 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 1.097 ' OE1' ' CG ' ' A' ' 110' ' ' GLU . 5.2 mm-40 -76.99 -31.97 56.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.574 0.226 . . . . 0.0 111.542 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.4 ' CB ' ' O ' ' A' ' 107' ' ' ASP . . . -67.62 -59.52 3.28 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.845 0.355 . . . . 0.0 110.171 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.983 HG12 ' CB ' ' A' ' 112' ' ' VAL . 48.2 t -59.3 -31.44 46.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.423 0.63 . . . . 0.0 110.473 178.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.98 ' HB2' ' CB ' ' A' ' 113' ' ' ALA . . . -63.43 -46.36 86.65 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.067 179.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 1.042 HD13 ' CG ' ' A' ' 114' ' ' LEU . 29.4 tp -75.37 -22.4 57.55 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.992 -1.004 . . . . 0.0 111.802 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.995 HG13 ' CB ' ' A' ' 115' ' ' VAL . 4.2 p -79.26 -43.78 23.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.641 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 1.129 ' OE2' ' CG ' ' A' ' 116' ' ' GLU . 48.9 mt-10 -65.05 -44.69 88.22 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.949 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 1.514 ' CB ' ' CD ' ' A' ' 117' ' ' ARG . 0.0 OUTLIER -61.07 -24.73 66.44 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.859 179.772 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.509 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -71.27 -45.81 62.32 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.954 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 1.011 HD12 ' CG1' ' A' ' 119' ' ' ILE . 4.7 mt -69.67 -31.57 49.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.257 0.551 . . . . 0.0 111.034 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 1.495 ' HG ' ' CB ' ' A' ' 120' ' ' SER . 4.4 t -70.33 -47.38 61.32 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.32 -0.854 . . . . 0.0 111.086 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 19.4 m80 -63.8 -25.92 68.4 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.059 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 1.637 ' CG ' ' CE2' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -74.39 -52.12 13.05 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.232 -179.98 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 1.586 HE22 ' CG ' ' A' ' 123' ' ' GLN 0.76 3.8 tt0 -34.99 -178.2 0.0 OUTLIER 'General case' 2 CA--C 0.881 -24.778 2 CA-C-O 89.335 -14.65 . . . . 0.0 126.055 179.967 . . . . . . . . 5 3 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 1.505 ' HG3' ' N ' ' A' ' 124' ' ' GLU 1.541 5.7 tt0 . . . . . 4 C--O 0.216 -53.309 5 N-CA-C 172.136 22.643 . . . . 0.0 172.136 179.998 . . . . . . . . 4 2 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 ptt? . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.76 0.314 . . . . 0.0 111.238 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.452 ' O ' ' HB3' ' A' ' 3' ' ' ARG . 3.6 mt-30 -123.27 -34.75 3.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.781 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.452 ' HB3' ' O ' ' A' ' 2' ' ' GLN . 0.1 OUTLIER 76.19 -20.05 0.38 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.702 -179.806 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 52.06 78.72 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.795 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.416 ' CD1' ' HB3' ' A' ' 3' ' ' ARG . 3.6 mp -110.88 112.35 40.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.75 0.31 . . . . 0.0 110.831 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.552 ' O ' ' HA ' ' A' ' 30' ' ' CYS . 7.2 p -107.59 123.43 62.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.7 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.522 ' HB2' ' HG3' ' A' ' 48' ' ' PRO . 30.7 m0 -114.35 131.71 56.45 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.995 0.426 . . . . 0.0 110.924 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.3 OUTLIER -113.95 146.88 17.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.909 -179.588 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.65 HG12 ' HA2' ' A' ' 36' ' ' GLY . 0.0 OUTLIER -130.42 105.89 12.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.951 0.405 . . . . 0.0 110.099 179.377 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.427 ' C ' ' H ' ' A' ' 12' ' ' ASP . 1.0 OUTLIER -161.33 -155.14 0.39 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.822 -179.068 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -69.58 12.15 0.21 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.427 ' H ' ' C ' ' A' ' 10' ' ' ASP . 2.7 p30 46.94 -152.4 0.08 Allowed 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.4 t 38.02 -91.51 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.9 t -54.87 -60.15 3.76 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.727 0.299 . . . . 0.0 110.785 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.4 mm -63.28 -24.46 35.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.727 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.548 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 0.0 OUTLIER -71.57 -55.16 8.34 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.618 -179.598 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.414 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 86.3 t90 -61.15 -41.49 96.84 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -179.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.412 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 6.3 t -65.35 -44.56 94.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -178.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.412 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 26.5 mt -83.8 -25.68 30.21 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -178.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.571 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 18.8 pt-20 -67.7 -57.96 5.46 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -179.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.509 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 1.9 mmt-85 -65.47 -47.78 74.91 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.857 -0.611 . . . . 0.0 112.044 -178.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' A' ' 18' ' ' VAL . . . -54.41 -60.08 3.82 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 120.901 0.381 . . . . 0.0 111.317 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.49 ' CD2' ' CD1' ' A' ' 28' ' ' LEU . 3.3 mt -63.25 -29.14 70.53 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.01 179.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.26 -36.1 82.53 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.7 -24.9 71.48 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.247 -0.978 . . . . 0.0 111.086 178.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.404 ' CB ' HD11 ' A' ' 28' ' ' LEU . . . -77.48 -15.52 59.26 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 120.6 0.238 . . . . 0.0 111.241 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.5 25.88 8.46 Favored Glycine 0 CA--C 1.522 0.505 0 C-N-CA 120.791 -0.719 . . . . 0.0 113.887 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.49 ' CD1' ' CD2' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -124.64 171.13 10.3 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 117.691 0.745 . . . . 0.0 111.996 -179.83 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 32.4 m -99.12 106.45 18.66 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.371 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.571 ' HB3' ' HA ' ' A' ' 20' ' ' GLU . 48.7 t -103.15 113.39 26.82 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -178.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.498 ' CG2' ' CD1' ' A' ' 7' ' ' TRP . 2.6 t -120.73 149.04 43.14 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.548 ' CG2' ' HA ' ' A' ' 16' ' ' ARG . 32.7 p -119.8 166.12 13.68 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.318 0.58 . . . . 0.0 112.336 -178.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.653 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 3.9 m-85 -135.6 173.92 11.19 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.414 -178.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.635 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 2.6 pp20? -62.08 -43.21 99.34 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -177.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -166.07 -62.99 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.65 ' HA2' HG12 ' A' ' 9' ' ' VAL . . . -157.73 -48.87 0.01 OUTLIER Glycine 0 C--N 1.318 -0.466 0 C-N-CA 120.517 -0.849 . . . . 0.0 113.429 -178.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.717 ' HA ' HD12 ' A' ' 40' ' ' LEU . 0.4 OUTLIER -60.85 -24.51 65.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.975 0.417 . . . . 0.0 111.435 -179.072 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.653 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -60.25 -59.02 6.08 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.262 -179.866 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.66 HG11 ' HG ' ' A' ' 43' ' ' LEU . 4.7 t -52.49 -35.35 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 C-N-CA 120.431 -0.508 . . . . 0.0 111.135 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.717 HD12 ' HA ' ' A' ' 37' ' ' ASN . 19.5 mt -56.02 -42.37 76.37 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.03 0.443 . . . . 0.0 110.976 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.76 -47.47 21.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.2 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.16 -36.49 83.8 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.783 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.66 ' HG ' HG11 ' A' ' 39' ' ' VAL . 12.7 mt -59.81 -20.72 58.53 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.135 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.71 -16.79 52.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.501 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -120.68 -5.91 9.69 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -179.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.478 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.1 OUTLIER -162.9 160.77 25.33 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.865 0.364 . . . . 0.0 111.325 -179.746 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 96.5 m -138.61 115.08 8.86 Favored Pre-proline 0 N--CA 1.453 -0.302 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.535 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.522 ' HG3' ' HB2' ' A' ' 7' ' ' TRP . 65.9 Cg_endo -73.46 157.02 49.72 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.595 2.197 . . . . 0.0 111.471 178.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -77.0 -22.95 52.32 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.25 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.491 ' CG2' HD11 ' A' ' 79' ' ' ILE . 7.1 p -150.7 98.19 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-O 120.783 0.325 . . . . 0.0 111.46 -179.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.459 ' HB3' ' O ' ' A' ' 77' ' ' PRO . 29.1 tp -86.63 138.27 31.81 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.893 0.377 . . . . 0.0 111.435 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.526 ' O ' HG21 ' A' ' 9' ' ' VAL . 0.4 OUTLIER -123.29 113.93 19.53 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.663 179.49 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.429 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -116.54 154.6 30.14 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.322 0.582 . . . . 0.0 112.132 -179.384 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.1 p30 -83.39 -169.7 2.68 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.738 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.626 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 0.9 OUTLIER -158.15 65.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.15 0.5 . . . . 0.0 111.307 178.988 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 29.4 ptt180 -177.18 65.07 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.232 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.58 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . 2.2 tpt -161.97 -64.44 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.696 179.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.58 ' HD3' ' HB3' ' A' ' 57' ' ' MET . 42.0 Cg_endo -65.99 -173.15 0.31 Allowed 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.265 1.977 . . . . 0.0 112.913 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.95 -67.03 2.41 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.233 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.558 ' O ' ' N ' ' A' ' 62' ' ' GLY . 0.0 OUTLIER -76.98 55.31 1.1 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.063 0.459 . . . . 0.0 110.344 179.457 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.461 ' O ' ' HD2' ' A' ' 58' ' ' PRO . 1.0 OUTLIER 42.41 -77.8 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.711 -179.739 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.716 ' O ' ' HG ' ' A' ' 65' ' ' LEU . . . -135.34 -30.6 0.34 Allowed Glycine 0 C--O 1.225 -0.419 0 C-N-CA 120.367 -0.92 . . . . 0.0 113.224 -179.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.582 HD11 ' HB3' ' A' ' 86' ' ' ASP . 0.2 OUTLIER -67.75 -12.54 60.77 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.619 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.5 ' HB1' ' HB2' ' A' ' 60' ' ' MET . . . -56.34 -56.79 16.79 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-O 121.056 0.455 . . . . 0.0 110.116 178.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.716 ' HG ' ' O ' ' A' ' 62' ' ' GLY . 3.1 pp -54.78 -42.3 71.58 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.498 179.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.54 ' HG ' HD11 ' A' ' 65' ' ' LEU . 28.8 mt -48.19 -52.62 20.05 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.005 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.751 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 34.5 tttp -54.58 -43.13 71.85 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.09 0.472 . . . . 0.0 110.711 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.685 ' HB2' HD13 ' A' ' 40' ' ' LEU . 34.4 mm-40 -64.75 -28.4 69.55 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.615 179.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.494 HD12 HD13 ' A' ' 65' ' ' LEU . 96.2 mt -63.83 -40.45 89.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.726 -179.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.751 ' HG2' ' O ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -75.22 -25.38 58.11 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.893 -179.187 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.22 -50.8 70.31 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.209 -0.45 . . . . 0.0 112.175 -179.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 14.2 mtt-85 -96.26 -45.32 6.88 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -178.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.493 ' NE2' HD11 ' A' ' 43' ' ' LEU . 1.8 m-70 -91.41 130.3 40.01 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.198 -178.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_exo -56.76 -70.77 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.54 2.16 . . . . 0.0 113.099 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.7 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 2.1 mpt? -133.74 46.88 2.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.932 0.396 . . . . 0.0 111.412 -179.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.482 HD21 ' HD2' ' A' ' 48' ' ' PRO . 2.8 tm? -64.31 110.61 4.15 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.53 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.459 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 38.0 Cg_exo -58.49 131.58 43.46 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.624 2.216 . . . . 0.0 112.168 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.614 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 2.8 t -131.34 151.93 36.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.107 0.479 . . . . 0.0 111.431 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.491 HD11 ' CG2' ' A' ' 50' ' ' VAL . 4.0 mt -134.08 115.58 21.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.952 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.532 ' CG2' ' HB ' ' A' ' 55' ' ' ILE . 26.4 mm -93.68 141.95 14.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.525 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 7.7 ptm -71.99 -35.44 69.49 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -178.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.546 ' H ' HG23 ' A' ' 55' ' ' ILE . 4.1 m -147.31 149.4 32.76 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -179.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -108.64 83.31 1.75 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.798 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.421 ' CE1' HG23 ' A' ' 82' ' ' THR . 14.0 m-70 -66.87 -159.34 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.669 -179.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.457 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 0.4 OUTLIER -80.46 78.98 7.13 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-O 121.079 0.466 . . . . 0.0 112.152 -178.455 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.582 ' HB3' HD11 ' A' ' 63' ' ' LEU . 13.7 t70 175.74 26.6 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.777 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 13.3 mt -45.73 -22.96 0.21 Allowed 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -47.98 -46.9 33.14 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.61 0.243 . . . . 0.0 111.325 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.495 ' HB2' ' CB ' ' A' ' 63' ' ' LEU . . . -74.05 -22.04 59.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.334 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.483 ' HB2' ' CD2' ' A' ' 63' ' ' LEU . . . -65.41 -40.89 93.94 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.182 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.618 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 6.6 t -65.26 -40.06 87.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.933 -179.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.454 ' O ' ' HG3' ' A' ' 95' ' ' GLN . 19.5 m -63.42 -16.49 60.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.124 0.488 . . . . 0.0 109.903 178.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.768 ' O ' ' HG3' ' A' ' 96' ' ' GLN . . . -75.94 -55.01 6.02 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 121.503 0.668 . . . . 0.0 111.062 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.618 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 3.6 m-85 -57.38 -34.69 69.11 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.291 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.454 ' HG3' ' O ' ' A' ' 92' ' ' SER . 2.3 pp0? -77.19 -35.2 55.97 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.119 -179.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.768 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 1.9 pp0? -77.65 -18.41 56.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.096 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 147.37 -27.61 1.52 Allowed Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.987 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.614 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -41.95 152.7 0.07 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.563 0.181 . . . . 0.0 111.378 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.515 ' O ' ' HB2' ' A' ' 100' ' ' ASP . 59.6 t80 -85.63 -53.58 5.07 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 121.084 -0.246 . . . . 0.0 111.544 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.515 ' HB2' ' O ' ' A' ' 99' ' ' PHE . 1.0 OUTLIER 170.79 -176.19 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.009 0.433 . . . . 0.0 111.243 -179.717 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.531 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 3.9 m-85 -112.04 152.71 27.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.333 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.614 HD22 ' O ' ' A' ' 105' ' ' PRO . 6.5 tp -104.64 139.62 20.28 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.09 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -66.51 -164.29 0.08 OUTLIER 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.779 2.32 . . . . 0.0 113.1 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.471 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 85.6 mttt -46.37 -59.71 4.61 Favored Pre-proline 0 CA--C 1.533 0.315 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.779 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.614 ' O ' HD22 ' A' ' 102' ' ' LEU . 8.4 Cg_endo -50.74 164.4 0.57 Allowed 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.699 2.266 . . . . 0.0 112.157 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.624 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 86.7 t80 -162.16 -99.93 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.665 -0.243 . . . . 0.0 110.914 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.586 ' O ' ' O ' ' A' ' 106' ' ' PHE . 2.9 p-10 40.06 -177.2 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.977 0.418 . . . . 0.0 111.562 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.418 HG22 HG22 ' A' ' 112' ' ' VAL . 0.8 OUTLIER -67.76 -43.52 86.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.106 0.479 . . . . 0.0 111.024 179.474 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.524 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 8.1 t70 -49.42 -59.07 4.06 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.896 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.624 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 21.4 mm-40 -76.95 -27.51 54.83 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 111.841 0.312 . . . . 0.0 111.841 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.407 ' CB ' ' O ' ' A' ' 107' ' ' ASP . . . -71.01 -59.59 2.7 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 179.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.692 ' O ' HG12 ' A' ' 115' ' ' VAL . 53.6 t -59.61 -30.67 45.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.348 0.595 . . . . 0.0 110.271 178.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.524 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -63.61 -46.3 86.41 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.928 179.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.422 ' HA ' ' HG2' ' A' ' 117' ' ' ARG . 53.8 tp -74.86 -23.16 58.38 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.695 -179.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.692 HG12 ' O ' ' A' ' 112' ' ' VAL . 2.8 p -79.53 -42.38 22.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.997 -0.281 . . . . 0.0 111.547 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.563 ' HA ' HD13 ' A' ' 119' ' ' ILE . 47.6 mt-10 -63.71 -43.6 96.08 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.088 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.422 ' HG2' ' HA ' ' A' ' 114' ' ' LEU . 0.4 OUTLIER -64.35 -23.97 67.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.862 0.363 . . . . 0.0 110.739 179.638 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.449 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -71.35 -45.12 63.71 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.835 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.563 HD13 ' HA ' ' A' ' 116' ' ' GLU . 6.4 mt -62.71 -31.66 52.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.217 0.532 . . . . 0.0 110.709 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 9.2 m -71.19 -54.85 9.55 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.87 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -59.48 -27.2 65.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.912 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -75.64 -57.89 3.61 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.933 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 57.69 177.45 0.05 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.715 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.986 -179.93 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 tpp . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.83 0.348 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.4 tp60 -67.51 -67.34 0.46 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.26 0.552 . . . . 0.0 111.066 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 3' ' ' ARG . 0.1 OUTLIER 57.57 58.71 3.62 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.399 -0.818 . . . . 0.0 111.173 -179.988 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -82.64 86.03 1.48 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.557 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.6 mm -111.81 112.76 41.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.864 0.364 . . . . 0.0 111.157 -179.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.564 ' CG1' HD22 ' A' ' 23' ' ' LEU . 7.3 p -108.77 124.87 65.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.902 0.382 . . . . 0.0 110.521 179.205 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.552 ' NE1' HG22 ' A' ' 31' ' ' THR . 22.5 m0 -115.17 135.87 53.72 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.965 0.412 . . . . 0.0 110.637 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.742 ' O ' ' HA ' ' A' ' 32' ' ' THR . 1.3 t -126.22 146.04 32.69 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.332 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.431 -178.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.454 ' CG2' ' CG2' ' A' ' 39' ' ' VAL . 45.2 t -120.6 112.62 36.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 177.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -161.65 -158.21 0.54 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.96 -178.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -76.31 19.25 0.25 Allowed 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.506 ' HA ' ' HG1' ' A' ' 32' ' ' THR . 2.6 p30 46.25 -156.2 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 179.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.433 ' OG ' ' N ' ' A' ' 14' ' ' SER . 76.7 p 35.83 -95.09 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.433 ' N ' ' OG ' ' A' ' 13' ' ' SER . 0.3 OUTLIER -52.77 -62.04 1.91 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.911 -178.969 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 18.4 mm -63.93 -23.88 34.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.977 0.418 . . . . 0.0 111.063 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.483 ' HG3' ' OG1' ' A' ' 32' ' ' THR . 3.0 ttt-85 -75.95 -50.84 13.81 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.906 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.447 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 44.8 t90 -58.91 -37.41 76.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.188 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.425 ' CG1' HG12 ' A' ' 108' ' ' ILE . 11.2 t -69.39 -43.92 80.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.3 tp -84.03 -27.34 28.42 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.416 -178.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.65 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 12.8 pt-20 -67.82 -60.98 2.1 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.624 -0.431 . . . . 0.0 111.845 -179.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.457 ' N ' ' CG ' ' A' ' 20' ' ' GLU . 3.9 mmt-85 -59.65 -52.19 66.59 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.805 -179.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.07 -52.36 64.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.982 0.42 . . . . 0.0 111.316 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.739 HD13 ' CD1' ' A' ' 28' ' ' LEU . 1.8 tp -68.06 -24.98 65.13 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.342 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.444 ' HB1' ' O ' ' A' ' 20' ' ' GLU . . . -68.13 -35.61 78.38 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.229 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.87 -25.98 68.35 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.411 -0.9 . . . . 0.0 111.244 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.15 -15.78 59.39 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 120.675 0.274 . . . . 0.0 111.07 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.96 26.59 8.33 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.457 -0.878 . . . . 0.0 114.28 178.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.739 ' CD1' HD13 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -126.51 170.85 11.59 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 117.938 0.869 . . . . 0.0 111.897 -179.913 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.477 ' O ' HG11 ' A' ' 6' ' ' VAL . 35.2 m -99.8 104.95 16.67 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.091 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.65 ' HB3' ' HA ' ' A' ' 20' ' ' GLU . 51.5 t -100.1 111.52 23.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.582 -179.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.552 HG22 ' NE1' ' A' ' 7' ' ' TRP . 2.6 t -124.06 147.39 47.9 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.742 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 65.7 p -116.95 166.11 12.55 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -178.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.849 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 5.0 m-85 -135.66 170.3 16.18 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.002 -178.039 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.897 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 2.1 pp20? -68.96 -54.13 16.99 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -179.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.437 ' HB2' ' OE2' ' A' ' 34' ' ' GLU . 14.0 m120 -155.81 -178.65 7.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.898 0.38 . . . . 0.0 110.8 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.528 ' O ' ' HG ' ' A' ' 40' ' ' LEU . . . -50.98 -16.39 1.81 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.89 -0.671 . . . . 0.0 114.1 -178.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.474 ' HA ' HD12 ' A' ' 40' ' ' LEU . 0.4 OUTLIER -85.54 -36.33 20.54 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 117.766 0.783 . . . . 0.0 112.131 -179.262 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.897 ' HB2' ' HG3' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -55.37 -62.07 1.92 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -178.444 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.606 HG11 HD11 ' A' ' 51' ' ' LEU . 48.6 t -49.06 -32.23 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.999 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.528 ' HG ' ' O ' ' A' ' 36' ' ' GLY . 30.5 mt -59.9 -41.03 90.77 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.031 0.443 . . . . 0.0 110.209 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.53 -48.32 78.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.185 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.11 -29.65 64.29 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.829 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.625 ' HB3' ' CE1' ' A' ' 73' ' ' HIS . 5.9 mt -61.51 -33.52 73.94 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.017 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.56 -19.45 15.85 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.617 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.8 m -125.47 2.58 7.67 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.476 ' HD2' ' CZ2' ' A' ' 7' ' ' TRP . 0.1 OUTLIER -161.9 166.18 26.6 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 120.832 0.349 . . . . 0.0 111.165 179.966 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 85.1 m -138.41 114.78 8.96 Favored Pre-proline 0 N--CA 1.453 -0.289 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.999 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.47 ' HB3' ' CG ' ' A' ' 7' ' ' TRP . 61.2 Cg_endo -71.09 148.16 55.89 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.283 1.989 . . . . 0.0 111.886 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -74.21 -30.34 62.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.758 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.438 HG13 ' CG1' ' A' ' 119' ' ' ILE . 7.3 p -146.88 101.36 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.841 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.606 HD11 HG11 ' A' ' 39' ' ' VAL . 13.8 tp -85.46 125.6 33.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.08 0.467 . . . . 0.0 111.343 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.591 ' O ' ' HA ' ' A' ' 8' ' ' VAL . 1.2 tt -120.64 120.26 35.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.823 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.532 ' HB2' HD23 ' A' ' 65' ' ' LEU . 8.1 t -118.38 130.2 55.86 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.067 0.461 . . . . 0.0 111.106 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.401 ' HA ' ' HG2' ' A' ' 81' ' ' MET . 24.5 t70 -83.24 15.19 3.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.805 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.676 HG13 ' O ' ' A' ' 61' ' ' ASP . 3.5 tt 33.51 93.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 120.766 0.317 . . . . 0.0 111.813 -179.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.9 tpt180 -104.7 34.1 3.3 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.356 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.531 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER 53.14 47.35 4.04 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.674 179.08 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.732 ' HD2' ' O ' ' A' ' 61' ' ' ASP . 21.0 Cg_endo -61.26 -74.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.096 1.864 . . . . 0.0 111.272 178.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -117.01 -80.94 0.81 Allowed Glycine 0 C--N 1.332 0.306 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 178.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.563 ' O ' ' N ' ' A' ' 62' ' ' GLY . 0.0 OUTLIER -85.6 56.27 3.89 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 177.781 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.732 ' O ' ' HD2' ' A' ' 58' ' ' PRO . 4.1 p30 55.92 -62.88 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.224 -0.898 . . . . 0.0 112.106 -178.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 60' ' ' MET . . . -155.47 -35.97 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 121.147 -0.549 . . . . 0.0 112.276 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.734 ' HA ' HD13 ' A' ' 66' ' ' LEU . 0.3 OUTLIER -61.38 -22.0 64.57 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.73 0.3 . . . . 0.0 111.085 -179.802 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.414 ' HB3' ' HB2' ' A' ' 60' ' ' MET . . . -54.91 -42.76 72.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.092 0.473 . . . . 0.0 111.135 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.703 ' HG ' HD13 ' A' ' 69' ' ' ILE . 7.4 tp -52.96 -43.85 66.69 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.252 -179.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.734 HD13 ' HA ' ' A' ' 63' ' ' LEU . 2.9 mt -59.93 -43.83 94.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.912 0.387 . . . . 0.0 110.862 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.413 ' HG3' ' HE3' ' A' ' 70' ' ' LYS . 4.1 tttt -53.07 -54.92 28.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.775 -179.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 66.2 mm-40 -61.18 -44.66 96.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.911 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.703 HD13 ' HG ' ' A' ' 65' ' ' LEU . 22.7 mt -56.92 -54.18 33.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.287 0.565 . . . . 0.0 111.409 -178.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.449 ' HB3' ' CB ' ' A' ' 96' ' ' GLN . 11.0 pttt -57.45 -23.7 51.32 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.496 -179.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.65 -51.96 50.32 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.722 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 75.0 mtt-85 -100.37 -7.19 24.68 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.379 -178.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.625 ' CE1' ' HB3' ' A' ' 43' ' ' LEU . 71.6 m-70 -125.52 139.09 33.14 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-O 120.896 0.379 . . . . 0.0 112.015 -179.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -68.86 -62.33 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.95 2.433 . . . . 0.0 113.417 -179.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.722 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 1.8 mtt -136.06 49.0 2.14 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.574 ' HB3' HG22 ' A' ' 69' ' ' ILE . 0.9 OUTLIER -68.26 108.49 2.85 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.014 178.916 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.507 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 18.1 Cg_endo -59.42 132.32 45.6 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.419 2.079 . . . . 0.0 112.336 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.415 HG12 HD12 ' A' ' 80' ' ' ILE . 3.3 t -129.48 136.24 59.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.738 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.443 ' CG2' HD22 ' A' ' 114' ' ' LEU . 1.9 mt -127.61 110.89 23.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.934 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.607 HG13 ' CZ ' ' A' ' 101' ' ' TYR . 15.2 mm -99.79 147.53 7.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.538 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.485 ' HG3' ' N ' ' A' ' 82' ' ' THR . 0.3 OUTLIER -81.66 -34.58 30.69 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.261 -179.767 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.485 ' N ' ' HG3' ' A' ' 81' ' ' MET . 21.6 m -133.79 148.28 51.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.517 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.534 ' HA ' ' CE2' ' A' ' 101' ' ' TYR . . . -99.94 -25.82 14.2 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.41 ' CE1' HG22 ' A' ' 82' ' ' THR . 3.3 m-70 46.77 -158.87 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.764 -0.198 . . . . 0.0 110.913 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 94.0 p -80.25 175.44 10.64 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.977 0.417 . . . . 0.0 111.469 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.433 ' O ' HD23 ' A' ' 63' ' ' LEU . 0.7 OUTLIER 62.89 32.46 15.72 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.989 -179.897 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.576 ' HA ' HD23 ' A' ' 63' ' ' LEU . 1.9 mt -49.05 -21.66 0.75 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.414 -179.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -48.39 -41.36 28.75 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.806 0.298 . . . . 0.0 111.806 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.16 -23.79 66.53 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.594 ' HB3' HD21 ' A' ' 63' ' ' LEU . . . -77.3 -26.86 52.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.819 0.342 . . . . 0.0 110.726 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.513 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 6.3 t -68.22 -39.21 80.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.936 0.398 . . . . 0.0 110.073 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 30.9 m -68.55 -20.54 64.55 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.742 178.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.635 ' HB2' ' CB ' ' A' ' 98' ' ' ALA . . . -67.41 -42.99 82.33 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.668 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.513 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 12.5 m-85 -62.39 -25.79 68.12 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.18 -41.13 42.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.282 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.722 ' O ' ' HA ' ' A' ' 75' ' ' MET . 0.0 OUTLIER -76.06 -16.91 59.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.206 -179.876 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 119.16 17.63 4.87 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.461 -0.876 . . . . 0.0 113.652 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.635 ' CB ' ' HB2' ' A' ' 93' ' ' ALA . . . -64.43 165.05 10.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 117.141 0.47 . . . . 0.0 110.811 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.482 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 13.9 t80 -87.16 -54.42 4.32 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.456 ' HB3' ' O ' ' A' ' 99' ' ' PHE . 9.5 p30 167.77 -164.55 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.782 0.325 . . . . 0.0 110.887 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.607 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 5.6 m-85 -138.63 153.19 48.6 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.755 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.695 HD13 HD23 ' A' ' 114' ' ' LEU . 0.8 OUTLIER -103.25 122.34 45.57 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.074 179.863 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -70.13 -69.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.078 1.852 . . . . 0.0 112.501 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.595 ' H ' ' HD2' ' A' ' 105' ' ' PRO . 0.9 OUTLIER -119.07 -60.42 0.03 OUTLIER Pre-proline 0 CA--C 1.533 0.301 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.901 -179.637 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.595 ' HD2' ' H ' ' A' ' 104' ' ' LYS . 11.7 Cg_endo -54.12 160.53 6.17 Favored 'Trans proline' 0 C--N 1.35 0.605 0 C-N-CA 122.214 1.943 . . . . 0.0 112.513 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.632 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 50.5 t80 -170.8 -102.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.551 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.628 ' O ' ' HB1' ' A' ' 111' ' ' ALA . 2.3 p-10 43.26 178.46 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.558 0.218 . . . . 0.0 111.052 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.425 HG12 ' CG1' ' A' ' 18' ' ' VAL . 0.8 OUTLIER -67.82 -44.13 85.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.231 0.539 . . . . 0.0 111.217 179.852 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.586 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 1.5 t70 -49.42 -58.78 4.52 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.703 -179.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.632 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 6.4 mm-40 -74.17 -30.41 62.23 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 111.771 0.285 . . . . 0.0 111.771 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.628 ' HB1' ' O ' ' A' ' 107' ' ' ASP . . . -68.76 -62.05 1.55 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.817 0.341 . . . . 0.0 110.331 179.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.628 ' O ' HG12 ' A' ' 115' ' ' VAL . 44.0 t -57.84 -31.56 40.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.477 0.656 . . . . 0.0 110.716 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.586 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -64.0 -44.3 93.06 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.848 179.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.726 ' HA ' ' HD3' ' A' ' 117' ' ' ARG . 10.0 tp -78.33 -23.01 47.23 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.778 -179.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.628 HG12 ' O ' ' A' ' 112' ' ' VAL . 4.8 p -79.45 -41.77 22.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.026 0.441 . . . . 0.0 111.47 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -59.65 -47.76 84.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.274 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.726 ' HD3' ' HA ' ' A' ' 114' ' ' LEU . 0.8 OUTLIER -59.24 -23.96 62.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.44 -179.531 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.482 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -71.03 -39.34 72.39 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.105 0.478 . . . . 0.0 111.0 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.502 HD13 HD21 ' A' ' 28' ' ' LEU . 4.6 mt -76.95 -30.95 18.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.728 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.4 t -67.44 -41.15 85.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.602 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 17.5 m80 -73.67 -23.43 59.84 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.979 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -69.94 -60.69 2.15 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.695 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 42.44 -169.14 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.805 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.806 -179.581 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.453 0 CA-C-O 120.78 0.324 . . . . 0.0 111.099 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.413 ' NE2' ' HB3' ' A' ' 123' ' ' GLN . 0.0 OUTLIER -82.42 148.4 28.23 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.93 0.395 . . . . 0.0 110.852 -179.958 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -89.44 -26.99 20.69 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.079 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.435 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . 53.65 82.76 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.536 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.8 mp -108.4 112.38 40.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.713 0.292 . . . . 0.0 111.545 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.562 HG11 ' O ' ' A' ' 29' ' ' THR . 7.5 p -106.64 123.37 61.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.974 0.416 . . . . 0.0 110.911 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.538 ' NE1' HG21 ' A' ' 31' ' ' THR . 28.6 m0 -114.53 136.94 52.47 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.363 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.531 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.0 OUTLIER -129.68 141.49 46.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.478 -178.408 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.765 HG13 ' N ' ' A' ' 36' ' ' GLY . 0.2 OUTLIER -119.45 104.83 16.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 178.673 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.554 ' HB3' HG13 ' A' ' 15' ' ' ILE . 8.3 t0 -172.42 114.98 0.31 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.387 0.613 . . . . 0.0 111.401 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.659 ' O ' ' HB2' ' A' ' 12' ' ' ASP . 0.4 OUTLIER 49.75 -87.46 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.761 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.659 ' HB2' ' O ' ' A' ' 11' ' ' ASP . 22.9 t0 168.01 -125.72 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.51 0 O-C-N 123.041 0.213 . . . . 0.0 110.842 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.467 ' HA ' ' HB3' ' A' ' 16' ' ' ARG . 72.7 m -41.36 -43.58 2.54 Favored 'General case' 0 C--N 1.342 0.275 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.0 m -52.9 -62.4 1.67 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.65 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.554 HG13 ' HB3' ' A' ' 10' ' ' ASP . 21.8 mm -72.33 -20.08 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.617 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.73 ' HG2' ' HG3' ' A' ' 20' ' ' GLU . 3.0 tmm_? -72.38 -30.97 65.16 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-O 121.529 0.681 . . . . 0.0 110.244 178.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.624 ' O ' ' HB2' ' A' ' 21' ' ' ARG . 41.2 t90 -72.16 -58.07 3.73 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.886 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.503 HG12 HG12 ' A' ' 108' ' ' ILE . 0.8 OUTLIER -60.68 -62.24 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 -177.467 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.511 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -68.81 -49.52 57.84 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 114.29 1.218 . . . . 0.0 114.29 -176.818 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.73 ' HG3' ' HG2' ' A' ' 16' ' ' ARG . 1.5 mm-40 -67.87 -61.23 1.97 Allowed 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -177.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.624 ' HB2' ' O ' ' A' ' 17' ' ' TRP . 8.5 mmt180 -48.61 -44.22 36.92 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.327 -177.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.22 -28.6 62.26 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.878 0.37 . . . . 0.0 110.887 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.704 HD12 ' CD1' ' A' ' 28' ' ' LEU . 5.0 tp -80.93 -23.35 38.93 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.406 179.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' A' ' 20' ' ' GLU . . . -69.31 -35.14 75.68 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.87 -27.08 66.22 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.202 -0.999 . . . . 0.0 110.84 178.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.68 -15.86 58.89 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.623 0.249 . . . . 0.0 111.071 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.75 26.71 11.31 Favored Glycine 0 CA--C 1.522 0.47 0 C-N-CA 120.548 -0.834 . . . . 0.0 114.732 178.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.704 ' CD1' HD12 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -117.77 166.36 12.54 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 118.548 1.174 . . . . 0.0 112.007 -179.887 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.562 ' O ' HG11 ' A' ' 6' ' ' VAL . 88.5 m -84.73 104.66 14.89 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.776 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.504 ' HB2' ' HA ' ' A' ' 20' ' ' GLU . 2.8 p -106.29 109.31 21.2 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.956 -178.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.538 HG21 ' NE1' ' A' ' 7' ' ' TRP . 2.7 t -125.26 152.46 44.58 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.558 ' CG2' ' HA ' ' A' ' 16' ' ' ARG . 64.7 p -122.9 164.16 18.97 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.392 0.615 . . . . 0.0 112.597 -178.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.884 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 26.3 m-85 -135.93 172.95 12.26 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.025 -0.989 . . . . 0.0 112.033 -177.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.442 ' HG2' ' H ' ' A' ' 35' ' ' ASN . 5.3 pt-20 -63.26 -50.92 68.27 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.318 0.858 . . . . 0.0 113.318 -177.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.662 ' C ' HG13 ' A' ' 9' ' ' VAL . 10.5 m-20 -168.75 -26.06 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -179.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.765 ' N ' HG13 ' A' ' 9' ' ' VAL . . . 174.29 -61.62 0.12 Allowed Glycine 0 N--CA 1.453 -0.191 0 C-N-CA 120.115 -1.041 . . . . 0.0 113.029 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.771 ' HA ' HD12 ' A' ' 40' ' ' LEU . 0.5 OUTLIER -51.93 -28.38 16.3 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.69 0.281 . . . . 0.0 111.24 -179.536 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.884 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.7 OUTLIER -58.83 -58.34 9.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.67 179.245 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.656 HG23 HG11 ' A' ' 9' ' ' VAL . 7.7 t -50.74 -38.16 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 120.619 -0.433 . . . . 0.0 111.339 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.771 HD12 ' HA ' ' A' ' 37' ' ' ASN . 17.5 mt -53.81 -43.88 69.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.394 -179.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.89 -48.94 62.13 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.546 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.63 -35.28 78.63 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.37 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.648 ' HG ' HG11 ' A' ' 39' ' ' VAL . 14.2 mt -60.2 -26.31 66.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.076 0.465 . . . . 0.0 110.909 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.06 -20.46 25.01 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.302 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.3 m -123.08 4.67 9.28 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 112.146 0.425 . . . . 0.0 112.146 -179.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.522 ' HB3' ' CH2' ' A' ' 7' ' ' TRP . 0.0 OUTLIER -164.51 158.99 18.83 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.893 0.378 . . . . 0.0 111.273 -179.768 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.401 HG21 ' CD2' ' A' ' 76' ' ' LEU . 90.8 m -138.23 112.14 8.64 Favored Pre-proline 0 N--CA 1.452 -0.347 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.688 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.567 ' HD2' HD21 ' A' ' 76' ' ' LEU . 73.9 Cg_endo -73.58 156.21 49.57 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.703 2.268 . . . . 0.0 111.477 178.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -78.47 -22.92 46.8 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.174 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.454 ' CG2' HD12 ' A' ' 79' ' ' ILE . 7.3 p -150.58 96.66 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-O 120.663 0.268 . . . . 0.0 111.542 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.48 HD11 ' CB ' ' A' ' 7' ' ' TRP . 27.7 tp -87.09 145.8 26.31 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 121.123 0.487 . . . . 0.0 111.367 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.657 ' HG ' ' HB ' ' A' ' 79' ' ' ILE . 0.6 OUTLIER -131.36 114.18 14.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.323 179.637 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.672 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 35.3 t -115.32 144.52 43.64 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.62 0.724 . . . . 0.0 112.126 -179.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -83.14 168.36 16.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.395 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.545 HG13 ' O ' ' A' ' 61' ' ' ASP . 3.6 tt -142.58 87.6 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.721 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.5 ptm85 -118.51 36.22 4.48 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.541 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.657 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 1.2 ttt 64.46 46.3 0.59 Allowed Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.099 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.554 ' HD2' ' O ' ' A' ' 61' ' ' ASP . 27.0 Cg_endo -64.23 -74.81 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.024 1.816 . . . . 0.0 110.769 178.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -111.84 -85.58 1.53 Allowed Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 109.981 -1.247 . . . . 0.0 109.981 177.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.501 ' HB3' ' CB ' ' A' ' 64' ' ' ALA . 0.5 OUTLIER -87.72 58.65 5.0 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 177.408 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.657 ' HA ' ' HA ' ' A' ' 57' ' ' MET . 0.2 OUTLIER 62.54 -42.69 0.18 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.993 -179.5 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.467 ' HA3' HD12 ' A' ' 55' ' ' ILE . . . 171.31 -29.52 0.12 Allowed Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 111.494 -0.642 . . . . 0.0 111.494 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.579 HD21 ' N ' ' A' ' 90' ' ' ALA . 0.5 OUTLIER -72.46 -17.48 61.77 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 120.992 -0.283 . . . . 0.0 110.452 179.427 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.501 ' CB ' ' HB3' ' A' ' 60' ' ' MET . . . -53.94 -29.25 41.65 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 121.103 0.478 . . . . 0.0 110.54 178.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.497 HD12 ' HA3' ' A' ' 36' ' ' GLY . 1.4 mm? -66.77 -24.22 66.18 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.24 -179.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.48 HD12 ' O ' ' A' ' 89' ' ' ALA . 3.7 mt -77.73 -46.5 21.59 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.668 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 1.7 mtpt -46.09 -51.92 12.99 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.501 178.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.656 ' CB ' HD13 ' A' ' 40' ' ' LEU . 2.6 mp0 -64.42 -48.44 75.35 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.241 0.543 . . . . 0.0 110.335 178.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.519 ' HA ' ' CD2' ' A' ' 73' ' ' HIS . 4.2 mm -54.71 -39.05 45.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.665 -179.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.668 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -78.14 -30.58 49.34 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.199 -178.97 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.404 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -75.35 -40.93 57.69 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.825 -178.638 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.88 -46.31 9.52 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -179.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.528 ' CD2' HD11 ' A' ' 43' ' ' LEU . 1.2 m-70 -103.69 142.87 25.49 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.95 -178.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.29 -71.17 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.733 2.289 . . . . 0.0 113.272 -179.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 13.8 mtt -140.28 47.08 1.8 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.884 0.373 . . . . 0.0 110.805 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.567 HD21 ' HD2' ' A' ' 48' ' ' PRO . 3.1 tm? -59.31 110.31 2.6 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.684 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -63.02 116.51 3.62 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 123.086 2.524 . . . . 0.0 113.427 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.928 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 3.3 t -118.56 152.43 20.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.652 179.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.657 ' HB ' ' HG ' ' A' ' 52' ' ' LEU . 3.6 mt -132.25 114.28 23.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.548 -0.297 . . . . 0.0 110.572 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.672 ' HA ' ' O ' ' A' ' 53' ' ' SER . 11.6 mm -95.59 142.5 13.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.133 0.492 . . . . 0.0 111.788 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.453 ' CB ' ' CE1' ' A' ' 106' ' ' PHE . 2.8 ptt? -66.65 -28.74 68.71 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.308 -179.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.435 ' O ' HG22 ' A' ' 80' ' ' ILE . 5.0 m -147.07 167.78 23.21 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.43 0.157 . . . . 0.0 111.293 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.527 ' HB1' ' CD2' ' A' ' 101' ' ' TYR . . . -122.3 61.94 0.97 Allowed 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -179.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.406 ' CE1' HG22 ' A' ' 82' ' ' THR . 4.2 m-70 -73.16 162.87 28.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.824 0.345 . . . . 0.0 110.851 179.029 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.406 ' HB2' ' CB ' ' A' ' 61' ' ' ASP . 8.3 t 63.8 -167.41 0.21 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.124 0.488 . . . . 0.0 112.151 178.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.453 ' O ' HD22 ' A' ' 63' ' ' LEU . 16.6 p-10 -56.06 92.44 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.493 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.439 ' HG ' ' HB2' ' A' ' 83' ' ' ALA . 0.6 OUTLIER -47.76 -20.46 0.29 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.997 179.343 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -47.45 -45.98 26.28 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -178.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.48 ' O ' HD12 ' A' ' 66' ' ' LEU . . . -63.93 -25.73 68.27 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.786 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.579 ' N ' HD21 ' A' ' 63' ' ' LEU . . . -72.54 -48.79 37.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.768 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.637 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 3.4 t -63.48 -53.62 42.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.086 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 92.4 p -57.28 -23.94 51.65 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 178.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.575 ' C ' ' HB2' ' A' ' 98' ' ' ALA . . . -57.57 -53.77 54.37 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.438 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.677 ' CE1' ' HA ' ' A' ' 100' ' ' ASP . 5.9 m-85 -51.13 -33.16 25.41 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.764 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.91 -39.37 56.43 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.447 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.563 ' HB2' ' HB2' ' A' ' 70' ' ' LYS . 6.5 pt20 -94.39 5.8 50.67 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.063 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 93' ' ' ALA . . . 123.1 80.32 0.5 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.55 -0.834 . . . . 0.0 113.019 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.928 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -168.57 135.82 2.0 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.979 0.418 . . . . 0.0 111.27 179.185 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.471 ' HB3' HG12 ' A' ' 79' ' ' ILE . 38.5 t80 -75.84 -53.44 8.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.534 -179.354 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.677 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 1.0 OUTLIER 177.7 -172.84 0.12 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.177 0.513 . . . . 0.0 112.005 -179.535 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.527 ' CD2' ' HB1' ' A' ' 83' ' ' ALA . 3.2 m-85 -130.19 153.46 48.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.387 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.683 HD22 ' HA ' ' A' ' 106' ' ' PHE . 1.9 mp -103.97 118.38 57.3 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.62 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -73.24 -71.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 121.93 1.753 . . . . 0.0 111.895 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.596 ' H ' ' HD2' ' A' ' 105' ' ' PRO . 9.6 tttm -108.55 -58.66 0.05 OUTLIER Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.623 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.596 ' HD2' ' H ' ' A' ' 104' ' ' LYS . 15.6 Cg_endo -57.51 152.53 47.05 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.3 2.0 . . . . 0.0 113.014 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.683 ' HA ' HD22 ' A' ' 102' ' ' LEU . 14.9 t80 -163.22 -118.38 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.176 179.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.558 ' O ' ' O ' ' A' ' 106' ' ' PHE . 2.9 p30 42.5 -179.46 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 118.164 0.438 . . . . 0.0 111.486 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.503 HG12 HG12 ' A' ' 18' ' ' VAL . 1.0 OUTLIER -67.86 -40.92 84.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.516 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.496 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 30.8 t0 -49.18 -58.64 4.65 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.495 -179.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.537 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 74.9 mm-40 -77.87 -32.17 51.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.694 0.283 . . . . 0.0 111.371 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.409 ' CB ' ' O ' ' A' ' 107' ' ' ASP . . . -64.88 -62.5 1.52 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.931 0.396 . . . . 0.0 109.978 179.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.622 ' O ' HG13 ' A' ' 115' ' ' VAL . 47.0 t -58.4 -31.32 42.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.496 0.665 . . . . 0.0 110.802 179.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.505 ' O ' ' HG2' ' A' ' 117' ' ' ARG . . . -63.46 -45.97 88.38 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.196 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.499 HD23 HG21 ' A' ' 79' ' ' ILE . 5.5 tp -76.76 -22.47 53.74 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.786 -1.097 . . . . 0.0 112.169 -179.052 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.622 HG13 ' O ' ' A' ' 112' ' ' VAL . 4.7 p -79.28 -46.44 23.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.321 -0.552 . . . . 0.0 111.595 -179.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -64.35 -47.89 77.62 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.746 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.505 ' HG2' ' O ' ' A' ' 113' ' ' ALA . 2.8 ptp180 -60.46 -27.93 67.92 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.14 0.495 . . . . 0.0 110.404 179.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.436 ' HA ' ' CZ ' ' A' ' 99' ' ' PHE . . . -66.77 -47.02 73.47 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.792 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.429 ' CG1' HG12 ' A' ' 50' ' ' VAL . 4.4 mt -70.26 -30.69 44.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.689 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 10.5 t -66.72 -43.83 83.23 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.21 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 13.0 m80 -68.09 -25.87 65.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.147 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -82.27 -43.23 17.81 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.873 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.413 ' HB3' ' NE2' ' A' ' 2' ' ' GLN . 9.0 pt20 -75.43 -175.66 2.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.01 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.805 -179.725 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.727 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.738 ' O ' ' HG2' ' A' ' 3' ' ' ARG . 0.0 OUTLIER -137.71 -176.23 4.35 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.509 0.195 . . . . 0.0 110.749 179.968 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.738 ' HG2' ' O ' ' A' ' 2' ' ' GLN . 0.3 OUTLIER 66.08 -15.52 0.13 Allowed 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 179.834 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.475 ' H ' ' C ' ' A' ' 2' ' ' GLN . . . 98.49 92.92 1.99 Allowed Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.242 179.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.554 HD11 ' HG2' ' A' ' 3' ' ' ARG . 5.0 mm -126.04 112.48 30.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.074 0.464 . . . . 0.0 111.754 -179.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.82 HG12 ' HA ' ' A' ' 30' ' ' CYS . 14.3 p -109.93 128.69 65.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.684 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.578 ' HB2' ' HG3' ' A' ' 48' ' ' PRO . 26.4 m0 -117.32 126.31 52.49 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.962 0.41 . . . . 0.0 110.112 179.09 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.593 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.5 OUTLIER -116.66 145.82 21.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.814 -178.105 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.937 HG11 ' HB2' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -124.52 111.1 27.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.919 0.39 . . . . 0.0 110.649 179.24 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -161.32 -159.15 0.62 Allowed 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.976 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -66.99 -0.64 3.29 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.474 ' O ' ' N ' ' A' ' 14' ' ' SER . 0.4 OUTLIER 68.08 -158.51 0.2 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 121.415 -0.114 . . . . 0.0 111.033 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 t 33.52 -86.46 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.474 ' N ' ' O ' ' A' ' 12' ' ' ASP . 37.6 t -54.21 -63.9 1.0 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.741 0.305 . . . . 0.0 111.324 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.0 mm -61.44 -28.15 43.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.012 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.494 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 2.7 ttm180 -73.29 -43.58 60.69 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.211 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 55.1 t90 -67.77 -40.75 84.0 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.965 -179.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.4 t -70.01 -39.27 77.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -178.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 16.2 mt -84.38 -27.72 27.47 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -178.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.595 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 24.5 pt-20 -67.44 -57.65 6.16 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.032 0.444 . . . . 0.0 111.655 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.453 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 0.7 OUTLIER -60.85 -52.49 64.85 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.937 -179.284 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.57 -43.85 84.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.866 0.365 . . . . 0.0 111.4 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.778 ' CD1' HG13 ' A' ' 6' ' ' VAL . 2.5 tm? -70.69 -31.78 68.79 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.331 0.586 . . . . 0.0 110.306 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.38 -34.22 77.67 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.16 -26.08 68.89 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.391 -0.909 . . . . 0.0 111.111 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.62 -15.56 59.13 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 120.751 0.31 . . . . 0.0 110.74 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.36 26.2 10.3 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.822 -0.704 . . . . 0.0 113.903 179.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.531 ' HB2' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -133.37 171.28 14.27 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 117.752 0.776 . . . . 0.0 111.902 179.705 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.486 ' O ' HG12 ' A' ' 6' ' ' VAL . 16.0 m -94.13 128.22 40.42 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.95 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.82 ' HA ' HG12 ' A' ' 6' ' ' VAL . 50.9 t -121.96 113.65 19.89 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 121.331 0.586 . . . . 0.0 111.477 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.523 HG23 ' CE1' ' A' ' 33' ' ' PHE . 2.7 t -117.8 151.86 36.49 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.594 178.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.593 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 40.2 p -124.35 164.46 19.58 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.219 0.533 . . . . 0.0 111.773 -179.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.937 ' HB2' HG11 ' A' ' 9' ' ' VAL . 2.3 m-85 -133.06 174.43 10.37 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.505 -178.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -61.49 -40.7 95.54 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 -176.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.438 ' C ' HG12 ' A' ' 9' ' ' VAL . 1.4 m120 -170.96 -38.39 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 119.073 0.851 . . . . 0.0 112.589 -179.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.482 ' HA2' HG13 ' A' ' 9' ' ' VAL . . . -178.77 -61.12 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.841 -179.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.56 ' HA ' HD13 ' A' ' 40' ' ' LEU . 13.0 m120 -50.74 -33.39 22.91 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 111.621 0.23 . . . . 0.0 111.621 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.829 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -57.7 -50.05 74.48 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.639 -0.425 . . . . 0.0 111.182 -179.98 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.61 HG21 ' CD1' ' A' ' 33' ' ' PHE . 5.5 t -62.44 -38.68 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 C-N-CA 119.93 -0.708 . . . . 0.0 110.442 179.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.611 HD11 ' HB2' ' A' ' 68' ' ' GLN . 12.9 mt -56.78 -42.16 78.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.524 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.35 -48.15 36.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.31 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.81 -28.41 69.84 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.364 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.744 HD12 ' NE2' ' A' ' 73' ' ' HIS . 8.4 mt -69.38 -24.12 63.83 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.083 -179.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.36 -17.69 5.32 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.266 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -123.97 0.61 8.57 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.503 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.1 OUTLIER -161.96 155.57 21.2 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.912 0.387 . . . . 0.0 111.348 179.913 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 91.0 m -139.05 114.7 8.46 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.212 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.578 ' HG3' ' HB2' ' A' ' 7' ' ' TRP . 73.8 Cg_endo -76.19 166.1 28.36 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.41 2.073 . . . . 0.0 110.965 178.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -74.14 -21.92 59.66 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.681 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.781 HG11 HG23 ' A' ' 6' ' ' VAL . 7.4 p -146.7 168.45 5.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.23 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.43 ' HA ' ' O ' ' A' ' 7' ' ' TRP . 13.5 tp -152.92 120.43 5.97 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.0 0.429 . . . . 0.0 111.53 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.506 ' HG ' ' HB ' ' A' ' 79' ' ' ILE . 0.3 OUTLIER -105.89 122.19 45.62 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.217 179.815 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.531 ' HB3' HD21 ' A' ' 65' ' ' LEU . 36.4 m -113.68 138.13 50.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.089 0.471 . . . . 0.0 112.021 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.521 ' O ' ' CG2' ' A' ' 55' ' ' ILE . 45.8 p-10 -78.23 -12.77 60.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.594 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.546 HG22 ' O ' ' A' ' 55' ' ' ILE . 5.3 tt 50.62 82.31 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-O 121.387 0.613 . . . . 0.0 111.867 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.748 ' C ' ' HD2' ' A' ' 58' ' ' PRO . 1.0 OUTLIER 175.93 145.8 0.08 Allowed 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.708 179.273 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.529 ' CB ' ' O ' ' A' ' 56' ' ' ARG . 14.1 ttt 96.52 -52.12 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.766 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 178.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.748 ' HD2' ' C ' ' A' ' 56' ' ' ARG . 20.4 Cg_endo -58.58 175.83 0.51 Allowed 'Trans proline' 0 C--N 1.35 0.643 0 CA-C-N 121.147 1.445 . . . . 0.0 112.286 -178.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -42.17 -74.46 0.17 Allowed Glycine 0 C--N 1.335 0.522 0 C-N-CA 121.126 -0.559 . . . . 0.0 112.501 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.582 ' H ' ' HB3' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -69.46 56.22 0.12 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.773 0.32 . . . . 0.0 110.597 179.221 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 56.75 -80.37 0.01 OUTLIER 'General case' 0 C--O 1.231 0.111 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.735 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.483 ' HA3' ' C ' ' A' ' 55' ' ' ILE . . . -137.1 -34.46 0.2 Allowed Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.655 -0.783 . . . . 0.0 113.007 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.544 ' CD1' HD12 ' A' ' 55' ' ' ILE . 5.2 mp -63.28 -15.76 58.2 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.864 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.588 ' HB2' ' HB2' ' A' ' 58' ' ' PRO . . . -53.82 -48.61 69.72 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 120.929 0.395 . . . . 0.0 111.355 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.531 HD21 ' HB3' ' A' ' 53' ' ' SER . 4.0 pp -51.42 -39.36 57.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.065 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.581 ' O ' ' HB ' ' A' ' 69' ' ' ILE . 5.1 mp -57.65 -47.98 80.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.912 0.387 . . . . 0.0 110.216 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.726 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 0.2 OUTLIER -49.98 -44.43 50.93 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.192 0.52 . . . . 0.0 110.097 178.954 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.611 ' HB2' HD11 ' A' ' 40' ' ' LEU . 11.6 mm100 -65.6 -26.42 67.83 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.262 179.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.849 HG12 ' CE1' ' A' ' 73' ' ' HIS . 94.0 mt -64.02 -39.62 86.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.486 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.726 ' HG2' ' O ' ' A' ' 67' ' ' LYS . 12.1 pttp -74.1 -27.22 60.78 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.893 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -85.85 -33.66 21.24 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.044 -179.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -106.54 -35.11 7.16 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -178.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.849 ' CE1' HG12 ' A' ' 69' ' ' ILE . 0.3 OUTLIER -99.44 136.07 20.49 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.891 -179.326 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -92.94 100.6 0.16 Allowed 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.953 2.435 . . . . 0.0 112.537 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.543 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 1.8 mtt 52.44 26.22 4.04 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.662 179.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.428 HD22 ' HB2' ' A' ' 51' ' ' LEU . 12.9 tp -69.79 112.66 13.01 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.815 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.4 125.41 18.82 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.353 2.035 . . . . 0.0 112.09 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.458 HG21 HD12 ' A' ' 69' ' ' ILE . 3.7 t -118.25 148.52 21.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.934 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.506 ' HB ' ' HG ' ' A' ' 52' ' ' LEU . 2.0 mt -127.82 114.14 34.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.617 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.612 HG13 ' CZ ' ' A' ' 101' ' ' TYR . 13.2 mm -99.54 143.49 13.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.984 0.421 . . . . 0.0 111.804 -179.045 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.416 ' HG3' ' N ' ' A' ' 82' ' ' THR . 18.6 ptm -86.56 -39.71 15.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.067 -178.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.593 ' O ' HG21 ' A' ' 80' ' ' ILE . 2.7 m -122.65 166.53 14.74 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.209 -179.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.42 ' H ' HG21 ' A' ' 82' ' ' THR . . . -138.99 -28.33 0.8 Allowed 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.472 ' CE1' HD13 ' A' ' 55' ' ' ILE . 3.5 p-80 38.19 -160.97 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 122.928 0.491 . . . . 0.0 111.863 -179.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 27.4 t -82.66 42.05 0.75 Allowed 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -178.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.463 ' O ' HD21 ' A' ' 63' ' ' LEU . 6.7 m-20 -132.84 15.98 4.28 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.718 0.294 . . . . 0.0 110.773 179.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.409 HD21 ' CB ' ' A' ' 90' ' ' ALA . 1.4 mt -44.74 -21.78 0.06 Allowed 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.291 -0.413 . . . . 0.0 112.006 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -47.94 -50.35 27.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.771 0.319 . . . . 0.0 111.028 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.7 -21.19 62.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.986 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.559 ' HB2' ' CE1' ' A' ' 101' ' ' TYR . . . -64.38 -33.22 75.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.861 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.617 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 3.1 t -66.15 -42.89 92.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.428 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.582 ' O ' ' HG3' ' A' ' 95' ' ' GLN . 14.9 m -60.43 -19.42 56.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.035 0.445 . . . . 0.0 110.073 178.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.729 ' O ' ' HG3' ' A' ' 96' ' ' GLN . . . -75.76 -53.93 7.73 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.62 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.617 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 5.6 m-85 -57.01 -33.19 66.91 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.148 0.499 . . . . 0.0 110.838 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.582 ' HG3' ' O ' ' A' ' 92' ' ' SER . 2.2 pp0? -76.95 -31.25 56.48 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.031 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.729 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 2.0 pp0? -83.09 -18.5 39.36 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.829 -0.349 . . . . 0.0 111.032 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 133.06 4.71 3.24 Favored Glycine 0 C--N 1.335 0.501 0 C-N-CA 120.231 -0.985 . . . . 0.0 114.315 178.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.486 ' HB2' ' C ' ' A' ' 93' ' ' ALA . . . -58.03 158.34 6.87 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 117.85 0.825 . . . . 0.0 111.278 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.507 ' CD2' ' HB1' ' A' ' 118' ' ' ALA . 10.4 t80 -85.11 -53.73 5.08 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.481 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 177.02 -163.69 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.807 0.337 . . . . 0.0 111.297 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.612 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 5.9 m-85 -138.82 152.65 48.04 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.464 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.449 HD22 ' HA ' ' A' ' 106' ' ' PHE . 2.7 mp -104.25 122.19 44.9 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.939 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -66.38 -74.68 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.168 1.912 . . . . 0.0 112.395 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.596 ' H ' ' HD2' ' A' ' 105' ' ' PRO . 1.1 mtpm? -114.88 -60.81 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.808 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.596 ' HD2' ' H ' ' A' ' 104' ' ' LYS . 14.4 Cg_endo -56.55 163.22 7.15 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.368 2.046 . . . . 0.0 112.574 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.66 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 41.9 t80 -170.2 -99.94 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.562 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.541 ' O ' ' O ' ' A' ' 106' ' ' PHE . 1.0 OUTLIER 41.47 -175.67 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.812 0.339 . . . . 0.0 111.096 -179.575 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.469 HG23 HG22 ' A' ' 112' ' ' VAL . 1.0 OUTLIER -68.01 -40.3 82.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.011 0.434 . . . . 0.0 111.62 179.909 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.613 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 55.2 m-20 -51.85 -58.83 5.31 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.573 -179.052 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.66 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 6.8 mm-40 -75.08 -31.42 61.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.646 0.26 . . . . 0.0 111.417 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -69.91 -61.73 1.66 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.47 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.706 ' O ' HG13 ' A' ' 115' ' ' VAL . 54.4 t -57.31 -30.61 35.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.444 0.64 . . . . 0.0 110.298 178.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.613 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -65.12 -49.22 70.79 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.727 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.462 ' CD2' HG23 ' A' ' 79' ' ' ILE . 13.0 tp -71.71 -21.23 61.8 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.958 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.706 HG13 ' O ' ' A' ' 112' ' ' VAL . 4.3 p -79.43 -47.53 22.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 C-N-CA 120.446 -0.501 . . . . 0.0 111.497 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.419 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 45.3 mt-10 -66.15 -45.08 82.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.578 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.458 ' HG3' ' O ' ' A' ' 113' ' ' ALA . 0.0 OUTLIER -60.65 -24.41 65.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.583 179.501 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.507 ' HB1' ' CD2' ' A' ' 99' ' ' PHE . . . -71.26 -48.8 48.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.968 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.47 HD13 HG13 ' A' ' 50' ' ' VAL . 4.3 mt -68.49 -31.07 49.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.233 0.54 . . . . 0.0 110.755 179.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -75.7 -54.38 7.06 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.155 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 17.9 m80 -59.33 -28.0 66.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.112 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -71.46 -60.34 2.29 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.752 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 55.52 175.89 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.977 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.843 179.958 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.0 mtt . . . . . 0 N--CA 1.487 1.415 0 CA-C-O 120.918 0.39 . . . . 0.0 111.009 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.432 ' O ' ' HB3' ' A' ' 3' ' ' ARG . 0.0 OUTLIER -116.7 -32.57 5.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.579 179.655 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.432 ' HB3' ' O ' ' A' ' 2' ' ' GLN . 15.1 ttt180 70.62 -9.64 0.78 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.955 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.4 ' H ' ' C ' ' A' ' 2' ' ' GLN . . . 51.39 73.83 0.35 Allowed Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.992 -0.623 . . . . 0.0 113.444 179.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.485 ' HB ' ' HA ' ' A' ' 48' ' ' PRO . 2.9 mp -105.17 112.76 40.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.749 0.309 . . . . 0.0 111.055 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.588 HG12 ' HA ' ' A' ' 30' ' ' CYS . 6.9 p -105.6 125.61 60.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.251 178.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.538 ' NE1' HG22 ' A' ' 31' ' ' THR . 31.4 m0 -115.74 132.01 56.76 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.09 0.472 . . . . 0.0 110.282 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.735 ' O ' ' HA ' ' A' ' 32' ' ' THR . 46.6 t -118.8 145.86 24.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.664 -178.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.898 HG11 ' HB2' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -127.35 118.01 48.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.806 0.336 . . . . 0.0 110.559 179.782 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -163.48 -159.43 0.52 Allowed 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.775 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.94 -0.09 4.0 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 65.61 -158.33 0.27 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.495 0.188 . . . . 0.0 110.904 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.44 ' HB3' ' H ' ' A' ' 14' ' ' SER . 1.3 t 35.43 -90.93 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.44 ' H ' ' HB3' ' A' ' 13' ' ' SER . 2.1 t -58.39 -54.87 42.17 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.708 0.289 . . . . 0.0 111.321 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.7 mm -64.83 -25.14 37.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.941 0.4 . . . . 0.0 111.15 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.584 ' HA ' HG22 ' A' ' 32' ' ' THR . 4.1 ttp180 -75.65 -53.27 8.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.257 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.541 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 86.7 t90 -57.25 -40.45 77.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.84 0.352 . . . . 0.0 111.51 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.554 HG13 HG12 ' A' ' 108' ' ' ILE . 18.9 t -66.43 -47.95 82.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 112.154 0.428 . . . . 0.0 112.154 -178.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.605 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 2.1 tp -80.54 -29.16 37.15 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -178.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.541 ' HG2' ' HA ' ' A' ' 17' ' ' TRP . 1.3 pp20? -62.46 -60.31 3.73 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.468 -0.493 . . . . 0.0 112.026 -179.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.0 mmm180 -58.93 -47.51 84.81 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.696 0.284 . . . . 0.0 111.679 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.87 -34.37 77.24 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -178.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.796 ' CD2' HD12 ' A' ' 28' ' ' LEU . 0.4 OUTLIER -81.82 -26.74 34.07 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.627 179.553 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.41 -34.25 74.21 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 177.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.68 -24.15 69.47 Favored Glycine 0 N--CA 1.443 -0.897 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 177.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.498 ' CB ' HD13 ' A' ' 28' ' ' LEU . . . -76.95 -15.3 59.7 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.589 -0.306 . . . . 0.0 110.275 178.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 94.1 26.65 13.79 Favored Glycine 0 C--N 1.337 0.633 0 C-N-CA 120.812 -0.709 . . . . 0.0 114.293 178.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.796 HD12 ' CD2' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -133.87 166.67 22.13 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-N 118.215 1.007 . . . . 0.0 112.784 -179.609 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 60.1 m -85.65 118.17 24.99 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.051 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.588 ' HA ' HG12 ' A' ' 6' ' ' VAL . 1.7 p -116.68 117.13 28.97 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.967 -0.56 . . . . 0.0 112.208 -178.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.558 HG23 ' CE1' ' A' ' 33' ' ' PHE . 2.8 t -125.11 133.24 52.93 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.735 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 77.1 p -107.64 164.28 12.36 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.159 0.504 . . . . 0.0 111.659 -178.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.898 ' HB2' HG11 ' A' ' 9' ' ' VAL . 2.9 m-85 -134.94 174.33 10.71 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.879 -177.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.639 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 2.5 pp20? -63.18 -34.76 78.32 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -176.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.612 ' C ' HG12 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -171.04 -55.83 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 118.947 0.794 . . . . 0.0 112.799 -179.273 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.573 ' O ' ' HG ' ' A' ' 40' ' ' LEU . . . -170.43 -43.77 0.03 OUTLIER Glycine 0 C--N 1.316 -0.58 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.57 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.676 ' HA ' ' CD1' ' A' ' 40' ' ' LEU . 1.5 t-20 -62.98 -26.07 68.67 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 120.985 0.421 . . . . 0.0 110.714 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.818 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -62.02 -57.64 10.88 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.269 179.819 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.696 HG13 ' HG ' ' A' ' 43' ' ' LEU . 21.2 t -55.51 -32.22 29.71 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 C-N-CA 120.116 -0.634 . . . . 0.0 111.233 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.808 HD12 ' CB ' ' A' ' 68' ' ' GLN . 11.2 mt -58.83 -46.47 87.6 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.773 0.32 . . . . 0.0 110.652 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.27 -48.93 63.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.177 0.513 . . . . 0.0 110.794 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.55 -33.61 75.28 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.716 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.696 ' HG ' HG13 ' A' ' 39' ' ' VAL . 15.0 mt -63.23 -27.68 69.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.531 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.99 -18.41 45.68 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.299 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.2 m -115.06 -4.77 12.49 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.454 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.1 OUTLIER -165.64 161.98 18.62 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.885 0.374 . . . . 0.0 111.081 179.951 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 54.0 m -138.86 111.77 8.14 Favored Pre-proline 0 N--CA 1.45 -0.43 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.354 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.533 ' HD2' HD12 ' A' ' 76' ' ' LEU . 66.1 Cg_endo -73.3 164.37 35.41 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.162 1.908 . . . . 0.0 111.329 178.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -77.76 -22.1 50.74 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.151 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.631 ' HA ' ' HG2' ' A' ' 77' ' ' PRO . 9.8 p -145.15 164.41 12.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.655 HD22 HG11 ' A' ' 39' ' ' VAL . 11.6 tp -152.67 111.37 3.76 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 121.139 0.495 . . . . 0.0 112.008 -178.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.464 HD22 ' O ' ' A' ' 79' ' ' ILE . 1.4 tt -97.7 119.98 37.25 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.759 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.712 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 0.3 OUTLIER -125.47 137.96 53.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.435 0.636 . . . . 0.0 112.63 -178.758 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.468 ' HA ' ' HG2' ' A' ' 81' ' ' MET . 0.8 OUTLIER -83.14 177.37 8.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.172 179.319 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.773 HG12 ' HA3' ' A' ' 62' ' ' GLY . 0.0 OUTLIER -154.73 105.41 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.195 0.522 . . . . 0.0 110.807 178.978 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.56 36.77 3.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.152 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.499 ' N ' ' CD ' ' A' ' 58' ' ' PRO . 0.5 OUTLIER 66.42 41.55 0.27 Allowed Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 179.042 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.499 ' CD ' ' N ' ' A' ' 57' ' ' MET . 58.1 Cg_endo -68.81 -90.57 0.0 OUTLIER 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 122.042 1.828 . . . . 0.0 111.0 178.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -87.66 -91.46 1.03 Allowed Glycine 0 C--N 1.335 0.488 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.597 ' HB3' ' CB ' ' A' ' 64' ' ' ALA . 34.6 tpp -87.56 64.85 8.31 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 177.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.478 ' O ' HG12 ' A' ' 55' ' ' ILE . 0.2 OUTLIER 67.61 -20.71 0.12 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.695 -179.291 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.773 ' HA3' HG12 ' A' ' 55' ' ' ILE . . . 133.01 -32.33 2.77 Favored Glycine 0 N--CA 1.446 -0.69 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 -179.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.606 ' HA ' ' CD1' ' A' ' 66' ' ' LEU . 5.4 mp -68.27 -13.86 62.57 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 120.862 0.363 . . . . 0.0 110.332 179.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.597 ' CB ' ' HB3' ' A' ' 60' ' ' MET . . . -53.17 -36.22 60.67 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.558 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.502 HD11 ' N ' ' A' ' 66' ' ' LEU . 3.8 pp -59.73 -40.68 88.86 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 121.1 -0.24 . . . . 0.0 111.222 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.606 ' CD1' ' HA ' ' A' ' 63' ' ' LEU . 4.8 mp -60.38 -43.01 97.02 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-O 121.124 0.488 . . . . 0.0 110.226 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.567 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -54.62 -44.23 72.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.202 -179.749 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.808 ' CB ' HD12 ' A' ' 40' ' ' LEU . 8.6 mm-40 -71.92 -43.51 65.19 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.44 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.4 HD12 ' HA ' ' A' ' 66' ' ' LEU . 16.8 mt -60.95 -35.38 64.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-O 121.033 0.444 . . . . 0.0 110.973 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.567 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -72.75 -29.81 63.63 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.013 -179.826 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.46 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -76.37 -36.68 58.02 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.631 -179.67 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.16 -26.14 21.44 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.926 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.651 ' NE2' ' HB3' ' A' ' 43' ' ' LEU . 31.9 m-70 -153.35 82.9 4.65 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.733 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.724 ' HA ' ' HB2' ' A' ' 96' ' ' GLN . 59.2 Cg_endo -73.47 39.08 0.46 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.583 2.189 . . . . 0.0 112.869 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.41 ' HG2' ' C ' ' A' ' 74' ' ' PRO . 1.5 mmm -141.92 -32.09 0.53 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.971 0.415 . . . . 0.0 111.689 -179.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.533 HD12 ' HD2' ' A' ' 48' ' ' PRO . 0.3 OUTLIER -61.29 124.37 80.28 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.805 -179.44 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.631 ' HG2' ' HA ' ' A' ' 50' ' ' VAL . 57.6 Cg_endo -71.2 126.31 12.25 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.32 2.013 . . . . 0.0 112.239 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.526 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 9.5 t -106.93 140.21 25.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.301 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.466 HG23 HD23 ' A' ' 114' ' ' LEU . 2.6 mt -127.13 110.08 22.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.614 179.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.712 ' HA ' ' O ' ' A' ' 53' ' ' SER . 13.5 mm -103.88 148.04 9.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.923 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.499 ' HB2' ' CE1' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -69.83 -73.3 0.16 Allowed 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.715 179.647 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.424 ' O ' HG23 ' A' ' 55' ' ' ILE . 3.9 m -105.31 162.8 13.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.949 0.404 . . . . 0.0 110.996 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.454 ' CB ' ' HG ' ' A' ' 87' ' ' LEU . . . -111.93 -22.22 11.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.621 -179.182 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 44.39 -163.0 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 120.605 0.241 . . . . 0.0 111.359 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 47.9 t -81.54 29.2 0.38 Allowed 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.411 ' O ' HD21 ' A' ' 63' ' ' LEU . 0.4 OUTLIER -128.51 24.77 5.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.708 0.29 . . . . 0.0 110.865 179.624 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.454 ' HG ' ' CB ' ' A' ' 83' ' ' ALA . 1.7 mt -50.32 -23.77 2.53 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.456 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -48.09 -56.95 6.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.71 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.535 ' HB3' ' HB3' ' A' ' 63' ' ' LEU . . . -59.57 -22.18 61.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.582 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.511 ' HB3' ' CE1' ' A' ' 101' ' ' TYR . . . -71.02 -35.57 72.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.998 0.428 . . . . 0.0 110.143 179.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.638 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 13.7 t -60.03 -44.65 95.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.464 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 49.0 m -60.97 -34.69 75.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.005 0.431 . . . . 0.0 110.491 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.737 ' O ' ' HG3' ' A' ' 96' ' ' GLN . . . -59.63 -42.28 92.37 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.019 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.638 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 11.0 m-85 -55.49 -24.24 30.4 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.317 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.595 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -75.74 -40.78 54.86 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.912 179.336 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.737 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 5.3 pp0? -77.1 -17.87 58.38 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.903 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.461 ' O ' ' HA ' ' A' ' 77' ' ' PRO . . . 123.36 18.09 3.13 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.761 -0.733 . . . . 0.0 113.335 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.653 ' HB1' ' C ' ' A' ' 93' ' ' ALA . . . -48.92 141.03 8.11 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 117.283 0.541 . . . . 0.0 110.911 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.555 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 27.1 t80 -75.72 -53.43 8.53 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.965 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.468 ' OD1' HD23 ' A' ' 114' ' ' LEU . 1.7 p30 167.57 -171.27 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.953 0.406 . . . . 0.0 111.502 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.511 ' CE1' ' HB3' ' A' ' 90' ' ' ALA . 5.3 m-85 -131.0 153.71 48.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.583 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.64 HD23 ' HA ' ' A' ' 106' ' ' PHE . 1.6 tp -102.27 123.4 43.32 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.663 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -72.82 -78.08 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 121.981 1.788 . . . . 0.0 112.766 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.424 ' O ' ' CD2' ' A' ' 106' ' ' PHE . 2.4 tmtm? -108.28 -54.19 0.06 OUTLIER Pre-proline 0 CA--C 1.531 0.247 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.437 ' O ' ' CG ' ' A' ' 106' ' ' PHE . 52.6 Cg_exo -55.49 154.54 24.22 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.275 1.983 . . . . 0.0 112.508 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.64 ' HA ' HD23 ' A' ' 102' ' ' LEU . 59.9 m-85 -160.43 -119.14 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.9 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.494 ' O ' ' O ' ' A' ' 106' ' ' PHE . 2.6 p30 47.71 174.94 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 120.835 0.35 . . . . 0.0 111.142 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.554 HG12 HG13 ' A' ' 18' ' ' VAL . 1.1 mp -67.11 -44.5 87.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.027 0.442 . . . . 0.0 111.461 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.733 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 0.8 OUTLIER -49.23 -53.92 19.19 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.554 -179.384 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.605 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 3.2 mm-40 -82.47 -34.61 28.01 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 -179.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.427 ' HB1' ' O ' ' A' ' 107' ' ' ASP . . . -69.4 -57.35 5.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.807 0.337 . . . . 0.0 110.2 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.705 ' O ' HG11 ' A' ' 115' ' ' VAL . 46.4 t -59.92 -30.84 46.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.294 0.569 . . . . 0.0 110.481 178.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.733 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -62.07 -46.16 90.32 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.522 0.677 . . . . 0.0 109.997 178.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.47 ' HA ' ' HG2' ' A' ' 117' ' ' ARG . 13.9 tp -72.8 -26.69 61.6 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 114.691 -1.14 . . . . 0.0 111.585 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.705 HG11 ' O ' ' A' ' 112' ' ' VAL . 4.7 p -79.21 -43.03 23.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.833 0.349 . . . . 0.0 111.895 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -65.84 -45.68 81.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.786 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.47 ' HG2' ' HA ' ' A' ' 114' ' ' LEU . 6.6 ptp180 -59.19 -26.2 64.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.67 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.555 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -68.72 -42.17 78.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.978 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.471 HD11 HD21 ' A' ' 28' ' ' LEU . 5.0 mt -75.68 -30.94 22.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.88 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 10.3 t -70.6 -51.31 29.11 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.903 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 17.1 m80 -62.02 -22.89 66.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.073 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -68.65 -57.39 5.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.79 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.78 -170.25 1.27 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.04 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.862 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 ttp . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 120.766 0.317 . . . . 0.0 111.44 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.485 ' HG2' ' HB2' ' A' ' 124' ' ' GLU . 0.0 OUTLIER -127.01 174.53 8.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.11 -179.738 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.407 ' HB3' HD13 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -63.8 -60.04 3.78 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.406 -179.62 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 55.93 85.57 0.03 OUTLIER Glycine 0 C--N 1.319 -0.405 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.386 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.63 ' HB ' ' HA ' ' A' ' 48' ' ' PRO . 3.1 mp -108.5 114.87 47.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.668 0.271 . . . . 0.0 111.115 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.503 ' CG1' ' CD2' ' A' ' 23' ' ' LEU . 7.4 p -107.33 114.8 47.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.051 0.453 . . . . 0.0 111.067 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.823 ' CD1' HG21 ' A' ' 31' ' ' THR . 38.7 m0 -107.95 147.39 31.11 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.009 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.513 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.1 OUTLIER -137.42 146.1 28.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.353 -178.752 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 1.017 HG11 ' HB2' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -120.61 104.78 15.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.035 0.445 . . . . 0.0 110.786 179.1 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.522 ' HB3' HG13 ' A' ' 15' ' ' ILE . 0.8 OUTLIER -174.1 118.05 0.24 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.812 -179.801 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.571 ' O ' ' HB2' ' A' ' 12' ' ' ASP . 0.2 OUTLIER 41.96 -87.28 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.232 -0.895 . . . . 0.0 112.033 -179.541 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.571 ' HB2' ' O ' ' A' ' 11' ' ' ASP . 24.4 t70 160.07 -100.79 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 122.734 0.414 . . . . 0.0 111.048 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.6 p -36.77 -76.51 0.02 OUTLIER 'General case' 0 C--O 1.231 0.096 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -179.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 44.0 t -52.76 -37.97 60.29 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.322 -177.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.522 HG13 ' HB3' ' A' ' 10' ' ' ASP . 19.3 mm -78.72 -22.88 13.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.163 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.594 ' O ' ' HB2' ' A' ' 20' ' ' GLU . 3.8 ttm-85 -77.18 -31.37 55.39 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.243 0.544 . . . . 0.0 110.277 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.577 ' HA ' ' HG3' ' A' ' 21' ' ' ARG . 79.7 t90 -72.12 -60.49 2.21 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -54.59 -62.04 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -176.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.494 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -77.11 -46.49 23.37 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 -176.177 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.594 ' HB2' ' O ' ' A' ' 16' ' ' ARG . 4.7 mm-40 -68.01 -61.38 1.89 Allowed 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 113.456 0.909 . . . . 0.0 113.456 -177.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.577 ' HG3' ' HA ' ' A' ' 17' ' ' TRP . 2.4 mmt180 -48.74 -43.96 38.02 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.098 -177.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.41 -26.98 61.2 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.781 0.324 . . . . 0.0 111.045 179.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.778 HD13 ' CD1' ' A' ' 28' ' ' LEU . 5.9 tp -82.27 -24.66 34.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.288 0.566 . . . . 0.0 110.198 179.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.407 ' N ' ' O ' ' A' ' 20' ' ' GLU . . . -68.36 -36.11 78.73 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.29 -25.17 68.13 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.256 -0.973 . . . . 0.0 110.749 178.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.41 ' CB ' HD12 ' A' ' 28' ' ' LEU . . . -76.76 -15.83 59.65 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 120.627 0.251 . . . . 0.0 110.885 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.06 26.58 9.46 Favored Glycine 0 CA--C 1.523 0.547 0 C-N-CA 120.482 -0.866 . . . . 0.0 114.559 178.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.778 ' CD1' HD13 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -120.76 166.98 12.98 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 118.227 1.014 . . . . 0.0 111.93 -179.93 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.466 ' O ' HG11 ' A' ' 6' ' ' VAL . 87.2 m -86.52 104.27 15.82 Favored 'General case' 0 CA--C 1.522 -0.097 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.491 ' HB2' ' HB3' ' A' ' 20' ' ' GLU . 4.2 p -105.31 110.33 22.65 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.914 -178.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.823 HG21 ' CD1' ' A' ' 7' ' ' TRP . 2.8 t -127.16 153.4 46.09 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.513 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 58.8 p -125.77 163.76 22.16 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.145 0.498 . . . . 0.0 111.923 -179.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 1.017 ' HB2' HG11 ' A' ' 9' ' ' VAL . 9.4 m-85 -136.09 173.4 11.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.482 -178.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.0 -42.51 99.87 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -177.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.699 ' C ' HG12 ' A' ' 9' ' ' VAL . 1.0 OUTLIER -170.92 -35.05 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 118.66 0.664 . . . . 0.0 112.343 -179.653 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.569 ' N ' HG12 ' A' ' 9' ' ' VAL . . . 176.71 -54.12 0.11 Allowed Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.231 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.419 ' HA ' ' CD1' ' A' ' 40' ' ' LEU . 27.5 m120 -51.31 -31.34 21.23 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.688 0.28 . . . . 0.0 111.328 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.778 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -65.15 -51.6 60.21 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.951 -0.3 . . . . 0.0 111.084 179.471 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.561 HG22 ' CG2' ' A' ' 9' ' ' VAL . 21.5 t -55.34 -33.95 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 120.277 -0.569 . . . . 0.0 111.722 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.518 HD13 ' CB ' ' A' ' 68' ' ' GLN . 13.3 mt -59.79 -47.85 84.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.692 0.282 . . . . 0.0 111.402 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.23 -47.36 79.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.268 0.556 . . . . 0.0 111.03 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.52 -40.06 96.04 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.025 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.569 HD13 ' CD2' ' A' ' 73' ' ' HIS . 17.9 mt -59.44 -26.12 64.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.433 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.74 -21.55 7.44 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.337 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.2 m -126.15 4.72 7.13 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -161.36 155.68 22.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.772 0.32 . . . . 0.0 110.968 179.946 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.407 HG21 ' CD2' ' A' ' 76' ' ' LEU . 89.8 m -138.56 112.05 8.39 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.448 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.63 ' HA ' ' HB ' ' A' ' 5' ' ' ILE . 71.7 Cg_endo -77.34 163.25 30.24 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.007 1.805 . . . . 0.0 111.444 178.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.465 ' O ' ' HG2' ' A' ' 77' ' ' PRO . 1.7 m-20 -75.74 -23.17 56.0 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.361 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.596 HG21 HD12 ' A' ' 79' ' ' ILE . 7.3 p -145.83 158.59 12.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 C-N-CA 121.16 -0.216 . . . . 0.0 110.83 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.547 ' HA ' ' O ' ' A' ' 7' ' ' TRP . 12.8 tp -152.86 115.69 4.55 Favored 'General case' 0 C--N 1.333 -0.115 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.554 ' HG ' ' HB ' ' A' ' 79' ' ' ILE . 0.8 OUTLIER -101.77 117.14 34.24 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.593 178.446 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.45 ' HB3' ' CD1' ' A' ' 65' ' ' LEU . 71.9 m -114.22 151.75 32.31 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.95 0.405 . . . . 0.0 112.022 -178.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -82.66 175.5 10.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.435 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.787 HG23 ' HG3' ' A' ' 81' ' ' MET . 3.2 tt -151.38 67.69 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.136 0 CA-C-O 121.343 0.592 . . . . 0.0 111.705 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 177.6 51.66 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.283 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.579 ' HB3' ' CD ' ' A' ' 58' ' ' PRO . 3.1 ttt -159.8 -62.48 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.3 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.503 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.579 ' CD ' ' HB3' ' A' ' 57' ' ' MET . 33.3 Cg_endo -61.64 -165.41 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.307 2.005 . . . . 0.0 112.546 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.45 -80.97 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.976 -0.63 . . . . 0.0 112.909 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.583 ' O ' ' N ' ' A' ' 62' ' ' GLY . 0.0 OUTLIER -77.03 55.57 1.14 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.794 0.33 . . . . 0.0 111.277 -179.629 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.551 ' HB3' HG13 ' A' ' 55' ' ' ILE . 0.8 OUTLIER 56.77 -68.93 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.574 179.4 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.62 ' O ' ' HG ' ' A' ' 65' ' ' LEU . . . -153.05 -34.34 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.817 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.586 HD22 ' HB1' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -62.17 -19.8 63.46 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 122.56 -0.377 . . . . 0.0 110.05 179.732 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.494 ' CB ' ' HB2' ' A' ' 60' ' ' MET . . . -54.3 -36.7 63.97 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 121.437 0.636 . . . . 0.0 109.975 178.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.62 ' HG ' ' O ' ' A' ' 62' ' ' GLY . 10.9 mt -60.14 -56.79 17.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.034 -0.984 . . . . 0.0 110.605 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.521 HD22 ' HB ' ' A' ' 78' ' ' VAL . 9.6 mt -46.17 -43.77 15.41 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.552 179.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.454 ' HZ1' ' HB2' ' A' ' 92' ' ' SER . 0.6 OUTLIER -52.07 -55.45 20.66 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.252 178.68 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.518 ' CB ' HD13 ' A' ' 40' ' ' LEU . 42.5 mm-40 -68.49 -34.74 76.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.863 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.53 -36.7 78.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.562 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.401 ' HB2' ' HB3' ' A' ' 96' ' ' GLN . 11.9 pttt -78.19 -26.82 47.72 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.06 -0.518 . . . . 0.0 112.338 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -67.77 -48.67 65.71 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -178.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.8 mmm180 -91.68 -42.55 10.1 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -178.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.569 ' CD2' HD13 ' A' ' 43' ' ' LEU . 3.3 m-70 -90.98 149.24 39.74 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.442 -178.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -73.6 -77.51 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.599 2.199 . . . . 0.0 113.187 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.709 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 1.3 mtt -125.76 44.56 2.8 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.743 0.306 . . . . 0.0 111.711 -179.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.519 HD23 ' HD2' ' A' ' 48' ' ' PRO . 1.0 OUTLIER -60.27 109.51 2.08 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.414 179.414 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.465 ' HG2' ' O ' ' A' ' 49' ' ' ASP . 32.9 Cg_exo -60.74 115.37 2.64 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.525 2.15 . . . . 0.0 112.051 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.521 ' HB ' HD22 ' A' ' 66' ' ' LEU . 5.0 t -115.47 151.91 17.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.14 0 CA-C-O 121.075 0.464 . . . . 0.0 111.345 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.596 HD12 HG21 ' A' ' 50' ' ' VAL . 2.1 mt -138.41 112.82 8.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.569 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.623 ' CG2' ' HB ' ' A' ' 55' ' ' ILE . 16.6 mm -95.03 142.07 14.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.018 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.787 ' HG3' HG23 ' A' ' 55' ' ' ILE . 1.4 ppp? -71.59 -27.24 63.0 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -178.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.553 ' O ' HG23 ' A' ' 80' ' ' ILE . 5.4 m -147.22 164.45 33.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.652 0.263 . . . . 0.0 110.77 179.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.483 ' CB ' ' HG ' ' A' ' 87' ' ' LEU . . . -129.18 37.26 4.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.769 0.318 . . . . 0.0 111.65 -179.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.43 ' O ' ' HB3' ' A' ' 85' ' ' SER . 0.6 OUTLIER -85.83 -172.91 4.34 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.72 179.794 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.43 ' HB3' ' O ' ' A' ' 84' ' ' HIS . 29.7 t 68.7 -79.6 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.384 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -141.49 80.2 1.72 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.928 0.394 . . . . 0.0 111.268 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.483 ' HG ' ' CB ' ' A' ' 83' ' ' ALA . 0.5 OUTLIER -55.94 -21.82 22.83 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.604 179.912 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -48.29 -50.32 30.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.67 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.453 ' HB3' ' HB2' ' A' ' 63' ' ' LEU . . . -57.6 -20.1 30.38 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.731 0.3 . . . . 0.0 111.741 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.586 ' HB1' HD22 ' A' ' 63' ' ' LEU . . . -73.75 -26.02 60.46 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.964 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.586 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 12.2 t -64.84 -50.64 74.27 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.485 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.454 ' HB2' ' HZ1' ' A' ' 67' ' ' LYS . 3.8 m -62.44 -23.63 66.98 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.97 0.414 . . . . 0.0 110.149 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.573 ' O ' ' HG3' ' A' ' 96' ' ' GLN . . . -62.27 -38.37 89.03 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 121.291 0.567 . . . . 0.0 109.935 178.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.586 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 9.1 m-85 -68.15 -23.06 64.83 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.547 178.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.425 ' HB3' ' O ' ' A' ' 92' ' ' SER . 0.0 OUTLIER -77.25 -38.37 51.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.855 179.38 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.709 ' O ' ' HA ' ' A' ' 75' ' ' MET . 1.5 pp0? -80.61 -19.01 46.39 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 120.949 -0.301 . . . . 0.0 111.31 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 117.99 31.42 1.59 Allowed Glycine 0 CA--C 1.52 0.388 0 C-N-CA 120.584 -0.817 . . . . 0.0 113.344 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.49 ' HB2' ' HB2' ' A' ' 93' ' ' ALA . . . -67.33 151.34 47.64 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 122.833 -0.216 . . . . 0.0 110.774 179.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.512 ' CZ ' ' HA ' ' A' ' 118' ' ' ALA . 14.2 t80 -76.84 -53.83 7.39 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 121.094 -0.242 . . . . 0.0 111.324 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.477 ' HB2' ' O ' ' A' ' 99' ' ' PHE . 4.4 t0 171.08 -168.7 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.312 0.577 . . . . 0.0 111.39 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.541 ' CE1' ' HB2' ' A' ' 90' ' ' ALA . 3.7 m-85 -133.79 152.36 51.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.016 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.692 HD22 ' HA ' ' A' ' 106' ' ' PHE . 1.5 mp -105.22 118.97 54.55 Favored Pre-proline 0 C--N 1.329 -0.314 0 C-N-CA 121.11 -0.236 . . . . 0.0 111.11 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -81.18 -76.31 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.399 2.066 . . . . 0.0 112.508 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.479 ' H ' ' HD2' ' A' ' 105' ' ' PRO . 1.3 mtpp -99.31 -62.07 0.1 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.603 -0.272 . . . . 0.0 111.682 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.479 ' HD2' ' H ' ' A' ' 104' ' ' LYS . 19.5 Cg_endo -59.03 149.56 78.87 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.186 1.924 . . . . 0.0 112.361 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.692 ' HA ' HD22 ' A' ' 102' ' ' LEU . 48.4 t80 -160.35 -111.79 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.89 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.629 ' O ' ' O ' ' A' ' 106' ' ' PHE . 2.8 p30 39.07 179.4 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.99 0.424 . . . . 0.0 111.921 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.46 HG21 HG21 ' A' ' 112' ' ' VAL . 0.7 OUTLIER -67.6 -42.57 86.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.85 0.357 . . . . 0.0 111.776 -179.403 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.556 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 3.9 m-20 -49.55 -58.42 5.24 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.364 -179.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.636 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 13.8 mm-40 -73.96 -35.35 64.52 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.771 0.319 . . . . 0.0 111.08 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.54 -56.18 15.74 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.924 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.611 ' O ' HG11 ' A' ' 115' ' ' VAL . 52.8 t -63.89 -31.92 55.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.494 0.664 . . . . 0.0 110.598 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.556 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -62.7 -45.46 92.66 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.281 179.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.509 HD21 ' CG2' ' A' ' 79' ' ' ILE . 13.8 tp -78.15 -22.43 48.76 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.727 -1.124 . . . . 0.0 111.995 -178.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.611 HG11 ' O ' ' A' ' 112' ' ' VAL . 6.2 p -79.6 -47.34 22.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 C-N-CA 120.351 -0.54 . . . . 0.0 111.348 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -63.22 -43.43 98.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.762 0.315 . . . . 0.0 110.775 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 68.4 mtt180 -60.38 -24.99 65.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.008 0.432 . . . . 0.0 110.505 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.512 ' HA ' ' CZ ' ' A' ' 99' ' ' PHE . . . -68.9 -45.4 71.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.739 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.437 HD13 HG11 ' A' ' 50' ' ' VAL . 4.9 mt -73.86 -32.02 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-O 121.16 0.505 . . . . 0.0 110.706 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 29.6 t -75.47 -48.51 22.34 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.247 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -58.57 -28.72 65.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.027 0.441 . . . . 0.0 111.125 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -83.95 -50.74 7.75 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.267 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 57.48 171.63 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.408 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.485 ' HB2' ' HG2' ' A' ' 2' ' ' GLN . 5.1 mm-40 . . . . . 0 C--N 1.328 -0.365 0 CA-C-O 120.789 0.328 . . . . 0.0 111.004 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.827 0.346 . . . . 0.0 111.147 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -62.69 158.35 18.7 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.736 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.436 ' HB3' ' CD1' ' A' ' 5' ' ' ILE . 0.1 OUTLIER -58.19 -23.63 56.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.044 -179.888 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 67.32 73.02 0.7 Allowed Glycine 0 CA--C 1.517 0.179 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.067 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.436 ' CD1' ' HB3' ' A' ' 3' ' ' ARG . 3.4 mp -112.03 112.91 42.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.747 0.308 . . . . 0.0 111.447 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.564 ' O ' ' HA ' ' A' ' 30' ' ' CYS . 5.6 p -107.54 130.51 59.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.074 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.538 ' CD1' ' CG2' ' A' ' 31' ' ' THR . 36.7 m0 -114.61 140.48 48.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.46 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.634 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.9 OUTLIER -123.34 134.99 64.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.806 0.336 . . . . 0.0 111.683 -178.636 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.516 HG11 ' HB2' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -119.82 109.19 25.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 120.881 0.372 . . . . 0.0 110.729 179.557 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -162.29 -157.94 0.49 Allowed 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.855 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -66.1 -2.13 3.85 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -179.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.409 ' O ' ' N ' ' A' ' 14' ' ' SER . 0.6 OUTLIER 66.81 -153.33 0.22 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 121.235 -0.186 . . . . 0.0 111.05 179.253 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.7 t 33.94 -89.83 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.409 ' N ' ' O ' ' A' ' 12' ' ' ASP . 3.6 m -55.18 -55.91 25.86 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.827 0.346 . . . . 0.0 111.125 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 27.6 mm -65.83 -25.58 36.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.372 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.618 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 14.0 ttp180 -69.84 -55.64 9.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.467 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.435 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 71.2 t90 -58.39 -39.62 80.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.763 -179.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.547 HG13 ' CD1' ' A' ' 108' ' ' ILE . 12.3 t -65.67 -49.28 78.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.417 HD23 HD13 ' A' ' 108' ' ' ILE . 0.3 OUTLIER -82.99 -25.21 32.47 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -178.109 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.646 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 23.1 pt-20 -67.41 -59.94 2.98 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.607 -0.437 . . . . 0.0 112.061 -179.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.49 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 3.6 mmt85 -67.7 -49.71 61.31 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -179.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.0 -57.33 10.74 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 120.905 0.383 . . . . 0.0 111.657 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.639 HD12 ' CD1' ' A' ' 28' ' ' LEU . 2.1 tp -65.34 -22.94 66.88 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.363 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.62 ' HB3' ' O ' ' A' ' 20' ' ' GLU . . . -69.4 -37.32 77.44 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.44 -24.73 66.11 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.456 -0.878 . . . . 0.0 111.404 178.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.45 -15.43 59.33 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 120.668 0.27 . . . . 0.0 111.01 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.65 26.58 8.0 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 120.6 -0.809 . . . . 0.0 114.069 178.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.639 ' CD1' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -128.97 171.85 11.94 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 117.764 0.782 . . . . 0.0 111.852 179.931 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.476 ' O ' HG13 ' A' ' 6' ' ' VAL . 23.7 m -99.78 105.56 17.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.333 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.646 ' HB3' ' HA ' ' A' ' 20' ' ' GLU . 7.2 t -102.68 114.68 29.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.856 -179.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.599 HG22 ' CE1' ' A' ' 33' ' ' PHE . 2.5 t -115.01 156.95 24.15 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.634 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 28.3 p -131.15 163.43 27.72 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.918 0.39 . . . . 0.0 111.894 -179.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.599 ' CE1' HG22 ' A' ' 31' ' ' THR . 35.4 m-85 -136.02 174.7 10.32 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -178.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.75 ' HG2' ' CD ' ' A' ' 38' ' ' GLU . 1.6 pt-20 -59.31 -39.56 83.46 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -176.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.528 ' N ' ' HG2' ' A' ' 34' ' ' GLU . 44.8 m-20 -168.22 -67.04 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.992 0.425 . . . . 0.0 111.352 -178.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.423 ' HA2' ' CG1' ' A' ' 9' ' ' VAL . . . -160.82 -35.22 0.02 OUTLIER Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.327 -0.939 . . . . 0.0 114.165 -179.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.733 ' HA ' HD13 ' A' ' 40' ' ' LEU . 4.7 m120 -61.45 -35.35 77.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 117.34 0.57 . . . . 0.0 112.088 -178.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.75 ' CD ' ' HG2' ' A' ' 34' ' ' GLU . 1.4 mp0 -51.79 -61.73 2.07 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.589 HG11 ' HG ' ' A' ' 43' ' ' LEU . 94.2 t -45.84 -31.05 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-O 121.286 0.565 . . . . 0.0 110.745 -179.133 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.733 HD13 ' HA ' ' A' ' 37' ' ' ASN . 10.1 mt -64.52 -43.87 92.66 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.039 179.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -82.5 -47.94 11.61 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.337 0.589 . . . . 0.0 110.703 178.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.34 -37.78 65.3 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.568 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.589 ' HG ' HG11 ' A' ' 39' ' ' VAL . 37.3 mt -67.39 -22.99 65.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.843 0.354 . . . . 0.0 111.523 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.35 -18.07 3.69 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.752 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.7 m -119.92 -5.9 10.07 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.531 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.1 OUTLIER -165.71 162.65 18.85 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.041 0.448 . . . . 0.0 111.702 -179.889 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 100.0 m -139.38 119.5 9.37 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.139 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.45 ' HD2' HD22 ' A' ' 43' ' ' LEU . 91.1 Cg_endo -80.41 165.62 20.72 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.403 2.069 . . . . 0.0 111.101 178.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -74.25 -25.37 59.59 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.967 -0.293 . . . . 0.0 110.992 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.468 HG13 ' CG2' ' A' ' 6' ' ' VAL . 8.9 p -145.02 162.46 13.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.177 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.417 ' N ' HG21 ' A' ' 50' ' ' VAL . 20.5 tp -152.91 126.67 8.88 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.177 0.513 . . . . 0.0 111.913 -179.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.536 ' HB3' HG11 ' A' ' 8' ' ' VAL . 0.4 OUTLIER -104.49 114.66 29.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.27 179.275 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.667 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 1.7 t -110.79 139.03 46.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.167 0.508 . . . . 0.0 111.627 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 32.1 p-10 -82.8 -173.65 4.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.639 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.55 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 16.3 tt -161.46 170.7 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.175 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.494 ' N ' HG12 ' A' ' 55' ' ' ILE . 13.9 ptt85 58.55 43.25 19.53 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-O 121.526 0.679 . . . . 0.0 110.246 -178.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.497 ' CB ' ' CD ' ' A' ' 58' ' ' PRO . 6.3 mtm -151.67 -67.89 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.393 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.497 ' CD ' ' CB ' ' A' ' 57' ' ' MET . 27.2 Cg_endo -59.76 -163.29 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.87 2.38 . . . . 0.0 112.847 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -52.8 -87.52 0.01 OUTLIER Glycine 0 C--N 1.332 0.352 0 CA-C-N 115.964 -0.562 . . . . 0.0 113.258 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.529 ' O ' ' N ' ' A' ' 62' ' ' GLY . 0.0 OUTLIER -76.39 61.17 1.66 Allowed 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.093 0.473 . . . . 0.0 110.466 -179.934 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.485 ' O ' ' HD2' ' A' ' 58' ' ' PRO . 6.9 m-20 60.8 -65.67 0.06 Allowed 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.944 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.55 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -165.05 -32.88 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.631 HD12 ' HB3' ' A' ' 86' ' ' ASP . 0.9 OUTLIER -64.06 -13.25 45.86 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 120.54 0.21 . . . . 0.0 110.481 179.398 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.417 ' HB3' ' HB2' ' A' ' 60' ' ' MET . . . -53.68 -31.55 48.19 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 121.054 0.455 . . . . 0.0 110.164 179.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.0 mp -62.64 -53.11 59.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.914 178.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.473 HD23 ' HA ' ' A' ' 63' ' ' LEU . 3.5 mm? -45.71 -45.82 14.56 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.861 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.683 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 27.1 mttt -59.15 -54.3 48.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.993 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.646 ' HB2' HD11 ' A' ' 40' ' ' LEU . 28.4 mm100 -64.34 -27.78 69.26 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.903 0.382 . . . . 0.0 110.34 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.523 ' HA ' ' CD2' ' A' ' 73' ' ' HIS . 41.4 mt -65.0 -36.74 78.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.853 -179.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.683 ' HG2' ' O ' ' A' ' 67' ' ' LYS . 6.5 pttt -75.72 -28.83 58.72 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.546 -179.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -69.14 -30.57 68.84 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.797 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.22 -56.96 2.31 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -179.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.566 ' CE1' ' HB2' ' A' ' 43' ' ' LEU . 1.3 m-70 -81.31 151.81 69.79 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-O 120.983 0.421 . . . . 0.0 111.817 -178.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -74.07 -80.99 0.01 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.377 2.051 . . . . 0.0 112.823 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.458 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 4.7 mtt -135.71 49.01 2.17 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 120.936 0.398 . . . . 0.0 111.73 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.429 ' CD1' HD22 ' A' ' 43' ' ' LEU . 0.7 OUTLIER -64.76 115.94 24.96 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.007 179.605 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -55.61 116.95 3.52 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.376 2.051 . . . . 0.0 112.214 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.467 HG22 HD13 ' A' ' 66' ' ' LEU . 4.1 t -110.68 144.23 19.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.089 0.471 . . . . 0.0 111.365 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.7 mt -128.59 111.36 23.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.427 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.667 ' HA ' ' O ' ' A' ' 53' ' ' SER . 31.1 mm -96.89 141.6 15.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.929 0.395 . . . . 0.0 111.611 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.406 ' CG ' HG22 ' A' ' 55' ' ' ILE . 21.8 ptm -72.67 -31.25 64.92 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -178.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.569 ' HA ' ' O ' ' A' ' 102' ' ' LEU . 7.1 m -146.36 169.17 19.4 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.511 -179.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.413 ' CB ' ' HG ' ' A' ' 87' ' ' LEU . . . -141.86 -22.31 0.71 Allowed 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.479 ' HE1' HG12 ' A' ' 55' ' ' ILE . 1.9 p-80 35.6 -102.74 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.1 p -120.99 -11.95 8.83 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -178.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.631 ' HB3' HD12 ' A' ' 63' ' ' LEU . 5.8 m-20 -82.09 18.25 1.41 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.839 0.352 . . . . 0.0 111.265 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.413 ' HG ' ' CB ' ' A' ' 83' ' ' ALA . 3.0 mt -50.69 -20.47 1.24 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.961 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -46.88 -53.79 11.37 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -178.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.403 ' HB3' HD22 ' A' ' 63' ' ' LEU . . . -65.7 -20.59 66.34 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.737 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.452 ' HB3' HD21 ' A' ' 63' ' ' LEU . . . -68.16 -40.47 82.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.225 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.673 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 4.3 t -57.31 -46.34 85.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.183 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.625 ' O ' ' NE2' ' A' ' 95' ' ' GLN . 12.8 m -62.23 -44.64 96.1 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.232 0.539 . . . . 0.0 109.827 179.248 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.444 ' HB3' ' HB2' ' A' ' 98' ' ' ALA . . . -47.48 -42.37 22.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.02 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.673 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 16.4 m-85 -56.19 -25.96 49.03 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.24 179.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.625 ' NE2' ' O ' ' A' ' 92' ' ' SER . 0.0 OUTLIER -71.35 -45.54 62.68 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.287 -179.916 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.629 ' HG3' ' HB3' ' A' ' 70' ' ' LYS . 75.5 mm-40 -74.23 -18.08 60.79 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.11 -179.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 119.86 32.56 1.18 Allowed Glycine 0 N--CA 1.453 -0.186 0 C-N-CA 120.311 -0.947 . . . . 0.0 113.163 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.444 ' HB2' ' HB3' ' A' ' 93' ' ' ALA . . . -64.43 145.81 55.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.819 0.309 . . . . 0.0 110.225 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.532 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 10.9 t80 -77.17 -53.93 7.13 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.197 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.401 ' HB2' ' O ' ' A' ' 99' ' ' PHE . 0.2 OUTLIER 173.18 -166.86 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.208 0.528 . . . . 0.0 111.728 179.7 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.629 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 5.3 m-85 -142.43 150.59 40.8 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.119 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.569 ' O ' ' HA ' ' A' ' 82' ' ' THR . 2.4 mp -104.87 119.53 53.08 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.234 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -69.25 -75.24 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.02 1.813 . . . . 0.0 112.194 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.552 ' H ' ' HD2' ' A' ' 105' ' ' PRO . 1.8 tttm -106.44 -60.0 0.05 OUTLIER Pre-proline 0 CA--C 1.533 0.293 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.552 ' HD2' ' H ' ' A' ' 104' ' ' LYS . 18.0 Cg_endo -59.72 156.73 36.02 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.263 1.975 . . . . 0.0 112.735 -179.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.608 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 24.0 t80 -166.94 -105.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.123 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.54 ' O ' ' O ' ' A' ' 106' ' ' PHE . 3.3 p30 42.79 -178.03 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.86 0.362 . . . . 0.0 111.155 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.547 ' CD1' HG13 ' A' ' 18' ' ' VAL . 0.9 OUTLIER -67.88 -40.89 84.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.137 0.494 . . . . 0.0 111.583 179.922 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -49.98 -58.62 5.08 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.721 -179.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.608 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 5.0 mm-40 -76.61 -31.59 57.54 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.74 0.305 . . . . 0.0 111.241 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.96 -61.58 1.97 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.901 0.381 . . . . 0.0 110.127 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.683 ' O ' HG12 ' A' ' 115' ' ' VAL . 46.5 t -59.1 -30.71 44.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.483 0.659 . . . . 0.0 110.792 179.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -64.53 -45.33 87.68 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.799 179.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.42 HD13 ' CE2' ' A' ' 99' ' ' PHE . 33.5 tp -77.38 -20.98 53.91 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.689 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.683 HG12 ' O ' ' A' ' 112' ' ' VAL . 4.1 p -79.4 -44.31 23.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.659 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.518 ' HA ' HD13 ' A' ' 119' ' ' ILE . 58.4 mt-10 -60.35 -44.91 95.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.894 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 21.8 mmm180 -62.26 -23.86 66.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.248 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.532 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -74.48 -42.69 58.57 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.63 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.518 HD13 ' HA ' ' A' ' 116' ' ' GLU . 6.3 mt -65.09 -31.29 53.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.13 0.49 . . . . 0.0 110.922 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 2.8 m -68.83 -49.34 59.29 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.995 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 31.8 m80 -62.95 -24.12 67.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.143 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -67.63 -59.35 3.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.797 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 45.99 -170.58 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.461 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 . . . . . 0 C--N 1.33 -0.264 0 CA-C-O 121.039 0.447 . . . . 0.0 110.849 -179.996 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.3 ptm . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 120.949 0.404 . . . . 0.0 111.44 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -122.69 140.48 52.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.496 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.513 ' HB3' HD11 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -75.43 -62.5 1.55 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.447 -179.615 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.419 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . 71.11 76.7 0.55 Allowed Glycine 0 C--N 1.317 -0.5 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.704 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.513 HD11 ' HB3' ' A' ' 3' ' ' ARG . 2.4 mp -111.27 114.48 47.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.795 0.331 . . . . 0.0 111.267 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.571 ' O ' ' HA ' ' A' ' 30' ' ' CYS . 9.0 p -108.07 121.46 61.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.322 179.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.517 ' NE1' HG21 ' A' ' 31' ' ' THR . 27.4 m0 -111.55 133.32 53.9 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.912 0.387 . . . . 0.0 110.547 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.699 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.0 OUTLIER -124.89 149.15 29.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.149 -178.598 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.937 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -127.91 105.25 13.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 177.824 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.569 ' HB3' HG22 ' A' ' 15' ' ' ILE . 36.3 t0 -166.6 67.69 0.1 Allowed 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 120.952 0.406 . . . . 0.0 111.955 -179.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 20.6 t70 61.15 6.52 1.32 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.467 ' HA ' ' OG1' ' A' ' 32' ' ' THR . 4.5 p-10 44.28 -147.83 0.08 Allowed 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.41 ' HB3' ' H ' ' A' ' 14' ' ' SER . 1.7 t 36.05 -93.56 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 179.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.41 ' H ' ' HB3' ' A' ' 13' ' ' SER . 29.1 t -53.83 -65.66 0.53 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.652 0.263 . . . . 0.0 110.974 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.569 HG22 ' HB3' ' A' ' 10' ' ' ASP . 17.2 mm -60.57 -20.63 21.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.301 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.533 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 23.8 ttm-85 -69.74 -58.33 4.03 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 120.862 0.363 . . . . 0.0 110.848 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.457 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 49.8 t90 -51.5 -39.62 57.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.093 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.489 HG11 ' CD1' ' A' ' 108' ' ' ILE . 11.7 t -63.64 -51.59 68.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -178.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.667 HD22 HG11 ' A' ' 8' ' ' VAL . 6.2 tp -84.37 -24.97 29.46 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 -178.006 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.613 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 11.9 pt-20 -66.45 -59.86 3.27 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.416 -0.514 . . . . 0.0 111.565 -178.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.508 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 5.7 mmm180 -58.54 -52.78 64.19 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.848 -179.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.07 -47.92 77.05 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.81 0.338 . . . . 0.0 111.805 -179.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.771 HD11 ' CD1' ' A' ' 28' ' ' LEU . 1.7 tp -72.97 -24.65 60.81 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.126 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.5 ' HB2' ' O ' ' A' ' 20' ' ' GLU . . . -68.96 -34.27 75.05 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.37 -27.76 69.91 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.324 -0.941 . . . . 0.0 111.107 178.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.87 -16.0 59.54 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 120.605 0.241 . . . . 0.0 111.07 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.07 26.54 8.81 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 120.461 -0.876 . . . . 0.0 114.281 178.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.771 ' CD1' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -123.27 169.27 11.47 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 117.946 0.873 . . . . 0.0 111.653 179.756 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.442 ' O ' HG13 ' A' ' 6' ' ' VAL . 54.0 m -96.42 105.69 17.8 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.004 179.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.613 ' HB3' ' HA ' ' A' ' 20' ' ' GLU . 41.8 t -103.6 110.37 22.4 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.979 -179.103 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.517 HG21 ' NE1' ' A' ' 7' ' ' TRP . 2.6 t -117.37 154.16 31.78 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.699 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 29.1 p -126.11 165.56 18.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.301 0.572 . . . . 0.0 112.071 -179.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.937 ' HB2' HG13 ' A' ' 9' ' ' VAL . 16.2 m-85 -136.04 174.76 10.26 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.863 -178.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.757 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 2.3 pp20? -60.6 -49.19 78.53 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -176.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.728 ' C ' HG11 ' A' ' 9' ' ' VAL . 7.3 m-20 -165.56 -29.29 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -179.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.57 ' N ' HG11 ' A' ' 9' ' ' VAL . . . 174.92 -56.85 0.12 Allowed Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.448 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.594 ' HA ' HD13 ' A' ' 40' ' ' LEU . 1.2 t-20 -55.07 -30.59 59.96 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.674 0.273 . . . . 0.0 111.283 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.792 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -60.16 -55.66 31.11 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.709 179.796 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.656 HG21 HG12 ' A' ' 9' ' ' VAL . 5.5 t -50.9 -45.08 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.097 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.733 ' HB3' ' HD2' ' A' ' 72' ' ' ARG . 29.2 mt -52.1 -42.97 63.67 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.246 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.86 -50.78 67.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.202 0.525 . . . . 0.0 111.441 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.44 -29.36 65.93 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.766 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.836 HD13 ' NE2' ' A' ' 73' ' ' HIS . 5.6 mt -64.28 -25.44 68.05 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.8 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.9 -18.28 31.81 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.168 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 41.1 t -124.4 3.38 8.42 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 112.143 0.424 . . . . 0.0 112.143 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.43 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.4 OUTLIER -162.74 159.01 23.68 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-O 120.958 0.409 . . . . 0.0 111.497 179.924 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 98.4 m -138.62 115.48 8.94 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.459 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.572 ' HD2' HD22 ' A' ' 76' ' ' LEU . 72.7 Cg_endo -73.75 165.7 31.6 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.486 2.124 . . . . 0.0 111.363 178.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -76.72 -29.23 56.14 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 121.033 -0.267 . . . . 0.0 110.712 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.604 ' CG2' HD11 ' A' ' 79' ' ' ILE . 8.4 p -148.35 108.34 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.571 ' HB2' HD23 ' A' ' 76' ' ' LEU . 15.0 tp -86.99 136.92 32.75 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.889 0.376 . . . . 0.0 111.241 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.569 ' HB3' HG12 ' A' ' 8' ' ' VAL . 1.8 tt -124.2 124.17 41.88 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.099 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.565 ' HB2' ' CD1' ' A' ' 80' ' ' ILE . 67.0 m -110.94 136.61 49.7 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.045 0.45 . . . . 0.0 111.999 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.445 ' O ' ' HG2' ' A' ' 81' ' ' MET . 33.7 t70 -82.88 -12.91 57.02 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.209 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.827 HG13 ' HA3' ' A' ' 62' ' ' GLY . 6.5 tt 42.25 69.59 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-O 120.732 0.301 . . . . 0.0 111.502 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -112.06 44.85 1.34 Allowed 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.49 ' N ' ' CD ' ' A' ' 58' ' ' PRO . 0.5 OUTLIER 59.75 44.91 1.02 Allowed Pre-proline 0 N--CA 1.465 0.321 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 178.663 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.49 ' CD ' ' N ' ' A' ' 57' ' ' MET . 36.3 Cg_endo -65.08 -75.6 0.02 OUTLIER 'Trans proline' 0 CA--C 1.532 0.391 0 C-N-CA 122.579 2.186 . . . . 0.0 112.391 178.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -112.37 -27.67 3.81 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.074 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.619 ' N ' ' HB1' ' A' ' 64' ' ' ALA . 7.9 tpt -156.11 68.49 0.62 Allowed 'General case' 0 C--O 1.236 0.387 0 CA-C-O 120.981 0.419 . . . . 0.0 109.955 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.612 ' O ' HG13 ' A' ' 55' ' ' ILE . 0.4 OUTLIER 69.22 -26.43 0.15 Allowed 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.931 -179.709 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.827 ' HA3' HG13 ' A' ' 55' ' ' ILE . . . 139.32 -26.09 2.71 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -179.024 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.578 ' O ' ' HB2' ' A' ' 66' ' ' LEU . 3.1 mp -74.23 -15.14 61.0 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.619 ' HB1' ' N ' ' A' ' 60' ' ' MET . . . -53.74 -44.88 70.3 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.838 178.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.709 ' HG ' ' O ' ' A' ' 62' ' ' GLY . 4.0 pp -58.6 -36.64 74.33 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.289 179.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.578 ' HB2' ' O ' ' A' ' 63' ' ' LEU . 14.8 mt -55.75 -48.59 74.99 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.019 0.438 . . . . 0.0 110.402 179.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.539 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 12.6 tptt -53.23 -44.05 67.78 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.936 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.465 ' CB ' HD12 ' A' ' 40' ' ' LEU . 9.2 mm100 -67.08 -27.72 67.59 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.963 0.411 . . . . 0.0 110.704 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.701 HG12 ' CE1' ' A' ' 73' ' ' HIS . 96.8 mt -64.55 -38.13 81.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.527 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.539 ' HG2' ' O ' ' A' ' 67' ' ' LYS . 2.7 ptmt -74.97 -29.42 60.91 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.915 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.432 ' NE2' ' HG3' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -86.25 -30.61 22.21 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.735 -179.939 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.733 ' HD2' ' HB3' ' A' ' 40' ' ' LEU . 28.6 mtt85 -90.45 -68.01 0.81 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.856 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.836 ' NE2' HD13 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -88.04 144.63 34.86 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.629 -179.722 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -55.79 -67.49 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.603 2.202 . . . . 0.0 112.893 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.405 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 0.2 OUTLIER -146.89 40.13 1.06 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.934 0.397 . . . . 0.0 111.089 -179.554 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.644 ' HB3' ' HD1' ' A' ' 73' ' ' HIS . 22.7 tp -63.75 129.43 93.77 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.037 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.516 ' HA ' ' O ' ' A' ' 97' ' ' GLY . 58.2 Cg_endo -71.58 134.91 25.15 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.413 2.075 . . . . 0.0 112.278 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.612 HG21 HD13 ' A' ' 69' ' ' ILE . 5.5 t -123.95 148.57 28.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.944 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.604 HD11 ' CG2' ' A' ' 50' ' ' VAL . 2.2 mt -126.63 114.49 38.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.201 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.685 HG13 ' CZ ' ' A' ' 101' ' ' TYR . 9.7 mm -97.87 139.38 20.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.957 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.445 ' HG2' ' O ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -75.94 -30.76 58.8 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 112.357 0.502 . . . . 0.0 112.357 -178.882 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.566 ' O ' HG21 ' A' ' 80' ' ' ILE . 16.8 m -147.59 157.22 43.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.753 0.311 . . . . 0.0 111.574 -179.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -118.99 0.22 11.28 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.611 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.512 ' CE1' ' CD1' ' A' ' 55' ' ' ILE . 0.1 OUTLIER 25.75 -94.85 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 -179.168 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 16.1 m -136.89 -23.09 1.19 Allowed 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -178.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.561 ' O ' HD23 ' A' ' 63' ' ' LEU . 0.3 OUTLIER -78.66 28.39 0.2 Allowed 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -179.285 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.418 HD22 ' HB2' ' A' ' 90' ' ' ALA . 0.5 OUTLIER -46.84 -21.95 0.26 Allowed 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.887 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -48.11 -53.17 17.48 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.886 0.374 . . . . 0.0 111.264 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.436 ' HB1' ' CB ' ' A' ' 63' ' ' LEU . . . -64.05 -20.31 65.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.331 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.571 ' HB1' ' CE1' ' A' ' 101' ' ' TYR . . . -68.87 -33.89 74.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.837 0.351 . . . . 0.0 110.514 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.635 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 2.8 t -63.94 -46.61 93.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.81 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.591 ' O ' ' HG3' ' A' ' 95' ' ' GLN . 52.5 p -62.04 -16.89 55.19 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 178.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.729 ' O ' ' HG3' ' A' ' 96' ' ' GLN . . . -75.57 -52.14 11.29 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.408 0.623 . . . . 0.0 111.827 179.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.635 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 7.3 m-85 -57.9 -32.66 67.95 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.839 -179.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.591 ' HG3' ' O ' ' A' ' 92' ' ' SER . 2.1 pp0? -77.28 -32.06 55.23 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.247 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.729 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 3.3 pp0? -83.02 -15.95 49.05 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 121.13 -0.228 . . . . 0.0 111.295 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.516 ' O ' ' HA ' ' A' ' 77' ' ' PRO . . . 130.27 7.73 3.49 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.357 -0.925 . . . . 0.0 114.015 178.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.497 ' HB2' ' HB2' ' A' ' 93' ' ' ALA . . . -56.96 153.22 11.55 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 117.475 0.638 . . . . 0.0 111.138 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.551 ' CZ ' ' HA ' ' A' ' 118' ' ' ALA . 23.9 t80 -82.12 -53.65 5.92 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.336 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.544 ' HB3' ' O ' ' A' ' 99' ' ' PHE . 13.6 p-10 172.67 -161.49 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.311 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.685 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 4.6 m-85 -141.89 153.67 44.57 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.564 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.649 HD23 ' HA ' ' A' ' 106' ' ' PHE . 1.3 mp -102.32 120.01 54.62 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.71 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_exo -55.98 -69.19 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.478 2.118 . . . . 0.0 112.593 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.675 ' HB2' ' HD3' ' A' ' 105' ' ' PRO . 7.0 mmtt -128.42 -59.57 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.421 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.675 ' HD3' ' HB2' ' A' ' 104' ' ' LYS . 51.1 Cg_exo -54.16 161.56 5.04 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 121.74 1.627 . . . . 0.0 112.012 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.65 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 23.1 t80 -166.95 -105.6 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.653 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.484 ' O ' ' O ' ' A' ' 106' ' ' PHE . 2.8 p30 43.89 -175.57 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.778 0.323 . . . . 0.0 110.967 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.624 HG21 HG22 ' A' ' 112' ' ' VAL . 1.0 OUTLIER -67.86 -42.39 85.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 120.994 0.426 . . . . 0.0 111.416 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.624 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 26.3 t70 -49.12 -59.04 3.98 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.697 -179.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.65 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 7.0 mm-40 -76.16 -32.96 59.34 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.682 0.277 . . . . 0.0 111.376 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.419 ' CB ' ' O ' ' A' ' 107' ' ' ASP . . . -66.54 -59.37 3.7 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.486 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.656 ' O ' HG11 ' A' ' 115' ' ' VAL . 35.9 t -59.53 -31.37 46.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.444 0.64 . . . . 0.0 110.715 178.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.624 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -63.1 -44.8 94.69 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.096 179.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.489 ' CD2' HG23 ' A' ' 79' ' ' ILE . 36.0 tp -79.33 -21.26 46.13 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.86 -1.064 . . . . 0.0 112.072 -179.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.656 HG11 ' O ' ' A' ' 112' ' ' VAL . 6.0 p -79.2 -45.15 24.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.548 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -65.72 -45.4 82.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.693 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 42.8 mtp180 -60.03 -24.8 64.81 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.668 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.551 ' HA ' ' CZ ' ' A' ' 99' ' ' PHE . . . -72.27 -48.91 38.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.918 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.479 HD12 HG12 ' A' ' 50' ' ' VAL . 4.8 mt -65.27 -31.2 52.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.137 0.494 . . . . 0.0 110.75 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.3 t -72.24 -58.39 3.45 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.855 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 26.5 m80 -60.67 -26.72 67.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.885 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 36.3 t80 -73.62 -58.04 3.58 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.639 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 56.79 169.81 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.022 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.913 179.945 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.289 0 CA-C-O 120.757 0.313 . . . . 0.0 111.115 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 63.35 144.17 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.82 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 21.0 ptt180 -70.9 -13.35 61.99 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.001 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.548 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . 89.33 88.77 1.23 Allowed Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.097 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.8 mp -99.3 113.14 33.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 120.819 0.342 . . . . 0.0 111.297 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.566 HG12 ' O ' ' A' ' 29' ' ' THR . 6.2 p -105.69 123.41 60.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.061 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.538 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 31.4 m0 -115.08 127.91 55.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.633 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.624 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -112.86 143.02 23.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.401 -178.977 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.708 HG11 ' HB2' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -122.98 111.14 28.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.194 0.521 . . . . 0.0 110.633 179.367 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.414 ' HA ' ' OD2' ' A' ' 54' ' ' ASP . 3.9 t0 -161.43 -158.87 0.59 Allowed 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.188 -178.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.51 -2.25 4.49 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' A' ' 14' ' ' SER . 1.4 t0 67.76 -156.77 0.21 Allowed 'General case' 0 CA--C 1.531 0.233 0 O-C-N 122.381 -0.2 . . . . 0.0 110.833 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.412 ' HB3' ' H ' ' A' ' 14' ' ' SER . 3.3 t 34.66 -90.6 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.413 ' N ' ' O ' ' A' ' 12' ' ' ASP . 26.8 t -54.36 -61.15 2.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.741 0.305 . . . . 0.0 111.089 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 30.4 mm -61.75 -22.84 29.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.96 0.41 . . . . 0.0 110.754 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.891 ' HA ' HG21 ' A' ' 32' ' ' THR . 41.6 ttt180 -75.64 -54.85 6.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.634 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 83.4 t90 -58.65 -38.39 78.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.691 0.282 . . . . 0.0 111.595 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.438 ' CG1' HG12 ' A' ' 108' ' ' ILE . 3.6 t -69.52 -45.03 79.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -178.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.66 -26.69 29.67 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -178.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.599 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 10.9 pt-20 -67.74 -60.43 2.54 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -179.126 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.533 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 2.3 mmt-85 -60.71 -52.89 63.2 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -178.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.49 -50.4 65.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.948 0.404 . . . . 0.0 111.567 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.625 HD11 ' CD1' ' A' ' 28' ' ' LEU . 1.0 OUTLIER -70.4 -27.67 64.48 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.352 179.807 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.599 ' HB1' ' O ' ' A' ' 20' ' ' GLU . . . -67.56 -34.75 77.68 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.16 -26.45 69.26 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.417 -0.897 . . . . 0.0 111.038 178.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.414 ' CB ' HD12 ' A' ' 28' ' ' LEU . . . -77.26 -15.39 59.48 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.655 -0.273 . . . . 0.0 111.039 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.21 26.41 10.22 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.606 -0.807 . . . . 0.0 114.217 178.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.625 ' CD1' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -124.68 170.68 10.74 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 117.87 0.835 . . . . 0.0 111.775 179.722 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.566 ' O ' HG12 ' A' ' 6' ' ' VAL . 50.6 m -94.3 105.8 17.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.078 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.468 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 46.7 t -106.29 110.33 22.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.992 -178.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.524 HG22 ' CE1' ' A' ' 33' ' ' PHE . 2.8 t -118.73 153.05 35.03 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.891 HG21 ' HA ' ' A' ' 16' ' ' ARG . 20.5 p -126.43 157.12 39.42 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.558 0.694 . . . . 0.0 112.134 -179.214 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.774 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 1.0 OUTLIER -127.0 174.29 8.98 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.707 -1.133 . . . . 0.0 111.184 -178.73 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.643 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 3.0 pp20? -61.37 -34.23 74.97 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -177.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -176.92 -37.52 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.631 ' HA2' HG13 ' A' ' 9' ' ' VAL . . . 173.47 -47.02 0.16 Allowed Glycine 0 C--N 1.318 -0.438 0 C-N-CA 120.32 -0.943 . . . . 0.0 112.884 -179.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.531 ' HA ' HD11 ' A' ' 40' ' ' LEU . 0.8 OUTLIER -59.62 -29.66 68.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.154 0.502 . . . . 0.0 111.071 -179.765 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.774 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -62.97 -53.58 51.86 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.708 -179.525 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.449 ' CG2' ' CG1' ' A' ' 9' ' ' VAL . 21.3 t -50.08 -37.2 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 C-N-CA 120.349 -0.54 . . . . 0.0 110.661 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.531 HD11 ' HA ' ' A' ' 37' ' ' ASN . 12.6 mt -55.65 -48.13 75.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.479 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.01 -50.17 69.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.107 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.4 -34.6 77.07 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.726 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.552 ' HA ' ' O ' ' A' ' 46' ' ' LYS . 21.1 mt -59.23 -23.5 62.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.421 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.02 -17.8 28.6 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.826 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.5 t -128.52 3.08 5.59 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.552 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.2 OUTLIER -167.44 161.25 13.87 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.909 0.385 . . . . 0.0 111.216 179.895 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 90.4 m -138.96 111.74 8.06 Favored Pre-proline 0 N--CA 1.45 -0.457 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.201 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.477 ' HG2' HD21 ' A' ' 76' ' ' LEU . 43.3 Cg_endo -71.38 158.68 53.66 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.084 1.856 . . . . 0.0 111.276 179.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.441 ' O ' ' HG2' ' A' ' 77' ' ' PRO . 1.7 m-20 -74.24 -24.15 59.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.466 -179.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.52 HG13 ' HA ' ' A' ' 6' ' ' VAL . 7.6 p -145.98 166.47 8.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.582 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.538 ' HA ' ' O ' ' A' ' 7' ' ' TRP . 10.0 tp -152.96 137.36 16.68 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.985 0.422 . . . . 0.0 111.43 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.489 ' HG ' ' HB ' ' A' ' 79' ' ' ILE . 1.1 tt -121.9 119.21 30.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.713 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.411 ' HB2' ' CD1' ' A' ' 80' ' ' ILE . 0.6 OUTLIER -115.08 138.21 51.13 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.905 0.383 . . . . 0.0 111.408 -179.723 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.461 ' O ' ' CG2' ' A' ' 55' ' ' ILE . 2.9 p30 -82.27 -4.04 56.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 0.0 112.058 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.898 HG13 ' HA3' ' A' ' 62' ' ' GLY . 7.1 tt 50.47 169.4 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-O 120.953 0.406 . . . . 0.0 111.923 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.457 ' H ' ' HA3' ' A' ' 62' ' ' GLY . 8.2 ttt85 67.43 77.93 0.25 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.901 0.382 . . . . 0.0 110.696 -179.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.562 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . 7.5 tpt -163.14 -61.24 0.01 OUTLIER Pre-proline 0 CA--C 1.537 0.479 0 CA-C-N 116.081 -0.509 . . . . 0.0 112.063 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.72 ' HG3' ' HG ' ' A' ' 65' ' ' LEU . 94.3 Cg_endo -71.96 -164.58 0.17 Allowed 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.975 2.45 . . . . 0.0 113.47 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.64 -65.48 3.13 Favored Glycine 0 C--N 1.335 0.525 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.241 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.467 ' O ' ' N ' ' A' ' 62' ' ' GLY . 5.2 ttt -70.19 60.42 0.19 Allowed 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.082 0.468 . . . . 0.0 110.013 179.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 58.3 -81.79 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.558 -0.747 . . . . 0.0 109.812 -179.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.898 ' HA3' HG13 ' A' ' 55' ' ' ILE . . . -145.38 -28.96 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.593 179.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.53 ' HG ' ' HH ' ' A' ' 101' ' ' TYR . 4.0 mp -59.75 -18.85 46.27 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.497 ' HB1' ' HB2' ' A' ' 58' ' ' PRO . . . -55.63 -37.1 67.75 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 178.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.72 ' HG ' ' HG3' ' A' ' 58' ' ' PRO . 32.4 mt -60.76 -49.14 78.69 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.522 HD12 HD12 ' A' ' 80' ' ' ILE . 9.4 mp -51.1 -51.47 53.06 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.98 179.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.544 ' HA ' ' CE ' ' A' ' 70' ' ' LYS . 6.4 mtpm? -44.63 -49.43 10.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.851 179.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.479 ' HB3' HD13 ' A' ' 40' ' ' LEU . 60.8 mm-40 -68.22 -26.51 65.75 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.375 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.616 ' CG2' ' HD2' ' A' ' 73' ' ' HIS . 63.3 mt -63.89 -54.18 34.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.012 0.434 . . . . 0.0 111.119 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.785 ' HA ' ' CD2' ' A' ' 73' ' ' HIS . 0.0 OUTLIER -62.43 -28.35 69.74 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.16 -178.94 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -64.82 -22.48 67.0 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.179 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.72 -11.68 9.36 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.005 0.742 . . . . 0.0 113.005 -179.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.785 ' CD2' ' HA ' ' A' ' 70' ' ' LYS . 1.6 p80 -109.55 160.61 27.19 Favored Pre-proline 0 N--CA 1.465 0.321 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -179.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.455 ' O ' ' HG2' ' A' ' 75' ' ' MET . 60.6 Cg_endo -87.71 -59.45 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.976 2.451 . . . . 0.0 111.42 178.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.552 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 5.8 mmt -151.24 51.33 0.84 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.9 178.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.542 ' CD1' HD22 ' A' ' 43' ' ' LEU . 0.4 OUTLIER -76.66 123.25 87.58 Favored Pre-proline 0 N--CA 1.456 -0.135 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -179.147 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.441 ' HG2' ' O ' ' A' ' 49' ' ' ASP . 20.2 Cg_exo -64.72 138.07 56.88 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.189 1.926 . . . . 0.0 111.729 178.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.538 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 3.0 t -126.13 119.69 54.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.482 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.489 ' HB ' ' HG ' ' A' ' 52' ' ' LEU . 1.5 mp -109.83 110.22 31.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.863 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.729 HG23 ' HB ' ' A' ' 55' ' ' ILE . 37.0 mm -100.53 148.49 6.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.296 -178.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.544 ' N ' HG21 ' A' ' 80' ' ' ILE . 13.0 ptm -81.98 -35.32 29.07 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.61 -179.11 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.413 ' N ' ' HG3' ' A' ' 81' ' ' MET . 8.2 m -146.59 151.84 37.96 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.626 0.251 . . . . 0.0 111.138 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.409 ' O ' ' C ' ' A' ' 84' ' ' HIS . . . -117.03 10.24 13.9 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 111.803 0.297 . . . . 0.0 111.803 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.466 ' HE1' HD11 ' A' ' 63' ' ' LEU . 0.1 OUTLIER 25.84 -92.38 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -179.385 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 55.3 m -149.64 39.62 0.8 Allowed 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.527 ' HB3' ' CD1' ' A' ' 63' ' ' LEU . 0.4 OUTLIER -137.72 36.68 2.42 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.125 0.488 . . . . 0.0 110.349 179.236 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 7.9 mt -50.33 -20.86 1.19 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.993 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -47.69 -58.76 3.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.624 0.25 . . . . 0.0 111.434 -179.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.481 ' HB2' HD21 ' A' ' 63' ' ' LEU . . . -69.74 -19.64 63.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.892 0.377 . . . . 0.0 110.651 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.521 ' HB2' ' CE1' ' A' ' 101' ' ' TYR . . . -69.25 -46.42 67.35 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.878 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.64 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 3.5 t -67.0 -52.92 38.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 C-N-CA 120.474 -0.491 . . . . 0.0 111.297 -179.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.584 ' O ' ' HB3' ' A' ' 95' ' ' GLN . 24.4 m -60.21 -27.08 66.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.137 0.494 . . . . 0.0 109.786 178.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.577 ' HA ' ' OE1' ' A' ' 96' ' ' GLN . . . -60.72 -41.81 96.01 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.056 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.64 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 3.9 m-85 -67.73 -27.33 66.7 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.967 179.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.584 ' HB3' ' O ' ' A' ' 92' ' ' SER . 0.2 OUTLIER -60.92 -40.89 94.88 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.807 -179.192 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.577 ' OE1' ' HA ' ' A' ' 93' ' ' ALA . 0.0 OUTLIER -100.37 -19.3 16.35 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -179.565 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.441 ' O ' ' C ' ' A' ' 98' ' ' ALA . . . -176.01 -57.67 0.06 OUTLIER Glycine 0 C--N 1.335 0.474 0 C-N-CA 119.22 -1.467 . . . . 0.0 114.824 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.561 ' O ' ' HA ' ' A' ' 94' ' ' TYR . . . -29.1 139.37 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 117.32 0.56 . . . . 0.0 112.36 -178.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -84.78 -53.38 5.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.45 -179.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.44 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 7.9 p-10 -177.8 -164.65 0.09 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.747 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.692 ' CE2' HG22 ' A' ' 80' ' ' ILE . 4.1 m-85 -138.3 153.02 49.03 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.081 0.467 . . . . 0.0 111.004 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.74 HD21 ' HA ' ' A' ' 106' ' ' PHE . 3.2 mp -102.98 119.08 56.54 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.714 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -64.69 -66.84 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.537 2.158 . . . . 0.0 112.272 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.628 ' H ' ' HD2' ' A' ' 105' ' ' PRO . 5.6 mttp -119.81 -58.85 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.135 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.628 ' HD2' ' H ' ' A' ' 104' ' ' LYS . 11.9 Cg_endo -55.02 163.5 4.22 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.127 1.885 . . . . 0.0 112.347 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.74 ' HA ' HD21 ' A' ' 102' ' ' LEU . 39.9 t80 -172.08 -106.34 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.659 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.551 ' O ' ' O ' ' A' ' 106' ' ' PHE . 4.7 p-10 43.09 -179.94 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.744 0.307 . . . . 0.0 111.089 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.438 HG12 ' CG1' ' A' ' 18' ' ' VAL . 0.9 OUTLIER -67.87 -43.44 85.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -179.355 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.5 ' HB2' ' OD2' ' A' ' 107' ' ' ASP . 7.0 m-20 -49.82 -58.68 4.88 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.45 -179.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.604 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 6.1 mm-40 -74.46 -31.79 62.36 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.759 0.314 . . . . 0.0 111.318 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.419 ' CB ' ' O ' ' A' ' 107' ' ' ASP . . . -66.48 -61.18 2.13 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.336 179.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.654 ' O ' HG11 ' A' ' 115' ' ' VAL . 50.2 t -59.07 -31.51 45.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.5 0.667 . . . . 0.0 110.332 179.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.415 ' HB1' ' O ' ' A' ' 109' ' ' ASP . . . -64.24 -45.27 88.88 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.722 179.088 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.561 HD13 ' HD3' ' A' ' 117' ' ' ARG . 23.5 tp -74.89 -24.14 58.49 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.835 -1.075 . . . . 0.0 111.901 -179.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.654 HG11 ' O ' ' A' ' 112' ' ' VAL . 4.0 p -79.29 -43.83 23.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.668 -179.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -65.65 -43.76 88.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.114 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.561 ' HD3' HD13 ' A' ' 114' ' ' LEU . 7.8 ptm180 -63.27 -23.72 67.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.787 0.327 . . . . 0.0 110.844 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.38 -46.64 59.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.693 179.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.458 HD11 HG11 ' A' ' 50' ' ' VAL . 4.5 mt -68.62 -32.09 53.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.878 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 36.8 t -65.44 -41.89 93.0 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.492 -0.777 . . . . 0.0 110.819 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 2.4 m80 -62.38 -29.61 70.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.785 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.462 ' OH ' ' HB3' ' A' ' 75' ' ' MET . 0.1 OUTLIER -81.55 -50.86 8.87 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.663 179.605 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.59 170.86 15.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.709 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.873 179.986 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 mtt . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.842 0.353 . . . . 0.0 111.084 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -100.02 147.76 25.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.822 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.25 -13.75 20.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.222 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 89.3 94.39 1.11 Allowed Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.576 -0.821 . . . . 0.0 111.728 -179.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.8 mp -105.71 116.27 49.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.018 0.437 . . . . 0.0 111.451 -179.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.567 HG13 ' HG ' ' A' ' 23' ' ' LEU . 7.6 p -107.19 131.32 57.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.77 179.16 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.532 ' CD1' ' CG2' ' A' ' 31' ' ' THR . 39.5 m0 -117.44 142.2 47.43 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.132 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.72 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -134.18 145.37 33.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.011 0.434 . . . . 0.0 111.558 -178.421 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.977 HG13 ' HB2' ' A' ' 33' ' ' PHE . 3.1 m -131.39 105.93 11.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.262 178.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.414 ' O ' ' CG1' ' A' ' 15' ' ' ILE . 53.7 t0 -166.46 66.98 0.1 Allowed 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 121.148 0.499 . . . . 0.0 111.845 -179.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.2 t70 74.85 -9.11 1.41 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 178.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.7 t70 59.45 -154.36 0.37 Allowed 'General case' 0 CA--C 1.534 0.357 0 O-C-N 122.275 -0.266 . . . . 0.0 110.955 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 t 34.83 -91.01 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.483 ' O ' HG21 ' A' ' 18' ' ' VAL . 1.5 m -54.57 -65.98 0.48 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.513 0.197 . . . . 0.0 111.234 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.414 ' CG1' ' O ' ' A' ' 10' ' ' ASP . 40.2 mm -60.44 -20.58 21.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.771 0.319 . . . . 0.0 111.089 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.493 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 27.1 ttt180 -70.32 -57.81 4.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.238 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.462 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 50.1 t90 -53.9 -39.68 66.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.69 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.498 HG12 HG12 ' A' ' 108' ' ' ILE . 14.5 t -62.28 -54.82 29.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 113.018 0.748 . . . . 0.0 113.018 -178.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.441 ' CD1' HG22 ' A' ' 112' ' ' VAL . 7.8 tp -82.84 -22.4 34.1 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -177.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.579 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 22.8 pt-20 -67.75 -57.69 5.9 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.499 -178.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.514 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 0.1 OUTLIER -63.34 -49.83 72.37 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.93 -179.48 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.15 -47.5 83.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.84 0.353 . . . . 0.0 111.675 -179.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.733 HD13 ' CD1' ' A' ' 28' ' ' LEU . 2.4 tp -71.04 -25.28 62.59 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.259 179.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.08 -33.71 75.04 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.34 -25.04 71.06 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.475 -0.869 . . . . 0.0 111.028 178.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.423 ' CB ' HD12 ' A' ' 28' ' ' LEU . . . -76.68 -15.66 59.74 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 120.585 0.231 . . . . 0.0 110.78 179.197 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.14 26.41 9.55 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.68 -0.771 . . . . 0.0 113.825 179.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.733 ' CD1' HD13 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -123.94 168.12 13.22 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 117.848 0.824 . . . . 0.0 111.689 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.406 ' O ' HG12 ' A' ' 6' ' ' VAL . 73.5 m -94.75 105.66 17.61 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.627 179.085 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.579 ' HB3' ' HA ' ' A' ' 20' ' ' GLU . 10.8 t -100.77 112.44 24.85 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -178.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.54 HG22 ' CE1' ' A' ' 33' ' ' PHE . 2.5 t -120.21 144.75 47.56 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.335 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.72 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 43.6 p -121.53 157.96 29.54 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -178.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.977 ' HB2' HG13 ' A' ' 9' ' ' VAL . 0.4 OUTLIER -136.16 174.24 10.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.893 -1.049 . . . . 0.0 111.304 -179.882 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.571 ' HG2' ' N ' ' A' ' 35' ' ' ASN . 0.0 OUTLIER -63.19 -32.97 74.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.658 -179.294 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.571 ' N ' ' HG2' ' A' ' 34' ' ' GLU . 1.7 t-20 -178.61 179.0 0.77 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.356 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.485 ' O ' ' HG ' ' A' ' 40' ' ' LEU . . . -52.03 -19.93 5.94 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.646 -0.788 . . . . 0.0 113.058 -179.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -69.12 -50.9 43.85 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -179.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.631 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 3.9 tt0 -51.98 -51.7 55.5 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.055 -179.329 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.488 HG12 ' CD1' ' A' ' 43' ' ' LEU . 82.8 t -51.42 -32.7 13.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.133 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 36' ' ' GLY . 18.9 mt -58.3 -47.26 84.24 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.121 0.486 . . . . 0.0 110.065 179.167 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.47 -49.47 48.21 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.938 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.89 -32.08 71.55 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.206 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.583 ' HA ' ' O ' ' A' ' 46' ' ' LYS . 18.7 mt -68.78 -25.12 64.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.989 -179.294 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.31 -20.45 7.19 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.905 -179.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 28.6 t -124.8 4.92 8.1 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.583 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -167.69 155.73 9.02 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.972 0.415 . . . . 0.0 111.173 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.435 ' HA ' ' CD2' ' A' ' 43' ' ' LEU . 93.9 m -138.95 116.58 8.91 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.902 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.543 ' HD2' HD22 ' A' ' 43' ' ' LEU . 73.2 Cg_endo -77.92 163.0 28.95 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 121.988 1.792 . . . . 0.0 111.313 179.221 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -73.79 -21.0 60.31 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.818 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.524 HG11 ' CG2' ' A' ' 6' ' ' VAL . 5.5 p -147.63 161.42 7.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.715 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.75 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 26.8 tp -152.93 131.15 11.98 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 121.196 0.522 . . . . 0.0 111.947 -179.286 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.638 ' HG ' ' HB ' ' A' ' 79' ' ' ILE . 1.0 OUTLIER -114.45 118.18 33.07 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.447 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.784 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 3.8 m -117.26 144.37 44.91 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -178.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -82.98 179.15 7.85 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.559 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.713 HG13 ' HA3' ' A' ' 62' ' ' GLY . 9.0 tt -154.61 67.47 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.398 179.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.74 38.51 2.24 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.729 -179.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.534 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER 65.35 47.14 0.56 Allowed Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 178.947 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 62' ' ' GLY . 40.9 Cg_endo -68.18 -78.16 0.01 OUTLIER 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 122.387 2.058 . . . . 0.0 111.967 178.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -106.45 -27.71 5.43 Favored Glycine 0 C--N 1.335 0.496 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.126 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.618 ' HB3' ' CB ' ' A' ' 64' ' ' ALA . 2.2 tpt -159.51 67.97 0.41 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.885 0.374 . . . . 0.0 109.997 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.534 ' HA ' ' HA ' ' A' ' 57' ' ' MET . 0.2 OUTLIER 71.42 -29.12 0.19 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.338 -179.561 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.713 ' HA3' HG13 ' A' ' 55' ' ' ILE . . . 140.07 -28.45 2.49 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 -179.376 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.475 ' HA ' ' CD2' ' A' ' 66' ' ' LEU . 0.9 OUTLIER -72.74 -14.01 61.46 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 115.425 -0.387 . . . . 0.0 109.991 178.452 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.618 ' CB ' ' HB3' ' A' ' 60' ' ' MET . . . -53.38 -52.45 59.26 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-O 121.118 0.485 . . . . 0.0 110.428 178.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.611 HD11 HD23 ' A' ' 66' ' ' LEU . 3.5 pp -57.36 -33.23 67.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.121 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.611 HD23 HD11 ' A' ' 65' ' ' LEU . 3.9 mm? -59.36 -50.43 74.0 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.925 0.393 . . . . 0.0 110.766 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.518 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 6.9 mttt -54.54 -40.87 69.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.985 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.419 ' HB3' HD12 ' A' ' 40' ' ' LEU . 11.0 mm100 -65.84 -27.96 68.63 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.066 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.521 HG13 ' O ' ' A' ' 65' ' ' LEU . 87.9 mt -64.76 -53.94 36.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.8 -179.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.518 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.5 OUTLIER -64.7 -24.93 67.73 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.847 -179.099 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.86 -51.7 63.42 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -178.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.94 -26.4 15.59 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.201 -0.454 . . . . 0.0 112.176 -178.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.504 ' CE1' ' HB3' ' A' ' 43' ' ' LEU . 3.6 m-70 -110.3 139.34 21.37 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-O 120.706 0.289 . . . . 0.0 111.039 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.447 ' C ' ' HG3' ' A' ' 75' ' ' MET . 48.6 Cg_exo -54.24 -76.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.639 2.226 . . . . 0.0 112.937 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.538 ' HB3' ' HA2' ' A' ' 97' ' ' GLY . 2.8 mtm -144.14 54.34 1.29 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.845 0.355 . . . . 0.0 110.743 -179.407 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.411 ' CD1' HD11 ' A' ' 43' ' ' LEU . 1.9 tt -63.83 115.68 20.78 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.725 -179.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -56.72 118.04 4.81 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.497 2.131 . . . . 0.0 112.546 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.868 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 2.8 t -124.99 146.58 30.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.126 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.638 ' HB ' ' HG ' ' A' ' 52' ' ' LEU . 2.3 mp -128.07 116.23 41.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 179.271 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.784 ' HA ' ' O ' ' A' ' 53' ' ' SER . 18.0 mm -95.34 142.59 13.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.979 0.419 . . . . 0.0 112.086 -178.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.525 ' CB ' ' CE1' ' A' ' 106' ' ' PHE . 1.7 ptt? -66.46 -32.38 73.71 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.609 -178.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.549 ' HA ' ' O ' ' A' ' 102' ' ' LEU . 4.3 m -148.1 169.99 18.78 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.581 0.229 . . . . 0.0 111.362 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.512 ' HB3' HD23 ' A' ' 87' ' ' LEU . . . -144.69 56.06 1.27 Allowed 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 14.8 p80 -99.17 176.36 5.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.092 0.472 . . . . 0.0 111.897 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.4 t 67.44 -78.68 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.972 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.427 ' O ' HD21 ' A' ' 63' ' ' LEU . 0.8 OUTLIER -120.4 70.18 0.88 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.894 0.378 . . . . 0.0 111.277 -179.358 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.611 ' O ' ' HB2' ' A' ' 90' ' ' ALA . 3.0 tm? -54.93 -22.37 14.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.985 179.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -51.46 -56.26 14.28 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.756 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.423 ' HB2' HD21 ' A' ' 63' ' ' LEU . . . -59.47 -20.51 55.8 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.715 0.293 . . . . 0.0 111.147 -179.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.611 ' HB2' ' O ' ' A' ' 87' ' ' LEU . . . -69.13 -62.17 1.49 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.973 0.416 . . . . 0.0 110.776 179.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.598 HG22 HD13 ' A' ' 87' ' ' LEU . 8.4 t -53.62 -44.48 57.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.831 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.59 ' HA ' ' CG ' ' A' ' 95' ' ' GLN . 1.7 m -60.25 -25.24 65.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.17 0.51 . . . . 0.0 109.686 178.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.542 ' C ' ' HB1' ' A' ' 98' ' ' ALA . . . -75.88 -49.5 17.74 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.573 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.525 ' HA ' ' HB1' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -73.31 -29.25 62.57 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.038 -179.139 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.59 ' CG ' ' HA ' ' A' ' 92' ' ' SER . 2.1 pp0? -77.27 -37.61 52.58 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.547 178.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.542 ' HG2' ' O ' ' A' ' 93' ' ' ALA . 10.3 pt20 -73.47 -17.23 61.26 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.053 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.538 ' HA2' ' HB3' ' A' ' 75' ' ' MET . . . 165.16 -33.08 0.25 Allowed Glycine 0 C--N 1.335 0.473 0 C-N-CA 120.047 -1.073 . . . . 0.0 113.762 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.868 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -58.4 155.64 11.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 117.549 0.674 . . . . 0.0 111.218 -179.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.502 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 23.8 t80 -69.2 -53.88 17.7 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.735 -178.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.44 ' HB3' ' O ' ' A' ' 99' ' ' PHE . 17.1 p-10 178.99 -160.25 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 120.922 0.391 . . . . 0.0 111.084 -179.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.592 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 3.5 m-85 -135.98 153.36 51.42 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.986 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.699 HD23 ' HA ' ' A' ' 106' ' ' PHE . 1.4 tp -103.74 118.98 56.06 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.826 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -71.68 -75.38 0.01 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.034 1.823 . . . . 0.0 112.278 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.427 ' CB ' ' HD3' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -108.94 -57.03 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.503 -179.962 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.469 ' HB3' ' HG3' ' A' ' 110' ' ' GLU . 56.0 Cg_exo -52.31 154.15 11.8 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.295 1.996 . . . . 0.0 112.61 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.699 ' HA ' HD23 ' A' ' 102' ' ' LEU . 31.2 t80 -164.44 -116.52 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.197 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.55 ' O ' ' O ' ' A' ' 106' ' ' PHE . 2.9 p30 43.22 179.48 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.967 0.413 . . . . 0.0 111.449 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.498 HG12 HG12 ' A' ' 18' ' ' VAL . 0.8 OUTLIER -67.99 -43.75 85.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.892 0.377 . . . . 0.0 111.803 -179.617 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.473 ' HB2' ' OD1' ' A' ' 107' ' ' ASP . 4.2 m-20 -49.23 -58.28 5.31 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.567 -179.091 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.583 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 6.7 mm-40 -76.01 -32.02 59.2 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.591 0.234 . . . . 0.0 111.231 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.433 ' CB ' ' O ' ' A' ' 107' ' ' ASP . . . -66.21 -57.46 7.53 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.336 179.295 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.693 ' HA ' HG11 ' A' ' 115' ' ' VAL . 47.8 t -62.01 -33.52 58.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.362 0.601 . . . . 0.0 110.653 179.129 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.24 -46.26 89.63 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.551 179.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.509 HD21 ' CD1' ' A' ' 102' ' ' LEU . 37.9 tp -75.83 -21.98 56.75 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.96 -1.018 . . . . 0.0 112.205 -179.107 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.693 HG11 ' HA ' ' A' ' 112' ' ' VAL . 7.2 p -79.18 -41.44 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 C-N-CA 120.447 -0.501 . . . . 0.0 111.994 -179.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.468 ' N ' HG13 ' A' ' 115' ' ' VAL . 46.5 mt-10 -66.35 -42.95 87.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.825 0.345 . . . . 0.0 110.736 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.9 mtt180 -61.0 -23.86 65.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.385 179.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.502 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -72.17 -48.45 43.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.079 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.506 HD11 HG13 ' A' ' 50' ' ' VAL . 4.5 mt -69.63 -31.31 48.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.076 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 36.3 t -71.96 -50.84 25.52 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.165 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -60.27 -23.57 64.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.134 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -66.94 -44.84 79.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.08 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.17 170.38 16.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.152 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.892 -179.941 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.421 ' O ' ' HB3' ' A' ' 2' ' ' GLN . 13.7 mtm . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 120.619 0.247 . . . . 0.0 110.908 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.421 ' HB3' ' O ' ' A' ' 1' ' ' MET . 1.9 tp60 78.72 -20.69 0.37 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.436 -179.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.536 ' O ' ' HG3' ' A' ' 3' ' ' ARG . 10.2 tpt85 -63.94 -10.01 18.78 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.776 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.515 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . 68.16 63.06 3.8 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.773 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.473 ' CD1' ' HB3' ' A' ' 3' ' ' ARG . 3.8 mp -101.73 115.02 42.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.767 0.318 . . . . 0.0 110.839 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.513 HG11 ' CD2' ' A' ' 23' ' ' LEU . 7.3 p -105.66 126.41 60.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.327 179.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.593 ' CD1' HG21 ' A' ' 31' ' ' THR . 21.6 m0 -116.63 126.31 53.05 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.669 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.547 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -112.02 148.26 15.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.236 -179.056 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.773 HG11 ' C ' ' A' ' 35' ' ' ASN . 0.2 OUTLIER -130.79 113.36 24.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 120.885 0.374 . . . . 0.0 110.379 178.736 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -161.4 -156.63 0.45 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.798 -179.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -67.24 0.78 2.52 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.411 ' O ' ' N ' ' A' ' 14' ' ' SER . 0.1 OUTLIER 65.38 -158.68 0.28 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.509 0.195 . . . . 0.0 110.783 179.717 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.42 ' HB3' ' H ' ' A' ' 14' ' ' SER . 1.3 t 34.62 -90.51 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 179.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.42 ' H ' ' HB3' ' A' ' 13' ' ' SER . 0.4 OUTLIER -53.87 -57.56 10.5 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.824 0.345 . . . . 0.0 111.114 -179.702 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 22.4 mm -65.2 -24.5 35.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.89 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.6 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 14.7 ttm-85 -71.1 -58.18 3.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.165 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.446 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 57.9 t90 -54.43 -37.3 64.96 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -179.141 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.539 HG11 HG12 ' A' ' 108' ' ' ILE . 8.2 t -67.84 -47.08 80.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -178.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.548 HD22 ' CD1' ' A' ' 108' ' ' ILE . 0.2 OUTLIER -84.25 -27.63 27.78 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -178.636 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.483 ' HG3' ' N ' ' A' ' 21' ' ' ARG . 12.1 pt-20 -66.75 -59.77 3.27 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.846 -179.138 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.483 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 4.0 mmm180 -67.0 -47.7 70.68 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.846 -179.156 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.67 -54.53 45.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.917 0.389 . . . . 0.0 111.456 -179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.762 HD13 ' CD1' ' A' ' 28' ' ' LEU . 2.2 tp -67.68 -23.49 65.31 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.065 179.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.22 -36.31 77.1 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.89 -25.73 68.1 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.427 -0.892 . . . . 0.0 110.982 178.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.404 ' HB2' HD12 ' A' ' 28' ' ' LEU . . . -76.81 -16.11 59.54 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 120.665 0.269 . . . . 0.0 111.067 179.491 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.71 26.59 8.46 Favored Glycine 0 CA--C 1.522 0.514 0 C-N-CA 120.289 -0.958 . . . . 0.0 114.158 178.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.762 ' CD1' HD13 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -127.21 170.38 12.49 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 117.994 0.897 . . . . 0.0 111.805 179.942 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.478 ' O ' HG13 ' A' ' 6' ' ' VAL . 52.9 m -95.46 105.51 17.48 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.432 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.509 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 40.7 t -106.34 113.36 26.83 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.221 0.534 . . . . 0.0 111.948 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.636 HG23 ' CE1' ' A' ' 33' ' ' PHE . 2.8 t -116.85 156.43 27.31 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.6 ' CG2' ' HA ' ' A' ' 16' ' ' ARG . 28.9 p -127.04 158.44 36.95 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.358 0.599 . . . . 0.0 111.684 -179.347 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.806 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 17.0 m-85 -128.44 174.24 9.51 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.735 -178.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.469 ' HG3' ' ND2' ' A' ' 35' ' ' ASN . 1.6 pt-20 -63.3 -37.6 87.87 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.577 0.955 . . . . 0.0 113.577 -177.103 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.773 ' C ' HG11 ' A' ' 9' ' ' VAL . 18.0 p30 -174.92 -41.02 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 118.766 0.712 . . . . 0.0 112.696 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.723 ' N ' HG11 ' A' ' 9' ' ' VAL . . . -178.57 -47.07 0.07 OUTLIER Glycine 0 C--N 1.321 -0.271 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.738 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.517 ' HA ' HD13 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -61.25 -29.94 70.15 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.616 0.246 . . . . 0.0 111.353 -179.525 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.806 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 3.1 tt0 -59.98 -51.34 70.07 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 121.089 -0.245 . . . . 0.0 111.597 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.583 HG12 ' HG ' ' A' ' 43' ' ' LEU . 19.5 t -52.37 -41.13 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 C-N-CA 120.584 -0.446 . . . . 0.0 111.461 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.602 HD11 HE21 ' A' ' 68' ' ' GLN . 7.1 mt -54.7 -46.74 74.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.97 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.91 -49.17 71.48 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.425 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.431 ' HB1' ' HE2' ' A' ' 33' ' ' PHE . . . -66.31 -32.7 74.26 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.881 179.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.671 ' HB3' ' HE2' ' A' ' 73' ' ' HIS . 8.3 mt -60.7 -25.02 66.11 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.086 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.4 -16.84 50.57 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.779 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.3 m -125.72 -0.97 7.37 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.46 ' HD2' ' CZ2' ' A' ' 7' ' ' TRP . 0.0 OUTLIER -160.95 162.07 31.83 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.905 0.383 . . . . 0.0 111.024 179.834 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.457 HG21 HD22 ' A' ' 76' ' ' LEU . 57.8 m -138.42 116.0 9.21 Favored Pre-proline 0 N--CA 1.451 -0.414 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.134 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.487 ' HB3' ' CG ' ' A' ' 7' ' ' TRP . 70.9 Cg_endo -74.76 149.24 37.59 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 121.97 1.78 . . . . 0.0 111.881 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -73.73 -24.89 59.96 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.706 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.518 HG22 ' CG2' ' A' ' 115' ' ' VAL . 7.6 p -147.53 101.83 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.983 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.52 HD13 ' CG1' ' A' ' 39' ' ' VAL . 18.0 tp -87.13 134.48 33.51 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.116 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.548 ' O ' HG21 ' A' ' 9' ' ' VAL . 1.3 tt -121.73 122.54 39.77 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.333 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.562 ' HB3' HD23 ' A' ' 65' ' ' LEU . 2.2 m -123.67 125.51 44.92 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.416 0.627 . . . . 0.0 112.473 -178.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.619 ' HA ' ' HG2' ' A' ' 81' ' ' MET . 1.2 m-20 -83.18 107.14 15.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.78 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.958 HG23 ' HG3' ' A' ' 81' ' ' MET . 4.9 tt -69.99 116.41 11.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.955 179.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.22 58.13 0.46 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.036 0.446 . . . . 0.0 111.883 -179.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.456 ' N ' ' CD ' ' A' ' 58' ' ' PRO . 9.6 ptp 47.07 46.17 3.27 Favored Pre-proline 0 CA--C 1.537 0.473 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 178.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.596 ' CG ' ' HA2' ' A' ' 62' ' ' GLY . 50.3 Cg_endo -69.81 -81.94 0.01 OUTLIER 'Trans proline' 0 CA--C 1.533 0.475 0 C-N-CA 122.89 2.393 . . . . 0.0 111.885 178.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.403 ' H ' ' HG2' ' A' ' 58' ' ' PRO . . . -105.85 -25.68 6.41 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.088 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.554 ' N ' ' HB3' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -161.57 71.75 0.38 Allowed 'General case' 0 C--O 1.235 0.321 0 CA-C-O 120.985 0.421 . . . . 0.0 110.126 179.498 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.532 ' O ' HG13 ' A' ' 55' ' ' ILE . 0.2 OUTLIER 69.49 -25.77 0.15 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.886 -179.805 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.958 ' HA3' HG13 ' A' ' 55' ' ' ILE . . . 136.68 -26.34 3.04 Favored Glycine 0 CA--C 1.502 -0.737 0 N-CA-C 111.639 -0.584 . . . . 0.0 111.639 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.554 ' CB ' ' HB3' ' A' ' 89' ' ' ALA . 4.0 mp -78.26 -14.0 59.62 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-O 121.051 0.453 . . . . 0.0 109.977 178.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.554 ' HB3' ' N ' ' A' ' 60' ' ' MET . . . -53.83 -44.51 70.31 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.031 179.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.562 HD23 ' HB3' ' A' ' 53' ' ' SER . 3.1 pp -57.98 -32.35 67.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.041 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.523 HD22 HD13 ' A' ' 80' ' ' ILE . 7.1 mp -62.93 -44.99 94.58 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.365 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.516 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 30.2 tttt -56.16 -44.62 79.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.756 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.602 HE21 HD11 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -66.26 -39.96 89.83 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.662 -179.869 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.549 HG23 ' HB3' ' A' ' 76' ' ' LEU . 10.4 mt -65.03 -32.65 59.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.816 -179.564 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.516 ' HG2' ' O ' ' A' ' 67' ' ' LYS . 16.0 pttt -76.16 -29.04 57.57 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.966 0.413 . . . . 0.0 111.108 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.18 -44.01 89.82 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.382 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 79.3 mtt-85 -87.57 -23.09 24.43 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.735 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.713 ' CB ' ' HB2' ' A' ' 76' ' ' LEU . 88.7 m-70 -143.28 92.57 6.67 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.972 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.465 ' O ' ' O ' ' A' ' 96' ' ' GLN . 23.0 Cg_exo -64.86 6.11 0.39 Allowed 'Trans proline' 0 CA--C 1.531 0.343 0 C-N-CA 122.657 2.238 . . . . 0.0 113.123 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.584 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -143.35 14.08 1.81 Allowed 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.666 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.713 ' HB2' ' CB ' ' A' ' 73' ' ' HIS . 0.8 OUTLIER -75.53 113.06 22.64 Favored Pre-proline 0 C--N 1.332 -0.188 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -179.512 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.822 ' HB2' ' HD1' ' A' ' 99' ' ' PHE . 37.9 Cg_endo -67.5 116.66 4.35 Favored 'Trans proline' 0 CA--C 1.533 0.458 0 C-N-CA 122.546 2.164 . . . . 0.0 112.423 179.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.424 ' C ' ' HB2' ' A' ' 99' ' ' PHE . 3.6 t -115.05 136.61 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 120.921 0.391 . . . . 0.0 111.719 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.585 HG22 HD22 ' A' ' 114' ' ' LEU . 2.3 mt -110.37 116.54 52.62 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.207 0 CA-C-O 121.143 0.497 . . . . 0.0 110.956 179.04 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.623 HD11 ' O ' ' A' ' 100' ' ' ASP . 1.6 mp -98.77 134.26 38.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.385 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.958 ' HG3' HG23 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -73.61 -24.93 60.1 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -178.089 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.543 ' O ' HG23 ' A' ' 80' ' ' ILE . 3.9 m -147.38 159.21 43.95 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.154 0.502 . . . . 0.0 112.327 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.433 ' CB ' ' CD2' ' A' ' 101' ' ' TYR . . . -138.03 68.58 1.4 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.61 179.115 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -68.2 -141.87 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.067 -179.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.2 p -80.44 79.23 7.07 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-O 120.927 0.394 . . . . 0.0 111.558 -179.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.542 ' O ' HD21 ' A' ' 63' ' ' LEU . 2.1 t70 179.53 29.06 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.926 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.423 ' O ' HG21 ' A' ' 91' ' ' VAL . 0.3 OUTLIER -54.15 -21.41 8.66 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.653 -179.966 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -47.25 -54.45 10.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.741 0.305 . . . . 0.0 111.59 -179.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.554 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -69.6 -22.3 63.51 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.145 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.503 ' HB3' ' CD2' ' A' ' 63' ' ' LEU . . . -75.11 -42.14 57.07 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.792 0.329 . . . . 0.0 110.34 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.681 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 19.5 t -62.56 -52.8 55.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.034 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.3 p -57.39 -33.55 67.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.62 0.724 . . . . 0.0 109.833 179.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.613 ' HA ' ' CD ' ' A' ' 96' ' ' GLN . . . -57.56 -39.95 77.84 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.482 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.681 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 18.8 m-85 -60.67 -21.12 62.49 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.237 179.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.627 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -74.01 -43.83 56.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.312 179.715 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.627 ' N ' ' HG2' ' A' ' 95' ' ' GLN . 3.8 pm0 -80.33 -12.4 59.6 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.48 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.542 ' O ' ' HA ' ' A' ' 77' ' ' PRO . . . 117.17 38.38 0.87 Allowed Glycine 0 C--O 1.228 -0.25 0 C-N-CA 119.972 -1.109 . . . . 0.0 114.045 178.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.549 ' HB2' ' C ' ' A' ' 93' ' ' ALA . . . -63.04 146.36 53.4 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 117.319 0.559 . . . . 0.0 110.772 179.162 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.822 ' HD1' ' HB2' ' A' ' 77' ' ' PRO . 1.3 t80 -71.75 -54.35 10.51 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.167 179.405 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.623 ' O ' HD11 ' A' ' 80' ' ' ILE . 2.9 p30 166.79 -166.87 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.711 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.563 ' CZ ' HG12 ' A' ' 80' ' ' ILE . 4.8 m-85 -143.21 145.95 33.24 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.38 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.522 ' CD2' ' HA ' ' A' ' 106' ' ' PHE . 6.4 mp -102.26 119.76 55.45 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.625 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -58.53 -66.27 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.343 2.029 . . . . 0.0 112.593 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.625 ' H ' ' HD2' ' A' ' 105' ' ' PRO . 8.8 mtpp -124.5 -60.68 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.465 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.625 ' HD2' ' H ' ' A' ' 104' ' ' LYS . 16.7 Cg_endo -57.13 159.24 15.65 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.077 1.851 . . . . 0.0 112.422 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.616 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 29.1 t80 -170.62 -104.34 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.382 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.538 ' O ' ' O ' ' A' ' 106' ' ' PHE . 3.3 p30 42.85 -177.58 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.542 0.211 . . . . 0.0 110.833 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.548 ' CD1' HD22 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -67.93 -42.67 85.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.994 0.426 . . . . 0.0 111.681 -179.716 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.496 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 1.7 m-20 -49.03 -57.46 6.51 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.54 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.616 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 5.5 mm-40 -77.0 -32.28 57.09 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 121.047 -0.261 . . . . 0.0 111.699 -179.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' A' ' 107' ' ' ASP . . . -66.6 -62.59 1.38 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.077 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.784 ' O ' HG13 ' A' ' 115' ' ' VAL . 42.6 t -57.64 -30.37 36.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 121.31 0.576 . . . . 0.0 110.816 178.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.496 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -63.94 -47.04 82.06 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.412 0.625 . . . . 0.0 110.203 179.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.585 HD22 HG22 ' A' ' 79' ' ' ILE . 4.8 tp -72.63 -22.38 60.95 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.487 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.784 HG13 ' O ' ' A' ' 112' ' ' VAL . 9.9 p -79.56 -49.57 19.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 120.437 -0.505 . . . . 0.0 111.843 -179.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.409 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 7.5 mt-10 -65.47 -54.74 24.05 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.766 0.317 . . . . 0.0 111.092 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 27.7 mtp85 -57.21 -26.47 60.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.188 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.529 ' HB2' ' CZ ' ' A' ' 99' ' ' PHE . . . -73.3 -48.99 29.98 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.479 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.2 mt -63.52 -30.88 50.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.218 0.533 . . . . 0.0 110.469 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 46.4 t -73.13 -48.92 31.42 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.099 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 25.4 m80 -71.4 -23.37 61.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.271 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -68.63 -46.82 68.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.813 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 24.7 pt20 -75.62 -174.32 2.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.952 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 60.8 mt-10 . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.929 -179.88 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.9 mtp . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 120.775 0.322 . . . . 0.0 111.236 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 66.46 148.88 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.767 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.473 ' CG ' ' H ' ' A' ' 4' ' ' GLY . 0.0 OUTLIER -63.33 -69.71 0.25 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.285 -179.789 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.574 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . 167.93 89.78 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.701 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.462 HD13 ' HB ' ' A' ' 29' ' ' THR . 23.0 mm -117.74 112.76 40.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.768 0.318 . . . . 0.0 111.496 -179.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.732 HG13 ' HA ' ' A' ' 30' ' ' CYS . 12.2 p -105.26 128.36 59.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.054 178.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.774 ' CD1' HG21 ' A' ' 31' ' ' THR . 24.9 m0 -116.89 129.9 56.36 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.119 0.485 . . . . 0.0 110.009 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.648 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.9 OUTLIER -121.72 149.43 24.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.341 -177.681 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.941 HG11 ' HB2' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -125.31 113.41 35.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.555 178.973 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.444 ' OD2' ' OD2' ' A' ' 54' ' ' ASP . 2.3 t0 -164.78 -159.15 0.44 Allowed 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.14 -179.309 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -67.29 1.1 2.34 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -179.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.406 ' O ' ' N ' ' A' ' 14' ' ' SER . 14.7 t0 65.89 -158.33 0.27 Allowed 'General case' 0 CA--C 1.534 0.33 0 O-C-N 122.233 -0.292 . . . . 0.0 110.995 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.1 t 31.92 -89.84 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 179.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.406 ' N ' ' O ' ' A' ' 12' ' ' ASP . 3.5 t -53.72 -56.14 20.01 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.656 0.265 . . . . 0.0 111.468 -179.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.406 HG21 ' CB ' ' A' ' 10' ' ' ASP . 24.5 mm -66.51 -25.0 34.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.923 0.392 . . . . 0.0 111.048 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.616 ' HA ' HG21 ' A' ' 32' ' ' THR . 3.2 tmm_? -77.99 -44.48 26.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.777 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.43 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 82.3 t90 -64.49 -39.79 94.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.67 -179.128 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.645 HG12 HG12 ' A' ' 108' ' ' ILE . 6.3 t -69.14 -43.12 81.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 112.748 0.648 . . . . 0.0 112.748 -179.024 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.454 ' CD2' HG11 ' A' ' 8' ' ' VAL . 1.5 tp -84.53 -22.62 30.09 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -178.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.618 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 17.6 pt-20 -67.71 -57.11 6.93 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.099 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.474 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 5.8 mmt180 -63.22 -49.91 72.32 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.597 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.41 -56.3 20.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.154 0.502 . . . . 0.0 111.147 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.67 ' HG ' HG12 ' A' ' 6' ' ' VAL . 2.0 tm? -66.01 -28.21 68.7 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.537 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.26 -34.23 76.98 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.24 -26.73 66.43 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.379 -0.915 . . . . 0.0 111.366 178.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.442 ' HB1' HD12 ' A' ' 28' ' ' LEU . . . -76.84 -15.76 59.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.822 0.344 . . . . 0.0 110.919 179.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.25 25.5 10.21 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.797 -0.716 . . . . 0.0 113.596 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.574 ' HB3' ' O ' ' A' ' 4' ' ' GLY . 0.0 OUTLIER -130.74 171.67 12.84 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 117.762 0.781 . . . . 0.0 111.648 179.689 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.477 ' O ' HG11 ' A' ' 6' ' ' VAL . 32.1 m -94.35 130.71 40.55 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.175 -179.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.732 ' HA ' HG13 ' A' ' 6' ' ' VAL . 48.9 t -123.69 115.65 21.78 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 121.272 0.558 . . . . 0.0 111.83 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.774 HG21 ' CD1' ' A' ' 7' ' ' TRP . 2.9 t -117.44 156.5 27.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.597 178.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.648 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 55.5 p -132.53 151.41 51.93 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.142 0.496 . . . . 0.0 112.054 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.941 ' HB2' HG11 ' A' ' 9' ' ' VAL . 2.0 m-85 -125.46 174.42 8.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.228 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.615 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -61.66 -107.63 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.652 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.447 ' H ' ' CG ' ' A' ' 34' ' ' GLU . 0.6 OUTLIER -80.35 -69.84 0.57 Allowed 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.029 0.442 . . . . 0.0 112.038 -178.545 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.683 ' HA2' HG13 ' A' ' 9' ' ' VAL . . . -167.42 -36.56 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.484 -0.865 . . . . 0.0 113.543 -179.155 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.477 ' HA ' HD12 ' A' ' 40' ' ' LEU . 12.4 m120 -61.91 -30.0 70.59 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 116.999 0.399 . . . . 0.0 110.594 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.81 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -53.64 -56.86 13.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.624 179.225 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.584 HG22 HG13 ' A' ' 9' ' ' VAL . 2.9 t -51.75 -46.74 39.51 Favored 'Isoleucine or valine' 0 C--N 1.342 0.254 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.44 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.518 HD13 ' HB2' ' A' ' 68' ' ' GLN . 23.6 mt -55.23 -42.87 73.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.008 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.47 -49.65 72.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.159 0.504 . . . . 0.0 111.231 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.44 -26.4 63.63 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.05 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.707 HD13 ' NE2' ' A' ' 73' ' ' HIS . 6.5 mt -63.99 -21.3 66.43 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.445 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.72 -16.83 29.98 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.111 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.5 m -121.58 1.25 10.04 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -165.9 159.74 16.15 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.888 0.375 . . . . 0.0 111.367 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 90.8 m -138.58 111.84 8.34 Favored Pre-proline 0 N--CA 1.45 -0.441 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.422 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.709 ' HD2' HD11 ' A' ' 76' ' ' LEU . 51.8 Cg_endo -67.94 154.12 73.62 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.688 2.258 . . . . 0.0 111.891 179.041 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -74.66 -26.07 59.62 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.466 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.516 ' CG2' HD13 ' A' ' 79' ' ' ILE . 7.2 p -146.28 101.66 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.229 -178.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.618 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 19.5 tp -86.85 137.11 32.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.985 0.421 . . . . 0.0 111.427 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.564 ' HB3' HG12 ' A' ' 8' ' ' VAL . 1.9 tt -126.85 127.55 45.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.145 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -126.22 129.21 48.51 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.343 0.592 . . . . 0.0 111.474 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.444 ' OD2' ' OD2' ' A' ' 10' ' ' ASP . 0.5 OUTLIER -79.02 -0.24 30.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.324 -179.212 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.695 HG13 ' HA3' ' A' ' 62' ' ' GLY . 11.9 tt 36.82 94.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-O 120.89 0.376 . . . . 0.0 111.579 -179.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.8 mtt180 -118.84 40.51 3.25 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.775 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.581 ' HG2' ' HA ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER 59.59 46.19 1.33 Allowed Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 179.239 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.463 ' CD ' ' N ' ' A' ' 57' ' ' MET . 27.5 Cg_endo -61.9 -79.76 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.162 1.908 . . . . 0.0 111.23 178.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -106.35 -82.68 1.55 Allowed Glycine 0 C--N 1.332 0.343 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 178.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.696 ' H ' ' HB1' ' A' ' 64' ' ' ALA . 17.0 tpp -87.57 59.36 5.42 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 177.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.581 ' HA ' ' HG2' ' A' ' 57' ' ' MET . 0.1 OUTLIER 63.54 -16.05 0.07 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.021 -0.99 . . . . 0.0 111.851 -178.656 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.695 ' HA3' HG13 ' A' ' 55' ' ' ILE . . . 135.98 -30.95 2.69 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 -178.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.57 HD22 ' O ' ' A' ' 86' ' ' ASP . 1.9 tp -56.33 -30.17 62.26 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 178.117 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.696 ' HB1' ' H ' ' A' ' 60' ' ' MET . . . -53.69 -38.32 64.1 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.213 178.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.634 ' O ' HG13 ' A' ' 69' ' ' ILE . 1.7 tp -51.41 -50.04 60.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.368 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.732 HD11 ' OH ' ' A' ' 101' ' ' TYR . 81.3 mt -52.8 -42.87 65.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.141 179.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 31.3 mttm -58.47 -46.88 85.72 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.4 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.518 ' HB2' HD13 ' A' ' 40' ' ' LEU . 16.7 mm100 -65.0 -31.68 73.03 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.778 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.634 HG13 ' O ' ' A' ' 65' ' ' LEU . 88.7 mt -60.06 -45.72 95.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.728 -179.373 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.456 ' HG3' ' N ' ' A' ' 71' ' ' GLN . 0.4 OUTLIER -68.94 -29.5 67.75 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.536 -179.864 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.456 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 7.6 mt-30 -83.98 -33.21 24.63 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.565 -179.251 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.449 ' HB2' ' CD2' ' A' ' 73' ' ' HIS . 3.2 mtp85 -90.5 -65.26 1.03 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.18 -178.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.707 ' NE2' HD13 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -96.31 159.62 31.58 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.394 -178.956 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -96.44 101.2 0.09 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 123.489 2.793 . . . . 0.0 113.619 -179.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 6.8 mtt 57.04 24.2 9.29 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 177.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.709 HD11 ' HD2' ' A' ' 48' ' ' PRO . 2.2 tt -60.22 112.31 5.29 Favored Pre-proline 0 C--N 1.325 -0.487 0 C-N-CA 120.934 -0.307 . . . . 0.0 111.327 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.61 116.0 2.99 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.432 2.088 . . . . 0.0 112.153 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.886 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 19.0 t -115.06 145.14 21.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.985 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.516 HD13 ' CG2' ' A' ' 50' ' ' VAL . 1.8 mp -118.79 110.99 31.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.982 0.42 . . . . 0.0 111.031 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.526 ' HB ' ' CZ ' ' A' ' 101' ' ' TYR . 21.6 mm -103.3 146.72 10.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.578 -179.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.436 ' O ' ' HB2' ' A' ' 102' ' ' LEU . 7.2 ttt -69.06 -78.61 0.07 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.967 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.454 ' O ' HD13 ' A' ' 55' ' ' ILE . 4.0 m -106.62 159.08 16.47 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.118 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.478 ' HA ' ' CE2' ' A' ' 101' ' ' TYR . . . -87.52 -17.59 31.72 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.895 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.478 ' CD2' HG12 ' A' ' 55' ' ' ILE . 3.8 m-70 48.33 -89.63 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.409 ' N ' ' O ' ' A' ' 83' ' ' ALA . 4.7 m -81.83 -169.97 2.61 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.834 0.35 . . . . 0.0 111.087 -179.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.57 ' O ' HD22 ' A' ' 63' ' ' LEU . 24.7 m-20 -40.86 108.62 0.09 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.166 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.3 mt -48.15 -20.99 0.41 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.398 178.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -47.74 -43.58 27.24 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -178.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.556 ' HB2' ' HG ' ' A' ' 63' ' ' LEU . . . -74.1 -21.33 59.94 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 120.243 -0.583 . . . . 0.0 109.912 179.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.693 ' HA ' ' CD1' ' A' ' 66' ' ' LEU . . . -77.55 -58.91 3.01 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.615 178.239 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.742 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 18.3 t -58.25 -56.75 14.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.561 -179.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 57.6 p -52.79 -27.58 18.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.069 0.462 . . . . 0.0 110.696 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.493 ' C ' ' HB3' ' A' ' 98' ' ' ALA . . . -58.36 -46.08 86.97 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.003 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.742 ' CE2' ' HA ' ' A' ' 91' ' ' VAL . 5.5 m-85 -48.68 -27.95 3.22 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.767 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.6 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -76.91 -39.61 50.27 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.704 -179.903 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.6 ' N ' ' HG2' ' A' ' 95' ' ' GLN . 7.7 pt20 -100.14 5.33 44.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.979 -178.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 127.98 79.25 0.26 Allowed Glycine 0 CA--C 1.519 0.323 0 C-N-CA 120.101 -1.047 . . . . 0.0 113.178 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.886 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -171.62 127.04 0.63 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.008 0.432 . . . . 0.0 110.477 179.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.436 ' N ' ' O ' ' A' ' 78' ' ' VAL . 13.6 t80 -70.14 -53.73 16.0 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -178.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.681 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 0.1 OUTLIER 179.04 -170.48 0.12 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.011 0.434 . . . . 0.0 111.729 -179.291 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.732 ' OH ' HD11 ' A' ' 66' ' ' LEU . 3.0 m-85 -135.01 153.6 52.02 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.476 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.459 HD22 ' HA ' ' A' ' 106' ' ' PHE . 7.4 mp -102.19 123.76 42.21 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-O 120.768 0.318 . . . . 0.0 111.09 -179.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -69.71 -56.62 0.14 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.434 2.089 . . . . 0.0 112.475 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.657 ' HB3' ' HD3' ' A' ' 105' ' ' PRO . 1.8 ttmp? -133.52 -56.14 0.02 OUTLIER Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.474 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.657 ' HD3' ' HB3' ' A' ' 104' ' ' LYS . 45.1 Cg_exo -57.52 160.03 15.12 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 121.765 1.644 . . . . 0.0 111.758 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.634 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 62.9 t80 -165.85 -105.52 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.186 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.6 ' O ' ' O ' ' A' ' 106' ' ' PHE . 3.1 p30 41.65 178.63 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.959 0.409 . . . . 0.0 111.321 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.645 HG12 HG12 ' A' ' 18' ' ' VAL . 0.9 OUTLIER -67.89 -41.04 84.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.124 179.659 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.551 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 33.7 t0 -49.18 -58.54 4.83 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.602 -179.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.634 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 10.3 mm-40 -76.33 -32.6 58.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.711 0.291 . . . . 0.0 111.402 -179.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.85 -60.07 3.23 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.815 0.34 . . . . 0.0 110.407 179.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.627 ' O ' HG13 ' A' ' 115' ' ' VAL . 47.1 t -59.63 -30.79 45.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.576 0.703 . . . . 0.0 110.468 178.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.551 ' HB3' ' O ' ' A' ' 109' ' ' ASP . . . -63.66 -45.51 89.83 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.011 178.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.498 ' CD2' HG23 ' A' ' 79' ' ' ILE . 34.1 tp -77.35 -22.7 51.42 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.604 -179.344 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.627 HG13 ' O ' ' A' ' 112' ' ' VAL . 5.3 p -79.39 -40.98 22.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 120.467 -0.493 . . . . 0.0 111.412 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -67.19 -48.59 67.47 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.963 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.442 ' HE ' ' HA ' ' A' ' 114' ' ' LEU . 0.9 OUTLIER -58.93 -23.28 61.19 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.808 179.948 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.417 ' HA ' ' CZ ' ' A' ' 99' ' ' PHE . . . -72.43 -44.39 62.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.169 179.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.438 HG12 HG12 ' A' ' 50' ' ' VAL . 4.8 mt -72.18 -32.05 41.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.283 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 2.3 t -71.9 -47.2 54.33 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.805 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -65.45 -24.34 67.15 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.08 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -71.38 -49.89 37.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.956 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -75.16 176.76 7.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.105 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.908 179.95 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 ttp . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 120.738 0.304 . . . . 0.0 110.92 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -102.96 143.19 32.87 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.211 0.529 . . . . 0.0 111.31 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.453 ' HG3' HD13 ' A' ' 5' ' ' ILE . 15.2 ptt180 -60.4 -49.6 76.95 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.691 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.449 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . 101.45 112.79 3.59 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.836 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.453 HD13 ' HG3' ' A' ' 3' ' ' ARG . 8.7 mm -124.97 112.89 33.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.809 0.338 . . . . 0.0 111.576 -178.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.758 HG11 ' CD1' ' A' ' 23' ' ' LEU . 8.0 p -106.47 125.52 62.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.17 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.636 ' CH2' ' HG2' ' A' ' 46' ' ' LYS . 29.1 m0 -117.13 123.46 46.81 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.627 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.0 OUTLIER -116.97 137.83 49.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.329 -177.237 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.879 HG12 ' HB2' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -121.25 104.98 15.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.967 178.695 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.444 ' HB3' ' CG2' ' A' ' 15' ' ' ILE . 3.7 t70 -168.1 72.49 0.1 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.984 0.421 . . . . 0.0 111.87 -179.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 63.95 2.59 1.42 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 179.015 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.7 p30 44.83 -149.63 0.07 Allowed 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.423 ' O ' ' HB3' ' A' ' 16' ' ' ARG . 1.4 t 34.85 -92.17 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 179.56 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.422 ' O ' HG23 ' A' ' 18' ' ' VAL . 2.9 t -53.81 -66.06 0.46 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.776 0.322 . . . . 0.0 110.56 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.487 ' CG2' HD12 ' A' ' 19' ' ' LEU . 35.0 mm -60.98 -20.51 22.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.924 179.349 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.52 ' HG3' ' OG1' ' A' ' 32' ' ' THR . 2.0 ttt180 -69.86 -58.03 4.36 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.255 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.462 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 36.8 t90 -59.43 -41.24 89.11 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.048 -0.523 . . . . 0.0 112.273 -179.117 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 14' ' ' SER . 2.7 t -67.14 -42.19 87.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -178.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.53 HD11 HG12 ' A' ' 8' ' ' VAL . 24.0 mt -84.13 -26.85 28.58 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -178.407 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.532 ' HG3' ' N ' ' A' ' 21' ' ' ARG . 21.2 pt-20 -67.5 -58.71 4.25 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.036 0.446 . . . . 0.0 112.029 -178.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.532 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 0.9 OUTLIER -50.71 -53.53 30.59 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.168 -179.154 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.01 -50.25 67.04 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -179.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.758 ' CD1' HG11 ' A' ' 6' ' ' VAL . 3.0 tm? -70.09 -30.62 67.89 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.421 0.629 . . . . 0.0 110.336 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.77 -32.53 73.88 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.64 -27.94 70.64 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 110.701 -0.959 . . . . 0.0 110.701 177.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.66 -15.75 59.73 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 120.625 0.25 . . . . 0.0 110.5 179.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.51 26.33 12.19 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.533 -0.842 . . . . 0.0 114.271 178.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.531 ' HB2' HD13 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -125.41 165.78 17.78 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 118.257 1.028 . . . . 0.0 112.3 179.729 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.59 ' O ' HG13 ' A' ' 6' ' ' VAL . 91.8 m -75.06 125.95 30.01 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.783 -179.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.645 ' HA ' HG13 ' A' ' 6' ' ' VAL . 4.2 p -125.77 110.4 13.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.697 -179.447 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.607 HG23 ' NE1' ' A' ' 7' ' ' TRP . 2.6 t -125.46 149.71 47.98 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.627 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 53.1 p -126.95 161.36 28.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.529 0.68 . . . . 0.0 112.734 -179.254 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.879 ' HB2' HG12 ' A' ' 9' ' ' VAL . 0.7 OUTLIER -135.23 173.37 11.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.595 -179.714 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.583 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -59.3 -103.11 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.885 -178.234 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.511 ' OD1' ' HD3' ' A' ' 58' ' ' PRO . 0.2 OUTLIER -88.93 -71.44 0.6 Allowed 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.103 0.478 . . . . 0.0 111.814 -179.076 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.494 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . -163.45 -34.74 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.638 -0.71 . . . . 0.0 113.069 -178.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.405 ' HA ' ' CD1' ' A' ' 40' ' ' LEU . 28.1 m120 -58.43 -32.51 68.76 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 121.223 0.535 . . . . 0.0 110.11 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.719 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -54.67 -61.79 2.08 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.24 179.542 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.574 HG23 HG11 ' A' ' 9' ' ' VAL . 4.4 t -50.05 -32.51 8.56 Favored 'Isoleucine or valine' 0 C--N 1.342 0.282 0 C-N-CA 120.329 -0.549 . . . . 0.0 110.926 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.56 HD13 ' HB3' ' A' ' 68' ' ' GLN . 22.6 mt -58.49 -44.73 89.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.839 0.352 . . . . 0.0 110.56 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.33 -49.39 77.79 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.228 0.537 . . . . 0.0 110.348 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.69 -31.79 72.0 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.156 178.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.61 HD22 ' HD3' ' A' ' 48' ' ' PRO . 10.2 mt -63.65 -25.82 68.39 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.706 179.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.503 ' HA ' ' HD3' ' A' ' 72' ' ' ARG . . . -59.34 -24.25 63.19 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.155 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -128.61 9.35 5.97 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.636 ' HG2' ' CH2' ' A' ' 7' ' ' TRP . 25.2 tptt -146.02 162.46 37.81 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 121.365 0.602 . . . . 0.0 111.878 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.56 ' H ' ' HG3' ' A' ' 46' ' ' LYS . 95.2 m -138.92 110.47 7.89 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.072 177.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.61 ' HD3' HD22 ' A' ' 43' ' ' LEU . 87.2 Cg_endo -80.65 148.38 17.94 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 122.433 2.089 . . . . 0.0 111.735 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -74.46 -30.79 62.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.946 0.403 . . . . 0.0 110.966 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.586 HG11 HG23 ' A' ' 6' ' ' VAL . 6.7 p -149.84 94.12 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.554 -179.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.454 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 27.0 tp -86.79 141.02 29.14 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.627 -179.218 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.836 ' HG ' ' HB ' ' A' ' 79' ' ' ILE . 0.2 OUTLIER -122.01 114.77 21.41 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.193 179.951 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.639 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -107.71 143.58 36.02 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.405 0.621 . . . . 0.0 112.086 -179.599 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 30.2 p30 -83.06 -177.66 6.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.02 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.745 HG21 ' HG3' ' A' ' 81' ' ' MET . 3.5 tt -159.13 160.85 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.885 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.446 ' H ' HG13 ' A' ' 55' ' ' ILE . 0.1 OUTLIER 78.01 51.95 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.007 0.432 . . . . 0.0 110.499 -179.207 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.493 ' CB ' ' CD ' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -163.39 -65.24 0.01 OUTLIER Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.95 179.892 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.596 ' HD2' ' O ' ' A' ' 61' ' ' ASP . 37.6 Cg_endo -65.44 -163.46 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.115 2.544 . . . . 0.0 112.933 -179.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -52.81 -89.89 0.01 OUTLIER Glycine 0 C--N 1.332 0.315 0 CA-C-N 115.974 -0.557 . . . . 0.0 113.0 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.502 ' O ' ' N ' ' A' ' 62' ' ' GLY . 2.6 tpp -72.52 57.38 0.39 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.774 0.321 . . . . 0.0 110.77 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.596 ' O ' ' HD2' ' A' ' 58' ' ' PRO . 0.1 OUTLIER 59.67 -74.34 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.067 179.948 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.548 ' O ' HD23 ' A' ' 65' ' ' LEU . . . -152.65 -30.1 0.04 OUTLIER Glycine 0 C--N 1.321 -0.264 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.502 -179.361 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.767 HD11 ' HB3' ' A' ' 86' ' ' ASP . 0.3 OUTLIER -66.14 -22.17 66.37 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.742 0.306 . . . . 0.0 110.874 179.912 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.407 ' CB ' ' CB ' ' A' ' 60' ' ' MET . . . -54.95 -30.21 58.41 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.349 0.595 . . . . 0.0 109.923 179.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.548 HD23 ' O ' ' A' ' 62' ' ' GLY . 2.7 mm? -66.07 -45.29 81.83 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.998 179.309 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.615 HD12 ' OH ' ' A' ' 101' ' ' TYR . 10.2 mt -51.81 -44.22 63.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.509 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.424 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 2.8 ttmm -55.14 -44.54 75.17 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.474 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.56 ' HB3' HD13 ' A' ' 40' ' ' LEU . 51.0 mm-40 -70.6 -43.91 68.38 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.191 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 56.2 mt -60.68 -36.2 69.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 121.057 0.456 . . . . 0.0 111.431 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.52 ' HB3' ' CD ' ' A' ' 96' ' ' GLN . 16.2 pttp -73.07 -27.0 61.47 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.285 -179.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -65.08 -39.07 92.67 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.237 0.541 . . . . 0.0 110.663 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.503 ' HD3' ' HA ' ' A' ' 44' ' ' ALA . 15.4 mtt-85 -94.42 -24.76 17.21 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.21 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.525 ' CB ' ' HB2' ' A' ' 76' ' ' LEU . 83.1 m-70 -140.47 101.59 6.7 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.138 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -77.03 11.48 2.02 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.596 2.198 . . . . 0.0 113.702 -179.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.674 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 5.9 mtt -147.64 12.95 1.03 Allowed 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.567 HD22 ' HD2' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -76.24 110.53 11.49 Favored Pre-proline 0 N--CA 1.462 0.164 0 CA-C-O 120.583 0.23 . . . . 0.0 111.576 179.881 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.415 ' HD3' ' O ' ' A' ' 75' ' ' MET . 35.4 Cg_exo -62.57 128.22 22.89 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.478 2.119 . . . . 0.0 111.906 179.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.511 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 4.3 t -125.1 152.66 31.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.059 0.456 . . . . 0.0 111.48 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.836 ' HB ' ' HG ' ' A' ' 52' ' ' LEU . 1.9 mt -134.17 112.09 15.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.483 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.639 ' HA ' ' O ' ' A' ' 53' ' ' SER . 16.6 mm -94.83 138.03 21.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.383 -179.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.745 ' HG3' HG21 ' A' ' 55' ' ' ILE . 0.2 OUTLIER -68.43 -31.41 70.72 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -178.936 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.506 ' O ' HG22 ' A' ' 55' ' ' ILE . 91.4 m -146.83 153.93 40.76 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.607 0.241 . . . . 0.0 110.713 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.475 ' HA ' ' CE2' ' A' ' 101' ' ' TYR . . . -106.23 -33.1 7.92 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -179.219 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 45.88 -166.64 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.727 0.298 . . . . 0.0 111.52 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -80.32 79.51 6.89 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.725 -179.066 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.767 ' HB3' HD11 ' A' ' 63' ' ' LEU . 0.1 OUTLIER -179.22 28.61 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.831 179.197 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.595 HD11 ' HB1' ' A' ' 90' ' ' ALA . 0.5 OUTLIER -49.23 -20.8 0.67 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 112.088 -179.985 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -47.68 -54.94 10.59 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 -179.103 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.495 ' HB3' ' HB2' ' A' ' 63' ' ' LEU . . . -70.68 -21.49 62.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.851 0.358 . . . . 0.0 111.247 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.595 ' HB1' HD11 ' A' ' 87' ' ' LEU . . . -69.69 -41.95 74.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.654 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.633 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 3.4 t -62.07 -46.24 96.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.898 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.465 ' O ' ' HB3' ' A' ' 95' ' ' GLN . 38.5 m -65.14 -21.96 66.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.039 0.447 . . . . 0.0 109.834 179.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.566 ' HB3' ' O ' ' A' ' 90' ' ' ALA . . . -66.0 -39.33 90.2 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.296 0.57 . . . . 0.0 109.687 179.049 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.633 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 8.9 m-85 -69.89 -22.7 63.21 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.639 178.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.465 ' HB3' ' O ' ' A' ' 92' ' ' SER . 0.3 OUTLIER -69.39 -44.31 71.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.906 179.555 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.674 ' O ' ' HA ' ' A' ' 75' ' ' MET . 2.3 pt20 -75.68 -17.95 59.79 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.668 179.12 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 125.24 16.87 2.8 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.368 -0.92 . . . . 0.0 113.939 178.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.511 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -55.47 151.23 10.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 117.413 0.607 . . . . 0.0 110.79 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.551 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 14.3 t80 -77.07 -53.55 7.66 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.269 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 169.92 -166.0 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.0 0.428 . . . . 0.0 111.656 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.638 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 3.4 m-85 -133.4 153.35 51.68 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.086 -179.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.697 HD21 ' HA ' ' A' ' 106' ' ' PHE . 1.0 OUTLIER -103.42 118.64 57.19 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.887 179.943 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -73.7 -72.94 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.089 1.859 . . . . 0.0 112.444 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.459 ' CB ' ' HD3' ' A' ' 105' ' ' PRO . 2.2 tttt -111.38 -57.98 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.663 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.459 ' HD3' ' CB ' ' A' ' 104' ' ' LYS . 51.8 Cg_exo -54.45 153.35 23.18 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.165 1.91 . . . . 0.0 112.524 -179.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.697 ' HA ' HD21 ' A' ' 102' ' ' LEU . 41.1 t80 -163.54 -113.15 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.431 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.573 ' O ' ' O ' ' A' ' 106' ' ' PHE . 3.1 p30 42.6 178.3 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 118.122 0.419 . . . . 0.0 111.591 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.533 HG21 HG21 ' A' ' 112' ' ' VAL . 0.8 OUTLIER -67.78 -43.1 86.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.113 0.482 . . . . 0.0 111.272 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.443 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 0.4 OUTLIER -49.04 -58.11 5.46 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.594 -179.548 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.636 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 36.5 mm-40 -76.98 -33.29 57.64 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.757 0.313 . . . . 0.0 111.371 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.428 ' CB ' ' O ' ' A' ' 107' ' ' ASP . . . -64.41 -59.13 4.72 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.116 179.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.64 ' HA ' HG13 ' A' ' 115' ' ' VAL . 48.3 t -60.74 -32.0 50.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.514 179.108 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.443 ' HB3' ' O ' ' A' ' 109' ' ' ASP . . . -62.51 -46.08 90.07 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.09 179.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.521 HD23 HG23 ' A' ' 79' ' ' ILE . 20.6 tp -76.09 -21.12 57.06 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.835 -1.075 . . . . 0.0 111.907 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.64 HG13 ' HA ' ' A' ' 112' ' ' VAL . 3.7 p -78.92 -37.98 20.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.477 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.556 ' HA ' HD12 ' A' ' 119' ' ' ILE . 35.7 mt-10 -68.67 -38.73 80.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.966 0.413 . . . . 0.0 110.735 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.1 mmm180 -63.54 -27.52 69.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.091 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.551 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -69.42 -44.57 71.08 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.064 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.556 HD12 ' HA ' ' A' ' 116' ' ' GLU . 6.5 mt -62.81 -31.95 54.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.16 0.505 . . . . 0.0 110.699 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 9.1 t -75.13 -49.54 19.25 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.868 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 18.1 m80 -64.44 -28.9 69.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.137 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -67.49 -57.19 6.96 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.105 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.07 171.66 14.69 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.393 -179.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.677 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 120.909 0.385 . . . . 0.0 111.13 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.478 ' O ' ' HB3' ' A' ' 3' ' ' ARG . 8.4 tt0 -122.7 -29.69 3.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.871 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.478 ' HB3' ' O ' ' A' ' 2' ' ' GLN . 0.0 OUTLIER 74.47 -21.1 0.29 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.594 -179.771 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.506 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . 56.7 79.9 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.653 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.416 ' CD1' ' HB3' ' A' ' 3' ' ' ARG . 3.1 mp -116.71 112.18 38.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.697 0.285 . . . . 0.0 110.654 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.543 ' CG2' HG13 ' A' ' 50' ' ' VAL . 6.5 p -108.79 129.35 63.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.826 0.346 . . . . 0.0 110.929 179.242 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.569 ' CD1' HG21 ' A' ' 31' ' ' THR . 33.5 m0 -116.27 139.27 50.56 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.391 179.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.581 ' O ' ' HD1' ' A' ' 33' ' ' PHE . 0.4 OUTLIER -122.59 146.96 27.02 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.303 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.51 -178.352 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.87 HG12 ' HB2' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -129.12 109.33 18.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 120.92 0.391 . . . . 0.0 110.973 179.368 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.427 ' OD1' ' HB3' ' A' ' 54' ' ' ASP . 6.5 t0 -162.16 -158.19 0.51 Allowed 'General case' 0 CA--C 1.53 0.212 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.693 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -66.37 -2.73 4.81 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -179.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.6 t0 66.87 -144.31 0.15 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 121.296 -0.162 . . . . 0.0 110.628 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.411 ' OG ' ' N ' ' A' ' 14' ' ' SER . 53.1 p 33.48 -101.83 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 179.262 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.411 ' N ' ' OG ' ' A' ' 13' ' ' SER . 1.5 m -54.4 -49.5 69.77 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.675 0.274 . . . . 0.0 111.312 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.9 mm -62.97 -24.6 36.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.929 0.395 . . . . 0.0 111.11 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.496 ' HG3' HG21 ' A' ' 32' ' ' THR . 25.2 ttt180 -74.71 -55.09 6.23 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.022 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.428 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 14.6 t90 -56.3 -42.46 77.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.881 -0.6 . . . . 0.0 112.444 -178.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.402 ' CG1' HG12 ' A' ' 108' ' ' ILE . 5.3 t -66.53 -45.3 89.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -178.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.57 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 1.2 mp -83.77 -25.24 30.65 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -178.371 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.516 ' HG3' ' N ' ' A' ' 21' ' ' ARG . 14.8 pt-20 -66.58 -58.87 4.29 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.422 -0.511 . . . . 0.0 111.546 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.516 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -65.76 -51.23 60.88 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.121 -179.073 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.25 -45.27 80.1 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -178.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.57 ' HB2' ' O ' ' A' ' 19' ' ' LEU . 0.4 OUTLIER -74.88 -25.25 58.82 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.95 0.405 . . . . 0.0 110.63 179.688 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.404 ' HB1' ' O ' ' A' ' 20' ' ' GLU . . . -68.87 -34.22 75.08 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 177.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.69 -23.49 68.98 Favored Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 178.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.67 -15.73 58.98 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 120.805 0.336 . . . . 0.0 110.6 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.52 25.08 11.22 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.832 -0.699 . . . . 0.0 113.982 178.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.509 ' CD1' HD23 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -132.07 165.18 24.59 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 117.811 0.805 . . . . 0.0 112.562 179.694 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.499 ' O ' HG12 ' A' ' 6' ' ' VAL . 29.5 m -87.67 108.86 19.29 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.004 -179.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.513 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 42.2 t -106.63 111.71 24.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.031 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.569 HG21 ' CD1' ' A' ' 7' ' ' TRP . 2.4 t -118.04 154.99 31.11 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.04 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.496 HG21 ' HG3' ' A' ' 16' ' ' ARG . 38.5 p -124.37 164.51 19.51 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.123 0.487 . . . . 0.0 111.879 -179.129 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.87 ' HB2' HG12 ' A' ' 9' ' ' VAL . 2.3 m-85 -130.19 172.31 11.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.592 -178.236 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.621 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 3.0 pp20? -63.53 -44.87 92.98 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -177.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.624 ' C ' HG13 ' A' ' 9' ' ' VAL . 1.4 t30 -160.78 -58.2 0.05 Allowed 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -179.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.581 ' HA2' HG13 ' A' ' 9' ' ' VAL . . . -164.99 -43.47 0.02 OUTLIER Glycine 0 C--N 1.319 -0.382 0 C-N-CA 120.371 -0.919 . . . . 0.0 113.431 -179.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.745 ' HA ' HD11 ' A' ' 40' ' ' LEU . 11.2 m120 -67.4 -26.87 66.65 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -178.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.711 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 12.2 tt0 -58.92 -50.51 73.77 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.744 -0.382 . . . . 0.0 111.411 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.634 HG11 ' HG ' ' A' ' 43' ' ' LEU . 10.1 t -61.15 -35.46 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 C-N-CA 120.122 -0.631 . . . . 0.0 111.236 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.745 HD11 ' HA ' ' A' ' 37' ' ' ASN . 31.0 mt -56.94 -41.11 77.66 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.027 0.442 . . . . 0.0 110.728 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -77.53 -47.53 19.29 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.025 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.71 -36.38 80.77 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.069 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.634 ' HG ' HG11 ' A' ' 39' ' ' VAL . 16.0 mt -63.34 -22.98 67.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.031 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.17 -19.61 14.29 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.677 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -124.21 2.59 8.54 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -162.41 155.26 19.78 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.801 0.334 . . . . 0.0 110.862 179.965 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.463 HG21 ' CD2' ' A' ' 76' ' ' LEU . 98.6 m -138.97 112.84 8.23 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.573 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.536 ' HD2' HD21 ' A' ' 43' ' ' LEU . 72.4 Cg_endo -79.1 161.82 26.26 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.085 1.857 . . . . 0.0 111.436 178.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -73.98 -22.57 59.57 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.701 0.286 . . . . 0.0 111.294 -179.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.545 ' HA ' ' HG2' ' A' ' 77' ' ' PRO . 7.1 p -144.97 161.34 13.7 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.231 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.547 ' HB2' HD11 ' A' ' 76' ' ' LEU . 22.6 tp -152.87 133.19 13.59 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.164 0.507 . . . . 0.0 111.913 -178.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.428 ' O ' HG22 ' A' ' 9' ' ' VAL . 0.5 OUTLIER -111.86 115.54 29.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.265 179.983 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.568 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 2.1 m -110.98 138.57 47.22 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.124 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.427 ' HB3' ' OD1' ' A' ' 10' ' ' ASP . 15.4 p-10 -83.03 179.68 7.69 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.781 179.196 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.668 HG13 ' O ' ' A' ' 61' ' ' ASP . 1.0 OUTLIER -154.06 96.85 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.153 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -138.96 40.17 2.14 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.797 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.464 ' N ' ' CD ' ' A' ' 58' ' ' PRO . 0.0 OUTLIER 67.52 47.29 0.41 Allowed Pre-proline 0 CA--C 1.533 0.304 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 179.018 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 62' ' ' GLY . 37.5 Cg_endo -69.27 -76.45 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.309 2.006 . . . . 0.0 111.86 178.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -112.39 -25.25 4.74 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 121.069 -0.586 . . . . 0.0 111.928 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.519 ' C ' ' H ' ' A' ' 62' ' ' GLY . 1.0 OUTLIER -159.62 68.02 0.4 Allowed 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.261 0.553 . . . . 0.0 109.991 179.517 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.668 ' O ' HG13 ' A' ' 55' ' ' ILE . 0.1 OUTLIER 69.9 -29.21 0.18 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.862 -179.719 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.519 ' H ' ' C ' ' A' ' 60' ' ' MET . . . 142.58 -29.25 2.14 Favored Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.519 ' CD2' ' HB2' ' A' ' 90' ' ' ALA . 1.1 mp -70.24 -19.17 63.15 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 178.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.515 ' HB3' ' N ' ' A' ' 60' ' ' MET . . . -53.59 -32.18 49.93 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.532 179.068 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.1 tt -57.79 -46.14 85.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.315 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.479 ' HA ' HD12 ' A' ' 69' ' ' ILE . 6.5 mt -57.82 -44.68 86.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.948 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.411 ' O ' ' CG ' ' A' ' 70' ' ' LYS . 20.8 ttmt -52.76 -53.23 51.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.371 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.528 ' HB2' HD12 ' A' ' 40' ' ' LEU . 86.5 mm-40 -59.64 -34.6 73.01 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.923 0.392 . . . . 0.0 111.483 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.529 HD11 ' CG2' ' A' ' 78' ' ' VAL . 86.5 mt -61.57 -33.36 56.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.773 -178.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.521 ' HB3' ' CB ' ' A' ' 96' ' ' GLN . 0.2 OUTLIER -78.01 -29.44 49.55 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.999 0.428 . . . . 0.0 111.718 179.932 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.447 ' NE2' ' HA ' ' A' ' 68' ' ' GLN . 2.6 mt-30 -65.63 -48.23 72.91 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.152 -178.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.3 mtp85 -93.38 -55.94 3.11 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.97 -178.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.498 ' CD2' HD11 ' A' ' 43' ' ' LEU . 1.6 m-70 -84.25 152.82 62.04 Favored Pre-proline 0 C--N 1.319 -0.76 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.543 -178.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -69.85 -76.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.618 2.212 . . . . 0.0 112.882 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.649 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 6.6 mtm -138.71 53.49 1.77 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.185 0.517 . . . . 0.0 111.338 -179.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.552 ' O ' HG22 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -63.7 112.23 6.84 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.081 179.576 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.545 ' HG2' ' HA ' ' A' ' 50' ' ' VAL . 17.3 Cg_endo -57.19 122.73 12.32 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.188 1.925 . . . . 0.0 111.377 179.22 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.552 HG22 ' O ' ' A' ' 76' ' ' LEU . 3.9 t -119.54 152.03 22.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.167 0.508 . . . . 0.0 111.894 -178.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.412 ' O ' HD23 ' A' ' 52' ' ' LEU . 3.3 mt -131.6 113.74 23.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.363 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.568 ' HA ' ' O ' ' A' ' 53' ' ' SER . 2.4 mp -96.26 132.48 40.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.952 0.406 . . . . 0.0 110.829 -179.548 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.494 ' HB2' ' CE1' ' A' ' 106' ' ' PHE . 3.7 ptp -70.2 -24.65 63.15 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -177.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.407 ' HB ' ' CG2' ' A' ' 55' ' ' ILE . 12.0 m -146.96 160.16 42.69 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.974 0.416 . . . . 0.0 111.753 -179.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -142.32 57.84 1.46 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.56 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.471 ' H ' ' CD2' ' A' ' 84' ' ' HIS . 0.1 OUTLIER -75.34 -95.73 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.364 -179.896 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 6.9 t -89.87 173.01 8.47 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-O 121.109 0.48 . . . . 0.0 111.914 -179.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.518 ' O ' HD23 ' A' ' 63' ' ' LEU . 8.0 m-20 58.01 17.77 4.64 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.653 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.9 mt -48.8 -24.12 1.31 Allowed 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -48.01 -45.64 32.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.8 0.333 . . . . 0.0 111.062 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.44 ' HB1' ' HB2' ' A' ' 63' ' ' LEU . . . -65.99 -20.27 66.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.426 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.519 ' HB2' ' CD2' ' A' ' 63' ' ' LEU . . . -63.25 -44.86 93.97 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.845 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.55 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 5.6 t -59.41 -46.24 92.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.307 -179.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 98.4 p -62.87 -20.09 64.78 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.232 179.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.645 ' O ' ' HG3' ' A' ' 96' ' ' GLN . . . -65.05 -44.49 88.85 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 121.147 0.499 . . . . 0.0 110.367 179.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.55 ' CE2' ' HA ' ' A' ' 91' ' ' VAL . 8.5 m-85 -61.82 -25.13 67.32 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.696 178.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -76.55 -38.81 54.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.324 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.649 ' O ' ' HA ' ' A' ' 75' ' ' MET . 1.6 pp0? -78.85 -18.22 54.36 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.42 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 125.92 1.92 7.37 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 120.444 -0.884 . . . . 0.0 113.663 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.408 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -53.43 151.59 5.48 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 117.419 0.61 . . . . 0.0 110.699 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.512 ' CE2' HD13 ' A' ' 114' ' ' LEU . 11.4 t80 -79.63 -53.9 6.4 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 121.018 -0.273 . . . . 0.0 111.303 -179.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.409 ' O ' HD11 ' A' ' 80' ' ' ILE . 0.4 OUTLIER 175.04 -166.95 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.036 0.446 . . . . 0.0 111.594 179.787 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.515 ' CZ ' HG12 ' A' ' 80' ' ' ILE . 3.0 m-85 -133.95 153.53 51.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.034 -178.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.668 HD23 ' HA ' ' A' ' 106' ' ' PHE . 1.8 mp -103.62 118.83 56.54 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.197 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 102' ' ' LEU . 8.0 Cg_exo -70.63 -68.43 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.436 2.091 . . . . 0.0 111.97 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.625 ' H ' ' HD2' ' A' ' 105' ' ' PRO . 0.5 OUTLIER -117.92 -59.24 0.03 OUTLIER Pre-proline 0 CA--C 1.531 0.239 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -179.858 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.625 ' HD2' ' H ' ' A' ' 104' ' ' LYS . 13.0 Cg_endo -55.42 157.57 14.5 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.113 1.875 . . . . 0.0 112.44 -179.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.668 ' HA ' HD23 ' A' ' 102' ' ' LEU . 22.4 t80 -165.6 -111.01 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.434 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.548 ' O ' ' O ' ' A' ' 106' ' ' PHE . 3.0 p30 43.74 178.74 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.907 0.384 . . . . 0.0 111.257 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.439 HG22 HG22 ' A' ' 112' ' ' VAL . 0.9 OUTLIER -68.02 -42.88 85.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.979 0.418 . . . . 0.0 111.575 -179.643 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.426 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 78.8 m-20 -49.26 -58.35 5.2 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.413 -179.381 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.57 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 62.9 mm-40 -76.4 -32.26 58.43 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.678 0.275 . . . . 0.0 111.43 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.401 ' CB ' ' O ' ' A' ' 107' ' ' ASP . . . -64.92 -60.8 2.65 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.001 0.429 . . . . 0.0 109.946 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.67 ' O ' HG11 ' A' ' 115' ' ' VAL . 48.3 t -59.46 -31.27 46.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.413 0.625 . . . . 0.0 110.537 178.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.426 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -63.23 -45.07 93.35 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.01 179.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.587 HD23 ' CD1' ' A' ' 102' ' ' LEU . 55.7 tp -76.28 -23.44 54.41 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.703 -1.135 . . . . 0.0 111.782 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.67 HG11 ' O ' ' A' ' 112' ' ' VAL . 4.0 p -79.2 -41.25 22.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.801 0.334 . . . . 0.0 111.548 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.453 ' HA ' HD11 ' A' ' 119' ' ' ILE . 95.1 mt-10 -65.33 -44.48 87.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.181 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.433 ' HG2' ' HA ' ' A' ' 114' ' ' LEU . 6.5 ptp180 -62.29 -25.42 67.84 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.933 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.476 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -71.28 -44.56 64.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.088 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.486 HD12 HG12 ' A' ' 50' ' ' VAL . 4.8 mt -68.6 -30.8 48.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.252 0.548 . . . . 0.0 110.688 179.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 21.7 t -71.24 -45.03 64.16 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.212 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 30.1 m80 -67.44 -24.36 65.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.024 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -67.86 -50.05 58.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.651 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 3.0 tm0? -75.13 172.22 12.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.821 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.821 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.467 0 CA-C-O 120.807 0.336 . . . . 0.0 111.311 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 61.5 176.25 0.12 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.452 -179.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -76.39 1.96 14.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.561 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 84.4 86.33 0.9 Allowed Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.833 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.461 ' HB ' ' HA ' ' A' ' 48' ' ' PRO . 3.6 mp -110.56 112.75 41.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.102 0.477 . . . . 0.0 111.245 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.61 ' CG2' HD12 ' A' ' 23' ' ' LEU . 5.6 p -108.82 120.96 61.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.913 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.766 ' CD1' HG21 ' A' ' 31' ' ' THR . 31.4 m0 -112.32 141.74 45.67 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.117 0.484 . . . . 0.0 111.484 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.654 ' O ' ' HA ' ' A' ' 32' ' ' THR . 1.6 t -128.3 143.01 42.31 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.306 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.975 -178.261 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.842 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -120.95 110.69 28.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.456 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.555 ' HA ' ' HB3' ' A' ' 54' ' ' ASP . 4.5 p30 -161.3 -160.75 0.75 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.904 0.383 . . . . 0.0 111.67 -178.463 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -66.23 -3.28 5.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.681 -179.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 65.31 -155.91 0.28 Allowed 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 120.511 0.196 . . . . 0.0 110.927 179.439 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.444 ' OG ' ' N ' ' A' ' 14' ' ' SER . 64.0 p 33.56 -96.89 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 179.349 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.444 ' N ' ' OG ' ' A' ' 13' ' ' SER . 40.4 t -52.93 -57.41 10.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.535 -179.516 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.4 mm -64.61 -26.36 40.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.937 0.398 . . . . 0.0 111.182 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.49 ' HG3' HG23 ' A' ' 32' ' ' THR . 9.8 ttt180 -73.43 -49.29 27.7 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.447 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.417 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 87.0 t90 -63.4 -39.83 95.57 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -179.087 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.448 HG13 HG12 ' A' ' 108' ' ' ILE . 3.2 t -67.03 -42.87 89.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 112.133 0.419 . . . . 0.0 112.133 -178.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.559 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -84.12 -30.52 25.87 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -178.696 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.529 ' HG3' ' N ' ' A' ' 21' ' ' ARG . 17.2 pt-20 -64.09 -60.03 3.73 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -178.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.529 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 5.5 mmm180 -53.76 -52.59 59.72 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -178.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.17 -29.23 70.21 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -178.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.791 ' CD2' HD11 ' A' ' 28' ' ' LEU . 0.4 OUTLIER -85.32 -29.88 24.16 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.146 0.498 . . . . 0.0 110.088 179.175 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.38 -32.06 73.5 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 177.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.55 -25.16 72.7 Favored Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 177.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.482 ' CB ' HD12 ' A' ' 28' ' ' LEU . . . -77.11 -15.18 59.65 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.572 -0.314 . . . . 0.0 110.588 179.007 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.96 26.48 14.49 Favored Glycine 0 C--N 1.336 0.577 0 C-N-CA 120.959 -0.639 . . . . 0.0 114.28 178.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.791 HD11 ' CD2' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -127.25 161.28 28.94 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 117.889 0.845 . . . . 0.0 112.874 -179.303 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 99.4 m -75.98 116.85 17.1 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.973 179.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 2.0 p -111.18 109.31 19.3 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -178.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.766 HG21 ' CD1' ' A' ' 7' ' ' TRP . 2.8 t -130.21 138.23 50.46 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 178.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.654 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 81.5 p -115.32 160.59 19.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.498 0.666 . . . . 0.0 112.652 -178.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.842 ' HB2' HG13 ' A' ' 9' ' ' VAL . 1.4 m-85 -135.84 173.87 11.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.179 -179.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.658 ' HG2' ' HG3' ' A' ' 38' ' ' GLU . 0.1 OUTLIER -62.27 -105.45 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.939 -179.028 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.431 ' H ' ' CG ' ' A' ' 34' ' ' GLU . 14.2 m120 -86.45 -71.7 0.53 Allowed 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.319 0.581 . . . . 0.0 111.257 -179.313 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.691 ' HA2' HG12 ' A' ' 9' ' ' VAL . . . -159.76 -40.71 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.222 -0.899 . . . . 0.0 112.548 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.905 ' HA ' HD13 ' A' ' 40' ' ' LEU . 7.4 m120 -52.46 -30.08 27.97 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.726 0.298 . . . . 0.0 111.173 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.833 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -58.79 -58.0 10.52 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.417 179.526 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.518 ' CG1' HD13 ' A' ' 43' ' ' LEU . 6.0 t -54.58 -43.49 65.05 Favored 'Isoleucine or valine' 0 C--N 1.341 0.207 0 C-N-CA 120.24 -0.584 . . . . 0.0 111.295 -179.385 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.905 HD13 ' HA ' ' A' ' 37' ' ' ASN . 7.6 mt -53.37 -49.01 68.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.975 0.417 . . . . 0.0 110.564 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.73 -49.89 73.84 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.98 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.77 -28.05 67.28 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.838 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.518 HD13 ' CG1' ' A' ' 39' ' ' VAL . 5.9 mt -69.77 -26.11 64.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.631 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.22 -20.15 10.04 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.562 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 29.6 t -125.61 -0.27 7.47 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.478 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -154.3 155.66 35.56 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 120.761 0.315 . . . . 0.0 110.589 179.893 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.473 ' CG2' HD11 ' A' ' 76' ' ' LEU . 53.2 m -138.54 112.39 8.46 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.011 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.461 ' HA ' ' HB ' ' A' ' 5' ' ' ILE . 59.2 Cg_endo -77.98 161.77 29.62 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.031 1.82 . . . . 0.0 111.511 179.333 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -73.72 -23.76 59.82 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.175 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.511 HG11 HD11 ' A' ' 119' ' ' ILE . 7.8 p -145.35 167.32 9.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.914 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.422 HD23 HG13 ' A' ' 39' ' ' VAL . 11.3 tp -152.84 131.01 11.94 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.003 0.43 . . . . 0.0 111.833 -179.356 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.572 ' HB3' HG13 ' A' ' 8' ' ' VAL . 0.4 OUTLIER -113.84 128.21 56.31 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.243 179.695 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.2 m -105.69 134.23 49.15 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.835 0.35 . . . . 0.0 111.262 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.555 ' HB3' ' HA ' ' A' ' 10' ' ' ASP . 16.5 p-10 -72.75 -29.79 63.61 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.683 -179.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.989 HG12 ' HA3' ' A' ' 62' ' ' GLY . 0.0 OUTLIER 49.08 97.22 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.549 179.572 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 39.8 tpt85 -157.36 57.16 0.51 Allowed 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.452 ' N ' ' CD ' ' A' ' 58' ' ' PRO . 0.0 OUTLIER 61.21 46.59 1.08 Allowed Pre-proline 0 N--CA 1.47 0.54 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 178.476 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.61 ' CD ' ' HA2' ' A' ' 62' ' ' GLY . 39.0 Cg_endo -70.37 -75.46 0.01 OUTLIER 'Trans proline' 0 CA--C 1.53 0.301 0 C-N-CA 122.458 2.105 . . . . 0.0 111.522 178.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -119.19 -21.23 3.8 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.216 -0.516 . . . . 0.0 112.101 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.47 ' N ' ' HB2' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -159.95 67.78 0.38 Allowed 'General case' 0 C--O 1.236 0.393 0 CA-C-O 120.981 0.419 . . . . 0.0 110.177 179.748 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 72.93 -30.9 0.22 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.309 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.989 ' HA3' HG12 ' A' ' 55' ' ' ILE . . . 140.74 -24.2 2.61 Favored Glycine 0 CA--C 1.503 -0.679 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -179.124 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.792 HD22 ' HB1' ' A' ' 90' ' ' ALA . 3.1 mp -74.34 -23.67 59.07 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.47 ' HB2' ' N ' ' A' ' 60' ' ' MET . . . -53.96 -30.01 45.11 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.3 178.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.514 ' HA ' ' NE2' ' A' ' 68' ' ' GLN . 10.4 mt -58.48 -40.47 82.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.198 179.36 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.513 HD11 ' OH ' ' A' ' 101' ' ' TYR . 28.5 mt -63.51 -42.11 98.49 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.319 179.492 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.722 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 15.9 mttm -52.89 -42.2 65.07 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.152 179.088 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.622 ' CB ' HD11 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -71.54 -44.99 63.59 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.911 179.777 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.414 HG22 ' NE2' ' A' ' 73' ' ' HIS . 21.8 mt -56.1 -37.35 48.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.197 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.722 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -74.85 -28.17 60.57 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.892 179.885 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.56 -31.78 67.38 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.401 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.5 mtt-85 -91.73 -64.46 1.11 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.331 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.454 ' NE2' ' CD1' ' A' ' 43' ' ' LEU . 0.4 OUTLIER -125.06 76.22 67.34 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.996 179.718 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.431 ' HB3' ' O ' ' A' ' 70' ' ' LYS . 51.2 Cg_endo -69.59 60.82 1.62 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.528 2.152 . . . . 0.0 112.422 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 33.1 mtt -157.28 -35.45 0.08 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.534 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.561 ' HG ' ' HD2' ' A' ' 77' ' ' PRO . 0.6 OUTLIER -61.52 145.98 90.43 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.877 -179.44 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.561 ' HD2' ' HG ' ' A' ' 76' ' ' LEU . 94.9 Cg_endo -82.88 115.43 2.4 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.739 2.292 . . . . 0.0 112.697 179.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.643 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 3.2 t -98.92 139.16 21.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.685 179.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.522 ' HB ' ' HG ' ' A' ' 52' ' ' LEU . 2.0 mp -122.15 112.13 33.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.698 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.51 ' CG2' ' HB ' ' A' ' 55' ' ' ILE . 2.2 mp -98.32 134.6 36.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.135 0.493 . . . . 0.0 111.279 -179.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.515 ' HA ' ' HB2' ' A' ' 102' ' ' LEU . 4.7 ptm -87.23 -9.13 55.89 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -178.201 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.539 ' N ' HG22 ' A' ' 55' ' ' ILE . 19.0 m -149.02 136.78 20.51 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.642 0.258 . . . . 0.0 111.566 -179.197 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -123.0 82.27 1.97 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.834 0.35 . . . . 0.0 111.275 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -67.34 -166.32 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.574 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.35 80.53 6.78 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.022 0.439 . . . . 0.0 111.91 -179.06 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.537 ' O ' HD23 ' A' ' 63' ' ' LEU . 27.0 t0 -178.15 28.38 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.945 179.2 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -44.99 -23.1 0.12 Allowed 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -47.94 -44.04 29.76 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.569 ' HB2' ' CB ' ' A' ' 63' ' ' LEU . . . -73.38 -22.23 60.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.674 0.273 . . . . 0.0 111.595 -179.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.792 ' HB1' HD22 ' A' ' 63' ' ' LEU . . . -68.88 -39.66 79.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.972 0.415 . . . . 0.0 110.169 179.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.627 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 2.4 t -54.15 -39.93 44.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.207 -179.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.53 ' O ' ' HG3' ' A' ' 95' ' ' GLN . 85.5 p -63.09 -19.74 64.71 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.257 0.551 . . . . 0.0 109.745 178.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.748 ' O ' ' HG3' ' A' ' 96' ' ' GLN . . . -75.9 -55.43 5.62 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.204 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.627 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 4.4 m-85 -56.82 -33.61 66.91 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.921 -179.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.53 ' HG3' ' O ' ' A' ' 92' ' ' SER . 2.1 pp0? -75.46 -28.94 59.47 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.863 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.748 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 0.7 OUTLIER -87.03 -9.1 56.35 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 116.695 -0.23 . . . . 0.0 110.888 178.9 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 77' ' ' PRO . . . 121.58 6.7 8.56 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 120.407 -0.902 . . . . 0.0 113.774 179.238 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.643 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -55.3 157.38 3.67 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 117.213 0.507 . . . . 0.0 111.466 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.474 ' CD2' ' HB2' ' A' ' 118' ' ' ALA . 5.2 t80 -86.25 -53.89 4.77 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.584 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.479 ' O ' HD11 ' A' ' 80' ' ' ILE . 0.2 OUTLIER 170.19 -162.43 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.876 0.37 . . . . 0.0 111.867 -179.936 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.513 ' OH ' HD11 ' A' ' 66' ' ' LEU . 2.2 m-85 -134.61 153.26 52.05 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.567 -178.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.515 ' HB2' ' HA ' ' A' ' 81' ' ' MET . 1.0 OUTLIER -102.65 119.52 55.64 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.168 -179.905 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -65.18 -70.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.474 2.116 . . . . 0.0 112.553 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.586 ' H ' ' HD2' ' A' ' 105' ' ' PRO . 0.5 OUTLIER -123.63 -62.1 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.908 -179.611 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.586 ' HD2' ' H ' ' A' ' 104' ' ' LYS . 9.2 Cg_endo -50.12 163.56 0.57 Allowed 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.314 2.009 . . . . 0.0 112.367 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.594 ' O ' ' O ' ' A' ' 107' ' ' ASP . 58.9 t80 -171.71 -102.44 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.257 179.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.594 ' O ' ' O ' ' A' ' 106' ' ' PHE . 3.4 p30 43.14 178.39 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 117.792 0.269 . . . . 0.0 110.865 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.448 HG12 HG13 ' A' ' 18' ' ' VAL . 0.9 OUTLIER -67.91 -43.1 86.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 120.432 -0.507 . . . . 0.0 111.792 -179.738 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.497 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 32.7 t70 -49.62 -58.65 4.84 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.913 -179.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.587 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 3.7 mm-40 -74.81 -30.37 61.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.635 0.255 . . . . 0.0 111.6 -179.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -68.61 -62.53 1.35 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.279 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.604 ' O ' HG13 ' A' ' 115' ' ' VAL . 49.0 t -55.96 -31.35 30.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.559 0.695 . . . . 0.0 110.163 178.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.497 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -64.38 -46.68 82.29 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.327 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.507 ' CD2' HG21 ' A' ' 79' ' ' ILE . 19.6 tp -76.96 -21.2 55.12 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.996 -179.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.604 HG13 ' O ' ' A' ' 112' ' ' VAL . 4.7 p -79.4 -47.98 21.62 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 C-N-CA 120.401 -0.519 . . . . 0.0 111.715 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -64.38 -41.89 96.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.871 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.425 ' HG2' ' O ' ' A' ' 113' ' ' ALA . 20.1 mmm180 -61.77 -23.71 66.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.768 179.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.474 ' HB2' ' CD2' ' A' ' 99' ' ' PHE . . . -72.02 -49.34 37.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.941 179.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.511 HD11 HG11 ' A' ' 50' ' ' VAL . 3.9 mt -71.11 -31.66 45.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.16 0.505 . . . . 0.0 110.696 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.91 -48.63 52.59 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.122 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -57.48 -26.99 62.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.297 -179.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -80.36 -55.72 4.7 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.182 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 60.51 173.47 0.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.824 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 69.9 mt-10 . . . . . 0 C--N 1.326 -0.417 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.781 179.853 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.3 ptt? . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 120.836 0.351 . . . . 0.0 111.301 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.69 ' O ' ' HG2' ' A' ' 3' ' ' ARG . 7.8 mt-30 -120.33 -35.4 3.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.044 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.69 ' HG2' ' O ' ' A' ' 2' ' ' GLN . 2.9 ptm180 69.24 -28.14 0.16 Allowed 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.3 0.64 . . . . 0.0 112.672 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.475 ' H ' ' C ' ' A' ' 2' ' ' GLN . . . 104.24 91.14 2.2 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.616 179.001 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.486 HD12 ' HG2' ' A' ' 3' ' ' ARG . 5.9 mm -118.73 112.23 37.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.908 0.385 . . . . 0.0 111.188 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 30' ' ' CYS . 4.4 p -114.98 117.17 54.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.428 179.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.673 ' CH2' ' HG2' ' A' ' 46' ' ' LYS . 25.7 m0 -107.31 133.89 51.19 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.031 0.443 . . . . 0.0 110.442 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.739 HG12 ' HB3' ' A' ' 52' ' ' LEU . 1.8 t -122.01 148.8 25.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.382 -177.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.795 HG12 ' HB2' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -126.16 112.0 28.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.991 178.037 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.416 ' O ' ' O ' ' A' ' 33' ' ' PHE . 8.7 t0 -161.42 -161.79 0.83 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.648 -178.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -66.36 -2.22 4.27 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -179.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 68.77 -153.23 0.16 Allowed 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 120.566 0.222 . . . . 0.0 110.711 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.41 ' OG ' ' N ' ' A' ' 14' ' ' SER . 62.5 p 33.66 -97.87 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 179.301 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.41 ' N ' ' OG ' ' A' ' 13' ' ' SER . 0.3 OUTLIER -52.85 -52.1 58.5 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 111.608 0.225 . . . . 0.0 111.608 -179.417 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 20.1 mm -64.24 -30.56 50.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.866 0.365 . . . . 0.0 111.215 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.593 ' HG3' HG22 ' A' ' 32' ' ' THR . 47.3 ttp180 -72.83 -41.77 64.49 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.961 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.502 ' O ' ' HD2' ' A' ' 21' ' ' ARG . 57.3 t90 -65.11 -53.51 44.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.999 -179.229 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.442 ' O ' HG12 ' A' ' 108' ' ' ILE . 2.1 t -60.24 -43.16 92.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -178.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.449 ' HA ' HD13 ' A' ' 19' ' ' LEU . 12.0 tp -82.44 -27.64 31.8 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -177.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.628 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 12.2 pt-20 -67.1 -62.3 1.5 Allowed 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 119.917 -0.713 . . . . 0.0 112.062 -178.461 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.674 ' HD2' ' H ' ' A' ' 21' ' ' ARG . 1.3 mpt_? -54.83 -49.16 71.73 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -179.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.408 ' HB3' HG23 ' A' ' 112' ' ' VAL . . . -52.87 -60.11 3.68 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.52 -179.45 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.477 ' CD2' ' CD1' ' A' ' 28' ' ' LEU . 2.6 mt -64.82 -27.36 68.83 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.081 0.467 . . . . 0.0 109.78 179.317 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.34 -34.92 79.26 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.78 -25.34 71.76 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.302 -0.952 . . . . 0.0 111.225 178.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.8 -15.42 59.74 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 120.681 0.277 . . . . 0.0 111.076 179.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.81 26.4 8.53 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.547 -0.835 . . . . 0.0 114.023 178.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.477 ' CD1' ' CD2' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -125.83 172.45 9.85 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 117.73 0.765 . . . . 0.0 112.158 -179.632 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.427 ' O ' HG11 ' A' ' 6' ' ' VAL . 23.5 m -99.01 105.77 17.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.193 179.298 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.628 ' HB3' ' HA ' ' A' ' 20' ' ' GLU . 11.4 t -100.86 111.31 23.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.066 -179.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.65 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.9 t -120.18 156.52 30.94 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.596 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 64.3 p -129.97 161.83 30.04 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.278 0.561 . . . . 0.0 112.04 -179.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.795 ' HB2' HG12 ' A' ' 9' ' ' VAL . 3.8 m-85 -129.42 173.99 10.04 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.572 -178.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.67 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 2.3 pp20? -60.04 -51.59 68.98 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -177.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.506 ' OD1' ' HB3' ' A' ' 58' ' ' PRO . 0.7 OUTLIER -150.59 -71.74 0.17 Allowed 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -178.454 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.59 ' O ' ' HG ' ' A' ' 40' ' ' LEU . . . -153.39 -42.41 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.4 -0.905 . . . . 0.0 113.709 -178.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.554 ' HA ' HD13 ' A' ' 40' ' ' LEU . 0.5 OUTLIER -67.59 -30.77 70.46 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-O 120.852 0.358 . . . . 0.0 111.361 -178.956 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.737 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -51.87 -59.85 3.85 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.751 179.86 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.551 ' CG2' HG12 ' A' ' 9' ' ' VAL . 0.8 OUTLIER -55.4 -41.51 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 C-N-CA 119.804 -0.759 . . . . 0.0 110.083 -179.637 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.59 ' HG ' ' O ' ' A' ' 36' ' ' GLY . 6.7 mt -53.32 -41.56 65.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.308 0.575 . . . . 0.0 109.845 179.078 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.48 -48.15 76.3 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.711 179.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.95 -26.75 63.31 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.894 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.549 HD11 ' NE2' ' A' ' 73' ' ' HIS . 1.1 mt -69.94 -22.46 63.18 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.564 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.48 -22.12 11.9 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.981 0.419 . . . . 0.0 110.847 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -130.48 2.45 4.58 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.612 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.673 ' HG2' ' CH2' ' A' ' 7' ' ' TRP . 1.3 tptp -138.05 161.48 36.63 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 121.523 0.678 . . . . 0.0 111.962 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.554 ' H ' ' HG3' ' A' ' 46' ' ' LYS . 51.1 m -139.38 111.25 7.7 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.674 178.06 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.512 ' HD2' HD23 ' A' ' 76' ' ' LEU . 73.2 Cg_endo -80.84 153.31 19.61 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.301 2.001 . . . . 0.0 111.305 179.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -74.44 -30.93 62.09 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.057 -179.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.522 HG22 HD13 ' A' ' 79' ' ' ILE . 9.0 p -150.95 103.71 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-O 120.892 0.377 . . . . 0.0 111.534 -179.44 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.691 ' HB2' HD21 ' A' ' 76' ' ' LEU . 11.1 tp -87.63 131.23 34.5 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -179.14 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.739 ' HB3' HG12 ' A' ' 8' ' ' VAL . 0.4 OUTLIER -115.17 127.42 55.54 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.446 179.524 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.481 ' CB ' HD13 ' A' ' 80' ' ' ILE . 0.6 OUTLIER -108.48 136.55 47.92 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 120.846 0.355 . . . . 0.0 110.972 179.969 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.428 ' O ' HG23 ' A' ' 55' ' ' ILE . 25.5 p-10 -79.54 -21.33 45.32 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -178.385 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.553 HG13 ' HA3' ' A' ' 62' ' ' GLY . 0.7 OUTLIER 44.81 86.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -179.666 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.411 ' O ' ' HG3' ' A' ' 56' ' ' ARG . 4.9 ptt85 -147.83 56.54 1.08 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 120.925 0.393 . . . . 0.0 111.832 179.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.454 ' N ' ' HD3' ' A' ' 58' ' ' PRO . 6.0 ttt 62.55 50.26 1.43 Allowed Pre-proline 0 N--CA 1.465 0.315 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 178.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 62' ' ' GLY . 45.2 Cg_endo -77.09 -77.01 0.01 OUTLIER 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 122.421 2.081 . . . . 0.0 111.749 178.397 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -118.04 -21.15 4.25 Favored Glycine 0 C--N 1.332 0.359 0 N-CA-C 111.798 -0.521 . . . . 0.0 111.798 179.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.503 ' N ' ' HB1' ' A' ' 64' ' ' ALA . 5.1 ttt -161.3 67.61 0.3 Allowed 'General case' 0 C--O 1.236 0.351 0 CA-C-O 120.978 0.418 . . . . 0.0 110.415 179.393 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.419 ' OD1' ' CE1' ' A' ' 84' ' ' HIS . 0.2 OUTLIER 69.79 -23.07 0.16 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.484 179.543 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.569 ' N ' ' HD2' ' A' ' 58' ' ' PRO . . . 136.36 -29.58 2.79 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 -178.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.612 ' HA ' ' CD1' ' A' ' 66' ' ' LEU . 4.1 mp -71.56 -21.93 61.82 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.465 -0.368 . . . . 0.0 110.225 179.285 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.503 ' HB1' ' N ' ' A' ' 60' ' ' MET . . . -53.74 -33.48 55.83 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.952 179.054 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.408 ' CG ' ' HA3' ' A' ' 36' ' ' GLY . 6.4 mp -56.99 -48.44 78.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.106 0.479 . . . . 0.0 110.76 179.692 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.612 ' CD1' ' HA ' ' A' ' 63' ' ' LEU . 4.9 mp -55.69 -40.3 72.18 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.763 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.658 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 0.1 OUTLIER -53.85 -48.07 70.34 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.9 179.286 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.559 ' HB2' HD11 ' A' ' 40' ' ' LEU . 13.1 mm-40 -71.39 -29.88 65.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.698 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.608 ' HA ' ' CE1' ' A' ' 73' ' ' HIS . 37.6 mt -62.72 -40.76 89.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.665 -179.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.658 ' HG2' ' O ' ' A' ' 67' ' ' LYS . 23.9 pttt -74.68 -29.58 61.27 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.475 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -85.88 -38.17 18.36 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -178.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 22.0 mtt-85 -95.33 -27.24 15.56 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -178.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.608 ' CE1' ' HA ' ' A' ' 69' ' ' ILE . 0.2 OUTLIER -107.52 134.85 19.83 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.699 -0.228 . . . . 0.0 111.131 -179.107 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.561 ' O ' ' HG2' ' A' ' 75' ' ' MET . 23.6 Cg_exo -63.66 79.88 0.14 Allowed 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.657 2.238 . . . . 0.0 112.587 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.561 ' HG2' ' O ' ' A' ' 74' ' ' PRO . 0.0 OUTLIER 50.69 43.19 27.93 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 121.558 0.694 . . . . 0.0 110.795 179.742 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.691 HD21 ' HB2' ' A' ' 51' ' ' LEU . 5.8 tp -68.24 137.08 91.47 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.678 -179.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.551 ' HD2' ' HG ' ' A' ' 76' ' ' LEU . 47.3 Cg_endo -67.34 125.09 12.92 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.495 2.13 . . . . 0.0 111.951 179.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.493 HG13 ' HG ' ' A' ' 66' ' ' LEU . 3.8 t -110.92 143.53 20.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.09 0.472 . . . . 0.0 111.614 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.522 HD13 HG22 ' A' ' 50' ' ' VAL . 2.3 mp -132.97 113.19 19.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.338 179.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.618 HG13 ' CZ ' ' A' ' 101' ' ' TYR . 13.0 mm -101.22 142.21 16.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.326 -179.211 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.483 ' O ' ' HB3' ' A' ' 102' ' ' LEU . 11.4 ptm -82.79 -21.23 34.64 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -178.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.581 ' O ' HG23 ' A' ' 80' ' ' ILE . 3.0 m -147.65 158.05 43.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.637 0.256 . . . . 0.0 111.22 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -138.53 66.43 1.43 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.571 -179.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.419 ' CE1' ' OD1' ' A' ' 61' ' ' ASP . 16.1 p80 -99.24 120.62 39.84 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 120.898 0.38 . . . . 0.0 111.578 -179.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 55.77 165.83 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.752 179.385 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.423 ' O ' HD22 ' A' ' 63' ' ' LEU . 1.0 OUTLIER 52.89 26.86 4.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.079 -179.817 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.423 ' HA ' HD22 ' A' ' 63' ' ' LEU . 0.1 OUTLIER -54.82 -23.72 19.62 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.352 -179.961 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -50.63 -35.93 32.85 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.829 -179.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.419 ' HB1' ' CB ' ' A' ' 63' ' ' LEU . . . -69.56 -23.32 63.55 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.798 0.333 . . . . 0.0 111.447 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.427 ' HB3' ' CE1' ' A' ' 101' ' ' TYR . . . -72.12 -30.63 65.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.209 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.647 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 5.5 t -66.67 -46.72 85.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.365 -179.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.6 m -58.12 -37.81 75.3 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.482 0.658 . . . . 0.0 110.093 179.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.557 ' CB ' HD23 ' A' ' 66' ' ' LEU . . . -56.89 -41.53 78.25 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.319 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.647 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 12.4 m-85 -59.03 -22.31 60.48 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.212 179.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.541 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -74.76 -39.76 61.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.518 -179.999 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.541 ' N ' ' HG2' ' A' ' 95' ' ' GLN . 4.8 pt20 -79.18 -11.12 59.97 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.376 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 108.05 32.15 3.37 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.336 -0.935 . . . . 0.0 112.91 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.545 ' HB2' ' HB2' ' A' ' 93' ' ' ALA . . . -61.07 145.76 49.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.756 0.278 . . . . 0.0 110.566 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.52 ' O ' ' HB3' ' A' ' 100' ' ' ASP . 9.2 t80 -71.08 -53.87 13.11 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.548 -179.387 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.52 ' HB3' ' O ' ' A' ' 99' ' ' PHE . 2.8 p30 166.82 -166.4 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.185 0.517 . . . . 0.0 111.498 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.618 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 4.8 m-85 -133.95 152.42 51.85 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.99 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.532 HD22 ' HA ' ' A' ' 106' ' ' PHE . 1.0 OUTLIER -104.72 119.02 54.94 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.258 179.584 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -67.84 -67.52 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.306 2.004 . . . . 0.0 112.448 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.586 ' H ' ' HD2' ' A' ' 105' ' ' PRO . 4.9 mttt -121.76 -61.95 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.969 -179.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.586 ' HD2' ' H ' ' A' ' 104' ' ' LYS . 9.7 Cg_endo -50.29 159.76 1.81 Allowed 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.42 2.08 . . . . 0.0 112.279 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.605 ' O ' ' O ' ' A' ' 107' ' ' ASP . 47.8 t80 -169.74 -105.83 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.414 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.605 ' O ' ' O ' ' A' ' 106' ' ' PHE . 2.7 p30 43.1 175.38 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.033 0.444 . . . . 0.0 111.447 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.473 HG21 HG21 ' A' ' 112' ' ' VAL . 0.9 OUTLIER -67.62 -41.07 85.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.09 0.472 . . . . 0.0 111.288 179.956 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.527 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 0.3 OUTLIER -50.01 -58.21 5.96 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.596 -179.707 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.581 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 58.4 mm-40 -77.32 -32.05 55.01 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -179.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.461 ' HB2' ' O ' ' A' ' 107' ' ' ASP . . . -67.33 -58.44 4.79 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.858 0.361 . . . . 0.0 110.237 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.716 ' O ' HG11 ' A' ' 115' ' ' VAL . 51.8 t -60.89 -32.46 52.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.488 0.661 . . . . 0.0 110.189 179.176 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.527 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -62.07 -44.8 95.9 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.567 0.699 . . . . 0.0 109.911 178.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.471 ' CD2' HG22 ' A' ' 79' ' ' ILE . 6.1 tp -74.97 -23.7 58.32 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.588 -179.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.716 HG11 ' O ' ' A' ' 112' ' ' VAL . 2.7 p -79.57 -42.75 23.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.832 0.348 . . . . 0.0 111.736 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.443 ' HG3' ' O ' ' A' ' 112' ' ' VAL . 31.6 mt-10 -60.31 -51.92 67.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.298 -179.394 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.407 ' NE ' ' HA ' ' A' ' 114' ' ' LEU . 0.1 OUTLIER -57.25 -23.88 51.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.852 0.358 . . . . 0.0 110.979 -179.993 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.473 ' CB ' ' CE1' ' A' ' 99' ' ' PHE . . . -70.39 -45.58 65.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.814 179.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 4.7 mt -77.22 -34.11 20.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.464 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.9 m -65.18 -47.06 78.29 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.969 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 11.1 m80 -70.54 -29.67 66.21 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.986 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -78.81 -41.3 30.66 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.677 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -75.4 -179.49 4.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.647 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.768 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.8 mmm . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 120.78 0.324 . . . . 0.0 111.255 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.1 mp0 -86.66 155.61 20.33 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.43 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.29 -3.21 16.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.387 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.468 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . 84.89 85.81 0.95 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.79 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.7 mp -101.01 113.11 36.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.933 0.397 . . . . 0.0 111.218 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.661 ' O ' ' HA ' ' A' ' 30' ' ' CYS . 5.9 p -105.44 120.18 55.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.281 179.648 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.607 ' NE1' HG23 ' A' ' 31' ' ' THR . 26.3 m0 -112.21 139.8 47.45 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.915 0.388 . . . . 0.0 110.512 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.855 HG12 ' HB3' ' A' ' 52' ' ' LEU . 0.2 OUTLIER -126.94 148.83 31.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.749 -178.765 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.735 HG12 ' HB2' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -127.01 114.61 38.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.002 0.429 . . . . 0.0 109.995 179.023 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.937 ' HB3' HG13 ' A' ' 15' ' ' ILE . 9.1 t0 -171.05 -150.24 0.07 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.426 -178.306 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -66.49 -3.37 6.08 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.511 ' O ' ' N ' ' A' ' 16' ' ' ARG . 2.3 t0 69.19 -79.52 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 178.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -40.83 -78.35 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -178.327 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.505 ' O ' HG22 ' A' ' 18' ' ' VAL . 1.7 t -52.61 -32.6 42.44 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.669 -178.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.937 HG13 ' HB3' ' A' ' 10' ' ' ASP . 23.2 mm -77.53 -28.69 16.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.892 -179.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.592 ' HA ' ' HG3' ' A' ' 20' ' ' GLU . 14.1 ttt180 -58.35 -44.69 88.89 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.307 0.575 . . . . 0.0 110.176 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.729 ' O ' ' HB2' ' A' ' 21' ' ' ARG . 38.4 t90 -71.95 -62.22 1.5 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.766 -179.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.505 HG22 ' O ' ' A' ' 14' ' ' SER . 0.5 OUTLIER -59.17 -60.89 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 -177.056 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.722 ' CD1' HG11 ' A' ' 8' ' ' VAL . 13.9 mt -70.67 -51.49 27.42 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -175.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.592 ' HG3' ' HA ' ' A' ' 16' ' ' ARG . 5.1 mt-10 -67.62 -61.66 1.79 Allowed 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -178.316 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.729 ' HB2' ' O ' ' A' ' 17' ' ' TRP . 0.0 OUTLIER -49.99 -44.45 50.97 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.058 -178.202 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.82 -37.37 76.2 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.672 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.594 ' HB2' ' O ' ' A' ' 19' ' ' LEU . 3.0 mt -75.22 -27.1 59.42 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 178.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.409 ' N ' ' O ' ' A' ' 20' ' ' GLU . . . -63.72 -35.65 81.28 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.94 -26.2 69.97 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.171 -1.014 . . . . 0.0 110.993 178.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.467 ' CB ' HD13 ' A' ' 28' ' ' LEU . . . -76.85 -15.53 59.68 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 120.565 0.221 . . . . 0.0 110.923 179.345 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.13 26.71 9.97 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 120.636 -0.792 . . . . 0.0 113.955 179.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.499 ' CD1' ' CD2' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -123.72 168.87 12.12 Favored 'General case' 0 N--CA 1.456 -0.125 0 CA-C-N 117.707 0.754 . . . . 0.0 111.788 -179.983 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 58.2 m -96.44 113.52 25.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.918 179.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.661 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 3.1 t -112.05 117.51 32.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.093 0.473 . . . . 0.0 112.195 -179.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.607 HG23 ' NE1' ' A' ' 7' ' ' TRP . 3.3 t -123.57 139.85 53.59 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.169 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 76.8 p -112.5 161.42 16.76 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.129 0.49 . . . . 0.0 111.388 -178.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.74 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 3.7 m-85 -131.28 174.08 10.41 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.806 -177.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.703 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 3.2 pp20? -63.19 -39.04 93.5 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -177.219 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -164.2 -57.61 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.301 0 C-N-CA 119.755 -0.778 . . . . 0.0 113.049 -178.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.683 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . -169.07 -44.42 0.03 OUTLIER Glycine 0 C--N 1.318 -0.471 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.64 -178.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.508 ' N ' HD21 ' A' ' 65' ' ' LEU . 0.5 OUTLIER -64.88 -30.43 71.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.995 0.426 . . . . 0.0 110.96 -179.329 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.74 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -54.34 -52.84 60.29 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.551 -179.945 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.529 HG23 HG11 ' A' ' 9' ' ' VAL . 11.5 t -48.76 -38.77 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-O 121.017 0.437 . . . . 0.0 111.1 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.57 HD11 ' HB2' ' A' ' 68' ' ' GLN . 15.9 mt -61.82 -42.14 98.65 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.564 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.41 -49.45 73.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.19 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.86 -31.86 66.89 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.542 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.569 HD11 ' NE2' ' A' ' 73' ' ' HIS . 5.7 mt -59.88 -24.02 63.93 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.297 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.36 -19.32 34.53 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.439 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.5 t -121.52 0.88 10.03 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.451 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 3.6 tttt -165.37 164.39 19.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.944 0.402 . . . . 0.0 111.367 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.528 ' HA ' HD21 ' A' ' 43' ' ' LEU . 85.9 m -138.79 116.83 9.09 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.948 179.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.546 ' HD2' HD23 ' A' ' 43' ' ' LEU . 40.0 Cg_endo -74.82 156.06 43.8 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 121.796 1.664 . . . . 0.0 111.466 179.25 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -74.05 -30.84 62.6 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.079 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.518 HG22 HD13 ' A' ' 79' ' ' ILE . 14.9 p -149.49 106.27 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 CA-C-O 120.737 0.303 . . . . 0.0 111.699 -179.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.453 HD21 HG11 ' A' ' 39' ' ' VAL . 20.5 tp -87.07 155.32 20.19 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.937 0.399 . . . . 0.0 111.201 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.855 ' HB3' HG12 ' A' ' 8' ' ' VAL . 2.4 tt -137.16 119.6 15.85 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.197 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.518 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 0.6 OUTLIER -111.86 128.44 56.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.781 0.324 . . . . 0.0 111.378 -179.662 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.06 -2.9 56.55 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.463 HD11 ' CE1' ' A' ' 84' ' ' HIS . 3.0 tt 41.97 91.13 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-O 120.805 0.336 . . . . 0.0 111.698 179.409 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.4 ttt85 -117.56 40.17 3.14 Favored 'General case' 0 N--CA 1.461 0.111 0 N-CA-C 111.96 0.355 . . . . 0.0 111.96 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.592 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER 56.81 44.11 1.3 Allowed Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 179.042 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.478 ' CD ' ' N ' ' A' ' 57' ' ' MET . 30.1 Cg_endo -63.29 -80.81 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 121.959 1.773 . . . . 0.0 111.02 178.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -102.42 -86.6 1.95 Allowed Glycine 0 C--N 1.334 0.43 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 178.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.787 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -87.82 60.97 6.18 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 177.228 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.592 ' HA ' ' HA ' ' A' ' 57' ' ' MET . 0.1 OUTLIER 65.57 -28.2 0.11 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.65 -1.159 . . . . 0.0 112.447 -179.494 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.562 ' H ' ' C ' ' A' ' 60' ' ' MET . . . 152.15 -35.19 0.84 Allowed Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 110.946 -0.861 . . . . 0.0 110.946 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.425 ' CB ' ' HB1' ' A' ' 89' ' ' ALA . 1.0 OUTLIER -64.07 -21.43 66.52 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 178.878 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.787 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -53.56 -38.43 63.86 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 120.969 0.414 . . . . 0.0 110.389 179.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.572 ' O ' HG13 ' A' ' 69' ' ' ILE . 0.2 OUTLIER -55.03 -44.99 75.14 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.781 179.836 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.573 HD11 ' HB3' ' A' ' 93' ' ' ALA . 5.8 mt -54.5 -42.5 70.85 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.503 179.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.605 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 21.6 tttt -57.77 -43.47 85.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.704 179.451 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.57 ' HB2' HD11 ' A' ' 40' ' ' LEU . 8.2 mm100 -69.51 -27.78 65.47 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.851 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.572 HG13 ' O ' ' A' ' 65' ' ' LEU . 96.7 mt -64.58 -36.85 78.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.96 -179.083 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.605 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -78.15 -31.62 49.84 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.512 -179.52 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -63.72 -44.53 93.32 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.076 -178.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.2 mtt85 -96.42 -50.93 4.56 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.857 -179.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.569 ' NE2' HD11 ' A' ' 43' ' ' LEU . 0.3 OUTLIER -95.77 156.38 37.4 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.834 -179.326 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -66.28 -73.29 0.02 OUTLIER 'Trans proline' 0 CA--C 1.528 0.209 0 C-N-CA 122.538 2.159 . . . . 0.0 112.682 -179.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 7.3 mtt -145.16 55.52 1.22 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.7 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.536 HD23 HD23 ' A' ' 43' ' ' LEU . 22.5 tp -61.9 111.21 4.11 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.111 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -60.35 134.25 54.2 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.379 2.053 . . . . 0.0 112.387 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.742 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 5.1 t -131.43 152.93 38.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.25 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.661 ' HB ' ' HG ' ' A' ' 52' ' ' LEU . 1.1 mt -126.8 113.2 31.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.721 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.518 ' HA ' ' O ' ' A' ' 53' ' ' SER . 9.5 mm -101.86 134.9 41.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -178.051 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.539 ' HB2' ' CD1' ' A' ' 106' ' ' PHE . 2.4 ptt? -69.16 -34.01 74.3 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.271 -0.877 . . . . 0.0 112.216 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 7.3 m -139.16 150.72 45.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.752 0.311 . . . . 0.0 111.348 -179.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.541 ' CB ' ' CD2' ' A' ' 101' ' ' TYR . . . -121.06 70.58 0.92 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.731 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.463 ' CE1' HD11 ' A' ' 55' ' ' ILE . 2.6 p80 -98.94 -179.27 4.22 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.193 179.174 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 63.99 -161.42 0.29 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.769 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.41 88.74 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.924 0.392 . . . . 0.0 111.377 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.425 HD22 ' HB1' ' A' ' 83' ' ' ALA . 0.3 OUTLIER -51.85 -24.0 5.56 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.465 179.804 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -48.84 -36.36 16.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.008 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.425 ' HB1' ' CB ' ' A' ' 63' ' ' LEU . . . -72.84 -19.84 61.24 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.219 -179.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.459 ' HB1' ' CE1' ' A' ' 101' ' ' TYR . . . -68.93 -52.37 29.97 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.984 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.598 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 9.4 t -66.33 -44.94 90.72 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.19 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.845 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.662 ' O ' ' HG3' ' A' ' 95' ' ' GLN . 3.3 m -61.08 -14.54 24.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.889 0.376 . . . . 0.0 110.035 178.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.573 ' HB3' HD11 ' A' ' 66' ' ' LEU . . . -75.15 -61.74 1.79 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.113 0.482 . . . . 0.0 111.066 179.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.598 ' CE2' ' HA ' ' A' ' 91' ' ' VAL . 4.7 m-85 -44.84 -36.14 3.12 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.384 -178.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.662 ' HG3' ' O ' ' A' ' 92' ' ' SER . 1.7 pp0? -76.25 -37.01 58.21 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.959 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.498 ' HB2' ' HB3' ' A' ' 70' ' ' LYS . 10.3 pt20 -100.12 11.19 39.93 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -179.318 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 93' ' ' ALA . . . 122.21 79.0 0.48 Allowed Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.187 -1.006 . . . . 0.0 113.449 179.598 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.742 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -169.14 142.49 2.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.731 0.301 . . . . 0.0 110.637 178.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.503 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 3.3 t80 -84.49 -53.15 5.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.585 -178.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.577 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 0.4 OUTLIER 178.83 -165.58 0.05 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.139 0.495 . . . . 0.0 111.61 179.984 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.541 ' CD2' ' CB ' ' A' ' 83' ' ' ALA . 3.5 m-85 -136.38 153.73 51.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.458 -179.209 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.53 ' HG ' ' HB3' ' A' ' 106' ' ' PHE . 0.4 OUTLIER -101.9 118.85 58.5 Favored Pre-proline 0 C--N 1.327 -0.372 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 179.059 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.401 ' C ' ' HG3' ' A' ' 104' ' ' LYS . 61.5 Cg_exo -51.28 -42.49 53.97 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.58 2.187 . . . . 0.0 112.466 -179.211 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.603 ' HB2' ' HD3' ' A' ' 105' ' ' PRO . 40.3 mttp -156.07 -54.11 0.02 OUTLIER Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.173 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.603 ' HD3' ' HB2' ' A' ' 104' ' ' LYS . 98.1 Cg_endo -80.97 163.78 20.31 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.262 1.975 . . . . 0.0 112.229 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.672 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 0.5 OUTLIER -169.89 -75.88 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.487 178.928 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.547 ' O ' ' CB ' ' A' ' 111' ' ' ALA . 3.1 p30 37.32 -166.49 0.0 OUTLIER 'General case' 0 C--O 1.225 -0.189 0 CA-C-N 116.682 -0.235 . . . . 0.0 110.41 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.468 HD11 ' HG ' ' A' ' 19' ' ' LEU . 1.1 mp -67.85 -44.8 85.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 C-N-CA 120.11 -0.636 . . . . 0.0 111.366 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.76 ' O ' ' HB1' ' A' ' 113' ' ' ALA . 2.6 m-20 -53.58 -58.06 8.52 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.666 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.672 ' HB2' ' HA ' ' A' ' 106' ' ' PHE . 3.1 mm-40 -79.2 -28.04 42.58 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -178.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.547 ' CB ' ' O ' ' A' ' 107' ' ' ASP . . . -78.31 -55.09 5.52 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.349 -0.541 . . . . 0.0 110.084 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.789 ' O ' HG11 ' A' ' 115' ' ' VAL . 60.4 t -58.57 -29.51 39.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-O 121.549 0.69 . . . . 0.0 109.881 178.311 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.76 ' HB1' ' O ' ' A' ' 109' ' ' ASP . . . -64.82 -47.97 76.09 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.718 178.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.582 HD21 ' CG2' ' A' ' 79' ' ' ILE . 10.6 tp -73.83 -20.66 60.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.455 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.789 HG11 ' O ' ' A' ' 112' ' ' VAL . 2.6 p -78.52 -43.42 26.27 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-O 120.735 0.302 . . . . 0.0 111.526 -179.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.482 ' HA ' HD12 ' A' ' 119' ' ' ILE . 35.7 mt-10 -66.2 -41.92 89.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.209 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 28.4 mtp-105 -61.18 -25.64 67.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.646 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.51 ' HB2' HG23 ' A' ' 50' ' ' VAL . . . -73.01 -40.44 65.18 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.305 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.482 HD12 ' HA ' ' A' ' 116' ' ' GLU . 3.8 mt -75.42 -30.51 22.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 121.125 0.488 . . . . 0.0 110.658 179.117 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 91.5 p -67.35 -43.32 81.78 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.567 -179.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 17.8 m80 -66.76 -23.76 66.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.006 0.431 . . . . 0.0 110.943 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -77.88 -50.59 11.95 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.734 179.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.524 ' HG3' ' HG2' ' A' ' 124' ' ' GLU . 19.7 pt20 -75.9 -173.59 2.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.89 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.524 ' HG2' ' HG3' ' A' ' 123' ' ' GLN . 6.9 mm-40 . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.859 -179.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 120.92 0.39 . . . . 0.0 111.22 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -120.98 161.39 21.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.546 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.23 -4.97 19.88 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.475 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 90.27 81.57 1.37 Allowed Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.942 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.6 mp -103.3 112.32 36.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.96 0.41 . . . . 0.0 111.26 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.594 HG13 ' CD2' ' A' ' 23' ' ' LEU . 4.3 p -106.92 126.64 62.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.1 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.518 ' CD1' ' CG2' ' A' ' 31' ' ' THR . 40.6 m0 -112.82 136.46 52.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.896 0.379 . . . . 0.0 110.444 179.512 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.656 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.1 OUTLIER -125.95 138.81 53.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.336 -178.658 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 1.019 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -115.6 105.59 18.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.988 0.423 . . . . 0.0 110.217 178.58 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.652 ' HB3' HG21 ' A' ' 15' ' ' ILE . 10.2 t0 -173.09 117.12 0.29 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.226 -179.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.594 ' O ' ' HB2' ' A' ' 12' ' ' ASP . 0.1 OUTLIER 47.67 -86.4 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.787 179.826 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.594 ' HB2' ' O ' ' A' ' 11' ' ' ASP . 15.4 t0 170.91 -133.31 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.676 -0.238 . . . . 0.0 110.824 -179.57 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 75.0 m -40.89 -42.03 1.74 Allowed 'General case' 0 C--N 1.341 0.234 0 CA-C-O 121.072 0.463 . . . . 0.0 112.117 -179.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.434 ' O ' HG23 ' A' ' 18' ' ' VAL . 27.6 m -53.18 -63.51 1.12 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.675 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.652 HG21 ' HB3' ' A' ' 10' ' ' ASP . 15.1 mm -70.46 -20.61 22.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.871 0.367 . . . . 0.0 110.667 179.488 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.489 ' HB2' ' OG1' ' A' ' 32' ' ' THR . 3.4 ttt180 -69.77 -55.56 9.53 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.846 179.282 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.49 ' O ' ' HG3' ' A' ' 20' ' ' GLU . 89.6 t90 -53.58 -45.09 69.84 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.708 -179.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 14' ' ' SER . 3.1 t -65.58 -45.13 93.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -178.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.66 -26.93 29.45 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -177.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.52 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 1.0 OUTLIER -66.61 -60.92 2.28 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -179.063 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 31.1 mmm-85 -52.77 -63.21 1.22 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.734 0.302 . . . . 0.0 111.802 -179.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -49.75 -54.69 17.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.046 0.45 . . . . 0.0 111.554 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.649 HD13 ' CD1' ' A' ' 28' ' ' LEU . 9.3 tp -66.36 -19.43 65.8 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.183 179.316 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.52 ' HB2' ' O ' ' A' ' 20' ' ' GLU . . . -70.32 -35.85 73.91 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.13 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -57.59 -27.83 59.09 Favored Glycine 0 C--N 1.335 0.527 0 C-N-CA 120.51 -0.852 . . . . 0.0 111.035 178.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.438 ' CB ' HD13 ' A' ' 28' ' ' LEU . . . -77.98 -15.8 58.66 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 120.716 0.293 . . . . 0.0 110.495 178.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.94 26.61 14.17 Favored Glycine 0 C--N 1.337 0.609 0 C-N-CA 120.637 -0.792 . . . . 0.0 114.501 178.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.649 ' CD1' HD13 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -116.06 164.94 13.71 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 118.32 1.06 . . . . 0.0 112.23 -179.779 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.445 ' O ' HG12 ' A' ' 6' ' ' VAL . 27.0 m -94.4 118.56 31.81 Favored 'General case' 0 CA--C 1.521 -0.149 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.484 179.053 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.535 ' SG ' ' HB3' ' A' ' 23' ' ' LEU . 3.0 m -108.46 118.61 37.23 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -178.323 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.611 HG21 ' CE1' ' A' ' 33' ' ' PHE . 2.7 t -122.79 139.76 53.65 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.047 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.656 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 69.0 p -115.01 161.63 18.08 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -177.496 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 1.019 ' HB2' HG13 ' A' ' 9' ' ' VAL . 12.1 m-85 -136.27 174.88 10.13 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 114.868 -1.06 . . . . 0.0 111.834 -178.316 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.429 ' HG2' ' H ' ' A' ' 35' ' ' ASN . 3.6 pt-20 -62.0 -46.94 87.02 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -177.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.529 ' C ' HG11 ' A' ' 9' ' ' VAL . 0.5 OUTLIER -168.41 -27.97 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 118.58 0.627 . . . . 0.0 112.687 -179.573 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.519 ' HA2' HG12 ' A' ' 9' ' ' VAL . . . 171.91 -59.66 0.16 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.402 -0.904 . . . . 0.0 112.754 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.597 ' HA ' HD11 ' A' ' 40' ' ' LEU . 6.5 m120 -48.1 -34.52 9.86 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 120.845 0.355 . . . . 0.0 110.979 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.882 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 5.2 tt0 -60.25 -55.65 31.12 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.382 179.082 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.593 HG23 HG12 ' A' ' 9' ' ' VAL . 6.2 t -53.93 -44.22 60.56 Favored 'Isoleucine or valine' 0 C--N 1.345 0.401 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.459 179.126 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.597 HD11 ' HA ' ' A' ' 37' ' ' ASN . 21.0 mt -57.51 -42.68 83.27 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.877 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.53 -50.13 40.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.075 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.55 -27.58 69.35 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.639 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.764 HD13 ' NE2' ' A' ' 73' ' ' HIS . 6.1 mt -67.71 -23.53 65.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.556 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.39 -16.71 15.83 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.182 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -117.43 -3.39 11.4 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.824 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.33 163.06 15.16 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.984 0.421 . . . . 0.0 111.73 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 66.3 m -139.11 112.47 8.08 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.522 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.509 ' HD2' ' CD1' ' A' ' 76' ' ' LEU . 66.6 Cg_endo -72.52 165.49 32.56 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.179 1.92 . . . . 0.0 111.548 178.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -74.09 -24.34 59.47 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 121.132 -0.227 . . . . 0.0 111.26 -179.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.512 HG12 ' HA ' ' A' ' 6' ' ' VAL . 7.2 p -145.15 166.45 11.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.43 ' HB2' HD21 ' A' ' 76' ' ' LEU . 19.6 tp -152.91 132.55 13.07 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 121.06 0.457 . . . . 0.0 111.368 -179.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.62 HD22 ' O ' ' A' ' 79' ' ' ILE . 0.9 OUTLIER -116.52 139.33 50.6 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.795 -179.878 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.509 ' HB2' ' CD1' ' A' ' 80' ' ' ILE . 8.1 m -127.1 128.44 46.23 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.978 0.418 . . . . 0.0 111.384 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.439 ' O ' HG21 ' A' ' 55' ' ' ILE . 44.6 t0 -69.48 -16.65 63.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.587 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.677 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 2.5 tt 43.79 72.58 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.109 -0.496 . . . . 0.0 112.262 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 177.46 61.82 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.695 179.245 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.577 ' HB3' ' CD ' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -162.0 -64.25 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.698 179.964 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.577 ' CD ' ' HB3' ' A' ' 57' ' ' MET . 36.4 Cg_endo -63.02 -165.6 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.694 2.263 . . . . 0.0 113.228 -179.496 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.79 -67.32 2.13 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.656 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.589 ' HB2' ' HB2' ' A' ' 64' ' ' ALA . 0.2 OUTLIER -79.95 51.23 1.31 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.941 0.4 . . . . 0.0 110.762 179.809 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.477 ' O ' ' HD2' ' A' ' 58' ' ' PRO . 0.1 OUTLIER 54.42 -74.56 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.407 179.643 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.677 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -144.14 -34.84 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.456 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.521 HD22 ' O ' ' A' ' 86' ' ' ASP . 0.5 OUTLIER -54.05 -23.55 14.07 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.654 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.589 ' HB2' ' HB2' ' A' ' 60' ' ' MET . . . -54.22 -36.48 63.54 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.795 178.183 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.518 ' CD1' ' HG3' ' A' ' 58' ' ' PRO . 9.9 mp -59.47 -55.54 33.34 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.306 179.29 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.421 ' CD1' ' HB3' ' A' ' 93' ' ' ALA . 17.0 mt -44.24 -42.53 6.63 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.666 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.47 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 11.3 mttp -57.93 -47.19 83.59 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.037 179.159 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.491 ' HB2' HD12 ' A' ' 40' ' ' LEU . 10.6 mm100 -68.02 -30.33 69.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.375 179.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.659 HG22 ' CE1' ' A' ' 73' ' ' HIS . 77.9 mt -65.21 -45.11 94.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.222 -179.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.47 ' HG2' ' O ' ' A' ' 67' ' ' LYS . 8.9 ptmt -64.81 -29.31 70.27 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.961 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -72.72 -36.51 67.8 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.093 0.473 . . . . 0.0 110.928 179.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.44 -70.96 0.7 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.556 -179.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.764 ' NE2' HD13 ' A' ' 43' ' ' LEU . 2.2 p80 -117.83 78.0 12.11 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.59 -179.197 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.448 ' HA ' ' OE1' ' A' ' 96' ' ' GLN . 72.4 Cg_endo -76.46 56.27 5.02 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.536 2.157 . . . . 0.0 112.563 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 38.2 mtt -154.8 -43.02 0.09 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.093 0.473 . . . . 0.0 111.457 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.621 ' HB2' ' HD1' ' A' ' 73' ' ' HIS . 1.0 OUTLIER -53.08 125.11 40.2 Favored Pre-proline 0 C--N 1.32 -0.679 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.614 -179.941 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.535 ' HD2' HD23 ' A' ' 76' ' ' LEU . 24.8 Cg_exo -61.82 129.65 28.37 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.428 2.085 . . . . 0.0 112.871 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 5.2 t -110.2 138.87 36.1 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.78 179.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.62 ' O ' HD22 ' A' ' 52' ' ' LEU . 1.7 mt -123.8 113.2 36.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.545 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.543 HG13 ' CZ ' ' A' ' 101' ' ' TYR . 15.1 mm -101.08 145.87 10.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.299 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.567 ' HG3' ' CG2' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -80.5 -30.11 37.33 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.242 -0.435 . . . . 0.0 112.029 -179.038 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.436 HG21 ' ND1' ' A' ' 84' ' ' HIS . 4.8 m -147.44 146.48 29.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.836 0.35 . . . . 0.0 111.354 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.56 ' O ' ' HG ' ' A' ' 87' ' ' LEU . . . -112.67 47.94 1.05 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.351 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.436 ' ND1' HG21 ' A' ' 82' ' ' THR . 0.7 OUTLIER -98.49 -175.19 3.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.721 0.296 . . . . 0.0 110.743 179.816 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.415 ' HB2' ' O ' ' A' ' 84' ' ' HIS . 45.9 m 71.6 -78.39 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.793 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.521 ' O ' HD22 ' A' ' 63' ' ' LEU . 7.6 m-20 -138.99 68.1 1.38 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.64 0.257 . . . . 0.0 111.633 -179.327 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.56 ' HG ' ' O ' ' A' ' 83' ' ' ALA . 0.4 OUTLIER -45.69 -23.82 0.29 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.898 179.467 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -48.54 -46.13 38.42 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -179.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.455 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -65.07 -20.04 66.29 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.809 0.338 . . . . 0.0 111.622 -179.379 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.541 ' HB2' ' CE1' ' A' ' 101' ' ' TYR . . . -68.84 -36.11 77.77 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.055 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.641 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 8.2 t -63.07 -41.2 91.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.063 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 44.5 m -63.31 -35.26 79.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.224 0.535 . . . . 0.0 110.306 179.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.529 ' O ' ' HG3' ' A' ' 96' ' ' GLN . . . -57.78 -39.57 77.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.998 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.641 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 10.7 m-85 -63.24 -20.95 65.9 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.379 179.249 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.603 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -74.23 -41.37 61.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.723 -179.808 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.603 ' N ' ' HG2' ' A' ' 95' ' ' GLN . 1.0 OUTLIER -78.59 -18.47 54.53 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.494 -179.332 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 122.01 29.47 1.36 Allowed Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.789 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.504 ' HB1' ' HB1' ' A' ' 93' ' ' ALA . . . -64.1 143.32 57.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.762 0.281 . . . . 0.0 110.809 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.443 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 18.9 t80 -71.49 -53.96 12.19 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.249 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 168.21 -164.96 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.16 0.505 . . . . 0.0 111.124 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.543 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 3.3 m-85 -130.67 150.96 51.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.259 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.6 HD23 ' HA ' ' A' ' 106' ' ' PHE . 5.6 tp -102.87 135.56 19.42 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.986 -179.427 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -78.96 -152.87 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.426 2.084 . . . . 0.0 111.904 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.505 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 5.7 mtpt -43.05 -56.55 6.2 Favored Pre-proline 0 CA--C 1.533 0.322 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.505 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 13.2 Cg_endo -56.71 163.39 7.21 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.565 2.177 . . . . 0.0 112.282 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.6 ' HA ' HD23 ' A' ' 102' ' ' LEU . 45.5 t80 -171.92 -105.03 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.892 179.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.521 ' O ' ' O ' ' A' ' 106' ' ' PHE . 4.6 p-10 43.75 -179.08 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.98 0.419 . . . . 0.0 111.039 -179.421 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.405 HG23 HG23 ' A' ' 112' ' ' VAL . 0.9 OUTLIER -67.84 -41.13 84.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 120.969 0.414 . . . . 0.0 111.533 -179.852 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.497 ' O ' ' HB1' ' A' ' 113' ' ' ALA . 12.7 t70 -50.6 -58.56 5.54 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.623 -179.496 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.587 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 36.3 mm-40 -77.1 -30.89 55.51 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.663 0.268 . . . . 0.0 111.64 -179.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.403 ' CB ' ' O ' ' A' ' 107' ' ' ASP . . . -68.46 -61.13 1.97 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.018 0.437 . . . . 0.0 110.283 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.638 ' O ' HG12 ' A' ' 115' ' ' VAL . 58.1 t -57.63 -30.51 37.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.587 0.708 . . . . 0.0 110.25 178.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.497 ' HB1' ' O ' ' A' ' 109' ' ' ASP . . . -63.86 -46.33 85.48 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.191 179.207 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.528 ' HA ' ' HG2' ' A' ' 117' ' ' ARG . 35.6 tp -74.66 -22.87 58.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.085 -179.316 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.638 HG12 ' O ' ' A' ' 112' ' ' VAL . 4.8 p -79.39 -46.44 23.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 120.442 -0.503 . . . . 0.0 111.639 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -63.82 -45.29 90.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.963 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.528 ' HG2' ' HA ' ' A' ' 114' ' ' LEU . 0.0 OUTLIER -59.09 -27.06 65.19 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.956 0.408 . . . . 0.0 110.796 179.741 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.443 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -67.93 -47.64 68.17 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.629 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.416 HD13 ' CD2' ' A' ' 28' ' ' LEU . 4.5 mt -74.15 -31.17 28.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.819 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.0 t -69.64 -42.05 74.77 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.974 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -65.78 -22.81 66.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.976 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.417 ' OH ' ' HG3' ' A' ' 77' ' ' PRO . 5.4 m-85 -73.74 -48.24 33.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.89 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.39 -53.74 8.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.119 0.485 . . . . 0.0 110.527 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 . . . . . 0 C--N 1.319 -0.745 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.872 179.695 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.861 0.362 . . . . 0.0 111.174 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -58.71 174.52 0.33 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.047 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.05 -43.91 90.77 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.225 0.536 . . . . 0.0 110.764 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.516 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . 61.74 87.99 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.507 -0.769 . . . . 0.0 112.49 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.7 mp -111.0 112.34 40.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.848 0.356 . . . . 0.0 111.514 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.644 HG23 HD12 ' A' ' 23' ' ' LEU . 2.8 p -107.83 126.21 64.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.309 178.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.642 ' HB2' ' HG3' ' A' ' 48' ' ' PRO . 27.2 m0 -114.11 140.21 48.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.846 0.355 . . . . 0.0 110.181 179.17 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.517 HG22 ' CD2' ' A' ' 19' ' ' LEU . 1.1 t -123.73 147.71 28.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.36 -178.378 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.831 HG11 ' HB2' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -130.93 112.03 21.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.094 0.473 . . . . 0.0 110.446 179.146 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -161.64 -158.64 0.57 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.711 -178.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -66.87 -1.85 4.47 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.349 0.499 . . . . 0.0 112.349 -179.464 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.424 ' O ' ' N ' ' A' ' 14' ' ' SER . 0.2 OUTLIER 69.43 -157.97 0.16 Allowed 'General case' 0 CA--C 1.532 0.254 0 O-C-N 122.443 -0.16 . . . . 0.0 110.875 179.912 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.6 t 34.06 -88.96 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 179.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.424 ' N ' ' O ' ' A' ' 12' ' ' ASP . 3.6 m -53.02 -63.38 1.16 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.809 0.338 . . . . 0.0 111.216 -179.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.8 mm -61.46 -25.67 37.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.984 0.421 . . . . 0.0 110.89 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.512 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 30.8 ttt180 -71.42 -55.64 7.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.591 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.431 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 30.1 t90 -58.63 -41.1 85.17 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -179.193 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.436 HG11 HG12 ' A' ' 108' ' ' ILE . 2.5 t -65.26 -49.12 80.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -178.297 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.592 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 9.7 tp -82.64 -24.79 33.63 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -178.348 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.533 ' HG3' ' N ' ' A' ' 21' ' ' ARG . 10.7 pt-20 -65.75 -57.6 7.63 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.721 -179.368 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.533 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 1.2 mmt-85 -67.12 -48.99 66.44 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.063 -179.192 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.11 -40.57 81.54 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -178.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.669 ' CD2' HD13 ' A' ' 28' ' ' LEU . 0.2 OUTLIER -77.37 -25.13 50.68 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.225 0.536 . . . . 0.0 110.053 179.217 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.03 -34.24 77.63 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.97 -23.61 71.21 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 177.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.54 ' CB ' HD11 ' A' ' 28' ' ' LEU . . . -76.71 -15.4 59.79 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 120.87 0.366 . . . . 0.0 110.471 179.032 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.87 26.27 11.86 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 120.945 -0.645 . . . . 0.0 113.815 178.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.669 HD13 ' CD2' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -132.78 169.09 17.22 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 117.534 0.667 . . . . 0.0 112.384 -179.371 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 32.9 m -89.84 109.1 20.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.75 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.515 ' HA ' HG11 ' A' ' 6' ' ' VAL . 47.3 t -107.48 110.55 22.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.076 0.465 . . . . 0.0 111.585 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.51 ' CG2' ' CD1' ' A' ' 7' ' ' TRP . 2.7 t -118.96 153.45 34.61 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.512 ' CG2' ' HA ' ' A' ' 16' ' ' ARG . 34.5 p -125.35 162.79 24.0 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.301 0.572 . . . . 0.0 111.945 -179.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.831 ' HB2' HG11 ' A' ' 9' ' ' VAL . 1.1 m-85 -129.3 174.22 9.8 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.431 -178.264 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.44 ' HG2' ' N ' ' A' ' 35' ' ' ASN . 0.6 OUTLIER -61.6 -37.14 82.81 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 -177.299 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.44 ' N ' ' HG2' ' A' ' 34' ' ' GLU . 5.1 m120 -169.85 -56.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 118.443 0.565 . . . . 0.0 112.133 -179.474 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.551 ' HA2' HG13 ' A' ' 9' ' ' VAL . . . -164.7 -58.53 0.02 OUTLIER Glycine 0 C--N 1.318 -0.432 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.951 -179.175 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.603 ' HA ' HD11 ' A' ' 40' ' ' LEU . 0.4 OUTLIER -48.79 -34.98 13.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.687 0.28 . . . . 0.0 111.742 -179.456 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.703 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -55.33 -54.05 48.4 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.509 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.571 HG11 ' HG ' ' A' ' 43' ' ' LEU . 39.0 t -58.65 -42.53 85.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.569 179.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.603 HD11 ' HA ' ' A' ' 37' ' ' ASN . 4.0 mt -51.24 -45.47 62.01 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.794 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.64 -47.31 40.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.301 0.572 . . . . 0.0 110.867 179.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.81 -31.04 70.45 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.132 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.571 ' HG ' HG11 ' A' ' 39' ' ' VAL . 11.7 mt -68.68 -20.67 64.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.763 -179.553 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.77 -18.4 12.55 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.511 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.7 t -122.69 -0.46 9.13 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -164.22 157.15 17.56 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.064 0.459 . . . . 0.0 111.603 179.918 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.408 ' HA ' ' CD2' ' A' ' 43' ' ' LEU . 96.2 m -139.03 115.99 8.72 Favored Pre-proline 0 N--CA 1.45 -0.433 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.143 179.543 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.642 ' HG3' ' HB2' ' A' ' 7' ' ' TRP . 58.5 Cg_endo -72.24 165.08 33.68 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.267 1.978 . . . . 0.0 111.167 178.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -75.28 -27.09 59.23 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.966 -0.294 . . . . 0.0 111.267 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.454 ' CG2' HD12 ' A' ' 79' ' ' ILE . 7.2 p -148.79 104.9 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.553 -179.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.58 ' HB2' HD23 ' A' ' 76' ' ' LEU . 21.2 tp -86.52 132.04 34.02 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -179.125 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -114.82 123.19 48.56 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.289 179.044 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.685 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 0.5 OUTLIER -125.76 139.65 53.34 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 121.447 0.641 . . . . 0.0 112.254 -179.238 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.22 -170.05 2.84 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.231 178.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.594 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 3.6 tt -155.02 91.13 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.932 0.396 . . . . 0.0 111.048 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.424 ' HB3' ' O ' ' A' ' 55' ' ' ILE . 9.7 ptm180 172.73 47.02 0.0 OUTLIER 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.133 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.586 ' HB3' ' CD ' ' A' ' 58' ' ' PRO . 2.8 tpt -158.41 -64.29 0.02 OUTLIER Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.586 ' CD ' ' HB3' ' A' ' 57' ' ' MET . 11.9 Cg_endo -54.66 176.05 0.13 Allowed 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.368 2.045 . . . . 0.0 112.643 -179.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -52.37 -59.62 8.78 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.21 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.591 ' O ' ' N ' ' A' ' 62' ' ' GLY . 0.0 OUTLIER -82.55 52.26 2.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.552 0.215 . . . . 0.0 110.51 179.369 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 56.3 -71.81 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.143 0.497 . . . . 0.0 111.17 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.594 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -148.01 -36.16 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.641 -0.708 . . . . 0.0 111.753 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.532 HD23 ' O ' ' A' ' 86' ' ' ASP . 3.0 mp -53.17 -24.16 10.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.779 0.324 . . . . 0.0 110.408 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -56.92 -33.89 67.42 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.003 178.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.462 ' HB2' ' O ' ' A' ' 62' ' ' GLY . 0.2 OUTLIER -59.79 -35.86 75.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.429 179.39 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.63 HD23 HG13 ' A' ' 80' ' ' ILE . 3.3 mm? -63.67 -43.52 96.44 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.056 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.2 mmpt? -52.9 -50.62 63.55 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.325 179.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.578 ' HB2' HD12 ' A' ' 40' ' ' LEU . 12.2 mm100 -62.7 -38.46 90.49 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.517 179.16 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.654 HG12 ' CE1' ' A' ' 73' ' ' HIS . 18.5 mt -54.74 -46.09 73.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.645 -179.062 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.412 ' HB3' ' CD ' ' A' ' 96' ' ' GLN . 0.3 OUTLIER -69.61 -25.94 64.2 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.793 -179.27 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -85.62 -39.73 17.01 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -179.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.435 HH21 ' HB2' ' A' ' 40' ' ' LEU . 2.1 mtm180 -102.32 -40.9 6.54 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -178.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.654 ' CE1' HG12 ' A' ' 69' ' ' ILE . 0.5 OUTLIER -85.64 136.87 36.56 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.214 -178.962 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.604 ' O ' ' HG2' ' A' ' 75' ' ' MET . 17.2 Cg_exo -67.08 70.41 0.55 Allowed 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.509 2.139 . . . . 0.0 112.219 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.614 ' HB2' ' O ' ' A' ' 96' ' ' GLN . 0.2 OUTLIER 50.5 33.9 8.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.062 0.458 . . . . 0.0 111.114 179.843 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.58 HD23 ' HB2' ' A' ' 51' ' ' LEU . 20.7 tp -67.23 131.79 93.47 Favored Pre-proline 0 C--O 1.233 0.216 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.299 -179.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -63.66 127.32 19.45 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.383 2.055 . . . . 0.0 112.052 179.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.542 ' CG2' HG21 ' A' ' 69' ' ' ILE . 5.7 t -118.28 147.79 21.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.428 -179.423 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.497 ' CG2' HD21 ' A' ' 114' ' ' LEU . 2.0 mp -122.78 113.22 37.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.161 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.685 ' HA ' ' O ' ' A' ' 53' ' ' SER . 22.3 mm -99.31 144.22 12.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.568 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.545 ' O ' ' HB2' ' A' ' 102' ' ' LEU . 7.7 ttt -67.73 -67.22 0.48 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.47 -179.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.516 ' H ' ' CG2' ' A' ' 55' ' ' ILE . 3.7 m -106.45 169.65 8.39 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.524 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.464 ' O ' ' O ' ' A' ' 84' ' ' HIS . . . -124.22 -2.84 8.05 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -179.135 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.464 ' O ' ' O ' ' A' ' 83' ' ' ALA . 33.1 m170 31.23 -160.63 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 179.064 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 24.9 m -81.09 -22.58 39.05 Favored 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -178.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.532 ' O ' HD23 ' A' ' 63' ' ' LEU . 67.4 m-20 -79.81 21.6 0.53 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 120.549 0.214 . . . . 0.0 111.324 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.64 HD22 ' HB2' ' A' ' 90' ' ' ALA . 3.1 tm? -43.68 -24.37 0.12 Allowed 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -49.03 -38.2 22.93 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.4 -22.94 61.8 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -179.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.64 ' HB2' HD22 ' A' ' 87' ' ' LEU . . . -73.45 -29.82 62.8 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.878 0.37 . . . . 0.0 110.476 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.626 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 3.0 t -61.74 -45.6 98.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.177 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.511 ' O ' ' HB3' ' A' ' 95' ' ' GLN . 83.7 p -67.46 -22.25 65.49 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 178.299 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.544 ' HB2' ' O ' ' A' ' 90' ' ' ALA . . . -64.49 -39.73 94.34 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.306 0.574 . . . . 0.0 109.793 178.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.626 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 9.6 m-85 -69.19 -23.93 63.98 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.719 178.552 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.511 ' HB3' ' O ' ' A' ' 92' ' ' SER . 0.3 OUTLIER -67.59 -46.45 72.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.388 -179.949 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.614 ' O ' ' HB2' ' A' ' 75' ' ' MET . 4.5 pm0 -76.17 -18.14 59.24 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.751 179.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 117.7 33.9 1.24 Allowed Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.387 -0.911 . . . . 0.0 113.601 178.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.434 ' HB1' ' HB1' ' A' ' 93' ' ' ALA . . . -62.6 155.92 24.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.957 0.379 . . . . 0.0 110.553 179.339 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.458 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 15.4 t80 -76.45 -53.69 7.77 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.032 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 168.46 -166.99 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.241 0.543 . . . . 0.0 111.799 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.51 ' CE2' ' HB ' ' A' ' 80' ' ' ILE . 3.2 m-85 -136.07 153.23 51.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.888 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.653 HD21 ' HA ' ' A' ' 106' ' ' PHE . 5.8 mp -102.22 120.26 54.05 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 120.595 0.236 . . . . 0.0 110.565 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -61.71 -67.33 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.116 1.877 . . . . 0.0 112.334 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.684 ' HB3' ' HD3' ' A' ' 105' ' ' PRO . 3.1 tttm -126.57 -53.04 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.074 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.684 ' HD3' ' HB3' ' A' ' 104' ' ' LYS . 31.8 Cg_exo -58.85 164.02 10.43 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.293 1.995 . . . . 0.0 112.311 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.681 ' O ' ' O ' ' A' ' 107' ' ' ASP . 74.2 t80 -169.38 -97.45 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.943 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.681 ' O ' ' O ' ' A' ' 106' ' ' PHE . 0.3 OUTLIER 37.53 177.3 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.26 0.553 . . . . 0.0 112.356 179.344 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.513 HG21 HG23 ' A' ' 112' ' ' VAL . 0.5 OUTLIER -68.18 -48.22 74.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.899 0.38 . . . . 0.0 111.998 -179.75 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.431 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 4.9 p-10 -49.52 -58.7 4.71 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.913 -179.017 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.604 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 6.2 mm-40 -70.15 -30.75 67.99 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.811 0.339 . . . . 0.0 111.079 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -68.12 -62.17 1.52 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.063 179.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.56 ' HA ' HG12 ' A' ' 115' ' ' VAL . 38.7 t -56.01 -34.24 37.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.36 0.6 . . . . 0.0 110.682 178.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' A' ' 109' ' ' ASP . . . -60.12 -45.9 91.43 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.389 179.556 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.497 HD21 ' CG2' ' A' ' 79' ' ' ILE . 5.2 tp -78.5 -21.52 48.82 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.56 -179.505 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.56 HG12 ' HA ' ' A' ' 112' ' ' VAL . 1.3 p -77.98 -36.34 21.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.613 -179.413 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.499 ' N ' HG11 ' A' ' 115' ' ' VAL . 2.9 mm-40 -68.39 -41.08 81.03 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.098 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 5.6 mmt85 -60.47 -24.85 65.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.273 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.458 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -71.3 -43.33 67.3 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.937 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.406 ' CD1' HD23 ' A' ' 28' ' ' LEU . 4.9 mt -73.57 -31.98 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.175 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 33.5 t -64.57 -42.32 95.72 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.947 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 14.5 m80 -63.49 -27.56 69.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.92 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -81.95 -54.65 5.15 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.989 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 59.65 -177.78 0.09 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.92 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.935 179.912 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 ptt? . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.744 0.307 . . . . 0.0 111.254 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.421 ' OE1' ' HG2' ' A' ' 3' ' ' ARG . 0.0 OUTLIER -82.79 158.2 22.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.52 179.686 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.492 ' HG3' HD13 ' A' ' 5' ' ' ILE . 0.3 OUTLIER -64.17 -54.56 31.71 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.955 0.407 . . . . 0.0 111.231 -179.682 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 96.22 102.27 1.99 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.012 -179.915 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.602 ' HB ' ' HA ' ' A' ' 48' ' ' PRO . 7.4 mm -114.13 114.14 45.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.956 0.408 . . . . 0.0 111.737 -179.382 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.57 HG13 ' CD1' ' A' ' 23' ' ' LEU . 3.5 p -114.07 119.81 62.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.128 178.751 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.565 ' NE1' HG22 ' A' ' 31' ' ' THR . 39.0 m0 -112.46 143.74 43.09 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.009 0.433 . . . . 0.0 110.698 -179.806 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.644 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -129.3 136.91 58.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.539 -178.807 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.816 HG23 ' HA ' ' A' ' 53' ' ' SER . 3.0 m -115.64 110.09 30.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.625 178.947 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.515 ' OD1' ' HB ' ' A' ' 15' ' ' ILE . 1.9 p30 -164.05 -159.11 0.47 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.186 -178.052 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -66.45 -3.02 5.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.832 -179.619 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 66.41 -152.09 0.22 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.473 0.177 . . . . 0.0 111.271 179.359 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.41 ' OG ' ' N ' ' A' ' 14' ' ' SER . 72.0 p 34.89 -95.33 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 178.831 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.513 ' O ' HG21 ' A' ' 18' ' ' VAL . 8.2 t -52.79 -60.57 3.1 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.748 -178.984 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.515 ' HB ' ' OD1' ' A' ' 10' ' ' ASP . 9.9 mm -60.54 -24.99 33.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.684 0.278 . . . . 0.0 110.955 -179.781 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.42 ' CD ' ' OE1' ' A' ' 20' ' ' GLU . 3.2 ttm-85 -71.48 -51.89 21.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.794 0.331 . . . . 0.0 110.594 179.494 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 40.8 t90 -59.3 -38.44 80.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.824 -179.516 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.755 HG13 HG12 ' A' ' 108' ' ' ILE . 18.1 t -65.65 -54.18 30.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -178.717 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.663 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -76.18 -26.43 56.19 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -178.235 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.613 ' HA ' ' CB ' ' A' ' 30' ' ' CYS . 10.7 pt-20 -67.82 -60.69 2.32 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.56 -0.456 . . . . 0.0 112.109 -178.874 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.48 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 4.5 mmm180 -57.89 -55.94 28.44 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.921 -179.098 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.44 -50.09 65.99 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -179.198 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.663 ' HB2' ' O ' ' A' ' 19' ' ' LEU . 5.2 mt -69.44 -29.0 66.6 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.131 0.491 . . . . 0.0 110.16 179.532 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.1 -35.01 75.86 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.422 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.04 -28.09 69.92 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.048 -1.073 . . . . 0.0 110.462 177.762 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.53 -15.99 57.96 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 120.578 0.228 . . . . 0.0 110.88 179.173 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.86 27.11 13.09 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 120.482 -0.866 . . . . 0.0 114.491 178.665 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.499 ' CD1' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -118.04 167.53 11.37 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 118.407 1.104 . . . . 0.0 112.105 -179.921 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 98.7 m -88.28 117.23 27.04 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.941 179.223 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.613 ' CB ' ' HA ' ' A' ' 20' ' ' GLU . 3.1 m -108.96 110.19 21.43 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.661 -178.907 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.565 HG22 ' NE1' ' A' ' 7' ' ' TRP . 2.7 t -130.22 135.61 48.33 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 178.484 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.644 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 29.8 p -111.09 164.8 12.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.262 0.553 . . . . 0.0 111.915 -179.054 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.76 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 3.7 m-85 -136.39 172.17 13.41 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.302 -178.204 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.577 ' HG2' ' N ' ' A' ' 35' ' ' ASN . 0.1 OUTLIER -63.4 -32.63 74.12 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 121.445 0.64 . . . . 0.0 109.917 179.202 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.577 ' N ' ' HG2' ' A' ' 34' ' ' GLU . 8.1 t-20 179.81 170.2 1.14 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.994 -179.81 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.555 ' HA3' ' CG ' ' A' ' 65' ' ' LEU . . . -43.43 -29.9 1.23 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.788 -0.72 . . . . 0.0 113.629 -179.238 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.457 ' HA ' ' HG ' ' A' ' 40' ' ' LEU . 0.4 OUTLIER -58.88 -51.48 69.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.737 0.304 . . . . 0.0 111.525 -179.48 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.76 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -51.91 -48.72 64.04 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.909 -0.316 . . . . 0.0 111.289 -179.531 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.592 HG23 ' CE1' ' A' ' 33' ' ' PHE . 79.5 t -60.7 -27.4 40.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.113 179.808 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' A' ' 36' ' ' GLY . 33.9 mt -57.39 -46.88 82.96 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.222 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.31 -48.69 49.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.098 179.569 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.67 -31.6 68.34 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.832 179.818 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.566 ' HA ' ' O ' ' A' ' 46' ' ' LYS . 16.1 mt -70.02 -25.03 63.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.485 -179.936 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.24 -19.6 14.68 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.913 -179.36 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.8 2.13 8.13 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -179.663 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.566 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -163.65 155.6 17.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.793 0.33 . . . . 0.0 110.733 179.712 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.449 HG21 ' CD2' ' A' ' 76' ' ' LEU . 87.4 m -139.09 112.71 8.12 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.466 179.92 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.602 ' HA ' ' HB ' ' A' ' 5' ' ' ILE . 94.7 Cg_endo -78.22 165.59 25.57 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.063 1.842 . . . . 0.0 110.914 178.538 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.62 ' OD2' HG12 ' A' ' 119' ' ' ILE . 4.8 p-10 -74.59 -59.58 2.67 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.659 -179.733 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.517 HG21 HG23 ' A' ' 115' ' ' VAL . 10.0 p -101.91 164.85 2.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.926 179.558 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.621 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 14.5 tp -153.45 143.04 21.82 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 120.733 0.301 . . . . 0.0 111.072 -179.765 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.585 ' HG ' ' HB ' ' A' ' 79' ' ' ILE . 0.2 OUTLIER -129.17 142.15 50.96 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.631 -0.258 . . . . 0.0 110.783 -179.922 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.816 ' HA ' HG23 ' A' ' 9' ' ' VAL . 3.0 m -129.48 137.05 50.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.005 0.431 . . . . 0.0 111.494 -179.864 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.446 ' O ' ' CG2' ' A' ' 55' ' ' ILE . 20.7 p-10 -77.87 -18.03 56.68 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.745 -178.712 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.58 HG13 ' HA3' ' A' ' 62' ' ' GLY . 0.7 OUTLIER 45.28 91.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-O 120.823 0.344 . . . . 0.0 111.255 -179.779 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.0 49.66 2.25 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -179.108 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.451 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 1.1 ttt 57.01 51.01 4.99 Favored Pre-proline 0 N--CA 1.466 0.364 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 178.715 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.588 ' HD2' ' N ' ' A' ' 62' ' ' GLY . 42.8 Cg_endo -69.26 -78.87 0.01 OUTLIER 'Trans proline' 0 CA--C 1.533 0.428 0 C-N-CA 122.75 2.3 . . . . 0.0 112.102 178.685 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.401 ' H ' ' HG2' ' A' ' 58' ' ' PRO . . . -112.2 -20.81 6.51 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 121.262 -0.494 . . . . 0.0 112.09 179.603 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.528 ' C ' ' H ' ' A' ' 62' ' ' GLY . 0.8 OUTLIER -159.99 66.38 0.36 Allowed 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.084 0.469 . . . . 0.0 110.266 179.725 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.451 ' HA ' ' HA ' ' A' ' 57' ' ' MET . 0.9 OUTLIER 68.29 -23.56 0.13 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.321 179.746 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.588 ' N ' ' HD2' ' A' ' 58' ' ' PRO . . . 140.21 -31.67 2.24 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 111.286 -0.726 . . . . 0.0 111.286 -179.604 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.585 HD23 ' N ' ' A' ' 90' ' ' ALA . 2.4 mp -66.74 -28.23 68.25 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 178.92 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.517 ' HB2' ' N ' ' A' ' 60' ' ' MET . . . -53.79 -28.72 36.67 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.352 0.596 . . . . 0.0 109.791 178.074 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.555 ' CG ' ' HA3' ' A' ' 36' ' ' GLY . 4.9 tt -51.67 -57.06 10.27 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.343 179.243 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.586 HD21 ' HB1' ' A' ' 98' ' ' ALA . 1.9 mt -55.76 -40.99 73.34 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.746 -1.116 . . . . 0.0 110.692 179.91 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.502 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -47.72 -49.11 28.97 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 120.792 0.33 . . . . 0.0 111.039 179.197 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.42 ' HB2' HD11 ' A' ' 40' ' ' LEU . 2.7 mm-40 -69.22 -32.21 71.3 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.028 0.442 . . . . 0.0 110.831 -179.948 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.468 HD12 HG23 ' A' ' 78' ' ' VAL . 81.3 mt -60.75 -40.85 86.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.535 -179.222 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.502 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -74.61 -27.9 60.67 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.767 -179.666 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.0 -41.95 67.02 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.674 -178.925 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -94.84 -26.42 16.21 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.377 -0.374 . . . . 0.0 112.007 -179.15 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.495 ' CD2' HD12 ' A' ' 43' ' ' LEU . 1.3 m-70 -124.52 168.45 13.08 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-O 120.749 0.309 . . . . 0.0 111.173 -179.421 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.443 ' HD2' ' HB3' ' A' ' 73' ' ' HIS . 35.5 Cg_endo -69.6 -83.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.339 2.026 . . . . 0.0 112.723 -179.373 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.426 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 8.0 mtm -146.71 55.44 1.13 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.734 0.302 . . . . 0.0 111.406 -179.626 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.524 HD13 ' HD2' ' A' ' 77' ' ' PRO . 0.1 OUTLIER -57.22 111.09 2.96 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.427 179.811 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.524 ' HD2' HD13 ' A' ' 76' ' ' LEU . 38.6 Cg_exo -58.68 115.62 2.67 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.264 1.976 . . . . 0.0 112.593 179.841 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.905 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 5.0 t -117.59 145.96 22.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.951 179.622 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.585 ' HB ' ' HG ' ' A' ' 52' ' ' LEU . 1.6 mp -117.52 112.61 39.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 179.147 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.76 HG13 ' CZ ' ' A' ' 101' ' ' TYR . 16.5 mm -93.7 130.65 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -178.205 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.637 ' HB2' ' CD2' ' A' ' 106' ' ' PHE . 6.7 ptm -72.43 -29.8 64.03 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.693 -179.968 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.543 ' O ' HG21 ' A' ' 55' ' ' ILE . 5.3 m -135.6 138.3 42.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.386 -179.433 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.562 ' HA ' ' CE2' ' A' ' 101' ' ' TYR . . . -89.71 -27.05 20.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.574 179.957 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.416 ' CE1' HG22 ' A' ' 82' ' ' THR . 3.2 m-70 44.72 -159.74 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.286 179.609 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.6 t -81.41 164.31 22.18 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.937 0.399 . . . . 0.0 111.415 -179.529 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.405 ' O ' HD21 ' A' ' 63' ' ' LEU . 0.2 OUTLIER 72.07 31.24 2.01 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.746 179.99 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.1 mt -45.8 -21.84 0.15 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.793 -0.639 . . . . 0.0 112.502 -179.812 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -48.11 -44.23 31.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.617 0.246 . . . . 0.0 111.042 -179.657 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.447 ' O ' ' HB1' ' A' ' 93' ' ' ALA . . . -67.25 -20.55 65.68 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.191 179.902 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.585 ' N ' HD23 ' A' ' 63' ' ' LEU . . . -62.35 -50.5 71.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.886 -179.777 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.575 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 6.3 t -67.72 -45.47 84.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.41 179.587 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.658 ' O ' ' HG3' ' A' ' 95' ' ' GLN . 9.8 m -61.56 -14.07 26.83 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.088 0.471 . . . . 0.0 109.835 178.24 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.584 ' C ' ' HB3' ' A' ' 98' ' ' ALA . . . -75.66 -53.25 8.86 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.399 179.724 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.647 ' CE1' ' HA ' ' A' ' 100' ' ' ASP . 4.8 m-85 -55.81 -34.78 65.66 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.142 -178.805 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.658 ' HG3' ' O ' ' A' ' 92' ' ' SER . 1.8 pp0? -74.37 -34.14 63.26 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.242 -179.755 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.482 ' HB2' ' CB ' ' A' ' 70' ' ' LYS . 9.3 pt20 -100.29 11.29 39.75 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.141 -179.344 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 119.43 78.26 0.56 Allowed Glycine 0 C--N 1.334 0.441 0 C-N-CA 120.314 -0.946 . . . . 0.0 113.474 179.79 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.905 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -169.04 134.89 1.66 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.08 0.467 . . . . 0.0 111.623 178.966 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.548 ' CZ ' ' HA ' ' A' ' 118' ' ' ALA . 3.5 t80 -74.96 -52.53 10.94 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.237 -179.673 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.647 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 0.9 OUTLIER 179.15 -167.71 0.08 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.247 0.546 . . . . 0.0 111.955 -179.831 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.76 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 4.9 m-85 -136.04 153.17 51.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.275 -179.685 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.544 ' HG ' ' CB ' ' A' ' 106' ' ' PHE . 1.7 mm? -102.82 120.7 51.81 Favored Pre-proline 0 C--N 1.329 -0.299 0 C-N-CA 121.081 -0.247 . . . . 0.0 110.83 179.51 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -66.26 -78.7 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.318 2.012 . . . . 0.0 112.395 -179.838 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.611 ' HB3' ' HD3' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -108.81 -58.18 0.05 OUTLIER Pre-proline 0 C--O 1.232 0.175 0 C-N-CA 121.185 -0.206 . . . . 0.0 111.425 179.949 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.611 ' HD3' ' HB3' ' A' ' 104' ' ' LYS . 77.0 Cg_endo -79.07 163.03 25.79 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 121.693 1.595 . . . . 0.0 110.726 178.933 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.706 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 0.9 OUTLIER 177.58 -91.38 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 121.3 -0.16 . . . . 0.0 111.262 179.936 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.511 ' O ' ' CB ' ' A' ' 111' ' ' ALA . 2.7 p30 44.04 -165.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 -179.442 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.755 HG12 HG13 ' A' ' 18' ' ' VAL . 1.0 OUTLIER -66.67 -43.83 90.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 120.744 -0.383 . . . . 0.0 111.528 -179.727 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.44 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 8.6 t70 -48.84 -58.33 4.98 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.192 -179.684 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.706 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 5.2 mm-40 -78.23 -32.61 49.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.552 -179.68 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.511 ' CB ' ' O ' ' A' ' 107' ' ' ASP . . . -65.92 -59.58 3.7 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 179.398 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.759 ' O ' HG12 ' A' ' 115' ' ' VAL . 56.0 t -59.58 -29.85 43.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.452 0.644 . . . . 0.0 110.195 178.877 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.44 ' HB3' ' O ' ' A' ' 109' ' ' ASP . . . -66.49 -46.76 75.23 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.566 178.759 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.554 HD21 ' CG2' ' A' ' 79' ' ' ILE . 15.2 tp -74.81 -20.76 59.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.205 179.859 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.759 HG12 ' O ' ' A' ' 112' ' ' VAL . 5.5 p -79.31 -48.43 21.17 Favored 'Isoleucine or valine' 0 C--O 1.231 0.088 0 CA-C-O 120.841 0.353 . . . . 0.0 111.44 179.985 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.593 ' HA ' HD13 ' A' ' 119' ' ' ILE . 35.6 mt-10 -63.5 -38.13 89.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.938 -179.967 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 13.6 mmt180 -65.24 -24.88 67.45 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.901 179.761 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.548 ' HA ' ' CZ ' ' A' ' 99' ' ' PHE . . . -74.42 -39.63 62.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.222 179.935 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.62 HG12 ' OD2' ' A' ' 49' ' ' ASP . 4.9 mt -71.74 -30.67 38.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.135 0.493 . . . . 0.0 110.72 179.873 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 24.3 t -67.71 -35.77 79.38 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.02 179.823 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 25.9 m80 -69.46 -26.63 64.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.897 0.38 . . . . 0.0 111.161 -179.804 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -73.6 -53.71 9.86 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.825 179.972 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -77.71 -172.91 2.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.147 -179.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.2 tm-20 . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.947 179.988 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.1 mmt . . . . . 0 N--CA 1.488 1.45 0 CA-C-O 120.757 0.313 . . . . 0.0 111.255 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 62.61 152.73 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.228 179.899 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.446 ' HG3' HD13 ' A' ' 5' ' ' ILE . 10.2 ptt-85 -69.96 -60.63 2.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.828 -179.575 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 98.85 102.12 2.31 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.964 -0.636 . . . . 0.0 111.879 -179.301 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.446 HD13 ' HG3' ' A' ' 3' ' ' ARG . 8.4 mm -111.12 112.78 42.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.887 0.375 . . . . 0.0 111.351 -179.393 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.591 ' O ' ' HA ' ' A' ' 30' ' ' CYS . 7.7 p -109.06 123.47 64.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.818 179.459 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.517 ' CD1' ' CG2' ' A' ' 31' ' ' THR . 40.5 m0 -113.68 133.7 55.17 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.686 -179.798 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.628 HG13 ' HB3' ' A' ' 52' ' ' LEU . 0.6 OUTLIER -119.43 145.79 25.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.997 0.427 . . . . 0.0 111.965 -179.106 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.9 HG11 ' HB2' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -123.96 110.63 26.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.095 0.474 . . . . 0.0 110.985 178.999 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.408 ' CB ' HG23 ' A' ' 15' ' ' ILE . 5.0 t0 -161.17 -163.45 1.02 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.78 -179.549 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -66.66 -1.73 4.08 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -178.788 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.529 ' O ' ' N ' ' A' ' 14' ' ' SER . 1.2 t70 65.24 -141.85 0.21 Allowed 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 121.027 -0.269 . . . . 0.0 110.61 179.338 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 35.29 -82.21 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 179.07 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.529 ' N ' ' O ' ' A' ' 12' ' ' ASP . 1.8 m -80.17 -44.4 19.91 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -178.71 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.466 HD13 HG21 ' A' ' 15' ' ' ILE . 27.3 mm -65.24 -33.74 65.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 -178.773 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.503 ' HB3' ' OG1' ' A' ' 32' ' ' THR . 2.4 ppt_? -72.42 -55.27 7.32 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.881 -179.279 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.422 ' N ' ' HD2' ' A' ' 16' ' ' ARG . 81.4 t90 -48.12 -41.95 27.89 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -178.9 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -73.11 -57.48 6.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.137 0.494 . . . . 0.0 112.252 -178.557 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.578 HD22 HG12 ' A' ' 8' ' ' VAL . 7.3 mp -65.02 -30.94 71.95 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.573 -0.739 . . . . 0.0 112.567 -177.912 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.509 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 19.9 pt-20 -67.77 -59.18 3.51 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.877 0.37 . . . . 0.0 111.484 -179.63 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.459 ' N ' ' CG ' ' A' ' 20' ' ' GLU . 6.2 mmm180 -56.9 -51.45 69.06 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.586 -179.623 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.47 -43.56 93.23 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 120.876 0.37 . . . . 0.0 111.589 -179.355 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.576 HD11 ' CD1' ' A' ' 28' ' ' LEU . 2.1 tp -74.09 -24.58 59.5 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.214 179.634 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.47 -35.16 75.34 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.357 178.374 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.9 -26.09 69.81 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.522 -0.847 . . . . 0.0 111.283 178.656 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.68 -16.15 59.6 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 120.677 0.275 . . . . 0.0 111.246 179.636 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.46 26.65 8.05 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 120.45 -0.881 . . . . 0.0 114.374 178.748 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.576 ' CD1' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -125.72 170.83 11.16 Favored 'General case' 0 C--O 1.231 0.079 0 CA-C-N 118.28 1.04 . . . . 0.0 112.018 179.943 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.421 ' HB ' HD11 ' A' ' 5' ' ' ILE . 31.5 m -99.25 105.96 18.05 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.807 179.954 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.591 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 4.7 t -98.29 117.1 31.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.583 -179.675 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.531 HG22 ' CE1' ' A' ' 33' ' ' PHE . 2.2 t -126.66 130.92 51.37 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 178.401 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.542 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 60.4 p -103.26 164.51 11.59 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -177.713 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.9 ' HB2' HG11 ' A' ' 9' ' ' VAL . 3.4 m-85 -135.92 174.48 10.56 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.936 -178.057 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.722 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 2.9 pp20? -61.36 -40.13 93.16 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -177.561 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.443 ' C ' HG12 ' A' ' 9' ' ' VAL . 1.4 t-20 -168.31 -46.66 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -179.165 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.508 ' HA2' HG13 ' A' ' 9' ' ' VAL . . . -176.73 -47.48 0.06 OUTLIER Glycine 0 C--N 1.32 -0.318 0 C-N-CA 120.178 -1.011 . . . . 0.0 113.628 -178.907 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.493 ' HA ' HD11 ' A' ' 40' ' ' LEU . 0.6 OUTLIER -65.77 -27.94 68.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.896 0.379 . . . . 0.0 111.168 -179.2 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.722 ' HB2' ' HG3' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -58.62 -53.39 58.84 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.052 179.997 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.605 ' C ' HD13 ' A' ' 43' ' ' LEU . 8.2 t -51.94 -49.01 39.38 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.145 0 C-N-CA 120.39 -0.524 . . . . 0.0 109.925 179.683 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.528 HD13 ' HB3' ' A' ' 68' ' ' GLN . 22.3 mt -48.18 -42.55 30.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.08 179.879 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.62 -49.57 62.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.232 0.539 . . . . 0.0 110.862 179.576 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.14 -26.41 68.8 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.712 179.552 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.622 HD11 ' CE1' ' A' ' 73' ' ' HIS . 1.3 mt -69.7 -27.12 64.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.465 -178.918 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.46 -21.04 1.31 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.84 -179.556 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 29.9 t -126.09 6.56 7.2 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -179.435 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.524 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.3 OUTLIER -166.44 156.44 11.9 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.974 0.416 . . . . 0.0 111.451 179.969 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 98.2 m -139.09 112.51 8.1 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.22 179.616 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.569 ' HD2' HD22 ' A' ' 43' ' ' LEU . 57.7 Cg_endo -71.82 165.13 33.48 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 121.873 1.716 . . . . 0.0 111.027 178.974 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -76.43 -22.66 54.38 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.691 -0.403 . . . . 0.0 111.232 -179.795 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.552 HG11 ' HA ' ' A' ' 6' ' ' VAL . 9.1 p -145.55 165.48 10.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 116.679 -0.237 . . . . 0.0 111.222 -179.666 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 12.1 tp -152.69 136.31 16.07 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.999 0.428 . . . . 0.0 111.561 -179.353 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.628 ' HB3' HG13 ' A' ' 8' ' ' VAL . 0.6 OUTLIER -122.85 117.29 25.28 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.509 -179.991 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.442 ' HB2' ' CD1' ' A' ' 80' ' ' ILE . 3.3 m -105.76 134.53 48.73 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.232 0.539 . . . . 0.0 111.705 -179.667 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.487 ' C ' HG22 ' A' ' 55' ' ' ILE . 34.2 t70 -83.08 16.04 2.55 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -178.938 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.65 HG13 ' O ' ' A' ' 61' ' ' ASP . 1.1 tt 31.53 -107.75 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 179.434 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.478 ' N ' ' CG1' ' A' ' 55' ' ' ILE . 3.5 ttt180 54.16 43.42 30.67 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 179.618 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.515 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 1.0 OUTLIER 48.25 63.78 9.73 Favored Pre-proline 0 N--CA 1.468 0.44 0 N-CA-C 113.472 0.915 . . . . 0.0 113.472 178.694 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.575 ' HD2' ' N ' ' A' ' 62' ' ' GLY . 55.9 Cg_endo -73.86 -78.23 0.01 OUTLIER 'Trans proline' 0 CA--C 1.533 0.434 0 C-N-CA 122.419 2.079 . . . . 0.0 111.248 177.948 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.411 ' H ' ' HG2' ' A' ' 58' ' ' PRO . . . -109.61 -28.55 4.23 Favored Glycine 0 C--N 1.335 0.477 0 C-N-CA 121.127 -0.559 . . . . 0.0 112.16 179.068 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.638 ' HB3' ' CB ' ' A' ' 64' ' ' ALA . 0.4 OUTLIER -152.42 65.19 0.82 Allowed 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.173 0.511 . . . . 0.0 110.048 179.544 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.65 ' O ' HG13 ' A' ' 55' ' ' ILE . 0.4 OUTLIER 68.07 -25.29 0.13 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.184 -0.917 . . . . 0.0 112.161 -179.788 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.575 ' N ' ' HD2' ' A' ' 58' ' ' PRO . . . 141.84 -31.92 2.06 Favored Glycine 0 CA--C 1.502 -0.728 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 179.981 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.587 HD22 ' O ' ' A' ' 86' ' ' ASP . 1.2 mp -70.61 -16.75 62.87 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 115.068 -0.566 . . . . 0.0 110.044 179.124 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.638 ' CB ' ' HB3' ' A' ' 60' ' ' MET . . . -53.5 -39.26 64.45 Favored 'General case' 0 CA--C 1.522 -0.098 0 CA-C-O 121.312 0.577 . . . . 0.0 109.768 178.115 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.573 ' HB3' HD11 ' A' ' 69' ' ' ILE . 6.8 mt -62.3 -39.18 92.13 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.885 179.755 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.465 HD21 HD12 ' A' ' 80' ' ' ILE . 1.2 mm? -59.02 -44.12 91.68 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.272 0.558 . . . . 0.0 109.804 179.165 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.611 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -57.98 -43.7 86.7 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.729 179.474 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.528 ' HB3' HD13 ' A' ' 40' ' ' LEU . 30.3 mm100 -73.93 -38.41 64.28 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.659 179.692 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.573 HD11 ' HB3' ' A' ' 65' ' ' LEU . 17.1 mt -63.5 -36.0 74.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.364 -179.247 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.611 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -75.41 -26.64 58.57 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.056 -179.57 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.486 ' NE2' ' HG3' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -86.21 -32.62 21.09 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.603 -179.351 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.486 ' HG3' ' NE2' ' A' ' 71' ' ' GLN . 0.6 OUTLIER -95.41 -23.44 17.15 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.154 0.428 . . . . 0.0 112.154 -179.692 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.622 ' CE1' HD11 ' A' ' 43' ' ' LEU . 0.2 OUTLIER -111.11 135.23 20.9 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-O 120.673 0.273 . . . . 0.0 111.667 -179.07 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -59.76 -54.41 2.43 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.41 2.073 . . . . 0.0 112.082 179.116 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.436 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 22.2 mtt -156.47 36.74 0.32 Allowed 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.227 -179.9 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.574 ' HB2' ' HB3' ' A' ' 73' ' ' HIS . 0.7 OUTLIER -71.13 121.79 85.18 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.379 -179.891 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.485 ' HD2' HD22 ' A' ' 76' ' ' LEU . 15.7 Cg_exo -68.58 121.86 8.8 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.586 2.19 . . . . 0.0 112.762 -179.708 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.738 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 11.4 t -99.21 141.02 17.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.843 179.302 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.522 ' HB ' ' HG ' ' A' ' 52' ' ' LEU . 2.4 mt -127.07 110.67 23.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.945 179.853 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.531 ' HB ' ' CD2' ' A' ' 101' ' ' TYR . 5.4 mm -101.17 142.12 16.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.104 -179.926 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.602 ' O ' ' HE1' ' A' ' 106' ' ' PHE . 26.5 ptm -66.66 -56.51 10.3 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.943 179.607 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.416 ' OG1' ' CZ ' ' A' ' 106' ' ' PHE . 2.8 m -131.06 152.21 50.6 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 121.771 -0.581 . . . . 0.0 112.152 -179.809 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.506 ' CB ' ' CD2' ' A' ' 101' ' ' TYR . . . -116.71 46.18 1.68 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.825 -179.796 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 17.1 p80 -77.23 56.65 1.33 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.666 0.269 . . . . 0.0 111.192 -179.98 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.436 ' HB2' ' CD1' ' A' ' 63' ' ' LEU . 0.7 OUTLIER -159.64 -160.63 0.84 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 121.046 0.45 . . . . 0.0 111.67 -179.642 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.587 ' O ' HD22 ' A' ' 63' ' ' LEU . 0.5 OUTLIER -66.79 90.05 0.17 Allowed 'General case' 0 CA--C 1.528 0.097 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.834 179.559 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.424 HD13 HG21 ' A' ' 91' ' ' VAL . 0.2 OUTLIER -44.44 -21.29 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -179.965 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -48.12 -53.66 15.87 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -178.975 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.46 -22.04 66.2 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.642 0.258 . . . . 0.0 111.446 -179.648 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.537 ' N ' HD21 ' A' ' 63' ' ' LEU . . . -76.97 -42.91 37.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.754 0.311 . . . . 0.0 110.965 -179.865 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.56 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 13.6 t -64.69 -41.17 91.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.234 179.79 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 19.8 m -61.06 -36.08 78.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.922 179.0 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.488 ' O ' ' HG3' ' A' ' 96' ' ' GLN . . . -55.76 -45.44 78.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.644 179.622 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.56 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 7.4 m-85 -55.16 -25.02 29.53 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.525 179.507 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.59 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -72.19 -40.77 67.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.337 179.688 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.59 ' N ' ' HG2' ' A' ' 95' ' ' GLN . 1.6 pt20 -76.03 -18.13 59.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.547 -179.6 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 134.32 -8.78 4.71 Favored Glycine 0 CA--C 1.521 0.45 0 C-N-CA 120.318 -0.944 . . . . 0.0 113.508 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.738 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -43.67 143.92 0.91 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 117.268 0.534 . . . . 0.0 111.505 -179.817 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.433 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 39.5 t80 -80.73 -54.63 5.46 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 121.049 -0.26 . . . . 0.0 111.232 -179.59 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 166.71 -168.23 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.06 0.457 . . . . 0.0 111.546 179.582 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.531 ' CD2' ' HB ' ' A' ' 80' ' ' ILE . 9.2 m-85 -118.3 152.63 35.41 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.654 178.948 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.589 ' O ' ' O ' ' A' ' 81' ' ' MET . 19.6 tp -102.58 144.63 29.01 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-O 120.926 0.394 . . . . 0.0 111.5 -178.411 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.476 ' HD2' ' CD1' ' A' ' 102' ' ' LEU . 79.2 Cg_endo -80.22 -160.56 0.13 Allowed 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.513 2.142 . . . . 0.0 113.01 -179.399 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.492 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -42.15 -54.03 7.96 Favored Pre-proline 0 CA--C 1.534 0.347 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -179.165 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.492 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 18.2 Cg_endo -59.19 156.71 33.42 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.033 1.822 . . . . 0.0 112.39 -179.287 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.675 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 60.2 m-85 -157.36 -109.45 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.156 -179.924 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.505 ' O ' ' O ' ' A' ' 106' ' ' PHE . 2.6 p30 44.75 -179.48 0.0 OUTLIER 'General case' 0 C--O 1.227 -0.119 0 CA-C-O 121.336 0.588 . . . . 0.0 111.248 -179.579 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.528 HD12 ' HA ' ' A' ' 19' ' ' LEU . 0.5 OUTLIER -64.06 -53.64 41.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-O 121.473 0.654 . . . . 0.0 112.324 -179.788 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.723 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 1.0 OUTLIER -49.16 -52.91 23.54 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 114.947 -1.024 . . . . 0.0 111.961 -178.014 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.675 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 2.0 mm-40 -81.51 -27.78 34.32 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -179.13 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.44 ' CB ' ' O ' ' A' ' 107' ' ' ASP . . . -76.39 -55.39 5.59 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.252 179.933 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.615 ' O ' HG12 ' A' ' 115' ' ' VAL . 61.8 t -59.01 -30.47 43.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.502 0.668 . . . . 0.0 110.061 178.55 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.723 ' HB3' ' O ' ' A' ' 109' ' ' ASP . . . -62.04 -46.61 88.4 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.492 -0.777 . . . . 0.0 110.587 179.345 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.619 ' HA ' ' HD3' ' A' ' 117' ' ' ARG . 21.5 tp -71.36 -26.71 62.92 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.108 -0.951 . . . . 0.0 112.127 -178.764 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.615 HG12 ' O ' ' A' ' 112' ' ' VAL . 4.3 p -79.35 -40.04 21.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.886 0.374 . . . . 0.0 111.57 -179.805 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -67.31 -43.97 80.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.282 -179.448 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.619 ' HD3' ' HA ' ' A' ' 114' ' ' LEU . 6.7 ptm180 -60.09 -23.64 63.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.64 0.257 . . . . 0.0 110.827 179.807 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.433 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -72.16 -50.11 30.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.763 179.203 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.402 HD12 HG12 ' A' ' 50' ' ' VAL . 3.9 mt -69.65 -34.52 61.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.274 0.559 . . . . 0.0 110.649 179.554 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.3 t -63.49 -38.93 93.04 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.002 -179.958 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -62.08 -29.72 70.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.075 -179.907 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -75.89 -53.25 8.72 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.926 179.828 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.3 170.12 16.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.8 0.333 . . . . 0.0 110.964 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.857 179.891 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.471 0 CA-C-O 120.787 0.327 . . . . 0.0 111.187 . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -112.41 175.06 5.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.956 179.929 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -66.2 -27.79 68.26 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.95 0.405 . . . . 0.0 110.942 179.948 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.498 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . 56.54 85.94 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.05 -179.534 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.5 mp -116.81 117.62 56.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.74 0.305 . . . . 0.0 111.565 -179.292 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.774 HG11 ' HG ' ' A' ' 23' ' ' LEU . 5.4 p -104.95 129.22 57.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.722 179.414 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.561 ' CD1' HG22 ' A' ' 31' ' ' THR . 28.2 m0 -116.38 130.49 56.8 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.789 179.248 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.502 ' O ' ' HD1' ' A' ' 33' ' ' PHE . 1.6 t -114.43 135.71 53.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.503 -177.919 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.629 HG12 ' CG2' ' A' ' 39' ' ' VAL . 0.0 OUTLIER -121.0 106.39 18.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.329 -0.396 . . . . 0.0 109.999 179.43 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.402 ' O ' ' O ' ' A' ' 34' ' ' GLU . 2.9 p30 -161.17 -160.85 0.76 Allowed 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.215 -177.887 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -66.3 -2.77 4.76 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -178.663 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 67.69 -150.12 0.16 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 121.199 -0.201 . . . . 0.0 111.177 179.268 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.435 ' OG ' ' N ' ' A' ' 14' ' ' SER . 60.1 p 34.78 -97.72 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 179.205 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.435 ' N ' ' OG ' ' A' ' 13' ' ' SER . 12.5 t -53.17 -57.43 10.49 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.686 -0.234 . . . . 0.0 111.598 -179.069 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.6 mm -61.37 -25.1 35.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.78 0.324 . . . . 0.0 111.546 -179.854 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.438 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 5.8 ttm180 -70.89 -54.54 11.07 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.103 179.919 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.405 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 84.7 t90 -60.79 -43.57 97.95 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -179.03 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.6 t -64.73 -46.15 93.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.67 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.474 HD11 HG13 ' A' ' 108' ' ' ILE . 11.9 tp -84.13 -23.16 30.8 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -178.198 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.487 ' HG3' ' N ' ' A' ' 21' ' ' ARG . 15.1 pt-20 -67.46 -58.85 4.01 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.194 -0.602 . . . . 0.0 111.321 -179.277 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.487 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 3.1 mmm180 -59.73 -50.42 73.9 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.689 -179.396 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.29 -48.48 71.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.881 0.372 . . . . 0.0 111.713 -179.343 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.774 ' HG ' HG11 ' A' ' 6' ' ' VAL . 2.4 tm? -70.06 -30.27 67.48 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.393 0.616 . . . . 0.0 110.516 179.972 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.09 -31.94 72.77 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 178.298 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.31 -28.34 70.78 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 178.029 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.26 -15.67 59.35 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 120.82 0.343 . . . . 0.0 110.711 179.159 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 94.71 26.4 13.24 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.729 -0.748 . . . . 0.0 114.373 178.552 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.498 ' HB3' ' O ' ' A' ' 4' ' ' GLY . 0.0 OUTLIER -126.12 166.32 17.23 Favored 'General case' 0 C--N 1.334 -0.066 0 CA-C-N 118.27 1.035 . . . . 0.0 112.379 179.892 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.661 ' O ' HG13 ' A' ' 6' ' ' VAL . 93.4 m -81.34 127.47 32.78 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.591 -179.745 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.463 ' HA ' HG13 ' A' ' 6' ' ' VAL . 2.4 p -123.61 116.75 23.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.935 -178.947 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.561 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.4 t -129.12 133.46 47.65 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.396 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.464 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 44.1 p -105.92 162.73 13.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.209 0.528 . . . . 0.0 112.114 -178.393 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.774 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 1.2 m-85 -131.56 172.22 12.49 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.775 -178.017 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.683 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 2.9 pp20? -63.55 -42.57 98.36 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -178.786 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -166.3 -59.76 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.224 0.535 . . . . 0.0 111.707 -178.983 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.579 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . -162.98 -53.34 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.463 -0.79 . . . . 0.0 112.501 -179.485 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.655 ' HA ' HD13 ' A' ' 40' ' ' LEU . 0.8 OUTLIER -49.39 -28.4 5.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.996 0.427 . . . . 0.0 111.299 -179.817 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.774 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 2.1 tp10 -62.0 -56.74 15.94 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.253 179.919 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.725 HG13 ' HG ' ' A' ' 43' ' ' LEU . 38.6 t -60.52 -31.89 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.102 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.542 179.398 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.715 HD12 ' HB3' ' A' ' 68' ' ' GLN . 46.2 mt -55.21 -43.85 74.82 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.305 179.183 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -80.79 -48.71 12.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.142 -179.892 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.73 -30.94 64.05 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.317 -179.762 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.725 ' HG ' HG13 ' A' ' 39' ' ' VAL . 27.4 mt -64.26 -23.56 67.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.909 0.385 . . . . 0.0 111.323 179.986 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.95 -15.5 32.05 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.587 -179.911 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 31.4 t -119.47 -7.51 10.16 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.519 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.44 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -164.61 163.17 21.83 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.891 0.377 . . . . 0.0 111.413 -179.866 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 51.8 m -138.48 113.61 8.71 Favored Pre-proline 0 N--CA 1.452 -0.331 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.264 179.855 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.494 ' HG3' ' HB2' ' A' ' 7' ' ' TRP . 57.1 Cg_endo -71.14 149.06 57.5 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.546 2.164 . . . . 0.0 111.672 179.228 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -74.07 -22.88 59.34 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.185 -179.743 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.436 ' CG2' HG22 ' A' ' 115' ' ' VAL . 6.3 p -149.02 98.23 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.751 -179.349 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.49 HD13 ' HB2' ' A' ' 7' ' ' TRP . 38.9 tp -87.13 144.48 26.84 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.902 0.382 . . . . 0.0 111.863 -179.276 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -124.29 115.06 20.41 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.69 179.65 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.692 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 0.6 OUTLIER -115.23 134.03 55.5 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 121.567 0.699 . . . . 0.0 112.02 -179.337 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.08 -176.91 6.57 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.756 179.695 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.802 HG12 ' HA3' ' A' ' 62' ' ' GLY . 0.0 OUTLIER -149.17 108.62 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.492 179.623 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.448 ' O ' ' HG3' ' A' ' 57' ' ' MET . 0.1 OUTLIER -161.3 73.62 0.45 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.827 -179.463 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.448 ' HG3' ' O ' ' A' ' 56' ' ' ARG . 1.8 ptt? 38.85 51.45 3.14 Favored Pre-proline 0 CA--C 1.535 0.382 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 178.536 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.52 ' CG ' ' HA2' ' A' ' 62' ' ' GLY . 54.4 Cg_endo -76.4 -73.04 0.01 OUTLIER 'Trans proline' 0 CA--C 1.529 0.243 0 C-N-CA 122.215 1.944 . . . . 0.0 111.658 178.365 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.402 ' H ' ' HG2' ' A' ' 58' ' ' PRO . . . -117.7 -27.06 2.65 Favored Glycine 0 CA--C 1.52 0.385 0 N-CA-C 111.835 -0.506 . . . . 0.0 111.835 179.172 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.617 ' HB3' ' CB ' ' A' ' 64' ' ' ALA . 4.4 tpt -159.44 69.6 0.45 Allowed 'General case' 0 C--O 1.236 0.358 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.318 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.442 ' O ' HG12 ' A' ' 55' ' ' ILE . 0.2 OUTLIER 68.82 -25.76 0.14 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.406 -0.816 . . . . 0.0 112.327 -179.951 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.802 ' HA3' HG12 ' A' ' 55' ' ' ILE . . . 142.13 -30.7 2.12 Favored Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -179.723 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.444 HD23 ' HB1' ' A' ' 89' ' ' ALA . 3.3 mp -71.76 -21.36 61.75 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.456 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.617 ' CB ' ' HB3' ' A' ' 60' ' ' MET . . . -53.68 -42.38 67.88 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.008 0.433 . . . . 0.0 110.461 179.007 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.546 ' O ' HG13 ' A' ' 69' ' ' ILE . 15.9 mt -51.54 -50.28 60.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.134 179.5 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.792 HD13 HG13 ' A' ' 80' ' ' ILE . 17.2 mt -52.12 -56.78 12.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.542 179.632 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.531 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 28.4 mttp -41.19 -47.68 3.34 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.669 -179.277 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.715 ' HB3' HD12 ' A' ' 40' ' ' LEU . 60.1 mm-40 -69.27 -35.9 76.54 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.278 -179.547 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.713 HG21 ' HE2' ' A' ' 73' ' ' HIS . 59.0 mt -54.07 -46.45 66.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.08 179.881 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.583 ' HA ' ' CE1' ' A' ' 73' ' ' HIS . 0.0 OUTLIER -70.96 -26.72 63.29 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -179.619 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -61.87 -30.23 70.72 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.218 -178.839 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.43 ' HD3' ' HB3' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -90.2 -59.73 2.11 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.405 0.621 . . . . 0.0 111.409 179.669 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.713 ' HE2' HG21 ' A' ' 69' ' ' ILE . 3.8 p80 -81.22 172.52 9.55 Favored Pre-proline 0 C--N 1.318 -0.779 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.557 -179.183 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.468 ' HD2' ' HB2' ' A' ' 73' ' ' HIS . 73.4 Cg_endo -87.33 -52.8 0.03 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.948 2.432 . . . . 0.0 112.073 179.015 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.629 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 28.7 mtt -157.48 49.51 0.43 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.071 179.213 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.622 ' H ' ' ND1' ' A' ' 73' ' ' HIS . 2.1 tt -64.94 114.0 13.21 Favored Pre-proline 0 N--CA 1.454 -0.247 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.978 179.886 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.533 ' HG3' ' CE2' ' A' ' 122' ' ' TYR . 29.3 Cg_endo -64.71 115.45 3.24 Favored 'Trans proline' 0 CA--C 1.528 0.206 0 C-N-CA 122.389 2.06 . . . . 0.0 112.635 -179.796 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.943 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 5.3 t -115.51 154.45 16.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.104 179.909 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.428 HD12 ' CG2' ' A' ' 50' ' ' VAL . 1.9 mp -120.86 117.38 52.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.492 178.972 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.792 HG13 HD13 ' A' ' 66' ' ' LEU . 9.4 mm -99.04 150.21 5.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.098 0.475 . . . . 0.0 111.841 -179.409 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.536 ' HB3' HG21 ' A' ' 55' ' ' ILE . 53.5 ttp -67.59 -52.75 34.83 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.835 -179.129 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.0 m -143.91 146.85 33.28 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 122.306 -0.246 . . . . 0.0 111.584 -179.234 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.483 ' CB ' ' CD2' ' A' ' 101' ' ' TYR . . . -113.98 57.86 0.69 Allowed 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.37 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.471 ' CE1' ' CD1' ' A' ' 55' ' ' ILE . 10.6 p-80 -99.21 -176.6 3.35 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.946 -0.302 . . . . 0.0 110.952 179.392 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' A' ' 84' ' ' HIS . 20.8 p 71.09 -61.16 0.49 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.603 -179.709 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -154.01 85.64 1.16 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -179.096 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.42 ' O ' ' HB2' ' A' ' 90' ' ' ALA . 0.7 OUTLIER -52.73 -20.8 3.42 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.487 179.33 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -47.83 -57.09 6.07 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.607 -0.269 . . . . 0.0 111.664 -178.972 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.444 ' HB1' HD23 ' A' ' 63' ' ' LEU . . . -64.21 -19.94 65.69 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.725 0.297 . . . . 0.0 111.209 -179.968 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.505 ' CB ' ' CE1' ' A' ' 101' ' ' TYR . . . -77.26 -46.4 23.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.696 -179.696 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.612 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 6.6 t -62.64 -49.14 84.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 120.985 -0.286 . . . . 0.0 111.141 -179.7 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 52.5 p -56.51 -25.6 51.97 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.216 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.549 ' C ' ' HB3' ' A' ' 98' ' ' ALA . . . -60.08 -52.89 63.43 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.924 179.791 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.612 ' CE2' ' HA ' ' A' ' 91' ' ' VAL . 2.8 m-85 -55.78 -31.2 62.4 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.459 0.647 . . . . 0.0 109.917 179.771 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.12 -42.07 39.43 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.922 -1.036 . . . . 0.0 110.995 -179.967 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.629 ' O ' ' HA ' ' A' ' 75' ' ' MET . 7.3 pt20 -85.2 -18.15 34.94 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.785 -179.421 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 93' ' ' ALA . . . 140.29 85.32 0.1 Allowed Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.114 -179.101 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.943 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -168.26 123.81 0.99 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.157 0.503 . . . . 0.0 111.918 179.946 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -58.16 -52.77 64.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.773 -179.931 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.568 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 0.2 OUTLIER 170.12 -172.53 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 121.197 0.522 . . . . 0.0 111.675 -179.873 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.51 ' CD2' ' HB ' ' A' ' 80' ' ' ILE . 7.9 m-85 -113.38 153.57 28.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.263 179.621 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.672 HD21 ' O ' ' A' ' 105' ' ' PRO . 7.9 tp -102.3 144.97 29.66 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.827 -179.195 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.533 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 18.5 Cg_exo -66.69 -157.06 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.739 2.293 . . . . 0.0 112.838 -179.043 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.48 ' HB3' ' HD3' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -56.13 -55.08 45.62 Favored Pre-proline 0 CA--C 1.531 0.218 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.859 -179.246 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.672 ' O ' HD21 ' A' ' 102' ' ' LEU . 54.1 Cg_exo -52.31 164.23 1.37 Allowed 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.349 2.032 . . . . 0.0 111.923 179.695 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.611 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 57.6 t80 -158.2 -106.93 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.707 -0.224 . . . . 0.0 110.588 179.865 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.541 ' O ' ' O ' ' A' ' 106' ' ' PHE . 3.1 p30 42.37 -176.82 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.937 0.398 . . . . 0.0 111.041 -179.791 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.584 HG23 HG21 ' A' ' 112' ' ' VAL . 0.7 OUTLIER -68.0 -40.73 83.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.224 0.535 . . . . 0.0 111.155 -179.969 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.496 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 8.3 t0 -50.62 -58.88 4.79 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.919 -179.316 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.611 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 9.6 mm-40 -76.41 -30.36 57.42 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 111.725 0.268 . . . . 0.0 111.725 -179.366 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.478 ' HB1' ' O ' ' A' ' 107' ' ' ASP . . . -69.77 -55.63 9.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.928 0.394 . . . . 0.0 110.322 179.332 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.884 ' HA ' HG11 ' A' ' 115' ' ' VAL . 48.1 t -61.2 -33.61 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-O 121.357 0.598 . . . . 0.0 110.364 179.332 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.496 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -61.63 -47.14 86.75 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.618 179.723 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.417 ' CD2' ' HB2' ' A' ' 102' ' ' LEU . 55.4 tp -75.6 -21.43 57.8 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.632 -179.58 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.884 HG11 ' HA ' ' A' ' 112' ' ' VAL . 2.9 p -79.4 -38.8 20.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.776 -0.37 . . . . 0.0 111.836 -179.639 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.605 ' N ' HG13 ' A' ' 115' ' ' VAL . 36.7 mt-10 -68.44 -38.5 81.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.846 0.355 . . . . 0.0 110.773 179.997 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -64.21 -24.91 67.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.951 0.405 . . . . 0.0 110.367 179.531 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -70.62 -49.54 46.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.717 179.544 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 4.7 mt -70.36 -32.66 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-O 121.271 0.558 . . . . 0.0 110.965 179.759 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 15.1 m -70.01 -44.06 70.07 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.262 -179.786 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 11.2 m80 -60.19 -24.27 64.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.181 -179.841 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.533 ' CE2' ' HG3' ' A' ' 77' ' ' PRO . 0.5 OUTLIER -72.07 -53.07 13.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.075 0.464 . . . . 0.0 111.245 -179.71 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.491 ' O ' ' HG3' ' A' ' 124' ' ' GLU . 11.5 pt20 -75.59 -168.25 0.81 Allowed 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.284 179.999 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.491 ' HG3' ' O ' ' A' ' 123' ' ' GLN . 0.4 OUTLIER . . . . . 0 N--CA 1.463 0.201 0 CA-C-O 120.888 0.375 . . . . 0.0 111.577 -179.924 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.472 0 CA-C-O 120.701 0.286 . . . . 0.0 111.278 . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -119.55 -22.39 6.98 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.797 -179.958 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.74 -11.58 5.44 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.802 0.335 . . . . 0.0 111.093 179.698 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.451 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . 88.46 97.78 0.97 Allowed Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.426 -0.892 . . . . 0.0 111.074 -179.257 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.451 HD12 ' HB ' ' A' ' 29' ' ' THR . 4.9 mm -121.77 112.49 35.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 120.689 0.28 . . . . 0.0 111.361 -179.032 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.635 HG21 HG11 ' A' ' 50' ' ' VAL . 10.6 p -105.56 127.0 60.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.229 0.538 . . . . 0.0 110.657 179.101 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.606 ' NE1' HG22 ' A' ' 31' ' ' THR . 34.3 m0 -114.53 125.6 53.98 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.868 179.746 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.658 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -115.65 136.55 52.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.691 -177.956 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.545 ' CG2' ' HA ' ' A' ' 53' ' ' SER . 18.0 m -115.25 110.68 32.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.224 0.535 . . . . 0.0 110.746 179.062 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -162.22 -158.6 0.53 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.381 -179.166 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -67.83 -0.19 3.97 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.614 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 68.78 -154.07 0.16 Allowed 'General case' 0 CA--C 1.532 0.265 0 O-C-N 122.313 -0.242 . . . . 0.0 111.02 179.553 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.438 ' OG ' ' N ' ' A' ' 14' ' ' SER . 74.8 p 33.01 -96.37 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 179.219 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.438 ' N ' ' OG ' ' A' ' 13' ' ' SER . 4.4 t -53.06 -57.27 10.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.629 0.252 . . . . 0.0 111.599 -179.197 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 31.0 mm -61.41 -26.15 38.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.849 0.357 . . . . 0.0 111.078 179.931 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.444 ' HG3' HG21 ' A' ' 32' ' ' THR . 53.8 ttt180 -77.06 -44.27 31.31 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.708 179.803 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.434 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 70.2 t90 -64.23 -40.44 96.04 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.979 -179.275 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.5 t -70.48 -37.57 70.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.0 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.452 HD13 ' O ' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -84.26 -29.32 26.56 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.969 -179.171 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.537 ' HA ' ' SG ' ' A' ' 30' ' ' CYS . 24.9 pt-20 -67.53 -60.36 2.62 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.913 -178.906 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.445 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 5.7 mmt85 -58.11 -54.09 50.85 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.189 -0.459 . . . . 0.0 112.008 -179.588 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.56 -53.96 47.65 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.108 0.48 . . . . 0.0 111.343 -179.574 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.614 ' HG ' HG12 ' A' ' 6' ' ' VAL . 2.5 tm? -66.32 -27.98 68.32 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.582 0.706 . . . . 0.0 110.451 179.52 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.1 -34.55 77.86 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.527 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.53 -26.78 64.99 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.296 -0.954 . . . . 0.0 110.946 178.039 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.405 ' HB1' HD12 ' A' ' 28' ' ' LEU . . . -77.27 -16.22 59.09 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 120.701 0.286 . . . . 0.0 110.805 179.104 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.49 23.68 13.72 Favored Glycine 0 CA--C 1.521 0.419 0 C-N-CA 120.675 -0.774 . . . . 0.0 114.247 178.615 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.601 ' HB2' HD13 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -123.81 166.64 15.25 Favored 'General case' 0 CA--C 1.527 0.076 0 CA-C-N 118.107 0.954 . . . . 0.0 111.935 -179.802 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.451 ' HB ' HD12 ' A' ' 5' ' ' ILE . 97.6 m -84.83 138.54 32.5 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.027 -179.777 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.612 ' HA ' HG13 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -126.85 116.43 20.85 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.073 0.463 . . . . 0.0 111.694 -179.544 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.606 HG22 ' NE1' ' A' ' 7' ' ' TRP . 2.4 t -128.77 132.43 47.9 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.409 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.658 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 45.8 p -108.51 165.09 11.79 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.267 0.556 . . . . 0.0 111.749 -178.335 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.765 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 3.2 m-85 -135.06 172.09 13.51 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.196 -177.89 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.55 ' HG2' ' N ' ' A' ' 35' ' ' ASN . 0.0 OUTLIER -63.31 -32.67 74.15 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.797 -179.837 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.55 ' N ' ' HG2' ' A' ' 34' ' ' GLU . 50.1 p-10 -179.47 179.49 0.61 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.264 -179.434 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.609 ' O ' ' HG ' ' A' ' 40' ' ' LEU . . . -55.16 -10.2 2.48 Favored Glycine 0 CA--C 1.521 0.438 0 C-N-CA 120.709 -0.758 . . . . 0.0 114.011 -179.438 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.799 ' HA ' HD13 ' A' ' 40' ' ' LEU . 3.3 m120 -84.55 -44.57 13.44 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 117.727 0.763 . . . . 0.0 112.501 -179.315 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.765 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 6.6 tt0 -51.74 -58.72 5.6 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -179.271 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.702 HG11 HD12 ' A' ' 51' ' ' LEU . 55.1 t -47.55 -38.13 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 121.017 0.437 . . . . 0.0 111.173 -179.594 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.799 HD13 ' HA ' ' A' ' 37' ' ' ASN . 20.6 mt -57.03 -41.84 79.36 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.429 -179.956 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.87 -48.09 40.43 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.277 0.56 . . . . 0.0 110.177 178.911 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.48 -28.66 69.45 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.135 179.386 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.619 HD23 ' CE1' ' A' ' 73' ' ' HIS . 15.1 mt -65.56 -24.94 67.22 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.88 -179.412 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.64 -16.0 14.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.843 -179.471 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -125.68 -1.57 7.35 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.712 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.529 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -163.42 159.89 22.81 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.917 0.389 . . . . 0.0 111.419 179.822 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.508 ' CG2' HD21 ' A' ' 76' ' ' LEU . 83.1 m -139.08 116.03 8.7 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.297 -179.929 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.488 ' CD ' HD21 ' A' ' 43' ' ' LEU . 77.3 Cg_endo -77.42 163.21 30.09 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.056 1.837 . . . . 0.0 111.511 179.084 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -74.23 -22.17 59.46 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.973 -0.291 . . . . 0.0 111.33 -179.744 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.648 HG13 HD12 ' A' ' 119' ' ' ILE . 8.3 p -147.7 169.42 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.477 -179.562 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.702 HD12 HG11 ' A' ' 39' ' ' VAL . 10.0 tp -152.93 129.85 11.0 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 120.958 0.409 . . . . 0.0 111.318 -179.075 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.555 ' HG ' ' HB ' ' A' ' 79' ' ' ILE . 0.2 OUTLIER -115.69 126.76 54.52 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.78 179.789 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.62 ' HB2' HD21 ' A' ' 65' ' ' LEU . 0.2 OUTLIER -119.3 126.43 51.43 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -178.727 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -83.21 101.9 11.54 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.643 177.803 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.632 HG13 ' HA3' ' A' ' 62' ' ' GLY . 2.2 tt -68.79 93.03 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.665 -179.505 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.438 ' NH2' ' HB3' ' A' ' 35' ' ' ASN . 6.8 ptt85 -135.46 59.05 1.74 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.48 -179.446 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.5 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 24.6 ptm 41.04 48.94 2.98 Favored Pre-proline 0 N--CA 1.467 0.381 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 179.746 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 62' ' ' GLY . 43.5 Cg_endo -70.49 -80.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.267 1.978 . . . . 0.0 111.999 178.943 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -107.27 -23.72 6.85 Favored Glycine 0 N--CA 1.449 -0.441 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 179.359 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.543 ' N ' ' HB2' ' A' ' 64' ' ' ALA . 8.8 tpt -162.88 69.1 0.23 Allowed 'General case' 0 C--O 1.236 0.36 0 CA-C-O 120.923 0.392 . . . . 0.0 110.447 179.816 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.5 ' HA ' ' HA ' ' A' ' 57' ' ' MET . 0.3 OUTLIER 68.56 -26.46 0.14 Allowed 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.246 179.834 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.632 ' HA3' HG13 ' A' ' 55' ' ' ILE . . . 140.62 -29.58 2.36 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -179.441 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.476 HD22 ' O ' ' A' ' 86' ' ' ASP . 2.2 mp -75.62 -12.19 60.16 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.649 -0.275 . . . . 0.0 110.428 179.088 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.543 ' HB2' ' N ' ' A' ' 60' ' ' MET . . . -53.67 -26.9 24.7 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-O 120.925 0.393 . . . . 0.0 110.455 179.155 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.62 HD21 ' HB2' ' A' ' 53' ' ' SER . 0.2 OUTLIER -59.11 -62.15 2.1 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.954 -0.567 . . . . 0.0 109.714 178.982 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.496 HD13 ' HB2' ' A' ' 93' ' ' ALA . 7.9 mt -43.56 -43.39 5.55 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.243 179.513 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.417 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 19.4 mttt -54.0 -58.0 8.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.004 0.43 . . . . 0.0 111.225 179.507 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.697 ' HB2' HD11 ' A' ' 40' ' ' LEU . 21.5 mm-40 -62.07 -28.73 69.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.035 -179.846 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.624 HG21 ' CD2' ' A' ' 73' ' ' HIS . 77.0 mt -63.11 -42.02 95.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.029 0.442 . . . . 0.0 111.294 -179.846 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.589 ' HA ' ' HA ' ' A' ' 74' ' ' PRO . 0.1 OUTLIER -67.64 -29.25 68.51 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.573 -179.773 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.442 ' NE2' ' HA ' ' A' ' 68' ' ' GLN . 9.8 mt-30 -68.51 -40.61 80.76 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.036 179.527 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 52.0 mtt-85 -93.26 -76.22 0.48 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.743 -179.963 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.647 ' CE1' ' HG ' ' A' ' 76' ' ' LEU . 0.5 OUTLIER -114.5 79.18 5.28 Favored Pre-proline 0 C--N 1.318 -0.781 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.88 179.707 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.589 ' HA ' ' HA ' ' A' ' 70' ' ' LYS . 56.9 Cg_endo -70.87 50.28 1.07 Allowed 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.734 2.289 . . . . 0.0 113.131 -179.708 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.542 ' HG3' ' O ' ' A' ' 74' ' ' PRO . 2.8 mtp -150.65 -36.88 0.14 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.145 0.497 . . . . 0.0 110.82 179.716 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.647 ' HG ' ' CE1' ' A' ' 73' ' ' HIS . 0.2 OUTLIER -48.7 117.46 6.17 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.629 -179.831 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.456 ' HB3' ' HE2' ' A' ' 122' ' ' TYR . 31.5 Cg_endo -64.5 134.37 41.11 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.046 1.831 . . . . 0.0 111.627 179.051 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.571 HG22 HD13 ' A' ' 69' ' ' ILE . 5.8 t -122.15 143.62 34.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.932 0.396 . . . . 0.0 111.262 -179.56 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.555 ' HB ' ' HG ' ' A' ' 52' ' ' LEU . 1.6 mt -124.01 110.67 26.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.925 -180.0 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.454 HD11 ' HB3' ' A' ' 53' ' ' SER . 6.3 mm -99.01 148.28 6.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.586 -179.199 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.434 ' O ' ' HB2' ' A' ' 102' ' ' LEU . 62.2 ttp -76.21 -60.42 2.34 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.813 -0.631 . . . . 0.0 112.322 -179.211 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.624 ' HB ' ' CG2' ' A' ' 55' ' ' ILE . 40.9 m -109.76 151.57 26.78 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.31 -178.516 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.535 ' CB ' ' CD2' ' A' ' 101' ' ' TYR . . . -136.09 -3.7 2.21 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -179.377 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.575 ' H ' ' CD2' ' A' ' 84' ' ' HIS . 1.0 OUTLIER -71.49 35.41 0.06 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -178.982 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.415 ' H ' ' C ' ' A' ' 83' ' ' ALA . 80.2 p -159.79 102.16 1.49 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.698 0.285 . . . . 0.0 111.184 179.447 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.476 ' O ' HD22 ' A' ' 63' ' ' LEU . 0.7 OUTLIER 67.64 35.37 4.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.911 179.762 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.516 HD21 ' HB1' ' A' ' 90' ' ' ALA . 0.5 OUTLIER -46.52 -22.53 0.28 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.108 -0.496 . . . . 0.0 112.078 -179.931 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -47.98 -50.3 27.84 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 -179.498 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.407 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . . . -60.77 -21.02 62.63 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.649 0.261 . . . . 0.0 111.661 -179.601 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.57 ' HB3' ' CE1' ' A' ' 101' ' ' TYR . . . -70.29 -34.03 72.27 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.886 0.374 . . . . 0.0 110.711 179.625 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.584 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 4.5 t -61.75 -49.84 82.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.386 -179.961 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.444 ' O ' ' NE2' ' A' ' 95' ' ' GLN . 17.6 m -59.72 -22.51 62.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.063 0.459 . . . . 0.0 110.037 179.209 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.53 ' CB ' ' HB3' ' A' ' 98' ' ' ALA . . . -65.14 -50.85 64.43 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.526 179.419 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.584 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 9.8 m-85 -54.92 -24.48 23.82 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.089 179.146 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.444 ' NE2' ' O ' ' A' ' 92' ' ' SER . 0.0 OUTLIER -76.51 -30.58 57.25 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.991 179.254 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.518 ' HG2' ' HA ' ' A' ' 93' ' ' ALA . 1.7 pt20 -91.14 -18.31 24.69 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.93 179.403 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.433 ' O ' ' HA ' ' A' ' 77' ' ' PRO . . . 127.85 14.72 2.49 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.059 -1.067 . . . . 0.0 114.016 179.283 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.53 ' HB3' ' CB ' ' A' ' 93' ' ' ALA . . . -55.46 144.52 25.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 117.457 0.629 . . . . 0.0 110.785 179.569 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.566 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 12.3 t80 -78.49 -54.46 6.13 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.337 -179.548 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.524 ' HB3' ' O ' ' A' ' 99' ' ' PHE . 10.3 p-10 173.62 -165.26 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 121.065 0.46 . . . . 0.0 111.528 179.96 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.57 ' CE1' ' HB3' ' A' ' 90' ' ' ALA . 5.3 m-85 -138.78 153.8 48.45 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.097 -179.832 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.791 HD23 ' HA ' ' A' ' 106' ' ' PHE . 5.5 mp -103.0 127.9 28.87 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 120.662 0.267 . . . . 0.0 111.288 -179.918 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -77.84 -74.6 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 121.962 1.775 . . . . 0.0 112.252 179.593 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.597 ' H ' ' HD2' ' A' ' 105' ' ' PRO . 0.2 OUTLIER -107.77 -55.91 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 -179.661 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.597 ' HD2' ' H ' ' A' ' 104' ' ' LYS . 34.0 Cg_endo -64.44 160.01 41.42 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 121.909 1.739 . . . . 0.0 112.729 -179.5 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.791 ' HA ' HD23 ' A' ' 102' ' ' LEU . 47.5 t80 -166.21 -106.51 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.089 -179.929 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.686 ' O ' ' HB1' ' A' ' 111' ' ' ALA . 2.4 p30 42.98 177.47 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.859 0.361 . . . . 0.0 111.414 -179.888 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.455 HG22 HG21 ' A' ' 112' ' ' VAL . 0.9 OUTLIER -68.06 -42.37 85.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.001 0.429 . . . . 0.0 111.401 -179.624 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.494 ' HB2' ' OD1' ' A' ' 107' ' ' ASP . 6.1 m-20 -49.08 -58.27 5.22 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.521 -179.826 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.672 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 8.1 mm-40 -74.76 -35.6 62.58 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.646 0.26 . . . . 0.0 111.602 -179.675 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.686 ' HB1' ' O ' ' A' ' 107' ' ' ASP . . . -65.77 -56.15 13.51 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.692 179.693 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.764 ' HA ' HG11 ' A' ' 115' ' ' VAL . 54.7 t -62.1 -33.92 60.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.341 0.591 . . . . 0.0 110.585 179.364 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.489 ' HB3' ' O ' ' A' ' 109' ' ' ASP . . . -61.84 -46.45 89.44 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.427 179.19 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.583 HD22 HD12 ' A' ' 102' ' ' LEU . 36.3 tp -74.67 -23.66 58.68 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.837 -179.216 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.764 HG11 ' HA ' ' A' ' 112' ' ' VAL . 6.4 p -79.49 -43.12 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.586 -179.901 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.495 ' N ' HG13 ' A' ' 115' ' ' VAL . 13.3 mt-10 -62.73 -47.31 84.15 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.056 -179.695 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.557 ' HD2' HD12 ' A' ' 114' ' ' LEU . 6.4 ptp180 -60.05 -23.6 63.87 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.735 179.507 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.566 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -74.63 -48.15 28.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.121 179.998 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.648 HD12 HG13 ' A' ' 50' ' ' VAL . 3.8 mt -68.76 -32.69 55.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.173 0.511 . . . . 0.0 110.738 179.697 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.5 t -68.95 -55.06 12.12 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.239 -179.763 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 6.4 m80 -59.35 -25.89 64.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.519 -179.612 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.456 ' HE2' ' HB3' ' A' ' 77' ' ' PRO . 2.2 m-85 -81.42 -34.11 31.75 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.094 -179.772 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.24 177.51 6.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.707 179.688 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.024 179.996 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.488 1.45 0 CA-C-O 120.944 0.402 . . . . 0.0 111.281 . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 63.18 135.91 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.036 -179.779 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.45 -21.84 21.69 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.319 -179.84 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.445 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . 78.02 101.28 0.2 Allowed Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.809 -179.473 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.4 mp -118.72 113.24 41.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.913 0.387 . . . . 0.0 111.509 -179.419 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.768 HG13 ' HA ' ' A' ' 30' ' ' CYS . 11.6 p -105.97 128.33 60.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.675 179.297 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.616 ' CD1' HG21 ' A' ' 31' ' ' THR . 31.2 m0 -114.69 132.86 56.27 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.742 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.549 HG11 ' HB3' ' A' ' 52' ' ' LEU . 0.2 OUTLIER -123.86 141.6 43.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.066 0.46 . . . . 0.0 111.594 -178.06 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.596 ' HB ' ' C ' ' A' ' 35' ' ' ASN . 29.1 m -123.92 111.28 28.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.301 0.572 . . . . 0.0 111.005 179.474 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -161.38 -157.81 0.53 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.475 -179.557 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -72.0 9.12 1.01 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.987 0.365 . . . . 0.0 111.987 -179.929 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.532 ' O ' ' N ' ' A' ' 14' ' ' SER . 3.4 p30 47.8 -136.69 0.91 Allowed 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 179.662 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.518 ' N ' ' HG2' ' A' ' 16' ' ' ARG . 1.5 t 36.32 -84.44 0.0 OUTLIER 'General case' 0 C--O 1.236 0.348 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -179.584 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.532 ' N ' ' O ' ' A' ' 12' ' ' ASP . 35.6 t -77.8 -43.82 29.37 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.205 -0.452 . . . . 0.0 112.135 -179.21 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 27.4 mm -63.97 -34.34 67.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -178.893 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.606 ' HG3' ' H ' ' A' ' 17' ' ' TRP . 6.1 ptp180 -67.85 -52.69 33.76 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.789 -179.44 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.606 ' H ' ' HG3' ' A' ' 16' ' ' ARG . 28.4 t90 -54.85 -41.92 71.36 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.326 -178.782 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.5 t -67.55 -49.16 73.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -178.542 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.47 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 6.7 mt -79.72 -26.9 40.7 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.777 -178.112 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.595 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 19.3 pt-20 -66.8 -57.99 5.95 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.506 -0.477 . . . . 0.0 111.411 -179.604 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.461 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 3.4 mmt-85 -60.79 -54.46 44.88 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.927 -179.463 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.86 -33.29 68.52 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -179.055 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.67 ' CD1' HG11 ' A' ' 6' ' ' VAL . 2.7 tm? -76.01 -30.36 58.47 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.494 0.664 . . . . 0.0 110.308 179.602 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.61 -33.3 75.61 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.28 178.401 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.18 -26.15 68.98 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.198 178.607 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.25 -15.57 58.65 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 120.752 0.311 . . . . 0.0 110.823 179.371 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.98 26.06 10.74 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.647 -0.787 . . . . 0.0 113.596 179.211 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.598 ' HB2' HD13 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -132.77 170.89 14.62 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 117.571 0.685 . . . . 0.0 111.742 179.854 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.5 m -95.76 137.6 34.59 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.63 -179.438 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.768 ' HA ' HG13 ' A' ' 6' ' ' VAL . 10.9 t -125.38 119.86 29.47 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.088 0.471 . . . . 0.0 111.501 -179.569 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.621 HG23 ' CE1' ' A' ' 33' ' ' PHE . 2.5 t -125.95 132.27 52.11 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.833 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.537 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 69.9 p -103.4 164.11 11.85 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 -177.23 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.633 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 6.0 m-85 -134.41 172.96 12.18 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.59 -178.384 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.418 ' HG2' ' N ' ' A' ' 35' ' ' ASN . 0.5 OUTLIER -62.28 -34.83 77.32 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -177.175 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.596 ' C ' ' HB ' ' A' ' 9' ' ' VAL . 22.0 p30 -176.68 -26.44 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 179.622 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.459 ' N ' ' HB ' ' A' ' 9' ' ' VAL . . . 161.82 -56.64 0.3 Allowed Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.037 -1.077 . . . . 0.0 113.123 179.649 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.495 ' N ' HD13 ' A' ' 65' ' ' LEU . 0.7 OUTLIER -50.02 -34.03 19.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.12 0.486 . . . . 0.0 110.673 -179.764 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.633 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -54.22 -52.08 62.42 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.454 179.803 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.575 HG21 ' CG ' ' A' ' 33' ' ' PHE . 56.1 t -57.61 -40.98 78.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.036 -179.829 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.431 HD11 ' HA ' ' A' ' 37' ' ' ASN . 19.2 mt -53.12 -40.69 64.37 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.092 0.472 . . . . 0.0 110.426 179.459 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -77.25 -48.71 16.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.044 179.449 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.69 -25.15 67.22 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.763 179.67 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.569 ' HG ' HG11 ' A' ' 39' ' ' VAL . 9.3 mt -68.35 -22.05 64.7 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.036 -179.54 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.06 -17.09 36.84 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.737 -179.641 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.8 t -121.96 -3.48 9.12 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -179.611 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.495 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -162.71 159.02 23.78 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.038 0.447 . . . . 0.0 111.34 179.643 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.423 ' HA ' ' CD2' ' A' ' 43' ' ' LEU . 98.2 m -139.23 113.96 8.22 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.442 179.703 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.46 ' HG3' ' HB2' ' A' ' 7' ' ' TRP . 72.0 Cg_endo -75.7 161.64 36.42 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.049 1.832 . . . . 0.0 111.291 178.92 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.417 ' O ' ' HG2' ' A' ' 77' ' ' PRO . 1.2 m-20 -73.69 -21.15 60.34 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.649 0.261 . . . . 0.0 110.956 -179.869 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.481 HG11 ' HA ' ' A' ' 6' ' ' VAL . 7.5 p -148.75 166.7 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.347 179.958 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.526 HD12 ' O ' ' A' ' 7' ' ' TRP . 18.8 tp -153.02 130.78 11.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.736 0.303 . . . . 0.0 111.158 -179.467 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.549 ' HB3' HG11 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -112.31 121.44 44.9 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.531 -179.934 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.51 ' HA ' ' CG2' ' A' ' 9' ' ' VAL . 3.2 m -106.23 130.83 54.02 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.928 0.394 . . . . 0.0 111.488 -179.695 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.402 ' O ' ' CG2' ' A' ' 55' ' ' ILE . 35.4 t70 -73.78 -22.67 59.76 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.586 -179.803 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.763 HG12 ' HA3' ' A' ' 62' ' ' GLY . 0.0 OUTLIER 44.04 99.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 121.185 0.517 . . . . 0.0 111.832 -179.782 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -142.58 43.99 1.62 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.585 -179.57 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.525 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER 58.81 48.13 2.2 Favored Pre-proline 0 CA--C 1.532 0.264 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 179.296 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.545 ' HD2' ' N ' ' A' ' 62' ' ' GLY . 41.1 Cg_endo -68.06 -79.16 0.01 OUTLIER 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 122.327 2.018 . . . . 0.0 111.969 178.914 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -107.83 -25.15 6.04 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.331 179.478 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.526 ' C ' ' H ' ' A' ' 62' ' ' GLY . 0.3 OUTLIER -158.72 65.03 0.42 Allowed 'General case' 0 C--O 1.236 0.368 0 CA-C-O 120.962 0.41 . . . . 0.0 110.454 179.813 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.525 ' HA ' ' HA ' ' A' ' 57' ' ' MET . 0.2 OUTLIER 70.36 -21.24 0.19 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.961 179.998 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.763 ' HA3' HG12 ' A' ' 55' ' ' ILE . . . 130.76 -30.0 3.47 Favored Glycine 0 N--CA 1.446 -0.674 0 N-CA-C 110.146 -1.182 . . . . 0.0 110.146 -178.847 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.607 HD13 ' HB3' ' A' ' 86' ' ' ASP . 0.8 OUTLIER -70.54 -15.99 62.83 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.007 -0.596 . . . . 0.0 109.732 178.675 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.455 ' HB3' ' N ' ' A' ' 60' ' ' MET . . . -53.54 -32.08 49.15 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-O 120.906 0.384 . . . . 0.0 110.259 179.706 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.495 HD13 ' N ' ' A' ' 37' ' ' ASN . 0.1 OUTLIER -61.24 -43.38 98.97 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.311 179.027 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.596 ' HG ' ' CB ' ' A' ' 93' ' ' ALA . 3.1 mm? -57.69 -45.45 85.62 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.052 -179.493 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -55.55 -47.69 75.96 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.234 0.54 . . . . 0.0 110.361 179.15 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.425 ' HG2' ' O ' ' A' ' 64' ' ' ALA . 34.7 mm-40 -60.04 -29.74 68.73 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.503 179.62 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.555 ' HA ' ' CD2' ' A' ' 73' ' ' HIS . 59.4 mt -57.19 -48.98 81.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.224 0.535 . . . . 0.0 111.155 -179.705 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.523 ' HB3' ' CG ' ' A' ' 96' ' ' GLN . 7.6 pttt -63.02 -33.57 75.7 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.004 -179.232 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.487 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 4.4 mt-30 -72.73 -32.94 66.08 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.913 -179.478 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.2 mtt180 -108.87 -65.71 1.11 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -178.627 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.555 ' CD2' ' HA ' ' A' ' 69' ' ' ILE . 0.8 OUTLIER -82.12 169.04 19.84 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.679 -178.677 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -84.67 -68.99 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.885 2.39 . . . . 0.0 113.116 -179.579 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.418 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 69.7 mtm -150.98 45.83 0.84 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.823 0.344 . . . . 0.0 110.786 -179.8 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.433 HD11 ' HD2' ' A' ' 48' ' ' PRO . 25.3 tp -56.77 114.8 8.6 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.231 -179.589 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.424 ' HB3' ' CE2' ' A' ' 122' ' ' TYR . 19.6 Cg_endo -59.87 123.14 12.62 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.236 1.957 . . . . 0.0 112.011 179.531 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.851 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 4.6 t -124.59 153.07 31.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.843 -179.743 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.501 ' CD1' HG22 ' A' ' 115' ' ' VAL . 1.7 mt -128.45 114.39 33.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.94 179.939 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.567 HG13 ' CZ ' ' A' ' 101' ' ' TYR . 13.7 mm -93.83 141.01 15.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.889 -179.865 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.558 ' HA ' ' HB3' ' A' ' 102' ' ' LEU . 0.3 OUTLIER -80.26 -33.04 38.17 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.573 -179.334 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.46 ' N ' ' HG3' ' A' ' 81' ' ' MET . 19.8 m -147.83 144.92 28.5 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 120.96 0.41 . . . . 0.0 111.724 -179.244 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.474 ' HA ' ' CE2' ' A' ' 101' ' ' TYR . . . -86.92 -26.19 24.03 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.39 179.661 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 46.87 44.5 14.49 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.766 179.549 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 38.8 m 53.4 85.89 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.576 179.286 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.607 ' HB3' HD13 ' A' ' 63' ' ' LEU . 0.2 OUTLIER 177.03 35.71 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.825 179.822 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -49.12 -21.87 0.83 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.949 -179.509 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -47.7 -61.08 2.11 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.48 0.181 . . . . 0.0 111.422 -179.503 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.0 -20.03 60.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.824 0.345 . . . . 0.0 110.698 179.375 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.425 ' HB1' ' CE1' ' A' ' 101' ' ' TYR . . . -62.38 -47.57 83.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.345 -179.963 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.554 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 6.6 t -67.26 -41.05 86.16 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 C-N-CA 120.704 -0.399 . . . . 0.0 110.52 179.819 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.492 ' O ' ' HG3' ' A' ' 95' ' ' GLN . 39.7 m -62.19 -15.83 49.0 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.387 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.596 ' CB ' ' HG ' ' A' ' 66' ' ' LEU . . . -75.87 -64.0 1.18 Allowed 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 120.988 0.423 . . . . 0.0 111.625 179.904 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.625 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 3.9 m-85 -41.7 -44.35 3.14 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.782 -178.431 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.578 ' NE2' ' HG3' ' A' ' 96' ' ' GLN . 0.2 OUTLIER -69.97 -48.46 58.17 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.23 179.563 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.578 ' HG3' ' NE2' ' A' ' 95' ' ' GLN . 59.5 mt-30 -75.92 -9.83 58.93 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.292 -0.413 . . . . 0.0 112.106 -179.831 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 93' ' ' ALA . . . 133.48 80.64 0.16 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.063 -179.553 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.851 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -168.5 133.82 1.73 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.093 0.473 . . . . 0.0 111.309 -179.903 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.427 ' CG ' ' HB1' ' A' ' 118' ' ' ALA . 50.4 t80 -73.33 -53.37 10.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.773 -179.777 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.516 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 1.7 t0 175.84 -171.05 0.07 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.016 0.436 . . . . 0.0 111.404 -179.817 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.567 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 6.7 m-85 -114.35 152.88 30.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.233 179.328 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.683 HD22 ' O ' ' A' ' 105' ' ' PRO . 5.9 tp -105.52 137.32 19.26 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.142 -179.032 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.467 ' HD2' HD12 ' A' ' 102' ' ' LEU . 36.7 Cg_endo -65.23 -161.5 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.933 2.422 . . . . 0.0 112.726 -179.545 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.433 ' CB ' ' HD3' ' A' ' 105' ' ' PRO . 0.3 OUTLIER -48.89 -59.25 6.61 Favored Pre-proline 0 CA--C 1.531 0.223 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.819 -179.478 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.683 ' O ' HD22 ' A' ' 102' ' ' LEU . 73.8 Cg_exo -48.49 164.27 0.22 Allowed 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.44 2.093 . . . . 0.0 111.868 179.776 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.625 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 64.8 t80 -161.74 -102.42 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.706 -0.224 . . . . 0.0 110.719 179.844 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.583 ' O ' ' O ' ' A' ' 106' ' ' PHE . 2.6 p-10 42.09 179.3 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.915 0.388 . . . . 0.0 111.318 -179.983 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.513 HG23 HG23 ' A' ' 112' ' ' VAL . 1.0 OUTLIER -67.66 -42.29 86.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.084 0.468 . . . . 0.0 111.346 179.863 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.663 ' O ' ' HB3' ' A' ' 113' ' ' ALA . 3.4 t0 -51.86 -58.77 5.49 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.594 -179.36 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.625 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 3.3 mm-40 -75.62 -27.7 58.55 Favored 'General case' 0 C--N 1.333 -0.124 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -179.476 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.419 ' CB ' ' O ' ' A' ' 107' ' ' ASP . . . -73.82 -62.52 1.47 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.925 0.393 . . . . 0.0 110.256 179.519 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.65 ' O ' HG12 ' A' ' 115' ' ' VAL . 49.3 t -55.63 -29.86 25.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.484 0.659 . . . . 0.0 110.256 179.021 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.663 ' HB3' ' O ' ' A' ' 109' ' ' ASP . . . -63.46 -50.96 67.65 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.731 179.172 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.407 ' HG ' HG21 ' A' ' 79' ' ' ILE . 53.7 tp -72.4 -20.69 61.39 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.395 -0.82 . . . . 0.0 112.273 -179.705 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.65 HG12 ' O ' ' A' ' 112' ' ' VAL . 2.9 p -79.36 -47.67 22.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.686 -179.338 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.416 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 26.0 mt-10 -64.24 -42.8 96.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.855 0.36 . . . . 0.0 110.652 179.98 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.522 ' HG3' ' O ' ' A' ' 113' ' ' ALA . 40.5 mtt85 -63.36 -23.68 67.52 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.924 0.392 . . . . 0.0 110.551 179.224 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.427 ' HB1' ' CG ' ' A' ' 99' ' ' PHE . . . -70.16 -48.76 55.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.663 179.446 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.403 HG12 ' HB ' ' A' ' 50' ' ' VAL . 4.9 mt -68.1 -31.95 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.039 179.892 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 9.2 p -74.04 -49.05 25.91 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.382 -179.725 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -59.61 -28.21 66.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.312 -179.551 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.424 ' CE2' ' HB3' ' A' ' 77' ' ' PRO . 6.2 m-85 -83.06 -54.14 5.28 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.164 -179.87 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? 59.65 -179.38 0.09 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.953 179.898 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 6.4 pm0 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.876 -179.995 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.5 tpp . . . . . 0 N--CA 1.487 1.424 0 CA-C-O 120.762 0.315 . . . . 0.0 111.104 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.643 ' O ' ' HG2' ' A' ' 3' ' ' ARG . 1.1 mt-30 -84.85 -68.45 0.72 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.295 179.61 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.643 ' HG2' ' O ' ' A' ' 2' ' ' GLN . 0.0 OUTLIER 71.04 -34.01 0.29 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.487 -0.779 . . . . 0.0 112.046 179.758 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.467 ' H ' ' C ' ' A' ' 2' ' ' GLN . . . 104.84 103.46 2.86 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.444 179.41 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.491 HD11 ' HG2' ' A' ' 3' ' ' ARG . 7.5 mm -127.56 112.7 28.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 120.904 0.383 . . . . 0.0 111.813 -179.546 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.738 HG13 ' HA ' ' A' ' 30' ' ' CYS . 7.9 p -107.07 135.16 46.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.144 179.642 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.616 ' CG ' ' HB3' ' A' ' 48' ' ' PRO . 24.2 m0 -120.26 125.89 49.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.014 0.435 . . . . 0.0 110.657 179.447 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.731 HG13 ' HB3' ' A' ' 52' ' ' LEU . 0.5 OUTLIER -114.56 146.64 18.79 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.288 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.46 -178.365 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.746 HG12 ' HB2' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -124.7 110.8 25.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.821 0.343 . . . . 0.0 110.582 179.243 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.421 ' CB ' HG23 ' A' ' 15' ' ' ILE . 3.8 t0 -161.49 -161.18 0.77 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.228 -179.231 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.24 -0.23 3.29 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -179.487 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.436 ' O ' ' N ' ' A' ' 14' ' ' SER . 0.8 OUTLIER 69.51 -157.72 0.16 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.5 0.19 . . . . 0.0 110.894 179.896 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.6 t 34.54 -88.61 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 113.002 0.741 . . . . 0.0 113.002 179.51 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.436 ' N ' ' O ' ' A' ' 12' ' ' ASP . 28.4 t -56.07 -58.99 5.6 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.719 0.295 . . . . 0.0 111.235 -179.699 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.421 HG23 ' CB ' ' A' ' 10' ' ' ASP . 20.5 mm -65.77 -24.46 34.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.262 -179.821 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.464 ' HG3' HG23 ' A' ' 32' ' ' THR . 20.2 ttt-85 -78.39 -41.15 34.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.023 179.819 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.409 ' HA ' ' CD ' ' A' ' 20' ' ' GLU . 84.1 t90 -65.7 -40.17 91.99 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.541 -179.351 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.606 HG11 HG12 ' A' ' 108' ' ' ILE . 3.5 t -69.37 -38.17 76.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -178.93 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.43 HD21 HD13 ' A' ' 108' ' ' ILE . 0.2 OUTLIER -84.39 -29.29 26.33 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -178.962 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.732 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 24.4 pt-20 -67.87 -59.01 3.62 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -179.29 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.45 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 9.8 mmt180 -64.65 -51.69 61.23 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.885 -178.904 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.23 -44.43 79.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.103 0.478 . . . . 0.0 111.521 -179.384 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.717 ' CD1' HG11 ' A' ' 6' ' ' VAL . 2.1 tm? -72.04 -27.85 62.98 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.188 179.523 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.54 -33.63 76.11 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.29 178.397 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.18 -28.65 69.45 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.498 -0.858 . . . . 0.0 111.16 178.772 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.84 -15.35 59.74 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 120.717 0.294 . . . . 0.0 110.947 179.412 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.49 26.08 11.36 Favored Glycine 0 C--N 1.334 0.422 0 C-N-CA 120.7 -0.762 . . . . 0.0 113.657 179.001 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.479 ' HB2' HD13 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -131.5 172.65 11.96 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 117.528 0.664 . . . . 0.0 111.583 179.625 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.462 ' HB ' HD12 ' A' ' 5' ' ' ILE . 16.6 m -96.62 138.08 34.73 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.43 -179.256 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.738 ' HA ' HG13 ' A' ' 6' ' ' VAL . 8.5 t -127.61 117.5 22.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.884 179.972 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.583 HG22 ' CE1' ' A' ' 33' ' ' PHE . 2.8 t -122.08 142.77 50.02 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.275 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.691 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 66.7 p -118.26 159.81 22.7 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.181 0.515 . . . . 0.0 112.165 -178.889 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.859 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 0.2 OUTLIER -135.1 171.92 13.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.823 -179.007 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.677 ' HG2' ' N ' ' A' ' 35' ' ' ASN . 0.0 OUTLIER -64.17 -43.53 94.84 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.212 -179.532 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.677 ' N ' ' HG2' ' A' ' 34' ' ' GLU . 29.3 p30 -173.1 178.89 2.37 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.104 0.478 . . . . 0.0 110.988 -179.018 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.59 ' HA3' ' HB3' ' A' ' 65' ' ' LEU . . . -43.05 -32.21 1.46 Allowed Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.46 -0.791 . . . . 0.0 113.825 -179.47 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.623 ' HA ' HD13 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -72.67 -45.68 57.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.945 0.373 . . . . 0.0 111.613 -178.966 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.859 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -52.2 -54.47 30.5 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 -179.836 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.54 HG23 HG11 ' A' ' 9' ' ' VAL . 3.5 t -48.86 -36.26 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.32 -179.438 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.623 HD13 ' HA ' ' A' ' 37' ' ' ASN . 7.0 mt -62.62 -49.6 74.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.838 0.351 . . . . 0.0 110.532 179.85 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -54.35 -50.39 67.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.32 -179.488 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.531 ' CB ' ' HE2' ' A' ' 33' ' ' PHE . . . -70.77 -33.46 70.78 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.258 179.953 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.559 ' HA ' ' O ' ' A' ' 46' ' ' LYS . 16.0 mt -61.19 -27.12 68.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.307 -179.821 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.79 -17.99 4.2 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.618 -179.583 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 23.9 t -120.85 -3.39 9.7 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -179.635 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.559 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.4 OUTLIER -167.66 165.38 14.37 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.883 0.373 . . . . 0.0 111.47 -179.73 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 59.3 m -139.18 128.14 13.94 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.221 179.585 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.616 ' HB3' ' CG ' ' A' ' 7' ' ' TRP . 74.1 Cg_endo -78.06 159.66 30.33 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.38 2.053 . . . . 0.0 111.904 179.195 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -75.42 -31.37 60.35 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.622 179.847 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.593 HG22 HG23 ' A' ' 115' ' ' VAL . 13.5 p -149.68 111.82 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.446 -179.435 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.445 HD21 HG13 ' A' ' 39' ' ' VAL . 15.3 tp -87.13 150.2 24.14 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.925 0.393 . . . . 0.0 111.949 -179.656 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.731 ' HB3' HG13 ' A' ' 8' ' ' VAL . 1.4 tt -138.75 118.13 12.83 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.743 179.539 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.498 ' N ' HD23 ' A' ' 52' ' ' LEU . 3.2 m -112.42 135.16 53.46 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 121.038 0.447 . . . . 0.0 111.286 179.756 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.523 ' O ' HG21 ' A' ' 55' ' ' ILE . 25.7 t0 -77.36 -8.01 56.99 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -178.705 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.968 HG12 ' HA3' ' A' ' 62' ' ' GLY . 0.0 OUTLIER 37.61 100.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 179.908 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.3 ptt85 -146.03 44.0 1.24 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.501 179.68 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.502 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 37.7 ttp 65.27 49.37 0.72 Allowed Pre-proline 0 CA--C 1.532 0.285 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 178.894 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' A' ' 62' ' ' GLY . 57.5 Cg_endo -72.05 -84.54 0.0 OUTLIER 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 122.757 2.305 . . . . 0.0 112.116 178.711 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -100.33 -29.33 6.76 Favored Glycine 0 C--N 1.337 0.636 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.433 179.696 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.571 ' HB3' ' CB ' ' A' ' 64' ' ' ALA . 0.7 OUTLIER -157.23 69.4 0.57 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.907 0.384 . . . . 0.0 110.114 179.496 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.502 ' HA ' ' HA ' ' A' ' 57' ' ' MET . 0.2 OUTLIER 68.56 -22.96 0.13 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.964 -179.694 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.968 ' HA3' HG12 ' A' ' 55' ' ' ILE . . . 136.69 -26.63 3.01 Favored Glycine 0 CA--C 1.498 -0.997 0 C-N-CA 120.981 -0.628 . . . . 0.0 111.682 -179.838 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.551 ' HA ' HD13 ' A' ' 66' ' ' LEU . 1.0 OUTLIER -75.95 -17.56 59.69 Favored 'General case' 0 N--CA 1.44 -0.971 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.157 179.221 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.571 ' CB ' ' HB3' ' A' ' 60' ' ' MET . . . -53.47 -38.34 63.51 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 121.002 0.429 . . . . 0.0 110.601 179.085 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.59 ' HB3' ' HA3' ' A' ' 36' ' ' GLY . 3.8 pp -58.76 -36.94 75.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.197 -179.795 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.551 HD13 ' HA ' ' A' ' 63' ' ' LEU . 9.6 mt -62.7 -43.73 98.04 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.835 0.35 . . . . 0.0 110.308 179.586 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.488 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 0.4 OUTLIER -52.9 -59.75 4.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.499 179.563 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.514 ' CB ' HD11 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -55.86 -38.19 69.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.023 0.44 . . . . 0.0 111.146 179.422 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.437 ' HA ' ' CD2' ' A' ' 73' ' ' HIS . 6.7 mm -61.56 -36.74 75.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.218 -178.738 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.584 ' HB2' ' HB2' ' A' ' 96' ' ' GLN . 1.1 pttt -78.44 -24.86 45.87 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.247 -0.433 . . . . 0.0 112.084 -179.613 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.49 ' NE2' ' HG3' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -80.57 -30.03 37.01 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.694 -178.251 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.49 ' HG3' ' NE2' ' A' ' 71' ' ' GLN . 27.5 mtt180 -103.9 -21.78 13.59 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -179.684 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.551 ' NE2' HD11 ' A' ' 43' ' ' LEU . 1.9 m-70 -128.67 156.24 77.77 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-O 120.776 0.322 . . . . 0.0 111.255 -178.935 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -95.25 100.88 0.11 Allowed 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 123.214 2.609 . . . . 0.0 113.687 -178.88 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.458 ' HA ' ' CA ' ' A' ' 97' ' ' GLY . 3.9 mtt 55.53 38.57 30.4 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.261 178.169 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.539 ' O ' HG22 ' A' ' 78' ' ' VAL . 1.4 tt -60.52 114.19 9.51 Favored Pre-proline 0 C--N 1.325 -0.483 0 C-N-CA 121.143 -0.223 . . . . 0.0 110.867 179.602 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.526 ' HB3' ' CE2' ' A' ' 122' ' ' TYR . 50.7 Cg_exo -55.87 129.94 37.65 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.532 2.155 . . . . 0.0 112.848 -179.948 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.601 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 4.4 t -137.59 147.06 26.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.286 179.55 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.587 ' HB ' ' HG ' ' A' ' 52' ' ' LEU . 2.0 mt -122.47 111.07 28.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.212 179.563 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.63 HG22 ' CE2' ' A' ' 101' ' ' TYR . 8.6 mm -99.2 142.13 15.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 120.996 0.426 . . . . 0.0 111.839 -178.903 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.626 ' O ' ' HB2' ' A' ' 102' ' ' LEU . 13.8 ttt -70.72 -75.73 0.12 Allowed 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.631 -179.42 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.472 ' H ' ' CG2' ' A' ' 55' ' ' ILE . 3.0 m -105.65 147.39 28.54 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.089 0.471 . . . . 0.0 111.542 -178.936 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.538 ' O ' ' HG ' ' A' ' 87' ' ' LEU . . . -116.29 59.12 0.74 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.902 179.941 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 21.1 p80 -99.07 135.28 40.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.913 0.387 . . . . 0.0 111.561 -179.674 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.432 ' HB3' ' CG ' ' A' ' 61' ' ' ASP . 9.5 t 62.85 134.11 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.648 179.183 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.43 ' O ' HD23 ' A' ' 63' ' ' LEU . 1.8 t70 55.49 36.65 27.57 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.128 179.65 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' A' ' 83' ' ' ALA . 0.5 OUTLIER -53.48 -24.27 12.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.566 -179.901 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -49.5 -47.46 48.63 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.96 0.41 . . . . 0.0 111.357 -179.782 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.512 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -62.66 -19.74 64.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.258 -179.888 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.507 ' HB1' HD22 ' A' ' 63' ' ' LEU . . . -72.09 -57.49 4.22 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.775 0.321 . . . . 0.0 110.972 179.527 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.677 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 3.5 t -59.95 -52.45 60.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.299 -179.55 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 89.9 p -58.44 -22.25 53.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.01 0.434 . . . . 0.0 109.98 178.975 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.507 ' O ' ' N ' ' A' ' 97' ' ' GLY . . . -59.92 -48.81 80.17 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.365 179.154 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.677 ' CE2' ' HA ' ' A' ' 91' ' ' VAL . 2.8 m-85 -57.62 -30.89 65.72 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.186 -180.0 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.77 -36.37 59.85 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.306 -179.911 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.584 ' HB2' ' HB2' ' A' ' 70' ' ' LYS . 11.8 pt20 -100.18 0.88 41.34 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.526 -178.98 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 93' ' ' ALA . . . 128.4 81.32 0.31 Allowed Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.347 -0.93 . . . . 0.0 113.323 179.955 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.601 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -169.7 136.04 1.56 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.778 0.323 . . . . 0.0 110.26 179.162 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.515 ' CZ ' ' HA ' ' A' ' 118' ' ' ALA . 32.0 t80 -74.97 -53.32 9.16 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.976 -0.29 . . . . 0.0 111.325 -179.449 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.613 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 2.4 t70 179.82 -172.76 0.2 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.265 0.555 . . . . 0.0 111.924 -179.756 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.63 ' CE2' HG22 ' A' ' 80' ' ' ILE . 3.1 m-85 -128.36 154.1 46.34 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.811 179.986 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.626 ' HB2' ' O ' ' A' ' 81' ' ' MET . 9.0 mp -102.04 123.58 43.07 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-O 120.719 0.295 . . . . 0.0 110.614 179.958 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -68.62 -66.8 0.03 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.19 1.927 . . . . 0.0 112.337 -179.753 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.641 ' H ' ' HD2' ' A' ' 105' ' ' PRO . 0.7 OUTLIER -119.4 -58.39 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.244 -0.434 . . . . 0.0 112.117 -179.535 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.641 ' HD2' ' H ' ' A' ' 104' ' ' LYS . 17.8 Cg_endo -59.5 163.1 13.43 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.255 1.97 . . . . 0.0 112.697 -179.501 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.593 ' O ' ' O ' ' A' ' 107' ' ' ASP . 38.9 t80 -166.86 -108.61 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.223 179.609 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.594 ' O ' ' HB2' ' A' ' 111' ' ' ALA . 3.1 p30 43.04 176.57 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.896 0.379 . . . . 0.0 111.274 -179.975 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.606 HG12 HG11 ' A' ' 18' ' ' VAL . 1.0 OUTLIER -67.7 -39.41 82.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 121.903 -0.498 . . . . 0.0 111.278 -179.82 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.462 ' O ' ' HB1' ' A' ' 113' ' ' ALA . 4.4 t70 -49.82 -58.47 5.3 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.246 -179.75 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.581 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 3.4 mm-40 -77.61 -34.32 53.42 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 111.709 0.263 . . . . 0.0 111.709 -179.76 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.594 ' HB2' ' O ' ' A' ' 107' ' ' ASP . . . -64.39 -59.56 4.21 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 179.328 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.758 ' O ' HG13 ' A' ' 115' ' ' VAL . 55.8 t -59.54 -30.27 44.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.466 0.65 . . . . 0.0 110.506 178.86 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.462 ' HB1' ' O ' ' A' ' 109' ' ' ASP . . . -65.37 -47.55 76.0 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.158 179.367 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.542 HD22 HD12 ' A' ' 102' ' ' LEU . 23.6 tp -73.51 -21.33 60.43 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.551 -179.627 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.758 HG13 ' O ' ' A' ' 112' ' ' VAL . 5.7 p -79.44 -47.08 22.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.779 0.323 . . . . 0.0 111.679 -179.838 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.578 ' HA ' HD12 ' A' ' 119' ' ' ILE . 31.8 mt-10 -67.88 -46.8 70.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.88 -179.786 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 55.8 mtp180 -61.01 -24.2 65.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.091 0.472 . . . . 0.0 110.567 179.392 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.515 ' HA ' ' CZ ' ' A' ' 99' ' ' PHE . . . -71.16 -47.4 57.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.97 179.625 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.585 HD13 HG12 ' A' ' 50' ' ' VAL . 4.6 mt -62.94 -31.17 51.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.127 -179.95 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.0 t -74.55 -51.0 15.86 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.422 -179.387 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 20.5 m80 -68.89 -24.95 64.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.394 -179.464 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.526 ' CE2' ' HB3' ' A' ' 77' ' ' PRO . 1.1 m-85 -67.93 -55.62 12.11 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.959 -179.816 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -75.62 -176.1 3.14 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.972 179.987 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.819 179.913 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.695 ' HG2' HD11 ' A' ' 5' ' ' ILE . 0.0 OUTLIER . . . . . 2 N--CA 1.274 -9.244 0 CA-C-O 124.789 2.233 . . . . 0.0 114.498 . . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.464 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . 79.76 87.59 0.54 Allowed Glycine 1 C--N 1.149 -9.831 1 O-C-N 113.565 -5.709 . . . . 0.0 112.665 -179.864 . . . . . . . . 4 3 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 1.134 ' CD1' ' CB ' ' A' ' 5' ' ' ILE . 0.7 OUTLIER -112.7 113.3 43.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 O-C-N 122.59 -0.359 . . . . 0.0 111.365 -179.679 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.825 HG23 HG13 ' A' ' 50' ' ' VAL . 7.1 p -107.71 125.39 64.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.676 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.894 ' CD1' HG22 ' A' ' 31' ' ' THR . 31.4 m0 -114.44 134.13 55.23 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.03 0.443 . . . . 0.0 110.374 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.698 HG13 ' HB3' ' A' ' 52' ' ' LEU . 0.3 OUTLIER -122.29 143.83 33.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.653 -178.405 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.706 HG11 ' HA2' ' A' ' 36' ' ' GLY . 0.0 OUTLIER -123.81 109.65 23.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.038 0.447 . . . . 0.0 110.321 178.901 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.497 ' O ' ' N ' ' A' ' 12' ' ' ASP . 5.8 t0 -164.55 -177.24 4.72 Favored 'General case' 1 C--O 0.895 -17.579 0 CA-C-O 125.923 2.773 . . . . 0.0 111.103 -179.075 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 1.303 ' OD2' ' CB ' ' A' ' 11' ' ' ASP . 0.7 OUTLIER -44.89 -10.47 0.01 OUTLIER 'General case' 2 C--N 1.074 -11.412 3 O-C-N 104.073 -11.642 . . . . 0.0 112.854 -178.827 . . . . . . . . 5 4 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.497 ' N ' ' O ' ' A' ' 10' ' ' ASP . 2.6 t70 76.01 -147.53 0.03 OUTLIER 'General case' 1 C--O 1.13 -5.215 0 O-C-N 117.905 -2.997 . . . . 0.0 111.76 179.803 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . 1.091 ' OG ' ' HB2' ' A' ' 13' ' ' SER . 8.2 t 22.05 -85.74 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.777 0 C-N-CA 126.371 1.868 . . . . 0.0 114.676 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.754 ' O ' HG23 ' A' ' 18' ' ' VAL . 0.3 OUTLIER -55.87 -56.92 14.9 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 120.925 0.393 . . . . 0.0 111.514 -179.447 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.0 mm -65.09 -24.99 36.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-O 120.823 0.344 . . . . 0.0 111.141 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 1.253 ' NH2' ' NE ' ' A' ' 16' ' ' ARG . 1.8 ttt180 -72.29 -50.2 28.84 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.291 0.567 . . . . 0.0 111.201 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 72.1 t90 -60.33 -43.24 96.6 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.754 HG23 ' O ' ' A' ' 14' ' ' SER . 3.2 t -65.84 -48.05 83.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -178.553 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 1.418 ' CD1' ' CB ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -81.15 -29.29 34.76 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -178.093 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 1.327 ' OE1' ' CG ' ' A' ' 20' ' ' GLU . 12.9 pt-20 -67.13 -59.33 3.54 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -178.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 1.202 ' NE ' ' CG ' ' A' ' 21' ' ' ARG . 11.8 mmt180 -59.2 -51.27 70.73 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.821 -179.09 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.64 -46.11 84.6 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.91 0.386 . . . . 0.0 111.83 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 1.479 ' CD1' ' CB ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -72.2 -26.46 62.06 Favored 'General case' 0 C--N 1.311 -1.109 0 CA-C-O 121.225 0.536 . . . . 0.0 110.408 179.577 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.09 -34.62 78.03 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.269 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.93 -26.14 68.63 Favored Glycine 0 N--CA 1.44 -1.073 0 C-N-CA 120.247 -0.978 . . . . 0.0 111.032 178.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.673 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -77.21 -15.71 59.37 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 120.802 0.334 . . . . 0.0 110.939 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.3 26.23 10.32 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.514 -0.851 . . . . 0.0 114.143 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.673 ' CD1' ' HB3' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -126.18 168.74 13.64 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 117.982 0.891 . . . . 0.0 112.238 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 53.7 m -91.85 115.3 27.95 Favored 'General case' 0 C--O 1.211 -0.953 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.627 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 1.223 ' SG ' ' CA ' ' A' ' 30' ' ' CYS . 49.1 t -110.81 113.55 26.23 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.008 0.433 . . . . 0.0 112.083 -179.259 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.894 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.7 t -122.48 146.22 47.59 Favored 'General case' 0 C--O 1.219 -0.509 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.536 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.816 HG21 ' HA ' ' A' ' 16' ' ' ARG . 60.3 p -119.52 162.57 18.68 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.315 0.579 . . . . 0.0 112.258 -178.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.816 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 3.0 m-85 -133.65 173.54 11.4 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.371 -0.832 . . . . 0.0 111.7 -178.442 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.676 ' HG3' ' N ' ' A' ' 35' ' ' ASN . 17.1 pt-20 -62.55 -47.03 85.66 Favored 'General case' 1 C--O 1.149 -4.211 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -177.98 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 1.103 ' CG ' ' CA ' ' A' ' 35' ' ' ASN . 0.0 OUTLIER -161.25 -61.73 0.05 Allowed 'General case' 1 C--O 0.886 -18.048 0 O-C-N 118.598 -2.564 . . . . 0.0 112.277 -179.252 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.968 ' HA3' HD23 ' A' ' 65' ' ' LEU . . . -163.39 -43.95 0.02 OUTLIER Glycine 1 C--N 1.066 -14.464 3 O-C-N 103.777 -11.827 . . . . 0.0 113.315 -179.399 . . . . . . . . 4 3 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 1.329 ' ND2' ' CB ' ' A' ' 37' ' ' ASN . 2.0 m-20 -60.43 -33.31 72.35 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 122.208 -0.584 . . . . 0.0 111.358 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 1.103 ' CD ' ' HG2' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -57.1 -55.27 36.91 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.384 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.657 HG23 HG13 ' A' ' 9' ' ' VAL . 21.5 t -53.44 -37.62 30.42 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.289 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.816 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.68 HD13 ' HB3' ' A' ' 68' ' ' GLN . 18.5 mt -56.42 -44.72 80.66 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.681 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.39 -48.77 63.84 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.212 0.529 . . . . 0.0 111.218 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.64 -31.77 73.14 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.913 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 1.187 HD13 ' CE1' ' A' ' 73' ' ' HIS . 12.9 mt -64.4 -24.93 67.8 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.515 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.35 -18.72 18.65 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.66 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.39 0.11 8.84 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 1.256 ' NZ ' ' CD ' ' A' ' 46' ' ' LYS . 0.3 OUTLIER -162.4 160.38 26.36 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-O 120.779 0.323 . . . . 0.0 111.55 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 97.3 m -138.91 114.7 8.57 Favored Pre-proline 0 N--CA 1.448 -0.556 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.447 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.602 ' HD2' HD21 ' A' ' 43' ' ' LEU . 68.4 Cg_endo -75.29 159.58 40.15 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.441 2.094 . . . . 0.0 111.599 179.108 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -75.26 -26.53 58.88 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.803 0.335 . . . . 0.0 111.108 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.825 HG13 HG23 ' A' ' 6' ' ' VAL . 7.1 p -146.04 133.52 15.26 Favored 'Isoleucine or valine' 1 C--O 1.079 -7.92 0 CA-C-O 122.88 1.324 . . . . 0.0 110.861 -179.652 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.548 HD12 ' O ' ' A' ' 7' ' ' TRP . 18.2 tp -120.02 134.45 55.25 Favored 'General case' 1 C--N 1.203 -5.766 1 O-C-N 114.859 -4.901 . . . . 0.0 111.649 -179.262 . . . . . . . . 4 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.698 ' HB3' HG13 ' A' ' 8' ' ' VAL . 0.6 OUTLIER -119.15 122.13 41.32 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 122.824 0.45 . . . . 0.0 110.232 179.676 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.452 ' HA ' HG23 ' A' ' 9' ' ' VAL . 0.5 OUTLIER -115.96 136.59 52.9 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.273 0.559 . . . . 0.0 112.169 -179.541 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 1.282 ' O ' ' CA ' ' A' ' 55' ' ' ILE . 10.3 t70 -80.96 -2.32 47.27 Favored 'General case' 1 C--O 0.48 -39.423 1 CA-C-O 162.772 20.32 . . . . 0.0 112.03 -179.978 . . . . . . . . 4 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 1.282 ' CA ' ' O ' ' A' ' 54' ' ' ASP . 14.7 tt 32.72 97.83 0.0 OUTLIER 'Isoleucine or valine' 2 C--N 0.776 -24.364 3 O-C-N 28.812 -58.68 . . . . 0.0 111.483 -179.326 . . . . . . . . 4 3 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 1.555 ' CB ' ' CD ' ' A' ' 56' ' ' ARG 0.266 0.3 OUTLIER -158.85 47.77 0.33 Allowed 'General case' 3 C--N 1.154 -7.898 1 O-C-N 112.899 -6.125 . . . . 0.0 117.447 -179.837 . . . . . . . . 6 4 . 1 . 001 nuclear build core ' A' A ' 57' ' ' MET . . . . . 1.532 ' CE ' ' CG ' ' A' ' 57' ' ' MET 0.684 11.2 ttt 88.93 28.48 0.0 OUTLIER Pre-proline 3 N--CA 1.257 -10.121 1 N-CA-C 139.177 10.436 . . . . 0.0 139.177 179.064 . . . . . . . . 5 3 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.421 ' HD2' ' O ' ' A' ' 61' ' ' ASP . 36.9 Cg_endo -65.36 -101.48 0.0 OUTLIER 'Trans proline' 3 C--O 0.983 -12.226 0 O-C-N 125.966 2.561 . . . . 0.0 112.862 178.977 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -98.25 -53.3 1.27 Allowed Glycine 4 C--O 0.965 -16.705 0 CA-C-N 125.744 3.884 . . . . 0.0 112.79 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' MET . . . . . 1.282 ' CE ' ' CG ' ' A' ' 60' ' ' MET . 0.0 OUTLIER -118.1 63.28 0.76 Allowed 'General case' 1 C--N 1.163 -7.537 2 O-C-N 113.5 -5.706 . . . . 0.0 109.958 178.763 . . . . . . . . 5 4 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 1.246 ' OD1' ' CB ' ' A' ' 61' ' ' ASP . 0.3 OUTLIER 62.99 -42.67 0.19 Allowed 'General case' 1 C--O 1.044 -9.721 0 CA-C-O 122.324 1.059 . . . . 0.0 112.137 -179.756 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 1.062 ' HA3' HG13 ' A' ' 55' ' ' ILE . . . 165.91 -30.87 0.21 Allowed Glycine 1 C--N 1.185 -7.814 1 O-C-N 114.55 -5.094 . . . . 0.0 111.417 -179.713 . . . . . . . . 4 3 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.717 HD12 ' H ' ' A' ' 63' ' ' LEU . 2.2 mp -67.01 -19.19 65.66 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-O 120.852 0.358 . . . . 0.0 110.193 179.159 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.838 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -54.25 -37.49 64.74 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-O 121.183 0.516 . . . . 0.0 110.498 178.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 1.42 ' HG ' ' CA ' ' A' ' 65' ' ' LEU . 1.2 mt -58.33 -44.32 88.61 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.736 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 1.308 ' CD1' ' CB ' ' A' ' 66' ' ' LEU . 20.4 mt -55.88 -45.44 78.57 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.08 0.467 . . . . 0.0 110.619 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.2 mttt -53.34 -48.41 68.53 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.856 179.458 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 1.448 ' OE1' ' CG ' ' A' ' 68' ' ' GLN . 11.8 mm-40 -66.4 -34.55 78.21 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.963 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.576 HG13 ' O ' ' A' ' 65' ' ' LEU . 98.4 mt -61.34 -41.78 91.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.727 -179.521 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 1.25 ' NZ ' ' CD ' ' A' ' 70' ' ' LYS . 17.4 pttt -71.51 -28.1 63.66 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.669 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.618 ' OE1' ' HA ' ' A' ' 68' ' ' GLN . 1.9 mt-30 -72.84 -38.05 67.23 Favored 'General case' 0 C--O 1.213 -0.848 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.763 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 70.7 mtt-85 -97.14 -41.65 8.22 Favored 'General case' 0 C--O 1.173 -2.949 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 1.659 ' CE1' ' CD2' ' A' ' 73' ' ' HIS . 0.0 OUTLIER -108.39 139.38 20.72 Favored Pre-proline 1 C--O 1.001 -11.985 0 CA-C-O 124.121 1.915 . . . . 0.0 112.683 -179.053 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.806 ' O ' ' HG3' ' A' ' 75' ' ' MET 0.337 8.3 Cg_endo -74.0 -36.37 3.51 Favored 'Trans proline' 4 C--O 0.774 -22.703 3 C-N-CA 128.145 5.896 . . . . 0.0 123.185 -179.942 . . . . . . . . 5 3 . 1 . 001 nuclear build core ' A' A ' 75' ' ' MET . . . . . 1.194 ' CE ' ' CG ' ' A' ' 75' ' ' MET . 47.5 mtt -159.83 31.21 0.18 Allowed 'General case' 2 C--N 0.983 -15.339 3 O-C-N 101.657 -13.152 . . . . 0.0 115.154 -179.923 . . . . . . . . 4 3 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 1.306 ' CD1' ' CB ' ' A' ' 76' ' ' LEU . 1.5 tt -64.24 118.77 49.98 Favored Pre-proline 0 C--N 1.306 -1.316 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.621 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.49 ' HA ' ' O ' ' A' ' 97' ' ' GLY . 3.4 Cg_exo -63.44 125.1 14.94 Favored 'Trans proline' 0 C--O 1.212 -0.808 0 C-N-CA 122.809 2.339 . . . . 0.0 112.31 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.648 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 4.3 t -119.32 145.15 25.88 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-O 120.997 0.427 . . . . 0.0 111.321 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.664 ' CG2' HD23 ' A' ' 114' ' ' LEU . 2.0 mt -125.71 113.08 33.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.618 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.584 HD11 HD21 ' A' ' 66' ' ' LEU . 15.9 mm -98.69 141.77 15.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.604 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' MET . . . . . 1.0 ' SD ' ' CE ' ' A' ' 81' ' ' MET . 2.2 ptm -73.64 -41.0 63.33 Favored 'General case' 0 C--O 1.165 -3.381 0 CA-C-N 116.081 -0.509 . . . . 0.0 112.232 -179.162 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.567 ' H ' HG21 ' A' ' 55' ' ' ILE . 7.0 m -135.42 155.39 50.64 Favored 'General case' 0 C--N 1.29 -2.019 0 O-C-N 120.435 -1.416 . . . . 0.0 111.818 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.65 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -118.55 20.93 12.82 Favored 'General case' 1 C--O 0.955 -14.412 0 CA-C-O 121.331 0.586 . . . . 0.0 111.748 -179.667 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.559 ' O ' ' O ' ' A' ' 83' ' ' ALA 0.257 0.0 OUTLIER -25.71 -163.74 0.0 OUTLIER 'General case' 3 C--O 0.554 -35.513 2 O-C-N 111.277 -7.14 . . . . 0.0 118.378 -179.582 . . . . . . . . 6 4 . 1 . 001 nuclear build core ' A' A ' 85' ' ' SER . . . . . 1.147 ' O ' ' CA ' ' A' ' 86' ' ' ASP 0.46 0.2 OUTLIER -32.87 6.71 0.0 OUTLIER 'General case' 4 C--O 0.302 -48.796 5 O-C-N 90.034 -20.417 . . . . 0.0 127.013 -178.286 . . . . . . . . 6 4 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 1.354 ' OD2' ' CB ' ' A' ' 86' ' ' ASP . 0.5 OUTLIER -148.27 44.23 1.05 Allowed 'General case' 2 C--N 0.866 -20.424 3 O-C-N 41.666 -50.646 . . . . 0.0 115.159 178.086 . . . . . . . . 5 4 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.624 HD23 ' HB1' ' A' ' 83' ' ' ALA . 0.2 OUTLIER -48.95 -22.44 0.85 Allowed 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.967 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -48.11 -49.37 32.22 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -179.419 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.498 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -67.14 -21.19 65.84 Favored 'General case' 0 C--N 1.317 -0.807 0 O-C-N 122.371 -0.206 . . . . 0.0 111.081 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.55 ' O ' ' HB3' ' A' ' 93' ' ' ALA . . . -70.73 -42.14 70.94 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-O 121.282 0.563 . . . . 0.0 111.013 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.5 t -62.67 -46.06 97.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 CA-C-O 121.702 0.763 . . . . 0.0 111.725 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.37 -24.65 66.64 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.177 0.513 . . . . 0.0 110.267 178.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.55 ' HB3' ' O ' ' A' ' 90' ' ' ALA . . . -64.51 -47.81 77.5 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-O 121.809 0.814 . . . . 0.0 110.948 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 1.507 ' CZ ' ' CD1' ' A' ' 94' ' ' TYR . 12.3 m-85 -58.17 -28.33 64.66 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-O 122.211 1.005 . . . . 0.0 110.829 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.403 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -74.13 -38.11 63.89 Favored 'General case' 0 C--N 1.286 -2.188 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.523 179.91 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.914 ' OE1' ' HB3' ' A' ' 70' ' ' LYS . 7.6 pt20 -84.74 -12.44 53.75 Favored 'General case' 0 C--O 1.16 -3.634 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.263 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.49 ' O ' ' HA ' ' A' ' 77' ' ' PRO . . . 131.51 20.14 1.13 Allowed Glycine 2 C--O 0.905 -20.412 1 CA-C-O 128.143 4.19 . . . . 0.0 116.333 179.562 . . . . . . . . 4 3 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.648 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -77.62 145.55 36.69 Favored 'General case' 1 C--N 1.022 -13.635 3 O-C-N 102.124 -12.398 . . . . 0.0 110.88 179.427 . . . . . . . . 4 3 . 1 . 001 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.516 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 17.8 t80 -77.5 -53.7 7.3 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.707 -0.224 . . . . 0.0 111.433 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 1.14 ' CG ' ' CA ' ' A' ' 100' ' ' ASP . 2.9 t0 173.07 -167.3 0.03 OUTLIER 'General case' 0 C--O 1.221 -0.43 0 CA-C-O 120.882 0.372 . . . . 0.0 111.654 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.65 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 4.3 m-85 -132.42 152.82 51.33 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.365 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.573 ' CD1' HD22 ' A' ' 114' ' ' LEU . 0.9 OUTLIER -103.17 124.29 38.88 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-O 121.25 0.548 . . . . 0.0 110.903 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -68.19 -84.64 0.01 OUTLIER 'Trans proline' 1 C--O 1.101 -6.348 0 C-N-CA 122.104 1.869 . . . . 0.0 113.151 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.621 ' H ' ' HD2' ' A' ' 105' ' ' PRO . 14.1 mttt -106.62 -58.03 0.06 OUTLIER Pre-proline 1 C--N 1.184 -6.62 1 O-C-N 115.977 -4.202 . . . . 0.0 111.964 -179.604 . . . . . . . . 4 3 . 1 . 001 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.621 ' HD2' ' H ' ' A' ' 104' ' ' LYS . 1.1 Cg_endo -57.49 160.29 14.38 Favored 'Trans proline' 0 CA--C 1.508 -0.81 0 C-N-CA 122.342 2.028 . . . . 0.0 112.748 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.666 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 3.0 t80 -166.73 -105.57 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.859 0 O-C-N 123.463 0.477 . . . . 0.0 111.131 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.564 ' O ' ' O ' ' A' ' 106' ' ' PHE . 2.9 p30 42.49 -179.44 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.861 0.362 . . . . 0.0 111.375 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.729 HG12 HG12 ' A' ' 18' ' ' VAL . 0.9 OUTLIER -67.63 -42.85 86.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.071 0.462 . . . . 0.0 111.594 -179.848 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 1.408 ' OD1' ' CB ' ' A' ' 109' ' ' ASP . 0.2 OUTLIER -49.76 -57.84 6.53 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.61 -179.407 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 1.097 ' OE1' ' CG ' ' A' ' 110' ' ' GLU . 5.2 mm-40 -76.99 -31.97 56.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.574 0.226 . . . . 0.0 111.542 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.4 ' CB ' ' O ' ' A' ' 107' ' ' ASP . . . -67.62 -59.52 3.28 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.845 0.355 . . . . 0.0 110.171 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.64 ' O ' HG12 ' A' ' 115' ' ' VAL . 48.2 t -59.3 -31.44 46.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.423 0.63 . . . . 0.0 110.473 178.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.502 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -63.43 -46.36 86.65 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.067 179.261 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.664 HD23 ' CG2' ' A' ' 79' ' ' ILE . 29.4 tp -75.37 -22.4 57.55 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.992 -1.004 . . . . 0.0 111.802 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.64 HG12 ' O ' ' A' ' 112' ' ' VAL . 4.2 p -79.26 -43.78 23.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.641 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 1.129 ' OE2' ' CG ' ' A' ' 116' ' ' GLU . 48.9 mt-10 -65.05 -44.69 88.22 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.949 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 1.514 ' CB ' ' CD ' ' A' ' 117' ' ' ARG . 0.0 OUTLIER -61.07 -24.73 66.44 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.859 179.772 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.516 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -71.27 -45.81 62.32 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.954 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.5 HD11 HG11 ' A' ' 50' ' ' VAL . 4.7 mt -69.67 -31.57 49.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.257 0.551 . . . . 0.0 111.034 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.4 t -70.33 -47.38 61.32 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.32 -0.854 . . . . 0.0 111.086 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 19.4 m80 . . . . . 0 C--N 1.314 -0.964 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.059 -179.834 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.765 ' HB3' HD11 ' A' ' 5' ' ' ILE . 0.1 OUTLIER . . . . . 0 CA--C 1.531 0.216 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 52.06 78.72 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.795 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.765 HD11 ' HB3' ' A' ' 3' ' ' ARG . 3.6 mp -110.88 112.35 40.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.75 0.31 . . . . 0.0 110.831 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 1.023 HG11 HD13 ' A' ' 23' ' ' LEU . 7.2 p -107.59 123.43 62.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.7 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.905 ' CD1' HG22 ' A' ' 31' ' ' THR . 30.7 m0 -114.35 131.71 56.45 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.995 0.426 . . . . 0.0 110.924 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.788 HG11 ' CD1' ' A' ' 19' ' ' LEU . 0.3 OUTLIER -113.95 146.88 17.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.909 -179.588 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.799 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -130.42 105.89 12.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.951 0.405 . . . . 0.0 110.099 179.377 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -161.33 -155.14 0.39 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.822 -179.068 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -69.58 12.15 0.21 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.7 p30 46.94 -152.4 0.08 Allowed 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.4 t 38.02 -91.51 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.869 ' O ' HG23 ' A' ' 18' ' ' VAL . 1.9 t -54.87 -60.15 3.76 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.727 0.299 . . . . 0.0 110.785 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.4 mm -63.28 -24.46 35.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.727 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 1.021 ' HA ' HG21 ' A' ' 32' ' ' THR . 0.0 OUTLIER -71.57 -55.16 8.34 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.618 -179.598 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.417 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 86.3 t90 -61.15 -41.49 96.84 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -179.393 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.869 HG23 ' O ' ' A' ' 14' ' ' SER . 6.3 t -65.35 -44.56 94.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -178.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.788 ' CD1' HG11 ' A' ' 8' ' ' VAL . 26.5 mt -83.8 -25.68 30.21 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -178.362 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.577 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 18.8 pt-20 -67.7 -57.96 5.46 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -179.097 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.531 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 1.9 mmt-85 -65.47 -47.78 74.91 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.857 -0.611 . . . . 0.0 112.044 -178.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.41 -60.08 3.82 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 120.901 0.381 . . . . 0.0 111.317 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 1.036 HD22 HD13 ' A' ' 28' ' ' LEU . 3.3 mt -63.25 -29.14 70.53 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.01 179.25 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.535 ' HB2' ' O ' ' A' ' 20' ' ' GLU . . . -63.26 -36.1 82.53 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.22 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.7 -24.9 71.48 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.247 -0.978 . . . . 0.0 111.086 178.247 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.726 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -77.48 -15.52 59.26 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 120.6 0.238 . . . . 0.0 111.241 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.5 25.88 8.46 Favored Glycine 0 CA--C 1.522 0.505 0 C-N-CA 120.791 -0.719 . . . . 0.0 113.887 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 1.036 HD13 HD22 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -124.64 171.13 10.3 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 117.691 0.745 . . . . 0.0 111.996 -179.83 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 32.4 m -99.12 106.45 18.66 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.371 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.577 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 48.7 t -103.15 113.39 26.82 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -178.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.905 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.6 t -120.73 149.04 43.14 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.352 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' THR . . . . . 1.021 HG21 ' HA ' ' A' ' 16' ' ' ARG . 32.7 p -119.8 166.12 13.68 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.318 0.58 . . . . 0.0 112.336 -178.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.799 ' HB2' HG13 ' A' ' 9' ' ' VAL . 3.9 m-85 -135.6 173.92 11.19 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.414 -178.215 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.666 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 2.6 pp20? -62.08 -43.21 99.34 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -177.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.462 ' C ' HG12 ' A' ' 9' ' ' VAL . 4.9 m120 -166.07 -62.99 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.549 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . -157.73 -48.87 0.01 OUTLIER Glycine 0 C--N 1.318 -0.466 0 C-N-CA 120.517 -0.849 . . . . 0.0 113.429 -178.725 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.444 ' HA ' ' CD1' ' A' ' 40' ' ' LEU . 1.0 OUTLIER -60.85 -24.51 65.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.975 0.417 . . . . 0.0 111.435 -179.072 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.676 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -60.25 -59.02 6.08 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.262 -179.866 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.756 HG12 ' CD1' ' A' ' 43' ' ' LEU . 4.7 t -52.49 -35.35 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 C-N-CA 120.431 -0.508 . . . . 0.0 111.135 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.559 HD13 ' CB ' ' A' ' 68' ' ' GLN . 19.5 mt -56.02 -42.37 76.37 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.03 0.443 . . . . 0.0 110.976 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.76 -47.47 21.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.2 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.405 ' CB ' ' HE2' ' A' ' 33' ' ' PHE . . . -63.16 -36.49 83.8 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.783 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.756 ' CD1' HG12 ' A' ' 39' ' ' VAL . 12.7 mt -59.81 -20.72 58.53 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.135 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.71 -16.79 52.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.501 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -120.68 -5.91 9.69 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -179.434 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.524 ' O ' HD23 ' A' ' 43' ' ' LEU . 0.1 OUTLIER -162.9 160.77 25.33 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.865 0.364 . . . . 0.0 111.325 -179.746 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.967 HG23 HD23 ' A' ' 76' ' ' LEU . 96.5 m -138.61 115.08 8.86 Favored Pre-proline 0 N--CA 1.453 -0.302 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.535 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.709 ' HD2' HD21 ' A' ' 43' ' ' LEU . 65.9 Cg_endo -73.46 157.02 49.72 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.595 2.197 . . . . 0.0 111.471 178.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.412 ' OD2' HD12 ' A' ' 5' ' ' ILE . 60.1 m-20 -77.0 -22.95 52.32 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.25 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.74 HG13 HG23 ' A' ' 6' ' ' VAL . 7.1 p -150.7 98.19 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-O 120.783 0.325 . . . . 0.0 111.46 -179.255 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.492 HD12 ' O ' ' A' ' 7' ' ' TRP . 29.1 tp -86.63 138.27 31.81 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.893 0.377 . . . . 0.0 111.435 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.531 ' HB3' HG13 ' A' ' 8' ' ' VAL . 0.4 OUTLIER -123.29 113.93 19.53 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.663 179.49 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.438 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -116.54 154.6 30.14 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.322 0.582 . . . . 0.0 112.132 -179.384 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.1 p30 -83.39 -169.7 2.68 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.738 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.66 HG21 ' O ' ' A' ' 82' ' ' THR . 0.9 OUTLIER -158.15 65.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.15 0.5 . . . . 0.0 111.307 178.988 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 29.4 ptt180 -177.18 65.07 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.232 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.627 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . 2.2 tpt -161.97 -64.44 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.696 179.338 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.627 ' HD3' ' HB3' ' A' ' 57' ' ' MET . 42.0 Cg_endo -65.99 -173.15 0.31 Allowed 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.265 1.977 . . . . 0.0 112.913 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.95 -67.03 2.41 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.233 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.558 ' O ' ' N ' ' A' ' 62' ' ' GLY . 0.0 OUTLIER -76.98 55.31 1.1 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.063 0.459 . . . . 0.0 110.344 179.457 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.448 ' O ' ' HD2' ' A' ' 58' ' ' PRO . 1.0 OUTLIER 42.41 -77.8 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.711 -179.739 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.723 ' O ' ' HG ' ' A' ' 65' ' ' LEU . . . -135.34 -30.6 0.34 Allowed Glycine 0 C--O 1.225 -0.419 0 C-N-CA 120.367 -0.92 . . . . 0.0 113.224 -179.434 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.76 ' HA ' HD12 ' A' ' 66' ' ' LEU . 0.2 OUTLIER -67.75 -12.54 60.77 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.619 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.487 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -56.34 -56.79 16.79 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-O 121.056 0.455 . . . . 0.0 110.116 178.671 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.859 HD12 ' N ' ' A' ' 66' ' ' LEU . 3.1 pp -54.78 -42.3 71.58 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.498 179.182 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.859 ' N ' HD12 ' A' ' 65' ' ' LEU . 28.8 mt -48.19 -52.62 20.05 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.005 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.773 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 34.5 tttp -54.58 -43.13 71.85 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.09 0.472 . . . . 0.0 110.711 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.559 ' CB ' HD13 ' A' ' 40' ' ' LEU . 34.4 mm-40 -64.75 -28.4 69.55 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.615 179.519 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.891 HD13 HG21 ' A' ' 78' ' ' VAL . 96.2 mt -63.83 -40.45 89.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.726 -179.128 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.773 ' HG2' ' O ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -75.22 -25.38 58.11 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.893 -179.187 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -62.22 -50.8 70.31 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.209 -0.45 . . . . 0.0 112.175 -179.211 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 14.2 mtt-85 -96.26 -45.32 6.88 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -178.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.453 ' HE1' ' HA ' ' A' ' 40' ' ' LEU . 0.4 OUTLIER -91.41 130.3 40.01 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.198 -178.649 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 73' ' ' HIS . 44.4 Cg_exo -56.76 -70.77 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.54 2.16 . . . . 0.0 113.099 -179.101 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.712 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 2.1 mpt? -133.74 46.88 2.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.932 0.396 . . . . 0.0 111.412 -179.355 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.967 HD23 HG23 ' A' ' 47' ' ' THR . 2.8 tm? -64.31 110.61 4.15 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.53 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.59 ' HD2' HD22 ' A' ' 76' ' ' LEU . 38.0 Cg_exo -58.49 131.58 43.46 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.624 2.216 . . . . 0.0 112.168 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.891 HG21 HD13 ' A' ' 69' ' ' ILE . 2.8 t -131.34 151.93 36.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.107 0.479 . . . . 0.0 111.431 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.624 HD11 ' CG2' ' A' ' 50' ' ' VAL . 4.0 mt -134.08 115.58 21.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.952 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.677 HG13 HD11 ' A' ' 66' ' ' LEU . 26.4 mm -93.68 141.95 14.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.525 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.635 ' HG3' HG22 ' A' ' 55' ' ' ILE . 7.7 ptm -71.99 -35.44 69.49 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -178.544 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.66 ' O ' HG21 ' A' ' 55' ' ' ILE . 4.1 m -147.31 149.4 32.76 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -179.328 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.717 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -108.64 83.31 1.75 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.798 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 -66.87 -159.34 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.669 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.469 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 0.4 OUTLIER -80.46 78.98 7.13 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-O 121.079 0.466 . . . . 0.0 112.152 -178.455 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.483 ' HB3' HD13 ' A' ' 63' ' ' LEU . 13.7 t70 175.74 26.6 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.777 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.577 HD21 ' HB1' ' A' ' 83' ' ' ALA . 13.3 mt -45.73 -22.96 0.21 Allowed 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -179.328 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -47.98 -46.9 33.14 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.61 0.243 . . . . 0.0 111.325 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.05 -22.04 59.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.334 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.599 ' HB2' HD23 ' A' ' 63' ' ' LEU . . . -65.41 -40.89 93.94 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.182 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.63 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 6.6 t -65.26 -40.06 87.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.933 -179.554 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.463 ' O ' ' HG3' ' A' ' 95' ' ' GLN . 19.5 m -63.42 -16.49 60.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.124 0.488 . . . . 0.0 109.903 178.456 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.789 ' O ' ' HG3' ' A' ' 96' ' ' GLN . . . -75.94 -55.01 6.02 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 121.503 0.668 . . . . 0.0 111.062 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.63 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 3.6 m-85 -57.38 -34.69 69.11 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.291 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.463 ' HG3' ' O ' ' A' ' 92' ' ' SER . 2.3 pp0? -77.19 -35.2 55.97 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.119 -179.274 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.789 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 1.9 pp0? -77.65 -18.41 56.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.096 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 147.37 -27.61 1.52 Allowed Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.987 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.69 ' HB3' ' C ' ' A' ' 93' ' ' ALA . . . -41.95 152.7 0.07 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.563 0.181 . . . . 0.0 111.378 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.517 ' O ' ' HB2' ' A' ' 100' ' ' ASP . 59.6 t80 -85.63 -53.58 5.07 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 121.084 -0.246 . . . . 0.0 111.544 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.517 ' HB2' ' O ' ' A' ' 99' ' ' PHE . 1.0 OUTLIER 170.79 -176.19 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.009 0.433 . . . . 0.0 111.243 -179.717 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.717 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 3.9 m-85 -112.04 152.71 27.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.333 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.668 HD21 ' HA ' ' A' ' 106' ' ' PHE . 6.5 tp -104.64 139.62 20.28 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.09 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.513 ' HD2' HD12 ' A' ' 102' ' ' LEU . 38.7 Cg_endo -66.51 -164.29 0.08 OUTLIER 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.779 2.32 . . . . 0.0 113.1 -179.505 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.479 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 85.6 mttt -46.37 -59.71 4.61 Favored Pre-proline 0 CA--C 1.533 0.315 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.779 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 8.4 Cg_endo -50.74 164.4 0.57 Allowed 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.699 2.266 . . . . 0.0 112.157 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.668 ' HA ' HD21 ' A' ' 102' ' ' LEU . 86.7 t80 -162.16 -99.93 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.665 -0.243 . . . . 0.0 110.914 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.586 ' O ' ' O ' ' A' ' 106' ' ' PHE . 2.9 p-10 40.06 -177.2 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.977 0.418 . . . . 0.0 111.562 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.65 HG12 HG12 ' A' ' 18' ' ' VAL . 0.8 OUTLIER -67.76 -43.52 86.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.106 0.479 . . . . 0.0 111.024 179.474 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.497 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 8.1 t70 -49.42 -59.07 4.06 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.896 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.631 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 21.4 mm-40 -76.95 -27.51 54.83 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 111.841 0.312 . . . . 0.0 111.841 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.407 ' CB ' ' O ' ' A' ' 107' ' ' ASP . . . -71.01 -59.59 2.7 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 179.362 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.643 ' O ' HG12 ' A' ' 115' ' ' VAL . 53.6 t -59.61 -30.67 45.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.348 0.595 . . . . 0.0 110.271 178.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.497 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -63.61 -46.3 86.41 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.928 179.407 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.468 ' HA ' ' HG2' ' A' ' 117' ' ' ARG . 53.8 tp -74.86 -23.16 58.38 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.695 -179.654 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.643 HG12 ' O ' ' A' ' 112' ' ' VAL . 2.8 p -79.53 -42.38 22.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.997 -0.281 . . . . 0.0 111.547 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.583 ' HA ' HD12 ' A' ' 119' ' ' ILE . 47.6 mt-10 -63.71 -43.6 96.08 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.088 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.468 ' HG2' ' HA ' ' A' ' 114' ' ' LEU . 0.4 OUTLIER -64.35 -23.97 67.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.862 0.363 . . . . 0.0 110.739 179.638 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.458 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -71.35 -45.12 63.71 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.835 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.583 HD12 ' HA ' ' A' ' 116' ' ' GLU . 6.4 mt -62.71 -31.66 52.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.217 0.532 . . . . 0.0 110.709 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 9.2 m -71.19 -54.85 9.55 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.87 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 1.7 m80 . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.912 179.983 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.979 0.419 . . . . 0.0 111.173 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.691 ' C ' HD13 ' A' ' 5' ' ' ILE . . . -82.64 86.03 1.48 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.557 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.691 HD13 ' C ' ' A' ' 4' ' ' GLY . 2.6 mm -111.81 112.76 41.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.864 0.364 . . . . 0.0 111.157 -179.023 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.89 HG23 HG13 ' A' ' 50' ' ' VAL . 7.3 p -108.77 124.87 65.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.902 0.382 . . . . 0.0 110.521 179.205 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.942 ' CD1' HG22 ' A' ' 31' ' ' THR . 22.5 m0 -115.17 135.87 53.72 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.965 0.412 . . . . 0.0 110.637 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.856 HG13 ' HB3' ' A' ' 52' ' ' LEU . 1.3 t -126.22 146.04 32.69 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.332 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.431 -178.449 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.722 HG22 HG23 ' A' ' 39' ' ' VAL . 45.2 t -120.6 112.62 36.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 177.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -161.65 -158.21 0.54 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.96 -178.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -76.31 19.25 0.25 Allowed 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.6 p30 46.25 -156.2 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.433 ' OG ' ' N ' ' A' ' 14' ' ' SER . 76.7 p 35.83 -95.09 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.752 ' O ' HG23 ' A' ' 18' ' ' VAL . 0.3 OUTLIER -52.77 -62.04 1.91 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.911 -178.969 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 18.4 mm -63.93 -23.88 34.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.977 0.418 . . . . 0.0 111.063 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.565 ' HA ' HG21 ' A' ' 32' ' ' THR . 3.0 ttt-85 -75.95 -50.84 13.81 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.906 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.466 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 44.8 t90 -58.91 -37.41 76.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.188 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.752 HG23 ' O ' ' A' ' 14' ' ' SER . 11.2 t -69.39 -43.92 80.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.114 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.733 HD23 HG21 ' A' ' 8' ' ' VAL . 2.3 tp -84.03 -27.34 28.42 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.416 -178.568 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.661 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 12.8 pt-20 -67.82 -60.98 2.1 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.624 -0.431 . . . . 0.0 111.845 -179.065 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.479 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 3.9 mmt-85 -59.65 -52.19 66.59 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.805 -179.322 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.07 -52.36 64.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.982 0.42 . . . . 0.0 111.316 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.754 ' CD2' HG11 ' A' ' 6' ' ' VAL . 1.8 tp -68.06 -24.98 65.13 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.342 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.13 -35.61 78.38 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.229 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.87 -25.98 68.35 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.411 -0.9 . . . . 0.0 111.244 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.658 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -77.15 -15.78 59.39 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 120.675 0.274 . . . . 0.0 111.07 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.96 26.59 8.33 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.457 -0.878 . . . . 0.0 114.28 178.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.726 HD12 ' O ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -126.51 170.85 11.59 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 117.938 0.869 . . . . 0.0 111.897 -179.913 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 35.2 m -99.8 104.95 16.67 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.091 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.833 ' HA ' HG13 ' A' ' 6' ' ' VAL . 51.5 t -100.1 111.52 23.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.582 -179.187 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.942 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.6 t -124.06 147.39 47.9 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.349 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.77 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 65.7 p -116.95 166.11 12.55 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -178.284 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.88 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 5.0 m-85 -135.66 170.3 16.18 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.002 -178.039 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.927 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 2.1 pp20? -68.96 -54.13 16.99 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -179.13 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.7 ' C ' HG11 ' A' ' 9' ' ' VAL . 14.0 m120 -155.81 -178.65 7.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.898 0.38 . . . . 0.0 110.8 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.52 ' O ' ' HG ' ' A' ' 40' ' ' LEU . . . -50.98 -16.39 1.81 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.89 -0.671 . . . . 0.0 114.1 -178.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -85.54 -36.33 20.54 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 117.766 0.783 . . . . 0.0 112.131 -179.262 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.927 ' HB2' ' HG3' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -55.37 -62.07 1.92 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -178.444 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.722 HG23 HG22 ' A' ' 9' ' ' VAL . 48.6 t -49.06 -32.23 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.999 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' A' ' 36' ' ' GLY . 30.5 mt -59.9 -41.03 90.77 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.031 0.443 . . . . 0.0 110.209 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.53 -48.32 78.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.185 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.11 -29.65 64.29 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.829 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.727 HD13 ' NE2' ' A' ' 73' ' ' HIS . 5.9 mt -61.51 -33.52 73.94 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.017 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.56 -19.45 15.85 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.617 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.8 m -125.47 2.58 7.67 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.532 ' O ' HD23 ' A' ' 43' ' ' LEU . 0.1 OUTLIER -161.9 166.18 26.6 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 120.832 0.349 . . . . 0.0 111.165 179.966 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.788 HG23 HD23 ' A' ' 76' ' ' LEU . 85.1 m -138.41 114.78 8.96 Favored Pre-proline 0 N--CA 1.453 -0.289 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.999 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.625 ' HD2' HD21 ' A' ' 43' ' ' LEU . 61.2 Cg_endo -71.09 148.16 55.89 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.283 1.989 . . . . 0.0 111.886 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -74.21 -30.34 62.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.758 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.89 HG13 HG23 ' A' ' 6' ' ' VAL . 7.3 p -146.88 101.36 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.841 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.61 HD11 HG21 ' A' ' 39' ' ' VAL . 13.8 tp -85.46 125.6 33.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.08 0.467 . . . . 0.0 111.343 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.856 ' HB3' HG13 ' A' ' 8' ' ' VAL . 1.2 tt -120.64 120.26 35.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.823 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.502 ' CB ' HD23 ' A' ' 65' ' ' LEU . 8.1 t -118.38 130.2 55.86 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.067 0.461 . . . . 0.0 111.106 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.415 ' HA ' ' HG2' ' A' ' 81' ' ' MET . 24.5 t70 -83.24 15.19 3.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.805 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.696 HG13 ' O ' ' A' ' 61' ' ' ASP . 3.5 tt 33.51 93.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 120.766 0.317 . . . . 0.0 111.813 -179.396 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.9 tpt180 -104.7 34.1 3.3 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.356 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.534 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER 53.14 47.35 4.04 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.674 179.08 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.747 ' HD2' ' O ' ' A' ' 61' ' ' ASP . 21.0 Cg_endo -61.26 -74.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.096 1.864 . . . . 0.0 111.272 178.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -117.01 -80.94 0.81 Allowed Glycine 0 C--N 1.332 0.306 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 178.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.747 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -85.6 56.27 3.89 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 177.781 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.747 ' O ' ' HD2' ' A' ' 58' ' ' PRO . 4.1 p30 55.92 -62.88 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.224 -0.898 . . . . 0.0 112.106 -178.674 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 60' ' ' MET . . . -155.47 -35.97 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 121.147 -0.549 . . . . 0.0 112.276 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.763 HD21 ' HA ' ' A' ' 87' ' ' LEU . 0.3 OUTLIER -61.38 -22.0 64.57 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.73 0.3 . . . . 0.0 111.085 -179.802 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.747 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -54.91 -42.76 72.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.092 0.473 . . . . 0.0 111.135 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.546 ' HG ' HD11 ' A' ' 69' ' ' ILE . 7.4 tp -52.96 -43.85 66.69 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.252 -179.507 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 1.0 HD22 ' HB1' ' A' ' 93' ' ' ALA . 2.9 mt -59.93 -43.83 94.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.912 0.387 . . . . 0.0 110.862 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.439 ' HG3' ' HE3' ' A' ' 70' ' ' LYS . 4.1 tttt -53.07 -54.92 28.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.775 -179.378 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.519 ' HB3' HD13 ' A' ' 40' ' ' LEU . 66.2 mm-40 -61.18 -44.66 96.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.911 -179.219 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.59 ' CG2' ' HB3' ' A' ' 76' ' ' LEU . 22.7 mt -56.92 -54.18 33.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.287 0.565 . . . . 0.0 111.409 -178.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.473 ' HB3' ' CB ' ' A' ' 96' ' ' GLN . 11.0 pttt -57.45 -23.7 51.32 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.496 -179.098 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.65 -51.96 50.32 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.722 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 75.0 mtt-85 -100.37 -7.19 24.68 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.379 -178.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.727 ' NE2' HD13 ' A' ' 43' ' ' LEU . 71.6 m-70 -125.52 139.09 33.14 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-O 120.896 0.379 . . . . 0.0 112.015 -179.233 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -68.86 -62.33 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.95 2.433 . . . . 0.0 113.417 -179.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.739 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 1.8 mtt -136.06 49.0 2.14 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.163 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.788 HD23 HG23 ' A' ' 47' ' ' THR . 0.9 OUTLIER -68.26 108.49 2.85 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.014 178.916 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.525 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 18.1 Cg_endo -59.42 132.32 45.6 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.419 2.079 . . . . 0.0 112.336 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.422 ' CG2' HD13 ' A' ' 69' ' ' ILE . 3.3 t -129.48 136.24 59.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.738 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.616 HD11 HG23 ' A' ' 50' ' ' VAL . 1.9 mt -127.61 110.89 23.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.934 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.633 HG13 ' CZ ' ' A' ' 101' ' ' TYR . 15.2 mm -99.79 147.53 7.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.538 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.489 ' HG3' ' N ' ' A' ' 82' ' ' THR . 0.3 OUTLIER -81.66 -34.58 30.69 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.261 -179.767 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.489 ' N ' ' HG3' ' A' ' 81' ' ' MET . 21.6 m -133.79 148.28 51.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.517 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.535 ' HA ' ' CE2' ' A' ' 101' ' ' TYR . . . -99.94 -25.82 14.2 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.417 ' HB3' ' H ' ' A' ' 85' ' ' SER . 3.3 m-70 46.77 -158.87 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.764 -0.198 . . . . 0.0 110.913 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.417 ' H ' ' HB3' ' A' ' 84' ' ' HIS . 94.0 p -80.25 175.44 10.64 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.977 0.417 . . . . 0.0 111.469 -179.581 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.657 ' O ' HD22 ' A' ' 63' ' ' LEU . 0.7 OUTLIER 62.89 32.46 15.72 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.989 -179.897 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.763 ' HA ' HD21 ' A' ' 63' ' ' LEU . 1.9 mt -49.05 -21.66 0.75 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.414 -179.509 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -48.39 -41.36 28.75 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.806 0.298 . . . . 0.0 111.806 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.638 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -66.16 -23.79 66.53 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.733 ' HB2' HD23 ' A' ' 63' ' ' LEU . . . -77.3 -26.86 52.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.819 0.342 . . . . 0.0 110.726 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.511 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 6.3 t -68.22 -39.21 80.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.936 0.398 . . . . 0.0 110.073 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 30.9 m -68.55 -20.54 64.55 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.742 178.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 1.0 ' HB1' HD22 ' A' ' 66' ' ' LEU . . . -67.41 -42.99 82.33 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.668 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.511 ' CE2' ' HA ' ' A' ' 91' ' ' VAL . 12.5 m-85 -62.39 -25.79 68.12 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.332 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.18 -41.13 42.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.282 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.739 ' O ' ' HA ' ' A' ' 75' ' ' MET . 0.0 OUTLIER -76.06 -16.91 59.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.206 -179.876 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 119.16 17.63 4.87 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.461 -0.876 . . . . 0.0 113.652 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.58 ' HB2' ' HB1' ' A' ' 93' ' ' ALA . . . -64.43 165.05 10.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 117.141 0.47 . . . . 0.0 110.811 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.481 ' HZ ' ' HG3' ' A' ' 117' ' ' ARG . 13.9 t80 -87.16 -54.42 4.32 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.497 ' OD2' HD11 ' A' ' 114' ' ' LEU . 9.5 p30 167.77 -164.55 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.782 0.325 . . . . 0.0 110.887 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.633 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 5.6 m-85 -138.63 153.19 48.6 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.755 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.404 ' CD1' HD22 ' A' ' 114' ' ' LEU . 0.8 OUTLIER -103.25 122.34 45.57 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.074 179.863 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -70.13 -69.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.078 1.852 . . . . 0.0 112.501 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.692 ' H ' ' HD2' ' A' ' 105' ' ' PRO . 0.9 OUTLIER -119.07 -60.42 0.03 OUTLIER Pre-proline 0 CA--C 1.533 0.301 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.901 -179.637 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.692 ' HD2' ' H ' ' A' ' 104' ' ' LYS . 11.7 Cg_endo -54.12 160.53 6.17 Favored 'Trans proline' 0 C--N 1.35 0.605 0 C-N-CA 122.214 1.943 . . . . 0.0 112.513 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.639 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 50.5 t80 -170.8 -102.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.551 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.566 ' O ' ' O ' ' A' ' 106' ' ' PHE . 2.3 p-10 43.26 178.46 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.558 0.218 . . . . 0.0 111.052 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.713 HG12 HG12 ' A' ' 18' ' ' VAL . 0.8 OUTLIER -67.82 -44.13 85.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.231 0.539 . . . . 0.0 111.217 179.852 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.492 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 1.5 t70 -49.42 -58.78 4.52 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.703 -179.223 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.639 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 6.4 mm-40 -74.17 -30.41 62.23 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 111.771 0.285 . . . . 0.0 111.771 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -68.76 -62.05 1.55 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.817 0.341 . . . . 0.0 110.331 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.641 ' HA ' HG12 ' A' ' 115' ' ' VAL . 44.0 t -57.84 -31.56 40.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.477 0.656 . . . . 0.0 110.716 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.492 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -64.0 -44.3 93.06 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.848 179.079 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.768 ' HA ' ' HD3' ' A' ' 117' ' ' ARG . 10.0 tp -78.33 -23.01 47.23 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.778 -179.131 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.641 HG12 ' HA ' ' A' ' 112' ' ' VAL . 4.8 p -79.45 -41.77 22.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.026 0.441 . . . . 0.0 111.47 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.495 ' HA ' HD12 ' A' ' 119' ' ' ILE . 20.8 mt-10 -59.65 -47.76 84.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.274 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.768 ' HD3' ' HA ' ' A' ' 114' ' ' LEU . 0.8 OUTLIER -59.24 -23.96 62.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.44 -179.531 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.479 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -71.03 -39.34 72.39 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.105 0.478 . . . . 0.0 111.0 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.696 HD13 ' CD2' ' A' ' 28' ' ' LEU . 4.6 mt -76.95 -30.95 18.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.728 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.4 t -67.44 -41.15 85.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.602 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 17.5 m80 . . . . . 0 C--O 1.233 0.198 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.979 179.992 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.634 ' HB3' HD11 ' A' ' 5' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.453 -0.288 0 CA-C-O 120.905 0.383 . . . . 0.0 111.079 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.44 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . 53.65 82.76 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.536 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.634 HD11 ' HB3' ' A' ' 3' ' ' ARG . 3.8 mp -108.4 112.38 40.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.713 0.292 . . . . 0.0 111.545 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 1.003 HG11 ' CD2' ' A' ' 23' ' ' LEU . 7.5 p -106.64 123.37 61.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.974 0.416 . . . . 0.0 110.911 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.795 ' CD1' HG22 ' A' ' 31' ' ' THR . 28.6 m0 -114.53 136.94 52.47 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.363 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.693 HG21 ' OE1' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -129.68 141.49 46.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.478 -178.408 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 1.085 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -119.45 104.83 16.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 178.673 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.707 ' HB3' HG21 ' A' ' 15' ' ' ILE . 8.3 t0 -172.42 114.98 0.31 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.387 0.613 . . . . 0.0 111.401 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.672 ' O ' ' HB2' ' A' ' 12' ' ' ASP . 0.4 OUTLIER 49.75 -87.46 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.761 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.672 ' HB2' ' O ' ' A' ' 11' ' ' ASP . 22.9 t0 168.01 -125.72 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.51 0 O-C-N 123.041 0.213 . . . . 0.0 110.842 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.521 ' HA ' ' HB3' ' A' ' 16' ' ' ARG . 72.7 m -41.36 -43.58 2.54 Favored 'General case' 0 C--N 1.342 0.275 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.0 m -52.9 -62.4 1.67 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.65 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.707 HG21 ' HB3' ' A' ' 10' ' ' ASP . 21.8 mm -72.33 -20.08 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.617 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.85 ' HA ' HG21 ' A' ' 32' ' ' THR . 3.0 tmm_? -72.38 -30.97 65.16 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-O 121.529 0.681 . . . . 0.0 110.244 178.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.622 ' O ' ' HB2' ' A' ' 21' ' ' ARG . 41.2 t90 -72.16 -58.07 3.73 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.886 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.449 HG12 HG12 ' A' ' 108' ' ' ILE . 0.8 OUTLIER -60.68 -62.24 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 -177.467 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.53 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -68.81 -49.52 57.84 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 114.29 1.218 . . . . 0.0 114.29 -176.818 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.755 ' HG3' ' HG2' ' A' ' 16' ' ' ARG . 1.5 mm-40 -67.87 -61.23 1.97 Allowed 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -177.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.622 ' HB2' ' O ' ' A' ' 17' ' ' TRP . 8.5 mmt180 -48.61 -44.22 36.92 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.327 -177.274 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.22 -28.6 62.26 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.878 0.37 . . . . 0.0 110.887 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 1.003 ' CD2' HG11 ' A' ' 6' ' ' VAL . 5.0 tp -80.93 -23.35 38.93 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.406 179.356 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' A' ' 20' ' ' GLU . . . -69.31 -35.14 75.68 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.468 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.87 -27.08 66.22 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.202 -0.999 . . . . 0.0 110.84 178.072 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.671 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -77.68 -15.86 58.89 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.623 0.249 . . . . 0.0 111.071 179.424 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.75 26.71 11.31 Favored Glycine 0 CA--C 1.522 0.47 0 C-N-CA 120.548 -0.834 . . . . 0.0 114.732 178.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.769 HD13 ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -117.77 166.36 12.54 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 118.548 1.174 . . . . 0.0 112.007 -179.887 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.493 ' HB ' HG23 ' A' ' 5' ' ' ILE . 88.5 m -84.73 104.66 14.89 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.776 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.474 ' HA ' HG13 ' A' ' 6' ' ' VAL . 2.8 p -106.29 109.31 21.2 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.956 -178.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.795 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.7 t -125.26 152.46 44.58 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.481 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.85 HG21 ' HA ' ' A' ' 16' ' ' ARG . 64.7 p -122.9 164.16 18.97 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.392 0.615 . . . . 0.0 112.597 -178.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 1.085 ' HB2' HG13 ' A' ' 9' ' ' VAL . 26.3 m-85 -135.93 172.95 12.26 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.025 -0.989 . . . . 0.0 112.033 -177.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.435 ' HG2' ' H ' ' A' ' 35' ' ' ASN . 5.3 pt-20 -63.26 -50.92 68.27 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.318 0.858 . . . . 0.0 113.318 -177.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.435 ' H ' ' HG2' ' A' ' 34' ' ' GLU . 10.5 m-20 -168.75 -26.06 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -179.279 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.609 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . 174.29 -61.62 0.12 Allowed Glycine 0 N--CA 1.453 -0.191 0 C-N-CA 120.115 -1.041 . . . . 0.0 113.029 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.516 ' HA ' ' CD1' ' A' ' 40' ' ' LEU . 1.2 t30 -51.93 -28.38 16.3 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.69 0.281 . . . . 0.0 111.24 -179.536 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.908 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.7 OUTLIER -58.83 -58.34 9.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.67 179.245 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.694 HG12 ' HG ' ' A' ' 43' ' ' LEU . 7.7 t -50.74 -38.16 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 120.619 -0.433 . . . . 0.0 111.339 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.715 HD13 ' HB3' ' A' ' 68' ' ' GLN . 17.5 mt -53.81 -43.88 69.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.394 -179.173 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.89 -48.94 62.13 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.546 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.63 -35.28 78.63 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.37 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.694 ' HG ' HG12 ' A' ' 39' ' ' VAL . 14.2 mt -60.2 -26.31 66.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.076 0.465 . . . . 0.0 110.909 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.06 -20.46 25.01 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.302 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.3 m -123.08 4.67 9.28 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 112.146 0.425 . . . . 0.0 112.146 -179.276 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.543 ' HB3' ' CH2' ' A' ' 7' ' ' TRP . 0.0 OUTLIER -164.51 158.99 18.83 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.893 0.378 . . . . 0.0 111.273 -179.768 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.982 HG23 HD23 ' A' ' 76' ' ' LEU . 90.8 m -138.23 112.14 8.64 Favored Pre-proline 0 N--CA 1.452 -0.347 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.688 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.588 ' HD2' HD21 ' A' ' 43' ' ' LEU . 73.9 Cg_endo -73.58 156.21 49.57 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.703 2.268 . . . . 0.0 111.477 178.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -78.47 -22.92 46.8 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.174 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.641 ' O ' HG13 ' A' ' 50' ' ' VAL . 7.3 p -150.58 96.66 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-O 120.663 0.268 . . . . 0.0 111.542 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 27.7 tp -87.09 145.8 26.31 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 121.123 0.487 . . . . 0.0 111.367 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.769 HD23 ' O ' ' A' ' 79' ' ' ILE . 0.6 OUTLIER -131.36 114.18 14.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.323 179.637 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.685 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 35.3 t -115.32 144.52 43.64 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.62 0.724 . . . . 0.0 112.126 -179.235 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -83.14 168.36 16.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.395 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.558 HG13 ' O ' ' A' ' 61' ' ' ASP . 3.6 tt -142.58 87.6 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.721 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.5 ptm85 -118.51 36.22 4.48 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.541 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.687 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 1.2 ttt 64.46 46.3 0.59 Allowed Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.099 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.58 ' HD2' ' O ' ' A' ' 61' ' ' ASP . 27.0 Cg_endo -64.23 -74.81 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.024 1.816 . . . . 0.0 110.769 178.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -111.84 -85.58 1.53 Allowed Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 109.981 -1.247 . . . . 0.0 109.981 177.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.881 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 0.5 OUTLIER -87.72 58.65 5.0 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 177.408 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.687 ' HA ' ' HA ' ' A' ' 57' ' ' MET . 0.2 OUTLIER 62.54 -42.69 0.18 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.993 -179.5 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.514 ' HA3' HD12 ' A' ' 55' ' ' ILE . . . 171.31 -29.52 0.12 Allowed Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 111.494 -0.642 . . . . 0.0 111.494 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.661 HD11 ' O ' ' A' ' 84' ' ' HIS . 0.5 OUTLIER -72.46 -17.48 61.77 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 120.992 -0.283 . . . . 0.0 110.452 179.427 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.881 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -53.94 -29.25 41.65 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 121.103 0.478 . . . . 0.0 110.54 178.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.451 ' HA ' ' OE1' ' A' ' 68' ' ' GLN . 1.4 mm? -66.77 -24.22 66.18 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.24 -179.465 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.96 HD13 ' HB2' ' A' ' 93' ' ' ALA . 3.7 mt -77.73 -46.5 21.59 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.134 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.696 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 1.7 mtpt -46.09 -51.92 12.99 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.501 178.57 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.715 ' HB3' HD13 ' A' ' 40' ' ' LEU . 2.6 mp0 -64.42 -48.44 75.35 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.241 0.543 . . . . 0.0 110.335 178.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.479 HG21 ' CG2' ' A' ' 78' ' ' VAL . 4.2 mm -54.71 -39.05 45.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.665 -179.196 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.696 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -78.14 -30.58 49.34 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.199 -178.97 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.35 -40.93 57.69 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.825 -178.638 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.88 -46.31 9.52 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -179.121 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.653 ' CE1' HD13 ' A' ' 43' ' ' LEU . 0.1 OUTLIER -103.69 142.87 25.49 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.95 -178.896 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.29 -71.17 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.733 2.289 . . . . 0.0 113.272 -179.027 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 13.8 mtt -140.28 47.08 1.8 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.884 0.373 . . . . 0.0 110.805 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.982 HD23 HG23 ' A' ' 47' ' ' THR . 3.1 tm? -59.31 110.31 2.6 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.684 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.489 ' HD2' HD22 ' A' ' 76' ' ' LEU . 28.9 Cg_exo -63.02 116.51 3.62 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 123.086 2.524 . . . . 0.0 113.427 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.968 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 3.3 t -118.56 152.43 20.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.652 179.59 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.769 ' O ' HD23 ' A' ' 52' ' ' LEU . 3.6 mt -132.25 114.28 23.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.548 -0.297 . . . . 0.0 110.572 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.685 ' HA ' ' O ' ' A' ' 53' ' ' SER . 11.6 mm -95.59 142.5 13.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.133 0.492 . . . . 0.0 111.788 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.457 ' HB2' ' CE1' ' A' ' 106' ' ' PHE . 2.8 ptt? -66.65 -28.74 68.71 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.308 -179.295 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.444 ' H ' HG22 ' A' ' 80' ' ' ILE . 5.0 m -147.07 167.78 23.21 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.43 0.157 . . . . 0.0 111.293 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.501 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -122.3 61.94 0.97 Allowed 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -179.346 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.661 ' O ' HD11 ' A' ' 63' ' ' LEU . 67.7 m170 -73.16 162.87 28.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.824 0.345 . . . . 0.0 110.851 179.029 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.434 ' HB2' ' CB ' ' A' ' 61' ' ' ASP . 8.3 t 63.8 -167.41 0.21 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.124 0.488 . . . . 0.0 112.151 178.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -56.06 92.44 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.493 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.774 HD23 ' HB3' ' A' ' 90' ' ' ALA . 0.6 OUTLIER -47.76 -20.46 0.29 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.997 179.343 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -47.45 -45.98 26.28 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -178.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.402 ' HB3' HD22 ' A' ' 63' ' ' LEU . . . -63.93 -25.73 68.27 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.786 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.774 ' HB3' HD23 ' A' ' 87' ' ' LEU . . . -72.54 -48.79 37.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.768 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.653 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 3.4 t -63.48 -53.62 42.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.086 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 92.4 p -57.28 -23.94 51.65 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 178.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.96 ' HB2' HD13 ' A' ' 66' ' ' LEU . . . -57.57 -53.77 54.37 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.438 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.702 ' CE1' ' HA ' ' A' ' 100' ' ' ASP . 5.9 m-85 -51.13 -33.16 25.41 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.764 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.91 -39.37 56.43 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.447 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.597 ' HB2' ' HB2' ' A' ' 70' ' ' LYS . 6.5 pt20 -94.39 5.8 50.67 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.063 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 93' ' ' ALA . . . 123.1 80.32 0.5 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.55 -0.834 . . . . 0.0 113.019 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.968 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -168.57 135.82 2.0 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.979 0.418 . . . . 0.0 111.27 179.185 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.511 ' HB3' HG12 ' A' ' 79' ' ' ILE . 38.5 t80 -75.84 -53.44 8.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.534 -179.354 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.702 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 1.0 OUTLIER 177.7 -172.84 0.12 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.177 0.513 . . . . 0.0 112.005 -179.535 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.661 ' OH ' HD11 ' A' ' 66' ' ' LEU . 3.2 m-85 -130.19 153.46 48.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.387 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.639 HD23 ' HA ' ' A' ' 106' ' ' PHE . 1.9 mp -103.97 118.38 57.3 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.62 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -73.24 -71.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 121.93 1.753 . . . . 0.0 111.895 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.691 ' H ' ' HD2' ' A' ' 105' ' ' PRO . 9.6 tttm -108.55 -58.66 0.05 OUTLIER Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.623 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.691 ' HD2' ' H ' ' A' ' 104' ' ' LYS . 15.6 Cg_endo -57.51 152.53 47.05 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.3 2.0 . . . . 0.0 113.014 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.639 ' HA ' HD23 ' A' ' 102' ' ' LEU . 14.9 t80 -163.22 -118.38 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.176 179.323 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.558 ' O ' ' O ' ' A' ' 106' ' ' PHE . 2.9 p30 42.5 -179.46 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 118.164 0.438 . . . . 0.0 111.486 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.449 HG12 HG12 ' A' ' 18' ' ' VAL . 1.0 OUTLIER -67.86 -40.92 84.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.516 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.539 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 30.8 t0 -49.18 -58.64 4.65 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.495 -179.21 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.545 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 74.9 mm-40 -77.87 -32.17 51.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.694 0.283 . . . . 0.0 111.371 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.409 ' CB ' ' O ' ' A' ' 107' ' ' ASP . . . -64.88 -62.5 1.52 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.931 0.396 . . . . 0.0 109.978 179.171 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.564 ' O ' HG12 ' A' ' 115' ' ' VAL . 47.0 t -58.4 -31.32 42.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.496 0.665 . . . . 0.0 110.802 179.053 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.539 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -63.46 -45.97 88.38 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.196 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.742 HD23 HG21 ' A' ' 79' ' ' ILE . 5.5 tp -76.76 -22.47 53.74 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.786 -1.097 . . . . 0.0 112.169 -179.052 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.564 HG12 ' O ' ' A' ' 112' ' ' VAL . 4.7 p -79.28 -46.44 23.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.321 -0.552 . . . . 0.0 111.595 -179.115 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.415 ' HA ' HD12 ' A' ' 119' ' ' ILE . 38.4 mt-10 -64.35 -47.89 77.62 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.746 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.54 ' HG2' ' HA ' ' A' ' 114' ' ' LEU . 2.8 ptp180 -60.46 -27.93 67.92 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.14 0.495 . . . . 0.0 110.404 179.346 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.471 ' HB2' ' CE2' ' A' ' 99' ' ' PHE . . . -66.77 -47.02 73.47 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.792 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.429 HD11 HG11 ' A' ' 50' ' ' VAL . 4.4 mt -70.26 -30.69 44.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.689 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 10.5 t -66.72 -43.83 83.23 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.21 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 13.0 m80 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.147 -179.853 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.825 ' HG2' HD11 ' A' ' 5' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.469 0.492 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.864 ' O ' HD13 ' A' ' 5' ' ' ILE . . . 98.49 92.92 1.99 Allowed Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.242 179.351 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.864 HD13 ' O ' ' A' ' 4' ' ' GLY . 5.0 mm -126.04 112.48 30.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.074 0.464 . . . . 0.0 111.754 -179.174 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.951 HG11 ' HG ' ' A' ' 23' ' ' LEU . 14.3 p -109.93 128.69 65.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.684 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.877 ' CD1' HG22 ' A' ' 31' ' ' THR . 26.4 m0 -117.32 126.31 52.49 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.962 0.41 . . . . 0.0 110.112 179.09 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.743 HG11 ' CD1' ' A' ' 19' ' ' LEU . 0.5 OUTLIER -116.66 145.82 21.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.814 -178.105 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.813 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -124.52 111.1 27.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.919 0.39 . . . . 0.0 110.649 179.24 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -161.32 -159.15 0.62 Allowed 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.976 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -66.99 -0.64 3.29 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.474 ' O ' ' N ' ' A' ' 14' ' ' SER . 0.4 OUTLIER 68.08 -158.51 0.2 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 121.415 -0.114 . . . . 0.0 111.033 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.418 ' HB3' ' H ' ' A' ' 14' ' ' SER . 1.4 t 33.52 -86.46 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.758 ' O ' HG23 ' A' ' 18' ' ' VAL . 37.6 t -54.21 -63.9 1.0 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.741 0.305 . . . . 0.0 111.324 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.0 mm -61.44 -28.15 43.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.012 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.871 ' HA ' HG21 ' A' ' 32' ' ' THR . 2.7 ttm180 -73.29 -43.58 60.69 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.211 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 55.1 t90 -67.77 -40.75 84.0 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.965 -179.058 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.758 HG23 ' O ' ' A' ' 14' ' ' SER . 4.4 t -70.01 -39.27 77.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -178.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.743 ' CD1' HG11 ' A' ' 8' ' ' VAL . 16.2 mt -84.38 -27.72 27.47 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -178.649 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.604 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 24.5 pt-20 -67.44 -57.65 6.16 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.032 0.444 . . . . 0.0 111.655 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.472 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 0.7 OUTLIER -60.85 -52.49 64.85 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.937 -179.284 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.57 -43.85 84.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.866 0.365 . . . . 0.0 111.4 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.951 ' HG ' HG11 ' A' ' 6' ' ' VAL . 2.5 tm? -70.69 -31.78 68.79 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.331 0.586 . . . . 0.0 110.306 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.38 -34.22 77.67 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.49 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.16 -26.08 68.89 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.391 -0.909 . . . . 0.0 111.111 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.567 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -77.62 -15.56 59.13 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 120.751 0.31 . . . . 0.0 110.74 179.281 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.36 26.2 10.3 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.822 -0.704 . . . . 0.0 113.903 179.039 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.626 ' HB2' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -133.37 171.28 14.27 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 117.752 0.776 . . . . 0.0 111.902 179.705 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.649 ' O ' HG12 ' A' ' 6' ' ' VAL . 16.0 m -94.13 128.22 40.42 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.95 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.667 ' HA ' HG13 ' A' ' 6' ' ' VAL . 50.9 t -121.96 113.65 19.89 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 121.331 0.586 . . . . 0.0 111.477 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.877 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.7 t -117.8 151.86 36.49 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.594 178.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.871 HG21 ' HA ' ' A' ' 16' ' ' ARG . 40.2 p -124.35 164.46 19.58 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.219 0.533 . . . . 0.0 111.773 -179.511 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.859 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 2.3 m-85 -133.06 174.43 10.37 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.505 -178.302 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.402 ' HG2' ' N ' ' A' ' 35' ' ' ASN . 1.7 pt-20 -61.49 -40.7 95.54 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 -176.626 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.402 ' N ' ' HG2' ' A' ' 34' ' ' GLU . 1.4 m120 -170.96 -38.39 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 119.073 0.851 . . . . 0.0 112.589 -179.181 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.731 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . -178.77 -61.12 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.841 -179.472 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.478 ' HA ' HD12 ' A' ' 40' ' ' LEU . 61.2 m-20 -50.74 -33.39 22.91 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 111.621 0.23 . . . . 0.0 111.621 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.859 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -57.7 -50.05 74.48 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.639 -0.425 . . . . 0.0 111.182 -179.98 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.869 HG11 HD11 ' A' ' 51' ' ' LEU . 5.5 t -62.44 -38.68 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 C-N-CA 119.93 -0.708 . . . . 0.0 110.442 179.378 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.798 HD13 ' CB ' ' A' ' 68' ' ' GLN . 12.9 mt -56.78 -42.16 78.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.524 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.35 -48.15 36.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.31 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.81 -28.41 69.84 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.364 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.664 HD21 ' HD2' ' A' ' 48' ' ' PRO . 8.4 mt -69.38 -24.12 63.83 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.083 -179.149 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.36 -17.69 5.32 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.266 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -123.97 0.61 8.57 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.657 ' O ' HD23 ' A' ' 43' ' ' LEU . 0.1 OUTLIER -161.96 155.57 21.2 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.912 0.387 . . . . 0.0 111.348 179.913 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.5 HG23 HD13 ' A' ' 76' ' ' LEU . 91.0 m -139.05 114.7 8.46 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.212 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.664 ' HD2' HD21 ' A' ' 43' ' ' LEU . 73.8 Cg_endo -76.19 166.1 28.36 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.41 2.073 . . . . 0.0 110.965 178.699 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -74.14 -21.92 59.66 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.681 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.711 HG13 HG23 ' A' ' 6' ' ' VAL . 7.4 p -146.7 168.45 5.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.23 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.869 HD11 HG11 ' A' ' 39' ' ' VAL . 13.5 tp -152.92 120.43 5.97 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.0 0.429 . . . . 0.0 111.53 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.682 ' HB3' HG13 ' A' ' 8' ' ' VAL . 0.3 OUTLIER -105.89 122.19 45.62 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.217 179.815 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.442 ' HB2' ' CD1' ' A' ' 80' ' ' ILE . 36.4 m -113.68 138.13 50.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.089 0.471 . . . . 0.0 112.021 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.526 ' O ' HG22 ' A' ' 55' ' ' ILE . 45.8 p-10 -78.23 -12.77 60.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.594 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.613 ' HB ' HG23 ' A' ' 80' ' ' ILE . 5.3 tt 50.62 82.31 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-O 121.387 0.613 . . . . 0.0 111.867 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.786 ' C ' ' HD2' ' A' ' 58' ' ' PRO . 1.0 OUTLIER 175.93 145.8 0.08 Allowed 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.708 179.273 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.529 ' CB ' ' O ' ' A' ' 56' ' ' ARG . 14.1 ttt 96.52 -52.12 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.766 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 178.678 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.786 ' HD2' ' C ' ' A' ' 56' ' ' ARG . 20.4 Cg_endo -58.58 175.83 0.51 Allowed 'Trans proline' 0 C--N 1.35 0.643 0 CA-C-N 121.147 1.445 . . . . 0.0 112.286 -178.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -42.17 -74.46 0.17 Allowed Glycine 0 C--N 1.335 0.522 0 C-N-CA 121.126 -0.559 . . . . 0.0 112.501 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.618 ' H ' ' HB2' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -69.46 56.22 0.12 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.773 0.32 . . . . 0.0 110.597 179.221 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 56.75 -80.37 0.01 OUTLIER 'General case' 0 C--O 1.231 0.111 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.735 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.508 ' HA3' ' C ' ' A' ' 55' ' ' ILE . . . -137.1 -34.46 0.2 Allowed Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.655 -0.783 . . . . 0.0 113.007 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.699 ' HA ' HD13 ' A' ' 66' ' ' LEU . 5.2 mp -63.28 -15.76 58.2 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.864 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.69 ' HB3' ' HB2' ' A' ' 58' ' ' PRO . . . -53.82 -48.61 69.72 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 120.929 0.395 . . . . 0.0 111.355 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.507 HD12 ' N ' ' A' ' 66' ' ' LEU . 4.0 pp -51.42 -39.36 57.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.065 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.851 ' HA ' HD12 ' A' ' 69' ' ' ILE . 5.1 mp -57.65 -47.98 80.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.912 0.387 . . . . 0.0 110.216 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.741 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 0.2 OUTLIER -49.98 -44.43 50.93 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.192 0.52 . . . . 0.0 110.097 178.954 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.798 ' CB ' HD13 ' A' ' 40' ' ' LEU . 11.6 mm100 -65.6 -26.42 67.83 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.262 179.238 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.879 HG12 ' CE1' ' A' ' 73' ' ' HIS . 94.0 mt -64.02 -39.62 86.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.486 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.741 ' HG2' ' O ' ' A' ' 67' ' ' LYS . 12.1 pttp -74.1 -27.22 60.78 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.893 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -85.85 -33.66 21.24 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.044 -179.39 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -106.54 -35.11 7.16 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -178.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.879 ' CE1' HG12 ' A' ' 69' ' ' ILE . 0.3 OUTLIER -99.44 136.07 20.49 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.891 -179.326 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 73' ' ' HIS . 91.4 Cg_endo -92.94 100.6 0.16 Allowed 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.953 2.435 . . . . 0.0 112.537 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.549 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 1.8 mtt 52.44 26.22 4.04 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.662 179.011 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.5 HD13 HG23 ' A' ' 47' ' ' THR . 12.9 tp -69.79 112.66 13.01 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.815 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.4 125.41 18.82 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.353 2.035 . . . . 0.0 112.09 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.832 HG21 HD13 ' A' ' 69' ' ' ILE . 3.7 t -118.25 148.52 21.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.934 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.894 ' CG2' HD23 ' A' ' 114' ' ' LEU . 2.0 mt -127.82 114.14 34.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.617 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.641 HG21 ' CE2' ' A' ' 101' ' ' TYR . 13.2 mm -99.54 143.49 13.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.984 0.421 . . . . 0.0 111.804 -179.045 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.437 ' HA ' ' HB2' ' A' ' 102' ' ' LEU . 18.6 ptm -86.56 -39.71 15.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.067 -178.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.431 ' H ' HG21 ' A' ' 55' ' ' ILE . 2.7 m -122.65 166.53 14.74 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.209 -179.164 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -138.99 -28.33 0.8 Allowed 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.458 ' CE1' ' CD1' ' A' ' 55' ' ' ILE . 3.5 p-80 38.19 -160.97 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 122.928 0.491 . . . . 0.0 111.863 -179.419 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.446 ' H ' ' HB2' ' A' ' 84' ' ' HIS . 27.4 t -82.66 42.05 0.75 Allowed 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -178.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.503 ' CB ' HD13 ' A' ' 63' ' ' LEU . 6.7 m-20 -132.84 15.98 4.28 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.718 0.294 . . . . 0.0 110.773 179.054 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.754 HD23 ' CB ' ' A' ' 90' ' ' ALA . 1.4 mt -44.74 -21.78 0.06 Allowed 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.291 -0.413 . . . . 0.0 112.006 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -47.94 -50.35 27.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.771 0.319 . . . . 0.0 111.028 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.403 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -70.7 -21.19 62.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.986 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.754 ' CB ' HD23 ' A' ' 87' ' ' LEU . . . -64.38 -33.22 75.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.861 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.631 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 3.1 t -66.15 -42.89 92.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.428 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.599 ' O ' ' HG3' ' A' ' 95' ' ' GLN . 14.9 m -60.43 -19.42 56.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.035 0.445 . . . . 0.0 110.073 178.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.742 ' O ' ' HG3' ' A' ' 96' ' ' GLN . . . -75.76 -53.93 7.73 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.62 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.631 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 5.6 m-85 -57.01 -33.19 66.91 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.148 0.499 . . . . 0.0 110.838 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.599 ' HG3' ' O ' ' A' ' 92' ' ' SER . 2.2 pp0? -76.95 -31.25 56.48 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.031 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.742 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 2.0 pp0? -83.09 -18.5 39.36 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.829 -0.349 . . . . 0.0 111.032 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 133.06 4.71 3.24 Favored Glycine 0 C--N 1.335 0.501 0 C-N-CA 120.231 -0.985 . . . . 0.0 114.315 178.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.68 ' HB2' ' HB1' ' A' ' 93' ' ' ALA . . . -58.03 158.34 6.87 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 117.85 0.825 . . . . 0.0 111.278 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.478 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 10.4 t80 -85.11 -53.73 5.08 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.481 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 177.02 -163.69 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.807 0.337 . . . . 0.0 111.297 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.641 ' CE2' HG21 ' A' ' 80' ' ' ILE . 5.9 m-85 -138.82 152.65 48.04 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.464 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.727 ' CD1' HD22 ' A' ' 114' ' ' LEU . 2.7 mp -104.25 122.19 44.9 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.939 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -66.38 -74.68 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.168 1.912 . . . . 0.0 112.395 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.698 ' H ' ' HD2' ' A' ' 105' ' ' PRO . 1.1 mtpm? -114.88 -60.81 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.808 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.698 ' HD2' ' H ' ' A' ' 104' ' ' LYS . 14.4 Cg_endo -56.55 163.22 7.15 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.368 2.046 . . . . 0.0 112.574 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.674 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 41.9 t80 -170.2 -99.94 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.562 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.541 ' O ' ' O ' ' A' ' 106' ' ' PHE . 1.0 OUTLIER 41.47 -175.67 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.812 0.339 . . . . 0.0 111.096 -179.575 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.693 HD11 ' HG ' ' A' ' 19' ' ' LEU . 1.0 OUTLIER -68.01 -40.3 82.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.011 0.434 . . . . 0.0 111.62 179.909 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.494 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 55.2 m-20 -51.85 -58.83 5.31 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.573 -179.052 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.674 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 6.8 mm-40 -75.08 -31.42 61.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.646 0.26 . . . . 0.0 111.417 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -69.91 -61.73 1.66 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.47 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.664 ' O ' HG12 ' A' ' 115' ' ' VAL . 54.4 t -57.31 -30.61 35.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.444 0.64 . . . . 0.0 110.298 178.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.494 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -65.12 -49.22 70.79 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.727 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.894 HD23 ' CG2' ' A' ' 79' ' ' ILE . 13.0 tp -71.71 -21.23 61.8 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.958 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.664 HG12 ' O ' ' A' ' 112' ' ' VAL . 4.3 p -79.43 -47.53 22.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 C-N-CA 120.446 -0.501 . . . . 0.0 111.497 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.427 ' N ' HG13 ' A' ' 115' ' ' VAL . 45.3 mt-10 -66.15 -45.08 82.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.578 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' A' ' 113' ' ' ALA . 0.0 OUTLIER -60.65 -24.41 65.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.583 179.501 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.478 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -71.26 -48.8 48.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.968 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 4.3 mt -68.49 -31.07 49.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.233 0.54 . . . . 0.0 110.755 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -75.7 -54.38 7.06 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.155 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 17.9 m80 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.112 -179.717 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.744 ' HB3' HD11 ' A' ' 5' ' ' ILE . 15.1 ttt180 . . . . . 0 CA--C 1.532 0.279 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 51.39 73.83 0.35 Allowed Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.992 -0.623 . . . . 0.0 113.444 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.744 HD11 ' HB3' ' A' ' 3' ' ' ARG . 2.9 mp -105.17 112.76 40.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.749 0.309 . . . . 0.0 111.055 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.817 HG23 HG13 ' A' ' 50' ' ' VAL . 6.9 p -105.6 125.61 60.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.251 178.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.916 ' CD1' HG22 ' A' ' 31' ' ' THR . 31.4 m0 -115.74 132.01 56.76 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.09 0.472 . . . . 0.0 110.282 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.847 ' HB ' HG22 ' A' ' 32' ' ' THR . 46.6 t -118.8 145.86 24.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.664 -178.346 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.699 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -127.35 118.01 48.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.806 0.336 . . . . 0.0 110.559 179.782 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.554 ' CB ' HG21 ' A' ' 15' ' ' ILE . 2.1 t0 -163.48 -159.43 0.52 Allowed 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.775 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.94 -0.09 4.0 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 65.61 -158.33 0.27 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.495 0.188 . . . . 0.0 110.904 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.432 ' HB3' ' H ' ' A' ' 14' ' ' SER . 1.3 t 35.43 -90.93 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.845 ' O ' HG23 ' A' ' 18' ' ' VAL . 2.1 t -58.39 -54.87 42.17 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.708 0.289 . . . . 0.0 111.321 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.554 HG21 ' CB ' ' A' ' 10' ' ' ASP . 24.7 mm -64.83 -25.14 37.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.941 0.4 . . . . 0.0 111.15 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.551 ' HA ' HG21 ' A' ' 32' ' ' THR . 4.1 ttp180 -75.65 -53.27 8.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.257 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.588 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 86.7 t90 -57.25 -40.45 77.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.84 0.352 . . . . 0.0 111.51 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.845 HG23 ' O ' ' A' ' 14' ' ' SER . 18.9 t -66.43 -47.95 82.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 112.154 0.428 . . . . 0.0 112.154 -178.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.683 HD23 HG21 ' A' ' 8' ' ' VAL . 2.1 tp -80.54 -29.16 37.15 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -178.301 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.588 ' HG2' ' HA ' ' A' ' 17' ' ' TRP . 1.3 pp20? -62.46 -60.31 3.73 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.468 -0.493 . . . . 0.0 112.026 -179.055 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.422 ' HG2' ' CD ' ' A' ' 20' ' ' GLU . 3.0 mmm180 -58.93 -47.51 84.81 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.696 0.284 . . . . 0.0 111.679 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.87 -34.37 77.24 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -178.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.789 HD22 HG11 ' A' ' 6' ' ' VAL . 0.4 OUTLIER -81.82 -26.74 34.07 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.627 179.553 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.41 -34.25 74.21 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 177.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.68 -24.15 69.47 Favored Glycine 0 N--CA 1.443 -0.897 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 177.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.488 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -76.95 -15.3 59.7 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.589 -0.306 . . . . 0.0 110.275 178.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 94.1 26.65 13.79 Favored Glycine 0 C--N 1.337 0.633 0 C-N-CA 120.812 -0.709 . . . . 0.0 114.293 178.221 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.764 HD13 ' CD2' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -133.87 166.67 22.13 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-N 118.215 1.007 . . . . 0.0 112.784 -179.609 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.46 ' O ' HG12 ' A' ' 6' ' ' VAL . 60.1 m -85.65 118.17 24.99 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.051 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.589 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 1.7 p -116.68 117.13 28.97 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.967 -0.56 . . . . 0.0 112.208 -178.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.916 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.8 t -125.11 133.24 52.93 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.439 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.847 HG22 ' HB ' ' A' ' 8' ' ' VAL . 77.1 p -107.64 164.28 12.36 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.159 0.504 . . . . 0.0 111.659 -178.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.858 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 2.9 m-85 -134.94 174.33 10.71 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.879 -177.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.66 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 2.5 pp20? -63.18 -34.76 78.32 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -176.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -171.04 -55.83 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 118.947 0.794 . . . . 0.0 112.799 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.663 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . -170.43 -43.77 0.03 OUTLIER Glycine 0 C--N 1.316 -0.58 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.57 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.695 ' HA ' ' CD1' ' A' ' 40' ' ' LEU . 3.9 t30 -62.98 -26.07 68.67 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 120.985 0.421 . . . . 0.0 110.714 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.858 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -62.02 -57.64 10.88 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.269 179.819 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.713 HG22 ' CD1' ' A' ' 33' ' ' PHE . 21.2 t -55.51 -32.22 29.71 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 C-N-CA 120.116 -0.634 . . . . 0.0 111.233 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.695 ' CD1' ' HA ' ' A' ' 37' ' ' ASN . 11.2 mt -58.83 -46.47 87.6 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.773 0.32 . . . . 0.0 110.652 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.27 -48.93 63.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.177 0.513 . . . . 0.0 110.794 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.55 -33.61 75.28 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.716 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.671 ' HB3' ' NE2' ' A' ' 73' ' ' HIS . 15.0 mt -63.23 -27.68 69.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.531 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.99 -18.41 45.68 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.299 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.2 m -115.06 -4.77 12.49 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.1 OUTLIER -165.64 161.98 18.62 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.885 0.374 . . . . 0.0 111.081 179.951 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.583 HG23 HD12 ' A' ' 76' ' ' LEU . 54.0 m -138.86 111.77 8.14 Favored Pre-proline 0 N--CA 1.45 -0.43 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.354 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.855 ' HD2' HD11 ' A' ' 76' ' ' LEU . 66.1 Cg_endo -73.3 164.37 35.41 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.162 1.908 . . . . 0.0 111.329 178.747 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -77.76 -22.1 50.74 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.151 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.817 HG13 HG23 ' A' ' 6' ' ' VAL . 9.8 p -145.15 164.41 12.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.782 HD12 ' O ' ' A' ' 7' ' ' TRP . 11.6 tp -152.67 111.37 3.76 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 121.139 0.495 . . . . 0.0 112.008 -178.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.48 HD13 HD21 ' A' ' 19' ' ' LEU . 1.4 tt -97.7 119.98 37.25 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.759 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.718 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 0.3 OUTLIER -125.47 137.96 53.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.435 0.636 . . . . 0.0 112.63 -178.758 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.505 ' HA ' ' HG2' ' A' ' 81' ' ' MET . 0.8 OUTLIER -83.14 177.37 8.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.172 179.319 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.876 HG21 ' O ' ' A' ' 82' ' ' THR . 0.0 OUTLIER -154.73 105.41 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.195 0.522 . . . . 0.0 110.807 178.978 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.433 ' H ' ' HD3' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -133.56 36.77 3.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.152 -179.508 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.499 ' N ' ' CD ' ' A' ' 58' ' ' PRO . 0.5 OUTLIER 66.42 41.55 0.27 Allowed Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 179.042 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.499 ' CD ' ' N ' ' A' ' 57' ' ' MET . 58.1 Cg_endo -68.81 -90.57 0.0 OUTLIER 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 122.042 1.828 . . . . 0.0 111.0 178.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -87.66 -91.46 1.03 Allowed Glycine 0 C--N 1.335 0.488 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' MET . . . . . 1.018 ' HB3' ' HB2' ' A' ' 64' ' ' ALA . 34.6 tpp -87.56 64.85 8.31 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 177.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.482 ' HA ' ' HA ' ' A' ' 57' ' ' MET . 0.2 OUTLIER 67.61 -20.71 0.12 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.695 -179.291 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.82 ' HA3' HG12 ' A' ' 55' ' ' ILE . . . 133.01 -32.33 2.77 Favored Glycine 0 N--CA 1.446 -0.69 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 -179.132 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.874 HD13 ' HB3' ' A' ' 86' ' ' ASP . 5.4 mp -68.27 -13.86 62.57 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 120.862 0.363 . . . . 0.0 110.332 179.135 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 1.018 ' HB2' ' HB3' ' A' ' 60' ' ' MET . . . -53.17 -36.22 60.67 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.558 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.6 HD11 HD11 ' A' ' 80' ' ' ILE . 3.8 pp -59.73 -40.68 88.86 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 121.1 -0.24 . . . . 0.0 111.222 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.617 ' CD1' ' HA ' ' A' ' 63' ' ' LEU . 4.8 mp -60.38 -43.01 97.02 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-O 121.124 0.488 . . . . 0.0 110.226 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.6 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -54.62 -44.23 72.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.202 -179.749 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.602 ' HB3' HD13 ' A' ' 40' ' ' LEU . 14.0 mm100 -71.92 -43.51 65.19 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.44 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.428 HD12 ' HA ' ' A' ' 66' ' ' LEU . 16.8 mt -60.95 -35.38 64.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-O 121.033 0.444 . . . . 0.0 110.973 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.6 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -72.75 -29.81 63.63 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.013 -179.826 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.452 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -76.37 -36.68 58.02 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.631 -179.67 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.16 -26.14 21.44 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.926 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.671 ' NE2' ' HB3' ' A' ' 43' ' ' LEU . 31.9 m-70 -153.35 82.9 4.65 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.733 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.797 ' HA ' ' HB2' ' A' ' 96' ' ' GLN . 59.2 Cg_endo -73.47 39.08 0.46 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.583 2.189 . . . . 0.0 112.869 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.406 ' HG2' ' C ' ' A' ' 74' ' ' PRO . 1.5 mmm -141.92 -32.09 0.53 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.971 0.415 . . . . 0.0 111.689 -179.65 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.855 HD11 ' HD2' ' A' ' 48' ' ' PRO . 0.3 OUTLIER -61.29 124.37 80.28 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.805 -179.44 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.712 ' HD2' HD23 ' A' ' 76' ' ' LEU . 57.6 Cg_endo -71.2 126.31 12.25 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.32 2.013 . . . . 0.0 112.239 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.605 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 9.5 t -106.93 140.21 25.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.301 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.518 ' CG2' HD23 ' A' ' 114' ' ' LEU . 2.6 mt -127.13 110.08 22.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.614 179.42 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.718 ' HA ' ' O ' ' A' ' 53' ' ' SER . 13.5 mm -103.88 148.04 9.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.923 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.763 ' HG3' HG22 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -69.83 -73.3 0.16 Allowed 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.715 179.647 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.876 ' O ' HG21 ' A' ' 55' ' ' ILE . 3.9 m -105.31 162.8 13.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.949 0.404 . . . . 0.0 110.996 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.8 ' HB1' ' HG ' ' A' ' 87' ' ' LEU . . . -111.93 -22.22 11.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.621 -179.182 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.45 ' H ' HG22 ' A' ' 82' ' ' THR . 22.4 m170 44.39 -163.0 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 120.605 0.241 . . . . 0.0 111.359 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 47.9 t -81.54 29.2 0.38 Allowed 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.874 ' HB3' HD13 ' A' ' 63' ' ' LEU . 0.4 OUTLIER -128.51 24.77 5.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.708 0.29 . . . . 0.0 110.865 179.624 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.8 ' HG ' ' HB1' ' A' ' 83' ' ' ALA . 1.7 mt -50.32 -23.77 2.53 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.456 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -48.09 -56.95 6.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.71 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.482 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -59.57 -22.18 61.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.582 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.459 ' HB2' ' CD2' ' A' ' 63' ' ' LEU . . . -71.02 -35.57 72.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.998 0.428 . . . . 0.0 110.143 179.204 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.65 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 13.7 t -60.03 -44.65 95.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.464 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 49.0 m -60.97 -34.69 75.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.005 0.431 . . . . 0.0 110.491 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.884 ' HB1' ' HB2' ' A' ' 98' ' ' ALA . . . -59.63 -42.28 92.37 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.019 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.65 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 11.0 m-85 -55.49 -24.24 30.4 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.317 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.605 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -75.74 -40.78 54.86 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.912 179.336 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.797 ' HB2' ' HA ' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -77.1 -17.87 58.38 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.903 179.864 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.421 ' O ' ' HA ' ' A' ' 77' ' ' PRO . . . 123.36 18.09 3.13 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.761 -0.733 . . . . 0.0 113.335 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.884 ' HB2' ' HB1' ' A' ' 93' ' ' ALA . . . -48.92 141.03 8.11 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 117.283 0.541 . . . . 0.0 110.911 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.556 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 27.1 t80 -75.72 -53.43 8.53 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.965 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.625 ' OD1' HD21 ' A' ' 114' ' ' LEU . 1.7 p30 167.57 -171.27 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.953 0.406 . . . . 0.0 111.502 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.513 ' CE2' ' HB ' ' A' ' 80' ' ' ILE . 5.3 m-85 -131.0 153.71 48.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.583 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.78 HD23 ' CD1' ' A' ' 106' ' ' PHE . 1.6 tp -102.27 123.4 43.32 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.663 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -72.82 -78.08 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 121.981 1.788 . . . . 0.0 112.766 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.424 ' O ' ' CD2' ' A' ' 106' ' ' PHE . 2.4 tmtm? -108.28 -54.19 0.06 OUTLIER Pre-proline 0 CA--C 1.531 0.247 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.461 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.437 ' O ' ' CG ' ' A' ' 106' ' ' PHE . 52.6 Cg_exo -55.49 154.54 24.22 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.275 1.983 . . . . 0.0 112.508 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.78 ' CD1' HD23 ' A' ' 102' ' ' LEU . 59.9 m-85 -160.43 -119.14 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.9 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.494 ' O ' ' O ' ' A' ' 106' ' ' PHE . 2.6 p30 47.71 174.94 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 120.835 0.35 . . . . 0.0 111.142 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.621 HG12 HG12 ' A' ' 18' ' ' VAL . 1.1 mp -67.11 -44.5 87.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.027 0.442 . . . . 0.0 111.461 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.609 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 0.8 OUTLIER -49.23 -53.92 19.19 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.554 -179.384 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.606 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 3.2 mm-40 -82.47 -34.61 28.01 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 -179.537 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.42 ' CB ' ' O ' ' A' ' 107' ' ' ASP . . . -69.4 -57.35 5.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.807 0.337 . . . . 0.0 110.2 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.684 HG12 ' OE2' ' A' ' 116' ' ' GLU . 46.4 t -59.92 -30.84 46.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.294 0.569 . . . . 0.0 110.481 178.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.609 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -62.07 -46.16 90.32 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.522 0.677 . . . . 0.0 109.997 178.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.655 HD22 HD13 ' A' ' 102' ' ' LEU . 13.9 tp -72.8 -26.69 61.6 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 114.691 -1.14 . . . . 0.0 111.585 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.634 HG12 ' HA ' ' A' ' 112' ' ' VAL . 4.7 p -79.21 -43.03 23.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.833 0.349 . . . . 0.0 111.895 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.684 ' OE2' HG12 ' A' ' 112' ' ' VAL . 44.1 mt-10 -65.84 -45.68 81.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.786 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.511 ' HG2' ' HA ' ' A' ' 114' ' ' LEU . 6.6 ptp180 -59.19 -26.2 64.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.67 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.556 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -68.72 -42.17 78.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.978 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.727 HD13 HD22 ' A' ' 28' ' ' LEU . 5.0 mt -75.68 -30.94 22.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.88 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 10.3 t -70.6 -51.31 29.11 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.903 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 17.1 m80 . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.073 -179.885 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.814 ' HG2' HD11 ' A' ' 5' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.22 0 CA-C-O 121.005 0.431 . . . . 0.0 111.406 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 55.93 85.57 0.03 OUTLIER Glycine 0 C--N 1.319 -0.405 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.386 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.814 HD11 ' HG2' ' A' ' 3' ' ' ARG . 3.1 mp -108.5 114.87 47.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.668 0.271 . . . . 0.0 111.115 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.958 HG11 ' CD2' ' A' ' 23' ' ' LEU . 7.4 p -107.33 114.8 47.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.051 0.453 . . . . 0.0 111.067 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.801 ' CD1' HG22 ' A' ' 31' ' ' THR . 38.7 m0 -107.95 147.39 31.11 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.009 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.747 HG21 ' OE2' ' A' ' 20' ' ' GLU . 0.1 OUTLIER -137.42 146.1 28.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.353 -178.752 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.882 HG11 ' HA2' ' A' ' 36' ' ' GLY . 0.0 OUTLIER -120.61 104.78 15.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.035 0.445 . . . . 0.0 110.786 179.1 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.815 ' HB3' HG21 ' A' ' 15' ' ' ILE . 0.8 OUTLIER -174.1 118.05 0.24 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.812 -179.801 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.591 ' O ' ' HB2' ' A' ' 12' ' ' ASP . 0.2 OUTLIER 41.96 -87.28 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.232 -0.895 . . . . 0.0 112.033 -179.541 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.591 ' HB2' ' O ' ' A' ' 11' ' ' ASP . 24.4 t70 160.07 -100.79 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 122.734 0.414 . . . . 0.0 111.048 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.6 p -36.77 -76.51 0.02 OUTLIER 'General case' 0 C--O 1.231 0.096 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -179.049 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.654 ' O ' HG23 ' A' ' 18' ' ' VAL . 44.0 t -52.76 -37.97 60.29 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.322 -177.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.815 HG21 ' HB3' ' A' ' 10' ' ' ASP . 19.3 mm -78.72 -22.88 13.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.163 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.643 ' HA ' HG21 ' A' ' 32' ' ' THR . 3.8 ttm-85 -77.18 -31.37 55.39 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.243 0.544 . . . . 0.0 110.277 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.617 ' HA ' ' HG3' ' A' ' 21' ' ' ARG . 79.7 t90 -72.12 -60.49 2.21 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.683 HG12 HG12 ' A' ' 108' ' ' ILE . 0.8 OUTLIER -54.59 -62.04 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -176.816 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.516 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -77.11 -46.49 23.37 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 -176.177 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.747 ' OE2' HG21 ' A' ' 8' ' ' VAL . 4.7 mm-40 -68.01 -61.38 1.89 Allowed 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 113.456 0.909 . . . . 0.0 113.456 -177.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.617 ' HG3' ' HA ' ' A' ' 17' ' ' TRP . 2.4 mmt180 -48.74 -43.96 38.02 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.098 -177.268 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.41 -26.98 61.2 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.781 0.324 . . . . 0.0 111.045 179.431 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.958 ' CD2' HG11 ' A' ' 6' ' ' VAL . 5.9 tp -82.27 -24.66 34.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.288 0.566 . . . . 0.0 110.198 179.224 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.495 ' HB2' ' SG ' ' A' ' 30' ' ' CYS . . . -68.36 -36.11 78.73 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.397 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.29 -25.17 68.13 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.256 -0.973 . . . . 0.0 110.749 178.105 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.675 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -76.76 -15.83 59.65 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 120.627 0.251 . . . . 0.0 110.885 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.06 26.58 9.46 Favored Glycine 0 CA--C 1.523 0.547 0 C-N-CA 120.482 -0.866 . . . . 0.0 114.559 178.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.737 HD13 ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -120.76 166.98 12.98 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 118.227 1.014 . . . . 0.0 111.93 -179.93 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.646 ' HB ' HG23 ' A' ' 5' ' ' ILE . 87.2 m -86.52 104.27 15.82 Favored 'General case' 0 CA--C 1.522 -0.097 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.309 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 4.2 p -105.31 110.33 22.65 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.914 -178.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.801 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.8 t -127.16 153.4 46.09 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.643 HG21 ' HA ' ' A' ' 16' ' ' ARG . 58.8 p -125.77 163.76 22.16 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.145 0.498 . . . . 0.0 111.923 -179.319 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.841 ' HB2' HG13 ' A' ' 9' ' ' VAL . 9.4 m-85 -136.09 173.4 11.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.482 -178.447 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.568 ' HG3' ' ND2' ' A' ' 35' ' ' ASN . 0.9 OUTLIER -63.0 -42.51 99.87 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -177.562 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.568 ' ND2' ' HG3' ' A' ' 34' ' ' GLU . 13.5 p30 -170.92 -35.05 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 118.66 0.664 . . . . 0.0 112.343 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.91 ' HA3' HD22 ' A' ' 65' ' ' LEU . . . 176.71 -54.12 0.11 Allowed Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.231 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.455 ' HA ' HD12 ' A' ' 40' ' ' LEU . 77.3 m-20 -51.31 -31.34 21.23 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.688 0.28 . . . . 0.0 111.328 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.814 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -65.15 -51.6 60.21 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.951 -0.3 . . . . 0.0 111.084 179.471 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.732 HG22 ' CD1' ' A' ' 33' ' ' PHE . 21.5 t -55.34 -33.95 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 120.277 -0.569 . . . . 0.0 111.722 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.455 HD12 ' HA ' ' A' ' 37' ' ' ASN . 13.3 mt -59.79 -47.85 84.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.692 0.282 . . . . 0.0 111.402 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.23 -47.36 79.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.268 0.556 . . . . 0.0 111.03 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.52 -40.06 96.04 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.025 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.541 HD21 ' HD2' ' A' ' 48' ' ' PRO . 17.9 mt -59.44 -26.12 64.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.433 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.74 -21.55 7.44 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.337 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.2 m -126.15 4.72 7.13 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -161.36 155.68 22.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.772 0.32 . . . . 0.0 110.968 179.946 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.93 HG23 HD23 ' A' ' 76' ' ' LEU . 89.8 m -138.56 112.05 8.39 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.448 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.661 ' HD2' HD21 ' A' ' 76' ' ' LEU . 71.7 Cg_endo -77.34 163.25 30.24 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.007 1.805 . . . . 0.0 111.444 178.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.462 ' O ' ' HG2' ' A' ' 77' ' ' PRO . 1.7 m-20 -75.74 -23.17 56.0 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.361 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.741 HG13 HG23 ' A' ' 6' ' ' VAL . 7.3 p -145.83 158.59 12.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 C-N-CA 121.16 -0.216 . . . . 0.0 110.83 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.562 ' HA ' ' O ' ' A' ' 7' ' ' TRP . 12.8 tp -152.86 115.69 4.55 Favored 'General case' 0 C--N 1.333 -0.115 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.574 ' HG ' ' HB ' ' A' ' 79' ' ' ILE . 0.8 OUTLIER -101.77 117.14 34.24 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.593 178.446 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.603 ' HB3' HD12 ' A' ' 65' ' ' LEU . 71.9 m -114.22 151.75 32.31 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.95 0.405 . . . . 0.0 112.022 -178.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -82.66 175.5 10.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.435 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.841 HG22 ' HG3' ' A' ' 81' ' ' MET . 3.2 tt -151.38 67.69 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.136 0 CA-C-O 121.343 0.592 . . . . 0.0 111.705 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 177.6 51.66 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.283 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.599 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . 3.1 ttt -159.8 -62.48 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.3 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.503 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.599 ' HD3' ' HB3' ' A' ' 57' ' ' MET . 33.3 Cg_endo -61.64 -165.41 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.307 2.005 . . . . 0.0 112.546 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.45 -80.97 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.976 -0.63 . . . . 0.0 112.909 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.94 ' HB2' ' HB2' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -77.03 55.57 1.14 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.794 0.33 . . . . 0.0 111.277 -179.629 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.589 ' HB3' HG13 ' A' ' 55' ' ' ILE . 0.8 OUTLIER 56.77 -68.93 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.574 179.4 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.637 ' O ' ' HG ' ' A' ' 65' ' ' LEU . . . -153.05 -34.34 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.817 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.6 HD23 ' HB2' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -62.17 -19.8 63.46 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 122.56 -0.377 . . . . 0.0 110.05 179.732 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.94 ' HB2' ' HB2' ' A' ' 60' ' ' MET . . . -54.3 -36.7 63.97 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 121.437 0.636 . . . . 0.0 109.975 178.712 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.91 HD22 ' HA3' ' A' ' 36' ' ' GLY . 10.9 mt -60.14 -56.79 17.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.034 -0.984 . . . . 0.0 110.605 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.705 HD22 ' HB1' ' A' ' 93' ' ' ALA . 9.6 mt -46.17 -43.77 15.41 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.552 179.368 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.428 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 0.6 OUTLIER -52.07 -55.45 20.66 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.252 178.68 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.445 ' HB3' HD13 ' A' ' 40' ' ' LEU . 42.5 mm-40 -68.49 -34.74 76.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.863 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.53 -36.7 78.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.562 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.442 ' HB2' ' HB3' ' A' ' 96' ' ' GLN . 11.9 pttt -78.19 -26.82 47.72 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.06 -0.518 . . . . 0.0 112.338 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -67.77 -48.67 65.71 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -178.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.8 mmm180 -91.68 -42.55 10.1 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -178.486 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.516 ' CE1' ' CD1' ' A' ' 43' ' ' LEU . 2.1 m80 -90.98 149.24 39.74 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.442 -178.741 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -73.6 -77.51 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.599 2.199 . . . . 0.0 113.187 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.721 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 1.3 mtt -125.76 44.56 2.8 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.743 0.306 . . . . 0.0 111.711 -179.367 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.93 HD23 HG23 ' A' ' 47' ' ' THR . 1.0 OUTLIER -60.27 109.51 2.08 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.414 179.414 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.462 ' HG2' ' O ' ' A' ' 49' ' ' ASP . 32.9 Cg_exo -60.74 115.37 2.64 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.525 2.15 . . . . 0.0 112.051 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 5.0 t -115.47 151.91 17.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.14 0 CA-C-O 121.075 0.464 . . . . 0.0 111.345 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.585 HD11 HG23 ' A' ' 50' ' ' VAL . 2.1 mt -138.41 112.82 8.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.569 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.633 ' CG2' ' HB ' ' A' ' 55' ' ' ILE . 16.6 mm -95.03 142.07 14.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.018 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.841 ' HG3' HG22 ' A' ' 55' ' ' ILE . 1.4 ppp? -71.59 -27.24 63.0 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -178.368 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.547 ' O ' HD13 ' A' ' 55' ' ' ILE . 5.4 m -147.22 164.45 33.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.652 0.263 . . . . 0.0 110.77 179.442 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.883 ' HB1' ' HG ' ' A' ' 87' ' ' LEU . . . -129.18 37.26 4.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.769 0.318 . . . . 0.0 111.65 -179.596 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.438 ' O ' ' HB3' ' A' ' 85' ' ' SER . 0.6 OUTLIER -85.83 -172.91 4.34 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.72 179.794 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.438 ' HB3' ' O ' ' A' ' 84' ' ' HIS . 29.7 t 68.7 -79.6 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.384 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.535 ' O ' HD22 ' A' ' 63' ' ' LEU . 0.1 OUTLIER -141.49 80.2 1.72 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.928 0.394 . . . . 0.0 111.268 -179.568 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.883 ' HG ' ' HB1' ' A' ' 83' ' ' ALA . 0.5 OUTLIER -55.94 -21.82 22.83 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.604 179.912 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -48.29 -50.32 30.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.67 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.595 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -57.6 -20.1 30.38 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.731 0.3 . . . . 0.0 111.741 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.633 ' HB3' HD23 ' A' ' 87' ' ' LEU . . . -73.75 -26.02 60.46 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.964 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.595 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 12.2 t -64.84 -50.64 74.27 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.485 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.428 ' O ' ' HB3' ' A' ' 95' ' ' GLN . 3.8 m -62.44 -23.63 66.98 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.97 0.414 . . . . 0.0 110.149 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.705 ' HB1' HD22 ' A' ' 66' ' ' LEU . . . -62.27 -38.37 89.03 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 121.291 0.567 . . . . 0.0 109.935 178.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.595 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 9.1 m-85 -68.15 -23.06 64.83 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.547 178.396 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.428 ' HB3' ' O ' ' A' ' 92' ' ' SER . 0.0 OUTLIER -77.25 -38.37 51.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.855 179.38 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.721 ' O ' ' HA ' ' A' ' 75' ' ' MET . 1.5 pp0? -80.61 -19.01 46.39 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 120.949 -0.301 . . . . 0.0 111.31 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 117.99 31.42 1.59 Allowed Glycine 0 CA--C 1.52 0.388 0 C-N-CA 120.584 -0.817 . . . . 0.0 113.344 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.633 ' HB2' ' HB1' ' A' ' 93' ' ' ALA . . . -67.33 151.34 47.64 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 122.833 -0.216 . . . . 0.0 110.774 179.576 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.536 ' CZ ' ' HB2' ' A' ' 118' ' ' ALA . 14.2 t80 -76.84 -53.83 7.39 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 121.094 -0.242 . . . . 0.0 111.324 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.473 ' HB2' ' O ' ' A' ' 99' ' ' PHE . 4.4 t0 171.08 -168.7 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.312 0.577 . . . . 0.0 111.39 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.788 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 3.7 m-85 -133.79 152.36 51.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.016 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.596 HD11 HD22 ' A' ' 114' ' ' LEU . 1.5 mp -105.22 118.97 54.55 Favored Pre-proline 0 C--N 1.329 -0.314 0 C-N-CA 121.11 -0.236 . . . . 0.0 111.11 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -81.18 -76.31 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.399 2.066 . . . . 0.0 112.508 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.579 ' H ' ' HD2' ' A' ' 105' ' ' PRO . 1.3 mtpp -99.31 -62.07 0.1 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.603 -0.272 . . . . 0.0 111.682 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.579 ' HD2' ' H ' ' A' ' 104' ' ' LYS . 19.5 Cg_endo -59.03 149.56 78.87 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.186 1.924 . . . . 0.0 112.361 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.658 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 48.4 t80 -160.35 -111.79 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.89 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.629 ' O ' ' O ' ' A' ' 106' ' ' PHE . 2.8 p30 39.07 179.4 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.99 0.424 . . . . 0.0 111.921 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.683 HG12 HG12 ' A' ' 18' ' ' VAL . 0.7 OUTLIER -67.6 -42.57 86.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.85 0.357 . . . . 0.0 111.776 -179.403 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.447 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 3.9 m-20 -49.55 -58.42 5.24 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.364 -179.322 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.658 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 13.8 mm-40 -73.96 -35.35 64.52 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.771 0.319 . . . . 0.0 111.08 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.54 -56.18 15.74 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.924 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.637 ' HA ' HG12 ' A' ' 115' ' ' VAL . 52.8 t -63.89 -31.92 55.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.494 0.664 . . . . 0.0 110.598 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.447 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -62.7 -45.46 92.66 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.281 179.275 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.596 HD22 HD11 ' A' ' 102' ' ' LEU . 13.8 tp -78.15 -22.43 48.76 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.727 -1.124 . . . . 0.0 111.995 -178.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.637 HG12 ' HA ' ' A' ' 112' ' ' VAL . 6.2 p -79.6 -47.34 22.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 C-N-CA 120.351 -0.54 . . . . 0.0 111.348 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.418 ' N ' HG13 ' A' ' 115' ' ' VAL . 45.5 mt-10 -63.22 -43.43 98.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.762 0.315 . . . . 0.0 110.775 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 68.4 mtt180 -60.38 -24.99 65.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.008 0.432 . . . . 0.0 110.505 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.536 ' HB2' ' CZ ' ' A' ' 99' ' ' PHE . . . -68.9 -45.4 71.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.739 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 4.9 mt -73.86 -32.02 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-O 121.16 0.505 . . . . 0.0 110.706 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 29.6 t -75.47 -48.51 22.34 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.247 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.254 0 CA-C-O 121.027 0.441 . . . . 0.0 111.125 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.709 ' HB3' HD11 ' A' ' 5' ' ' ILE . 0.1 OUTLIER . . . . . 0 CA--C 1.529 0.144 0 CA-C-O 120.852 0.358 . . . . 0.0 111.044 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 67.32 73.02 0.7 Allowed Glycine 0 CA--C 1.517 0.179 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.067 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.709 HD11 ' HB3' ' A' ' 3' ' ' ARG . 3.4 mp -112.03 112.91 42.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.747 0.308 . . . . 0.0 111.447 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.886 HG11 ' CD2' ' A' ' 23' ' ' LEU . 5.6 p -107.54 130.51 59.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.074 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.822 ' CD1' HG22 ' A' ' 31' ' ' THR . 36.7 m0 -114.61 140.48 48.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.46 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.658 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.9 OUTLIER -123.34 134.99 64.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.806 0.336 . . . . 0.0 111.683 -178.636 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.696 HG13 HG23 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -119.82 109.19 25.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 120.881 0.372 . . . . 0.0 110.729 179.557 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -162.29 -157.94 0.49 Allowed 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.855 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -66.1 -2.13 3.85 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -179.17 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.409 ' O ' ' N ' ' A' ' 14' ' ' SER . 0.6 OUTLIER 66.81 -153.33 0.22 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 121.235 -0.186 . . . . 0.0 111.05 179.253 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.7 t 33.94 -89.83 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.806 ' O ' HG23 ' A' ' 18' ' ' VAL . 3.6 m -55.18 -55.91 25.86 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.827 0.346 . . . . 0.0 111.125 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 27.6 mm -65.83 -25.58 36.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.372 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 1.15 ' HA ' HG21 ' A' ' 32' ' ' THR . 14.0 ttp180 -69.84 -55.64 9.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.467 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.446 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 71.2 t90 -58.39 -39.62 80.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.763 -179.112 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.806 HG23 ' O ' ' A' ' 14' ' ' SER . 12.3 t -65.67 -49.28 78.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.479 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.621 HD23 HD11 ' A' ' 108' ' ' ILE . 0.3 OUTLIER -82.99 -25.21 32.47 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -178.109 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.663 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 23.1 pt-20 -67.41 -59.94 2.98 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.607 -0.437 . . . . 0.0 112.061 -179.022 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.511 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 3.6 mmt85 -67.7 -49.71 61.31 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -179.234 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.0 -57.33 10.74 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 120.905 0.383 . . . . 0.0 111.657 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.886 ' CD2' HG11 ' A' ' 6' ' ' VAL . 2.1 tp -65.34 -22.94 66.88 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.363 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.407 ' HB2' ' O ' ' A' ' 20' ' ' GLU . . . -69.4 -37.32 77.44 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.299 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.44 -24.73 66.11 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.456 -0.878 . . . . 0.0 111.404 178.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.636 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -77.45 -15.43 59.33 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 120.668 0.27 . . . . 0.0 111.01 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.65 26.58 8.0 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 120.6 -0.809 . . . . 0.0 114.069 178.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.737 HD13 ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -128.97 171.85 11.94 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 117.764 0.782 . . . . 0.0 111.852 179.931 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.7 m -99.78 105.56 17.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.333 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.709 ' HA ' HG13 ' A' ' 6' ' ' VAL . 7.2 t -102.68 114.68 29.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.856 -179.261 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.822 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.5 t -115.01 156.95 24.15 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.157 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' THR . . . . . 1.15 HG21 ' HA ' ' A' ' 16' ' ' ARG . 28.3 p -131.15 163.43 27.72 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.918 0.39 . . . . 0.0 111.894 -179.488 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.559 ' CE1' HG23 ' A' ' 31' ' ' THR . 35.4 m-85 -136.02 174.7 10.32 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -178.473 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.734 ' HG2' ' CD ' ' A' ' 38' ' ' GLU . 1.6 pt-20 -59.31 -39.56 83.46 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -176.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.558 ' N ' ' HG2' ' A' ' 34' ' ' GLU . 44.8 m-20 -168.22 -67.04 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.992 0.425 . . . . 0.0 111.352 -178.604 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.762 ' CA ' HD21 ' A' ' 65' ' ' LEU . . . -160.82 -35.22 0.02 OUTLIER Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.327 -0.939 . . . . 0.0 114.165 -179.176 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.41 ' HA ' ' CD1' ' A' ' 40' ' ' LEU . 20.6 m-20 -61.45 -35.35 77.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 117.34 0.57 . . . . 0.0 112.088 -178.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.734 ' CD ' ' HG2' ' A' ' 34' ' ' GLU . 1.4 mp0 -51.79 -61.73 2.07 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.762 HG12 ' CD1' ' A' ' 43' ' ' LEU . 94.2 t -45.84 -31.05 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-O 121.286 0.565 . . . . 0.0 110.745 -179.133 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.852 HD13 ' CB ' ' A' ' 68' ' ' GLN . 10.1 mt -64.52 -43.87 92.66 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.039 179.312 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -82.5 -47.94 11.61 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.337 0.589 . . . . 0.0 110.703 178.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.34 -37.78 65.3 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.568 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.762 ' CD1' HG12 ' A' ' 39' ' ' VAL . 37.3 mt -67.39 -22.99 65.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.843 0.354 . . . . 0.0 111.523 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.35 -18.07 3.69 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.752 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.7 m -119.92 -5.9 10.07 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.539 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.1 OUTLIER -165.71 162.65 18.85 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.041 0.448 . . . . 0.0 111.702 -179.889 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 100.0 m -139.38 119.5 9.37 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.139 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.777 ' HD2' HD11 ' A' ' 76' ' ' LEU . 91.1 Cg_endo -80.41 165.62 20.72 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.403 2.069 . . . . 0.0 111.101 178.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -74.25 -25.37 59.59 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.967 -0.293 . . . . 0.0 110.992 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.813 HG13 HG23 ' A' ' 6' ' ' VAL . 8.9 p -145.02 162.46 13.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.177 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.758 ' CD2' HG11 ' A' ' 39' ' ' VAL . 20.5 tp -152.91 126.67 8.88 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.177 0.513 . . . . 0.0 111.913 -179.406 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.606 ' O ' HG23 ' A' ' 9' ' ' VAL . 0.4 OUTLIER -104.49 114.66 29.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.27 179.275 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.68 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 1.7 t -110.79 139.03 46.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.167 0.508 . . . . 0.0 111.627 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 32.1 p-10 -82.8 -173.65 4.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.639 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.57 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 16.3 tt -161.46 170.7 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.175 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.53 ' N ' HG12 ' A' ' 55' ' ' ILE . 13.9 ptt85 58.55 43.25 19.53 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-O 121.526 0.679 . . . . 0.0 110.246 -178.454 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.497 ' CB ' ' CD ' ' A' ' 58' ' ' PRO . 6.3 mtm -151.67 -67.89 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.393 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.497 ' CD ' ' CB ' ' A' ' 57' ' ' MET . 27.2 Cg_endo -59.76 -163.29 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.87 2.38 . . . . 0.0 112.847 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -52.8 -87.52 0.01 OUTLIER Glycine 0 C--N 1.332 0.352 0 CA-C-N 115.964 -0.562 . . . . 0.0 113.258 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.664 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -76.39 61.17 1.66 Allowed 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.093 0.473 . . . . 0.0 110.466 -179.934 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.464 ' O ' ' HD2' ' A' ' 58' ' ' PRO . 6.9 m-20 60.8 -65.67 0.06 Allowed 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.944 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.57 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -165.05 -32.88 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.654 ' H ' HD12 ' A' ' 63' ' ' LEU . 0.9 OUTLIER -64.06 -13.25 45.86 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 120.54 0.21 . . . . 0.0 110.481 179.398 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.664 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -53.68 -31.55 48.19 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 121.054 0.455 . . . . 0.0 110.164 179.238 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.762 HD21 ' CA ' ' A' ' 36' ' ' GLY . 7.0 mp -62.64 -53.11 59.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.914 178.755 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.6 ' HA ' HD12 ' A' ' 69' ' ' ILE . 3.5 mm? -45.71 -45.82 14.56 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.861 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.715 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 27.1 mttt -59.15 -54.3 48.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.993 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.852 ' CB ' HD13 ' A' ' 40' ' ' LEU . 28.4 mm100 -64.34 -27.78 69.26 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.903 0.382 . . . . 0.0 110.34 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.602 HD13 HG21 ' A' ' 78' ' ' VAL . 41.4 mt -65.0 -36.74 78.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.853 -179.395 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.715 ' HG2' ' O ' ' A' ' 67' ' ' LYS . 6.5 pttt -75.72 -28.83 58.72 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.546 -179.207 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -69.14 -30.57 68.84 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.797 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.22 -56.96 2.31 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -179.178 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.735 ' CE1' HD12 ' A' ' 43' ' ' LEU . 0.3 OUTLIER -81.31 151.81 69.79 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-O 120.983 0.421 . . . . 0.0 111.817 -178.543 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -74.07 -80.99 0.01 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.377 2.051 . . . . 0.0 112.823 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.453 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 4.7 mtt -135.71 49.01 2.17 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 120.936 0.398 . . . . 0.0 111.73 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.777 HD11 ' HD2' ' A' ' 48' ' ' PRO . 0.7 OUTLIER -64.76 115.94 24.96 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.007 179.605 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.564 ' HD2' HD23 ' A' ' 76' ' ' LEU . 46.6 Cg_exo -55.61 116.95 3.52 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.376 2.051 . . . . 0.0 112.214 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.602 HG21 HD13 ' A' ' 69' ' ' ILE . 4.1 t -110.68 144.23 19.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.089 0.471 . . . . 0.0 111.365 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.585 ' CG2' HD23 ' A' ' 114' ' ' LEU . 1.7 mt -128.59 111.36 23.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.427 179.467 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.68 ' HA ' ' O ' ' A' ' 53' ' ' SER . 31.1 mm -96.89 141.6 15.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.929 0.395 . . . . 0.0 111.611 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.504 ' CG ' HG22 ' A' ' 55' ' ' ILE . 21.8 ptm -72.67 -31.25 64.92 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -178.469 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.587 ' HA ' ' O ' ' A' ' 102' ' ' LEU . 7.1 m -146.36 169.17 19.4 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.511 -179.341 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.815 ' HB1' ' HG ' ' A' ' 87' ' ' LEU . . . -141.86 -22.31 0.71 Allowed 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.476 ' HE1' HG12 ' A' ' 55' ' ' ILE . 1.9 p-80 35.6 -102.74 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.1 p -120.99 -11.95 8.83 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -178.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.507 ' HB3' HD13 ' A' ' 63' ' ' LEU . 5.8 m-20 -82.09 18.25 1.41 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.839 0.352 . . . . 0.0 111.265 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.815 ' HG ' ' HB1' ' A' ' 83' ' ' ALA . 3.0 mt -50.69 -20.47 1.24 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.961 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -46.88 -53.79 11.37 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -178.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.483 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -65.7 -20.59 66.34 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.737 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.6 ' HB3' ' O ' ' A' ' 87' ' ' LEU . . . -68.16 -40.47 82.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.225 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.687 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 4.3 t -57.31 -46.34 85.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.183 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.475 ' O ' ' OE1' ' A' ' 95' ' ' GLN . 12.8 m -62.23 -44.64 96.1 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.232 0.539 . . . . 0.0 109.827 179.248 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.695 ' HB1' ' HB2' ' A' ' 98' ' ' ALA . . . -47.48 -42.37 22.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.02 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.687 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 16.4 m-85 -56.19 -25.96 49.03 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.24 179.245 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.6 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -71.35 -45.54 62.68 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.287 -179.916 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.679 ' HG3' ' HB3' ' A' ' 70' ' ' LYS . 75.5 mm-40 -74.23 -18.08 60.79 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.11 -179.297 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 119.86 32.56 1.18 Allowed Glycine 0 N--CA 1.453 -0.186 0 C-N-CA 120.311 -0.947 . . . . 0.0 113.163 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.695 ' HB2' ' HB1' ' A' ' 93' ' ' ALA . . . -64.43 145.81 55.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.819 0.309 . . . . 0.0 110.225 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.527 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 10.9 t80 -77.17 -53.93 7.13 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.197 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 173.18 -166.86 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.208 0.528 . . . . 0.0 111.728 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.66 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 5.3 m-85 -142.43 150.59 40.8 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.119 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.712 HD23 ' HA ' ' A' ' 106' ' ' PHE . 2.4 mp -104.87 119.53 53.08 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.234 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -69.25 -75.24 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.02 1.813 . . . . 0.0 112.194 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.65 ' H ' ' HD2' ' A' ' 105' ' ' PRO . 1.8 tttm -106.44 -60.0 0.05 OUTLIER Pre-proline 0 CA--C 1.533 0.293 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.65 ' HD2' ' H ' ' A' ' 104' ' ' LYS . 18.0 Cg_endo -59.72 156.73 36.02 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.263 1.975 . . . . 0.0 112.735 -179.261 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.712 ' HA ' HD23 ' A' ' 102' ' ' LEU . 24.0 t80 -166.94 -105.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.123 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.54 ' O ' ' O ' ' A' ' 106' ' ' PHE . 3.3 p30 42.79 -178.03 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.86 0.362 . . . . 0.0 111.155 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.621 HD11 HD23 ' A' ' 19' ' ' LEU . 0.9 OUTLIER -67.88 -40.89 84.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.137 0.494 . . . . 0.0 111.583 179.922 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.488 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 1.1 t70 -49.98 -58.62 5.08 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.721 -179.106 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.615 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 5.0 mm-40 -76.61 -31.59 57.54 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.74 0.305 . . . . 0.0 111.241 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.96 -61.58 1.97 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.901 0.381 . . . . 0.0 110.127 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.623 ' O ' HG12 ' A' ' 115' ' ' VAL . 46.5 t -59.1 -30.71 44.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.483 0.659 . . . . 0.0 110.792 179.205 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.488 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -64.53 -45.33 87.68 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.799 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.585 HD23 ' CG2' ' A' ' 79' ' ' ILE . 33.5 tp -77.38 -20.98 53.91 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.689 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.623 HG12 ' O ' ' A' ' 112' ' ' VAL . 4.1 p -79.4 -44.31 23.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.659 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.531 ' HA ' HD12 ' A' ' 119' ' ' ILE . 58.4 mt-10 -60.35 -44.91 95.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.894 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 21.8 mmm180 -62.26 -23.86 66.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.248 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.527 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -74.48 -42.69 58.57 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.63 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.531 HD12 ' HA ' ' A' ' 116' ' ' GLU . 6.3 mt -65.09 -31.29 53.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.13 0.49 . . . . 0.0 110.922 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 2.8 m -68.83 -49.34 59.29 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.995 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 31.8 m80 . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.143 -179.861 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.729 ' HG2' HD11 ' A' ' 5' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.518 -0.26 0 CA-C-O 121.149 0.5 . . . . 0.0 111.447 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.43 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . 71.11 76.7 0.55 Allowed Glycine 0 C--N 1.317 -0.5 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.704 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.729 HD11 ' HG2' ' A' ' 3' ' ' ARG . 2.4 mp -111.27 114.48 47.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.795 0.331 . . . . 0.0 111.267 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.878 HG11 HD23 ' A' ' 23' ' ' LEU . 9.0 p -108.07 121.46 61.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.322 179.227 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.84 ' CD1' HG22 ' A' ' 31' ' ' THR . 27.4 m0 -111.55 133.32 53.9 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.912 0.387 . . . . 0.0 110.547 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.715 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.0 OUTLIER -124.89 149.15 29.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.149 -178.598 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 1.042 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -127.91 105.25 13.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 177.824 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.658 ' HB3' HG21 ' A' ' 15' ' ' ILE . 36.3 t0 -166.6 67.69 0.1 Allowed 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 120.952 0.406 . . . . 0.0 111.955 -179.16 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 20.6 t70 61.15 6.52 1.32 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.474 ' HA ' ' OG1' ' A' ' 32' ' ' THR . 4.5 p-10 44.28 -147.83 0.08 Allowed 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.7 t 36.05 -93.56 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.445 ' O ' HG23 ' A' ' 18' ' ' VAL . 29.1 t -53.83 -65.66 0.53 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.652 0.263 . . . . 0.0 110.974 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.658 HG21 ' HB3' ' A' ' 10' ' ' ASP . 17.2 mm -60.57 -20.63 21.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.301 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.947 ' HA ' HG21 ' A' ' 32' ' ' THR . 23.8 ttm-85 -69.74 -58.33 4.03 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 120.862 0.363 . . . . 0.0 110.848 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.479 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 49.8 t90 -51.5 -39.62 57.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.093 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.596 HG12 HG12 ' A' ' 108' ' ' ILE . 11.7 t -63.64 -51.59 68.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -178.559 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.746 HD11 HG22 ' A' ' 112' ' ' VAL . 6.2 tp -84.37 -24.97 29.46 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 -178.006 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.623 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 11.9 pt-20 -66.45 -59.86 3.27 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.416 -0.514 . . . . 0.0 111.565 -178.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.529 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 5.7 mmm180 -58.54 -52.78 64.19 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.848 -179.182 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.07 -47.92 77.05 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.81 0.338 . . . . 0.0 111.805 -179.252 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.878 HD23 HG11 ' A' ' 6' ' ' VAL . 1.7 tp -72.97 -24.65 60.81 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.126 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.96 -34.27 75.05 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.192 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.37 -27.76 69.91 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.324 -0.941 . . . . 0.0 111.107 178.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.671 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -76.87 -16.0 59.54 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 120.605 0.241 . . . . 0.0 111.07 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.07 26.54 8.81 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 120.461 -0.876 . . . . 0.0 114.281 178.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.72 HD13 ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -123.27 169.27 11.47 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 117.946 0.873 . . . . 0.0 111.653 179.756 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 54.0 m -96.42 105.69 17.8 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.004 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.694 ' HA ' HG13 ' A' ' 6' ' ' VAL . 41.8 t -103.6 110.37 22.4 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.979 -179.103 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.84 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.6 t -117.37 154.16 31.78 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.768 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.947 HG21 ' HA ' ' A' ' 16' ' ' ARG . 29.1 p -126.11 165.56 18.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.301 0.572 . . . . 0.0 112.071 -179.448 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 1.042 ' HB2' HG13 ' A' ' 9' ' ' VAL . 16.2 m-85 -136.04 174.76 10.26 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.863 -178.264 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.794 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 2.3 pp20? -60.6 -49.19 78.53 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -176.672 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -165.56 -29.29 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -179.155 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.565 ' CA ' HG11 ' A' ' 9' ' ' VAL . . . 174.92 -56.85 0.12 Allowed Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.448 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.45 ' HA ' HD12 ' A' ' 40' ' ' LEU . 3.2 t30 -55.07 -30.59 59.96 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.674 0.273 . . . . 0.0 111.283 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.825 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -60.16 -55.66 31.11 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.709 179.796 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.784 HG12 ' CD1' ' A' ' 43' ' ' LEU . 5.5 t -50.9 -45.08 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.097 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.759 ' HB3' ' HD2' ' A' ' 72' ' ' ARG . 29.2 mt -52.1 -42.97 63.67 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.246 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.86 -50.78 67.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.202 0.525 . . . . 0.0 111.441 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.44 -29.36 65.93 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.766 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.868 HD13 ' NE2' ' A' ' 73' ' ' HIS . 5.6 mt -64.28 -25.44 68.05 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.8 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.9 -18.28 31.81 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.168 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 41.1 t -124.4 3.38 8.42 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 112.143 0.424 . . . . 0.0 112.143 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.64 ' O ' HD23 ' A' ' 43' ' ' LEU . 0.4 OUTLIER -162.74 159.01 23.68 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-O 120.958 0.409 . . . . 0.0 111.497 179.924 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.898 HG23 HD13 ' A' ' 76' ' ' LEU . 98.4 m -138.62 115.48 8.94 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.459 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.642 ' HD2' HD21 ' A' ' 43' ' ' LEU . 72.7 Cg_endo -73.75 165.7 31.6 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.486 2.124 . . . . 0.0 111.363 178.63 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -76.72 -29.23 56.14 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 121.033 -0.267 . . . . 0.0 110.712 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.748 HG13 HG23 ' A' ' 6' ' ' VAL . 8.4 p -148.35 108.34 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.094 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.587 ' CD1' HG11 ' A' ' 39' ' ' VAL . 15.0 tp -86.99 136.92 32.75 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.889 0.376 . . . . 0.0 111.241 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.721 ' O ' HG23 ' A' ' 9' ' ' VAL . 1.8 tt -124.2 124.17 41.88 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.099 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.872 ' HB2' HD13 ' A' ' 80' ' ' ILE . 67.0 m -110.94 136.61 49.7 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.045 0.45 . . . . 0.0 111.999 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.467 ' O ' ' HG2' ' A' ' 81' ' ' MET . 33.7 t70 -82.88 -12.91 57.02 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.209 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.995 HD11 ' CE1' ' A' ' 84' ' ' HIS . 6.5 tt 42.25 69.59 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-O 120.732 0.301 . . . . 0.0 111.502 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -112.06 44.85 1.34 Allowed 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.326 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.492 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 0.5 OUTLIER 59.75 44.91 1.02 Allowed Pre-proline 0 N--CA 1.465 0.321 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 178.663 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' ' 62' ' ' GLY . 36.3 Cg_endo -65.08 -75.6 0.02 OUTLIER 'Trans proline' 0 CA--C 1.532 0.391 0 C-N-CA 122.579 2.186 . . . . 0.0 112.391 178.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -112.37 -27.67 3.81 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.074 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.807 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 7.9 tpt -156.11 68.49 0.62 Allowed 'General case' 0 C--O 1.236 0.387 0 CA-C-O 120.981 0.419 . . . . 0.0 109.955 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.638 ' O ' HG13 ' A' ' 55' ' ' ILE . 0.4 OUTLIER 69.22 -26.43 0.15 Allowed 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.931 -179.709 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.843 ' HA3' HG13 ' A' ' 55' ' ' ILE . . . 139.32 -26.09 2.71 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -179.024 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.741 HD13 ' HB3' ' A' ' 86' ' ' ASP . 3.1 mp -74.23 -15.14 61.0 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.387 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.807 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -53.74 -44.88 70.3 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.838 178.375 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.704 ' HG ' ' O ' ' A' ' 62' ' ' GLY . 4.0 pp -58.6 -36.64 74.33 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.289 179.303 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.907 HD13 ' HB2' ' A' ' 93' ' ' ALA . 14.8 mt -55.75 -48.59 74.99 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.019 0.438 . . . . 0.0 110.402 179.303 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.571 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 12.6 tptt -53.23 -44.05 67.78 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.936 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.662 ' CB ' HD13 ' A' ' 40' ' ' LEU . 9.2 mm100 -67.08 -27.72 67.59 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.963 0.411 . . . . 0.0 110.704 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 1.043 HD13 HG21 ' A' ' 78' ' ' VAL . 96.8 mt -64.55 -38.13 81.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.527 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.571 ' HG2' ' O ' ' A' ' 67' ' ' LYS . 2.7 ptmt -74.97 -29.42 60.91 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.915 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.25 -30.61 22.21 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.735 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.759 ' HD2' ' HB3' ' A' ' 40' ' ' LEU . 28.6 mtt85 -90.45 -68.01 0.81 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.856 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 1.024 ' ND1' HG23 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -88.04 144.63 34.86 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.629 -179.722 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -55.79 -67.49 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.603 2.202 . . . . 0.0 112.893 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.413 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 0.2 OUTLIER -146.89 40.13 1.06 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.934 0.397 . . . . 0.0 111.089 -179.554 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.898 HD13 HG23 ' A' ' 47' ' ' THR . 22.7 tp -63.75 129.43 93.77 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.037 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.534 ' HD2' HD12 ' A' ' 76' ' ' LEU . 58.2 Cg_endo -71.58 134.91 25.15 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.413 2.075 . . . . 0.0 112.278 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 1.043 HG21 HD13 ' A' ' 69' ' ' ILE . 5.5 t -123.95 148.57 28.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.944 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.687 ' CG2' HD23 ' A' ' 114' ' ' LEU . 2.2 mt -126.63 114.49 38.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.201 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.872 HD13 ' HB2' ' A' ' 53' ' ' SER . 9.7 mm -97.87 139.38 20.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.957 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.467 ' HG2' ' O ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -75.94 -30.76 58.8 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 112.357 0.502 . . . . 0.0 112.357 -178.882 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.81 ' O ' HD13 ' A' ' 55' ' ' ILE . 16.8 m -147.59 157.22 43.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.753 0.311 . . . . 0.0 111.574 -179.049 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.785 ' HB1' ' HG ' ' A' ' 87' ' ' LEU . . . -118.99 0.22 11.28 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.611 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.995 ' CE1' HD11 ' A' ' 55' ' ' ILE . 0.1 OUTLIER 25.75 -94.85 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 -179.168 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 16.1 m -136.89 -23.09 1.19 Allowed 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -178.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.741 ' HB3' HD13 ' A' ' 63' ' ' LEU . 0.3 OUTLIER -78.66 28.39 0.2 Allowed 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -179.285 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.813 HD23 ' HB3' ' A' ' 90' ' ' ALA . 0.5 OUTLIER -46.84 -21.95 0.26 Allowed 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.887 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -48.11 -53.17 17.48 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.886 0.374 . . . . 0.0 111.264 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.643 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -64.05 -20.31 65.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.331 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.813 ' HB3' HD23 ' A' ' 87' ' ' LEU . . . -68.87 -33.89 74.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.837 0.351 . . . . 0.0 110.514 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.64 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 2.8 t -63.94 -46.61 93.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.81 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.604 ' O ' ' HG3' ' A' ' 95' ' ' GLN . 52.5 p -62.04 -16.89 55.19 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 178.305 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.907 ' HB2' HD13 ' A' ' 66' ' ' LEU . . . -75.57 -52.14 11.29 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.408 0.623 . . . . 0.0 111.827 179.298 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.64 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 7.3 m-85 -57.9 -32.66 67.95 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.839 -179.5 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.604 ' HG3' ' O ' ' A' ' 92' ' ' SER . 2.1 pp0? -77.28 -32.06 55.23 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.247 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.739 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 3.3 pp0? -83.02 -15.95 49.05 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 121.13 -0.228 . . . . 0.0 111.295 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.503 ' O ' ' HA ' ' A' ' 77' ' ' PRO . . . 130.27 7.73 3.49 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.357 -0.925 . . . . 0.0 114.015 178.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.741 ' HB2' ' HB1' ' A' ' 93' ' ' ALA . . . -56.96 153.22 11.55 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 117.475 0.638 . . . . 0.0 111.138 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.553 ' CZ ' ' HA ' ' A' ' 118' ' ' ALA . 23.9 t80 -82.12 -53.65 5.92 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.336 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.548 ' HB3' ' O ' ' A' ' 99' ' ' PHE . 13.6 p-10 172.67 -161.49 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.311 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.706 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 4.6 m-85 -141.89 153.67 44.57 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.564 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.657 ' CD1' HD22 ' A' ' 114' ' ' LEU . 1.3 mp -102.32 120.01 54.62 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.71 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_exo -55.98 -69.19 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.478 2.118 . . . . 0.0 112.593 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.717 ' HB2' ' HD3' ' A' ' 105' ' ' PRO . 7.0 mmtt -128.42 -59.57 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.421 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.717 ' HD3' ' HB2' ' A' ' 104' ' ' LYS . 51.1 Cg_exo -54.16 161.56 5.04 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 121.74 1.627 . . . . 0.0 112.012 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.659 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 23.1 t80 -166.95 -105.6 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.653 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.484 ' O ' ' O ' ' A' ' 106' ' ' PHE . 2.8 p30 43.89 -175.57 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.778 0.323 . . . . 0.0 110.967 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.596 HG12 HG12 ' A' ' 18' ' ' VAL . 1.0 OUTLIER -67.86 -42.39 85.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 120.994 0.426 . . . . 0.0 111.416 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.469 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 26.3 t70 -49.12 -59.04 3.98 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.697 -179.525 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.659 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 7.0 mm-40 -76.16 -32.96 59.34 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.682 0.277 . . . . 0.0 111.376 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.419 ' CB ' ' O ' ' A' ' 107' ' ' ASP . . . -66.54 -59.37 3.7 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.486 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.746 HG22 HD11 ' A' ' 19' ' ' LEU . 35.9 t -59.53 -31.37 46.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.444 0.64 . . . . 0.0 110.715 178.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.469 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -63.1 -44.8 94.69 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.096 179.127 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.687 HD23 ' CG2' ' A' ' 79' ' ' ILE . 36.0 tp -79.33 -21.26 46.13 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.86 -1.064 . . . . 0.0 112.072 -179.196 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.648 HG12 ' HA ' ' A' ' 112' ' ' VAL . 6.0 p -79.2 -45.15 24.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.548 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.414 ' HA ' HD12 ' A' ' 119' ' ' ILE . 53.8 mt-10 -65.72 -45.4 82.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.693 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 42.8 mtp180 -60.03 -24.8 64.81 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.668 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.553 ' HA ' ' CZ ' ' A' ' 99' ' ' PHE . . . -72.27 -48.91 38.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.918 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.428 HD11 HG11 ' A' ' 50' ' ' VAL . 4.8 mt -65.27 -31.2 52.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.137 0.494 . . . . 0.0 110.75 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.3 t -72.24 -58.39 3.45 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.855 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 26.5 m80 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.885 -179.899 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 21.0 ptt180 . . . . . 0 N--CA 1.456 -0.141 0 CA-C-O 120.688 0.28 . . . . 0.0 111.001 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.561 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . 89.33 88.77 1.23 Allowed Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.097 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.8 mp -99.3 113.14 33.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 120.819 0.342 . . . . 0.0 111.297 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.819 HG23 HG13 ' A' ' 50' ' ' VAL . 6.2 p -105.69 123.41 60.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.061 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.898 ' CD1' HG22 ' A' ' 31' ' ' THR . 31.4 m0 -115.08 127.91 55.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.633 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.687 HG13 ' HB3' ' A' ' 52' ' ' LEU . 0.2 OUTLIER -112.86 143.02 23.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.401 -178.977 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.757 HG11 ' HA2' ' A' ' 36' ' ' GLY . 0.1 OUTLIER -122.98 111.14 28.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.194 0.521 . . . . 0.0 110.633 179.367 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.423 ' HA ' ' OD2' ' A' ' 54' ' ' ASP . 3.9 t0 -161.43 -158.87 0.59 Allowed 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.188 -178.724 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.51 -2.25 4.49 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' A' ' 14' ' ' SER . 1.4 t0 67.76 -156.77 0.21 Allowed 'General case' 0 CA--C 1.531 0.233 0 O-C-N 122.381 -0.2 . . . . 0.0 110.833 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.4 ' HB3' ' H ' ' A' ' 14' ' ' SER . 3.3 t 34.66 -90.6 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.884 ' O ' HG23 ' A' ' 18' ' ' VAL . 26.8 t -54.36 -61.15 2.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.741 0.305 . . . . 0.0 111.089 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 30.4 mm -61.75 -22.84 29.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.96 0.41 . . . . 0.0 110.754 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.918 ' HA ' HG21 ' A' ' 32' ' ' THR . 41.6 ttt180 -75.64 -54.85 6.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.634 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.412 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 83.4 t90 -58.65 -38.39 78.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.691 0.282 . . . . 0.0 111.595 -179.41 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.884 HG23 ' O ' ' A' ' 14' ' ' SER . 3.6 t -69.52 -45.03 79.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -178.611 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.66 -26.69 29.67 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -178.644 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.555 ' HG3' ' N ' ' A' ' 21' ' ' ARG . 10.9 pt-20 -67.74 -60.43 2.54 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -179.126 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.555 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 2.3 mmt-85 -60.71 -52.89 63.2 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -178.792 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.49 -50.4 65.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.948 0.404 . . . . 0.0 111.567 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.796 ' CD2' HG11 ' A' ' 6' ' ' VAL . 1.0 OUTLIER -70.4 -27.67 64.48 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.352 179.807 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.56 -34.75 77.68 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.192 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.16 -26.45 69.26 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.417 -0.897 . . . . 0.0 111.038 178.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.649 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -77.26 -15.39 59.48 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.655 -0.273 . . . . 0.0 111.039 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.21 26.41 10.22 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.606 -0.807 . . . . 0.0 114.217 178.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.738 HD13 ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -124.68 170.68 10.74 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 117.87 0.835 . . . . 0.0 111.775 179.722 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 50.6 m -94.3 105.8 17.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.078 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.694 ' HA ' HG13 ' A' ' 6' ' ' VAL . 46.7 t -106.29 110.33 22.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.992 -178.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.898 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.8 t -118.73 153.05 35.03 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.918 HG21 ' HA ' ' A' ' 16' ' ' ARG . 20.5 p -126.43 157.12 39.42 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.558 0.694 . . . . 0.0 112.134 -179.214 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.807 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 1.0 OUTLIER -127.0 174.29 8.98 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.707 -1.133 . . . . 0.0 111.184 -178.73 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.684 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 3.0 pp20? -61.37 -34.23 74.97 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -177.456 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -176.92 -37.52 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.757 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . 173.47 -47.02 0.16 Allowed Glycine 0 C--N 1.318 -0.438 0 C-N-CA 120.32 -0.943 . . . . 0.0 112.884 -179.147 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.454 ' HA ' ' CD1' ' A' ' 40' ' ' LEU . 2.4 t30 -59.62 -29.66 68.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.154 0.502 . . . . 0.0 111.071 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.807 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -62.97 -53.58 51.86 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.708 -179.525 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.689 HG23 ' CG1' ' A' ' 9' ' ' VAL . 21.3 t -50.08 -37.2 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 C-N-CA 120.349 -0.54 . . . . 0.0 110.661 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.653 HD13 ' HB3' ' A' ' 68' ' ' GLN . 12.6 mt -55.65 -48.13 75.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.479 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.01 -50.17 69.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.107 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.4 -34.6 77.07 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.726 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.569 ' HA ' ' O ' ' A' ' 46' ' ' LYS . 21.1 mt -59.23 -23.5 62.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.421 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.02 -17.8 28.6 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.826 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.5 t -128.52 3.08 5.59 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.569 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.2 OUTLIER -167.44 161.25 13.87 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.909 0.385 . . . . 0.0 111.216 179.895 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.405 HG23 HD12 ' A' ' 76' ' ' LEU . 90.4 m -138.96 111.74 8.06 Favored Pre-proline 0 N--CA 1.45 -0.457 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.201 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.894 ' HD2' HD11 ' A' ' 76' ' ' LEU . 43.3 Cg_endo -71.38 158.68 53.66 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.084 1.856 . . . . 0.0 111.276 179.131 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.442 ' O ' ' HG2' ' A' ' 77' ' ' PRO . 1.7 m-20 -74.24 -24.15 59.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.466 -179.275 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.819 HG13 HG23 ' A' ' 6' ' ' VAL . 7.6 p -145.98 166.47 8.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.582 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.852 HD12 ' O ' ' A' ' 7' ' ' TRP . 10.0 tp -152.96 137.36 16.68 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.985 0.422 . . . . 0.0 111.43 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.687 ' HB3' HG13 ' A' ' 8' ' ' VAL . 1.1 tt -121.9 119.21 30.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.713 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.44 ' HB2' ' CD1' ' A' ' 80' ' ' ILE . 0.6 OUTLIER -115.08 138.21 51.13 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.905 0.383 . . . . 0.0 111.408 -179.723 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.64 ' O ' HG22 ' A' ' 55' ' ' ILE . 2.9 p30 -82.27 -4.04 56.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 0.0 112.058 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.931 HG13 ' HA3' ' A' ' 62' ' ' GLY . 7.1 tt 50.47 169.4 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-O 120.953 0.406 . . . . 0.0 111.923 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.484 ' H ' ' HA3' ' A' ' 62' ' ' GLY . 8.2 ttt85 67.43 77.93 0.25 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.901 0.382 . . . . 0.0 110.696 -179.114 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.608 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . 7.5 tpt -163.14 -61.24 0.01 OUTLIER Pre-proline 0 CA--C 1.537 0.479 0 CA-C-N 116.081 -0.509 . . . . 0.0 112.063 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.716 ' HG3' ' HG ' ' A' ' 65' ' ' LEU . 94.3 Cg_endo -71.96 -164.58 0.17 Allowed 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.975 2.45 . . . . 0.0 113.47 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.64 -65.48 3.13 Favored Glycine 0 C--N 1.335 0.525 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.241 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.467 ' O ' ' N ' ' A' ' 62' ' ' GLY . 5.2 ttt -70.19 60.42 0.19 Allowed 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.082 0.468 . . . . 0.0 110.013 179.124 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 58.3 -81.79 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.558 -0.747 . . . . 0.0 109.812 -179.058 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.931 ' HA3' HG13 ' A' ' 55' ' ' ILE . . . -145.38 -28.96 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.593 179.005 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.854 HD13 ' HB3' ' A' ' 86' ' ' ASP . 4.0 mp -59.75 -18.85 46.27 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.503 ' HB3' ' CG ' ' A' ' 58' ' ' PRO . . . -55.63 -37.1 67.75 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 178.289 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.716 ' HG ' ' HG3' ' A' ' 58' ' ' PRO . 32.4 mt -60.76 -49.14 78.69 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.391 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.738 HD11 HD11 ' A' ' 80' ' ' ILE . 9.4 mp -51.1 -51.47 53.06 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.98 179.023 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.564 ' HA ' ' CE ' ' A' ' 70' ' ' LYS . 6.4 mtpm? -44.63 -49.43 10.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.851 179.439 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.653 ' HB3' HD13 ' A' ' 40' ' ' LEU . 16.0 mm100 -68.22 -26.51 65.75 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.375 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 1.069 HG22 ' CD2' ' A' ' 73' ' ' HIS . 63.3 mt -63.89 -54.18 34.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.012 0.434 . . . . 0.0 111.119 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.799 ' HA ' ' CD2' ' A' ' 73' ' ' HIS . 0.0 OUTLIER -62.43 -28.35 69.74 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.16 -178.94 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -64.82 -22.48 67.0 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.179 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.72 -11.68 9.36 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.005 0.742 . . . . 0.0 113.005 -179.067 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 1.069 ' CD2' HG22 ' A' ' 69' ' ' ILE . 1.6 p80 -109.55 160.61 27.19 Favored Pre-proline 0 N--CA 1.465 0.321 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -179.248 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.455 ' O ' ' HG2' ' A' ' 75' ' ' MET . 60.6 Cg_endo -87.71 -59.45 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.976 2.451 . . . . 0.0 111.42 178.222 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.566 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 5.8 mmt -151.24 51.33 0.84 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.9 178.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.894 HD11 ' HD2' ' A' ' 48' ' ' PRO . 0.4 OUTLIER -76.66 123.25 87.58 Favored Pre-proline 0 N--CA 1.456 -0.135 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -179.147 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.663 ' HD2' HD23 ' A' ' 76' ' ' LEU . 20.2 Cg_exo -64.72 138.07 56.88 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.189 1.926 . . . . 0.0 111.729 178.505 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.64 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 3.0 t -126.13 119.69 54.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.482 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.82 ' CG2' HD23 ' A' ' 114' ' ' LEU . 1.5 mp -109.83 110.22 31.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.863 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.738 HD11 HD11 ' A' ' 66' ' ' LEU . 37.0 mm -100.53 148.49 6.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.296 -178.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.515 ' HB3' ' CE1' ' A' ' 106' ' ' PHE . 13.0 ptm -81.98 -35.32 29.07 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.61 -179.11 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.826 ' O ' HD13 ' A' ' 55' ' ' ILE . 8.2 m -146.59 151.84 37.96 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.626 0.251 . . . . 0.0 111.138 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.833 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -117.03 10.24 13.9 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 111.803 0.297 . . . . 0.0 111.803 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.675 ' H ' HG22 ' A' ' 82' ' ' THR . 0.1 OUTLIER 25.84 -92.38 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -179.385 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 55.3 m -149.64 39.62 0.8 Allowed 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.854 ' HB3' HD13 ' A' ' 63' ' ' LEU . 0.4 OUTLIER -137.72 36.68 2.42 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.125 0.488 . . . . 0.0 110.349 179.236 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.45 ' O ' ' HB3' ' A' ' 90' ' ' ALA . 7.9 mt -50.33 -20.86 1.19 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.993 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -47.69 -58.76 3.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.624 0.25 . . . . 0.0 111.434 -179.308 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.58 ' O ' ' HB2' ' A' ' 93' ' ' ALA . . . -69.74 -19.64 63.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.892 0.377 . . . . 0.0 110.651 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 87' ' ' LEU . . . -69.25 -46.42 67.35 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.878 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.646 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 3.5 t -67.0 -52.92 38.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 C-N-CA 120.474 -0.491 . . . . 0.0 111.297 -179.262 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.595 ' O ' ' HB3' ' A' ' 95' ' ' GLN . 24.4 m -60.21 -27.08 66.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.137 0.494 . . . . 0.0 109.786 178.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.587 ' HA ' ' OE1' ' A' ' 96' ' ' GLN . . . -60.72 -41.81 96.01 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.056 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.646 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 3.9 m-85 -67.73 -27.33 66.7 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.967 179.043 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.595 ' HB3' ' O ' ' A' ' 92' ' ' SER . 0.2 OUTLIER -60.92 -40.89 94.88 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.807 -179.192 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.587 ' OE1' ' HA ' ' A' ' 93' ' ' ALA . 0.0 OUTLIER -100.37 -19.3 16.35 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -179.565 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.441 ' O ' ' C ' ' A' ' 98' ' ' ALA . . . -176.01 -57.67 0.06 OUTLIER Glycine 0 C--N 1.335 0.474 0 C-N-CA 119.22 -1.467 . . . . 0.0 114.824 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.64 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -29.1 139.37 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 117.32 0.56 . . . . 0.0 112.36 -178.318 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -84.78 -53.38 5.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.45 -179.07 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.67 ' OD1' HD21 ' A' ' 114' ' ' LEU . 7.9 p-10 -177.8 -164.65 0.09 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.747 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.833 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 4.1 m-85 -138.3 153.02 49.03 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.081 0.467 . . . . 0.0 111.004 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.816 ' CD1' HD22 ' A' ' 114' ' ' LEU . 3.2 mp -102.98 119.08 56.54 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.714 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 102' ' ' LEU . 21.1 Cg_exo -64.69 -66.84 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.537 2.158 . . . . 0.0 112.272 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.735 ' H ' ' HD2' ' A' ' 105' ' ' PRO . 5.6 mttp -119.81 -58.85 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.135 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.735 ' HD2' ' H ' ' A' ' 104' ' ' LYS . 11.9 Cg_endo -55.02 163.5 4.22 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.127 1.885 . . . . 0.0 112.347 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.665 ' HA ' HD23 ' A' ' 102' ' ' LEU . 39.9 t80 -172.08 -106.34 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.659 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.551 ' O ' ' O ' ' A' ' 106' ' ' PHE . 4.7 p-10 43.09 -179.94 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.744 0.307 . . . . 0.0 111.089 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.66 HG12 HG12 ' A' ' 18' ' ' VAL . 0.9 OUTLIER -67.87 -43.44 85.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -179.355 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.503 ' HB2' ' OD2' ' A' ' 107' ' ' ASP . 7.0 m-20 -49.82 -58.68 4.88 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.45 -179.201 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.612 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 6.1 mm-40 -74.46 -31.79 62.36 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.759 0.314 . . . . 0.0 111.318 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.419 ' CB ' ' O ' ' A' ' 107' ' ' ASP . . . -66.48 -61.18 2.13 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.336 179.542 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.608 ' O ' HG12 ' A' ' 115' ' ' VAL . 50.2 t -59.07 -31.51 45.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.5 0.667 . . . . 0.0 110.332 179.129 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.49 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -64.24 -45.27 88.88 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.722 179.088 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.82 HD23 ' CG2' ' A' ' 79' ' ' ILE . 23.5 tp -74.89 -24.14 58.49 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.835 -1.075 . . . . 0.0 111.901 -179.397 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.697 HG23 HD13 ' A' ' 79' ' ' ILE . 4.0 p -79.29 -43.83 23.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.668 -179.302 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.41 ' HA ' HD12 ' A' ' 119' ' ' ILE . 50.8 mt-10 -65.65 -43.76 88.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.114 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.769 ' HD3' HD12 ' A' ' 114' ' ' LEU . 7.8 ptm180 -63.27 -23.72 67.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.787 0.327 . . . . 0.0 110.844 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.38 -46.64 59.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.693 179.384 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.541 HD11 HG11 ' A' ' 50' ' ' VAL . 4.5 mt -68.62 -32.09 53.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.878 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 36.8 t -65.44 -41.89 93.0 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.492 -0.777 . . . . 0.0 110.819 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 2.4 m80 . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.785 179.947 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.528 0.116 0 CA-C-O 120.684 0.278 . . . . 0.0 111.222 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 89.3 94.39 1.11 Allowed Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.576 -0.821 . . . . 0.0 111.728 -179.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.8 mp -105.71 116.27 49.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.018 0.437 . . . . 0.0 111.451 -179.356 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.788 HG23 HG13 ' A' ' 50' ' ' VAL . 7.6 p -107.19 131.32 57.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.77 179.16 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.933 ' CD1' HG22 ' A' ' 31' ' ' THR . 39.5 m0 -117.44 142.2 47.43 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.132 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.732 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -134.18 145.37 33.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.011 0.434 . . . . 0.0 111.558 -178.421 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.992 HG12 ' HB2' ' A' ' 33' ' ' PHE . 3.1 m -131.39 105.93 11.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.262 178.67 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.767 ' HB3' HG21 ' A' ' 15' ' ' ILE . 53.7 t0 -166.46 66.98 0.1 Allowed 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 121.148 0.499 . . . . 0.0 111.845 -179.37 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.2 t70 74.85 -9.11 1.41 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 178.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.7 t70 59.45 -154.36 0.37 Allowed 'General case' 0 CA--C 1.534 0.357 0 O-C-N 122.275 -0.266 . . . . 0.0 110.955 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 t 34.83 -91.01 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.538 ' O ' HG23 ' A' ' 18' ' ' VAL . 1.5 m -54.57 -65.98 0.48 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.513 0.197 . . . . 0.0 111.234 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.767 HG21 ' HB3' ' A' ' 10' ' ' ASP . 40.2 mm -60.44 -20.58 21.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.771 0.319 . . . . 0.0 111.089 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.987 ' HA ' HG21 ' A' ' 32' ' ' THR . 27.1 ttt180 -70.32 -57.81 4.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.238 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.475 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 50.1 t90 -53.9 -39.68 66.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.69 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.66 HG12 HG12 ' A' ' 108' ' ' ILE . 14.5 t -62.28 -54.82 29.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 113.018 0.748 . . . . 0.0 113.018 -178.657 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.613 HD11 HG22 ' A' ' 112' ' ' VAL . 7.8 tp -82.84 -22.4 34.1 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -177.791 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.594 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 22.8 pt-20 -67.75 -57.69 5.9 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.499 -178.896 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.536 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 0.1 OUTLIER -63.34 -49.83 72.37 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.93 -179.48 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.15 -47.5 83.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.84 0.353 . . . . 0.0 111.675 -179.264 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.778 ' CD2' HG11 ' A' ' 6' ' ' VAL . 2.4 tp -71.04 -25.28 62.59 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.259 179.723 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.08 -33.71 75.04 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.29 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.34 -25.04 71.06 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.475 -0.869 . . . . 0.0 111.028 178.349 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.733 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -76.68 -15.66 59.74 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 120.585 0.231 . . . . 0.0 110.78 179.197 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.14 26.41 9.55 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.68 -0.771 . . . . 0.0 113.825 179.292 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.733 ' CD1' ' HB3' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -123.94 168.12 13.22 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 117.848 0.824 . . . . 0.0 111.689 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 73.5 m -94.75 105.66 17.61 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.627 179.085 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.72 ' HA ' HG13 ' A' ' 6' ' ' VAL . 10.8 t -100.77 112.44 24.85 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -178.608 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.933 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.5 t -120.21 144.75 47.56 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.335 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.987 HG21 ' HA ' ' A' ' 16' ' ' ARG . 43.6 p -121.53 157.96 29.54 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -178.586 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.992 ' HB2' HG12 ' A' ' 9' ' ' VAL . 0.4 OUTLIER -136.16 174.24 10.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.893 -1.049 . . . . 0.0 111.304 -179.882 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.575 ' HG2' ' N ' ' A' ' 35' ' ' ASN . 0.0 OUTLIER -63.19 -32.97 74.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.658 -179.294 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.575 ' N ' ' HG2' ' A' ' 34' ' ' GLU . 1.7 t-20 -178.61 179.0 0.77 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.356 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.708 ' HA3' HD13 ' A' ' 65' ' ' LEU . . . -52.03 -19.93 5.94 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.646 -0.788 . . . . 0.0 113.058 -179.67 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -69.12 -50.9 43.85 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -179.542 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.673 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 3.9 tt0 -51.98 -51.7 55.5 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.055 -179.329 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.714 HG23 ' CG1' ' A' ' 9' ' ' VAL . 82.8 t -51.42 -32.7 13.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.133 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.551 HD13 ' CB ' ' A' ' 68' ' ' GLN . 18.9 mt -58.3 -47.26 84.24 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.121 0.486 . . . . 0.0 110.065 179.167 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.47 -49.47 48.21 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.938 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.89 -32.08 71.55 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.206 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.608 ' CD1' ' CE1' ' A' ' 73' ' ' HIS . 18.7 mt -68.78 -25.12 64.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.989 -179.294 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.31 -20.45 7.19 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.905 -179.198 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 28.6 t -124.8 4.92 8.1 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.584 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -167.69 155.73 9.02 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.972 0.415 . . . . 0.0 111.173 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.454 ' HA ' ' CD2' ' A' ' 43' ' ' LEU . 93.9 m -138.95 116.58 8.91 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.902 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.578 ' HD2' HD21 ' A' ' 43' ' ' LEU . 73.2 Cg_endo -77.92 163.0 28.95 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 121.988 1.792 . . . . 0.0 111.313 179.221 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -73.79 -21.0 60.31 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.818 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.788 HG13 HG23 ' A' ' 6' ' ' VAL . 5.5 p -147.63 161.42 7.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.715 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.745 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 26.8 tp -152.93 131.15 11.98 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 121.196 0.522 . . . . 0.0 111.947 -179.286 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.67 ' HB3' HG13 ' A' ' 8' ' ' VAL . 1.0 OUTLIER -114.45 118.18 33.07 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.447 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.852 ' HA ' HG23 ' A' ' 9' ' ' VAL . 3.8 m -117.26 144.37 44.91 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -178.577 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -82.98 179.15 7.85 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.559 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.737 HG13 ' HA3' ' A' ' 62' ' ' GLY . 9.0 tt -154.61 67.47 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.398 179.567 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.74 38.51 2.24 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.729 -179.263 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.547 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER 65.35 47.14 0.56 Allowed Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 178.947 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.511 ' HD2' ' N ' ' A' ' 62' ' ' GLY . 40.9 Cg_endo -68.18 -78.16 0.01 OUTLIER 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 122.387 2.058 . . . . 0.0 111.967 178.559 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -106.45 -27.71 5.43 Favored Glycine 0 C--N 1.335 0.496 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.126 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' MET . . . . . 1.024 ' HB3' ' HB2' ' A' ' 64' ' ' ALA . 2.2 tpt -159.51 67.97 0.41 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.885 0.374 . . . . 0.0 109.997 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.547 ' HA ' ' HA ' ' A' ' 57' ' ' MET . 0.2 OUTLIER 71.42 -29.12 0.19 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.338 -179.561 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.737 ' HA3' HG13 ' A' ' 55' ' ' ILE . . . 140.07 -28.45 2.49 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 -179.376 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.999 ' HA ' HD23 ' A' ' 66' ' ' LEU . 0.9 OUTLIER -72.74 -14.01 61.46 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 115.425 -0.387 . . . . 0.0 109.991 178.452 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 1.024 ' HB2' ' HB3' ' A' ' 60' ' ' MET . . . -53.38 -52.45 59.26 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-O 121.118 0.485 . . . . 0.0 110.428 178.82 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.708 HD13 ' HA3' ' A' ' 36' ' ' GLY . 3.5 pp -57.36 -33.23 67.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.121 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.999 HD23 ' HA ' ' A' ' 63' ' ' LEU . 3.9 mm? -59.36 -50.43 74.0 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.925 0.393 . . . . 0.0 110.766 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.543 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 6.9 mttt -54.54 -40.87 69.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.985 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.551 ' CB ' HD13 ' A' ' 40' ' ' LEU . 11.0 mm100 -65.84 -27.96 68.63 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.066 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.836 HD12 ' HA ' ' A' ' 66' ' ' LEU . 87.9 mt -64.76 -53.94 36.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.8 -179.263 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.543 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.5 OUTLIER -64.7 -24.93 67.73 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.847 -179.099 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.86 -51.7 63.42 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -178.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.94 -26.4 15.59 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.201 -0.454 . . . . 0.0 112.176 -178.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.608 ' CE1' ' CD1' ' A' ' 43' ' ' LEU . 1.6 m80 -110.3 139.34 21.37 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-O 120.706 0.289 . . . . 0.0 111.039 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.452 ' C ' ' HG3' ' A' ' 75' ' ' MET . 48.6 Cg_exo -54.24 -76.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.639 2.226 . . . . 0.0 112.937 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.566 ' HB3' ' HA2' ' A' ' 97' ' ' GLY . 2.8 mtm -144.14 54.34 1.29 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.845 0.355 . . . . 0.0 110.743 -179.407 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.528 ' O ' HG23 ' A' ' 78' ' ' VAL . 1.9 tt -63.83 115.68 20.78 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.725 -179.344 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -56.72 118.04 4.81 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.497 2.131 . . . . 0.0 112.546 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.918 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 2.8 t -124.99 146.58 30.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.126 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.67 ' HB ' ' HG ' ' A' ' 52' ' ' LEU . 2.3 mp -128.07 116.23 41.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 179.271 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.798 ' HA ' ' O ' ' A' ' 53' ' ' SER . 18.0 mm -95.34 142.59 13.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.979 0.419 . . . . 0.0 112.086 -178.647 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.544 ' HG3' HG22 ' A' ' 55' ' ' ILE . 1.7 ptt? -66.46 -32.38 73.71 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.609 -178.49 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.565 ' HA ' ' O ' ' A' ' 102' ' ' LEU . 4.3 m -148.1 169.99 18.78 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.581 0.229 . . . . 0.0 111.362 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 1.008 ' HB1' HD23 ' A' ' 87' ' ' LEU . . . -144.69 56.06 1.27 Allowed 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 14.8 p80 -99.17 176.36 5.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.092 0.472 . . . . 0.0 111.897 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.4 t 67.44 -78.68 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.972 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.547 ' O ' HD22 ' A' ' 63' ' ' LEU . 0.8 OUTLIER -120.4 70.18 0.88 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.894 0.378 . . . . 0.0 111.277 -179.358 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 1.008 HD23 ' HB1' ' A' ' 83' ' ' ALA . 3.0 tm? -54.93 -22.37 14.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.985 179.692 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -51.46 -56.26 14.28 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.756 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.47 -20.51 55.8 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.715 0.293 . . . . 0.0 111.147 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.841 ' HB3' HD22 ' A' ' 87' ' ' LEU . . . -69.13 -62.17 1.49 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.973 0.416 . . . . 0.0 110.776 179.505 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.465 ' HA ' ' HD2' ' A' ' 94' ' ' TYR . 8.4 t -53.62 -44.48 57.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.831 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.594 ' HA ' ' CG ' ' A' ' 95' ' ' GLN . 1.7 m -60.25 -25.24 65.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.17 0.51 . . . . 0.0 109.686 178.68 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.575 ' HB3' ' O ' ' A' ' 90' ' ' ALA . . . -75.88 -49.5 17.74 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.573 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.71 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -73.31 -29.25 62.57 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.038 -179.139 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.594 ' CG ' ' HA ' ' A' ' 92' ' ' SER . 2.1 pp0? -77.27 -37.61 52.58 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.547 178.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.57 ' HG2' ' O ' ' A' ' 93' ' ' ALA . 10.3 pt20 -73.47 -17.23 61.26 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.053 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.566 ' HA2' ' HB3' ' A' ' 75' ' ' MET . . . 165.16 -33.08 0.25 Allowed Glycine 0 C--N 1.335 0.473 0 C-N-CA 120.047 -1.073 . . . . 0.0 113.762 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.918 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -58.4 155.64 11.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 117.549 0.674 . . . . 0.0 111.218 -179.074 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.507 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 23.8 t80 -69.2 -53.88 17.7 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.735 -178.782 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.439 ' HB3' ' O ' ' A' ' 99' ' ' PHE . 17.1 p-10 178.99 -160.25 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 120.922 0.391 . . . . 0.0 111.084 -179.515 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.923 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 3.5 m-85 -135.98 153.36 51.42 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.986 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.601 HD13 HD22 ' A' ' 114' ' ' LEU . 1.4 tp -103.74 118.98 56.06 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.826 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -71.68 -75.38 0.01 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.034 1.823 . . . . 0.0 112.278 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.441 ' CB ' ' HD3' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -108.94 -57.03 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.503 -179.962 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.497 ' HB3' ' HG3' ' A' ' 110' ' ' GLU . 56.0 Cg_exo -52.31 154.15 11.8 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.295 1.996 . . . . 0.0 112.61 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.59 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 31.2 t80 -164.44 -116.52 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.197 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.55 ' O ' ' O ' ' A' ' 106' ' ' PHE . 2.9 p30 43.22 179.48 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.967 0.413 . . . . 0.0 111.449 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.66 HG12 HG12 ' A' ' 18' ' ' VAL . 0.8 OUTLIER -67.99 -43.75 85.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.892 0.377 . . . . 0.0 111.803 -179.617 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.491 ' HB2' ' OD1' ' A' ' 107' ' ' ASP . 4.2 m-20 -49.23 -58.28 5.31 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.567 -179.091 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.59 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 6.7 mm-40 -76.01 -32.02 59.2 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.591 0.234 . . . . 0.0 111.231 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.433 ' CB ' ' O ' ' A' ' 107' ' ' ASP . . . -66.21 -57.46 7.53 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.336 179.295 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.653 ' O ' HG12 ' A' ' 115' ' ' VAL . 47.8 t -62.01 -33.52 58.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.362 0.601 . . . . 0.0 110.653 179.129 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.477 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -62.24 -46.26 89.63 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.551 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.601 HD22 HD13 ' A' ' 102' ' ' LEU . 37.9 tp -75.83 -21.98 56.75 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.96 -1.018 . . . . 0.0 112.205 -179.107 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.653 HG12 ' O ' ' A' ' 112' ' ' VAL . 7.2 p -79.18 -41.44 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 C-N-CA 120.447 -0.501 . . . . 0.0 111.994 -179.319 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -66.35 -42.95 87.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.825 0.345 . . . . 0.0 110.736 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.9 mtt180 -61.0 -23.86 65.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.385 179.38 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.507 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -72.17 -48.45 43.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.079 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.481 HD11 HG11 ' A' ' 50' ' ' VAL . 4.5 mt -69.63 -31.31 48.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.076 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 36.3 t -71.96 -50.84 25.52 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.165 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.134 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.804 ' HB3' HD11 ' A' ' 5' ' ' ILE . 10.2 tpt85 . . . . . 0 N--CA 1.455 -0.224 0 CA-C-O 120.768 0.318 . . . . 0.0 110.776 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.528 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . 68.16 63.06 3.8 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.773 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.804 HD11 ' HB3' ' A' ' 3' ' ' ARG . 3.8 mp -101.73 115.02 42.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.767 0.318 . . . . 0.0 110.839 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.849 HG11 ' CD2' ' A' ' 23' ' ' LEU . 7.3 p -105.66 126.41 60.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.327 179.532 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.799 ' CD1' HG22 ' A' ' 31' ' ' THR . 21.6 m0 -116.63 126.31 53.05 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.669 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.711 HG13 ' HB3' ' A' ' 52' ' ' LEU . 0.2 OUTLIER -112.02 148.26 15.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.236 -179.056 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 1.098 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -130.79 113.36 24.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 120.885 0.374 . . . . 0.0 110.379 178.736 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -161.4 -156.63 0.45 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.798 -179.232 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -67.24 0.78 2.52 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.411 ' O ' ' N ' ' A' ' 14' ' ' SER . 0.1 OUTLIER 65.38 -158.68 0.28 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.509 0.195 . . . . 0.0 110.783 179.717 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.436 ' HB3' ' H ' ' A' ' 14' ' ' SER . 1.3 t 34.62 -90.51 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 179.423 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.813 ' O ' HG23 ' A' ' 18' ' ' VAL . 0.4 OUTLIER -53.87 -57.56 10.5 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.824 0.345 . . . . 0.0 111.114 -179.702 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 22.4 mm -65.2 -24.5 35.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.89 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 1.097 ' HA ' HG21 ' A' ' 32' ' ' THR . 14.7 ttm-85 -71.1 -58.18 3.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.165 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.475 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 57.9 t90 -54.43 -37.3 64.96 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -179.141 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.813 HG23 ' O ' ' A' ' 14' ' ' SER . 8.2 t -67.84 -47.08 80.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -178.418 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.749 HD23 HD11 ' A' ' 108' ' ' ILE . 0.2 OUTLIER -84.25 -27.63 27.78 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -178.636 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.542 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 12.1 pt-20 -66.75 -59.77 3.27 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.846 -179.138 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.504 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 4.0 mmm180 -67.0 -47.7 70.68 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.846 -179.156 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.67 -54.53 45.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.917 0.389 . . . . 0.0 111.456 -179.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.849 ' CD2' HG11 ' A' ' 6' ' ' VAL . 2.2 tp -67.68 -23.49 65.31 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.065 179.372 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.542 ' HB2' ' O ' ' A' ' 20' ' ' GLU . . . -69.22 -36.31 77.1 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.336 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.89 -25.73 68.1 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.427 -0.892 . . . . 0.0 110.982 178.2 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.611 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -76.81 -16.11 59.54 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 120.665 0.269 . . . . 0.0 111.067 179.491 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.71 26.59 8.46 Favored Glycine 0 CA--C 1.522 0.514 0 C-N-CA 120.289 -0.958 . . . . 0.0 114.158 178.726 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.718 HD12 ' O ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -127.21 170.38 12.49 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 117.994 0.897 . . . . 0.0 111.805 179.942 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 52.9 m -95.46 105.51 17.48 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.432 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.719 ' HA ' HG13 ' A' ' 6' ' ' VAL . 40.7 t -106.34 113.36 26.83 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.221 0.534 . . . . 0.0 111.948 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.799 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.8 t -116.85 156.43 27.31 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.387 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' THR . . . . . 1.097 HG21 ' HA ' ' A' ' 16' ' ' ARG . 28.9 p -127.04 158.44 36.95 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.358 0.599 . . . . 0.0 111.684 -179.347 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 1.098 ' HB2' HG13 ' A' ' 9' ' ' VAL . 17.0 m-85 -128.44 174.24 9.51 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.735 -178.133 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.488 ' HG3' ' ND2' ' A' ' 35' ' ' ASN . 1.6 pt-20 -63.3 -37.6 87.87 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.577 0.955 . . . . 0.0 113.577 -177.103 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.488 ' ND2' ' HG3' ' A' ' 34' ' ' GLU . 18.0 p30 -174.92 -41.02 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 118.766 0.712 . . . . 0.0 112.696 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.754 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . -178.57 -47.07 0.07 OUTLIER Glycine 0 C--N 1.321 -0.271 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.738 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.418 ' HA ' ' CD1' ' A' ' 40' ' ' LEU . 0.9 OUTLIER -61.25 -29.94 70.15 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.616 0.246 . . . . 0.0 111.353 -179.525 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.836 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 3.1 tt0 -59.98 -51.34 70.07 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 121.089 -0.245 . . . . 0.0 111.597 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.621 HG21 ' CG2' ' A' ' 9' ' ' VAL . 19.5 t -52.37 -41.13 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 C-N-CA 120.584 -0.446 . . . . 0.0 111.461 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.74 HD13 ' HB3' ' A' ' 68' ' ' GLN . 7.1 mt -54.7 -46.74 74.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.97 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.91 -49.17 71.48 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.425 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.31 -32.7 74.26 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.881 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.642 HD21 ' HD2' ' A' ' 48' ' ' PRO . 8.3 mt -60.7 -25.02 66.11 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.086 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.4 -16.84 50.57 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.779 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.3 m -125.72 -0.97 7.37 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.548 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.515 ' O ' HD23 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -160.95 162.07 31.83 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.905 0.383 . . . . 0.0 111.024 179.834 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.443 HG23 HD23 ' A' ' 76' ' ' LEU . 57.8 m -138.42 116.0 9.21 Favored Pre-proline 0 N--CA 1.451 -0.414 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.134 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.642 ' HD2' HD21 ' A' ' 43' ' ' LEU . 70.9 Cg_endo -74.76 149.24 37.59 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 121.97 1.78 . . . . 0.0 111.881 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -73.73 -24.89 59.96 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.706 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.788 ' CG2' HD11 ' A' ' 79' ' ' ILE . 7.6 p -147.53 101.83 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.983 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.495 HD12 ' O ' ' A' ' 7' ' ' TRP . 18.0 tp -87.13 134.48 33.51 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.116 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.711 ' HB3' HG13 ' A' ' 8' ' ' VAL . 1.3 tt -121.73 122.54 39.77 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.333 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.55 ' OG ' HD13 ' A' ' 65' ' ' LEU . 2.2 m -123.67 125.51 44.92 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.416 0.627 . . . . 0.0 112.473 -178.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.649 ' HA ' ' HG2' ' A' ' 81' ' ' MET . 1.2 m-20 -83.18 107.14 15.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.78 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.985 HG13 ' HA3' ' A' ' 62' ' ' GLY . 4.9 tt -69.99 116.41 11.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.955 179.272 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.473 ' H ' ' HD3' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -158.22 58.13 0.46 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.036 0.446 . . . . 0.0 111.883 -179.783 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.456 ' N ' ' CD ' ' A' ' 58' ' ' PRO . 9.6 ptp 47.07 46.17 3.27 Favored Pre-proline 0 CA--C 1.537 0.473 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 178.784 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.608 ' CG ' ' HA2' ' A' ' 62' ' ' GLY . 50.3 Cg_endo -69.81 -81.94 0.01 OUTLIER 'Trans proline' 0 CA--C 1.533 0.475 0 C-N-CA 122.89 2.393 . . . . 0.0 111.885 178.411 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -105.85 -25.68 6.41 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.088 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.971 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -161.57 71.75 0.38 Allowed 'General case' 0 C--O 1.235 0.321 0 CA-C-O 120.985 0.421 . . . . 0.0 110.126 179.498 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.55 ' O ' HG13 ' A' ' 55' ' ' ILE . 0.2 OUTLIER 69.49 -25.77 0.15 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.886 -179.805 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.985 ' HA3' HG13 ' A' ' 55' ' ' ILE . . . 136.68 -26.34 3.04 Favored Glycine 0 CA--C 1.502 -0.737 0 N-CA-C 111.639 -0.584 . . . . 0.0 111.639 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.857 ' HA ' HD13 ' A' ' 66' ' ' LEU . 4.0 mp -78.26 -14.0 59.62 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-O 121.051 0.453 . . . . 0.0 109.977 178.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.971 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -53.83 -44.51 70.31 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.031 179.272 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.758 ' CD1' HD12 ' A' ' 66' ' ' LEU . 3.1 pp -57.98 -32.35 67.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.041 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.857 HD13 ' HA ' ' A' ' 63' ' ' LEU . 7.1 mp -62.93 -44.99 94.58 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.365 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.551 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 30.2 tttt -56.16 -44.62 79.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.756 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.74 ' HB3' HD13 ' A' ' 40' ' ' LEU . 2.5 mt-30 -66.26 -39.96 89.83 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.662 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.667 HD12 ' HA ' ' A' ' 66' ' ' LEU . 10.4 mt -65.03 -32.65 59.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.816 -179.564 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.551 ' HG2' ' O ' ' A' ' 67' ' ' LYS . 16.0 pttt -76.16 -29.04 57.57 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.966 0.413 . . . . 0.0 111.108 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.18 -44.01 89.82 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.382 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 79.3 mtt-85 -87.57 -23.09 24.43 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.735 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.736 ' CB ' ' HB2' ' A' ' 76' ' ' LEU . 88.7 m-70 -143.28 92.57 6.67 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.972 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.465 ' O ' ' O ' ' A' ' 96' ' ' GLN . 23.0 Cg_exo -64.86 6.11 0.39 Allowed 'Trans proline' 0 CA--C 1.531 0.343 0 C-N-CA 122.657 2.238 . . . . 0.0 113.123 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.609 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -143.35 14.08 1.81 Allowed 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.666 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.736 ' HB2' ' CB ' ' A' ' 73' ' ' HIS . 0.8 OUTLIER -75.53 113.06 22.64 Favored Pre-proline 0 C--N 1.332 -0.188 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -179.512 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.861 ' HB2' ' HD1' ' A' ' 99' ' ' PHE . 37.9 Cg_endo -67.5 116.66 4.35 Favored 'Trans proline' 0 CA--C 1.533 0.458 0 C-N-CA 122.546 2.164 . . . . 0.0 112.423 179.316 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.461 ' C ' ' HB2' ' A' ' 99' ' ' PHE . 3.6 t -115.05 136.61 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 120.921 0.391 . . . . 0.0 111.719 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.788 HD11 ' CG2' ' A' ' 50' ' ' VAL . 2.3 mt -110.37 116.54 52.62 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.207 0 CA-C-O 121.143 0.497 . . . . 0.0 110.956 179.04 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.847 HD11 HD21 ' A' ' 66' ' ' LEU . 1.6 mp -98.77 134.26 38.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.385 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.964 ' HG3' HG22 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -73.61 -24.93 60.1 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -178.089 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.521 ' HB ' HG21 ' A' ' 55' ' ' ILE . 3.9 m -147.38 159.21 43.95 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.154 0.502 . . . . 0.0 112.327 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.911 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -138.03 68.58 1.4 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.61 179.115 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -68.2 -141.87 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.067 -179.609 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.2 p -80.44 79.23 7.07 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-O 120.927 0.394 . . . . 0.0 111.558 -179.23 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.624 ' HB3' HD13 ' A' ' 63' ' ' LEU . 2.1 t70 179.53 29.06 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.926 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.893 HD13 ' HB3' ' A' ' 90' ' ' ALA . 0.3 OUTLIER -54.15 -21.41 8.66 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.653 -179.966 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -47.25 -54.45 10.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.741 0.305 . . . . 0.0 111.59 -179.022 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.518 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -69.6 -22.3 63.51 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.145 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.893 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -75.11 -42.14 57.07 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.792 0.329 . . . . 0.0 110.34 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.691 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 19.5 t -62.56 -52.8 55.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.034 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.3 p -57.39 -33.55 67.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.62 0.724 . . . . 0.0 109.833 179.107 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.644 ' HA ' ' CD ' ' A' ' 96' ' ' GLN . . . -57.56 -39.95 77.84 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.482 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.691 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 18.8 m-85 -60.67 -21.12 62.49 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.237 179.569 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.65 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -74.01 -43.83 56.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.312 179.715 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.65 ' N ' ' HG2' ' A' ' 95' ' ' GLN . 3.8 pm0 -80.33 -12.4 59.6 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.48 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.525 ' O ' ' HA ' ' A' ' 77' ' ' PRO . . . 117.17 38.38 0.87 Allowed Glycine 0 C--O 1.228 -0.25 0 C-N-CA 119.972 -1.109 . . . . 0.0 114.045 178.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.544 ' HB2' ' HB1' ' A' ' 93' ' ' ALA . . . -63.04 146.36 53.4 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 117.319 0.559 . . . . 0.0 110.772 179.162 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.861 ' HD1' ' HB2' ' A' ' 77' ' ' PRO . 1.3 t80 -71.75 -54.35 10.51 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.167 179.405 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.539 ' HB3' ' O ' ' A' ' 99' ' ' PHE . 2.9 p30 166.79 -166.87 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.711 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.911 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 4.8 m-85 -143.21 145.95 33.24 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.38 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.67 HD23 ' O ' ' A' ' 105' ' ' PRO . 6.4 mp -102.26 119.76 55.45 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.625 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -58.53 -66.27 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.343 2.029 . . . . 0.0 112.593 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.727 ' H ' ' HD2' ' A' ' 105' ' ' PRO . 8.8 mtpp -124.5 -60.68 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.465 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.727 ' HD2' ' H ' ' A' ' 104' ' ' LYS . 16.7 Cg_endo -57.13 159.24 15.65 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.077 1.851 . . . . 0.0 112.422 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.62 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 29.1 t80 -170.62 -104.34 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.382 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.538 ' O ' ' O ' ' A' ' 106' ' ' PHE . 3.3 p30 42.85 -177.58 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.542 0.211 . . . . 0.0 110.833 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.749 HD11 HD23 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -67.93 -42.67 85.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.994 0.426 . . . . 0.0 111.681 -179.716 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.551 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 1.7 m-20 -49.03 -57.46 6.51 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.54 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.62 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 5.5 mm-40 -77.0 -32.28 57.09 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 121.047 -0.261 . . . . 0.0 111.699 -179.407 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.6 -62.59 1.38 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.077 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.713 ' O ' HG12 ' A' ' 115' ' ' VAL . 42.6 t -57.64 -30.37 36.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 121.31 0.576 . . . . 0.0 110.816 178.786 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.551 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -63.94 -47.04 82.06 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.412 0.625 . . . . 0.0 110.203 179.142 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.571 HD23 HG21 ' A' ' 79' ' ' ILE . 4.8 tp -72.63 -22.38 60.95 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.487 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.778 HG23 HG21 ' A' ' 50' ' ' VAL . 9.9 p -79.56 -49.57 19.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 120.437 -0.505 . . . . 0.0 111.843 -179.514 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.493 ' N ' HG13 ' A' ' 115' ' ' VAL . 7.5 mt-10 -65.47 -54.74 24.05 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.766 0.317 . . . . 0.0 111.092 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 27.7 mtp85 -57.21 -26.47 60.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.188 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.531 ' HB1' ' CZ ' ' A' ' 99' ' ' PHE . . . -73.3 -48.99 29.98 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.479 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.2 mt -63.52 -30.88 50.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.218 0.533 . . . . 0.0 110.469 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 46.4 t -73.13 -48.92 31.42 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.099 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 25.4 m80 . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.271 -179.881 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.44 ' CG ' ' H ' ' A' ' 4' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.132 0 CA-C-O 121.05 0.453 . . . . 0.0 111.285 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.59 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . 167.93 89.78 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.701 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 23.0 mm -117.74 112.76 40.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.768 0.318 . . . . 0.0 111.496 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.969 HG23 HG13 ' A' ' 50' ' ' VAL . 12.2 p -105.26 128.36 59.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.054 178.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.814 ' CD1' HG22 ' A' ' 31' ' ' THR . 24.9 m0 -116.89 129.9 56.36 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.119 0.485 . . . . 0.0 110.009 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.81 HG13 ' HB3' ' A' ' 52' ' ' LEU . 0.9 OUTLIER -121.72 149.43 24.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.341 -177.681 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.955 HG11 ' HA2' ' A' ' 36' ' ' GLY . 0.0 OUTLIER -125.31 113.41 35.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.555 178.973 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.444 ' OD2' ' OD2' ' A' ' 54' ' ' ASP . 2.3 t0 -164.78 -159.15 0.44 Allowed 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.14 -179.309 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -67.29 1.1 2.34 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -179.371 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.406 ' O ' ' N ' ' A' ' 14' ' ' SER . 14.7 t0 65.89 -158.33 0.27 Allowed 'General case' 0 CA--C 1.534 0.33 0 O-C-N 122.233 -0.292 . . . . 0.0 110.995 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.1 t 31.92 -89.84 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 179.589 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.866 ' O ' HG23 ' A' ' 18' ' ' VAL . 3.5 t -53.72 -56.14 20.01 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.656 0.265 . . . . 0.0 111.468 -179.504 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.5 mm -66.51 -25.0 34.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.923 0.392 . . . . 0.0 111.048 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.741 ' HA ' HG21 ' A' ' 32' ' ' THR . 3.2 tmm_? -77.99 -44.48 26.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.777 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.452 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 82.3 t90 -64.49 -39.79 94.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.67 -179.128 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.866 HG23 ' O ' ' A' ' 14' ' ' SER . 6.3 t -69.14 -43.12 81.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 112.748 0.648 . . . . 0.0 112.748 -179.024 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.665 HD23 HG21 ' A' ' 8' ' ' VAL . 1.5 tp -84.53 -22.62 30.09 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -178.42 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.634 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 17.6 pt-20 -67.71 -57.11 6.93 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.099 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.495 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 5.8 mmt180 -63.22 -49.91 72.32 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.597 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.41 -56.3 20.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.154 0.502 . . . . 0.0 111.147 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.778 ' HG ' HG11 ' A' ' 6' ' ' VAL . 2.0 tm? -66.01 -28.21 68.7 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.537 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.45 ' HB2' ' O ' ' A' ' 20' ' ' GLU . . . -67.26 -34.23 76.98 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.548 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.24 -26.73 66.43 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.379 -0.915 . . . . 0.0 111.366 178.481 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.621 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -76.84 -15.76 59.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.822 0.344 . . . . 0.0 110.919 179.392 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.25 25.5 10.21 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.797 -0.716 . . . . 0.0 113.596 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.621 ' CD1' ' HB3' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -130.74 171.67 12.84 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 117.762 0.781 . . . . 0.0 111.648 179.689 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.677 ' O ' HG12 ' A' ' 6' ' ' VAL . 32.1 m -94.35 130.71 40.55 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.175 -179.284 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.634 ' HB3' ' HA ' ' A' ' 20' ' ' GLU . 48.9 t -123.69 115.65 21.78 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 121.272 0.558 . . . . 0.0 111.83 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.814 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.9 t -117.44 156.5 27.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.597 178.808 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.741 HG21 ' HA ' ' A' ' 16' ' ' ARG . 55.5 p -132.53 151.41 51.93 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.142 0.496 . . . . 0.0 112.054 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.899 ' HB2' HG13 ' A' ' 9' ' ' VAL . 2.0 m-85 -125.46 174.42 8.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.228 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.655 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -61.66 -107.63 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.652 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.464 ' H ' ' CD ' ' A' ' 34' ' ' GLU . 0.6 OUTLIER -80.35 -69.84 0.57 Allowed 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.029 0.442 . . . . 0.0 112.038 -178.545 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.955 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . -167.42 -36.56 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.484 -0.865 . . . . 0.0 113.543 -179.155 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 54.4 m-20 -61.91 -30.0 70.59 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 116.999 0.399 . . . . 0.0 110.594 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.844 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -53.64 -56.86 13.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.624 179.225 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.825 HG21 HG22 ' A' ' 9' ' ' VAL . 2.9 t -51.75 -46.74 39.51 Favored 'Isoleucine or valine' 0 C--N 1.342 0.254 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.44 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.689 HD13 ' CB ' ' A' ' 68' ' ' GLN . 23.6 mt -55.23 -42.87 73.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.008 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.47 -49.65 72.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.159 0.504 . . . . 0.0 111.231 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.44 -26.4 63.63 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.05 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.846 HD13 ' NE2' ' A' ' 73' ' ' HIS . 6.5 mt -63.99 -21.3 66.43 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.445 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.72 -16.83 29.98 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.111 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.5 m -121.58 1.25 10.04 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.478 ' O ' HD23 ' A' ' 43' ' ' LEU . 0.7 OUTLIER -165.9 159.74 16.15 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.888 0.375 . . . . 0.0 111.367 179.764 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.642 HG23 HD12 ' A' ' 76' ' ' LEU . 90.8 m -138.58 111.84 8.34 Favored Pre-proline 0 N--CA 1.45 -0.441 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.422 179.555 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.713 ' HD2' HD11 ' A' ' 76' ' ' LEU . 51.8 Cg_endo -67.94 154.12 73.62 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.688 2.258 . . . . 0.0 111.891 179.041 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -74.66 -26.07 59.62 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.466 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.969 HG13 HG23 ' A' ' 6' ' ' VAL . 7.2 p -146.28 101.66 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.229 -178.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.69 HD12 ' O ' ' A' ' 7' ' ' TRP . 19.5 tp -86.85 137.11 32.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.985 0.421 . . . . 0.0 111.427 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.81 ' HB3' HG13 ' A' ' 8' ' ' VAL . 1.9 tt -126.85 127.55 45.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.145 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.517 ' N ' HD23 ' A' ' 52' ' ' LEU . 0.5 OUTLIER -126.22 129.21 48.51 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.343 0.592 . . . . 0.0 111.474 179.96 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.444 ' OD2' ' OD2' ' A' ' 10' ' ' ASP . 0.5 OUTLIER -79.02 -0.24 30.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.324 -179.212 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.705 HG13 ' HA3' ' A' ' 62' ' ' GLY . 11.9 tt 36.82 94.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-O 120.89 0.376 . . . . 0.0 111.579 -179.605 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.8 mtt180 -118.84 40.51 3.25 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.775 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.595 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER 59.59 46.19 1.33 Allowed Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 179.239 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.467 ' CG ' ' HA2' ' A' ' 62' ' ' GLY . 27.5 Cg_endo -61.9 -79.76 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.162 1.908 . . . . 0.0 111.23 178.735 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -106.35 -82.68 1.55 Allowed Glycine 0 C--N 1.332 0.343 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 178.374 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.82 ' HB3' ' HB2' ' A' ' 64' ' ' ALA . 17.0 tpp -87.57 59.36 5.42 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 177.18 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.595 ' HA ' ' HA ' ' A' ' 57' ' ' MET . 0.1 OUTLIER 63.54 -16.05 0.07 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.021 -0.99 . . . . 0.0 111.851 -178.656 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.705 ' HA3' HG13 ' A' ' 55' ' ' ILE . . . 135.98 -30.95 2.69 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 -178.568 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.803 HD11 ' HB2' ' A' ' 90' ' ' ALA . 1.9 tp -56.33 -30.17 62.26 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 178.117 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.82 ' HB2' ' HB3' ' A' ' 60' ' ' MET . . . -53.69 -38.32 64.1 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.213 178.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.638 ' O ' HG13 ' A' ' 69' ' ' ILE . 1.7 tp -51.41 -50.04 60.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.368 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 1.035 ' HA ' HD12 ' A' ' 69' ' ' ILE . 81.3 mt -52.8 -42.87 65.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.141 179.464 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 31.3 mttm -58.47 -46.88 85.72 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.4 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.689 ' CB ' HD13 ' A' ' 40' ' ' LEU . 16.7 mm100 -65.0 -31.68 73.03 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.778 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 1.035 HD12 ' HA ' ' A' ' 66' ' ' LEU . 88.7 mt -60.06 -45.72 95.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.728 -179.373 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.455 ' HG3' ' N ' ' A' ' 71' ' ' GLN . 0.4 OUTLIER -68.94 -29.5 67.75 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.536 -179.864 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.455 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 7.6 mt-30 -83.98 -33.21 24.63 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.565 -179.251 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.472 ' HB2' ' CD2' ' A' ' 73' ' ' HIS . 3.2 mtp85 -90.5 -65.26 1.03 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.18 -178.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.948 ' CE1' HG23 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -96.31 159.62 31.58 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.394 -178.956 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -96.44 101.2 0.09 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 123.489 2.793 . . . . 0.0 113.619 -179.349 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 6.8 mtt 57.04 24.2 9.29 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 177.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.713 HD11 ' HD2' ' A' ' 48' ' ' PRO . 2.2 tt -60.22 112.31 5.29 Favored Pre-proline 0 C--N 1.325 -0.487 0 C-N-CA 120.934 -0.307 . . . . 0.0 111.327 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.61 116.0 2.99 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.432 2.088 . . . . 0.0 112.153 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.989 HG21 HD13 ' A' ' 69' ' ' ILE . 19.0 t -115.06 145.14 21.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.985 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.631 ' CG2' HD23 ' A' ' 114' ' ' LEU . 1.8 mp -118.79 110.99 31.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.982 0.42 . . . . 0.0 111.031 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.55 ' HB ' ' CZ ' ' A' ' 101' ' ' TYR . 21.6 mm -103.3 146.72 10.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.578 -179.575 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.445 ' O ' ' HB2' ' A' ' 102' ' ' LEU . 7.2 ttt -69.06 -78.61 0.07 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.967 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.601 ' O ' HD13 ' A' ' 55' ' ' ILE . 4.0 m -106.62 159.08 16.47 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.118 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.487 ' HA ' ' CE2' ' A' ' 101' ' ' TYR . . . -87.52 -17.59 31.72 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.895 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.471 ' H ' HG22 ' A' ' 82' ' ' THR . 23.5 m170 48.33 -89.63 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.409 ' N ' ' O ' ' A' ' 83' ' ' ALA . 4.7 m -81.83 -169.97 2.61 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.834 0.35 . . . . 0.0 111.087 -179.492 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.524 ' O ' HD21 ' A' ' 63' ' ' LEU . 24.7 m-20 -40.86 108.62 0.09 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.166 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.76 HD23 ' HB3' ' A' ' 90' ' ' ALA . 1.3 mt -48.15 -20.99 0.41 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.398 178.761 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -47.74 -43.58 27.24 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -178.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.617 ' HB3' ' HG ' ' A' ' 63' ' ' LEU . . . -74.1 -21.33 59.94 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 120.243 -0.583 . . . . 0.0 109.912 179.506 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.803 ' HB2' HD11 ' A' ' 63' ' ' LEU . . . -77.55 -58.91 3.01 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.615 178.239 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.757 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 18.3 t -58.25 -56.75 14.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.561 -179.486 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 57.6 p -52.79 -27.58 18.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.069 0.462 . . . . 0.0 110.696 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.656 ' CB ' HD13 ' A' ' 66' ' ' LEU . . . -58.36 -46.08 86.97 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.003 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.757 ' CE2' ' HA ' ' A' ' 91' ' ' VAL . 5.5 m-85 -48.68 -27.95 3.22 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.767 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.622 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -76.91 -39.61 50.27 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.704 -179.903 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.622 ' N ' ' HG2' ' A' ' 95' ' ' GLN . 7.7 pt20 -100.14 5.33 44.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.979 -178.4 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 127.98 79.25 0.26 Allowed Glycine 0 CA--C 1.519 0.323 0 C-N-CA 120.101 -1.047 . . . . 0.0 113.178 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.964 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -171.62 127.04 0.63 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.008 0.432 . . . . 0.0 110.477 179.142 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.568 ' CE2' ' HB2' ' A' ' 118' ' ' ALA . 13.6 t80 -70.14 -53.73 16.0 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -178.501 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.702 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 0.1 OUTLIER 179.04 -170.48 0.12 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.011 0.434 . . . . 0.0 111.729 -179.291 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.638 ' CE1' HD11 ' A' ' 66' ' ' LEU . 3.0 m-85 -135.01 153.6 52.02 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.476 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.78 HD11 HD22 ' A' ' 114' ' ' LEU . 7.4 mp -102.19 123.76 42.21 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-O 120.768 0.318 . . . . 0.0 111.09 -179.549 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -69.71 -56.62 0.14 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.434 2.089 . . . . 0.0 112.475 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.681 ' HB3' ' HD3' ' A' ' 105' ' ' PRO . 1.8 ttmp? -133.52 -56.14 0.02 OUTLIER Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.474 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.681 ' HD3' ' HB3' ' A' ' 104' ' ' LYS . 45.1 Cg_exo -57.52 160.03 15.12 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 121.765 1.644 . . . . 0.0 111.758 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.645 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 62.9 t80 -165.85 -105.52 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.186 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.6 ' O ' ' O ' ' A' ' 106' ' ' PHE . 3.1 p30 41.65 178.63 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.959 0.409 . . . . 0.0 111.321 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.665 HD11 HD13 ' A' ' 19' ' ' LEU . 0.9 OUTLIER -67.89 -41.04 84.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.124 179.659 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.477 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 33.7 t0 -49.18 -58.54 4.83 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.602 -179.402 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.645 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 10.3 mm-40 -76.33 -32.6 58.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.711 0.291 . . . . 0.0 111.402 -179.61 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.85 -60.07 3.23 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.815 0.34 . . . . 0.0 110.407 179.688 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.65 ' HA ' HG12 ' A' ' 115' ' ' VAL . 47.1 t -59.63 -30.79 45.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.576 0.703 . . . . 0.0 110.468 178.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.477 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -63.66 -45.51 89.83 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.011 178.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.78 HD22 HD11 ' A' ' 102' ' ' LEU . 34.1 tp -77.35 -22.7 51.42 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.604 -179.344 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.65 HG12 ' HA ' ' A' ' 112' ' ' VAL . 5.3 p -79.39 -40.98 22.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 120.467 -0.493 . . . . 0.0 111.412 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -67.19 -48.59 67.47 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.963 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.454 ' NH2' ' HB1' ' A' ' 113' ' ' ALA . 0.9 OUTLIER -58.93 -23.28 61.19 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.808 179.948 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.568 ' HB2' ' CE2' ' A' ' 99' ' ' PHE . . . -72.43 -44.39 62.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.169 179.456 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.653 HD11 HG11 ' A' ' 50' ' ' VAL . 4.8 mt -72.18 -32.05 41.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.283 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 2.3 t -71.9 -47.2 54.33 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.805 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 . . . . . 0 C--N 1.327 -0.393 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.08 179.875 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.522 ' HD2' HD11 ' A' ' 5' ' ' ILE . 15.2 ptt180 . . . . . 0 CA--C 1.52 -0.2 0 CA-C-O 121.224 0.535 . . . . 0.0 110.691 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.701 ' O ' HD13 ' A' ' 5' ' ' ILE . . . 101.45 112.79 3.59 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.836 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.701 HD13 ' O ' ' A' ' 4' ' ' GLY . 8.7 mm -124.97 112.89 33.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.809 0.338 . . . . 0.0 111.576 -178.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.859 HG23 HG13 ' A' ' 50' ' ' VAL . 8.0 p -106.47 125.52 62.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.17 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.875 ' CD1' HG22 ' A' ' 31' ' ' THR . 29.1 m0 -117.13 123.46 46.81 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.502 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.897 HG11 HD13 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -116.97 137.83 49.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.329 -177.237 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.845 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -121.25 104.98 15.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.967 178.695 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.806 ' HB3' HG21 ' A' ' 15' ' ' ILE . 3.7 t70 -168.1 72.49 0.1 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.984 0.421 . . . . 0.0 111.87 -179.53 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 63.95 2.59 1.42 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 179.015 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.7 p30 44.83 -149.63 0.07 Allowed 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.436 ' O ' ' HB3' ' A' ' 16' ' ' ARG . 1.4 t 34.85 -92.17 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 179.56 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.694 ' O ' HG23 ' A' ' 18' ' ' VAL . 2.9 t -53.81 -66.06 0.46 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.776 0.322 . . . . 0.0 110.56 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.806 HG21 ' HB3' ' A' ' 10' ' ' ASP . 35.0 mm -60.98 -20.51 22.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.924 179.349 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.95 ' HA ' HG21 ' A' ' 32' ' ' THR . 2.0 ttt180 -69.86 -58.03 4.36 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.255 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.492 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 36.8 t90 -59.43 -41.24 89.11 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.048 -0.523 . . . . 0.0 112.273 -179.117 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.896 HG12 HG12 ' A' ' 108' ' ' ILE . 2.7 t -67.14 -42.19 87.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -178.729 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.897 HD13 HG11 ' A' ' 8' ' ' VAL . 24.0 mt -84.13 -26.85 28.58 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -178.407 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.555 ' HG3' ' N ' ' A' ' 21' ' ' ARG . 21.2 pt-20 -67.5 -58.71 4.25 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.036 0.446 . . . . 0.0 112.029 -178.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.555 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 0.9 OUTLIER -50.71 -53.53 30.59 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.168 -179.154 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.01 -50.25 67.04 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -179.338 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.834 ' HG ' HG11 ' A' ' 6' ' ' VAL . 3.0 tm? -70.09 -30.62 67.89 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.421 0.629 . . . . 0.0 110.336 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.77 -32.53 73.88 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.472 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.64 -27.94 70.64 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 110.701 -0.959 . . . . 0.0 110.701 177.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.606 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -76.66 -15.75 59.73 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 120.625 0.25 . . . . 0.0 110.5 179.13 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.51 26.33 12.19 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.533 -0.842 . . . . 0.0 114.271 178.414 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.703 ' HB2' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -125.41 165.78 17.78 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 118.257 1.028 . . . . 0.0 112.3 179.729 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.727 ' O ' HG12 ' A' ' 6' ' ' VAL . 91.8 m -75.06 125.95 30.01 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.783 -179.599 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.443 ' HA ' HG13 ' A' ' 6' ' ' VAL . 4.2 p -125.77 110.4 13.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.697 -179.447 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.875 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.6 t -125.46 149.71 47.98 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.826 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.95 HG21 ' HA ' ' A' ' 16' ' ' ARG . 53.1 p -126.95 161.36 28.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.529 0.68 . . . . 0.0 112.734 -179.254 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.845 ' HB2' HG13 ' A' ' 9' ' ' VAL . 0.7 OUTLIER -135.23 173.37 11.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.595 -179.714 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.61 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -59.3 -103.11 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.885 -178.234 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.498 ' OD1' ' HD3' ' A' ' 58' ' ' PRO . 0.2 OUTLIER -88.93 -71.44 0.6 Allowed 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.103 0.478 . . . . 0.0 111.814 -179.076 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.772 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . -163.45 -34.74 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.638 -0.71 . . . . 0.0 113.069 -178.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.418 ' HA ' ' CD1' ' A' ' 40' ' ' LEU . 80.0 m-20 -58.43 -32.51 68.76 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 121.223 0.535 . . . . 0.0 110.11 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.753 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -54.67 -61.79 2.08 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.24 179.542 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.831 HG11 HD11 ' A' ' 51' ' ' LEU . 4.4 t -50.05 -32.51 8.56 Favored 'Isoleucine or valine' 0 C--N 1.342 0.282 0 C-N-CA 120.329 -0.549 . . . . 0.0 110.926 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.533 HD13 ' HB3' ' A' ' 68' ' ' GLN . 22.6 mt -58.49 -44.73 89.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.839 0.352 . . . . 0.0 110.56 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.33 -49.39 77.79 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.228 0.537 . . . . 0.0 110.348 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.69 -31.79 72.0 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.156 178.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.608 HD22 ' CD2' ' A' ' 73' ' ' HIS . 10.2 mt -63.65 -25.82 68.39 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.706 179.298 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.527 ' HA ' ' HD3' ' A' ' 72' ' ' ARG . . . -59.34 -24.25 63.19 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.155 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -128.61 9.35 5.97 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.643 ' HG2' ' CH2' ' A' ' 7' ' ' TRP . 25.2 tptt -146.02 162.46 37.81 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 121.365 0.602 . . . . 0.0 111.878 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.515 HG23 HD23 ' A' ' 76' ' ' LEU . 95.2 m -138.92 110.47 7.89 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.072 177.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.912 ' HG2' HD11 ' A' ' 76' ' ' LEU . 87.2 Cg_endo -80.65 148.38 17.94 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 122.433 2.089 . . . . 0.0 111.735 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -74.46 -30.79 62.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.946 0.403 . . . . 0.0 110.966 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.859 HG13 HG23 ' A' ' 6' ' ' VAL . 6.7 p -149.84 94.12 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.554 -179.615 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.831 HD11 HG11 ' A' ' 39' ' ' VAL . 27.0 tp -86.79 141.02 29.14 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.627 -179.218 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.868 ' HG ' ' HB ' ' A' ' 79' ' ' ILE . 0.2 OUTLIER -122.01 114.77 21.41 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.193 179.951 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.651 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -107.71 143.58 36.02 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.405 0.621 . . . . 0.0 112.086 -179.599 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 30.2 p30 -83.06 -177.66 6.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.02 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.795 HG22 ' HG3' ' A' ' 81' ' ' MET . 3.5 tt -159.13 160.85 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.885 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.466 ' H ' HG13 ' A' ' 55' ' ' ILE . 0.1 OUTLIER 78.01 51.95 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.007 0.432 . . . . 0.0 110.499 -179.207 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.493 ' CB ' ' CD ' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -163.39 -65.24 0.01 OUTLIER Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.95 179.892 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.795 ' HG3' HD21 ' A' ' 65' ' ' LEU . 37.6 Cg_endo -65.44 -163.46 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.115 2.544 . . . . 0.0 112.933 -179.547 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -52.81 -89.89 0.01 OUTLIER Glycine 0 C--N 1.332 0.315 0 CA-C-N 115.974 -0.557 . . . . 0.0 113.0 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.913 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 2.6 tpp -72.52 57.38 0.39 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.774 0.321 . . . . 0.0 110.77 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.585 ' O ' ' HD2' ' A' ' 58' ' ' PRO . 0.1 OUTLIER 59.67 -74.34 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.067 179.948 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 60' ' ' MET . . . -152.65 -30.1 0.04 OUTLIER Glycine 0 C--N 1.321 -0.264 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.502 -179.361 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.638 ' H ' HD12 ' A' ' 63' ' ' LEU . 0.3 OUTLIER -66.14 -22.17 66.37 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.742 0.306 . . . . 0.0 110.874 179.912 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.913 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -54.95 -30.21 58.41 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.349 0.595 . . . . 0.0 109.923 179.292 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.795 HD21 ' HG3' ' A' ' 58' ' ' PRO . 2.7 mm? -66.07 -45.29 81.83 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.998 179.309 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.871 HD21 HD11 ' A' ' 80' ' ' ILE . 10.2 mt -51.81 -44.22 63.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.509 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.455 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 2.8 ttmm -55.14 -44.54 75.17 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.474 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.533 ' HB3' HD13 ' A' ' 40' ' ' LEU . 51.0 mm-40 -70.6 -43.91 68.38 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.191 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.476 HD13 HD23 ' A' ' 51' ' ' LEU . 56.2 mt -60.68 -36.2 69.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 121.057 0.456 . . . . 0.0 111.431 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.549 ' HB3' ' CD ' ' A' ' 96' ' ' GLN . 16.2 pttp -73.07 -27.0 61.47 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.285 -179.364 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -65.08 -39.07 92.67 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.237 0.541 . . . . 0.0 110.663 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.527 ' HD3' ' HA ' ' A' ' 44' ' ' ALA . 15.4 mtt-85 -94.42 -24.76 17.21 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.21 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.608 ' CD2' HD22 ' A' ' 43' ' ' LEU . 83.1 m-70 -140.47 101.59 6.7 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.138 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.403 ' O ' ' HG3' ' A' ' 75' ' ' MET . 88.7 Cg_endo -77.03 11.48 2.02 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.596 2.198 . . . . 0.0 113.702 -179.478 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.693 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 5.9 mtt -147.64 12.95 1.03 Allowed 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.912 HD11 ' HG2' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -76.24 110.53 11.49 Favored Pre-proline 0 N--CA 1.462 0.164 0 CA-C-O 120.583 0.23 . . . . 0.0 111.576 179.881 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.402 ' HD3' ' O ' ' A' ' 75' ' ' MET . 35.4 Cg_exo -62.57 128.22 22.89 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.478 2.119 . . . . 0.0 111.906 179.319 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.57 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 4.3 t -125.1 152.66 31.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.059 0.456 . . . . 0.0 111.48 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.868 ' HB ' ' HG ' ' A' ' 52' ' ' LEU . 1.9 mt -134.17 112.09 15.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.483 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.871 HD11 HD21 ' A' ' 66' ' ' LEU . 16.6 mm -94.83 138.03 21.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.383 -179.408 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.795 ' HG3' HG22 ' A' ' 55' ' ' ILE . 0.2 OUTLIER -68.43 -31.41 70.72 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -178.936 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.667 ' O ' HD13 ' A' ' 55' ' ' ILE . 91.4 m -146.83 153.93 40.76 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.607 0.241 . . . . 0.0 110.713 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.712 ' HB1' ' CD2' ' A' ' 87' ' ' LEU . . . -106.23 -33.1 7.92 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -179.219 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 45.88 -166.64 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.727 0.298 . . . . 0.0 111.52 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -80.32 79.51 6.89 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.725 -179.066 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.561 ' HB3' HD13 ' A' ' 63' ' ' LEU . 0.1 OUTLIER -179.22 28.61 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.831 179.197 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.712 ' CD2' ' HB1' ' A' ' 83' ' ' ALA . 0.5 OUTLIER -49.23 -20.8 0.67 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 112.088 -179.985 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -47.68 -54.94 10.59 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 -179.103 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.481 ' HB3' ' HB2' ' A' ' 63' ' ' LEU . . . -70.68 -21.49 62.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.851 0.358 . . . . 0.0 111.247 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.697 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -69.69 -41.95 74.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.654 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.64 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 3.4 t -62.07 -46.24 96.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.898 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.47 ' O ' ' HB3' ' A' ' 95' ' ' GLN . 38.5 m -65.14 -21.96 66.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.039 0.447 . . . . 0.0 109.834 179.048 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.796 ' HB2' HD13 ' A' ' 66' ' ' LEU . . . -66.0 -39.33 90.2 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.296 0.57 . . . . 0.0 109.687 179.049 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.64 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 8.9 m-85 -69.89 -22.7 63.21 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.639 178.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.47 ' HB3' ' O ' ' A' ' 92' ' ' SER . 1.9 tm0? -69.39 -44.31 71.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.906 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.693 ' O ' ' HA ' ' A' ' 75' ' ' MET . 2.3 pt20 -75.68 -17.95 59.79 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.668 179.12 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 125.24 16.87 2.8 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.368 -0.92 . . . . 0.0 113.939 178.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.57 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -55.47 151.23 10.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 117.413 0.607 . . . . 0.0 110.79 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.553 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 14.3 t80 -77.07 -53.55 7.66 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.269 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 169.92 -166.0 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.0 0.428 . . . . 0.0 111.656 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.663 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 3.4 m-85 -133.4 153.35 51.68 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.086 -179.539 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.581 ' CD1' HD22 ' A' ' 114' ' ' LEU . 1.0 OUTLIER -103.42 118.64 57.19 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.887 179.943 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -73.7 -72.94 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.089 1.859 . . . . 0.0 112.444 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.474 ' CB ' ' HD3' ' A' ' 105' ' ' PRO . 2.2 tttt -111.38 -57.98 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.663 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.474 ' HD3' ' CB ' ' A' ' 104' ' ' LYS . 51.8 Cg_exo -54.45 153.35 23.18 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.165 1.91 . . . . 0.0 112.524 -179.669 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.653 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 41.1 t80 -163.54 -113.15 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.431 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.573 ' O ' ' O ' ' A' ' 106' ' ' PHE . 3.1 p30 42.6 178.3 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 118.122 0.419 . . . . 0.0 111.591 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.896 HG12 HG12 ' A' ' 18' ' ' VAL . 0.8 OUTLIER -67.78 -43.1 86.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.113 0.482 . . . . 0.0 111.272 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.501 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 0.4 OUTLIER -49.04 -58.11 5.46 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.594 -179.548 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.653 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 36.5 mm-40 -76.98 -33.29 57.64 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.757 0.313 . . . . 0.0 111.371 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.428 ' CB ' ' O ' ' A' ' 107' ' ' ASP . . . -64.41 -59.13 4.72 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.116 179.461 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.688 ' O ' HG12 ' A' ' 115' ' ' VAL . 48.3 t -60.74 -32.0 50.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.514 179.108 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.501 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -62.51 -46.08 90.07 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.09 179.292 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.581 HD22 ' CD1' ' A' ' 102' ' ' LEU . 20.6 tp -76.09 -21.12 57.06 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.835 -1.075 . . . . 0.0 111.907 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.688 HG12 ' O ' ' A' ' 112' ' ' VAL . 3.7 p -78.92 -37.98 20.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.477 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.602 ' HA ' HD12 ' A' ' 119' ' ' ILE . 35.7 mt-10 -68.67 -38.73 80.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.966 0.413 . . . . 0.0 110.735 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.1 mmm180 -63.54 -27.52 69.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.091 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.553 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -69.42 -44.57 71.08 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.064 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.602 HD12 ' HA ' ' A' ' 116' ' ' GLU . 6.5 mt -62.81 -31.95 54.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.16 0.505 . . . . 0.0 110.699 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 9.1 t -75.13 -49.54 19.25 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.868 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 18.1 m80 . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.137 179.855 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.729 ' HB3' HD11 ' A' ' 5' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.272 0 CA-C-O 120.721 0.296 . . . . 0.0 111.594 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.515 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . 56.7 79.9 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.653 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.729 HD11 ' HB3' ' A' ' 3' ' ' ARG . 3.1 mp -116.71 112.18 38.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.697 0.285 . . . . 0.0 110.654 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.857 HG11 HD13 ' A' ' 23' ' ' LEU . 6.5 p -108.79 129.35 63.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.826 0.346 . . . . 0.0 110.929 179.242 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.859 ' CD1' HG22 ' A' ' 31' ' ' THR . 33.5 m0 -116.27 139.27 50.56 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.391 179.687 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.726 HG13 ' HB3' ' A' ' 52' ' ' LEU . 0.4 OUTLIER -122.59 146.96 27.02 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.303 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.51 -178.352 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.928 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -129.12 109.33 18.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 120.92 0.391 . . . . 0.0 110.973 179.368 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.439 ' OD1' ' HB3' ' A' ' 54' ' ' ASP . 6.5 t0 -162.16 -158.19 0.51 Allowed 'General case' 0 CA--C 1.53 0.212 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.693 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -66.37 -2.73 4.81 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -179.248 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.6 t0 66.87 -144.31 0.15 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 121.296 -0.162 . . . . 0.0 110.628 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.465 ' OG ' ' N ' ' A' ' 14' ' ' SER . 53.1 p 33.48 -101.83 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 179.262 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.784 ' O ' HG23 ' A' ' 18' ' ' VAL . 1.5 m -54.4 -49.5 69.77 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.675 0.274 . . . . 0.0 111.312 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.9 mm -62.97 -24.6 36.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.929 0.395 . . . . 0.0 111.11 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.867 ' HA ' HG21 ' A' ' 32' ' ' THR . 25.2 ttt180 -74.71 -55.09 6.23 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.022 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.452 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 14.6 t90 -56.3 -42.46 77.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.881 -0.6 . . . . 0.0 112.444 -178.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.784 HG23 ' O ' ' A' ' 14' ' ' SER . 5.3 t -66.53 -45.3 89.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -178.728 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.645 HD13 HD11 ' A' ' 108' ' ' ILE . 1.2 mp -83.77 -25.24 30.65 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -178.371 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.541 ' HG3' ' N ' ' A' ' 21' ' ' ARG . 14.8 pt-20 -66.58 -58.87 4.29 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.422 -0.511 . . . . 0.0 111.546 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.541 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -65.76 -51.23 60.88 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.121 -179.073 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.25 -45.27 80.1 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -178.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.857 HD13 HG11 ' A' ' 6' ' ' VAL . 0.4 OUTLIER -74.88 -25.25 58.82 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.95 0.405 . . . . 0.0 110.63 179.688 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.87 -34.22 75.08 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 177.762 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.69 -23.49 68.98 Favored Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 178.019 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.462 ' HB3' HD12 ' A' ' 28' ' ' LEU . . . -77.67 -15.73 58.98 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 120.805 0.336 . . . . 0.0 110.6 179.115 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.52 25.08 11.22 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.832 -0.699 . . . . 0.0 113.982 178.835 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.843 HD13 ' CD2' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -132.07 165.18 24.59 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 117.811 0.805 . . . . 0.0 112.562 179.694 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 29.5 m -87.67 108.86 19.29 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.004 -179.269 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.622 ' HA ' HG13 ' A' ' 6' ' ' VAL . 42.2 t -106.63 111.71 24.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.031 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.859 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.4 t -118.04 154.99 31.11 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.04 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.867 HG21 ' HA ' ' A' ' 16' ' ' ARG . 38.5 p -124.37 164.51 19.51 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.123 0.487 . . . . 0.0 111.879 -179.129 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.928 ' HB2' HG13 ' A' ' 9' ' ' VAL . 2.3 m-85 -130.19 172.31 11.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.592 -178.236 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.68 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 3.0 pp20? -63.53 -44.87 92.98 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -177.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.458 ' C ' HG12 ' A' ' 9' ' ' VAL . 16.3 t-20 -160.78 -58.2 0.05 Allowed 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -179.158 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.73 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . -164.99 -43.47 0.02 OUTLIER Glycine 0 C--N 1.319 -0.382 0 C-N-CA 120.371 -0.919 . . . . 0.0 113.431 -179.319 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.538 ' HA ' HD12 ' A' ' 40' ' ' LEU . 39.0 m-80 -67.4 -26.87 66.65 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -178.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.732 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 12.2 tt0 -58.92 -50.51 73.77 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.744 -0.382 . . . . 0.0 111.411 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.766 HG22 ' CG ' ' A' ' 33' ' ' PHE . 10.1 t -61.15 -35.46 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 C-N-CA 120.122 -0.631 . . . . 0.0 111.236 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.622 HD13 ' HB3' ' A' ' 68' ' ' GLN . 31.0 mt -56.94 -41.11 77.66 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.027 0.442 . . . . 0.0 110.728 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -77.53 -47.53 19.29 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.025 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.425 ' HB3' ' HE2' ' A' ' 33' ' ' PHE . . . -61.71 -36.38 80.77 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.069 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.6 HD21 ' HD2' ' A' ' 48' ' ' PRO . 16.0 mt -63.34 -22.98 67.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.031 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.17 -19.61 14.29 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.677 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -124.21 2.59 8.54 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.538 ' O ' HD23 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -162.41 155.26 19.78 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.801 0.334 . . . . 0.0 110.862 179.965 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.615 HG23 ' CD2' ' A' ' 76' ' ' LEU . 98.6 m -138.97 112.84 8.23 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.573 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.6 ' HD2' HD21 ' A' ' 43' ' ' LEU . 72.4 Cg_endo -79.1 161.82 26.26 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.085 1.857 . . . . 0.0 111.436 178.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -73.98 -22.57 59.57 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.701 0.286 . . . . 0.0 111.294 -179.552 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.81 HG13 HG23 ' A' ' 6' ' ' VAL . 7.1 p -144.97 161.34 13.7 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.231 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.622 HD12 ' O ' ' A' ' 7' ' ' TRP . 22.6 tp -152.87 133.19 13.59 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.164 0.507 . . . . 0.0 111.913 -178.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.726 ' HB3' HG13 ' A' ' 8' ' ' VAL . 0.5 OUTLIER -111.86 115.54 29.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.265 179.983 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.58 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 2.1 m -110.98 138.57 47.22 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.124 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.439 ' HB3' ' OD1' ' A' ' 10' ' ' ASP . 15.4 p-10 -83.03 179.68 7.69 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.781 179.196 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.678 HG13 ' O ' ' A' ' 61' ' ' ASP . 1.0 OUTLIER -154.06 96.85 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.153 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -138.96 40.17 2.14 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.797 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.471 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER 67.52 47.29 0.41 Allowed Pre-proline 0 CA--C 1.533 0.304 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 179.018 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.507 ' HD2' ' N ' ' A' ' 62' ' ' GLY . 37.5 Cg_endo -69.27 -76.45 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.309 2.006 . . . . 0.0 111.86 178.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -112.39 -25.25 4.74 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 121.069 -0.586 . . . . 0.0 111.928 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.9 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 1.0 OUTLIER -159.62 68.02 0.4 Allowed 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.261 0.553 . . . . 0.0 109.991 179.517 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.678 ' O ' HG13 ' A' ' 55' ' ' ILE . 0.1 OUTLIER 69.9 -29.21 0.18 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.862 -179.719 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.507 ' N ' ' HD2' ' A' ' 58' ' ' PRO . . . 142.58 -29.25 2.14 Favored Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.692 ' H ' HD12 ' A' ' 63' ' ' LEU . 1.1 mp -70.24 -19.17 63.15 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 178.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.9 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -53.59 -32.18 49.93 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.532 179.068 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.635 HD11 ' HA2' ' A' ' 36' ' ' GLY . 1.1 tt -57.79 -46.14 85.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.315 179.414 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.804 HD21 HD11 ' A' ' 80' ' ' ILE . 6.5 mt -57.82 -44.68 86.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.948 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.411 ' O ' ' CG ' ' A' ' 70' ' ' LYS . 20.8 ttmt -52.76 -53.23 51.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.371 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.622 ' HB3' HD13 ' A' ' 40' ' ' LEU . 26.7 mm100 -59.64 -34.6 73.01 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.923 0.392 . . . . 0.0 111.483 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.587 HD12 ' HA ' ' A' ' 66' ' ' LEU . 86.5 mt -61.57 -33.36 56.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.773 -178.853 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.548 ' HB3' ' CB ' ' A' ' 96' ' ' GLN . 0.2 OUTLIER -78.01 -29.44 49.55 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.999 0.428 . . . . 0.0 111.718 179.932 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.431 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 3.9 mt-30 -65.63 -48.23 72.91 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.152 -178.825 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.3 mtp85 -93.38 -55.94 3.11 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.97 -178.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.565 ' CE1' ' CD1' ' A' ' 43' ' ' LEU . 0.5 OUTLIER -84.25 152.82 62.04 Favored Pre-proline 0 C--N 1.319 -0.76 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.543 -178.852 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -69.85 -76.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.618 2.212 . . . . 0.0 112.882 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.664 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 6.6 mtm -138.71 53.49 1.77 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.185 0.517 . . . . 0.0 111.338 -179.691 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.615 ' CD2' HG23 ' A' ' 47' ' ' THR . 0.2 OUTLIER -63.7 112.23 6.84 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.081 179.576 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.574 ' HG2' ' HA ' ' A' ' 50' ' ' VAL . 17.3 Cg_endo -57.19 122.73 12.32 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.188 1.925 . . . . 0.0 111.377 179.22 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.5 HG21 HD13 ' A' ' 69' ' ' ILE . 3.9 t -119.54 152.03 22.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.167 0.508 . . . . 0.0 111.894 -178.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.653 ' O ' HD23 ' A' ' 52' ' ' LEU . 3.3 mt -131.6 113.74 23.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.363 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.804 HD11 HD21 ' A' ' 66' ' ' LEU . 2.4 mp -96.26 132.48 40.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.952 0.406 . . . . 0.0 110.829 -179.548 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.518 ' HB2' ' CE1' ' A' ' 106' ' ' PHE . 3.7 ptp -70.2 -24.65 63.15 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -177.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.43 ' H ' HG21 ' A' ' 55' ' ' ILE . 12.0 m -146.96 160.16 42.69 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.974 0.416 . . . . 0.0 111.753 -179.248 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.827 ' HB1' HD21 ' A' ' 87' ' ' LEU . . . -142.32 57.84 1.46 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.56 -179.643 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -75.34 -95.73 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.364 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 6.9 t -89.87 173.01 8.47 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-O 121.109 0.48 . . . . 0.0 111.914 -179.384 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.42 ' CB ' HD13 ' A' ' 63' ' ' LEU . 8.0 m-20 58.01 17.77 4.64 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.653 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.827 HD21 ' HB1' ' A' ' 83' ' ' ALA . 1.9 mt -48.8 -24.12 1.31 Allowed 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -48.01 -45.64 32.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.8 0.333 . . . . 0.0 111.062 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.547 ' HB3' ' HB2' ' A' ' 63' ' ' LEU . . . -65.99 -20.27 66.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.426 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.608 ' HB2' HD23 ' A' ' 63' ' ' LEU . . . -63.25 -44.86 93.97 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.845 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.566 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 5.6 t -59.41 -46.24 92.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.307 -179.578 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 98.4 p -62.87 -20.09 64.78 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.232 179.154 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.685 ' HB1' HD22 ' A' ' 66' ' ' LEU . . . -65.05 -44.49 88.85 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 121.147 0.499 . . . . 0.0 110.367 179.461 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.566 ' CE2' ' HA ' ' A' ' 91' ' ' VAL . 8.5 m-85 -61.82 -25.13 67.32 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.696 178.671 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -76.55 -38.81 54.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.324 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.674 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 1.6 pp0? -78.85 -18.22 54.36 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.42 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 125.92 1.92 7.37 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 120.444 -0.884 . . . . 0.0 113.663 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.603 ' CB ' ' HB1' ' A' ' 93' ' ' ALA . . . -53.43 151.59 5.48 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 117.419 0.61 . . . . 0.0 110.699 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.575 ' CE2' ' HB2' ' A' ' 118' ' ' ALA . 11.4 t80 -79.63 -53.9 6.4 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 121.018 -0.273 . . . . 0.0 111.303 -179.601 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 175.04 -166.95 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.036 0.446 . . . . 0.0 111.594 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.818 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 3.0 m-85 -133.95 153.53 51.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.034 -178.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.614 ' CD1' HD22 ' A' ' 114' ' ' LEU . 1.8 mp -103.62 118.83 56.54 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.197 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 102' ' ' LEU . 8.0 Cg_exo -70.63 -68.43 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.436 2.091 . . . . 0.0 111.97 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.731 ' H ' ' HD2' ' A' ' 105' ' ' PRO . 0.5 OUTLIER -117.92 -59.24 0.03 OUTLIER Pre-proline 0 CA--C 1.531 0.239 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -179.858 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.731 ' HD2' ' H ' ' A' ' 104' ' ' LYS . 13.0 Cg_endo -55.42 157.57 14.5 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.113 1.875 . . . . 0.0 112.44 -179.615 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.571 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 22.4 t80 -165.6 -111.01 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.434 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.548 ' O ' ' O ' ' A' ' 106' ' ' PHE . 3.0 p30 43.74 178.74 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.907 0.384 . . . . 0.0 111.257 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.71 HG12 HG12 ' A' ' 18' ' ' VAL . 0.9 OUTLIER -68.02 -42.88 85.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.979 0.418 . . . . 0.0 111.575 -179.643 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.492 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 78.8 m-20 -49.26 -58.35 5.2 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.413 -179.381 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.571 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 62.9 mm-40 -76.4 -32.26 58.43 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.678 0.275 . . . . 0.0 111.43 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.401 ' CB ' ' O ' ' A' ' 107' ' ' ASP . . . -64.92 -60.8 2.65 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.001 0.429 . . . . 0.0 109.946 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.608 ' O ' HG12 ' A' ' 115' ' ' VAL . 48.3 t -59.46 -31.27 46.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.413 0.625 . . . . 0.0 110.537 178.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.492 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -63.23 -45.07 93.35 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.01 179.211 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.658 HD12 ' HD2' ' A' ' 117' ' ' ARG . 55.7 tp -76.28 -23.44 54.41 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.703 -1.135 . . . . 0.0 111.782 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.608 HG12 ' O ' ' A' ' 112' ' ' VAL . 4.0 p -79.2 -41.25 22.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.801 0.334 . . . . 0.0 111.548 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.475 ' HA ' HD12 ' A' ' 119' ' ' ILE . 95.1 mt-10 -65.33 -44.48 87.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.181 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.658 ' HD2' HD12 ' A' ' 114' ' ' LEU . 6.5 ptp180 -62.29 -25.42 67.84 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.933 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.575 ' HB2' ' CE2' ' A' ' 99' ' ' PHE . . . -71.28 -44.56 64.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.088 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.489 HD11 HG11 ' A' ' 50' ' ' VAL . 4.8 mt -68.6 -30.8 48.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.252 0.548 . . . . 0.0 110.688 179.506 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 21.7 t -71.24 -45.03 64.16 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.212 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 30.1 m80 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.024 -179.753 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.53 0.188 0 N-CA-C 111.561 0.208 . . . . 0.0 111.561 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 84.4 86.33 0.9 Allowed Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.833 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.469 ' HB ' ' HA ' ' A' ' 48' ' ' PRO . 3.6 mp -110.56 112.75 41.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.102 0.477 . . . . 0.0 111.245 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.687 HG23 HG13 ' A' ' 50' ' ' VAL . 5.6 p -108.82 120.96 61.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.913 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.885 ' CD1' HG22 ' A' ' 31' ' ' THR . 31.4 m0 -112.32 141.74 45.67 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.117 0.484 . . . . 0.0 111.484 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.808 ' HB ' HG22 ' A' ' 32' ' ' THR . 1.6 t -128.3 143.01 42.31 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.306 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.975 -178.261 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.871 HG11 ' HA2' ' A' ' 36' ' ' GLY . 0.0 OUTLIER -120.95 110.69 28.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.456 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.548 ' HA ' ' HB3' ' A' ' 54' ' ' ASP . 4.5 p30 -161.3 -160.75 0.75 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.904 0.383 . . . . 0.0 111.67 -178.463 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -66.23 -3.28 5.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.681 -179.246 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 65.31 -155.91 0.28 Allowed 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 120.511 0.196 . . . . 0.0 110.927 179.439 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.444 ' OG ' ' N ' ' A' ' 14' ' ' SER . 64.0 p 33.56 -96.89 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 179.349 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.909 ' O ' HG23 ' A' ' 18' ' ' VAL . 40.4 t -52.93 -57.41 10.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.535 -179.516 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.4 mm -64.61 -26.36 40.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.937 0.398 . . . . 0.0 111.182 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.694 ' HA ' HG21 ' A' ' 32' ' ' THR . 9.8 ttt180 -73.43 -49.29 27.7 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.447 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.427 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 87.0 t90 -63.4 -39.83 95.57 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -179.087 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.909 HG23 ' O ' ' A' ' 14' ' ' SER . 3.2 t -67.03 -42.87 89.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 112.133 0.419 . . . . 0.0 112.133 -178.702 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.752 ' CD1' HD12 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -84.12 -30.52 25.87 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -178.696 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.553 ' HG3' ' N ' ' A' ' 21' ' ' ARG . 17.2 pt-20 -64.09 -60.03 3.73 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -178.732 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.553 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 5.5 mmm180 -53.76 -52.59 59.72 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -178.737 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.17 -29.23 70.21 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -178.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.88 ' CD2' HD13 ' A' ' 28' ' ' LEU . 0.4 OUTLIER -85.32 -29.88 24.16 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.146 0.498 . . . . 0.0 110.088 179.175 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.38 -32.06 73.5 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 177.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.55 -25.16 72.7 Favored Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 177.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.622 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -77.11 -15.18 59.65 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.572 -0.314 . . . . 0.0 110.588 179.007 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.96 26.48 14.49 Favored Glycine 0 C--N 1.336 0.577 0 C-N-CA 120.959 -0.639 . . . . 0.0 114.28 178.66 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.88 HD13 ' CD2' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -127.25 161.28 28.94 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 117.889 0.845 . . . . 0.0 112.874 -179.303 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 99.4 m -75.98 116.85 17.1 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.973 179.462 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 2.0 p -111.18 109.31 19.3 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -178.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.885 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.8 t -130.21 138.23 50.46 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 178.477 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.808 HG22 ' HB ' ' A' ' 8' ' ' VAL . 81.5 p -115.32 160.59 19.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.498 0.666 . . . . 0.0 112.652 -178.789 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.874 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 1.4 m-85 -135.84 173.87 11.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.179 -179.24 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.698 ' HG2' ' HG3' ' A' ' 38' ' ' GLU . 0.1 OUTLIER -62.27 -105.45 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.939 -179.028 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.423 ' H ' ' CG ' ' A' ' 34' ' ' GLU . 14.2 m120 -86.45 -71.7 0.53 Allowed 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.319 0.581 . . . . 0.0 111.257 -179.313 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.871 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . -159.76 -40.71 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.222 -0.899 . . . . 0.0 112.548 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.696 ' HA ' HD12 ' A' ' 40' ' ' LEU . 31.7 m-20 -52.46 -30.08 27.97 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.726 0.298 . . . . 0.0 111.173 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.874 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -58.79 -58.0 10.52 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.417 179.526 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.778 HG23 HG13 ' A' ' 9' ' ' VAL . 6.0 t -54.58 -43.49 65.05 Favored 'Isoleucine or valine' 0 C--N 1.341 0.207 0 C-N-CA 120.24 -0.584 . . . . 0.0 111.295 -179.385 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.716 HD13 ' HB3' ' A' ' 68' ' ' GLN . 7.6 mt -53.37 -49.01 68.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.975 0.417 . . . . 0.0 110.564 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.73 -49.89 73.84 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.98 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.77 -28.05 67.28 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.838 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.847 HD13 ' NE2' ' A' ' 73' ' ' HIS . 5.9 mt -69.77 -26.11 64.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.631 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.22 -20.15 10.04 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.562 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 29.6 t -125.61 -0.27 7.47 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -154.3 155.66 35.56 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 120.761 0.315 . . . . 0.0 110.589 179.893 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.431 HG23 HD13 ' A' ' 76' ' ' LEU . 53.2 m -138.54 112.39 8.46 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.011 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.838 ' O ' HD11 ' A' ' 76' ' ' LEU . 59.2 Cg_endo -77.98 161.77 29.62 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.031 1.82 . . . . 0.0 111.511 179.333 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -73.72 -23.76 59.82 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.175 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.687 HG13 HG23 ' A' ' 6' ' ' VAL . 7.8 p -145.35 167.32 9.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.914 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.67 HD11 HG11 ' A' ' 39' ' ' VAL . 11.3 tp -152.84 131.01 11.94 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.003 0.43 . . . . 0.0 111.833 -179.356 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.666 ' O ' HG23 ' A' ' 9' ' ' VAL . 0.4 OUTLIER -113.84 128.21 56.31 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.243 179.695 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.2 m -105.69 134.23 49.15 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.835 0.35 . . . . 0.0 111.262 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.587 ' O ' HG22 ' A' ' 55' ' ' ILE . 16.5 p-10 -72.75 -29.79 63.61 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.683 -179.657 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 1.022 HG12 ' HA3' ' A' ' 62' ' ' GLY . 0.0 OUTLIER 49.08 97.22 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.549 179.572 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 39.8 tpt85 -157.36 57.16 0.51 Allowed 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.315 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.452 ' N ' ' CD ' ' A' ' 58' ' ' PRO . 0.0 OUTLIER 61.21 46.59 1.08 Allowed Pre-proline 0 N--CA 1.47 0.54 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 178.476 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.628 ' CD ' ' HA2' ' A' ' 62' ' ' GLY . 39.0 Cg_endo -70.37 -75.46 0.01 OUTLIER 'Trans proline' 0 CA--C 1.53 0.301 0 C-N-CA 122.458 2.105 . . . . 0.0 111.522 178.51 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -119.19 -21.23 3.8 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.216 -0.516 . . . . 0.0 112.101 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.979 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -159.95 67.78 0.38 Allowed 'General case' 0 C--O 1.236 0.393 0 CA-C-O 120.981 0.419 . . . . 0.0 110.177 179.748 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 72.93 -30.9 0.22 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.309 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 1.022 ' HA3' HG12 ' A' ' 55' ' ' ILE . . . 140.74 -24.2 2.61 Favored Glycine 0 CA--C 1.503 -0.679 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -179.124 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.828 HD23 ' HB2' ' A' ' 90' ' ' ALA . 3.1 mp -74.34 -23.67 59.07 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.631 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.979 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -53.96 -30.01 45.11 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.3 178.739 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.655 HD22 ' HA3' ' A' ' 36' ' ' GLY . 10.4 mt -58.48 -40.47 82.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.198 179.36 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.736 HD23 HG11 ' A' ' 78' ' ' VAL . 28.5 mt -63.51 -42.11 98.49 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.319 179.492 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.755 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 15.9 mttm -52.89 -42.2 65.07 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.152 179.088 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.716 ' HB3' HD13 ' A' ' 40' ' ' LEU . 2.4 mt-30 -71.54 -44.99 63.59 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.911 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.685 HD12 ' HA ' ' A' ' 66' ' ' LEU . 21.8 mt -56.1 -37.35 48.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.197 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.755 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -74.85 -28.17 60.57 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.892 179.885 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.56 -31.78 67.38 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.401 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.5 mtt-85 -91.73 -64.46 1.11 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.331 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.847 ' NE2' HD13 ' A' ' 43' ' ' LEU . 0.4 OUTLIER -125.06 76.22 67.34 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.996 179.718 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.419 ' HB3' ' O ' ' A' ' 70' ' ' LYS . 51.2 Cg_endo -69.59 60.82 1.62 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.528 2.152 . . . . 0.0 112.422 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 33.1 mtt -157.28 -35.45 0.08 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.534 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.838 HD11 ' O ' ' A' ' 48' ' ' PRO . 0.6 OUTLIER -61.52 145.98 90.43 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.877 -179.44 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.607 ' HD2' ' HG ' ' A' ' 76' ' ' LEU . 94.9 Cg_endo -82.88 115.43 2.4 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.739 2.292 . . . . 0.0 112.697 179.674 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.736 HG11 HD23 ' A' ' 66' ' ' LEU . 3.2 t -98.92 139.16 21.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.685 179.404 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.732 ' CG2' HD23 ' A' ' 114' ' ' LEU . 2.0 mp -122.15 112.13 33.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.698 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.752 HD13 ' CE1' ' A' ' 101' ' ' TYR . 2.2 mp -98.32 134.6 36.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.135 0.493 . . . . 0.0 111.279 -179.363 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.58 ' HA ' ' HB2' ' A' ' 102' ' ' LEU . 4.7 ptm -87.23 -9.13 55.89 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -178.201 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.875 ' HB ' HD12 ' A' ' 55' ' ' ILE . 19.0 m -149.02 136.78 20.51 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.642 0.258 . . . . 0.0 111.566 -179.197 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.694 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -123.0 82.27 1.97 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.834 0.35 . . . . 0.0 111.275 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 43.9 m170 -67.34 -166.32 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.574 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.35 80.53 6.78 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.022 0.439 . . . . 0.0 111.91 -179.06 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.68 ' HB3' HD13 ' A' ' 63' ' ' LEU . 27.0 t0 -178.15 28.38 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.945 179.2 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.869 HD13 ' HB3' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -44.99 -23.1 0.12 Allowed 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -179.687 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -47.94 -44.04 29.76 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.514 ' HB3' ' HB2' ' A' ' 63' ' ' LEU . . . -73.38 -22.23 60.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.674 0.273 . . . . 0.0 111.595 -179.505 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.869 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -68.88 -39.66 79.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.972 0.415 . . . . 0.0 110.169 179.291 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.645 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 2.4 t -54.15 -39.93 44.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.207 -179.529 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.544 ' O ' ' HG3' ' A' ' 95' ' ' GLN . 85.5 p -63.09 -19.74 64.71 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.257 0.551 . . . . 0.0 109.745 178.793 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.771 ' O ' ' HG3' ' A' ' 96' ' ' GLN . . . -75.9 -55.43 5.62 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.204 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.645 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 4.4 m-85 -56.82 -33.61 66.91 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.921 -179.509 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.544 ' HG3' ' O ' ' A' ' 92' ' ' SER . 2.1 pp0? -75.46 -28.94 59.47 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.863 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.771 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 0.7 OUTLIER -87.03 -9.1 56.35 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 116.695 -0.23 . . . . 0.0 110.888 178.9 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 121.58 6.7 8.56 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 120.407 -0.902 . . . . 0.0 113.774 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.744 ' HB2' ' HB1' ' A' ' 93' ' ' ALA . . . -55.3 157.38 3.67 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 117.213 0.507 . . . . 0.0 111.466 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.471 ' CZ ' ' HA ' ' A' ' 118' ' ' ALA . 5.2 t80 -86.25 -53.89 4.77 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.584 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 170.19 -162.43 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.876 0.37 . . . . 0.0 111.867 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.752 ' CE1' HD13 ' A' ' 80' ' ' ILE . 2.2 m-85 -134.61 153.26 52.05 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.567 -178.684 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.62 ' CD1' HD22 ' A' ' 114' ' ' LEU . 1.0 OUTLIER -102.65 119.52 55.64 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.168 -179.905 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -65.18 -70.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.474 2.116 . . . . 0.0 112.553 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.682 ' H ' ' HD2' ' A' ' 105' ' ' PRO . 0.5 OUTLIER -123.63 -62.1 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.908 -179.611 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.682 ' HD2' ' H ' ' A' ' 104' ' ' LYS . 9.2 Cg_endo -50.12 163.56 0.57 Allowed 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.314 2.009 . . . . 0.0 112.367 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.594 ' O ' ' O ' ' A' ' 107' ' ' ASP . 58.9 t80 -171.71 -102.44 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.257 179.488 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.594 ' O ' ' O ' ' A' ' 106' ' ' PHE . 3.4 p30 43.14 178.39 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 117.792 0.269 . . . . 0.0 110.865 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.539 HD11 HD23 ' A' ' 19' ' ' LEU . 0.9 OUTLIER -67.91 -43.1 86.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 120.432 -0.507 . . . . 0.0 111.792 -179.738 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.485 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 32.7 t70 -49.62 -58.65 4.84 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.913 -179.31 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.589 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 3.7 mm-40 -74.81 -30.37 61.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.635 0.255 . . . . 0.0 111.6 -179.529 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -68.61 -62.53 1.35 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.279 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.546 ' HA ' HG12 ' A' ' 115' ' ' VAL . 49.0 t -55.96 -31.35 30.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.559 0.695 . . . . 0.0 110.163 178.744 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.485 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -64.38 -46.68 82.29 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.327 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.732 HD23 ' CG2' ' A' ' 79' ' ' ILE . 19.6 tp -76.96 -21.2 55.12 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.996 -179.351 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.546 HG12 ' HA ' ' A' ' 112' ' ' VAL . 4.7 p -79.4 -47.98 21.62 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 C-N-CA 120.401 -0.519 . . . . 0.0 111.715 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.415 ' N ' HG13 ' A' ' 115' ' ' VAL . 79.3 mt-10 -64.38 -41.89 96.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.871 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.451 ' HG2' ' O ' ' A' ' 113' ' ' ALA . 20.1 mmm180 -61.77 -23.71 66.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.768 179.526 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.471 ' HA ' ' CZ ' ' A' ' 99' ' ' PHE . . . -72.02 -49.34 37.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.941 179.382 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.447 HD11 HG11 ' A' ' 50' ' ' VAL . 3.9 mt -71.11 -31.66 45.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.16 0.505 . . . . 0.0 110.696 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.91 -48.63 52.59 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.122 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.297 -179.625 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.684 ' CG ' HD11 ' A' ' 5' ' ' ILE . 2.9 ptm180 . . . . . 0 N--CA 1.468 0.462 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.667 ' C ' HD13 ' A' ' 5' ' ' ILE . . . 104.24 91.14 2.2 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.616 179.001 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.684 HD11 ' CG ' ' A' ' 3' ' ' ARG . 5.9 mm -118.73 112.23 37.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.908 0.385 . . . . 0.0 111.188 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.997 HG11 HD13 ' A' ' 23' ' ' LEU . 4.4 p -114.98 117.17 54.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.428 179.38 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.849 ' CD1' HG22 ' A' ' 31' ' ' THR . 25.7 m0 -107.31 133.89 51.19 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.031 0.443 . . . . 0.0 110.442 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.854 HG21 HD23 ' A' ' 19' ' ' LEU . 1.8 t -122.01 148.8 25.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.382 -177.851 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.792 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -126.16 112.0 28.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.991 178.037 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.469 ' OD2' HG21 ' A' ' 15' ' ' ILE . 8.7 t0 -161.42 -161.79 0.83 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.648 -178.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -66.36 -2.22 4.27 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -179.488 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 68.77 -153.23 0.16 Allowed 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 120.566 0.222 . . . . 0.0 110.711 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.462 ' OG ' ' N ' ' A' ' 14' ' ' SER . 62.5 p 33.66 -97.87 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 179.301 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.786 ' O ' HG23 ' A' ' 18' ' ' VAL . 0.3 OUTLIER -52.85 -52.1 58.5 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 111.608 0.225 . . . . 0.0 111.608 -179.417 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.469 HG21 ' OD2' ' A' ' 10' ' ' ASP . 20.1 mm -64.24 -30.56 50.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.866 0.365 . . . . 0.0 111.215 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.686 ' HA ' HG21 ' A' ' 32' ' ' THR . 47.3 ttp180 -72.83 -41.77 64.49 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.961 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.566 ' O ' ' HD2' ' A' ' 21' ' ' ARG . 57.3 t90 -65.11 -53.51 44.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.999 -179.229 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.786 HG23 ' O ' ' A' ' 14' ' ' SER . 2.1 t -60.24 -43.16 92.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -178.462 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.854 HD23 HG21 ' A' ' 8' ' ' VAL . 12.0 tp -82.44 -27.64 31.8 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -177.699 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.646 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 12.2 pt-20 -67.1 -62.3 1.5 Allowed 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 119.917 -0.713 . . . . 0.0 112.062 -178.461 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.733 ' HD2' ' H ' ' A' ' 21' ' ' ARG . 1.3 mpt_? -54.83 -49.16 71.73 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -179.576 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.87 -60.11 3.68 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.52 -179.45 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 1.057 HD22 HD13 ' A' ' 28' ' ' LEU . 2.6 mt -64.82 -27.36 68.83 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.081 0.467 . . . . 0.0 109.78 179.317 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.34 -34.92 79.26 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.274 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.78 -25.34 71.76 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.302 -0.952 . . . . 0.0 111.225 178.483 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.735 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -76.8 -15.42 59.74 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 120.681 0.277 . . . . 0.0 111.076 179.426 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.81 26.4 8.53 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.547 -0.835 . . . . 0.0 114.023 178.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 1.057 HD13 HD22 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -125.83 172.45 9.85 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 117.73 0.765 . . . . 0.0 112.158 -179.632 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.5 m -99.01 105.77 17.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.193 179.298 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.685 ' HA ' HG13 ' A' ' 6' ' ' VAL . 11.4 t -100.86 111.31 23.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.066 -179.169 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.849 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.9 t -120.18 156.52 30.94 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.499 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.686 HG21 ' HA ' ' A' ' 16' ' ' ARG . 64.3 p -129.97 161.83 30.04 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.278 0.561 . . . . 0.0 112.04 -179.348 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.792 ' HB2' HG13 ' A' ' 9' ' ' VAL . 3.8 m-85 -129.42 173.99 10.04 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.572 -178.554 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.719 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 2.3 pp20? -60.04 -51.59 68.98 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -177.645 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.502 ' OD1' ' HB3' ' A' ' 58' ' ' PRO . 0.7 OUTLIER -150.59 -71.74 0.17 Allowed 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -178.454 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.615 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . -153.39 -42.41 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.4 -0.905 . . . . 0.0 113.709 -178.684 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.405 ' HA ' ' HG ' ' A' ' 40' ' ' LEU . 1.2 m120 -67.59 -30.77 70.46 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-O 120.852 0.358 . . . . 0.0 111.361 -178.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.767 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -51.87 -59.85 3.85 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.751 179.86 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.785 HG21 HG22 ' A' ' 9' ' ' VAL . 0.8 OUTLIER -55.4 -41.51 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 C-N-CA 119.804 -0.759 . . . . 0.0 110.083 -179.637 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.694 HD13 ' CB ' ' A' ' 68' ' ' GLN . 6.7 mt -53.32 -41.56 65.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.308 0.575 . . . . 0.0 109.845 179.078 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.48 -48.15 76.3 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.711 179.236 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.95 -26.75 63.31 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.894 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 1.053 HD13 ' CE1' ' A' ' 73' ' ' HIS . 1.1 mt -69.94 -22.46 63.18 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.564 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.48 -22.12 11.9 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.981 0.419 . . . . 0.0 110.847 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -130.48 2.45 4.58 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.612 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.68 ' HG2' ' CH2' ' A' ' 7' ' ' TRP . 1.3 tptp -138.05 161.48 36.63 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 121.523 0.678 . . . . 0.0 111.962 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.499 ' H ' ' HG3' ' A' ' 46' ' ' LYS . 51.1 m -139.38 111.25 7.7 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.674 178.06 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.797 ' HG2' HD21 ' A' ' 76' ' ' LEU . 73.2 Cg_endo -80.84 153.31 19.61 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.301 2.001 . . . . 0.0 111.305 179.196 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -74.44 -30.93 62.09 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.057 -179.461 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.868 HG13 HG23 ' A' ' 6' ' ' VAL . 9.0 p -150.95 103.71 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-O 120.892 0.377 . . . . 0.0 111.534 -179.44 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.703 HD11 HG11 ' A' ' 39' ' ' VAL . 11.1 tp -87.63 131.23 34.5 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -179.14 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.731 ' HB3' HG13 ' A' ' 8' ' ' VAL . 0.4 OUTLIER -115.17 127.42 55.54 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.446 179.524 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.699 ' OG ' HD23 ' A' ' 65' ' ' LEU . 0.6 OUTLIER -108.48 136.55 47.92 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 120.846 0.355 . . . . 0.0 110.972 179.969 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.424 ' O ' ' CG2' ' A' ' 55' ' ' ILE . 25.5 p-10 -79.54 -21.33 45.32 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -178.385 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.604 HG21 HG22 ' A' ' 80' ' ' ILE . 0.7 OUTLIER 44.81 86.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -179.666 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.408 ' O ' ' HG3' ' A' ' 56' ' ' ARG . 4.9 ptt85 -147.83 56.54 1.08 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 120.925 0.393 . . . . 0.0 111.832 179.596 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.475 ' N ' ' HD3' ' A' ' 58' ' ' PRO . 6.0 ttt 62.55 50.26 1.43 Allowed Pre-proline 0 N--CA 1.465 0.315 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 178.851 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.592 ' HD2' ' N ' ' A' ' 62' ' ' GLY . 45.2 Cg_endo -77.09 -77.01 0.01 OUTLIER 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 122.421 2.081 . . . . 0.0 111.749 178.397 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -118.04 -21.15 4.25 Favored Glycine 0 C--N 1.332 0.359 0 N-CA-C 111.798 -0.521 . . . . 0.0 111.798 179.171 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.993 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 5.1 ttt -161.3 67.61 0.3 Allowed 'General case' 0 C--O 1.236 0.351 0 CA-C-O 120.978 0.418 . . . . 0.0 110.415 179.393 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 69.79 -23.07 0.16 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.484 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.592 ' N ' ' HD2' ' A' ' 58' ' ' PRO . . . 136.36 -29.58 2.79 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 -178.811 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.73 HD13 ' HB3' ' A' ' 86' ' ' ASP . 4.1 mp -71.56 -21.93 61.82 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.465 -0.368 . . . . 0.0 110.225 179.285 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.993 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -53.74 -33.48 55.83 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.952 179.054 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.699 HD23 ' OG ' ' A' ' 53' ' ' SER . 6.4 mp -56.99 -48.44 78.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.106 0.479 . . . . 0.0 110.76 179.692 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.96 ' HA ' HD12 ' A' ' 69' ' ' ILE . 4.9 mp -55.69 -40.3 72.18 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.763 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.687 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 0.1 OUTLIER -53.85 -48.07 70.34 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.9 179.286 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.694 ' CB ' HD13 ' A' ' 40' ' ' LEU . 13.1 mm-40 -71.39 -29.88 65.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.698 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.983 HG23 ' CD2' ' A' ' 73' ' ' HIS . 37.6 mt -62.72 -40.76 89.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.665 -179.162 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.687 ' HG2' ' O ' ' A' ' 67' ' ' LYS . 23.9 pttt -74.68 -29.58 61.27 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.475 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -85.88 -38.17 18.36 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -178.709 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 22.0 mtt-85 -95.33 -27.24 15.56 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -178.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 1.053 ' CE1' HD13 ' A' ' 43' ' ' LEU . 0.2 OUTLIER -107.52 134.85 19.83 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.699 -0.228 . . . . 0.0 111.131 -179.107 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.561 ' O ' ' HG2' ' A' ' 75' ' ' MET . 23.6 Cg_exo -63.66 79.88 0.14 Allowed 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.657 2.238 . . . . 0.0 112.587 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.561 ' HG2' ' O ' ' A' ' 74' ' ' PRO . 0.0 OUTLIER 50.69 43.19 27.93 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 121.558 0.694 . . . . 0.0 110.795 179.742 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.797 HD21 ' HG2' ' A' ' 48' ' ' PRO . 5.8 tp -68.24 137.08 91.47 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.678 -179.742 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.547 ' HD2' ' HG ' ' A' ' 76' ' ' LEU . 47.3 Cg_endo -67.34 125.09 12.92 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.495 2.13 . . . . 0.0 111.951 179.363 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.863 HG22 HG21 ' A' ' 69' ' ' ILE . 3.8 t -110.92 143.53 20.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.09 0.472 . . . . 0.0 111.614 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.564 HG21 HD23 ' A' ' 114' ' ' LEU . 2.3 mp -132.97 113.19 19.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.338 179.2 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.66 HD13 ' HB2' ' A' ' 53' ' ' SER . 13.0 mm -101.22 142.21 16.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.326 -179.211 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.503 ' O ' ' HB3' ' A' ' 102' ' ' LEU . 11.4 ptm -82.79 -21.23 34.64 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -178.66 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.557 ' H ' HG21 ' A' ' 55' ' ' ILE . 3.0 m -147.65 158.05 43.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.637 0.256 . . . . 0.0 111.22 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.851 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -138.53 66.43 1.43 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.571 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 43.6 p-80 -99.24 120.62 39.84 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 120.898 0.38 . . . . 0.0 111.578 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 55.77 165.83 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.752 179.385 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.73 ' HB3' HD13 ' A' ' 63' ' ' LEU . 1.0 OUTLIER 52.89 26.86 4.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.079 -179.817 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.765 HD21 ' HB1' ' A' ' 83' ' ' ALA . 0.1 OUTLIER -54.82 -23.72 19.62 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.352 -179.961 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -50.63 -35.93 32.85 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.829 -179.465 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.599 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -69.56 -23.32 63.55 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.798 0.333 . . . . 0.0 111.447 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.605 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -72.12 -30.63 65.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.209 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.659 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 5.5 t -66.67 -46.72 85.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.365 -179.472 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.6 m -58.12 -37.81 75.3 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.482 0.658 . . . . 0.0 110.093 179.413 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.591 ' HB1' ' HB2' ' A' ' 98' ' ' ALA . . . -56.89 -41.53 78.25 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.319 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.659 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 12.4 m-85 -59.03 -22.31 60.48 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.212 179.279 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.561 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -74.76 -39.76 61.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.518 -179.999 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.561 ' N ' ' HG2' ' A' ' 95' ' ' GLN . 4.8 pt20 -79.18 -11.12 59.97 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.376 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 108.05 32.15 3.37 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.336 -0.935 . . . . 0.0 112.91 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.591 ' HB2' ' HB1' ' A' ' 93' ' ' ALA . . . -61.07 145.76 49.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.756 0.278 . . . . 0.0 110.566 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.619 ' CZ ' ' HB2' ' A' ' 118' ' ' ALA . 9.2 t80 -71.08 -53.87 13.11 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.548 -179.387 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.559 ' OD2' HD11 ' A' ' 114' ' ' LEU . 2.8 p30 166.82 -166.4 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.185 0.517 . . . . 0.0 111.498 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.851 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 4.8 m-85 -133.95 152.42 51.85 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.99 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.503 ' HB3' ' O ' ' A' ' 81' ' ' MET . 1.0 OUTLIER -104.72 119.02 54.94 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.258 179.584 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -67.84 -67.52 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.306 2.004 . . . . 0.0 112.448 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.685 ' H ' ' HD2' ' A' ' 105' ' ' PRO . 4.9 mttt -121.76 -61.95 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.969 -179.424 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.685 ' HD2' ' H ' ' A' ' 104' ' ' LYS . 9.7 Cg_endo -50.29 159.76 1.81 Allowed 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.42 2.08 . . . . 0.0 112.279 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.605 ' O ' ' O ' ' A' ' 107' ' ' ASP . 47.8 t80 -169.74 -105.83 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.414 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.605 ' O ' ' O ' ' A' ' 106' ' ' PHE . 2.7 p30 43.1 175.38 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.033 0.444 . . . . 0.0 111.447 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.455 HG12 ' O ' ' A' ' 18' ' ' VAL . 0.9 OUTLIER -67.62 -41.07 85.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.09 0.472 . . . . 0.0 111.288 179.956 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.511 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 0.3 OUTLIER -50.01 -58.21 5.96 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.596 -179.707 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.587 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 58.4 mm-40 -77.32 -32.05 55.01 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -179.623 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -67.33 -58.44 4.79 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.858 0.361 . . . . 0.0 110.237 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.666 ' O ' HG12 ' A' ' 115' ' ' VAL . 51.8 t -60.89 -32.46 52.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.488 0.661 . . . . 0.0 110.189 179.176 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.511 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -62.07 -44.8 95.9 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.567 0.699 . . . . 0.0 109.911 178.549 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.656 HD12 ' HE ' ' A' ' 117' ' ' ARG . 6.1 tp -74.97 -23.7 58.32 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.588 -179.51 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.666 HG12 ' O ' ' A' ' 112' ' ' VAL . 2.7 p -79.57 -42.75 23.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.832 0.348 . . . . 0.0 111.736 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.448 ' HG3' ' O ' ' A' ' 112' ' ' VAL . 31.6 mt-10 -60.31 -51.92 67.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.298 -179.394 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.656 ' HE ' HD12 ' A' ' 114' ' ' LEU . 0.1 OUTLIER -57.25 -23.88 51.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.852 0.358 . . . . 0.0 110.979 -179.993 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.619 ' HB2' ' CZ ' ' A' ' 99' ' ' PHE . . . -70.39 -45.58 65.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.814 179.483 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.641 HD13 ' CD2' ' A' ' 28' ' ' LEU . 4.7 mt -77.22 -34.11 20.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.464 -179.663 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.9 m -65.18 -47.06 78.29 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.969 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 11.1 m80 . . . . . 0 C--N 1.327 -0.391 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.986 -179.995 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.529 0.141 0 CA-C-O 120.498 0.19 . . . . 0.0 111.387 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.479 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . 84.89 85.81 0.95 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.79 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.7 mp -101.01 113.11 36.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.933 0.397 . . . . 0.0 111.218 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 1.013 HG11 HD13 ' A' ' 23' ' ' LEU . 5.9 p -105.44 120.18 55.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.281 179.648 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.856 ' CD1' HG22 ' A' ' 31' ' ' THR . 26.3 m0 -112.21 139.8 47.45 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.915 0.388 . . . . 0.0 110.512 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.957 HG11 HD13 ' A' ' 19' ' ' LEU . 0.2 OUTLIER -126.94 148.83 31.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.749 -178.765 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.818 HG23 ' O ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -127.01 114.61 38.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.002 0.429 . . . . 0.0 109.995 179.023 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.982 ' HB3' HG13 ' A' ' 15' ' ' ILE . 9.1 t0 -171.05 -150.24 0.07 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.426 -178.306 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -66.49 -3.37 6.08 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.511 ' O ' ' N ' ' A' ' 16' ' ' ARG . 2.3 t0 69.19 -79.52 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 178.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -40.83 -78.35 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -178.327 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.78 ' O ' HG23 ' A' ' 18' ' ' VAL . 1.7 t -52.61 -32.6 42.44 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.669 -178.766 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.982 HG13 ' HB3' ' A' ' 10' ' ' ASP . 23.2 mm -77.53 -28.69 16.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.892 -179.301 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.61 ' HA ' ' HG3' ' A' ' 20' ' ' GLU . 14.1 ttt180 -58.35 -44.69 88.89 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.307 0.575 . . . . 0.0 110.176 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.734 ' O ' ' HB2' ' A' ' 21' ' ' ARG . 38.4 t90 -71.95 -62.22 1.5 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.766 -179.471 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.78 HG23 ' O ' ' A' ' 14' ' ' SER . 0.5 OUTLIER -59.17 -60.89 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 -177.056 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.957 HD13 HG11 ' A' ' 8' ' ' VAL . 13.9 mt -70.67 -51.49 27.42 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -175.709 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.61 ' HG3' ' HA ' ' A' ' 16' ' ' ARG . 5.1 mt-10 -67.62 -61.66 1.79 Allowed 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -178.316 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.734 ' HB2' ' O ' ' A' ' 17' ' ' TRP . 0.0 OUTLIER -49.99 -44.45 50.97 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.058 -178.202 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.82 -37.37 76.2 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.672 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 1.013 HD13 HG11 ' A' ' 6' ' ' VAL . 3.0 mt -75.22 -27.1 59.42 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 178.854 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.409 ' N ' ' O ' ' A' ' 20' ' ' GLU . . . -63.72 -35.65 81.28 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.728 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.94 -26.2 69.97 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.171 -1.014 . . . . 0.0 110.993 178.143 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.764 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -76.85 -15.53 59.68 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 120.565 0.221 . . . . 0.0 110.923 179.345 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.13 26.71 9.97 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 120.636 -0.792 . . . . 0.0 113.955 179.013 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 1.001 HD13 HD22 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -123.72 168.87 12.12 Favored 'General case' 0 N--CA 1.456 -0.125 0 CA-C-N 117.707 0.754 . . . . 0.0 111.788 -179.983 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 58.2 m -96.44 113.52 25.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.918 179.302 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.682 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 3.1 t -112.05 117.51 32.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.093 0.473 . . . . 0.0 112.195 -179.344 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.856 HG22 ' CD1' ' A' ' 7' ' ' TRP . 3.3 t -123.57 139.85 53.59 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.169 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.487 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 76.8 p -112.5 161.42 16.76 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.129 0.49 . . . . 0.0 111.388 -178.674 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.775 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 3.7 m-85 -131.28 174.08 10.41 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.806 -177.6 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.728 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 3.2 pp20? -63.19 -39.04 93.5 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -177.219 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -164.2 -57.61 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.301 0 C-N-CA 119.755 -0.778 . . . . 0.0 113.049 -178.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.816 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . -169.07 -44.42 0.03 OUTLIER Glycine 0 C--N 1.318 -0.471 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.64 -178.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.503 ' N ' HD21 ' A' ' 65' ' ' LEU . 2.2 t30 -64.88 -30.43 71.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.995 0.426 . . . . 0.0 110.96 -179.329 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.775 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -54.34 -52.84 60.29 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.551 -179.945 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.772 HG12 ' CD1' ' A' ' 43' ' ' LEU . 11.5 t -48.76 -38.77 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-O 121.017 0.437 . . . . 0.0 111.1 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.811 HD21 ' CD1' ' A' ' 65' ' ' LEU . 15.9 mt -61.82 -42.14 98.65 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.564 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.41 -49.45 73.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.19 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.86 -31.86 66.89 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.542 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.867 HD13 ' CE1' ' A' ' 73' ' ' HIS . 5.7 mt -59.88 -24.02 63.93 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.297 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.36 -19.32 34.53 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.439 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.5 t -121.52 0.88 10.03 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.557 ' O ' HD23 ' A' ' 43' ' ' LEU . 3.6 tttt -165.37 164.39 19.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.944 0.402 . . . . 0.0 111.367 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.523 ' HA ' HD23 ' A' ' 43' ' ' LEU . 85.9 m -138.79 116.83 9.09 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.948 179.545 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.741 ' HD2' HD21 ' A' ' 43' ' ' LEU . 40.0 Cg_endo -74.82 156.06 43.8 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 121.796 1.664 . . . . 0.0 111.466 179.25 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -74.05 -30.84 62.6 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.079 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.689 ' O ' HG13 ' A' ' 50' ' ' VAL . 14.9 p -149.49 106.27 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 CA-C-O 120.737 0.303 . . . . 0.0 111.699 -179.441 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.709 ' O ' HD12 ' A' ' 79' ' ' ILE . 20.5 tp -87.07 155.32 20.19 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.937 0.399 . . . . 0.0 111.201 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.818 ' O ' HG23 ' A' ' 9' ' ' VAL . 2.4 tt -137.16 119.6 15.85 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.197 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.528 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 0.6 OUTLIER -111.86 128.44 56.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.781 0.324 . . . . 0.0 111.378 -179.662 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.06 -2.9 56.55 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.514 HD11 ' CE1' ' A' ' 84' ' ' HIS . 3.0 tt 41.97 91.13 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-O 120.805 0.336 . . . . 0.0 111.698 179.409 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.4 ttt85 -117.56 40.17 3.14 Favored 'General case' 0 N--CA 1.461 0.111 0 N-CA-C 111.96 0.355 . . . . 0.0 111.96 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.624 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER 56.81 44.11 1.3 Allowed Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 179.042 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.478 ' CD ' ' N ' ' A' ' 57' ' ' MET . 30.1 Cg_endo -63.29 -80.81 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 121.959 1.773 . . . . 0.0 111.02 178.704 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -102.42 -86.6 1.95 Allowed Glycine 0 C--N 1.334 0.43 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 178.237 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.802 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -87.82 60.97 6.18 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 177.228 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.624 ' HA ' ' HA ' ' A' ' 57' ' ' MET . 0.1 OUTLIER 65.57 -28.2 0.11 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.65 -1.159 . . . . 0.0 112.447 -179.494 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.533 ' H ' ' C ' ' A' ' 60' ' ' MET . . . 152.15 -35.19 0.84 Allowed Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 110.946 -0.861 . . . . 0.0 110.946 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.586 ' H ' HD12 ' A' ' 63' ' ' LEU . 1.0 OUTLIER -64.07 -21.43 66.52 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 178.878 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.802 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -53.56 -38.43 63.86 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 120.969 0.414 . . . . 0.0 110.389 179.627 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.811 ' CD1' HD21 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -55.03 -44.99 75.14 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.781 179.836 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.851 ' HA ' HD12 ' A' ' 69' ' ' ILE . 5.8 mt -54.5 -42.5 70.85 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.503 179.539 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.637 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 21.6 tttt -57.77 -43.47 85.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.704 179.451 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 8.2 mm100 -69.51 -27.78 65.47 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.851 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.851 HD12 ' HA ' ' A' ' 66' ' ' LEU . 96.7 mt -64.58 -36.85 78.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.96 -179.083 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.637 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -78.15 -31.62 49.84 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.512 -179.52 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -63.72 -44.53 93.32 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.076 -178.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.2 mtt85 -96.42 -50.93 4.56 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.857 -179.077 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.867 ' CE1' HD13 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -95.77 156.38 37.4 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.834 -179.326 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -66.28 -73.29 0.02 OUTLIER 'Trans proline' 0 CA--C 1.528 0.209 0 C-N-CA 122.538 2.159 . . . . 0.0 112.682 -179.405 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 7.3 mtt -145.16 55.52 1.22 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.7 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.455 HD13 HG23 ' A' ' 47' ' ' THR . 22.5 tp -61.9 111.21 4.11 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.111 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -60.35 134.25 54.2 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.379 2.053 . . . . 0.0 112.387 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.791 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 5.1 t -131.43 152.93 38.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.25 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.709 HD12 ' O ' ' A' ' 51' ' ' LEU . 1.1 mt -126.8 113.2 31.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.721 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.528 ' HA ' ' O ' ' A' ' 53' ' ' SER . 9.5 mm -101.86 134.9 41.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -178.051 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.557 ' HB2' ' CD1' ' A' ' 106' ' ' PHE . 2.4 ptt? -69.16 -34.01 74.3 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.271 -0.877 . . . . 0.0 112.216 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 7.3 m -139.16 150.72 45.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.752 0.311 . . . . 0.0 111.348 -179.605 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.916 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -121.06 70.58 0.92 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.731 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.514 ' CE1' HD11 ' A' ' 55' ' ' ILE . 2.6 p80 -98.94 -179.27 4.22 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.193 179.174 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.4 ' HB2' ' CB ' ' A' ' 61' ' ' ASP . 0.1 OUTLIER 63.99 -161.42 0.29 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.769 -179.892 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.41 88.74 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.924 0.392 . . . . 0.0 111.377 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.859 HD21 ' HB1' ' A' ' 83' ' ' ALA . 0.3 OUTLIER -51.85 -24.0 5.56 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.465 179.804 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -48.84 -36.36 16.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.008 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.429 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -72.84 -19.84 61.24 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.219 -179.608 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.747 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -68.93 -52.37 29.97 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.984 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.62 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 9.4 t -66.33 -44.94 90.72 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.19 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.845 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.685 ' O ' ' HG3' ' A' ' 95' ' ' GLN . 3.3 m -61.08 -14.54 24.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.889 0.376 . . . . 0.0 110.035 178.739 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.699 ' HB2' HD13 ' A' ' 66' ' ' LEU . . . -75.15 -61.74 1.79 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.113 0.482 . . . . 0.0 111.066 179.545 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.66 ' N ' ' HB3' ' A' ' 98' ' ' ALA . 4.7 m-85 -44.84 -36.14 3.12 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.384 -178.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.685 ' HG3' ' O ' ' A' ' 92' ' ' SER . 1.7 pp0? -76.25 -37.01 58.21 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.959 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.526 ' HB2' ' HB3' ' A' ' 70' ' ' LYS . 10.3 pt20 -100.12 11.19 39.93 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -179.318 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 93' ' ' ALA . . . 122.21 79.0 0.48 Allowed Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.187 -1.006 . . . . 0.0 113.449 179.598 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.791 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -169.14 142.49 2.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.731 0.301 . . . . 0.0 110.637 178.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.502 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 3.3 t80 -84.49 -53.15 5.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.585 -178.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.591 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 0.4 OUTLIER 178.83 -165.58 0.05 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.139 0.495 . . . . 0.0 111.61 179.984 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.916 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 3.5 m-85 -136.38 153.73 51.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.458 -179.209 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.531 ' HG ' ' HB3' ' A' ' 106' ' ' PHE . 0.4 OUTLIER -101.9 118.85 58.5 Favored Pre-proline 0 C--N 1.327 -0.372 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 179.059 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.417 ' C ' ' HG3' ' A' ' 104' ' ' LYS . 61.5 Cg_exo -51.28 -42.49 53.97 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.58 2.187 . . . . 0.0 112.466 -179.211 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.642 ' HB2' ' HD3' ' A' ' 105' ' ' PRO . 40.3 mttp -156.07 -54.11 0.02 OUTLIER Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.173 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.642 ' HD3' ' HB2' ' A' ' 104' ' ' LYS . 98.1 Cg_endo -80.97 163.78 20.31 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.262 1.975 . . . . 0.0 112.229 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.677 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 0.5 OUTLIER -169.89 -75.88 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.487 178.928 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.554 ' O ' ' HB3' ' A' ' 111' ' ' ALA . 3.1 p30 37.32 -166.49 0.0 OUTLIER 'General case' 0 C--O 1.225 -0.189 0 CA-C-N 116.682 -0.235 . . . . 0.0 110.41 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.842 HD11 ' HG ' ' A' ' 19' ' ' LEU . 1.1 mp -67.85 -44.8 85.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 C-N-CA 120.11 -0.636 . . . . 0.0 111.366 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.521 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 2.6 m-20 -53.58 -58.06 8.52 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.666 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.677 ' HB2' ' HA ' ' A' ' 106' ' ' PHE . 3.1 mm-40 -79.2 -28.04 42.58 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -178.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.583 ' HB1' HD11 ' A' ' 52' ' ' LEU . . . -78.31 -55.09 5.52 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.349 -0.541 . . . . 0.0 110.084 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.783 ' O ' HG12 ' A' ' 115' ' ' VAL . 60.4 t -58.57 -29.51 39.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-O 121.549 0.69 . . . . 0.0 109.881 178.311 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.521 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -64.82 -47.97 76.09 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.718 178.84 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.605 HD23 ' CG2' ' A' ' 79' ' ' ILE . 10.6 tp -73.83 -20.66 60.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.455 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.783 HG12 ' O ' ' A' ' 112' ' ' VAL . 2.6 p -78.52 -43.42 26.27 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-O 120.735 0.302 . . . . 0.0 111.526 -179.566 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.48 ' HA ' HD12 ' A' ' 119' ' ' ILE . 35.7 mt-10 -66.2 -41.92 89.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.209 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.505 HH11 HD12 ' A' ' 114' ' ' LEU . 28.4 mtp-105 -61.18 -25.64 67.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.646 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.523 ' HB3' HG21 ' A' ' 50' ' ' VAL . . . -73.01 -40.44 65.18 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.305 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.48 HD12 ' HA ' ' A' ' 116' ' ' GLU . 3.8 mt -75.42 -30.51 22.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 121.125 0.488 . . . . 0.0 110.658 179.117 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 91.5 p -67.35 -43.32 81.78 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.567 -179.09 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 17.8 m80 . . . . . 0 C--N 1.328 -0.359 0 CA-C-O 121.006 0.431 . . . . 0.0 110.943 -179.823 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.529 0.161 0 CA-C-O 120.589 0.233 . . . . 0.0 111.475 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 90.27 81.57 1.37 Allowed Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.942 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.6 mp -103.3 112.32 36.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.96 0.41 . . . . 0.0 111.26 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.852 HG21 HD21 ' A' ' 23' ' ' LEU . 4.3 p -106.92 126.64 62.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.1 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.919 ' CD1' HG22 ' A' ' 31' ' ' THR . 40.6 m0 -112.82 136.46 52.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.896 0.379 . . . . 0.0 110.444 179.512 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.681 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.1 OUTLIER -125.95 138.81 53.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.336 -178.658 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.952 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -115.6 105.59 18.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.988 0.423 . . . . 0.0 110.217 178.58 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.681 ' HB3' HG21 ' A' ' 15' ' ' ILE . 10.2 t0 -173.09 117.12 0.29 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.226 -179.577 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.599 ' O ' ' HB2' ' A' ' 12' ' ' ASP . 0.1 OUTLIER 47.67 -86.4 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.787 179.826 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.599 ' HB2' ' O ' ' A' ' 11' ' ' ASP . 15.4 t0 170.91 -133.31 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.676 -0.238 . . . . 0.0 110.824 -179.57 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.437 ' HA ' ' HB3' ' A' ' 16' ' ' ARG . 75.0 m -40.89 -42.03 1.74 Allowed 'General case' 0 C--N 1.341 0.234 0 CA-C-O 121.072 0.463 . . . . 0.0 112.117 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.602 ' O ' HG23 ' A' ' 18' ' ' VAL . 27.6 m -53.18 -63.51 1.12 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.675 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.681 HG21 ' HB3' ' A' ' 10' ' ' ASP . 15.1 mm -70.46 -20.61 22.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.871 0.367 . . . . 0.0 110.667 179.488 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.709 ' HA ' HG21 ' A' ' 32' ' ' THR . 3.4 ttt180 -69.77 -55.56 9.53 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.846 179.282 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.505 ' O ' ' HG3' ' A' ' 20' ' ' GLU . 89.6 t90 -53.58 -45.09 69.84 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.708 -179.674 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.852 HG12 HG12 ' A' ' 108' ' ' ILE . 3.1 t -65.58 -45.13 93.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -178.806 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.52 HD13 ' O ' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -83.66 -26.93 29.45 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -177.786 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.505 ' HG3' ' O ' ' A' ' 17' ' ' TRP . 1.0 OUTLIER -66.61 -60.92 2.28 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -179.063 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.577 ' O ' ' HB3' ' A' ' 24' ' ' ALA . 31.1 mmm-85 -52.77 -63.21 1.22 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.734 0.302 . . . . 0.0 111.802 -179.623 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -49.75 -54.69 17.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.046 0.45 . . . . 0.0 111.554 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.852 HD21 HG21 ' A' ' 6' ' ' VAL . 9.3 tp -66.36 -19.43 65.8 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.183 179.316 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.577 ' HB3' ' O ' ' A' ' 21' ' ' ARG . . . -70.32 -35.85 73.91 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.13 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -57.59 -27.83 59.09 Favored Glycine 0 C--N 1.335 0.527 0 C-N-CA 120.51 -0.852 . . . . 0.0 111.035 178.485 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.746 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -77.98 -15.8 58.66 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 120.716 0.293 . . . . 0.0 110.495 178.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.94 26.61 14.17 Favored Glycine 0 C--N 1.337 0.609 0 C-N-CA 120.637 -0.792 . . . . 0.0 114.501 178.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.799 HD13 ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -116.06 164.94 13.71 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 118.32 1.06 . . . . 0.0 112.23 -179.779 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 27.0 m -94.4 118.56 31.81 Favored 'General case' 0 CA--C 1.521 -0.149 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.484 179.053 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.552 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 3.0 m -108.46 118.61 37.23 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -178.323 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.919 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.7 t -122.79 139.76 53.65 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.047 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.709 HG21 ' HA ' ' A' ' 16' ' ' ARG . 69.0 p -115.01 161.63 18.08 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -177.496 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.952 ' HB2' HG13 ' A' ' 9' ' ' VAL . 12.1 m-85 -136.27 174.88 10.13 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 114.868 -1.06 . . . . 0.0 111.834 -178.316 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.422 ' HG2' ' H ' ' A' ' 35' ' ' ASN . 3.6 pt-20 -62.0 -46.94 87.02 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -177.382 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.422 ' H ' ' HG2' ' A' ' 34' ' ' GLU . 0.5 OUTLIER -168.41 -27.97 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 118.58 0.627 . . . . 0.0 112.687 -179.573 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.7 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . 171.91 -59.66 0.16 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.402 -0.904 . . . . 0.0 112.754 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.587 ' HA ' HD12 ' A' ' 40' ' ' LEU . 51.6 m-20 -48.1 -34.52 9.86 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 120.845 0.355 . . . . 0.0 110.979 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.913 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 5.2 tt0 -60.25 -55.65 31.12 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.382 179.082 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.919 HG11 HD11 ' A' ' 51' ' ' LEU . 6.2 t -53.93 -44.22 60.56 Favored 'Isoleucine or valine' 0 C--N 1.345 0.401 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.459 179.126 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.826 HD13 ' CB ' ' A' ' 68' ' ' GLN . 21.0 mt -57.51 -42.68 83.27 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.877 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.53 -50.13 40.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.075 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.55 -27.58 69.35 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.639 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.747 HD13 ' NE2' ' A' ' 73' ' ' HIS . 6.1 mt -67.71 -23.53 65.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.556 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.39 -16.71 15.83 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.182 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -117.43 -3.39 11.4 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.824 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.501 ' O ' HD23 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -167.33 163.06 15.16 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.984 0.421 . . . . 0.0 111.73 -179.917 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.979 HG23 HD12 ' A' ' 76' ' ' LEU . 66.3 m -139.11 112.47 8.08 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.522 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.713 ' HD2' HD21 ' A' ' 43' ' ' LEU . 66.6 Cg_endo -72.52 165.49 32.56 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.179 1.92 . . . . 0.0 111.548 178.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -74.09 -24.34 59.47 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 121.132 -0.227 . . . . 0.0 111.26 -179.667 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.832 HG13 HG23 ' A' ' 6' ' ' VAL . 7.2 p -145.15 166.45 11.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.919 HD11 HG11 ' A' ' 39' ' ' VAL . 19.6 tp -152.91 132.55 13.07 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 121.06 0.457 . . . . 0.0 111.368 -179.036 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.741 ' O ' HG23 ' A' ' 9' ' ' VAL . 0.9 OUTLIER -116.52 139.33 50.6 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.795 -179.878 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.555 ' HB2' HD13 ' A' ' 80' ' ' ILE . 8.1 m -127.1 128.44 46.23 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.978 0.418 . . . . 0.0 111.384 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.402 ' C ' HG22 ' A' ' 55' ' ' ILE . 44.6 t0 -69.48 -16.65 63.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.587 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.706 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 2.5 tt 43.79 72.58 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.109 -0.496 . . . . 0.0 112.262 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 177.46 61.82 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.695 179.245 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.61 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -162.0 -64.25 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.698 179.964 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.61 ' HD3' ' HB3' ' A' ' 57' ' ' MET . 36.4 Cg_endo -63.02 -165.6 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.694 2.263 . . . . 0.0 113.228 -179.496 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.79 -67.32 2.13 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.656 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.734 ' HB2' ' HB2' ' A' ' 64' ' ' ALA . 0.2 OUTLIER -79.95 51.23 1.31 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.941 0.4 . . . . 0.0 110.762 179.809 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.462 ' O ' ' HD2' ' A' ' 58' ' ' PRO . 0.1 OUTLIER 54.42 -74.56 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.407 179.643 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.706 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -144.14 -34.84 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.456 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.687 ' CB ' ' HB3' ' A' ' 89' ' ' ALA . 0.5 OUTLIER -54.05 -23.55 14.07 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.654 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.734 ' HB2' ' HB2' ' A' ' 60' ' ' MET . . . -54.22 -36.48 63.54 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.795 178.183 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.538 ' CD1' ' HG3' ' A' ' 58' ' ' PRO . 9.9 mp -59.47 -55.54 33.34 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.306 179.29 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.9 ' HA ' HD12 ' A' ' 69' ' ' ILE . 17.0 mt -44.24 -42.53 6.63 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.666 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.501 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 11.3 mttp -57.93 -47.19 83.59 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.037 179.159 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.826 ' CB ' HD13 ' A' ' 40' ' ' LEU . 10.6 mm100 -68.02 -30.33 69.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.375 179.444 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.9 HD12 ' HA ' ' A' ' 66' ' ' LEU . 77.9 mt -65.21 -45.11 94.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.222 -179.715 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.501 ' HG2' ' O ' ' A' ' 67' ' ' LYS . 8.9 ptmt -64.81 -29.31 70.27 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.961 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -72.72 -36.51 67.8 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.093 0.473 . . . . 0.0 110.928 179.585 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.44 -70.96 0.7 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.556 -179.616 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.747 ' NE2' HD13 ' A' ' 43' ' ' LEU . 2.2 p80 -117.83 78.0 12.11 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.59 -179.197 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.494 ' HA ' ' OE1' ' A' ' 96' ' ' GLN . 72.4 Cg_endo -76.46 56.27 5.02 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.536 2.157 . . . . 0.0 112.563 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 38.2 mtt -154.8 -43.02 0.09 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.093 0.473 . . . . 0.0 111.457 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.979 HD12 HG23 ' A' ' 47' ' ' THR . 1.0 OUTLIER -53.08 125.11 40.2 Favored Pre-proline 0 C--N 1.32 -0.679 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.614 -179.941 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.632 ' HD2' HD23 ' A' ' 76' ' ' LEU . 24.8 Cg_exo -61.82 129.65 28.37 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.428 2.085 . . . . 0.0 112.871 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.576 HG11 ' CD2' ' A' ' 66' ' ' LEU . 5.2 t -110.2 138.87 36.1 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.78 179.157 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.74 ' CG2' HD23 ' A' ' 114' ' ' LEU . 1.7 mt -123.8 113.2 36.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.545 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.585 HG22 HG21 ' A' ' 55' ' ' ILE . 15.1 mm -101.08 145.87 10.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.299 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.597 ' HG3' ' CG2' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -80.5 -30.11 37.33 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.242 -0.435 . . . . 0.0 112.029 -179.038 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.538 ' O ' HD13 ' A' ' 55' ' ' ILE . 4.8 m -147.44 146.48 29.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.836 0.35 . . . . 0.0 111.354 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.828 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -112.67 47.94 1.05 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.351 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.407 ' O ' ' HB2' ' A' ' 85' ' ' SER . 0.7 OUTLIER -98.49 -175.19 3.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.721 0.296 . . . . 0.0 110.743 179.816 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.407 ' HB2' ' O ' ' A' ' 84' ' ' HIS . 45.9 m 71.6 -78.39 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.793 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.567 ' O ' HD22 ' A' ' 63' ' ' LEU . 7.6 m-20 -138.99 68.1 1.38 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.64 0.257 . . . . 0.0 111.633 -179.327 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.723 ' HG ' ' HB1' ' A' ' 83' ' ' ALA . 0.4 OUTLIER -45.69 -23.82 0.29 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.898 179.467 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -48.54 -46.13 38.42 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -179.232 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.687 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -65.07 -20.04 66.29 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.809 0.338 . . . . 0.0 111.622 -179.379 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.571 ' HB2' HD23 ' A' ' 63' ' ' LEU . . . -68.84 -36.11 77.77 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.055 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.651 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 8.2 t -63.07 -41.2 91.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.063 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 44.5 m -63.31 -35.26 79.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.224 0.535 . . . . 0.0 110.306 179.255 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.805 ' HB2' HD13 ' A' ' 66' ' ' LEU . . . -57.78 -39.57 77.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.998 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.651 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 10.7 m-85 -63.24 -20.95 65.9 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.379 179.249 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.621 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -74.23 -41.37 61.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.723 -179.808 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.621 ' N ' ' HG2' ' A' ' 95' ' ' GLN . 1.0 OUTLIER -78.59 -18.47 54.53 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.494 -179.332 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 122.01 29.47 1.36 Allowed Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.789 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.605 ' HB2' ' HB1' ' A' ' 93' ' ' ALA . . . -64.1 143.32 57.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.762 0.281 . . . . 0.0 110.809 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.55 ' CE2' ' HB2' ' A' ' 118' ' ' ALA . 18.9 t80 -71.49 -53.96 12.19 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.249 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 168.21 -164.96 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.16 0.505 . . . . 0.0 111.124 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.828 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 3.3 m-85 -130.67 150.96 51.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.259 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.961 HD13 HD22 ' A' ' 114' ' ' LEU . 5.6 tp -102.87 135.56 19.42 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.986 -179.427 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.411 ' HG2' ' HG2' ' A' ' 105' ' ' PRO . 93.7 Cg_endo -78.96 -152.87 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.426 2.084 . . . . 0.0 111.904 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.515 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 5.7 mtpt -43.05 -56.55 6.2 Favored Pre-proline 0 CA--C 1.533 0.322 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.515 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 13.2 Cg_endo -56.71 163.39 7.21 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.565 2.177 . . . . 0.0 112.282 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.6 ' HD1' HD23 ' A' ' 102' ' ' LEU . 45.5 t80 -171.92 -105.03 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.892 179.758 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.521 ' O ' ' O ' ' A' ' 106' ' ' PHE . 4.6 p-10 43.75 -179.08 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.98 0.419 . . . . 0.0 111.039 -179.421 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.852 HG12 HG12 ' A' ' 18' ' ' VAL . 0.9 OUTLIER -67.84 -41.13 84.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 120.969 0.414 . . . . 0.0 111.533 -179.852 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.524 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 12.7 t70 -50.6 -58.56 5.54 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.623 -179.496 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.591 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 36.3 mm-40 -77.1 -30.89 55.51 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.663 0.268 . . . . 0.0 111.64 -179.447 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.403 ' CB ' ' O ' ' A' ' 107' ' ' ASP . . . -68.46 -61.13 1.97 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.018 0.437 . . . . 0.0 110.283 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.613 ' O ' HG12 ' A' ' 115' ' ' VAL . 58.1 t -57.63 -30.51 37.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.587 0.708 . . . . 0.0 110.25 178.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.524 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -63.86 -46.33 85.48 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.191 179.207 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.961 HD22 HD13 ' A' ' 102' ' ' LEU . 35.6 tp -74.66 -22.87 58.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.085 -179.316 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.613 HG12 ' O ' ' A' ' 112' ' ' VAL . 4.8 p -79.39 -46.44 23.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 120.442 -0.503 . . . . 0.0 111.639 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.412 ' N ' HG13 ' A' ' 115' ' ' VAL . 8.6 mt-10 -63.82 -45.29 90.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.963 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.577 ' HG2' ' HA ' ' A' ' 114' ' ' LEU . 0.0 OUTLIER -59.09 -27.06 65.19 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.956 0.408 . . . . 0.0 110.796 179.741 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.55 ' HB2' ' CE2' ' A' ' 99' ' ' PHE . . . -67.93 -47.64 68.17 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.629 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.671 HD13 ' CD2' ' A' ' 28' ' ' LEU . 4.5 mt -74.15 -31.17 28.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.819 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.0 t -69.64 -42.05 74.77 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.974 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 1.3 m80 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.976 179.963 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.52 -0.192 0 CA-C-O 121.225 0.536 . . . . 0.0 110.764 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.524 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . 61.74 87.99 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.507 -0.769 . . . . 0.0 112.49 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.7 mp -111.0 112.34 40.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.848 0.356 . . . . 0.0 111.514 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.859 HG11 HD22 ' A' ' 23' ' ' LEU . 2.8 p -107.83 126.21 64.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.309 178.734 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.879 ' CD1' HG22 ' A' ' 31' ' ' THR . 27.2 m0 -114.11 140.21 48.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.846 0.355 . . . . 0.0 110.181 179.17 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.673 HG13 ' HB3' ' A' ' 52' ' ' LEU . 1.1 t -123.73 147.71 28.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.36 -178.378 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.773 HG13 HG23 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -130.93 112.03 21.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.094 0.473 . . . . 0.0 110.446 179.146 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -161.64 -158.64 0.57 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.711 -178.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -66.87 -1.85 4.47 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.349 0.499 . . . . 0.0 112.349 -179.464 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.424 ' O ' ' N ' ' A' ' 14' ' ' SER . 0.2 OUTLIER 69.43 -157.97 0.16 Allowed 'General case' 0 CA--C 1.532 0.254 0 O-C-N 122.443 -0.16 . . . . 0.0 110.875 179.912 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.6 t 34.06 -88.96 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 179.355 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.882 ' O ' HG23 ' A' ' 18' ' ' VAL . 3.6 m -53.02 -63.38 1.16 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.809 0.338 . . . . 0.0 111.216 -179.701 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.8 mm -61.46 -25.67 37.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.984 0.421 . . . . 0.0 110.89 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.971 ' HA ' HG21 ' A' ' 32' ' ' THR . 30.8 ttt180 -71.42 -55.64 7.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.591 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.445 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 30.1 t90 -58.63 -41.1 85.17 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -179.193 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.895 HG12 HG12 ' A' ' 108' ' ' ILE . 2.5 t -65.26 -49.12 80.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -178.297 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.621 HD23 HG11 ' A' ' 8' ' ' VAL . 9.7 tp -82.64 -24.79 33.63 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -178.348 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.555 ' HG3' ' N ' ' A' ' 21' ' ' ARG . 10.7 pt-20 -65.75 -57.6 7.63 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.721 -179.368 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.555 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 1.2 mmt-85 -67.12 -48.99 66.44 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.063 -179.192 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.11 -40.57 81.54 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -178.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.904 ' CD2' HD13 ' A' ' 28' ' ' LEU . 0.2 OUTLIER -77.37 -25.13 50.68 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.225 0.536 . . . . 0.0 110.053 179.217 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.03 -34.24 77.63 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.689 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.97 -23.61 71.21 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 177.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.624 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -76.71 -15.4 59.79 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 120.87 0.366 . . . . 0.0 110.471 179.032 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.87 26.27 11.86 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 120.945 -0.645 . . . . 0.0 113.815 178.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.904 HD13 ' CD2' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -132.78 169.09 17.22 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 117.534 0.667 . . . . 0.0 112.384 -179.371 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 32.9 m -89.84 109.1 20.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.75 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.585 ' HA ' HG13 ' A' ' 6' ' ' VAL . 47.3 t -107.48 110.55 22.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.076 0.465 . . . . 0.0 111.585 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.879 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.7 t -118.96 153.45 34.61 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.971 HG21 ' HA ' ' A' ' 16' ' ' ARG . 34.5 p -125.35 162.79 24.0 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.301 0.572 . . . . 0.0 111.945 -179.259 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.732 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 1.1 m-85 -129.3 174.22 9.8 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.431 -178.264 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.46 ' HG2' ' N ' ' A' ' 35' ' ' ASN . 0.6 OUTLIER -61.6 -37.14 82.81 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 -177.299 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.46 ' N ' ' HG2' ' A' ' 34' ' ' GLU . 5.1 m120 -169.85 -56.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 118.443 0.565 . . . . 0.0 112.133 -179.474 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.947 ' CA ' HD21 ' A' ' 65' ' ' LEU . . . -164.7 -58.53 0.02 OUTLIER Glycine 0 C--N 1.318 -0.432 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.951 -179.175 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.429 ' HA ' ' CD1' ' A' ' 40' ' ' LEU . 1.0 OUTLIER -48.79 -34.98 13.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.687 0.28 . . . . 0.0 111.742 -179.456 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.732 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -55.33 -54.05 48.4 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.509 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.834 HG12 ' CD1' ' A' ' 43' ' ' LEU . 39.0 t -58.65 -42.53 85.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.569 179.436 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.785 HD13 ' CB ' ' A' ' 68' ' ' GLN . 4.0 mt -51.24 -45.47 62.01 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.794 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.64 -47.31 40.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.301 0.572 . . . . 0.0 110.867 179.354 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.81 -31.04 70.45 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.132 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.834 ' CD1' HG12 ' A' ' 39' ' ' VAL . 11.7 mt -68.68 -20.67 64.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.763 -179.553 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.77 -18.4 12.55 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.511 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.7 t -122.69 -0.46 9.13 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.326 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.688 ' O ' HD23 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -164.22 157.15 17.56 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.064 0.459 . . . . 0.0 111.603 179.918 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.773 ' CG2' HD13 ' A' ' 76' ' ' LEU . 96.2 m -139.03 115.99 8.72 Favored Pre-proline 0 N--CA 1.45 -0.433 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.143 179.543 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.659 ' HG3' ' HB2' ' A' ' 7' ' ' TRP . 58.5 Cg_endo -72.24 165.08 33.68 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.267 1.978 . . . . 0.0 111.167 178.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -75.28 -27.09 59.23 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.966 -0.294 . . . . 0.0 111.267 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.703 HG11 HG22 ' A' ' 115' ' ' VAL . 7.2 p -148.79 104.9 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.553 -179.494 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.619 HD11 HG11 ' A' ' 39' ' ' VAL . 21.2 tp -86.52 132.04 34.02 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -179.125 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.75 ' O ' HG23 ' A' ' 9' ' ' VAL . 0.3 OUTLIER -114.82 123.19 48.56 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.289 179.044 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.699 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 0.5 OUTLIER -125.76 139.65 53.34 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 121.447 0.641 . . . . 0.0 112.254 -179.238 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.22 -170.05 2.84 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.231 178.801 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.617 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 3.6 tt -155.02 91.13 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.932 0.396 . . . . 0.0 111.048 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.421 ' HB3' ' O ' ' A' ' 55' ' ' ILE . 9.7 ptm180 172.73 47.02 0.0 OUTLIER 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.133 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.597 ' HB3' ' CD ' ' A' ' 58' ' ' PRO . 2.8 tpt -158.41 -64.29 0.02 OUTLIER Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.597 ' CD ' ' HB3' ' A' ' 57' ' ' MET . 11.9 Cg_endo -54.66 176.05 0.13 Allowed 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.368 2.045 . . . . 0.0 112.643 -179.75 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -52.37 -59.62 8.78 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.21 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.591 ' O ' ' N ' ' A' ' 62' ' ' GLY . 0.0 OUTLIER -82.55 52.26 2.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.552 0.215 . . . . 0.0 110.51 179.369 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 56.3 -71.81 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.143 0.497 . . . . 0.0 111.17 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.617 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -148.01 -36.16 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.641 -0.708 . . . . 0.0 111.753 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.91 ' HA ' HD23 ' A' ' 66' ' ' LEU . 3.0 mp -53.17 -24.16 10.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.779 0.324 . . . . 0.0 110.408 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.542 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -56.92 -33.89 67.42 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.003 178.301 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.947 HD21 ' CA ' ' A' ' 36' ' ' GLY . 0.2 OUTLIER -59.79 -35.86 75.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.429 179.39 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.986 ' HA ' HD12 ' A' ' 69' ' ' ILE . 3.3 mm? -63.67 -43.52 96.44 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.056 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.412 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 5.2 mmpt? -52.9 -50.62 63.55 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.325 179.085 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.785 ' CB ' HD13 ' A' ' 40' ' ' LEU . 12.2 mm100 -62.7 -38.46 90.49 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.517 179.16 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.986 HD12 ' HA ' ' A' ' 66' ' ' LEU . 18.5 mt -54.74 -46.09 73.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.645 -179.062 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.428 ' HB3' ' CD ' ' A' ' 96' ' ' GLN . 0.3 OUTLIER -69.61 -25.94 64.2 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.793 -179.27 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -85.62 -39.73 17.01 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -179.086 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.478 HH21 ' HB2' ' A' ' 40' ' ' LEU . 2.1 mtm180 -102.32 -40.9 6.54 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -178.48 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.696 ' CE1' HG12 ' A' ' 69' ' ' ILE . 0.5 OUTLIER -85.64 136.87 36.56 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.214 -178.962 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.602 ' O ' ' HG2' ' A' ' 75' ' ' MET . 17.2 Cg_exo -67.08 70.41 0.55 Allowed 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.509 2.139 . . . . 0.0 112.219 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.627 ' HB2' ' O ' ' A' ' 96' ' ' GLN . 0.2 OUTLIER 50.5 33.9 8.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.062 0.458 . . . . 0.0 111.114 179.843 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.773 HD13 ' CG2' ' A' ' 47' ' ' THR . 20.7 tp -67.23 131.79 93.47 Favored Pre-proline 0 C--O 1.233 0.216 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.299 -179.772 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.737 ' HD2' HD12 ' A' ' 76' ' ' LEU . 27.9 Cg_endo -63.66 127.32 19.45 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.383 2.055 . . . . 0.0 112.052 179.562 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.958 HG21 HD13 ' A' ' 69' ' ' ILE . 5.7 t -118.28 147.79 21.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.428 -179.423 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.674 HG21 HD23 ' A' ' 114' ' ' LEU . 2.0 mp -122.78 113.22 37.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.161 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.699 ' HA ' ' O ' ' A' ' 53' ' ' SER . 22.3 mm -99.31 144.22 12.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.568 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.561 ' O ' ' HB2' ' A' ' 102' ' ' LEU . 7.7 ttt -67.73 -67.22 0.48 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.47 -179.58 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.603 ' H ' ' CG2' ' A' ' 55' ' ' ILE . 3.7 m -106.45 169.65 8.39 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.524 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 1.036 ' HB1' HD23 ' A' ' 87' ' ' LEU . . . -124.22 -2.84 8.05 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -179.135 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.464 ' O ' ' O ' ' A' ' 83' ' ' ALA . 33.1 m170 31.23 -160.63 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 179.064 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 24.9 m -81.09 -22.58 39.05 Favored 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -178.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.489 ' HB2' HD13 ' A' ' 63' ' ' LEU . 67.4 m-20 -79.81 21.6 0.53 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 120.549 0.214 . . . . 0.0 111.324 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 1.036 HD23 ' HB1' ' A' ' 83' ' ' ALA . 3.1 tm? -43.68 -24.37 0.12 Allowed 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -49.03 -38.2 22.93 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.647 ' HB3' ' HB3' ' A' ' 63' ' ' LEU . . . -71.4 -22.94 61.8 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -179.034 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.676 ' HB2' HD23 ' A' ' 63' ' ' LEU . . . -73.45 -29.82 62.8 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.878 0.37 . . . . 0.0 110.476 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.623 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 3.0 t -61.74 -45.6 98.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.177 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.515 ' O ' ' HB3' ' A' ' 95' ' ' GLN . 83.7 p -67.46 -22.25 65.49 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 178.299 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' A' ' 90' ' ' ALA . . . -64.49 -39.73 94.34 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.306 0.574 . . . . 0.0 109.793 178.843 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.623 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 9.6 m-85 -69.19 -23.93 63.98 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.719 178.552 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.515 ' HB3' ' O ' ' A' ' 92' ' ' SER . 0.3 OUTLIER -67.59 -46.45 72.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.388 -179.949 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.627 ' O ' ' HB2' ' A' ' 75' ' ' MET . 4.5 pm0 -76.17 -18.14 59.24 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.751 179.389 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 117.7 33.9 1.24 Allowed Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.387 -0.911 . . . . 0.0 113.601 178.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.436 ' HB2' ' HB1' ' A' ' 93' ' ' ALA . . . -62.6 155.92 24.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.957 0.379 . . . . 0.0 110.553 179.339 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.597 ' CZ ' ' HB2' ' A' ' 118' ' ' ALA . 15.4 t80 -76.45 -53.69 7.77 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.032 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 168.46 -166.99 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.241 0.543 . . . . 0.0 111.799 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.525 ' CE2' ' HB ' ' A' ' 80' ' ' ILE . 3.2 m-85 -136.07 153.23 51.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.888 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.631 HD11 HD22 ' A' ' 114' ' ' LEU . 5.8 mp -102.22 120.26 54.05 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 120.595 0.236 . . . . 0.0 110.565 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -61.71 -67.33 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.116 1.877 . . . . 0.0 112.334 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.697 ' HB3' ' HD3' ' A' ' 105' ' ' PRO . 3.1 tttm -126.57 -53.04 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.074 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.697 ' HD3' ' HB3' ' A' ' 104' ' ' LYS . 31.8 Cg_exo -58.85 164.02 10.43 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.293 1.995 . . . . 0.0 112.311 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.681 ' O ' ' O ' ' A' ' 107' ' ' ASP . 74.2 t80 -169.38 -97.45 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.943 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.681 ' O ' ' O ' ' A' ' 106' ' ' PHE . 0.3 OUTLIER 37.53 177.3 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.26 0.553 . . . . 0.0 112.356 179.344 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.895 HG12 HG12 ' A' ' 18' ' ' VAL . 0.5 OUTLIER -68.18 -48.22 74.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.899 0.38 . . . . 0.0 111.998 -179.75 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -49.52 -58.7 4.71 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.913 -179.017 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.616 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 6.2 mm-40 -70.15 -30.75 67.99 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.811 0.339 . . . . 0.0 111.079 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -68.12 -62.17 1.52 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.063 179.457 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.635 ' O ' HG12 ' A' ' 115' ' ' VAL . 38.7 t -56.01 -34.24 37.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.36 0.6 . . . . 0.0 110.682 178.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.12 -45.9 91.43 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.389 179.556 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.674 HD23 HG21 ' A' ' 79' ' ' ILE . 5.2 tp -78.5 -21.52 48.82 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.56 -179.505 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.703 HG22 HG11 ' A' ' 50' ' ' VAL . 1.3 p -77.98 -36.34 21.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.613 -179.413 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -68.39 -41.08 81.03 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.098 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 5.6 mmt85 -60.47 -24.85 65.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.273 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.597 ' HB2' ' CZ ' ' A' ' 99' ' ' PHE . . . -71.3 -43.33 67.3 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.937 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.621 HD13 ' CD2' ' A' ' 28' ' ' LEU . 4.9 mt -73.57 -31.98 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.175 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 33.5 t -64.57 -42.32 95.72 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.947 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 14.5 m80 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.92 -179.941 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.732 ' HG3' HD11 ' A' ' 5' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.955 0.407 . . . . 0.0 111.231 . . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.473 ' C ' HD13 ' A' ' 5' ' ' ILE . . . 96.22 102.27 1.99 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.012 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.732 HD11 ' HG3' ' A' ' 3' ' ' ARG . 7.4 mm -114.13 114.14 45.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.956 0.408 . . . . 0.0 111.737 -179.382 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 1.025 HG11 HD13 ' A' ' 23' ' ' LEU . 3.5 p -114.07 119.81 62.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.128 178.751 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.952 ' CD1' HG22 ' A' ' 31' ' ' THR . 39.0 m0 -112.46 143.74 43.09 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.009 0.433 . . . . 0.0 110.698 -179.806 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.655 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -129.3 136.91 58.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.539 -178.807 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.897 HG11 ' HA2' ' A' ' 36' ' ' GLY . 3.0 m -115.64 110.09 30.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.625 178.947 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.531 ' OD1' ' HB ' ' A' ' 15' ' ' ILE . 1.9 p30 -164.05 -159.11 0.47 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.186 -178.052 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -66.45 -3.02 5.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.832 -179.619 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 66.41 -152.09 0.22 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.473 0.177 . . . . 0.0 111.271 179.359 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.456 ' OG ' ' N ' ' A' ' 14' ' ' SER . 72.0 p 34.89 -95.33 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 178.831 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.71 ' O ' HG23 ' A' ' 18' ' ' VAL . 8.2 t -52.79 -60.57 3.1 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.748 -178.984 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.531 ' HB ' ' OD1' ' A' ' 10' ' ' ASP . 9.9 mm -60.54 -24.99 33.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.684 0.278 . . . . 0.0 110.955 -179.781 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.699 ' HA ' HG21 ' A' ' 32' ' ' THR . 3.2 ttm-85 -71.48 -51.89 21.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.794 0.331 . . . . 0.0 110.594 179.494 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.402 ' HA ' ' CD ' ' A' ' 20' ' ' GLU . 40.8 t90 -59.3 -38.44 80.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.824 -179.516 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.71 HG23 ' O ' ' A' ' 14' ' ' SER . 18.1 t -65.65 -54.18 30.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -178.717 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.748 HD12 HD12 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -76.18 -26.43 56.19 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -178.235 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.631 ' HA ' ' CB ' ' A' ' 30' ' ' CYS . 10.7 pt-20 -67.82 -60.69 2.32 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.56 -0.456 . . . . 0.0 112.109 -178.874 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.501 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 4.5 mmm180 -57.89 -55.94 28.44 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.921 -179.098 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.44 -50.09 65.99 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -179.198 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 1.04 HD22 HD13 ' A' ' 28' ' ' LEU . 5.2 mt -69.44 -29.0 66.6 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.131 0.491 . . . . 0.0 110.16 179.532 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.1 -35.01 75.86 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.422 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.04 -28.09 69.92 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.048 -1.073 . . . . 0.0 110.462 177.762 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.72 ' HB3' HD11 ' A' ' 28' ' ' LEU . . . -78.53 -15.99 57.96 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 120.578 0.228 . . . . 0.0 110.88 179.173 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.86 27.11 13.09 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 120.482 -0.866 . . . . 0.0 114.491 178.665 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 1.04 HD13 HD22 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -118.04 167.53 11.37 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 118.407 1.104 . . . . 0.0 112.105 -179.921 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 98.7 m -88.28 117.23 27.04 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.941 179.223 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.631 ' CB ' ' HA ' ' A' ' 20' ' ' GLU . 3.1 m -108.96 110.19 21.43 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.661 -178.907 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.952 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.7 t -130.22 135.61 48.33 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 178.484 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.699 HG21 ' HA ' ' A' ' 16' ' ' ARG . 29.8 p -111.09 164.8 12.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.262 0.553 . . . . 0.0 111.915 -179.054 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.793 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 3.7 m-85 -136.39 172.17 13.41 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.302 -178.204 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.584 ' HG2' ' N ' ' A' ' 35' ' ' ASN . 0.1 OUTLIER -63.4 -32.63 74.12 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 121.445 0.64 . . . . 0.0 109.917 179.202 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.584 ' N ' ' HG2' ' A' ' 34' ' ' GLU . 8.1 t-20 179.81 170.2 1.14 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.994 -179.81 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.897 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . -43.43 -29.9 1.23 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.788 -0.72 . . . . 0.0 113.629 -179.238 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.47 ' HA ' ' HG ' ' A' ' 40' ' ' LEU . 0.4 OUTLIER -58.88 -51.48 69.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.737 0.304 . . . . 0.0 111.525 -179.48 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.793 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -51.91 -48.72 64.04 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.909 -0.316 . . . . 0.0 111.289 -179.531 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.621 HG22 ' CE1' ' A' ' 33' ' ' PHE . 79.5 t -60.7 -27.4 40.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.113 179.808 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.541 ' HG ' ' O ' ' A' ' 36' ' ' GLY . 33.9 mt -57.39 -46.88 82.96 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.222 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.31 -48.69 49.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.098 179.569 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.67 -31.6 68.34 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.832 179.818 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.695 HD21 ' HD2' ' A' ' 48' ' ' PRO . 16.1 mt -70.02 -25.03 63.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.485 -179.936 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.24 -19.6 14.68 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.913 -179.36 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.8 2.13 8.13 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -179.663 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.58 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -163.65 155.6 17.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.793 0.33 . . . . 0.0 110.733 179.712 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.622 HG23 ' CD2' ' A' ' 76' ' ' LEU . 87.4 m -139.09 112.71 8.12 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.466 179.92 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.695 ' HD2' HD21 ' A' ' 43' ' ' LEU . 94.7 Cg_endo -78.22 165.59 25.57 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.063 1.842 . . . . 0.0 110.914 178.538 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.633 ' OD2' HG12 ' A' ' 119' ' ' ILE . 4.8 p-10 -74.59 -59.58 2.67 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.659 -179.733 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.746 HG13 HG23 ' A' ' 6' ' ' VAL . 10.0 p -101.91 164.85 2.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.926 179.558 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.638 HD23 HG22 ' A' ' 78' ' ' VAL . 14.5 tp -153.45 143.04 21.82 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 120.733 0.301 . . . . 0.0 111.072 -179.765 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.602 ' HG ' ' HB ' ' A' ' 79' ' ' ILE . 0.2 OUTLIER -129.17 142.15 50.96 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.631 -0.258 . . . . 0.0 110.783 -179.922 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.798 ' HA ' HG23 ' A' ' 9' ' ' VAL . 3.0 m -129.48 137.05 50.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.005 0.431 . . . . 0.0 111.494 -179.864 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.471 ' HB3' ' HB3' ' A' ' 10' ' ' ASP . 20.7 p-10 -77.87 -18.03 56.68 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.745 -178.712 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.579 HG13 ' HA3' ' A' ' 62' ' ' GLY . 0.7 OUTLIER 45.28 91.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-O 120.823 0.344 . . . . 0.0 111.255 -179.779 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.0 49.66 2.25 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -179.108 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.476 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 1.1 ttt 57.01 51.01 4.99 Favored Pre-proline 0 N--CA 1.466 0.364 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 178.715 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 62' ' ' GLY . 42.8 Cg_endo -69.26 -78.87 0.01 OUTLIER 'Trans proline' 0 CA--C 1.533 0.428 0 C-N-CA 122.75 2.3 . . . . 0.0 112.102 178.685 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -112.2 -20.81 6.51 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 121.262 -0.494 . . . . 0.0 112.09 179.603 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' MET . . . . . 1.001 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 0.8 OUTLIER -159.99 66.38 0.36 Allowed 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.084 0.469 . . . . 0.0 110.266 179.725 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.476 ' HA ' ' HA ' ' A' ' 57' ' ' MET . 0.9 OUTLIER 68.29 -23.56 0.13 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.321 179.746 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.607 ' N ' ' HD2' ' A' ' 58' ' ' PRO . . . 140.21 -31.67 2.24 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 111.286 -0.726 . . . . 0.0 111.286 -179.604 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.657 HD12 ' H ' ' A' ' 63' ' ' LEU . 2.4 mp -66.74 -28.23 68.25 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 178.92 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 1.001 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -53.79 -28.72 36.67 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.352 0.596 . . . . 0.0 109.791 178.074 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.705 ' CD2' HD11 ' A' ' 69' ' ' ILE . 4.9 tt -51.67 -57.06 10.27 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.343 179.243 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.726 HD13 ' CB ' ' A' ' 93' ' ' ALA . 1.9 mt -55.76 -40.99 73.34 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.746 -1.116 . . . . 0.0 110.692 179.91 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.531 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -47.72 -49.11 28.97 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 120.792 0.33 . . . . 0.0 111.039 179.197 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 8.8 mm100 -69.22 -32.21 71.3 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.028 0.442 . . . . 0.0 110.831 -179.948 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.705 HD11 ' CD2' ' A' ' 65' ' ' LEU . 81.3 mt -60.75 -40.85 86.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.535 -179.222 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.531 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -74.61 -27.9 60.67 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.767 -179.666 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.0 -41.95 67.02 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.674 -178.925 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 72' ' ' ARG . 1.0 OUTLIER -94.84 -26.42 16.21 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.377 -0.374 . . . . 0.0 112.007 -179.15 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.592 ' CE1' HD12 ' A' ' 43' ' ' LEU . 0.1 OUTLIER -124.52 168.45 13.08 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-O 120.749 0.309 . . . . 0.0 111.173 -179.421 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.492 ' HD2' ' HB3' ' A' ' 73' ' ' HIS . 35.5 Cg_endo -69.6 -83.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.339 2.026 . . . . 0.0 112.723 -179.373 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.435 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 8.0 mtm -146.71 55.44 1.13 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.734 0.302 . . . . 0.0 111.406 -179.626 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.622 ' CD2' HG23 ' A' ' 47' ' ' THR . 0.1 OUTLIER -57.22 111.09 2.96 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.427 179.811 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.615 ' HD2' HD13 ' A' ' 76' ' ' LEU . 38.6 Cg_exo -58.68 115.62 2.67 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.264 1.976 . . . . 0.0 112.593 179.841 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.962 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 5.0 t -117.59 145.96 22.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.951 179.622 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.602 ' HB ' ' HG ' ' A' ' 52' ' ' LEU . 1.6 mp -117.52 112.61 39.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 179.147 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.785 HG13 ' CZ ' ' A' ' 101' ' ' TYR . 16.5 mm -93.7 130.65 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -178.205 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.667 ' HB2' ' CD2' ' A' ' 106' ' ' PHE . 6.7 ptm -72.43 -29.8 64.03 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.693 -179.968 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.568 ' H ' HG21 ' A' ' 55' ' ' ILE . 5.3 m -135.6 138.3 42.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.386 -179.433 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.571 ' HA ' ' CE2' ' A' ' 101' ' ' TYR . . . -89.71 -27.05 20.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.574 179.957 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.534 ' CE1' HG21 ' A' ' 82' ' ' THR . 3.2 m-70 44.72 -159.74 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.286 179.609 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.423 ' H ' ' HB3' ' A' ' 84' ' ' HIS . 2.6 t -81.41 164.31 22.18 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.937 0.399 . . . . 0.0 111.415 -179.529 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.406 ' O ' HD22 ' A' ' 63' ' ' LEU . 0.2 OUTLIER 72.07 31.24 2.01 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.746 179.99 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.607 HD23 ' CB ' ' A' ' 90' ' ' ALA . 1.1 mt -45.8 -21.84 0.15 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.793 -0.639 . . . . 0.0 112.502 -179.812 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -48.11 -44.23 31.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.617 0.246 . . . . 0.0 111.042 -179.657 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.505 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -67.25 -20.55 65.68 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.191 179.902 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.61 ' O ' ' HB3' ' A' ' 93' ' ' ALA . . . -62.35 -50.5 71.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.886 -179.777 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.587 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 6.3 t -67.72 -45.47 84.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.41 179.587 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.678 ' O ' ' HG3' ' A' ' 95' ' ' GLN . 9.8 m -61.56 -14.07 26.83 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.088 0.471 . . . . 0.0 109.835 178.24 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.726 ' CB ' HD13 ' A' ' 66' ' ' LEU . . . -75.66 -53.25 8.86 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.399 179.724 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.667 ' CE1' ' HA ' ' A' ' 100' ' ' ASP . 4.8 m-85 -55.81 -34.78 65.66 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.142 -178.805 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.678 ' HG3' ' O ' ' A' ' 92' ' ' SER . 1.8 pp0? -74.37 -34.14 63.26 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.242 -179.755 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.507 ' HG2' ' HA ' ' A' ' 93' ' ' ALA . 9.3 pt20 -100.29 11.29 39.75 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.141 -179.344 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 119.43 78.26 0.56 Allowed Glycine 0 C--N 1.334 0.441 0 C-N-CA 120.314 -0.946 . . . . 0.0 113.474 179.79 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.962 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -169.04 134.89 1.66 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.08 0.467 . . . . 0.0 111.623 178.966 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.724 ' CD2' ' HB2' ' A' ' 118' ' ' ALA . 3.5 t80 -74.96 -52.53 10.94 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.237 -179.673 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.667 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 0.9 OUTLIER 179.15 -167.71 0.08 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.247 0.546 . . . . 0.0 111.955 -179.831 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.785 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 4.9 m-85 -136.04 153.17 51.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.275 -179.685 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.602 HD23 ' HA ' ' A' ' 81' ' ' MET . 1.7 mm? -102.82 120.7 51.81 Favored Pre-proline 0 C--N 1.329 -0.299 0 C-N-CA 121.081 -0.247 . . . . 0.0 110.83 179.51 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -66.26 -78.7 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.318 2.012 . . . . 0.0 112.395 -179.838 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.648 ' HB3' ' HD3' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -108.81 -58.18 0.05 OUTLIER Pre-proline 0 C--O 1.232 0.175 0 C-N-CA 121.185 -0.206 . . . . 0.0 111.425 179.949 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.648 ' HD3' ' HB3' ' A' ' 104' ' ' LYS . 77.0 Cg_endo -79.07 163.03 25.79 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 121.693 1.595 . . . . 0.0 110.726 178.933 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.717 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 0.9 OUTLIER 177.58 -91.38 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 121.3 -0.16 . . . . 0.0 111.262 179.936 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.511 ' O ' ' CB ' ' A' ' 111' ' ' ALA . 2.7 p30 44.04 -165.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 -179.442 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.534 HG12 HG12 ' A' ' 18' ' ' VAL . 1.0 OUTLIER -66.67 -43.83 90.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 120.744 -0.383 . . . . 0.0 111.528 -179.727 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.471 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 8.6 t70 -48.84 -58.33 4.98 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.192 -179.684 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.717 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 5.2 mm-40 -78.23 -32.61 49.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.552 -179.68 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.511 ' CB ' ' O ' ' A' ' 107' ' ' ASP . . . -65.92 -59.58 3.7 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 179.398 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.709 ' O ' HG12 ' A' ' 115' ' ' VAL . 56.0 t -59.58 -29.85 43.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.452 0.644 . . . . 0.0 110.195 178.877 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.471 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -66.49 -46.76 75.23 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.566 178.759 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.521 HD23 ' CG2' ' A' ' 79' ' ' ILE . 15.2 tp -74.81 -20.76 59.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.205 179.859 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.709 HG12 ' O ' ' A' ' 112' ' ' VAL . 5.5 p -79.31 -48.43 21.17 Favored 'Isoleucine or valine' 0 C--O 1.231 0.088 0 CA-C-O 120.841 0.353 . . . . 0.0 111.44 179.985 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.629 ' HA ' HD12 ' A' ' 119' ' ' ILE . 35.6 mt-10 -63.5 -38.13 89.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.938 -179.967 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 13.6 mmt180 -65.24 -24.88 67.45 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.901 179.761 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.724 ' HB2' ' CD2' ' A' ' 99' ' ' PHE . . . -74.42 -39.63 62.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.222 179.935 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.633 HG12 ' OD2' ' A' ' 49' ' ' ASP . 4.9 mt -71.74 -30.67 38.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.135 0.493 . . . . 0.0 110.72 179.873 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 24.3 t -67.71 -35.77 79.38 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.02 179.823 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 25.9 m80 . . . . . 0 C--N 1.33 -0.263 0 CA-C-O 120.897 0.38 . . . . 0.0 111.161 -179.804 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.408 ' HG3' HD11 ' A' ' 5' ' ' ILE . 10.2 ptt-85 . . . . . 0 C--O 1.231 0.121 0 CA-C-O 121.039 0.447 . . . . 0.0 111.828 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.416 ' C ' HD13 ' A' ' 5' ' ' ILE . . . 98.85 102.12 2.31 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.964 -0.636 . . . . 0.0 111.879 -179.301 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.439 ' HB ' ' HA ' ' A' ' 48' ' ' PRO . 8.4 mm -111.12 112.78 42.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.887 0.375 . . . . 0.0 111.351 -179.393 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.92 HG23 HG13 ' A' ' 50' ' ' VAL . 7.7 p -109.06 123.47 64.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.818 179.459 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.955 ' CD1' HG22 ' A' ' 31' ' ' THR . 40.5 m0 -113.68 133.7 55.17 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.686 -179.798 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.567 HG13 ' HB3' ' A' ' 52' ' ' LEU . 0.6 OUTLIER -119.43 145.79 25.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.997 0.427 . . . . 0.0 111.965 -179.106 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.806 HG11 ' HA2' ' A' ' 36' ' ' GLY . 0.0 OUTLIER -123.96 110.63 26.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.095 0.474 . . . . 0.0 110.985 178.999 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.418 ' CB ' HG21 ' A' ' 15' ' ' ILE . 5.0 t0 -161.17 -163.45 1.02 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.78 -179.549 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -66.66 -1.73 4.08 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -178.788 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.529 ' O ' ' N ' ' A' ' 14' ' ' SER . 1.2 t70 65.24 -141.85 0.21 Allowed 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 121.027 -0.269 . . . . 0.0 110.61 179.338 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.486 ' HA ' ' HE ' ' A' ' 16' ' ' ARG . 1.0 OUTLIER 35.29 -82.21 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 179.07 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.758 ' O ' HG23 ' A' ' 18' ' ' VAL . 1.8 m -80.17 -44.4 19.91 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -178.71 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.418 HG21 ' CB ' ' A' ' 10' ' ' ASP . 27.3 mm -65.24 -33.74 65.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 -178.773 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.809 ' HA ' HG21 ' A' ' 32' ' ' THR . 2.4 ppt_? -72.42 -55.27 7.32 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.881 -179.279 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.422 ' N ' ' HD2' ' A' ' 16' ' ' ARG . 81.4 t90 -48.12 -41.95 27.89 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -178.9 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.943 HG12 HD13 ' A' ' 108' ' ' ILE . 0.8 OUTLIER -73.11 -57.48 6.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.137 0.494 . . . . 0.0 112.252 -178.557 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 1.046 HD12 HD12 ' A' ' 108' ' ' ILE . 7.3 mp -65.02 -30.94 71.95 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.573 -0.739 . . . . 0.0 112.567 -177.912 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.523 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 19.9 pt-20 -67.77 -59.18 3.51 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.877 0.37 . . . . 0.0 111.484 -179.63 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.473 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 6.2 mmm180 -56.9 -51.45 69.06 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.586 -179.623 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.567 ' HB3' HD11 ' A' ' 108' ' ' ILE . . . -59.47 -43.56 93.23 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 120.876 0.37 . . . . 0.0 111.589 -179.355 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.855 ' CD2' HG11 ' A' ' 6' ' ' VAL . 2.1 tp -74.09 -24.58 59.5 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.214 179.634 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.47 -35.16 75.34 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.357 178.374 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.9 -26.09 69.81 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.522 -0.847 . . . . 0.0 111.283 178.656 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.595 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -76.68 -16.15 59.6 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 120.677 0.275 . . . . 0.0 111.246 179.636 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.46 26.65 8.05 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 120.45 -0.881 . . . . 0.0 114.374 178.748 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.783 HD13 ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -125.72 170.83 11.16 Favored 'General case' 0 C--O 1.231 0.079 0 CA-C-N 118.28 1.04 . . . . 0.0 112.018 179.943 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 31.5 m -99.25 105.96 18.05 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.807 179.954 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.618 ' HA ' HG13 ' A' ' 6' ' ' VAL . 4.7 t -98.29 117.1 31.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.583 -179.675 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.955 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.2 t -126.66 130.92 51.37 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 178.401 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.809 HG21 ' HA ' ' A' ' 16' ' ' ARG . 60.4 p -103.26 164.51 11.59 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -177.713 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.718 ' CE1' HG23 ' A' ' 31' ' ' THR . 3.4 m-85 -135.92 174.48 10.56 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.936 -178.057 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.75 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 2.9 pp20? -61.36 -40.13 93.16 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -177.561 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.408 ' O ' ' HB ' ' A' ' 9' ' ' VAL . 1.4 t-20 -168.31 -46.66 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -179.165 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.833 ' CA ' HD21 ' A' ' 65' ' ' LEU . . . -176.73 -47.48 0.06 OUTLIER Glycine 0 C--N 1.32 -0.318 0 C-N-CA 120.178 -1.011 . . . . 0.0 113.628 -178.907 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -65.77 -27.94 68.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.896 0.379 . . . . 0.0 111.168 -179.2 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.75 ' HB2' ' HG3' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -58.62 -53.39 58.84 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.052 179.997 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.743 HG12 ' CD1' ' A' ' 43' ' ' LEU . 8.2 t -51.94 -49.01 39.38 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.145 0 C-N-CA 120.39 -0.524 . . . . 0.0 109.925 179.683 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.802 HD13 ' HB3' ' A' ' 68' ' ' GLN . 22.3 mt -48.18 -42.55 30.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.08 179.879 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.62 -49.57 62.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.232 0.539 . . . . 0.0 110.862 179.576 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.14 -26.41 68.8 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.712 179.552 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.774 HD13 ' NE2' ' A' ' 73' ' ' HIS . 1.3 mt -69.7 -27.12 64.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.465 -178.918 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.46 -21.04 1.31 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.84 -179.556 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 29.9 t -126.09 6.56 7.2 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -179.435 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.54 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.3 OUTLIER -166.44 156.44 11.9 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.974 0.416 . . . . 0.0 111.451 179.969 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 47' ' ' THR . . . . . 1.023 HG23 HD12 ' A' ' 76' ' ' LEU . 98.2 m -139.09 112.51 8.1 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.22 179.616 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.613 ' CD ' HD11 ' A' ' 76' ' ' LEU . 57.7 Cg_endo -71.82 165.13 33.48 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 121.873 1.716 . . . . 0.0 111.027 178.974 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -76.43 -22.66 54.38 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.691 -0.403 . . . . 0.0 111.232 -179.795 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.92 HG13 HG23 ' A' ' 6' ' ' VAL . 9.1 p -145.55 165.48 10.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 116.679 -0.237 . . . . 0.0 111.222 -179.666 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.764 HD12 ' O ' ' A' ' 7' ' ' TRP . 12.1 tp -152.69 136.31 16.07 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.999 0.428 . . . . 0.0 111.561 -179.353 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.567 ' HB3' HG13 ' A' ' 8' ' ' VAL . 0.6 OUTLIER -122.85 117.29 25.28 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.509 -179.991 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.481 ' OG ' HD13 ' A' ' 65' ' ' LEU . 3.3 m -105.76 134.53 48.73 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.232 0.539 . . . . 0.0 111.705 -179.667 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -83.08 16.04 2.55 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -178.938 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.774 HG22 ' HG2' ' A' ' 81' ' ' MET . 1.1 tt 31.53 -107.75 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 179.434 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.478 ' N ' ' CG1' ' A' ' 55' ' ' ILE . 3.5 ttt180 54.16 43.42 30.67 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 179.618 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.524 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 1.0 OUTLIER 48.25 63.78 9.73 Favored Pre-proline 0 N--CA 1.468 0.44 0 N-CA-C 113.472 0.915 . . . . 0.0 113.472 178.694 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.604 ' HD2' ' N ' ' A' ' 62' ' ' GLY . 55.9 Cg_endo -73.86 -78.23 0.01 OUTLIER 'Trans proline' 0 CA--C 1.533 0.434 0 C-N-CA 122.419 2.079 . . . . 0.0 111.248 177.948 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -109.61 -28.55 4.23 Favored Glycine 0 C--N 1.335 0.477 0 C-N-CA 121.127 -0.559 . . . . 0.0 112.16 179.068 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' MET . . . . . 1.025 ' HB3' ' HB2' ' A' ' 64' ' ' ALA . 0.4 OUTLIER -152.42 65.19 0.82 Allowed 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.173 0.511 . . . . 0.0 110.048 179.544 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.654 ' O ' HG13 ' A' ' 55' ' ' ILE . 0.4 OUTLIER 68.07 -25.29 0.13 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.184 -0.917 . . . . 0.0 112.161 -179.788 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.604 ' N ' ' HD2' ' A' ' 58' ' ' PRO . . . 141.84 -31.92 2.06 Favored Glycine 0 CA--C 1.502 -0.728 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 179.981 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.842 HD11 ' HB2' ' A' ' 85' ' ' SER . 1.2 mp -70.61 -16.75 62.87 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 115.068 -0.566 . . . . 0.0 110.044 179.124 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 1.025 ' HB2' ' HB3' ' A' ' 60' ' ' MET . . . -53.5 -39.26 64.45 Favored 'General case' 0 CA--C 1.522 -0.098 0 CA-C-O 121.312 0.577 . . . . 0.0 109.768 178.115 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.833 HD21 ' CA ' ' A' ' 36' ' ' GLY . 6.8 mt -62.3 -39.18 92.13 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.885 179.755 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.789 HD23 ' HA ' ' A' ' 63' ' ' LEU . 1.2 mm? -59.02 -44.12 91.68 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.272 0.558 . . . . 0.0 109.804 179.165 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.639 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -57.98 -43.7 86.7 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.729 179.474 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.802 ' HB3' HD13 ' A' ' 40' ' ' LEU . 30.3 mm100 -73.93 -38.41 64.28 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.659 179.692 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.811 HG21 HG22 ' A' ' 78' ' ' VAL . 17.1 mt -63.5 -36.0 74.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.364 -179.247 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.639 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -75.41 -26.64 58.57 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.056 -179.57 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -86.21 -32.62 21.09 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.603 -179.351 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.422 ' HD2' ' HB3' ' A' ' 40' ' ' LEU . 0.6 OUTLIER -95.41 -23.44 17.15 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.154 0.428 . . . . 0.0 112.154 -179.692 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.802 ' CE1' HG23 ' A' ' 69' ' ' ILE . 0.2 OUTLIER -111.11 135.23 20.9 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-O 120.673 0.273 . . . . 0.0 111.667 -179.07 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -59.76 -54.41 2.43 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.41 2.073 . . . . 0.0 112.082 179.116 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.449 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 22.2 mtt -156.47 36.74 0.32 Allowed 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.227 -179.9 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 1.023 HD12 HG23 ' A' ' 47' ' ' THR . 0.7 OUTLIER -71.13 121.79 85.18 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.379 -179.891 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.448 ' HD2' HD23 ' A' ' 76' ' ' LEU . 15.7 Cg_exo -68.58 121.86 8.8 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.586 2.19 . . . . 0.0 112.762 -179.708 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.811 HG22 HG21 ' A' ' 69' ' ' ILE . 11.4 t -99.21 141.02 17.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.843 179.302 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.964 HD13 HG23 ' A' ' 115' ' ' VAL . 2.4 mt -127.07 110.67 23.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.945 179.853 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.545 ' HB ' ' CD2' ' A' ' 101' ' ' TYR . 5.4 mm -101.17 142.12 16.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.104 -179.926 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.774 ' HG2' HG22 ' A' ' 55' ' ' ILE . 26.5 ptm -66.66 -56.51 10.3 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.943 179.607 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.682 ' O ' HD13 ' A' ' 55' ' ' ILE . 2.8 m -131.06 152.21 50.6 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 121.771 -0.581 . . . . 0.0 112.152 -179.809 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.968 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -116.71 46.18 1.68 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.825 -179.796 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 17.1 p80 -77.23 56.65 1.33 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.666 0.269 . . . . 0.0 111.192 -179.98 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.842 ' HB2' HD11 ' A' ' 63' ' ' LEU . 0.7 OUTLIER -159.64 -160.63 0.84 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 121.046 0.45 . . . . 0.0 111.67 -179.642 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.79 90.05 0.17 Allowed 'General case' 0 CA--C 1.528 0.097 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.834 179.559 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.761 HD13 ' HB3' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -44.44 -21.29 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -179.965 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -48.12 -53.66 15.87 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -178.975 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.554 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -66.46 -22.04 66.2 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.642 0.258 . . . . 0.0 111.446 -179.648 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.761 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -76.97 -42.91 37.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.754 0.311 . . . . 0.0 110.965 -179.865 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.561 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 13.6 t -64.69 -41.17 91.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.234 179.79 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 19.8 m -61.06 -36.08 78.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.922 179.0 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.549 ' HB1' ' HB2' ' A' ' 98' ' ' ALA . . . -55.76 -45.44 78.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.644 179.622 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.561 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 7.4 m-85 -55.16 -25.02 29.53 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.525 179.507 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.61 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -72.19 -40.77 67.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.337 179.688 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.61 ' N ' ' HG2' ' A' ' 95' ' ' GLN . 0.0 OUTLIER -76.03 -18.13 59.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.547 -179.6 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 134.32 -8.78 4.71 Favored Glycine 0 CA--C 1.521 0.45 0 C-N-CA 120.318 -0.944 . . . . 0.0 113.508 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.805 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -43.67 143.92 0.91 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 117.268 0.534 . . . . 0.0 111.505 -179.817 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.434 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 39.5 t80 -80.73 -54.63 5.46 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 121.049 -0.26 . . . . 0.0 111.232 -179.59 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 166.71 -168.23 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.06 0.457 . . . . 0.0 111.546 179.582 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.968 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 9.2 m-85 -118.3 152.63 35.41 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.654 178.948 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.909 HD13 HD22 ' A' ' 114' ' ' LEU . 19.6 tp -102.58 144.63 29.01 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-O 120.926 0.394 . . . . 0.0 111.5 -178.411 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.504 ' HD2' ' CD1' ' A' ' 102' ' ' LEU . 79.2 Cg_endo -80.22 -160.56 0.13 Allowed 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.513 2.142 . . . . 0.0 113.01 -179.399 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.503 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -42.15 -54.03 7.96 Favored Pre-proline 0 CA--C 1.534 0.347 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -179.165 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.503 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 18.2 Cg_endo -59.19 156.71 33.42 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.033 1.822 . . . . 0.0 112.39 -179.287 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.853 ' CD1' HD23 ' A' ' 102' ' ' LEU . 60.2 m-85 -157.36 -109.45 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.156 -179.924 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.505 ' O ' ' O ' ' A' ' 106' ' ' PHE . 2.6 p30 44.75 -179.48 0.0 OUTLIER 'General case' 0 C--O 1.227 -0.119 0 CA-C-O 121.336 0.588 . . . . 0.0 111.248 -179.579 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 1.046 HD12 HD12 ' A' ' 19' ' ' LEU . 0.5 OUTLIER -64.06 -53.64 41.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-O 121.473 0.654 . . . . 0.0 112.324 -179.788 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.629 ' N ' HG23 ' A' ' 108' ' ' ILE . 1.0 OUTLIER -49.16 -52.91 23.54 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 114.947 -1.024 . . . . 0.0 111.961 -178.014 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.682 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 2.0 mm-40 -81.51 -27.78 34.32 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -179.13 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.44 ' CB ' ' O ' ' A' ' 107' ' ' ASP . . . -76.39 -55.39 5.59 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.252 179.933 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.619 ' O ' HG12 ' A' ' 115' ' ' VAL . 61.8 t -59.01 -30.47 43.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.502 0.668 . . . . 0.0 110.061 178.55 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.491 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -62.04 -46.61 88.4 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.492 -0.777 . . . . 0.0 110.587 179.345 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.909 HD22 HD13 ' A' ' 102' ' ' LEU . 21.5 tp -71.36 -26.71 62.92 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.108 -0.951 . . . . 0.0 112.127 -178.764 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.964 HG23 HD13 ' A' ' 79' ' ' ILE . 4.3 p -79.35 -40.04 21.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.886 0.374 . . . . 0.0 111.57 -179.805 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -67.31 -43.97 80.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.282 -179.448 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.643 ' HD3' ' HA ' ' A' ' 114' ' ' LEU . 6.7 ptm180 -60.09 -23.64 63.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.64 0.257 . . . . 0.0 110.827 179.807 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.434 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -72.16 -50.11 30.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.763 179.203 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.751 HD11 HG11 ' A' ' 50' ' ' VAL . 3.9 mt -69.65 -34.52 61.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.274 0.559 . . . . 0.0 110.649 179.554 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.3 t -63.49 -38.93 93.04 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.002 -179.958 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.075 -179.907 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.616 ' HB3' HD11 ' A' ' 5' ' ' ILE . 0.8 OUTLIER . . . . . 0 N--CA 1.456 -0.154 0 CA-C-O 120.95 0.405 . . . . 0.0 110.942 . . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.509 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . 56.54 85.94 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.05 -179.534 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.616 HD11 ' HB3' ' A' ' 3' ' ' ARG . 3.5 mp -116.81 117.62 56.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.74 0.305 . . . . 0.0 111.565 -179.292 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.833 HG23 HG13 ' A' ' 50' ' ' VAL . 5.4 p -104.95 129.22 57.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.722 179.414 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.925 ' CD1' HG22 ' A' ' 31' ' ' THR . 28.2 m0 -116.38 130.49 56.8 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.789 179.248 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.545 HG11 HD23 ' A' ' 19' ' ' LEU . 1.6 t -114.43 135.71 53.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.503 -177.919 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.853 HG13 HG23 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -121.0 106.39 18.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.329 -0.396 . . . . 0.0 109.999 179.43 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.414 ' OD2' HG21 ' A' ' 15' ' ' ILE . 2.9 p30 -161.17 -160.85 0.76 Allowed 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.215 -177.887 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -66.3 -2.77 4.76 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -178.663 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 67.69 -150.12 0.16 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 121.199 -0.201 . . . . 0.0 111.177 179.268 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.438 ' OG ' ' N ' ' A' ' 14' ' ' SER . 60.1 p 34.78 -97.72 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 179.205 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.789 ' O ' HG23 ' A' ' 18' ' ' VAL . 12.5 t -53.17 -57.43 10.49 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.686 -0.234 . . . . 0.0 111.598 -179.069 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.414 HG21 ' OD2' ' A' ' 10' ' ' ASP . 17.6 mm -61.37 -25.1 35.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.78 0.324 . . . . 0.0 111.546 -179.854 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.952 ' HA ' HG21 ' A' ' 32' ' ' THR . 5.8 ttm180 -70.89 -54.54 11.07 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.103 179.919 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.427 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 84.7 t90 -60.79 -43.57 97.95 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -179.03 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.789 HG23 ' O ' ' A' ' 14' ' ' SER . 4.6 t -64.73 -46.15 93.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.67 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.545 HD23 HG11 ' A' ' 8' ' ' VAL . 11.9 tp -84.13 -23.16 30.8 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -178.198 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.508 ' HG3' ' N ' ' A' ' 21' ' ' ARG . 15.1 pt-20 -67.46 -58.85 4.01 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.194 -0.602 . . . . 0.0 111.321 -179.277 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.508 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 3.1 mmm180 -59.73 -50.42 73.9 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.689 -179.396 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.29 -48.48 71.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.881 0.372 . . . . 0.0 111.713 -179.343 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.805 ' HG ' HG11 ' A' ' 6' ' ' VAL . 2.4 tm? -70.06 -30.27 67.48 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.393 0.616 . . . . 0.0 110.516 179.972 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.09 -31.94 72.77 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 178.298 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.31 -28.34 70.78 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 178.029 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.595 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -77.26 -15.67 59.35 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 120.82 0.343 . . . . 0.0 110.711 179.159 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 94.71 26.4 13.24 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.729 -0.748 . . . . 0.0 114.373 178.552 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.626 ' HB2' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -126.12 166.32 17.23 Favored 'General case' 0 C--N 1.334 -0.066 0 CA-C-N 118.27 1.035 . . . . 0.0 112.379 179.892 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.599 ' O ' HG12 ' A' ' 6' ' ' VAL . 93.4 m -81.34 127.47 32.78 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.591 -179.745 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 2.4 p -123.61 116.75 23.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.935 -178.947 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.925 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.4 t -129.12 133.46 47.65 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.396 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.952 HG21 ' HA ' ' A' ' 16' ' ' ARG . 44.1 p -105.92 162.73 13.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.209 0.528 . . . . 0.0 112.114 -178.393 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.795 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 1.2 m-85 -131.56 172.22 12.49 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.775 -178.017 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.737 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 2.9 pp20? -63.55 -42.57 98.36 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -178.786 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -166.3 -59.76 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.224 0.535 . . . . 0.0 111.707 -178.983 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.782 ' HA3' HD22 ' A' ' 65' ' ' LEU . . . -162.98 -53.34 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.463 -0.79 . . . . 0.0 112.501 -179.485 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.706 ' HA ' HD12 ' A' ' 40' ' ' LEU . 0.8 OUTLIER -49.39 -28.4 5.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.996 0.427 . . . . 0.0 111.299 -179.817 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.795 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 2.1 tp10 -62.0 -56.74 15.94 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.253 179.919 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.853 HG23 HG13 ' A' ' 9' ' ' VAL . 38.6 t -60.52 -31.89 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.102 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.542 179.398 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.724 HD13 ' HB3' ' A' ' 68' ' ' GLN . 46.2 mt -55.21 -43.85 74.82 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.305 179.183 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -80.79 -48.71 12.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.142 -179.892 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.422 ' HB3' ' HE2' ' A' ' 33' ' ' PHE . . . -56.73 -30.94 64.05 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.317 -179.762 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.554 ' HG ' HG12 ' A' ' 39' ' ' VAL . 27.4 mt -64.26 -23.56 67.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.909 0.385 . . . . 0.0 111.323 179.986 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.95 -15.5 32.05 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.587 -179.911 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 31.4 t -119.47 -7.51 10.16 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.519 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.455 ' HB3' ' CH2' ' A' ' 7' ' ' TRP . 0.0 OUTLIER -164.61 163.17 21.83 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.891 0.377 . . . . 0.0 111.413 -179.866 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 51.8 m -138.48 113.61 8.71 Favored Pre-proline 0 N--CA 1.452 -0.331 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.264 179.855 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.741 ' HD2' HD11 ' A' ' 76' ' ' LEU . 57.1 Cg_endo -71.14 149.06 57.5 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.546 2.164 . . . . 0.0 111.672 179.228 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -74.07 -22.88 59.34 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.185 -179.743 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.835 HG11 HD11 ' A' ' 119' ' ' ILE . 6.3 p -149.02 98.23 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.751 -179.349 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.555 HD12 ' O ' ' A' ' 7' ' ' TRP . 38.9 tp -87.13 144.48 26.84 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.902 0.382 . . . . 0.0 111.863 -179.276 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.602 ' O ' HG23 ' A' ' 9' ' ' VAL . 1.0 OUTLIER -124.29 115.06 20.41 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.69 179.65 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.696 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 0.6 OUTLIER -115.23 134.03 55.5 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 121.567 0.699 . . . . 0.0 112.02 -179.337 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.08 -176.91 6.57 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.756 179.695 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.852 HG12 ' HA3' ' A' ' 62' ' ' GLY . 0.0 OUTLIER -149.17 108.62 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.492 179.623 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.467 ' O ' ' HG3' ' A' ' 57' ' ' MET . 0.1 OUTLIER -161.3 73.62 0.45 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.827 -179.463 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.467 ' HG3' ' O ' ' A' ' 56' ' ' ARG . 1.8 ptt? 38.85 51.45 3.14 Favored Pre-proline 0 CA--C 1.535 0.382 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 178.536 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.531 ' CG ' ' HA2' ' A' ' 62' ' ' GLY . 54.4 Cg_endo -76.4 -73.04 0.01 OUTLIER 'Trans proline' 0 CA--C 1.529 0.243 0 C-N-CA 122.215 1.944 . . . . 0.0 111.658 178.365 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -117.7 -27.06 2.65 Favored Glycine 0 CA--C 1.52 0.385 0 N-CA-C 111.835 -0.506 . . . . 0.0 111.835 179.172 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' MET . . . . . 1.059 ' HB3' ' HB2' ' A' ' 64' ' ' ALA . 4.4 tpt -159.44 69.6 0.45 Allowed 'General case' 0 C--O 1.236 0.358 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.318 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.445 ' O ' HG12 ' A' ' 55' ' ' ILE . 0.2 OUTLIER 68.82 -25.76 0.14 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.406 -0.816 . . . . 0.0 112.327 -179.951 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.852 ' HA3' HG12 ' A' ' 55' ' ' ILE . . . 142.13 -30.7 2.12 Favored Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -179.723 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.558 ' H ' HD12 ' A' ' 63' ' ' LEU . 3.3 mp -71.76 -21.36 61.75 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.456 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 1.059 ' HB2' ' HB3' ' A' ' 60' ' ' MET . . . -53.68 -42.38 67.88 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.008 0.433 . . . . 0.0 110.461 179.007 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.782 HD22 ' HA3' ' A' ' 36' ' ' GLY . 15.9 mt -51.54 -50.28 60.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.134 179.5 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.736 HD11 HG13 ' A' ' 80' ' ' ILE . 17.2 mt -52.12 -56.78 12.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.542 179.632 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.562 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 28.4 mttp -41.19 -47.68 3.34 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.669 -179.277 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.724 ' HB3' HD13 ' A' ' 40' ' ' LEU . 60.1 mm-40 -69.27 -35.9 76.54 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.278 -179.547 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.832 HG22 ' CD2' ' A' ' 73' ' ' HIS . 59.0 mt -54.07 -46.45 66.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.08 179.881 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.594 ' HA ' ' CE1' ' A' ' 73' ' ' HIS . 0.0 OUTLIER -70.96 -26.72 63.29 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -179.619 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -61.87 -30.23 70.72 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.218 -178.839 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.438 ' HD3' ' HB3' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -90.2 -59.73 2.11 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.405 0.621 . . . . 0.0 111.409 179.669 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.832 ' CD2' HG22 ' A' ' 69' ' ' ILE . 3.8 p80 -81.22 172.52 9.55 Favored Pre-proline 0 C--N 1.318 -0.779 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.557 -179.183 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.499 ' HD2' ' HB2' ' A' ' 73' ' ' HIS . 73.4 Cg_endo -87.33 -52.8 0.03 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.948 2.432 . . . . 0.0 112.073 179.015 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.638 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 28.7 mtt -157.48 49.51 0.43 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.071 179.213 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.741 HD11 ' HD2' ' A' ' 48' ' ' PRO . 2.1 tt -64.94 114.0 13.21 Favored Pre-proline 0 N--CA 1.454 -0.247 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.978 179.886 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -64.71 115.45 3.24 Favored 'Trans proline' 0 CA--C 1.528 0.206 0 C-N-CA 122.389 2.06 . . . . 0.0 112.635 -179.796 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 1.007 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 5.3 t -115.51 154.45 16.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.104 179.909 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.562 HD11 HG23 ' A' ' 50' ' ' VAL . 1.9 mp -120.86 117.38 52.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.492 178.972 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.736 HG13 HD11 ' A' ' 66' ' ' LEU . 9.4 mm -99.04 150.21 5.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.098 0.475 . . . . 0.0 111.841 -179.409 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.556 ' HB3' HG22 ' A' ' 55' ' ' ILE . 53.5 ttp -67.59 -52.75 34.83 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.835 -179.129 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.436 ' H ' HG21 ' A' ' 55' ' ' ILE . 3.0 m -143.91 146.85 33.28 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 122.306 -0.246 . . . . 0.0 111.584 -179.234 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.91 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -113.98 57.86 0.69 Allowed 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.37 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.406 ' O ' ' OG ' ' A' ' 85' ' ' SER . 26.7 p80 -99.21 -176.6 3.35 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.946 -0.302 . . . . 0.0 110.952 179.392 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.406 ' OG ' ' O ' ' A' ' 84' ' ' HIS . 20.8 p 71.09 -61.16 0.49 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.603 -179.709 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.458 ' OD2' HD13 ' A' ' 63' ' ' LEU . 4.0 p-10 -154.01 85.64 1.16 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -179.096 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.878 HD23 ' HB3' ' A' ' 90' ' ' ALA . 0.7 OUTLIER -52.73 -20.8 3.42 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.487 179.33 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -47.83 -57.09 6.07 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.607 -0.269 . . . . 0.0 111.664 -178.972 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.466 ' HB3' HD22 ' A' ' 63' ' ' LEU . . . -64.21 -19.94 65.69 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.725 0.297 . . . . 0.0 111.209 -179.968 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.878 ' HB3' HD23 ' A' ' 87' ' ' LEU . . . -77.26 -46.4 23.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.696 -179.696 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.63 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 6.6 t -62.64 -49.14 84.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 120.985 -0.286 . . . . 0.0 111.141 -179.7 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 52.5 p -56.51 -25.6 51.97 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.216 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.589 ' HB3' ' O ' ' A' ' 90' ' ' ALA . . . -60.08 -52.89 63.43 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.924 179.791 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.63 ' CE2' ' HA ' ' A' ' 91' ' ' VAL . 2.8 m-85 -55.78 -31.2 62.4 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.459 0.647 . . . . 0.0 109.917 179.771 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.12 -42.07 39.43 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.922 -1.036 . . . . 0.0 110.995 -179.967 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.638 ' O ' ' HA ' ' A' ' 75' ' ' MET . 7.3 pt20 -85.2 -18.15 34.94 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.785 -179.421 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 93' ' ' ALA . . . 140.29 85.32 0.1 Allowed Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.114 -179.101 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 1.007 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -168.26 123.81 0.99 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.157 0.503 . . . . 0.0 111.918 179.946 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -58.16 -52.77 64.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.773 -179.931 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.584 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 0.2 OUTLIER 170.12 -172.53 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 121.197 0.522 . . . . 0.0 111.675 -179.873 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.91 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 7.9 m-85 -113.38 153.57 28.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.263 179.621 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.576 HD21 ' HA ' ' A' ' 106' ' ' PHE . 7.9 tp -102.3 144.97 29.66 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.827 -179.195 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.563 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 18.5 Cg_exo -66.69 -157.06 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.739 2.293 . . . . 0.0 112.838 -179.043 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.504 ' HB3' ' HD3' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -56.13 -55.08 45.62 Favored Pre-proline 0 CA--C 1.531 0.218 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.859 -179.246 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.563 ' HD2' ' HB2' ' A' ' 103' ' ' PRO . 54.1 Cg_exo -52.31 164.23 1.37 Allowed 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.349 2.032 . . . . 0.0 111.923 179.695 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.616 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 57.6 t80 -158.2 -106.93 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.707 -0.224 . . . . 0.0 110.588 179.865 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.541 ' O ' ' O ' ' A' ' 106' ' ' PHE . 3.1 p30 42.37 -176.82 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.937 0.398 . . . . 0.0 111.041 -179.791 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.628 HG12 HG12 ' A' ' 18' ' ' VAL . 0.7 OUTLIER -68.0 -40.73 83.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.224 0.535 . . . . 0.0 111.155 -179.969 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.44 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 8.3 t0 -50.62 -58.88 4.79 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.919 -179.316 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.616 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 9.6 mm-40 -76.41 -30.36 57.42 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 111.725 0.268 . . . . 0.0 111.725 -179.366 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -69.77 -55.63 9.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.928 0.394 . . . . 0.0 110.322 179.332 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.676 ' O ' HG12 ' A' ' 115' ' ' VAL . 48.1 t -61.2 -33.61 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-O 121.357 0.598 . . . . 0.0 110.364 179.332 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.44 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -61.63 -47.14 86.75 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.618 179.723 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.472 HD23 ' CG2' ' A' ' 79' ' ' ILE . 55.4 tp -75.6 -21.43 57.8 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.632 -179.58 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.676 HG12 ' O ' ' A' ' 112' ' ' VAL . 2.9 p -79.4 -38.8 20.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.776 -0.37 . . . . 0.0 111.836 -179.639 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.533 ' OE2' HG12 ' A' ' 112' ' ' VAL . 36.7 mt-10 -68.44 -38.5 81.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.846 0.355 . . . . 0.0 110.773 179.997 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -64.21 -24.91 67.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.951 0.405 . . . . 0.0 110.367 179.531 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -70.62 -49.54 46.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.717 179.544 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.835 HD11 HG11 ' A' ' 50' ' ' VAL . 4.7 mt -70.36 -32.66 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-O 121.271 0.558 . . . . 0.0 110.965 179.759 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 15.1 m -70.01 -44.06 70.07 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.262 -179.786 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 11.2 m80 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.181 -179.841 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.796 ' CG ' HD11 ' A' ' 5' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.802 0.335 . . . . 0.0 111.093 . . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.761 ' C ' HD13 ' A' ' 5' ' ' ILE . . . 88.46 97.78 0.97 Allowed Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.426 -0.892 . . . . 0.0 111.074 -179.257 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.796 HD11 ' CG ' ' A' ' 3' ' ' ARG . 4.9 mm -121.77 112.49 35.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 120.689 0.28 . . . . 0.0 111.361 -179.032 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.782 HG11 ' HG ' ' A' ' 23' ' ' LEU . 10.6 p -105.56 127.0 60.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.229 0.538 . . . . 0.0 110.657 179.101 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.944 ' CD1' HG22 ' A' ' 31' ' ' THR . 34.3 m0 -114.53 125.6 53.98 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.868 179.746 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.73 ' HB ' HG22 ' A' ' 32' ' ' THR . 0.2 OUTLIER -115.65 136.55 52.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.691 -177.956 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.698 HG12 ' HB2' ' A' ' 33' ' ' PHE . 18.0 m -115.25 110.68 32.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.224 0.535 . . . . 0.0 110.746 179.062 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.471 ' CB ' HG21 ' A' ' 15' ' ' ILE . 3.9 t0 -162.22 -158.6 0.53 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.381 -179.166 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -67.83 -0.19 3.97 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.614 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 68.78 -154.07 0.16 Allowed 'General case' 0 CA--C 1.532 0.265 0 O-C-N 122.313 -0.242 . . . . 0.0 111.02 179.553 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.438 ' OG ' ' N ' ' A' ' 14' ' ' SER . 74.8 p 33.01 -96.37 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 179.219 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.76 ' O ' HG23 ' A' ' 18' ' ' VAL . 4.4 t -53.06 -57.27 10.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.629 0.252 . . . . 0.0 111.599 -179.197 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.471 HG21 ' CB ' ' A' ' 10' ' ' ASP . 31.0 mm -61.41 -26.15 38.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.849 0.357 . . . . 0.0 111.078 179.931 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.706 ' HA ' HG21 ' A' ' 32' ' ' THR . 53.8 ttt180 -77.06 -44.27 31.31 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.708 179.803 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.447 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 70.2 t90 -64.23 -40.44 96.04 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.979 -179.275 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.76 HG23 ' O ' ' A' ' 14' ' ' SER . 3.5 t -70.48 -37.57 70.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.0 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.412 ' O ' HD13 ' A' ' 19' ' ' LEU . 0.2 OUTLIER -84.26 -29.32 26.56 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.969 -179.171 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.558 ' HA ' ' SG ' ' A' ' 30' ' ' CYS . 24.9 pt-20 -67.53 -60.36 2.62 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.913 -178.906 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.464 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 5.7 mmt85 -58.11 -54.09 50.85 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.189 -0.459 . . . . 0.0 112.008 -179.588 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.56 -53.96 47.65 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.108 0.48 . . . . 0.0 111.343 -179.574 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.782 ' HG ' HG11 ' A' ' 6' ' ' VAL . 2.5 tm? -66.32 -27.98 68.32 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.582 0.706 . . . . 0.0 110.451 179.52 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.428 ' HB2' ' O ' ' A' ' 20' ' ' GLU . . . -67.1 -34.55 77.86 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.527 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.53 -26.78 64.99 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.296 -0.954 . . . . 0.0 110.946 178.039 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.664 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -77.27 -16.22 59.09 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 120.701 0.286 . . . . 0.0 110.805 179.104 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.49 23.68 13.72 Favored Glycine 0 CA--C 1.521 0.419 0 C-N-CA 120.675 -0.774 . . . . 0.0 114.247 178.615 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.668 ' HB2' HD11 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -123.81 166.64 15.25 Favored 'General case' 0 CA--C 1.527 0.076 0 CA-C-N 118.107 0.954 . . . . 0.0 111.935 -179.802 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.736 ' O ' HG12 ' A' ' 6' ' ' VAL . 97.6 m -84.83 138.54 32.5 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.027 -179.777 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.558 ' SG ' ' HA ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -126.85 116.43 20.85 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.073 0.463 . . . . 0.0 111.694 -179.544 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.944 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.4 t -128.77 132.43 47.9 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.409 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.73 HG22 ' HB ' ' A' ' 8' ' ' VAL . 45.8 p -108.51 165.09 11.79 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.267 0.556 . . . . 0.0 111.749 -178.335 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.808 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 3.2 m-85 -135.06 172.09 13.51 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.196 -177.89 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.561 ' HG2' ' N ' ' A' ' 35' ' ' ASN . 0.0 OUTLIER -63.31 -32.67 74.15 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.797 -179.837 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.561 ' N ' ' HG2' ' A' ' 34' ' ' GLU . 50.1 p-10 -179.47 179.49 0.61 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.264 -179.434 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.603 ' O ' ' HG ' ' A' ' 40' ' ' LEU . . . -55.16 -10.2 2.48 Favored Glycine 0 CA--C 1.521 0.438 0 C-N-CA 120.709 -0.758 . . . . 0.0 114.011 -179.438 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.545 ' HA ' HD12 ' A' ' 40' ' ' LEU . 25.2 m-20 -84.55 -44.57 13.44 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 117.727 0.763 . . . . 0.0 112.501 -179.315 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.808 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 6.6 tt0 -51.74 -58.72 5.6 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -179.271 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.615 HG22 ' CE1' ' A' ' 33' ' ' PHE . 55.1 t -47.55 -38.13 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 121.017 0.437 . . . . 0.0 111.173 -179.594 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.771 HD13 ' CB ' ' A' ' 68' ' ' GLN . 20.6 mt -57.03 -41.84 79.36 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.429 -179.956 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.87 -48.09 40.43 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.277 0.56 . . . . 0.0 110.177 178.911 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.48 -28.66 69.45 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.135 179.386 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.563 ' CD1' ' CE1' ' A' ' 73' ' ' HIS . 15.1 mt -65.56 -24.94 67.22 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.88 -179.412 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.64 -16.0 14.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.843 -179.471 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -125.68 -1.57 7.35 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.712 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.535 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -163.42 159.89 22.81 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.917 0.389 . . . . 0.0 111.419 179.822 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 83.1 m -139.08 116.03 8.7 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.297 -179.929 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.731 ' O ' HD21 ' A' ' 76' ' ' LEU . 77.3 Cg_endo -77.42 163.21 30.09 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.056 1.837 . . . . 0.0 111.511 179.084 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.472 ' HB3' HG23 ' A' ' 119' ' ' ILE . 1.5 m-20 -74.23 -22.17 59.46 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.973 -0.291 . . . . 0.0 111.33 -179.744 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.775 HG13 HG23 ' A' ' 6' ' ' VAL . 8.3 p -147.7 169.42 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.477 -179.562 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.785 HD12 ' O ' ' A' ' 7' ' ' TRP . 10.0 tp -152.93 129.85 11.0 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 120.958 0.409 . . . . 0.0 111.318 -179.075 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.577 ' HG ' ' HB ' ' A' ' 79' ' ' ILE . 0.2 OUTLIER -115.69 126.76 54.52 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.78 179.789 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.72 ' CB ' HD22 ' A' ' 65' ' ' LEU . 0.2 OUTLIER -119.3 126.43 51.43 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -178.727 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -83.21 101.9 11.54 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.643 177.803 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.683 ' CG2' ' HB ' ' A' ' 82' ' ' THR . 2.2 tt -68.79 93.03 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.665 -179.505 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.462 ' NH2' ' HB3' ' A' ' 35' ' ' ASN . 6.8 ptt85 -135.46 59.05 1.74 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.48 -179.446 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.529 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 24.6 ptm 41.04 48.94 2.98 Favored Pre-proline 0 N--CA 1.467 0.381 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 179.746 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 62' ' ' GLY . 43.5 Cg_endo -70.49 -80.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.267 1.978 . . . . 0.0 111.999 178.943 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -107.27 -23.72 6.85 Favored Glycine 0 N--CA 1.449 -0.441 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 179.359 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.941 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 8.8 tpt -162.88 69.1 0.23 Allowed 'General case' 0 C--O 1.236 0.36 0 CA-C-O 120.923 0.392 . . . . 0.0 110.447 179.816 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.529 ' HA ' ' HA ' ' A' ' 57' ' ' MET . 0.3 OUTLIER 68.56 -26.46 0.14 Allowed 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.246 179.834 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.652 ' HA3' HG13 ' A' ' 55' ' ' ILE . . . 140.62 -29.58 2.36 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -179.441 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.644 HD12 ' H ' ' A' ' 63' ' ' LEU . 2.2 mp -75.62 -12.19 60.16 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.649 -0.275 . . . . 0.0 110.428 179.088 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.941 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -53.67 -26.9 24.7 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-O 120.925 0.393 . . . . 0.0 110.455 179.155 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.832 ' CD2' HG11 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -59.11 -62.15 2.1 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.954 -0.567 . . . . 0.0 109.714 178.982 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.959 ' HA ' HD12 ' A' ' 69' ' ' ILE . 7.9 mt -43.56 -43.39 5.55 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.243 179.513 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.447 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 19.4 mttt -54.0 -58.0 8.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.004 0.43 . . . . 0.0 111.225 179.507 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.771 ' CB ' HD13 ' A' ' 40' ' ' LEU . 21.5 mm-40 -62.07 -28.73 69.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.035 -179.846 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.959 HD12 ' HA ' ' A' ' 66' ' ' LEU . 77.0 mt -63.11 -42.02 95.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.029 0.442 . . . . 0.0 111.294 -179.846 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.529 ' HA ' ' HA ' ' A' ' 74' ' ' PRO . 0.1 OUTLIER -67.64 -29.25 68.51 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.573 -179.773 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -68.51 -40.61 80.76 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.036 179.527 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.403 ' NE ' ' HB3' ' A' ' 40' ' ' LEU . 52.0 mtt-85 -93.26 -76.22 0.48 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.743 -179.963 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.893 ' CD2' HG23 ' A' ' 69' ' ' ILE . 0.5 OUTLIER -114.5 79.18 5.28 Favored Pre-proline 0 C--N 1.318 -0.781 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.88 179.707 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.553 ' O ' ' HG3' ' A' ' 75' ' ' MET . 56.9 Cg_endo -70.87 50.28 1.07 Allowed 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.734 2.289 . . . . 0.0 113.131 -179.708 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.553 ' HG3' ' O ' ' A' ' 74' ' ' PRO . 2.8 mtp -150.65 -36.88 0.14 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.145 0.497 . . . . 0.0 110.82 179.716 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.731 HD21 ' O ' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -48.7 117.46 6.17 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.629 -179.831 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.407 ' HA ' ' O ' ' A' ' 97' ' ' GLY . 31.5 Cg_endo -64.5 134.37 41.11 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.046 1.831 . . . . 0.0 111.627 179.051 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.882 HG21 HD13 ' A' ' 69' ' ' ILE . 5.8 t -122.15 143.62 34.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.932 0.396 . . . . 0.0 111.262 -179.56 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.643 ' CG2' HD23 ' A' ' 114' ' ' LEU . 1.6 mt -124.01 110.67 26.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.925 -180.0 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.674 HD12 ' HB3' ' A' ' 53' ' ' SER . 6.3 mm -99.01 148.28 6.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.586 -179.199 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.449 ' O ' ' HB2' ' A' ' 102' ' ' LEU . 62.2 ttp -76.21 -60.42 2.34 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.813 -0.631 . . . . 0.0 112.322 -179.211 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.683 ' HB ' ' CG2' ' A' ' 55' ' ' ILE . 40.9 m -109.76 151.57 26.78 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.31 -178.516 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.983 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -136.09 -3.7 2.21 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -179.377 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.48 ' HE1' ' O ' ' A' ' 103' ' ' PRO . 0.5 OUTLIER -71.49 35.41 0.06 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -178.982 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.503 ' O ' HD11 ' A' ' 63' ' ' LEU . 80.2 p -159.79 102.16 1.49 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.698 0.285 . . . . 0.0 111.184 179.447 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.534 ' HB3' HD13 ' A' ' 63' ' ' LEU . 0.7 OUTLIER 67.64 35.37 4.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.911 179.762 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.55 HD23 ' HB3' ' A' ' 90' ' ' ALA . 0.5 OUTLIER -46.52 -22.53 0.28 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.108 -0.496 . . . . 0.0 112.078 -179.931 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -47.98 -50.3 27.84 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 -179.498 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.481 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -60.77 -21.02 62.63 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.649 0.261 . . . . 0.0 111.661 -179.601 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.576 ' O ' ' HB3' ' A' ' 93' ' ' ALA . . . -70.29 -34.03 72.27 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.886 0.374 . . . . 0.0 110.711 179.625 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.593 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 4.5 t -61.75 -49.84 82.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.386 -179.961 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 17.6 m -59.72 -22.51 62.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.063 0.459 . . . . 0.0 110.037 179.209 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.929 ' HB1' ' HB2' ' A' ' 98' ' ' ALA . . . -65.14 -50.85 64.43 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.526 179.419 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.593 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 9.8 m-85 -54.92 -24.48 23.82 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.089 179.146 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -76.51 -30.58 57.25 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.991 179.254 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.57 ' HG2' ' HA ' ' A' ' 93' ' ' ALA . 1.7 pt20 -91.14 -18.31 24.69 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.93 179.403 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 77' ' ' PRO . . . 127.85 14.72 2.49 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.059 -1.067 . . . . 0.0 114.016 179.283 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.929 ' HB2' ' HB1' ' A' ' 93' ' ' ALA . . . -55.46 144.52 25.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 117.457 0.629 . . . . 0.0 110.785 179.569 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.569 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 12.3 t80 -78.49 -54.46 6.13 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.337 -179.548 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.56 ' OD1' HD21 ' A' ' 114' ' ' LEU . 10.3 p-10 173.62 -165.26 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 121.065 0.46 . . . . 0.0 111.528 179.96 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.983 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 5.3 m-85 -138.78 153.8 48.45 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.097 -179.832 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.776 HD11 HD22 ' A' ' 114' ' ' LEU . 5.5 mp -103.0 127.9 28.87 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 120.662 0.267 . . . . 0.0 111.288 -179.918 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.48 ' O ' ' HE1' ' A' ' 84' ' ' HIS . 39.2 Cg_endo -77.84 -74.6 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 121.962 1.775 . . . . 0.0 112.252 179.593 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.704 ' H ' ' HD2' ' A' ' 105' ' ' PRO . 0.2 OUTLIER -107.77 -55.91 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 -179.661 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.704 ' HD2' ' H ' ' A' ' 104' ' ' LYS . 34.0 Cg_endo -64.44 160.01 41.42 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 121.909 1.739 . . . . 0.0 112.729 -179.5 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.681 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 47.5 t80 -166.21 -106.51 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.089 -179.929 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.566 ' O ' ' O ' ' A' ' 106' ' ' PHE . 2.4 p30 42.98 177.47 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.859 0.361 . . . . 0.0 111.414 -179.888 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.73 HG12 HG12 ' A' ' 18' ' ' VAL . 0.9 OUTLIER -68.06 -42.37 85.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.001 0.429 . . . . 0.0 111.401 -179.624 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.502 ' HB2' ' OD1' ' A' ' 107' ' ' ASP . 6.1 m-20 -49.08 -58.27 5.22 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.521 -179.826 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.681 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 8.1 mm-40 -74.76 -35.6 62.58 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.646 0.26 . . . . 0.0 111.602 -179.675 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.77 -56.15 13.51 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.692 179.693 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.627 ' O ' HG12 ' A' ' 115' ' ' VAL . 54.7 t -62.1 -33.92 60.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.341 0.591 . . . . 0.0 110.585 179.364 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.477 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -61.84 -46.45 89.44 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.427 179.19 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.776 HD22 HD11 ' A' ' 102' ' ' LEU . 36.3 tp -74.67 -23.66 58.68 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.837 -179.216 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.737 HG23 HG21 ' A' ' 50' ' ' VAL . 6.4 p -79.49 -43.12 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.586 -179.901 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -62.73 -47.31 84.15 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.056 -179.695 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.651 ' HD2' HD12 ' A' ' 114' ' ' LEU . 6.4 ptp180 -60.05 -23.6 63.87 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.735 179.507 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.569 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -74.63 -48.15 28.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.121 179.998 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.472 HG23 ' HB3' ' A' ' 49' ' ' ASP . 3.8 mt -68.76 -32.69 55.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.173 0.511 . . . . 0.0 110.738 179.697 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.5 t -68.95 -55.06 12.12 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.239 -179.763 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 6.4 m80 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.519 -179.612 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.316 0 CA-C-O 120.797 0.332 . . . . 0.0 111.319 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.459 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . 78.02 101.28 0.2 Allowed Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.809 -179.473 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.4 mp -118.72 113.24 41.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.913 0.387 . . . . 0.0 111.509 -179.419 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 1.02 HG11 ' HG ' ' A' ' 23' ' ' LEU . 11.6 p -105.97 128.33 60.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.675 179.297 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.914 ' CD1' HG22 ' A' ' 31' ' ' THR . 31.2 m0 -114.69 132.86 56.27 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.742 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.569 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -123.86 141.6 43.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.066 0.46 . . . . 0.0 111.594 -178.06 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.934 HG12 ' HB2' ' A' ' 33' ' ' PHE . 29.1 m -123.92 111.28 28.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.301 0.572 . . . . 0.0 111.005 179.474 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -161.38 -157.81 0.53 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.475 -179.557 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -72.0 9.12 1.01 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.987 0.365 . . . . 0.0 111.987 -179.929 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.532 ' O ' ' N ' ' A' ' 14' ' ' SER . 3.4 p30 47.8 -136.69 0.91 Allowed 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 179.662 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.53 ' N ' ' HG2' ' A' ' 16' ' ' ARG . 1.5 t 36.32 -84.44 0.0 OUTLIER 'General case' 0 C--O 1.236 0.348 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -179.584 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.715 ' O ' HG23 ' A' ' 18' ' ' VAL . 35.6 t -77.8 -43.82 29.37 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.205 -0.452 . . . . 0.0 112.135 -179.21 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 27.4 mm -63.97 -34.34 67.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -178.893 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.862 ' HA ' HG21 ' A' ' 32' ' ' THR . 6.1 ptp180 -67.85 -52.69 33.76 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.789 -179.44 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.586 ' H ' ' HG3' ' A' ' 16' ' ' ARG . 28.4 t90 -54.85 -41.92 71.36 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.326 -178.782 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.715 HG23 ' O ' ' A' ' 14' ' ' SER . 13.5 t -67.55 -49.16 73.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -178.542 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.683 ' HG ' HD11 ' A' ' 108' ' ' ILE . 6.7 mt -79.72 -26.9 40.7 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.777 -178.112 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.611 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 19.3 pt-20 -66.8 -57.99 5.95 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.506 -0.477 . . . . 0.0 111.411 -179.604 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.482 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 3.4 mmt-85 -60.79 -54.46 44.88 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.927 -179.463 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.86 -33.29 68.52 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -179.055 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 1.02 ' HG ' HG11 ' A' ' 6' ' ' VAL . 2.7 tm? -76.01 -30.36 58.47 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.494 0.664 . . . . 0.0 110.308 179.602 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.61 -33.3 75.61 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.28 178.401 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.18 -26.15 68.98 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.198 178.607 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.617 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -78.25 -15.57 58.65 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 120.752 0.311 . . . . 0.0 110.823 179.371 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.98 26.06 10.74 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.647 -0.787 . . . . 0.0 113.596 179.211 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.682 ' HB2' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -132.77 170.89 14.62 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 117.571 0.685 . . . . 0.0 111.742 179.854 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.779 ' O ' HG12 ' A' ' 6' ' ' VAL . 23.5 m -95.76 137.6 34.59 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.63 -179.438 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.611 ' HB3' ' HA ' ' A' ' 20' ' ' GLU . 10.9 t -125.38 119.86 29.47 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.088 0.471 . . . . 0.0 111.501 -179.569 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.914 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.5 t -125.95 132.27 52.11 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.833 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.862 HG21 ' HA ' ' A' ' 16' ' ' ARG . 69.9 p -103.4 164.11 11.85 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 -177.23 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.934 ' HB2' HG12 ' A' ' 9' ' ' VAL . 6.0 m-85 -134.41 172.96 12.18 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.59 -178.384 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.435 ' HG2' ' N ' ' A' ' 35' ' ' ASN . 0.5 OUTLIER -62.28 -34.83 77.32 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -177.175 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.613 ' C ' ' HB ' ' A' ' 9' ' ' VAL . 22.0 p30 -176.68 -26.44 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 179.622 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.614 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . 161.82 -56.64 0.3 Allowed Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.037 -1.077 . . . . 0.0 113.123 179.649 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.529 ' N ' HD11 ' A' ' 65' ' ' LEU . 1.9 t30 -50.02 -34.03 19.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.12 0.486 . . . . 0.0 110.673 -179.764 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.659 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -54.22 -52.08 62.42 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.454 179.803 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.672 HG12 ' CD1' ' A' ' 43' ' ' LEU . 56.1 t -57.61 -40.98 78.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.036 -179.829 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.801 HD13 ' HB2' ' A' ' 68' ' ' GLN . 19.2 mt -53.12 -40.69 64.37 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.092 0.472 . . . . 0.0 110.426 179.459 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -77.25 -48.71 16.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.044 179.449 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.69 -25.15 67.22 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.763 179.67 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.77 HD21 ' HD2' ' A' ' 48' ' ' PRO . 9.3 mt -68.35 -22.05 64.7 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.036 -179.54 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.06 -17.09 36.84 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.737 -179.641 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.8 t -121.96 -3.48 9.12 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -179.611 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.647 ' O ' HD23 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -162.71 159.02 23.78 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.038 0.447 . . . . 0.0 111.34 179.643 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.696 HG23 HD13 ' A' ' 76' ' ' LEU . 98.2 m -139.23 113.96 8.22 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.442 179.703 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.77 ' HD2' HD21 ' A' ' 43' ' ' LEU . 72.0 Cg_endo -75.7 161.64 36.42 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.049 1.832 . . . . 0.0 111.291 178.92 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.45 ' O ' ' HG2' ' A' ' 77' ' ' PRO . 1.2 m-20 -73.69 -21.15 60.34 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.649 0.261 . . . . 0.0 110.956 -179.869 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.87 HG13 HG23 ' A' ' 6' ' ' VAL . 7.5 p -148.75 166.7 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.347 179.958 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.596 HD11 HG21 ' A' ' 39' ' ' VAL . 18.8 tp -153.02 130.78 11.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.736 0.303 . . . . 0.0 111.158 -179.467 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.31 121.44 44.9 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.531 -179.934 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.764 ' HB2' HD13 ' A' ' 80' ' ' ILE . 3.2 m -106.23 130.83 54.02 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.928 0.394 . . . . 0.0 111.488 -179.695 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.402 ' O ' ' CG2' ' A' ' 55' ' ' ILE . 35.4 t70 -73.78 -22.67 59.76 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.586 -179.803 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.813 HG12 ' HA3' ' A' ' 62' ' ' GLY . 0.0 OUTLIER 44.04 99.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 121.185 0.517 . . . . 0.0 111.832 -179.782 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -142.58 43.99 1.62 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.585 -179.57 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.555 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER 58.81 48.13 2.2 Favored Pre-proline 0 CA--C 1.532 0.264 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 179.296 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.556 ' HD2' ' N ' ' A' ' 62' ' ' GLY . 41.1 Cg_endo -68.06 -79.16 0.01 OUTLIER 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 122.327 2.018 . . . . 0.0 111.969 178.914 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -107.83 -25.15 6.04 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.331 179.478 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.966 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 0.3 OUTLIER -158.72 65.03 0.42 Allowed 'General case' 0 C--O 1.236 0.368 0 CA-C-O 120.962 0.41 . . . . 0.0 110.454 179.813 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.555 ' HA ' ' HA ' ' A' ' 57' ' ' MET . 0.2 OUTLIER 70.36 -21.24 0.19 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.961 179.998 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.813 ' HA3' HG12 ' A' ' 55' ' ' ILE . . . 130.76 -30.0 3.47 Favored Glycine 0 N--CA 1.446 -0.674 0 N-CA-C 110.146 -1.182 . . . . 0.0 110.146 -178.847 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.901 ' HA ' HD23 ' A' ' 66' ' ' LEU . 0.8 OUTLIER -70.54 -15.99 62.83 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.007 -0.596 . . . . 0.0 109.732 178.675 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.966 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -53.54 -32.08 49.15 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-O 120.906 0.384 . . . . 0.0 110.259 179.706 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.651 ' HG ' HD11 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -61.24 -43.38 98.97 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.311 179.027 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.901 HD23 ' HA ' ' A' ' 63' ' ' LEU . 3.1 mm? -57.69 -45.45 85.62 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.052 -179.493 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -55.55 -47.69 75.96 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.234 0.54 . . . . 0.0 110.361 179.15 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.801 ' HB2' HD13 ' A' ' 40' ' ' LEU . 34.7 mm-40 -60.04 -29.74 68.73 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.503 179.62 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.555 ' HB ' ' O ' ' A' ' 66' ' ' LEU . 59.4 mt -57.19 -48.98 81.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.224 0.535 . . . . 0.0 111.155 -179.705 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.55 ' HB3' ' CG ' ' A' ' 96' ' ' GLN . 7.6 pttt -63.02 -33.57 75.7 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.004 -179.232 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.493 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 4.4 mt-30 -72.73 -32.94 66.08 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.913 -179.478 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.2 mtt180 -108.87 -65.71 1.11 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -178.627 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.696 ' CE1' HD13 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -82.12 169.04 19.84 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.679 -178.677 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -84.67 -68.99 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.885 2.39 . . . . 0.0 113.116 -179.579 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.426 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 69.7 mtm -150.98 45.83 0.84 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.823 0.344 . . . . 0.0 110.786 -179.8 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.696 HD13 HG23 ' A' ' 47' ' ' THR . 25.3 tp -56.77 114.8 8.6 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.231 -179.589 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.45 ' HG2' ' O ' ' A' ' 49' ' ' ASP . 19.6 Cg_endo -59.87 123.14 12.62 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.236 1.957 . . . . 0.0 112.011 179.531 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.957 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 4.6 t -124.59 153.07 31.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.843 -179.743 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.884 HD13 HG23 ' A' ' 115' ' ' VAL . 1.7 mt -128.45 114.39 33.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.94 179.939 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.764 HD13 ' HB2' ' A' ' 53' ' ' SER . 13.7 mm -93.83 141.01 15.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.889 -179.865 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.593 ' HA ' ' HB3' ' A' ' 102' ' ' LEU . 0.3 OUTLIER -80.26 -33.04 38.17 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.573 -179.334 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.538 ' H ' HG21 ' A' ' 55' ' ' ILE . 19.8 m -147.83 144.92 28.5 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 120.96 0.41 . . . . 0.0 111.724 -179.244 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.474 ' HA ' ' CE2' ' A' ' 101' ' ' TYR . . . -86.92 -26.19 24.03 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.39 179.661 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.52 ' H ' HG22 ' A' ' 82' ' ' THR . 21.9 m170 46.87 44.5 14.49 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.766 179.549 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 38.8 m 53.4 85.89 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.576 179.286 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 177.03 35.71 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.825 179.822 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.806 HD13 ' HB3' ' A' ' 90' ' ' ALA . 0.3 OUTLIER -49.12 -21.87 0.83 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.949 -179.509 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -47.7 -61.08 2.11 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.48 0.181 . . . . 0.0 111.422 -179.503 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.0 -20.03 60.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.824 0.345 . . . . 0.0 110.698 179.375 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.806 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -62.38 -47.57 83.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.345 -179.963 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.564 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 6.6 t -67.26 -41.05 86.16 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 C-N-CA 120.704 -0.399 . . . . 0.0 110.52 179.819 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.504 ' O ' ' HG3' ' A' ' 95' ' ' GLN . 39.7 m -62.19 -15.83 49.0 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.387 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.638 ' HB2' ' HG ' ' A' ' 66' ' ' LEU . . . -75.87 -64.0 1.18 Allowed 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 120.988 0.423 . . . . 0.0 111.625 179.904 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.636 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 3.9 m-85 -41.7 -44.35 3.14 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.782 -178.431 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.504 ' HG3' ' O ' ' A' ' 92' ' ' SER . 0.0 OUTLIER -69.97 -48.46 58.17 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.23 179.563 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.55 ' CG ' ' HB3' ' A' ' 70' ' ' LYS . 59.5 mt-30 -75.92 -9.83 58.93 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.292 -0.413 . . . . 0.0 112.106 -179.831 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 93' ' ' ALA . . . 133.48 80.64 0.16 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.063 -179.553 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.957 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -168.5 133.82 1.73 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.093 0.473 . . . . 0.0 111.309 -179.903 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.42 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 50.4 t80 -73.33 -53.37 10.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.773 -179.777 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.53 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 1.7 t0 175.84 -171.05 0.07 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.016 0.436 . . . . 0.0 111.404 -179.817 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.678 ' CE2' HG21 ' A' ' 80' ' ' ILE . 6.7 m-85 -114.35 152.88 30.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.233 179.328 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.702 HD21 ' HA ' ' A' ' 106' ' ' PHE . 5.9 tp -105.52 137.32 19.26 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.142 -179.032 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.23 -161.5 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.933 2.422 . . . . 0.0 112.726 -179.545 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.445 ' CB ' ' HD3' ' A' ' 105' ' ' PRO . 0.3 OUTLIER -48.89 -59.25 6.61 Favored Pre-proline 0 CA--C 1.531 0.223 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.819 -179.478 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.445 ' HD3' ' CB ' ' A' ' 104' ' ' LYS . 73.8 Cg_exo -48.49 164.27 0.22 Allowed 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.44 2.093 . . . . 0.0 111.868 179.776 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.702 ' HA ' HD21 ' A' ' 102' ' ' LEU . 64.8 t80 -161.74 -102.42 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.706 -0.224 . . . . 0.0 110.719 179.844 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.583 ' O ' ' O ' ' A' ' 106' ' ' PHE . 2.6 p-10 42.09 179.3 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.915 0.388 . . . . 0.0 111.318 -179.983 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.697 HG12 HG12 ' A' ' 18' ' ' VAL . 1.0 OUTLIER -67.66 -42.29 86.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.084 0.468 . . . . 0.0 111.346 179.863 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.52 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 3.4 t0 -51.86 -58.77 5.49 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.594 -179.36 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.63 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 3.3 mm-40 -75.62 -27.7 58.55 Favored 'General case' 0 C--N 1.333 -0.124 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -179.476 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.419 ' CB ' ' O ' ' A' ' 107' ' ' ASP . . . -73.82 -62.52 1.47 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.925 0.393 . . . . 0.0 110.256 179.519 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.62 ' O ' HG12 ' A' ' 115' ' ' VAL . 49.3 t -55.63 -29.86 25.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.484 0.659 . . . . 0.0 110.256 179.021 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.53 ' O ' ' HG3' ' A' ' 117' ' ' ARG . . . -63.46 -50.96 67.65 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.731 179.172 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 53.7 tp -72.4 -20.69 61.39 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.395 -0.82 . . . . 0.0 112.273 -179.705 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.884 HG23 HD13 ' A' ' 79' ' ' ILE . 2.9 p -79.36 -47.67 22.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.686 -179.338 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.416 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 26.0 mt-10 -64.24 -42.8 96.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.855 0.36 . . . . 0.0 110.652 179.98 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.53 ' HG3' ' O ' ' A' ' 113' ' ' ALA . 40.5 mtt85 -63.36 -23.68 67.52 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.924 0.392 . . . . 0.0 110.551 179.224 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.42 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -70.16 -48.76 55.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.663 179.446 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.687 HD11 HG11 ' A' ' 50' ' ' VAL . 4.9 mt -68.1 -31.95 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.039 179.892 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 9.2 p -74.04 -49.05 25.91 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.382 -179.725 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 1.6 m80 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.312 -179.551 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.639 ' CG ' HD11 ' A' ' 5' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.341 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 . . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.881 ' O ' HD13 ' A' ' 5' ' ' ILE . . . 104.84 103.46 2.86 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.444 179.41 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.881 HD13 ' O ' ' A' ' 4' ' ' GLY . 7.5 mm -127.56 112.7 28.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 120.904 0.383 . . . . 0.0 111.813 -179.546 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.953 HG23 HG13 ' A' ' 50' ' ' VAL . 7.9 p -107.07 135.16 46.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.144 179.642 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.908 ' CD1' HG22 ' A' ' 31' ' ' THR . 24.2 m0 -120.26 125.89 49.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.014 0.435 . . . . 0.0 110.657 179.447 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.734 ' HB ' HG22 ' A' ' 32' ' ' THR . 0.5 OUTLIER -114.56 146.64 18.79 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.288 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.46 -178.365 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.697 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -124.7 110.8 25.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.821 0.343 . . . . 0.0 110.582 179.243 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.503 ' OD2' HG21 ' A' ' 15' ' ' ILE . 3.8 t0 -161.49 -161.18 0.77 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.228 -179.231 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.24 -0.23 3.29 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -179.487 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.436 ' O ' ' N ' ' A' ' 14' ' ' SER . 0.8 OUTLIER 69.51 -157.72 0.16 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.5 0.19 . . . . 0.0 110.894 179.896 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.404 ' HB3' ' H ' ' A' ' 14' ' ' SER . 1.6 t 34.54 -88.61 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 113.002 0.741 . . . . 0.0 113.002 179.51 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.797 ' O ' HG23 ' A' ' 18' ' ' VAL . 28.4 t -56.07 -58.99 5.6 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.719 0.295 . . . . 0.0 111.235 -179.699 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.503 HG21 ' OD2' ' A' ' 10' ' ' ASP . 20.5 mm -65.77 -24.46 34.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.262 -179.821 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.76 ' HA ' HG21 ' A' ' 32' ' ' THR . 20.2 ttt-85 -78.39 -41.15 34.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.023 179.819 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.426 ' HA ' ' CD ' ' A' ' 20' ' ' GLU . 84.1 t90 -65.7 -40.17 91.99 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.541 -179.351 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.797 HG23 ' O ' ' A' ' 14' ' ' SER . 3.5 t -69.37 -38.17 76.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -178.93 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.652 ' CD2' HD11 ' A' ' 108' ' ' ILE . 0.2 OUTLIER -84.39 -29.29 26.33 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -178.962 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.766 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 24.4 pt-20 -67.87 -59.01 3.62 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -179.29 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.466 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 9.8 mmt180 -64.65 -51.69 61.23 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.885 -178.904 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.23 -44.43 79.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.103 0.478 . . . . 0.0 111.521 -179.384 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.909 ' HG ' HG11 ' A' ' 6' ' ' VAL . 2.1 tm? -72.04 -27.85 62.98 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.188 179.523 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.54 -33.63 76.11 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.29 178.397 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.18 -28.65 69.45 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.498 -0.858 . . . . 0.0 111.16 178.772 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.631 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -76.84 -15.35 59.74 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 120.717 0.294 . . . . 0.0 110.947 179.412 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.49 26.08 11.36 Favored Glycine 0 C--N 1.334 0.422 0 C-N-CA 120.7 -0.762 . . . . 0.0 113.657 179.001 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.631 ' CD1' ' HB3' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -131.5 172.65 11.96 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 117.528 0.664 . . . . 0.0 111.583 179.625 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.694 ' O ' HG12 ' A' ' 6' ' ' VAL . 16.6 m -96.62 138.08 34.73 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.43 -179.256 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.766 ' HB3' ' HA ' ' A' ' 20' ' ' GLU . 8.5 t -127.61 117.5 22.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.884 179.972 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.908 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.8 t -122.08 142.77 50.02 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.275 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.76 HG21 ' HA ' ' A' ' 16' ' ' ARG . 66.7 p -118.26 159.81 22.7 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.181 0.515 . . . . 0.0 112.165 -178.889 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.9 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 0.2 OUTLIER -135.1 171.92 13.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.823 -179.007 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.698 ' HG2' ' N ' ' A' ' 35' ' ' ASN . 0.0 OUTLIER -64.17 -43.53 94.84 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.212 -179.532 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.698 ' N ' ' HG2' ' A' ' 34' ' ' GLU . 29.3 p30 -173.1 178.89 2.37 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.104 0.478 . . . . 0.0 110.988 -179.018 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.637 ' HA3' ' HB3' ' A' ' 65' ' ' LEU . . . -43.05 -32.21 1.46 Allowed Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.46 -0.791 . . . . 0.0 113.825 -179.47 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.407 ' HA ' ' CD1' ' A' ' 40' ' ' LEU . 1.4 t30 -72.67 -45.68 57.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.945 0.373 . . . . 0.0 111.613 -178.966 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.9 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -52.2 -54.47 30.5 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 -179.836 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.544 HG12 ' CD1' ' A' ' 43' ' ' LEU . 3.5 t -48.86 -36.26 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.32 -179.438 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.624 HD13 ' HB3' ' A' ' 68' ' ' GLN . 7.0 mt -62.62 -49.6 74.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.838 0.351 . . . . 0.0 110.532 179.85 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -54.35 -50.39 67.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.32 -179.488 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.619 ' HB3' ' HE2' ' A' ' 33' ' ' PHE . . . -70.77 -33.46 70.78 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.258 179.953 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.815 HD13 ' CE1' ' A' ' 73' ' ' HIS . 16.0 mt -61.19 -27.12 68.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.307 -179.821 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.79 -17.99 4.2 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.618 -179.583 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 23.9 t -120.85 -3.39 9.7 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -179.635 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.608 ' NZ ' HG21 ' A' ' 5' ' ' ILE . 0.4 OUTLIER -167.66 165.38 14.37 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.883 0.373 . . . . 0.0 111.47 -179.73 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.464 ' HA ' HD23 ' A' ' 43' ' ' LEU . 59.3 m -139.18 128.14 13.94 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.221 179.585 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.643 ' HB3' ' CG ' ' A' ' 7' ' ' TRP . 74.1 Cg_endo -78.06 159.66 30.33 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.38 2.053 . . . . 0.0 111.904 179.195 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -75.42 -31.37 60.35 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.622 179.847 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.953 HG13 HG23 ' A' ' 6' ' ' VAL . 13.5 p -149.68 111.82 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.446 -179.435 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.709 HD12 ' O ' ' A' ' 7' ' ' TRP . 15.3 tp -87.13 150.2 24.14 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.925 0.393 . . . . 0.0 111.949 -179.656 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.696 ' HB3' HG13 ' A' ' 8' ' ' VAL . 1.4 tt -138.75 118.13 12.83 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.743 179.539 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.481 ' HB2' ' CD1' ' A' ' 80' ' ' ILE . 3.2 m -112.42 135.16 53.46 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 121.038 0.447 . . . . 0.0 111.286 179.756 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.411 ' O ' ' O ' ' A' ' 55' ' ' ILE . 25.7 t0 -77.36 -8.01 56.99 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -178.705 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 1.012 HG12 ' HA3' ' A' ' 62' ' ' GLY . 0.0 OUTLIER 37.61 100.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 179.908 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.401 HH21 ' HA ' ' A' ' 10' ' ' ASP . 1.3 ptt85 -146.03 44.0 1.24 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.501 179.68 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.524 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 37.7 ttp 65.27 49.37 0.72 Allowed Pre-proline 0 CA--C 1.532 0.285 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 178.894 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' A' ' 62' ' ' GLY . 57.5 Cg_endo -72.05 -84.54 0.0 OUTLIER 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 122.757 2.305 . . . . 0.0 112.116 178.711 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -100.33 -29.33 6.76 Favored Glycine 0 C--N 1.337 0.636 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.433 179.696 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.99 ' HB3' ' HB2' ' A' ' 64' ' ' ALA . 0.7 OUTLIER -157.23 69.4 0.57 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.907 0.384 . . . . 0.0 110.114 179.496 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.524 ' HA ' ' HA ' ' A' ' 57' ' ' MET . 0.2 OUTLIER 68.56 -22.96 0.13 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.964 -179.694 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 1.012 ' HA3' HG12 ' A' ' 55' ' ' ILE . . . 136.69 -26.63 3.01 Favored Glycine 0 CA--C 1.498 -0.997 0 C-N-CA 120.981 -0.628 . . . . 0.0 111.682 -179.838 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.638 HD12 ' H ' ' A' ' 63' ' ' LEU . 1.0 OUTLIER -75.95 -17.56 59.69 Favored 'General case' 0 N--CA 1.44 -0.971 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.157 179.221 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.99 ' HB2' ' HB3' ' A' ' 60' ' ' MET . . . -53.47 -38.34 63.51 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 121.002 0.429 . . . . 0.0 110.601 179.085 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.637 ' HB3' ' HA3' ' A' ' 36' ' ' GLY . 3.8 pp -58.76 -36.94 75.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.197 -179.795 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.792 HD13 ' HB2' ' A' ' 93' ' ' ALA . 9.6 mt -62.7 -43.73 98.04 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.835 0.35 . . . . 0.0 110.308 179.586 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.52 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 0.4 OUTLIER -52.9 -59.75 4.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.499 179.563 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.624 ' HB3' HD13 ' A' ' 40' ' ' LEU . 4.2 mp0 -55.86 -38.19 69.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.023 0.44 . . . . 0.0 111.146 179.422 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 6.7 mm -61.56 -36.74 75.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.218 -178.738 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.623 ' HB2' ' HB2' ' A' ' 96' ' ' GLN . 1.1 pttt -78.44 -24.86 45.87 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.247 -0.433 . . . . 0.0 112.084 -179.613 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -80.57 -30.03 37.01 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.694 -178.251 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 27.5 mtt180 -103.9 -21.78 13.59 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -179.684 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.815 ' CE1' HD13 ' A' ' 43' ' ' LEU . 0.4 OUTLIER -128.67 156.24 77.77 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-O 120.776 0.322 . . . . 0.0 111.255 -178.935 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -95.25 100.88 0.11 Allowed 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 123.214 2.609 . . . . 0.0 113.687 -178.88 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.493 ' HA ' ' CA ' ' A' ' 97' ' ' GLY . 3.9 mtt 55.53 38.57 30.4 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.261 178.169 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.54 HD11 ' CD2' ' A' ' 43' ' ' LEU . 1.4 tt -60.52 114.19 9.51 Favored Pre-proline 0 C--N 1.325 -0.483 0 C-N-CA 121.143 -0.223 . . . . 0.0 110.867 179.602 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.453 ' HD2' HD23 ' A' ' 76' ' ' LEU . 50.7 Cg_exo -55.87 129.94 37.65 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.532 2.155 . . . . 0.0 112.848 -179.948 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.668 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 4.4 t -137.59 147.06 26.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.286 179.55 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.832 ' CG2' HD23 ' A' ' 114' ' ' LEU . 2.0 mt -122.47 111.07 28.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.212 179.563 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.549 HG13 ' CZ ' ' A' ' 101' ' ' TYR . 8.6 mm -99.2 142.13 15.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 120.996 0.426 . . . . 0.0 111.839 -178.903 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.642 ' O ' ' HB2' ' A' ' 102' ' ' LEU . 13.8 ttt -70.72 -75.73 0.12 Allowed 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.631 -179.42 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.526 ' H ' ' CG2' ' A' ' 55' ' ' ILE . 3.0 m -105.65 147.39 28.54 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.089 0.471 . . . . 0.0 111.542 -178.936 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.918 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -116.29 59.12 0.74 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.902 179.941 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 21.1 p80 -99.07 135.28 40.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.913 0.387 . . . . 0.0 111.561 -179.674 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.444 ' HB3' ' CG ' ' A' ' 61' ' ' ASP . 9.5 t 62.85 134.11 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.648 179.183 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.526 ' HB3' HD13 ' A' ' 63' ' ' LEU . 1.8 t70 55.49 36.65 27.57 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.128 179.65 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.72 HD21 ' HB1' ' A' ' 83' ' ' ALA . 0.5 OUTLIER -53.48 -24.27 12.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.566 -179.901 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -49.5 -47.46 48.63 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.96 0.41 . . . . 0.0 111.357 -179.782 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.478 ' O ' ' HB2' ' A' ' 93' ' ' ALA . . . -62.66 -19.74 64.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.258 -179.888 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.689 ' O ' ' HB3' ' A' ' 93' ' ' ALA . . . -72.09 -57.49 4.22 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.775 0.321 . . . . 0.0 110.972 179.527 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.694 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 3.5 t -59.95 -52.45 60.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.299 -179.55 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 89.9 p -58.44 -22.25 53.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.01 0.434 . . . . 0.0 109.98 178.975 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.792 ' HB2' HD13 ' A' ' 66' ' ' LEU . . . -59.92 -48.81 80.17 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.365 179.154 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.694 ' CE2' ' HA ' ' A' ' 91' ' ' VAL . 2.8 m-85 -57.62 -30.89 65.72 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.186 -180.0 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.77 -36.37 59.85 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.306 -179.911 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.623 ' HB2' ' HB2' ' A' ' 70' ' ' LYS . 11.8 pt20 -100.18 0.88 41.34 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.526 -178.98 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 93' ' ' ALA . . . 128.4 81.32 0.31 Allowed Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.347 -0.93 . . . . 0.0 113.323 179.955 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.668 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -169.7 136.04 1.56 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.778 0.323 . . . . 0.0 110.26 179.162 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.519 ' CZ ' ' HA ' ' A' ' 118' ' ' ALA . 32.0 t80 -74.97 -53.32 9.16 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.976 -0.29 . . . . 0.0 111.325 -179.449 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.634 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 2.4 t70 179.82 -172.76 0.2 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.265 0.555 . . . . 0.0 111.924 -179.756 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.918 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 3.1 m-85 -128.36 154.1 46.34 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.811 179.986 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.794 HD11 HD22 ' A' ' 114' ' ' LEU . 9.0 mp -102.04 123.58 43.07 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-O 120.719 0.295 . . . . 0.0 110.614 179.958 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -68.62 -66.8 0.03 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.19 1.927 . . . . 0.0 112.337 -179.753 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.755 ' H ' ' HD2' ' A' ' 105' ' ' PRO . 0.7 OUTLIER -119.4 -58.39 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.244 -0.434 . . . . 0.0 112.117 -179.535 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.755 ' HD2' ' H ' ' A' ' 104' ' ' LYS . 17.8 Cg_endo -59.5 163.1 13.43 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.255 1.97 . . . . 0.0 112.697 -179.501 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.616 ' HA ' HD23 ' A' ' 102' ' ' LEU . 38.9 t80 -166.86 -108.61 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.223 179.609 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.593 ' O ' ' O ' ' A' ' 106' ' ' PHE . 3.1 p30 43.04 176.57 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.896 0.379 . . . . 0.0 111.274 -179.975 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.652 HD11 ' CD2' ' A' ' 19' ' ' LEU . 1.0 OUTLIER -67.7 -39.41 82.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 121.903 -0.498 . . . . 0.0 111.278 -179.82 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.486 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 4.4 t70 -49.82 -58.47 5.3 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.246 -179.75 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.585 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 3.4 mm-40 -77.61 -34.32 53.42 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 111.709 0.263 . . . . 0.0 111.709 -179.76 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.39 -59.56 4.21 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 179.328 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.726 ' O ' HG12 ' A' ' 115' ' ' VAL . 55.8 t -59.54 -30.27 44.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.466 0.65 . . . . 0.0 110.506 178.86 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.486 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -65.37 -47.55 76.0 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.158 179.367 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.832 HD23 ' CG2' ' A' ' 79' ' ' ILE . 23.6 tp -73.51 -21.33 60.43 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.551 -179.627 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.726 HG12 ' O ' ' A' ' 112' ' ' VAL . 5.7 p -79.44 -47.08 22.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.779 0.323 . . . . 0.0 111.679 -179.838 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.642 ' HA ' HD12 ' A' ' 119' ' ' ILE . 31.8 mt-10 -67.88 -46.8 70.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.88 -179.786 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 55.8 mtp180 -61.01 -24.2 65.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.091 0.472 . . . . 0.0 110.567 179.392 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.519 ' HA ' ' CZ ' ' A' ' 99' ' ' PHE . . . -71.16 -47.4 57.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.97 179.625 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.642 HD12 ' HA ' ' A' ' 116' ' ' GLU . 4.6 mt -62.94 -31.17 51.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.127 -179.95 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.0 t -74.55 -51.0 15.86 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.422 -179.387 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 20.5 m80 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.394 -179.464 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.663 ' HG3' ' HE3' ' A' ' 1' ' ' MET 1.51 3.9 mtm . . . . . 3 N--CA 0.345 -55.692 2 N-CA-C 162.743 19.164 . . . . 0.0 162.743 . . . . . . . . . 4 2 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.586 2.3 mt-30 -124.41 111.4 15.7 Favored 'General case' 4 C--N 0.591 -32.401 5 O-C-N 76.631 -28.793 . . . . 0.0 122.754 179.739 . . . . . . . . 4 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.695 ' HG2' HD11 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -46.67 -29.08 1.7 Allowed 'General case' 3 C--N 0.87 -20.26 3 O-C-N 94.922 -17.361 . . . . 0.0 114.498 -179.438 . . . . . . . . 5 4 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.464 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . 79.76 87.59 0.54 Allowed Glycine 1 C--N 1.149 -9.831 1 O-C-N 113.565 -5.709 . . . . 0.0 112.665 -179.864 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 1.134 ' CD1' ' CB ' ' A' ' 5' ' ' ILE . 0.7 OUTLIER -112.7 113.3 43.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 O-C-N 122.59 -0.359 . . . . 0.0 111.365 -179.679 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.825 HG23 HG13 ' A' ' 50' ' ' VAL . 7.1 p -107.71 125.39 64.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.676 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.894 ' CD1' HG22 ' A' ' 31' ' ' THR . 31.4 m0 -114.44 134.13 55.23 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.03 0.443 . . . . 0.0 110.374 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.698 HG13 ' HB3' ' A' ' 52' ' ' LEU . 0.3 OUTLIER -122.29 143.83 33.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.653 -178.405 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.706 HG11 ' HA2' ' A' ' 36' ' ' GLY . 0.0 OUTLIER -123.81 109.65 23.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.038 0.447 . . . . 0.0 110.321 178.901 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.497 ' O ' ' N ' ' A' ' 12' ' ' ASP . 5.8 t0 -164.55 -177.24 4.72 Favored 'General case' 1 C--O 0.895 -17.579 0 CA-C-O 125.923 2.773 . . . . 0.0 111.103 -179.075 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 1.303 ' OD2' ' CB ' ' A' ' 11' ' ' ASP . 0.7 OUTLIER -44.89 -10.47 0.01 OUTLIER 'General case' 2 C--N 1.074 -11.412 3 O-C-N 104.073 -11.642 . . . . 0.0 112.854 -178.827 . . . . . . . . 5 4 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.497 ' N ' ' O ' ' A' ' 10' ' ' ASP . 2.6 t70 76.01 -147.53 0.03 OUTLIER 'General case' 1 C--O 1.13 -5.215 0 O-C-N 117.905 -2.997 . . . . 0.0 111.76 179.803 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . 1.091 ' OG ' ' HB2' ' A' ' 13' ' ' SER . 8.2 t 22.05 -85.74 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.777 0 C-N-CA 126.371 1.868 . . . . 0.0 114.676 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.754 ' O ' HG23 ' A' ' 18' ' ' VAL . 0.3 OUTLIER -55.87 -56.92 14.9 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 120.925 0.393 . . . . 0.0 111.514 -179.447 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.0 mm -65.09 -24.99 36.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-O 120.823 0.344 . . . . 0.0 111.141 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 1.253 ' NH2' ' NE ' ' A' ' 16' ' ' ARG . 1.8 ttt180 -72.29 -50.2 28.84 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.291 0.567 . . . . 0.0 111.201 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 72.1 t90 -60.33 -43.24 96.6 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.754 HG23 ' O ' ' A' ' 14' ' ' SER . 3.2 t -65.84 -48.05 83.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -178.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 1.418 ' CD1' ' CB ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -81.15 -29.29 34.76 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -178.093 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 1.327 ' OE1' ' CG ' ' A' ' 20' ' ' GLU . 12.9 pt-20 -67.13 -59.33 3.54 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -178.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 1.202 ' NE ' ' CG ' ' A' ' 21' ' ' ARG . 11.8 mmt180 -59.2 -51.27 70.73 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.821 -179.09 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.64 -46.11 84.6 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.91 0.386 . . . . 0.0 111.83 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.479 ' CD1' ' CB ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -72.2 -26.46 62.06 Favored 'General case' 0 C--N 1.311 -1.109 0 CA-C-O 121.225 0.536 . . . . 0.0 110.408 179.577 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.09 -34.62 78.03 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.93 -26.14 68.63 Favored Glycine 0 N--CA 1.44 -1.073 0 C-N-CA 120.247 -0.978 . . . . 0.0 111.032 178.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.673 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -77.21 -15.71 59.37 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 120.802 0.334 . . . . 0.0 110.939 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.3 26.23 10.32 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.514 -0.851 . . . . 0.0 114.143 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.673 ' CD1' ' HB3' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -126.18 168.74 13.64 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 117.982 0.891 . . . . 0.0 112.238 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 53.7 m -91.85 115.3 27.95 Favored 'General case' 0 C--O 1.211 -0.953 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.627 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 1.223 ' SG ' ' CA ' ' A' ' 30' ' ' CYS . 49.1 t -110.81 113.55 26.23 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.008 0.433 . . . . 0.0 112.083 -179.259 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.894 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.7 t -122.48 146.22 47.59 Favored 'General case' 0 C--O 1.219 -0.509 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.816 HG21 ' HA ' ' A' ' 16' ' ' ARG . 60.3 p -119.52 162.57 18.68 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.315 0.579 . . . . 0.0 112.258 -178.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.816 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 3.0 m-85 -133.65 173.54 11.4 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.371 -0.832 . . . . 0.0 111.7 -178.442 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.676 ' HG3' ' N ' ' A' ' 35' ' ' ASN . 17.1 pt-20 -62.55 -47.03 85.66 Favored 'General case' 1 C--O 1.149 -4.211 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -177.98 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 1.103 ' CG ' ' CA ' ' A' ' 35' ' ' ASN . 0.0 OUTLIER -161.25 -61.73 0.05 Allowed 'General case' 1 C--O 0.886 -18.048 0 O-C-N 118.598 -2.564 . . . . 0.0 112.277 -179.252 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.968 ' HA3' HD23 ' A' ' 65' ' ' LEU . . . -163.39 -43.95 0.02 OUTLIER Glycine 1 C--N 1.066 -14.464 3 O-C-N 103.777 -11.827 . . . . 0.0 113.315 -179.399 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 1.329 ' ND2' ' CB ' ' A' ' 37' ' ' ASN . 2.0 m-20 -60.43 -33.31 72.35 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 122.208 -0.584 . . . . 0.0 111.358 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 1.103 ' CD ' ' HG2' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -57.1 -55.27 36.91 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.384 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.657 HG23 HG13 ' A' ' 9' ' ' VAL . 21.5 t -53.44 -37.62 30.42 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.289 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.816 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.68 HD13 ' HB3' ' A' ' 68' ' ' GLN . 18.5 mt -56.42 -44.72 80.66 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.681 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.39 -48.77 63.84 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.212 0.529 . . . . 0.0 111.218 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.64 -31.77 73.14 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.913 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 1.187 HD13 ' CE1' ' A' ' 73' ' ' HIS . 12.9 mt -64.4 -24.93 67.8 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.515 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.35 -18.72 18.65 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.66 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.39 0.11 8.84 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 1.256 ' NZ ' ' CD ' ' A' ' 46' ' ' LYS . 0.3 OUTLIER -162.4 160.38 26.36 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-O 120.779 0.323 . . . . 0.0 111.55 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 97.3 m -138.91 114.7 8.57 Favored Pre-proline 0 N--CA 1.448 -0.556 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.447 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.602 ' HD2' HD21 ' A' ' 43' ' ' LEU . 68.4 Cg_endo -75.29 159.58 40.15 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.441 2.094 . . . . 0.0 111.599 179.108 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -75.26 -26.53 58.88 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.803 0.335 . . . . 0.0 111.108 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.825 HG13 HG23 ' A' ' 6' ' ' VAL . 7.1 p -146.04 133.52 15.26 Favored 'Isoleucine or valine' 1 C--O 1.079 -7.92 0 CA-C-O 122.88 1.324 . . . . 0.0 110.861 -179.652 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.548 HD12 ' O ' ' A' ' 7' ' ' TRP . 18.2 tp -120.02 134.45 55.25 Favored 'General case' 1 C--N 1.203 -5.766 1 O-C-N 114.859 -4.901 . . . . 0.0 111.649 -179.262 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.698 ' HB3' HG13 ' A' ' 8' ' ' VAL . 0.6 OUTLIER -119.15 122.13 41.32 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 122.824 0.45 . . . . 0.0 110.232 179.676 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.452 ' HA ' HG23 ' A' ' 9' ' ' VAL . 0.5 OUTLIER -115.96 136.59 52.9 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.273 0.559 . . . . 0.0 112.169 -179.541 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 1.282 ' O ' ' CA ' ' A' ' 55' ' ' ILE . 10.3 t70 -80.96 -2.32 47.27 Favored 'General case' 1 C--O 0.48 -39.423 1 CA-C-O 162.772 20.32 . . . . 0.0 112.03 -179.978 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 1.282 ' CA ' ' O ' ' A' ' 54' ' ' ASP . 14.7 tt 32.72 97.83 0.0 OUTLIER 'Isoleucine or valine' 2 C--N 0.776 -24.364 3 O-C-N 28.812 -58.68 . . . . 0.0 111.483 -179.326 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 1.555 ' CB ' ' CD ' ' A' ' 56' ' ' ARG 0.266 0.3 OUTLIER -158.85 47.77 0.33 Allowed 'General case' 3 C--N 1.154 -7.898 1 O-C-N 112.899 -6.125 . . . . 0.0 117.447 -179.837 . . . . . . . . 6 4 . 1 . 001 nuclear build full ' A' A ' 57' ' ' MET . . . . . 1.532 ' CE ' ' CG ' ' A' ' 57' ' ' MET 0.684 11.2 ttt 88.93 28.48 0.0 OUTLIER Pre-proline 3 N--CA 1.257 -10.121 1 N-CA-C 139.177 10.436 . . . . 0.0 139.177 179.064 . . . . . . . . 5 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.421 ' HD2' ' O ' ' A' ' 61' ' ' ASP . 36.9 Cg_endo -65.36 -101.48 0.0 OUTLIER 'Trans proline' 3 C--O 0.983 -12.226 0 O-C-N 125.966 2.561 . . . . 0.0 112.862 178.977 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -98.25 -53.3 1.27 Allowed Glycine 4 C--O 0.965 -16.705 0 CA-C-N 125.744 3.884 . . . . 0.0 112.79 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' MET . . . . . 1.282 ' CE ' ' CG ' ' A' ' 60' ' ' MET . 0.0 OUTLIER -118.1 63.28 0.76 Allowed 'General case' 1 C--N 1.163 -7.537 2 O-C-N 113.5 -5.706 . . . . 0.0 109.958 178.763 . . . . . . . . 5 4 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 1.246 ' OD1' ' CB ' ' A' ' 61' ' ' ASP . 0.3 OUTLIER 62.99 -42.67 0.19 Allowed 'General case' 1 C--O 1.044 -9.721 0 CA-C-O 122.324 1.059 . . . . 0.0 112.137 -179.756 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 1.062 ' HA3' HG13 ' A' ' 55' ' ' ILE . . . 165.91 -30.87 0.21 Allowed Glycine 1 C--N 1.185 -7.814 1 O-C-N 114.55 -5.094 . . . . 0.0 111.417 -179.713 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.717 HD12 ' H ' ' A' ' 63' ' ' LEU . 2.2 mp -67.01 -19.19 65.66 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-O 120.852 0.358 . . . . 0.0 110.193 179.159 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.838 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -54.25 -37.49 64.74 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-O 121.183 0.516 . . . . 0.0 110.498 178.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 1.42 ' HG ' ' CA ' ' A' ' 65' ' ' LEU . 1.2 mt -58.33 -44.32 88.61 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.736 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 1.308 ' CD1' ' CB ' ' A' ' 66' ' ' LEU . 20.4 mt -55.88 -45.44 78.57 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.08 0.467 . . . . 0.0 110.619 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.2 mttt -53.34 -48.41 68.53 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.856 179.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 1.448 ' OE1' ' CG ' ' A' ' 68' ' ' GLN . 11.8 mm-40 -66.4 -34.55 78.21 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.963 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.576 HG13 ' O ' ' A' ' 65' ' ' LEU . 98.4 mt -61.34 -41.78 91.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.727 -179.521 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 1.25 ' NZ ' ' CD ' ' A' ' 70' ' ' LYS . 17.4 pttt -71.51 -28.1 63.66 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.669 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.618 ' OE1' ' HA ' ' A' ' 68' ' ' GLN . 1.9 mt-30 -72.84 -38.05 67.23 Favored 'General case' 0 C--O 1.213 -0.848 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.763 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 70.7 mtt-85 -97.14 -41.65 8.22 Favored 'General case' 0 C--O 1.173 -2.949 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 1.659 ' CE1' ' CD2' ' A' ' 73' ' ' HIS . 0.0 OUTLIER -108.39 139.38 20.72 Favored Pre-proline 1 C--O 1.001 -11.985 0 CA-C-O 124.121 1.915 . . . . 0.0 112.683 -179.053 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.806 ' O ' ' HG3' ' A' ' 75' ' ' MET 0.337 8.3 Cg_endo -74.0 -36.37 3.51 Favored 'Trans proline' 4 C--O 0.774 -22.703 3 C-N-CA 128.145 5.896 . . . . 0.0 123.185 -179.942 . . . . . . . . 5 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' MET . . . . . 1.194 ' CE ' ' CG ' ' A' ' 75' ' ' MET . 47.5 mtt -159.83 31.21 0.18 Allowed 'General case' 2 C--N 0.983 -15.339 3 O-C-N 101.657 -13.152 . . . . 0.0 115.154 -179.923 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 1.306 ' CD1' ' CB ' ' A' ' 76' ' ' LEU . 1.5 tt -64.24 118.77 49.98 Favored Pre-proline 0 C--N 1.306 -1.316 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.621 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.49 ' HA ' ' O ' ' A' ' 97' ' ' GLY . 3.4 Cg_exo -63.44 125.1 14.94 Favored 'Trans proline' 0 C--O 1.212 -0.808 0 C-N-CA 122.809 2.339 . . . . 0.0 112.31 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.648 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 4.3 t -119.32 145.15 25.88 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-O 120.997 0.427 . . . . 0.0 111.321 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.664 ' CG2' HD23 ' A' ' 114' ' ' LEU . 2.0 mt -125.71 113.08 33.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.618 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.584 HD11 HD21 ' A' ' 66' ' ' LEU . 15.9 mm -98.69 141.77 15.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.604 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' MET . . . . . 1.0 ' SD ' ' CE ' ' A' ' 81' ' ' MET . 2.2 ptm -73.64 -41.0 63.33 Favored 'General case' 0 C--O 1.165 -3.381 0 CA-C-N 116.081 -0.509 . . . . 0.0 112.232 -179.162 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.567 ' H ' HG21 ' A' ' 55' ' ' ILE . 7.0 m -135.42 155.39 50.64 Favored 'General case' 0 C--N 1.29 -2.019 0 O-C-N 120.435 -1.416 . . . . 0.0 111.818 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.65 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -118.55 20.93 12.82 Favored 'General case' 1 C--O 0.955 -14.412 0 CA-C-O 121.331 0.586 . . . . 0.0 111.748 -179.667 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.559 ' O ' ' O ' ' A' ' 83' ' ' ALA 0.257 0.0 OUTLIER -25.71 -163.74 0.0 OUTLIER 'General case' 3 C--O 0.554 -35.513 2 O-C-N 111.277 -7.14 . . . . 0.0 118.378 -179.582 . . . . . . . . 6 4 . 1 . 001 nuclear build full ' A' A ' 85' ' ' SER . . . . . 1.147 ' O ' ' CA ' ' A' ' 86' ' ' ASP 0.46 0.2 OUTLIER -32.87 6.71 0.0 OUTLIER 'General case' 4 C--O 0.302 -48.796 5 O-C-N 90.034 -20.417 . . . . 0.0 127.013 -178.286 . . . . . . . . 6 4 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 1.354 ' OD2' ' CB ' ' A' ' 86' ' ' ASP . 0.5 OUTLIER -148.27 44.23 1.05 Allowed 'General case' 2 C--N 0.866 -20.424 3 O-C-N 41.666 -50.646 . . . . 0.0 115.159 178.086 . . . . . . . . 5 4 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.624 HD23 ' HB1' ' A' ' 83' ' ' ALA . 0.2 OUTLIER -48.95 -22.44 0.85 Allowed 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.967 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -48.11 -49.37 32.22 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -179.419 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.498 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -67.14 -21.19 65.84 Favored 'General case' 0 C--N 1.317 -0.807 0 O-C-N 122.371 -0.206 . . . . 0.0 111.081 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.55 ' O ' ' HB3' ' A' ' 93' ' ' ALA . . . -70.73 -42.14 70.94 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-O 121.282 0.563 . . . . 0.0 111.013 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.5 t -62.67 -46.06 97.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 CA-C-O 121.702 0.763 . . . . 0.0 111.725 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.37 -24.65 66.64 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.177 0.513 . . . . 0.0 110.267 178.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.55 ' HB3' ' O ' ' A' ' 90' ' ' ALA . . . -64.51 -47.81 77.5 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-O 121.809 0.814 . . . . 0.0 110.948 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 1.507 ' CZ ' ' CD1' ' A' ' 94' ' ' TYR . 12.3 m-85 -58.17 -28.33 64.66 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-O 122.211 1.005 . . . . 0.0 110.829 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.403 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -74.13 -38.11 63.89 Favored 'General case' 0 C--N 1.286 -2.188 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.523 179.91 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.914 ' OE1' ' HB3' ' A' ' 70' ' ' LYS . 7.6 pt20 -84.74 -12.44 53.75 Favored 'General case' 0 C--O 1.16 -3.634 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.263 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.49 ' O ' ' HA ' ' A' ' 77' ' ' PRO . . . 131.51 20.14 1.13 Allowed Glycine 2 C--O 0.905 -20.412 1 CA-C-O 128.143 4.19 . . . . 0.0 116.333 179.562 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.648 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -77.62 145.55 36.69 Favored 'General case' 1 C--N 1.022 -13.635 3 O-C-N 102.124 -12.398 . . . . 0.0 110.88 179.427 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.516 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 17.8 t80 -77.5 -53.7 7.3 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.707 -0.224 . . . . 0.0 111.433 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 1.14 ' CG ' ' CA ' ' A' ' 100' ' ' ASP . 2.9 t0 173.07 -167.3 0.03 OUTLIER 'General case' 0 C--O 1.221 -0.43 0 CA-C-O 120.882 0.372 . . . . 0.0 111.654 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.65 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 4.3 m-85 -132.42 152.82 51.33 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.365 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.573 ' CD1' HD22 ' A' ' 114' ' ' LEU . 0.9 OUTLIER -103.17 124.29 38.88 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-O 121.25 0.548 . . . . 0.0 110.903 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -68.19 -84.64 0.01 OUTLIER 'Trans proline' 1 C--O 1.101 -6.348 0 C-N-CA 122.104 1.869 . . . . 0.0 113.151 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.621 ' H ' ' HD2' ' A' ' 105' ' ' PRO . 14.1 mttt -106.62 -58.03 0.06 OUTLIER Pre-proline 1 C--N 1.184 -6.62 1 O-C-N 115.977 -4.202 . . . . 0.0 111.964 -179.604 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.621 ' HD2' ' H ' ' A' ' 104' ' ' LYS . 1.1 Cg_endo -57.49 160.29 14.38 Favored 'Trans proline' 0 CA--C 1.508 -0.81 0 C-N-CA 122.342 2.028 . . . . 0.0 112.748 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.666 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 3.0 t80 -166.73 -105.57 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.859 0 O-C-N 123.463 0.477 . . . . 0.0 111.131 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.564 ' O ' ' O ' ' A' ' 106' ' ' PHE . 2.9 p30 42.49 -179.44 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.861 0.362 . . . . 0.0 111.375 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.729 HG12 HG12 ' A' ' 18' ' ' VAL . 0.9 OUTLIER -67.63 -42.85 86.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.071 0.462 . . . . 0.0 111.594 -179.848 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 1.408 ' OD1' ' CB ' ' A' ' 109' ' ' ASP . 0.2 OUTLIER -49.76 -57.84 6.53 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.61 -179.407 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 1.097 ' OE1' ' CG ' ' A' ' 110' ' ' GLU . 5.2 mm-40 -76.99 -31.97 56.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.574 0.226 . . . . 0.0 111.542 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.4 ' CB ' ' O ' ' A' ' 107' ' ' ASP . . . -67.62 -59.52 3.28 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.845 0.355 . . . . 0.0 110.171 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.64 ' O ' HG12 ' A' ' 115' ' ' VAL . 48.2 t -59.3 -31.44 46.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.423 0.63 . . . . 0.0 110.473 178.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.502 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -63.43 -46.36 86.65 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.067 179.261 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.664 HD23 ' CG2' ' A' ' 79' ' ' ILE . 29.4 tp -75.37 -22.4 57.55 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.992 -1.004 . . . . 0.0 111.802 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.64 HG12 ' O ' ' A' ' 112' ' ' VAL . 4.2 p -79.26 -43.78 23.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.641 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 1.129 ' OE2' ' CG ' ' A' ' 116' ' ' GLU . 48.9 mt-10 -65.05 -44.69 88.22 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.949 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 1.514 ' CB ' ' CD ' ' A' ' 117' ' ' ARG . 0.0 OUTLIER -61.07 -24.73 66.44 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.859 179.772 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.516 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -71.27 -45.81 62.32 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.954 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.5 HD11 HG11 ' A' ' 50' ' ' VAL . 4.7 mt -69.67 -31.57 49.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.257 0.551 . . . . 0.0 111.034 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.4 t -70.33 -47.38 61.32 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.32 -0.854 . . . . 0.0 111.086 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 19.4 m80 -63.8 -25.92 68.4 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.059 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 1.637 ' CG ' ' CE2' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -74.39 -52.12 13.05 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.232 -179.98 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.736 ' O ' ' O ' ' A' ' 122' ' ' TYR 0.76 3.8 tt0 -34.99 -178.2 0.0 OUTLIER 'General case' 2 CA--C 0.881 -24.778 2 CA-C-O 89.335 -14.65 . . . . 0.0 126.055 179.967 . . . . . . . . 5 3 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . 1.541 5.7 tt0 . . . . . 4 C--O 0.216 -53.309 5 N-CA-C 172.136 22.643 . . . . 0.0 172.136 179.998 . . . . . . . . 3 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 ptt? . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.76 0.314 . . . . 0.0 111.238 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.464 ' O ' ' HB3' ' A' ' 3' ' ' ARG . 3.6 mt-30 -123.27 -34.75 3.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.781 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.765 ' HB3' HD11 ' A' ' 5' ' ' ILE . 0.1 OUTLIER 76.19 -20.05 0.38 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.702 -179.806 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 52.06 78.72 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.795 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.765 HD11 ' HB3' ' A' ' 3' ' ' ARG . 3.6 mp -110.88 112.35 40.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.75 0.31 . . . . 0.0 110.831 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 1.023 HG11 HD13 ' A' ' 23' ' ' LEU . 7.2 p -107.59 123.43 62.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.7 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.905 ' CD1' HG22 ' A' ' 31' ' ' THR . 30.7 m0 -114.35 131.71 56.45 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.995 0.426 . . . . 0.0 110.924 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.788 HG11 ' CD1' ' A' ' 19' ' ' LEU . 0.3 OUTLIER -113.95 146.88 17.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.909 -179.588 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.799 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -130.42 105.89 12.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.951 0.405 . . . . 0.0 110.099 179.377 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -161.33 -155.14 0.39 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.822 -179.068 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -69.58 12.15 0.21 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.7 p30 46.94 -152.4 0.08 Allowed 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.4 t 38.02 -91.51 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.869 ' O ' HG23 ' A' ' 18' ' ' VAL . 1.9 t -54.87 -60.15 3.76 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.727 0.299 . . . . 0.0 110.785 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.4 mm -63.28 -24.46 35.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.727 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 1.021 ' HA ' HG21 ' A' ' 32' ' ' THR . 0.0 OUTLIER -71.57 -55.16 8.34 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.618 -179.598 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.417 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 86.3 t90 -61.15 -41.49 96.84 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -179.393 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.869 HG23 ' O ' ' A' ' 14' ' ' SER . 6.3 t -65.35 -44.56 94.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -178.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.788 ' CD1' HG11 ' A' ' 8' ' ' VAL . 26.5 mt -83.8 -25.68 30.21 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -178.362 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.577 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 18.8 pt-20 -67.7 -57.96 5.46 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -179.097 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.531 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 1.9 mmt-85 -65.47 -47.78 74.91 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.857 -0.611 . . . . 0.0 112.044 -178.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.41 -60.08 3.82 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 120.901 0.381 . . . . 0.0 111.317 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.036 HD22 HD13 ' A' ' 28' ' ' LEU . 3.3 mt -63.25 -29.14 70.53 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.01 179.25 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.535 ' HB2' ' O ' ' A' ' 20' ' ' GLU . . . -63.26 -36.1 82.53 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.22 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.7 -24.9 71.48 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.247 -0.978 . . . . 0.0 111.086 178.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.726 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -77.48 -15.52 59.26 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 120.6 0.238 . . . . 0.0 111.241 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.5 25.88 8.46 Favored Glycine 0 CA--C 1.522 0.505 0 C-N-CA 120.791 -0.719 . . . . 0.0 113.887 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 1.036 HD13 HD22 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -124.64 171.13 10.3 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 117.691 0.745 . . . . 0.0 111.996 -179.83 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 32.4 m -99.12 106.45 18.66 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.371 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.577 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 48.7 t -103.15 113.39 26.82 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -178.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.905 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.6 t -120.73 149.04 43.14 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.352 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . 1.021 HG21 ' HA ' ' A' ' 16' ' ' ARG . 32.7 p -119.8 166.12 13.68 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.318 0.58 . . . . 0.0 112.336 -178.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.799 ' HB2' HG13 ' A' ' 9' ' ' VAL . 3.9 m-85 -135.6 173.92 11.19 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.414 -178.215 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.666 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 2.6 pp20? -62.08 -43.21 99.34 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -177.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.462 ' C ' HG12 ' A' ' 9' ' ' VAL . 4.9 m120 -166.07 -62.99 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.549 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . -157.73 -48.87 0.01 OUTLIER Glycine 0 C--N 1.318 -0.466 0 C-N-CA 120.517 -0.849 . . . . 0.0 113.429 -178.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.444 ' HA ' ' CD1' ' A' ' 40' ' ' LEU . 1.0 OUTLIER -60.85 -24.51 65.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.975 0.417 . . . . 0.0 111.435 -179.072 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.676 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -60.25 -59.02 6.08 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.262 -179.866 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.756 HG12 ' CD1' ' A' ' 43' ' ' LEU . 4.7 t -52.49 -35.35 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 C-N-CA 120.431 -0.508 . . . . 0.0 111.135 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.559 HD13 ' CB ' ' A' ' 68' ' ' GLN . 19.5 mt -56.02 -42.37 76.37 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.03 0.443 . . . . 0.0 110.976 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.76 -47.47 21.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.2 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.405 ' CB ' ' HE2' ' A' ' 33' ' ' PHE . . . -63.16 -36.49 83.8 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.783 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.756 ' CD1' HG12 ' A' ' 39' ' ' VAL . 12.7 mt -59.81 -20.72 58.53 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.135 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.71 -16.79 52.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.501 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -120.68 -5.91 9.69 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -179.434 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.524 ' O ' HD23 ' A' ' 43' ' ' LEU . 0.1 OUTLIER -162.9 160.77 25.33 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.865 0.364 . . . . 0.0 111.325 -179.746 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.967 HG23 HD23 ' A' ' 76' ' ' LEU . 96.5 m -138.61 115.08 8.86 Favored Pre-proline 0 N--CA 1.453 -0.302 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.535 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.709 ' HD2' HD21 ' A' ' 43' ' ' LEU . 65.9 Cg_endo -73.46 157.02 49.72 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.595 2.197 . . . . 0.0 111.471 178.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.412 ' OD2' HD12 ' A' ' 5' ' ' ILE . 60.1 m-20 -77.0 -22.95 52.32 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.25 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.74 HG13 HG23 ' A' ' 6' ' ' VAL . 7.1 p -150.7 98.19 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-O 120.783 0.325 . . . . 0.0 111.46 -179.255 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.492 HD12 ' O ' ' A' ' 7' ' ' TRP . 29.1 tp -86.63 138.27 31.81 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.893 0.377 . . . . 0.0 111.435 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.531 ' HB3' HG13 ' A' ' 8' ' ' VAL . 0.4 OUTLIER -123.29 113.93 19.53 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.663 179.49 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.438 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -116.54 154.6 30.14 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.322 0.582 . . . . 0.0 112.132 -179.384 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.1 p30 -83.39 -169.7 2.68 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.738 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.66 HG21 ' O ' ' A' ' 82' ' ' THR . 0.9 OUTLIER -158.15 65.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.15 0.5 . . . . 0.0 111.307 178.988 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 29.4 ptt180 -177.18 65.07 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.232 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.627 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . 2.2 tpt -161.97 -64.44 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.696 179.338 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.627 ' HD3' ' HB3' ' A' ' 57' ' ' MET . 42.0 Cg_endo -65.99 -173.15 0.31 Allowed 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.265 1.977 . . . . 0.0 112.913 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.95 -67.03 2.41 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.233 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.558 ' O ' ' N ' ' A' ' 62' ' ' GLY . 0.0 OUTLIER -76.98 55.31 1.1 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.063 0.459 . . . . 0.0 110.344 179.457 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.448 ' O ' ' HD2' ' A' ' 58' ' ' PRO . 1.0 OUTLIER 42.41 -77.8 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.711 -179.739 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.723 ' O ' ' HG ' ' A' ' 65' ' ' LEU . . . -135.34 -30.6 0.34 Allowed Glycine 0 C--O 1.225 -0.419 0 C-N-CA 120.367 -0.92 . . . . 0.0 113.224 -179.434 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.76 ' HA ' HD12 ' A' ' 66' ' ' LEU . 0.2 OUTLIER -67.75 -12.54 60.77 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.619 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.487 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -56.34 -56.79 16.79 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-O 121.056 0.455 . . . . 0.0 110.116 178.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.859 HD12 ' N ' ' A' ' 66' ' ' LEU . 3.1 pp -54.78 -42.3 71.58 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.498 179.182 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.859 ' N ' HD12 ' A' ' 65' ' ' LEU . 28.8 mt -48.19 -52.62 20.05 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.005 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.773 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 34.5 tttp -54.58 -43.13 71.85 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.09 0.472 . . . . 0.0 110.711 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.559 ' CB ' HD13 ' A' ' 40' ' ' LEU . 34.4 mm-40 -64.75 -28.4 69.55 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.615 179.519 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.891 HD13 HG21 ' A' ' 78' ' ' VAL . 96.2 mt -63.83 -40.45 89.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.726 -179.128 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.773 ' HG2' ' O ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -75.22 -25.38 58.11 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.893 -179.187 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -62.22 -50.8 70.31 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.209 -0.45 . . . . 0.0 112.175 -179.211 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 14.2 mtt-85 -96.26 -45.32 6.88 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -178.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.453 ' HE1' ' HA ' ' A' ' 40' ' ' LEU . 0.4 OUTLIER -91.41 130.3 40.01 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.198 -178.649 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 73' ' ' HIS . 44.4 Cg_exo -56.76 -70.77 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.54 2.16 . . . . 0.0 113.099 -179.101 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.712 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 2.1 mpt? -133.74 46.88 2.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.932 0.396 . . . . 0.0 111.412 -179.355 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.967 HD23 HG23 ' A' ' 47' ' ' THR . 2.8 tm? -64.31 110.61 4.15 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.53 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.59 ' HD2' HD22 ' A' ' 76' ' ' LEU . 38.0 Cg_exo -58.49 131.58 43.46 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.624 2.216 . . . . 0.0 112.168 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.891 HG21 HD13 ' A' ' 69' ' ' ILE . 2.8 t -131.34 151.93 36.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.107 0.479 . . . . 0.0 111.431 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.624 HD11 ' CG2' ' A' ' 50' ' ' VAL . 4.0 mt -134.08 115.58 21.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.952 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.677 HG13 HD11 ' A' ' 66' ' ' LEU . 26.4 mm -93.68 141.95 14.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.525 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.635 ' HG3' HG22 ' A' ' 55' ' ' ILE . 7.7 ptm -71.99 -35.44 69.49 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -178.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.66 ' O ' HG21 ' A' ' 55' ' ' ILE . 4.1 m -147.31 149.4 32.76 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -179.328 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.717 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -108.64 83.31 1.75 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.798 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 -66.87 -159.34 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.669 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.469 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 0.4 OUTLIER -80.46 78.98 7.13 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-O 121.079 0.466 . . . . 0.0 112.152 -178.455 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.483 ' HB3' HD13 ' A' ' 63' ' ' LEU . 13.7 t70 175.74 26.6 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.777 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.577 HD21 ' HB1' ' A' ' 83' ' ' ALA . 13.3 mt -45.73 -22.96 0.21 Allowed 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -179.328 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -47.98 -46.9 33.14 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.61 0.243 . . . . 0.0 111.325 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.05 -22.04 59.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.334 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.599 ' HB2' HD23 ' A' ' 63' ' ' LEU . . . -65.41 -40.89 93.94 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.182 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.63 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 6.6 t -65.26 -40.06 87.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.933 -179.554 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.463 ' O ' ' HG3' ' A' ' 95' ' ' GLN . 19.5 m -63.42 -16.49 60.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.124 0.488 . . . . 0.0 109.903 178.456 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.789 ' O ' ' HG3' ' A' ' 96' ' ' GLN . . . -75.94 -55.01 6.02 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 121.503 0.668 . . . . 0.0 111.062 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.63 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 3.6 m-85 -57.38 -34.69 69.11 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.291 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.463 ' HG3' ' O ' ' A' ' 92' ' ' SER . 2.3 pp0? -77.19 -35.2 55.97 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.119 -179.274 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.789 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 1.9 pp0? -77.65 -18.41 56.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.096 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 147.37 -27.61 1.52 Allowed Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.987 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.69 ' HB3' ' C ' ' A' ' 93' ' ' ALA . . . -41.95 152.7 0.07 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.563 0.181 . . . . 0.0 111.378 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.517 ' O ' ' HB2' ' A' ' 100' ' ' ASP . 59.6 t80 -85.63 -53.58 5.07 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 121.084 -0.246 . . . . 0.0 111.544 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.517 ' HB2' ' O ' ' A' ' 99' ' ' PHE . 1.0 OUTLIER 170.79 -176.19 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.009 0.433 . . . . 0.0 111.243 -179.717 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.717 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 3.9 m-85 -112.04 152.71 27.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.333 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.668 HD21 ' HA ' ' A' ' 106' ' ' PHE . 6.5 tp -104.64 139.62 20.28 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.09 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.513 ' HD2' HD12 ' A' ' 102' ' ' LEU . 38.7 Cg_endo -66.51 -164.29 0.08 OUTLIER 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.779 2.32 . . . . 0.0 113.1 -179.505 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.479 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 85.6 mttt -46.37 -59.71 4.61 Favored Pre-proline 0 CA--C 1.533 0.315 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.779 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 8.4 Cg_endo -50.74 164.4 0.57 Allowed 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.699 2.266 . . . . 0.0 112.157 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.668 ' HA ' HD21 ' A' ' 102' ' ' LEU . 86.7 t80 -162.16 -99.93 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.665 -0.243 . . . . 0.0 110.914 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.586 ' O ' ' O ' ' A' ' 106' ' ' PHE . 2.9 p-10 40.06 -177.2 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.977 0.418 . . . . 0.0 111.562 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.65 HG12 HG12 ' A' ' 18' ' ' VAL . 0.8 OUTLIER -67.76 -43.52 86.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.106 0.479 . . . . 0.0 111.024 179.474 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.497 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 8.1 t70 -49.42 -59.07 4.06 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.896 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.631 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 21.4 mm-40 -76.95 -27.51 54.83 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 111.841 0.312 . . . . 0.0 111.841 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.407 ' CB ' ' O ' ' A' ' 107' ' ' ASP . . . -71.01 -59.59 2.7 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 179.362 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.643 ' O ' HG12 ' A' ' 115' ' ' VAL . 53.6 t -59.61 -30.67 45.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.348 0.595 . . . . 0.0 110.271 178.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.497 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -63.61 -46.3 86.41 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.928 179.407 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.468 ' HA ' ' HG2' ' A' ' 117' ' ' ARG . 53.8 tp -74.86 -23.16 58.38 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.695 -179.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.643 HG12 ' O ' ' A' ' 112' ' ' VAL . 2.8 p -79.53 -42.38 22.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.997 -0.281 . . . . 0.0 111.547 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.583 ' HA ' HD12 ' A' ' 119' ' ' ILE . 47.6 mt-10 -63.71 -43.6 96.08 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.088 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.468 ' HG2' ' HA ' ' A' ' 114' ' ' LEU . 0.4 OUTLIER -64.35 -23.97 67.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.862 0.363 . . . . 0.0 110.739 179.638 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.458 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -71.35 -45.12 63.71 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.835 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.583 HD12 ' HA ' ' A' ' 116' ' ' GLU . 6.4 mt -62.71 -31.66 52.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.217 0.532 . . . . 0.0 110.709 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 9.2 m -71.19 -54.85 9.55 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.87 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -59.48 -27.2 65.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.912 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -75.64 -57.89 3.61 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.933 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 57.69 177.45 0.05 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.715 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.438 ' HB2' ' HG2' ' A' ' 2' ' ' GLN . 4.4 tm-20 . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.986 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 tpp . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.83 0.348 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.4 tp60 -67.51 -67.34 0.46 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.26 0.552 . . . . 0.0 111.066 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 57.57 58.71 3.62 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.399 -0.818 . . . . 0.0 111.173 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.691 ' C ' HD13 ' A' ' 5' ' ' ILE . . . -82.64 86.03 1.48 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.557 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.691 HD13 ' C ' ' A' ' 4' ' ' GLY . 2.6 mm -111.81 112.76 41.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.864 0.364 . . . . 0.0 111.157 -179.023 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.89 HG23 HG13 ' A' ' 50' ' ' VAL . 7.3 p -108.77 124.87 65.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.902 0.382 . . . . 0.0 110.521 179.205 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.942 ' CD1' HG22 ' A' ' 31' ' ' THR . 22.5 m0 -115.17 135.87 53.72 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.965 0.412 . . . . 0.0 110.637 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.856 HG13 ' HB3' ' A' ' 52' ' ' LEU . 1.3 t -126.22 146.04 32.69 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.332 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.431 -178.449 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.722 HG22 HG23 ' A' ' 39' ' ' VAL . 45.2 t -120.6 112.62 36.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 177.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -161.65 -158.21 0.54 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.96 -178.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -76.31 19.25 0.25 Allowed 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.6 p30 46.25 -156.2 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.433 ' OG ' ' N ' ' A' ' 14' ' ' SER . 76.7 p 35.83 -95.09 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.752 ' O ' HG23 ' A' ' 18' ' ' VAL . 0.3 OUTLIER -52.77 -62.04 1.91 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.911 -178.969 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 18.4 mm -63.93 -23.88 34.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.977 0.418 . . . . 0.0 111.063 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.565 ' HA ' HG21 ' A' ' 32' ' ' THR . 3.0 ttt-85 -75.95 -50.84 13.81 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.906 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.466 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 44.8 t90 -58.91 -37.41 76.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.188 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.752 HG23 ' O ' ' A' ' 14' ' ' SER . 11.2 t -69.39 -43.92 80.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.114 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.733 HD23 HG21 ' A' ' 8' ' ' VAL . 2.3 tp -84.03 -27.34 28.42 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.416 -178.568 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.661 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 12.8 pt-20 -67.82 -60.98 2.1 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.624 -0.431 . . . . 0.0 111.845 -179.065 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.479 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 3.9 mmt-85 -59.65 -52.19 66.59 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.805 -179.322 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.07 -52.36 64.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.982 0.42 . . . . 0.0 111.316 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.754 ' CD2' HG11 ' A' ' 6' ' ' VAL . 1.8 tp -68.06 -24.98 65.13 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.342 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.13 -35.61 78.38 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.87 -25.98 68.35 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.411 -0.9 . . . . 0.0 111.244 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.658 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -77.15 -15.78 59.39 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 120.675 0.274 . . . . 0.0 111.07 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.96 26.59 8.33 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.457 -0.878 . . . . 0.0 114.28 178.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.726 HD12 ' O ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -126.51 170.85 11.59 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 117.938 0.869 . . . . 0.0 111.897 -179.913 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 35.2 m -99.8 104.95 16.67 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.091 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.833 ' HA ' HG13 ' A' ' 6' ' ' VAL . 51.5 t -100.1 111.52 23.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.582 -179.187 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.942 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.6 t -124.06 147.39 47.9 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.349 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.77 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 65.7 p -116.95 166.11 12.55 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -178.284 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.88 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 5.0 m-85 -135.66 170.3 16.18 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.002 -178.039 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.927 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 2.1 pp20? -68.96 -54.13 16.99 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -179.13 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.7 ' C ' HG11 ' A' ' 9' ' ' VAL . 14.0 m120 -155.81 -178.65 7.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.898 0.38 . . . . 0.0 110.8 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.52 ' O ' ' HG ' ' A' ' 40' ' ' LEU . . . -50.98 -16.39 1.81 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.89 -0.671 . . . . 0.0 114.1 -178.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -85.54 -36.33 20.54 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 117.766 0.783 . . . . 0.0 112.131 -179.262 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.927 ' HB2' ' HG3' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -55.37 -62.07 1.92 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -178.444 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.722 HG23 HG22 ' A' ' 9' ' ' VAL . 48.6 t -49.06 -32.23 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.999 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' A' ' 36' ' ' GLY . 30.5 mt -59.9 -41.03 90.77 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.031 0.443 . . . . 0.0 110.209 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.53 -48.32 78.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.185 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.11 -29.65 64.29 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.829 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.727 HD13 ' NE2' ' A' ' 73' ' ' HIS . 5.9 mt -61.51 -33.52 73.94 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.017 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.56 -19.45 15.85 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.617 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.8 m -125.47 2.58 7.67 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.532 ' O ' HD23 ' A' ' 43' ' ' LEU . 0.1 OUTLIER -161.9 166.18 26.6 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 120.832 0.349 . . . . 0.0 111.165 179.966 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.788 HG23 HD23 ' A' ' 76' ' ' LEU . 85.1 m -138.41 114.78 8.96 Favored Pre-proline 0 N--CA 1.453 -0.289 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.999 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.625 ' HD2' HD21 ' A' ' 43' ' ' LEU . 61.2 Cg_endo -71.09 148.16 55.89 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.283 1.989 . . . . 0.0 111.886 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -74.21 -30.34 62.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.758 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.89 HG13 HG23 ' A' ' 6' ' ' VAL . 7.3 p -146.88 101.36 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.841 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.61 HD11 HG21 ' A' ' 39' ' ' VAL . 13.8 tp -85.46 125.6 33.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.08 0.467 . . . . 0.0 111.343 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.856 ' HB3' HG13 ' A' ' 8' ' ' VAL . 1.2 tt -120.64 120.26 35.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.823 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.502 ' CB ' HD23 ' A' ' 65' ' ' LEU . 8.1 t -118.38 130.2 55.86 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.067 0.461 . . . . 0.0 111.106 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.415 ' HA ' ' HG2' ' A' ' 81' ' ' MET . 24.5 t70 -83.24 15.19 3.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.805 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.696 HG13 ' O ' ' A' ' 61' ' ' ASP . 3.5 tt 33.51 93.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 120.766 0.317 . . . . 0.0 111.813 -179.396 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.9 tpt180 -104.7 34.1 3.3 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.356 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.534 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER 53.14 47.35 4.04 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.674 179.08 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.747 ' HD2' ' O ' ' A' ' 61' ' ' ASP . 21.0 Cg_endo -61.26 -74.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.096 1.864 . . . . 0.0 111.272 178.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -117.01 -80.94 0.81 Allowed Glycine 0 C--N 1.332 0.306 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 178.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.747 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -85.6 56.27 3.89 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 177.781 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.747 ' O ' ' HD2' ' A' ' 58' ' ' PRO . 4.1 p30 55.92 -62.88 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.224 -0.898 . . . . 0.0 112.106 -178.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 60' ' ' MET . . . -155.47 -35.97 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 121.147 -0.549 . . . . 0.0 112.276 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.763 HD21 ' HA ' ' A' ' 87' ' ' LEU . 0.3 OUTLIER -61.38 -22.0 64.57 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.73 0.3 . . . . 0.0 111.085 -179.802 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.747 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -54.91 -42.76 72.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.092 0.473 . . . . 0.0 111.135 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.546 ' HG ' HD11 ' A' ' 69' ' ' ILE . 7.4 tp -52.96 -43.85 66.69 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.252 -179.507 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 1.0 HD22 ' HB1' ' A' ' 93' ' ' ALA . 2.9 mt -59.93 -43.83 94.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.912 0.387 . . . . 0.0 110.862 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.439 ' HG3' ' HE3' ' A' ' 70' ' ' LYS . 4.1 tttt -53.07 -54.92 28.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.775 -179.378 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.519 ' HB3' HD13 ' A' ' 40' ' ' LEU . 66.2 mm-40 -61.18 -44.66 96.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.911 -179.219 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.59 ' CG2' ' HB3' ' A' ' 76' ' ' LEU . 22.7 mt -56.92 -54.18 33.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.287 0.565 . . . . 0.0 111.409 -178.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.473 ' HB3' ' CB ' ' A' ' 96' ' ' GLN . 11.0 pttt -57.45 -23.7 51.32 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.496 -179.098 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.65 -51.96 50.32 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.722 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 75.0 mtt-85 -100.37 -7.19 24.68 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.379 -178.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.727 ' NE2' HD13 ' A' ' 43' ' ' LEU . 71.6 m-70 -125.52 139.09 33.14 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-O 120.896 0.379 . . . . 0.0 112.015 -179.233 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -68.86 -62.33 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.95 2.433 . . . . 0.0 113.417 -179.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.739 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 1.8 mtt -136.06 49.0 2.14 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.163 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.788 HD23 HG23 ' A' ' 47' ' ' THR . 0.9 OUTLIER -68.26 108.49 2.85 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.014 178.916 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.525 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 18.1 Cg_endo -59.42 132.32 45.6 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.419 2.079 . . . . 0.0 112.336 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.422 ' CG2' HD13 ' A' ' 69' ' ' ILE . 3.3 t -129.48 136.24 59.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.738 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.616 HD11 HG23 ' A' ' 50' ' ' VAL . 1.9 mt -127.61 110.89 23.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.934 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.633 HG13 ' CZ ' ' A' ' 101' ' ' TYR . 15.2 mm -99.79 147.53 7.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.538 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.489 ' HG3' ' N ' ' A' ' 82' ' ' THR . 0.3 OUTLIER -81.66 -34.58 30.69 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.261 -179.767 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.489 ' N ' ' HG3' ' A' ' 81' ' ' MET . 21.6 m -133.79 148.28 51.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.517 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.535 ' HA ' ' CE2' ' A' ' 101' ' ' TYR . . . -99.94 -25.82 14.2 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.417 ' HB3' ' H ' ' A' ' 85' ' ' SER . 3.3 m-70 46.77 -158.87 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.764 -0.198 . . . . 0.0 110.913 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.417 ' H ' ' HB3' ' A' ' 84' ' ' HIS . 94.0 p -80.25 175.44 10.64 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.977 0.417 . . . . 0.0 111.469 -179.581 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.657 ' O ' HD22 ' A' ' 63' ' ' LEU . 0.7 OUTLIER 62.89 32.46 15.72 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.989 -179.897 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.763 ' HA ' HD21 ' A' ' 63' ' ' LEU . 1.9 mt -49.05 -21.66 0.75 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.414 -179.509 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -48.39 -41.36 28.75 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.806 0.298 . . . . 0.0 111.806 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.638 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -66.16 -23.79 66.53 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.733 ' HB2' HD23 ' A' ' 63' ' ' LEU . . . -77.3 -26.86 52.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.819 0.342 . . . . 0.0 110.726 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.511 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 6.3 t -68.22 -39.21 80.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.936 0.398 . . . . 0.0 110.073 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 30.9 m -68.55 -20.54 64.55 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.742 178.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 1.0 ' HB1' HD22 ' A' ' 66' ' ' LEU . . . -67.41 -42.99 82.33 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.668 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.511 ' CE2' ' HA ' ' A' ' 91' ' ' VAL . 12.5 m-85 -62.39 -25.79 68.12 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.332 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.18 -41.13 42.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.282 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.739 ' O ' ' HA ' ' A' ' 75' ' ' MET . 0.0 OUTLIER -76.06 -16.91 59.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.206 -179.876 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 119.16 17.63 4.87 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.461 -0.876 . . . . 0.0 113.652 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.58 ' HB2' ' HB1' ' A' ' 93' ' ' ALA . . . -64.43 165.05 10.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 117.141 0.47 . . . . 0.0 110.811 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.481 ' HZ ' ' HG3' ' A' ' 117' ' ' ARG . 13.9 t80 -87.16 -54.42 4.32 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.497 ' OD2' HD11 ' A' ' 114' ' ' LEU . 9.5 p30 167.77 -164.55 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.782 0.325 . . . . 0.0 110.887 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.633 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 5.6 m-85 -138.63 153.19 48.6 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.755 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.404 ' CD1' HD22 ' A' ' 114' ' ' LEU . 0.8 OUTLIER -103.25 122.34 45.57 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.074 179.863 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -70.13 -69.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.078 1.852 . . . . 0.0 112.501 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.692 ' H ' ' HD2' ' A' ' 105' ' ' PRO . 0.9 OUTLIER -119.07 -60.42 0.03 OUTLIER Pre-proline 0 CA--C 1.533 0.301 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.901 -179.637 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.692 ' HD2' ' H ' ' A' ' 104' ' ' LYS . 11.7 Cg_endo -54.12 160.53 6.17 Favored 'Trans proline' 0 C--N 1.35 0.605 0 C-N-CA 122.214 1.943 . . . . 0.0 112.513 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.639 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 50.5 t80 -170.8 -102.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.551 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.566 ' O ' ' O ' ' A' ' 106' ' ' PHE . 2.3 p-10 43.26 178.46 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.558 0.218 . . . . 0.0 111.052 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.713 HG12 HG12 ' A' ' 18' ' ' VAL . 0.8 OUTLIER -67.82 -44.13 85.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.231 0.539 . . . . 0.0 111.217 179.852 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.492 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 1.5 t70 -49.42 -58.78 4.52 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.703 -179.223 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.639 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 6.4 mm-40 -74.17 -30.41 62.23 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 111.771 0.285 . . . . 0.0 111.771 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -68.76 -62.05 1.55 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.817 0.341 . . . . 0.0 110.331 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.641 ' HA ' HG12 ' A' ' 115' ' ' VAL . 44.0 t -57.84 -31.56 40.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.477 0.656 . . . . 0.0 110.716 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.492 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -64.0 -44.3 93.06 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.848 179.079 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.768 ' HA ' ' HD3' ' A' ' 117' ' ' ARG . 10.0 tp -78.33 -23.01 47.23 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.778 -179.131 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.641 HG12 ' HA ' ' A' ' 112' ' ' VAL . 4.8 p -79.45 -41.77 22.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.026 0.441 . . . . 0.0 111.47 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.495 ' HA ' HD12 ' A' ' 119' ' ' ILE . 20.8 mt-10 -59.65 -47.76 84.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.274 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.768 ' HD3' ' HA ' ' A' ' 114' ' ' LEU . 0.8 OUTLIER -59.24 -23.96 62.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.44 -179.531 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.479 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -71.03 -39.34 72.39 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.105 0.478 . . . . 0.0 111.0 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.696 HD13 ' CD2' ' A' ' 28' ' ' LEU . 4.6 mt -76.95 -30.95 18.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.728 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.4 t -67.44 -41.15 85.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.602 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 17.5 m80 -73.67 -23.43 59.84 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.979 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.42 ' O ' ' HG2' ' A' ' 123' ' ' GLN . 7.2 t80 -69.94 -60.69 2.15 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.695 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.42 ' HG2' ' O ' ' A' ' 122' ' ' TYR . 14.2 pt20 42.44 -169.14 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.805 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.806 -179.581 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.453 0 CA-C-O 120.78 0.324 . . . . 0.0 111.099 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.432 ' NE2' ' HB3' ' A' ' 123' ' ' GLN . 0.0 OUTLIER -82.42 148.4 28.23 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.93 0.395 . . . . 0.0 110.852 -179.958 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.634 ' HB3' HD11 ' A' ' 5' ' ' ILE . 0.3 OUTLIER -89.44 -26.99 20.69 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.079 -179.968 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.44 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . 53.65 82.76 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.536 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.634 HD11 ' HB3' ' A' ' 3' ' ' ARG . 3.8 mp -108.4 112.38 40.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.713 0.292 . . . . 0.0 111.545 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 1.003 HG11 ' CD2' ' A' ' 23' ' ' LEU . 7.5 p -106.64 123.37 61.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.974 0.416 . . . . 0.0 110.911 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.795 ' CD1' HG22 ' A' ' 31' ' ' THR . 28.6 m0 -114.53 136.94 52.47 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.363 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.693 HG21 ' OE1' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -129.68 141.49 46.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.478 -178.408 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 1.085 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -119.45 104.83 16.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 178.673 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.707 ' HB3' HG21 ' A' ' 15' ' ' ILE . 8.3 t0 -172.42 114.98 0.31 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.387 0.613 . . . . 0.0 111.401 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.672 ' O ' ' HB2' ' A' ' 12' ' ' ASP . 0.4 OUTLIER 49.75 -87.46 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.761 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.672 ' HB2' ' O ' ' A' ' 11' ' ' ASP . 22.9 t0 168.01 -125.72 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.51 0 O-C-N 123.041 0.213 . . . . 0.0 110.842 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.521 ' HA ' ' HB3' ' A' ' 16' ' ' ARG . 72.7 m -41.36 -43.58 2.54 Favored 'General case' 0 C--N 1.342 0.275 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.0 m -52.9 -62.4 1.67 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.65 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.707 HG21 ' HB3' ' A' ' 10' ' ' ASP . 21.8 mm -72.33 -20.08 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.617 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.85 ' HA ' HG21 ' A' ' 32' ' ' THR . 3.0 tmm_? -72.38 -30.97 65.16 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-O 121.529 0.681 . . . . 0.0 110.244 178.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.622 ' O ' ' HB2' ' A' ' 21' ' ' ARG . 41.2 t90 -72.16 -58.07 3.73 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.886 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.449 HG12 HG12 ' A' ' 108' ' ' ILE . 0.8 OUTLIER -60.68 -62.24 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 -177.467 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.53 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -68.81 -49.52 57.84 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 114.29 1.218 . . . . 0.0 114.29 -176.818 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.755 ' HG3' ' HG2' ' A' ' 16' ' ' ARG . 1.5 mm-40 -67.87 -61.23 1.97 Allowed 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -177.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.622 ' HB2' ' O ' ' A' ' 17' ' ' TRP . 8.5 mmt180 -48.61 -44.22 36.92 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.327 -177.274 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.22 -28.6 62.26 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.878 0.37 . . . . 0.0 110.887 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.003 ' CD2' HG11 ' A' ' 6' ' ' VAL . 5.0 tp -80.93 -23.35 38.93 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.406 179.356 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' A' ' 20' ' ' GLU . . . -69.31 -35.14 75.68 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.468 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.87 -27.08 66.22 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.202 -0.999 . . . . 0.0 110.84 178.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.671 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -77.68 -15.86 58.89 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.623 0.249 . . . . 0.0 111.071 179.424 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.75 26.71 11.31 Favored Glycine 0 CA--C 1.522 0.47 0 C-N-CA 120.548 -0.834 . . . . 0.0 114.732 178.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.769 HD13 ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -117.77 166.36 12.54 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 118.548 1.174 . . . . 0.0 112.007 -179.887 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.493 ' HB ' HG23 ' A' ' 5' ' ' ILE . 88.5 m -84.73 104.66 14.89 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.776 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.474 ' HA ' HG13 ' A' ' 6' ' ' VAL . 2.8 p -106.29 109.31 21.2 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.956 -178.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.795 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.7 t -125.26 152.46 44.58 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.85 HG21 ' HA ' ' A' ' 16' ' ' ARG . 64.7 p -122.9 164.16 18.97 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.392 0.615 . . . . 0.0 112.597 -178.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 1.085 ' HB2' HG13 ' A' ' 9' ' ' VAL . 26.3 m-85 -135.93 172.95 12.26 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.025 -0.989 . . . . 0.0 112.033 -177.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.435 ' HG2' ' H ' ' A' ' 35' ' ' ASN . 5.3 pt-20 -63.26 -50.92 68.27 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.318 0.858 . . . . 0.0 113.318 -177.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.435 ' H ' ' HG2' ' A' ' 34' ' ' GLU . 10.5 m-20 -168.75 -26.06 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -179.279 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.609 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . 174.29 -61.62 0.12 Allowed Glycine 0 N--CA 1.453 -0.191 0 C-N-CA 120.115 -1.041 . . . . 0.0 113.029 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.516 ' HA ' ' CD1' ' A' ' 40' ' ' LEU . 1.2 t30 -51.93 -28.38 16.3 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.69 0.281 . . . . 0.0 111.24 -179.536 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.908 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.7 OUTLIER -58.83 -58.34 9.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.67 179.245 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.694 HG12 ' HG ' ' A' ' 43' ' ' LEU . 7.7 t -50.74 -38.16 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 120.619 -0.433 . . . . 0.0 111.339 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.715 HD13 ' HB3' ' A' ' 68' ' ' GLN . 17.5 mt -53.81 -43.88 69.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.394 -179.173 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.89 -48.94 62.13 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.546 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.63 -35.28 78.63 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.37 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.694 ' HG ' HG12 ' A' ' 39' ' ' VAL . 14.2 mt -60.2 -26.31 66.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.076 0.465 . . . . 0.0 110.909 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.06 -20.46 25.01 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.302 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.3 m -123.08 4.67 9.28 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 112.146 0.425 . . . . 0.0 112.146 -179.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.543 ' HB3' ' CH2' ' A' ' 7' ' ' TRP . 0.0 OUTLIER -164.51 158.99 18.83 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.893 0.378 . . . . 0.0 111.273 -179.768 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.982 HG23 HD23 ' A' ' 76' ' ' LEU . 90.8 m -138.23 112.14 8.64 Favored Pre-proline 0 N--CA 1.452 -0.347 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.688 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.588 ' HD2' HD21 ' A' ' 43' ' ' LEU . 73.9 Cg_endo -73.58 156.21 49.57 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.703 2.268 . . . . 0.0 111.477 178.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -78.47 -22.92 46.8 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.174 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.641 ' O ' HG13 ' A' ' 50' ' ' VAL . 7.3 p -150.58 96.66 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-O 120.663 0.268 . . . . 0.0 111.542 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 27.7 tp -87.09 145.8 26.31 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 121.123 0.487 . . . . 0.0 111.367 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.769 HD23 ' O ' ' A' ' 79' ' ' ILE . 0.6 OUTLIER -131.36 114.18 14.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.323 179.637 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.685 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 35.3 t -115.32 144.52 43.64 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.62 0.724 . . . . 0.0 112.126 -179.235 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -83.14 168.36 16.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.395 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.558 HG13 ' O ' ' A' ' 61' ' ' ASP . 3.6 tt -142.58 87.6 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.721 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.5 ptm85 -118.51 36.22 4.48 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.541 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.687 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 1.2 ttt 64.46 46.3 0.59 Allowed Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.099 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.58 ' HD2' ' O ' ' A' ' 61' ' ' ASP . 27.0 Cg_endo -64.23 -74.81 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.024 1.816 . . . . 0.0 110.769 178.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -111.84 -85.58 1.53 Allowed Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 109.981 -1.247 . . . . 0.0 109.981 177.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.881 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 0.5 OUTLIER -87.72 58.65 5.0 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 177.408 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.687 ' HA ' ' HA ' ' A' ' 57' ' ' MET . 0.2 OUTLIER 62.54 -42.69 0.18 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.993 -179.5 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.514 ' HA3' HD12 ' A' ' 55' ' ' ILE . . . 171.31 -29.52 0.12 Allowed Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 111.494 -0.642 . . . . 0.0 111.494 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.661 HD11 ' O ' ' A' ' 84' ' ' HIS . 0.5 OUTLIER -72.46 -17.48 61.77 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 120.992 -0.283 . . . . 0.0 110.452 179.427 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.881 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -53.94 -29.25 41.65 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 121.103 0.478 . . . . 0.0 110.54 178.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.451 ' HA ' ' OE1' ' A' ' 68' ' ' GLN . 1.4 mm? -66.77 -24.22 66.18 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.24 -179.465 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.96 HD13 ' HB2' ' A' ' 93' ' ' ALA . 3.7 mt -77.73 -46.5 21.59 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.134 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.696 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 1.7 mtpt -46.09 -51.92 12.99 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.501 178.57 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.715 ' HB3' HD13 ' A' ' 40' ' ' LEU . 2.6 mp0 -64.42 -48.44 75.35 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.241 0.543 . . . . 0.0 110.335 178.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.479 HG21 ' CG2' ' A' ' 78' ' ' VAL . 4.2 mm -54.71 -39.05 45.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.665 -179.196 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.696 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -78.14 -30.58 49.34 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.199 -178.97 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.35 -40.93 57.69 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.825 -178.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.88 -46.31 9.52 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -179.121 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.653 ' CE1' HD13 ' A' ' 43' ' ' LEU . 0.1 OUTLIER -103.69 142.87 25.49 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.95 -178.896 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.29 -71.17 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.733 2.289 . . . . 0.0 113.272 -179.027 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 13.8 mtt -140.28 47.08 1.8 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.884 0.373 . . . . 0.0 110.805 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.982 HD23 HG23 ' A' ' 47' ' ' THR . 3.1 tm? -59.31 110.31 2.6 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.684 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.489 ' HD2' HD22 ' A' ' 76' ' ' LEU . 28.9 Cg_exo -63.02 116.51 3.62 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 123.086 2.524 . . . . 0.0 113.427 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.968 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 3.3 t -118.56 152.43 20.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.652 179.59 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.769 ' O ' HD23 ' A' ' 52' ' ' LEU . 3.6 mt -132.25 114.28 23.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.548 -0.297 . . . . 0.0 110.572 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.685 ' HA ' ' O ' ' A' ' 53' ' ' SER . 11.6 mm -95.59 142.5 13.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.133 0.492 . . . . 0.0 111.788 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.457 ' HB2' ' CE1' ' A' ' 106' ' ' PHE . 2.8 ptt? -66.65 -28.74 68.71 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.308 -179.295 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.444 ' H ' HG22 ' A' ' 80' ' ' ILE . 5.0 m -147.07 167.78 23.21 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.43 0.157 . . . . 0.0 111.293 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.501 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -122.3 61.94 0.97 Allowed 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -179.346 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.661 ' O ' HD11 ' A' ' 63' ' ' LEU . 67.7 m170 -73.16 162.87 28.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.824 0.345 . . . . 0.0 110.851 179.029 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.434 ' HB2' ' CB ' ' A' ' 61' ' ' ASP . 8.3 t 63.8 -167.41 0.21 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.124 0.488 . . . . 0.0 112.151 178.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -56.06 92.44 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.493 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.774 HD23 ' HB3' ' A' ' 90' ' ' ALA . 0.6 OUTLIER -47.76 -20.46 0.29 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.997 179.343 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -47.45 -45.98 26.28 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -178.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.402 ' HB3' HD22 ' A' ' 63' ' ' LEU . . . -63.93 -25.73 68.27 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.786 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.774 ' HB3' HD23 ' A' ' 87' ' ' LEU . . . -72.54 -48.79 37.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.768 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.653 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 3.4 t -63.48 -53.62 42.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.086 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 92.4 p -57.28 -23.94 51.65 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 178.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.96 ' HB2' HD13 ' A' ' 66' ' ' LEU . . . -57.57 -53.77 54.37 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.438 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.702 ' CE1' ' HA ' ' A' ' 100' ' ' ASP . 5.9 m-85 -51.13 -33.16 25.41 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.764 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.91 -39.37 56.43 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.447 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.597 ' HB2' ' HB2' ' A' ' 70' ' ' LYS . 6.5 pt20 -94.39 5.8 50.67 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.063 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 93' ' ' ALA . . . 123.1 80.32 0.5 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.55 -0.834 . . . . 0.0 113.019 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.968 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -168.57 135.82 2.0 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.979 0.418 . . . . 0.0 111.27 179.185 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.511 ' HB3' HG12 ' A' ' 79' ' ' ILE . 38.5 t80 -75.84 -53.44 8.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.534 -179.354 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.702 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 1.0 OUTLIER 177.7 -172.84 0.12 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.177 0.513 . . . . 0.0 112.005 -179.535 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.661 ' OH ' HD11 ' A' ' 66' ' ' LEU . 3.2 m-85 -130.19 153.46 48.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.387 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.639 HD23 ' HA ' ' A' ' 106' ' ' PHE . 1.9 mp -103.97 118.38 57.3 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.62 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -73.24 -71.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 121.93 1.753 . . . . 0.0 111.895 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.691 ' H ' ' HD2' ' A' ' 105' ' ' PRO . 9.6 tttm -108.55 -58.66 0.05 OUTLIER Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.623 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.691 ' HD2' ' H ' ' A' ' 104' ' ' LYS . 15.6 Cg_endo -57.51 152.53 47.05 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.3 2.0 . . . . 0.0 113.014 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.639 ' HA ' HD23 ' A' ' 102' ' ' LEU . 14.9 t80 -163.22 -118.38 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.176 179.323 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.558 ' O ' ' O ' ' A' ' 106' ' ' PHE . 2.9 p30 42.5 -179.46 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 118.164 0.438 . . . . 0.0 111.486 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.449 HG12 HG12 ' A' ' 18' ' ' VAL . 1.0 OUTLIER -67.86 -40.92 84.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.516 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.539 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 30.8 t0 -49.18 -58.64 4.65 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.495 -179.21 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.545 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 74.9 mm-40 -77.87 -32.17 51.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.694 0.283 . . . . 0.0 111.371 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.409 ' CB ' ' O ' ' A' ' 107' ' ' ASP . . . -64.88 -62.5 1.52 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.931 0.396 . . . . 0.0 109.978 179.171 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.564 ' O ' HG12 ' A' ' 115' ' ' VAL . 47.0 t -58.4 -31.32 42.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.496 0.665 . . . . 0.0 110.802 179.053 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.539 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -63.46 -45.97 88.38 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.196 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.742 HD23 HG21 ' A' ' 79' ' ' ILE . 5.5 tp -76.76 -22.47 53.74 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.786 -1.097 . . . . 0.0 112.169 -179.052 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.564 HG12 ' O ' ' A' ' 112' ' ' VAL . 4.7 p -79.28 -46.44 23.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.321 -0.552 . . . . 0.0 111.595 -179.115 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.415 ' HA ' HD12 ' A' ' 119' ' ' ILE . 38.4 mt-10 -64.35 -47.89 77.62 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.746 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.54 ' HG2' ' HA ' ' A' ' 114' ' ' LEU . 2.8 ptp180 -60.46 -27.93 67.92 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.14 0.495 . . . . 0.0 110.404 179.346 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.471 ' HB2' ' CE2' ' A' ' 99' ' ' PHE . . . -66.77 -47.02 73.47 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.792 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.429 HD11 HG11 ' A' ' 50' ' ' VAL . 4.4 mt -70.26 -30.69 44.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.689 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 10.5 t -66.72 -43.83 83.23 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.21 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 13.0 m80 -68.09 -25.87 65.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.147 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -82.27 -43.23 17.81 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.873 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.432 ' HB3' ' NE2' ' A' ' 2' ' ' GLN . 9.0 pt20 -75.43 -175.66 2.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.01 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.805 -179.725 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.727 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.734 ' O ' ' HG2' ' A' ' 3' ' ' ARG . 0.0 OUTLIER -137.71 -176.23 4.35 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.509 0.195 . . . . 0.0 110.749 179.968 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.825 ' HG2' HD11 ' A' ' 5' ' ' ILE . 0.3 OUTLIER 66.08 -15.52 0.13 Allowed 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 179.834 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.864 ' O ' HD13 ' A' ' 5' ' ' ILE . . . 98.49 92.92 1.99 Allowed Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.242 179.351 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.864 HD13 ' O ' ' A' ' 4' ' ' GLY . 5.0 mm -126.04 112.48 30.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.074 0.464 . . . . 0.0 111.754 -179.174 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.951 HG11 ' HG ' ' A' ' 23' ' ' LEU . 14.3 p -109.93 128.69 65.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.684 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.877 ' CD1' HG22 ' A' ' 31' ' ' THR . 26.4 m0 -117.32 126.31 52.49 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.962 0.41 . . . . 0.0 110.112 179.09 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.743 HG11 ' CD1' ' A' ' 19' ' ' LEU . 0.5 OUTLIER -116.66 145.82 21.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.814 -178.105 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.813 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -124.52 111.1 27.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.919 0.39 . . . . 0.0 110.649 179.24 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -161.32 -159.15 0.62 Allowed 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.976 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -66.99 -0.64 3.29 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.474 ' O ' ' N ' ' A' ' 14' ' ' SER . 0.4 OUTLIER 68.08 -158.51 0.2 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 121.415 -0.114 . . . . 0.0 111.033 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.418 ' HB3' ' H ' ' A' ' 14' ' ' SER . 1.4 t 33.52 -86.46 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.758 ' O ' HG23 ' A' ' 18' ' ' VAL . 37.6 t -54.21 -63.9 1.0 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.741 0.305 . . . . 0.0 111.324 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.0 mm -61.44 -28.15 43.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.012 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.871 ' HA ' HG21 ' A' ' 32' ' ' THR . 2.7 ttm180 -73.29 -43.58 60.69 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.211 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 55.1 t90 -67.77 -40.75 84.0 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.965 -179.058 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.758 HG23 ' O ' ' A' ' 14' ' ' SER . 4.4 t -70.01 -39.27 77.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -178.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.743 ' CD1' HG11 ' A' ' 8' ' ' VAL . 16.2 mt -84.38 -27.72 27.47 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -178.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.604 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 24.5 pt-20 -67.44 -57.65 6.16 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.032 0.444 . . . . 0.0 111.655 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.472 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 0.7 OUTLIER -60.85 -52.49 64.85 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.937 -179.284 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.57 -43.85 84.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.866 0.365 . . . . 0.0 111.4 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.951 ' HG ' HG11 ' A' ' 6' ' ' VAL . 2.5 tm? -70.69 -31.78 68.79 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.331 0.586 . . . . 0.0 110.306 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.38 -34.22 77.67 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.16 -26.08 68.89 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.391 -0.909 . . . . 0.0 111.111 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.567 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -77.62 -15.56 59.13 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 120.751 0.31 . . . . 0.0 110.74 179.281 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.36 26.2 10.3 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.822 -0.704 . . . . 0.0 113.903 179.039 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.626 ' HB2' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -133.37 171.28 14.27 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 117.752 0.776 . . . . 0.0 111.902 179.705 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.649 ' O ' HG12 ' A' ' 6' ' ' VAL . 16.0 m -94.13 128.22 40.42 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.95 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.667 ' HA ' HG13 ' A' ' 6' ' ' VAL . 50.9 t -121.96 113.65 19.89 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 121.331 0.586 . . . . 0.0 111.477 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.877 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.7 t -117.8 151.86 36.49 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.594 178.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.871 HG21 ' HA ' ' A' ' 16' ' ' ARG . 40.2 p -124.35 164.46 19.58 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.219 0.533 . . . . 0.0 111.773 -179.511 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.859 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 2.3 m-85 -133.06 174.43 10.37 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.505 -178.302 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.402 ' HG2' ' N ' ' A' ' 35' ' ' ASN . 1.7 pt-20 -61.49 -40.7 95.54 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 -176.626 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.402 ' N ' ' HG2' ' A' ' 34' ' ' GLU . 1.4 m120 -170.96 -38.39 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 119.073 0.851 . . . . 0.0 112.589 -179.181 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.731 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . -178.77 -61.12 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.841 -179.472 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.478 ' HA ' HD12 ' A' ' 40' ' ' LEU . 61.2 m-20 -50.74 -33.39 22.91 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 111.621 0.23 . . . . 0.0 111.621 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.859 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -57.7 -50.05 74.48 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.639 -0.425 . . . . 0.0 111.182 -179.98 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.869 HG11 HD11 ' A' ' 51' ' ' LEU . 5.5 t -62.44 -38.68 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 C-N-CA 119.93 -0.708 . . . . 0.0 110.442 179.378 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.798 HD13 ' CB ' ' A' ' 68' ' ' GLN . 12.9 mt -56.78 -42.16 78.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.524 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.35 -48.15 36.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.31 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.81 -28.41 69.84 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.364 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.664 HD21 ' HD2' ' A' ' 48' ' ' PRO . 8.4 mt -69.38 -24.12 63.83 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.083 -179.149 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.36 -17.69 5.32 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.266 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -123.97 0.61 8.57 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.657 ' O ' HD23 ' A' ' 43' ' ' LEU . 0.1 OUTLIER -161.96 155.57 21.2 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.912 0.387 . . . . 0.0 111.348 179.913 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.5 HG23 HD13 ' A' ' 76' ' ' LEU . 91.0 m -139.05 114.7 8.46 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.212 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.664 ' HD2' HD21 ' A' ' 43' ' ' LEU . 73.8 Cg_endo -76.19 166.1 28.36 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.41 2.073 . . . . 0.0 110.965 178.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -74.14 -21.92 59.66 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.681 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.711 HG13 HG23 ' A' ' 6' ' ' VAL . 7.4 p -146.7 168.45 5.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.23 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.869 HD11 HG11 ' A' ' 39' ' ' VAL . 13.5 tp -152.92 120.43 5.97 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.0 0.429 . . . . 0.0 111.53 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.682 ' HB3' HG13 ' A' ' 8' ' ' VAL . 0.3 OUTLIER -105.89 122.19 45.62 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.217 179.815 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.442 ' HB2' ' CD1' ' A' ' 80' ' ' ILE . 36.4 m -113.68 138.13 50.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.089 0.471 . . . . 0.0 112.021 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.526 ' O ' HG22 ' A' ' 55' ' ' ILE . 45.8 p-10 -78.23 -12.77 60.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.594 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.613 ' HB ' HG23 ' A' ' 80' ' ' ILE . 5.3 tt 50.62 82.31 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-O 121.387 0.613 . . . . 0.0 111.867 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.786 ' C ' ' HD2' ' A' ' 58' ' ' PRO . 1.0 OUTLIER 175.93 145.8 0.08 Allowed 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.708 179.273 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.529 ' CB ' ' O ' ' A' ' 56' ' ' ARG . 14.1 ttt 96.52 -52.12 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.766 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 178.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.786 ' HD2' ' C ' ' A' ' 56' ' ' ARG . 20.4 Cg_endo -58.58 175.83 0.51 Allowed 'Trans proline' 0 C--N 1.35 0.643 0 CA-C-N 121.147 1.445 . . . . 0.0 112.286 -178.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -42.17 -74.46 0.17 Allowed Glycine 0 C--N 1.335 0.522 0 C-N-CA 121.126 -0.559 . . . . 0.0 112.501 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.618 ' H ' ' HB2' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -69.46 56.22 0.12 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.773 0.32 . . . . 0.0 110.597 179.221 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 56.75 -80.37 0.01 OUTLIER 'General case' 0 C--O 1.231 0.111 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.735 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.508 ' HA3' ' C ' ' A' ' 55' ' ' ILE . . . -137.1 -34.46 0.2 Allowed Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.655 -0.783 . . . . 0.0 113.007 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.699 ' HA ' HD13 ' A' ' 66' ' ' LEU . 5.2 mp -63.28 -15.76 58.2 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.864 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.69 ' HB3' ' HB2' ' A' ' 58' ' ' PRO . . . -53.82 -48.61 69.72 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 120.929 0.395 . . . . 0.0 111.355 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.507 HD12 ' N ' ' A' ' 66' ' ' LEU . 4.0 pp -51.42 -39.36 57.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.065 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.851 ' HA ' HD12 ' A' ' 69' ' ' ILE . 5.1 mp -57.65 -47.98 80.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.912 0.387 . . . . 0.0 110.216 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.741 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 0.2 OUTLIER -49.98 -44.43 50.93 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.192 0.52 . . . . 0.0 110.097 178.954 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.798 ' CB ' HD13 ' A' ' 40' ' ' LEU . 11.6 mm100 -65.6 -26.42 67.83 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.262 179.238 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.879 HG12 ' CE1' ' A' ' 73' ' ' HIS . 94.0 mt -64.02 -39.62 86.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.486 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.741 ' HG2' ' O ' ' A' ' 67' ' ' LYS . 12.1 pttp -74.1 -27.22 60.78 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.893 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -85.85 -33.66 21.24 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.044 -179.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -106.54 -35.11 7.16 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -178.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.879 ' CE1' HG12 ' A' ' 69' ' ' ILE . 0.3 OUTLIER -99.44 136.07 20.49 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.891 -179.326 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 73' ' ' HIS . 91.4 Cg_endo -92.94 100.6 0.16 Allowed 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.953 2.435 . . . . 0.0 112.537 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.549 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 1.8 mtt 52.44 26.22 4.04 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.662 179.011 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.5 HD13 HG23 ' A' ' 47' ' ' THR . 12.9 tp -69.79 112.66 13.01 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.815 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.4 125.41 18.82 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.353 2.035 . . . . 0.0 112.09 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.832 HG21 HD13 ' A' ' 69' ' ' ILE . 3.7 t -118.25 148.52 21.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.934 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.894 ' CG2' HD23 ' A' ' 114' ' ' LEU . 2.0 mt -127.82 114.14 34.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.617 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.641 HG21 ' CE2' ' A' ' 101' ' ' TYR . 13.2 mm -99.54 143.49 13.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.984 0.421 . . . . 0.0 111.804 -179.045 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.437 ' HA ' ' HB2' ' A' ' 102' ' ' LEU . 18.6 ptm -86.56 -39.71 15.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.067 -178.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.431 ' H ' HG21 ' A' ' 55' ' ' ILE . 2.7 m -122.65 166.53 14.74 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.209 -179.164 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -138.99 -28.33 0.8 Allowed 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.458 ' CE1' ' CD1' ' A' ' 55' ' ' ILE . 3.5 p-80 38.19 -160.97 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 122.928 0.491 . . . . 0.0 111.863 -179.419 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.446 ' H ' ' HB2' ' A' ' 84' ' ' HIS . 27.4 t -82.66 42.05 0.75 Allowed 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -178.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.503 ' CB ' HD13 ' A' ' 63' ' ' LEU . 6.7 m-20 -132.84 15.98 4.28 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.718 0.294 . . . . 0.0 110.773 179.054 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.754 HD23 ' CB ' ' A' ' 90' ' ' ALA . 1.4 mt -44.74 -21.78 0.06 Allowed 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.291 -0.413 . . . . 0.0 112.006 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -47.94 -50.35 27.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.771 0.319 . . . . 0.0 111.028 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.403 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -70.7 -21.19 62.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.986 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.754 ' CB ' HD23 ' A' ' 87' ' ' LEU . . . -64.38 -33.22 75.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.861 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.631 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 3.1 t -66.15 -42.89 92.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.428 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.599 ' O ' ' HG3' ' A' ' 95' ' ' GLN . 14.9 m -60.43 -19.42 56.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.035 0.445 . . . . 0.0 110.073 178.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.742 ' O ' ' HG3' ' A' ' 96' ' ' GLN . . . -75.76 -53.93 7.73 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.62 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.631 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 5.6 m-85 -57.01 -33.19 66.91 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.148 0.499 . . . . 0.0 110.838 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.599 ' HG3' ' O ' ' A' ' 92' ' ' SER . 2.2 pp0? -76.95 -31.25 56.48 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.031 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.742 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 2.0 pp0? -83.09 -18.5 39.36 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.829 -0.349 . . . . 0.0 111.032 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 133.06 4.71 3.24 Favored Glycine 0 C--N 1.335 0.501 0 C-N-CA 120.231 -0.985 . . . . 0.0 114.315 178.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.68 ' HB2' ' HB1' ' A' ' 93' ' ' ALA . . . -58.03 158.34 6.87 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 117.85 0.825 . . . . 0.0 111.278 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.478 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 10.4 t80 -85.11 -53.73 5.08 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.481 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 177.02 -163.69 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.807 0.337 . . . . 0.0 111.297 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.641 ' CE2' HG21 ' A' ' 80' ' ' ILE . 5.9 m-85 -138.82 152.65 48.04 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.464 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.727 ' CD1' HD22 ' A' ' 114' ' ' LEU . 2.7 mp -104.25 122.19 44.9 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.939 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -66.38 -74.68 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.168 1.912 . . . . 0.0 112.395 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.698 ' H ' ' HD2' ' A' ' 105' ' ' PRO . 1.1 mtpm? -114.88 -60.81 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.808 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.698 ' HD2' ' H ' ' A' ' 104' ' ' LYS . 14.4 Cg_endo -56.55 163.22 7.15 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.368 2.046 . . . . 0.0 112.574 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.674 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 41.9 t80 -170.2 -99.94 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.562 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.541 ' O ' ' O ' ' A' ' 106' ' ' PHE . 1.0 OUTLIER 41.47 -175.67 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.812 0.339 . . . . 0.0 111.096 -179.575 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.693 HD11 ' HG ' ' A' ' 19' ' ' LEU . 1.0 OUTLIER -68.01 -40.3 82.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.011 0.434 . . . . 0.0 111.62 179.909 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.494 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 55.2 m-20 -51.85 -58.83 5.31 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.573 -179.052 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.674 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 6.8 mm-40 -75.08 -31.42 61.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.646 0.26 . . . . 0.0 111.417 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -69.91 -61.73 1.66 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.47 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.664 ' O ' HG12 ' A' ' 115' ' ' VAL . 54.4 t -57.31 -30.61 35.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.444 0.64 . . . . 0.0 110.298 178.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.494 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -65.12 -49.22 70.79 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.727 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.894 HD23 ' CG2' ' A' ' 79' ' ' ILE . 13.0 tp -71.71 -21.23 61.8 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.958 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.664 HG12 ' O ' ' A' ' 112' ' ' VAL . 4.3 p -79.43 -47.53 22.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 C-N-CA 120.446 -0.501 . . . . 0.0 111.497 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.427 ' N ' HG13 ' A' ' 115' ' ' VAL . 45.3 mt-10 -66.15 -45.08 82.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.578 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' A' ' 113' ' ' ALA . 0.0 OUTLIER -60.65 -24.41 65.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.583 179.501 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.478 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -71.26 -48.8 48.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.968 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 4.3 mt -68.49 -31.07 49.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.233 0.54 . . . . 0.0 110.755 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -75.7 -54.38 7.06 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.155 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 17.9 m80 -59.33 -28.0 66.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.112 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -71.46 -60.34 2.29 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.752 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 55.52 175.89 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.977 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.843 179.958 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.0 mtt . . . . . 0 N--CA 1.487 1.415 0 CA-C-O 120.918 0.39 . . . . 0.0 111.009 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.446 ' O ' ' HB3' ' A' ' 3' ' ' ARG . 0.0 OUTLIER -116.7 -32.57 5.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.579 179.655 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.744 ' HB3' HD11 ' A' ' 5' ' ' ILE . 15.1 ttt180 70.62 -9.64 0.78 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.955 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 51.39 73.83 0.35 Allowed Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.992 -0.623 . . . . 0.0 113.444 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.744 HD11 ' HB3' ' A' ' 3' ' ' ARG . 2.9 mp -105.17 112.76 40.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.749 0.309 . . . . 0.0 111.055 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.817 HG23 HG13 ' A' ' 50' ' ' VAL . 6.9 p -105.6 125.61 60.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.251 178.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.916 ' CD1' HG22 ' A' ' 31' ' ' THR . 31.4 m0 -115.74 132.01 56.76 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.09 0.472 . . . . 0.0 110.282 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.847 ' HB ' HG22 ' A' ' 32' ' ' THR . 46.6 t -118.8 145.86 24.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.664 -178.346 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.699 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -127.35 118.01 48.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.806 0.336 . . . . 0.0 110.559 179.782 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.554 ' CB ' HG21 ' A' ' 15' ' ' ILE . 2.1 t0 -163.48 -159.43 0.52 Allowed 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.775 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.94 -0.09 4.0 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 65.61 -158.33 0.27 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.495 0.188 . . . . 0.0 110.904 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.432 ' HB3' ' H ' ' A' ' 14' ' ' SER . 1.3 t 35.43 -90.93 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.845 ' O ' HG23 ' A' ' 18' ' ' VAL . 2.1 t -58.39 -54.87 42.17 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.708 0.289 . . . . 0.0 111.321 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.554 HG21 ' CB ' ' A' ' 10' ' ' ASP . 24.7 mm -64.83 -25.14 37.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.941 0.4 . . . . 0.0 111.15 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.551 ' HA ' HG21 ' A' ' 32' ' ' THR . 4.1 ttp180 -75.65 -53.27 8.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.257 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.588 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 86.7 t90 -57.25 -40.45 77.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.84 0.352 . . . . 0.0 111.51 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.845 HG23 ' O ' ' A' ' 14' ' ' SER . 18.9 t -66.43 -47.95 82.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 112.154 0.428 . . . . 0.0 112.154 -178.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.683 HD23 HG21 ' A' ' 8' ' ' VAL . 2.1 tp -80.54 -29.16 37.15 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -178.301 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.588 ' HG2' ' HA ' ' A' ' 17' ' ' TRP . 1.3 pp20? -62.46 -60.31 3.73 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.468 -0.493 . . . . 0.0 112.026 -179.055 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.422 ' HG2' ' CD ' ' A' ' 20' ' ' GLU . 3.0 mmm180 -58.93 -47.51 84.81 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.696 0.284 . . . . 0.0 111.679 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.87 -34.37 77.24 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -178.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.789 HD22 HG11 ' A' ' 6' ' ' VAL . 0.4 OUTLIER -81.82 -26.74 34.07 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.627 179.553 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.41 -34.25 74.21 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 177.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.68 -24.15 69.47 Favored Glycine 0 N--CA 1.443 -0.897 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 177.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.488 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -76.95 -15.3 59.7 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.589 -0.306 . . . . 0.0 110.275 178.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 94.1 26.65 13.79 Favored Glycine 0 C--N 1.337 0.633 0 C-N-CA 120.812 -0.709 . . . . 0.0 114.293 178.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.764 HD13 ' CD2' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -133.87 166.67 22.13 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-N 118.215 1.007 . . . . 0.0 112.784 -179.609 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.46 ' O ' HG12 ' A' ' 6' ' ' VAL . 60.1 m -85.65 118.17 24.99 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.051 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.589 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 1.7 p -116.68 117.13 28.97 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.967 -0.56 . . . . 0.0 112.208 -178.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.916 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.8 t -125.11 133.24 52.93 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.439 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.847 HG22 ' HB ' ' A' ' 8' ' ' VAL . 77.1 p -107.64 164.28 12.36 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.159 0.504 . . . . 0.0 111.659 -178.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.858 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 2.9 m-85 -134.94 174.33 10.71 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.879 -177.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.66 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 2.5 pp20? -63.18 -34.76 78.32 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -176.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -171.04 -55.83 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 118.947 0.794 . . . . 0.0 112.799 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.663 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . -170.43 -43.77 0.03 OUTLIER Glycine 0 C--N 1.316 -0.58 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.57 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.695 ' HA ' ' CD1' ' A' ' 40' ' ' LEU . 3.9 t30 -62.98 -26.07 68.67 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 120.985 0.421 . . . . 0.0 110.714 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.858 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -62.02 -57.64 10.88 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.269 179.819 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.713 HG22 ' CD1' ' A' ' 33' ' ' PHE . 21.2 t -55.51 -32.22 29.71 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 C-N-CA 120.116 -0.634 . . . . 0.0 111.233 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.695 ' CD1' ' HA ' ' A' ' 37' ' ' ASN . 11.2 mt -58.83 -46.47 87.6 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.773 0.32 . . . . 0.0 110.652 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.27 -48.93 63.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.177 0.513 . . . . 0.0 110.794 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.55 -33.61 75.28 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.716 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.671 ' HB3' ' NE2' ' A' ' 73' ' ' HIS . 15.0 mt -63.23 -27.68 69.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.531 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.99 -18.41 45.68 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.299 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.2 m -115.06 -4.77 12.49 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.1 OUTLIER -165.64 161.98 18.62 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.885 0.374 . . . . 0.0 111.081 179.951 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.583 HG23 HD12 ' A' ' 76' ' ' LEU . 54.0 m -138.86 111.77 8.14 Favored Pre-proline 0 N--CA 1.45 -0.43 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.354 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.855 ' HD2' HD11 ' A' ' 76' ' ' LEU . 66.1 Cg_endo -73.3 164.37 35.41 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.162 1.908 . . . . 0.0 111.329 178.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -77.76 -22.1 50.74 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.151 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.817 HG13 HG23 ' A' ' 6' ' ' VAL . 9.8 p -145.15 164.41 12.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.782 HD12 ' O ' ' A' ' 7' ' ' TRP . 11.6 tp -152.67 111.37 3.76 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 121.139 0.495 . . . . 0.0 112.008 -178.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.48 HD13 HD21 ' A' ' 19' ' ' LEU . 1.4 tt -97.7 119.98 37.25 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.759 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.718 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 0.3 OUTLIER -125.47 137.96 53.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.435 0.636 . . . . 0.0 112.63 -178.758 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.505 ' HA ' ' HG2' ' A' ' 81' ' ' MET . 0.8 OUTLIER -83.14 177.37 8.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.172 179.319 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.876 HG21 ' O ' ' A' ' 82' ' ' THR . 0.0 OUTLIER -154.73 105.41 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.195 0.522 . . . . 0.0 110.807 178.978 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.433 ' H ' ' HD3' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -133.56 36.77 3.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.152 -179.508 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.499 ' N ' ' CD ' ' A' ' 58' ' ' PRO . 0.5 OUTLIER 66.42 41.55 0.27 Allowed Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 179.042 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.499 ' CD ' ' N ' ' A' ' 57' ' ' MET . 58.1 Cg_endo -68.81 -90.57 0.0 OUTLIER 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 122.042 1.828 . . . . 0.0 111.0 178.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -87.66 -91.46 1.03 Allowed Glycine 0 C--N 1.335 0.488 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' MET . . . . . 1.018 ' HB3' ' HB2' ' A' ' 64' ' ' ALA . 34.6 tpp -87.56 64.85 8.31 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 177.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.482 ' HA ' ' HA ' ' A' ' 57' ' ' MET . 0.2 OUTLIER 67.61 -20.71 0.12 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.695 -179.291 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.82 ' HA3' HG12 ' A' ' 55' ' ' ILE . . . 133.01 -32.33 2.77 Favored Glycine 0 N--CA 1.446 -0.69 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 -179.132 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.874 HD13 ' HB3' ' A' ' 86' ' ' ASP . 5.4 mp -68.27 -13.86 62.57 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 120.862 0.363 . . . . 0.0 110.332 179.135 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 1.018 ' HB2' ' HB3' ' A' ' 60' ' ' MET . . . -53.17 -36.22 60.67 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.558 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.6 HD11 HD11 ' A' ' 80' ' ' ILE . 3.8 pp -59.73 -40.68 88.86 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 121.1 -0.24 . . . . 0.0 111.222 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.617 ' CD1' ' HA ' ' A' ' 63' ' ' LEU . 4.8 mp -60.38 -43.01 97.02 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-O 121.124 0.488 . . . . 0.0 110.226 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.6 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -54.62 -44.23 72.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.202 -179.749 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.602 ' HB3' HD13 ' A' ' 40' ' ' LEU . 14.0 mm100 -71.92 -43.51 65.19 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.44 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.428 HD12 ' HA ' ' A' ' 66' ' ' LEU . 16.8 mt -60.95 -35.38 64.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-O 121.033 0.444 . . . . 0.0 110.973 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.6 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -72.75 -29.81 63.63 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.013 -179.826 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.452 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -76.37 -36.68 58.02 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.631 -179.67 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.16 -26.14 21.44 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.926 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.671 ' NE2' ' HB3' ' A' ' 43' ' ' LEU . 31.9 m-70 -153.35 82.9 4.65 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.733 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.797 ' HA ' ' HB2' ' A' ' 96' ' ' GLN . 59.2 Cg_endo -73.47 39.08 0.46 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.583 2.189 . . . . 0.0 112.869 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.406 ' HG2' ' C ' ' A' ' 74' ' ' PRO . 1.5 mmm -141.92 -32.09 0.53 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.971 0.415 . . . . 0.0 111.689 -179.65 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.855 HD11 ' HD2' ' A' ' 48' ' ' PRO . 0.3 OUTLIER -61.29 124.37 80.28 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.805 -179.44 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.712 ' HD2' HD23 ' A' ' 76' ' ' LEU . 57.6 Cg_endo -71.2 126.31 12.25 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.32 2.013 . . . . 0.0 112.239 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.605 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 9.5 t -106.93 140.21 25.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.301 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.518 ' CG2' HD23 ' A' ' 114' ' ' LEU . 2.6 mt -127.13 110.08 22.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.614 179.42 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.718 ' HA ' ' O ' ' A' ' 53' ' ' SER . 13.5 mm -103.88 148.04 9.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.923 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.763 ' HG3' HG22 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -69.83 -73.3 0.16 Allowed 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.715 179.647 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.876 ' O ' HG21 ' A' ' 55' ' ' ILE . 3.9 m -105.31 162.8 13.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.949 0.404 . . . . 0.0 110.996 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.8 ' HB1' ' HG ' ' A' ' 87' ' ' LEU . . . -111.93 -22.22 11.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.621 -179.182 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.45 ' H ' HG22 ' A' ' 82' ' ' THR . 22.4 m170 44.39 -163.0 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 120.605 0.241 . . . . 0.0 111.359 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 47.9 t -81.54 29.2 0.38 Allowed 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.874 ' HB3' HD13 ' A' ' 63' ' ' LEU . 0.4 OUTLIER -128.51 24.77 5.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.708 0.29 . . . . 0.0 110.865 179.624 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.8 ' HG ' ' HB1' ' A' ' 83' ' ' ALA . 1.7 mt -50.32 -23.77 2.53 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.456 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -48.09 -56.95 6.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.71 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.482 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -59.57 -22.18 61.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.582 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.459 ' HB2' ' CD2' ' A' ' 63' ' ' LEU . . . -71.02 -35.57 72.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.998 0.428 . . . . 0.0 110.143 179.204 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.65 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 13.7 t -60.03 -44.65 95.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.464 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 49.0 m -60.97 -34.69 75.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.005 0.431 . . . . 0.0 110.491 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.884 ' HB1' ' HB2' ' A' ' 98' ' ' ALA . . . -59.63 -42.28 92.37 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.019 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.65 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 11.0 m-85 -55.49 -24.24 30.4 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.317 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.605 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -75.74 -40.78 54.86 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.912 179.336 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.797 ' HB2' ' HA ' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -77.1 -17.87 58.38 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.903 179.864 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.421 ' O ' ' HA ' ' A' ' 77' ' ' PRO . . . 123.36 18.09 3.13 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.761 -0.733 . . . . 0.0 113.335 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.884 ' HB2' ' HB1' ' A' ' 93' ' ' ALA . . . -48.92 141.03 8.11 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 117.283 0.541 . . . . 0.0 110.911 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.556 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 27.1 t80 -75.72 -53.43 8.53 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.965 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.625 ' OD1' HD21 ' A' ' 114' ' ' LEU . 1.7 p30 167.57 -171.27 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.953 0.406 . . . . 0.0 111.502 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.513 ' CE2' ' HB ' ' A' ' 80' ' ' ILE . 5.3 m-85 -131.0 153.71 48.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.583 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.78 HD23 ' CD1' ' A' ' 106' ' ' PHE . 1.6 tp -102.27 123.4 43.32 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.663 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -72.82 -78.08 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 121.981 1.788 . . . . 0.0 112.766 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.424 ' O ' ' CD2' ' A' ' 106' ' ' PHE . 2.4 tmtm? -108.28 -54.19 0.06 OUTLIER Pre-proline 0 CA--C 1.531 0.247 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.461 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.437 ' O ' ' CG ' ' A' ' 106' ' ' PHE . 52.6 Cg_exo -55.49 154.54 24.22 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.275 1.983 . . . . 0.0 112.508 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.78 ' CD1' HD23 ' A' ' 102' ' ' LEU . 59.9 m-85 -160.43 -119.14 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.9 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.494 ' O ' ' O ' ' A' ' 106' ' ' PHE . 2.6 p30 47.71 174.94 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 120.835 0.35 . . . . 0.0 111.142 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.621 HG12 HG12 ' A' ' 18' ' ' VAL . 1.1 mp -67.11 -44.5 87.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.027 0.442 . . . . 0.0 111.461 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.609 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 0.8 OUTLIER -49.23 -53.92 19.19 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.554 -179.384 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.606 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 3.2 mm-40 -82.47 -34.61 28.01 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 -179.537 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.42 ' CB ' ' O ' ' A' ' 107' ' ' ASP . . . -69.4 -57.35 5.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.807 0.337 . . . . 0.0 110.2 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.684 HG12 ' OE2' ' A' ' 116' ' ' GLU . 46.4 t -59.92 -30.84 46.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.294 0.569 . . . . 0.0 110.481 178.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.609 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -62.07 -46.16 90.32 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.522 0.677 . . . . 0.0 109.997 178.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.655 HD22 HD13 ' A' ' 102' ' ' LEU . 13.9 tp -72.8 -26.69 61.6 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 114.691 -1.14 . . . . 0.0 111.585 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.634 HG12 ' HA ' ' A' ' 112' ' ' VAL . 4.7 p -79.21 -43.03 23.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.833 0.349 . . . . 0.0 111.895 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.684 ' OE2' HG12 ' A' ' 112' ' ' VAL . 44.1 mt-10 -65.84 -45.68 81.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.786 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.511 ' HG2' ' HA ' ' A' ' 114' ' ' LEU . 6.6 ptp180 -59.19 -26.2 64.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.67 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.556 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -68.72 -42.17 78.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.978 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.727 HD13 HD22 ' A' ' 28' ' ' LEU . 5.0 mt -75.68 -30.94 22.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.88 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 10.3 t -70.6 -51.31 29.11 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.903 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 17.1 m80 -62.02 -22.89 66.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.073 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -68.65 -57.39 5.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.79 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.78 -170.25 1.27 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.04 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.862 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 ttp . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 120.766 0.317 . . . . 0.0 111.44 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.508 ' HG2' ' HB2' ' A' ' 124' ' ' GLU . 0.0 OUTLIER -127.01 174.53 8.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.11 -179.738 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.814 ' HG2' HD11 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -63.8 -60.04 3.78 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.406 -179.62 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 55.93 85.57 0.03 OUTLIER Glycine 0 C--N 1.319 -0.405 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.386 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.814 HD11 ' HG2' ' A' ' 3' ' ' ARG . 3.1 mp -108.5 114.87 47.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.668 0.271 . . . . 0.0 111.115 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.958 HG11 ' CD2' ' A' ' 23' ' ' LEU . 7.4 p -107.33 114.8 47.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.051 0.453 . . . . 0.0 111.067 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.801 ' CD1' HG22 ' A' ' 31' ' ' THR . 38.7 m0 -107.95 147.39 31.11 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.009 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.747 HG21 ' OE2' ' A' ' 20' ' ' GLU . 0.1 OUTLIER -137.42 146.1 28.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.353 -178.752 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.882 HG11 ' HA2' ' A' ' 36' ' ' GLY . 0.0 OUTLIER -120.61 104.78 15.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.035 0.445 . . . . 0.0 110.786 179.1 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.815 ' HB3' HG21 ' A' ' 15' ' ' ILE . 0.8 OUTLIER -174.1 118.05 0.24 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.812 -179.801 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.591 ' O ' ' HB2' ' A' ' 12' ' ' ASP . 0.2 OUTLIER 41.96 -87.28 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.232 -0.895 . . . . 0.0 112.033 -179.541 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.591 ' HB2' ' O ' ' A' ' 11' ' ' ASP . 24.4 t70 160.07 -100.79 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 122.734 0.414 . . . . 0.0 111.048 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.6 p -36.77 -76.51 0.02 OUTLIER 'General case' 0 C--O 1.231 0.096 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -179.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.654 ' O ' HG23 ' A' ' 18' ' ' VAL . 44.0 t -52.76 -37.97 60.29 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.322 -177.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.815 HG21 ' HB3' ' A' ' 10' ' ' ASP . 19.3 mm -78.72 -22.88 13.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.163 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.643 ' HA ' HG21 ' A' ' 32' ' ' THR . 3.8 ttm-85 -77.18 -31.37 55.39 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.243 0.544 . . . . 0.0 110.277 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.617 ' HA ' ' HG3' ' A' ' 21' ' ' ARG . 79.7 t90 -72.12 -60.49 2.21 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.683 HG12 HG12 ' A' ' 108' ' ' ILE . 0.8 OUTLIER -54.59 -62.04 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -176.816 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.516 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -77.11 -46.49 23.37 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 -176.177 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.747 ' OE2' HG21 ' A' ' 8' ' ' VAL . 4.7 mm-40 -68.01 -61.38 1.89 Allowed 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 113.456 0.909 . . . . 0.0 113.456 -177.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.617 ' HG3' ' HA ' ' A' ' 17' ' ' TRP . 2.4 mmt180 -48.74 -43.96 38.02 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.098 -177.268 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.41 -26.98 61.2 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.781 0.324 . . . . 0.0 111.045 179.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.958 ' CD2' HG11 ' A' ' 6' ' ' VAL . 5.9 tp -82.27 -24.66 34.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.288 0.566 . . . . 0.0 110.198 179.224 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.495 ' HB2' ' SG ' ' A' ' 30' ' ' CYS . . . -68.36 -36.11 78.73 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.397 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.29 -25.17 68.13 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.256 -0.973 . . . . 0.0 110.749 178.105 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.675 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -76.76 -15.83 59.65 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 120.627 0.251 . . . . 0.0 110.885 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.06 26.58 9.46 Favored Glycine 0 CA--C 1.523 0.547 0 C-N-CA 120.482 -0.866 . . . . 0.0 114.559 178.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.737 HD13 ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -120.76 166.98 12.98 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 118.227 1.014 . . . . 0.0 111.93 -179.93 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.646 ' HB ' HG23 ' A' ' 5' ' ' ILE . 87.2 m -86.52 104.27 15.82 Favored 'General case' 0 CA--C 1.522 -0.097 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.309 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 4.2 p -105.31 110.33 22.65 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.914 -178.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.801 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.8 t -127.16 153.4 46.09 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.643 HG21 ' HA ' ' A' ' 16' ' ' ARG . 58.8 p -125.77 163.76 22.16 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.145 0.498 . . . . 0.0 111.923 -179.319 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.841 ' HB2' HG13 ' A' ' 9' ' ' VAL . 9.4 m-85 -136.09 173.4 11.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.482 -178.447 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.568 ' HG3' ' ND2' ' A' ' 35' ' ' ASN . 0.9 OUTLIER -63.0 -42.51 99.87 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -177.562 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.568 ' ND2' ' HG3' ' A' ' 34' ' ' GLU . 13.5 p30 -170.92 -35.05 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 118.66 0.664 . . . . 0.0 112.343 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.91 ' HA3' HD22 ' A' ' 65' ' ' LEU . . . 176.71 -54.12 0.11 Allowed Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.231 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.455 ' HA ' HD12 ' A' ' 40' ' ' LEU . 77.3 m-20 -51.31 -31.34 21.23 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.688 0.28 . . . . 0.0 111.328 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.814 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -65.15 -51.6 60.21 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.951 -0.3 . . . . 0.0 111.084 179.471 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.732 HG22 ' CD1' ' A' ' 33' ' ' PHE . 21.5 t -55.34 -33.95 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 120.277 -0.569 . . . . 0.0 111.722 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.455 HD12 ' HA ' ' A' ' 37' ' ' ASN . 13.3 mt -59.79 -47.85 84.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.692 0.282 . . . . 0.0 111.402 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.23 -47.36 79.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.268 0.556 . . . . 0.0 111.03 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.52 -40.06 96.04 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.025 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.541 HD21 ' HD2' ' A' ' 48' ' ' PRO . 17.9 mt -59.44 -26.12 64.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.433 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.74 -21.55 7.44 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.337 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.2 m -126.15 4.72 7.13 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -161.36 155.68 22.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.772 0.32 . . . . 0.0 110.968 179.946 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.93 HG23 HD23 ' A' ' 76' ' ' LEU . 89.8 m -138.56 112.05 8.39 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.448 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.661 ' HD2' HD21 ' A' ' 76' ' ' LEU . 71.7 Cg_endo -77.34 163.25 30.24 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.007 1.805 . . . . 0.0 111.444 178.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.462 ' O ' ' HG2' ' A' ' 77' ' ' PRO . 1.7 m-20 -75.74 -23.17 56.0 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.361 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.741 HG13 HG23 ' A' ' 6' ' ' VAL . 7.3 p -145.83 158.59 12.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 C-N-CA 121.16 -0.216 . . . . 0.0 110.83 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.562 ' HA ' ' O ' ' A' ' 7' ' ' TRP . 12.8 tp -152.86 115.69 4.55 Favored 'General case' 0 C--N 1.333 -0.115 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.574 ' HG ' ' HB ' ' A' ' 79' ' ' ILE . 0.8 OUTLIER -101.77 117.14 34.24 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.593 178.446 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.603 ' HB3' HD12 ' A' ' 65' ' ' LEU . 71.9 m -114.22 151.75 32.31 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.95 0.405 . . . . 0.0 112.022 -178.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -82.66 175.5 10.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.435 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.841 HG22 ' HG3' ' A' ' 81' ' ' MET . 3.2 tt -151.38 67.69 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.136 0 CA-C-O 121.343 0.592 . . . . 0.0 111.705 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 177.6 51.66 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.283 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.599 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . 3.1 ttt -159.8 -62.48 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.3 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.503 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.599 ' HD3' ' HB3' ' A' ' 57' ' ' MET . 33.3 Cg_endo -61.64 -165.41 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.307 2.005 . . . . 0.0 112.546 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.45 -80.97 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.976 -0.63 . . . . 0.0 112.909 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.94 ' HB2' ' HB2' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -77.03 55.57 1.14 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.794 0.33 . . . . 0.0 111.277 -179.629 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.589 ' HB3' HG13 ' A' ' 55' ' ' ILE . 0.8 OUTLIER 56.77 -68.93 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.574 179.4 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.637 ' O ' ' HG ' ' A' ' 65' ' ' LEU . . . -153.05 -34.34 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.817 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.6 HD23 ' HB2' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -62.17 -19.8 63.46 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 122.56 -0.377 . . . . 0.0 110.05 179.732 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.94 ' HB2' ' HB2' ' A' ' 60' ' ' MET . . . -54.3 -36.7 63.97 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 121.437 0.636 . . . . 0.0 109.975 178.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.91 HD22 ' HA3' ' A' ' 36' ' ' GLY . 10.9 mt -60.14 -56.79 17.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.034 -0.984 . . . . 0.0 110.605 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.705 HD22 ' HB1' ' A' ' 93' ' ' ALA . 9.6 mt -46.17 -43.77 15.41 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.552 179.368 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.428 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 0.6 OUTLIER -52.07 -55.45 20.66 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.252 178.68 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.445 ' HB3' HD13 ' A' ' 40' ' ' LEU . 42.5 mm-40 -68.49 -34.74 76.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.863 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.53 -36.7 78.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.562 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.442 ' HB2' ' HB3' ' A' ' 96' ' ' GLN . 11.9 pttt -78.19 -26.82 47.72 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.06 -0.518 . . . . 0.0 112.338 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -67.77 -48.67 65.71 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -178.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.8 mmm180 -91.68 -42.55 10.1 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -178.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.516 ' CE1' ' CD1' ' A' ' 43' ' ' LEU . 2.1 m80 -90.98 149.24 39.74 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.442 -178.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -73.6 -77.51 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.599 2.199 . . . . 0.0 113.187 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.721 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 1.3 mtt -125.76 44.56 2.8 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.743 0.306 . . . . 0.0 111.711 -179.367 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.93 HD23 HG23 ' A' ' 47' ' ' THR . 1.0 OUTLIER -60.27 109.51 2.08 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.414 179.414 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.462 ' HG2' ' O ' ' A' ' 49' ' ' ASP . 32.9 Cg_exo -60.74 115.37 2.64 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.525 2.15 . . . . 0.0 112.051 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 5.0 t -115.47 151.91 17.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.14 0 CA-C-O 121.075 0.464 . . . . 0.0 111.345 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.585 HD11 HG23 ' A' ' 50' ' ' VAL . 2.1 mt -138.41 112.82 8.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.569 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.633 ' CG2' ' HB ' ' A' ' 55' ' ' ILE . 16.6 mm -95.03 142.07 14.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.018 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.841 ' HG3' HG22 ' A' ' 55' ' ' ILE . 1.4 ppp? -71.59 -27.24 63.0 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -178.368 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.547 ' O ' HD13 ' A' ' 55' ' ' ILE . 5.4 m -147.22 164.45 33.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.652 0.263 . . . . 0.0 110.77 179.442 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.883 ' HB1' ' HG ' ' A' ' 87' ' ' LEU . . . -129.18 37.26 4.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.769 0.318 . . . . 0.0 111.65 -179.596 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.438 ' O ' ' HB3' ' A' ' 85' ' ' SER . 0.6 OUTLIER -85.83 -172.91 4.34 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.72 179.794 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.438 ' HB3' ' O ' ' A' ' 84' ' ' HIS . 29.7 t 68.7 -79.6 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.384 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.535 ' O ' HD22 ' A' ' 63' ' ' LEU . 0.1 OUTLIER -141.49 80.2 1.72 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.928 0.394 . . . . 0.0 111.268 -179.568 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.883 ' HG ' ' HB1' ' A' ' 83' ' ' ALA . 0.5 OUTLIER -55.94 -21.82 22.83 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.604 179.912 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -48.29 -50.32 30.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.67 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.595 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -57.6 -20.1 30.38 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.731 0.3 . . . . 0.0 111.741 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.633 ' HB3' HD23 ' A' ' 87' ' ' LEU . . . -73.75 -26.02 60.46 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.964 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.595 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 12.2 t -64.84 -50.64 74.27 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.485 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.428 ' O ' ' HB3' ' A' ' 95' ' ' GLN . 3.8 m -62.44 -23.63 66.98 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.97 0.414 . . . . 0.0 110.149 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.705 ' HB1' HD22 ' A' ' 66' ' ' LEU . . . -62.27 -38.37 89.03 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 121.291 0.567 . . . . 0.0 109.935 178.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.595 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 9.1 m-85 -68.15 -23.06 64.83 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.547 178.396 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.428 ' HB3' ' O ' ' A' ' 92' ' ' SER . 0.0 OUTLIER -77.25 -38.37 51.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.855 179.38 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.721 ' O ' ' HA ' ' A' ' 75' ' ' MET . 1.5 pp0? -80.61 -19.01 46.39 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 120.949 -0.301 . . . . 0.0 111.31 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 117.99 31.42 1.59 Allowed Glycine 0 CA--C 1.52 0.388 0 C-N-CA 120.584 -0.817 . . . . 0.0 113.344 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.633 ' HB2' ' HB1' ' A' ' 93' ' ' ALA . . . -67.33 151.34 47.64 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 122.833 -0.216 . . . . 0.0 110.774 179.576 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.536 ' CZ ' ' HB2' ' A' ' 118' ' ' ALA . 14.2 t80 -76.84 -53.83 7.39 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 121.094 -0.242 . . . . 0.0 111.324 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.473 ' HB2' ' O ' ' A' ' 99' ' ' PHE . 4.4 t0 171.08 -168.7 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.312 0.577 . . . . 0.0 111.39 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.788 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 3.7 m-85 -133.79 152.36 51.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.016 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.596 HD11 HD22 ' A' ' 114' ' ' LEU . 1.5 mp -105.22 118.97 54.55 Favored Pre-proline 0 C--N 1.329 -0.314 0 C-N-CA 121.11 -0.236 . . . . 0.0 111.11 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -81.18 -76.31 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.399 2.066 . . . . 0.0 112.508 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.579 ' H ' ' HD2' ' A' ' 105' ' ' PRO . 1.3 mtpp -99.31 -62.07 0.1 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.603 -0.272 . . . . 0.0 111.682 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.579 ' HD2' ' H ' ' A' ' 104' ' ' LYS . 19.5 Cg_endo -59.03 149.56 78.87 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.186 1.924 . . . . 0.0 112.361 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.658 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 48.4 t80 -160.35 -111.79 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.89 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.629 ' O ' ' O ' ' A' ' 106' ' ' PHE . 2.8 p30 39.07 179.4 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.99 0.424 . . . . 0.0 111.921 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.683 HG12 HG12 ' A' ' 18' ' ' VAL . 0.7 OUTLIER -67.6 -42.57 86.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.85 0.357 . . . . 0.0 111.776 -179.403 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.447 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 3.9 m-20 -49.55 -58.42 5.24 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.364 -179.322 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.658 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 13.8 mm-40 -73.96 -35.35 64.52 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.771 0.319 . . . . 0.0 111.08 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.54 -56.18 15.74 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.924 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.637 ' HA ' HG12 ' A' ' 115' ' ' VAL . 52.8 t -63.89 -31.92 55.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.494 0.664 . . . . 0.0 110.598 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.447 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -62.7 -45.46 92.66 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.281 179.275 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.596 HD22 HD11 ' A' ' 102' ' ' LEU . 13.8 tp -78.15 -22.43 48.76 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.727 -1.124 . . . . 0.0 111.995 -178.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.637 HG12 ' HA ' ' A' ' 112' ' ' VAL . 6.2 p -79.6 -47.34 22.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 C-N-CA 120.351 -0.54 . . . . 0.0 111.348 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.418 ' N ' HG13 ' A' ' 115' ' ' VAL . 45.5 mt-10 -63.22 -43.43 98.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.762 0.315 . . . . 0.0 110.775 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 68.4 mtt180 -60.38 -24.99 65.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.008 0.432 . . . . 0.0 110.505 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.536 ' HB2' ' CZ ' ' A' ' 99' ' ' PHE . . . -68.9 -45.4 71.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.739 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 4.9 mt -73.86 -32.02 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-O 121.16 0.505 . . . . 0.0 110.706 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 29.6 t -75.47 -48.51 22.34 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.247 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -58.57 -28.72 65.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.027 0.441 . . . . 0.0 111.125 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -83.95 -50.74 7.75 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.267 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 57.48 171.63 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.408 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.508 ' HB2' ' HG2' ' A' ' 2' ' ' GLN . 5.1 mm-40 . . . . . 0 C--N 1.328 -0.365 0 CA-C-O 120.789 0.328 . . . . 0.0 111.004 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.827 0.346 . . . . 0.0 111.147 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -62.69 158.35 18.7 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.736 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.709 ' HB3' HD11 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -58.19 -23.63 56.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.044 -179.888 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 67.32 73.02 0.7 Allowed Glycine 0 CA--C 1.517 0.179 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.067 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.709 HD11 ' HB3' ' A' ' 3' ' ' ARG . 3.4 mp -112.03 112.91 42.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.747 0.308 . . . . 0.0 111.447 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.886 HG11 ' CD2' ' A' ' 23' ' ' LEU . 5.6 p -107.54 130.51 59.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.074 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.822 ' CD1' HG22 ' A' ' 31' ' ' THR . 36.7 m0 -114.61 140.48 48.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.46 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.658 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.9 OUTLIER -123.34 134.99 64.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.806 0.336 . . . . 0.0 111.683 -178.636 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.696 HG13 HG23 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -119.82 109.19 25.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 120.881 0.372 . . . . 0.0 110.729 179.557 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -162.29 -157.94 0.49 Allowed 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.855 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -66.1 -2.13 3.85 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -179.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.409 ' O ' ' N ' ' A' ' 14' ' ' SER . 0.6 OUTLIER 66.81 -153.33 0.22 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 121.235 -0.186 . . . . 0.0 111.05 179.253 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.7 t 33.94 -89.83 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.806 ' O ' HG23 ' A' ' 18' ' ' VAL . 3.6 m -55.18 -55.91 25.86 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.827 0.346 . . . . 0.0 111.125 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 27.6 mm -65.83 -25.58 36.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.372 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 1.15 ' HA ' HG21 ' A' ' 32' ' ' THR . 14.0 ttp180 -69.84 -55.64 9.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.467 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.446 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 71.2 t90 -58.39 -39.62 80.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.763 -179.112 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.806 HG23 ' O ' ' A' ' 14' ' ' SER . 12.3 t -65.67 -49.28 78.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.479 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.621 HD23 HD11 ' A' ' 108' ' ' ILE . 0.3 OUTLIER -82.99 -25.21 32.47 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -178.109 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.663 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 23.1 pt-20 -67.41 -59.94 2.98 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.607 -0.437 . . . . 0.0 112.061 -179.022 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.511 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 3.6 mmt85 -67.7 -49.71 61.31 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -179.234 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.0 -57.33 10.74 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 120.905 0.383 . . . . 0.0 111.657 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.886 ' CD2' HG11 ' A' ' 6' ' ' VAL . 2.1 tp -65.34 -22.94 66.88 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.363 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.407 ' HB2' ' O ' ' A' ' 20' ' ' GLU . . . -69.4 -37.32 77.44 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.299 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.44 -24.73 66.11 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.456 -0.878 . . . . 0.0 111.404 178.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.636 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -77.45 -15.43 59.33 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 120.668 0.27 . . . . 0.0 111.01 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.65 26.58 8.0 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 120.6 -0.809 . . . . 0.0 114.069 178.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.737 HD13 ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -128.97 171.85 11.94 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 117.764 0.782 . . . . 0.0 111.852 179.931 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.7 m -99.78 105.56 17.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.333 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.709 ' HA ' HG13 ' A' ' 6' ' ' VAL . 7.2 t -102.68 114.68 29.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.856 -179.261 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.822 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.5 t -115.01 156.95 24.15 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.157 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . 1.15 HG21 ' HA ' ' A' ' 16' ' ' ARG . 28.3 p -131.15 163.43 27.72 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.918 0.39 . . . . 0.0 111.894 -179.488 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.559 ' CE1' HG23 ' A' ' 31' ' ' THR . 35.4 m-85 -136.02 174.7 10.32 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -178.473 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.734 ' HG2' ' CD ' ' A' ' 38' ' ' GLU . 1.6 pt-20 -59.31 -39.56 83.46 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -176.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.558 ' N ' ' HG2' ' A' ' 34' ' ' GLU . 44.8 m-20 -168.22 -67.04 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.992 0.425 . . . . 0.0 111.352 -178.604 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.762 ' CA ' HD21 ' A' ' 65' ' ' LEU . . . -160.82 -35.22 0.02 OUTLIER Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.327 -0.939 . . . . 0.0 114.165 -179.176 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.41 ' HA ' ' CD1' ' A' ' 40' ' ' LEU . 20.6 m-20 -61.45 -35.35 77.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 117.34 0.57 . . . . 0.0 112.088 -178.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.734 ' CD ' ' HG2' ' A' ' 34' ' ' GLU . 1.4 mp0 -51.79 -61.73 2.07 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.762 HG12 ' CD1' ' A' ' 43' ' ' LEU . 94.2 t -45.84 -31.05 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-O 121.286 0.565 . . . . 0.0 110.745 -179.133 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.852 HD13 ' CB ' ' A' ' 68' ' ' GLN . 10.1 mt -64.52 -43.87 92.66 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.039 179.312 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -82.5 -47.94 11.61 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.337 0.589 . . . . 0.0 110.703 178.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.34 -37.78 65.3 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.568 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.762 ' CD1' HG12 ' A' ' 39' ' ' VAL . 37.3 mt -67.39 -22.99 65.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.843 0.354 . . . . 0.0 111.523 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.35 -18.07 3.69 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.752 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.7 m -119.92 -5.9 10.07 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.539 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.1 OUTLIER -165.71 162.65 18.85 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.041 0.448 . . . . 0.0 111.702 -179.889 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 100.0 m -139.38 119.5 9.37 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.139 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.777 ' HD2' HD11 ' A' ' 76' ' ' LEU . 91.1 Cg_endo -80.41 165.62 20.72 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.403 2.069 . . . . 0.0 111.101 178.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -74.25 -25.37 59.59 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.967 -0.293 . . . . 0.0 110.992 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.813 HG13 HG23 ' A' ' 6' ' ' VAL . 8.9 p -145.02 162.46 13.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.177 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.758 ' CD2' HG11 ' A' ' 39' ' ' VAL . 20.5 tp -152.91 126.67 8.88 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.177 0.513 . . . . 0.0 111.913 -179.406 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.606 ' O ' HG23 ' A' ' 9' ' ' VAL . 0.4 OUTLIER -104.49 114.66 29.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.27 179.275 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.68 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 1.7 t -110.79 139.03 46.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.167 0.508 . . . . 0.0 111.627 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 32.1 p-10 -82.8 -173.65 4.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.639 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.57 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 16.3 tt -161.46 170.7 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.175 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.53 ' N ' HG12 ' A' ' 55' ' ' ILE . 13.9 ptt85 58.55 43.25 19.53 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-O 121.526 0.679 . . . . 0.0 110.246 -178.454 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.497 ' CB ' ' CD ' ' A' ' 58' ' ' PRO . 6.3 mtm -151.67 -67.89 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.393 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.497 ' CD ' ' CB ' ' A' ' 57' ' ' MET . 27.2 Cg_endo -59.76 -163.29 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.87 2.38 . . . . 0.0 112.847 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -52.8 -87.52 0.01 OUTLIER Glycine 0 C--N 1.332 0.352 0 CA-C-N 115.964 -0.562 . . . . 0.0 113.258 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.664 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -76.39 61.17 1.66 Allowed 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.093 0.473 . . . . 0.0 110.466 -179.934 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.464 ' O ' ' HD2' ' A' ' 58' ' ' PRO . 6.9 m-20 60.8 -65.67 0.06 Allowed 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.944 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.57 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -165.05 -32.88 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.654 ' H ' HD12 ' A' ' 63' ' ' LEU . 0.9 OUTLIER -64.06 -13.25 45.86 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 120.54 0.21 . . . . 0.0 110.481 179.398 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.664 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -53.68 -31.55 48.19 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 121.054 0.455 . . . . 0.0 110.164 179.238 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.762 HD21 ' CA ' ' A' ' 36' ' ' GLY . 7.0 mp -62.64 -53.11 59.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.914 178.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.6 ' HA ' HD12 ' A' ' 69' ' ' ILE . 3.5 mm? -45.71 -45.82 14.56 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.861 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.715 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 27.1 mttt -59.15 -54.3 48.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.993 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.852 ' CB ' HD13 ' A' ' 40' ' ' LEU . 28.4 mm100 -64.34 -27.78 69.26 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.903 0.382 . . . . 0.0 110.34 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.602 HD13 HG21 ' A' ' 78' ' ' VAL . 41.4 mt -65.0 -36.74 78.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.853 -179.395 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.715 ' HG2' ' O ' ' A' ' 67' ' ' LYS . 6.5 pttt -75.72 -28.83 58.72 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.546 -179.207 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -69.14 -30.57 68.84 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.797 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.22 -56.96 2.31 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -179.178 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.735 ' CE1' HD12 ' A' ' 43' ' ' LEU . 0.3 OUTLIER -81.31 151.81 69.79 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-O 120.983 0.421 . . . . 0.0 111.817 -178.543 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -74.07 -80.99 0.01 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.377 2.051 . . . . 0.0 112.823 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.453 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 4.7 mtt -135.71 49.01 2.17 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 120.936 0.398 . . . . 0.0 111.73 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.777 HD11 ' HD2' ' A' ' 48' ' ' PRO . 0.7 OUTLIER -64.76 115.94 24.96 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.007 179.605 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.564 ' HD2' HD23 ' A' ' 76' ' ' LEU . 46.6 Cg_exo -55.61 116.95 3.52 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.376 2.051 . . . . 0.0 112.214 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.602 HG21 HD13 ' A' ' 69' ' ' ILE . 4.1 t -110.68 144.23 19.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.089 0.471 . . . . 0.0 111.365 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.585 ' CG2' HD23 ' A' ' 114' ' ' LEU . 1.7 mt -128.59 111.36 23.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.427 179.467 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.68 ' HA ' ' O ' ' A' ' 53' ' ' SER . 31.1 mm -96.89 141.6 15.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.929 0.395 . . . . 0.0 111.611 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.504 ' CG ' HG22 ' A' ' 55' ' ' ILE . 21.8 ptm -72.67 -31.25 64.92 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -178.469 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.587 ' HA ' ' O ' ' A' ' 102' ' ' LEU . 7.1 m -146.36 169.17 19.4 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.511 -179.341 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.815 ' HB1' ' HG ' ' A' ' 87' ' ' LEU . . . -141.86 -22.31 0.71 Allowed 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.476 ' HE1' HG12 ' A' ' 55' ' ' ILE . 1.9 p-80 35.6 -102.74 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.1 p -120.99 -11.95 8.83 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -178.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.507 ' HB3' HD13 ' A' ' 63' ' ' LEU . 5.8 m-20 -82.09 18.25 1.41 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.839 0.352 . . . . 0.0 111.265 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.815 ' HG ' ' HB1' ' A' ' 83' ' ' ALA . 3.0 mt -50.69 -20.47 1.24 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.961 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -46.88 -53.79 11.37 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -178.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.483 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -65.7 -20.59 66.34 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.737 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.6 ' HB3' ' O ' ' A' ' 87' ' ' LEU . . . -68.16 -40.47 82.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.225 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.687 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 4.3 t -57.31 -46.34 85.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.183 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.475 ' O ' ' OE1' ' A' ' 95' ' ' GLN . 12.8 m -62.23 -44.64 96.1 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.232 0.539 . . . . 0.0 109.827 179.248 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.695 ' HB1' ' HB2' ' A' ' 98' ' ' ALA . . . -47.48 -42.37 22.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.02 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.687 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 16.4 m-85 -56.19 -25.96 49.03 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.24 179.245 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.6 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -71.35 -45.54 62.68 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.287 -179.916 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.679 ' HG3' ' HB3' ' A' ' 70' ' ' LYS . 75.5 mm-40 -74.23 -18.08 60.79 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.11 -179.297 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 119.86 32.56 1.18 Allowed Glycine 0 N--CA 1.453 -0.186 0 C-N-CA 120.311 -0.947 . . . . 0.0 113.163 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.695 ' HB2' ' HB1' ' A' ' 93' ' ' ALA . . . -64.43 145.81 55.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.819 0.309 . . . . 0.0 110.225 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.527 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 10.9 t80 -77.17 -53.93 7.13 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.197 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 173.18 -166.86 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.208 0.528 . . . . 0.0 111.728 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.66 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 5.3 m-85 -142.43 150.59 40.8 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.119 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.712 HD23 ' HA ' ' A' ' 106' ' ' PHE . 2.4 mp -104.87 119.53 53.08 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.234 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -69.25 -75.24 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.02 1.813 . . . . 0.0 112.194 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.65 ' H ' ' HD2' ' A' ' 105' ' ' PRO . 1.8 tttm -106.44 -60.0 0.05 OUTLIER Pre-proline 0 CA--C 1.533 0.293 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.65 ' HD2' ' H ' ' A' ' 104' ' ' LYS . 18.0 Cg_endo -59.72 156.73 36.02 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.263 1.975 . . . . 0.0 112.735 -179.261 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.712 ' HA ' HD23 ' A' ' 102' ' ' LEU . 24.0 t80 -166.94 -105.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.123 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.54 ' O ' ' O ' ' A' ' 106' ' ' PHE . 3.3 p30 42.79 -178.03 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.86 0.362 . . . . 0.0 111.155 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.621 HD11 HD23 ' A' ' 19' ' ' LEU . 0.9 OUTLIER -67.88 -40.89 84.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.137 0.494 . . . . 0.0 111.583 179.922 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.488 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 1.1 t70 -49.98 -58.62 5.08 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.721 -179.106 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.615 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 5.0 mm-40 -76.61 -31.59 57.54 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.74 0.305 . . . . 0.0 111.241 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.96 -61.58 1.97 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.901 0.381 . . . . 0.0 110.127 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.623 ' O ' HG12 ' A' ' 115' ' ' VAL . 46.5 t -59.1 -30.71 44.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.483 0.659 . . . . 0.0 110.792 179.205 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.488 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -64.53 -45.33 87.68 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.799 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.585 HD23 ' CG2' ' A' ' 79' ' ' ILE . 33.5 tp -77.38 -20.98 53.91 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.689 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.623 HG12 ' O ' ' A' ' 112' ' ' VAL . 4.1 p -79.4 -44.31 23.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.659 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.531 ' HA ' HD12 ' A' ' 119' ' ' ILE . 58.4 mt-10 -60.35 -44.91 95.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.894 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 21.8 mmm180 -62.26 -23.86 66.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.248 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.527 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -74.48 -42.69 58.57 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.63 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.531 HD12 ' HA ' ' A' ' 116' ' ' GLU . 6.3 mt -65.09 -31.29 53.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.13 0.49 . . . . 0.0 110.922 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 2.8 m -68.83 -49.34 59.29 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.995 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 31.8 m80 -62.95 -24.12 67.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.143 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -67.63 -59.35 3.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.797 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 45.99 -170.58 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.461 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 . . . . . 0 C--N 1.33 -0.264 0 CA-C-O 121.039 0.447 . . . . 0.0 110.849 -179.996 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.3 ptm . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 120.949 0.404 . . . . 0.0 111.44 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -122.69 140.48 52.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.496 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.729 ' HG2' HD11 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -75.43 -62.5 1.55 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.447 -179.615 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.43 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . 71.11 76.7 0.55 Allowed Glycine 0 C--N 1.317 -0.5 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.704 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.729 HD11 ' HG2' ' A' ' 3' ' ' ARG . 2.4 mp -111.27 114.48 47.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.795 0.331 . . . . 0.0 111.267 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.878 HG11 HD23 ' A' ' 23' ' ' LEU . 9.0 p -108.07 121.46 61.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.322 179.227 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.84 ' CD1' HG22 ' A' ' 31' ' ' THR . 27.4 m0 -111.55 133.32 53.9 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.912 0.387 . . . . 0.0 110.547 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.715 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.0 OUTLIER -124.89 149.15 29.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.149 -178.598 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 1.042 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -127.91 105.25 13.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 177.824 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.658 ' HB3' HG21 ' A' ' 15' ' ' ILE . 36.3 t0 -166.6 67.69 0.1 Allowed 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 120.952 0.406 . . . . 0.0 111.955 -179.16 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 20.6 t70 61.15 6.52 1.32 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.474 ' HA ' ' OG1' ' A' ' 32' ' ' THR . 4.5 p-10 44.28 -147.83 0.08 Allowed 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.7 t 36.05 -93.56 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.445 ' O ' HG23 ' A' ' 18' ' ' VAL . 29.1 t -53.83 -65.66 0.53 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.652 0.263 . . . . 0.0 110.974 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.658 HG21 ' HB3' ' A' ' 10' ' ' ASP . 17.2 mm -60.57 -20.63 21.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.301 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.947 ' HA ' HG21 ' A' ' 32' ' ' THR . 23.8 ttm-85 -69.74 -58.33 4.03 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 120.862 0.363 . . . . 0.0 110.848 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.479 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 49.8 t90 -51.5 -39.62 57.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.093 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.596 HG12 HG12 ' A' ' 108' ' ' ILE . 11.7 t -63.64 -51.59 68.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -178.559 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.746 HD11 HG22 ' A' ' 112' ' ' VAL . 6.2 tp -84.37 -24.97 29.46 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 -178.006 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.623 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 11.9 pt-20 -66.45 -59.86 3.27 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.416 -0.514 . . . . 0.0 111.565 -178.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.529 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 5.7 mmm180 -58.54 -52.78 64.19 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.848 -179.182 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.07 -47.92 77.05 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.81 0.338 . . . . 0.0 111.805 -179.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.878 HD23 HG11 ' A' ' 6' ' ' VAL . 1.7 tp -72.97 -24.65 60.81 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.126 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.96 -34.27 75.05 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.37 -27.76 69.91 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.324 -0.941 . . . . 0.0 111.107 178.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.671 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -76.87 -16.0 59.54 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 120.605 0.241 . . . . 0.0 111.07 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.07 26.54 8.81 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 120.461 -0.876 . . . . 0.0 114.281 178.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.72 HD13 ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -123.27 169.27 11.47 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 117.946 0.873 . . . . 0.0 111.653 179.756 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 54.0 m -96.42 105.69 17.8 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.004 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.694 ' HA ' HG13 ' A' ' 6' ' ' VAL . 41.8 t -103.6 110.37 22.4 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.979 -179.103 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.84 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.6 t -117.37 154.16 31.78 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.947 HG21 ' HA ' ' A' ' 16' ' ' ARG . 29.1 p -126.11 165.56 18.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.301 0.572 . . . . 0.0 112.071 -179.448 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 1.042 ' HB2' HG13 ' A' ' 9' ' ' VAL . 16.2 m-85 -136.04 174.76 10.26 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.863 -178.264 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.794 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 2.3 pp20? -60.6 -49.19 78.53 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -176.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -165.56 -29.29 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -179.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.565 ' CA ' HG11 ' A' ' 9' ' ' VAL . . . 174.92 -56.85 0.12 Allowed Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.448 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.45 ' HA ' HD12 ' A' ' 40' ' ' LEU . 3.2 t30 -55.07 -30.59 59.96 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.674 0.273 . . . . 0.0 111.283 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.825 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -60.16 -55.66 31.11 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.709 179.796 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.784 HG12 ' CD1' ' A' ' 43' ' ' LEU . 5.5 t -50.9 -45.08 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.097 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.759 ' HB3' ' HD2' ' A' ' 72' ' ' ARG . 29.2 mt -52.1 -42.97 63.67 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.246 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.86 -50.78 67.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.202 0.525 . . . . 0.0 111.441 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.44 -29.36 65.93 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.766 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.868 HD13 ' NE2' ' A' ' 73' ' ' HIS . 5.6 mt -64.28 -25.44 68.05 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.8 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.9 -18.28 31.81 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.168 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 41.1 t -124.4 3.38 8.42 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 112.143 0.424 . . . . 0.0 112.143 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.64 ' O ' HD23 ' A' ' 43' ' ' LEU . 0.4 OUTLIER -162.74 159.01 23.68 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-O 120.958 0.409 . . . . 0.0 111.497 179.924 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.898 HG23 HD13 ' A' ' 76' ' ' LEU . 98.4 m -138.62 115.48 8.94 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.459 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.642 ' HD2' HD21 ' A' ' 43' ' ' LEU . 72.7 Cg_endo -73.75 165.7 31.6 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.486 2.124 . . . . 0.0 111.363 178.63 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -76.72 -29.23 56.14 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 121.033 -0.267 . . . . 0.0 110.712 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.748 HG13 HG23 ' A' ' 6' ' ' VAL . 8.4 p -148.35 108.34 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.094 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.587 ' CD1' HG11 ' A' ' 39' ' ' VAL . 15.0 tp -86.99 136.92 32.75 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.889 0.376 . . . . 0.0 111.241 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.721 ' O ' HG23 ' A' ' 9' ' ' VAL . 1.8 tt -124.2 124.17 41.88 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.099 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.872 ' HB2' HD13 ' A' ' 80' ' ' ILE . 67.0 m -110.94 136.61 49.7 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.045 0.45 . . . . 0.0 111.999 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.467 ' O ' ' HG2' ' A' ' 81' ' ' MET . 33.7 t70 -82.88 -12.91 57.02 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.209 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.995 HD11 ' CE1' ' A' ' 84' ' ' HIS . 6.5 tt 42.25 69.59 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-O 120.732 0.301 . . . . 0.0 111.502 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -112.06 44.85 1.34 Allowed 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.492 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 0.5 OUTLIER 59.75 44.91 1.02 Allowed Pre-proline 0 N--CA 1.465 0.321 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 178.663 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' ' 62' ' ' GLY . 36.3 Cg_endo -65.08 -75.6 0.02 OUTLIER 'Trans proline' 0 CA--C 1.532 0.391 0 C-N-CA 122.579 2.186 . . . . 0.0 112.391 178.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -112.37 -27.67 3.81 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.074 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.807 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 7.9 tpt -156.11 68.49 0.62 Allowed 'General case' 0 C--O 1.236 0.387 0 CA-C-O 120.981 0.419 . . . . 0.0 109.955 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.638 ' O ' HG13 ' A' ' 55' ' ' ILE . 0.4 OUTLIER 69.22 -26.43 0.15 Allowed 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.931 -179.709 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.843 ' HA3' HG13 ' A' ' 55' ' ' ILE . . . 139.32 -26.09 2.71 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -179.024 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.741 HD13 ' HB3' ' A' ' 86' ' ' ASP . 3.1 mp -74.23 -15.14 61.0 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.387 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.807 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -53.74 -44.88 70.3 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.838 178.375 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.704 ' HG ' ' O ' ' A' ' 62' ' ' GLY . 4.0 pp -58.6 -36.64 74.33 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.289 179.303 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.907 HD13 ' HB2' ' A' ' 93' ' ' ALA . 14.8 mt -55.75 -48.59 74.99 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.019 0.438 . . . . 0.0 110.402 179.303 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.571 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 12.6 tptt -53.23 -44.05 67.78 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.936 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.662 ' CB ' HD13 ' A' ' 40' ' ' LEU . 9.2 mm100 -67.08 -27.72 67.59 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.963 0.411 . . . . 0.0 110.704 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 1.043 HD13 HG21 ' A' ' 78' ' ' VAL . 96.8 mt -64.55 -38.13 81.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.527 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.571 ' HG2' ' O ' ' A' ' 67' ' ' LYS . 2.7 ptmt -74.97 -29.42 60.91 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.915 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.25 -30.61 22.21 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.735 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.759 ' HD2' ' HB3' ' A' ' 40' ' ' LEU . 28.6 mtt85 -90.45 -68.01 0.81 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.856 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 1.024 ' ND1' HG23 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -88.04 144.63 34.86 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.629 -179.722 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -55.79 -67.49 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.603 2.202 . . . . 0.0 112.893 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.413 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 0.2 OUTLIER -146.89 40.13 1.06 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.934 0.397 . . . . 0.0 111.089 -179.554 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.898 HD13 HG23 ' A' ' 47' ' ' THR . 22.7 tp -63.75 129.43 93.77 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.037 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.534 ' HD2' HD12 ' A' ' 76' ' ' LEU . 58.2 Cg_endo -71.58 134.91 25.15 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.413 2.075 . . . . 0.0 112.278 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 1.043 HG21 HD13 ' A' ' 69' ' ' ILE . 5.5 t -123.95 148.57 28.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.944 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.687 ' CG2' HD23 ' A' ' 114' ' ' LEU . 2.2 mt -126.63 114.49 38.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.201 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.872 HD13 ' HB2' ' A' ' 53' ' ' SER . 9.7 mm -97.87 139.38 20.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.957 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.467 ' HG2' ' O ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -75.94 -30.76 58.8 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 112.357 0.502 . . . . 0.0 112.357 -178.882 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.81 ' O ' HD13 ' A' ' 55' ' ' ILE . 16.8 m -147.59 157.22 43.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.753 0.311 . . . . 0.0 111.574 -179.049 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.785 ' HB1' ' HG ' ' A' ' 87' ' ' LEU . . . -118.99 0.22 11.28 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.611 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.995 ' CE1' HD11 ' A' ' 55' ' ' ILE . 0.1 OUTLIER 25.75 -94.85 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 -179.168 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 16.1 m -136.89 -23.09 1.19 Allowed 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -178.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.741 ' HB3' HD13 ' A' ' 63' ' ' LEU . 0.3 OUTLIER -78.66 28.39 0.2 Allowed 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -179.285 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.813 HD23 ' HB3' ' A' ' 90' ' ' ALA . 0.5 OUTLIER -46.84 -21.95 0.26 Allowed 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.887 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -48.11 -53.17 17.48 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.886 0.374 . . . . 0.0 111.264 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.643 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -64.05 -20.31 65.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.331 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.813 ' HB3' HD23 ' A' ' 87' ' ' LEU . . . -68.87 -33.89 74.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.837 0.351 . . . . 0.0 110.514 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.64 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 2.8 t -63.94 -46.61 93.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.81 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.604 ' O ' ' HG3' ' A' ' 95' ' ' GLN . 52.5 p -62.04 -16.89 55.19 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 178.305 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.907 ' HB2' HD13 ' A' ' 66' ' ' LEU . . . -75.57 -52.14 11.29 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.408 0.623 . . . . 0.0 111.827 179.298 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.64 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 7.3 m-85 -57.9 -32.66 67.95 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.839 -179.5 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.604 ' HG3' ' O ' ' A' ' 92' ' ' SER . 2.1 pp0? -77.28 -32.06 55.23 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.247 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.739 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 3.3 pp0? -83.02 -15.95 49.05 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 121.13 -0.228 . . . . 0.0 111.295 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.503 ' O ' ' HA ' ' A' ' 77' ' ' PRO . . . 130.27 7.73 3.49 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.357 -0.925 . . . . 0.0 114.015 178.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.741 ' HB2' ' HB1' ' A' ' 93' ' ' ALA . . . -56.96 153.22 11.55 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 117.475 0.638 . . . . 0.0 111.138 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.553 ' CZ ' ' HA ' ' A' ' 118' ' ' ALA . 23.9 t80 -82.12 -53.65 5.92 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.336 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.548 ' HB3' ' O ' ' A' ' 99' ' ' PHE . 13.6 p-10 172.67 -161.49 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.311 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.706 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 4.6 m-85 -141.89 153.67 44.57 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.564 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.657 ' CD1' HD22 ' A' ' 114' ' ' LEU . 1.3 mp -102.32 120.01 54.62 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.71 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_exo -55.98 -69.19 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.478 2.118 . . . . 0.0 112.593 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.717 ' HB2' ' HD3' ' A' ' 105' ' ' PRO . 7.0 mmtt -128.42 -59.57 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.421 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.717 ' HD3' ' HB2' ' A' ' 104' ' ' LYS . 51.1 Cg_exo -54.16 161.56 5.04 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 121.74 1.627 . . . . 0.0 112.012 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.659 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 23.1 t80 -166.95 -105.6 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.653 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.484 ' O ' ' O ' ' A' ' 106' ' ' PHE . 2.8 p30 43.89 -175.57 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.778 0.323 . . . . 0.0 110.967 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.596 HG12 HG12 ' A' ' 18' ' ' VAL . 1.0 OUTLIER -67.86 -42.39 85.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 120.994 0.426 . . . . 0.0 111.416 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.469 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 26.3 t70 -49.12 -59.04 3.98 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.697 -179.525 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.659 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 7.0 mm-40 -76.16 -32.96 59.34 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.682 0.277 . . . . 0.0 111.376 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.419 ' CB ' ' O ' ' A' ' 107' ' ' ASP . . . -66.54 -59.37 3.7 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.486 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.746 HG22 HD11 ' A' ' 19' ' ' LEU . 35.9 t -59.53 -31.37 46.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.444 0.64 . . . . 0.0 110.715 178.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.469 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -63.1 -44.8 94.69 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.096 179.127 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.687 HD23 ' CG2' ' A' ' 79' ' ' ILE . 36.0 tp -79.33 -21.26 46.13 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.86 -1.064 . . . . 0.0 112.072 -179.196 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.648 HG12 ' HA ' ' A' ' 112' ' ' VAL . 6.0 p -79.2 -45.15 24.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.548 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.414 ' HA ' HD12 ' A' ' 119' ' ' ILE . 53.8 mt-10 -65.72 -45.4 82.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.693 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 42.8 mtp180 -60.03 -24.8 64.81 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.668 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.553 ' HA ' ' CZ ' ' A' ' 99' ' ' PHE . . . -72.27 -48.91 38.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.918 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.428 HD11 HG11 ' A' ' 50' ' ' VAL . 4.8 mt -65.27 -31.2 52.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.137 0.494 . . . . 0.0 110.75 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.3 t -72.24 -58.39 3.45 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.855 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 26.5 m80 -60.67 -26.72 67.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.885 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.412 ' HB2' ' O ' ' A' ' 118' ' ' ALA . 36.3 t80 -73.62 -58.04 3.58 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.639 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 56.79 169.81 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.022 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.913 179.945 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.289 0 CA-C-O 120.757 0.313 . . . . 0.0 111.115 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 63.35 144.17 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.82 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 21.0 ptt180 -70.9 -13.35 61.99 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.001 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.561 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . 89.33 88.77 1.23 Allowed Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.097 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.8 mp -99.3 113.14 33.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 120.819 0.342 . . . . 0.0 111.297 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.819 HG23 HG13 ' A' ' 50' ' ' VAL . 6.2 p -105.69 123.41 60.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.061 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.898 ' CD1' HG22 ' A' ' 31' ' ' THR . 31.4 m0 -115.08 127.91 55.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.633 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.687 HG13 ' HB3' ' A' ' 52' ' ' LEU . 0.2 OUTLIER -112.86 143.02 23.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.401 -178.977 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.757 HG11 ' HA2' ' A' ' 36' ' ' GLY . 0.1 OUTLIER -122.98 111.14 28.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.194 0.521 . . . . 0.0 110.633 179.367 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.423 ' HA ' ' OD2' ' A' ' 54' ' ' ASP . 3.9 t0 -161.43 -158.87 0.59 Allowed 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.188 -178.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.51 -2.25 4.49 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' A' ' 14' ' ' SER . 1.4 t0 67.76 -156.77 0.21 Allowed 'General case' 0 CA--C 1.531 0.233 0 O-C-N 122.381 -0.2 . . . . 0.0 110.833 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.4 ' HB3' ' H ' ' A' ' 14' ' ' SER . 3.3 t 34.66 -90.6 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.884 ' O ' HG23 ' A' ' 18' ' ' VAL . 26.8 t -54.36 -61.15 2.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.741 0.305 . . . . 0.0 111.089 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 30.4 mm -61.75 -22.84 29.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.96 0.41 . . . . 0.0 110.754 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.918 ' HA ' HG21 ' A' ' 32' ' ' THR . 41.6 ttt180 -75.64 -54.85 6.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.634 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.412 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 83.4 t90 -58.65 -38.39 78.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.691 0.282 . . . . 0.0 111.595 -179.41 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.884 HG23 ' O ' ' A' ' 14' ' ' SER . 3.6 t -69.52 -45.03 79.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -178.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.66 -26.69 29.67 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -178.644 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.555 ' HG3' ' N ' ' A' ' 21' ' ' ARG . 10.9 pt-20 -67.74 -60.43 2.54 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -179.126 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.555 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 2.3 mmt-85 -60.71 -52.89 63.2 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -178.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.49 -50.4 65.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.948 0.404 . . . . 0.0 111.567 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.796 ' CD2' HG11 ' A' ' 6' ' ' VAL . 1.0 OUTLIER -70.4 -27.67 64.48 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.352 179.807 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.56 -34.75 77.68 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.16 -26.45 69.26 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.417 -0.897 . . . . 0.0 111.038 178.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.649 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -77.26 -15.39 59.48 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.655 -0.273 . . . . 0.0 111.039 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.21 26.41 10.22 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.606 -0.807 . . . . 0.0 114.217 178.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.738 HD13 ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -124.68 170.68 10.74 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 117.87 0.835 . . . . 0.0 111.775 179.722 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 50.6 m -94.3 105.8 17.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.078 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.694 ' HA ' HG13 ' A' ' 6' ' ' VAL . 46.7 t -106.29 110.33 22.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.992 -178.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.898 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.8 t -118.73 153.05 35.03 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.918 HG21 ' HA ' ' A' ' 16' ' ' ARG . 20.5 p -126.43 157.12 39.42 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.558 0.694 . . . . 0.0 112.134 -179.214 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.807 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 1.0 OUTLIER -127.0 174.29 8.98 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.707 -1.133 . . . . 0.0 111.184 -178.73 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.684 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 3.0 pp20? -61.37 -34.23 74.97 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -177.456 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -176.92 -37.52 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.757 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . 173.47 -47.02 0.16 Allowed Glycine 0 C--N 1.318 -0.438 0 C-N-CA 120.32 -0.943 . . . . 0.0 112.884 -179.147 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.454 ' HA ' ' CD1' ' A' ' 40' ' ' LEU . 2.4 t30 -59.62 -29.66 68.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.154 0.502 . . . . 0.0 111.071 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.807 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -62.97 -53.58 51.86 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.708 -179.525 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.689 HG23 ' CG1' ' A' ' 9' ' ' VAL . 21.3 t -50.08 -37.2 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 C-N-CA 120.349 -0.54 . . . . 0.0 110.661 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.653 HD13 ' HB3' ' A' ' 68' ' ' GLN . 12.6 mt -55.65 -48.13 75.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.479 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.01 -50.17 69.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.107 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.4 -34.6 77.07 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.726 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.569 ' HA ' ' O ' ' A' ' 46' ' ' LYS . 21.1 mt -59.23 -23.5 62.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.421 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.02 -17.8 28.6 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.826 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.5 t -128.52 3.08 5.59 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.569 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.2 OUTLIER -167.44 161.25 13.87 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.909 0.385 . . . . 0.0 111.216 179.895 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.405 HG23 HD12 ' A' ' 76' ' ' LEU . 90.4 m -138.96 111.74 8.06 Favored Pre-proline 0 N--CA 1.45 -0.457 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.201 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.894 ' HD2' HD11 ' A' ' 76' ' ' LEU . 43.3 Cg_endo -71.38 158.68 53.66 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.084 1.856 . . . . 0.0 111.276 179.131 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.442 ' O ' ' HG2' ' A' ' 77' ' ' PRO . 1.7 m-20 -74.24 -24.15 59.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.466 -179.275 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.819 HG13 HG23 ' A' ' 6' ' ' VAL . 7.6 p -145.98 166.47 8.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.582 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.852 HD12 ' O ' ' A' ' 7' ' ' TRP . 10.0 tp -152.96 137.36 16.68 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.985 0.422 . . . . 0.0 111.43 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.687 ' HB3' HG13 ' A' ' 8' ' ' VAL . 1.1 tt -121.9 119.21 30.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.713 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.44 ' HB2' ' CD1' ' A' ' 80' ' ' ILE . 0.6 OUTLIER -115.08 138.21 51.13 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.905 0.383 . . . . 0.0 111.408 -179.723 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.64 ' O ' HG22 ' A' ' 55' ' ' ILE . 2.9 p30 -82.27 -4.04 56.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 0.0 112.058 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.931 HG13 ' HA3' ' A' ' 62' ' ' GLY . 7.1 tt 50.47 169.4 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-O 120.953 0.406 . . . . 0.0 111.923 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.484 ' H ' ' HA3' ' A' ' 62' ' ' GLY . 8.2 ttt85 67.43 77.93 0.25 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.901 0.382 . . . . 0.0 110.696 -179.114 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.608 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . 7.5 tpt -163.14 -61.24 0.01 OUTLIER Pre-proline 0 CA--C 1.537 0.479 0 CA-C-N 116.081 -0.509 . . . . 0.0 112.063 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.716 ' HG3' ' HG ' ' A' ' 65' ' ' LEU . 94.3 Cg_endo -71.96 -164.58 0.17 Allowed 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.975 2.45 . . . . 0.0 113.47 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.64 -65.48 3.13 Favored Glycine 0 C--N 1.335 0.525 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.241 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.467 ' O ' ' N ' ' A' ' 62' ' ' GLY . 5.2 ttt -70.19 60.42 0.19 Allowed 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.082 0.468 . . . . 0.0 110.013 179.124 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 58.3 -81.79 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.558 -0.747 . . . . 0.0 109.812 -179.058 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.931 ' HA3' HG13 ' A' ' 55' ' ' ILE . . . -145.38 -28.96 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.593 179.005 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.854 HD13 ' HB3' ' A' ' 86' ' ' ASP . 4.0 mp -59.75 -18.85 46.27 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.503 ' HB3' ' CG ' ' A' ' 58' ' ' PRO . . . -55.63 -37.1 67.75 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 178.289 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.716 ' HG ' ' HG3' ' A' ' 58' ' ' PRO . 32.4 mt -60.76 -49.14 78.69 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.391 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.738 HD11 HD11 ' A' ' 80' ' ' ILE . 9.4 mp -51.1 -51.47 53.06 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.98 179.023 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.564 ' HA ' ' CE ' ' A' ' 70' ' ' LYS . 6.4 mtpm? -44.63 -49.43 10.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.851 179.439 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.653 ' HB3' HD13 ' A' ' 40' ' ' LEU . 16.0 mm100 -68.22 -26.51 65.75 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.375 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 1.069 HG22 ' CD2' ' A' ' 73' ' ' HIS . 63.3 mt -63.89 -54.18 34.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.012 0.434 . . . . 0.0 111.119 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.799 ' HA ' ' CD2' ' A' ' 73' ' ' HIS . 0.0 OUTLIER -62.43 -28.35 69.74 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.16 -178.94 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -64.82 -22.48 67.0 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.179 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.72 -11.68 9.36 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.005 0.742 . . . . 0.0 113.005 -179.067 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 1.069 ' CD2' HG22 ' A' ' 69' ' ' ILE . 1.6 p80 -109.55 160.61 27.19 Favored Pre-proline 0 N--CA 1.465 0.321 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -179.248 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.455 ' O ' ' HG2' ' A' ' 75' ' ' MET . 60.6 Cg_endo -87.71 -59.45 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.976 2.451 . . . . 0.0 111.42 178.222 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.566 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 5.8 mmt -151.24 51.33 0.84 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.9 178.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.894 HD11 ' HD2' ' A' ' 48' ' ' PRO . 0.4 OUTLIER -76.66 123.25 87.58 Favored Pre-proline 0 N--CA 1.456 -0.135 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -179.147 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.663 ' HD2' HD23 ' A' ' 76' ' ' LEU . 20.2 Cg_exo -64.72 138.07 56.88 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.189 1.926 . . . . 0.0 111.729 178.505 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.64 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 3.0 t -126.13 119.69 54.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.482 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.82 ' CG2' HD23 ' A' ' 114' ' ' LEU . 1.5 mp -109.83 110.22 31.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.863 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.738 HD11 HD11 ' A' ' 66' ' ' LEU . 37.0 mm -100.53 148.49 6.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.296 -178.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.515 ' HB3' ' CE1' ' A' ' 106' ' ' PHE . 13.0 ptm -81.98 -35.32 29.07 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.61 -179.11 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.826 ' O ' HD13 ' A' ' 55' ' ' ILE . 8.2 m -146.59 151.84 37.96 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.626 0.251 . . . . 0.0 111.138 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.833 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -117.03 10.24 13.9 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 111.803 0.297 . . . . 0.0 111.803 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.675 ' H ' HG22 ' A' ' 82' ' ' THR . 0.1 OUTLIER 25.84 -92.38 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -179.385 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 55.3 m -149.64 39.62 0.8 Allowed 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.854 ' HB3' HD13 ' A' ' 63' ' ' LEU . 0.4 OUTLIER -137.72 36.68 2.42 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.125 0.488 . . . . 0.0 110.349 179.236 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.45 ' O ' ' HB3' ' A' ' 90' ' ' ALA . 7.9 mt -50.33 -20.86 1.19 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.993 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -47.69 -58.76 3.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.624 0.25 . . . . 0.0 111.434 -179.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.58 ' O ' ' HB2' ' A' ' 93' ' ' ALA . . . -69.74 -19.64 63.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.892 0.377 . . . . 0.0 110.651 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 87' ' ' LEU . . . -69.25 -46.42 67.35 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.878 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.646 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 3.5 t -67.0 -52.92 38.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 C-N-CA 120.474 -0.491 . . . . 0.0 111.297 -179.262 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.595 ' O ' ' HB3' ' A' ' 95' ' ' GLN . 24.4 m -60.21 -27.08 66.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.137 0.494 . . . . 0.0 109.786 178.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.587 ' HA ' ' OE1' ' A' ' 96' ' ' GLN . . . -60.72 -41.81 96.01 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.056 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.646 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 3.9 m-85 -67.73 -27.33 66.7 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.967 179.043 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.595 ' HB3' ' O ' ' A' ' 92' ' ' SER . 0.2 OUTLIER -60.92 -40.89 94.88 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.807 -179.192 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.587 ' OE1' ' HA ' ' A' ' 93' ' ' ALA . 0.0 OUTLIER -100.37 -19.3 16.35 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -179.565 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.441 ' O ' ' C ' ' A' ' 98' ' ' ALA . . . -176.01 -57.67 0.06 OUTLIER Glycine 0 C--N 1.335 0.474 0 C-N-CA 119.22 -1.467 . . . . 0.0 114.824 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.64 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -29.1 139.37 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 117.32 0.56 . . . . 0.0 112.36 -178.318 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -84.78 -53.38 5.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.45 -179.07 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.67 ' OD1' HD21 ' A' ' 114' ' ' LEU . 7.9 p-10 -177.8 -164.65 0.09 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.747 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.833 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 4.1 m-85 -138.3 153.02 49.03 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.081 0.467 . . . . 0.0 111.004 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.816 ' CD1' HD22 ' A' ' 114' ' ' LEU . 3.2 mp -102.98 119.08 56.54 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.714 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 102' ' ' LEU . 21.1 Cg_exo -64.69 -66.84 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.537 2.158 . . . . 0.0 112.272 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.735 ' H ' ' HD2' ' A' ' 105' ' ' PRO . 5.6 mttp -119.81 -58.85 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.135 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.735 ' HD2' ' H ' ' A' ' 104' ' ' LYS . 11.9 Cg_endo -55.02 163.5 4.22 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.127 1.885 . . . . 0.0 112.347 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.665 ' HA ' HD23 ' A' ' 102' ' ' LEU . 39.9 t80 -172.08 -106.34 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.659 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.551 ' O ' ' O ' ' A' ' 106' ' ' PHE . 4.7 p-10 43.09 -179.94 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.744 0.307 . . . . 0.0 111.089 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.66 HG12 HG12 ' A' ' 18' ' ' VAL . 0.9 OUTLIER -67.87 -43.44 85.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -179.355 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.503 ' HB2' ' OD2' ' A' ' 107' ' ' ASP . 7.0 m-20 -49.82 -58.68 4.88 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.45 -179.201 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.612 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 6.1 mm-40 -74.46 -31.79 62.36 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.759 0.314 . . . . 0.0 111.318 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.419 ' CB ' ' O ' ' A' ' 107' ' ' ASP . . . -66.48 -61.18 2.13 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.336 179.542 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.608 ' O ' HG12 ' A' ' 115' ' ' VAL . 50.2 t -59.07 -31.51 45.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.5 0.667 . . . . 0.0 110.332 179.129 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.49 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -64.24 -45.27 88.88 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.722 179.088 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.82 HD23 ' CG2' ' A' ' 79' ' ' ILE . 23.5 tp -74.89 -24.14 58.49 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.835 -1.075 . . . . 0.0 111.901 -179.397 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.697 HG23 HD13 ' A' ' 79' ' ' ILE . 4.0 p -79.29 -43.83 23.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.668 -179.302 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.41 ' HA ' HD12 ' A' ' 119' ' ' ILE . 50.8 mt-10 -65.65 -43.76 88.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.114 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.769 ' HD3' HD12 ' A' ' 114' ' ' LEU . 7.8 ptm180 -63.27 -23.72 67.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.787 0.327 . . . . 0.0 110.844 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.38 -46.64 59.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.693 179.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.541 HD11 HG11 ' A' ' 50' ' ' VAL . 4.5 mt -68.62 -32.09 53.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.878 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 36.8 t -65.44 -41.89 93.0 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.492 -0.777 . . . . 0.0 110.819 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 2.4 m80 -62.38 -29.61 70.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.785 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.518 ' HH ' ' HB3' ' A' ' 75' ' ' MET . 0.1 OUTLIER -81.55 -50.86 8.87 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.663 179.605 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.59 170.86 15.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.709 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.873 179.986 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 mtt . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.842 0.353 . . . . 0.0 111.084 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -100.02 147.76 25.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.822 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.25 -13.75 20.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.222 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 89.3 94.39 1.11 Allowed Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.576 -0.821 . . . . 0.0 111.728 -179.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.8 mp -105.71 116.27 49.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.018 0.437 . . . . 0.0 111.451 -179.356 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.788 HG23 HG13 ' A' ' 50' ' ' VAL . 7.6 p -107.19 131.32 57.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.77 179.16 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.933 ' CD1' HG22 ' A' ' 31' ' ' THR . 39.5 m0 -117.44 142.2 47.43 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.132 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.732 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -134.18 145.37 33.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.011 0.434 . . . . 0.0 111.558 -178.421 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.992 HG12 ' HB2' ' A' ' 33' ' ' PHE . 3.1 m -131.39 105.93 11.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.262 178.67 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.767 ' HB3' HG21 ' A' ' 15' ' ' ILE . 53.7 t0 -166.46 66.98 0.1 Allowed 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 121.148 0.499 . . . . 0.0 111.845 -179.37 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.2 t70 74.85 -9.11 1.41 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 178.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.7 t70 59.45 -154.36 0.37 Allowed 'General case' 0 CA--C 1.534 0.357 0 O-C-N 122.275 -0.266 . . . . 0.0 110.955 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 t 34.83 -91.01 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.538 ' O ' HG23 ' A' ' 18' ' ' VAL . 1.5 m -54.57 -65.98 0.48 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.513 0.197 . . . . 0.0 111.234 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.767 HG21 ' HB3' ' A' ' 10' ' ' ASP . 40.2 mm -60.44 -20.58 21.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.771 0.319 . . . . 0.0 111.089 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.987 ' HA ' HG21 ' A' ' 32' ' ' THR . 27.1 ttt180 -70.32 -57.81 4.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.238 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.475 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 50.1 t90 -53.9 -39.68 66.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.69 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.66 HG12 HG12 ' A' ' 108' ' ' ILE . 14.5 t -62.28 -54.82 29.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 113.018 0.748 . . . . 0.0 113.018 -178.657 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.613 HD11 HG22 ' A' ' 112' ' ' VAL . 7.8 tp -82.84 -22.4 34.1 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -177.791 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.594 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 22.8 pt-20 -67.75 -57.69 5.9 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.499 -178.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.536 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 0.1 OUTLIER -63.34 -49.83 72.37 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.93 -179.48 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.15 -47.5 83.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.84 0.353 . . . . 0.0 111.675 -179.264 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.778 ' CD2' HG11 ' A' ' 6' ' ' VAL . 2.4 tp -71.04 -25.28 62.59 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.259 179.723 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.08 -33.71 75.04 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.34 -25.04 71.06 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.475 -0.869 . . . . 0.0 111.028 178.349 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.733 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -76.68 -15.66 59.74 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 120.585 0.231 . . . . 0.0 110.78 179.197 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.14 26.41 9.55 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.68 -0.771 . . . . 0.0 113.825 179.292 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.733 ' CD1' ' HB3' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -123.94 168.12 13.22 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 117.848 0.824 . . . . 0.0 111.689 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 73.5 m -94.75 105.66 17.61 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.627 179.085 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.72 ' HA ' HG13 ' A' ' 6' ' ' VAL . 10.8 t -100.77 112.44 24.85 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -178.608 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.933 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.5 t -120.21 144.75 47.56 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.335 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.987 HG21 ' HA ' ' A' ' 16' ' ' ARG . 43.6 p -121.53 157.96 29.54 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -178.586 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.992 ' HB2' HG12 ' A' ' 9' ' ' VAL . 0.4 OUTLIER -136.16 174.24 10.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.893 -1.049 . . . . 0.0 111.304 -179.882 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.575 ' HG2' ' N ' ' A' ' 35' ' ' ASN . 0.0 OUTLIER -63.19 -32.97 74.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.658 -179.294 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.575 ' N ' ' HG2' ' A' ' 34' ' ' GLU . 1.7 t-20 -178.61 179.0 0.77 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.356 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.708 ' HA3' HD13 ' A' ' 65' ' ' LEU . . . -52.03 -19.93 5.94 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.646 -0.788 . . . . 0.0 113.058 -179.67 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -69.12 -50.9 43.85 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -179.542 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.673 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 3.9 tt0 -51.98 -51.7 55.5 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.055 -179.329 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.714 HG23 ' CG1' ' A' ' 9' ' ' VAL . 82.8 t -51.42 -32.7 13.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.133 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.551 HD13 ' CB ' ' A' ' 68' ' ' GLN . 18.9 mt -58.3 -47.26 84.24 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.121 0.486 . . . . 0.0 110.065 179.167 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.47 -49.47 48.21 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.938 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.89 -32.08 71.55 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.206 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.608 ' CD1' ' CE1' ' A' ' 73' ' ' HIS . 18.7 mt -68.78 -25.12 64.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.989 -179.294 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.31 -20.45 7.19 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.905 -179.198 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 28.6 t -124.8 4.92 8.1 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.584 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -167.69 155.73 9.02 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.972 0.415 . . . . 0.0 111.173 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.454 ' HA ' ' CD2' ' A' ' 43' ' ' LEU . 93.9 m -138.95 116.58 8.91 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.902 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.578 ' HD2' HD21 ' A' ' 43' ' ' LEU . 73.2 Cg_endo -77.92 163.0 28.95 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 121.988 1.792 . . . . 0.0 111.313 179.221 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -73.79 -21.0 60.31 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.818 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.788 HG13 HG23 ' A' ' 6' ' ' VAL . 5.5 p -147.63 161.42 7.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.715 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.745 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 26.8 tp -152.93 131.15 11.98 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 121.196 0.522 . . . . 0.0 111.947 -179.286 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.67 ' HB3' HG13 ' A' ' 8' ' ' VAL . 1.0 OUTLIER -114.45 118.18 33.07 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.447 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.852 ' HA ' HG23 ' A' ' 9' ' ' VAL . 3.8 m -117.26 144.37 44.91 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -178.577 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -82.98 179.15 7.85 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.559 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.737 HG13 ' HA3' ' A' ' 62' ' ' GLY . 9.0 tt -154.61 67.47 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.398 179.567 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.74 38.51 2.24 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.729 -179.263 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.547 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER 65.35 47.14 0.56 Allowed Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 178.947 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.511 ' HD2' ' N ' ' A' ' 62' ' ' GLY . 40.9 Cg_endo -68.18 -78.16 0.01 OUTLIER 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 122.387 2.058 . . . . 0.0 111.967 178.559 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -106.45 -27.71 5.43 Favored Glycine 0 C--N 1.335 0.496 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.126 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' MET . . . . . 1.024 ' HB3' ' HB2' ' A' ' 64' ' ' ALA . 2.2 tpt -159.51 67.97 0.41 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.885 0.374 . . . . 0.0 109.997 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.547 ' HA ' ' HA ' ' A' ' 57' ' ' MET . 0.2 OUTLIER 71.42 -29.12 0.19 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.338 -179.561 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.737 ' HA3' HG13 ' A' ' 55' ' ' ILE . . . 140.07 -28.45 2.49 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 -179.376 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.999 ' HA ' HD23 ' A' ' 66' ' ' LEU . 0.9 OUTLIER -72.74 -14.01 61.46 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 115.425 -0.387 . . . . 0.0 109.991 178.452 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 1.024 ' HB2' ' HB3' ' A' ' 60' ' ' MET . . . -53.38 -52.45 59.26 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-O 121.118 0.485 . . . . 0.0 110.428 178.82 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.708 HD13 ' HA3' ' A' ' 36' ' ' GLY . 3.5 pp -57.36 -33.23 67.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.121 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.999 HD23 ' HA ' ' A' ' 63' ' ' LEU . 3.9 mm? -59.36 -50.43 74.0 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.925 0.393 . . . . 0.0 110.766 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.543 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 6.9 mttt -54.54 -40.87 69.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.985 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.551 ' CB ' HD13 ' A' ' 40' ' ' LEU . 11.0 mm100 -65.84 -27.96 68.63 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.066 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.836 HD12 ' HA ' ' A' ' 66' ' ' LEU . 87.9 mt -64.76 -53.94 36.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.8 -179.263 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.543 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.5 OUTLIER -64.7 -24.93 67.73 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.847 -179.099 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.86 -51.7 63.42 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -178.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.94 -26.4 15.59 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.201 -0.454 . . . . 0.0 112.176 -178.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.608 ' CE1' ' CD1' ' A' ' 43' ' ' LEU . 1.6 m80 -110.3 139.34 21.37 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-O 120.706 0.289 . . . . 0.0 111.039 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.452 ' C ' ' HG3' ' A' ' 75' ' ' MET . 48.6 Cg_exo -54.24 -76.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.639 2.226 . . . . 0.0 112.937 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.566 ' HB3' ' HA2' ' A' ' 97' ' ' GLY . 2.8 mtm -144.14 54.34 1.29 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.845 0.355 . . . . 0.0 110.743 -179.407 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.528 ' O ' HG23 ' A' ' 78' ' ' VAL . 1.9 tt -63.83 115.68 20.78 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.725 -179.344 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -56.72 118.04 4.81 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.497 2.131 . . . . 0.0 112.546 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.918 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 2.8 t -124.99 146.58 30.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.126 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.67 ' HB ' ' HG ' ' A' ' 52' ' ' LEU . 2.3 mp -128.07 116.23 41.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 179.271 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.798 ' HA ' ' O ' ' A' ' 53' ' ' SER . 18.0 mm -95.34 142.59 13.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.979 0.419 . . . . 0.0 112.086 -178.647 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.544 ' HG3' HG22 ' A' ' 55' ' ' ILE . 1.7 ptt? -66.46 -32.38 73.71 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.609 -178.49 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.565 ' HA ' ' O ' ' A' ' 102' ' ' LEU . 4.3 m -148.1 169.99 18.78 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.581 0.229 . . . . 0.0 111.362 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 1.008 ' HB1' HD23 ' A' ' 87' ' ' LEU . . . -144.69 56.06 1.27 Allowed 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 14.8 p80 -99.17 176.36 5.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.092 0.472 . . . . 0.0 111.897 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.4 t 67.44 -78.68 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.972 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.547 ' O ' HD22 ' A' ' 63' ' ' LEU . 0.8 OUTLIER -120.4 70.18 0.88 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.894 0.378 . . . . 0.0 111.277 -179.358 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 1.008 HD23 ' HB1' ' A' ' 83' ' ' ALA . 3.0 tm? -54.93 -22.37 14.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.985 179.692 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -51.46 -56.26 14.28 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.756 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.47 -20.51 55.8 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.715 0.293 . . . . 0.0 111.147 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.841 ' HB3' HD22 ' A' ' 87' ' ' LEU . . . -69.13 -62.17 1.49 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.973 0.416 . . . . 0.0 110.776 179.505 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.465 ' HA ' ' HD2' ' A' ' 94' ' ' TYR . 8.4 t -53.62 -44.48 57.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.831 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.594 ' HA ' ' CG ' ' A' ' 95' ' ' GLN . 1.7 m -60.25 -25.24 65.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.17 0.51 . . . . 0.0 109.686 178.68 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.575 ' HB3' ' O ' ' A' ' 90' ' ' ALA . . . -75.88 -49.5 17.74 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.573 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.71 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -73.31 -29.25 62.57 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.038 -179.139 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.594 ' CG ' ' HA ' ' A' ' 92' ' ' SER . 2.1 pp0? -77.27 -37.61 52.58 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.547 178.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.57 ' HG2' ' O ' ' A' ' 93' ' ' ALA . 10.3 pt20 -73.47 -17.23 61.26 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.053 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.566 ' HA2' ' HB3' ' A' ' 75' ' ' MET . . . 165.16 -33.08 0.25 Allowed Glycine 0 C--N 1.335 0.473 0 C-N-CA 120.047 -1.073 . . . . 0.0 113.762 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.918 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -58.4 155.64 11.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 117.549 0.674 . . . . 0.0 111.218 -179.074 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.507 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 23.8 t80 -69.2 -53.88 17.7 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.735 -178.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.439 ' HB3' ' O ' ' A' ' 99' ' ' PHE . 17.1 p-10 178.99 -160.25 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 120.922 0.391 . . . . 0.0 111.084 -179.515 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.923 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 3.5 m-85 -135.98 153.36 51.42 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.986 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.601 HD13 HD22 ' A' ' 114' ' ' LEU . 1.4 tp -103.74 118.98 56.06 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.826 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -71.68 -75.38 0.01 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.034 1.823 . . . . 0.0 112.278 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.441 ' CB ' ' HD3' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -108.94 -57.03 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.503 -179.962 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.497 ' HB3' ' HG3' ' A' ' 110' ' ' GLU . 56.0 Cg_exo -52.31 154.15 11.8 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.295 1.996 . . . . 0.0 112.61 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.59 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 31.2 t80 -164.44 -116.52 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.197 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.55 ' O ' ' O ' ' A' ' 106' ' ' PHE . 2.9 p30 43.22 179.48 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.967 0.413 . . . . 0.0 111.449 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.66 HG12 HG12 ' A' ' 18' ' ' VAL . 0.8 OUTLIER -67.99 -43.75 85.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.892 0.377 . . . . 0.0 111.803 -179.617 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.491 ' HB2' ' OD1' ' A' ' 107' ' ' ASP . 4.2 m-20 -49.23 -58.28 5.31 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.567 -179.091 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.59 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 6.7 mm-40 -76.01 -32.02 59.2 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.591 0.234 . . . . 0.0 111.231 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.433 ' CB ' ' O ' ' A' ' 107' ' ' ASP . . . -66.21 -57.46 7.53 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.336 179.295 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.653 ' O ' HG12 ' A' ' 115' ' ' VAL . 47.8 t -62.01 -33.52 58.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.362 0.601 . . . . 0.0 110.653 179.129 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.477 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -62.24 -46.26 89.63 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.551 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.601 HD22 HD13 ' A' ' 102' ' ' LEU . 37.9 tp -75.83 -21.98 56.75 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.96 -1.018 . . . . 0.0 112.205 -179.107 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.653 HG12 ' O ' ' A' ' 112' ' ' VAL . 7.2 p -79.18 -41.44 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 C-N-CA 120.447 -0.501 . . . . 0.0 111.994 -179.319 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -66.35 -42.95 87.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.825 0.345 . . . . 0.0 110.736 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.9 mtt180 -61.0 -23.86 65.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.385 179.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.507 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -72.17 -48.45 43.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.079 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.481 HD11 HG11 ' A' ' 50' ' ' VAL . 4.5 mt -69.63 -31.31 48.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.076 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 36.3 t -71.96 -50.84 25.52 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.165 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -60.27 -23.57 64.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.134 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -66.94 -44.84 79.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.08 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.17 170.38 16.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.152 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.892 -179.941 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.438 ' O ' ' HB3' ' A' ' 2' ' ' GLN . 13.7 mtm . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 120.619 0.247 . . . . 0.0 110.908 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.438 ' HB3' ' O ' ' A' ' 1' ' ' MET . 1.9 tp60 78.72 -20.69 0.37 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.436 -179.541 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.804 ' HB3' HD11 ' A' ' 5' ' ' ILE . 10.2 tpt85 -63.94 -10.01 18.78 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.776 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.528 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . 68.16 63.06 3.8 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.773 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.804 HD11 ' HB3' ' A' ' 3' ' ' ARG . 3.8 mp -101.73 115.02 42.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.767 0.318 . . . . 0.0 110.839 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.849 HG11 ' CD2' ' A' ' 23' ' ' LEU . 7.3 p -105.66 126.41 60.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.327 179.532 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.799 ' CD1' HG22 ' A' ' 31' ' ' THR . 21.6 m0 -116.63 126.31 53.05 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.669 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.711 HG13 ' HB3' ' A' ' 52' ' ' LEU . 0.2 OUTLIER -112.02 148.26 15.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.236 -179.056 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 1.098 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -130.79 113.36 24.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 120.885 0.374 . . . . 0.0 110.379 178.736 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -161.4 -156.63 0.45 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.798 -179.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -67.24 0.78 2.52 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.411 ' O ' ' N ' ' A' ' 14' ' ' SER . 0.1 OUTLIER 65.38 -158.68 0.28 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.509 0.195 . . . . 0.0 110.783 179.717 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.436 ' HB3' ' H ' ' A' ' 14' ' ' SER . 1.3 t 34.62 -90.51 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 179.423 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.813 ' O ' HG23 ' A' ' 18' ' ' VAL . 0.4 OUTLIER -53.87 -57.56 10.5 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.824 0.345 . . . . 0.0 111.114 -179.702 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 22.4 mm -65.2 -24.5 35.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.89 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 1.097 ' HA ' HG21 ' A' ' 32' ' ' THR . 14.7 ttm-85 -71.1 -58.18 3.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.165 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.475 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 57.9 t90 -54.43 -37.3 64.96 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -179.141 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.813 HG23 ' O ' ' A' ' 14' ' ' SER . 8.2 t -67.84 -47.08 80.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -178.418 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.749 HD23 HD11 ' A' ' 108' ' ' ILE . 0.2 OUTLIER -84.25 -27.63 27.78 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -178.636 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.542 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 12.1 pt-20 -66.75 -59.77 3.27 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.846 -179.138 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.504 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 4.0 mmm180 -67.0 -47.7 70.68 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.846 -179.156 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.67 -54.53 45.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.917 0.389 . . . . 0.0 111.456 -179.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.849 ' CD2' HG11 ' A' ' 6' ' ' VAL . 2.2 tp -67.68 -23.49 65.31 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.065 179.372 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.542 ' HB2' ' O ' ' A' ' 20' ' ' GLU . . . -69.22 -36.31 77.1 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.336 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.89 -25.73 68.1 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.427 -0.892 . . . . 0.0 110.982 178.2 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.611 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -76.81 -16.11 59.54 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 120.665 0.269 . . . . 0.0 111.067 179.491 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.71 26.59 8.46 Favored Glycine 0 CA--C 1.522 0.514 0 C-N-CA 120.289 -0.958 . . . . 0.0 114.158 178.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.718 HD12 ' O ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -127.21 170.38 12.49 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 117.994 0.897 . . . . 0.0 111.805 179.942 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 52.9 m -95.46 105.51 17.48 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.432 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.719 ' HA ' HG13 ' A' ' 6' ' ' VAL . 40.7 t -106.34 113.36 26.83 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.221 0.534 . . . . 0.0 111.948 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.799 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.8 t -116.85 156.43 27.31 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.387 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' THR . . . . . 1.097 HG21 ' HA ' ' A' ' 16' ' ' ARG . 28.9 p -127.04 158.44 36.95 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.358 0.599 . . . . 0.0 111.684 -179.347 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 1.098 ' HB2' HG13 ' A' ' 9' ' ' VAL . 17.0 m-85 -128.44 174.24 9.51 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.735 -178.133 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.488 ' HG3' ' ND2' ' A' ' 35' ' ' ASN . 1.6 pt-20 -63.3 -37.6 87.87 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.577 0.955 . . . . 0.0 113.577 -177.103 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.488 ' ND2' ' HG3' ' A' ' 34' ' ' GLU . 18.0 p30 -174.92 -41.02 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 118.766 0.712 . . . . 0.0 112.696 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.754 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . -178.57 -47.07 0.07 OUTLIER Glycine 0 C--N 1.321 -0.271 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.738 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.418 ' HA ' ' CD1' ' A' ' 40' ' ' LEU . 0.9 OUTLIER -61.25 -29.94 70.15 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.616 0.246 . . . . 0.0 111.353 -179.525 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.836 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 3.1 tt0 -59.98 -51.34 70.07 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 121.089 -0.245 . . . . 0.0 111.597 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.621 HG21 ' CG2' ' A' ' 9' ' ' VAL . 19.5 t -52.37 -41.13 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 C-N-CA 120.584 -0.446 . . . . 0.0 111.461 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.74 HD13 ' HB3' ' A' ' 68' ' ' GLN . 7.1 mt -54.7 -46.74 74.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.97 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.91 -49.17 71.48 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.425 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.31 -32.7 74.26 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.881 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.642 HD21 ' HD2' ' A' ' 48' ' ' PRO . 8.3 mt -60.7 -25.02 66.11 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.086 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.4 -16.84 50.57 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.779 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.3 m -125.72 -0.97 7.37 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.515 ' O ' HD23 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -160.95 162.07 31.83 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.905 0.383 . . . . 0.0 111.024 179.834 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.443 HG23 HD23 ' A' ' 76' ' ' LEU . 57.8 m -138.42 116.0 9.21 Favored Pre-proline 0 N--CA 1.451 -0.414 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.134 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.642 ' HD2' HD21 ' A' ' 43' ' ' LEU . 70.9 Cg_endo -74.76 149.24 37.59 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 121.97 1.78 . . . . 0.0 111.881 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -73.73 -24.89 59.96 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.706 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.788 ' CG2' HD11 ' A' ' 79' ' ' ILE . 7.6 p -147.53 101.83 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.983 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.495 HD12 ' O ' ' A' ' 7' ' ' TRP . 18.0 tp -87.13 134.48 33.51 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.116 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.711 ' HB3' HG13 ' A' ' 8' ' ' VAL . 1.3 tt -121.73 122.54 39.77 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.333 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.55 ' OG ' HD13 ' A' ' 65' ' ' LEU . 2.2 m -123.67 125.51 44.92 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.416 0.627 . . . . 0.0 112.473 -178.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.649 ' HA ' ' HG2' ' A' ' 81' ' ' MET . 1.2 m-20 -83.18 107.14 15.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.78 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.985 HG13 ' HA3' ' A' ' 62' ' ' GLY . 4.9 tt -69.99 116.41 11.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.955 179.272 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.473 ' H ' ' HD3' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -158.22 58.13 0.46 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.036 0.446 . . . . 0.0 111.883 -179.783 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.456 ' N ' ' CD ' ' A' ' 58' ' ' PRO . 9.6 ptp 47.07 46.17 3.27 Favored Pre-proline 0 CA--C 1.537 0.473 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 178.784 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.608 ' CG ' ' HA2' ' A' ' 62' ' ' GLY . 50.3 Cg_endo -69.81 -81.94 0.01 OUTLIER 'Trans proline' 0 CA--C 1.533 0.475 0 C-N-CA 122.89 2.393 . . . . 0.0 111.885 178.411 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -105.85 -25.68 6.41 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.088 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.971 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -161.57 71.75 0.38 Allowed 'General case' 0 C--O 1.235 0.321 0 CA-C-O 120.985 0.421 . . . . 0.0 110.126 179.498 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.55 ' O ' HG13 ' A' ' 55' ' ' ILE . 0.2 OUTLIER 69.49 -25.77 0.15 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.886 -179.805 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.985 ' HA3' HG13 ' A' ' 55' ' ' ILE . . . 136.68 -26.34 3.04 Favored Glycine 0 CA--C 1.502 -0.737 0 N-CA-C 111.639 -0.584 . . . . 0.0 111.639 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.857 ' HA ' HD13 ' A' ' 66' ' ' LEU . 4.0 mp -78.26 -14.0 59.62 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-O 121.051 0.453 . . . . 0.0 109.977 178.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.971 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -53.83 -44.51 70.31 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.031 179.272 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.758 ' CD1' HD12 ' A' ' 66' ' ' LEU . 3.1 pp -57.98 -32.35 67.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.041 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.857 HD13 ' HA ' ' A' ' 63' ' ' LEU . 7.1 mp -62.93 -44.99 94.58 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.365 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.551 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 30.2 tttt -56.16 -44.62 79.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.756 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.74 ' HB3' HD13 ' A' ' 40' ' ' LEU . 2.5 mt-30 -66.26 -39.96 89.83 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.662 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.667 HD12 ' HA ' ' A' ' 66' ' ' LEU . 10.4 mt -65.03 -32.65 59.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.816 -179.564 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.551 ' HG2' ' O ' ' A' ' 67' ' ' LYS . 16.0 pttt -76.16 -29.04 57.57 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.966 0.413 . . . . 0.0 111.108 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.18 -44.01 89.82 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.382 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 79.3 mtt-85 -87.57 -23.09 24.43 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.735 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.736 ' CB ' ' HB2' ' A' ' 76' ' ' LEU . 88.7 m-70 -143.28 92.57 6.67 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.972 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.465 ' O ' ' O ' ' A' ' 96' ' ' GLN . 23.0 Cg_exo -64.86 6.11 0.39 Allowed 'Trans proline' 0 CA--C 1.531 0.343 0 C-N-CA 122.657 2.238 . . . . 0.0 113.123 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.609 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -143.35 14.08 1.81 Allowed 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.666 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.736 ' HB2' ' CB ' ' A' ' 73' ' ' HIS . 0.8 OUTLIER -75.53 113.06 22.64 Favored Pre-proline 0 C--N 1.332 -0.188 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -179.512 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.861 ' HB2' ' HD1' ' A' ' 99' ' ' PHE . 37.9 Cg_endo -67.5 116.66 4.35 Favored 'Trans proline' 0 CA--C 1.533 0.458 0 C-N-CA 122.546 2.164 . . . . 0.0 112.423 179.316 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.461 ' C ' ' HB2' ' A' ' 99' ' ' PHE . 3.6 t -115.05 136.61 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 120.921 0.391 . . . . 0.0 111.719 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.788 HD11 ' CG2' ' A' ' 50' ' ' VAL . 2.3 mt -110.37 116.54 52.62 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.207 0 CA-C-O 121.143 0.497 . . . . 0.0 110.956 179.04 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.847 HD11 HD21 ' A' ' 66' ' ' LEU . 1.6 mp -98.77 134.26 38.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.385 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.964 ' HG3' HG22 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -73.61 -24.93 60.1 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -178.089 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.521 ' HB ' HG21 ' A' ' 55' ' ' ILE . 3.9 m -147.38 159.21 43.95 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.154 0.502 . . . . 0.0 112.327 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.911 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -138.03 68.58 1.4 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.61 179.115 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -68.2 -141.87 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.067 -179.609 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.2 p -80.44 79.23 7.07 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-O 120.927 0.394 . . . . 0.0 111.558 -179.23 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.624 ' HB3' HD13 ' A' ' 63' ' ' LEU . 2.1 t70 179.53 29.06 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.926 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.893 HD13 ' HB3' ' A' ' 90' ' ' ALA . 0.3 OUTLIER -54.15 -21.41 8.66 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.653 -179.966 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -47.25 -54.45 10.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.741 0.305 . . . . 0.0 111.59 -179.022 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.518 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -69.6 -22.3 63.51 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.145 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.893 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -75.11 -42.14 57.07 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.792 0.329 . . . . 0.0 110.34 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.691 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 19.5 t -62.56 -52.8 55.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.034 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.3 p -57.39 -33.55 67.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.62 0.724 . . . . 0.0 109.833 179.107 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.644 ' HA ' ' CD ' ' A' ' 96' ' ' GLN . . . -57.56 -39.95 77.84 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.482 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.691 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 18.8 m-85 -60.67 -21.12 62.49 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.237 179.569 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.65 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -74.01 -43.83 56.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.312 179.715 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.65 ' N ' ' HG2' ' A' ' 95' ' ' GLN . 3.8 pm0 -80.33 -12.4 59.6 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.48 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.525 ' O ' ' HA ' ' A' ' 77' ' ' PRO . . . 117.17 38.38 0.87 Allowed Glycine 0 C--O 1.228 -0.25 0 C-N-CA 119.972 -1.109 . . . . 0.0 114.045 178.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.544 ' HB2' ' HB1' ' A' ' 93' ' ' ALA . . . -63.04 146.36 53.4 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 117.319 0.559 . . . . 0.0 110.772 179.162 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.861 ' HD1' ' HB2' ' A' ' 77' ' ' PRO . 1.3 t80 -71.75 -54.35 10.51 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.167 179.405 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.539 ' HB3' ' O ' ' A' ' 99' ' ' PHE . 2.9 p30 166.79 -166.87 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.711 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.911 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 4.8 m-85 -143.21 145.95 33.24 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.38 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.67 HD23 ' O ' ' A' ' 105' ' ' PRO . 6.4 mp -102.26 119.76 55.45 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.625 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -58.53 -66.27 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.343 2.029 . . . . 0.0 112.593 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.727 ' H ' ' HD2' ' A' ' 105' ' ' PRO . 8.8 mtpp -124.5 -60.68 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.465 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.727 ' HD2' ' H ' ' A' ' 104' ' ' LYS . 16.7 Cg_endo -57.13 159.24 15.65 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.077 1.851 . . . . 0.0 112.422 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.62 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 29.1 t80 -170.62 -104.34 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.382 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.538 ' O ' ' O ' ' A' ' 106' ' ' PHE . 3.3 p30 42.85 -177.58 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.542 0.211 . . . . 0.0 110.833 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.749 HD11 HD23 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -67.93 -42.67 85.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.994 0.426 . . . . 0.0 111.681 -179.716 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.551 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 1.7 m-20 -49.03 -57.46 6.51 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.54 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.62 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 5.5 mm-40 -77.0 -32.28 57.09 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 121.047 -0.261 . . . . 0.0 111.699 -179.407 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.6 -62.59 1.38 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.077 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.713 ' O ' HG12 ' A' ' 115' ' ' VAL . 42.6 t -57.64 -30.37 36.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 121.31 0.576 . . . . 0.0 110.816 178.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.551 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -63.94 -47.04 82.06 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.412 0.625 . . . . 0.0 110.203 179.142 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.571 HD23 HG21 ' A' ' 79' ' ' ILE . 4.8 tp -72.63 -22.38 60.95 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.487 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.778 HG23 HG21 ' A' ' 50' ' ' VAL . 9.9 p -79.56 -49.57 19.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 120.437 -0.505 . . . . 0.0 111.843 -179.514 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.493 ' N ' HG13 ' A' ' 115' ' ' VAL . 7.5 mt-10 -65.47 -54.74 24.05 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.766 0.317 . . . . 0.0 111.092 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 27.7 mtp85 -57.21 -26.47 60.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.188 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.531 ' HB1' ' CZ ' ' A' ' 99' ' ' PHE . . . -73.3 -48.99 29.98 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.479 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.2 mt -63.52 -30.88 50.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.218 0.533 . . . . 0.0 110.469 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 46.4 t -73.13 -48.92 31.42 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.099 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 25.4 m80 -71.4 -23.37 61.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.271 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -68.63 -46.82 68.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.813 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 24.7 pt20 -75.62 -174.32 2.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.952 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 60.8 mt-10 . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.929 -179.88 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.9 mtp . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 120.775 0.322 . . . . 0.0 111.236 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 66.46 148.88 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.767 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.44 ' CG ' ' H ' ' A' ' 4' ' ' GLY . 0.0 OUTLIER -63.33 -69.71 0.25 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.285 -179.789 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.59 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . 167.93 89.78 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.701 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 23.0 mm -117.74 112.76 40.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.768 0.318 . . . . 0.0 111.496 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.969 HG23 HG13 ' A' ' 50' ' ' VAL . 12.2 p -105.26 128.36 59.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.054 178.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.814 ' CD1' HG22 ' A' ' 31' ' ' THR . 24.9 m0 -116.89 129.9 56.36 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.119 0.485 . . . . 0.0 110.009 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.81 HG13 ' HB3' ' A' ' 52' ' ' LEU . 0.9 OUTLIER -121.72 149.43 24.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.341 -177.681 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.955 HG11 ' HA2' ' A' ' 36' ' ' GLY . 0.0 OUTLIER -125.31 113.41 35.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.555 178.973 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.444 ' OD2' ' OD2' ' A' ' 54' ' ' ASP . 2.3 t0 -164.78 -159.15 0.44 Allowed 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.14 -179.309 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -67.29 1.1 2.34 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -179.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.406 ' O ' ' N ' ' A' ' 14' ' ' SER . 14.7 t0 65.89 -158.33 0.27 Allowed 'General case' 0 CA--C 1.534 0.33 0 O-C-N 122.233 -0.292 . . . . 0.0 110.995 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.1 t 31.92 -89.84 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 179.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.866 ' O ' HG23 ' A' ' 18' ' ' VAL . 3.5 t -53.72 -56.14 20.01 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.656 0.265 . . . . 0.0 111.468 -179.504 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.5 mm -66.51 -25.0 34.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.923 0.392 . . . . 0.0 111.048 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.741 ' HA ' HG21 ' A' ' 32' ' ' THR . 3.2 tmm_? -77.99 -44.48 26.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.777 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.452 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 82.3 t90 -64.49 -39.79 94.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.67 -179.128 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.866 HG23 ' O ' ' A' ' 14' ' ' SER . 6.3 t -69.14 -43.12 81.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 112.748 0.648 . . . . 0.0 112.748 -179.024 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.665 HD23 HG21 ' A' ' 8' ' ' VAL . 1.5 tp -84.53 -22.62 30.09 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -178.42 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.634 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 17.6 pt-20 -67.71 -57.11 6.93 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.099 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.495 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 5.8 mmt180 -63.22 -49.91 72.32 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.597 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.41 -56.3 20.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.154 0.502 . . . . 0.0 111.147 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.778 ' HG ' HG11 ' A' ' 6' ' ' VAL . 2.0 tm? -66.01 -28.21 68.7 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.537 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.45 ' HB2' ' O ' ' A' ' 20' ' ' GLU . . . -67.26 -34.23 76.98 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.548 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.24 -26.73 66.43 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.379 -0.915 . . . . 0.0 111.366 178.481 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.621 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -76.84 -15.76 59.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.822 0.344 . . . . 0.0 110.919 179.392 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.25 25.5 10.21 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.797 -0.716 . . . . 0.0 113.596 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.621 ' CD1' ' HB3' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -130.74 171.67 12.84 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 117.762 0.781 . . . . 0.0 111.648 179.689 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.677 ' O ' HG12 ' A' ' 6' ' ' VAL . 32.1 m -94.35 130.71 40.55 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.175 -179.284 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.634 ' HB3' ' HA ' ' A' ' 20' ' ' GLU . 48.9 t -123.69 115.65 21.78 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 121.272 0.558 . . . . 0.0 111.83 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.814 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.9 t -117.44 156.5 27.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.597 178.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.741 HG21 ' HA ' ' A' ' 16' ' ' ARG . 55.5 p -132.53 151.41 51.93 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.142 0.496 . . . . 0.0 112.054 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.899 ' HB2' HG13 ' A' ' 9' ' ' VAL . 2.0 m-85 -125.46 174.42 8.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.228 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.655 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -61.66 -107.63 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.652 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.464 ' H ' ' CD ' ' A' ' 34' ' ' GLU . 0.6 OUTLIER -80.35 -69.84 0.57 Allowed 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.029 0.442 . . . . 0.0 112.038 -178.545 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.955 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . -167.42 -36.56 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.484 -0.865 . . . . 0.0 113.543 -179.155 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 54.4 m-20 -61.91 -30.0 70.59 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 116.999 0.399 . . . . 0.0 110.594 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.844 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -53.64 -56.86 13.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.624 179.225 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.825 HG21 HG22 ' A' ' 9' ' ' VAL . 2.9 t -51.75 -46.74 39.51 Favored 'Isoleucine or valine' 0 C--N 1.342 0.254 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.44 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.689 HD13 ' CB ' ' A' ' 68' ' ' GLN . 23.6 mt -55.23 -42.87 73.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.008 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.47 -49.65 72.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.159 0.504 . . . . 0.0 111.231 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.44 -26.4 63.63 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.05 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.846 HD13 ' NE2' ' A' ' 73' ' ' HIS . 6.5 mt -63.99 -21.3 66.43 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.445 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.72 -16.83 29.98 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.111 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.5 m -121.58 1.25 10.04 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.478 ' O ' HD23 ' A' ' 43' ' ' LEU . 0.7 OUTLIER -165.9 159.74 16.15 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.888 0.375 . . . . 0.0 111.367 179.764 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.642 HG23 HD12 ' A' ' 76' ' ' LEU . 90.8 m -138.58 111.84 8.34 Favored Pre-proline 0 N--CA 1.45 -0.441 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.422 179.555 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.713 ' HD2' HD11 ' A' ' 76' ' ' LEU . 51.8 Cg_endo -67.94 154.12 73.62 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.688 2.258 . . . . 0.0 111.891 179.041 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -74.66 -26.07 59.62 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.466 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.969 HG13 HG23 ' A' ' 6' ' ' VAL . 7.2 p -146.28 101.66 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.229 -178.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.69 HD12 ' O ' ' A' ' 7' ' ' TRP . 19.5 tp -86.85 137.11 32.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.985 0.421 . . . . 0.0 111.427 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.81 ' HB3' HG13 ' A' ' 8' ' ' VAL . 1.9 tt -126.85 127.55 45.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.145 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.517 ' N ' HD23 ' A' ' 52' ' ' LEU . 0.5 OUTLIER -126.22 129.21 48.51 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.343 0.592 . . . . 0.0 111.474 179.96 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.444 ' OD2' ' OD2' ' A' ' 10' ' ' ASP . 0.5 OUTLIER -79.02 -0.24 30.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.324 -179.212 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.705 HG13 ' HA3' ' A' ' 62' ' ' GLY . 11.9 tt 36.82 94.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-O 120.89 0.376 . . . . 0.0 111.579 -179.605 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.8 mtt180 -118.84 40.51 3.25 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.775 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.595 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER 59.59 46.19 1.33 Allowed Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 179.239 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.467 ' CG ' ' HA2' ' A' ' 62' ' ' GLY . 27.5 Cg_endo -61.9 -79.76 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.162 1.908 . . . . 0.0 111.23 178.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -106.35 -82.68 1.55 Allowed Glycine 0 C--N 1.332 0.343 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 178.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.82 ' HB3' ' HB2' ' A' ' 64' ' ' ALA . 17.0 tpp -87.57 59.36 5.42 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 177.18 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.595 ' HA ' ' HA ' ' A' ' 57' ' ' MET . 0.1 OUTLIER 63.54 -16.05 0.07 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.021 -0.99 . . . . 0.0 111.851 -178.656 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.705 ' HA3' HG13 ' A' ' 55' ' ' ILE . . . 135.98 -30.95 2.69 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 -178.568 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.803 HD11 ' HB2' ' A' ' 90' ' ' ALA . 1.9 tp -56.33 -30.17 62.26 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 178.117 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.82 ' HB2' ' HB3' ' A' ' 60' ' ' MET . . . -53.69 -38.32 64.1 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.213 178.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.638 ' O ' HG13 ' A' ' 69' ' ' ILE . 1.7 tp -51.41 -50.04 60.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.368 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 1.035 ' HA ' HD12 ' A' ' 69' ' ' ILE . 81.3 mt -52.8 -42.87 65.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.141 179.464 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 31.3 mttm -58.47 -46.88 85.72 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.4 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.689 ' CB ' HD13 ' A' ' 40' ' ' LEU . 16.7 mm100 -65.0 -31.68 73.03 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.778 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 1.035 HD12 ' HA ' ' A' ' 66' ' ' LEU . 88.7 mt -60.06 -45.72 95.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.728 -179.373 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.455 ' HG3' ' N ' ' A' ' 71' ' ' GLN . 0.4 OUTLIER -68.94 -29.5 67.75 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.536 -179.864 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.455 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 7.6 mt-30 -83.98 -33.21 24.63 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.565 -179.251 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.472 ' HB2' ' CD2' ' A' ' 73' ' ' HIS . 3.2 mtp85 -90.5 -65.26 1.03 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.18 -178.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.948 ' CE1' HG23 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -96.31 159.62 31.58 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.394 -178.956 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -96.44 101.2 0.09 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 123.489 2.793 . . . . 0.0 113.619 -179.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 6.8 mtt 57.04 24.2 9.29 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 177.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.713 HD11 ' HD2' ' A' ' 48' ' ' PRO . 2.2 tt -60.22 112.31 5.29 Favored Pre-proline 0 C--N 1.325 -0.487 0 C-N-CA 120.934 -0.307 . . . . 0.0 111.327 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.61 116.0 2.99 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.432 2.088 . . . . 0.0 112.153 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.989 HG21 HD13 ' A' ' 69' ' ' ILE . 19.0 t -115.06 145.14 21.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.985 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.631 ' CG2' HD23 ' A' ' 114' ' ' LEU . 1.8 mp -118.79 110.99 31.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.982 0.42 . . . . 0.0 111.031 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.55 ' HB ' ' CZ ' ' A' ' 101' ' ' TYR . 21.6 mm -103.3 146.72 10.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.578 -179.575 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.445 ' O ' ' HB2' ' A' ' 102' ' ' LEU . 7.2 ttt -69.06 -78.61 0.07 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.967 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.601 ' O ' HD13 ' A' ' 55' ' ' ILE . 4.0 m -106.62 159.08 16.47 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.118 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.487 ' HA ' ' CE2' ' A' ' 101' ' ' TYR . . . -87.52 -17.59 31.72 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.895 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.471 ' H ' HG22 ' A' ' 82' ' ' THR . 23.5 m170 48.33 -89.63 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.409 ' N ' ' O ' ' A' ' 83' ' ' ALA . 4.7 m -81.83 -169.97 2.61 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.834 0.35 . . . . 0.0 111.087 -179.492 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.524 ' O ' HD21 ' A' ' 63' ' ' LEU . 24.7 m-20 -40.86 108.62 0.09 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.166 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.76 HD23 ' HB3' ' A' ' 90' ' ' ALA . 1.3 mt -48.15 -20.99 0.41 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.398 178.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -47.74 -43.58 27.24 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -178.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.617 ' HB3' ' HG ' ' A' ' 63' ' ' LEU . . . -74.1 -21.33 59.94 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 120.243 -0.583 . . . . 0.0 109.912 179.506 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.803 ' HB2' HD11 ' A' ' 63' ' ' LEU . . . -77.55 -58.91 3.01 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.615 178.239 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.757 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 18.3 t -58.25 -56.75 14.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.561 -179.486 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 57.6 p -52.79 -27.58 18.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.069 0.462 . . . . 0.0 110.696 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.656 ' CB ' HD13 ' A' ' 66' ' ' LEU . . . -58.36 -46.08 86.97 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.003 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.757 ' CE2' ' HA ' ' A' ' 91' ' ' VAL . 5.5 m-85 -48.68 -27.95 3.22 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.767 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.622 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -76.91 -39.61 50.27 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.704 -179.903 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.622 ' N ' ' HG2' ' A' ' 95' ' ' GLN . 7.7 pt20 -100.14 5.33 44.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.979 -178.4 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 127.98 79.25 0.26 Allowed Glycine 0 CA--C 1.519 0.323 0 C-N-CA 120.101 -1.047 . . . . 0.0 113.178 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.964 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -171.62 127.04 0.63 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.008 0.432 . . . . 0.0 110.477 179.142 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.568 ' CE2' ' HB2' ' A' ' 118' ' ' ALA . 13.6 t80 -70.14 -53.73 16.0 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -178.501 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.702 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 0.1 OUTLIER 179.04 -170.48 0.12 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.011 0.434 . . . . 0.0 111.729 -179.291 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.638 ' CE1' HD11 ' A' ' 66' ' ' LEU . 3.0 m-85 -135.01 153.6 52.02 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.476 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.78 HD11 HD22 ' A' ' 114' ' ' LEU . 7.4 mp -102.19 123.76 42.21 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-O 120.768 0.318 . . . . 0.0 111.09 -179.549 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -69.71 -56.62 0.14 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.434 2.089 . . . . 0.0 112.475 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.681 ' HB3' ' HD3' ' A' ' 105' ' ' PRO . 1.8 ttmp? -133.52 -56.14 0.02 OUTLIER Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.474 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.681 ' HD3' ' HB3' ' A' ' 104' ' ' LYS . 45.1 Cg_exo -57.52 160.03 15.12 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 121.765 1.644 . . . . 0.0 111.758 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.645 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 62.9 t80 -165.85 -105.52 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.186 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.6 ' O ' ' O ' ' A' ' 106' ' ' PHE . 3.1 p30 41.65 178.63 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.959 0.409 . . . . 0.0 111.321 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.665 HD11 HD13 ' A' ' 19' ' ' LEU . 0.9 OUTLIER -67.89 -41.04 84.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.124 179.659 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.477 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 33.7 t0 -49.18 -58.54 4.83 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.602 -179.402 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.645 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 10.3 mm-40 -76.33 -32.6 58.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.711 0.291 . . . . 0.0 111.402 -179.61 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.85 -60.07 3.23 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.815 0.34 . . . . 0.0 110.407 179.688 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.65 ' HA ' HG12 ' A' ' 115' ' ' VAL . 47.1 t -59.63 -30.79 45.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.576 0.703 . . . . 0.0 110.468 178.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.477 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -63.66 -45.51 89.83 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.011 178.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.78 HD22 HD11 ' A' ' 102' ' ' LEU . 34.1 tp -77.35 -22.7 51.42 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.604 -179.344 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.65 HG12 ' HA ' ' A' ' 112' ' ' VAL . 5.3 p -79.39 -40.98 22.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 120.467 -0.493 . . . . 0.0 111.412 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -67.19 -48.59 67.47 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.963 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.454 ' NH2' ' HB1' ' A' ' 113' ' ' ALA . 0.9 OUTLIER -58.93 -23.28 61.19 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.808 179.948 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.568 ' HB2' ' CE2' ' A' ' 99' ' ' PHE . . . -72.43 -44.39 62.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.169 179.456 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.653 HD11 HG11 ' A' ' 50' ' ' VAL . 4.8 mt -72.18 -32.05 41.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.283 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 2.3 t -71.9 -47.2 54.33 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.805 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -65.45 -24.34 67.15 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.08 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -71.38 -49.89 37.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.956 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -75.16 176.76 7.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.105 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.908 179.95 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 ttp . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 120.738 0.304 . . . . 0.0 110.92 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -102.96 143.19 32.87 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.211 0.529 . . . . 0.0 111.31 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.522 ' HD2' HD11 ' A' ' 5' ' ' ILE . 15.2 ptt180 -60.4 -49.6 76.95 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.691 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.701 ' O ' HD13 ' A' ' 5' ' ' ILE . . . 101.45 112.79 3.59 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.836 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.701 HD13 ' O ' ' A' ' 4' ' ' GLY . 8.7 mm -124.97 112.89 33.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.809 0.338 . . . . 0.0 111.576 -178.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.859 HG23 HG13 ' A' ' 50' ' ' VAL . 8.0 p -106.47 125.52 62.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.17 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.875 ' CD1' HG22 ' A' ' 31' ' ' THR . 29.1 m0 -117.13 123.46 46.81 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.502 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.897 HG11 HD13 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -116.97 137.83 49.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.329 -177.237 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.845 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -121.25 104.98 15.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.967 178.695 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.806 ' HB3' HG21 ' A' ' 15' ' ' ILE . 3.7 t70 -168.1 72.49 0.1 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.984 0.421 . . . . 0.0 111.87 -179.53 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 63.95 2.59 1.42 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 179.015 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.7 p30 44.83 -149.63 0.07 Allowed 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.436 ' O ' ' HB3' ' A' ' 16' ' ' ARG . 1.4 t 34.85 -92.17 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 179.56 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.694 ' O ' HG23 ' A' ' 18' ' ' VAL . 2.9 t -53.81 -66.06 0.46 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.776 0.322 . . . . 0.0 110.56 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.806 HG21 ' HB3' ' A' ' 10' ' ' ASP . 35.0 mm -60.98 -20.51 22.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.924 179.349 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.95 ' HA ' HG21 ' A' ' 32' ' ' THR . 2.0 ttt180 -69.86 -58.03 4.36 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.255 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.492 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 36.8 t90 -59.43 -41.24 89.11 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.048 -0.523 . . . . 0.0 112.273 -179.117 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.896 HG12 HG12 ' A' ' 108' ' ' ILE . 2.7 t -67.14 -42.19 87.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -178.729 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.897 HD13 HG11 ' A' ' 8' ' ' VAL . 24.0 mt -84.13 -26.85 28.58 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -178.407 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.555 ' HG3' ' N ' ' A' ' 21' ' ' ARG . 21.2 pt-20 -67.5 -58.71 4.25 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.036 0.446 . . . . 0.0 112.029 -178.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.555 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 0.9 OUTLIER -50.71 -53.53 30.59 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.168 -179.154 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.01 -50.25 67.04 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -179.338 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.834 ' HG ' HG11 ' A' ' 6' ' ' VAL . 3.0 tm? -70.09 -30.62 67.89 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.421 0.629 . . . . 0.0 110.336 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.77 -32.53 73.88 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.64 -27.94 70.64 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 110.701 -0.959 . . . . 0.0 110.701 177.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.606 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -76.66 -15.75 59.73 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 120.625 0.25 . . . . 0.0 110.5 179.13 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.51 26.33 12.19 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.533 -0.842 . . . . 0.0 114.271 178.414 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.703 ' HB2' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -125.41 165.78 17.78 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 118.257 1.028 . . . . 0.0 112.3 179.729 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.727 ' O ' HG12 ' A' ' 6' ' ' VAL . 91.8 m -75.06 125.95 30.01 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.783 -179.599 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.443 ' HA ' HG13 ' A' ' 6' ' ' VAL . 4.2 p -125.77 110.4 13.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.697 -179.447 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.875 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.6 t -125.46 149.71 47.98 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.95 HG21 ' HA ' ' A' ' 16' ' ' ARG . 53.1 p -126.95 161.36 28.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.529 0.68 . . . . 0.0 112.734 -179.254 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.845 ' HB2' HG13 ' A' ' 9' ' ' VAL . 0.7 OUTLIER -135.23 173.37 11.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.595 -179.714 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.61 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -59.3 -103.11 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.885 -178.234 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.498 ' OD1' ' HD3' ' A' ' 58' ' ' PRO . 0.2 OUTLIER -88.93 -71.44 0.6 Allowed 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.103 0.478 . . . . 0.0 111.814 -179.076 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.772 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . -163.45 -34.74 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.638 -0.71 . . . . 0.0 113.069 -178.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.418 ' HA ' ' CD1' ' A' ' 40' ' ' LEU . 80.0 m-20 -58.43 -32.51 68.76 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 121.223 0.535 . . . . 0.0 110.11 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.753 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -54.67 -61.79 2.08 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.24 179.542 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.831 HG11 HD11 ' A' ' 51' ' ' LEU . 4.4 t -50.05 -32.51 8.56 Favored 'Isoleucine or valine' 0 C--N 1.342 0.282 0 C-N-CA 120.329 -0.549 . . . . 0.0 110.926 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.533 HD13 ' HB3' ' A' ' 68' ' ' GLN . 22.6 mt -58.49 -44.73 89.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.839 0.352 . . . . 0.0 110.56 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.33 -49.39 77.79 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.228 0.537 . . . . 0.0 110.348 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.69 -31.79 72.0 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.156 178.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.608 HD22 ' CD2' ' A' ' 73' ' ' HIS . 10.2 mt -63.65 -25.82 68.39 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.706 179.298 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.527 ' HA ' ' HD3' ' A' ' 72' ' ' ARG . . . -59.34 -24.25 63.19 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.155 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -128.61 9.35 5.97 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.643 ' HG2' ' CH2' ' A' ' 7' ' ' TRP . 25.2 tptt -146.02 162.46 37.81 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 121.365 0.602 . . . . 0.0 111.878 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.515 HG23 HD23 ' A' ' 76' ' ' LEU . 95.2 m -138.92 110.47 7.89 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.072 177.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.912 ' HG2' HD11 ' A' ' 76' ' ' LEU . 87.2 Cg_endo -80.65 148.38 17.94 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 122.433 2.089 . . . . 0.0 111.735 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -74.46 -30.79 62.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.946 0.403 . . . . 0.0 110.966 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.859 HG13 HG23 ' A' ' 6' ' ' VAL . 6.7 p -149.84 94.12 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.554 -179.615 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.831 HD11 HG11 ' A' ' 39' ' ' VAL . 27.0 tp -86.79 141.02 29.14 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.627 -179.218 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.868 ' HG ' ' HB ' ' A' ' 79' ' ' ILE . 0.2 OUTLIER -122.01 114.77 21.41 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.193 179.951 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.651 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -107.71 143.58 36.02 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.405 0.621 . . . . 0.0 112.086 -179.599 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 30.2 p30 -83.06 -177.66 6.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.02 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.795 HG22 ' HG3' ' A' ' 81' ' ' MET . 3.5 tt -159.13 160.85 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.885 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.466 ' H ' HG13 ' A' ' 55' ' ' ILE . 0.1 OUTLIER 78.01 51.95 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.007 0.432 . . . . 0.0 110.499 -179.207 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.493 ' CB ' ' CD ' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -163.39 -65.24 0.01 OUTLIER Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.95 179.892 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.795 ' HG3' HD21 ' A' ' 65' ' ' LEU . 37.6 Cg_endo -65.44 -163.46 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.115 2.544 . . . . 0.0 112.933 -179.547 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -52.81 -89.89 0.01 OUTLIER Glycine 0 C--N 1.332 0.315 0 CA-C-N 115.974 -0.557 . . . . 0.0 113.0 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.913 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 2.6 tpp -72.52 57.38 0.39 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.774 0.321 . . . . 0.0 110.77 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.585 ' O ' ' HD2' ' A' ' 58' ' ' PRO . 0.1 OUTLIER 59.67 -74.34 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.067 179.948 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 60' ' ' MET . . . -152.65 -30.1 0.04 OUTLIER Glycine 0 C--N 1.321 -0.264 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.502 -179.361 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.638 ' H ' HD12 ' A' ' 63' ' ' LEU . 0.3 OUTLIER -66.14 -22.17 66.37 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.742 0.306 . . . . 0.0 110.874 179.912 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.913 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -54.95 -30.21 58.41 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.349 0.595 . . . . 0.0 109.923 179.292 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.795 HD21 ' HG3' ' A' ' 58' ' ' PRO . 2.7 mm? -66.07 -45.29 81.83 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.998 179.309 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.871 HD21 HD11 ' A' ' 80' ' ' ILE . 10.2 mt -51.81 -44.22 63.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.509 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.455 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 2.8 ttmm -55.14 -44.54 75.17 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.474 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.533 ' HB3' HD13 ' A' ' 40' ' ' LEU . 51.0 mm-40 -70.6 -43.91 68.38 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.191 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.476 HD13 HD23 ' A' ' 51' ' ' LEU . 56.2 mt -60.68 -36.2 69.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 121.057 0.456 . . . . 0.0 111.431 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.549 ' HB3' ' CD ' ' A' ' 96' ' ' GLN . 16.2 pttp -73.07 -27.0 61.47 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.285 -179.364 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -65.08 -39.07 92.67 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.237 0.541 . . . . 0.0 110.663 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.527 ' HD3' ' HA ' ' A' ' 44' ' ' ALA . 15.4 mtt-85 -94.42 -24.76 17.21 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.21 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.608 ' CD2' HD22 ' A' ' 43' ' ' LEU . 83.1 m-70 -140.47 101.59 6.7 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.138 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.403 ' O ' ' HG3' ' A' ' 75' ' ' MET . 88.7 Cg_endo -77.03 11.48 2.02 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.596 2.198 . . . . 0.0 113.702 -179.478 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.693 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 5.9 mtt -147.64 12.95 1.03 Allowed 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.912 HD11 ' HG2' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -76.24 110.53 11.49 Favored Pre-proline 0 N--CA 1.462 0.164 0 CA-C-O 120.583 0.23 . . . . 0.0 111.576 179.881 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.402 ' HD3' ' O ' ' A' ' 75' ' ' MET . 35.4 Cg_exo -62.57 128.22 22.89 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.478 2.119 . . . . 0.0 111.906 179.319 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.57 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 4.3 t -125.1 152.66 31.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.059 0.456 . . . . 0.0 111.48 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.868 ' HB ' ' HG ' ' A' ' 52' ' ' LEU . 1.9 mt -134.17 112.09 15.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.483 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.871 HD11 HD21 ' A' ' 66' ' ' LEU . 16.6 mm -94.83 138.03 21.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.383 -179.408 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.795 ' HG3' HG22 ' A' ' 55' ' ' ILE . 0.2 OUTLIER -68.43 -31.41 70.72 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -178.936 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.667 ' O ' HD13 ' A' ' 55' ' ' ILE . 91.4 m -146.83 153.93 40.76 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.607 0.241 . . . . 0.0 110.713 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.712 ' HB1' ' CD2' ' A' ' 87' ' ' LEU . . . -106.23 -33.1 7.92 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -179.219 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 45.88 -166.64 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.727 0.298 . . . . 0.0 111.52 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -80.32 79.51 6.89 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.725 -179.066 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.561 ' HB3' HD13 ' A' ' 63' ' ' LEU . 0.1 OUTLIER -179.22 28.61 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.831 179.197 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.712 ' CD2' ' HB1' ' A' ' 83' ' ' ALA . 0.5 OUTLIER -49.23 -20.8 0.67 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 112.088 -179.985 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -47.68 -54.94 10.59 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 -179.103 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.481 ' HB3' ' HB2' ' A' ' 63' ' ' LEU . . . -70.68 -21.49 62.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.851 0.358 . . . . 0.0 111.247 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.697 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -69.69 -41.95 74.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.654 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.64 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 3.4 t -62.07 -46.24 96.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.898 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.47 ' O ' ' HB3' ' A' ' 95' ' ' GLN . 38.5 m -65.14 -21.96 66.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.039 0.447 . . . . 0.0 109.834 179.048 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.796 ' HB2' HD13 ' A' ' 66' ' ' LEU . . . -66.0 -39.33 90.2 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.296 0.57 . . . . 0.0 109.687 179.049 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.64 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 8.9 m-85 -69.89 -22.7 63.21 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.639 178.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.47 ' HB3' ' O ' ' A' ' 92' ' ' SER . 1.9 tm0? -69.39 -44.31 71.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.906 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.693 ' O ' ' HA ' ' A' ' 75' ' ' MET . 2.3 pt20 -75.68 -17.95 59.79 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.668 179.12 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 125.24 16.87 2.8 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.368 -0.92 . . . . 0.0 113.939 178.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.57 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -55.47 151.23 10.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 117.413 0.607 . . . . 0.0 110.79 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.553 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 14.3 t80 -77.07 -53.55 7.66 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.269 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 169.92 -166.0 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.0 0.428 . . . . 0.0 111.656 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.663 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 3.4 m-85 -133.4 153.35 51.68 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.086 -179.539 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.581 ' CD1' HD22 ' A' ' 114' ' ' LEU . 1.0 OUTLIER -103.42 118.64 57.19 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.887 179.943 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -73.7 -72.94 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.089 1.859 . . . . 0.0 112.444 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.474 ' CB ' ' HD3' ' A' ' 105' ' ' PRO . 2.2 tttt -111.38 -57.98 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.663 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.474 ' HD3' ' CB ' ' A' ' 104' ' ' LYS . 51.8 Cg_exo -54.45 153.35 23.18 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.165 1.91 . . . . 0.0 112.524 -179.669 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.653 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 41.1 t80 -163.54 -113.15 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.431 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.573 ' O ' ' O ' ' A' ' 106' ' ' PHE . 3.1 p30 42.6 178.3 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 118.122 0.419 . . . . 0.0 111.591 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.896 HG12 HG12 ' A' ' 18' ' ' VAL . 0.8 OUTLIER -67.78 -43.1 86.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.113 0.482 . . . . 0.0 111.272 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.501 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 0.4 OUTLIER -49.04 -58.11 5.46 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.594 -179.548 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.653 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 36.5 mm-40 -76.98 -33.29 57.64 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.757 0.313 . . . . 0.0 111.371 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.428 ' CB ' ' O ' ' A' ' 107' ' ' ASP . . . -64.41 -59.13 4.72 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.116 179.461 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.688 ' O ' HG12 ' A' ' 115' ' ' VAL . 48.3 t -60.74 -32.0 50.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.514 179.108 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.501 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -62.51 -46.08 90.07 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.09 179.292 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.581 HD22 ' CD1' ' A' ' 102' ' ' LEU . 20.6 tp -76.09 -21.12 57.06 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.835 -1.075 . . . . 0.0 111.907 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.688 HG12 ' O ' ' A' ' 112' ' ' VAL . 3.7 p -78.92 -37.98 20.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.477 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.602 ' HA ' HD12 ' A' ' 119' ' ' ILE . 35.7 mt-10 -68.67 -38.73 80.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.966 0.413 . . . . 0.0 110.735 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.1 mmm180 -63.54 -27.52 69.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.091 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.553 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -69.42 -44.57 71.08 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.064 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.602 HD12 ' HA ' ' A' ' 116' ' ' GLU . 6.5 mt -62.81 -31.95 54.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.16 0.505 . . . . 0.0 110.699 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 9.1 t -75.13 -49.54 19.25 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.868 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 18.1 m80 -64.44 -28.9 69.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.137 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -67.49 -57.19 6.96 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.105 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.07 171.66 14.69 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.393 -179.663 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.677 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 120.909 0.385 . . . . 0.0 111.13 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.493 ' O ' ' HB3' ' A' ' 3' ' ' ARG . 8.4 tt0 -122.7 -29.69 3.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.871 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.729 ' HB3' HD11 ' A' ' 5' ' ' ILE . 0.0 OUTLIER 74.47 -21.1 0.29 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.594 -179.771 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.515 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . 56.7 79.9 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.653 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.729 HD11 ' HB3' ' A' ' 3' ' ' ARG . 3.1 mp -116.71 112.18 38.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.697 0.285 . . . . 0.0 110.654 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.857 HG11 HD13 ' A' ' 23' ' ' LEU . 6.5 p -108.79 129.35 63.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.826 0.346 . . . . 0.0 110.929 179.242 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.859 ' CD1' HG22 ' A' ' 31' ' ' THR . 33.5 m0 -116.27 139.27 50.56 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.391 179.687 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.726 HG13 ' HB3' ' A' ' 52' ' ' LEU . 0.4 OUTLIER -122.59 146.96 27.02 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.303 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.51 -178.352 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.928 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -129.12 109.33 18.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 120.92 0.391 . . . . 0.0 110.973 179.368 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.439 ' OD1' ' HB3' ' A' ' 54' ' ' ASP . 6.5 t0 -162.16 -158.19 0.51 Allowed 'General case' 0 CA--C 1.53 0.212 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.693 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -66.37 -2.73 4.81 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -179.248 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.6 t0 66.87 -144.31 0.15 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 121.296 -0.162 . . . . 0.0 110.628 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.465 ' OG ' ' N ' ' A' ' 14' ' ' SER . 53.1 p 33.48 -101.83 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 179.262 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.784 ' O ' HG23 ' A' ' 18' ' ' VAL . 1.5 m -54.4 -49.5 69.77 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.675 0.274 . . . . 0.0 111.312 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.9 mm -62.97 -24.6 36.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.929 0.395 . . . . 0.0 111.11 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.867 ' HA ' HG21 ' A' ' 32' ' ' THR . 25.2 ttt180 -74.71 -55.09 6.23 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.022 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.452 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 14.6 t90 -56.3 -42.46 77.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.881 -0.6 . . . . 0.0 112.444 -178.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.784 HG23 ' O ' ' A' ' 14' ' ' SER . 5.3 t -66.53 -45.3 89.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -178.728 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.645 HD13 HD11 ' A' ' 108' ' ' ILE . 1.2 mp -83.77 -25.24 30.65 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -178.371 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.541 ' HG3' ' N ' ' A' ' 21' ' ' ARG . 14.8 pt-20 -66.58 -58.87 4.29 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.422 -0.511 . . . . 0.0 111.546 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.541 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -65.76 -51.23 60.88 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.121 -179.073 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.25 -45.27 80.1 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -178.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.857 HD13 HG11 ' A' ' 6' ' ' VAL . 0.4 OUTLIER -74.88 -25.25 58.82 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.95 0.405 . . . . 0.0 110.63 179.688 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.87 -34.22 75.08 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 177.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.69 -23.49 68.98 Favored Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 178.019 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.462 ' HB3' HD12 ' A' ' 28' ' ' LEU . . . -77.67 -15.73 58.98 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 120.805 0.336 . . . . 0.0 110.6 179.115 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.52 25.08 11.22 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.832 -0.699 . . . . 0.0 113.982 178.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.843 HD13 ' CD2' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -132.07 165.18 24.59 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 117.811 0.805 . . . . 0.0 112.562 179.694 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 29.5 m -87.67 108.86 19.29 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.004 -179.269 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.622 ' HA ' HG13 ' A' ' 6' ' ' VAL . 42.2 t -106.63 111.71 24.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.031 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.859 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.4 t -118.04 154.99 31.11 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.04 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.867 HG21 ' HA ' ' A' ' 16' ' ' ARG . 38.5 p -124.37 164.51 19.51 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.123 0.487 . . . . 0.0 111.879 -179.129 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.928 ' HB2' HG13 ' A' ' 9' ' ' VAL . 2.3 m-85 -130.19 172.31 11.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.592 -178.236 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.68 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 3.0 pp20? -63.53 -44.87 92.98 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -177.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.458 ' C ' HG12 ' A' ' 9' ' ' VAL . 16.3 t-20 -160.78 -58.2 0.05 Allowed 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -179.158 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.73 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . -164.99 -43.47 0.02 OUTLIER Glycine 0 C--N 1.319 -0.382 0 C-N-CA 120.371 -0.919 . . . . 0.0 113.431 -179.319 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.538 ' HA ' HD12 ' A' ' 40' ' ' LEU . 39.0 m-80 -67.4 -26.87 66.65 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -178.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.732 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 12.2 tt0 -58.92 -50.51 73.77 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.744 -0.382 . . . . 0.0 111.411 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.766 HG22 ' CG ' ' A' ' 33' ' ' PHE . 10.1 t -61.15 -35.46 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 C-N-CA 120.122 -0.631 . . . . 0.0 111.236 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.622 HD13 ' HB3' ' A' ' 68' ' ' GLN . 31.0 mt -56.94 -41.11 77.66 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.027 0.442 . . . . 0.0 110.728 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -77.53 -47.53 19.29 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.025 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.425 ' HB3' ' HE2' ' A' ' 33' ' ' PHE . . . -61.71 -36.38 80.77 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.069 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.6 HD21 ' HD2' ' A' ' 48' ' ' PRO . 16.0 mt -63.34 -22.98 67.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.031 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.17 -19.61 14.29 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.677 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -124.21 2.59 8.54 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.538 ' O ' HD23 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -162.41 155.26 19.78 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.801 0.334 . . . . 0.0 110.862 179.965 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.615 HG23 ' CD2' ' A' ' 76' ' ' LEU . 98.6 m -138.97 112.84 8.23 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.573 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.6 ' HD2' HD21 ' A' ' 43' ' ' LEU . 72.4 Cg_endo -79.1 161.82 26.26 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.085 1.857 . . . . 0.0 111.436 178.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -73.98 -22.57 59.57 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.701 0.286 . . . . 0.0 111.294 -179.552 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.81 HG13 HG23 ' A' ' 6' ' ' VAL . 7.1 p -144.97 161.34 13.7 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.231 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.622 HD12 ' O ' ' A' ' 7' ' ' TRP . 22.6 tp -152.87 133.19 13.59 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.164 0.507 . . . . 0.0 111.913 -178.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.726 ' HB3' HG13 ' A' ' 8' ' ' VAL . 0.5 OUTLIER -111.86 115.54 29.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.265 179.983 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.58 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 2.1 m -110.98 138.57 47.22 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.124 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.439 ' HB3' ' OD1' ' A' ' 10' ' ' ASP . 15.4 p-10 -83.03 179.68 7.69 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.781 179.196 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.678 HG13 ' O ' ' A' ' 61' ' ' ASP . 1.0 OUTLIER -154.06 96.85 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.153 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -138.96 40.17 2.14 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.797 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.471 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER 67.52 47.29 0.41 Allowed Pre-proline 0 CA--C 1.533 0.304 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 179.018 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.507 ' HD2' ' N ' ' A' ' 62' ' ' GLY . 37.5 Cg_endo -69.27 -76.45 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.309 2.006 . . . . 0.0 111.86 178.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -112.39 -25.25 4.74 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 121.069 -0.586 . . . . 0.0 111.928 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.9 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 1.0 OUTLIER -159.62 68.02 0.4 Allowed 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.261 0.553 . . . . 0.0 109.991 179.517 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.678 ' O ' HG13 ' A' ' 55' ' ' ILE . 0.1 OUTLIER 69.9 -29.21 0.18 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.862 -179.719 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.507 ' N ' ' HD2' ' A' ' 58' ' ' PRO . . . 142.58 -29.25 2.14 Favored Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.692 ' H ' HD12 ' A' ' 63' ' ' LEU . 1.1 mp -70.24 -19.17 63.15 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 178.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.9 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -53.59 -32.18 49.93 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.532 179.068 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.635 HD11 ' HA2' ' A' ' 36' ' ' GLY . 1.1 tt -57.79 -46.14 85.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.315 179.414 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.804 HD21 HD11 ' A' ' 80' ' ' ILE . 6.5 mt -57.82 -44.68 86.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.948 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.411 ' O ' ' CG ' ' A' ' 70' ' ' LYS . 20.8 ttmt -52.76 -53.23 51.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.371 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.622 ' HB3' HD13 ' A' ' 40' ' ' LEU . 26.7 mm100 -59.64 -34.6 73.01 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.923 0.392 . . . . 0.0 111.483 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.587 HD12 ' HA ' ' A' ' 66' ' ' LEU . 86.5 mt -61.57 -33.36 56.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.773 -178.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.548 ' HB3' ' CB ' ' A' ' 96' ' ' GLN . 0.2 OUTLIER -78.01 -29.44 49.55 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.999 0.428 . . . . 0.0 111.718 179.932 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.431 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 3.9 mt-30 -65.63 -48.23 72.91 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.152 -178.825 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.3 mtp85 -93.38 -55.94 3.11 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.97 -178.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.565 ' CE1' ' CD1' ' A' ' 43' ' ' LEU . 0.5 OUTLIER -84.25 152.82 62.04 Favored Pre-proline 0 C--N 1.319 -0.76 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.543 -178.852 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -69.85 -76.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.618 2.212 . . . . 0.0 112.882 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.664 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 6.6 mtm -138.71 53.49 1.77 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.185 0.517 . . . . 0.0 111.338 -179.691 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.615 ' CD2' HG23 ' A' ' 47' ' ' THR . 0.2 OUTLIER -63.7 112.23 6.84 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.081 179.576 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.574 ' HG2' ' HA ' ' A' ' 50' ' ' VAL . 17.3 Cg_endo -57.19 122.73 12.32 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.188 1.925 . . . . 0.0 111.377 179.22 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.5 HG21 HD13 ' A' ' 69' ' ' ILE . 3.9 t -119.54 152.03 22.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.167 0.508 . . . . 0.0 111.894 -178.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.653 ' O ' HD23 ' A' ' 52' ' ' LEU . 3.3 mt -131.6 113.74 23.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.363 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.804 HD11 HD21 ' A' ' 66' ' ' LEU . 2.4 mp -96.26 132.48 40.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.952 0.406 . . . . 0.0 110.829 -179.548 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.518 ' HB2' ' CE1' ' A' ' 106' ' ' PHE . 3.7 ptp -70.2 -24.65 63.15 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -177.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.43 ' H ' HG21 ' A' ' 55' ' ' ILE . 12.0 m -146.96 160.16 42.69 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.974 0.416 . . . . 0.0 111.753 -179.248 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.827 ' HB1' HD21 ' A' ' 87' ' ' LEU . . . -142.32 57.84 1.46 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.56 -179.643 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -75.34 -95.73 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.364 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 6.9 t -89.87 173.01 8.47 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-O 121.109 0.48 . . . . 0.0 111.914 -179.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.42 ' CB ' HD13 ' A' ' 63' ' ' LEU . 8.0 m-20 58.01 17.77 4.64 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.653 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.827 HD21 ' HB1' ' A' ' 83' ' ' ALA . 1.9 mt -48.8 -24.12 1.31 Allowed 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -48.01 -45.64 32.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.8 0.333 . . . . 0.0 111.062 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.547 ' HB3' ' HB2' ' A' ' 63' ' ' LEU . . . -65.99 -20.27 66.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.426 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.608 ' HB2' HD23 ' A' ' 63' ' ' LEU . . . -63.25 -44.86 93.97 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.845 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.566 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 5.6 t -59.41 -46.24 92.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.307 -179.578 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 98.4 p -62.87 -20.09 64.78 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.232 179.154 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.685 ' HB1' HD22 ' A' ' 66' ' ' LEU . . . -65.05 -44.49 88.85 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 121.147 0.499 . . . . 0.0 110.367 179.461 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.566 ' CE2' ' HA ' ' A' ' 91' ' ' VAL . 8.5 m-85 -61.82 -25.13 67.32 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.696 178.671 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -76.55 -38.81 54.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.324 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.674 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 1.6 pp0? -78.85 -18.22 54.36 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.42 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 125.92 1.92 7.37 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 120.444 -0.884 . . . . 0.0 113.663 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.603 ' CB ' ' HB1' ' A' ' 93' ' ' ALA . . . -53.43 151.59 5.48 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 117.419 0.61 . . . . 0.0 110.699 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.575 ' CE2' ' HB2' ' A' ' 118' ' ' ALA . 11.4 t80 -79.63 -53.9 6.4 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 121.018 -0.273 . . . . 0.0 111.303 -179.601 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 175.04 -166.95 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.036 0.446 . . . . 0.0 111.594 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.818 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 3.0 m-85 -133.95 153.53 51.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.034 -178.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.614 ' CD1' HD22 ' A' ' 114' ' ' LEU . 1.8 mp -103.62 118.83 56.54 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.197 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 102' ' ' LEU . 8.0 Cg_exo -70.63 -68.43 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.436 2.091 . . . . 0.0 111.97 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.731 ' H ' ' HD2' ' A' ' 105' ' ' PRO . 0.5 OUTLIER -117.92 -59.24 0.03 OUTLIER Pre-proline 0 CA--C 1.531 0.239 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -179.858 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.731 ' HD2' ' H ' ' A' ' 104' ' ' LYS . 13.0 Cg_endo -55.42 157.57 14.5 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.113 1.875 . . . . 0.0 112.44 -179.615 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.571 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 22.4 t80 -165.6 -111.01 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.434 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.548 ' O ' ' O ' ' A' ' 106' ' ' PHE . 3.0 p30 43.74 178.74 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.907 0.384 . . . . 0.0 111.257 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.71 HG12 HG12 ' A' ' 18' ' ' VAL . 0.9 OUTLIER -68.02 -42.88 85.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.979 0.418 . . . . 0.0 111.575 -179.643 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.492 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 78.8 m-20 -49.26 -58.35 5.2 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.413 -179.381 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.571 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 62.9 mm-40 -76.4 -32.26 58.43 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.678 0.275 . . . . 0.0 111.43 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.401 ' CB ' ' O ' ' A' ' 107' ' ' ASP . . . -64.92 -60.8 2.65 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.001 0.429 . . . . 0.0 109.946 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.608 ' O ' HG12 ' A' ' 115' ' ' VAL . 48.3 t -59.46 -31.27 46.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.413 0.625 . . . . 0.0 110.537 178.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.492 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -63.23 -45.07 93.35 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.01 179.211 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.658 HD12 ' HD2' ' A' ' 117' ' ' ARG . 55.7 tp -76.28 -23.44 54.41 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.703 -1.135 . . . . 0.0 111.782 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.608 HG12 ' O ' ' A' ' 112' ' ' VAL . 4.0 p -79.2 -41.25 22.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.801 0.334 . . . . 0.0 111.548 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.475 ' HA ' HD12 ' A' ' 119' ' ' ILE . 95.1 mt-10 -65.33 -44.48 87.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.181 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.658 ' HD2' HD12 ' A' ' 114' ' ' LEU . 6.5 ptp180 -62.29 -25.42 67.84 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.933 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.575 ' HB2' ' CE2' ' A' ' 99' ' ' PHE . . . -71.28 -44.56 64.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.088 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.489 HD11 HG11 ' A' ' 50' ' ' VAL . 4.8 mt -68.6 -30.8 48.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.252 0.548 . . . . 0.0 110.688 179.506 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 21.7 t -71.24 -45.03 64.16 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.212 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 30.1 m80 -67.44 -24.36 65.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.024 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -67.86 -50.05 58.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.651 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 3.0 tm0? -75.13 172.22 12.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.821 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.821 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.467 0 CA-C-O 120.807 0.336 . . . . 0.0 111.311 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 61.5 176.25 0.12 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.452 -179.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -76.39 1.96 14.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.561 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 84.4 86.33 0.9 Allowed Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.833 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.469 ' HB ' ' HA ' ' A' ' 48' ' ' PRO . 3.6 mp -110.56 112.75 41.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.102 0.477 . . . . 0.0 111.245 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.687 HG23 HG13 ' A' ' 50' ' ' VAL . 5.6 p -108.82 120.96 61.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.913 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.885 ' CD1' HG22 ' A' ' 31' ' ' THR . 31.4 m0 -112.32 141.74 45.67 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.117 0.484 . . . . 0.0 111.484 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.808 ' HB ' HG22 ' A' ' 32' ' ' THR . 1.6 t -128.3 143.01 42.31 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.306 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.975 -178.261 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.871 HG11 ' HA2' ' A' ' 36' ' ' GLY . 0.0 OUTLIER -120.95 110.69 28.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.456 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.548 ' HA ' ' HB3' ' A' ' 54' ' ' ASP . 4.5 p30 -161.3 -160.75 0.75 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.904 0.383 . . . . 0.0 111.67 -178.463 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -66.23 -3.28 5.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.681 -179.246 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 65.31 -155.91 0.28 Allowed 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 120.511 0.196 . . . . 0.0 110.927 179.439 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.444 ' OG ' ' N ' ' A' ' 14' ' ' SER . 64.0 p 33.56 -96.89 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 179.349 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.909 ' O ' HG23 ' A' ' 18' ' ' VAL . 40.4 t -52.93 -57.41 10.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.535 -179.516 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.4 mm -64.61 -26.36 40.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.937 0.398 . . . . 0.0 111.182 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.694 ' HA ' HG21 ' A' ' 32' ' ' THR . 9.8 ttt180 -73.43 -49.29 27.7 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.447 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.427 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 87.0 t90 -63.4 -39.83 95.57 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -179.087 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.909 HG23 ' O ' ' A' ' 14' ' ' SER . 3.2 t -67.03 -42.87 89.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 112.133 0.419 . . . . 0.0 112.133 -178.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.752 ' CD1' HD12 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -84.12 -30.52 25.87 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -178.696 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.553 ' HG3' ' N ' ' A' ' 21' ' ' ARG . 17.2 pt-20 -64.09 -60.03 3.73 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -178.732 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.553 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 5.5 mmm180 -53.76 -52.59 59.72 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -178.737 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.17 -29.23 70.21 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -178.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.88 ' CD2' HD13 ' A' ' 28' ' ' LEU . 0.4 OUTLIER -85.32 -29.88 24.16 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.146 0.498 . . . . 0.0 110.088 179.175 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.38 -32.06 73.5 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 177.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.55 -25.16 72.7 Favored Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 177.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.622 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -77.11 -15.18 59.65 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.572 -0.314 . . . . 0.0 110.588 179.007 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.96 26.48 14.49 Favored Glycine 0 C--N 1.336 0.577 0 C-N-CA 120.959 -0.639 . . . . 0.0 114.28 178.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.88 HD13 ' CD2' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -127.25 161.28 28.94 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 117.889 0.845 . . . . 0.0 112.874 -179.303 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 99.4 m -75.98 116.85 17.1 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.973 179.462 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 2.0 p -111.18 109.31 19.3 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -178.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.885 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.8 t -130.21 138.23 50.46 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 178.477 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.808 HG22 ' HB ' ' A' ' 8' ' ' VAL . 81.5 p -115.32 160.59 19.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.498 0.666 . . . . 0.0 112.652 -178.789 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.874 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 1.4 m-85 -135.84 173.87 11.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.179 -179.24 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.698 ' HG2' ' HG3' ' A' ' 38' ' ' GLU . 0.1 OUTLIER -62.27 -105.45 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.939 -179.028 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.423 ' H ' ' CG ' ' A' ' 34' ' ' GLU . 14.2 m120 -86.45 -71.7 0.53 Allowed 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.319 0.581 . . . . 0.0 111.257 -179.313 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.871 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . -159.76 -40.71 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.222 -0.899 . . . . 0.0 112.548 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.696 ' HA ' HD12 ' A' ' 40' ' ' LEU . 31.7 m-20 -52.46 -30.08 27.97 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.726 0.298 . . . . 0.0 111.173 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.874 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -58.79 -58.0 10.52 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.417 179.526 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.778 HG23 HG13 ' A' ' 9' ' ' VAL . 6.0 t -54.58 -43.49 65.05 Favored 'Isoleucine or valine' 0 C--N 1.341 0.207 0 C-N-CA 120.24 -0.584 . . . . 0.0 111.295 -179.385 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.716 HD13 ' HB3' ' A' ' 68' ' ' GLN . 7.6 mt -53.37 -49.01 68.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.975 0.417 . . . . 0.0 110.564 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.73 -49.89 73.84 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.98 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.77 -28.05 67.28 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.838 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.847 HD13 ' NE2' ' A' ' 73' ' ' HIS . 5.9 mt -69.77 -26.11 64.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.631 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.22 -20.15 10.04 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.562 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 29.6 t -125.61 -0.27 7.47 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -154.3 155.66 35.56 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 120.761 0.315 . . . . 0.0 110.589 179.893 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.431 HG23 HD13 ' A' ' 76' ' ' LEU . 53.2 m -138.54 112.39 8.46 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.011 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.838 ' O ' HD11 ' A' ' 76' ' ' LEU . 59.2 Cg_endo -77.98 161.77 29.62 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.031 1.82 . . . . 0.0 111.511 179.333 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -73.72 -23.76 59.82 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.175 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.687 HG13 HG23 ' A' ' 6' ' ' VAL . 7.8 p -145.35 167.32 9.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.914 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.67 HD11 HG11 ' A' ' 39' ' ' VAL . 11.3 tp -152.84 131.01 11.94 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.003 0.43 . . . . 0.0 111.833 -179.356 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.666 ' O ' HG23 ' A' ' 9' ' ' VAL . 0.4 OUTLIER -113.84 128.21 56.31 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.243 179.695 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.2 m -105.69 134.23 49.15 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.835 0.35 . . . . 0.0 111.262 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.587 ' O ' HG22 ' A' ' 55' ' ' ILE . 16.5 p-10 -72.75 -29.79 63.61 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.683 -179.657 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 1.022 HG12 ' HA3' ' A' ' 62' ' ' GLY . 0.0 OUTLIER 49.08 97.22 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.549 179.572 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 39.8 tpt85 -157.36 57.16 0.51 Allowed 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.315 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.452 ' N ' ' CD ' ' A' ' 58' ' ' PRO . 0.0 OUTLIER 61.21 46.59 1.08 Allowed Pre-proline 0 N--CA 1.47 0.54 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 178.476 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.628 ' CD ' ' HA2' ' A' ' 62' ' ' GLY . 39.0 Cg_endo -70.37 -75.46 0.01 OUTLIER 'Trans proline' 0 CA--C 1.53 0.301 0 C-N-CA 122.458 2.105 . . . . 0.0 111.522 178.51 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -119.19 -21.23 3.8 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.216 -0.516 . . . . 0.0 112.101 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.979 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -159.95 67.78 0.38 Allowed 'General case' 0 C--O 1.236 0.393 0 CA-C-O 120.981 0.419 . . . . 0.0 110.177 179.748 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 72.93 -30.9 0.22 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.309 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 1.022 ' HA3' HG12 ' A' ' 55' ' ' ILE . . . 140.74 -24.2 2.61 Favored Glycine 0 CA--C 1.503 -0.679 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -179.124 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.828 HD23 ' HB2' ' A' ' 90' ' ' ALA . 3.1 mp -74.34 -23.67 59.07 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.631 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.979 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -53.96 -30.01 45.11 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.3 178.739 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.655 HD22 ' HA3' ' A' ' 36' ' ' GLY . 10.4 mt -58.48 -40.47 82.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.198 179.36 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.736 HD23 HG11 ' A' ' 78' ' ' VAL . 28.5 mt -63.51 -42.11 98.49 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.319 179.492 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.755 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 15.9 mttm -52.89 -42.2 65.07 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.152 179.088 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.716 ' HB3' HD13 ' A' ' 40' ' ' LEU . 2.4 mt-30 -71.54 -44.99 63.59 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.911 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.685 HD12 ' HA ' ' A' ' 66' ' ' LEU . 21.8 mt -56.1 -37.35 48.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.197 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.755 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -74.85 -28.17 60.57 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.892 179.885 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.56 -31.78 67.38 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.401 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.5 mtt-85 -91.73 -64.46 1.11 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.331 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.847 ' NE2' HD13 ' A' ' 43' ' ' LEU . 0.4 OUTLIER -125.06 76.22 67.34 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.996 179.718 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.419 ' HB3' ' O ' ' A' ' 70' ' ' LYS . 51.2 Cg_endo -69.59 60.82 1.62 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.528 2.152 . . . . 0.0 112.422 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 33.1 mtt -157.28 -35.45 0.08 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.534 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.838 HD11 ' O ' ' A' ' 48' ' ' PRO . 0.6 OUTLIER -61.52 145.98 90.43 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.877 -179.44 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.607 ' HD2' ' HG ' ' A' ' 76' ' ' LEU . 94.9 Cg_endo -82.88 115.43 2.4 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.739 2.292 . . . . 0.0 112.697 179.674 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.736 HG11 HD23 ' A' ' 66' ' ' LEU . 3.2 t -98.92 139.16 21.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.685 179.404 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.732 ' CG2' HD23 ' A' ' 114' ' ' LEU . 2.0 mp -122.15 112.13 33.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.698 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.752 HD13 ' CE1' ' A' ' 101' ' ' TYR . 2.2 mp -98.32 134.6 36.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.135 0.493 . . . . 0.0 111.279 -179.363 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.58 ' HA ' ' HB2' ' A' ' 102' ' ' LEU . 4.7 ptm -87.23 -9.13 55.89 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -178.201 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.875 ' HB ' HD12 ' A' ' 55' ' ' ILE . 19.0 m -149.02 136.78 20.51 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.642 0.258 . . . . 0.0 111.566 -179.197 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.694 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -123.0 82.27 1.97 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.834 0.35 . . . . 0.0 111.275 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 43.9 m170 -67.34 -166.32 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.574 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.35 80.53 6.78 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.022 0.439 . . . . 0.0 111.91 -179.06 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.68 ' HB3' HD13 ' A' ' 63' ' ' LEU . 27.0 t0 -178.15 28.38 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.945 179.2 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.869 HD13 ' HB3' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -44.99 -23.1 0.12 Allowed 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -179.687 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -47.94 -44.04 29.76 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.514 ' HB3' ' HB2' ' A' ' 63' ' ' LEU . . . -73.38 -22.23 60.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.674 0.273 . . . . 0.0 111.595 -179.505 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.869 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -68.88 -39.66 79.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.972 0.415 . . . . 0.0 110.169 179.291 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.645 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 2.4 t -54.15 -39.93 44.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.207 -179.529 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.544 ' O ' ' HG3' ' A' ' 95' ' ' GLN . 85.5 p -63.09 -19.74 64.71 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.257 0.551 . . . . 0.0 109.745 178.793 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.771 ' O ' ' HG3' ' A' ' 96' ' ' GLN . . . -75.9 -55.43 5.62 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.204 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.645 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 4.4 m-85 -56.82 -33.61 66.91 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.921 -179.509 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.544 ' HG3' ' O ' ' A' ' 92' ' ' SER . 2.1 pp0? -75.46 -28.94 59.47 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.863 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.771 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 0.7 OUTLIER -87.03 -9.1 56.35 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 116.695 -0.23 . . . . 0.0 110.888 178.9 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 121.58 6.7 8.56 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 120.407 -0.902 . . . . 0.0 113.774 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.744 ' HB2' ' HB1' ' A' ' 93' ' ' ALA . . . -55.3 157.38 3.67 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 117.213 0.507 . . . . 0.0 111.466 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.471 ' CZ ' ' HA ' ' A' ' 118' ' ' ALA . 5.2 t80 -86.25 -53.89 4.77 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.584 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 170.19 -162.43 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.876 0.37 . . . . 0.0 111.867 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.752 ' CE1' HD13 ' A' ' 80' ' ' ILE . 2.2 m-85 -134.61 153.26 52.05 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.567 -178.684 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.62 ' CD1' HD22 ' A' ' 114' ' ' LEU . 1.0 OUTLIER -102.65 119.52 55.64 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.168 -179.905 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -65.18 -70.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.474 2.116 . . . . 0.0 112.553 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.682 ' H ' ' HD2' ' A' ' 105' ' ' PRO . 0.5 OUTLIER -123.63 -62.1 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.908 -179.611 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.682 ' HD2' ' H ' ' A' ' 104' ' ' LYS . 9.2 Cg_endo -50.12 163.56 0.57 Allowed 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.314 2.009 . . . . 0.0 112.367 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.594 ' O ' ' O ' ' A' ' 107' ' ' ASP . 58.9 t80 -171.71 -102.44 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.257 179.488 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.594 ' O ' ' O ' ' A' ' 106' ' ' PHE . 3.4 p30 43.14 178.39 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 117.792 0.269 . . . . 0.0 110.865 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.539 HD11 HD23 ' A' ' 19' ' ' LEU . 0.9 OUTLIER -67.91 -43.1 86.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 120.432 -0.507 . . . . 0.0 111.792 -179.738 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.485 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 32.7 t70 -49.62 -58.65 4.84 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.913 -179.31 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.589 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 3.7 mm-40 -74.81 -30.37 61.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.635 0.255 . . . . 0.0 111.6 -179.529 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -68.61 -62.53 1.35 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.279 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.546 ' HA ' HG12 ' A' ' 115' ' ' VAL . 49.0 t -55.96 -31.35 30.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.559 0.695 . . . . 0.0 110.163 178.744 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.485 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -64.38 -46.68 82.29 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.327 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.732 HD23 ' CG2' ' A' ' 79' ' ' ILE . 19.6 tp -76.96 -21.2 55.12 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.996 -179.351 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.546 HG12 ' HA ' ' A' ' 112' ' ' VAL . 4.7 p -79.4 -47.98 21.62 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 C-N-CA 120.401 -0.519 . . . . 0.0 111.715 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.415 ' N ' HG13 ' A' ' 115' ' ' VAL . 79.3 mt-10 -64.38 -41.89 96.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.871 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.451 ' HG2' ' O ' ' A' ' 113' ' ' ALA . 20.1 mmm180 -61.77 -23.71 66.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.768 179.526 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.471 ' HA ' ' CZ ' ' A' ' 99' ' ' PHE . . . -72.02 -49.34 37.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.941 179.382 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.447 HD11 HG11 ' A' ' 50' ' ' VAL . 3.9 mt -71.11 -31.66 45.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.16 0.505 . . . . 0.0 110.696 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.91 -48.63 52.59 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.122 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -57.48 -26.99 62.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.297 -179.625 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -80.36 -55.72 4.7 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.182 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 60.51 173.47 0.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.824 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 69.9 mt-10 . . . . . 0 C--N 1.326 -0.417 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.781 179.853 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.3 ptt? . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 120.836 0.351 . . . . 0.0 111.301 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.687 ' O ' ' HG2' ' A' ' 3' ' ' ARG . 10.9 mt-30 -120.33 -35.4 3.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.044 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.687 ' HG2' ' O ' ' A' ' 2' ' ' GLN . 2.9 ptm180 69.24 -28.14 0.16 Allowed 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.3 0.64 . . . . 0.0 112.672 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.667 ' C ' HD13 ' A' ' 5' ' ' ILE . . . 104.24 91.14 2.2 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.616 179.001 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.684 HD11 ' CG ' ' A' ' 3' ' ' ARG . 5.9 mm -118.73 112.23 37.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.908 0.385 . . . . 0.0 111.188 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.997 HG11 HD13 ' A' ' 23' ' ' LEU . 4.4 p -114.98 117.17 54.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.428 179.38 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.849 ' CD1' HG22 ' A' ' 31' ' ' THR . 25.7 m0 -107.31 133.89 51.19 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.031 0.443 . . . . 0.0 110.442 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.854 HG21 HD23 ' A' ' 19' ' ' LEU . 1.8 t -122.01 148.8 25.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.382 -177.851 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.792 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -126.16 112.0 28.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.991 178.037 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.469 ' OD2' HG21 ' A' ' 15' ' ' ILE . 8.7 t0 -161.42 -161.79 0.83 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.648 -178.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -66.36 -2.22 4.27 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -179.488 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 68.77 -153.23 0.16 Allowed 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 120.566 0.222 . . . . 0.0 110.711 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.462 ' OG ' ' N ' ' A' ' 14' ' ' SER . 62.5 p 33.66 -97.87 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 179.301 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.786 ' O ' HG23 ' A' ' 18' ' ' VAL . 0.3 OUTLIER -52.85 -52.1 58.5 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 111.608 0.225 . . . . 0.0 111.608 -179.417 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.469 HG21 ' OD2' ' A' ' 10' ' ' ASP . 20.1 mm -64.24 -30.56 50.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.866 0.365 . . . . 0.0 111.215 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.686 ' HA ' HG21 ' A' ' 32' ' ' THR . 47.3 ttp180 -72.83 -41.77 64.49 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.961 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.566 ' O ' ' HD2' ' A' ' 21' ' ' ARG . 57.3 t90 -65.11 -53.51 44.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.999 -179.229 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.786 HG23 ' O ' ' A' ' 14' ' ' SER . 2.1 t -60.24 -43.16 92.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -178.462 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.854 HD23 HG21 ' A' ' 8' ' ' VAL . 12.0 tp -82.44 -27.64 31.8 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -177.699 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.646 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 12.2 pt-20 -67.1 -62.3 1.5 Allowed 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 119.917 -0.713 . . . . 0.0 112.062 -178.461 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.733 ' HD2' ' H ' ' A' ' 21' ' ' ARG . 1.3 mpt_? -54.83 -49.16 71.73 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -179.576 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.87 -60.11 3.68 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.52 -179.45 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.057 HD22 HD13 ' A' ' 28' ' ' LEU . 2.6 mt -64.82 -27.36 68.83 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.081 0.467 . . . . 0.0 109.78 179.317 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.34 -34.92 79.26 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.274 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.78 -25.34 71.76 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.302 -0.952 . . . . 0.0 111.225 178.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.735 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -76.8 -15.42 59.74 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 120.681 0.277 . . . . 0.0 111.076 179.426 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.81 26.4 8.53 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.547 -0.835 . . . . 0.0 114.023 178.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 1.057 HD13 HD22 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -125.83 172.45 9.85 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 117.73 0.765 . . . . 0.0 112.158 -179.632 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.5 m -99.01 105.77 17.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.193 179.298 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.685 ' HA ' HG13 ' A' ' 6' ' ' VAL . 11.4 t -100.86 111.31 23.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.066 -179.169 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.849 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.9 t -120.18 156.52 30.94 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.499 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.686 HG21 ' HA ' ' A' ' 16' ' ' ARG . 64.3 p -129.97 161.83 30.04 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.278 0.561 . . . . 0.0 112.04 -179.348 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.792 ' HB2' HG13 ' A' ' 9' ' ' VAL . 3.8 m-85 -129.42 173.99 10.04 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.572 -178.554 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.719 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 2.3 pp20? -60.04 -51.59 68.98 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -177.645 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.502 ' OD1' ' HB3' ' A' ' 58' ' ' PRO . 0.7 OUTLIER -150.59 -71.74 0.17 Allowed 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -178.454 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.615 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . -153.39 -42.41 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.4 -0.905 . . . . 0.0 113.709 -178.684 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.405 ' HA ' ' HG ' ' A' ' 40' ' ' LEU . 1.2 m120 -67.59 -30.77 70.46 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-O 120.852 0.358 . . . . 0.0 111.361 -178.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.767 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -51.87 -59.85 3.85 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.751 179.86 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.785 HG21 HG22 ' A' ' 9' ' ' VAL . 0.8 OUTLIER -55.4 -41.51 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 C-N-CA 119.804 -0.759 . . . . 0.0 110.083 -179.637 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.694 HD13 ' CB ' ' A' ' 68' ' ' GLN . 6.7 mt -53.32 -41.56 65.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.308 0.575 . . . . 0.0 109.845 179.078 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.48 -48.15 76.3 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.711 179.236 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.95 -26.75 63.31 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.894 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 1.053 HD13 ' CE1' ' A' ' 73' ' ' HIS . 1.1 mt -69.94 -22.46 63.18 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.564 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.48 -22.12 11.9 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.981 0.419 . . . . 0.0 110.847 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -130.48 2.45 4.58 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.612 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.68 ' HG2' ' CH2' ' A' ' 7' ' ' TRP . 1.3 tptp -138.05 161.48 36.63 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 121.523 0.678 . . . . 0.0 111.962 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.499 ' H ' ' HG3' ' A' ' 46' ' ' LYS . 51.1 m -139.38 111.25 7.7 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.674 178.06 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.797 ' HG2' HD21 ' A' ' 76' ' ' LEU . 73.2 Cg_endo -80.84 153.31 19.61 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.301 2.001 . . . . 0.0 111.305 179.196 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -74.44 -30.93 62.09 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.057 -179.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.868 HG13 HG23 ' A' ' 6' ' ' VAL . 9.0 p -150.95 103.71 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-O 120.892 0.377 . . . . 0.0 111.534 -179.44 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.703 HD11 HG11 ' A' ' 39' ' ' VAL . 11.1 tp -87.63 131.23 34.5 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -179.14 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.731 ' HB3' HG13 ' A' ' 8' ' ' VAL . 0.4 OUTLIER -115.17 127.42 55.54 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.446 179.524 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.699 ' OG ' HD23 ' A' ' 65' ' ' LEU . 0.6 OUTLIER -108.48 136.55 47.92 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 120.846 0.355 . . . . 0.0 110.972 179.969 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.424 ' O ' ' CG2' ' A' ' 55' ' ' ILE . 25.5 p-10 -79.54 -21.33 45.32 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -178.385 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.604 HG21 HG22 ' A' ' 80' ' ' ILE . 0.7 OUTLIER 44.81 86.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -179.666 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.408 ' O ' ' HG3' ' A' ' 56' ' ' ARG . 4.9 ptt85 -147.83 56.54 1.08 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 120.925 0.393 . . . . 0.0 111.832 179.596 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.475 ' N ' ' HD3' ' A' ' 58' ' ' PRO . 6.0 ttt 62.55 50.26 1.43 Allowed Pre-proline 0 N--CA 1.465 0.315 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 178.851 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.592 ' HD2' ' N ' ' A' ' 62' ' ' GLY . 45.2 Cg_endo -77.09 -77.01 0.01 OUTLIER 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 122.421 2.081 . . . . 0.0 111.749 178.397 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -118.04 -21.15 4.25 Favored Glycine 0 C--N 1.332 0.359 0 N-CA-C 111.798 -0.521 . . . . 0.0 111.798 179.171 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.993 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 5.1 ttt -161.3 67.61 0.3 Allowed 'General case' 0 C--O 1.236 0.351 0 CA-C-O 120.978 0.418 . . . . 0.0 110.415 179.393 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 69.79 -23.07 0.16 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.484 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.592 ' N ' ' HD2' ' A' ' 58' ' ' PRO . . . 136.36 -29.58 2.79 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 -178.811 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.73 HD13 ' HB3' ' A' ' 86' ' ' ASP . 4.1 mp -71.56 -21.93 61.82 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.465 -0.368 . . . . 0.0 110.225 179.285 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.993 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -53.74 -33.48 55.83 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.952 179.054 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.699 HD23 ' OG ' ' A' ' 53' ' ' SER . 6.4 mp -56.99 -48.44 78.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.106 0.479 . . . . 0.0 110.76 179.692 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.96 ' HA ' HD12 ' A' ' 69' ' ' ILE . 4.9 mp -55.69 -40.3 72.18 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.763 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.687 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 0.1 OUTLIER -53.85 -48.07 70.34 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.9 179.286 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.694 ' CB ' HD13 ' A' ' 40' ' ' LEU . 13.1 mm-40 -71.39 -29.88 65.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.698 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.983 HG23 ' CD2' ' A' ' 73' ' ' HIS . 37.6 mt -62.72 -40.76 89.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.665 -179.162 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.687 ' HG2' ' O ' ' A' ' 67' ' ' LYS . 23.9 pttt -74.68 -29.58 61.27 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.475 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -85.88 -38.17 18.36 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -178.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 22.0 mtt-85 -95.33 -27.24 15.56 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -178.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 1.053 ' CE1' HD13 ' A' ' 43' ' ' LEU . 0.2 OUTLIER -107.52 134.85 19.83 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.699 -0.228 . . . . 0.0 111.131 -179.107 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.561 ' O ' ' HG2' ' A' ' 75' ' ' MET . 23.6 Cg_exo -63.66 79.88 0.14 Allowed 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.657 2.238 . . . . 0.0 112.587 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.561 ' HG2' ' O ' ' A' ' 74' ' ' PRO . 0.0 OUTLIER 50.69 43.19 27.93 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 121.558 0.694 . . . . 0.0 110.795 179.742 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.797 HD21 ' HG2' ' A' ' 48' ' ' PRO . 5.8 tp -68.24 137.08 91.47 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.678 -179.742 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.547 ' HD2' ' HG ' ' A' ' 76' ' ' LEU . 47.3 Cg_endo -67.34 125.09 12.92 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.495 2.13 . . . . 0.0 111.951 179.363 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.863 HG22 HG21 ' A' ' 69' ' ' ILE . 3.8 t -110.92 143.53 20.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.09 0.472 . . . . 0.0 111.614 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.564 HG21 HD23 ' A' ' 114' ' ' LEU . 2.3 mp -132.97 113.19 19.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.338 179.2 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.66 HD13 ' HB2' ' A' ' 53' ' ' SER . 13.0 mm -101.22 142.21 16.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.326 -179.211 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.503 ' O ' ' HB3' ' A' ' 102' ' ' LEU . 11.4 ptm -82.79 -21.23 34.64 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -178.66 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.557 ' H ' HG21 ' A' ' 55' ' ' ILE . 3.0 m -147.65 158.05 43.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.637 0.256 . . . . 0.0 111.22 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.851 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -138.53 66.43 1.43 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.571 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 43.6 p-80 -99.24 120.62 39.84 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 120.898 0.38 . . . . 0.0 111.578 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 55.77 165.83 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.752 179.385 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.73 ' HB3' HD13 ' A' ' 63' ' ' LEU . 1.0 OUTLIER 52.89 26.86 4.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.079 -179.817 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.765 HD21 ' HB1' ' A' ' 83' ' ' ALA . 0.1 OUTLIER -54.82 -23.72 19.62 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.352 -179.961 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -50.63 -35.93 32.85 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.829 -179.465 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.599 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -69.56 -23.32 63.55 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.798 0.333 . . . . 0.0 111.447 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.605 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -72.12 -30.63 65.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.209 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.659 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 5.5 t -66.67 -46.72 85.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.365 -179.472 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.6 m -58.12 -37.81 75.3 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.482 0.658 . . . . 0.0 110.093 179.413 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.591 ' HB1' ' HB2' ' A' ' 98' ' ' ALA . . . -56.89 -41.53 78.25 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.319 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.659 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 12.4 m-85 -59.03 -22.31 60.48 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.212 179.279 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.561 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -74.76 -39.76 61.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.518 -179.999 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.561 ' N ' ' HG2' ' A' ' 95' ' ' GLN . 4.8 pt20 -79.18 -11.12 59.97 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.376 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 108.05 32.15 3.37 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.336 -0.935 . . . . 0.0 112.91 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.591 ' HB2' ' HB1' ' A' ' 93' ' ' ALA . . . -61.07 145.76 49.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.756 0.278 . . . . 0.0 110.566 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.619 ' CZ ' ' HB2' ' A' ' 118' ' ' ALA . 9.2 t80 -71.08 -53.87 13.11 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.548 -179.387 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.559 ' OD2' HD11 ' A' ' 114' ' ' LEU . 2.8 p30 166.82 -166.4 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.185 0.517 . . . . 0.0 111.498 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.851 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 4.8 m-85 -133.95 152.42 51.85 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.99 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.503 ' HB3' ' O ' ' A' ' 81' ' ' MET . 1.0 OUTLIER -104.72 119.02 54.94 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.258 179.584 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -67.84 -67.52 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.306 2.004 . . . . 0.0 112.448 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.685 ' H ' ' HD2' ' A' ' 105' ' ' PRO . 4.9 mttt -121.76 -61.95 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.969 -179.424 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.685 ' HD2' ' H ' ' A' ' 104' ' ' LYS . 9.7 Cg_endo -50.29 159.76 1.81 Allowed 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.42 2.08 . . . . 0.0 112.279 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.605 ' O ' ' O ' ' A' ' 107' ' ' ASP . 47.8 t80 -169.74 -105.83 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.414 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.605 ' O ' ' O ' ' A' ' 106' ' ' PHE . 2.7 p30 43.1 175.38 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.033 0.444 . . . . 0.0 111.447 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.455 HG12 ' O ' ' A' ' 18' ' ' VAL . 0.9 OUTLIER -67.62 -41.07 85.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.09 0.472 . . . . 0.0 111.288 179.956 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.511 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 0.3 OUTLIER -50.01 -58.21 5.96 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.596 -179.707 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.587 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 58.4 mm-40 -77.32 -32.05 55.01 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -179.623 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -67.33 -58.44 4.79 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.858 0.361 . . . . 0.0 110.237 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.666 ' O ' HG12 ' A' ' 115' ' ' VAL . 51.8 t -60.89 -32.46 52.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.488 0.661 . . . . 0.0 110.189 179.176 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.511 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -62.07 -44.8 95.9 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.567 0.699 . . . . 0.0 109.911 178.549 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.656 HD12 ' HE ' ' A' ' 117' ' ' ARG . 6.1 tp -74.97 -23.7 58.32 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.588 -179.51 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.666 HG12 ' O ' ' A' ' 112' ' ' VAL . 2.7 p -79.57 -42.75 23.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.832 0.348 . . . . 0.0 111.736 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.448 ' HG3' ' O ' ' A' ' 112' ' ' VAL . 31.6 mt-10 -60.31 -51.92 67.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.298 -179.394 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.656 ' HE ' HD12 ' A' ' 114' ' ' LEU . 0.1 OUTLIER -57.25 -23.88 51.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.852 0.358 . . . . 0.0 110.979 -179.993 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.619 ' HB2' ' CZ ' ' A' ' 99' ' ' PHE . . . -70.39 -45.58 65.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.814 179.483 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.641 HD13 ' CD2' ' A' ' 28' ' ' LEU . 4.7 mt -77.22 -34.11 20.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.464 -179.663 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.9 m -65.18 -47.06 78.29 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.969 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 11.1 m80 -70.54 -29.67 66.21 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.986 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -78.81 -41.3 30.66 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.677 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -75.4 -179.49 4.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.647 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.768 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.8 mmm . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 120.78 0.324 . . . . 0.0 111.255 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.1 mp0 -86.66 155.61 20.33 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.43 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.29 -3.21 16.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.387 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.479 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . 84.89 85.81 0.95 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.79 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.7 mp -101.01 113.11 36.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.933 0.397 . . . . 0.0 111.218 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 1.013 HG11 HD13 ' A' ' 23' ' ' LEU . 5.9 p -105.44 120.18 55.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.281 179.648 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.856 ' CD1' HG22 ' A' ' 31' ' ' THR . 26.3 m0 -112.21 139.8 47.45 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.915 0.388 . . . . 0.0 110.512 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.957 HG11 HD13 ' A' ' 19' ' ' LEU . 0.2 OUTLIER -126.94 148.83 31.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.749 -178.765 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.818 HG23 ' O ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -127.01 114.61 38.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.002 0.429 . . . . 0.0 109.995 179.023 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.982 ' HB3' HG13 ' A' ' 15' ' ' ILE . 9.1 t0 -171.05 -150.24 0.07 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.426 -178.306 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -66.49 -3.37 6.08 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.511 ' O ' ' N ' ' A' ' 16' ' ' ARG . 2.3 t0 69.19 -79.52 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 178.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -40.83 -78.35 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -178.327 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.78 ' O ' HG23 ' A' ' 18' ' ' VAL . 1.7 t -52.61 -32.6 42.44 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.669 -178.766 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.982 HG13 ' HB3' ' A' ' 10' ' ' ASP . 23.2 mm -77.53 -28.69 16.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.892 -179.301 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.61 ' HA ' ' HG3' ' A' ' 20' ' ' GLU . 14.1 ttt180 -58.35 -44.69 88.89 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.307 0.575 . . . . 0.0 110.176 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.734 ' O ' ' HB2' ' A' ' 21' ' ' ARG . 38.4 t90 -71.95 -62.22 1.5 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.766 -179.471 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.78 HG23 ' O ' ' A' ' 14' ' ' SER . 0.5 OUTLIER -59.17 -60.89 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 -177.056 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.957 HD13 HG11 ' A' ' 8' ' ' VAL . 13.9 mt -70.67 -51.49 27.42 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -175.709 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.61 ' HG3' ' HA ' ' A' ' 16' ' ' ARG . 5.1 mt-10 -67.62 -61.66 1.79 Allowed 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -178.316 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.734 ' HB2' ' O ' ' A' ' 17' ' ' TRP . 0.0 OUTLIER -49.99 -44.45 50.97 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.058 -178.202 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.82 -37.37 76.2 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.672 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.013 HD13 HG11 ' A' ' 6' ' ' VAL . 3.0 mt -75.22 -27.1 59.42 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 178.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.409 ' N ' ' O ' ' A' ' 20' ' ' GLU . . . -63.72 -35.65 81.28 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.728 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.94 -26.2 69.97 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.171 -1.014 . . . . 0.0 110.993 178.143 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.764 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -76.85 -15.53 59.68 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 120.565 0.221 . . . . 0.0 110.923 179.345 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.13 26.71 9.97 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 120.636 -0.792 . . . . 0.0 113.955 179.013 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 1.001 HD13 HD22 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -123.72 168.87 12.12 Favored 'General case' 0 N--CA 1.456 -0.125 0 CA-C-N 117.707 0.754 . . . . 0.0 111.788 -179.983 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 58.2 m -96.44 113.52 25.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.918 179.302 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.682 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 3.1 t -112.05 117.51 32.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.093 0.473 . . . . 0.0 112.195 -179.344 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.856 HG22 ' CD1' ' A' ' 7' ' ' TRP . 3.3 t -123.57 139.85 53.59 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.169 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.487 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 76.8 p -112.5 161.42 16.76 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.129 0.49 . . . . 0.0 111.388 -178.674 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.775 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 3.7 m-85 -131.28 174.08 10.41 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.806 -177.6 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.728 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 3.2 pp20? -63.19 -39.04 93.5 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -177.219 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -164.2 -57.61 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.301 0 C-N-CA 119.755 -0.778 . . . . 0.0 113.049 -178.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.816 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . -169.07 -44.42 0.03 OUTLIER Glycine 0 C--N 1.318 -0.471 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.64 -178.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.503 ' N ' HD21 ' A' ' 65' ' ' LEU . 2.2 t30 -64.88 -30.43 71.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.995 0.426 . . . . 0.0 110.96 -179.329 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.775 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -54.34 -52.84 60.29 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.551 -179.945 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.772 HG12 ' CD1' ' A' ' 43' ' ' LEU . 11.5 t -48.76 -38.77 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-O 121.017 0.437 . . . . 0.0 111.1 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.811 HD21 ' CD1' ' A' ' 65' ' ' LEU . 15.9 mt -61.82 -42.14 98.65 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.564 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.41 -49.45 73.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.19 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.86 -31.86 66.89 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.542 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.867 HD13 ' CE1' ' A' ' 73' ' ' HIS . 5.7 mt -59.88 -24.02 63.93 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.297 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.36 -19.32 34.53 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.439 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.5 t -121.52 0.88 10.03 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.557 ' O ' HD23 ' A' ' 43' ' ' LEU . 3.6 tttt -165.37 164.39 19.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.944 0.402 . . . . 0.0 111.367 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.523 ' HA ' HD23 ' A' ' 43' ' ' LEU . 85.9 m -138.79 116.83 9.09 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.948 179.545 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.741 ' HD2' HD21 ' A' ' 43' ' ' LEU . 40.0 Cg_endo -74.82 156.06 43.8 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 121.796 1.664 . . . . 0.0 111.466 179.25 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -74.05 -30.84 62.6 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.079 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.689 ' O ' HG13 ' A' ' 50' ' ' VAL . 14.9 p -149.49 106.27 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 CA-C-O 120.737 0.303 . . . . 0.0 111.699 -179.441 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.709 ' O ' HD12 ' A' ' 79' ' ' ILE . 20.5 tp -87.07 155.32 20.19 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.937 0.399 . . . . 0.0 111.201 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.818 ' O ' HG23 ' A' ' 9' ' ' VAL . 2.4 tt -137.16 119.6 15.85 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.197 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.528 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 0.6 OUTLIER -111.86 128.44 56.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.781 0.324 . . . . 0.0 111.378 -179.662 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.06 -2.9 56.55 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.514 HD11 ' CE1' ' A' ' 84' ' ' HIS . 3.0 tt 41.97 91.13 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-O 120.805 0.336 . . . . 0.0 111.698 179.409 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.4 ttt85 -117.56 40.17 3.14 Favored 'General case' 0 N--CA 1.461 0.111 0 N-CA-C 111.96 0.355 . . . . 0.0 111.96 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.624 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER 56.81 44.11 1.3 Allowed Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 179.042 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.478 ' CD ' ' N ' ' A' ' 57' ' ' MET . 30.1 Cg_endo -63.29 -80.81 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 121.959 1.773 . . . . 0.0 111.02 178.704 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -102.42 -86.6 1.95 Allowed Glycine 0 C--N 1.334 0.43 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 178.237 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.802 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -87.82 60.97 6.18 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 177.228 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.624 ' HA ' ' HA ' ' A' ' 57' ' ' MET . 0.1 OUTLIER 65.57 -28.2 0.11 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.65 -1.159 . . . . 0.0 112.447 -179.494 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.533 ' H ' ' C ' ' A' ' 60' ' ' MET . . . 152.15 -35.19 0.84 Allowed Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 110.946 -0.861 . . . . 0.0 110.946 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.586 ' H ' HD12 ' A' ' 63' ' ' LEU . 1.0 OUTLIER -64.07 -21.43 66.52 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 178.878 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.802 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -53.56 -38.43 63.86 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 120.969 0.414 . . . . 0.0 110.389 179.627 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.811 ' CD1' HD21 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -55.03 -44.99 75.14 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.781 179.836 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.851 ' HA ' HD12 ' A' ' 69' ' ' ILE . 5.8 mt -54.5 -42.5 70.85 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.503 179.539 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.637 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 21.6 tttt -57.77 -43.47 85.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.704 179.451 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 8.2 mm100 -69.51 -27.78 65.47 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.851 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.851 HD12 ' HA ' ' A' ' 66' ' ' LEU . 96.7 mt -64.58 -36.85 78.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.96 -179.083 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.637 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -78.15 -31.62 49.84 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.512 -179.52 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -63.72 -44.53 93.32 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.076 -178.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.2 mtt85 -96.42 -50.93 4.56 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.857 -179.077 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.867 ' CE1' HD13 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -95.77 156.38 37.4 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.834 -179.326 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -66.28 -73.29 0.02 OUTLIER 'Trans proline' 0 CA--C 1.528 0.209 0 C-N-CA 122.538 2.159 . . . . 0.0 112.682 -179.405 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 7.3 mtt -145.16 55.52 1.22 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.7 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.455 HD13 HG23 ' A' ' 47' ' ' THR . 22.5 tp -61.9 111.21 4.11 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.111 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -60.35 134.25 54.2 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.379 2.053 . . . . 0.0 112.387 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.791 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 5.1 t -131.43 152.93 38.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.25 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.709 HD12 ' O ' ' A' ' 51' ' ' LEU . 1.1 mt -126.8 113.2 31.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.721 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.528 ' HA ' ' O ' ' A' ' 53' ' ' SER . 9.5 mm -101.86 134.9 41.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -178.051 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.557 ' HB2' ' CD1' ' A' ' 106' ' ' PHE . 2.4 ptt? -69.16 -34.01 74.3 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.271 -0.877 . . . . 0.0 112.216 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 7.3 m -139.16 150.72 45.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.752 0.311 . . . . 0.0 111.348 -179.605 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.916 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -121.06 70.58 0.92 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.731 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.514 ' CE1' HD11 ' A' ' 55' ' ' ILE . 2.6 p80 -98.94 -179.27 4.22 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.193 179.174 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.4 ' HB2' ' CB ' ' A' ' 61' ' ' ASP . 0.1 OUTLIER 63.99 -161.42 0.29 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.769 -179.892 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.41 88.74 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.924 0.392 . . . . 0.0 111.377 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.859 HD21 ' HB1' ' A' ' 83' ' ' ALA . 0.3 OUTLIER -51.85 -24.0 5.56 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.465 179.804 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -48.84 -36.36 16.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.008 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.429 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -72.84 -19.84 61.24 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.219 -179.608 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.747 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -68.93 -52.37 29.97 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.984 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.62 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 9.4 t -66.33 -44.94 90.72 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.19 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.845 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.685 ' O ' ' HG3' ' A' ' 95' ' ' GLN . 3.3 m -61.08 -14.54 24.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.889 0.376 . . . . 0.0 110.035 178.739 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.699 ' HB2' HD13 ' A' ' 66' ' ' LEU . . . -75.15 -61.74 1.79 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.113 0.482 . . . . 0.0 111.066 179.545 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.66 ' N ' ' HB3' ' A' ' 98' ' ' ALA . 4.7 m-85 -44.84 -36.14 3.12 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.384 -178.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.685 ' HG3' ' O ' ' A' ' 92' ' ' SER . 1.7 pp0? -76.25 -37.01 58.21 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.959 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.526 ' HB2' ' HB3' ' A' ' 70' ' ' LYS . 10.3 pt20 -100.12 11.19 39.93 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -179.318 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 93' ' ' ALA . . . 122.21 79.0 0.48 Allowed Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.187 -1.006 . . . . 0.0 113.449 179.598 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.791 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -169.14 142.49 2.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.731 0.301 . . . . 0.0 110.637 178.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.502 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 3.3 t80 -84.49 -53.15 5.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.585 -178.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.591 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 0.4 OUTLIER 178.83 -165.58 0.05 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.139 0.495 . . . . 0.0 111.61 179.984 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.916 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 3.5 m-85 -136.38 153.73 51.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.458 -179.209 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.531 ' HG ' ' HB3' ' A' ' 106' ' ' PHE . 0.4 OUTLIER -101.9 118.85 58.5 Favored Pre-proline 0 C--N 1.327 -0.372 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 179.059 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.417 ' C ' ' HG3' ' A' ' 104' ' ' LYS . 61.5 Cg_exo -51.28 -42.49 53.97 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.58 2.187 . . . . 0.0 112.466 -179.211 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.642 ' HB2' ' HD3' ' A' ' 105' ' ' PRO . 40.3 mttp -156.07 -54.11 0.02 OUTLIER Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.173 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.642 ' HD3' ' HB2' ' A' ' 104' ' ' LYS . 98.1 Cg_endo -80.97 163.78 20.31 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.262 1.975 . . . . 0.0 112.229 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.677 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 0.5 OUTLIER -169.89 -75.88 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.487 178.928 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.554 ' O ' ' HB3' ' A' ' 111' ' ' ALA . 3.1 p30 37.32 -166.49 0.0 OUTLIER 'General case' 0 C--O 1.225 -0.189 0 CA-C-N 116.682 -0.235 . . . . 0.0 110.41 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.842 HD11 ' HG ' ' A' ' 19' ' ' LEU . 1.1 mp -67.85 -44.8 85.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 C-N-CA 120.11 -0.636 . . . . 0.0 111.366 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.521 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 2.6 m-20 -53.58 -58.06 8.52 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.666 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.677 ' HB2' ' HA ' ' A' ' 106' ' ' PHE . 3.1 mm-40 -79.2 -28.04 42.58 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -178.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.583 ' HB1' HD11 ' A' ' 52' ' ' LEU . . . -78.31 -55.09 5.52 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.349 -0.541 . . . . 0.0 110.084 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.783 ' O ' HG12 ' A' ' 115' ' ' VAL . 60.4 t -58.57 -29.51 39.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-O 121.549 0.69 . . . . 0.0 109.881 178.311 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.521 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -64.82 -47.97 76.09 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.718 178.84 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.605 HD23 ' CG2' ' A' ' 79' ' ' ILE . 10.6 tp -73.83 -20.66 60.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.455 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.783 HG12 ' O ' ' A' ' 112' ' ' VAL . 2.6 p -78.52 -43.42 26.27 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-O 120.735 0.302 . . . . 0.0 111.526 -179.566 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.48 ' HA ' HD12 ' A' ' 119' ' ' ILE . 35.7 mt-10 -66.2 -41.92 89.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.209 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.505 HH11 HD12 ' A' ' 114' ' ' LEU . 28.4 mtp-105 -61.18 -25.64 67.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.646 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.523 ' HB3' HG21 ' A' ' 50' ' ' VAL . . . -73.01 -40.44 65.18 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.305 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.48 HD12 ' HA ' ' A' ' 116' ' ' GLU . 3.8 mt -75.42 -30.51 22.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 121.125 0.488 . . . . 0.0 110.658 179.117 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 91.5 p -67.35 -43.32 81.78 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.567 -179.09 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 17.8 m80 -66.76 -23.76 66.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.006 0.431 . . . . 0.0 110.943 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -77.88 -50.59 11.95 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.734 179.582 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.551 ' HG3' ' HG2' ' A' ' 124' ' ' GLU . 12.4 pt20 -75.9 -173.59 2.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.89 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.551 ' HG2' ' HG3' ' A' ' 123' ' ' GLN . 6.9 mm-40 . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.859 -179.615 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 120.92 0.39 . . . . 0.0 111.22 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -120.98 161.39 21.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.546 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.23 -4.97 19.88 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.475 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 90.27 81.57 1.37 Allowed Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.942 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.6 mp -103.3 112.32 36.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.96 0.41 . . . . 0.0 111.26 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.852 HG21 HD21 ' A' ' 23' ' ' LEU . 4.3 p -106.92 126.64 62.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.1 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.919 ' CD1' HG22 ' A' ' 31' ' ' THR . 40.6 m0 -112.82 136.46 52.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.896 0.379 . . . . 0.0 110.444 179.512 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.681 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.1 OUTLIER -125.95 138.81 53.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.336 -178.658 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.952 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -115.6 105.59 18.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.988 0.423 . . . . 0.0 110.217 178.58 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.681 ' HB3' HG21 ' A' ' 15' ' ' ILE . 10.2 t0 -173.09 117.12 0.29 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.226 -179.577 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.599 ' O ' ' HB2' ' A' ' 12' ' ' ASP . 0.1 OUTLIER 47.67 -86.4 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.787 179.826 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.599 ' HB2' ' O ' ' A' ' 11' ' ' ASP . 15.4 t0 170.91 -133.31 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.676 -0.238 . . . . 0.0 110.824 -179.57 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.437 ' HA ' ' HB3' ' A' ' 16' ' ' ARG . 75.0 m -40.89 -42.03 1.74 Allowed 'General case' 0 C--N 1.341 0.234 0 CA-C-O 121.072 0.463 . . . . 0.0 112.117 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.602 ' O ' HG23 ' A' ' 18' ' ' VAL . 27.6 m -53.18 -63.51 1.12 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.675 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.681 HG21 ' HB3' ' A' ' 10' ' ' ASP . 15.1 mm -70.46 -20.61 22.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.871 0.367 . . . . 0.0 110.667 179.488 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.709 ' HA ' HG21 ' A' ' 32' ' ' THR . 3.4 ttt180 -69.77 -55.56 9.53 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.846 179.282 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.505 ' O ' ' HG3' ' A' ' 20' ' ' GLU . 89.6 t90 -53.58 -45.09 69.84 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.708 -179.674 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.852 HG12 HG12 ' A' ' 108' ' ' ILE . 3.1 t -65.58 -45.13 93.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -178.806 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.52 HD13 ' O ' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -83.66 -26.93 29.45 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -177.786 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.505 ' HG3' ' O ' ' A' ' 17' ' ' TRP . 1.0 OUTLIER -66.61 -60.92 2.28 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -179.063 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.577 ' O ' ' HB3' ' A' ' 24' ' ' ALA . 31.1 mmm-85 -52.77 -63.21 1.22 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.734 0.302 . . . . 0.0 111.802 -179.623 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -49.75 -54.69 17.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.046 0.45 . . . . 0.0 111.554 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.852 HD21 HG21 ' A' ' 6' ' ' VAL . 9.3 tp -66.36 -19.43 65.8 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.183 179.316 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.577 ' HB3' ' O ' ' A' ' 21' ' ' ARG . . . -70.32 -35.85 73.91 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.13 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -57.59 -27.83 59.09 Favored Glycine 0 C--N 1.335 0.527 0 C-N-CA 120.51 -0.852 . . . . 0.0 111.035 178.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.746 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -77.98 -15.8 58.66 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 120.716 0.293 . . . . 0.0 110.495 178.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.94 26.61 14.17 Favored Glycine 0 C--N 1.337 0.609 0 C-N-CA 120.637 -0.792 . . . . 0.0 114.501 178.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.799 HD13 ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -116.06 164.94 13.71 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 118.32 1.06 . . . . 0.0 112.23 -179.779 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 27.0 m -94.4 118.56 31.81 Favored 'General case' 0 CA--C 1.521 -0.149 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.484 179.053 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.552 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 3.0 m -108.46 118.61 37.23 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -178.323 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.919 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.7 t -122.79 139.76 53.65 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.047 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.709 HG21 ' HA ' ' A' ' 16' ' ' ARG . 69.0 p -115.01 161.63 18.08 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -177.496 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.952 ' HB2' HG13 ' A' ' 9' ' ' VAL . 12.1 m-85 -136.27 174.88 10.13 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 114.868 -1.06 . . . . 0.0 111.834 -178.316 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.422 ' HG2' ' H ' ' A' ' 35' ' ' ASN . 3.6 pt-20 -62.0 -46.94 87.02 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -177.382 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.422 ' H ' ' HG2' ' A' ' 34' ' ' GLU . 0.5 OUTLIER -168.41 -27.97 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 118.58 0.627 . . . . 0.0 112.687 -179.573 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.7 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . 171.91 -59.66 0.16 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.402 -0.904 . . . . 0.0 112.754 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.587 ' HA ' HD12 ' A' ' 40' ' ' LEU . 51.6 m-20 -48.1 -34.52 9.86 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 120.845 0.355 . . . . 0.0 110.979 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.913 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 5.2 tt0 -60.25 -55.65 31.12 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.382 179.082 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.919 HG11 HD11 ' A' ' 51' ' ' LEU . 6.2 t -53.93 -44.22 60.56 Favored 'Isoleucine or valine' 0 C--N 1.345 0.401 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.459 179.126 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.826 HD13 ' CB ' ' A' ' 68' ' ' GLN . 21.0 mt -57.51 -42.68 83.27 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.877 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.53 -50.13 40.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.075 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.55 -27.58 69.35 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.639 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.747 HD13 ' NE2' ' A' ' 73' ' ' HIS . 6.1 mt -67.71 -23.53 65.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.556 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.39 -16.71 15.83 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.182 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -117.43 -3.39 11.4 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.824 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.501 ' O ' HD23 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -167.33 163.06 15.16 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.984 0.421 . . . . 0.0 111.73 -179.917 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.979 HG23 HD12 ' A' ' 76' ' ' LEU . 66.3 m -139.11 112.47 8.08 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.522 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.713 ' HD2' HD21 ' A' ' 43' ' ' LEU . 66.6 Cg_endo -72.52 165.49 32.56 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.179 1.92 . . . . 0.0 111.548 178.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -74.09 -24.34 59.47 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 121.132 -0.227 . . . . 0.0 111.26 -179.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.832 HG13 HG23 ' A' ' 6' ' ' VAL . 7.2 p -145.15 166.45 11.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.919 HD11 HG11 ' A' ' 39' ' ' VAL . 19.6 tp -152.91 132.55 13.07 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 121.06 0.457 . . . . 0.0 111.368 -179.036 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.741 ' O ' HG23 ' A' ' 9' ' ' VAL . 0.9 OUTLIER -116.52 139.33 50.6 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.795 -179.878 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.555 ' HB2' HD13 ' A' ' 80' ' ' ILE . 8.1 m -127.1 128.44 46.23 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.978 0.418 . . . . 0.0 111.384 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.402 ' C ' HG22 ' A' ' 55' ' ' ILE . 44.6 t0 -69.48 -16.65 63.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.587 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.706 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 2.5 tt 43.79 72.58 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.109 -0.496 . . . . 0.0 112.262 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 177.46 61.82 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.695 179.245 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.61 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -162.0 -64.25 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.698 179.964 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.61 ' HD3' ' HB3' ' A' ' 57' ' ' MET . 36.4 Cg_endo -63.02 -165.6 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.694 2.263 . . . . 0.0 113.228 -179.496 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.79 -67.32 2.13 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.656 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.734 ' HB2' ' HB2' ' A' ' 64' ' ' ALA . 0.2 OUTLIER -79.95 51.23 1.31 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.941 0.4 . . . . 0.0 110.762 179.809 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.462 ' O ' ' HD2' ' A' ' 58' ' ' PRO . 0.1 OUTLIER 54.42 -74.56 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.407 179.643 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.706 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -144.14 -34.84 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.456 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.687 ' CB ' ' HB3' ' A' ' 89' ' ' ALA . 0.5 OUTLIER -54.05 -23.55 14.07 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.654 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.734 ' HB2' ' HB2' ' A' ' 60' ' ' MET . . . -54.22 -36.48 63.54 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.795 178.183 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.538 ' CD1' ' HG3' ' A' ' 58' ' ' PRO . 9.9 mp -59.47 -55.54 33.34 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.306 179.29 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.9 ' HA ' HD12 ' A' ' 69' ' ' ILE . 17.0 mt -44.24 -42.53 6.63 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.666 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.501 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 11.3 mttp -57.93 -47.19 83.59 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.037 179.159 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.826 ' CB ' HD13 ' A' ' 40' ' ' LEU . 10.6 mm100 -68.02 -30.33 69.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.375 179.444 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.9 HD12 ' HA ' ' A' ' 66' ' ' LEU . 77.9 mt -65.21 -45.11 94.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.222 -179.715 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.501 ' HG2' ' O ' ' A' ' 67' ' ' LYS . 8.9 ptmt -64.81 -29.31 70.27 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.961 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -72.72 -36.51 67.8 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.093 0.473 . . . . 0.0 110.928 179.585 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.44 -70.96 0.7 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.556 -179.616 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.747 ' NE2' HD13 ' A' ' 43' ' ' LEU . 2.2 p80 -117.83 78.0 12.11 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.59 -179.197 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.494 ' HA ' ' OE1' ' A' ' 96' ' ' GLN . 72.4 Cg_endo -76.46 56.27 5.02 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.536 2.157 . . . . 0.0 112.563 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 38.2 mtt -154.8 -43.02 0.09 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.093 0.473 . . . . 0.0 111.457 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.979 HD12 HG23 ' A' ' 47' ' ' THR . 1.0 OUTLIER -53.08 125.11 40.2 Favored Pre-proline 0 C--N 1.32 -0.679 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.614 -179.941 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.632 ' HD2' HD23 ' A' ' 76' ' ' LEU . 24.8 Cg_exo -61.82 129.65 28.37 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.428 2.085 . . . . 0.0 112.871 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.576 HG11 ' CD2' ' A' ' 66' ' ' LEU . 5.2 t -110.2 138.87 36.1 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.78 179.157 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.74 ' CG2' HD23 ' A' ' 114' ' ' LEU . 1.7 mt -123.8 113.2 36.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.545 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.585 HG22 HG21 ' A' ' 55' ' ' ILE . 15.1 mm -101.08 145.87 10.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.299 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.597 ' HG3' ' CG2' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -80.5 -30.11 37.33 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.242 -0.435 . . . . 0.0 112.029 -179.038 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.538 ' O ' HD13 ' A' ' 55' ' ' ILE . 4.8 m -147.44 146.48 29.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.836 0.35 . . . . 0.0 111.354 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.828 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -112.67 47.94 1.05 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.351 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.407 ' O ' ' HB2' ' A' ' 85' ' ' SER . 0.7 OUTLIER -98.49 -175.19 3.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.721 0.296 . . . . 0.0 110.743 179.816 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.407 ' HB2' ' O ' ' A' ' 84' ' ' HIS . 45.9 m 71.6 -78.39 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.793 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.567 ' O ' HD22 ' A' ' 63' ' ' LEU . 7.6 m-20 -138.99 68.1 1.38 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.64 0.257 . . . . 0.0 111.633 -179.327 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.723 ' HG ' ' HB1' ' A' ' 83' ' ' ALA . 0.4 OUTLIER -45.69 -23.82 0.29 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.898 179.467 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -48.54 -46.13 38.42 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -179.232 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.687 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -65.07 -20.04 66.29 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.809 0.338 . . . . 0.0 111.622 -179.379 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.571 ' HB2' HD23 ' A' ' 63' ' ' LEU . . . -68.84 -36.11 77.77 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.055 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.651 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 8.2 t -63.07 -41.2 91.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.063 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 44.5 m -63.31 -35.26 79.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.224 0.535 . . . . 0.0 110.306 179.255 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.805 ' HB2' HD13 ' A' ' 66' ' ' LEU . . . -57.78 -39.57 77.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.998 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.651 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 10.7 m-85 -63.24 -20.95 65.9 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.379 179.249 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.621 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -74.23 -41.37 61.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.723 -179.808 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.621 ' N ' ' HG2' ' A' ' 95' ' ' GLN . 1.0 OUTLIER -78.59 -18.47 54.53 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.494 -179.332 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 122.01 29.47 1.36 Allowed Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.789 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.605 ' HB2' ' HB1' ' A' ' 93' ' ' ALA . . . -64.1 143.32 57.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.762 0.281 . . . . 0.0 110.809 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.55 ' CE2' ' HB2' ' A' ' 118' ' ' ALA . 18.9 t80 -71.49 -53.96 12.19 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.249 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 168.21 -164.96 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.16 0.505 . . . . 0.0 111.124 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.828 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 3.3 m-85 -130.67 150.96 51.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.259 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.961 HD13 HD22 ' A' ' 114' ' ' LEU . 5.6 tp -102.87 135.56 19.42 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.986 -179.427 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.411 ' HG2' ' HG2' ' A' ' 105' ' ' PRO . 93.7 Cg_endo -78.96 -152.87 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.426 2.084 . . . . 0.0 111.904 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.515 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 5.7 mtpt -43.05 -56.55 6.2 Favored Pre-proline 0 CA--C 1.533 0.322 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.515 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 13.2 Cg_endo -56.71 163.39 7.21 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.565 2.177 . . . . 0.0 112.282 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.6 ' HD1' HD23 ' A' ' 102' ' ' LEU . 45.5 t80 -171.92 -105.03 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.892 179.758 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.521 ' O ' ' O ' ' A' ' 106' ' ' PHE . 4.6 p-10 43.75 -179.08 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.98 0.419 . . . . 0.0 111.039 -179.421 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.852 HG12 HG12 ' A' ' 18' ' ' VAL . 0.9 OUTLIER -67.84 -41.13 84.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 120.969 0.414 . . . . 0.0 111.533 -179.852 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.524 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 12.7 t70 -50.6 -58.56 5.54 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.623 -179.496 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.591 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 36.3 mm-40 -77.1 -30.89 55.51 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.663 0.268 . . . . 0.0 111.64 -179.447 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.403 ' CB ' ' O ' ' A' ' 107' ' ' ASP . . . -68.46 -61.13 1.97 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.018 0.437 . . . . 0.0 110.283 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.613 ' O ' HG12 ' A' ' 115' ' ' VAL . 58.1 t -57.63 -30.51 37.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.587 0.708 . . . . 0.0 110.25 178.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.524 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -63.86 -46.33 85.48 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.191 179.207 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.961 HD22 HD13 ' A' ' 102' ' ' LEU . 35.6 tp -74.66 -22.87 58.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.085 -179.316 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.613 HG12 ' O ' ' A' ' 112' ' ' VAL . 4.8 p -79.39 -46.44 23.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 120.442 -0.503 . . . . 0.0 111.639 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.412 ' N ' HG13 ' A' ' 115' ' ' VAL . 8.6 mt-10 -63.82 -45.29 90.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.963 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.577 ' HG2' ' HA ' ' A' ' 114' ' ' LEU . 0.0 OUTLIER -59.09 -27.06 65.19 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.956 0.408 . . . . 0.0 110.796 179.741 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.55 ' HB2' ' CE2' ' A' ' 99' ' ' PHE . . . -67.93 -47.64 68.17 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.629 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.671 HD13 ' CD2' ' A' ' 28' ' ' LEU . 4.5 mt -74.15 -31.17 28.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.819 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.0 t -69.64 -42.05 74.77 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.974 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -65.78 -22.81 66.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.976 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.439 ' OH ' ' HG3' ' A' ' 77' ' ' PRO . 5.4 m-85 -73.74 -48.24 33.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.89 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.404 ' H ' ' HG3' ' A' ' 123' ' ' GLN . 0.0 OUTLIER -75.39 -53.74 8.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.119 0.485 . . . . 0.0 110.527 179.911 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 . . . . . 0 C--N 1.319 -0.745 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.872 179.695 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.861 0.362 . . . . 0.0 111.174 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -58.71 174.52 0.33 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.047 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.05 -43.91 90.77 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.225 0.536 . . . . 0.0 110.764 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.524 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . 61.74 87.99 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.507 -0.769 . . . . 0.0 112.49 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.7 mp -111.0 112.34 40.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.848 0.356 . . . . 0.0 111.514 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.859 HG11 HD22 ' A' ' 23' ' ' LEU . 2.8 p -107.83 126.21 64.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.309 178.734 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.879 ' CD1' HG22 ' A' ' 31' ' ' THR . 27.2 m0 -114.11 140.21 48.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.846 0.355 . . . . 0.0 110.181 179.17 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.673 HG13 ' HB3' ' A' ' 52' ' ' LEU . 1.1 t -123.73 147.71 28.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.36 -178.378 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.773 HG13 HG23 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -130.93 112.03 21.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.094 0.473 . . . . 0.0 110.446 179.146 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -161.64 -158.64 0.57 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.711 -178.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -66.87 -1.85 4.47 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.349 0.499 . . . . 0.0 112.349 -179.464 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.424 ' O ' ' N ' ' A' ' 14' ' ' SER . 0.2 OUTLIER 69.43 -157.97 0.16 Allowed 'General case' 0 CA--C 1.532 0.254 0 O-C-N 122.443 -0.16 . . . . 0.0 110.875 179.912 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.6 t 34.06 -88.96 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 179.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.882 ' O ' HG23 ' A' ' 18' ' ' VAL . 3.6 m -53.02 -63.38 1.16 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.809 0.338 . . . . 0.0 111.216 -179.701 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.8 mm -61.46 -25.67 37.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.984 0.421 . . . . 0.0 110.89 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.971 ' HA ' HG21 ' A' ' 32' ' ' THR . 30.8 ttt180 -71.42 -55.64 7.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.591 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.445 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 30.1 t90 -58.63 -41.1 85.17 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -179.193 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.895 HG12 HG12 ' A' ' 108' ' ' ILE . 2.5 t -65.26 -49.12 80.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -178.297 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.621 HD23 HG11 ' A' ' 8' ' ' VAL . 9.7 tp -82.64 -24.79 33.63 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -178.348 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.555 ' HG3' ' N ' ' A' ' 21' ' ' ARG . 10.7 pt-20 -65.75 -57.6 7.63 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.721 -179.368 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.555 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 1.2 mmt-85 -67.12 -48.99 66.44 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.063 -179.192 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.11 -40.57 81.54 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -178.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.904 ' CD2' HD13 ' A' ' 28' ' ' LEU . 0.2 OUTLIER -77.37 -25.13 50.68 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.225 0.536 . . . . 0.0 110.053 179.217 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.03 -34.24 77.63 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.97 -23.61 71.21 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 177.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.624 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -76.71 -15.4 59.79 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 120.87 0.366 . . . . 0.0 110.471 179.032 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.87 26.27 11.86 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 120.945 -0.645 . . . . 0.0 113.815 178.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.904 HD13 ' CD2' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -132.78 169.09 17.22 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 117.534 0.667 . . . . 0.0 112.384 -179.371 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 32.9 m -89.84 109.1 20.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.75 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.585 ' HA ' HG13 ' A' ' 6' ' ' VAL . 47.3 t -107.48 110.55 22.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.076 0.465 . . . . 0.0 111.585 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.879 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.7 t -118.96 153.45 34.61 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.971 HG21 ' HA ' ' A' ' 16' ' ' ARG . 34.5 p -125.35 162.79 24.0 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.301 0.572 . . . . 0.0 111.945 -179.259 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.732 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 1.1 m-85 -129.3 174.22 9.8 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.431 -178.264 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.46 ' HG2' ' N ' ' A' ' 35' ' ' ASN . 0.6 OUTLIER -61.6 -37.14 82.81 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 -177.299 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.46 ' N ' ' HG2' ' A' ' 34' ' ' GLU . 5.1 m120 -169.85 -56.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 118.443 0.565 . . . . 0.0 112.133 -179.474 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.947 ' CA ' HD21 ' A' ' 65' ' ' LEU . . . -164.7 -58.53 0.02 OUTLIER Glycine 0 C--N 1.318 -0.432 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.951 -179.175 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.429 ' HA ' ' CD1' ' A' ' 40' ' ' LEU . 1.0 OUTLIER -48.79 -34.98 13.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.687 0.28 . . . . 0.0 111.742 -179.456 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.732 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -55.33 -54.05 48.4 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.509 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.834 HG12 ' CD1' ' A' ' 43' ' ' LEU . 39.0 t -58.65 -42.53 85.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.569 179.436 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.785 HD13 ' CB ' ' A' ' 68' ' ' GLN . 4.0 mt -51.24 -45.47 62.01 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.794 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.64 -47.31 40.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.301 0.572 . . . . 0.0 110.867 179.354 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.81 -31.04 70.45 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.132 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.834 ' CD1' HG12 ' A' ' 39' ' ' VAL . 11.7 mt -68.68 -20.67 64.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.763 -179.553 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.77 -18.4 12.55 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.511 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.7 t -122.69 -0.46 9.13 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.326 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.688 ' O ' HD23 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -164.22 157.15 17.56 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.064 0.459 . . . . 0.0 111.603 179.918 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.773 ' CG2' HD13 ' A' ' 76' ' ' LEU . 96.2 m -139.03 115.99 8.72 Favored Pre-proline 0 N--CA 1.45 -0.433 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.143 179.543 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.659 ' HG3' ' HB2' ' A' ' 7' ' ' TRP . 58.5 Cg_endo -72.24 165.08 33.68 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.267 1.978 . . . . 0.0 111.167 178.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -75.28 -27.09 59.23 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.966 -0.294 . . . . 0.0 111.267 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.703 HG11 HG22 ' A' ' 115' ' ' VAL . 7.2 p -148.79 104.9 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.553 -179.494 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.619 HD11 HG11 ' A' ' 39' ' ' VAL . 21.2 tp -86.52 132.04 34.02 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -179.125 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.75 ' O ' HG23 ' A' ' 9' ' ' VAL . 0.3 OUTLIER -114.82 123.19 48.56 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.289 179.044 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.699 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 0.5 OUTLIER -125.76 139.65 53.34 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 121.447 0.641 . . . . 0.0 112.254 -179.238 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.22 -170.05 2.84 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.231 178.801 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.617 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 3.6 tt -155.02 91.13 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.932 0.396 . . . . 0.0 111.048 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.421 ' HB3' ' O ' ' A' ' 55' ' ' ILE . 9.7 ptm180 172.73 47.02 0.0 OUTLIER 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.133 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.597 ' HB3' ' CD ' ' A' ' 58' ' ' PRO . 2.8 tpt -158.41 -64.29 0.02 OUTLIER Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.597 ' CD ' ' HB3' ' A' ' 57' ' ' MET . 11.9 Cg_endo -54.66 176.05 0.13 Allowed 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.368 2.045 . . . . 0.0 112.643 -179.75 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -52.37 -59.62 8.78 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.21 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.591 ' O ' ' N ' ' A' ' 62' ' ' GLY . 0.0 OUTLIER -82.55 52.26 2.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.552 0.215 . . . . 0.0 110.51 179.369 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 56.3 -71.81 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.143 0.497 . . . . 0.0 111.17 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.617 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -148.01 -36.16 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.641 -0.708 . . . . 0.0 111.753 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.91 ' HA ' HD23 ' A' ' 66' ' ' LEU . 3.0 mp -53.17 -24.16 10.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.779 0.324 . . . . 0.0 110.408 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.542 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -56.92 -33.89 67.42 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.003 178.301 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.947 HD21 ' CA ' ' A' ' 36' ' ' GLY . 0.2 OUTLIER -59.79 -35.86 75.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.429 179.39 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.986 ' HA ' HD12 ' A' ' 69' ' ' ILE . 3.3 mm? -63.67 -43.52 96.44 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.056 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.412 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 5.2 mmpt? -52.9 -50.62 63.55 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.325 179.085 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.785 ' CB ' HD13 ' A' ' 40' ' ' LEU . 12.2 mm100 -62.7 -38.46 90.49 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.517 179.16 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.986 HD12 ' HA ' ' A' ' 66' ' ' LEU . 18.5 mt -54.74 -46.09 73.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.645 -179.062 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.428 ' HB3' ' CD ' ' A' ' 96' ' ' GLN . 0.3 OUTLIER -69.61 -25.94 64.2 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.793 -179.27 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -85.62 -39.73 17.01 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -179.086 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.478 HH21 ' HB2' ' A' ' 40' ' ' LEU . 2.1 mtm180 -102.32 -40.9 6.54 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -178.48 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.696 ' CE1' HG12 ' A' ' 69' ' ' ILE . 0.5 OUTLIER -85.64 136.87 36.56 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.214 -178.962 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.602 ' O ' ' HG2' ' A' ' 75' ' ' MET . 17.2 Cg_exo -67.08 70.41 0.55 Allowed 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.509 2.139 . . . . 0.0 112.219 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.627 ' HB2' ' O ' ' A' ' 96' ' ' GLN . 0.2 OUTLIER 50.5 33.9 8.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.062 0.458 . . . . 0.0 111.114 179.843 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.773 HD13 ' CG2' ' A' ' 47' ' ' THR . 20.7 tp -67.23 131.79 93.47 Favored Pre-proline 0 C--O 1.233 0.216 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.299 -179.772 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.737 ' HD2' HD12 ' A' ' 76' ' ' LEU . 27.9 Cg_endo -63.66 127.32 19.45 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.383 2.055 . . . . 0.0 112.052 179.562 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.958 HG21 HD13 ' A' ' 69' ' ' ILE . 5.7 t -118.28 147.79 21.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.428 -179.423 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.674 HG21 HD23 ' A' ' 114' ' ' LEU . 2.0 mp -122.78 113.22 37.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.161 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.699 ' HA ' ' O ' ' A' ' 53' ' ' SER . 22.3 mm -99.31 144.22 12.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.568 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.561 ' O ' ' HB2' ' A' ' 102' ' ' LEU . 7.7 ttt -67.73 -67.22 0.48 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.47 -179.58 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.603 ' H ' ' CG2' ' A' ' 55' ' ' ILE . 3.7 m -106.45 169.65 8.39 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.524 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 1.036 ' HB1' HD23 ' A' ' 87' ' ' LEU . . . -124.22 -2.84 8.05 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -179.135 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.464 ' O ' ' O ' ' A' ' 83' ' ' ALA . 33.1 m170 31.23 -160.63 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 179.064 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 24.9 m -81.09 -22.58 39.05 Favored 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -178.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.489 ' HB2' HD13 ' A' ' 63' ' ' LEU . 67.4 m-20 -79.81 21.6 0.53 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 120.549 0.214 . . . . 0.0 111.324 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 1.036 HD23 ' HB1' ' A' ' 83' ' ' ALA . 3.1 tm? -43.68 -24.37 0.12 Allowed 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -49.03 -38.2 22.93 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.647 ' HB3' ' HB3' ' A' ' 63' ' ' LEU . . . -71.4 -22.94 61.8 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -179.034 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.676 ' HB2' HD23 ' A' ' 63' ' ' LEU . . . -73.45 -29.82 62.8 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.878 0.37 . . . . 0.0 110.476 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.623 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 3.0 t -61.74 -45.6 98.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.177 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.515 ' O ' ' HB3' ' A' ' 95' ' ' GLN . 83.7 p -67.46 -22.25 65.49 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 178.299 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' A' ' 90' ' ' ALA . . . -64.49 -39.73 94.34 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.306 0.574 . . . . 0.0 109.793 178.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.623 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 9.6 m-85 -69.19 -23.93 63.98 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.719 178.552 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.515 ' HB3' ' O ' ' A' ' 92' ' ' SER . 0.3 OUTLIER -67.59 -46.45 72.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.388 -179.949 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.627 ' O ' ' HB2' ' A' ' 75' ' ' MET . 4.5 pm0 -76.17 -18.14 59.24 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.751 179.389 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 117.7 33.9 1.24 Allowed Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.387 -0.911 . . . . 0.0 113.601 178.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.436 ' HB2' ' HB1' ' A' ' 93' ' ' ALA . . . -62.6 155.92 24.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.957 0.379 . . . . 0.0 110.553 179.339 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.597 ' CZ ' ' HB2' ' A' ' 118' ' ' ALA . 15.4 t80 -76.45 -53.69 7.77 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.032 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 168.46 -166.99 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.241 0.543 . . . . 0.0 111.799 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.525 ' CE2' ' HB ' ' A' ' 80' ' ' ILE . 3.2 m-85 -136.07 153.23 51.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.888 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.631 HD11 HD22 ' A' ' 114' ' ' LEU . 5.8 mp -102.22 120.26 54.05 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 120.595 0.236 . . . . 0.0 110.565 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -61.71 -67.33 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.116 1.877 . . . . 0.0 112.334 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.697 ' HB3' ' HD3' ' A' ' 105' ' ' PRO . 3.1 tttm -126.57 -53.04 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.074 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.697 ' HD3' ' HB3' ' A' ' 104' ' ' LYS . 31.8 Cg_exo -58.85 164.02 10.43 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.293 1.995 . . . . 0.0 112.311 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.681 ' O ' ' O ' ' A' ' 107' ' ' ASP . 74.2 t80 -169.38 -97.45 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.943 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.681 ' O ' ' O ' ' A' ' 106' ' ' PHE . 0.3 OUTLIER 37.53 177.3 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.26 0.553 . . . . 0.0 112.356 179.344 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.895 HG12 HG12 ' A' ' 18' ' ' VAL . 0.5 OUTLIER -68.18 -48.22 74.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.899 0.38 . . . . 0.0 111.998 -179.75 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -49.52 -58.7 4.71 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.913 -179.017 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.616 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 6.2 mm-40 -70.15 -30.75 67.99 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.811 0.339 . . . . 0.0 111.079 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -68.12 -62.17 1.52 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.063 179.457 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.635 ' O ' HG12 ' A' ' 115' ' ' VAL . 38.7 t -56.01 -34.24 37.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.36 0.6 . . . . 0.0 110.682 178.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.12 -45.9 91.43 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.389 179.556 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.674 HD23 HG21 ' A' ' 79' ' ' ILE . 5.2 tp -78.5 -21.52 48.82 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.56 -179.505 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.703 HG22 HG11 ' A' ' 50' ' ' VAL . 1.3 p -77.98 -36.34 21.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.613 -179.413 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -68.39 -41.08 81.03 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.098 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 5.6 mmt85 -60.47 -24.85 65.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.273 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.597 ' HB2' ' CZ ' ' A' ' 99' ' ' PHE . . . -71.3 -43.33 67.3 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.937 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.621 HD13 ' CD2' ' A' ' 28' ' ' LEU . 4.9 mt -73.57 -31.98 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.175 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 33.5 t -64.57 -42.32 95.72 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.947 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 14.5 m80 -63.49 -27.56 69.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.92 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -81.95 -54.65 5.15 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.989 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 59.65 -177.78 0.09 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.92 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.935 179.912 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 ptt? . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.744 0.307 . . . . 0.0 111.254 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.437 ' OE1' ' HG2' ' A' ' 3' ' ' ARG . 0.0 OUTLIER -82.79 158.2 22.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.52 179.686 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.732 ' HG3' HD11 ' A' ' 5' ' ' ILE . 0.3 OUTLIER -64.17 -54.56 31.71 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.955 0.407 . . . . 0.0 111.231 -179.682 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.473 ' C ' HD13 ' A' ' 5' ' ' ILE . . . 96.22 102.27 1.99 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.012 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.732 HD11 ' HG3' ' A' ' 3' ' ' ARG . 7.4 mm -114.13 114.14 45.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.956 0.408 . . . . 0.0 111.737 -179.382 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 1.025 HG11 HD13 ' A' ' 23' ' ' LEU . 3.5 p -114.07 119.81 62.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.128 178.751 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.952 ' CD1' HG22 ' A' ' 31' ' ' THR . 39.0 m0 -112.46 143.74 43.09 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.009 0.433 . . . . 0.0 110.698 -179.806 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.655 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -129.3 136.91 58.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.539 -178.807 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.897 HG11 ' HA2' ' A' ' 36' ' ' GLY . 3.0 m -115.64 110.09 30.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.625 178.947 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.531 ' OD1' ' HB ' ' A' ' 15' ' ' ILE . 1.9 p30 -164.05 -159.11 0.47 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.186 -178.052 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -66.45 -3.02 5.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.832 -179.619 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 66.41 -152.09 0.22 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.473 0.177 . . . . 0.0 111.271 179.359 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.456 ' OG ' ' N ' ' A' ' 14' ' ' SER . 72.0 p 34.89 -95.33 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 178.831 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.71 ' O ' HG23 ' A' ' 18' ' ' VAL . 8.2 t -52.79 -60.57 3.1 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.748 -178.984 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.531 ' HB ' ' OD1' ' A' ' 10' ' ' ASP . 9.9 mm -60.54 -24.99 33.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.684 0.278 . . . . 0.0 110.955 -179.781 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.699 ' HA ' HG21 ' A' ' 32' ' ' THR . 3.2 ttm-85 -71.48 -51.89 21.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.794 0.331 . . . . 0.0 110.594 179.494 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.402 ' HA ' ' CD ' ' A' ' 20' ' ' GLU . 40.8 t90 -59.3 -38.44 80.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.824 -179.516 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.71 HG23 ' O ' ' A' ' 14' ' ' SER . 18.1 t -65.65 -54.18 30.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -178.717 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.748 HD12 HD12 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -76.18 -26.43 56.19 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -178.235 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.631 ' HA ' ' CB ' ' A' ' 30' ' ' CYS . 10.7 pt-20 -67.82 -60.69 2.32 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.56 -0.456 . . . . 0.0 112.109 -178.874 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.501 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 4.5 mmm180 -57.89 -55.94 28.44 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.921 -179.098 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.44 -50.09 65.99 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -179.198 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.04 HD22 HD13 ' A' ' 28' ' ' LEU . 5.2 mt -69.44 -29.0 66.6 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.131 0.491 . . . . 0.0 110.16 179.532 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.1 -35.01 75.86 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.422 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.04 -28.09 69.92 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.048 -1.073 . . . . 0.0 110.462 177.762 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.72 ' HB3' HD11 ' A' ' 28' ' ' LEU . . . -78.53 -15.99 57.96 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 120.578 0.228 . . . . 0.0 110.88 179.173 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.86 27.11 13.09 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 120.482 -0.866 . . . . 0.0 114.491 178.665 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 1.04 HD13 HD22 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -118.04 167.53 11.37 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 118.407 1.104 . . . . 0.0 112.105 -179.921 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 98.7 m -88.28 117.23 27.04 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.941 179.223 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.631 ' CB ' ' HA ' ' A' ' 20' ' ' GLU . 3.1 m -108.96 110.19 21.43 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.661 -178.907 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.952 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.7 t -130.22 135.61 48.33 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 178.484 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.699 HG21 ' HA ' ' A' ' 16' ' ' ARG . 29.8 p -111.09 164.8 12.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.262 0.553 . . . . 0.0 111.915 -179.054 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.793 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 3.7 m-85 -136.39 172.17 13.41 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.302 -178.204 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.584 ' HG2' ' N ' ' A' ' 35' ' ' ASN . 0.1 OUTLIER -63.4 -32.63 74.12 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 121.445 0.64 . . . . 0.0 109.917 179.202 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.584 ' N ' ' HG2' ' A' ' 34' ' ' GLU . 8.1 t-20 179.81 170.2 1.14 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.994 -179.81 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.897 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . -43.43 -29.9 1.23 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.788 -0.72 . . . . 0.0 113.629 -179.238 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.47 ' HA ' ' HG ' ' A' ' 40' ' ' LEU . 0.4 OUTLIER -58.88 -51.48 69.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.737 0.304 . . . . 0.0 111.525 -179.48 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.793 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -51.91 -48.72 64.04 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.909 -0.316 . . . . 0.0 111.289 -179.531 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.621 HG22 ' CE1' ' A' ' 33' ' ' PHE . 79.5 t -60.7 -27.4 40.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.113 179.808 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.541 ' HG ' ' O ' ' A' ' 36' ' ' GLY . 33.9 mt -57.39 -46.88 82.96 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.222 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.31 -48.69 49.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.098 179.569 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.67 -31.6 68.34 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.832 179.818 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.695 HD21 ' HD2' ' A' ' 48' ' ' PRO . 16.1 mt -70.02 -25.03 63.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.485 -179.936 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.24 -19.6 14.68 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.913 -179.36 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.8 2.13 8.13 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -179.663 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.58 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -163.65 155.6 17.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.793 0.33 . . . . 0.0 110.733 179.712 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.622 HG23 ' CD2' ' A' ' 76' ' ' LEU . 87.4 m -139.09 112.71 8.12 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.466 179.92 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.695 ' HD2' HD21 ' A' ' 43' ' ' LEU . 94.7 Cg_endo -78.22 165.59 25.57 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.063 1.842 . . . . 0.0 110.914 178.538 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.633 ' OD2' HG12 ' A' ' 119' ' ' ILE . 4.8 p-10 -74.59 -59.58 2.67 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.659 -179.733 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.746 HG13 HG23 ' A' ' 6' ' ' VAL . 10.0 p -101.91 164.85 2.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.926 179.558 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.638 HD23 HG22 ' A' ' 78' ' ' VAL . 14.5 tp -153.45 143.04 21.82 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 120.733 0.301 . . . . 0.0 111.072 -179.765 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.602 ' HG ' ' HB ' ' A' ' 79' ' ' ILE . 0.2 OUTLIER -129.17 142.15 50.96 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.631 -0.258 . . . . 0.0 110.783 -179.922 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.798 ' HA ' HG23 ' A' ' 9' ' ' VAL . 3.0 m -129.48 137.05 50.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.005 0.431 . . . . 0.0 111.494 -179.864 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.471 ' HB3' ' HB3' ' A' ' 10' ' ' ASP . 20.7 p-10 -77.87 -18.03 56.68 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.745 -178.712 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.579 HG13 ' HA3' ' A' ' 62' ' ' GLY . 0.7 OUTLIER 45.28 91.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-O 120.823 0.344 . . . . 0.0 111.255 -179.779 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.0 49.66 2.25 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -179.108 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.476 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 1.1 ttt 57.01 51.01 4.99 Favored Pre-proline 0 N--CA 1.466 0.364 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 178.715 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 62' ' ' GLY . 42.8 Cg_endo -69.26 -78.87 0.01 OUTLIER 'Trans proline' 0 CA--C 1.533 0.428 0 C-N-CA 122.75 2.3 . . . . 0.0 112.102 178.685 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -112.2 -20.81 6.51 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 121.262 -0.494 . . . . 0.0 112.09 179.603 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' MET . . . . . 1.001 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 0.8 OUTLIER -159.99 66.38 0.36 Allowed 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.084 0.469 . . . . 0.0 110.266 179.725 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.476 ' HA ' ' HA ' ' A' ' 57' ' ' MET . 0.9 OUTLIER 68.29 -23.56 0.13 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.321 179.746 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.607 ' N ' ' HD2' ' A' ' 58' ' ' PRO . . . 140.21 -31.67 2.24 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 111.286 -0.726 . . . . 0.0 111.286 -179.604 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.657 HD12 ' H ' ' A' ' 63' ' ' LEU . 2.4 mp -66.74 -28.23 68.25 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 178.92 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 1.001 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -53.79 -28.72 36.67 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.352 0.596 . . . . 0.0 109.791 178.074 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.705 ' CD2' HD11 ' A' ' 69' ' ' ILE . 4.9 tt -51.67 -57.06 10.27 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.343 179.243 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.726 HD13 ' CB ' ' A' ' 93' ' ' ALA . 1.9 mt -55.76 -40.99 73.34 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.746 -1.116 . . . . 0.0 110.692 179.91 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.531 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -47.72 -49.11 28.97 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 120.792 0.33 . . . . 0.0 111.039 179.197 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 8.8 mm100 -69.22 -32.21 71.3 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.028 0.442 . . . . 0.0 110.831 -179.948 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.705 HD11 ' CD2' ' A' ' 65' ' ' LEU . 81.3 mt -60.75 -40.85 86.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.535 -179.222 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.531 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -74.61 -27.9 60.67 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.767 -179.666 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.0 -41.95 67.02 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.674 -178.925 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 72' ' ' ARG . 1.0 OUTLIER -94.84 -26.42 16.21 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.377 -0.374 . . . . 0.0 112.007 -179.15 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.592 ' CE1' HD12 ' A' ' 43' ' ' LEU . 0.1 OUTLIER -124.52 168.45 13.08 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-O 120.749 0.309 . . . . 0.0 111.173 -179.421 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.492 ' HD2' ' HB3' ' A' ' 73' ' ' HIS . 35.5 Cg_endo -69.6 -83.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.339 2.026 . . . . 0.0 112.723 -179.373 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.435 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 8.0 mtm -146.71 55.44 1.13 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.734 0.302 . . . . 0.0 111.406 -179.626 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.622 ' CD2' HG23 ' A' ' 47' ' ' THR . 0.1 OUTLIER -57.22 111.09 2.96 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.427 179.811 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.615 ' HD2' HD13 ' A' ' 76' ' ' LEU . 38.6 Cg_exo -58.68 115.62 2.67 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.264 1.976 . . . . 0.0 112.593 179.841 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.962 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 5.0 t -117.59 145.96 22.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.951 179.622 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.602 ' HB ' ' HG ' ' A' ' 52' ' ' LEU . 1.6 mp -117.52 112.61 39.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 179.147 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.785 HG13 ' CZ ' ' A' ' 101' ' ' TYR . 16.5 mm -93.7 130.65 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -178.205 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.667 ' HB2' ' CD2' ' A' ' 106' ' ' PHE . 6.7 ptm -72.43 -29.8 64.03 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.693 -179.968 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.568 ' H ' HG21 ' A' ' 55' ' ' ILE . 5.3 m -135.6 138.3 42.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.386 -179.433 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.571 ' HA ' ' CE2' ' A' ' 101' ' ' TYR . . . -89.71 -27.05 20.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.574 179.957 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.534 ' CE1' HG21 ' A' ' 82' ' ' THR . 3.2 m-70 44.72 -159.74 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.286 179.609 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.423 ' H ' ' HB3' ' A' ' 84' ' ' HIS . 2.6 t -81.41 164.31 22.18 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.937 0.399 . . . . 0.0 111.415 -179.529 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.406 ' O ' HD22 ' A' ' 63' ' ' LEU . 0.2 OUTLIER 72.07 31.24 2.01 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.746 179.99 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.607 HD23 ' CB ' ' A' ' 90' ' ' ALA . 1.1 mt -45.8 -21.84 0.15 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.793 -0.639 . . . . 0.0 112.502 -179.812 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -48.11 -44.23 31.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.617 0.246 . . . . 0.0 111.042 -179.657 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.505 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -67.25 -20.55 65.68 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.191 179.902 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.61 ' O ' ' HB3' ' A' ' 93' ' ' ALA . . . -62.35 -50.5 71.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.886 -179.777 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.587 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 6.3 t -67.72 -45.47 84.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.41 179.587 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.678 ' O ' ' HG3' ' A' ' 95' ' ' GLN . 9.8 m -61.56 -14.07 26.83 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.088 0.471 . . . . 0.0 109.835 178.24 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.726 ' CB ' HD13 ' A' ' 66' ' ' LEU . . . -75.66 -53.25 8.86 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.399 179.724 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.667 ' CE1' ' HA ' ' A' ' 100' ' ' ASP . 4.8 m-85 -55.81 -34.78 65.66 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.142 -178.805 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.678 ' HG3' ' O ' ' A' ' 92' ' ' SER . 1.8 pp0? -74.37 -34.14 63.26 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.242 -179.755 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.507 ' HG2' ' HA ' ' A' ' 93' ' ' ALA . 9.3 pt20 -100.29 11.29 39.75 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.141 -179.344 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 119.43 78.26 0.56 Allowed Glycine 0 C--N 1.334 0.441 0 C-N-CA 120.314 -0.946 . . . . 0.0 113.474 179.79 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.962 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -169.04 134.89 1.66 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.08 0.467 . . . . 0.0 111.623 178.966 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.724 ' CD2' ' HB2' ' A' ' 118' ' ' ALA . 3.5 t80 -74.96 -52.53 10.94 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.237 -179.673 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.667 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 0.9 OUTLIER 179.15 -167.71 0.08 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.247 0.546 . . . . 0.0 111.955 -179.831 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.785 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 4.9 m-85 -136.04 153.17 51.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.275 -179.685 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.602 HD23 ' HA ' ' A' ' 81' ' ' MET . 1.7 mm? -102.82 120.7 51.81 Favored Pre-proline 0 C--N 1.329 -0.299 0 C-N-CA 121.081 -0.247 . . . . 0.0 110.83 179.51 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -66.26 -78.7 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.318 2.012 . . . . 0.0 112.395 -179.838 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.648 ' HB3' ' HD3' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -108.81 -58.18 0.05 OUTLIER Pre-proline 0 C--O 1.232 0.175 0 C-N-CA 121.185 -0.206 . . . . 0.0 111.425 179.949 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.648 ' HD3' ' HB3' ' A' ' 104' ' ' LYS . 77.0 Cg_endo -79.07 163.03 25.79 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 121.693 1.595 . . . . 0.0 110.726 178.933 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.717 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 0.9 OUTLIER 177.58 -91.38 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 121.3 -0.16 . . . . 0.0 111.262 179.936 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.511 ' O ' ' CB ' ' A' ' 111' ' ' ALA . 2.7 p30 44.04 -165.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 -179.442 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.534 HG12 HG12 ' A' ' 18' ' ' VAL . 1.0 OUTLIER -66.67 -43.83 90.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 120.744 -0.383 . . . . 0.0 111.528 -179.727 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.471 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 8.6 t70 -48.84 -58.33 4.98 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.192 -179.684 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.717 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 5.2 mm-40 -78.23 -32.61 49.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.552 -179.68 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.511 ' CB ' ' O ' ' A' ' 107' ' ' ASP . . . -65.92 -59.58 3.7 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 179.398 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.709 ' O ' HG12 ' A' ' 115' ' ' VAL . 56.0 t -59.58 -29.85 43.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.452 0.644 . . . . 0.0 110.195 178.877 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.471 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -66.49 -46.76 75.23 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.566 178.759 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.521 HD23 ' CG2' ' A' ' 79' ' ' ILE . 15.2 tp -74.81 -20.76 59.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.205 179.859 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.709 HG12 ' O ' ' A' ' 112' ' ' VAL . 5.5 p -79.31 -48.43 21.17 Favored 'Isoleucine or valine' 0 C--O 1.231 0.088 0 CA-C-O 120.841 0.353 . . . . 0.0 111.44 179.985 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.629 ' HA ' HD12 ' A' ' 119' ' ' ILE . 35.6 mt-10 -63.5 -38.13 89.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.938 -179.967 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 13.6 mmt180 -65.24 -24.88 67.45 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.901 179.761 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.724 ' HB2' ' CD2' ' A' ' 99' ' ' PHE . . . -74.42 -39.63 62.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.222 179.935 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.633 HG12 ' OD2' ' A' ' 49' ' ' ASP . 4.9 mt -71.74 -30.67 38.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.135 0.493 . . . . 0.0 110.72 179.873 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 24.3 t -67.71 -35.77 79.38 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.02 179.823 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 25.9 m80 -69.46 -26.63 64.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.897 0.38 . . . . 0.0 111.161 -179.804 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -73.6 -53.71 9.86 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.825 179.972 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -77.71 -172.91 2.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.147 -179.994 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.2 tm-20 . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.947 179.988 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.1 mmt . . . . . 0 N--CA 1.488 1.45 0 CA-C-O 120.757 0.313 . . . . 0.0 111.255 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 62.61 152.73 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.228 179.899 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.408 ' HG3' HD11 ' A' ' 5' ' ' ILE . 10.2 ptt-85 -69.96 -60.63 2.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.828 -179.575 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.416 ' C ' HD13 ' A' ' 5' ' ' ILE . . . 98.85 102.12 2.31 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.964 -0.636 . . . . 0.0 111.879 -179.301 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.439 ' HB ' ' HA ' ' A' ' 48' ' ' PRO . 8.4 mm -111.12 112.78 42.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.887 0.375 . . . . 0.0 111.351 -179.393 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.92 HG23 HG13 ' A' ' 50' ' ' VAL . 7.7 p -109.06 123.47 64.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.818 179.459 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.955 ' CD1' HG22 ' A' ' 31' ' ' THR . 40.5 m0 -113.68 133.7 55.17 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.686 -179.798 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.567 HG13 ' HB3' ' A' ' 52' ' ' LEU . 0.6 OUTLIER -119.43 145.79 25.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.997 0.427 . . . . 0.0 111.965 -179.106 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.806 HG11 ' HA2' ' A' ' 36' ' ' GLY . 0.0 OUTLIER -123.96 110.63 26.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.095 0.474 . . . . 0.0 110.985 178.999 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.418 ' CB ' HG21 ' A' ' 15' ' ' ILE . 5.0 t0 -161.17 -163.45 1.02 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.78 -179.549 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -66.66 -1.73 4.08 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -178.788 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.529 ' O ' ' N ' ' A' ' 14' ' ' SER . 1.2 t70 65.24 -141.85 0.21 Allowed 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 121.027 -0.269 . . . . 0.0 110.61 179.338 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.486 ' HA ' ' HE ' ' A' ' 16' ' ' ARG . 1.0 OUTLIER 35.29 -82.21 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 179.07 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.758 ' O ' HG23 ' A' ' 18' ' ' VAL . 1.8 m -80.17 -44.4 19.91 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -178.71 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.418 HG21 ' CB ' ' A' ' 10' ' ' ASP . 27.3 mm -65.24 -33.74 65.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 -178.773 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.809 ' HA ' HG21 ' A' ' 32' ' ' THR . 2.4 ppt_? -72.42 -55.27 7.32 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.881 -179.279 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.422 ' N ' ' HD2' ' A' ' 16' ' ' ARG . 81.4 t90 -48.12 -41.95 27.89 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -178.9 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.943 HG12 HD13 ' A' ' 108' ' ' ILE . 0.8 OUTLIER -73.11 -57.48 6.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.137 0.494 . . . . 0.0 112.252 -178.557 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 1.046 HD12 HD12 ' A' ' 108' ' ' ILE . 7.3 mp -65.02 -30.94 71.95 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.573 -0.739 . . . . 0.0 112.567 -177.912 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.523 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 19.9 pt-20 -67.77 -59.18 3.51 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.877 0.37 . . . . 0.0 111.484 -179.63 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.473 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 6.2 mmm180 -56.9 -51.45 69.06 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.586 -179.623 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.567 ' HB3' HD11 ' A' ' 108' ' ' ILE . . . -59.47 -43.56 93.23 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 120.876 0.37 . . . . 0.0 111.589 -179.355 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.855 ' CD2' HG11 ' A' ' 6' ' ' VAL . 2.1 tp -74.09 -24.58 59.5 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.214 179.634 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.47 -35.16 75.34 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.357 178.374 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.9 -26.09 69.81 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.522 -0.847 . . . . 0.0 111.283 178.656 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.595 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -76.68 -16.15 59.6 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 120.677 0.275 . . . . 0.0 111.246 179.636 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.46 26.65 8.05 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 120.45 -0.881 . . . . 0.0 114.374 178.748 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.783 HD13 ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -125.72 170.83 11.16 Favored 'General case' 0 C--O 1.231 0.079 0 CA-C-N 118.28 1.04 . . . . 0.0 112.018 179.943 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 31.5 m -99.25 105.96 18.05 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.807 179.954 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.618 ' HA ' HG13 ' A' ' 6' ' ' VAL . 4.7 t -98.29 117.1 31.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.583 -179.675 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.955 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.2 t -126.66 130.92 51.37 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 178.401 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.809 HG21 ' HA ' ' A' ' 16' ' ' ARG . 60.4 p -103.26 164.51 11.59 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -177.713 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.718 ' CE1' HG23 ' A' ' 31' ' ' THR . 3.4 m-85 -135.92 174.48 10.56 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.936 -178.057 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.75 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 2.9 pp20? -61.36 -40.13 93.16 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -177.561 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.408 ' O ' ' HB ' ' A' ' 9' ' ' VAL . 1.4 t-20 -168.31 -46.66 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -179.165 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.833 ' CA ' HD21 ' A' ' 65' ' ' LEU . . . -176.73 -47.48 0.06 OUTLIER Glycine 0 C--N 1.32 -0.318 0 C-N-CA 120.178 -1.011 . . . . 0.0 113.628 -178.907 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -65.77 -27.94 68.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.896 0.379 . . . . 0.0 111.168 -179.2 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.75 ' HB2' ' HG3' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -58.62 -53.39 58.84 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.052 179.997 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.743 HG12 ' CD1' ' A' ' 43' ' ' LEU . 8.2 t -51.94 -49.01 39.38 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.145 0 C-N-CA 120.39 -0.524 . . . . 0.0 109.925 179.683 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.802 HD13 ' HB3' ' A' ' 68' ' ' GLN . 22.3 mt -48.18 -42.55 30.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.08 179.879 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.62 -49.57 62.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.232 0.539 . . . . 0.0 110.862 179.576 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.14 -26.41 68.8 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.712 179.552 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.774 HD13 ' NE2' ' A' ' 73' ' ' HIS . 1.3 mt -69.7 -27.12 64.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.465 -178.918 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.46 -21.04 1.31 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.84 -179.556 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 29.9 t -126.09 6.56 7.2 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -179.435 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.54 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.3 OUTLIER -166.44 156.44 11.9 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.974 0.416 . . . . 0.0 111.451 179.969 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 47' ' ' THR . . . . . 1.023 HG23 HD12 ' A' ' 76' ' ' LEU . 98.2 m -139.09 112.51 8.1 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.22 179.616 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.613 ' CD ' HD11 ' A' ' 76' ' ' LEU . 57.7 Cg_endo -71.82 165.13 33.48 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 121.873 1.716 . . . . 0.0 111.027 178.974 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -76.43 -22.66 54.38 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.691 -0.403 . . . . 0.0 111.232 -179.795 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.92 HG13 HG23 ' A' ' 6' ' ' VAL . 9.1 p -145.55 165.48 10.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 116.679 -0.237 . . . . 0.0 111.222 -179.666 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.764 HD12 ' O ' ' A' ' 7' ' ' TRP . 12.1 tp -152.69 136.31 16.07 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.999 0.428 . . . . 0.0 111.561 -179.353 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.567 ' HB3' HG13 ' A' ' 8' ' ' VAL . 0.6 OUTLIER -122.85 117.29 25.28 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.509 -179.991 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.481 ' OG ' HD13 ' A' ' 65' ' ' LEU . 3.3 m -105.76 134.53 48.73 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.232 0.539 . . . . 0.0 111.705 -179.667 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -83.08 16.04 2.55 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -178.938 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.774 HG22 ' HG2' ' A' ' 81' ' ' MET . 1.1 tt 31.53 -107.75 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 179.434 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.478 ' N ' ' CG1' ' A' ' 55' ' ' ILE . 3.5 ttt180 54.16 43.42 30.67 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 179.618 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.524 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 1.0 OUTLIER 48.25 63.78 9.73 Favored Pre-proline 0 N--CA 1.468 0.44 0 N-CA-C 113.472 0.915 . . . . 0.0 113.472 178.694 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.604 ' HD2' ' N ' ' A' ' 62' ' ' GLY . 55.9 Cg_endo -73.86 -78.23 0.01 OUTLIER 'Trans proline' 0 CA--C 1.533 0.434 0 C-N-CA 122.419 2.079 . . . . 0.0 111.248 177.948 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -109.61 -28.55 4.23 Favored Glycine 0 C--N 1.335 0.477 0 C-N-CA 121.127 -0.559 . . . . 0.0 112.16 179.068 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' MET . . . . . 1.025 ' HB3' ' HB2' ' A' ' 64' ' ' ALA . 0.4 OUTLIER -152.42 65.19 0.82 Allowed 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.173 0.511 . . . . 0.0 110.048 179.544 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.654 ' O ' HG13 ' A' ' 55' ' ' ILE . 0.4 OUTLIER 68.07 -25.29 0.13 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.184 -0.917 . . . . 0.0 112.161 -179.788 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.604 ' N ' ' HD2' ' A' ' 58' ' ' PRO . . . 141.84 -31.92 2.06 Favored Glycine 0 CA--C 1.502 -0.728 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 179.981 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.842 HD11 ' HB2' ' A' ' 85' ' ' SER . 1.2 mp -70.61 -16.75 62.87 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 115.068 -0.566 . . . . 0.0 110.044 179.124 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 1.025 ' HB2' ' HB3' ' A' ' 60' ' ' MET . . . -53.5 -39.26 64.45 Favored 'General case' 0 CA--C 1.522 -0.098 0 CA-C-O 121.312 0.577 . . . . 0.0 109.768 178.115 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.833 HD21 ' CA ' ' A' ' 36' ' ' GLY . 6.8 mt -62.3 -39.18 92.13 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.885 179.755 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.789 HD23 ' HA ' ' A' ' 63' ' ' LEU . 1.2 mm? -59.02 -44.12 91.68 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.272 0.558 . . . . 0.0 109.804 179.165 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.639 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -57.98 -43.7 86.7 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.729 179.474 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.802 ' HB3' HD13 ' A' ' 40' ' ' LEU . 30.3 mm100 -73.93 -38.41 64.28 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.659 179.692 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.811 HG21 HG22 ' A' ' 78' ' ' VAL . 17.1 mt -63.5 -36.0 74.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.364 -179.247 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.639 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -75.41 -26.64 58.57 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.056 -179.57 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -86.21 -32.62 21.09 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.603 -179.351 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.422 ' HD2' ' HB3' ' A' ' 40' ' ' LEU . 0.6 OUTLIER -95.41 -23.44 17.15 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.154 0.428 . . . . 0.0 112.154 -179.692 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.802 ' CE1' HG23 ' A' ' 69' ' ' ILE . 0.2 OUTLIER -111.11 135.23 20.9 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-O 120.673 0.273 . . . . 0.0 111.667 -179.07 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -59.76 -54.41 2.43 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.41 2.073 . . . . 0.0 112.082 179.116 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.449 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 22.2 mtt -156.47 36.74 0.32 Allowed 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.227 -179.9 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 1.023 HD12 HG23 ' A' ' 47' ' ' THR . 0.7 OUTLIER -71.13 121.79 85.18 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.379 -179.891 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.448 ' HD2' HD23 ' A' ' 76' ' ' LEU . 15.7 Cg_exo -68.58 121.86 8.8 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.586 2.19 . . . . 0.0 112.762 -179.708 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.811 HG22 HG21 ' A' ' 69' ' ' ILE . 11.4 t -99.21 141.02 17.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.843 179.302 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.964 HD13 HG23 ' A' ' 115' ' ' VAL . 2.4 mt -127.07 110.67 23.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.945 179.853 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.545 ' HB ' ' CD2' ' A' ' 101' ' ' TYR . 5.4 mm -101.17 142.12 16.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.104 -179.926 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.774 ' HG2' HG22 ' A' ' 55' ' ' ILE . 26.5 ptm -66.66 -56.51 10.3 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.943 179.607 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.682 ' O ' HD13 ' A' ' 55' ' ' ILE . 2.8 m -131.06 152.21 50.6 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 121.771 -0.581 . . . . 0.0 112.152 -179.809 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.968 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -116.71 46.18 1.68 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.825 -179.796 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 17.1 p80 -77.23 56.65 1.33 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.666 0.269 . . . . 0.0 111.192 -179.98 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.842 ' HB2' HD11 ' A' ' 63' ' ' LEU . 0.7 OUTLIER -159.64 -160.63 0.84 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 121.046 0.45 . . . . 0.0 111.67 -179.642 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.79 90.05 0.17 Allowed 'General case' 0 CA--C 1.528 0.097 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.834 179.559 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.761 HD13 ' HB3' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -44.44 -21.29 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -179.965 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -48.12 -53.66 15.87 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -178.975 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.554 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -66.46 -22.04 66.2 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.642 0.258 . . . . 0.0 111.446 -179.648 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.761 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -76.97 -42.91 37.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.754 0.311 . . . . 0.0 110.965 -179.865 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.561 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 13.6 t -64.69 -41.17 91.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.234 179.79 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 19.8 m -61.06 -36.08 78.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.922 179.0 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.549 ' HB1' ' HB2' ' A' ' 98' ' ' ALA . . . -55.76 -45.44 78.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.644 179.622 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.561 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 7.4 m-85 -55.16 -25.02 29.53 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.525 179.507 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.61 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -72.19 -40.77 67.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.337 179.688 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.61 ' N ' ' HG2' ' A' ' 95' ' ' GLN . 0.0 OUTLIER -76.03 -18.13 59.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.547 -179.6 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 134.32 -8.78 4.71 Favored Glycine 0 CA--C 1.521 0.45 0 C-N-CA 120.318 -0.944 . . . . 0.0 113.508 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.805 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -43.67 143.92 0.91 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 117.268 0.534 . . . . 0.0 111.505 -179.817 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.434 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 39.5 t80 -80.73 -54.63 5.46 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 121.049 -0.26 . . . . 0.0 111.232 -179.59 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 166.71 -168.23 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.06 0.457 . . . . 0.0 111.546 179.582 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.968 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 9.2 m-85 -118.3 152.63 35.41 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.654 178.948 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.909 HD13 HD22 ' A' ' 114' ' ' LEU . 19.6 tp -102.58 144.63 29.01 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-O 120.926 0.394 . . . . 0.0 111.5 -178.411 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.504 ' HD2' ' CD1' ' A' ' 102' ' ' LEU . 79.2 Cg_endo -80.22 -160.56 0.13 Allowed 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.513 2.142 . . . . 0.0 113.01 -179.399 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.503 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -42.15 -54.03 7.96 Favored Pre-proline 0 CA--C 1.534 0.347 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -179.165 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.503 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 18.2 Cg_endo -59.19 156.71 33.42 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.033 1.822 . . . . 0.0 112.39 -179.287 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.853 ' CD1' HD23 ' A' ' 102' ' ' LEU . 60.2 m-85 -157.36 -109.45 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.156 -179.924 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.505 ' O ' ' O ' ' A' ' 106' ' ' PHE . 2.6 p30 44.75 -179.48 0.0 OUTLIER 'General case' 0 C--O 1.227 -0.119 0 CA-C-O 121.336 0.588 . . . . 0.0 111.248 -179.579 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 1.046 HD12 HD12 ' A' ' 19' ' ' LEU . 0.5 OUTLIER -64.06 -53.64 41.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-O 121.473 0.654 . . . . 0.0 112.324 -179.788 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.629 ' N ' HG23 ' A' ' 108' ' ' ILE . 1.0 OUTLIER -49.16 -52.91 23.54 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 114.947 -1.024 . . . . 0.0 111.961 -178.014 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.682 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 2.0 mm-40 -81.51 -27.78 34.32 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -179.13 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.44 ' CB ' ' O ' ' A' ' 107' ' ' ASP . . . -76.39 -55.39 5.59 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.252 179.933 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.619 ' O ' HG12 ' A' ' 115' ' ' VAL . 61.8 t -59.01 -30.47 43.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.502 0.668 . . . . 0.0 110.061 178.55 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.491 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -62.04 -46.61 88.4 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.492 -0.777 . . . . 0.0 110.587 179.345 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.909 HD22 HD13 ' A' ' 102' ' ' LEU . 21.5 tp -71.36 -26.71 62.92 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.108 -0.951 . . . . 0.0 112.127 -178.764 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.964 HG23 HD13 ' A' ' 79' ' ' ILE . 4.3 p -79.35 -40.04 21.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.886 0.374 . . . . 0.0 111.57 -179.805 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -67.31 -43.97 80.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.282 -179.448 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.643 ' HD3' ' HA ' ' A' ' 114' ' ' LEU . 6.7 ptm180 -60.09 -23.64 63.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.64 0.257 . . . . 0.0 110.827 179.807 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.434 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -72.16 -50.11 30.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.763 179.203 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.751 HD11 HG11 ' A' ' 50' ' ' VAL . 3.9 mt -69.65 -34.52 61.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.274 0.559 . . . . 0.0 110.649 179.554 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.3 t -63.49 -38.93 93.04 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.002 -179.958 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -62.08 -29.72 70.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.075 -179.907 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -75.89 -53.25 8.72 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.926 179.828 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.3 170.12 16.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.8 0.333 . . . . 0.0 110.964 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.857 179.891 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.471 0 CA-C-O 120.787 0.327 . . . . 0.0 111.187 . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -112.41 175.06 5.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.956 179.929 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.616 ' HB3' HD11 ' A' ' 5' ' ' ILE . 0.8 OUTLIER -66.2 -27.79 68.26 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.95 0.405 . . . . 0.0 110.942 179.948 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.509 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . 56.54 85.94 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.05 -179.534 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.616 HD11 ' HB3' ' A' ' 3' ' ' ARG . 3.5 mp -116.81 117.62 56.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.74 0.305 . . . . 0.0 111.565 -179.292 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.833 HG23 HG13 ' A' ' 50' ' ' VAL . 5.4 p -104.95 129.22 57.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.722 179.414 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.925 ' CD1' HG22 ' A' ' 31' ' ' THR . 28.2 m0 -116.38 130.49 56.8 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.789 179.248 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.545 HG11 HD23 ' A' ' 19' ' ' LEU . 1.6 t -114.43 135.71 53.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.503 -177.919 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.853 HG13 HG23 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -121.0 106.39 18.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.329 -0.396 . . . . 0.0 109.999 179.43 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.414 ' OD2' HG21 ' A' ' 15' ' ' ILE . 2.9 p30 -161.17 -160.85 0.76 Allowed 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.215 -177.887 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -66.3 -2.77 4.76 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -178.663 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 67.69 -150.12 0.16 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 121.199 -0.201 . . . . 0.0 111.177 179.268 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.438 ' OG ' ' N ' ' A' ' 14' ' ' SER . 60.1 p 34.78 -97.72 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 179.205 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.789 ' O ' HG23 ' A' ' 18' ' ' VAL . 12.5 t -53.17 -57.43 10.49 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.686 -0.234 . . . . 0.0 111.598 -179.069 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.414 HG21 ' OD2' ' A' ' 10' ' ' ASP . 17.6 mm -61.37 -25.1 35.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.78 0.324 . . . . 0.0 111.546 -179.854 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.952 ' HA ' HG21 ' A' ' 32' ' ' THR . 5.8 ttm180 -70.89 -54.54 11.07 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.103 179.919 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.427 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 84.7 t90 -60.79 -43.57 97.95 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -179.03 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.789 HG23 ' O ' ' A' ' 14' ' ' SER . 4.6 t -64.73 -46.15 93.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.67 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.545 HD23 HG11 ' A' ' 8' ' ' VAL . 11.9 tp -84.13 -23.16 30.8 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -178.198 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.508 ' HG3' ' N ' ' A' ' 21' ' ' ARG . 15.1 pt-20 -67.46 -58.85 4.01 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.194 -0.602 . . . . 0.0 111.321 -179.277 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.508 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 3.1 mmm180 -59.73 -50.42 73.9 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.689 -179.396 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.29 -48.48 71.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.881 0.372 . . . . 0.0 111.713 -179.343 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.805 ' HG ' HG11 ' A' ' 6' ' ' VAL . 2.4 tm? -70.06 -30.27 67.48 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.393 0.616 . . . . 0.0 110.516 179.972 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.09 -31.94 72.77 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 178.298 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.31 -28.34 70.78 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 178.029 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.595 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -77.26 -15.67 59.35 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 120.82 0.343 . . . . 0.0 110.711 179.159 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 94.71 26.4 13.24 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.729 -0.748 . . . . 0.0 114.373 178.552 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.626 ' HB2' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -126.12 166.32 17.23 Favored 'General case' 0 C--N 1.334 -0.066 0 CA-C-N 118.27 1.035 . . . . 0.0 112.379 179.892 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.599 ' O ' HG12 ' A' ' 6' ' ' VAL . 93.4 m -81.34 127.47 32.78 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.591 -179.745 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 2.4 p -123.61 116.75 23.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.935 -178.947 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.925 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.4 t -129.12 133.46 47.65 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.396 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.952 HG21 ' HA ' ' A' ' 16' ' ' ARG . 44.1 p -105.92 162.73 13.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.209 0.528 . . . . 0.0 112.114 -178.393 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.795 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 1.2 m-85 -131.56 172.22 12.49 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.775 -178.017 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.737 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 2.9 pp20? -63.55 -42.57 98.36 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -178.786 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -166.3 -59.76 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.224 0.535 . . . . 0.0 111.707 -178.983 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.782 ' HA3' HD22 ' A' ' 65' ' ' LEU . . . -162.98 -53.34 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.463 -0.79 . . . . 0.0 112.501 -179.485 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.706 ' HA ' HD12 ' A' ' 40' ' ' LEU . 0.8 OUTLIER -49.39 -28.4 5.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.996 0.427 . . . . 0.0 111.299 -179.817 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.795 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 2.1 tp10 -62.0 -56.74 15.94 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.253 179.919 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.853 HG23 HG13 ' A' ' 9' ' ' VAL . 38.6 t -60.52 -31.89 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.102 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.542 179.398 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.724 HD13 ' HB3' ' A' ' 68' ' ' GLN . 46.2 mt -55.21 -43.85 74.82 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.305 179.183 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -80.79 -48.71 12.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.142 -179.892 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.422 ' HB3' ' HE2' ' A' ' 33' ' ' PHE . . . -56.73 -30.94 64.05 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.317 -179.762 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.554 ' HG ' HG12 ' A' ' 39' ' ' VAL . 27.4 mt -64.26 -23.56 67.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.909 0.385 . . . . 0.0 111.323 179.986 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.95 -15.5 32.05 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.587 -179.911 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 31.4 t -119.47 -7.51 10.16 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.519 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.455 ' HB3' ' CH2' ' A' ' 7' ' ' TRP . 0.0 OUTLIER -164.61 163.17 21.83 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.891 0.377 . . . . 0.0 111.413 -179.866 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 51.8 m -138.48 113.61 8.71 Favored Pre-proline 0 N--CA 1.452 -0.331 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.264 179.855 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.741 ' HD2' HD11 ' A' ' 76' ' ' LEU . 57.1 Cg_endo -71.14 149.06 57.5 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.546 2.164 . . . . 0.0 111.672 179.228 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -74.07 -22.88 59.34 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.185 -179.743 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.835 HG11 HD11 ' A' ' 119' ' ' ILE . 6.3 p -149.02 98.23 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.751 -179.349 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.555 HD12 ' O ' ' A' ' 7' ' ' TRP . 38.9 tp -87.13 144.48 26.84 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.902 0.382 . . . . 0.0 111.863 -179.276 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.602 ' O ' HG23 ' A' ' 9' ' ' VAL . 1.0 OUTLIER -124.29 115.06 20.41 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.69 179.65 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.696 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 0.6 OUTLIER -115.23 134.03 55.5 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 121.567 0.699 . . . . 0.0 112.02 -179.337 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.08 -176.91 6.57 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.756 179.695 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.852 HG12 ' HA3' ' A' ' 62' ' ' GLY . 0.0 OUTLIER -149.17 108.62 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.492 179.623 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.467 ' O ' ' HG3' ' A' ' 57' ' ' MET . 0.1 OUTLIER -161.3 73.62 0.45 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.827 -179.463 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.467 ' HG3' ' O ' ' A' ' 56' ' ' ARG . 1.8 ptt? 38.85 51.45 3.14 Favored Pre-proline 0 CA--C 1.535 0.382 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 178.536 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.531 ' CG ' ' HA2' ' A' ' 62' ' ' GLY . 54.4 Cg_endo -76.4 -73.04 0.01 OUTLIER 'Trans proline' 0 CA--C 1.529 0.243 0 C-N-CA 122.215 1.944 . . . . 0.0 111.658 178.365 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -117.7 -27.06 2.65 Favored Glycine 0 CA--C 1.52 0.385 0 N-CA-C 111.835 -0.506 . . . . 0.0 111.835 179.172 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' MET . . . . . 1.059 ' HB3' ' HB2' ' A' ' 64' ' ' ALA . 4.4 tpt -159.44 69.6 0.45 Allowed 'General case' 0 C--O 1.236 0.358 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.318 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.445 ' O ' HG12 ' A' ' 55' ' ' ILE . 0.2 OUTLIER 68.82 -25.76 0.14 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.406 -0.816 . . . . 0.0 112.327 -179.951 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.852 ' HA3' HG12 ' A' ' 55' ' ' ILE . . . 142.13 -30.7 2.12 Favored Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -179.723 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.558 ' H ' HD12 ' A' ' 63' ' ' LEU . 3.3 mp -71.76 -21.36 61.75 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.456 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 1.059 ' HB2' ' HB3' ' A' ' 60' ' ' MET . . . -53.68 -42.38 67.88 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.008 0.433 . . . . 0.0 110.461 179.007 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.782 HD22 ' HA3' ' A' ' 36' ' ' GLY . 15.9 mt -51.54 -50.28 60.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.134 179.5 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.736 HD11 HG13 ' A' ' 80' ' ' ILE . 17.2 mt -52.12 -56.78 12.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.542 179.632 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.562 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 28.4 mttp -41.19 -47.68 3.34 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.669 -179.277 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.724 ' HB3' HD13 ' A' ' 40' ' ' LEU . 60.1 mm-40 -69.27 -35.9 76.54 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.278 -179.547 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.832 HG22 ' CD2' ' A' ' 73' ' ' HIS . 59.0 mt -54.07 -46.45 66.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.08 179.881 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.594 ' HA ' ' CE1' ' A' ' 73' ' ' HIS . 0.0 OUTLIER -70.96 -26.72 63.29 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -179.619 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -61.87 -30.23 70.72 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.218 -178.839 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.438 ' HD3' ' HB3' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -90.2 -59.73 2.11 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.405 0.621 . . . . 0.0 111.409 179.669 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.832 ' CD2' HG22 ' A' ' 69' ' ' ILE . 3.8 p80 -81.22 172.52 9.55 Favored Pre-proline 0 C--N 1.318 -0.779 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.557 -179.183 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.499 ' HD2' ' HB2' ' A' ' 73' ' ' HIS . 73.4 Cg_endo -87.33 -52.8 0.03 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.948 2.432 . . . . 0.0 112.073 179.015 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.638 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 28.7 mtt -157.48 49.51 0.43 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.071 179.213 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.741 HD11 ' HD2' ' A' ' 48' ' ' PRO . 2.1 tt -64.94 114.0 13.21 Favored Pre-proline 0 N--CA 1.454 -0.247 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.978 179.886 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.556 ' HG3' ' CE2' ' A' ' 122' ' ' TYR . 29.3 Cg_endo -64.71 115.45 3.24 Favored 'Trans proline' 0 CA--C 1.528 0.206 0 C-N-CA 122.389 2.06 . . . . 0.0 112.635 -179.796 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 1.007 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 5.3 t -115.51 154.45 16.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.104 179.909 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.562 HD11 HG23 ' A' ' 50' ' ' VAL . 1.9 mp -120.86 117.38 52.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.492 178.972 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.736 HG13 HD11 ' A' ' 66' ' ' LEU . 9.4 mm -99.04 150.21 5.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.098 0.475 . . . . 0.0 111.841 -179.409 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.556 ' HB3' HG22 ' A' ' 55' ' ' ILE . 53.5 ttp -67.59 -52.75 34.83 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.835 -179.129 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.436 ' H ' HG21 ' A' ' 55' ' ' ILE . 3.0 m -143.91 146.85 33.28 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 122.306 -0.246 . . . . 0.0 111.584 -179.234 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.91 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -113.98 57.86 0.69 Allowed 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.37 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.406 ' O ' ' OG ' ' A' ' 85' ' ' SER . 26.7 p80 -99.21 -176.6 3.35 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.946 -0.302 . . . . 0.0 110.952 179.392 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.406 ' OG ' ' O ' ' A' ' 84' ' ' HIS . 20.8 p 71.09 -61.16 0.49 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.603 -179.709 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.458 ' OD2' HD13 ' A' ' 63' ' ' LEU . 4.0 p-10 -154.01 85.64 1.16 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -179.096 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.878 HD23 ' HB3' ' A' ' 90' ' ' ALA . 0.7 OUTLIER -52.73 -20.8 3.42 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.487 179.33 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -47.83 -57.09 6.07 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.607 -0.269 . . . . 0.0 111.664 -178.972 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.466 ' HB3' HD22 ' A' ' 63' ' ' LEU . . . -64.21 -19.94 65.69 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.725 0.297 . . . . 0.0 111.209 -179.968 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.878 ' HB3' HD23 ' A' ' 87' ' ' LEU . . . -77.26 -46.4 23.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.696 -179.696 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.63 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 6.6 t -62.64 -49.14 84.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 120.985 -0.286 . . . . 0.0 111.141 -179.7 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 52.5 p -56.51 -25.6 51.97 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.216 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.589 ' HB3' ' O ' ' A' ' 90' ' ' ALA . . . -60.08 -52.89 63.43 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.924 179.791 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.63 ' CE2' ' HA ' ' A' ' 91' ' ' VAL . 2.8 m-85 -55.78 -31.2 62.4 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.459 0.647 . . . . 0.0 109.917 179.771 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.12 -42.07 39.43 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.922 -1.036 . . . . 0.0 110.995 -179.967 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.638 ' O ' ' HA ' ' A' ' 75' ' ' MET . 7.3 pt20 -85.2 -18.15 34.94 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.785 -179.421 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 93' ' ' ALA . . . 140.29 85.32 0.1 Allowed Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.114 -179.101 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 1.007 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -168.26 123.81 0.99 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.157 0.503 . . . . 0.0 111.918 179.946 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -58.16 -52.77 64.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.773 -179.931 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.584 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 0.2 OUTLIER 170.12 -172.53 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 121.197 0.522 . . . . 0.0 111.675 -179.873 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.91 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 7.9 m-85 -113.38 153.57 28.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.263 179.621 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.576 HD21 ' HA ' ' A' ' 106' ' ' PHE . 7.9 tp -102.3 144.97 29.66 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.827 -179.195 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.563 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 18.5 Cg_exo -66.69 -157.06 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.739 2.293 . . . . 0.0 112.838 -179.043 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.504 ' HB3' ' HD3' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -56.13 -55.08 45.62 Favored Pre-proline 0 CA--C 1.531 0.218 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.859 -179.246 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.563 ' HD2' ' HB2' ' A' ' 103' ' ' PRO . 54.1 Cg_exo -52.31 164.23 1.37 Allowed 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.349 2.032 . . . . 0.0 111.923 179.695 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.616 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 57.6 t80 -158.2 -106.93 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.707 -0.224 . . . . 0.0 110.588 179.865 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.541 ' O ' ' O ' ' A' ' 106' ' ' PHE . 3.1 p30 42.37 -176.82 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.937 0.398 . . . . 0.0 111.041 -179.791 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.628 HG12 HG12 ' A' ' 18' ' ' VAL . 0.7 OUTLIER -68.0 -40.73 83.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.224 0.535 . . . . 0.0 111.155 -179.969 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.44 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 8.3 t0 -50.62 -58.88 4.79 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.919 -179.316 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.616 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 9.6 mm-40 -76.41 -30.36 57.42 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 111.725 0.268 . . . . 0.0 111.725 -179.366 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -69.77 -55.63 9.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.928 0.394 . . . . 0.0 110.322 179.332 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.676 ' O ' HG12 ' A' ' 115' ' ' VAL . 48.1 t -61.2 -33.61 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-O 121.357 0.598 . . . . 0.0 110.364 179.332 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.44 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -61.63 -47.14 86.75 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.618 179.723 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.472 HD23 ' CG2' ' A' ' 79' ' ' ILE . 55.4 tp -75.6 -21.43 57.8 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.632 -179.58 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.676 HG12 ' O ' ' A' ' 112' ' ' VAL . 2.9 p -79.4 -38.8 20.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.776 -0.37 . . . . 0.0 111.836 -179.639 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.533 ' OE2' HG12 ' A' ' 112' ' ' VAL . 36.7 mt-10 -68.44 -38.5 81.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.846 0.355 . . . . 0.0 110.773 179.997 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -64.21 -24.91 67.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.951 0.405 . . . . 0.0 110.367 179.531 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -70.62 -49.54 46.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.717 179.544 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.835 HD11 HG11 ' A' ' 50' ' ' VAL . 4.7 mt -70.36 -32.66 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-O 121.271 0.558 . . . . 0.0 110.965 179.759 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 15.1 m -70.01 -44.06 70.07 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.262 -179.786 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 11.2 m80 -60.19 -24.27 64.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.181 -179.841 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.556 ' CE2' ' HG3' ' A' ' 77' ' ' PRO . 0.5 OUTLIER -72.07 -53.07 13.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.075 0.464 . . . . 0.0 111.245 -179.71 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.515 ' O ' ' HG3' ' A' ' 124' ' ' GLU . 11.5 pt20 -75.59 -168.25 0.81 Allowed 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.284 179.999 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.515 ' HG3' ' O ' ' A' ' 123' ' ' GLN . 0.4 OUTLIER . . . . . 0 N--CA 1.463 0.201 0 CA-C-O 120.888 0.375 . . . . 0.0 111.577 -179.924 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.472 0 CA-C-O 120.701 0.286 . . . . 0.0 111.278 . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -119.55 -22.39 6.98 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.797 -179.958 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.796 ' CG ' HD11 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -59.74 -11.58 5.44 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.802 0.335 . . . . 0.0 111.093 179.698 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.761 ' C ' HD13 ' A' ' 5' ' ' ILE . . . 88.46 97.78 0.97 Allowed Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.426 -0.892 . . . . 0.0 111.074 -179.257 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.796 HD11 ' CG ' ' A' ' 3' ' ' ARG . 4.9 mm -121.77 112.49 35.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 120.689 0.28 . . . . 0.0 111.361 -179.032 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.782 HG11 ' HG ' ' A' ' 23' ' ' LEU . 10.6 p -105.56 127.0 60.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.229 0.538 . . . . 0.0 110.657 179.101 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.944 ' CD1' HG22 ' A' ' 31' ' ' THR . 34.3 m0 -114.53 125.6 53.98 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.868 179.746 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.73 ' HB ' HG22 ' A' ' 32' ' ' THR . 0.2 OUTLIER -115.65 136.55 52.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.691 -177.956 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.698 HG12 ' HB2' ' A' ' 33' ' ' PHE . 18.0 m -115.25 110.68 32.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.224 0.535 . . . . 0.0 110.746 179.062 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.471 ' CB ' HG21 ' A' ' 15' ' ' ILE . 3.9 t0 -162.22 -158.6 0.53 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.381 -179.166 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -67.83 -0.19 3.97 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.614 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 68.78 -154.07 0.16 Allowed 'General case' 0 CA--C 1.532 0.265 0 O-C-N 122.313 -0.242 . . . . 0.0 111.02 179.553 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.438 ' OG ' ' N ' ' A' ' 14' ' ' SER . 74.8 p 33.01 -96.37 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 179.219 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.76 ' O ' HG23 ' A' ' 18' ' ' VAL . 4.4 t -53.06 -57.27 10.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.629 0.252 . . . . 0.0 111.599 -179.197 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.471 HG21 ' CB ' ' A' ' 10' ' ' ASP . 31.0 mm -61.41 -26.15 38.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.849 0.357 . . . . 0.0 111.078 179.931 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.706 ' HA ' HG21 ' A' ' 32' ' ' THR . 53.8 ttt180 -77.06 -44.27 31.31 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.708 179.803 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.447 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 70.2 t90 -64.23 -40.44 96.04 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.979 -179.275 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.76 HG23 ' O ' ' A' ' 14' ' ' SER . 3.5 t -70.48 -37.57 70.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.0 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.412 ' O ' HD13 ' A' ' 19' ' ' LEU . 0.2 OUTLIER -84.26 -29.32 26.56 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.969 -179.171 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.558 ' HA ' ' SG ' ' A' ' 30' ' ' CYS . 24.9 pt-20 -67.53 -60.36 2.62 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.913 -178.906 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.464 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 5.7 mmt85 -58.11 -54.09 50.85 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.189 -0.459 . . . . 0.0 112.008 -179.588 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.56 -53.96 47.65 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.108 0.48 . . . . 0.0 111.343 -179.574 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.782 ' HG ' HG11 ' A' ' 6' ' ' VAL . 2.5 tm? -66.32 -27.98 68.32 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.582 0.706 . . . . 0.0 110.451 179.52 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.428 ' HB2' ' O ' ' A' ' 20' ' ' GLU . . . -67.1 -34.55 77.86 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.527 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.53 -26.78 64.99 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.296 -0.954 . . . . 0.0 110.946 178.039 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.664 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -77.27 -16.22 59.09 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 120.701 0.286 . . . . 0.0 110.805 179.104 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.49 23.68 13.72 Favored Glycine 0 CA--C 1.521 0.419 0 C-N-CA 120.675 -0.774 . . . . 0.0 114.247 178.615 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.668 ' HB2' HD11 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -123.81 166.64 15.25 Favored 'General case' 0 CA--C 1.527 0.076 0 CA-C-N 118.107 0.954 . . . . 0.0 111.935 -179.802 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.736 ' O ' HG12 ' A' ' 6' ' ' VAL . 97.6 m -84.83 138.54 32.5 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.027 -179.777 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.558 ' SG ' ' HA ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -126.85 116.43 20.85 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.073 0.463 . . . . 0.0 111.694 -179.544 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.944 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.4 t -128.77 132.43 47.9 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.409 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.73 HG22 ' HB ' ' A' ' 8' ' ' VAL . 45.8 p -108.51 165.09 11.79 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.267 0.556 . . . . 0.0 111.749 -178.335 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.808 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 3.2 m-85 -135.06 172.09 13.51 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.196 -177.89 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.561 ' HG2' ' N ' ' A' ' 35' ' ' ASN . 0.0 OUTLIER -63.31 -32.67 74.15 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.797 -179.837 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.561 ' N ' ' HG2' ' A' ' 34' ' ' GLU . 50.1 p-10 -179.47 179.49 0.61 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.264 -179.434 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.603 ' O ' ' HG ' ' A' ' 40' ' ' LEU . . . -55.16 -10.2 2.48 Favored Glycine 0 CA--C 1.521 0.438 0 C-N-CA 120.709 -0.758 . . . . 0.0 114.011 -179.438 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.545 ' HA ' HD12 ' A' ' 40' ' ' LEU . 25.2 m-20 -84.55 -44.57 13.44 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 117.727 0.763 . . . . 0.0 112.501 -179.315 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.808 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 6.6 tt0 -51.74 -58.72 5.6 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -179.271 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.615 HG22 ' CE1' ' A' ' 33' ' ' PHE . 55.1 t -47.55 -38.13 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 121.017 0.437 . . . . 0.0 111.173 -179.594 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.771 HD13 ' CB ' ' A' ' 68' ' ' GLN . 20.6 mt -57.03 -41.84 79.36 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.429 -179.956 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.87 -48.09 40.43 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.277 0.56 . . . . 0.0 110.177 178.911 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.48 -28.66 69.45 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.135 179.386 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.563 ' CD1' ' CE1' ' A' ' 73' ' ' HIS . 15.1 mt -65.56 -24.94 67.22 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.88 -179.412 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.64 -16.0 14.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.843 -179.471 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -125.68 -1.57 7.35 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.712 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.535 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -163.42 159.89 22.81 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.917 0.389 . . . . 0.0 111.419 179.822 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 83.1 m -139.08 116.03 8.7 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.297 -179.929 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.731 ' O ' HD21 ' A' ' 76' ' ' LEU . 77.3 Cg_endo -77.42 163.21 30.09 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.056 1.837 . . . . 0.0 111.511 179.084 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.472 ' HB3' HG23 ' A' ' 119' ' ' ILE . 1.5 m-20 -74.23 -22.17 59.46 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.973 -0.291 . . . . 0.0 111.33 -179.744 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.775 HG13 HG23 ' A' ' 6' ' ' VAL . 8.3 p -147.7 169.42 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.477 -179.562 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.785 HD12 ' O ' ' A' ' 7' ' ' TRP . 10.0 tp -152.93 129.85 11.0 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 120.958 0.409 . . . . 0.0 111.318 -179.075 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.577 ' HG ' ' HB ' ' A' ' 79' ' ' ILE . 0.2 OUTLIER -115.69 126.76 54.52 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.78 179.789 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.72 ' CB ' HD22 ' A' ' 65' ' ' LEU . 0.2 OUTLIER -119.3 126.43 51.43 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -178.727 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -83.21 101.9 11.54 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.643 177.803 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.683 ' CG2' ' HB ' ' A' ' 82' ' ' THR . 2.2 tt -68.79 93.03 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.665 -179.505 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.462 ' NH2' ' HB3' ' A' ' 35' ' ' ASN . 6.8 ptt85 -135.46 59.05 1.74 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.48 -179.446 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.529 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 24.6 ptm 41.04 48.94 2.98 Favored Pre-proline 0 N--CA 1.467 0.381 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 179.746 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 62' ' ' GLY . 43.5 Cg_endo -70.49 -80.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.267 1.978 . . . . 0.0 111.999 178.943 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -107.27 -23.72 6.85 Favored Glycine 0 N--CA 1.449 -0.441 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 179.359 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.941 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 8.8 tpt -162.88 69.1 0.23 Allowed 'General case' 0 C--O 1.236 0.36 0 CA-C-O 120.923 0.392 . . . . 0.0 110.447 179.816 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.529 ' HA ' ' HA ' ' A' ' 57' ' ' MET . 0.3 OUTLIER 68.56 -26.46 0.14 Allowed 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.246 179.834 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.652 ' HA3' HG13 ' A' ' 55' ' ' ILE . . . 140.62 -29.58 2.36 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -179.441 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.644 HD12 ' H ' ' A' ' 63' ' ' LEU . 2.2 mp -75.62 -12.19 60.16 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.649 -0.275 . . . . 0.0 110.428 179.088 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.941 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -53.67 -26.9 24.7 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-O 120.925 0.393 . . . . 0.0 110.455 179.155 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.832 ' CD2' HG11 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -59.11 -62.15 2.1 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.954 -0.567 . . . . 0.0 109.714 178.982 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.959 ' HA ' HD12 ' A' ' 69' ' ' ILE . 7.9 mt -43.56 -43.39 5.55 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.243 179.513 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.447 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 19.4 mttt -54.0 -58.0 8.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.004 0.43 . . . . 0.0 111.225 179.507 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.771 ' CB ' HD13 ' A' ' 40' ' ' LEU . 21.5 mm-40 -62.07 -28.73 69.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.035 -179.846 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.959 HD12 ' HA ' ' A' ' 66' ' ' LEU . 77.0 mt -63.11 -42.02 95.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.029 0.442 . . . . 0.0 111.294 -179.846 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.529 ' HA ' ' HA ' ' A' ' 74' ' ' PRO . 0.1 OUTLIER -67.64 -29.25 68.51 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.573 -179.773 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -68.51 -40.61 80.76 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.036 179.527 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.403 ' NE ' ' HB3' ' A' ' 40' ' ' LEU . 52.0 mtt-85 -93.26 -76.22 0.48 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.743 -179.963 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.893 ' CD2' HG23 ' A' ' 69' ' ' ILE . 0.5 OUTLIER -114.5 79.18 5.28 Favored Pre-proline 0 C--N 1.318 -0.781 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.88 179.707 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.553 ' O ' ' HG3' ' A' ' 75' ' ' MET . 56.9 Cg_endo -70.87 50.28 1.07 Allowed 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.734 2.289 . . . . 0.0 113.131 -179.708 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.553 ' HG3' ' O ' ' A' ' 74' ' ' PRO . 2.8 mtp -150.65 -36.88 0.14 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.145 0.497 . . . . 0.0 110.82 179.716 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.731 HD21 ' O ' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -48.7 117.46 6.17 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.629 -179.831 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.493 ' HB3' ' HE2' ' A' ' 122' ' ' TYR . 31.5 Cg_endo -64.5 134.37 41.11 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.046 1.831 . . . . 0.0 111.627 179.051 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.882 HG21 HD13 ' A' ' 69' ' ' ILE . 5.8 t -122.15 143.62 34.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.932 0.396 . . . . 0.0 111.262 -179.56 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.643 ' CG2' HD23 ' A' ' 114' ' ' LEU . 1.6 mt -124.01 110.67 26.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.925 -180.0 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.674 HD12 ' HB3' ' A' ' 53' ' ' SER . 6.3 mm -99.01 148.28 6.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.586 -179.199 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.449 ' O ' ' HB2' ' A' ' 102' ' ' LEU . 62.2 ttp -76.21 -60.42 2.34 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.813 -0.631 . . . . 0.0 112.322 -179.211 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.683 ' HB ' ' CG2' ' A' ' 55' ' ' ILE . 40.9 m -109.76 151.57 26.78 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.31 -178.516 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.983 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -136.09 -3.7 2.21 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -179.377 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.48 ' HE1' ' O ' ' A' ' 103' ' ' PRO . 0.5 OUTLIER -71.49 35.41 0.06 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -178.982 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.503 ' O ' HD11 ' A' ' 63' ' ' LEU . 80.2 p -159.79 102.16 1.49 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.698 0.285 . . . . 0.0 111.184 179.447 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.534 ' HB3' HD13 ' A' ' 63' ' ' LEU . 0.7 OUTLIER 67.64 35.37 4.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.911 179.762 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.55 HD23 ' HB3' ' A' ' 90' ' ' ALA . 0.5 OUTLIER -46.52 -22.53 0.28 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.108 -0.496 . . . . 0.0 112.078 -179.931 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -47.98 -50.3 27.84 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 -179.498 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.481 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -60.77 -21.02 62.63 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.649 0.261 . . . . 0.0 111.661 -179.601 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.576 ' O ' ' HB3' ' A' ' 93' ' ' ALA . . . -70.29 -34.03 72.27 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.886 0.374 . . . . 0.0 110.711 179.625 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.593 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 4.5 t -61.75 -49.84 82.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.386 -179.961 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 17.6 m -59.72 -22.51 62.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.063 0.459 . . . . 0.0 110.037 179.209 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.929 ' HB1' ' HB2' ' A' ' 98' ' ' ALA . . . -65.14 -50.85 64.43 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.526 179.419 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.593 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 9.8 m-85 -54.92 -24.48 23.82 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.089 179.146 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -76.51 -30.58 57.25 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.991 179.254 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.57 ' HG2' ' HA ' ' A' ' 93' ' ' ALA . 1.7 pt20 -91.14 -18.31 24.69 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.93 179.403 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 77' ' ' PRO . . . 127.85 14.72 2.49 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.059 -1.067 . . . . 0.0 114.016 179.283 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.929 ' HB2' ' HB1' ' A' ' 93' ' ' ALA . . . -55.46 144.52 25.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 117.457 0.629 . . . . 0.0 110.785 179.569 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.569 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 12.3 t80 -78.49 -54.46 6.13 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.337 -179.548 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.56 ' OD1' HD21 ' A' ' 114' ' ' LEU . 10.3 p-10 173.62 -165.26 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 121.065 0.46 . . . . 0.0 111.528 179.96 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.983 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 5.3 m-85 -138.78 153.8 48.45 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.097 -179.832 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.776 HD11 HD22 ' A' ' 114' ' ' LEU . 5.5 mp -103.0 127.9 28.87 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 120.662 0.267 . . . . 0.0 111.288 -179.918 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.48 ' O ' ' HE1' ' A' ' 84' ' ' HIS . 39.2 Cg_endo -77.84 -74.6 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 121.962 1.775 . . . . 0.0 112.252 179.593 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.704 ' H ' ' HD2' ' A' ' 105' ' ' PRO . 0.2 OUTLIER -107.77 -55.91 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 -179.661 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.704 ' HD2' ' H ' ' A' ' 104' ' ' LYS . 34.0 Cg_endo -64.44 160.01 41.42 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 121.909 1.739 . . . . 0.0 112.729 -179.5 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.681 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 47.5 t80 -166.21 -106.51 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.089 -179.929 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.566 ' O ' ' O ' ' A' ' 106' ' ' PHE . 2.4 p30 42.98 177.47 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.859 0.361 . . . . 0.0 111.414 -179.888 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.73 HG12 HG12 ' A' ' 18' ' ' VAL . 0.9 OUTLIER -68.06 -42.37 85.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.001 0.429 . . . . 0.0 111.401 -179.624 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.502 ' HB2' ' OD1' ' A' ' 107' ' ' ASP . 6.1 m-20 -49.08 -58.27 5.22 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.521 -179.826 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.681 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 8.1 mm-40 -74.76 -35.6 62.58 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.646 0.26 . . . . 0.0 111.602 -179.675 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.77 -56.15 13.51 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.692 179.693 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.627 ' O ' HG12 ' A' ' 115' ' ' VAL . 54.7 t -62.1 -33.92 60.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.341 0.591 . . . . 0.0 110.585 179.364 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.477 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -61.84 -46.45 89.44 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.427 179.19 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.776 HD22 HD11 ' A' ' 102' ' ' LEU . 36.3 tp -74.67 -23.66 58.68 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.837 -179.216 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.737 HG23 HG21 ' A' ' 50' ' ' VAL . 6.4 p -79.49 -43.12 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.586 -179.901 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -62.73 -47.31 84.15 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.056 -179.695 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.651 ' HD2' HD12 ' A' ' 114' ' ' LEU . 6.4 ptp180 -60.05 -23.6 63.87 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.735 179.507 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.569 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -74.63 -48.15 28.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.121 179.998 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.472 HG23 ' HB3' ' A' ' 49' ' ' ASP . 3.8 mt -68.76 -32.69 55.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.173 0.511 . . . . 0.0 110.738 179.697 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.5 t -68.95 -55.06 12.12 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.239 -179.763 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 6.4 m80 -59.35 -25.89 64.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.519 -179.612 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.493 ' HE2' ' HB3' ' A' ' 77' ' ' PRO . 2.2 m-85 -81.42 -34.11 31.75 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.094 -179.772 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.24 177.51 6.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.707 179.688 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.024 179.996 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.488 1.45 0 CA-C-O 120.944 0.402 . . . . 0.0 111.281 . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 63.18 135.91 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.036 -179.779 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.45 -21.84 21.69 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.319 -179.84 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.459 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . 78.02 101.28 0.2 Allowed Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.809 -179.473 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.4 mp -118.72 113.24 41.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.913 0.387 . . . . 0.0 111.509 -179.419 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 1.02 HG11 ' HG ' ' A' ' 23' ' ' LEU . 11.6 p -105.97 128.33 60.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.675 179.297 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.914 ' CD1' HG22 ' A' ' 31' ' ' THR . 31.2 m0 -114.69 132.86 56.27 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.742 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.569 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -123.86 141.6 43.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.066 0.46 . . . . 0.0 111.594 -178.06 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.934 HG12 ' HB2' ' A' ' 33' ' ' PHE . 29.1 m -123.92 111.28 28.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.301 0.572 . . . . 0.0 111.005 179.474 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -161.38 -157.81 0.53 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.475 -179.557 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -72.0 9.12 1.01 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.987 0.365 . . . . 0.0 111.987 -179.929 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.532 ' O ' ' N ' ' A' ' 14' ' ' SER . 3.4 p30 47.8 -136.69 0.91 Allowed 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 179.662 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.53 ' N ' ' HG2' ' A' ' 16' ' ' ARG . 1.5 t 36.32 -84.44 0.0 OUTLIER 'General case' 0 C--O 1.236 0.348 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -179.584 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.715 ' O ' HG23 ' A' ' 18' ' ' VAL . 35.6 t -77.8 -43.82 29.37 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.205 -0.452 . . . . 0.0 112.135 -179.21 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 27.4 mm -63.97 -34.34 67.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -178.893 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.862 ' HA ' HG21 ' A' ' 32' ' ' THR . 6.1 ptp180 -67.85 -52.69 33.76 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.789 -179.44 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.586 ' H ' ' HG3' ' A' ' 16' ' ' ARG . 28.4 t90 -54.85 -41.92 71.36 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.326 -178.782 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.715 HG23 ' O ' ' A' ' 14' ' ' SER . 13.5 t -67.55 -49.16 73.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -178.542 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.683 ' HG ' HD11 ' A' ' 108' ' ' ILE . 6.7 mt -79.72 -26.9 40.7 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.777 -178.112 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.611 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 19.3 pt-20 -66.8 -57.99 5.95 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.506 -0.477 . . . . 0.0 111.411 -179.604 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.482 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 3.4 mmt-85 -60.79 -54.46 44.88 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.927 -179.463 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.86 -33.29 68.52 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -179.055 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.02 ' HG ' HG11 ' A' ' 6' ' ' VAL . 2.7 tm? -76.01 -30.36 58.47 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.494 0.664 . . . . 0.0 110.308 179.602 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.61 -33.3 75.61 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.28 178.401 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.18 -26.15 68.98 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.198 178.607 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.617 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -78.25 -15.57 58.65 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 120.752 0.311 . . . . 0.0 110.823 179.371 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.98 26.06 10.74 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.647 -0.787 . . . . 0.0 113.596 179.211 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.682 ' HB2' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -132.77 170.89 14.62 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 117.571 0.685 . . . . 0.0 111.742 179.854 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.779 ' O ' HG12 ' A' ' 6' ' ' VAL . 23.5 m -95.76 137.6 34.59 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.63 -179.438 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.611 ' HB3' ' HA ' ' A' ' 20' ' ' GLU . 10.9 t -125.38 119.86 29.47 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.088 0.471 . . . . 0.0 111.501 -179.569 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.914 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.5 t -125.95 132.27 52.11 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.833 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.862 HG21 ' HA ' ' A' ' 16' ' ' ARG . 69.9 p -103.4 164.11 11.85 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 -177.23 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.934 ' HB2' HG12 ' A' ' 9' ' ' VAL . 6.0 m-85 -134.41 172.96 12.18 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.59 -178.384 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.435 ' HG2' ' N ' ' A' ' 35' ' ' ASN . 0.5 OUTLIER -62.28 -34.83 77.32 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -177.175 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.613 ' C ' ' HB ' ' A' ' 9' ' ' VAL . 22.0 p30 -176.68 -26.44 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 179.622 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.614 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . 161.82 -56.64 0.3 Allowed Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.037 -1.077 . . . . 0.0 113.123 179.649 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.529 ' N ' HD11 ' A' ' 65' ' ' LEU . 1.9 t30 -50.02 -34.03 19.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.12 0.486 . . . . 0.0 110.673 -179.764 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.659 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -54.22 -52.08 62.42 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.454 179.803 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.672 HG12 ' CD1' ' A' ' 43' ' ' LEU . 56.1 t -57.61 -40.98 78.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.036 -179.829 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.801 HD13 ' HB2' ' A' ' 68' ' ' GLN . 19.2 mt -53.12 -40.69 64.37 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.092 0.472 . . . . 0.0 110.426 179.459 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -77.25 -48.71 16.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.044 179.449 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.69 -25.15 67.22 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.763 179.67 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.77 HD21 ' HD2' ' A' ' 48' ' ' PRO . 9.3 mt -68.35 -22.05 64.7 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.036 -179.54 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.06 -17.09 36.84 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.737 -179.641 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.8 t -121.96 -3.48 9.12 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -179.611 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.647 ' O ' HD23 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -162.71 159.02 23.78 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.038 0.447 . . . . 0.0 111.34 179.643 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.696 HG23 HD13 ' A' ' 76' ' ' LEU . 98.2 m -139.23 113.96 8.22 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.442 179.703 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.77 ' HD2' HD21 ' A' ' 43' ' ' LEU . 72.0 Cg_endo -75.7 161.64 36.42 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.049 1.832 . . . . 0.0 111.291 178.92 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.45 ' O ' ' HG2' ' A' ' 77' ' ' PRO . 1.2 m-20 -73.69 -21.15 60.34 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.649 0.261 . . . . 0.0 110.956 -179.869 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.87 HG13 HG23 ' A' ' 6' ' ' VAL . 7.5 p -148.75 166.7 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.347 179.958 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.596 HD11 HG21 ' A' ' 39' ' ' VAL . 18.8 tp -153.02 130.78 11.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.736 0.303 . . . . 0.0 111.158 -179.467 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.31 121.44 44.9 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.531 -179.934 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.764 ' HB2' HD13 ' A' ' 80' ' ' ILE . 3.2 m -106.23 130.83 54.02 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.928 0.394 . . . . 0.0 111.488 -179.695 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.402 ' O ' ' CG2' ' A' ' 55' ' ' ILE . 35.4 t70 -73.78 -22.67 59.76 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.586 -179.803 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.813 HG12 ' HA3' ' A' ' 62' ' ' GLY . 0.0 OUTLIER 44.04 99.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 121.185 0.517 . . . . 0.0 111.832 -179.782 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -142.58 43.99 1.62 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.585 -179.57 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.555 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER 58.81 48.13 2.2 Favored Pre-proline 0 CA--C 1.532 0.264 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 179.296 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.556 ' HD2' ' N ' ' A' ' 62' ' ' GLY . 41.1 Cg_endo -68.06 -79.16 0.01 OUTLIER 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 122.327 2.018 . . . . 0.0 111.969 178.914 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -107.83 -25.15 6.04 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.331 179.478 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.966 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 0.3 OUTLIER -158.72 65.03 0.42 Allowed 'General case' 0 C--O 1.236 0.368 0 CA-C-O 120.962 0.41 . . . . 0.0 110.454 179.813 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.555 ' HA ' ' HA ' ' A' ' 57' ' ' MET . 0.2 OUTLIER 70.36 -21.24 0.19 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.961 179.998 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.813 ' HA3' HG12 ' A' ' 55' ' ' ILE . . . 130.76 -30.0 3.47 Favored Glycine 0 N--CA 1.446 -0.674 0 N-CA-C 110.146 -1.182 . . . . 0.0 110.146 -178.847 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.901 ' HA ' HD23 ' A' ' 66' ' ' LEU . 0.8 OUTLIER -70.54 -15.99 62.83 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.007 -0.596 . . . . 0.0 109.732 178.675 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.966 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -53.54 -32.08 49.15 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-O 120.906 0.384 . . . . 0.0 110.259 179.706 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.651 ' HG ' HD11 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -61.24 -43.38 98.97 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.311 179.027 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.901 HD23 ' HA ' ' A' ' 63' ' ' LEU . 3.1 mm? -57.69 -45.45 85.62 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.052 -179.493 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -55.55 -47.69 75.96 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.234 0.54 . . . . 0.0 110.361 179.15 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.801 ' HB2' HD13 ' A' ' 40' ' ' LEU . 34.7 mm-40 -60.04 -29.74 68.73 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.503 179.62 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.555 ' HB ' ' O ' ' A' ' 66' ' ' LEU . 59.4 mt -57.19 -48.98 81.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.224 0.535 . . . . 0.0 111.155 -179.705 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.55 ' HB3' ' CG ' ' A' ' 96' ' ' GLN . 7.6 pttt -63.02 -33.57 75.7 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.004 -179.232 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.493 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 4.4 mt-30 -72.73 -32.94 66.08 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.913 -179.478 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.2 mtt180 -108.87 -65.71 1.11 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -178.627 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.696 ' CE1' HD13 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -82.12 169.04 19.84 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.679 -178.677 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -84.67 -68.99 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.885 2.39 . . . . 0.0 113.116 -179.579 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.426 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 69.7 mtm -150.98 45.83 0.84 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.823 0.344 . . . . 0.0 110.786 -179.8 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.696 HD13 HG23 ' A' ' 47' ' ' THR . 25.3 tp -56.77 114.8 8.6 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.231 -179.589 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.45 ' HG2' ' O ' ' A' ' 49' ' ' ASP . 19.6 Cg_endo -59.87 123.14 12.62 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.236 1.957 . . . . 0.0 112.011 179.531 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.957 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 4.6 t -124.59 153.07 31.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.843 -179.743 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.884 HD13 HG23 ' A' ' 115' ' ' VAL . 1.7 mt -128.45 114.39 33.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.94 179.939 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.764 HD13 ' HB2' ' A' ' 53' ' ' SER . 13.7 mm -93.83 141.01 15.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.889 -179.865 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.593 ' HA ' ' HB3' ' A' ' 102' ' ' LEU . 0.3 OUTLIER -80.26 -33.04 38.17 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.573 -179.334 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.538 ' H ' HG21 ' A' ' 55' ' ' ILE . 19.8 m -147.83 144.92 28.5 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 120.96 0.41 . . . . 0.0 111.724 -179.244 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.474 ' HA ' ' CE2' ' A' ' 101' ' ' TYR . . . -86.92 -26.19 24.03 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.39 179.661 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.52 ' H ' HG22 ' A' ' 82' ' ' THR . 21.9 m170 46.87 44.5 14.49 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.766 179.549 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 38.8 m 53.4 85.89 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.576 179.286 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 177.03 35.71 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.825 179.822 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.806 HD13 ' HB3' ' A' ' 90' ' ' ALA . 0.3 OUTLIER -49.12 -21.87 0.83 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.949 -179.509 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -47.7 -61.08 2.11 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.48 0.181 . . . . 0.0 111.422 -179.503 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.0 -20.03 60.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.824 0.345 . . . . 0.0 110.698 179.375 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.806 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -62.38 -47.57 83.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.345 -179.963 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.564 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 6.6 t -67.26 -41.05 86.16 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 C-N-CA 120.704 -0.399 . . . . 0.0 110.52 179.819 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.504 ' O ' ' HG3' ' A' ' 95' ' ' GLN . 39.7 m -62.19 -15.83 49.0 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.387 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.638 ' HB2' ' HG ' ' A' ' 66' ' ' LEU . . . -75.87 -64.0 1.18 Allowed 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 120.988 0.423 . . . . 0.0 111.625 179.904 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.636 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 3.9 m-85 -41.7 -44.35 3.14 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.782 -178.431 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.504 ' HG3' ' O ' ' A' ' 92' ' ' SER . 0.0 OUTLIER -69.97 -48.46 58.17 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.23 179.563 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.55 ' CG ' ' HB3' ' A' ' 70' ' ' LYS . 59.5 mt-30 -75.92 -9.83 58.93 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.292 -0.413 . . . . 0.0 112.106 -179.831 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 93' ' ' ALA . . . 133.48 80.64 0.16 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.063 -179.553 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.957 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -168.5 133.82 1.73 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.093 0.473 . . . . 0.0 111.309 -179.903 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.42 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 50.4 t80 -73.33 -53.37 10.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.773 -179.777 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.53 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 1.7 t0 175.84 -171.05 0.07 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.016 0.436 . . . . 0.0 111.404 -179.817 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.678 ' CE2' HG21 ' A' ' 80' ' ' ILE . 6.7 m-85 -114.35 152.88 30.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.233 179.328 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.702 HD21 ' HA ' ' A' ' 106' ' ' PHE . 5.9 tp -105.52 137.32 19.26 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.142 -179.032 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.23 -161.5 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.933 2.422 . . . . 0.0 112.726 -179.545 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.445 ' CB ' ' HD3' ' A' ' 105' ' ' PRO . 0.3 OUTLIER -48.89 -59.25 6.61 Favored Pre-proline 0 CA--C 1.531 0.223 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.819 -179.478 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.445 ' HD3' ' CB ' ' A' ' 104' ' ' LYS . 73.8 Cg_exo -48.49 164.27 0.22 Allowed 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.44 2.093 . . . . 0.0 111.868 179.776 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.702 ' HA ' HD21 ' A' ' 102' ' ' LEU . 64.8 t80 -161.74 -102.42 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.706 -0.224 . . . . 0.0 110.719 179.844 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.583 ' O ' ' O ' ' A' ' 106' ' ' PHE . 2.6 p-10 42.09 179.3 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.915 0.388 . . . . 0.0 111.318 -179.983 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.697 HG12 HG12 ' A' ' 18' ' ' VAL . 1.0 OUTLIER -67.66 -42.29 86.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.084 0.468 . . . . 0.0 111.346 179.863 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.52 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 3.4 t0 -51.86 -58.77 5.49 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.594 -179.36 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.63 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 3.3 mm-40 -75.62 -27.7 58.55 Favored 'General case' 0 C--N 1.333 -0.124 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -179.476 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.419 ' CB ' ' O ' ' A' ' 107' ' ' ASP . . . -73.82 -62.52 1.47 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.925 0.393 . . . . 0.0 110.256 179.519 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.62 ' O ' HG12 ' A' ' 115' ' ' VAL . 49.3 t -55.63 -29.86 25.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.484 0.659 . . . . 0.0 110.256 179.021 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.53 ' O ' ' HG3' ' A' ' 117' ' ' ARG . . . -63.46 -50.96 67.65 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.731 179.172 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 53.7 tp -72.4 -20.69 61.39 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.395 -0.82 . . . . 0.0 112.273 -179.705 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.884 HG23 HD13 ' A' ' 79' ' ' ILE . 2.9 p -79.36 -47.67 22.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.686 -179.338 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.416 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 26.0 mt-10 -64.24 -42.8 96.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.855 0.36 . . . . 0.0 110.652 179.98 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.53 ' HG3' ' O ' ' A' ' 113' ' ' ALA . 40.5 mtt85 -63.36 -23.68 67.52 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.924 0.392 . . . . 0.0 110.551 179.224 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.42 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -70.16 -48.76 55.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.663 179.446 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.687 HD11 HG11 ' A' ' 50' ' ' VAL . 4.9 mt -68.1 -31.95 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.039 179.892 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 9.2 p -74.04 -49.05 25.91 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.382 -179.725 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -59.61 -28.21 66.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.312 -179.551 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.443 ' CE2' ' HB3' ' A' ' 77' ' ' PRO . 6.2 m-85 -83.06 -54.14 5.28 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.164 -179.87 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? 59.65 -179.38 0.09 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.953 179.898 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 6.4 pm0 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.876 -179.995 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.5 tpp . . . . . 0 N--CA 1.487 1.424 0 CA-C-O 120.762 0.315 . . . . 0.0 111.104 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.639 ' O ' ' HG2' ' A' ' 3' ' ' ARG . 1.1 mt-30 -84.85 -68.45 0.72 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.295 179.61 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.639 ' HG2' ' O ' ' A' ' 2' ' ' GLN . 0.0 OUTLIER 71.04 -34.01 0.29 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.487 -0.779 . . . . 0.0 112.046 179.758 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.881 ' O ' HD13 ' A' ' 5' ' ' ILE . . . 104.84 103.46 2.86 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.444 179.41 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.881 HD13 ' O ' ' A' ' 4' ' ' GLY . 7.5 mm -127.56 112.7 28.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 120.904 0.383 . . . . 0.0 111.813 -179.546 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.953 HG23 HG13 ' A' ' 50' ' ' VAL . 7.9 p -107.07 135.16 46.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.144 179.642 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.908 ' CD1' HG22 ' A' ' 31' ' ' THR . 24.2 m0 -120.26 125.89 49.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.014 0.435 . . . . 0.0 110.657 179.447 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.734 ' HB ' HG22 ' A' ' 32' ' ' THR . 0.5 OUTLIER -114.56 146.64 18.79 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.288 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.46 -178.365 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.697 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -124.7 110.8 25.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.821 0.343 . . . . 0.0 110.582 179.243 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.503 ' OD2' HG21 ' A' ' 15' ' ' ILE . 3.8 t0 -161.49 -161.18 0.77 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.228 -179.231 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.24 -0.23 3.29 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -179.487 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.436 ' O ' ' N ' ' A' ' 14' ' ' SER . 0.8 OUTLIER 69.51 -157.72 0.16 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.5 0.19 . . . . 0.0 110.894 179.896 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.404 ' HB3' ' H ' ' A' ' 14' ' ' SER . 1.6 t 34.54 -88.61 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 113.002 0.741 . . . . 0.0 113.002 179.51 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.797 ' O ' HG23 ' A' ' 18' ' ' VAL . 28.4 t -56.07 -58.99 5.6 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.719 0.295 . . . . 0.0 111.235 -179.699 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.503 HG21 ' OD2' ' A' ' 10' ' ' ASP . 20.5 mm -65.77 -24.46 34.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.262 -179.821 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.76 ' HA ' HG21 ' A' ' 32' ' ' THR . 20.2 ttt-85 -78.39 -41.15 34.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.023 179.819 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.426 ' HA ' ' CD ' ' A' ' 20' ' ' GLU . 84.1 t90 -65.7 -40.17 91.99 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.541 -179.351 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.797 HG23 ' O ' ' A' ' 14' ' ' SER . 3.5 t -69.37 -38.17 76.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -178.93 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.652 ' CD2' HD11 ' A' ' 108' ' ' ILE . 0.2 OUTLIER -84.39 -29.29 26.33 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -178.962 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.766 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 24.4 pt-20 -67.87 -59.01 3.62 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -179.29 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.466 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 9.8 mmt180 -64.65 -51.69 61.23 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.885 -178.904 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.23 -44.43 79.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.103 0.478 . . . . 0.0 111.521 -179.384 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.909 ' HG ' HG11 ' A' ' 6' ' ' VAL . 2.1 tm? -72.04 -27.85 62.98 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.188 179.523 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.54 -33.63 76.11 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.29 178.397 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.18 -28.65 69.45 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.498 -0.858 . . . . 0.0 111.16 178.772 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.631 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -76.84 -15.35 59.74 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 120.717 0.294 . . . . 0.0 110.947 179.412 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.49 26.08 11.36 Favored Glycine 0 C--N 1.334 0.422 0 C-N-CA 120.7 -0.762 . . . . 0.0 113.657 179.001 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.631 ' CD1' ' HB3' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -131.5 172.65 11.96 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 117.528 0.664 . . . . 0.0 111.583 179.625 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.694 ' O ' HG12 ' A' ' 6' ' ' VAL . 16.6 m -96.62 138.08 34.73 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.43 -179.256 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.766 ' HB3' ' HA ' ' A' ' 20' ' ' GLU . 8.5 t -127.61 117.5 22.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.884 179.972 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.908 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.8 t -122.08 142.77 50.02 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.275 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.76 HG21 ' HA ' ' A' ' 16' ' ' ARG . 66.7 p -118.26 159.81 22.7 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.181 0.515 . . . . 0.0 112.165 -178.889 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.9 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 0.2 OUTLIER -135.1 171.92 13.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.823 -179.007 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.698 ' HG2' ' N ' ' A' ' 35' ' ' ASN . 0.0 OUTLIER -64.17 -43.53 94.84 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.212 -179.532 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.698 ' N ' ' HG2' ' A' ' 34' ' ' GLU . 29.3 p30 -173.1 178.89 2.37 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.104 0.478 . . . . 0.0 110.988 -179.018 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.637 ' HA3' ' HB3' ' A' ' 65' ' ' LEU . . . -43.05 -32.21 1.46 Allowed Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.46 -0.791 . . . . 0.0 113.825 -179.47 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.407 ' HA ' ' CD1' ' A' ' 40' ' ' LEU . 1.4 t30 -72.67 -45.68 57.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.945 0.373 . . . . 0.0 111.613 -178.966 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.9 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -52.2 -54.47 30.5 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 -179.836 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.544 HG12 ' CD1' ' A' ' 43' ' ' LEU . 3.5 t -48.86 -36.26 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.32 -179.438 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.624 HD13 ' HB3' ' A' ' 68' ' ' GLN . 7.0 mt -62.62 -49.6 74.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.838 0.351 . . . . 0.0 110.532 179.85 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -54.35 -50.39 67.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.32 -179.488 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.619 ' HB3' ' HE2' ' A' ' 33' ' ' PHE . . . -70.77 -33.46 70.78 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.258 179.953 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.815 HD13 ' CE1' ' A' ' 73' ' ' HIS . 16.0 mt -61.19 -27.12 68.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.307 -179.821 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.79 -17.99 4.2 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.618 -179.583 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 23.9 t -120.85 -3.39 9.7 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -179.635 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.608 ' NZ ' HG21 ' A' ' 5' ' ' ILE . 0.4 OUTLIER -167.66 165.38 14.37 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.883 0.373 . . . . 0.0 111.47 -179.73 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.464 ' HA ' HD23 ' A' ' 43' ' ' LEU . 59.3 m -139.18 128.14 13.94 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.221 179.585 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.643 ' HB3' ' CG ' ' A' ' 7' ' ' TRP . 74.1 Cg_endo -78.06 159.66 30.33 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.38 2.053 . . . . 0.0 111.904 179.195 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -75.42 -31.37 60.35 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.622 179.847 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.953 HG13 HG23 ' A' ' 6' ' ' VAL . 13.5 p -149.68 111.82 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.446 -179.435 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.709 HD12 ' O ' ' A' ' 7' ' ' TRP . 15.3 tp -87.13 150.2 24.14 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.925 0.393 . . . . 0.0 111.949 -179.656 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.696 ' HB3' HG13 ' A' ' 8' ' ' VAL . 1.4 tt -138.75 118.13 12.83 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.743 179.539 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.481 ' HB2' ' CD1' ' A' ' 80' ' ' ILE . 3.2 m -112.42 135.16 53.46 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 121.038 0.447 . . . . 0.0 111.286 179.756 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.411 ' O ' ' O ' ' A' ' 55' ' ' ILE . 25.7 t0 -77.36 -8.01 56.99 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -178.705 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 1.012 HG12 ' HA3' ' A' ' 62' ' ' GLY . 0.0 OUTLIER 37.61 100.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 179.908 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.401 HH21 ' HA ' ' A' ' 10' ' ' ASP . 1.3 ptt85 -146.03 44.0 1.24 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.501 179.68 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.524 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 37.7 ttp 65.27 49.37 0.72 Allowed Pre-proline 0 CA--C 1.532 0.285 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 178.894 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' A' ' 62' ' ' GLY . 57.5 Cg_endo -72.05 -84.54 0.0 OUTLIER 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 122.757 2.305 . . . . 0.0 112.116 178.711 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -100.33 -29.33 6.76 Favored Glycine 0 C--N 1.337 0.636 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.433 179.696 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.99 ' HB3' ' HB2' ' A' ' 64' ' ' ALA . 0.7 OUTLIER -157.23 69.4 0.57 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.907 0.384 . . . . 0.0 110.114 179.496 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.524 ' HA ' ' HA ' ' A' ' 57' ' ' MET . 0.2 OUTLIER 68.56 -22.96 0.13 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.964 -179.694 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 1.012 ' HA3' HG12 ' A' ' 55' ' ' ILE . . . 136.69 -26.63 3.01 Favored Glycine 0 CA--C 1.498 -0.997 0 C-N-CA 120.981 -0.628 . . . . 0.0 111.682 -179.838 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.638 HD12 ' H ' ' A' ' 63' ' ' LEU . 1.0 OUTLIER -75.95 -17.56 59.69 Favored 'General case' 0 N--CA 1.44 -0.971 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.157 179.221 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.99 ' HB2' ' HB3' ' A' ' 60' ' ' MET . . . -53.47 -38.34 63.51 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 121.002 0.429 . . . . 0.0 110.601 179.085 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.637 ' HB3' ' HA3' ' A' ' 36' ' ' GLY . 3.8 pp -58.76 -36.94 75.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.197 -179.795 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.792 HD13 ' HB2' ' A' ' 93' ' ' ALA . 9.6 mt -62.7 -43.73 98.04 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.835 0.35 . . . . 0.0 110.308 179.586 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.52 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 0.4 OUTLIER -52.9 -59.75 4.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.499 179.563 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.624 ' HB3' HD13 ' A' ' 40' ' ' LEU . 4.2 mp0 -55.86 -38.19 69.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.023 0.44 . . . . 0.0 111.146 179.422 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 6.7 mm -61.56 -36.74 75.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.218 -178.738 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.623 ' HB2' ' HB2' ' A' ' 96' ' ' GLN . 1.1 pttt -78.44 -24.86 45.87 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.247 -0.433 . . . . 0.0 112.084 -179.613 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -80.57 -30.03 37.01 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.694 -178.251 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 27.5 mtt180 -103.9 -21.78 13.59 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -179.684 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.815 ' CE1' HD13 ' A' ' 43' ' ' LEU . 0.4 OUTLIER -128.67 156.24 77.77 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-O 120.776 0.322 . . . . 0.0 111.255 -178.935 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -95.25 100.88 0.11 Allowed 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 123.214 2.609 . . . . 0.0 113.687 -178.88 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.493 ' HA ' ' CA ' ' A' ' 97' ' ' GLY . 3.9 mtt 55.53 38.57 30.4 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.261 178.169 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.54 HD11 ' CD2' ' A' ' 43' ' ' LEU . 1.4 tt -60.52 114.19 9.51 Favored Pre-proline 0 C--N 1.325 -0.483 0 C-N-CA 121.143 -0.223 . . . . 0.0 110.867 179.602 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.542 ' HB3' ' CE2' ' A' ' 122' ' ' TYR . 50.7 Cg_exo -55.87 129.94 37.65 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.532 2.155 . . . . 0.0 112.848 -179.948 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.668 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 4.4 t -137.59 147.06 26.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.286 179.55 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.832 ' CG2' HD23 ' A' ' 114' ' ' LEU . 2.0 mt -122.47 111.07 28.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.212 179.563 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.549 HG13 ' CZ ' ' A' ' 101' ' ' TYR . 8.6 mm -99.2 142.13 15.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 120.996 0.426 . . . . 0.0 111.839 -178.903 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.642 ' O ' ' HB2' ' A' ' 102' ' ' LEU . 13.8 ttt -70.72 -75.73 0.12 Allowed 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.631 -179.42 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.526 ' H ' ' CG2' ' A' ' 55' ' ' ILE . 3.0 m -105.65 147.39 28.54 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.089 0.471 . . . . 0.0 111.542 -178.936 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.918 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -116.29 59.12 0.74 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.902 179.941 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 21.1 p80 -99.07 135.28 40.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.913 0.387 . . . . 0.0 111.561 -179.674 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.444 ' HB3' ' CG ' ' A' ' 61' ' ' ASP . 9.5 t 62.85 134.11 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.648 179.183 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.526 ' HB3' HD13 ' A' ' 63' ' ' LEU . 1.8 t70 55.49 36.65 27.57 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.128 179.65 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.72 HD21 ' HB1' ' A' ' 83' ' ' ALA . 0.5 OUTLIER -53.48 -24.27 12.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.566 -179.901 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -49.5 -47.46 48.63 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.96 0.41 . . . . 0.0 111.357 -179.782 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.478 ' O ' ' HB2' ' A' ' 93' ' ' ALA . . . -62.66 -19.74 64.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.258 -179.888 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.689 ' O ' ' HB3' ' A' ' 93' ' ' ALA . . . -72.09 -57.49 4.22 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.775 0.321 . . . . 0.0 110.972 179.527 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.694 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 3.5 t -59.95 -52.45 60.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.299 -179.55 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 89.9 p -58.44 -22.25 53.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.01 0.434 . . . . 0.0 109.98 178.975 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.792 ' HB2' HD13 ' A' ' 66' ' ' LEU . . . -59.92 -48.81 80.17 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.365 179.154 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.694 ' CE2' ' HA ' ' A' ' 91' ' ' VAL . 2.8 m-85 -57.62 -30.89 65.72 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.186 -180.0 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.77 -36.37 59.85 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.306 -179.911 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.623 ' HB2' ' HB2' ' A' ' 70' ' ' LYS . 11.8 pt20 -100.18 0.88 41.34 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.526 -178.98 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 93' ' ' ALA . . . 128.4 81.32 0.31 Allowed Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.347 -0.93 . . . . 0.0 113.323 179.955 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.668 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -169.7 136.04 1.56 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.778 0.323 . . . . 0.0 110.26 179.162 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.519 ' CZ ' ' HA ' ' A' ' 118' ' ' ALA . 32.0 t80 -74.97 -53.32 9.16 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.976 -0.29 . . . . 0.0 111.325 -179.449 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.634 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 2.4 t70 179.82 -172.76 0.2 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.265 0.555 . . . . 0.0 111.924 -179.756 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.918 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 3.1 m-85 -128.36 154.1 46.34 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.811 179.986 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.794 HD11 HD22 ' A' ' 114' ' ' LEU . 9.0 mp -102.04 123.58 43.07 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-O 120.719 0.295 . . . . 0.0 110.614 179.958 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -68.62 -66.8 0.03 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.19 1.927 . . . . 0.0 112.337 -179.753 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.755 ' H ' ' HD2' ' A' ' 105' ' ' PRO . 0.7 OUTLIER -119.4 -58.39 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.244 -0.434 . . . . 0.0 112.117 -179.535 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.755 ' HD2' ' H ' ' A' ' 104' ' ' LYS . 17.8 Cg_endo -59.5 163.1 13.43 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.255 1.97 . . . . 0.0 112.697 -179.501 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.616 ' HA ' HD23 ' A' ' 102' ' ' LEU . 38.9 t80 -166.86 -108.61 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.223 179.609 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.593 ' O ' ' O ' ' A' ' 106' ' ' PHE . 3.1 p30 43.04 176.57 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.896 0.379 . . . . 0.0 111.274 -179.975 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.652 HD11 ' CD2' ' A' ' 19' ' ' LEU . 1.0 OUTLIER -67.7 -39.41 82.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 121.903 -0.498 . . . . 0.0 111.278 -179.82 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.486 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 4.4 t70 -49.82 -58.47 5.3 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.246 -179.75 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.585 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 3.4 mm-40 -77.61 -34.32 53.42 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 111.709 0.263 . . . . 0.0 111.709 -179.76 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.39 -59.56 4.21 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 179.328 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.726 ' O ' HG12 ' A' ' 115' ' ' VAL . 55.8 t -59.54 -30.27 44.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.466 0.65 . . . . 0.0 110.506 178.86 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.486 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -65.37 -47.55 76.0 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.158 179.367 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.832 HD23 ' CG2' ' A' ' 79' ' ' ILE . 23.6 tp -73.51 -21.33 60.43 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.551 -179.627 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.726 HG12 ' O ' ' A' ' 112' ' ' VAL . 5.7 p -79.44 -47.08 22.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.779 0.323 . . . . 0.0 111.679 -179.838 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.642 ' HA ' HD12 ' A' ' 119' ' ' ILE . 31.8 mt-10 -67.88 -46.8 70.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.88 -179.786 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 55.8 mtp180 -61.01 -24.2 65.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.091 0.472 . . . . 0.0 110.567 179.392 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.519 ' HA ' ' CZ ' ' A' ' 99' ' ' PHE . . . -71.16 -47.4 57.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.97 179.625 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.642 HD12 ' HA ' ' A' ' 116' ' ' GLU . 4.6 mt -62.94 -31.17 51.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.127 -179.95 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.0 t -74.55 -51.0 15.86 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.422 -179.387 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 20.5 m80 -68.89 -24.95 64.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.394 -179.464 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.542 ' CE2' ' HB3' ' A' ' 77' ' ' PRO . 1.1 m-85 -67.93 -55.62 12.11 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.959 -179.816 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -75.62 -176.1 3.14 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.972 179.987 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.819 179.913 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.695 ' HG2' HD11 ' A' ' 5' ' ' ILE . 0.0 OUTLIER . . . . . 2 N--CA 1.274 -9.244 0 CA-C-O 124.789 2.233 . . . . 0.0 114.498 . . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.464 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . 79.76 87.59 0.54 Allowed Glycine 1 C--N 1.149 -9.831 1 O-C-N 113.565 -5.709 . . . . 0.0 112.665 -179.864 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 1.134 ' CD1' ' CB ' ' A' ' 5' ' ' ILE . 0.7 OUTLIER -112.7 113.3 43.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 O-C-N 122.59 -0.359 . . . . 0.0 111.365 -179.679 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.825 HG23 HG13 ' A' ' 50' ' ' VAL . 7.1 p -107.71 125.39 64.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.676 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.894 ' CD1' HG22 ' A' ' 31' ' ' THR . 31.4 m0 -114.44 134.13 55.23 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.03 0.443 . . . . 0.0 110.374 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.698 HG13 ' HB3' ' A' ' 52' ' ' LEU . 0.3 OUTLIER -122.29 143.83 33.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.653 -178.405 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.706 HG11 ' HA2' ' A' ' 36' ' ' GLY . 0.0 OUTLIER -123.81 109.65 23.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.038 0.447 . . . . 0.0 110.321 178.901 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.497 ' O ' ' N ' ' A' ' 12' ' ' ASP . 5.8 t0 -164.55 -177.24 4.72 Favored 'General case' 1 C--O 0.895 -17.579 0 CA-C-O 125.923 2.773 . . . . 0.0 111.103 -179.075 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 1.303 ' OD2' ' CB ' ' A' ' 11' ' ' ASP . 0.7 OUTLIER -44.89 -10.47 0.01 OUTLIER 'General case' 2 C--N 1.074 -11.412 3 O-C-N 104.073 -11.642 . . . . 0.0 112.854 -178.827 . . . . . . . . 5 4 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.497 ' N ' ' O ' ' A' ' 10' ' ' ASP . 2.6 t70 76.01 -147.53 0.03 OUTLIER 'General case' 1 C--O 1.13 -5.215 0 O-C-N 117.905 -2.997 . . . . 0.0 111.76 179.803 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 1.091 ' OG ' ' HB2' ' A' ' 13' ' ' SER . 8.2 t 22.05 -85.74 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.777 0 C-N-CA 126.371 1.868 . . . . 0.0 114.676 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.754 ' O ' HG23 ' A' ' 18' ' ' VAL . 0.3 OUTLIER -55.87 -56.92 14.9 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 120.925 0.393 . . . . 0.0 111.514 -179.447 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.0 mm -65.09 -24.99 36.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-O 120.823 0.344 . . . . 0.0 111.141 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 1.253 ' NH2' ' NE ' ' A' ' 16' ' ' ARG . 1.8 ttt180 -72.29 -50.2 28.84 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.291 0.567 . . . . 0.0 111.201 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 72.1 t90 -60.33 -43.24 96.6 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.754 HG23 ' O ' ' A' ' 14' ' ' SER . 3.2 t -65.84 -48.05 83.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -178.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 1.418 ' CD1' ' CB ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -81.15 -29.29 34.76 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -178.093 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 1.327 ' OE1' ' CG ' ' A' ' 20' ' ' GLU . 12.9 pt-20 -67.13 -59.33 3.54 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -178.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 1.202 ' NE ' ' CG ' ' A' ' 21' ' ' ARG . 11.8 mmt180 -59.2 -51.27 70.73 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.821 -179.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.64 -46.11 84.6 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.91 0.386 . . . . 0.0 111.83 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 1.479 ' CD1' ' CB ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -72.2 -26.46 62.06 Favored 'General case' 0 C--N 1.311 -1.109 0 CA-C-O 121.225 0.536 . . . . 0.0 110.408 179.577 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.09 -34.62 78.03 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.93 -26.14 68.63 Favored Glycine 0 N--CA 1.44 -1.073 0 C-N-CA 120.247 -0.978 . . . . 0.0 111.032 178.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.673 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -77.21 -15.71 59.37 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 120.802 0.334 . . . . 0.0 110.939 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.3 26.23 10.32 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.514 -0.851 . . . . 0.0 114.143 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.673 ' CD1' ' HB3' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -126.18 168.74 13.64 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 117.982 0.891 . . . . 0.0 112.238 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 53.7 m -91.85 115.3 27.95 Favored 'General case' 0 C--O 1.211 -0.953 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.627 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 1.223 ' SG ' ' CA ' ' A' ' 30' ' ' CYS . 49.1 t -110.81 113.55 26.23 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.008 0.433 . . . . 0.0 112.083 -179.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.894 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.7 t -122.48 146.22 47.59 Favored 'General case' 0 C--O 1.219 -0.509 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.816 HG21 ' HA ' ' A' ' 16' ' ' ARG . 60.3 p -119.52 162.57 18.68 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.315 0.579 . . . . 0.0 112.258 -178.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.816 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 3.0 m-85 -133.65 173.54 11.4 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.371 -0.832 . . . . 0.0 111.7 -178.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.676 ' HG3' ' N ' ' A' ' 35' ' ' ASN . 17.1 pt-20 -62.55 -47.03 85.66 Favored 'General case' 1 C--O 1.149 -4.211 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -177.98 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 1.103 ' CG ' ' CA ' ' A' ' 35' ' ' ASN . 0.0 OUTLIER -161.25 -61.73 0.05 Allowed 'General case' 1 C--O 0.886 -18.048 0 O-C-N 118.598 -2.564 . . . . 0.0 112.277 -179.252 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.968 ' HA3' HD23 ' A' ' 65' ' ' LEU . . . -163.39 -43.95 0.02 OUTLIER Glycine 1 C--N 1.066 -14.464 3 O-C-N 103.777 -11.827 . . . . 0.0 113.315 -179.399 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.451 ' HA ' HD12 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -60.43 -33.31 72.35 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 122.208 -0.584 . . . . 0.0 111.358 -179.359 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 1.103 ' CD ' ' HG2' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -57.1 -55.27 36.91 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.384 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.657 HG23 HG13 ' A' ' 9' ' ' VAL . 21.5 t -53.44 -37.62 30.42 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.289 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.816 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.68 HD13 ' HB3' ' A' ' 68' ' ' GLN . 18.5 mt -56.42 -44.72 80.66 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.681 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.39 -48.77 63.84 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.212 0.529 . . . . 0.0 111.218 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.64 -31.77 73.14 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.913 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 1.167 HD13 ' CE1' ' A' ' 73' ' ' HIS . 12.9 mt -64.4 -24.93 67.8 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.515 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.35 -18.72 18.65 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.66 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.39 0.11 8.84 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 1.256 ' NZ ' ' CD ' ' A' ' 46' ' ' LYS . 0.3 OUTLIER -162.4 160.38 26.36 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-O 120.779 0.323 . . . . 0.0 111.55 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 97.3 m -138.91 114.7 8.57 Favored Pre-proline 0 N--CA 1.448 -0.556 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.447 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.602 ' HD2' HD21 ' A' ' 43' ' ' LEU . 68.4 Cg_endo -75.29 159.58 40.15 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.441 2.094 . . . . 0.0 111.599 179.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -75.26 -26.53 58.88 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.803 0.335 . . . . 0.0 111.108 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.825 HG13 HG23 ' A' ' 6' ' ' VAL . 7.1 p -146.04 133.52 15.26 Favored 'Isoleucine or valine' 1 C--O 1.079 -7.92 0 CA-C-O 122.88 1.324 . . . . 0.0 110.861 -179.652 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.548 HD12 ' O ' ' A' ' 7' ' ' TRP . 18.2 tp -120.02 134.45 55.25 Favored 'General case' 1 C--N 1.203 -5.766 1 O-C-N 114.859 -4.901 . . . . 0.0 111.649 -179.262 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.698 ' HB3' HG13 ' A' ' 8' ' ' VAL . 0.6 OUTLIER -119.15 122.13 41.32 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 122.824 0.45 . . . . 0.0 110.232 179.676 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.452 ' HA ' HG23 ' A' ' 9' ' ' VAL . 0.5 OUTLIER -115.96 136.59 52.9 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.273 0.559 . . . . 0.0 112.169 -179.541 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 1.282 ' O ' ' CA ' ' A' ' 55' ' ' ILE . 10.3 t70 -80.96 -2.32 47.27 Favored 'General case' 1 C--O 0.48 -39.423 1 CA-C-O 162.772 20.32 . . . . 0.0 112.03 -179.978 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 1.282 ' CA ' ' O ' ' A' ' 54' ' ' ASP . 14.7 tt 32.72 97.83 0.0 OUTLIER 'Isoleucine or valine' 2 C--N 0.776 -24.364 3 O-C-N 28.812 -58.68 . . . . 0.0 111.483 -179.326 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 1.555 ' CB ' ' CD ' ' A' ' 56' ' ' ARG 0.266 0.3 OUTLIER -158.85 47.77 0.33 Allowed 'General case' 3 C--N 1.154 -7.898 1 O-C-N 112.899 -6.125 . . . . 0.0 117.447 -179.837 . . . . . . . . 6 4 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 1.532 ' CE ' ' CG ' ' A' ' 57' ' ' MET 0.684 11.2 ttt 88.93 28.48 0.0 OUTLIER Pre-proline 3 N--CA 1.257 -10.121 1 N-CA-C 139.177 10.436 . . . . 0.0 139.177 179.064 . . . . . . . . 5 3 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.421 ' HD2' ' O ' ' A' ' 61' ' ' ASP . 36.9 Cg_endo -65.36 -101.48 0.0 OUTLIER 'Trans proline' 3 C--O 0.983 -12.226 0 O-C-N 125.966 2.561 . . . . 0.0 112.862 178.977 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -98.25 -53.3 1.27 Allowed Glycine 4 C--O 0.965 -16.705 0 CA-C-N 125.744 3.884 . . . . 0.0 112.79 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 1.282 ' CE ' ' CG ' ' A' ' 60' ' ' MET . 0.0 OUTLIER -118.1 63.28 0.76 Allowed 'General case' 1 C--N 1.163 -7.537 2 O-C-N 113.5 -5.706 . . . . 0.0 109.958 178.763 . . . . . . . . 5 4 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 1.246 ' OD1' ' CB ' ' A' ' 61' ' ' ASP . 0.3 OUTLIER 62.99 -42.67 0.19 Allowed 'General case' 1 C--O 1.044 -9.721 0 CA-C-O 122.324 1.059 . . . . 0.0 112.137 -179.756 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 1.062 ' HA3' HG13 ' A' ' 55' ' ' ILE . . . 165.91 -30.87 0.21 Allowed Glycine 1 C--N 1.185 -7.814 1 O-C-N 114.55 -5.094 . . . . 0.0 111.417 -179.713 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.717 HD12 ' H ' ' A' ' 63' ' ' LEU . 2.2 mp -67.01 -19.19 65.66 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-O 120.852 0.358 . . . . 0.0 110.193 179.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.838 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -54.25 -37.49 64.74 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-O 121.183 0.516 . . . . 0.0 110.498 178.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 1.42 ' HG ' ' CA ' ' A' ' 65' ' ' LEU . 1.2 mt -58.33 -44.32 88.61 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.736 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 1.308 ' CD1' ' CB ' ' A' ' 66' ' ' LEU . 20.4 mt -55.88 -45.44 78.57 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.08 0.467 . . . . 0.0 110.619 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.2 mttt -53.34 -48.41 68.53 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.856 179.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 1.448 ' OE1' ' CG ' ' A' ' 68' ' ' GLN . 11.8 mm-40 -66.4 -34.55 78.21 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.963 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.576 HG13 ' O ' ' A' ' 65' ' ' LEU . 98.4 mt -61.34 -41.78 91.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.727 -179.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 1.25 ' NZ ' ' CD ' ' A' ' 70' ' ' LYS . 17.4 pttt -71.51 -28.1 63.66 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.669 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.772 ' NE2' ' HA ' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -72.84 -38.05 67.23 Favored 'General case' 0 C--O 1.213 -0.848 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.763 -179.441 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 70.7 mtt-85 -97.14 -41.65 8.22 Favored 'General case' 0 C--O 1.173 -2.949 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 1.415 ' NE2' ' CG ' ' A' ' 73' ' ' HIS . 0.0 OUTLIER -108.39 139.38 20.72 Favored Pre-proline 1 C--O 1.001 -11.985 0 CA-C-O 124.121 1.915 . . . . 0.0 112.683 -179.053 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.806 ' O ' ' HG3' ' A' ' 75' ' ' MET 0.337 8.3 Cg_endo -74.0 -36.37 3.51 Favored 'Trans proline' 4 C--O 0.774 -22.703 3 C-N-CA 128.145 5.896 . . . . 0.0 123.185 -179.942 . . . . . . . . 5 3 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 1.194 ' CE ' ' CG ' ' A' ' 75' ' ' MET . 47.5 mtt -159.83 31.21 0.18 Allowed 'General case' 2 C--N 0.983 -15.339 3 O-C-N 101.657 -13.152 . . . . 0.0 115.154 -179.923 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 1.306 ' CD1' ' CB ' ' A' ' 76' ' ' LEU . 1.5 tt -64.24 118.77 49.98 Favored Pre-proline 0 C--N 1.306 -1.316 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.621 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.49 ' HA ' ' O ' ' A' ' 97' ' ' GLY . 3.4 Cg_exo -63.44 125.1 14.94 Favored 'Trans proline' 0 C--O 1.212 -0.808 0 C-N-CA 122.809 2.339 . . . . 0.0 112.31 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.648 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 4.3 t -119.32 145.15 25.88 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-O 120.997 0.427 . . . . 0.0 111.321 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.664 ' CG2' HD23 ' A' ' 114' ' ' LEU . 2.0 mt -125.71 113.08 33.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.618 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.584 HD11 HD21 ' A' ' 66' ' ' LEU . 15.9 mm -98.69 141.77 15.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.604 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 1.0 ' SD ' ' CE ' ' A' ' 81' ' ' MET . 2.2 ptm -73.64 -41.0 63.33 Favored 'General case' 0 C--O 1.165 -3.381 0 CA-C-N 116.081 -0.509 . . . . 0.0 112.232 -179.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.567 ' H ' HG21 ' A' ' 55' ' ' ILE . 7.0 m -135.42 155.39 50.64 Favored 'General case' 0 C--N 1.29 -2.019 0 O-C-N 120.435 -1.416 . . . . 0.0 111.818 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.65 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -118.55 20.93 12.82 Favored 'General case' 1 C--O 0.955 -14.412 0 CA-C-O 121.331 0.586 . . . . 0.0 111.748 -179.667 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.559 ' O ' ' O ' ' A' ' 83' ' ' ALA 0.257 0.0 OUTLIER -25.71 -163.74 0.0 OUTLIER 'General case' 3 C--O 0.554 -35.513 2 O-C-N 111.277 -7.14 . . . . 0.0 118.378 -179.582 . . . . . . . . 6 4 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 1.147 ' O ' ' CA ' ' A' ' 86' ' ' ASP 0.46 0.2 OUTLIER -32.87 6.71 0.0 OUTLIER 'General case' 4 C--O 0.302 -48.796 5 O-C-N 90.034 -20.417 . . . . 0.0 127.013 -178.286 . . . . . . . . 6 4 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 1.354 ' OD2' ' CB ' ' A' ' 86' ' ' ASP . 0.5 OUTLIER -148.27 44.23 1.05 Allowed 'General case' 2 C--N 0.866 -20.424 3 O-C-N 41.666 -50.646 . . . . 0.0 115.159 178.086 . . . . . . . . 5 4 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.624 HD23 ' HB1' ' A' ' 83' ' ' ALA . 0.2 OUTLIER -48.95 -22.44 0.85 Allowed 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.967 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -48.11 -49.37 32.22 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -179.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.498 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -67.14 -21.19 65.84 Favored 'General case' 0 C--N 1.317 -0.807 0 O-C-N 122.371 -0.206 . . . . 0.0 111.081 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.55 ' O ' ' HB3' ' A' ' 93' ' ' ALA . . . -70.73 -42.14 70.94 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-O 121.282 0.563 . . . . 0.0 111.013 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.5 t -62.67 -46.06 97.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 CA-C-O 121.702 0.763 . . . . 0.0 111.725 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.37 -24.65 66.64 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.177 0.513 . . . . 0.0 110.267 178.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.55 ' HB3' ' O ' ' A' ' 90' ' ' ALA . . . -64.51 -47.81 77.5 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-O 121.809 0.814 . . . . 0.0 110.948 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 1.507 ' CZ ' ' CD1' ' A' ' 94' ' ' TYR . 12.3 m-85 -58.17 -28.33 64.66 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-O 122.211 1.005 . . . . 0.0 110.829 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.403 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -74.13 -38.11 63.89 Favored 'General case' 0 C--N 1.286 -2.188 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.523 179.91 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.914 ' OE1' ' HB3' ' A' ' 70' ' ' LYS . 7.6 pt20 -84.74 -12.44 53.75 Favored 'General case' 0 C--O 1.16 -3.634 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.263 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.49 ' O ' ' HA ' ' A' ' 77' ' ' PRO . . . 131.51 20.14 1.13 Allowed Glycine 2 C--O 0.905 -20.412 1 CA-C-O 128.143 4.19 . . . . 0.0 116.333 179.562 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.648 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -77.62 145.55 36.69 Favored 'General case' 1 C--N 1.022 -13.635 3 O-C-N 102.124 -12.398 . . . . 0.0 110.88 179.427 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.516 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 17.8 t80 -77.5 -53.7 7.3 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.707 -0.224 . . . . 0.0 111.433 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 1.14 ' CG ' ' CA ' ' A' ' 100' ' ' ASP . 2.9 t0 173.07 -167.3 0.03 OUTLIER 'General case' 0 C--O 1.221 -0.43 0 CA-C-O 120.882 0.372 . . . . 0.0 111.654 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.65 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 4.3 m-85 -132.42 152.82 51.33 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.365 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.573 ' CD1' HD22 ' A' ' 114' ' ' LEU . 0.9 OUTLIER -103.17 124.29 38.88 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-O 121.25 0.548 . . . . 0.0 110.903 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -68.19 -84.64 0.01 OUTLIER 'Trans proline' 1 C--O 1.101 -6.348 0 C-N-CA 122.104 1.869 . . . . 0.0 113.151 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.621 ' H ' ' HD2' ' A' ' 105' ' ' PRO . 14.1 mttt -106.62 -58.03 0.06 OUTLIER Pre-proline 1 C--N 1.184 -6.62 1 O-C-N 115.977 -4.202 . . . . 0.0 111.964 -179.604 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.621 ' HD2' ' H ' ' A' ' 104' ' ' LYS . 1.1 Cg_endo -57.49 160.29 14.38 Favored 'Trans proline' 0 CA--C 1.508 -0.81 0 C-N-CA 122.342 2.028 . . . . 0.0 112.748 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.666 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 3.0 t80 -166.73 -105.57 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.859 0 O-C-N 123.463 0.477 . . . . 0.0 111.131 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.564 ' O ' ' O ' ' A' ' 106' ' ' PHE . 2.9 p30 42.49 -179.44 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.861 0.362 . . . . 0.0 111.375 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.729 HG12 HG12 ' A' ' 18' ' ' VAL . 0.9 OUTLIER -67.63 -42.85 86.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.071 0.462 . . . . 0.0 111.594 -179.848 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 1.408 ' OD1' ' CB ' ' A' ' 109' ' ' ASP . 0.2 OUTLIER -49.76 -57.84 6.53 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.61 -179.407 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 1.097 ' OE1' ' CG ' ' A' ' 110' ' ' GLU . 5.2 mm-40 -76.99 -31.97 56.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.574 0.226 . . . . 0.0 111.542 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.4 ' CB ' ' O ' ' A' ' 107' ' ' ASP . . . -67.62 -59.52 3.28 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.845 0.355 . . . . 0.0 110.171 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.64 ' O ' HG12 ' A' ' 115' ' ' VAL . 48.2 t -59.3 -31.44 46.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.423 0.63 . . . . 0.0 110.473 178.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.502 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -63.43 -46.36 86.65 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.067 179.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.664 HD23 ' CG2' ' A' ' 79' ' ' ILE . 29.4 tp -75.37 -22.4 57.55 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.992 -1.004 . . . . 0.0 111.802 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.64 HG12 ' O ' ' A' ' 112' ' ' VAL . 4.2 p -79.26 -43.78 23.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.641 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 1.129 ' OE2' ' CG ' ' A' ' 116' ' ' GLU . 48.9 mt-10 -65.05 -44.69 88.22 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.949 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 1.514 ' CB ' ' CD ' ' A' ' 117' ' ' ARG . 0.0 OUTLIER -61.07 -24.73 66.44 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.859 179.772 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.516 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -71.27 -45.81 62.32 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.954 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.5 HD11 HG11 ' A' ' 50' ' ' VAL . 4.7 mt -69.67 -31.57 49.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.257 0.551 . . . . 0.0 111.034 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.4 t -70.33 -47.38 61.32 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.32 -0.854 . . . . 0.0 111.086 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 19.4 m80 . . . . . 0 C--N 1.314 -0.964 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.059 -179.834 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.765 ' HB3' HD11 ' A' ' 5' ' ' ILE . 0.1 OUTLIER . . . . . 0 CA--C 1.531 0.216 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 52.06 78.72 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.795 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.765 HD11 ' HB3' ' A' ' 3' ' ' ARG . 3.6 mp -110.88 112.35 40.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.75 0.31 . . . . 0.0 110.831 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 1.023 HG11 HD13 ' A' ' 23' ' ' LEU . 7.2 p -107.59 123.43 62.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.7 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.905 ' CD1' HG22 ' A' ' 31' ' ' THR . 30.7 m0 -114.35 131.71 56.45 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.995 0.426 . . . . 0.0 110.924 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.788 HG11 ' CD1' ' A' ' 19' ' ' LEU . 0.3 OUTLIER -113.95 146.88 17.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.909 -179.588 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.799 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -130.42 105.89 12.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.951 0.405 . . . . 0.0 110.099 179.377 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -161.33 -155.14 0.39 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.822 -179.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -69.58 12.15 0.21 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.7 p30 46.94 -152.4 0.08 Allowed 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.4 t 38.02 -91.51 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.869 ' O ' HG23 ' A' ' 18' ' ' VAL . 1.9 t -54.87 -60.15 3.76 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.727 0.299 . . . . 0.0 110.785 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.4 mm -63.28 -24.46 35.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.727 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 1.021 ' HA ' HG21 ' A' ' 32' ' ' THR . 0.0 OUTLIER -71.57 -55.16 8.34 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.618 -179.598 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.417 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 86.3 t90 -61.15 -41.49 96.84 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -179.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.869 HG23 ' O ' ' A' ' 14' ' ' SER . 6.3 t -65.35 -44.56 94.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -178.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.788 ' CD1' HG11 ' A' ' 8' ' ' VAL . 26.5 mt -83.8 -25.68 30.21 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -178.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.577 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 18.8 pt-20 -67.7 -57.96 5.46 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -179.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.531 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 1.9 mmt-85 -65.47 -47.78 74.91 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.857 -0.611 . . . . 0.0 112.044 -178.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.41 -60.08 3.82 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 120.901 0.381 . . . . 0.0 111.317 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 1.036 HD22 HD13 ' A' ' 28' ' ' LEU . 3.3 mt -63.25 -29.14 70.53 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.01 179.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.535 ' HB2' ' O ' ' A' ' 20' ' ' GLU . . . -63.26 -36.1 82.53 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.7 -24.9 71.48 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.247 -0.978 . . . . 0.0 111.086 178.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.726 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -77.48 -15.52 59.26 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 120.6 0.238 . . . . 0.0 111.241 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.5 25.88 8.46 Favored Glycine 0 CA--C 1.522 0.505 0 C-N-CA 120.791 -0.719 . . . . 0.0 113.887 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 1.036 HD13 HD22 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -124.64 171.13 10.3 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 117.691 0.745 . . . . 0.0 111.996 -179.83 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 32.4 m -99.12 106.45 18.66 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.371 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.577 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 48.7 t -103.15 113.39 26.82 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -178.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.905 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.6 t -120.73 149.04 43.14 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 1.021 HG21 ' HA ' ' A' ' 16' ' ' ARG . 32.7 p -119.8 166.12 13.68 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.318 0.58 . . . . 0.0 112.336 -178.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.799 ' HB2' HG13 ' A' ' 9' ' ' VAL . 3.9 m-85 -135.6 173.92 11.19 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.414 -178.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.666 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 2.6 pp20? -62.08 -43.21 99.34 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -177.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.462 ' C ' HG12 ' A' ' 9' ' ' VAL . 4.9 m120 -166.07 -62.99 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.549 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . -157.73 -48.87 0.01 OUTLIER Glycine 0 C--N 1.318 -0.466 0 C-N-CA 120.517 -0.849 . . . . 0.0 113.429 -178.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.444 ' HA ' ' CD1' ' A' ' 40' ' ' LEU . 0.4 OUTLIER -60.85 -24.51 65.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.975 0.417 . . . . 0.0 111.435 -179.072 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.676 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -60.25 -59.02 6.08 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.262 -179.866 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.756 HG12 ' CD1' ' A' ' 43' ' ' LEU . 4.7 t -52.49 -35.35 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 C-N-CA 120.431 -0.508 . . . . 0.0 111.135 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.559 HD13 ' CB ' ' A' ' 68' ' ' GLN . 19.5 mt -56.02 -42.37 76.37 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.03 0.443 . . . . 0.0 110.976 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.76 -47.47 21.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.2 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.405 ' CB ' ' HE2' ' A' ' 33' ' ' PHE . . . -63.16 -36.49 83.8 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.783 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.756 ' CD1' HG12 ' A' ' 39' ' ' VAL . 12.7 mt -59.81 -20.72 58.53 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.135 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.71 -16.79 52.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.501 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -120.68 -5.91 9.69 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -179.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.524 ' O ' HD23 ' A' ' 43' ' ' LEU . 0.1 OUTLIER -162.9 160.77 25.33 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.865 0.364 . . . . 0.0 111.325 -179.746 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.967 HG23 HD23 ' A' ' 76' ' ' LEU . 96.5 m -138.61 115.08 8.86 Favored Pre-proline 0 N--CA 1.453 -0.302 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.535 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.709 ' HD2' HD21 ' A' ' 43' ' ' LEU . 65.9 Cg_endo -73.46 157.02 49.72 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.595 2.197 . . . . 0.0 111.471 178.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.412 ' OD2' HD12 ' A' ' 5' ' ' ILE . 60.1 m-20 -77.0 -22.95 52.32 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.25 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.74 HG13 HG23 ' A' ' 6' ' ' VAL . 7.1 p -150.7 98.19 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-O 120.783 0.325 . . . . 0.0 111.46 -179.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.492 HD12 ' O ' ' A' ' 7' ' ' TRP . 29.1 tp -86.63 138.27 31.81 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.893 0.377 . . . . 0.0 111.435 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.531 ' HB3' HG13 ' A' ' 8' ' ' VAL . 0.4 OUTLIER -123.29 113.93 19.53 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.663 179.49 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.438 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -116.54 154.6 30.14 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.322 0.582 . . . . 0.0 112.132 -179.384 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.1 p30 -83.39 -169.7 2.68 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.738 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.66 HG21 ' O ' ' A' ' 82' ' ' THR . 0.9 OUTLIER -158.15 65.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.15 0.5 . . . . 0.0 111.307 178.988 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 29.4 ptt180 -177.18 65.07 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.232 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.627 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . 2.2 tpt -161.97 -64.44 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.696 179.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.627 ' HD3' ' HB3' ' A' ' 57' ' ' MET . 42.0 Cg_endo -65.99 -173.15 0.31 Allowed 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.265 1.977 . . . . 0.0 112.913 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.95 -67.03 2.41 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.233 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.558 ' O ' ' N ' ' A' ' 62' ' ' GLY . 0.0 OUTLIER -76.98 55.31 1.1 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.063 0.459 . . . . 0.0 110.344 179.457 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.448 ' O ' ' HD2' ' A' ' 58' ' ' PRO . 1.0 OUTLIER 42.41 -77.8 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.711 -179.739 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.723 ' O ' ' HG ' ' A' ' 65' ' ' LEU . . . -135.34 -30.6 0.34 Allowed Glycine 0 C--O 1.225 -0.419 0 C-N-CA 120.367 -0.92 . . . . 0.0 113.224 -179.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.76 ' HA ' HD12 ' A' ' 66' ' ' LEU . 0.2 OUTLIER -67.75 -12.54 60.77 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.619 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.487 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -56.34 -56.79 16.79 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-O 121.056 0.455 . . . . 0.0 110.116 178.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.859 HD12 ' N ' ' A' ' 66' ' ' LEU . 3.1 pp -54.78 -42.3 71.58 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.498 179.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.859 ' N ' HD12 ' A' ' 65' ' ' LEU . 28.8 mt -48.19 -52.62 20.05 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.005 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.773 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 34.5 tttp -54.58 -43.13 71.85 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.09 0.472 . . . . 0.0 110.711 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.559 ' CB ' HD13 ' A' ' 40' ' ' LEU . 34.4 mm-40 -64.75 -28.4 69.55 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.615 179.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.891 HD13 HG21 ' A' ' 78' ' ' VAL . 96.2 mt -63.83 -40.45 89.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.726 -179.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.773 ' HG2' ' O ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -75.22 -25.38 58.11 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.893 -179.187 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.22 -50.8 70.31 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.209 -0.45 . . . . 0.0 112.175 -179.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 14.2 mtt-85 -96.26 -45.32 6.88 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -178.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.454 ' HD2' HG23 ' A' ' 69' ' ' ILE . 1.8 m-70 -91.41 130.3 40.01 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.198 -178.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 73' ' ' HIS . 44.4 Cg_exo -56.76 -70.77 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.54 2.16 . . . . 0.0 113.099 -179.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.712 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 2.1 mpt? -133.74 46.88 2.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.932 0.396 . . . . 0.0 111.412 -179.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.967 HD23 HG23 ' A' ' 47' ' ' THR . 2.8 tm? -64.31 110.61 4.15 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.53 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.59 ' HD2' HD22 ' A' ' 76' ' ' LEU . 38.0 Cg_exo -58.49 131.58 43.46 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.624 2.216 . . . . 0.0 112.168 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.891 HG21 HD13 ' A' ' 69' ' ' ILE . 2.8 t -131.34 151.93 36.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.107 0.479 . . . . 0.0 111.431 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.624 HD11 ' CG2' ' A' ' 50' ' ' VAL . 4.0 mt -134.08 115.58 21.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.952 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.677 HG13 HD11 ' A' ' 66' ' ' LEU . 26.4 mm -93.68 141.95 14.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.525 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.635 ' HG3' HG22 ' A' ' 55' ' ' ILE . 7.7 ptm -71.99 -35.44 69.49 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -178.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.66 ' O ' HG21 ' A' ' 55' ' ' ILE . 4.1 m -147.31 149.4 32.76 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -179.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.717 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -108.64 83.31 1.75 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.798 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 -66.87 -159.34 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.669 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.469 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 0.4 OUTLIER -80.46 78.98 7.13 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-O 121.079 0.466 . . . . 0.0 112.152 -178.455 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.483 ' HB3' HD13 ' A' ' 63' ' ' LEU . 13.7 t70 175.74 26.6 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.777 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.577 HD21 ' HB1' ' A' ' 83' ' ' ALA . 13.3 mt -45.73 -22.96 0.21 Allowed 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -179.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -47.98 -46.9 33.14 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.61 0.243 . . . . 0.0 111.325 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.05 -22.04 59.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.334 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.599 ' HB2' HD23 ' A' ' 63' ' ' LEU . . . -65.41 -40.89 93.94 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.182 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.63 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 6.6 t -65.26 -40.06 87.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.933 -179.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.463 ' O ' ' HG3' ' A' ' 95' ' ' GLN . 19.5 m -63.42 -16.49 60.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.124 0.488 . . . . 0.0 109.903 178.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.789 ' O ' ' HG3' ' A' ' 96' ' ' GLN . . . -75.94 -55.01 6.02 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 121.503 0.668 . . . . 0.0 111.062 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.63 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 3.6 m-85 -57.38 -34.69 69.11 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.291 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.463 ' HG3' ' O ' ' A' ' 92' ' ' SER . 2.3 pp0? -77.19 -35.2 55.97 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.119 -179.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.789 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 1.9 pp0? -77.65 -18.41 56.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.096 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 147.37 -27.61 1.52 Allowed Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.987 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.69 ' HB3' ' C ' ' A' ' 93' ' ' ALA . . . -41.95 152.7 0.07 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.563 0.181 . . . . 0.0 111.378 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.517 ' O ' ' HB2' ' A' ' 100' ' ' ASP . 59.6 t80 -85.63 -53.58 5.07 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 121.084 -0.246 . . . . 0.0 111.544 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.517 ' HB2' ' O ' ' A' ' 99' ' ' PHE . 1.0 OUTLIER 170.79 -176.19 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.009 0.433 . . . . 0.0 111.243 -179.717 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.717 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 3.9 m-85 -112.04 152.71 27.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.333 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.668 HD21 ' HA ' ' A' ' 106' ' ' PHE . 6.5 tp -104.64 139.62 20.28 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.09 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.513 ' HD2' HD12 ' A' ' 102' ' ' LEU . 38.7 Cg_endo -66.51 -164.29 0.08 OUTLIER 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.779 2.32 . . . . 0.0 113.1 -179.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.479 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 85.6 mttt -46.37 -59.71 4.61 Favored Pre-proline 0 CA--C 1.533 0.315 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.779 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 8.4 Cg_endo -50.74 164.4 0.57 Allowed 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.699 2.266 . . . . 0.0 112.157 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.668 ' HA ' HD21 ' A' ' 102' ' ' LEU . 86.7 t80 -162.16 -99.93 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.665 -0.243 . . . . 0.0 110.914 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.586 ' O ' ' O ' ' A' ' 106' ' ' PHE . 2.9 p-10 40.06 -177.2 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.977 0.418 . . . . 0.0 111.562 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.65 HG12 HG12 ' A' ' 18' ' ' VAL . 0.8 OUTLIER -67.76 -43.52 86.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.106 0.479 . . . . 0.0 111.024 179.474 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.497 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 8.1 t70 -49.42 -59.07 4.06 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.896 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.631 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 21.4 mm-40 -76.95 -27.51 54.83 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 111.841 0.312 . . . . 0.0 111.841 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.407 ' CB ' ' O ' ' A' ' 107' ' ' ASP . . . -71.01 -59.59 2.7 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 179.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.643 ' O ' HG12 ' A' ' 115' ' ' VAL . 53.6 t -59.61 -30.67 45.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.348 0.595 . . . . 0.0 110.271 178.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.497 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -63.61 -46.3 86.41 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.928 179.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.468 ' HA ' ' HG2' ' A' ' 117' ' ' ARG . 53.8 tp -74.86 -23.16 58.38 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.695 -179.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.643 HG12 ' O ' ' A' ' 112' ' ' VAL . 2.8 p -79.53 -42.38 22.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.997 -0.281 . . . . 0.0 111.547 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.583 ' HA ' HD12 ' A' ' 119' ' ' ILE . 47.6 mt-10 -63.71 -43.6 96.08 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.088 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.468 ' HG2' ' HA ' ' A' ' 114' ' ' LEU . 0.4 OUTLIER -64.35 -23.97 67.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.862 0.363 . . . . 0.0 110.739 179.638 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.458 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -71.35 -45.12 63.71 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.835 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.583 HD12 ' HA ' ' A' ' 116' ' ' GLU . 6.4 mt -62.71 -31.66 52.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.217 0.532 . . . . 0.0 110.709 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 9.2 m -71.19 -54.85 9.55 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.87 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 1.7 m80 . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.912 179.983 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.979 0.419 . . . . 0.0 111.173 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.691 ' C ' HD13 ' A' ' 5' ' ' ILE . . . -82.64 86.03 1.48 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.557 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.691 HD13 ' C ' ' A' ' 4' ' ' GLY . 2.6 mm -111.81 112.76 41.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.864 0.364 . . . . 0.0 111.157 -179.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.89 HG23 HG13 ' A' ' 50' ' ' VAL . 7.3 p -108.77 124.87 65.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.902 0.382 . . . . 0.0 110.521 179.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.942 ' CD1' HG22 ' A' ' 31' ' ' THR . 22.5 m0 -115.17 135.87 53.72 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.965 0.412 . . . . 0.0 110.637 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.856 HG13 ' HB3' ' A' ' 52' ' ' LEU . 1.3 t -126.22 146.04 32.69 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.332 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.431 -178.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.722 HG22 HG23 ' A' ' 39' ' ' VAL . 45.2 t -120.6 112.62 36.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 177.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -161.65 -158.21 0.54 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.96 -178.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -76.31 19.25 0.25 Allowed 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.6 p30 46.25 -156.2 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.433 ' OG ' ' N ' ' A' ' 14' ' ' SER . 76.7 p 35.83 -95.09 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.752 ' O ' HG23 ' A' ' 18' ' ' VAL . 0.3 OUTLIER -52.77 -62.04 1.91 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.911 -178.969 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 18.4 mm -63.93 -23.88 34.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.977 0.418 . . . . 0.0 111.063 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.565 ' HA ' HG21 ' A' ' 32' ' ' THR . 3.0 ttt-85 -75.95 -50.84 13.81 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.906 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.466 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 44.8 t90 -58.91 -37.41 76.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.188 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.752 HG23 ' O ' ' A' ' 14' ' ' SER . 11.2 t -69.39 -43.92 80.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.733 HD23 HG21 ' A' ' 8' ' ' VAL . 2.3 tp -84.03 -27.34 28.42 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.416 -178.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.661 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 12.8 pt-20 -67.82 -60.98 2.1 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.624 -0.431 . . . . 0.0 111.845 -179.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.479 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 3.9 mmt-85 -59.65 -52.19 66.59 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.805 -179.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.07 -52.36 64.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.982 0.42 . . . . 0.0 111.316 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.754 ' CD2' HG11 ' A' ' 6' ' ' VAL . 1.8 tp -68.06 -24.98 65.13 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.342 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.13 -35.61 78.38 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.87 -25.98 68.35 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.411 -0.9 . . . . 0.0 111.244 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.658 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -77.15 -15.78 59.39 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 120.675 0.274 . . . . 0.0 111.07 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.96 26.59 8.33 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.457 -0.878 . . . . 0.0 114.28 178.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.726 HD12 ' O ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -126.51 170.85 11.59 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 117.938 0.869 . . . . 0.0 111.897 -179.913 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 35.2 m -99.8 104.95 16.67 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.091 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.833 ' HA ' HG13 ' A' ' 6' ' ' VAL . 51.5 t -100.1 111.52 23.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.582 -179.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.942 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.6 t -124.06 147.39 47.9 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.77 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 65.7 p -116.95 166.11 12.55 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -178.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.88 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 5.0 m-85 -135.66 170.3 16.18 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.002 -178.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.927 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 2.1 pp20? -68.96 -54.13 16.99 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -179.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.7 ' C ' HG11 ' A' ' 9' ' ' VAL . 14.0 m120 -155.81 -178.65 7.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.898 0.38 . . . . 0.0 110.8 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.52 ' O ' ' HG ' ' A' ' 40' ' ' LEU . . . -50.98 -16.39 1.81 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.89 -0.671 . . . . 0.0 114.1 -178.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -85.54 -36.33 20.54 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 117.766 0.783 . . . . 0.0 112.131 -179.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.927 ' HB2' ' HG3' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -55.37 -62.07 1.92 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -178.444 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.722 HG23 HG22 ' A' ' 9' ' ' VAL . 48.6 t -49.06 -32.23 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.999 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' A' ' 36' ' ' GLY . 30.5 mt -59.9 -41.03 90.77 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.031 0.443 . . . . 0.0 110.209 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.53 -48.32 78.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.185 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.11 -29.65 64.29 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.829 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.727 HD13 ' NE2' ' A' ' 73' ' ' HIS . 5.9 mt -61.51 -33.52 73.94 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.017 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.56 -19.45 15.85 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.617 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.8 m -125.47 2.58 7.67 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.532 ' O ' HD23 ' A' ' 43' ' ' LEU . 0.1 OUTLIER -161.9 166.18 26.6 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 120.832 0.349 . . . . 0.0 111.165 179.966 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.788 HG23 HD23 ' A' ' 76' ' ' LEU . 85.1 m -138.41 114.78 8.96 Favored Pre-proline 0 N--CA 1.453 -0.289 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.999 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.625 ' HD2' HD21 ' A' ' 43' ' ' LEU . 61.2 Cg_endo -71.09 148.16 55.89 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.283 1.989 . . . . 0.0 111.886 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -74.21 -30.34 62.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.758 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.89 HG13 HG23 ' A' ' 6' ' ' VAL . 7.3 p -146.88 101.36 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.841 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.61 HD11 HG21 ' A' ' 39' ' ' VAL . 13.8 tp -85.46 125.6 33.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.08 0.467 . . . . 0.0 111.343 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.856 ' HB3' HG13 ' A' ' 8' ' ' VAL . 1.2 tt -120.64 120.26 35.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.823 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.502 ' CB ' HD23 ' A' ' 65' ' ' LEU . 8.1 t -118.38 130.2 55.86 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.067 0.461 . . . . 0.0 111.106 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.415 ' HA ' ' HG2' ' A' ' 81' ' ' MET . 24.5 t70 -83.24 15.19 3.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.805 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.696 HG13 ' O ' ' A' ' 61' ' ' ASP . 3.5 tt 33.51 93.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 120.766 0.317 . . . . 0.0 111.813 -179.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.9 tpt180 -104.7 34.1 3.3 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.356 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.534 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER 53.14 47.35 4.04 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.674 179.08 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.747 ' HD2' ' O ' ' A' ' 61' ' ' ASP . 21.0 Cg_endo -61.26 -74.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.096 1.864 . . . . 0.0 111.272 178.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -117.01 -80.94 0.81 Allowed Glycine 0 C--N 1.332 0.306 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 178.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.747 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -85.6 56.27 3.89 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 177.781 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.747 ' O ' ' HD2' ' A' ' 58' ' ' PRO . 4.1 p30 55.92 -62.88 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.224 -0.898 . . . . 0.0 112.106 -178.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 60' ' ' MET . . . -155.47 -35.97 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 121.147 -0.549 . . . . 0.0 112.276 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.763 HD21 ' HA ' ' A' ' 87' ' ' LEU . 0.3 OUTLIER -61.38 -22.0 64.57 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.73 0.3 . . . . 0.0 111.085 -179.802 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.747 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -54.91 -42.76 72.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.092 0.473 . . . . 0.0 111.135 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.546 ' HG ' HD11 ' A' ' 69' ' ' ILE . 7.4 tp -52.96 -43.85 66.69 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.252 -179.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 1.0 HD22 ' HB1' ' A' ' 93' ' ' ALA . 2.9 mt -59.93 -43.83 94.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.912 0.387 . . . . 0.0 110.862 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.439 ' HG3' ' HE3' ' A' ' 70' ' ' LYS . 4.1 tttt -53.07 -54.92 28.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.775 -179.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.519 ' HB3' HD13 ' A' ' 40' ' ' LEU . 66.2 mm-40 -61.18 -44.66 96.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.911 -179.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.59 ' CG2' ' HB3' ' A' ' 76' ' ' LEU . 22.7 mt -56.92 -54.18 33.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.287 0.565 . . . . 0.0 111.409 -178.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.473 ' HB3' ' CB ' ' A' ' 96' ' ' GLN . 11.0 pttt -57.45 -23.7 51.32 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.496 -179.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.65 -51.96 50.32 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.722 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 75.0 mtt-85 -100.37 -7.19 24.68 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.379 -178.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.727 ' NE2' HD13 ' A' ' 43' ' ' LEU . 71.6 m-70 -125.52 139.09 33.14 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-O 120.896 0.379 . . . . 0.0 112.015 -179.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -68.86 -62.33 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.95 2.433 . . . . 0.0 113.417 -179.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.739 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 1.8 mtt -136.06 49.0 2.14 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.788 HD23 HG23 ' A' ' 47' ' ' THR . 0.9 OUTLIER -68.26 108.49 2.85 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.014 178.916 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.525 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 18.1 Cg_endo -59.42 132.32 45.6 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.419 2.079 . . . . 0.0 112.336 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.422 ' CG2' HD13 ' A' ' 69' ' ' ILE . 3.3 t -129.48 136.24 59.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.738 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.616 HD11 HG23 ' A' ' 50' ' ' VAL . 1.9 mt -127.61 110.89 23.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.934 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.633 HG13 ' CZ ' ' A' ' 101' ' ' TYR . 15.2 mm -99.79 147.53 7.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.538 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.489 ' HG3' ' N ' ' A' ' 82' ' ' THR . 0.3 OUTLIER -81.66 -34.58 30.69 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.261 -179.767 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.489 ' N ' ' HG3' ' A' ' 81' ' ' MET . 21.6 m -133.79 148.28 51.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.517 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.535 ' HA ' ' CE2' ' A' ' 101' ' ' TYR . . . -99.94 -25.82 14.2 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.417 ' HB3' ' H ' ' A' ' 85' ' ' SER . 3.3 m-70 46.77 -158.87 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.764 -0.198 . . . . 0.0 110.913 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.417 ' H ' ' HB3' ' A' ' 84' ' ' HIS . 94.0 p -80.25 175.44 10.64 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.977 0.417 . . . . 0.0 111.469 -179.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.657 ' O ' HD22 ' A' ' 63' ' ' LEU . 0.7 OUTLIER 62.89 32.46 15.72 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.989 -179.897 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.763 ' HA ' HD21 ' A' ' 63' ' ' LEU . 1.9 mt -49.05 -21.66 0.75 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.414 -179.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -48.39 -41.36 28.75 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.806 0.298 . . . . 0.0 111.806 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.638 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -66.16 -23.79 66.53 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.733 ' HB2' HD23 ' A' ' 63' ' ' LEU . . . -77.3 -26.86 52.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.819 0.342 . . . . 0.0 110.726 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.511 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 6.3 t -68.22 -39.21 80.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.936 0.398 . . . . 0.0 110.073 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 30.9 m -68.55 -20.54 64.55 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.742 178.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 1.0 ' HB1' HD22 ' A' ' 66' ' ' LEU . . . -67.41 -42.99 82.33 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.668 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.511 ' CE2' ' HA ' ' A' ' 91' ' ' VAL . 12.5 m-85 -62.39 -25.79 68.12 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.18 -41.13 42.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.282 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.739 ' O ' ' HA ' ' A' ' 75' ' ' MET . 0.0 OUTLIER -76.06 -16.91 59.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.206 -179.876 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 119.16 17.63 4.87 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.461 -0.876 . . . . 0.0 113.652 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.58 ' HB2' ' HB1' ' A' ' 93' ' ' ALA . . . -64.43 165.05 10.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 117.141 0.47 . . . . 0.0 110.811 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.481 ' HZ ' ' HG3' ' A' ' 117' ' ' ARG . 13.9 t80 -87.16 -54.42 4.32 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.497 ' OD2' HD11 ' A' ' 114' ' ' LEU . 9.5 p30 167.77 -164.55 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.782 0.325 . . . . 0.0 110.887 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.633 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 5.6 m-85 -138.63 153.19 48.6 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.755 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.404 ' CD1' HD22 ' A' ' 114' ' ' LEU . 0.8 OUTLIER -103.25 122.34 45.57 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.074 179.863 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -70.13 -69.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.078 1.852 . . . . 0.0 112.501 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.692 ' H ' ' HD2' ' A' ' 105' ' ' PRO . 0.9 OUTLIER -119.07 -60.42 0.03 OUTLIER Pre-proline 0 CA--C 1.533 0.301 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.901 -179.637 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.692 ' HD2' ' H ' ' A' ' 104' ' ' LYS . 11.7 Cg_endo -54.12 160.53 6.17 Favored 'Trans proline' 0 C--N 1.35 0.605 0 C-N-CA 122.214 1.943 . . . . 0.0 112.513 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.639 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 50.5 t80 -170.8 -102.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.551 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.566 ' O ' ' O ' ' A' ' 106' ' ' PHE . 2.3 p-10 43.26 178.46 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.558 0.218 . . . . 0.0 111.052 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.713 HG12 HG12 ' A' ' 18' ' ' VAL . 0.8 OUTLIER -67.82 -44.13 85.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.231 0.539 . . . . 0.0 111.217 179.852 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.492 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 1.5 t70 -49.42 -58.78 4.52 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.703 -179.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.639 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 6.4 mm-40 -74.17 -30.41 62.23 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 111.771 0.285 . . . . 0.0 111.771 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -68.76 -62.05 1.55 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.817 0.341 . . . . 0.0 110.331 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.641 ' HA ' HG12 ' A' ' 115' ' ' VAL . 44.0 t -57.84 -31.56 40.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.477 0.656 . . . . 0.0 110.716 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.492 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -64.0 -44.3 93.06 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.848 179.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.768 ' HA ' ' HD3' ' A' ' 117' ' ' ARG . 10.0 tp -78.33 -23.01 47.23 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.778 -179.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.641 HG12 ' HA ' ' A' ' 112' ' ' VAL . 4.8 p -79.45 -41.77 22.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.026 0.441 . . . . 0.0 111.47 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.495 ' HA ' HD12 ' A' ' 119' ' ' ILE . 20.8 mt-10 -59.65 -47.76 84.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.274 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.768 ' HD3' ' HA ' ' A' ' 114' ' ' LEU . 0.8 OUTLIER -59.24 -23.96 62.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.44 -179.531 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.479 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -71.03 -39.34 72.39 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.105 0.478 . . . . 0.0 111.0 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.696 HD13 ' CD2' ' A' ' 28' ' ' LEU . 4.6 mt -76.95 -30.95 18.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.728 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.4 t -67.44 -41.15 85.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.602 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 17.5 m80 . . . . . 0 C--O 1.233 0.198 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.979 179.992 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.634 ' HB3' HD11 ' A' ' 5' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.453 -0.288 0 CA-C-O 120.905 0.383 . . . . 0.0 111.079 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.44 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . 53.65 82.76 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.536 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.634 HD11 ' HB3' ' A' ' 3' ' ' ARG . 3.8 mp -108.4 112.38 40.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.713 0.292 . . . . 0.0 111.545 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 1.003 HG11 ' CD2' ' A' ' 23' ' ' LEU . 7.5 p -106.64 123.37 61.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.974 0.416 . . . . 0.0 110.911 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.795 ' CD1' HG22 ' A' ' 31' ' ' THR . 28.6 m0 -114.53 136.94 52.47 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.363 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.693 HG21 ' OE1' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -129.68 141.49 46.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.478 -178.408 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 1.085 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -119.45 104.83 16.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 178.673 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.707 ' HB3' HG21 ' A' ' 15' ' ' ILE . 8.3 t0 -172.42 114.98 0.31 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.387 0.613 . . . . 0.0 111.401 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.672 ' O ' ' HB2' ' A' ' 12' ' ' ASP . 0.4 OUTLIER 49.75 -87.46 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.761 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.672 ' HB2' ' O ' ' A' ' 11' ' ' ASP . 22.9 t0 168.01 -125.72 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.51 0 O-C-N 123.041 0.213 . . . . 0.0 110.842 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.521 ' HA ' ' HB3' ' A' ' 16' ' ' ARG . 72.7 m -41.36 -43.58 2.54 Favored 'General case' 0 C--N 1.342 0.275 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.0 m -52.9 -62.4 1.67 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.65 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.707 HG21 ' HB3' ' A' ' 10' ' ' ASP . 21.8 mm -72.33 -20.08 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.617 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.85 ' HA ' HG21 ' A' ' 32' ' ' THR . 3.0 tmm_? -72.38 -30.97 65.16 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-O 121.529 0.681 . . . . 0.0 110.244 178.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.622 ' O ' ' HB2' ' A' ' 21' ' ' ARG . 41.2 t90 -72.16 -58.07 3.73 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.886 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.449 HG12 HG12 ' A' ' 108' ' ' ILE . 0.8 OUTLIER -60.68 -62.24 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 -177.467 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.53 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -68.81 -49.52 57.84 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 114.29 1.218 . . . . 0.0 114.29 -176.818 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.755 ' HG3' ' HG2' ' A' ' 16' ' ' ARG . 1.5 mm-40 -67.87 -61.23 1.97 Allowed 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -177.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.622 ' HB2' ' O ' ' A' ' 17' ' ' TRP . 8.5 mmt180 -48.61 -44.22 36.92 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.327 -177.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.22 -28.6 62.26 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.878 0.37 . . . . 0.0 110.887 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 1.003 ' CD2' HG11 ' A' ' 6' ' ' VAL . 5.0 tp -80.93 -23.35 38.93 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.406 179.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' A' ' 20' ' ' GLU . . . -69.31 -35.14 75.68 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.87 -27.08 66.22 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.202 -0.999 . . . . 0.0 110.84 178.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.671 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -77.68 -15.86 58.89 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.623 0.249 . . . . 0.0 111.071 179.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.75 26.71 11.31 Favored Glycine 0 CA--C 1.522 0.47 0 C-N-CA 120.548 -0.834 . . . . 0.0 114.732 178.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.769 HD13 ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -117.77 166.36 12.54 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 118.548 1.174 . . . . 0.0 112.007 -179.887 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.493 ' HB ' HG23 ' A' ' 5' ' ' ILE . 88.5 m -84.73 104.66 14.89 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.776 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.474 ' HA ' HG13 ' A' ' 6' ' ' VAL . 2.8 p -106.29 109.31 21.2 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.956 -178.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.795 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.7 t -125.26 152.46 44.58 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.85 HG21 ' HA ' ' A' ' 16' ' ' ARG . 64.7 p -122.9 164.16 18.97 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.392 0.615 . . . . 0.0 112.597 -178.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 1.085 ' HB2' HG13 ' A' ' 9' ' ' VAL . 26.3 m-85 -135.93 172.95 12.26 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.025 -0.989 . . . . 0.0 112.033 -177.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.435 ' HG2' ' H ' ' A' ' 35' ' ' ASN . 5.3 pt-20 -63.26 -50.92 68.27 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.318 0.858 . . . . 0.0 113.318 -177.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.435 ' H ' ' HG2' ' A' ' 34' ' ' GLU . 10.5 m-20 -168.75 -26.06 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -179.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.609 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . 174.29 -61.62 0.12 Allowed Glycine 0 N--CA 1.453 -0.191 0 C-N-CA 120.115 -1.041 . . . . 0.0 113.029 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.516 ' HA ' ' CD1' ' A' ' 40' ' ' LEU . 0.5 OUTLIER -51.93 -28.38 16.3 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.69 0.281 . . . . 0.0 111.24 -179.536 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.908 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.7 OUTLIER -58.83 -58.34 9.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.67 179.245 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.694 HG12 ' HG ' ' A' ' 43' ' ' LEU . 7.7 t -50.74 -38.16 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 120.619 -0.433 . . . . 0.0 111.339 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.715 HD13 ' HB3' ' A' ' 68' ' ' GLN . 17.5 mt -53.81 -43.88 69.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.394 -179.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.89 -48.94 62.13 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.546 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.63 -35.28 78.63 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.37 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.694 ' HG ' HG12 ' A' ' 39' ' ' VAL . 14.2 mt -60.2 -26.31 66.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.076 0.465 . . . . 0.0 110.909 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.06 -20.46 25.01 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.302 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.3 m -123.08 4.67 9.28 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 112.146 0.425 . . . . 0.0 112.146 -179.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.543 ' HB3' ' CH2' ' A' ' 7' ' ' TRP . 0.0 OUTLIER -164.51 158.99 18.83 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.893 0.378 . . . . 0.0 111.273 -179.768 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.982 HG23 HD23 ' A' ' 76' ' ' LEU . 90.8 m -138.23 112.14 8.64 Favored Pre-proline 0 N--CA 1.452 -0.347 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.688 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.588 ' HD2' HD21 ' A' ' 43' ' ' LEU . 73.9 Cg_endo -73.58 156.21 49.57 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.703 2.268 . . . . 0.0 111.477 178.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -78.47 -22.92 46.8 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.174 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.641 ' O ' HG13 ' A' ' 50' ' ' VAL . 7.3 p -150.58 96.66 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-O 120.663 0.268 . . . . 0.0 111.542 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 27.7 tp -87.09 145.8 26.31 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 121.123 0.487 . . . . 0.0 111.367 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.769 HD23 ' O ' ' A' ' 79' ' ' ILE . 0.6 OUTLIER -131.36 114.18 14.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.323 179.637 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.685 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 35.3 t -115.32 144.52 43.64 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.62 0.724 . . . . 0.0 112.126 -179.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -83.14 168.36 16.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.395 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.558 HG13 ' O ' ' A' ' 61' ' ' ASP . 3.6 tt -142.58 87.6 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.721 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.5 ptm85 -118.51 36.22 4.48 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.541 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.687 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 1.2 ttt 64.46 46.3 0.59 Allowed Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.099 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.58 ' HD2' ' O ' ' A' ' 61' ' ' ASP . 27.0 Cg_endo -64.23 -74.81 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.024 1.816 . . . . 0.0 110.769 178.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -111.84 -85.58 1.53 Allowed Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 109.981 -1.247 . . . . 0.0 109.981 177.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.881 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 0.5 OUTLIER -87.72 58.65 5.0 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 177.408 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.687 ' HA ' ' HA ' ' A' ' 57' ' ' MET . 0.2 OUTLIER 62.54 -42.69 0.18 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.993 -179.5 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.514 ' HA3' HD12 ' A' ' 55' ' ' ILE . . . 171.31 -29.52 0.12 Allowed Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 111.494 -0.642 . . . . 0.0 111.494 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.661 HD11 ' O ' ' A' ' 84' ' ' HIS . 0.5 OUTLIER -72.46 -17.48 61.77 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 120.992 -0.283 . . . . 0.0 110.452 179.427 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.881 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -53.94 -29.25 41.65 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 121.103 0.478 . . . . 0.0 110.54 178.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.451 ' HA ' ' OE1' ' A' ' 68' ' ' GLN . 1.4 mm? -66.77 -24.22 66.18 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.24 -179.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.96 HD13 ' HB2' ' A' ' 93' ' ' ALA . 3.7 mt -77.73 -46.5 21.59 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.696 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 1.7 mtpt -46.09 -51.92 12.99 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.501 178.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.715 ' HB3' HD13 ' A' ' 40' ' ' LEU . 2.6 mp0 -64.42 -48.44 75.35 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.241 0.543 . . . . 0.0 110.335 178.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.533 ' HA ' ' CD2' ' A' ' 73' ' ' HIS . 4.2 mm -54.71 -39.05 45.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.665 -179.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.696 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -78.14 -30.58 49.34 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.199 -178.97 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.35 -40.93 57.69 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.825 -178.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.88 -46.31 9.52 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -179.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.559 ' CD2' HD13 ' A' ' 43' ' ' LEU . 1.2 m-70 -103.69 142.87 25.49 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.95 -178.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.29 -71.17 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.733 2.289 . . . . 0.0 113.272 -179.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 13.8 mtt -140.28 47.08 1.8 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.884 0.373 . . . . 0.0 110.805 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.982 HD23 HG23 ' A' ' 47' ' ' THR . 3.1 tm? -59.31 110.31 2.6 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.684 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.489 ' HD2' HD22 ' A' ' 76' ' ' LEU . 28.9 Cg_exo -63.02 116.51 3.62 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 123.086 2.524 . . . . 0.0 113.427 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.968 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 3.3 t -118.56 152.43 20.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.652 179.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.769 ' O ' HD23 ' A' ' 52' ' ' LEU . 3.6 mt -132.25 114.28 23.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.548 -0.297 . . . . 0.0 110.572 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.685 ' HA ' ' O ' ' A' ' 53' ' ' SER . 11.6 mm -95.59 142.5 13.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.133 0.492 . . . . 0.0 111.788 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.457 ' HB2' ' CE1' ' A' ' 106' ' ' PHE . 2.8 ptt? -66.65 -28.74 68.71 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.308 -179.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.611 HG21 ' CE1' ' A' ' 84' ' ' HIS . 5.0 m -147.07 167.78 23.21 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.43 0.157 . . . . 0.0 111.293 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.501 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -122.3 61.94 0.97 Allowed 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -179.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.661 ' O ' HD11 ' A' ' 63' ' ' LEU . 4.2 m-70 -73.16 162.87 28.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.824 0.345 . . . . 0.0 110.851 179.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.434 ' HB2' ' CB ' ' A' ' 61' ' ' ASP . 8.3 t 63.8 -167.41 0.21 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.124 0.488 . . . . 0.0 112.151 178.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -56.06 92.44 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.493 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.774 HD23 ' HB3' ' A' ' 90' ' ' ALA . 0.6 OUTLIER -47.76 -20.46 0.29 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.997 179.343 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -47.45 -45.98 26.28 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -178.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.402 ' HB3' HD22 ' A' ' 63' ' ' LEU . . . -63.93 -25.73 68.27 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.786 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.774 ' HB3' HD23 ' A' ' 87' ' ' LEU . . . -72.54 -48.79 37.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.768 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.653 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 3.4 t -63.48 -53.62 42.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.086 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 92.4 p -57.28 -23.94 51.65 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 178.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.96 ' HB2' HD13 ' A' ' 66' ' ' LEU . . . -57.57 -53.77 54.37 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.438 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.702 ' CE1' ' HA ' ' A' ' 100' ' ' ASP . 5.9 m-85 -51.13 -33.16 25.41 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.764 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.91 -39.37 56.43 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.447 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.597 ' HB2' ' HB2' ' A' ' 70' ' ' LYS . 6.5 pt20 -94.39 5.8 50.67 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.063 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 93' ' ' ALA . . . 123.1 80.32 0.5 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.55 -0.834 . . . . 0.0 113.019 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.968 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -168.57 135.82 2.0 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.979 0.418 . . . . 0.0 111.27 179.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.511 ' HB3' HG12 ' A' ' 79' ' ' ILE . 38.5 t80 -75.84 -53.44 8.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.534 -179.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.702 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 1.0 OUTLIER 177.7 -172.84 0.12 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.177 0.513 . . . . 0.0 112.005 -179.535 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.661 ' OH ' HD11 ' A' ' 66' ' ' LEU . 3.2 m-85 -130.19 153.46 48.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.387 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.639 HD23 ' HA ' ' A' ' 106' ' ' PHE . 1.9 mp -103.97 118.38 57.3 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.62 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -73.24 -71.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 121.93 1.753 . . . . 0.0 111.895 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.691 ' H ' ' HD2' ' A' ' 105' ' ' PRO . 9.6 tttm -108.55 -58.66 0.05 OUTLIER Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.623 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.691 ' HD2' ' H ' ' A' ' 104' ' ' LYS . 15.6 Cg_endo -57.51 152.53 47.05 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.3 2.0 . . . . 0.0 113.014 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.639 ' HA ' HD23 ' A' ' 102' ' ' LEU . 14.9 t80 -163.22 -118.38 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.176 179.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.558 ' O ' ' O ' ' A' ' 106' ' ' PHE . 2.9 p30 42.5 -179.46 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 118.164 0.438 . . . . 0.0 111.486 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.449 HG12 HG12 ' A' ' 18' ' ' VAL . 1.0 OUTLIER -67.86 -40.92 84.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.516 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.539 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 30.8 t0 -49.18 -58.64 4.65 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.495 -179.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.545 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 74.9 mm-40 -77.87 -32.17 51.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.694 0.283 . . . . 0.0 111.371 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.409 ' CB ' ' O ' ' A' ' 107' ' ' ASP . . . -64.88 -62.5 1.52 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.931 0.396 . . . . 0.0 109.978 179.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.564 ' O ' HG12 ' A' ' 115' ' ' VAL . 47.0 t -58.4 -31.32 42.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.496 0.665 . . . . 0.0 110.802 179.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.539 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -63.46 -45.97 88.38 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.196 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.742 HD23 HG21 ' A' ' 79' ' ' ILE . 5.5 tp -76.76 -22.47 53.74 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.786 -1.097 . . . . 0.0 112.169 -179.052 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.564 HG12 ' O ' ' A' ' 112' ' ' VAL . 4.7 p -79.28 -46.44 23.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.321 -0.552 . . . . 0.0 111.595 -179.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.415 ' HA ' HD12 ' A' ' 119' ' ' ILE . 38.4 mt-10 -64.35 -47.89 77.62 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.746 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.54 ' HG2' ' HA ' ' A' ' 114' ' ' LEU . 2.8 ptp180 -60.46 -27.93 67.92 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.14 0.495 . . . . 0.0 110.404 179.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.471 ' HB2' ' CE2' ' A' ' 99' ' ' PHE . . . -66.77 -47.02 73.47 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.792 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.429 HD11 HG11 ' A' ' 50' ' ' VAL . 4.4 mt -70.26 -30.69 44.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.689 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 10.5 t -66.72 -43.83 83.23 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.21 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 13.0 m80 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.147 -179.853 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.825 ' HG2' HD11 ' A' ' 5' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.469 0.492 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.864 ' O ' HD13 ' A' ' 5' ' ' ILE . . . 98.49 92.92 1.99 Allowed Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.242 179.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.864 HD13 ' O ' ' A' ' 4' ' ' GLY . 5.0 mm -126.04 112.48 30.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.074 0.464 . . . . 0.0 111.754 -179.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.951 HG11 ' HG ' ' A' ' 23' ' ' LEU . 14.3 p -109.93 128.69 65.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.684 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.877 ' CD1' HG22 ' A' ' 31' ' ' THR . 26.4 m0 -117.32 126.31 52.49 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.962 0.41 . . . . 0.0 110.112 179.09 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.743 HG11 ' CD1' ' A' ' 19' ' ' LEU . 0.5 OUTLIER -116.66 145.82 21.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.814 -178.105 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.813 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -124.52 111.1 27.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.919 0.39 . . . . 0.0 110.649 179.24 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -161.32 -159.15 0.62 Allowed 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.976 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -66.99 -0.64 3.29 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.474 ' O ' ' N ' ' A' ' 14' ' ' SER . 0.4 OUTLIER 68.08 -158.51 0.2 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 121.415 -0.114 . . . . 0.0 111.033 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.418 ' HB3' ' H ' ' A' ' 14' ' ' SER . 1.4 t 33.52 -86.46 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.758 ' O ' HG23 ' A' ' 18' ' ' VAL . 37.6 t -54.21 -63.9 1.0 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.741 0.305 . . . . 0.0 111.324 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.0 mm -61.44 -28.15 43.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.012 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.871 ' HA ' HG21 ' A' ' 32' ' ' THR . 2.7 ttm180 -73.29 -43.58 60.69 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.211 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 55.1 t90 -67.77 -40.75 84.0 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.965 -179.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.758 HG23 ' O ' ' A' ' 14' ' ' SER . 4.4 t -70.01 -39.27 77.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -178.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.743 ' CD1' HG11 ' A' ' 8' ' ' VAL . 16.2 mt -84.38 -27.72 27.47 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -178.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.604 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 24.5 pt-20 -67.44 -57.65 6.16 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.032 0.444 . . . . 0.0 111.655 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.472 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 0.7 OUTLIER -60.85 -52.49 64.85 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.937 -179.284 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.57 -43.85 84.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.866 0.365 . . . . 0.0 111.4 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.951 ' HG ' HG11 ' A' ' 6' ' ' VAL . 2.5 tm? -70.69 -31.78 68.79 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.331 0.586 . . . . 0.0 110.306 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.38 -34.22 77.67 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.16 -26.08 68.89 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.391 -0.909 . . . . 0.0 111.111 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.567 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -77.62 -15.56 59.13 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 120.751 0.31 . . . . 0.0 110.74 179.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.36 26.2 10.3 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.822 -0.704 . . . . 0.0 113.903 179.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.626 ' HB2' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -133.37 171.28 14.27 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 117.752 0.776 . . . . 0.0 111.902 179.705 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.649 ' O ' HG12 ' A' ' 6' ' ' VAL . 16.0 m -94.13 128.22 40.42 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.95 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.667 ' HA ' HG13 ' A' ' 6' ' ' VAL . 50.9 t -121.96 113.65 19.89 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 121.331 0.586 . . . . 0.0 111.477 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.877 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.7 t -117.8 151.86 36.49 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.594 178.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.871 HG21 ' HA ' ' A' ' 16' ' ' ARG . 40.2 p -124.35 164.46 19.58 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.219 0.533 . . . . 0.0 111.773 -179.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.859 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 2.3 m-85 -133.06 174.43 10.37 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.505 -178.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.402 ' HG2' ' N ' ' A' ' 35' ' ' ASN . 1.7 pt-20 -61.49 -40.7 95.54 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 -176.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.402 ' N ' ' HG2' ' A' ' 34' ' ' GLU . 1.4 m120 -170.96 -38.39 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 119.073 0.851 . . . . 0.0 112.589 -179.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.731 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . -178.77 -61.12 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.841 -179.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.635 HD22 HD12 ' A' ' 40' ' ' LEU . 13.0 m120 -50.74 -33.39 22.91 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 111.621 0.23 . . . . 0.0 111.621 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.859 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -57.7 -50.05 74.48 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.639 -0.425 . . . . 0.0 111.182 -179.98 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.869 HG11 HD11 ' A' ' 51' ' ' LEU . 5.5 t -62.44 -38.68 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 C-N-CA 119.93 -0.708 . . . . 0.0 110.442 179.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.798 HD13 ' CB ' ' A' ' 68' ' ' GLN . 12.9 mt -56.78 -42.16 78.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.524 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.35 -48.15 36.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.31 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.81 -28.41 69.84 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.364 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.664 HD21 ' HD2' ' A' ' 48' ' ' PRO . 8.4 mt -69.38 -24.12 63.83 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.083 -179.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.36 -17.69 5.32 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.266 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -123.97 0.61 8.57 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.657 ' O ' HD23 ' A' ' 43' ' ' LEU . 0.1 OUTLIER -161.96 155.57 21.2 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.912 0.387 . . . . 0.0 111.348 179.913 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.5 HG23 HD13 ' A' ' 76' ' ' LEU . 91.0 m -139.05 114.7 8.46 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.212 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.664 ' HD2' HD21 ' A' ' 43' ' ' LEU . 73.8 Cg_endo -76.19 166.1 28.36 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.41 2.073 . . . . 0.0 110.965 178.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -74.14 -21.92 59.66 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.681 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.711 HG13 HG23 ' A' ' 6' ' ' VAL . 7.4 p -146.7 168.45 5.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.23 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.869 HD11 HG11 ' A' ' 39' ' ' VAL . 13.5 tp -152.92 120.43 5.97 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.0 0.429 . . . . 0.0 111.53 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.682 ' HB3' HG13 ' A' ' 8' ' ' VAL . 0.3 OUTLIER -105.89 122.19 45.62 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.217 179.815 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.442 ' HB2' ' CD1' ' A' ' 80' ' ' ILE . 36.4 m -113.68 138.13 50.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.089 0.471 . . . . 0.0 112.021 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.526 ' O ' HG22 ' A' ' 55' ' ' ILE . 45.8 p-10 -78.23 -12.77 60.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.594 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.613 ' HB ' HG23 ' A' ' 80' ' ' ILE . 5.3 tt 50.62 82.31 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-O 121.387 0.613 . . . . 0.0 111.867 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.786 ' C ' ' HD2' ' A' ' 58' ' ' PRO . 1.0 OUTLIER 175.93 145.8 0.08 Allowed 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.708 179.273 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.529 ' CB ' ' O ' ' A' ' 56' ' ' ARG . 14.1 ttt 96.52 -52.12 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.766 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 178.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.786 ' HD2' ' C ' ' A' ' 56' ' ' ARG . 20.4 Cg_endo -58.58 175.83 0.51 Allowed 'Trans proline' 0 C--N 1.35 0.643 0 CA-C-N 121.147 1.445 . . . . 0.0 112.286 -178.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -42.17 -74.46 0.17 Allowed Glycine 0 C--N 1.335 0.522 0 C-N-CA 121.126 -0.559 . . . . 0.0 112.501 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.618 ' H ' ' HB2' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -69.46 56.22 0.12 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.773 0.32 . . . . 0.0 110.597 179.221 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 56.75 -80.37 0.01 OUTLIER 'General case' 0 C--O 1.231 0.111 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.735 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.508 ' HA3' ' C ' ' A' ' 55' ' ' ILE . . . -137.1 -34.46 0.2 Allowed Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.655 -0.783 . . . . 0.0 113.007 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.699 ' HA ' HD13 ' A' ' 66' ' ' LEU . 5.2 mp -63.28 -15.76 58.2 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.864 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.69 ' HB3' ' HB2' ' A' ' 58' ' ' PRO . . . -53.82 -48.61 69.72 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 120.929 0.395 . . . . 0.0 111.355 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.507 HD12 ' N ' ' A' ' 66' ' ' LEU . 4.0 pp -51.42 -39.36 57.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.065 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.851 ' HA ' HD12 ' A' ' 69' ' ' ILE . 5.1 mp -57.65 -47.98 80.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.912 0.387 . . . . 0.0 110.216 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.741 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 0.2 OUTLIER -49.98 -44.43 50.93 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.192 0.52 . . . . 0.0 110.097 178.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.798 ' CB ' HD13 ' A' ' 40' ' ' LEU . 11.6 mm100 -65.6 -26.42 67.83 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.262 179.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.879 HG12 ' CE1' ' A' ' 73' ' ' HIS . 94.0 mt -64.02 -39.62 86.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.486 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.741 ' HG2' ' O ' ' A' ' 67' ' ' LYS . 12.1 pttp -74.1 -27.22 60.78 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.893 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -85.85 -33.66 21.24 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.044 -179.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -106.54 -35.11 7.16 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -178.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.879 ' CE1' HG12 ' A' ' 69' ' ' ILE . 0.3 OUTLIER -99.44 136.07 20.49 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.891 -179.326 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 73' ' ' HIS . 91.4 Cg_endo -92.94 100.6 0.16 Allowed 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.953 2.435 . . . . 0.0 112.537 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.549 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 1.8 mtt 52.44 26.22 4.04 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.662 179.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.5 HD13 HG23 ' A' ' 47' ' ' THR . 12.9 tp -69.79 112.66 13.01 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.815 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.4 125.41 18.82 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.353 2.035 . . . . 0.0 112.09 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.832 HG21 HD13 ' A' ' 69' ' ' ILE . 3.7 t -118.25 148.52 21.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.934 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.894 ' CG2' HD23 ' A' ' 114' ' ' LEU . 2.0 mt -127.82 114.14 34.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.617 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.641 HG21 ' CE2' ' A' ' 101' ' ' TYR . 13.2 mm -99.54 143.49 13.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.984 0.421 . . . . 0.0 111.804 -179.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.437 ' HA ' ' HB2' ' A' ' 102' ' ' LEU . 18.6 ptm -86.56 -39.71 15.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.067 -178.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.431 ' H ' HG21 ' A' ' 55' ' ' ILE . 2.7 m -122.65 166.53 14.74 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.209 -179.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -138.99 -28.33 0.8 Allowed 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.458 ' CE1' ' CD1' ' A' ' 55' ' ' ILE . 3.5 p-80 38.19 -160.97 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 122.928 0.491 . . . . 0.0 111.863 -179.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.446 ' H ' ' HB2' ' A' ' 84' ' ' HIS . 27.4 t -82.66 42.05 0.75 Allowed 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -178.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.503 ' CB ' HD13 ' A' ' 63' ' ' LEU . 6.7 m-20 -132.84 15.98 4.28 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.718 0.294 . . . . 0.0 110.773 179.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.754 HD23 ' CB ' ' A' ' 90' ' ' ALA . 1.4 mt -44.74 -21.78 0.06 Allowed 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.291 -0.413 . . . . 0.0 112.006 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -47.94 -50.35 27.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.771 0.319 . . . . 0.0 111.028 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.403 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -70.7 -21.19 62.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.986 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.754 ' CB ' HD23 ' A' ' 87' ' ' LEU . . . -64.38 -33.22 75.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.861 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.631 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 3.1 t -66.15 -42.89 92.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.428 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.599 ' O ' ' HG3' ' A' ' 95' ' ' GLN . 14.9 m -60.43 -19.42 56.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.035 0.445 . . . . 0.0 110.073 178.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.742 ' O ' ' HG3' ' A' ' 96' ' ' GLN . . . -75.76 -53.93 7.73 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.62 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.631 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 5.6 m-85 -57.01 -33.19 66.91 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.148 0.499 . . . . 0.0 110.838 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.599 ' HG3' ' O ' ' A' ' 92' ' ' SER . 2.2 pp0? -76.95 -31.25 56.48 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.031 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.742 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 2.0 pp0? -83.09 -18.5 39.36 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.829 -0.349 . . . . 0.0 111.032 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 133.06 4.71 3.24 Favored Glycine 0 C--N 1.335 0.501 0 C-N-CA 120.231 -0.985 . . . . 0.0 114.315 178.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.68 ' HB2' ' HB1' ' A' ' 93' ' ' ALA . . . -58.03 158.34 6.87 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 117.85 0.825 . . . . 0.0 111.278 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.478 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 10.4 t80 -85.11 -53.73 5.08 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.481 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 177.02 -163.69 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.807 0.337 . . . . 0.0 111.297 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.641 ' CE2' HG21 ' A' ' 80' ' ' ILE . 5.9 m-85 -138.82 152.65 48.04 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.464 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.727 ' CD1' HD22 ' A' ' 114' ' ' LEU . 2.7 mp -104.25 122.19 44.9 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.939 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -66.38 -74.68 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.168 1.912 . . . . 0.0 112.395 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.698 ' H ' ' HD2' ' A' ' 105' ' ' PRO . 1.1 mtpm? -114.88 -60.81 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.808 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.698 ' HD2' ' H ' ' A' ' 104' ' ' LYS . 14.4 Cg_endo -56.55 163.22 7.15 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.368 2.046 . . . . 0.0 112.574 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.674 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 41.9 t80 -170.2 -99.94 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.562 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.541 ' O ' ' O ' ' A' ' 106' ' ' PHE . 1.0 OUTLIER 41.47 -175.67 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.812 0.339 . . . . 0.0 111.096 -179.575 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.693 HD11 ' HG ' ' A' ' 19' ' ' LEU . 1.0 OUTLIER -68.01 -40.3 82.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.011 0.434 . . . . 0.0 111.62 179.909 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.494 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 55.2 m-20 -51.85 -58.83 5.31 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.573 -179.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.674 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 6.8 mm-40 -75.08 -31.42 61.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.646 0.26 . . . . 0.0 111.417 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -69.91 -61.73 1.66 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.47 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.664 ' O ' HG12 ' A' ' 115' ' ' VAL . 54.4 t -57.31 -30.61 35.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.444 0.64 . . . . 0.0 110.298 178.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.494 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -65.12 -49.22 70.79 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.727 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.894 HD23 ' CG2' ' A' ' 79' ' ' ILE . 13.0 tp -71.71 -21.23 61.8 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.958 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.664 HG12 ' O ' ' A' ' 112' ' ' VAL . 4.3 p -79.43 -47.53 22.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 C-N-CA 120.446 -0.501 . . . . 0.0 111.497 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.427 ' N ' HG13 ' A' ' 115' ' ' VAL . 45.3 mt-10 -66.15 -45.08 82.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.578 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' A' ' 113' ' ' ALA . 0.0 OUTLIER -60.65 -24.41 65.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.583 179.501 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.478 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -71.26 -48.8 48.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.968 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 4.3 mt -68.49 -31.07 49.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.233 0.54 . . . . 0.0 110.755 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -75.7 -54.38 7.06 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.155 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 17.9 m80 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.112 -179.717 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.744 ' HB3' HD11 ' A' ' 5' ' ' ILE . 15.1 ttt180 . . . . . 0 CA--C 1.532 0.279 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 51.39 73.83 0.35 Allowed Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.992 -0.623 . . . . 0.0 113.444 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.744 HD11 ' HB3' ' A' ' 3' ' ' ARG . 2.9 mp -105.17 112.76 40.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.749 0.309 . . . . 0.0 111.055 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.817 HG23 HG13 ' A' ' 50' ' ' VAL . 6.9 p -105.6 125.61 60.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.251 178.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.916 ' CD1' HG22 ' A' ' 31' ' ' THR . 31.4 m0 -115.74 132.01 56.76 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.09 0.472 . . . . 0.0 110.282 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.847 ' HB ' HG22 ' A' ' 32' ' ' THR . 46.6 t -118.8 145.86 24.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.664 -178.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.699 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -127.35 118.01 48.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.806 0.336 . . . . 0.0 110.559 179.782 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.554 ' CB ' HG21 ' A' ' 15' ' ' ILE . 2.1 t0 -163.48 -159.43 0.52 Allowed 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.775 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.94 -0.09 4.0 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 65.61 -158.33 0.27 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.495 0.188 . . . . 0.0 110.904 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.432 ' HB3' ' H ' ' A' ' 14' ' ' SER . 1.3 t 35.43 -90.93 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.845 ' O ' HG23 ' A' ' 18' ' ' VAL . 2.1 t -58.39 -54.87 42.17 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.708 0.289 . . . . 0.0 111.321 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.554 HG21 ' CB ' ' A' ' 10' ' ' ASP . 24.7 mm -64.83 -25.14 37.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.941 0.4 . . . . 0.0 111.15 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.551 ' HA ' HG21 ' A' ' 32' ' ' THR . 4.1 ttp180 -75.65 -53.27 8.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.257 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.588 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 86.7 t90 -57.25 -40.45 77.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.84 0.352 . . . . 0.0 111.51 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.845 HG23 ' O ' ' A' ' 14' ' ' SER . 18.9 t -66.43 -47.95 82.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 112.154 0.428 . . . . 0.0 112.154 -178.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.683 HD23 HG21 ' A' ' 8' ' ' VAL . 2.1 tp -80.54 -29.16 37.15 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -178.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.588 ' HG2' ' HA ' ' A' ' 17' ' ' TRP . 1.3 pp20? -62.46 -60.31 3.73 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.468 -0.493 . . . . 0.0 112.026 -179.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.422 ' HG2' ' CD ' ' A' ' 20' ' ' GLU . 3.0 mmm180 -58.93 -47.51 84.81 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.696 0.284 . . . . 0.0 111.679 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.87 -34.37 77.24 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -178.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.789 HD22 HG11 ' A' ' 6' ' ' VAL . 0.4 OUTLIER -81.82 -26.74 34.07 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.627 179.553 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.41 -34.25 74.21 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 177.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.68 -24.15 69.47 Favored Glycine 0 N--CA 1.443 -0.897 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 177.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.488 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -76.95 -15.3 59.7 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.589 -0.306 . . . . 0.0 110.275 178.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 94.1 26.65 13.79 Favored Glycine 0 C--N 1.337 0.633 0 C-N-CA 120.812 -0.709 . . . . 0.0 114.293 178.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.764 HD13 ' CD2' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -133.87 166.67 22.13 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-N 118.215 1.007 . . . . 0.0 112.784 -179.609 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.46 ' O ' HG12 ' A' ' 6' ' ' VAL . 60.1 m -85.65 118.17 24.99 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.051 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.589 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 1.7 p -116.68 117.13 28.97 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.967 -0.56 . . . . 0.0 112.208 -178.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.916 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.8 t -125.11 133.24 52.93 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.847 HG22 ' HB ' ' A' ' 8' ' ' VAL . 77.1 p -107.64 164.28 12.36 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.159 0.504 . . . . 0.0 111.659 -178.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.858 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 2.9 m-85 -134.94 174.33 10.71 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.879 -177.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.66 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 2.5 pp20? -63.18 -34.76 78.32 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -176.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -171.04 -55.83 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 118.947 0.794 . . . . 0.0 112.799 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.663 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . -170.43 -43.77 0.03 OUTLIER Glycine 0 C--N 1.316 -0.58 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.57 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.695 ' HA ' ' CD1' ' A' ' 40' ' ' LEU . 1.5 t-20 -62.98 -26.07 68.67 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 120.985 0.421 . . . . 0.0 110.714 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.858 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -62.02 -57.64 10.88 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.269 179.819 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.713 HG22 ' CD1' ' A' ' 33' ' ' PHE . 21.2 t -55.51 -32.22 29.71 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 C-N-CA 120.116 -0.634 . . . . 0.0 111.233 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.695 ' CD1' ' HA ' ' A' ' 37' ' ' ASN . 11.2 mt -58.83 -46.47 87.6 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.773 0.32 . . . . 0.0 110.652 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.27 -48.93 63.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.177 0.513 . . . . 0.0 110.794 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.55 -33.61 75.28 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.716 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.671 ' HB3' ' NE2' ' A' ' 73' ' ' HIS . 15.0 mt -63.23 -27.68 69.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.531 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.99 -18.41 45.68 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.299 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.2 m -115.06 -4.77 12.49 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.1 OUTLIER -165.64 161.98 18.62 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.885 0.374 . . . . 0.0 111.081 179.951 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.583 HG23 HD12 ' A' ' 76' ' ' LEU . 54.0 m -138.86 111.77 8.14 Favored Pre-proline 0 N--CA 1.45 -0.43 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.354 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.855 ' HD2' HD11 ' A' ' 76' ' ' LEU . 66.1 Cg_endo -73.3 164.37 35.41 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.162 1.908 . . . . 0.0 111.329 178.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -77.76 -22.1 50.74 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.151 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.817 HG13 HG23 ' A' ' 6' ' ' VAL . 9.8 p -145.15 164.41 12.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.782 HD12 ' O ' ' A' ' 7' ' ' TRP . 11.6 tp -152.67 111.37 3.76 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 121.139 0.495 . . . . 0.0 112.008 -178.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.48 HD13 HD21 ' A' ' 19' ' ' LEU . 1.4 tt -97.7 119.98 37.25 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.759 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.718 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 0.3 OUTLIER -125.47 137.96 53.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.435 0.636 . . . . 0.0 112.63 -178.758 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.505 ' HA ' ' HG2' ' A' ' 81' ' ' MET . 0.8 OUTLIER -83.14 177.37 8.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.172 179.319 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.876 HG21 ' O ' ' A' ' 82' ' ' THR . 0.0 OUTLIER -154.73 105.41 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.195 0.522 . . . . 0.0 110.807 178.978 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.433 ' H ' ' HD3' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -133.56 36.77 3.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.152 -179.508 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.499 ' N ' ' CD ' ' A' ' 58' ' ' PRO . 0.5 OUTLIER 66.42 41.55 0.27 Allowed Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 179.042 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.499 ' CD ' ' N ' ' A' ' 57' ' ' MET . 58.1 Cg_endo -68.81 -90.57 0.0 OUTLIER 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 122.042 1.828 . . . . 0.0 111.0 178.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -87.66 -91.46 1.03 Allowed Glycine 0 C--N 1.335 0.488 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 1.018 ' HB3' ' HB2' ' A' ' 64' ' ' ALA . 34.6 tpp -87.56 64.85 8.31 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 177.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.482 ' HA ' ' HA ' ' A' ' 57' ' ' MET . 0.2 OUTLIER 67.61 -20.71 0.12 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.695 -179.291 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.82 ' HA3' HG12 ' A' ' 55' ' ' ILE . . . 133.01 -32.33 2.77 Favored Glycine 0 N--CA 1.446 -0.69 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 -179.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.874 HD13 ' HB3' ' A' ' 86' ' ' ASP . 5.4 mp -68.27 -13.86 62.57 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 120.862 0.363 . . . . 0.0 110.332 179.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 1.018 ' HB2' ' HB3' ' A' ' 60' ' ' MET . . . -53.17 -36.22 60.67 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.558 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.6 HD11 HD11 ' A' ' 80' ' ' ILE . 3.8 pp -59.73 -40.68 88.86 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 121.1 -0.24 . . . . 0.0 111.222 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.617 ' CD1' ' HA ' ' A' ' 63' ' ' LEU . 4.8 mp -60.38 -43.01 97.02 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-O 121.124 0.488 . . . . 0.0 110.226 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.6 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -54.62 -44.23 72.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.202 -179.749 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.602 ' HB3' HD13 ' A' ' 40' ' ' LEU . 8.6 mm-40 -71.92 -43.51 65.19 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.44 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.428 HD12 ' HA ' ' A' ' 66' ' ' LEU . 16.8 mt -60.95 -35.38 64.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-O 121.033 0.444 . . . . 0.0 110.973 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.6 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -72.75 -29.81 63.63 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.013 -179.826 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.452 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -76.37 -36.68 58.02 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.631 -179.67 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.16 -26.14 21.44 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.926 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.671 ' NE2' ' HB3' ' A' ' 43' ' ' LEU . 31.9 m-70 -153.35 82.9 4.65 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.733 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.797 ' HA ' ' HB2' ' A' ' 96' ' ' GLN . 59.2 Cg_endo -73.47 39.08 0.46 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.583 2.189 . . . . 0.0 112.869 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.406 ' HG2' ' C ' ' A' ' 74' ' ' PRO . 1.5 mmm -141.92 -32.09 0.53 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.971 0.415 . . . . 0.0 111.689 -179.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.855 HD11 ' HD2' ' A' ' 48' ' ' PRO . 0.3 OUTLIER -61.29 124.37 80.28 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.805 -179.44 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.712 ' HD2' HD23 ' A' ' 76' ' ' LEU . 57.6 Cg_endo -71.2 126.31 12.25 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.32 2.013 . . . . 0.0 112.239 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.605 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 9.5 t -106.93 140.21 25.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.301 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.518 ' CG2' HD23 ' A' ' 114' ' ' LEU . 2.6 mt -127.13 110.08 22.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.614 179.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.718 ' HA ' ' O ' ' A' ' 53' ' ' SER . 13.5 mm -103.88 148.04 9.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.923 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.763 ' HG3' HG22 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -69.83 -73.3 0.16 Allowed 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.715 179.647 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.876 ' O ' HG21 ' A' ' 55' ' ' ILE . 3.9 m -105.31 162.8 13.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.949 0.404 . . . . 0.0 110.996 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.8 ' HB1' ' HG ' ' A' ' 87' ' ' LEU . . . -111.93 -22.22 11.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.621 -179.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.45 ' H ' HG22 ' A' ' 82' ' ' THR . 2.8 m-70 44.39 -163.0 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 120.605 0.241 . . . . 0.0 111.359 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 47.9 t -81.54 29.2 0.38 Allowed 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.874 ' HB3' HD13 ' A' ' 63' ' ' LEU . 0.4 OUTLIER -128.51 24.77 5.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.708 0.29 . . . . 0.0 110.865 179.624 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.8 ' HG ' ' HB1' ' A' ' 83' ' ' ALA . 1.7 mt -50.32 -23.77 2.53 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.456 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -48.09 -56.95 6.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.71 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.482 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -59.57 -22.18 61.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.582 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.459 ' HB2' ' CD2' ' A' ' 63' ' ' LEU . . . -71.02 -35.57 72.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.998 0.428 . . . . 0.0 110.143 179.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.65 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 13.7 t -60.03 -44.65 95.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.464 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 49.0 m -60.97 -34.69 75.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.005 0.431 . . . . 0.0 110.491 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.884 ' HB1' ' HB2' ' A' ' 98' ' ' ALA . . . -59.63 -42.28 92.37 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.019 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.65 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 11.0 m-85 -55.49 -24.24 30.4 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.317 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.605 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -75.74 -40.78 54.86 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.912 179.336 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.797 ' HB2' ' HA ' ' A' ' 74' ' ' PRO . 5.3 pp0? -77.1 -17.87 58.38 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.903 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.421 ' O ' ' HA ' ' A' ' 77' ' ' PRO . . . 123.36 18.09 3.13 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.761 -0.733 . . . . 0.0 113.335 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.884 ' HB2' ' HB1' ' A' ' 93' ' ' ALA . . . -48.92 141.03 8.11 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 117.283 0.541 . . . . 0.0 110.911 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.556 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 27.1 t80 -75.72 -53.43 8.53 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.965 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.625 ' OD1' HD21 ' A' ' 114' ' ' LEU . 1.7 p30 167.57 -171.27 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.953 0.406 . . . . 0.0 111.502 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.513 ' CE2' ' HB ' ' A' ' 80' ' ' ILE . 5.3 m-85 -131.0 153.71 48.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.583 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.78 HD23 ' CD1' ' A' ' 106' ' ' PHE . 1.6 tp -102.27 123.4 43.32 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.663 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -72.82 -78.08 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 121.981 1.788 . . . . 0.0 112.766 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.424 ' O ' ' CD2' ' A' ' 106' ' ' PHE . 2.4 tmtm? -108.28 -54.19 0.06 OUTLIER Pre-proline 0 CA--C 1.531 0.247 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.437 ' O ' ' CG ' ' A' ' 106' ' ' PHE . 52.6 Cg_exo -55.49 154.54 24.22 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.275 1.983 . . . . 0.0 112.508 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.78 ' CD1' HD23 ' A' ' 102' ' ' LEU . 59.9 m-85 -160.43 -119.14 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.9 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.494 ' O ' ' O ' ' A' ' 106' ' ' PHE . 2.6 p30 47.71 174.94 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 120.835 0.35 . . . . 0.0 111.142 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.621 HG12 HG12 ' A' ' 18' ' ' VAL . 1.1 mp -67.11 -44.5 87.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.027 0.442 . . . . 0.0 111.461 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.609 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 0.8 OUTLIER -49.23 -53.92 19.19 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.554 -179.384 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.606 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 3.2 mm-40 -82.47 -34.61 28.01 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 -179.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.42 ' CB ' ' O ' ' A' ' 107' ' ' ASP . . . -69.4 -57.35 5.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.807 0.337 . . . . 0.0 110.2 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.684 HG12 ' OE2' ' A' ' 116' ' ' GLU . 46.4 t -59.92 -30.84 46.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.294 0.569 . . . . 0.0 110.481 178.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.609 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -62.07 -46.16 90.32 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.522 0.677 . . . . 0.0 109.997 178.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.655 HD22 HD13 ' A' ' 102' ' ' LEU . 13.9 tp -72.8 -26.69 61.6 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 114.691 -1.14 . . . . 0.0 111.585 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.634 HG12 ' HA ' ' A' ' 112' ' ' VAL . 4.7 p -79.21 -43.03 23.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.833 0.349 . . . . 0.0 111.895 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.684 ' OE2' HG12 ' A' ' 112' ' ' VAL . 44.1 mt-10 -65.84 -45.68 81.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.786 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.511 ' HG2' ' HA ' ' A' ' 114' ' ' LEU . 6.6 ptp180 -59.19 -26.2 64.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.67 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.556 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -68.72 -42.17 78.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.978 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.727 HD13 HD22 ' A' ' 28' ' ' LEU . 5.0 mt -75.68 -30.94 22.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.88 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 10.3 t -70.6 -51.31 29.11 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.903 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 17.1 m80 . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.073 -179.885 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.814 ' HG2' HD11 ' A' ' 5' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.22 0 CA-C-O 121.005 0.431 . . . . 0.0 111.406 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 55.93 85.57 0.03 OUTLIER Glycine 0 C--N 1.319 -0.405 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.386 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.814 HD11 ' HG2' ' A' ' 3' ' ' ARG . 3.1 mp -108.5 114.87 47.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.668 0.271 . . . . 0.0 111.115 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.958 HG11 ' CD2' ' A' ' 23' ' ' LEU . 7.4 p -107.33 114.8 47.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.051 0.453 . . . . 0.0 111.067 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.801 ' CD1' HG22 ' A' ' 31' ' ' THR . 38.7 m0 -107.95 147.39 31.11 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.009 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.747 HG21 ' OE2' ' A' ' 20' ' ' GLU . 0.1 OUTLIER -137.42 146.1 28.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.353 -178.752 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.882 HG11 ' HA2' ' A' ' 36' ' ' GLY . 0.0 OUTLIER -120.61 104.78 15.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.035 0.445 . . . . 0.0 110.786 179.1 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.815 ' HB3' HG21 ' A' ' 15' ' ' ILE . 0.8 OUTLIER -174.1 118.05 0.24 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.812 -179.801 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.591 ' O ' ' HB2' ' A' ' 12' ' ' ASP . 0.2 OUTLIER 41.96 -87.28 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.232 -0.895 . . . . 0.0 112.033 -179.541 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.591 ' HB2' ' O ' ' A' ' 11' ' ' ASP . 24.4 t70 160.07 -100.79 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 122.734 0.414 . . . . 0.0 111.048 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.6 p -36.77 -76.51 0.02 OUTLIER 'General case' 0 C--O 1.231 0.096 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -179.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.654 ' O ' HG23 ' A' ' 18' ' ' VAL . 44.0 t -52.76 -37.97 60.29 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.322 -177.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.815 HG21 ' HB3' ' A' ' 10' ' ' ASP . 19.3 mm -78.72 -22.88 13.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.163 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.643 ' HA ' HG21 ' A' ' 32' ' ' THR . 3.8 ttm-85 -77.18 -31.37 55.39 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.243 0.544 . . . . 0.0 110.277 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.617 ' HA ' ' HG3' ' A' ' 21' ' ' ARG . 79.7 t90 -72.12 -60.49 2.21 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.683 HG12 HG12 ' A' ' 108' ' ' ILE . 0.8 OUTLIER -54.59 -62.04 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -176.816 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.516 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -77.11 -46.49 23.37 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 -176.177 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.747 ' OE2' HG21 ' A' ' 8' ' ' VAL . 4.7 mm-40 -68.01 -61.38 1.89 Allowed 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 113.456 0.909 . . . . 0.0 113.456 -177.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.617 ' HG3' ' HA ' ' A' ' 17' ' ' TRP . 2.4 mmt180 -48.74 -43.96 38.02 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.098 -177.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.41 -26.98 61.2 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.781 0.324 . . . . 0.0 111.045 179.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.958 ' CD2' HG11 ' A' ' 6' ' ' VAL . 5.9 tp -82.27 -24.66 34.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.288 0.566 . . . . 0.0 110.198 179.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.495 ' HB2' ' SG ' ' A' ' 30' ' ' CYS . . . -68.36 -36.11 78.73 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.29 -25.17 68.13 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.256 -0.973 . . . . 0.0 110.749 178.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.675 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -76.76 -15.83 59.65 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 120.627 0.251 . . . . 0.0 110.885 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.06 26.58 9.46 Favored Glycine 0 CA--C 1.523 0.547 0 C-N-CA 120.482 -0.866 . . . . 0.0 114.559 178.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.737 HD13 ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -120.76 166.98 12.98 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 118.227 1.014 . . . . 0.0 111.93 -179.93 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.646 ' HB ' HG23 ' A' ' 5' ' ' ILE . 87.2 m -86.52 104.27 15.82 Favored 'General case' 0 CA--C 1.522 -0.097 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 4.2 p -105.31 110.33 22.65 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.914 -178.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.801 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.8 t -127.16 153.4 46.09 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.643 HG21 ' HA ' ' A' ' 16' ' ' ARG . 58.8 p -125.77 163.76 22.16 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.145 0.498 . . . . 0.0 111.923 -179.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.841 ' HB2' HG13 ' A' ' 9' ' ' VAL . 9.4 m-85 -136.09 173.4 11.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.482 -178.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.418 ' HG3' ' OD1' ' A' ' 35' ' ' ASN . 0.9 OUTLIER -63.0 -42.51 99.87 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -177.562 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.418 ' OD1' ' HG3' ' A' ' 34' ' ' GLU . 1.0 OUTLIER -170.92 -35.05 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 118.66 0.664 . . . . 0.0 112.343 -179.653 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.91 ' HA3' HD22 ' A' ' 65' ' ' LEU . . . 176.71 -54.12 0.11 Allowed Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.231 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.455 ' HA ' HD12 ' A' ' 40' ' ' LEU . 27.5 m120 -51.31 -31.34 21.23 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.688 0.28 . . . . 0.0 111.328 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.814 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -65.15 -51.6 60.21 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.951 -0.3 . . . . 0.0 111.084 179.471 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.732 HG22 ' CD1' ' A' ' 33' ' ' PHE . 21.5 t -55.34 -33.95 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 120.277 -0.569 . . . . 0.0 111.722 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.455 HD12 ' HA ' ' A' ' 37' ' ' ASN . 13.3 mt -59.79 -47.85 84.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.692 0.282 . . . . 0.0 111.402 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.23 -47.36 79.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.268 0.556 . . . . 0.0 111.03 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.52 -40.06 96.04 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.025 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.55 HD13 ' CD2' ' A' ' 73' ' ' HIS . 17.9 mt -59.44 -26.12 64.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.433 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.74 -21.55 7.44 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.337 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.2 m -126.15 4.72 7.13 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -161.36 155.68 22.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.772 0.32 . . . . 0.0 110.968 179.946 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.93 HG23 HD23 ' A' ' 76' ' ' LEU . 89.8 m -138.56 112.05 8.39 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.448 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.661 ' HD2' HD21 ' A' ' 76' ' ' LEU . 71.7 Cg_endo -77.34 163.25 30.24 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.007 1.805 . . . . 0.0 111.444 178.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.462 ' O ' ' HG2' ' A' ' 77' ' ' PRO . 1.7 m-20 -75.74 -23.17 56.0 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.361 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.741 HG13 HG23 ' A' ' 6' ' ' VAL . 7.3 p -145.83 158.59 12.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 C-N-CA 121.16 -0.216 . . . . 0.0 110.83 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.562 ' HA ' ' O ' ' A' ' 7' ' ' TRP . 12.8 tp -152.86 115.69 4.55 Favored 'General case' 0 C--N 1.333 -0.115 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.574 ' HG ' ' HB ' ' A' ' 79' ' ' ILE . 0.8 OUTLIER -101.77 117.14 34.24 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.593 178.446 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.603 ' HB3' HD12 ' A' ' 65' ' ' LEU . 71.9 m -114.22 151.75 32.31 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.95 0.405 . . . . 0.0 112.022 -178.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -82.66 175.5 10.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.435 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.841 HG22 ' HG3' ' A' ' 81' ' ' MET . 3.2 tt -151.38 67.69 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.136 0 CA-C-O 121.343 0.592 . . . . 0.0 111.705 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 177.6 51.66 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.283 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.599 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . 3.1 ttt -159.8 -62.48 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.3 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.503 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.599 ' HD3' ' HB3' ' A' ' 57' ' ' MET . 33.3 Cg_endo -61.64 -165.41 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.307 2.005 . . . . 0.0 112.546 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.45 -80.97 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.976 -0.63 . . . . 0.0 112.909 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.94 ' HB2' ' HB2' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -77.03 55.57 1.14 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.794 0.33 . . . . 0.0 111.277 -179.629 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.589 ' HB3' HG13 ' A' ' 55' ' ' ILE . 0.8 OUTLIER 56.77 -68.93 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.574 179.4 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.637 ' O ' ' HG ' ' A' ' 65' ' ' LEU . . . -153.05 -34.34 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.817 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.6 HD23 ' HB2' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -62.17 -19.8 63.46 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 122.56 -0.377 . . . . 0.0 110.05 179.732 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.94 ' HB2' ' HB2' ' A' ' 60' ' ' MET . . . -54.3 -36.7 63.97 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 121.437 0.636 . . . . 0.0 109.975 178.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.91 HD22 ' HA3' ' A' ' 36' ' ' GLY . 10.9 mt -60.14 -56.79 17.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.034 -0.984 . . . . 0.0 110.605 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.705 HD22 ' HB1' ' A' ' 93' ' ' ALA . 9.6 mt -46.17 -43.77 15.41 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.552 179.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.428 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 0.6 OUTLIER -52.07 -55.45 20.66 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.252 178.68 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.445 ' HB3' HD13 ' A' ' 40' ' ' LEU . 42.5 mm-40 -68.49 -34.74 76.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.863 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.564 HG23 ' HD2' ' A' ' 73' ' ' HIS . 96.8 mt -65.53 -36.7 78.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.562 -179.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.442 ' HB2' ' HB3' ' A' ' 96' ' ' GLN . 11.9 pttt -78.19 -26.82 47.72 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.06 -0.518 . . . . 0.0 112.338 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -67.77 -48.67 65.71 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -178.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.8 mmm180 -91.68 -42.55 10.1 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -178.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.564 ' HD2' HG23 ' A' ' 69' ' ' ILE . 3.3 m-70 -90.98 149.24 39.74 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.442 -178.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -73.6 -77.51 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.599 2.199 . . . . 0.0 113.187 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.721 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 1.3 mtt -125.76 44.56 2.8 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.743 0.306 . . . . 0.0 111.711 -179.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.93 HD23 HG23 ' A' ' 47' ' ' THR . 1.0 OUTLIER -60.27 109.51 2.08 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.414 179.414 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.462 ' HG2' ' O ' ' A' ' 49' ' ' ASP . 32.9 Cg_exo -60.74 115.37 2.64 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.525 2.15 . . . . 0.0 112.051 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 5.0 t -115.47 151.91 17.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.14 0 CA-C-O 121.075 0.464 . . . . 0.0 111.345 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.585 HD11 HG23 ' A' ' 50' ' ' VAL . 2.1 mt -138.41 112.82 8.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.569 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.633 ' CG2' ' HB ' ' A' ' 55' ' ' ILE . 16.6 mm -95.03 142.07 14.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.018 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.841 ' HG3' HG22 ' A' ' 55' ' ' ILE . 1.4 ppp? -71.59 -27.24 63.0 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -178.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.547 ' O ' HD13 ' A' ' 55' ' ' ILE . 5.4 m -147.22 164.45 33.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.652 0.263 . . . . 0.0 110.77 179.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.883 ' HB1' ' HG ' ' A' ' 87' ' ' LEU . . . -129.18 37.26 4.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.769 0.318 . . . . 0.0 111.65 -179.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.438 ' O ' ' HB3' ' A' ' 85' ' ' SER . 0.6 OUTLIER -85.83 -172.91 4.34 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.72 179.794 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.438 ' HB3' ' O ' ' A' ' 84' ' ' HIS . 29.7 t 68.7 -79.6 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.384 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.535 ' O ' HD22 ' A' ' 63' ' ' LEU . 0.1 OUTLIER -141.49 80.2 1.72 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.928 0.394 . . . . 0.0 111.268 -179.568 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.883 ' HG ' ' HB1' ' A' ' 83' ' ' ALA . 0.5 OUTLIER -55.94 -21.82 22.83 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.604 179.912 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -48.29 -50.32 30.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.67 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.595 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -57.6 -20.1 30.38 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.731 0.3 . . . . 0.0 111.741 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.633 ' HB3' HD23 ' A' ' 87' ' ' LEU . . . -73.75 -26.02 60.46 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.964 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.595 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 12.2 t -64.84 -50.64 74.27 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.485 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.428 ' O ' ' HB3' ' A' ' 95' ' ' GLN . 3.8 m -62.44 -23.63 66.98 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.97 0.414 . . . . 0.0 110.149 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.705 ' HB1' HD22 ' A' ' 66' ' ' LEU . . . -62.27 -38.37 89.03 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 121.291 0.567 . . . . 0.0 109.935 178.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.595 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 9.1 m-85 -68.15 -23.06 64.83 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.547 178.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.428 ' HB3' ' O ' ' A' ' 92' ' ' SER . 0.0 OUTLIER -77.25 -38.37 51.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.855 179.38 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.721 ' O ' ' HA ' ' A' ' 75' ' ' MET . 1.5 pp0? -80.61 -19.01 46.39 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 120.949 -0.301 . . . . 0.0 111.31 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 117.99 31.42 1.59 Allowed Glycine 0 CA--C 1.52 0.388 0 C-N-CA 120.584 -0.817 . . . . 0.0 113.344 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.633 ' HB2' ' HB1' ' A' ' 93' ' ' ALA . . . -67.33 151.34 47.64 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 122.833 -0.216 . . . . 0.0 110.774 179.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.536 ' CZ ' ' HB2' ' A' ' 118' ' ' ALA . 14.2 t80 -76.84 -53.83 7.39 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 121.094 -0.242 . . . . 0.0 111.324 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.473 ' HB2' ' O ' ' A' ' 99' ' ' PHE . 4.4 t0 171.08 -168.7 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.312 0.577 . . . . 0.0 111.39 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.788 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 3.7 m-85 -133.79 152.36 51.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.016 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.596 HD11 HD22 ' A' ' 114' ' ' LEU . 1.5 mp -105.22 118.97 54.55 Favored Pre-proline 0 C--N 1.329 -0.314 0 C-N-CA 121.11 -0.236 . . . . 0.0 111.11 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -81.18 -76.31 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.399 2.066 . . . . 0.0 112.508 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.579 ' H ' ' HD2' ' A' ' 105' ' ' PRO . 1.3 mtpp -99.31 -62.07 0.1 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.603 -0.272 . . . . 0.0 111.682 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.579 ' HD2' ' H ' ' A' ' 104' ' ' LYS . 19.5 Cg_endo -59.03 149.56 78.87 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.186 1.924 . . . . 0.0 112.361 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.658 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 48.4 t80 -160.35 -111.79 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.89 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.629 ' O ' ' O ' ' A' ' 106' ' ' PHE . 2.8 p30 39.07 179.4 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.99 0.424 . . . . 0.0 111.921 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.683 HG12 HG12 ' A' ' 18' ' ' VAL . 0.7 OUTLIER -67.6 -42.57 86.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.85 0.357 . . . . 0.0 111.776 -179.403 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.447 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 3.9 m-20 -49.55 -58.42 5.24 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.364 -179.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.658 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 13.8 mm-40 -73.96 -35.35 64.52 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.771 0.319 . . . . 0.0 111.08 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.54 -56.18 15.74 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.924 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.637 ' HA ' HG12 ' A' ' 115' ' ' VAL . 52.8 t -63.89 -31.92 55.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.494 0.664 . . . . 0.0 110.598 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.447 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -62.7 -45.46 92.66 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.281 179.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.596 HD22 HD11 ' A' ' 102' ' ' LEU . 13.8 tp -78.15 -22.43 48.76 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.727 -1.124 . . . . 0.0 111.995 -178.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.637 HG12 ' HA ' ' A' ' 112' ' ' VAL . 6.2 p -79.6 -47.34 22.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 C-N-CA 120.351 -0.54 . . . . 0.0 111.348 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.418 ' N ' HG13 ' A' ' 115' ' ' VAL . 45.5 mt-10 -63.22 -43.43 98.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.762 0.315 . . . . 0.0 110.775 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 68.4 mtt180 -60.38 -24.99 65.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.008 0.432 . . . . 0.0 110.505 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.536 ' HB2' ' CZ ' ' A' ' 99' ' ' PHE . . . -68.9 -45.4 71.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.739 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 4.9 mt -73.86 -32.02 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-O 121.16 0.505 . . . . 0.0 110.706 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 29.6 t -75.47 -48.51 22.34 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.247 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.254 0 CA-C-O 121.027 0.441 . . . . 0.0 111.125 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.709 ' HB3' HD11 ' A' ' 5' ' ' ILE . 0.1 OUTLIER . . . . . 0 CA--C 1.529 0.144 0 CA-C-O 120.852 0.358 . . . . 0.0 111.044 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 67.32 73.02 0.7 Allowed Glycine 0 CA--C 1.517 0.179 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.067 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.709 HD11 ' HB3' ' A' ' 3' ' ' ARG . 3.4 mp -112.03 112.91 42.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.747 0.308 . . . . 0.0 111.447 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.886 HG11 ' CD2' ' A' ' 23' ' ' LEU . 5.6 p -107.54 130.51 59.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.074 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.822 ' CD1' HG22 ' A' ' 31' ' ' THR . 36.7 m0 -114.61 140.48 48.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.46 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.658 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.9 OUTLIER -123.34 134.99 64.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.806 0.336 . . . . 0.0 111.683 -178.636 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.696 HG13 HG23 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -119.82 109.19 25.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 120.881 0.372 . . . . 0.0 110.729 179.557 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -162.29 -157.94 0.49 Allowed 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.855 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -66.1 -2.13 3.85 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -179.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.409 ' O ' ' N ' ' A' ' 14' ' ' SER . 0.6 OUTLIER 66.81 -153.33 0.22 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 121.235 -0.186 . . . . 0.0 111.05 179.253 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.7 t 33.94 -89.83 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.806 ' O ' HG23 ' A' ' 18' ' ' VAL . 3.6 m -55.18 -55.91 25.86 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.827 0.346 . . . . 0.0 111.125 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 27.6 mm -65.83 -25.58 36.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.372 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 1.15 ' HA ' HG21 ' A' ' 32' ' ' THR . 14.0 ttp180 -69.84 -55.64 9.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.467 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.446 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 71.2 t90 -58.39 -39.62 80.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.763 -179.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.806 HG23 ' O ' ' A' ' 14' ' ' SER . 12.3 t -65.67 -49.28 78.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.621 HD23 HD11 ' A' ' 108' ' ' ILE . 0.3 OUTLIER -82.99 -25.21 32.47 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -178.109 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.663 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 23.1 pt-20 -67.41 -59.94 2.98 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.607 -0.437 . . . . 0.0 112.061 -179.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.511 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 3.6 mmt85 -67.7 -49.71 61.31 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -179.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.0 -57.33 10.74 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 120.905 0.383 . . . . 0.0 111.657 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.886 ' CD2' HG11 ' A' ' 6' ' ' VAL . 2.1 tp -65.34 -22.94 66.88 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.363 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.407 ' HB2' ' O ' ' A' ' 20' ' ' GLU . . . -69.4 -37.32 77.44 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.44 -24.73 66.11 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.456 -0.878 . . . . 0.0 111.404 178.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.636 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -77.45 -15.43 59.33 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 120.668 0.27 . . . . 0.0 111.01 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.65 26.58 8.0 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 120.6 -0.809 . . . . 0.0 114.069 178.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.737 HD13 ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -128.97 171.85 11.94 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 117.764 0.782 . . . . 0.0 111.852 179.931 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.7 m -99.78 105.56 17.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.333 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.709 ' HA ' HG13 ' A' ' 6' ' ' VAL . 7.2 t -102.68 114.68 29.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.856 -179.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.822 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.5 t -115.01 156.95 24.15 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 1.15 HG21 ' HA ' ' A' ' 16' ' ' ARG . 28.3 p -131.15 163.43 27.72 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.918 0.39 . . . . 0.0 111.894 -179.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.559 ' CE1' HG23 ' A' ' 31' ' ' THR . 35.4 m-85 -136.02 174.7 10.32 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -178.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.734 ' HG2' ' CD ' ' A' ' 38' ' ' GLU . 1.6 pt-20 -59.31 -39.56 83.46 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -176.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.558 ' N ' ' HG2' ' A' ' 34' ' ' GLU . 44.8 m-20 -168.22 -67.04 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.992 0.425 . . . . 0.0 111.352 -178.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.762 ' CA ' HD21 ' A' ' 65' ' ' LEU . . . -160.82 -35.22 0.02 OUTLIER Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.327 -0.939 . . . . 0.0 114.165 -179.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.653 HD22 HD12 ' A' ' 40' ' ' LEU . 4.7 m120 -61.45 -35.35 77.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 117.34 0.57 . . . . 0.0 112.088 -178.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.734 ' CD ' ' HG2' ' A' ' 34' ' ' GLU . 1.4 mp0 -51.79 -61.73 2.07 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.762 HG12 ' CD1' ' A' ' 43' ' ' LEU . 94.2 t -45.84 -31.05 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-O 121.286 0.565 . . . . 0.0 110.745 -179.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.852 HD13 ' CB ' ' A' ' 68' ' ' GLN . 10.1 mt -64.52 -43.87 92.66 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.039 179.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -82.5 -47.94 11.61 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.337 0.589 . . . . 0.0 110.703 178.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.34 -37.78 65.3 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.568 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.762 ' CD1' HG12 ' A' ' 39' ' ' VAL . 37.3 mt -67.39 -22.99 65.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.843 0.354 . . . . 0.0 111.523 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.35 -18.07 3.69 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.752 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.7 m -119.92 -5.9 10.07 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.539 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.1 OUTLIER -165.71 162.65 18.85 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.041 0.448 . . . . 0.0 111.702 -179.889 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 100.0 m -139.38 119.5 9.37 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.139 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.777 ' HD2' HD11 ' A' ' 76' ' ' LEU . 91.1 Cg_endo -80.41 165.62 20.72 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.403 2.069 . . . . 0.0 111.101 178.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -74.25 -25.37 59.59 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.967 -0.293 . . . . 0.0 110.992 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.813 HG13 HG23 ' A' ' 6' ' ' VAL . 8.9 p -145.02 162.46 13.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.177 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.758 ' CD2' HG11 ' A' ' 39' ' ' VAL . 20.5 tp -152.91 126.67 8.88 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.177 0.513 . . . . 0.0 111.913 -179.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.606 ' O ' HG23 ' A' ' 9' ' ' VAL . 0.4 OUTLIER -104.49 114.66 29.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.27 179.275 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.68 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 1.7 t -110.79 139.03 46.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.167 0.508 . . . . 0.0 111.627 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 32.1 p-10 -82.8 -173.65 4.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.639 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.57 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 16.3 tt -161.46 170.7 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.175 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.53 ' N ' HG12 ' A' ' 55' ' ' ILE . 13.9 ptt85 58.55 43.25 19.53 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-O 121.526 0.679 . . . . 0.0 110.246 -178.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.497 ' CB ' ' CD ' ' A' ' 58' ' ' PRO . 6.3 mtm -151.67 -67.89 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.393 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.497 ' CD ' ' CB ' ' A' ' 57' ' ' MET . 27.2 Cg_endo -59.76 -163.29 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.87 2.38 . . . . 0.0 112.847 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -52.8 -87.52 0.01 OUTLIER Glycine 0 C--N 1.332 0.352 0 CA-C-N 115.964 -0.562 . . . . 0.0 113.258 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.664 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -76.39 61.17 1.66 Allowed 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.093 0.473 . . . . 0.0 110.466 -179.934 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.464 ' O ' ' HD2' ' A' ' 58' ' ' PRO . 6.9 m-20 60.8 -65.67 0.06 Allowed 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.944 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.57 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -165.05 -32.88 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.654 ' H ' HD12 ' A' ' 63' ' ' LEU . 0.9 OUTLIER -64.06 -13.25 45.86 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 120.54 0.21 . . . . 0.0 110.481 179.398 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.664 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -53.68 -31.55 48.19 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 121.054 0.455 . . . . 0.0 110.164 179.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.762 HD21 ' CA ' ' A' ' 36' ' ' GLY . 7.0 mp -62.64 -53.11 59.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.914 178.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.6 ' HA ' HD12 ' A' ' 69' ' ' ILE . 3.5 mm? -45.71 -45.82 14.56 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.861 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.715 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 27.1 mttt -59.15 -54.3 48.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.993 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.852 ' CB ' HD13 ' A' ' 40' ' ' LEU . 28.4 mm100 -64.34 -27.78 69.26 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.903 0.382 . . . . 0.0 110.34 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.602 HD13 HG21 ' A' ' 78' ' ' VAL . 41.4 mt -65.0 -36.74 78.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.853 -179.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.715 ' HG2' ' O ' ' A' ' 67' ' ' LYS . 6.5 pttt -75.72 -28.83 58.72 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.546 -179.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -69.14 -30.57 68.84 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.797 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.22 -56.96 2.31 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -179.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.58 ' CE1' ' HB2' ' A' ' 43' ' ' LEU . 1.3 m-70 -81.31 151.81 69.79 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-O 120.983 0.421 . . . . 0.0 111.817 -178.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -74.07 -80.99 0.01 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.377 2.051 . . . . 0.0 112.823 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.453 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 4.7 mtt -135.71 49.01 2.17 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 120.936 0.398 . . . . 0.0 111.73 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.777 HD11 ' HD2' ' A' ' 48' ' ' PRO . 0.7 OUTLIER -64.76 115.94 24.96 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.007 179.605 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.564 ' HD2' HD23 ' A' ' 76' ' ' LEU . 46.6 Cg_exo -55.61 116.95 3.52 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.376 2.051 . . . . 0.0 112.214 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.602 HG21 HD13 ' A' ' 69' ' ' ILE . 4.1 t -110.68 144.23 19.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.089 0.471 . . . . 0.0 111.365 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.585 ' CG2' HD23 ' A' ' 114' ' ' LEU . 1.7 mt -128.59 111.36 23.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.427 179.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.68 ' HA ' ' O ' ' A' ' 53' ' ' SER . 31.1 mm -96.89 141.6 15.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.929 0.395 . . . . 0.0 111.611 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.504 ' CG ' HG22 ' A' ' 55' ' ' ILE . 21.8 ptm -72.67 -31.25 64.92 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -178.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.587 ' HA ' ' O ' ' A' ' 102' ' ' LEU . 7.1 m -146.36 169.17 19.4 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.511 -179.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.815 ' HB1' ' HG ' ' A' ' 87' ' ' LEU . . . -141.86 -22.31 0.71 Allowed 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.476 ' HE1' HG12 ' A' ' 55' ' ' ILE . 1.9 p-80 35.6 -102.74 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.1 p -120.99 -11.95 8.83 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -178.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.507 ' HB3' HD13 ' A' ' 63' ' ' LEU . 5.8 m-20 -82.09 18.25 1.41 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.839 0.352 . . . . 0.0 111.265 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.815 ' HG ' ' HB1' ' A' ' 83' ' ' ALA . 3.0 mt -50.69 -20.47 1.24 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.961 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -46.88 -53.79 11.37 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -178.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.483 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -65.7 -20.59 66.34 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.737 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.6 ' HB3' ' O ' ' A' ' 87' ' ' LEU . . . -68.16 -40.47 82.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.225 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.687 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 4.3 t -57.31 -46.34 85.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.183 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.625 ' O ' ' NE2' ' A' ' 95' ' ' GLN . 12.8 m -62.23 -44.64 96.1 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.232 0.539 . . . . 0.0 109.827 179.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.695 ' HB1' ' HB2' ' A' ' 98' ' ' ALA . . . -47.48 -42.37 22.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.02 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.687 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 16.4 m-85 -56.19 -25.96 49.03 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.24 179.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.625 ' NE2' ' O ' ' A' ' 92' ' ' SER . 0.0 OUTLIER -71.35 -45.54 62.68 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.287 -179.916 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.679 ' HG3' ' HB3' ' A' ' 70' ' ' LYS . 75.5 mm-40 -74.23 -18.08 60.79 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.11 -179.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 119.86 32.56 1.18 Allowed Glycine 0 N--CA 1.453 -0.186 0 C-N-CA 120.311 -0.947 . . . . 0.0 113.163 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.695 ' HB2' ' HB1' ' A' ' 93' ' ' ALA . . . -64.43 145.81 55.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.819 0.309 . . . . 0.0 110.225 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.527 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 10.9 t80 -77.17 -53.93 7.13 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.197 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 173.18 -166.86 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.208 0.528 . . . . 0.0 111.728 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.66 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 5.3 m-85 -142.43 150.59 40.8 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.119 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.712 HD23 ' HA ' ' A' ' 106' ' ' PHE . 2.4 mp -104.87 119.53 53.08 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.234 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -69.25 -75.24 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.02 1.813 . . . . 0.0 112.194 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.65 ' H ' ' HD2' ' A' ' 105' ' ' PRO . 1.8 tttm -106.44 -60.0 0.05 OUTLIER Pre-proline 0 CA--C 1.533 0.293 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.65 ' HD2' ' H ' ' A' ' 104' ' ' LYS . 18.0 Cg_endo -59.72 156.73 36.02 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.263 1.975 . . . . 0.0 112.735 -179.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.712 ' HA ' HD23 ' A' ' 102' ' ' LEU . 24.0 t80 -166.94 -105.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.123 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.54 ' O ' ' O ' ' A' ' 106' ' ' PHE . 3.3 p30 42.79 -178.03 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.86 0.362 . . . . 0.0 111.155 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.621 HD11 HD23 ' A' ' 19' ' ' LEU . 0.9 OUTLIER -67.88 -40.89 84.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.137 0.494 . . . . 0.0 111.583 179.922 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.488 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 1.1 t70 -49.98 -58.62 5.08 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.721 -179.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.615 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 5.0 mm-40 -76.61 -31.59 57.54 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.74 0.305 . . . . 0.0 111.241 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.96 -61.58 1.97 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.901 0.381 . . . . 0.0 110.127 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.623 ' O ' HG12 ' A' ' 115' ' ' VAL . 46.5 t -59.1 -30.71 44.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.483 0.659 . . . . 0.0 110.792 179.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.488 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -64.53 -45.33 87.68 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.799 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.585 HD23 ' CG2' ' A' ' 79' ' ' ILE . 33.5 tp -77.38 -20.98 53.91 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.689 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.623 HG12 ' O ' ' A' ' 112' ' ' VAL . 4.1 p -79.4 -44.31 23.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.659 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.531 ' HA ' HD12 ' A' ' 119' ' ' ILE . 58.4 mt-10 -60.35 -44.91 95.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.894 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 21.8 mmm180 -62.26 -23.86 66.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.248 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.527 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -74.48 -42.69 58.57 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.63 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.531 HD12 ' HA ' ' A' ' 116' ' ' GLU . 6.3 mt -65.09 -31.29 53.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.13 0.49 . . . . 0.0 110.922 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 2.8 m -68.83 -49.34 59.29 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.995 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 31.8 m80 . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.143 -179.861 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.729 ' HG2' HD11 ' A' ' 5' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.518 -0.26 0 CA-C-O 121.149 0.5 . . . . 0.0 111.447 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.43 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . 71.11 76.7 0.55 Allowed Glycine 0 C--N 1.317 -0.5 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.704 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.729 HD11 ' HG2' ' A' ' 3' ' ' ARG . 2.4 mp -111.27 114.48 47.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.795 0.331 . . . . 0.0 111.267 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.878 HG11 HD23 ' A' ' 23' ' ' LEU . 9.0 p -108.07 121.46 61.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.322 179.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.84 ' CD1' HG22 ' A' ' 31' ' ' THR . 27.4 m0 -111.55 133.32 53.9 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.912 0.387 . . . . 0.0 110.547 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.715 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.0 OUTLIER -124.89 149.15 29.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.149 -178.598 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 1.042 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -127.91 105.25 13.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 177.824 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.658 ' HB3' HG21 ' A' ' 15' ' ' ILE . 36.3 t0 -166.6 67.69 0.1 Allowed 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 120.952 0.406 . . . . 0.0 111.955 -179.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 20.6 t70 61.15 6.52 1.32 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.474 ' HA ' ' OG1' ' A' ' 32' ' ' THR . 4.5 p-10 44.28 -147.83 0.08 Allowed 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.7 t 36.05 -93.56 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.445 ' O ' HG23 ' A' ' 18' ' ' VAL . 29.1 t -53.83 -65.66 0.53 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.652 0.263 . . . . 0.0 110.974 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.658 HG21 ' HB3' ' A' ' 10' ' ' ASP . 17.2 mm -60.57 -20.63 21.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.301 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.947 ' HA ' HG21 ' A' ' 32' ' ' THR . 23.8 ttm-85 -69.74 -58.33 4.03 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 120.862 0.363 . . . . 0.0 110.848 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.479 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 49.8 t90 -51.5 -39.62 57.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.093 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.596 HG12 HG12 ' A' ' 108' ' ' ILE . 11.7 t -63.64 -51.59 68.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -178.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.746 HD11 HG22 ' A' ' 112' ' ' VAL . 6.2 tp -84.37 -24.97 29.46 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 -178.006 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.623 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 11.9 pt-20 -66.45 -59.86 3.27 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.416 -0.514 . . . . 0.0 111.565 -178.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.529 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 5.7 mmm180 -58.54 -52.78 64.19 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.848 -179.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.07 -47.92 77.05 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.81 0.338 . . . . 0.0 111.805 -179.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.878 HD23 HG11 ' A' ' 6' ' ' VAL . 1.7 tp -72.97 -24.65 60.81 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.126 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.96 -34.27 75.05 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.37 -27.76 69.91 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.324 -0.941 . . . . 0.0 111.107 178.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.671 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -76.87 -16.0 59.54 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 120.605 0.241 . . . . 0.0 111.07 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.07 26.54 8.81 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 120.461 -0.876 . . . . 0.0 114.281 178.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.72 HD13 ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -123.27 169.27 11.47 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 117.946 0.873 . . . . 0.0 111.653 179.756 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 54.0 m -96.42 105.69 17.8 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.004 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.694 ' HA ' HG13 ' A' ' 6' ' ' VAL . 41.8 t -103.6 110.37 22.4 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.979 -179.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.84 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.6 t -117.37 154.16 31.78 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.947 HG21 ' HA ' ' A' ' 16' ' ' ARG . 29.1 p -126.11 165.56 18.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.301 0.572 . . . . 0.0 112.071 -179.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 1.042 ' HB2' HG13 ' A' ' 9' ' ' VAL . 16.2 m-85 -136.04 174.76 10.26 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.863 -178.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.794 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 2.3 pp20? -60.6 -49.19 78.53 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -176.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -165.56 -29.29 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -179.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.565 ' CA ' HG11 ' A' ' 9' ' ' VAL . . . 174.92 -56.85 0.12 Allowed Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.448 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.45 ' HA ' HD12 ' A' ' 40' ' ' LEU . 1.2 t-20 -55.07 -30.59 59.96 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.674 0.273 . . . . 0.0 111.283 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.825 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -60.16 -55.66 31.11 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.709 179.796 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.784 HG12 ' CD1' ' A' ' 43' ' ' LEU . 5.5 t -50.9 -45.08 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.097 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.759 ' HB3' ' HD2' ' A' ' 72' ' ' ARG . 29.2 mt -52.1 -42.97 63.67 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.246 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.86 -50.78 67.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.202 0.525 . . . . 0.0 111.441 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.44 -29.36 65.93 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.766 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.868 HD13 ' NE2' ' A' ' 73' ' ' HIS . 5.6 mt -64.28 -25.44 68.05 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.8 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.9 -18.28 31.81 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.168 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 41.1 t -124.4 3.38 8.42 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 112.143 0.424 . . . . 0.0 112.143 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.64 ' O ' HD23 ' A' ' 43' ' ' LEU . 0.4 OUTLIER -162.74 159.01 23.68 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-O 120.958 0.409 . . . . 0.0 111.497 179.924 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.898 HG23 HD13 ' A' ' 76' ' ' LEU . 98.4 m -138.62 115.48 8.94 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.459 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.642 ' HD2' HD21 ' A' ' 43' ' ' LEU . 72.7 Cg_endo -73.75 165.7 31.6 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.486 2.124 . . . . 0.0 111.363 178.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -76.72 -29.23 56.14 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 121.033 -0.267 . . . . 0.0 110.712 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.748 HG13 HG23 ' A' ' 6' ' ' VAL . 8.4 p -148.35 108.34 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.587 ' CD1' HG11 ' A' ' 39' ' ' VAL . 15.0 tp -86.99 136.92 32.75 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.889 0.376 . . . . 0.0 111.241 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.721 ' O ' HG23 ' A' ' 9' ' ' VAL . 1.8 tt -124.2 124.17 41.88 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.099 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.872 ' HB2' HD13 ' A' ' 80' ' ' ILE . 67.0 m -110.94 136.61 49.7 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.045 0.45 . . . . 0.0 111.999 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.467 ' O ' ' HG2' ' A' ' 81' ' ' MET . 33.7 t70 -82.88 -12.91 57.02 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.209 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.995 HD11 ' CE1' ' A' ' 84' ' ' HIS . 6.5 tt 42.25 69.59 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-O 120.732 0.301 . . . . 0.0 111.502 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -112.06 44.85 1.34 Allowed 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.492 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 0.5 OUTLIER 59.75 44.91 1.02 Allowed Pre-proline 0 N--CA 1.465 0.321 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 178.663 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' ' 62' ' ' GLY . 36.3 Cg_endo -65.08 -75.6 0.02 OUTLIER 'Trans proline' 0 CA--C 1.532 0.391 0 C-N-CA 122.579 2.186 . . . . 0.0 112.391 178.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -112.37 -27.67 3.81 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.074 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.807 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 7.9 tpt -156.11 68.49 0.62 Allowed 'General case' 0 C--O 1.236 0.387 0 CA-C-O 120.981 0.419 . . . . 0.0 109.955 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.638 ' O ' HG13 ' A' ' 55' ' ' ILE . 0.4 OUTLIER 69.22 -26.43 0.15 Allowed 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.931 -179.709 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.843 ' HA3' HG13 ' A' ' 55' ' ' ILE . . . 139.32 -26.09 2.71 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -179.024 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.741 HD13 ' HB3' ' A' ' 86' ' ' ASP . 3.1 mp -74.23 -15.14 61.0 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.807 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -53.74 -44.88 70.3 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.838 178.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.704 ' HG ' ' O ' ' A' ' 62' ' ' GLY . 4.0 pp -58.6 -36.64 74.33 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.289 179.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.907 HD13 ' HB2' ' A' ' 93' ' ' ALA . 14.8 mt -55.75 -48.59 74.99 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.019 0.438 . . . . 0.0 110.402 179.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.571 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 12.6 tptt -53.23 -44.05 67.78 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.936 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.662 ' CB ' HD13 ' A' ' 40' ' ' LEU . 9.2 mm100 -67.08 -27.72 67.59 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.963 0.411 . . . . 0.0 110.704 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 1.043 HD13 HG21 ' A' ' 78' ' ' VAL . 96.8 mt -64.55 -38.13 81.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.527 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.571 ' HG2' ' O ' ' A' ' 67' ' ' LYS . 2.7 ptmt -74.97 -29.42 60.91 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.915 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.458 ' NE2' ' HG3' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -86.25 -30.61 22.21 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.735 -179.939 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.759 ' HD2' ' HB3' ' A' ' 40' ' ' LEU . 28.6 mtt85 -90.45 -68.01 0.81 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.856 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 1.024 ' ND1' HG23 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -88.04 144.63 34.86 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.629 -179.722 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -55.79 -67.49 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.603 2.202 . . . . 0.0 112.893 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.413 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 0.2 OUTLIER -146.89 40.13 1.06 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.934 0.397 . . . . 0.0 111.089 -179.554 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.898 HD13 HG23 ' A' ' 47' ' ' THR . 22.7 tp -63.75 129.43 93.77 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.037 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.534 ' HD2' HD12 ' A' ' 76' ' ' LEU . 58.2 Cg_endo -71.58 134.91 25.15 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.413 2.075 . . . . 0.0 112.278 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 1.043 HG21 HD13 ' A' ' 69' ' ' ILE . 5.5 t -123.95 148.57 28.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.944 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.687 ' CG2' HD23 ' A' ' 114' ' ' LEU . 2.2 mt -126.63 114.49 38.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.201 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.872 HD13 ' HB2' ' A' ' 53' ' ' SER . 9.7 mm -97.87 139.38 20.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.957 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.467 ' HG2' ' O ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -75.94 -30.76 58.8 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 112.357 0.502 . . . . 0.0 112.357 -178.882 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.81 ' O ' HD13 ' A' ' 55' ' ' ILE . 16.8 m -147.59 157.22 43.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.753 0.311 . . . . 0.0 111.574 -179.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.785 ' HB1' ' HG ' ' A' ' 87' ' ' LEU . . . -118.99 0.22 11.28 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.611 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.995 ' CE1' HD11 ' A' ' 55' ' ' ILE . 0.1 OUTLIER 25.75 -94.85 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 -179.168 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 16.1 m -136.89 -23.09 1.19 Allowed 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -178.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.741 ' HB3' HD13 ' A' ' 63' ' ' LEU . 0.3 OUTLIER -78.66 28.39 0.2 Allowed 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -179.285 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.813 HD23 ' HB3' ' A' ' 90' ' ' ALA . 0.5 OUTLIER -46.84 -21.95 0.26 Allowed 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.887 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -48.11 -53.17 17.48 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.886 0.374 . . . . 0.0 111.264 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.643 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -64.05 -20.31 65.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.331 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.813 ' HB3' HD23 ' A' ' 87' ' ' LEU . . . -68.87 -33.89 74.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.837 0.351 . . . . 0.0 110.514 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.64 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 2.8 t -63.94 -46.61 93.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.81 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.604 ' O ' ' HG3' ' A' ' 95' ' ' GLN . 52.5 p -62.04 -16.89 55.19 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 178.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.907 ' HB2' HD13 ' A' ' 66' ' ' LEU . . . -75.57 -52.14 11.29 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.408 0.623 . . . . 0.0 111.827 179.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.64 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 7.3 m-85 -57.9 -32.66 67.95 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.839 -179.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.604 ' HG3' ' O ' ' A' ' 92' ' ' SER . 2.1 pp0? -77.28 -32.06 55.23 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.247 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.739 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 3.3 pp0? -83.02 -15.95 49.05 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 121.13 -0.228 . . . . 0.0 111.295 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.503 ' O ' ' HA ' ' A' ' 77' ' ' PRO . . . 130.27 7.73 3.49 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.357 -0.925 . . . . 0.0 114.015 178.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.741 ' HB2' ' HB1' ' A' ' 93' ' ' ALA . . . -56.96 153.22 11.55 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 117.475 0.638 . . . . 0.0 111.138 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.553 ' CZ ' ' HA ' ' A' ' 118' ' ' ALA . 23.9 t80 -82.12 -53.65 5.92 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.336 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.548 ' HB3' ' O ' ' A' ' 99' ' ' PHE . 13.6 p-10 172.67 -161.49 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.311 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.706 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 4.6 m-85 -141.89 153.67 44.57 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.564 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.657 ' CD1' HD22 ' A' ' 114' ' ' LEU . 1.3 mp -102.32 120.01 54.62 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.71 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_exo -55.98 -69.19 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.478 2.118 . . . . 0.0 112.593 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.717 ' HB2' ' HD3' ' A' ' 105' ' ' PRO . 7.0 mmtt -128.42 -59.57 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.421 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.717 ' HD3' ' HB2' ' A' ' 104' ' ' LYS . 51.1 Cg_exo -54.16 161.56 5.04 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 121.74 1.627 . . . . 0.0 112.012 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.659 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 23.1 t80 -166.95 -105.6 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.653 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.484 ' O ' ' O ' ' A' ' 106' ' ' PHE . 2.8 p30 43.89 -175.57 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.778 0.323 . . . . 0.0 110.967 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.596 HG12 HG12 ' A' ' 18' ' ' VAL . 1.0 OUTLIER -67.86 -42.39 85.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 120.994 0.426 . . . . 0.0 111.416 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.469 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 26.3 t70 -49.12 -59.04 3.98 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.697 -179.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.659 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 7.0 mm-40 -76.16 -32.96 59.34 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.682 0.277 . . . . 0.0 111.376 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.419 ' CB ' ' O ' ' A' ' 107' ' ' ASP . . . -66.54 -59.37 3.7 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.486 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.746 HG22 HD11 ' A' ' 19' ' ' LEU . 35.9 t -59.53 -31.37 46.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.444 0.64 . . . . 0.0 110.715 178.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.469 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -63.1 -44.8 94.69 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.096 179.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.687 HD23 ' CG2' ' A' ' 79' ' ' ILE . 36.0 tp -79.33 -21.26 46.13 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.86 -1.064 . . . . 0.0 112.072 -179.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.648 HG12 ' HA ' ' A' ' 112' ' ' VAL . 6.0 p -79.2 -45.15 24.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.548 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.414 ' HA ' HD12 ' A' ' 119' ' ' ILE . 53.8 mt-10 -65.72 -45.4 82.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.693 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 42.8 mtp180 -60.03 -24.8 64.81 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.668 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.553 ' HA ' ' CZ ' ' A' ' 99' ' ' PHE . . . -72.27 -48.91 38.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.918 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.428 HD11 HG11 ' A' ' 50' ' ' VAL . 4.8 mt -65.27 -31.2 52.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.137 0.494 . . . . 0.0 110.75 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.3 t -72.24 -58.39 3.45 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.855 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 26.5 m80 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.885 -179.899 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 21.0 ptt180 . . . . . 0 N--CA 1.456 -0.141 0 CA-C-O 120.688 0.28 . . . . 0.0 111.001 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.561 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . 89.33 88.77 1.23 Allowed Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.097 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.8 mp -99.3 113.14 33.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 120.819 0.342 . . . . 0.0 111.297 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.819 HG23 HG13 ' A' ' 50' ' ' VAL . 6.2 p -105.69 123.41 60.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.061 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.898 ' CD1' HG22 ' A' ' 31' ' ' THR . 31.4 m0 -115.08 127.91 55.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.633 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.687 HG13 ' HB3' ' A' ' 52' ' ' LEU . 0.2 OUTLIER -112.86 143.02 23.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.401 -178.977 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.757 HG11 ' HA2' ' A' ' 36' ' ' GLY . 0.1 OUTLIER -122.98 111.14 28.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.194 0.521 . . . . 0.0 110.633 179.367 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.423 ' HA ' ' OD2' ' A' ' 54' ' ' ASP . 3.9 t0 -161.43 -158.87 0.59 Allowed 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.188 -178.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.51 -2.25 4.49 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' A' ' 14' ' ' SER . 1.4 t0 67.76 -156.77 0.21 Allowed 'General case' 0 CA--C 1.531 0.233 0 O-C-N 122.381 -0.2 . . . . 0.0 110.833 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.4 ' HB3' ' H ' ' A' ' 14' ' ' SER . 3.3 t 34.66 -90.6 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.884 ' O ' HG23 ' A' ' 18' ' ' VAL . 26.8 t -54.36 -61.15 2.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.741 0.305 . . . . 0.0 111.089 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 30.4 mm -61.75 -22.84 29.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.96 0.41 . . . . 0.0 110.754 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.918 ' HA ' HG21 ' A' ' 32' ' ' THR . 41.6 ttt180 -75.64 -54.85 6.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.634 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.412 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 83.4 t90 -58.65 -38.39 78.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.691 0.282 . . . . 0.0 111.595 -179.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.884 HG23 ' O ' ' A' ' 14' ' ' SER . 3.6 t -69.52 -45.03 79.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -178.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.66 -26.69 29.67 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -178.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.555 ' HG3' ' N ' ' A' ' 21' ' ' ARG . 10.9 pt-20 -67.74 -60.43 2.54 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -179.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.555 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 2.3 mmt-85 -60.71 -52.89 63.2 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -178.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.49 -50.4 65.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.948 0.404 . . . . 0.0 111.567 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.796 ' CD2' HG11 ' A' ' 6' ' ' VAL . 1.0 OUTLIER -70.4 -27.67 64.48 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.352 179.807 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.56 -34.75 77.68 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.16 -26.45 69.26 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.417 -0.897 . . . . 0.0 111.038 178.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.649 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -77.26 -15.39 59.48 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.655 -0.273 . . . . 0.0 111.039 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.21 26.41 10.22 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.606 -0.807 . . . . 0.0 114.217 178.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.738 HD13 ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -124.68 170.68 10.74 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 117.87 0.835 . . . . 0.0 111.775 179.722 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 50.6 m -94.3 105.8 17.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.078 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.694 ' HA ' HG13 ' A' ' 6' ' ' VAL . 46.7 t -106.29 110.33 22.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.992 -178.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.898 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.8 t -118.73 153.05 35.03 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.918 HG21 ' HA ' ' A' ' 16' ' ' ARG . 20.5 p -126.43 157.12 39.42 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.558 0.694 . . . . 0.0 112.134 -179.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.807 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 1.0 OUTLIER -127.0 174.29 8.98 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.707 -1.133 . . . . 0.0 111.184 -178.73 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.684 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 3.0 pp20? -61.37 -34.23 74.97 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -177.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -176.92 -37.52 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.757 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . 173.47 -47.02 0.16 Allowed Glycine 0 C--N 1.318 -0.438 0 C-N-CA 120.32 -0.943 . . . . 0.0 112.884 -179.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.454 ' HA ' ' CD1' ' A' ' 40' ' ' LEU . 0.8 OUTLIER -59.62 -29.66 68.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.154 0.502 . . . . 0.0 111.071 -179.765 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.807 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -62.97 -53.58 51.86 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.708 -179.525 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.689 HG23 ' CG1' ' A' ' 9' ' ' VAL . 21.3 t -50.08 -37.2 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 C-N-CA 120.349 -0.54 . . . . 0.0 110.661 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.653 HD13 ' HB3' ' A' ' 68' ' ' GLN . 12.6 mt -55.65 -48.13 75.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.479 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.01 -50.17 69.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.107 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.4 -34.6 77.07 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.726 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.569 ' HA ' ' O ' ' A' ' 46' ' ' LYS . 21.1 mt -59.23 -23.5 62.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.421 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.02 -17.8 28.6 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.826 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.5 t -128.52 3.08 5.59 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.569 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.2 OUTLIER -167.44 161.25 13.87 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.909 0.385 . . . . 0.0 111.216 179.895 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.405 HG23 HD12 ' A' ' 76' ' ' LEU . 90.4 m -138.96 111.74 8.06 Favored Pre-proline 0 N--CA 1.45 -0.457 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.201 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.894 ' HD2' HD11 ' A' ' 76' ' ' LEU . 43.3 Cg_endo -71.38 158.68 53.66 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.084 1.856 . . . . 0.0 111.276 179.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.442 ' O ' ' HG2' ' A' ' 77' ' ' PRO . 1.7 m-20 -74.24 -24.15 59.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.466 -179.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.819 HG13 HG23 ' A' ' 6' ' ' VAL . 7.6 p -145.98 166.47 8.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.582 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.852 HD12 ' O ' ' A' ' 7' ' ' TRP . 10.0 tp -152.96 137.36 16.68 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.985 0.422 . . . . 0.0 111.43 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.687 ' HB3' HG13 ' A' ' 8' ' ' VAL . 1.1 tt -121.9 119.21 30.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.713 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.44 ' HB2' ' CD1' ' A' ' 80' ' ' ILE . 0.6 OUTLIER -115.08 138.21 51.13 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.905 0.383 . . . . 0.0 111.408 -179.723 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.64 ' O ' HG22 ' A' ' 55' ' ' ILE . 2.9 p30 -82.27 -4.04 56.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 0.0 112.058 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.931 HG13 ' HA3' ' A' ' 62' ' ' GLY . 7.1 tt 50.47 169.4 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-O 120.953 0.406 . . . . 0.0 111.923 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.484 ' H ' ' HA3' ' A' ' 62' ' ' GLY . 8.2 ttt85 67.43 77.93 0.25 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.901 0.382 . . . . 0.0 110.696 -179.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.608 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . 7.5 tpt -163.14 -61.24 0.01 OUTLIER Pre-proline 0 CA--C 1.537 0.479 0 CA-C-N 116.081 -0.509 . . . . 0.0 112.063 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.716 ' HG3' ' HG ' ' A' ' 65' ' ' LEU . 94.3 Cg_endo -71.96 -164.58 0.17 Allowed 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.975 2.45 . . . . 0.0 113.47 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.64 -65.48 3.13 Favored Glycine 0 C--N 1.335 0.525 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.241 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.467 ' O ' ' N ' ' A' ' 62' ' ' GLY . 5.2 ttt -70.19 60.42 0.19 Allowed 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.082 0.468 . . . . 0.0 110.013 179.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 58.3 -81.79 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.558 -0.747 . . . . 0.0 109.812 -179.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.931 ' HA3' HG13 ' A' ' 55' ' ' ILE . . . -145.38 -28.96 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.593 179.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.854 HD13 ' HB3' ' A' ' 86' ' ' ASP . 4.0 mp -59.75 -18.85 46.27 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.503 ' HB3' ' CG ' ' A' ' 58' ' ' PRO . . . -55.63 -37.1 67.75 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 178.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.716 ' HG ' ' HG3' ' A' ' 58' ' ' PRO . 32.4 mt -60.76 -49.14 78.69 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.738 HD11 HD11 ' A' ' 80' ' ' ILE . 9.4 mp -51.1 -51.47 53.06 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.98 179.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.564 ' HA ' ' CE ' ' A' ' 70' ' ' LYS . 6.4 mtpm? -44.63 -49.43 10.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.851 179.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.653 ' HB3' HD13 ' A' ' 40' ' ' LEU . 60.8 mm-40 -68.22 -26.51 65.75 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.375 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 1.069 HG22 ' CD2' ' A' ' 73' ' ' HIS . 63.3 mt -63.89 -54.18 34.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.012 0.434 . . . . 0.0 111.119 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.799 ' HA ' ' CD2' ' A' ' 73' ' ' HIS . 0.0 OUTLIER -62.43 -28.35 69.74 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.16 -178.94 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -64.82 -22.48 67.0 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.179 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.72 -11.68 9.36 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.005 0.742 . . . . 0.0 113.005 -179.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 1.069 ' CD2' HG22 ' A' ' 69' ' ' ILE . 1.6 p80 -109.55 160.61 27.19 Favored Pre-proline 0 N--CA 1.465 0.321 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -179.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.455 ' O ' ' HG2' ' A' ' 75' ' ' MET . 60.6 Cg_endo -87.71 -59.45 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.976 2.451 . . . . 0.0 111.42 178.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.566 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 5.8 mmt -151.24 51.33 0.84 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.9 178.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.894 HD11 ' HD2' ' A' ' 48' ' ' PRO . 0.4 OUTLIER -76.66 123.25 87.58 Favored Pre-proline 0 N--CA 1.456 -0.135 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -179.147 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.663 ' HD2' HD23 ' A' ' 76' ' ' LEU . 20.2 Cg_exo -64.72 138.07 56.88 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.189 1.926 . . . . 0.0 111.729 178.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.64 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 3.0 t -126.13 119.69 54.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.482 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.82 ' CG2' HD23 ' A' ' 114' ' ' LEU . 1.5 mp -109.83 110.22 31.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.863 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.738 HD11 HD11 ' A' ' 66' ' ' LEU . 37.0 mm -100.53 148.49 6.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.296 -178.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.515 ' HB3' ' CE1' ' A' ' 106' ' ' PHE . 13.0 ptm -81.98 -35.32 29.07 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.61 -179.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.826 ' O ' HD13 ' A' ' 55' ' ' ILE . 8.2 m -146.59 151.84 37.96 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.626 0.251 . . . . 0.0 111.138 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.833 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -117.03 10.24 13.9 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 111.803 0.297 . . . . 0.0 111.803 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.675 ' H ' HG22 ' A' ' 82' ' ' THR . 0.1 OUTLIER 25.84 -92.38 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -179.385 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 55.3 m -149.64 39.62 0.8 Allowed 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.854 ' HB3' HD13 ' A' ' 63' ' ' LEU . 0.4 OUTLIER -137.72 36.68 2.42 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.125 0.488 . . . . 0.0 110.349 179.236 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.45 ' O ' ' HB3' ' A' ' 90' ' ' ALA . 7.9 mt -50.33 -20.86 1.19 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.993 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -47.69 -58.76 3.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.624 0.25 . . . . 0.0 111.434 -179.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.58 ' O ' ' HB2' ' A' ' 93' ' ' ALA . . . -69.74 -19.64 63.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.892 0.377 . . . . 0.0 110.651 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 87' ' ' LEU . . . -69.25 -46.42 67.35 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.878 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.646 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 3.5 t -67.0 -52.92 38.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 C-N-CA 120.474 -0.491 . . . . 0.0 111.297 -179.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.595 ' O ' ' HB3' ' A' ' 95' ' ' GLN . 24.4 m -60.21 -27.08 66.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.137 0.494 . . . . 0.0 109.786 178.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.587 ' HA ' ' OE1' ' A' ' 96' ' ' GLN . . . -60.72 -41.81 96.01 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.056 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.646 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 3.9 m-85 -67.73 -27.33 66.7 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.967 179.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.595 ' HB3' ' O ' ' A' ' 92' ' ' SER . 0.2 OUTLIER -60.92 -40.89 94.88 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.807 -179.192 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.587 ' OE1' ' HA ' ' A' ' 93' ' ' ALA . 0.0 OUTLIER -100.37 -19.3 16.35 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -179.565 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.441 ' O ' ' C ' ' A' ' 98' ' ' ALA . . . -176.01 -57.67 0.06 OUTLIER Glycine 0 C--N 1.335 0.474 0 C-N-CA 119.22 -1.467 . . . . 0.0 114.824 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.64 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -29.1 139.37 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 117.32 0.56 . . . . 0.0 112.36 -178.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -84.78 -53.38 5.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.45 -179.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.67 ' OD1' HD21 ' A' ' 114' ' ' LEU . 7.9 p-10 -177.8 -164.65 0.09 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.747 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.833 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 4.1 m-85 -138.3 153.02 49.03 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.081 0.467 . . . . 0.0 111.004 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.816 ' CD1' HD22 ' A' ' 114' ' ' LEU . 3.2 mp -102.98 119.08 56.54 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.714 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 102' ' ' LEU . 21.1 Cg_exo -64.69 -66.84 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.537 2.158 . . . . 0.0 112.272 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.735 ' H ' ' HD2' ' A' ' 105' ' ' PRO . 5.6 mttp -119.81 -58.85 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.135 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.735 ' HD2' ' H ' ' A' ' 104' ' ' LYS . 11.9 Cg_endo -55.02 163.5 4.22 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.127 1.885 . . . . 0.0 112.347 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.665 ' HA ' HD23 ' A' ' 102' ' ' LEU . 39.9 t80 -172.08 -106.34 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.659 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.551 ' O ' ' O ' ' A' ' 106' ' ' PHE . 4.7 p-10 43.09 -179.94 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.744 0.307 . . . . 0.0 111.089 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.66 HG12 HG12 ' A' ' 18' ' ' VAL . 0.9 OUTLIER -67.87 -43.44 85.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -179.355 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.503 ' HB2' ' OD2' ' A' ' 107' ' ' ASP . 7.0 m-20 -49.82 -58.68 4.88 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.45 -179.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.612 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 6.1 mm-40 -74.46 -31.79 62.36 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.759 0.314 . . . . 0.0 111.318 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.419 ' CB ' ' O ' ' A' ' 107' ' ' ASP . . . -66.48 -61.18 2.13 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.336 179.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.608 ' O ' HG12 ' A' ' 115' ' ' VAL . 50.2 t -59.07 -31.51 45.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.5 0.667 . . . . 0.0 110.332 179.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.49 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -64.24 -45.27 88.88 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.722 179.088 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.82 HD23 ' CG2' ' A' ' 79' ' ' ILE . 23.5 tp -74.89 -24.14 58.49 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.835 -1.075 . . . . 0.0 111.901 -179.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.697 HG23 HD13 ' A' ' 79' ' ' ILE . 4.0 p -79.29 -43.83 23.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.668 -179.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.41 ' HA ' HD12 ' A' ' 119' ' ' ILE . 50.8 mt-10 -65.65 -43.76 88.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.114 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.769 ' HD3' HD12 ' A' ' 114' ' ' LEU . 7.8 ptm180 -63.27 -23.72 67.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.787 0.327 . . . . 0.0 110.844 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.38 -46.64 59.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.693 179.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.541 HD11 HG11 ' A' ' 50' ' ' VAL . 4.5 mt -68.62 -32.09 53.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.878 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 36.8 t -65.44 -41.89 93.0 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.492 -0.777 . . . . 0.0 110.819 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 2.4 m80 . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.785 179.947 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.528 0.116 0 CA-C-O 120.684 0.278 . . . . 0.0 111.222 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 89.3 94.39 1.11 Allowed Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.576 -0.821 . . . . 0.0 111.728 -179.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.8 mp -105.71 116.27 49.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.018 0.437 . . . . 0.0 111.451 -179.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.788 HG23 HG13 ' A' ' 50' ' ' VAL . 7.6 p -107.19 131.32 57.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.77 179.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.933 ' CD1' HG22 ' A' ' 31' ' ' THR . 39.5 m0 -117.44 142.2 47.43 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.132 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.732 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -134.18 145.37 33.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.011 0.434 . . . . 0.0 111.558 -178.421 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.992 HG12 ' HB2' ' A' ' 33' ' ' PHE . 3.1 m -131.39 105.93 11.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.262 178.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.767 ' HB3' HG21 ' A' ' 15' ' ' ILE . 53.7 t0 -166.46 66.98 0.1 Allowed 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 121.148 0.499 . . . . 0.0 111.845 -179.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.2 t70 74.85 -9.11 1.41 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 178.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.7 t70 59.45 -154.36 0.37 Allowed 'General case' 0 CA--C 1.534 0.357 0 O-C-N 122.275 -0.266 . . . . 0.0 110.955 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 t 34.83 -91.01 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.538 ' O ' HG23 ' A' ' 18' ' ' VAL . 1.5 m -54.57 -65.98 0.48 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.513 0.197 . . . . 0.0 111.234 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.767 HG21 ' HB3' ' A' ' 10' ' ' ASP . 40.2 mm -60.44 -20.58 21.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.771 0.319 . . . . 0.0 111.089 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.987 ' HA ' HG21 ' A' ' 32' ' ' THR . 27.1 ttt180 -70.32 -57.81 4.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.238 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.475 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 50.1 t90 -53.9 -39.68 66.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.69 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.66 HG12 HG12 ' A' ' 108' ' ' ILE . 14.5 t -62.28 -54.82 29.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 113.018 0.748 . . . . 0.0 113.018 -178.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.613 HD11 HG22 ' A' ' 112' ' ' VAL . 7.8 tp -82.84 -22.4 34.1 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -177.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.594 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 22.8 pt-20 -67.75 -57.69 5.9 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.499 -178.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.536 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 0.1 OUTLIER -63.34 -49.83 72.37 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.93 -179.48 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.15 -47.5 83.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.84 0.353 . . . . 0.0 111.675 -179.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.778 ' CD2' HG11 ' A' ' 6' ' ' VAL . 2.4 tp -71.04 -25.28 62.59 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.259 179.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.08 -33.71 75.04 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.34 -25.04 71.06 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.475 -0.869 . . . . 0.0 111.028 178.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.733 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -76.68 -15.66 59.74 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 120.585 0.231 . . . . 0.0 110.78 179.197 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.14 26.41 9.55 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.68 -0.771 . . . . 0.0 113.825 179.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.733 ' CD1' ' HB3' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -123.94 168.12 13.22 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 117.848 0.824 . . . . 0.0 111.689 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 73.5 m -94.75 105.66 17.61 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.627 179.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.72 ' HA ' HG13 ' A' ' 6' ' ' VAL . 10.8 t -100.77 112.44 24.85 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -178.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.933 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.5 t -120.21 144.75 47.56 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.987 HG21 ' HA ' ' A' ' 16' ' ' ARG . 43.6 p -121.53 157.96 29.54 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -178.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.992 ' HB2' HG12 ' A' ' 9' ' ' VAL . 0.4 OUTLIER -136.16 174.24 10.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.893 -1.049 . . . . 0.0 111.304 -179.882 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.575 ' HG2' ' N ' ' A' ' 35' ' ' ASN . 0.0 OUTLIER -63.19 -32.97 74.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.658 -179.294 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.575 ' N ' ' HG2' ' A' ' 34' ' ' GLU . 1.7 t-20 -178.61 179.0 0.77 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.356 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.708 ' HA3' HD13 ' A' ' 65' ' ' LEU . . . -52.03 -19.93 5.94 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.646 -0.788 . . . . 0.0 113.058 -179.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -69.12 -50.9 43.85 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -179.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.673 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 3.9 tt0 -51.98 -51.7 55.5 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.055 -179.329 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.714 HG23 ' CG1' ' A' ' 9' ' ' VAL . 82.8 t -51.42 -32.7 13.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.133 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.551 HD13 ' CB ' ' A' ' 68' ' ' GLN . 18.9 mt -58.3 -47.26 84.24 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.121 0.486 . . . . 0.0 110.065 179.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.47 -49.47 48.21 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.938 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.89 -32.08 71.55 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.206 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.584 ' HA ' ' O ' ' A' ' 46' ' ' LYS . 18.7 mt -68.78 -25.12 64.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.989 -179.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.31 -20.45 7.19 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.905 -179.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 28.6 t -124.8 4.92 8.1 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.584 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -167.69 155.73 9.02 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.972 0.415 . . . . 0.0 111.173 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.454 ' HA ' ' CD2' ' A' ' 43' ' ' LEU . 93.9 m -138.95 116.58 8.91 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.902 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.578 ' HD2' HD21 ' A' ' 43' ' ' LEU . 73.2 Cg_endo -77.92 163.0 28.95 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 121.988 1.792 . . . . 0.0 111.313 179.221 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -73.79 -21.0 60.31 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.818 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.788 HG13 HG23 ' A' ' 6' ' ' VAL . 5.5 p -147.63 161.42 7.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.715 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.745 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 26.8 tp -152.93 131.15 11.98 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 121.196 0.522 . . . . 0.0 111.947 -179.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.67 ' HB3' HG13 ' A' ' 8' ' ' VAL . 1.0 OUTLIER -114.45 118.18 33.07 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.447 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.852 ' HA ' HG23 ' A' ' 9' ' ' VAL . 3.8 m -117.26 144.37 44.91 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -178.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -82.98 179.15 7.85 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.559 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.737 HG13 ' HA3' ' A' ' 62' ' ' GLY . 9.0 tt -154.61 67.47 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.398 179.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.74 38.51 2.24 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.729 -179.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.547 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER 65.35 47.14 0.56 Allowed Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 178.947 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.511 ' HD2' ' N ' ' A' ' 62' ' ' GLY . 40.9 Cg_endo -68.18 -78.16 0.01 OUTLIER 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 122.387 2.058 . . . . 0.0 111.967 178.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -106.45 -27.71 5.43 Favored Glycine 0 C--N 1.335 0.496 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.126 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 1.024 ' HB3' ' HB2' ' A' ' 64' ' ' ALA . 2.2 tpt -159.51 67.97 0.41 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.885 0.374 . . . . 0.0 109.997 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.547 ' HA ' ' HA ' ' A' ' 57' ' ' MET . 0.2 OUTLIER 71.42 -29.12 0.19 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.338 -179.561 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.737 ' HA3' HG13 ' A' ' 55' ' ' ILE . . . 140.07 -28.45 2.49 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 -179.376 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.999 ' HA ' HD23 ' A' ' 66' ' ' LEU . 0.9 OUTLIER -72.74 -14.01 61.46 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 115.425 -0.387 . . . . 0.0 109.991 178.452 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 1.024 ' HB2' ' HB3' ' A' ' 60' ' ' MET . . . -53.38 -52.45 59.26 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-O 121.118 0.485 . . . . 0.0 110.428 178.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.708 HD13 ' HA3' ' A' ' 36' ' ' GLY . 3.5 pp -57.36 -33.23 67.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.121 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.999 HD23 ' HA ' ' A' ' 63' ' ' LEU . 3.9 mm? -59.36 -50.43 74.0 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.925 0.393 . . . . 0.0 110.766 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.543 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 6.9 mttt -54.54 -40.87 69.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.985 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.551 ' CB ' HD13 ' A' ' 40' ' ' LEU . 11.0 mm100 -65.84 -27.96 68.63 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.066 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.836 HD12 ' HA ' ' A' ' 66' ' ' LEU . 87.9 mt -64.76 -53.94 36.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.8 -179.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.543 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.5 OUTLIER -64.7 -24.93 67.73 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.847 -179.099 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.86 -51.7 63.42 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -178.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.94 -26.4 15.59 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.201 -0.454 . . . . 0.0 112.176 -178.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.54 ' CE1' ' HB3' ' A' ' 43' ' ' LEU . 3.6 m-70 -110.3 139.34 21.37 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-O 120.706 0.289 . . . . 0.0 111.039 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.452 ' C ' ' HG3' ' A' ' 75' ' ' MET . 48.6 Cg_exo -54.24 -76.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.639 2.226 . . . . 0.0 112.937 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.566 ' HB3' ' HA2' ' A' ' 97' ' ' GLY . 2.8 mtm -144.14 54.34 1.29 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.845 0.355 . . . . 0.0 110.743 -179.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.528 ' O ' HG23 ' A' ' 78' ' ' VAL . 1.9 tt -63.83 115.68 20.78 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.725 -179.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -56.72 118.04 4.81 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.497 2.131 . . . . 0.0 112.546 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.918 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 2.8 t -124.99 146.58 30.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.126 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.67 ' HB ' ' HG ' ' A' ' 52' ' ' LEU . 2.3 mp -128.07 116.23 41.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 179.271 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.798 ' HA ' ' O ' ' A' ' 53' ' ' SER . 18.0 mm -95.34 142.59 13.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.979 0.419 . . . . 0.0 112.086 -178.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.544 ' HG3' HG22 ' A' ' 55' ' ' ILE . 1.7 ptt? -66.46 -32.38 73.71 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.609 -178.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.565 ' HA ' ' O ' ' A' ' 102' ' ' LEU . 4.3 m -148.1 169.99 18.78 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.581 0.229 . . . . 0.0 111.362 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 1.008 ' HB1' HD23 ' A' ' 87' ' ' LEU . . . -144.69 56.06 1.27 Allowed 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 14.8 p80 -99.17 176.36 5.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.092 0.472 . . . . 0.0 111.897 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.4 t 67.44 -78.68 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.972 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.547 ' O ' HD22 ' A' ' 63' ' ' LEU . 0.8 OUTLIER -120.4 70.18 0.88 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.894 0.378 . . . . 0.0 111.277 -179.358 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 1.008 HD23 ' HB1' ' A' ' 83' ' ' ALA . 3.0 tm? -54.93 -22.37 14.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.985 179.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -51.46 -56.26 14.28 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.756 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.47 -20.51 55.8 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.715 0.293 . . . . 0.0 111.147 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.841 ' HB3' HD22 ' A' ' 87' ' ' LEU . . . -69.13 -62.17 1.49 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.973 0.416 . . . . 0.0 110.776 179.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.465 ' HA ' ' HD2' ' A' ' 94' ' ' TYR . 8.4 t -53.62 -44.48 57.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.831 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.594 ' HA ' ' CG ' ' A' ' 95' ' ' GLN . 1.7 m -60.25 -25.24 65.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.17 0.51 . . . . 0.0 109.686 178.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.575 ' HB3' ' O ' ' A' ' 90' ' ' ALA . . . -75.88 -49.5 17.74 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.573 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.71 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -73.31 -29.25 62.57 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.038 -179.139 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.594 ' CG ' ' HA ' ' A' ' 92' ' ' SER . 2.1 pp0? -77.27 -37.61 52.58 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.547 178.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.57 ' HG2' ' O ' ' A' ' 93' ' ' ALA . 10.3 pt20 -73.47 -17.23 61.26 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.053 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.566 ' HA2' ' HB3' ' A' ' 75' ' ' MET . . . 165.16 -33.08 0.25 Allowed Glycine 0 C--N 1.335 0.473 0 C-N-CA 120.047 -1.073 . . . . 0.0 113.762 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.918 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -58.4 155.64 11.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 117.549 0.674 . . . . 0.0 111.218 -179.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.507 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 23.8 t80 -69.2 -53.88 17.7 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.735 -178.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.439 ' HB3' ' O ' ' A' ' 99' ' ' PHE . 17.1 p-10 178.99 -160.25 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 120.922 0.391 . . . . 0.0 111.084 -179.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.923 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 3.5 m-85 -135.98 153.36 51.42 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.986 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.601 HD13 HD22 ' A' ' 114' ' ' LEU . 1.4 tp -103.74 118.98 56.06 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.826 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -71.68 -75.38 0.01 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.034 1.823 . . . . 0.0 112.278 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.441 ' CB ' ' HD3' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -108.94 -57.03 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.503 -179.962 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.497 ' HB3' ' HG3' ' A' ' 110' ' ' GLU . 56.0 Cg_exo -52.31 154.15 11.8 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.295 1.996 . . . . 0.0 112.61 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.59 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 31.2 t80 -164.44 -116.52 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.197 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.55 ' O ' ' O ' ' A' ' 106' ' ' PHE . 2.9 p30 43.22 179.48 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.967 0.413 . . . . 0.0 111.449 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.66 HG12 HG12 ' A' ' 18' ' ' VAL . 0.8 OUTLIER -67.99 -43.75 85.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.892 0.377 . . . . 0.0 111.803 -179.617 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.491 ' HB2' ' OD1' ' A' ' 107' ' ' ASP . 4.2 m-20 -49.23 -58.28 5.31 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.567 -179.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.59 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 6.7 mm-40 -76.01 -32.02 59.2 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.591 0.234 . . . . 0.0 111.231 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.433 ' CB ' ' O ' ' A' ' 107' ' ' ASP . . . -66.21 -57.46 7.53 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.336 179.295 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.653 ' O ' HG12 ' A' ' 115' ' ' VAL . 47.8 t -62.01 -33.52 58.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.362 0.601 . . . . 0.0 110.653 179.129 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.477 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -62.24 -46.26 89.63 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.551 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.601 HD22 HD13 ' A' ' 102' ' ' LEU . 37.9 tp -75.83 -21.98 56.75 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.96 -1.018 . . . . 0.0 112.205 -179.107 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.653 HG12 ' O ' ' A' ' 112' ' ' VAL . 7.2 p -79.18 -41.44 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 C-N-CA 120.447 -0.501 . . . . 0.0 111.994 -179.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -66.35 -42.95 87.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.825 0.345 . . . . 0.0 110.736 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.9 mtt180 -61.0 -23.86 65.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.385 179.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.507 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -72.17 -48.45 43.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.079 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.481 HD11 HG11 ' A' ' 50' ' ' VAL . 4.5 mt -69.63 -31.31 48.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.076 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 36.3 t -71.96 -50.84 25.52 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.165 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.134 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.804 ' HB3' HD11 ' A' ' 5' ' ' ILE . 10.2 tpt85 . . . . . 0 N--CA 1.455 -0.224 0 CA-C-O 120.768 0.318 . . . . 0.0 110.776 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.528 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . 68.16 63.06 3.8 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.773 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.804 HD11 ' HB3' ' A' ' 3' ' ' ARG . 3.8 mp -101.73 115.02 42.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.767 0.318 . . . . 0.0 110.839 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.849 HG11 ' CD2' ' A' ' 23' ' ' LEU . 7.3 p -105.66 126.41 60.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.327 179.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.799 ' CD1' HG22 ' A' ' 31' ' ' THR . 21.6 m0 -116.63 126.31 53.05 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.669 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.711 HG13 ' HB3' ' A' ' 52' ' ' LEU . 0.2 OUTLIER -112.02 148.26 15.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.236 -179.056 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 1.098 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -130.79 113.36 24.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 120.885 0.374 . . . . 0.0 110.379 178.736 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -161.4 -156.63 0.45 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.798 -179.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -67.24 0.78 2.52 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.411 ' O ' ' N ' ' A' ' 14' ' ' SER . 0.1 OUTLIER 65.38 -158.68 0.28 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.509 0.195 . . . . 0.0 110.783 179.717 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.436 ' HB3' ' H ' ' A' ' 14' ' ' SER . 1.3 t 34.62 -90.51 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 179.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.813 ' O ' HG23 ' A' ' 18' ' ' VAL . 0.4 OUTLIER -53.87 -57.56 10.5 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.824 0.345 . . . . 0.0 111.114 -179.702 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 22.4 mm -65.2 -24.5 35.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.89 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 1.097 ' HA ' HG21 ' A' ' 32' ' ' THR . 14.7 ttm-85 -71.1 -58.18 3.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.165 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.475 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 57.9 t90 -54.43 -37.3 64.96 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -179.141 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.813 HG23 ' O ' ' A' ' 14' ' ' SER . 8.2 t -67.84 -47.08 80.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -178.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.749 HD23 HD11 ' A' ' 108' ' ' ILE . 0.2 OUTLIER -84.25 -27.63 27.78 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -178.636 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.542 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 12.1 pt-20 -66.75 -59.77 3.27 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.846 -179.138 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.504 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 4.0 mmm180 -67.0 -47.7 70.68 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.846 -179.156 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.67 -54.53 45.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.917 0.389 . . . . 0.0 111.456 -179.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.849 ' CD2' HG11 ' A' ' 6' ' ' VAL . 2.2 tp -67.68 -23.49 65.31 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.065 179.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.542 ' HB2' ' O ' ' A' ' 20' ' ' GLU . . . -69.22 -36.31 77.1 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.336 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.89 -25.73 68.1 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.427 -0.892 . . . . 0.0 110.982 178.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.611 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -76.81 -16.11 59.54 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 120.665 0.269 . . . . 0.0 111.067 179.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.71 26.59 8.46 Favored Glycine 0 CA--C 1.522 0.514 0 C-N-CA 120.289 -0.958 . . . . 0.0 114.158 178.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.718 HD12 ' O ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -127.21 170.38 12.49 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 117.994 0.897 . . . . 0.0 111.805 179.942 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 52.9 m -95.46 105.51 17.48 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.432 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.719 ' HA ' HG13 ' A' ' 6' ' ' VAL . 40.7 t -106.34 113.36 26.83 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.221 0.534 . . . . 0.0 111.948 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.799 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.8 t -116.85 156.43 27.31 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 1.097 HG21 ' HA ' ' A' ' 16' ' ' ARG . 28.9 p -127.04 158.44 36.95 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.358 0.599 . . . . 0.0 111.684 -179.347 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 1.098 ' HB2' HG13 ' A' ' 9' ' ' VAL . 17.0 m-85 -128.44 174.24 9.51 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.735 -178.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.488 ' HG3' ' ND2' ' A' ' 35' ' ' ASN . 1.6 pt-20 -63.3 -37.6 87.87 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.577 0.955 . . . . 0.0 113.577 -177.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.488 ' ND2' ' HG3' ' A' ' 34' ' ' GLU . 18.0 p30 -174.92 -41.02 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 118.766 0.712 . . . . 0.0 112.696 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.754 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . -178.57 -47.07 0.07 OUTLIER Glycine 0 C--N 1.321 -0.271 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.738 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.418 ' HA ' ' CD1' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -61.25 -29.94 70.15 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.616 0.246 . . . . 0.0 111.353 -179.525 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.836 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 3.1 tt0 -59.98 -51.34 70.07 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 121.089 -0.245 . . . . 0.0 111.597 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.621 HG21 ' CG2' ' A' ' 9' ' ' VAL . 19.5 t -52.37 -41.13 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 C-N-CA 120.584 -0.446 . . . . 0.0 111.461 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.74 HD13 ' HB3' ' A' ' 68' ' ' GLN . 7.1 mt -54.7 -46.74 74.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.97 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.91 -49.17 71.48 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.425 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.31 -32.7 74.26 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.881 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.642 HD21 ' HD2' ' A' ' 48' ' ' PRO . 8.3 mt -60.7 -25.02 66.11 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.086 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.4 -16.84 50.57 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.779 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.3 m -125.72 -0.97 7.37 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.515 ' O ' HD23 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -160.95 162.07 31.83 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.905 0.383 . . . . 0.0 111.024 179.834 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.443 HG23 HD23 ' A' ' 76' ' ' LEU . 57.8 m -138.42 116.0 9.21 Favored Pre-proline 0 N--CA 1.451 -0.414 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.134 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.642 ' HD2' HD21 ' A' ' 43' ' ' LEU . 70.9 Cg_endo -74.76 149.24 37.59 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 121.97 1.78 . . . . 0.0 111.881 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -73.73 -24.89 59.96 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.706 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.788 ' CG2' HD11 ' A' ' 79' ' ' ILE . 7.6 p -147.53 101.83 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.983 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.495 HD12 ' O ' ' A' ' 7' ' ' TRP . 18.0 tp -87.13 134.48 33.51 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.116 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.711 ' HB3' HG13 ' A' ' 8' ' ' VAL . 1.3 tt -121.73 122.54 39.77 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.333 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.55 ' OG ' HD13 ' A' ' 65' ' ' LEU . 2.2 m -123.67 125.51 44.92 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.416 0.627 . . . . 0.0 112.473 -178.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.649 ' HA ' ' HG2' ' A' ' 81' ' ' MET . 1.2 m-20 -83.18 107.14 15.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.78 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.985 HG13 ' HA3' ' A' ' 62' ' ' GLY . 4.9 tt -69.99 116.41 11.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.955 179.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.473 ' H ' ' HD3' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -158.22 58.13 0.46 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.036 0.446 . . . . 0.0 111.883 -179.783 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.456 ' N ' ' CD ' ' A' ' 58' ' ' PRO . 9.6 ptp 47.07 46.17 3.27 Favored Pre-proline 0 CA--C 1.537 0.473 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 178.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.608 ' CG ' ' HA2' ' A' ' 62' ' ' GLY . 50.3 Cg_endo -69.81 -81.94 0.01 OUTLIER 'Trans proline' 0 CA--C 1.533 0.475 0 C-N-CA 122.89 2.393 . . . . 0.0 111.885 178.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -105.85 -25.68 6.41 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.088 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.971 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -161.57 71.75 0.38 Allowed 'General case' 0 C--O 1.235 0.321 0 CA-C-O 120.985 0.421 . . . . 0.0 110.126 179.498 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.55 ' O ' HG13 ' A' ' 55' ' ' ILE . 0.2 OUTLIER 69.49 -25.77 0.15 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.886 -179.805 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.985 ' HA3' HG13 ' A' ' 55' ' ' ILE . . . 136.68 -26.34 3.04 Favored Glycine 0 CA--C 1.502 -0.737 0 N-CA-C 111.639 -0.584 . . . . 0.0 111.639 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.857 ' HA ' HD13 ' A' ' 66' ' ' LEU . 4.0 mp -78.26 -14.0 59.62 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-O 121.051 0.453 . . . . 0.0 109.977 178.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.971 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -53.83 -44.51 70.31 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.031 179.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.758 ' CD1' HD12 ' A' ' 66' ' ' LEU . 3.1 pp -57.98 -32.35 67.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.041 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.857 HD13 ' HA ' ' A' ' 63' ' ' LEU . 7.1 mp -62.93 -44.99 94.58 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.365 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.551 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 30.2 tttt -56.16 -44.62 79.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.756 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.74 ' HB3' HD13 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -66.26 -39.96 89.83 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.662 -179.869 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.667 HD12 ' HA ' ' A' ' 66' ' ' LEU . 10.4 mt -65.03 -32.65 59.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.816 -179.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.551 ' HG2' ' O ' ' A' ' 67' ' ' LYS . 16.0 pttt -76.16 -29.04 57.57 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.966 0.413 . . . . 0.0 111.108 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.18 -44.01 89.82 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.382 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 79.3 mtt-85 -87.57 -23.09 24.43 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.735 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.736 ' CB ' ' HB2' ' A' ' 76' ' ' LEU . 88.7 m-70 -143.28 92.57 6.67 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.972 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.465 ' O ' ' O ' ' A' ' 96' ' ' GLN . 23.0 Cg_exo -64.86 6.11 0.39 Allowed 'Trans proline' 0 CA--C 1.531 0.343 0 C-N-CA 122.657 2.238 . . . . 0.0 113.123 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.609 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -143.35 14.08 1.81 Allowed 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.666 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.736 ' HB2' ' CB ' ' A' ' 73' ' ' HIS . 0.8 OUTLIER -75.53 113.06 22.64 Favored Pre-proline 0 C--N 1.332 -0.188 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -179.512 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.861 ' HB2' ' HD1' ' A' ' 99' ' ' PHE . 37.9 Cg_endo -67.5 116.66 4.35 Favored 'Trans proline' 0 CA--C 1.533 0.458 0 C-N-CA 122.546 2.164 . . . . 0.0 112.423 179.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.461 ' C ' ' HB2' ' A' ' 99' ' ' PHE . 3.6 t -115.05 136.61 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 120.921 0.391 . . . . 0.0 111.719 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.788 HD11 ' CG2' ' A' ' 50' ' ' VAL . 2.3 mt -110.37 116.54 52.62 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.207 0 CA-C-O 121.143 0.497 . . . . 0.0 110.956 179.04 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.847 HD11 HD21 ' A' ' 66' ' ' LEU . 1.6 mp -98.77 134.26 38.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.385 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.964 ' HG3' HG22 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -73.61 -24.93 60.1 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -178.089 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.521 ' HB ' HG21 ' A' ' 55' ' ' ILE . 3.9 m -147.38 159.21 43.95 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.154 0.502 . . . . 0.0 112.327 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.911 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -138.03 68.58 1.4 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.61 179.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -68.2 -141.87 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.067 -179.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.2 p -80.44 79.23 7.07 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-O 120.927 0.394 . . . . 0.0 111.558 -179.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.624 ' HB3' HD13 ' A' ' 63' ' ' LEU . 2.1 t70 179.53 29.06 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.926 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.893 HD13 ' HB3' ' A' ' 90' ' ' ALA . 0.3 OUTLIER -54.15 -21.41 8.66 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.653 -179.966 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -47.25 -54.45 10.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.741 0.305 . . . . 0.0 111.59 -179.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.518 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -69.6 -22.3 63.51 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.145 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.893 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -75.11 -42.14 57.07 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.792 0.329 . . . . 0.0 110.34 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.691 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 19.5 t -62.56 -52.8 55.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.034 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.3 p -57.39 -33.55 67.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.62 0.724 . . . . 0.0 109.833 179.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.644 ' HA ' ' CD ' ' A' ' 96' ' ' GLN . . . -57.56 -39.95 77.84 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.482 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.691 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 18.8 m-85 -60.67 -21.12 62.49 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.237 179.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.65 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -74.01 -43.83 56.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.312 179.715 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.65 ' N ' ' HG2' ' A' ' 95' ' ' GLN . 3.8 pm0 -80.33 -12.4 59.6 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.48 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.525 ' O ' ' HA ' ' A' ' 77' ' ' PRO . . . 117.17 38.38 0.87 Allowed Glycine 0 C--O 1.228 -0.25 0 C-N-CA 119.972 -1.109 . . . . 0.0 114.045 178.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.544 ' HB2' ' HB1' ' A' ' 93' ' ' ALA . . . -63.04 146.36 53.4 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 117.319 0.559 . . . . 0.0 110.772 179.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.861 ' HD1' ' HB2' ' A' ' 77' ' ' PRO . 1.3 t80 -71.75 -54.35 10.51 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.167 179.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.539 ' HB3' ' O ' ' A' ' 99' ' ' PHE . 2.9 p30 166.79 -166.87 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.711 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.911 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 4.8 m-85 -143.21 145.95 33.24 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.38 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.67 HD23 ' O ' ' A' ' 105' ' ' PRO . 6.4 mp -102.26 119.76 55.45 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.625 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -58.53 -66.27 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.343 2.029 . . . . 0.0 112.593 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.727 ' H ' ' HD2' ' A' ' 105' ' ' PRO . 8.8 mtpp -124.5 -60.68 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.465 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.727 ' HD2' ' H ' ' A' ' 104' ' ' LYS . 16.7 Cg_endo -57.13 159.24 15.65 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.077 1.851 . . . . 0.0 112.422 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.62 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 29.1 t80 -170.62 -104.34 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.382 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.538 ' O ' ' O ' ' A' ' 106' ' ' PHE . 3.3 p30 42.85 -177.58 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.542 0.211 . . . . 0.0 110.833 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.749 HD11 HD23 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -67.93 -42.67 85.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.994 0.426 . . . . 0.0 111.681 -179.716 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.551 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 1.7 m-20 -49.03 -57.46 6.51 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.54 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.62 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 5.5 mm-40 -77.0 -32.28 57.09 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 121.047 -0.261 . . . . 0.0 111.699 -179.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.6 -62.59 1.38 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.713 ' O ' HG12 ' A' ' 115' ' ' VAL . 42.6 t -57.64 -30.37 36.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 121.31 0.576 . . . . 0.0 110.816 178.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.551 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -63.94 -47.04 82.06 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.412 0.625 . . . . 0.0 110.203 179.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.571 HD23 HG21 ' A' ' 79' ' ' ILE . 4.8 tp -72.63 -22.38 60.95 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.487 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.778 HG23 HG21 ' A' ' 50' ' ' VAL . 9.9 p -79.56 -49.57 19.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 120.437 -0.505 . . . . 0.0 111.843 -179.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.493 ' N ' HG13 ' A' ' 115' ' ' VAL . 7.5 mt-10 -65.47 -54.74 24.05 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.766 0.317 . . . . 0.0 111.092 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 27.7 mtp85 -57.21 -26.47 60.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.188 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.531 ' HB1' ' CZ ' ' A' ' 99' ' ' PHE . . . -73.3 -48.99 29.98 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.479 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.2 mt -63.52 -30.88 50.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.218 0.533 . . . . 0.0 110.469 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 46.4 t -73.13 -48.92 31.42 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.099 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 25.4 m80 . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.271 -179.881 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.44 ' CG ' ' H ' ' A' ' 4' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.132 0 CA-C-O 121.05 0.453 . . . . 0.0 111.285 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.59 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . 167.93 89.78 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.701 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 23.0 mm -117.74 112.76 40.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.768 0.318 . . . . 0.0 111.496 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.969 HG23 HG13 ' A' ' 50' ' ' VAL . 12.2 p -105.26 128.36 59.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.054 178.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.814 ' CD1' HG22 ' A' ' 31' ' ' THR . 24.9 m0 -116.89 129.9 56.36 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.119 0.485 . . . . 0.0 110.009 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.81 HG13 ' HB3' ' A' ' 52' ' ' LEU . 0.9 OUTLIER -121.72 149.43 24.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.341 -177.681 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.955 HG11 ' HA2' ' A' ' 36' ' ' GLY . 0.0 OUTLIER -125.31 113.41 35.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.555 178.973 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.444 ' OD2' ' OD2' ' A' ' 54' ' ' ASP . 2.3 t0 -164.78 -159.15 0.44 Allowed 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.14 -179.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -67.29 1.1 2.34 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -179.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.406 ' O ' ' N ' ' A' ' 14' ' ' SER . 14.7 t0 65.89 -158.33 0.27 Allowed 'General case' 0 CA--C 1.534 0.33 0 O-C-N 122.233 -0.292 . . . . 0.0 110.995 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.1 t 31.92 -89.84 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 179.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.866 ' O ' HG23 ' A' ' 18' ' ' VAL . 3.5 t -53.72 -56.14 20.01 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.656 0.265 . . . . 0.0 111.468 -179.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.5 mm -66.51 -25.0 34.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.923 0.392 . . . . 0.0 111.048 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.741 ' HA ' HG21 ' A' ' 32' ' ' THR . 3.2 tmm_? -77.99 -44.48 26.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.777 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.452 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 82.3 t90 -64.49 -39.79 94.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.67 -179.128 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.866 HG23 ' O ' ' A' ' 14' ' ' SER . 6.3 t -69.14 -43.12 81.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 112.748 0.648 . . . . 0.0 112.748 -179.024 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.665 HD23 HG21 ' A' ' 8' ' ' VAL . 1.5 tp -84.53 -22.62 30.09 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -178.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.634 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 17.6 pt-20 -67.71 -57.11 6.93 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.099 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.495 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 5.8 mmt180 -63.22 -49.91 72.32 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.597 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.41 -56.3 20.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.154 0.502 . . . . 0.0 111.147 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.778 ' HG ' HG11 ' A' ' 6' ' ' VAL . 2.0 tm? -66.01 -28.21 68.7 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.537 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.45 ' HB2' ' O ' ' A' ' 20' ' ' GLU . . . -67.26 -34.23 76.98 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.24 -26.73 66.43 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.379 -0.915 . . . . 0.0 111.366 178.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.621 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -76.84 -15.76 59.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.822 0.344 . . . . 0.0 110.919 179.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.25 25.5 10.21 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.797 -0.716 . . . . 0.0 113.596 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.621 ' CD1' ' HB3' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -130.74 171.67 12.84 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 117.762 0.781 . . . . 0.0 111.648 179.689 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.677 ' O ' HG12 ' A' ' 6' ' ' VAL . 32.1 m -94.35 130.71 40.55 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.175 -179.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.634 ' HB3' ' HA ' ' A' ' 20' ' ' GLU . 48.9 t -123.69 115.65 21.78 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 121.272 0.558 . . . . 0.0 111.83 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.814 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.9 t -117.44 156.5 27.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.597 178.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.741 HG21 ' HA ' ' A' ' 16' ' ' ARG . 55.5 p -132.53 151.41 51.93 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.142 0.496 . . . . 0.0 112.054 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.899 ' HB2' HG13 ' A' ' 9' ' ' VAL . 2.0 m-85 -125.46 174.42 8.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.228 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.655 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -61.66 -107.63 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.652 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.464 ' H ' ' CD ' ' A' ' 34' ' ' GLU . 0.6 OUTLIER -80.35 -69.84 0.57 Allowed 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.029 0.442 . . . . 0.0 112.038 -178.545 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.955 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . -167.42 -36.56 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.484 -0.865 . . . . 0.0 113.543 -179.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.588 HD22 HD12 ' A' ' 40' ' ' LEU . 12.4 m120 -61.91 -30.0 70.59 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 116.999 0.399 . . . . 0.0 110.594 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.844 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -53.64 -56.86 13.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.624 179.225 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.825 HG21 HG22 ' A' ' 9' ' ' VAL . 2.9 t -51.75 -46.74 39.51 Favored 'Isoleucine or valine' 0 C--N 1.342 0.254 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.44 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.689 HD13 ' CB ' ' A' ' 68' ' ' GLN . 23.6 mt -55.23 -42.87 73.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.008 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.47 -49.65 72.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.159 0.504 . . . . 0.0 111.231 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.44 -26.4 63.63 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.05 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.846 HD13 ' NE2' ' A' ' 73' ' ' HIS . 6.5 mt -63.99 -21.3 66.43 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.445 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.72 -16.83 29.98 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.111 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.5 m -121.58 1.25 10.04 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.478 ' O ' HD23 ' A' ' 43' ' ' LEU . 0.7 OUTLIER -165.9 159.74 16.15 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.888 0.375 . . . . 0.0 111.367 179.764 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.642 HG23 HD12 ' A' ' 76' ' ' LEU . 90.8 m -138.58 111.84 8.34 Favored Pre-proline 0 N--CA 1.45 -0.441 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.422 179.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.713 ' HD2' HD11 ' A' ' 76' ' ' LEU . 51.8 Cg_endo -67.94 154.12 73.62 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.688 2.258 . . . . 0.0 111.891 179.041 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -74.66 -26.07 59.62 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.466 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.969 HG13 HG23 ' A' ' 6' ' ' VAL . 7.2 p -146.28 101.66 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.229 -178.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.69 HD12 ' O ' ' A' ' 7' ' ' TRP . 19.5 tp -86.85 137.11 32.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.985 0.421 . . . . 0.0 111.427 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.81 ' HB3' HG13 ' A' ' 8' ' ' VAL . 1.9 tt -126.85 127.55 45.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.145 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.517 ' N ' HD23 ' A' ' 52' ' ' LEU . 0.5 OUTLIER -126.22 129.21 48.51 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.343 0.592 . . . . 0.0 111.474 179.96 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.444 ' OD2' ' OD2' ' A' ' 10' ' ' ASP . 0.5 OUTLIER -79.02 -0.24 30.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.324 -179.212 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.705 HG13 ' HA3' ' A' ' 62' ' ' GLY . 11.9 tt 36.82 94.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-O 120.89 0.376 . . . . 0.0 111.579 -179.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.8 mtt180 -118.84 40.51 3.25 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.775 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.595 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER 59.59 46.19 1.33 Allowed Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 179.239 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.467 ' CG ' ' HA2' ' A' ' 62' ' ' GLY . 27.5 Cg_endo -61.9 -79.76 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.162 1.908 . . . . 0.0 111.23 178.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -106.35 -82.68 1.55 Allowed Glycine 0 C--N 1.332 0.343 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 178.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.82 ' HB3' ' HB2' ' A' ' 64' ' ' ALA . 17.0 tpp -87.57 59.36 5.42 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 177.18 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.595 ' HA ' ' HA ' ' A' ' 57' ' ' MET . 0.1 OUTLIER 63.54 -16.05 0.07 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.021 -0.99 . . . . 0.0 111.851 -178.656 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.705 ' HA3' HG13 ' A' ' 55' ' ' ILE . . . 135.98 -30.95 2.69 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 -178.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.803 HD11 ' HB2' ' A' ' 90' ' ' ALA . 1.9 tp -56.33 -30.17 62.26 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 178.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.82 ' HB2' ' HB3' ' A' ' 60' ' ' MET . . . -53.69 -38.32 64.1 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.213 178.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.638 ' O ' HG13 ' A' ' 69' ' ' ILE . 1.7 tp -51.41 -50.04 60.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.368 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 1.035 ' HA ' HD12 ' A' ' 69' ' ' ILE . 81.3 mt -52.8 -42.87 65.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.141 179.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 31.3 mttm -58.47 -46.88 85.72 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.4 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.689 ' CB ' HD13 ' A' ' 40' ' ' LEU . 16.7 mm100 -65.0 -31.68 73.03 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.778 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 1.035 HD12 ' HA ' ' A' ' 66' ' ' LEU . 88.7 mt -60.06 -45.72 95.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.728 -179.373 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.455 ' HG3' ' N ' ' A' ' 71' ' ' GLN . 0.4 OUTLIER -68.94 -29.5 67.75 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.536 -179.864 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.455 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 7.6 mt-30 -83.98 -33.21 24.63 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.565 -179.251 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.472 ' HB2' ' CD2' ' A' ' 73' ' ' HIS . 3.2 mtp85 -90.5 -65.26 1.03 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.18 -178.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.948 ' CE1' HG23 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -96.31 159.62 31.58 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.394 -178.956 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -96.44 101.2 0.09 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 123.489 2.793 . . . . 0.0 113.619 -179.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 6.8 mtt 57.04 24.2 9.29 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 177.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.713 HD11 ' HD2' ' A' ' 48' ' ' PRO . 2.2 tt -60.22 112.31 5.29 Favored Pre-proline 0 C--N 1.325 -0.487 0 C-N-CA 120.934 -0.307 . . . . 0.0 111.327 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.61 116.0 2.99 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.432 2.088 . . . . 0.0 112.153 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.989 HG21 HD13 ' A' ' 69' ' ' ILE . 19.0 t -115.06 145.14 21.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.985 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.631 ' CG2' HD23 ' A' ' 114' ' ' LEU . 1.8 mp -118.79 110.99 31.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.982 0.42 . . . . 0.0 111.031 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.55 ' HB ' ' CZ ' ' A' ' 101' ' ' TYR . 21.6 mm -103.3 146.72 10.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.578 -179.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.445 ' O ' ' HB2' ' A' ' 102' ' ' LEU . 7.2 ttt -69.06 -78.61 0.07 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.967 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.601 ' O ' HD13 ' A' ' 55' ' ' ILE . 4.0 m -106.62 159.08 16.47 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.118 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.487 ' HA ' ' CE2' ' A' ' 101' ' ' TYR . . . -87.52 -17.59 31.72 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.895 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.477 ' CD2' HG12 ' A' ' 55' ' ' ILE . 3.8 m-70 48.33 -89.63 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.409 ' N ' ' O ' ' A' ' 83' ' ' ALA . 4.7 m -81.83 -169.97 2.61 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.834 0.35 . . . . 0.0 111.087 -179.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.524 ' O ' HD21 ' A' ' 63' ' ' LEU . 24.7 m-20 -40.86 108.62 0.09 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.166 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.76 HD23 ' HB3' ' A' ' 90' ' ' ALA . 1.3 mt -48.15 -20.99 0.41 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.398 178.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -47.74 -43.58 27.24 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -178.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.617 ' HB3' ' HG ' ' A' ' 63' ' ' LEU . . . -74.1 -21.33 59.94 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 120.243 -0.583 . . . . 0.0 109.912 179.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.803 ' HB2' HD11 ' A' ' 63' ' ' LEU . . . -77.55 -58.91 3.01 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.615 178.239 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.757 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 18.3 t -58.25 -56.75 14.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.561 -179.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 57.6 p -52.79 -27.58 18.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.069 0.462 . . . . 0.0 110.696 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.656 ' CB ' HD13 ' A' ' 66' ' ' LEU . . . -58.36 -46.08 86.97 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.003 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.757 ' CE2' ' HA ' ' A' ' 91' ' ' VAL . 5.5 m-85 -48.68 -27.95 3.22 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.767 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.622 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -76.91 -39.61 50.27 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.704 -179.903 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.622 ' N ' ' HG2' ' A' ' 95' ' ' GLN . 7.7 pt20 -100.14 5.33 44.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.979 -178.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 127.98 79.25 0.26 Allowed Glycine 0 CA--C 1.519 0.323 0 C-N-CA 120.101 -1.047 . . . . 0.0 113.178 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.964 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -171.62 127.04 0.63 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.008 0.432 . . . . 0.0 110.477 179.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.568 ' CE2' ' HB2' ' A' ' 118' ' ' ALA . 13.6 t80 -70.14 -53.73 16.0 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -178.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.702 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 0.1 OUTLIER 179.04 -170.48 0.12 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.011 0.434 . . . . 0.0 111.729 -179.291 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.638 ' CE1' HD11 ' A' ' 66' ' ' LEU . 3.0 m-85 -135.01 153.6 52.02 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.476 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.78 HD11 HD22 ' A' ' 114' ' ' LEU . 7.4 mp -102.19 123.76 42.21 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-O 120.768 0.318 . . . . 0.0 111.09 -179.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -69.71 -56.62 0.14 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.434 2.089 . . . . 0.0 112.475 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.681 ' HB3' ' HD3' ' A' ' 105' ' ' PRO . 1.8 ttmp? -133.52 -56.14 0.02 OUTLIER Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.474 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.681 ' HD3' ' HB3' ' A' ' 104' ' ' LYS . 45.1 Cg_exo -57.52 160.03 15.12 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 121.765 1.644 . . . . 0.0 111.758 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.645 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 62.9 t80 -165.85 -105.52 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.186 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.6 ' O ' ' O ' ' A' ' 106' ' ' PHE . 3.1 p30 41.65 178.63 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.959 0.409 . . . . 0.0 111.321 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.665 HD11 HD13 ' A' ' 19' ' ' LEU . 0.9 OUTLIER -67.89 -41.04 84.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.124 179.659 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.477 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 33.7 t0 -49.18 -58.54 4.83 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.602 -179.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.645 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 10.3 mm-40 -76.33 -32.6 58.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.711 0.291 . . . . 0.0 111.402 -179.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.85 -60.07 3.23 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.815 0.34 . . . . 0.0 110.407 179.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.65 ' HA ' HG12 ' A' ' 115' ' ' VAL . 47.1 t -59.63 -30.79 45.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.576 0.703 . . . . 0.0 110.468 178.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.477 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -63.66 -45.51 89.83 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.011 178.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.78 HD22 HD11 ' A' ' 102' ' ' LEU . 34.1 tp -77.35 -22.7 51.42 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.604 -179.344 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.65 HG12 ' HA ' ' A' ' 112' ' ' VAL . 5.3 p -79.39 -40.98 22.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 120.467 -0.493 . . . . 0.0 111.412 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -67.19 -48.59 67.47 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.963 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.454 ' NH2' ' HB1' ' A' ' 113' ' ' ALA . 0.9 OUTLIER -58.93 -23.28 61.19 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.808 179.948 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.568 ' HB2' ' CE2' ' A' ' 99' ' ' PHE . . . -72.43 -44.39 62.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.169 179.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.653 HD11 HG11 ' A' ' 50' ' ' VAL . 4.8 mt -72.18 -32.05 41.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.283 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 2.3 t -71.9 -47.2 54.33 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.805 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 . . . . . 0 C--N 1.327 -0.393 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.08 179.875 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.522 ' HD2' HD11 ' A' ' 5' ' ' ILE . 15.2 ptt180 . . . . . 0 CA--C 1.52 -0.2 0 CA-C-O 121.224 0.535 . . . . 0.0 110.691 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.701 ' O ' HD13 ' A' ' 5' ' ' ILE . . . 101.45 112.79 3.59 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.836 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.701 HD13 ' O ' ' A' ' 4' ' ' GLY . 8.7 mm -124.97 112.89 33.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.809 0.338 . . . . 0.0 111.576 -178.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.859 HG23 HG13 ' A' ' 50' ' ' VAL . 8.0 p -106.47 125.52 62.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.17 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.875 ' CD1' HG22 ' A' ' 31' ' ' THR . 29.1 m0 -117.13 123.46 46.81 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.897 HG11 HD13 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -116.97 137.83 49.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.329 -177.237 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.845 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -121.25 104.98 15.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.967 178.695 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.806 ' HB3' HG21 ' A' ' 15' ' ' ILE . 3.7 t70 -168.1 72.49 0.1 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.984 0.421 . . . . 0.0 111.87 -179.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 63.95 2.59 1.42 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 179.015 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.7 p30 44.83 -149.63 0.07 Allowed 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.436 ' O ' ' HB3' ' A' ' 16' ' ' ARG . 1.4 t 34.85 -92.17 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 179.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.694 ' O ' HG23 ' A' ' 18' ' ' VAL . 2.9 t -53.81 -66.06 0.46 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.776 0.322 . . . . 0.0 110.56 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.806 HG21 ' HB3' ' A' ' 10' ' ' ASP . 35.0 mm -60.98 -20.51 22.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.924 179.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.95 ' HA ' HG21 ' A' ' 32' ' ' THR . 2.0 ttt180 -69.86 -58.03 4.36 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.255 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.492 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 36.8 t90 -59.43 -41.24 89.11 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.048 -0.523 . . . . 0.0 112.273 -179.117 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.896 HG12 HG12 ' A' ' 108' ' ' ILE . 2.7 t -67.14 -42.19 87.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -178.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.897 HD13 HG11 ' A' ' 8' ' ' VAL . 24.0 mt -84.13 -26.85 28.58 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -178.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.555 ' HG3' ' N ' ' A' ' 21' ' ' ARG . 21.2 pt-20 -67.5 -58.71 4.25 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.036 0.446 . . . . 0.0 112.029 -178.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.555 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 0.9 OUTLIER -50.71 -53.53 30.59 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.168 -179.154 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.01 -50.25 67.04 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -179.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.834 ' HG ' HG11 ' A' ' 6' ' ' VAL . 3.0 tm? -70.09 -30.62 67.89 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.421 0.629 . . . . 0.0 110.336 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.77 -32.53 73.88 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.64 -27.94 70.64 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 110.701 -0.959 . . . . 0.0 110.701 177.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.606 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -76.66 -15.75 59.73 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 120.625 0.25 . . . . 0.0 110.5 179.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.51 26.33 12.19 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.533 -0.842 . . . . 0.0 114.271 178.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.703 ' HB2' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -125.41 165.78 17.78 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 118.257 1.028 . . . . 0.0 112.3 179.729 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.727 ' O ' HG12 ' A' ' 6' ' ' VAL . 91.8 m -75.06 125.95 30.01 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.783 -179.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.443 ' HA ' HG13 ' A' ' 6' ' ' VAL . 4.2 p -125.77 110.4 13.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.697 -179.447 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.875 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.6 t -125.46 149.71 47.98 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.95 HG21 ' HA ' ' A' ' 16' ' ' ARG . 53.1 p -126.95 161.36 28.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.529 0.68 . . . . 0.0 112.734 -179.254 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.845 ' HB2' HG13 ' A' ' 9' ' ' VAL . 0.7 OUTLIER -135.23 173.37 11.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.595 -179.714 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.61 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -59.3 -103.11 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.885 -178.234 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.498 ' OD1' ' HD3' ' A' ' 58' ' ' PRO . 0.2 OUTLIER -88.93 -71.44 0.6 Allowed 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.103 0.478 . . . . 0.0 111.814 -179.076 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.772 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . -163.45 -34.74 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.638 -0.71 . . . . 0.0 113.069 -178.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.448 HD22 HD12 ' A' ' 40' ' ' LEU . 28.1 m120 -58.43 -32.51 68.76 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 121.223 0.535 . . . . 0.0 110.11 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.753 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -54.67 -61.79 2.08 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.24 179.542 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.831 HG11 HD11 ' A' ' 51' ' ' LEU . 4.4 t -50.05 -32.51 8.56 Favored 'Isoleucine or valine' 0 C--N 1.342 0.282 0 C-N-CA 120.329 -0.549 . . . . 0.0 110.926 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.533 HD13 ' HB3' ' A' ' 68' ' ' GLN . 22.6 mt -58.49 -44.73 89.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.839 0.352 . . . . 0.0 110.56 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.33 -49.39 77.79 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.228 0.537 . . . . 0.0 110.348 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.69 -31.79 72.0 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.156 178.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.608 HD22 ' CD2' ' A' ' 73' ' ' HIS . 10.2 mt -63.65 -25.82 68.39 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.706 179.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.527 ' HA ' ' HD3' ' A' ' 72' ' ' ARG . . . -59.34 -24.25 63.19 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.155 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -128.61 9.35 5.97 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.643 ' HG2' ' CH2' ' A' ' 7' ' ' TRP . 25.2 tptt -146.02 162.46 37.81 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 121.365 0.602 . . . . 0.0 111.878 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.515 HG23 HD23 ' A' ' 76' ' ' LEU . 95.2 m -138.92 110.47 7.89 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.072 177.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.912 ' HG2' HD11 ' A' ' 76' ' ' LEU . 87.2 Cg_endo -80.65 148.38 17.94 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 122.433 2.089 . . . . 0.0 111.735 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -74.46 -30.79 62.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.946 0.403 . . . . 0.0 110.966 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.859 HG13 HG23 ' A' ' 6' ' ' VAL . 6.7 p -149.84 94.12 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.554 -179.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.831 HD11 HG11 ' A' ' 39' ' ' VAL . 27.0 tp -86.79 141.02 29.14 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.627 -179.218 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.868 ' HG ' ' HB ' ' A' ' 79' ' ' ILE . 0.2 OUTLIER -122.01 114.77 21.41 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.193 179.951 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.651 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -107.71 143.58 36.02 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.405 0.621 . . . . 0.0 112.086 -179.599 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 30.2 p30 -83.06 -177.66 6.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.02 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.795 HG22 ' HG3' ' A' ' 81' ' ' MET . 3.5 tt -159.13 160.85 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.885 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.466 ' H ' HG13 ' A' ' 55' ' ' ILE . 0.1 OUTLIER 78.01 51.95 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.007 0.432 . . . . 0.0 110.499 -179.207 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.493 ' CB ' ' CD ' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -163.39 -65.24 0.01 OUTLIER Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.95 179.892 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.795 ' HG3' HD21 ' A' ' 65' ' ' LEU . 37.6 Cg_endo -65.44 -163.46 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.115 2.544 . . . . 0.0 112.933 -179.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -52.81 -89.89 0.01 OUTLIER Glycine 0 C--N 1.332 0.315 0 CA-C-N 115.974 -0.557 . . . . 0.0 113.0 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.913 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 2.6 tpp -72.52 57.38 0.39 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.774 0.321 . . . . 0.0 110.77 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.585 ' O ' ' HD2' ' A' ' 58' ' ' PRO . 0.1 OUTLIER 59.67 -74.34 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.067 179.948 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 60' ' ' MET . . . -152.65 -30.1 0.04 OUTLIER Glycine 0 C--N 1.321 -0.264 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.502 -179.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.638 ' H ' HD12 ' A' ' 63' ' ' LEU . 0.3 OUTLIER -66.14 -22.17 66.37 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.742 0.306 . . . . 0.0 110.874 179.912 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.913 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -54.95 -30.21 58.41 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.349 0.595 . . . . 0.0 109.923 179.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.795 HD21 ' HG3' ' A' ' 58' ' ' PRO . 2.7 mm? -66.07 -45.29 81.83 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.998 179.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.871 HD21 HD11 ' A' ' 80' ' ' ILE . 10.2 mt -51.81 -44.22 63.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.509 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.455 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 2.8 ttmm -55.14 -44.54 75.17 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.474 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.533 ' HB3' HD13 ' A' ' 40' ' ' LEU . 51.0 mm-40 -70.6 -43.91 68.38 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.191 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.476 HD13 HD23 ' A' ' 51' ' ' LEU . 56.2 mt -60.68 -36.2 69.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 121.057 0.456 . . . . 0.0 111.431 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.549 ' HB3' ' CD ' ' A' ' 96' ' ' GLN . 16.2 pttp -73.07 -27.0 61.47 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.285 -179.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -65.08 -39.07 92.67 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.237 0.541 . . . . 0.0 110.663 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.527 ' HD3' ' HA ' ' A' ' 44' ' ' ALA . 15.4 mtt-85 -94.42 -24.76 17.21 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.21 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.608 ' CD2' HD22 ' A' ' 43' ' ' LEU . 83.1 m-70 -140.47 101.59 6.7 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.138 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.403 ' O ' ' HG3' ' A' ' 75' ' ' MET . 88.7 Cg_endo -77.03 11.48 2.02 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.596 2.198 . . . . 0.0 113.702 -179.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.693 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 5.9 mtt -147.64 12.95 1.03 Allowed 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.912 HD11 ' HG2' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -76.24 110.53 11.49 Favored Pre-proline 0 N--CA 1.462 0.164 0 CA-C-O 120.583 0.23 . . . . 0.0 111.576 179.881 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.402 ' HD3' ' O ' ' A' ' 75' ' ' MET . 35.4 Cg_exo -62.57 128.22 22.89 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.478 2.119 . . . . 0.0 111.906 179.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.57 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 4.3 t -125.1 152.66 31.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.059 0.456 . . . . 0.0 111.48 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.868 ' HB ' ' HG ' ' A' ' 52' ' ' LEU . 1.9 mt -134.17 112.09 15.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.483 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.871 HD11 HD21 ' A' ' 66' ' ' LEU . 16.6 mm -94.83 138.03 21.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.383 -179.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.795 ' HG3' HG22 ' A' ' 55' ' ' ILE . 0.2 OUTLIER -68.43 -31.41 70.72 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -178.936 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.667 ' O ' HD13 ' A' ' 55' ' ' ILE . 91.4 m -146.83 153.93 40.76 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.607 0.241 . . . . 0.0 110.713 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.712 ' HB1' ' CD2' ' A' ' 87' ' ' LEU . . . -106.23 -33.1 7.92 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -179.219 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 45.88 -166.64 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.727 0.298 . . . . 0.0 111.52 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -80.32 79.51 6.89 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.725 -179.066 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.561 ' HB3' HD13 ' A' ' 63' ' ' LEU . 0.1 OUTLIER -179.22 28.61 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.831 179.197 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.712 ' CD2' ' HB1' ' A' ' 83' ' ' ALA . 0.5 OUTLIER -49.23 -20.8 0.67 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 112.088 -179.985 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -47.68 -54.94 10.59 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 -179.103 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.481 ' HB3' ' HB2' ' A' ' 63' ' ' LEU . . . -70.68 -21.49 62.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.851 0.358 . . . . 0.0 111.247 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.697 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -69.69 -41.95 74.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.654 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.64 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 3.4 t -62.07 -46.24 96.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.898 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.47 ' O ' ' HB3' ' A' ' 95' ' ' GLN . 38.5 m -65.14 -21.96 66.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.039 0.447 . . . . 0.0 109.834 179.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.796 ' HB2' HD13 ' A' ' 66' ' ' LEU . . . -66.0 -39.33 90.2 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.296 0.57 . . . . 0.0 109.687 179.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.64 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 8.9 m-85 -69.89 -22.7 63.21 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.639 178.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.47 ' HB3' ' O ' ' A' ' 92' ' ' SER . 0.3 OUTLIER -69.39 -44.31 71.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.906 179.555 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.693 ' O ' ' HA ' ' A' ' 75' ' ' MET . 2.3 pt20 -75.68 -17.95 59.79 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.668 179.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 125.24 16.87 2.8 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.368 -0.92 . . . . 0.0 113.939 178.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.57 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -55.47 151.23 10.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 117.413 0.607 . . . . 0.0 110.79 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.553 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 14.3 t80 -77.07 -53.55 7.66 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.269 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 169.92 -166.0 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.0 0.428 . . . . 0.0 111.656 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.663 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 3.4 m-85 -133.4 153.35 51.68 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.086 -179.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.581 ' CD1' HD22 ' A' ' 114' ' ' LEU . 1.0 OUTLIER -103.42 118.64 57.19 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.887 179.943 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -73.7 -72.94 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.089 1.859 . . . . 0.0 112.444 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.474 ' CB ' ' HD3' ' A' ' 105' ' ' PRO . 2.2 tttt -111.38 -57.98 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.663 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.474 ' HD3' ' CB ' ' A' ' 104' ' ' LYS . 51.8 Cg_exo -54.45 153.35 23.18 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.165 1.91 . . . . 0.0 112.524 -179.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.653 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 41.1 t80 -163.54 -113.15 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.431 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.573 ' O ' ' O ' ' A' ' 106' ' ' PHE . 3.1 p30 42.6 178.3 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 118.122 0.419 . . . . 0.0 111.591 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.896 HG12 HG12 ' A' ' 18' ' ' VAL . 0.8 OUTLIER -67.78 -43.1 86.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.113 0.482 . . . . 0.0 111.272 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.501 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 0.4 OUTLIER -49.04 -58.11 5.46 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.594 -179.548 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.653 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 36.5 mm-40 -76.98 -33.29 57.64 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.757 0.313 . . . . 0.0 111.371 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.428 ' CB ' ' O ' ' A' ' 107' ' ' ASP . . . -64.41 -59.13 4.72 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.116 179.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.688 ' O ' HG12 ' A' ' 115' ' ' VAL . 48.3 t -60.74 -32.0 50.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.514 179.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.501 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -62.51 -46.08 90.07 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.09 179.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.581 HD22 ' CD1' ' A' ' 102' ' ' LEU . 20.6 tp -76.09 -21.12 57.06 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.835 -1.075 . . . . 0.0 111.907 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.688 HG12 ' O ' ' A' ' 112' ' ' VAL . 3.7 p -78.92 -37.98 20.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.477 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.602 ' HA ' HD12 ' A' ' 119' ' ' ILE . 35.7 mt-10 -68.67 -38.73 80.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.966 0.413 . . . . 0.0 110.735 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.1 mmm180 -63.54 -27.52 69.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.091 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.553 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -69.42 -44.57 71.08 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.064 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.602 HD12 ' HA ' ' A' ' 116' ' ' GLU . 6.5 mt -62.81 -31.95 54.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.16 0.505 . . . . 0.0 110.699 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 9.1 t -75.13 -49.54 19.25 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.868 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 18.1 m80 . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.137 179.855 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.729 ' HB3' HD11 ' A' ' 5' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.272 0 CA-C-O 120.721 0.296 . . . . 0.0 111.594 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.515 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . 56.7 79.9 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.653 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.729 HD11 ' HB3' ' A' ' 3' ' ' ARG . 3.1 mp -116.71 112.18 38.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.697 0.285 . . . . 0.0 110.654 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.857 HG11 HD13 ' A' ' 23' ' ' LEU . 6.5 p -108.79 129.35 63.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.826 0.346 . . . . 0.0 110.929 179.242 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.859 ' CD1' HG22 ' A' ' 31' ' ' THR . 33.5 m0 -116.27 139.27 50.56 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.391 179.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.726 HG13 ' HB3' ' A' ' 52' ' ' LEU . 0.4 OUTLIER -122.59 146.96 27.02 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.303 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.51 -178.352 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.928 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -129.12 109.33 18.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 120.92 0.391 . . . . 0.0 110.973 179.368 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.439 ' OD1' ' HB3' ' A' ' 54' ' ' ASP . 6.5 t0 -162.16 -158.19 0.51 Allowed 'General case' 0 CA--C 1.53 0.212 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.693 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -66.37 -2.73 4.81 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -179.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.6 t0 66.87 -144.31 0.15 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 121.296 -0.162 . . . . 0.0 110.628 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.465 ' OG ' ' N ' ' A' ' 14' ' ' SER . 53.1 p 33.48 -101.83 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 179.262 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.784 ' O ' HG23 ' A' ' 18' ' ' VAL . 1.5 m -54.4 -49.5 69.77 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.675 0.274 . . . . 0.0 111.312 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.9 mm -62.97 -24.6 36.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.929 0.395 . . . . 0.0 111.11 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.867 ' HA ' HG21 ' A' ' 32' ' ' THR . 25.2 ttt180 -74.71 -55.09 6.23 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.022 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.452 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 14.6 t90 -56.3 -42.46 77.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.881 -0.6 . . . . 0.0 112.444 -178.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.784 HG23 ' O ' ' A' ' 14' ' ' SER . 5.3 t -66.53 -45.3 89.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -178.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.645 HD13 HD11 ' A' ' 108' ' ' ILE . 1.2 mp -83.77 -25.24 30.65 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -178.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.541 ' HG3' ' N ' ' A' ' 21' ' ' ARG . 14.8 pt-20 -66.58 -58.87 4.29 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.422 -0.511 . . . . 0.0 111.546 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.541 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -65.76 -51.23 60.88 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.121 -179.073 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.25 -45.27 80.1 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -178.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.857 HD13 HG11 ' A' ' 6' ' ' VAL . 0.4 OUTLIER -74.88 -25.25 58.82 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.95 0.405 . . . . 0.0 110.63 179.688 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.87 -34.22 75.08 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 177.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.69 -23.49 68.98 Favored Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 178.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.462 ' HB3' HD12 ' A' ' 28' ' ' LEU . . . -77.67 -15.73 58.98 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 120.805 0.336 . . . . 0.0 110.6 179.115 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.52 25.08 11.22 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.832 -0.699 . . . . 0.0 113.982 178.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.843 HD13 ' CD2' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -132.07 165.18 24.59 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 117.811 0.805 . . . . 0.0 112.562 179.694 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 29.5 m -87.67 108.86 19.29 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.004 -179.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.622 ' HA ' HG13 ' A' ' 6' ' ' VAL . 42.2 t -106.63 111.71 24.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.031 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.859 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.4 t -118.04 154.99 31.11 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.04 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.867 HG21 ' HA ' ' A' ' 16' ' ' ARG . 38.5 p -124.37 164.51 19.51 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.123 0.487 . . . . 0.0 111.879 -179.129 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.928 ' HB2' HG13 ' A' ' 9' ' ' VAL . 2.3 m-85 -130.19 172.31 11.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.592 -178.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.68 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 3.0 pp20? -63.53 -44.87 92.98 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -177.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.458 ' C ' HG12 ' A' ' 9' ' ' VAL . 1.4 t30 -160.78 -58.2 0.05 Allowed 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -179.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.73 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . -164.99 -43.47 0.02 OUTLIER Glycine 0 C--N 1.319 -0.382 0 C-N-CA 120.371 -0.919 . . . . 0.0 113.431 -179.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.616 HD22 HD12 ' A' ' 40' ' ' LEU . 11.2 m120 -67.4 -26.87 66.65 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -178.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.732 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 12.2 tt0 -58.92 -50.51 73.77 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.744 -0.382 . . . . 0.0 111.411 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.766 HG22 ' CG ' ' A' ' 33' ' ' PHE . 10.1 t -61.15 -35.46 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 C-N-CA 120.122 -0.631 . . . . 0.0 111.236 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.622 HD13 ' HB3' ' A' ' 68' ' ' GLN . 31.0 mt -56.94 -41.11 77.66 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.027 0.442 . . . . 0.0 110.728 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -77.53 -47.53 19.29 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.025 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.425 ' HB3' ' HE2' ' A' ' 33' ' ' PHE . . . -61.71 -36.38 80.77 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.069 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.6 HD21 ' HD2' ' A' ' 48' ' ' PRO . 16.0 mt -63.34 -22.98 67.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.031 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.17 -19.61 14.29 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.677 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -124.21 2.59 8.54 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.538 ' O ' HD23 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -162.41 155.26 19.78 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.801 0.334 . . . . 0.0 110.862 179.965 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.615 HG23 ' CD2' ' A' ' 76' ' ' LEU . 98.6 m -138.97 112.84 8.23 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.573 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.6 ' HD2' HD21 ' A' ' 43' ' ' LEU . 72.4 Cg_endo -79.1 161.82 26.26 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.085 1.857 . . . . 0.0 111.436 178.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -73.98 -22.57 59.57 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.701 0.286 . . . . 0.0 111.294 -179.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.81 HG13 HG23 ' A' ' 6' ' ' VAL . 7.1 p -144.97 161.34 13.7 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.231 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.622 HD12 ' O ' ' A' ' 7' ' ' TRP . 22.6 tp -152.87 133.19 13.59 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.164 0.507 . . . . 0.0 111.913 -178.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.726 ' HB3' HG13 ' A' ' 8' ' ' VAL . 0.5 OUTLIER -111.86 115.54 29.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.265 179.983 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.58 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 2.1 m -110.98 138.57 47.22 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.124 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.439 ' HB3' ' OD1' ' A' ' 10' ' ' ASP . 15.4 p-10 -83.03 179.68 7.69 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.781 179.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.678 HG13 ' O ' ' A' ' 61' ' ' ASP . 1.0 OUTLIER -154.06 96.85 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.153 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -138.96 40.17 2.14 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.797 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.471 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER 67.52 47.29 0.41 Allowed Pre-proline 0 CA--C 1.533 0.304 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 179.018 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.507 ' HD2' ' N ' ' A' ' 62' ' ' GLY . 37.5 Cg_endo -69.27 -76.45 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.309 2.006 . . . . 0.0 111.86 178.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -112.39 -25.25 4.74 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 121.069 -0.586 . . . . 0.0 111.928 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.9 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 1.0 OUTLIER -159.62 68.02 0.4 Allowed 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.261 0.553 . . . . 0.0 109.991 179.517 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.678 ' O ' HG13 ' A' ' 55' ' ' ILE . 0.1 OUTLIER 69.9 -29.21 0.18 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.862 -179.719 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.507 ' N ' ' HD2' ' A' ' 58' ' ' PRO . . . 142.58 -29.25 2.14 Favored Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.692 ' H ' HD12 ' A' ' 63' ' ' LEU . 1.1 mp -70.24 -19.17 63.15 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 178.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.9 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -53.59 -32.18 49.93 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.532 179.068 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.635 HD11 ' HA2' ' A' ' 36' ' ' GLY . 1.1 tt -57.79 -46.14 85.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.315 179.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.804 HD21 HD11 ' A' ' 80' ' ' ILE . 6.5 mt -57.82 -44.68 86.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.948 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.411 ' O ' ' CG ' ' A' ' 70' ' ' LYS . 20.8 ttmt -52.76 -53.23 51.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.371 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.622 ' HB3' HD13 ' A' ' 40' ' ' LEU . 86.5 mm-40 -59.64 -34.6 73.01 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.923 0.392 . . . . 0.0 111.483 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.627 HG23 ' HD2' ' A' ' 73' ' ' HIS . 86.5 mt -61.57 -33.36 56.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.773 -178.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.548 ' HB3' ' CB ' ' A' ' 96' ' ' GLN . 0.2 OUTLIER -78.01 -29.44 49.55 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.999 0.428 . . . . 0.0 111.718 179.932 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.468 ' NE2' ' HA ' ' A' ' 68' ' ' GLN . 2.6 mt-30 -65.63 -48.23 72.91 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.152 -178.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.3 mtp85 -93.38 -55.94 3.11 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.97 -178.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.627 ' HD2' HG23 ' A' ' 69' ' ' ILE . 1.6 m-70 -84.25 152.82 62.04 Favored Pre-proline 0 C--N 1.319 -0.76 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.543 -178.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -69.85 -76.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.618 2.212 . . . . 0.0 112.882 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.664 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 6.6 mtm -138.71 53.49 1.77 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.185 0.517 . . . . 0.0 111.338 -179.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.615 ' CD2' HG23 ' A' ' 47' ' ' THR . 0.2 OUTLIER -63.7 112.23 6.84 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.081 179.576 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.574 ' HG2' ' HA ' ' A' ' 50' ' ' VAL . 17.3 Cg_endo -57.19 122.73 12.32 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.188 1.925 . . . . 0.0 111.377 179.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.5 HG21 HD13 ' A' ' 69' ' ' ILE . 3.9 t -119.54 152.03 22.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.167 0.508 . . . . 0.0 111.894 -178.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.653 ' O ' HD23 ' A' ' 52' ' ' LEU . 3.3 mt -131.6 113.74 23.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.363 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.804 HD11 HD21 ' A' ' 66' ' ' LEU . 2.4 mp -96.26 132.48 40.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.952 0.406 . . . . 0.0 110.829 -179.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.518 ' HB2' ' CE1' ' A' ' 106' ' ' PHE . 3.7 ptp -70.2 -24.65 63.15 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -177.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.43 ' H ' HG21 ' A' ' 55' ' ' ILE . 12.0 m -146.96 160.16 42.69 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.974 0.416 . . . . 0.0 111.753 -179.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.827 ' HB1' HD21 ' A' ' 87' ' ' LEU . . . -142.32 57.84 1.46 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.56 -179.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.556 ' H ' ' CD2' ' A' ' 84' ' ' HIS . 0.1 OUTLIER -75.34 -95.73 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.364 -179.896 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 6.9 t -89.87 173.01 8.47 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-O 121.109 0.48 . . . . 0.0 111.914 -179.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.42 ' CB ' HD13 ' A' ' 63' ' ' LEU . 8.0 m-20 58.01 17.77 4.64 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.653 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.827 HD21 ' HB1' ' A' ' 83' ' ' ALA . 1.9 mt -48.8 -24.12 1.31 Allowed 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -48.01 -45.64 32.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.8 0.333 . . . . 0.0 111.062 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.547 ' HB3' ' HB2' ' A' ' 63' ' ' LEU . . . -65.99 -20.27 66.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.426 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.608 ' HB2' HD23 ' A' ' 63' ' ' LEU . . . -63.25 -44.86 93.97 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.845 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.566 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 5.6 t -59.41 -46.24 92.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.307 -179.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 98.4 p -62.87 -20.09 64.78 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.232 179.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.685 ' HB1' HD22 ' A' ' 66' ' ' LEU . . . -65.05 -44.49 88.85 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 121.147 0.499 . . . . 0.0 110.367 179.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.566 ' CE2' ' HA ' ' A' ' 91' ' ' VAL . 8.5 m-85 -61.82 -25.13 67.32 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.696 178.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -76.55 -38.81 54.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.324 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.674 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 1.6 pp0? -78.85 -18.22 54.36 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.42 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 125.92 1.92 7.37 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 120.444 -0.884 . . . . 0.0 113.663 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.603 ' CB ' ' HB1' ' A' ' 93' ' ' ALA . . . -53.43 151.59 5.48 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 117.419 0.61 . . . . 0.0 110.699 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.575 ' CE2' ' HB2' ' A' ' 118' ' ' ALA . 11.4 t80 -79.63 -53.9 6.4 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 121.018 -0.273 . . . . 0.0 111.303 -179.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 175.04 -166.95 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.036 0.446 . . . . 0.0 111.594 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.818 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 3.0 m-85 -133.95 153.53 51.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.034 -178.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.614 ' CD1' HD22 ' A' ' 114' ' ' LEU . 1.8 mp -103.62 118.83 56.54 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.197 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 102' ' ' LEU . 8.0 Cg_exo -70.63 -68.43 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.436 2.091 . . . . 0.0 111.97 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.731 ' H ' ' HD2' ' A' ' 105' ' ' PRO . 0.5 OUTLIER -117.92 -59.24 0.03 OUTLIER Pre-proline 0 CA--C 1.531 0.239 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -179.858 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.731 ' HD2' ' H ' ' A' ' 104' ' ' LYS . 13.0 Cg_endo -55.42 157.57 14.5 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.113 1.875 . . . . 0.0 112.44 -179.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.571 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 22.4 t80 -165.6 -111.01 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.434 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.548 ' O ' ' O ' ' A' ' 106' ' ' PHE . 3.0 p30 43.74 178.74 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.907 0.384 . . . . 0.0 111.257 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.71 HG12 HG12 ' A' ' 18' ' ' VAL . 0.9 OUTLIER -68.02 -42.88 85.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.979 0.418 . . . . 0.0 111.575 -179.643 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.492 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 78.8 m-20 -49.26 -58.35 5.2 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.413 -179.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.571 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 62.9 mm-40 -76.4 -32.26 58.43 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.678 0.275 . . . . 0.0 111.43 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.401 ' CB ' ' O ' ' A' ' 107' ' ' ASP . . . -64.92 -60.8 2.65 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.001 0.429 . . . . 0.0 109.946 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.608 ' O ' HG12 ' A' ' 115' ' ' VAL . 48.3 t -59.46 -31.27 46.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.413 0.625 . . . . 0.0 110.537 178.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.492 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -63.23 -45.07 93.35 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.01 179.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.658 HD12 ' HD2' ' A' ' 117' ' ' ARG . 55.7 tp -76.28 -23.44 54.41 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.703 -1.135 . . . . 0.0 111.782 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.608 HG12 ' O ' ' A' ' 112' ' ' VAL . 4.0 p -79.2 -41.25 22.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.801 0.334 . . . . 0.0 111.548 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.475 ' HA ' HD12 ' A' ' 119' ' ' ILE . 95.1 mt-10 -65.33 -44.48 87.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.181 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.658 ' HD2' HD12 ' A' ' 114' ' ' LEU . 6.5 ptp180 -62.29 -25.42 67.84 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.933 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.575 ' HB2' ' CE2' ' A' ' 99' ' ' PHE . . . -71.28 -44.56 64.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.088 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.489 HD11 HG11 ' A' ' 50' ' ' VAL . 4.8 mt -68.6 -30.8 48.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.252 0.548 . . . . 0.0 110.688 179.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 21.7 t -71.24 -45.03 64.16 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.212 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 30.1 m80 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.024 -179.753 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.53 0.188 0 N-CA-C 111.561 0.208 . . . . 0.0 111.561 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 84.4 86.33 0.9 Allowed Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.833 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.469 ' HB ' ' HA ' ' A' ' 48' ' ' PRO . 3.6 mp -110.56 112.75 41.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.102 0.477 . . . . 0.0 111.245 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.687 HG23 HG13 ' A' ' 50' ' ' VAL . 5.6 p -108.82 120.96 61.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.913 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.885 ' CD1' HG22 ' A' ' 31' ' ' THR . 31.4 m0 -112.32 141.74 45.67 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.117 0.484 . . . . 0.0 111.484 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.808 ' HB ' HG22 ' A' ' 32' ' ' THR . 1.6 t -128.3 143.01 42.31 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.306 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.975 -178.261 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.871 HG11 ' HA2' ' A' ' 36' ' ' GLY . 0.0 OUTLIER -120.95 110.69 28.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.456 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.548 ' HA ' ' HB3' ' A' ' 54' ' ' ASP . 4.5 p30 -161.3 -160.75 0.75 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.904 0.383 . . . . 0.0 111.67 -178.463 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -66.23 -3.28 5.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.681 -179.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 65.31 -155.91 0.28 Allowed 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 120.511 0.196 . . . . 0.0 110.927 179.439 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.444 ' OG ' ' N ' ' A' ' 14' ' ' SER . 64.0 p 33.56 -96.89 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 179.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.909 ' O ' HG23 ' A' ' 18' ' ' VAL . 40.4 t -52.93 -57.41 10.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.535 -179.516 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.4 mm -64.61 -26.36 40.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.937 0.398 . . . . 0.0 111.182 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.694 ' HA ' HG21 ' A' ' 32' ' ' THR . 9.8 ttt180 -73.43 -49.29 27.7 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.447 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.427 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 87.0 t90 -63.4 -39.83 95.57 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -179.087 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.909 HG23 ' O ' ' A' ' 14' ' ' SER . 3.2 t -67.03 -42.87 89.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 112.133 0.419 . . . . 0.0 112.133 -178.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.752 ' CD1' HD12 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -84.12 -30.52 25.87 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -178.696 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.553 ' HG3' ' N ' ' A' ' 21' ' ' ARG . 17.2 pt-20 -64.09 -60.03 3.73 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -178.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.553 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 5.5 mmm180 -53.76 -52.59 59.72 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -178.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.17 -29.23 70.21 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -178.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.88 ' CD2' HD13 ' A' ' 28' ' ' LEU . 0.4 OUTLIER -85.32 -29.88 24.16 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.146 0.498 . . . . 0.0 110.088 179.175 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.38 -32.06 73.5 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 177.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.55 -25.16 72.7 Favored Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 177.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.622 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -77.11 -15.18 59.65 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.572 -0.314 . . . . 0.0 110.588 179.007 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.96 26.48 14.49 Favored Glycine 0 C--N 1.336 0.577 0 C-N-CA 120.959 -0.639 . . . . 0.0 114.28 178.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.88 HD13 ' CD2' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -127.25 161.28 28.94 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 117.889 0.845 . . . . 0.0 112.874 -179.303 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 99.4 m -75.98 116.85 17.1 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.973 179.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 2.0 p -111.18 109.31 19.3 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -178.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.885 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.8 t -130.21 138.23 50.46 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 178.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.808 HG22 ' HB ' ' A' ' 8' ' ' VAL . 81.5 p -115.32 160.59 19.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.498 0.666 . . . . 0.0 112.652 -178.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.874 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 1.4 m-85 -135.84 173.87 11.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.179 -179.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.698 ' HG2' ' HG3' ' A' ' 38' ' ' GLU . 0.1 OUTLIER -62.27 -105.45 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.939 -179.028 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.423 ' H ' ' CG ' ' A' ' 34' ' ' GLU . 14.2 m120 -86.45 -71.7 0.53 Allowed 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.319 0.581 . . . . 0.0 111.257 -179.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.871 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . -159.76 -40.71 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.222 -0.899 . . . . 0.0 112.548 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.696 ' HA ' HD12 ' A' ' 40' ' ' LEU . 7.4 m120 -52.46 -30.08 27.97 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.726 0.298 . . . . 0.0 111.173 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.874 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -58.79 -58.0 10.52 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.417 179.526 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.778 HG23 HG13 ' A' ' 9' ' ' VAL . 6.0 t -54.58 -43.49 65.05 Favored 'Isoleucine or valine' 0 C--N 1.341 0.207 0 C-N-CA 120.24 -0.584 . . . . 0.0 111.295 -179.385 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.716 HD13 ' HB3' ' A' ' 68' ' ' GLN . 7.6 mt -53.37 -49.01 68.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.975 0.417 . . . . 0.0 110.564 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.73 -49.89 73.84 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.98 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.77 -28.05 67.28 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.838 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.847 HD13 ' NE2' ' A' ' 73' ' ' HIS . 5.9 mt -69.77 -26.11 64.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.631 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.22 -20.15 10.04 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.562 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 29.6 t -125.61 -0.27 7.47 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -154.3 155.66 35.56 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 120.761 0.315 . . . . 0.0 110.589 179.893 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.431 HG23 HD13 ' A' ' 76' ' ' LEU . 53.2 m -138.54 112.39 8.46 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.011 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.838 ' O ' HD11 ' A' ' 76' ' ' LEU . 59.2 Cg_endo -77.98 161.77 29.62 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.031 1.82 . . . . 0.0 111.511 179.333 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -73.72 -23.76 59.82 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.175 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.687 HG13 HG23 ' A' ' 6' ' ' VAL . 7.8 p -145.35 167.32 9.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.914 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.67 HD11 HG11 ' A' ' 39' ' ' VAL . 11.3 tp -152.84 131.01 11.94 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.003 0.43 . . . . 0.0 111.833 -179.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.666 ' O ' HG23 ' A' ' 9' ' ' VAL . 0.4 OUTLIER -113.84 128.21 56.31 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.243 179.695 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.2 m -105.69 134.23 49.15 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.835 0.35 . . . . 0.0 111.262 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.587 ' O ' HG22 ' A' ' 55' ' ' ILE . 16.5 p-10 -72.75 -29.79 63.61 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.683 -179.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 1.022 HG12 ' HA3' ' A' ' 62' ' ' GLY . 0.0 OUTLIER 49.08 97.22 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.549 179.572 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 39.8 tpt85 -157.36 57.16 0.51 Allowed 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.452 ' N ' ' CD ' ' A' ' 58' ' ' PRO . 0.0 OUTLIER 61.21 46.59 1.08 Allowed Pre-proline 0 N--CA 1.47 0.54 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 178.476 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.628 ' CD ' ' HA2' ' A' ' 62' ' ' GLY . 39.0 Cg_endo -70.37 -75.46 0.01 OUTLIER 'Trans proline' 0 CA--C 1.53 0.301 0 C-N-CA 122.458 2.105 . . . . 0.0 111.522 178.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -119.19 -21.23 3.8 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.216 -0.516 . . . . 0.0 112.101 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.979 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -159.95 67.78 0.38 Allowed 'General case' 0 C--O 1.236 0.393 0 CA-C-O 120.981 0.419 . . . . 0.0 110.177 179.748 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 72.93 -30.9 0.22 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.309 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 1.022 ' HA3' HG12 ' A' ' 55' ' ' ILE . . . 140.74 -24.2 2.61 Favored Glycine 0 CA--C 1.503 -0.679 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -179.124 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.828 HD23 ' HB2' ' A' ' 90' ' ' ALA . 3.1 mp -74.34 -23.67 59.07 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.979 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -53.96 -30.01 45.11 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.3 178.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.655 HD22 ' HA3' ' A' ' 36' ' ' GLY . 10.4 mt -58.48 -40.47 82.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.198 179.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.736 HD23 HG11 ' A' ' 78' ' ' VAL . 28.5 mt -63.51 -42.11 98.49 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.319 179.492 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.755 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 15.9 mttm -52.89 -42.2 65.07 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.152 179.088 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.716 ' HB3' HD13 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -71.54 -44.99 63.59 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.911 179.777 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.685 HD12 ' HA ' ' A' ' 66' ' ' LEU . 21.8 mt -56.1 -37.35 48.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.197 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.755 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -74.85 -28.17 60.57 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.892 179.885 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.56 -31.78 67.38 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.401 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.5 mtt-85 -91.73 -64.46 1.11 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.331 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.847 ' NE2' HD13 ' A' ' 43' ' ' LEU . 0.4 OUTLIER -125.06 76.22 67.34 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.996 179.718 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.419 ' HB3' ' O ' ' A' ' 70' ' ' LYS . 51.2 Cg_endo -69.59 60.82 1.62 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.528 2.152 . . . . 0.0 112.422 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 33.1 mtt -157.28 -35.45 0.08 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.534 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.838 HD11 ' O ' ' A' ' 48' ' ' PRO . 0.6 OUTLIER -61.52 145.98 90.43 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.877 -179.44 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.607 ' HD2' ' HG ' ' A' ' 76' ' ' LEU . 94.9 Cg_endo -82.88 115.43 2.4 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.739 2.292 . . . . 0.0 112.697 179.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.736 HG11 HD23 ' A' ' 66' ' ' LEU . 3.2 t -98.92 139.16 21.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.685 179.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.732 ' CG2' HD23 ' A' ' 114' ' ' LEU . 2.0 mp -122.15 112.13 33.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.698 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.752 HD13 ' CE1' ' A' ' 101' ' ' TYR . 2.2 mp -98.32 134.6 36.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.135 0.493 . . . . 0.0 111.279 -179.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.58 ' HA ' ' HB2' ' A' ' 102' ' ' LEU . 4.7 ptm -87.23 -9.13 55.89 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -178.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.875 ' HB ' HD12 ' A' ' 55' ' ' ILE . 19.0 m -149.02 136.78 20.51 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.642 0.258 . . . . 0.0 111.566 -179.197 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.694 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -123.0 82.27 1.97 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.834 0.35 . . . . 0.0 111.275 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -67.34 -166.32 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.574 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.35 80.53 6.78 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.022 0.439 . . . . 0.0 111.91 -179.06 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.68 ' HB3' HD13 ' A' ' 63' ' ' LEU . 27.0 t0 -178.15 28.38 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.945 179.2 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.869 HD13 ' HB3' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -44.99 -23.1 0.12 Allowed 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -179.687 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -47.94 -44.04 29.76 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.514 ' HB3' ' HB2' ' A' ' 63' ' ' LEU . . . -73.38 -22.23 60.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.674 0.273 . . . . 0.0 111.595 -179.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.869 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -68.88 -39.66 79.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.972 0.415 . . . . 0.0 110.169 179.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.645 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 2.4 t -54.15 -39.93 44.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.207 -179.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.544 ' O ' ' HG3' ' A' ' 95' ' ' GLN . 85.5 p -63.09 -19.74 64.71 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.257 0.551 . . . . 0.0 109.745 178.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.771 ' O ' ' HG3' ' A' ' 96' ' ' GLN . . . -75.9 -55.43 5.62 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.204 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.645 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 4.4 m-85 -56.82 -33.61 66.91 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.921 -179.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.544 ' HG3' ' O ' ' A' ' 92' ' ' SER . 2.1 pp0? -75.46 -28.94 59.47 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.863 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.771 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 0.7 OUTLIER -87.03 -9.1 56.35 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 116.695 -0.23 . . . . 0.0 110.888 178.9 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 121.58 6.7 8.56 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 120.407 -0.902 . . . . 0.0 113.774 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.744 ' HB2' ' HB1' ' A' ' 93' ' ' ALA . . . -55.3 157.38 3.67 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 117.213 0.507 . . . . 0.0 111.466 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.471 ' CZ ' ' HA ' ' A' ' 118' ' ' ALA . 5.2 t80 -86.25 -53.89 4.77 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.584 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 170.19 -162.43 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.876 0.37 . . . . 0.0 111.867 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.752 ' CE1' HD13 ' A' ' 80' ' ' ILE . 2.2 m-85 -134.61 153.26 52.05 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.567 -178.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.62 ' CD1' HD22 ' A' ' 114' ' ' LEU . 1.0 OUTLIER -102.65 119.52 55.64 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.168 -179.905 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -65.18 -70.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.474 2.116 . . . . 0.0 112.553 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.682 ' H ' ' HD2' ' A' ' 105' ' ' PRO . 0.5 OUTLIER -123.63 -62.1 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.908 -179.611 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.682 ' HD2' ' H ' ' A' ' 104' ' ' LYS . 9.2 Cg_endo -50.12 163.56 0.57 Allowed 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.314 2.009 . . . . 0.0 112.367 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.594 ' O ' ' O ' ' A' ' 107' ' ' ASP . 58.9 t80 -171.71 -102.44 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.257 179.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.594 ' O ' ' O ' ' A' ' 106' ' ' PHE . 3.4 p30 43.14 178.39 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 117.792 0.269 . . . . 0.0 110.865 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.539 HD11 HD23 ' A' ' 19' ' ' LEU . 0.9 OUTLIER -67.91 -43.1 86.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 120.432 -0.507 . . . . 0.0 111.792 -179.738 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.485 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 32.7 t70 -49.62 -58.65 4.84 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.913 -179.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.589 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 3.7 mm-40 -74.81 -30.37 61.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.635 0.255 . . . . 0.0 111.6 -179.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -68.61 -62.53 1.35 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.279 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.546 ' HA ' HG12 ' A' ' 115' ' ' VAL . 49.0 t -55.96 -31.35 30.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.559 0.695 . . . . 0.0 110.163 178.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.485 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -64.38 -46.68 82.29 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.327 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.732 HD23 ' CG2' ' A' ' 79' ' ' ILE . 19.6 tp -76.96 -21.2 55.12 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.996 -179.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.546 HG12 ' HA ' ' A' ' 112' ' ' VAL . 4.7 p -79.4 -47.98 21.62 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 C-N-CA 120.401 -0.519 . . . . 0.0 111.715 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.415 ' N ' HG13 ' A' ' 115' ' ' VAL . 79.3 mt-10 -64.38 -41.89 96.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.871 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.451 ' HG2' ' O ' ' A' ' 113' ' ' ALA . 20.1 mmm180 -61.77 -23.71 66.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.768 179.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.471 ' HA ' ' CZ ' ' A' ' 99' ' ' PHE . . . -72.02 -49.34 37.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.941 179.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.447 HD11 HG11 ' A' ' 50' ' ' VAL . 3.9 mt -71.11 -31.66 45.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.16 0.505 . . . . 0.0 110.696 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.91 -48.63 52.59 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.122 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.297 -179.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.684 ' CG ' HD11 ' A' ' 5' ' ' ILE . 2.9 ptm180 . . . . . 0 N--CA 1.468 0.462 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.667 ' C ' HD13 ' A' ' 5' ' ' ILE . . . 104.24 91.14 2.2 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.616 179.001 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.684 HD11 ' CG ' ' A' ' 3' ' ' ARG . 5.9 mm -118.73 112.23 37.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.908 0.385 . . . . 0.0 111.188 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.997 HG11 HD13 ' A' ' 23' ' ' LEU . 4.4 p -114.98 117.17 54.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.428 179.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.849 ' CD1' HG22 ' A' ' 31' ' ' THR . 25.7 m0 -107.31 133.89 51.19 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.031 0.443 . . . . 0.0 110.442 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.854 HG21 HD23 ' A' ' 19' ' ' LEU . 1.8 t -122.01 148.8 25.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.382 -177.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.792 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -126.16 112.0 28.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.991 178.037 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.469 ' OD2' HG21 ' A' ' 15' ' ' ILE . 8.7 t0 -161.42 -161.79 0.83 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.648 -178.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -66.36 -2.22 4.27 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -179.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 68.77 -153.23 0.16 Allowed 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 120.566 0.222 . . . . 0.0 110.711 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.462 ' OG ' ' N ' ' A' ' 14' ' ' SER . 62.5 p 33.66 -97.87 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 179.301 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.786 ' O ' HG23 ' A' ' 18' ' ' VAL . 0.3 OUTLIER -52.85 -52.1 58.5 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 111.608 0.225 . . . . 0.0 111.608 -179.417 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.469 HG21 ' OD2' ' A' ' 10' ' ' ASP . 20.1 mm -64.24 -30.56 50.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.866 0.365 . . . . 0.0 111.215 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.686 ' HA ' HG21 ' A' ' 32' ' ' THR . 47.3 ttp180 -72.83 -41.77 64.49 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.961 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.566 ' O ' ' HD2' ' A' ' 21' ' ' ARG . 57.3 t90 -65.11 -53.51 44.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.999 -179.229 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.786 HG23 ' O ' ' A' ' 14' ' ' SER . 2.1 t -60.24 -43.16 92.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -178.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.854 HD23 HG21 ' A' ' 8' ' ' VAL . 12.0 tp -82.44 -27.64 31.8 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -177.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.646 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 12.2 pt-20 -67.1 -62.3 1.5 Allowed 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 119.917 -0.713 . . . . 0.0 112.062 -178.461 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.733 ' HD2' ' H ' ' A' ' 21' ' ' ARG . 1.3 mpt_? -54.83 -49.16 71.73 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -179.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.87 -60.11 3.68 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.52 -179.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 1.057 HD22 HD13 ' A' ' 28' ' ' LEU . 2.6 mt -64.82 -27.36 68.83 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.081 0.467 . . . . 0.0 109.78 179.317 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.34 -34.92 79.26 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.78 -25.34 71.76 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.302 -0.952 . . . . 0.0 111.225 178.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.735 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -76.8 -15.42 59.74 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 120.681 0.277 . . . . 0.0 111.076 179.426 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.81 26.4 8.53 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.547 -0.835 . . . . 0.0 114.023 178.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 1.057 HD13 HD22 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -125.83 172.45 9.85 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 117.73 0.765 . . . . 0.0 112.158 -179.632 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.5 m -99.01 105.77 17.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.193 179.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.685 ' HA ' HG13 ' A' ' 6' ' ' VAL . 11.4 t -100.86 111.31 23.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.066 -179.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.849 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.9 t -120.18 156.52 30.94 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.686 HG21 ' HA ' ' A' ' 16' ' ' ARG . 64.3 p -129.97 161.83 30.04 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.278 0.561 . . . . 0.0 112.04 -179.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.792 ' HB2' HG13 ' A' ' 9' ' ' VAL . 3.8 m-85 -129.42 173.99 10.04 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.572 -178.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.719 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 2.3 pp20? -60.04 -51.59 68.98 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -177.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.502 ' OD1' ' HB3' ' A' ' 58' ' ' PRO . 0.7 OUTLIER -150.59 -71.74 0.17 Allowed 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -178.454 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.615 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . -153.39 -42.41 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.4 -0.905 . . . . 0.0 113.709 -178.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.405 ' HA ' ' HG ' ' A' ' 40' ' ' LEU . 0.5 OUTLIER -67.59 -30.77 70.46 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-O 120.852 0.358 . . . . 0.0 111.361 -178.956 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.767 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -51.87 -59.85 3.85 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.751 179.86 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.785 HG21 HG22 ' A' ' 9' ' ' VAL . 0.8 OUTLIER -55.4 -41.51 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 C-N-CA 119.804 -0.759 . . . . 0.0 110.083 -179.637 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.694 HD13 ' CB ' ' A' ' 68' ' ' GLN . 6.7 mt -53.32 -41.56 65.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.308 0.575 . . . . 0.0 109.845 179.078 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.48 -48.15 76.3 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.711 179.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.95 -26.75 63.31 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.894 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.952 HD13 ' CE1' ' A' ' 73' ' ' HIS . 1.1 mt -69.94 -22.46 63.18 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.564 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.48 -22.12 11.9 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.981 0.419 . . . . 0.0 110.847 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -130.48 2.45 4.58 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.612 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.68 ' HG2' ' CH2' ' A' ' 7' ' ' TRP . 1.3 tptp -138.05 161.48 36.63 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 121.523 0.678 . . . . 0.0 111.962 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.499 ' H ' ' HG3' ' A' ' 46' ' ' LYS . 51.1 m -139.38 111.25 7.7 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.674 178.06 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.797 ' HG2' HD21 ' A' ' 76' ' ' LEU . 73.2 Cg_endo -80.84 153.31 19.61 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.301 2.001 . . . . 0.0 111.305 179.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -74.44 -30.93 62.09 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.057 -179.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.868 HG13 HG23 ' A' ' 6' ' ' VAL . 9.0 p -150.95 103.71 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-O 120.892 0.377 . . . . 0.0 111.534 -179.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.703 HD11 HG11 ' A' ' 39' ' ' VAL . 11.1 tp -87.63 131.23 34.5 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -179.14 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.731 ' HB3' HG13 ' A' ' 8' ' ' VAL . 0.4 OUTLIER -115.17 127.42 55.54 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.446 179.524 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.699 ' OG ' HD23 ' A' ' 65' ' ' LEU . 0.6 OUTLIER -108.48 136.55 47.92 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 120.846 0.355 . . . . 0.0 110.972 179.969 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.424 ' O ' ' CG2' ' A' ' 55' ' ' ILE . 25.5 p-10 -79.54 -21.33 45.32 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -178.385 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.604 HG21 HG22 ' A' ' 80' ' ' ILE . 0.7 OUTLIER 44.81 86.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -179.666 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.408 ' O ' ' HG3' ' A' ' 56' ' ' ARG . 4.9 ptt85 -147.83 56.54 1.08 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 120.925 0.393 . . . . 0.0 111.832 179.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.475 ' N ' ' HD3' ' A' ' 58' ' ' PRO . 6.0 ttt 62.55 50.26 1.43 Allowed Pre-proline 0 N--CA 1.465 0.315 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 178.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.592 ' HD2' ' N ' ' A' ' 62' ' ' GLY . 45.2 Cg_endo -77.09 -77.01 0.01 OUTLIER 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 122.421 2.081 . . . . 0.0 111.749 178.397 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -118.04 -21.15 4.25 Favored Glycine 0 C--N 1.332 0.359 0 N-CA-C 111.798 -0.521 . . . . 0.0 111.798 179.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.993 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 5.1 ttt -161.3 67.61 0.3 Allowed 'General case' 0 C--O 1.236 0.351 0 CA-C-O 120.978 0.418 . . . . 0.0 110.415 179.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.419 ' OD1' ' CE1' ' A' ' 84' ' ' HIS . 0.2 OUTLIER 69.79 -23.07 0.16 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.484 179.543 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.592 ' N ' ' HD2' ' A' ' 58' ' ' PRO . . . 136.36 -29.58 2.79 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 -178.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.73 HD13 ' HB3' ' A' ' 86' ' ' ASP . 4.1 mp -71.56 -21.93 61.82 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.465 -0.368 . . . . 0.0 110.225 179.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.993 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -53.74 -33.48 55.83 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.952 179.054 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.699 HD23 ' OG ' ' A' ' 53' ' ' SER . 6.4 mp -56.99 -48.44 78.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.106 0.479 . . . . 0.0 110.76 179.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.96 ' HA ' HD12 ' A' ' 69' ' ' ILE . 4.9 mp -55.69 -40.3 72.18 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.763 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.687 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 0.1 OUTLIER -53.85 -48.07 70.34 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.9 179.286 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.694 ' CB ' HD13 ' A' ' 40' ' ' LEU . 13.1 mm-40 -71.39 -29.88 65.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.698 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.96 HD12 ' HA ' ' A' ' 66' ' ' LEU . 37.6 mt -62.72 -40.76 89.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.665 -179.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.687 ' HG2' ' O ' ' A' ' 67' ' ' LYS . 23.9 pttt -74.68 -29.58 61.27 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.475 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -85.88 -38.17 18.36 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -178.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 22.0 mtt-85 -95.33 -27.24 15.56 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -178.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.952 ' CE1' HD13 ' A' ' 43' ' ' LEU . 0.2 OUTLIER -107.52 134.85 19.83 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.699 -0.228 . . . . 0.0 111.131 -179.107 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.561 ' O ' ' HG2' ' A' ' 75' ' ' MET . 23.6 Cg_exo -63.66 79.88 0.14 Allowed 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.657 2.238 . . . . 0.0 112.587 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.561 ' HG2' ' O ' ' A' ' 74' ' ' PRO . 0.0 OUTLIER 50.69 43.19 27.93 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 121.558 0.694 . . . . 0.0 110.795 179.742 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.797 HD21 ' HG2' ' A' ' 48' ' ' PRO . 5.8 tp -68.24 137.08 91.47 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.678 -179.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.547 ' HD2' ' HG ' ' A' ' 76' ' ' LEU . 47.3 Cg_endo -67.34 125.09 12.92 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.495 2.13 . . . . 0.0 111.951 179.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.863 HG22 HG21 ' A' ' 69' ' ' ILE . 3.8 t -110.92 143.53 20.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.09 0.472 . . . . 0.0 111.614 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.564 HG21 HD23 ' A' ' 114' ' ' LEU . 2.3 mp -132.97 113.19 19.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.338 179.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.66 HD13 ' HB2' ' A' ' 53' ' ' SER . 13.0 mm -101.22 142.21 16.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.326 -179.211 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.503 ' O ' ' HB3' ' A' ' 102' ' ' LEU . 11.4 ptm -82.79 -21.23 34.64 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -178.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.557 ' H ' HG21 ' A' ' 55' ' ' ILE . 3.0 m -147.65 158.05 43.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.637 0.256 . . . . 0.0 111.22 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.851 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -138.53 66.43 1.43 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.571 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.419 ' CE1' ' OD1' ' A' ' 61' ' ' ASP . 16.1 p80 -99.24 120.62 39.84 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 120.898 0.38 . . . . 0.0 111.578 -179.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 55.77 165.83 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.752 179.385 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.73 ' HB3' HD13 ' A' ' 63' ' ' LEU . 1.0 OUTLIER 52.89 26.86 4.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.079 -179.817 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.765 HD21 ' HB1' ' A' ' 83' ' ' ALA . 0.1 OUTLIER -54.82 -23.72 19.62 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.352 -179.961 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -50.63 -35.93 32.85 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.829 -179.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.599 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -69.56 -23.32 63.55 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.798 0.333 . . . . 0.0 111.447 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.605 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -72.12 -30.63 65.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.209 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.659 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 5.5 t -66.67 -46.72 85.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.365 -179.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.6 m -58.12 -37.81 75.3 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.482 0.658 . . . . 0.0 110.093 179.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.591 ' HB1' ' HB2' ' A' ' 98' ' ' ALA . . . -56.89 -41.53 78.25 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.319 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.659 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 12.4 m-85 -59.03 -22.31 60.48 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.212 179.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.561 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -74.76 -39.76 61.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.518 -179.999 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.561 ' N ' ' HG2' ' A' ' 95' ' ' GLN . 4.8 pt20 -79.18 -11.12 59.97 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.376 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 108.05 32.15 3.37 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.336 -0.935 . . . . 0.0 112.91 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.591 ' HB2' ' HB1' ' A' ' 93' ' ' ALA . . . -61.07 145.76 49.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.756 0.278 . . . . 0.0 110.566 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.619 ' CZ ' ' HB2' ' A' ' 118' ' ' ALA . 9.2 t80 -71.08 -53.87 13.11 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.548 -179.387 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.559 ' OD2' HD11 ' A' ' 114' ' ' LEU . 2.8 p30 166.82 -166.4 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.185 0.517 . . . . 0.0 111.498 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.851 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 4.8 m-85 -133.95 152.42 51.85 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.99 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.503 ' HB3' ' O ' ' A' ' 81' ' ' MET . 1.0 OUTLIER -104.72 119.02 54.94 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.258 179.584 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -67.84 -67.52 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.306 2.004 . . . . 0.0 112.448 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.685 ' H ' ' HD2' ' A' ' 105' ' ' PRO . 4.9 mttt -121.76 -61.95 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.969 -179.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.685 ' HD2' ' H ' ' A' ' 104' ' ' LYS . 9.7 Cg_endo -50.29 159.76 1.81 Allowed 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.42 2.08 . . . . 0.0 112.279 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.605 ' O ' ' O ' ' A' ' 107' ' ' ASP . 47.8 t80 -169.74 -105.83 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.414 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.605 ' O ' ' O ' ' A' ' 106' ' ' PHE . 2.7 p30 43.1 175.38 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.033 0.444 . . . . 0.0 111.447 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.455 HG12 ' O ' ' A' ' 18' ' ' VAL . 0.9 OUTLIER -67.62 -41.07 85.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.09 0.472 . . . . 0.0 111.288 179.956 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.511 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 0.3 OUTLIER -50.01 -58.21 5.96 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.596 -179.707 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.587 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 58.4 mm-40 -77.32 -32.05 55.01 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -179.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -67.33 -58.44 4.79 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.858 0.361 . . . . 0.0 110.237 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.666 ' O ' HG12 ' A' ' 115' ' ' VAL . 51.8 t -60.89 -32.46 52.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.488 0.661 . . . . 0.0 110.189 179.176 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.511 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -62.07 -44.8 95.9 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.567 0.699 . . . . 0.0 109.911 178.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.656 HD12 ' HE ' ' A' ' 117' ' ' ARG . 6.1 tp -74.97 -23.7 58.32 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.588 -179.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.666 HG12 ' O ' ' A' ' 112' ' ' VAL . 2.7 p -79.57 -42.75 23.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.832 0.348 . . . . 0.0 111.736 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.448 ' HG3' ' O ' ' A' ' 112' ' ' VAL . 31.6 mt-10 -60.31 -51.92 67.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.298 -179.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.656 ' HE ' HD12 ' A' ' 114' ' ' LEU . 0.1 OUTLIER -57.25 -23.88 51.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.852 0.358 . . . . 0.0 110.979 -179.993 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.619 ' HB2' ' CZ ' ' A' ' 99' ' ' PHE . . . -70.39 -45.58 65.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.814 179.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.641 HD13 ' CD2' ' A' ' 28' ' ' LEU . 4.7 mt -77.22 -34.11 20.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.464 -179.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.9 m -65.18 -47.06 78.29 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.969 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 11.1 m80 . . . . . 0 C--N 1.327 -0.391 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.986 -179.995 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.529 0.141 0 CA-C-O 120.498 0.19 . . . . 0.0 111.387 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.479 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . 84.89 85.81 0.95 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.79 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.7 mp -101.01 113.11 36.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.933 0.397 . . . . 0.0 111.218 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 1.013 HG11 HD13 ' A' ' 23' ' ' LEU . 5.9 p -105.44 120.18 55.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.281 179.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.856 ' CD1' HG22 ' A' ' 31' ' ' THR . 26.3 m0 -112.21 139.8 47.45 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.915 0.388 . . . . 0.0 110.512 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.957 HG11 HD13 ' A' ' 19' ' ' LEU . 0.2 OUTLIER -126.94 148.83 31.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.749 -178.765 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.818 HG23 ' O ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -127.01 114.61 38.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.002 0.429 . . . . 0.0 109.995 179.023 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.982 ' HB3' HG13 ' A' ' 15' ' ' ILE . 9.1 t0 -171.05 -150.24 0.07 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.426 -178.306 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -66.49 -3.37 6.08 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.511 ' O ' ' N ' ' A' ' 16' ' ' ARG . 2.3 t0 69.19 -79.52 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 178.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -40.83 -78.35 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -178.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.78 ' O ' HG23 ' A' ' 18' ' ' VAL . 1.7 t -52.61 -32.6 42.44 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.669 -178.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.982 HG13 ' HB3' ' A' ' 10' ' ' ASP . 23.2 mm -77.53 -28.69 16.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.892 -179.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.61 ' HA ' ' HG3' ' A' ' 20' ' ' GLU . 14.1 ttt180 -58.35 -44.69 88.89 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.307 0.575 . . . . 0.0 110.176 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.734 ' O ' ' HB2' ' A' ' 21' ' ' ARG . 38.4 t90 -71.95 -62.22 1.5 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.766 -179.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.78 HG23 ' O ' ' A' ' 14' ' ' SER . 0.5 OUTLIER -59.17 -60.89 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 -177.056 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.957 HD13 HG11 ' A' ' 8' ' ' VAL . 13.9 mt -70.67 -51.49 27.42 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -175.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.61 ' HG3' ' HA ' ' A' ' 16' ' ' ARG . 5.1 mt-10 -67.62 -61.66 1.79 Allowed 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -178.316 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.734 ' HB2' ' O ' ' A' ' 17' ' ' TRP . 0.0 OUTLIER -49.99 -44.45 50.97 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.058 -178.202 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.82 -37.37 76.2 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.672 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 1.013 HD13 HG11 ' A' ' 6' ' ' VAL . 3.0 mt -75.22 -27.1 59.42 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 178.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.409 ' N ' ' O ' ' A' ' 20' ' ' GLU . . . -63.72 -35.65 81.28 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.94 -26.2 69.97 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.171 -1.014 . . . . 0.0 110.993 178.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.764 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -76.85 -15.53 59.68 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 120.565 0.221 . . . . 0.0 110.923 179.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.13 26.71 9.97 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 120.636 -0.792 . . . . 0.0 113.955 179.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 1.001 HD13 HD22 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -123.72 168.87 12.12 Favored 'General case' 0 N--CA 1.456 -0.125 0 CA-C-N 117.707 0.754 . . . . 0.0 111.788 -179.983 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 58.2 m -96.44 113.52 25.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.918 179.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.682 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 3.1 t -112.05 117.51 32.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.093 0.473 . . . . 0.0 112.195 -179.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.856 HG22 ' CD1' ' A' ' 7' ' ' TRP . 3.3 t -123.57 139.85 53.59 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.169 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.487 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 76.8 p -112.5 161.42 16.76 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.129 0.49 . . . . 0.0 111.388 -178.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.775 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 3.7 m-85 -131.28 174.08 10.41 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.806 -177.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.728 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 3.2 pp20? -63.19 -39.04 93.5 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -177.219 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -164.2 -57.61 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.301 0 C-N-CA 119.755 -0.778 . . . . 0.0 113.049 -178.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.816 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . -169.07 -44.42 0.03 OUTLIER Glycine 0 C--N 1.318 -0.471 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.64 -178.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.503 ' N ' HD21 ' A' ' 65' ' ' LEU . 0.5 OUTLIER -64.88 -30.43 71.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.995 0.426 . . . . 0.0 110.96 -179.329 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.775 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -54.34 -52.84 60.29 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.551 -179.945 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.772 HG12 ' CD1' ' A' ' 43' ' ' LEU . 11.5 t -48.76 -38.77 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-O 121.017 0.437 . . . . 0.0 111.1 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.811 HD21 ' CD1' ' A' ' 65' ' ' LEU . 15.9 mt -61.82 -42.14 98.65 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.564 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.41 -49.45 73.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.19 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.86 -31.86 66.89 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.542 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.772 ' CD1' HG12 ' A' ' 39' ' ' VAL . 5.7 mt -59.88 -24.02 63.93 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.297 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.36 -19.32 34.53 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.439 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.5 t -121.52 0.88 10.03 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.557 ' O ' HD23 ' A' ' 43' ' ' LEU . 3.6 tttt -165.37 164.39 19.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.944 0.402 . . . . 0.0 111.367 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.523 ' HA ' HD23 ' A' ' 43' ' ' LEU . 85.9 m -138.79 116.83 9.09 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.948 179.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.741 ' HD2' HD21 ' A' ' 43' ' ' LEU . 40.0 Cg_endo -74.82 156.06 43.8 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 121.796 1.664 . . . . 0.0 111.466 179.25 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -74.05 -30.84 62.6 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.079 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.689 ' O ' HG13 ' A' ' 50' ' ' VAL . 14.9 p -149.49 106.27 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 CA-C-O 120.737 0.303 . . . . 0.0 111.699 -179.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.709 ' O ' HD12 ' A' ' 79' ' ' ILE . 20.5 tp -87.07 155.32 20.19 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.937 0.399 . . . . 0.0 111.201 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.818 ' O ' HG23 ' A' ' 9' ' ' VAL . 2.4 tt -137.16 119.6 15.85 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.197 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.528 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 0.6 OUTLIER -111.86 128.44 56.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.781 0.324 . . . . 0.0 111.378 -179.662 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.06 -2.9 56.55 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.514 HD11 ' CE1' ' A' ' 84' ' ' HIS . 3.0 tt 41.97 91.13 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-O 120.805 0.336 . . . . 0.0 111.698 179.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.4 ttt85 -117.56 40.17 3.14 Favored 'General case' 0 N--CA 1.461 0.111 0 N-CA-C 111.96 0.355 . . . . 0.0 111.96 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.624 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER 56.81 44.11 1.3 Allowed Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 179.042 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.478 ' CD ' ' N ' ' A' ' 57' ' ' MET . 30.1 Cg_endo -63.29 -80.81 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 121.959 1.773 . . . . 0.0 111.02 178.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -102.42 -86.6 1.95 Allowed Glycine 0 C--N 1.334 0.43 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 178.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.802 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -87.82 60.97 6.18 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 177.228 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.624 ' HA ' ' HA ' ' A' ' 57' ' ' MET . 0.1 OUTLIER 65.57 -28.2 0.11 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.65 -1.159 . . . . 0.0 112.447 -179.494 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.533 ' H ' ' C ' ' A' ' 60' ' ' MET . . . 152.15 -35.19 0.84 Allowed Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 110.946 -0.861 . . . . 0.0 110.946 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.586 ' H ' HD12 ' A' ' 63' ' ' LEU . 1.0 OUTLIER -64.07 -21.43 66.52 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 178.878 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.802 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -53.56 -38.43 63.86 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 120.969 0.414 . . . . 0.0 110.389 179.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.811 ' CD1' HD21 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -55.03 -44.99 75.14 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.781 179.836 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.851 ' HA ' HD12 ' A' ' 69' ' ' ILE . 5.8 mt -54.5 -42.5 70.85 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.503 179.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.637 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 21.6 tttt -57.77 -43.47 85.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.704 179.451 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 8.2 mm100 -69.51 -27.78 65.47 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.851 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.851 HD12 ' HA ' ' A' ' 66' ' ' LEU . 96.7 mt -64.58 -36.85 78.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.96 -179.083 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.637 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -78.15 -31.62 49.84 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.512 -179.52 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -63.72 -44.53 93.32 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.076 -178.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.2 mtt85 -96.42 -50.93 4.56 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.857 -179.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.651 ' NE2' HD13 ' A' ' 43' ' ' LEU . 0.3 OUTLIER -95.77 156.38 37.4 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.834 -179.326 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -66.28 -73.29 0.02 OUTLIER 'Trans proline' 0 CA--C 1.528 0.209 0 C-N-CA 122.538 2.159 . . . . 0.0 112.682 -179.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 7.3 mtt -145.16 55.52 1.22 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.7 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.455 HD13 HG23 ' A' ' 47' ' ' THR . 22.5 tp -61.9 111.21 4.11 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.111 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -60.35 134.25 54.2 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.379 2.053 . . . . 0.0 112.387 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.791 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 5.1 t -131.43 152.93 38.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.25 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.709 HD12 ' O ' ' A' ' 51' ' ' LEU . 1.1 mt -126.8 113.2 31.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.721 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.528 ' HA ' ' O ' ' A' ' 53' ' ' SER . 9.5 mm -101.86 134.9 41.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -178.051 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.557 ' HB2' ' CD1' ' A' ' 106' ' ' PHE . 2.4 ptt? -69.16 -34.01 74.3 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.271 -0.877 . . . . 0.0 112.216 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 7.3 m -139.16 150.72 45.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.752 0.311 . . . . 0.0 111.348 -179.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.916 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -121.06 70.58 0.92 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.731 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.514 ' CE1' HD11 ' A' ' 55' ' ' ILE . 2.6 p80 -98.94 -179.27 4.22 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.193 179.174 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.4 ' HB2' ' CB ' ' A' ' 61' ' ' ASP . 0.1 OUTLIER 63.99 -161.42 0.29 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.769 -179.892 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.41 88.74 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.924 0.392 . . . . 0.0 111.377 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.859 HD21 ' HB1' ' A' ' 83' ' ' ALA . 0.3 OUTLIER -51.85 -24.0 5.56 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.465 179.804 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -48.84 -36.36 16.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.008 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.429 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -72.84 -19.84 61.24 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.219 -179.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.747 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -68.93 -52.37 29.97 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.984 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.62 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 9.4 t -66.33 -44.94 90.72 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.19 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.845 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.685 ' O ' ' HG3' ' A' ' 95' ' ' GLN . 3.3 m -61.08 -14.54 24.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.889 0.376 . . . . 0.0 110.035 178.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.699 ' HB2' HD13 ' A' ' 66' ' ' LEU . . . -75.15 -61.74 1.79 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.113 0.482 . . . . 0.0 111.066 179.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.66 ' N ' ' HB3' ' A' ' 98' ' ' ALA . 4.7 m-85 -44.84 -36.14 3.12 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.384 -178.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.685 ' HG3' ' O ' ' A' ' 92' ' ' SER . 1.7 pp0? -76.25 -37.01 58.21 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.959 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.526 ' HB2' ' HB3' ' A' ' 70' ' ' LYS . 10.3 pt20 -100.12 11.19 39.93 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -179.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 93' ' ' ALA . . . 122.21 79.0 0.48 Allowed Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.187 -1.006 . . . . 0.0 113.449 179.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.791 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -169.14 142.49 2.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.731 0.301 . . . . 0.0 110.637 178.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.502 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 3.3 t80 -84.49 -53.15 5.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.585 -178.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.591 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 0.4 OUTLIER 178.83 -165.58 0.05 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.139 0.495 . . . . 0.0 111.61 179.984 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.916 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 3.5 m-85 -136.38 153.73 51.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.458 -179.209 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.531 ' HG ' ' HB3' ' A' ' 106' ' ' PHE . 0.4 OUTLIER -101.9 118.85 58.5 Favored Pre-proline 0 C--N 1.327 -0.372 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 179.059 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.417 ' C ' ' HG3' ' A' ' 104' ' ' LYS . 61.5 Cg_exo -51.28 -42.49 53.97 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.58 2.187 . . . . 0.0 112.466 -179.211 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.642 ' HB2' ' HD3' ' A' ' 105' ' ' PRO . 40.3 mttp -156.07 -54.11 0.02 OUTLIER Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.173 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.642 ' HD3' ' HB2' ' A' ' 104' ' ' LYS . 98.1 Cg_endo -80.97 163.78 20.31 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.262 1.975 . . . . 0.0 112.229 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.677 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 0.5 OUTLIER -169.89 -75.88 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.487 178.928 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.554 ' O ' ' HB3' ' A' ' 111' ' ' ALA . 3.1 p30 37.32 -166.49 0.0 OUTLIER 'General case' 0 C--O 1.225 -0.189 0 CA-C-N 116.682 -0.235 . . . . 0.0 110.41 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.842 HD11 ' HG ' ' A' ' 19' ' ' LEU . 1.1 mp -67.85 -44.8 85.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 C-N-CA 120.11 -0.636 . . . . 0.0 111.366 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.521 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 2.6 m-20 -53.58 -58.06 8.52 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.666 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.677 ' HB2' ' HA ' ' A' ' 106' ' ' PHE . 3.1 mm-40 -79.2 -28.04 42.58 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -178.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.583 ' HB1' HD11 ' A' ' 52' ' ' LEU . . . -78.31 -55.09 5.52 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.349 -0.541 . . . . 0.0 110.084 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.783 ' O ' HG12 ' A' ' 115' ' ' VAL . 60.4 t -58.57 -29.51 39.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-O 121.549 0.69 . . . . 0.0 109.881 178.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.521 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -64.82 -47.97 76.09 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.718 178.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.605 HD23 ' CG2' ' A' ' 79' ' ' ILE . 10.6 tp -73.83 -20.66 60.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.455 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.783 HG12 ' O ' ' A' ' 112' ' ' VAL . 2.6 p -78.52 -43.42 26.27 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-O 120.735 0.302 . . . . 0.0 111.526 -179.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.48 ' HA ' HD12 ' A' ' 119' ' ' ILE . 35.7 mt-10 -66.2 -41.92 89.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.209 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.505 HH11 HD12 ' A' ' 114' ' ' LEU . 28.4 mtp-105 -61.18 -25.64 67.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.646 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.523 ' HB3' HG21 ' A' ' 50' ' ' VAL . . . -73.01 -40.44 65.18 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.305 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.48 HD12 ' HA ' ' A' ' 116' ' ' GLU . 3.8 mt -75.42 -30.51 22.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 121.125 0.488 . . . . 0.0 110.658 179.117 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 91.5 p -67.35 -43.32 81.78 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.567 -179.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 17.8 m80 . . . . . 0 C--N 1.328 -0.359 0 CA-C-O 121.006 0.431 . . . . 0.0 110.943 -179.823 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.529 0.161 0 CA-C-O 120.589 0.233 . . . . 0.0 111.475 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 90.27 81.57 1.37 Allowed Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.942 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.6 mp -103.3 112.32 36.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.96 0.41 . . . . 0.0 111.26 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.852 HG21 HD21 ' A' ' 23' ' ' LEU . 4.3 p -106.92 126.64 62.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.1 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.919 ' CD1' HG22 ' A' ' 31' ' ' THR . 40.6 m0 -112.82 136.46 52.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.896 0.379 . . . . 0.0 110.444 179.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.681 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.1 OUTLIER -125.95 138.81 53.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.336 -178.658 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.952 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -115.6 105.59 18.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.988 0.423 . . . . 0.0 110.217 178.58 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.681 ' HB3' HG21 ' A' ' 15' ' ' ILE . 10.2 t0 -173.09 117.12 0.29 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.226 -179.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.599 ' O ' ' HB2' ' A' ' 12' ' ' ASP . 0.1 OUTLIER 47.67 -86.4 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.787 179.826 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.599 ' HB2' ' O ' ' A' ' 11' ' ' ASP . 15.4 t0 170.91 -133.31 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.676 -0.238 . . . . 0.0 110.824 -179.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.437 ' HA ' ' HB3' ' A' ' 16' ' ' ARG . 75.0 m -40.89 -42.03 1.74 Allowed 'General case' 0 C--N 1.341 0.234 0 CA-C-O 121.072 0.463 . . . . 0.0 112.117 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.602 ' O ' HG23 ' A' ' 18' ' ' VAL . 27.6 m -53.18 -63.51 1.12 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.675 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.681 HG21 ' HB3' ' A' ' 10' ' ' ASP . 15.1 mm -70.46 -20.61 22.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.871 0.367 . . . . 0.0 110.667 179.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.709 ' HA ' HG21 ' A' ' 32' ' ' THR . 3.4 ttt180 -69.77 -55.56 9.53 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.846 179.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.505 ' O ' ' HG3' ' A' ' 20' ' ' GLU . 89.6 t90 -53.58 -45.09 69.84 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.708 -179.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.852 HG12 HG12 ' A' ' 108' ' ' ILE . 3.1 t -65.58 -45.13 93.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -178.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.52 HD13 ' O ' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -83.66 -26.93 29.45 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -177.786 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.505 ' HG3' ' O ' ' A' ' 17' ' ' TRP . 1.0 OUTLIER -66.61 -60.92 2.28 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -179.063 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.577 ' O ' ' HB3' ' A' ' 24' ' ' ALA . 31.1 mmm-85 -52.77 -63.21 1.22 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.734 0.302 . . . . 0.0 111.802 -179.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -49.75 -54.69 17.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.046 0.45 . . . . 0.0 111.554 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.852 HD21 HG21 ' A' ' 6' ' ' VAL . 9.3 tp -66.36 -19.43 65.8 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.183 179.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.577 ' HB3' ' O ' ' A' ' 21' ' ' ARG . . . -70.32 -35.85 73.91 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.13 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -57.59 -27.83 59.09 Favored Glycine 0 C--N 1.335 0.527 0 C-N-CA 120.51 -0.852 . . . . 0.0 111.035 178.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.746 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -77.98 -15.8 58.66 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 120.716 0.293 . . . . 0.0 110.495 178.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.94 26.61 14.17 Favored Glycine 0 C--N 1.337 0.609 0 C-N-CA 120.637 -0.792 . . . . 0.0 114.501 178.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.799 HD13 ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -116.06 164.94 13.71 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 118.32 1.06 . . . . 0.0 112.23 -179.779 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 27.0 m -94.4 118.56 31.81 Favored 'General case' 0 CA--C 1.521 -0.149 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.484 179.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.552 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 3.0 m -108.46 118.61 37.23 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -178.323 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.919 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.7 t -122.79 139.76 53.65 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.047 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.709 HG21 ' HA ' ' A' ' 16' ' ' ARG . 69.0 p -115.01 161.63 18.08 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -177.496 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.952 ' HB2' HG13 ' A' ' 9' ' ' VAL . 12.1 m-85 -136.27 174.88 10.13 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 114.868 -1.06 . . . . 0.0 111.834 -178.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.422 ' HG2' ' H ' ' A' ' 35' ' ' ASN . 3.6 pt-20 -62.0 -46.94 87.02 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -177.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.422 ' H ' ' HG2' ' A' ' 34' ' ' GLU . 0.5 OUTLIER -168.41 -27.97 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 118.58 0.627 . . . . 0.0 112.687 -179.573 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.7 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . 171.91 -59.66 0.16 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.402 -0.904 . . . . 0.0 112.754 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.587 ' HA ' HD12 ' A' ' 40' ' ' LEU . 6.5 m120 -48.1 -34.52 9.86 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 120.845 0.355 . . . . 0.0 110.979 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.913 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 5.2 tt0 -60.25 -55.65 31.12 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.382 179.082 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.919 HG11 HD11 ' A' ' 51' ' ' LEU . 6.2 t -53.93 -44.22 60.56 Favored 'Isoleucine or valine' 0 C--N 1.345 0.401 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.459 179.126 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.826 HD13 ' CB ' ' A' ' 68' ' ' GLN . 21.0 mt -57.51 -42.68 83.27 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.877 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.53 -50.13 40.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.075 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.55 -27.58 69.35 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.639 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.747 HD13 ' NE2' ' A' ' 73' ' ' HIS . 6.1 mt -67.71 -23.53 65.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.556 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.39 -16.71 15.83 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.182 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -117.43 -3.39 11.4 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.824 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.501 ' O ' HD23 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -167.33 163.06 15.16 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.984 0.421 . . . . 0.0 111.73 -179.917 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.979 HG23 HD12 ' A' ' 76' ' ' LEU . 66.3 m -139.11 112.47 8.08 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.522 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.713 ' HD2' HD21 ' A' ' 43' ' ' LEU . 66.6 Cg_endo -72.52 165.49 32.56 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.179 1.92 . . . . 0.0 111.548 178.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -74.09 -24.34 59.47 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 121.132 -0.227 . . . . 0.0 111.26 -179.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.832 HG13 HG23 ' A' ' 6' ' ' VAL . 7.2 p -145.15 166.45 11.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.919 HD11 HG11 ' A' ' 39' ' ' VAL . 19.6 tp -152.91 132.55 13.07 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 121.06 0.457 . . . . 0.0 111.368 -179.036 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.741 ' O ' HG23 ' A' ' 9' ' ' VAL . 0.9 OUTLIER -116.52 139.33 50.6 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.795 -179.878 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.555 ' HB2' HD13 ' A' ' 80' ' ' ILE . 8.1 m -127.1 128.44 46.23 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.978 0.418 . . . . 0.0 111.384 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.402 ' C ' HG22 ' A' ' 55' ' ' ILE . 44.6 t0 -69.48 -16.65 63.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.587 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.706 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 2.5 tt 43.79 72.58 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.109 -0.496 . . . . 0.0 112.262 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 177.46 61.82 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.695 179.245 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.61 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -162.0 -64.25 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.698 179.964 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.61 ' HD3' ' HB3' ' A' ' 57' ' ' MET . 36.4 Cg_endo -63.02 -165.6 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.694 2.263 . . . . 0.0 113.228 -179.496 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.79 -67.32 2.13 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.656 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.734 ' HB2' ' HB2' ' A' ' 64' ' ' ALA . 0.2 OUTLIER -79.95 51.23 1.31 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.941 0.4 . . . . 0.0 110.762 179.809 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.462 ' O ' ' HD2' ' A' ' 58' ' ' PRO . 0.1 OUTLIER 54.42 -74.56 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.407 179.643 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.706 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -144.14 -34.84 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.456 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.687 ' CB ' ' HB3' ' A' ' 89' ' ' ALA . 0.5 OUTLIER -54.05 -23.55 14.07 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.654 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.734 ' HB2' ' HB2' ' A' ' 60' ' ' MET . . . -54.22 -36.48 63.54 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.795 178.183 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.538 ' CD1' ' HG3' ' A' ' 58' ' ' PRO . 9.9 mp -59.47 -55.54 33.34 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.306 179.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.9 ' HA ' HD12 ' A' ' 69' ' ' ILE . 17.0 mt -44.24 -42.53 6.63 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.666 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.501 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 11.3 mttp -57.93 -47.19 83.59 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.037 179.159 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.826 ' CB ' HD13 ' A' ' 40' ' ' LEU . 10.6 mm100 -68.02 -30.33 69.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.375 179.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.9 HD12 ' HA ' ' A' ' 66' ' ' LEU . 77.9 mt -65.21 -45.11 94.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.222 -179.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.501 ' HG2' ' O ' ' A' ' 67' ' ' LYS . 8.9 ptmt -64.81 -29.31 70.27 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.961 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -72.72 -36.51 67.8 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.093 0.473 . . . . 0.0 110.928 179.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.44 -70.96 0.7 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.556 -179.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.747 ' NE2' HD13 ' A' ' 43' ' ' LEU . 2.2 p80 -117.83 78.0 12.11 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.59 -179.197 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.494 ' HA ' ' OE1' ' A' ' 96' ' ' GLN . 72.4 Cg_endo -76.46 56.27 5.02 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.536 2.157 . . . . 0.0 112.563 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 38.2 mtt -154.8 -43.02 0.09 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.093 0.473 . . . . 0.0 111.457 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.979 HD12 HG23 ' A' ' 47' ' ' THR . 1.0 OUTLIER -53.08 125.11 40.2 Favored Pre-proline 0 C--N 1.32 -0.679 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.614 -179.941 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.632 ' HD2' HD23 ' A' ' 76' ' ' LEU . 24.8 Cg_exo -61.82 129.65 28.37 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.428 2.085 . . . . 0.0 112.871 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.576 HG11 ' CD2' ' A' ' 66' ' ' LEU . 5.2 t -110.2 138.87 36.1 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.78 179.157 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.74 ' CG2' HD23 ' A' ' 114' ' ' LEU . 1.7 mt -123.8 113.2 36.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.545 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.585 HG22 HG21 ' A' ' 55' ' ' ILE . 15.1 mm -101.08 145.87 10.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.299 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.597 ' HG3' ' CG2' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -80.5 -30.11 37.33 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.242 -0.435 . . . . 0.0 112.029 -179.038 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.538 ' O ' HD13 ' A' ' 55' ' ' ILE . 4.8 m -147.44 146.48 29.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.836 0.35 . . . . 0.0 111.354 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.828 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -112.67 47.94 1.05 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.351 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.407 ' O ' ' HB2' ' A' ' 85' ' ' SER . 0.7 OUTLIER -98.49 -175.19 3.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.721 0.296 . . . . 0.0 110.743 179.816 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.407 ' HB2' ' O ' ' A' ' 84' ' ' HIS . 45.9 m 71.6 -78.39 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.793 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.567 ' O ' HD22 ' A' ' 63' ' ' LEU . 7.6 m-20 -138.99 68.1 1.38 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.64 0.257 . . . . 0.0 111.633 -179.327 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.723 ' HG ' ' HB1' ' A' ' 83' ' ' ALA . 0.4 OUTLIER -45.69 -23.82 0.29 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.898 179.467 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -48.54 -46.13 38.42 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -179.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.687 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -65.07 -20.04 66.29 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.809 0.338 . . . . 0.0 111.622 -179.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.571 ' HB2' HD23 ' A' ' 63' ' ' LEU . . . -68.84 -36.11 77.77 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.055 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.651 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 8.2 t -63.07 -41.2 91.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.063 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 44.5 m -63.31 -35.26 79.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.224 0.535 . . . . 0.0 110.306 179.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.805 ' HB2' HD13 ' A' ' 66' ' ' LEU . . . -57.78 -39.57 77.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.998 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.651 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 10.7 m-85 -63.24 -20.95 65.9 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.379 179.249 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.621 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -74.23 -41.37 61.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.723 -179.808 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.621 ' N ' ' HG2' ' A' ' 95' ' ' GLN . 1.0 OUTLIER -78.59 -18.47 54.53 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.494 -179.332 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 122.01 29.47 1.36 Allowed Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.789 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.605 ' HB2' ' HB1' ' A' ' 93' ' ' ALA . . . -64.1 143.32 57.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.762 0.281 . . . . 0.0 110.809 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.55 ' CE2' ' HB2' ' A' ' 118' ' ' ALA . 18.9 t80 -71.49 -53.96 12.19 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.249 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 168.21 -164.96 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.16 0.505 . . . . 0.0 111.124 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.828 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 3.3 m-85 -130.67 150.96 51.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.259 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.961 HD13 HD22 ' A' ' 114' ' ' LEU . 5.6 tp -102.87 135.56 19.42 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.986 -179.427 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.411 ' HG2' ' HG2' ' A' ' 105' ' ' PRO . 93.7 Cg_endo -78.96 -152.87 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.426 2.084 . . . . 0.0 111.904 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.515 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 5.7 mtpt -43.05 -56.55 6.2 Favored Pre-proline 0 CA--C 1.533 0.322 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.515 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 13.2 Cg_endo -56.71 163.39 7.21 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.565 2.177 . . . . 0.0 112.282 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.6 ' HD1' HD23 ' A' ' 102' ' ' LEU . 45.5 t80 -171.92 -105.03 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.892 179.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.521 ' O ' ' O ' ' A' ' 106' ' ' PHE . 4.6 p-10 43.75 -179.08 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.98 0.419 . . . . 0.0 111.039 -179.421 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.852 HG12 HG12 ' A' ' 18' ' ' VAL . 0.9 OUTLIER -67.84 -41.13 84.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 120.969 0.414 . . . . 0.0 111.533 -179.852 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.524 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 12.7 t70 -50.6 -58.56 5.54 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.623 -179.496 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.591 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 36.3 mm-40 -77.1 -30.89 55.51 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.663 0.268 . . . . 0.0 111.64 -179.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.403 ' CB ' ' O ' ' A' ' 107' ' ' ASP . . . -68.46 -61.13 1.97 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.018 0.437 . . . . 0.0 110.283 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.613 ' O ' HG12 ' A' ' 115' ' ' VAL . 58.1 t -57.63 -30.51 37.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.587 0.708 . . . . 0.0 110.25 178.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.524 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -63.86 -46.33 85.48 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.191 179.207 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.961 HD22 HD13 ' A' ' 102' ' ' LEU . 35.6 tp -74.66 -22.87 58.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.085 -179.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.613 HG12 ' O ' ' A' ' 112' ' ' VAL . 4.8 p -79.39 -46.44 23.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 120.442 -0.503 . . . . 0.0 111.639 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.412 ' N ' HG13 ' A' ' 115' ' ' VAL . 8.6 mt-10 -63.82 -45.29 90.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.963 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.577 ' HG2' ' HA ' ' A' ' 114' ' ' LEU . 0.0 OUTLIER -59.09 -27.06 65.19 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.956 0.408 . . . . 0.0 110.796 179.741 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.55 ' HB2' ' CE2' ' A' ' 99' ' ' PHE . . . -67.93 -47.64 68.17 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.629 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.671 HD13 ' CD2' ' A' ' 28' ' ' LEU . 4.5 mt -74.15 -31.17 28.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.819 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.0 t -69.64 -42.05 74.77 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.974 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 1.3 m80 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.976 179.963 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.52 -0.192 0 CA-C-O 121.225 0.536 . . . . 0.0 110.764 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.524 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . 61.74 87.99 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.507 -0.769 . . . . 0.0 112.49 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.7 mp -111.0 112.34 40.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.848 0.356 . . . . 0.0 111.514 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.859 HG11 HD22 ' A' ' 23' ' ' LEU . 2.8 p -107.83 126.21 64.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.309 178.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.879 ' CD1' HG22 ' A' ' 31' ' ' THR . 27.2 m0 -114.11 140.21 48.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.846 0.355 . . . . 0.0 110.181 179.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.673 HG13 ' HB3' ' A' ' 52' ' ' LEU . 1.1 t -123.73 147.71 28.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.36 -178.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.773 HG13 HG23 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -130.93 112.03 21.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.094 0.473 . . . . 0.0 110.446 179.146 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -161.64 -158.64 0.57 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.711 -178.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -66.87 -1.85 4.47 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.349 0.499 . . . . 0.0 112.349 -179.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.424 ' O ' ' N ' ' A' ' 14' ' ' SER . 0.2 OUTLIER 69.43 -157.97 0.16 Allowed 'General case' 0 CA--C 1.532 0.254 0 O-C-N 122.443 -0.16 . . . . 0.0 110.875 179.912 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.6 t 34.06 -88.96 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 179.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.882 ' O ' HG23 ' A' ' 18' ' ' VAL . 3.6 m -53.02 -63.38 1.16 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.809 0.338 . . . . 0.0 111.216 -179.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.8 mm -61.46 -25.67 37.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.984 0.421 . . . . 0.0 110.89 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.971 ' HA ' HG21 ' A' ' 32' ' ' THR . 30.8 ttt180 -71.42 -55.64 7.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.591 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.445 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 30.1 t90 -58.63 -41.1 85.17 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -179.193 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.895 HG12 HG12 ' A' ' 108' ' ' ILE . 2.5 t -65.26 -49.12 80.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -178.297 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.621 HD23 HG11 ' A' ' 8' ' ' VAL . 9.7 tp -82.64 -24.79 33.63 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -178.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.555 ' HG3' ' N ' ' A' ' 21' ' ' ARG . 10.7 pt-20 -65.75 -57.6 7.63 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.721 -179.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.555 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 1.2 mmt-85 -67.12 -48.99 66.44 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.063 -179.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.11 -40.57 81.54 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -178.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.904 ' CD2' HD13 ' A' ' 28' ' ' LEU . 0.2 OUTLIER -77.37 -25.13 50.68 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.225 0.536 . . . . 0.0 110.053 179.217 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.03 -34.24 77.63 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.97 -23.61 71.21 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 177.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.624 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -76.71 -15.4 59.79 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 120.87 0.366 . . . . 0.0 110.471 179.032 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.87 26.27 11.86 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 120.945 -0.645 . . . . 0.0 113.815 178.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.904 HD13 ' CD2' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -132.78 169.09 17.22 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 117.534 0.667 . . . . 0.0 112.384 -179.371 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 32.9 m -89.84 109.1 20.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.75 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.585 ' HA ' HG13 ' A' ' 6' ' ' VAL . 47.3 t -107.48 110.55 22.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.076 0.465 . . . . 0.0 111.585 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.879 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.7 t -118.96 153.45 34.61 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.971 HG21 ' HA ' ' A' ' 16' ' ' ARG . 34.5 p -125.35 162.79 24.0 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.301 0.572 . . . . 0.0 111.945 -179.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.732 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 1.1 m-85 -129.3 174.22 9.8 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.431 -178.264 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.46 ' HG2' ' N ' ' A' ' 35' ' ' ASN . 0.6 OUTLIER -61.6 -37.14 82.81 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 -177.299 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.46 ' N ' ' HG2' ' A' ' 34' ' ' GLU . 5.1 m120 -169.85 -56.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 118.443 0.565 . . . . 0.0 112.133 -179.474 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.947 ' CA ' HD21 ' A' ' 65' ' ' LEU . . . -164.7 -58.53 0.02 OUTLIER Glycine 0 C--N 1.318 -0.432 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.951 -179.175 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.429 ' HA ' ' CD1' ' A' ' 40' ' ' LEU . 0.4 OUTLIER -48.79 -34.98 13.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.687 0.28 . . . . 0.0 111.742 -179.456 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.732 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -55.33 -54.05 48.4 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.509 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.834 HG12 ' CD1' ' A' ' 43' ' ' LEU . 39.0 t -58.65 -42.53 85.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.569 179.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.785 HD13 ' CB ' ' A' ' 68' ' ' GLN . 4.0 mt -51.24 -45.47 62.01 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.794 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.64 -47.31 40.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.301 0.572 . . . . 0.0 110.867 179.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.81 -31.04 70.45 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.132 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.834 ' CD1' HG12 ' A' ' 39' ' ' VAL . 11.7 mt -68.68 -20.67 64.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.763 -179.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.77 -18.4 12.55 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.511 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.7 t -122.69 -0.46 9.13 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.688 ' O ' HD23 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -164.22 157.15 17.56 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.064 0.459 . . . . 0.0 111.603 179.918 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.773 ' CG2' HD13 ' A' ' 76' ' ' LEU . 96.2 m -139.03 115.99 8.72 Favored Pre-proline 0 N--CA 1.45 -0.433 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.143 179.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.659 ' HG3' ' HB2' ' A' ' 7' ' ' TRP . 58.5 Cg_endo -72.24 165.08 33.68 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.267 1.978 . . . . 0.0 111.167 178.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -75.28 -27.09 59.23 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.966 -0.294 . . . . 0.0 111.267 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.703 HG11 HG22 ' A' ' 115' ' ' VAL . 7.2 p -148.79 104.9 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.553 -179.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.619 HD11 HG11 ' A' ' 39' ' ' VAL . 21.2 tp -86.52 132.04 34.02 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -179.125 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.75 ' O ' HG23 ' A' ' 9' ' ' VAL . 0.3 OUTLIER -114.82 123.19 48.56 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.289 179.044 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.699 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 0.5 OUTLIER -125.76 139.65 53.34 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 121.447 0.641 . . . . 0.0 112.254 -179.238 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.22 -170.05 2.84 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.231 178.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.617 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 3.6 tt -155.02 91.13 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.932 0.396 . . . . 0.0 111.048 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.421 ' HB3' ' O ' ' A' ' 55' ' ' ILE . 9.7 ptm180 172.73 47.02 0.0 OUTLIER 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.133 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.597 ' HB3' ' CD ' ' A' ' 58' ' ' PRO . 2.8 tpt -158.41 -64.29 0.02 OUTLIER Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.597 ' CD ' ' HB3' ' A' ' 57' ' ' MET . 11.9 Cg_endo -54.66 176.05 0.13 Allowed 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.368 2.045 . . . . 0.0 112.643 -179.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -52.37 -59.62 8.78 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.21 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.591 ' O ' ' N ' ' A' ' 62' ' ' GLY . 0.0 OUTLIER -82.55 52.26 2.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.552 0.215 . . . . 0.0 110.51 179.369 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 56.3 -71.81 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.143 0.497 . . . . 0.0 111.17 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.617 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -148.01 -36.16 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.641 -0.708 . . . . 0.0 111.753 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.91 ' HA ' HD23 ' A' ' 66' ' ' LEU . 3.0 mp -53.17 -24.16 10.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.779 0.324 . . . . 0.0 110.408 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.542 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -56.92 -33.89 67.42 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.003 178.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.947 HD21 ' CA ' ' A' ' 36' ' ' GLY . 0.2 OUTLIER -59.79 -35.86 75.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.429 179.39 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.986 ' HA ' HD12 ' A' ' 69' ' ' ILE . 3.3 mm? -63.67 -43.52 96.44 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.056 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.412 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 5.2 mmpt? -52.9 -50.62 63.55 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.325 179.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.785 ' CB ' HD13 ' A' ' 40' ' ' LEU . 12.2 mm100 -62.7 -38.46 90.49 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.517 179.16 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.986 HD12 ' HA ' ' A' ' 66' ' ' LEU . 18.5 mt -54.74 -46.09 73.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.645 -179.062 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.428 ' HB3' ' CD ' ' A' ' 96' ' ' GLN . 0.3 OUTLIER -69.61 -25.94 64.2 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.793 -179.27 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -85.62 -39.73 17.01 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -179.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.478 HH21 ' HB2' ' A' ' 40' ' ' LEU . 2.1 mtm180 -102.32 -40.9 6.54 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -178.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.696 ' CE1' HG12 ' A' ' 69' ' ' ILE . 0.5 OUTLIER -85.64 136.87 36.56 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.214 -178.962 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.602 ' O ' ' HG2' ' A' ' 75' ' ' MET . 17.2 Cg_exo -67.08 70.41 0.55 Allowed 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.509 2.139 . . . . 0.0 112.219 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.627 ' HB2' ' O ' ' A' ' 96' ' ' GLN . 0.2 OUTLIER 50.5 33.9 8.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.062 0.458 . . . . 0.0 111.114 179.843 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.773 HD13 ' CG2' ' A' ' 47' ' ' THR . 20.7 tp -67.23 131.79 93.47 Favored Pre-proline 0 C--O 1.233 0.216 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.299 -179.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.737 ' HD2' HD12 ' A' ' 76' ' ' LEU . 27.9 Cg_endo -63.66 127.32 19.45 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.383 2.055 . . . . 0.0 112.052 179.562 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.958 HG21 HD13 ' A' ' 69' ' ' ILE . 5.7 t -118.28 147.79 21.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.428 -179.423 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.674 HG21 HD23 ' A' ' 114' ' ' LEU . 2.0 mp -122.78 113.22 37.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.161 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.699 ' HA ' ' O ' ' A' ' 53' ' ' SER . 22.3 mm -99.31 144.22 12.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.568 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.561 ' O ' ' HB2' ' A' ' 102' ' ' LEU . 7.7 ttt -67.73 -67.22 0.48 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.47 -179.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.603 ' H ' ' CG2' ' A' ' 55' ' ' ILE . 3.7 m -106.45 169.65 8.39 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.524 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 1.036 ' HB1' HD23 ' A' ' 87' ' ' LEU . . . -124.22 -2.84 8.05 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -179.135 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.464 ' O ' ' O ' ' A' ' 83' ' ' ALA . 33.1 m170 31.23 -160.63 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 179.064 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 24.9 m -81.09 -22.58 39.05 Favored 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -178.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.489 ' HB2' HD13 ' A' ' 63' ' ' LEU . 67.4 m-20 -79.81 21.6 0.53 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 120.549 0.214 . . . . 0.0 111.324 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 1.036 HD23 ' HB1' ' A' ' 83' ' ' ALA . 3.1 tm? -43.68 -24.37 0.12 Allowed 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -49.03 -38.2 22.93 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.647 ' HB3' ' HB3' ' A' ' 63' ' ' LEU . . . -71.4 -22.94 61.8 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -179.034 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.676 ' HB2' HD23 ' A' ' 63' ' ' LEU . . . -73.45 -29.82 62.8 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.878 0.37 . . . . 0.0 110.476 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.623 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 3.0 t -61.74 -45.6 98.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.177 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.515 ' O ' ' HB3' ' A' ' 95' ' ' GLN . 83.7 p -67.46 -22.25 65.49 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 178.299 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' A' ' 90' ' ' ALA . . . -64.49 -39.73 94.34 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.306 0.574 . . . . 0.0 109.793 178.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.623 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 9.6 m-85 -69.19 -23.93 63.98 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.719 178.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.515 ' HB3' ' O ' ' A' ' 92' ' ' SER . 0.3 OUTLIER -67.59 -46.45 72.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.388 -179.949 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.627 ' O ' ' HB2' ' A' ' 75' ' ' MET . 4.5 pm0 -76.17 -18.14 59.24 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.751 179.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 117.7 33.9 1.24 Allowed Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.387 -0.911 . . . . 0.0 113.601 178.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.436 ' HB2' ' HB1' ' A' ' 93' ' ' ALA . . . -62.6 155.92 24.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.957 0.379 . . . . 0.0 110.553 179.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.597 ' CZ ' ' HB2' ' A' ' 118' ' ' ALA . 15.4 t80 -76.45 -53.69 7.77 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.032 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 168.46 -166.99 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.241 0.543 . . . . 0.0 111.799 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.525 ' CE2' ' HB ' ' A' ' 80' ' ' ILE . 3.2 m-85 -136.07 153.23 51.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.888 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.631 HD11 HD22 ' A' ' 114' ' ' LEU . 5.8 mp -102.22 120.26 54.05 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 120.595 0.236 . . . . 0.0 110.565 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -61.71 -67.33 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.116 1.877 . . . . 0.0 112.334 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.697 ' HB3' ' HD3' ' A' ' 105' ' ' PRO . 3.1 tttm -126.57 -53.04 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.074 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.697 ' HD3' ' HB3' ' A' ' 104' ' ' LYS . 31.8 Cg_exo -58.85 164.02 10.43 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.293 1.995 . . . . 0.0 112.311 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.681 ' O ' ' O ' ' A' ' 107' ' ' ASP . 74.2 t80 -169.38 -97.45 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.943 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.681 ' O ' ' O ' ' A' ' 106' ' ' PHE . 0.3 OUTLIER 37.53 177.3 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.26 0.553 . . . . 0.0 112.356 179.344 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.895 HG12 HG12 ' A' ' 18' ' ' VAL . 0.5 OUTLIER -68.18 -48.22 74.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.899 0.38 . . . . 0.0 111.998 -179.75 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -49.52 -58.7 4.71 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.913 -179.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.616 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 6.2 mm-40 -70.15 -30.75 67.99 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.811 0.339 . . . . 0.0 111.079 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -68.12 -62.17 1.52 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.063 179.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.635 ' O ' HG12 ' A' ' 115' ' ' VAL . 38.7 t -56.01 -34.24 37.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.36 0.6 . . . . 0.0 110.682 178.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.12 -45.9 91.43 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.389 179.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.674 HD23 HG21 ' A' ' 79' ' ' ILE . 5.2 tp -78.5 -21.52 48.82 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.56 -179.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.703 HG22 HG11 ' A' ' 50' ' ' VAL . 1.3 p -77.98 -36.34 21.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.613 -179.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -68.39 -41.08 81.03 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.098 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 5.6 mmt85 -60.47 -24.85 65.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.273 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.597 ' HB2' ' CZ ' ' A' ' 99' ' ' PHE . . . -71.3 -43.33 67.3 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.937 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.621 HD13 ' CD2' ' A' ' 28' ' ' LEU . 4.9 mt -73.57 -31.98 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.175 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 33.5 t -64.57 -42.32 95.72 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.947 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 14.5 m80 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.92 -179.941 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.732 ' HG3' HD11 ' A' ' 5' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.955 0.407 . . . . 0.0 111.231 . . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.473 ' C ' HD13 ' A' ' 5' ' ' ILE . . . 96.22 102.27 1.99 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.012 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.732 HD11 ' HG3' ' A' ' 3' ' ' ARG . 7.4 mm -114.13 114.14 45.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.956 0.408 . . . . 0.0 111.737 -179.382 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 1.025 HG11 HD13 ' A' ' 23' ' ' LEU . 3.5 p -114.07 119.81 62.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.128 178.751 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.952 ' CD1' HG22 ' A' ' 31' ' ' THR . 39.0 m0 -112.46 143.74 43.09 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.009 0.433 . . . . 0.0 110.698 -179.806 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.655 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -129.3 136.91 58.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.539 -178.807 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.897 HG11 ' HA2' ' A' ' 36' ' ' GLY . 3.0 m -115.64 110.09 30.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.625 178.947 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.531 ' OD1' ' HB ' ' A' ' 15' ' ' ILE . 1.9 p30 -164.05 -159.11 0.47 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.186 -178.052 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -66.45 -3.02 5.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.832 -179.619 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 66.41 -152.09 0.22 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.473 0.177 . . . . 0.0 111.271 179.359 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.456 ' OG ' ' N ' ' A' ' 14' ' ' SER . 72.0 p 34.89 -95.33 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 178.831 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.71 ' O ' HG23 ' A' ' 18' ' ' VAL . 8.2 t -52.79 -60.57 3.1 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.748 -178.984 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.531 ' HB ' ' OD1' ' A' ' 10' ' ' ASP . 9.9 mm -60.54 -24.99 33.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.684 0.278 . . . . 0.0 110.955 -179.781 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.699 ' HA ' HG21 ' A' ' 32' ' ' THR . 3.2 ttm-85 -71.48 -51.89 21.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.794 0.331 . . . . 0.0 110.594 179.494 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.402 ' HA ' ' CD ' ' A' ' 20' ' ' GLU . 40.8 t90 -59.3 -38.44 80.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.824 -179.516 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.71 HG23 ' O ' ' A' ' 14' ' ' SER . 18.1 t -65.65 -54.18 30.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -178.717 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.748 HD12 HD12 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -76.18 -26.43 56.19 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -178.235 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.631 ' HA ' ' CB ' ' A' ' 30' ' ' CYS . 10.7 pt-20 -67.82 -60.69 2.32 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.56 -0.456 . . . . 0.0 112.109 -178.874 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.501 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 4.5 mmm180 -57.89 -55.94 28.44 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.921 -179.098 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.44 -50.09 65.99 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -179.198 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 1.04 HD22 HD13 ' A' ' 28' ' ' LEU . 5.2 mt -69.44 -29.0 66.6 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.131 0.491 . . . . 0.0 110.16 179.532 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.1 -35.01 75.86 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.422 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.04 -28.09 69.92 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.048 -1.073 . . . . 0.0 110.462 177.762 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.72 ' HB3' HD11 ' A' ' 28' ' ' LEU . . . -78.53 -15.99 57.96 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 120.578 0.228 . . . . 0.0 110.88 179.173 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.86 27.11 13.09 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 120.482 -0.866 . . . . 0.0 114.491 178.665 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 1.04 HD13 HD22 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -118.04 167.53 11.37 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 118.407 1.104 . . . . 0.0 112.105 -179.921 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 98.7 m -88.28 117.23 27.04 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.941 179.223 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.631 ' CB ' ' HA ' ' A' ' 20' ' ' GLU . 3.1 m -108.96 110.19 21.43 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.661 -178.907 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.952 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.7 t -130.22 135.61 48.33 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 178.484 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.699 HG21 ' HA ' ' A' ' 16' ' ' ARG . 29.8 p -111.09 164.8 12.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.262 0.553 . . . . 0.0 111.915 -179.054 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.793 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 3.7 m-85 -136.39 172.17 13.41 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.302 -178.204 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.584 ' HG2' ' N ' ' A' ' 35' ' ' ASN . 0.1 OUTLIER -63.4 -32.63 74.12 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 121.445 0.64 . . . . 0.0 109.917 179.202 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.584 ' N ' ' HG2' ' A' ' 34' ' ' GLU . 8.1 t-20 179.81 170.2 1.14 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.994 -179.81 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.897 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . -43.43 -29.9 1.23 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.788 -0.72 . . . . 0.0 113.629 -179.238 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.47 ' HA ' ' HG ' ' A' ' 40' ' ' LEU . 0.4 OUTLIER -58.88 -51.48 69.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.737 0.304 . . . . 0.0 111.525 -179.48 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.793 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -51.91 -48.72 64.04 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.909 -0.316 . . . . 0.0 111.289 -179.531 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.621 HG22 ' CE1' ' A' ' 33' ' ' PHE . 79.5 t -60.7 -27.4 40.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.113 179.808 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.541 ' HG ' ' O ' ' A' ' 36' ' ' GLY . 33.9 mt -57.39 -46.88 82.96 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.222 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.31 -48.69 49.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.098 179.569 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.67 -31.6 68.34 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.832 179.818 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.695 HD21 ' HD2' ' A' ' 48' ' ' PRO . 16.1 mt -70.02 -25.03 63.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.485 -179.936 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.24 -19.6 14.68 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.913 -179.36 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.8 2.13 8.13 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -179.663 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.58 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -163.65 155.6 17.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.793 0.33 . . . . 0.0 110.733 179.712 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.622 HG23 ' CD2' ' A' ' 76' ' ' LEU . 87.4 m -139.09 112.71 8.12 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.466 179.92 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.695 ' HD2' HD21 ' A' ' 43' ' ' LEU . 94.7 Cg_endo -78.22 165.59 25.57 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.063 1.842 . . . . 0.0 110.914 178.538 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.633 ' OD2' HG12 ' A' ' 119' ' ' ILE . 4.8 p-10 -74.59 -59.58 2.67 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.659 -179.733 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.746 HG13 HG23 ' A' ' 6' ' ' VAL . 10.0 p -101.91 164.85 2.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.926 179.558 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.638 HD23 HG22 ' A' ' 78' ' ' VAL . 14.5 tp -153.45 143.04 21.82 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 120.733 0.301 . . . . 0.0 111.072 -179.765 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.602 ' HG ' ' HB ' ' A' ' 79' ' ' ILE . 0.2 OUTLIER -129.17 142.15 50.96 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.631 -0.258 . . . . 0.0 110.783 -179.922 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.798 ' HA ' HG23 ' A' ' 9' ' ' VAL . 3.0 m -129.48 137.05 50.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.005 0.431 . . . . 0.0 111.494 -179.864 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.471 ' HB3' ' HB3' ' A' ' 10' ' ' ASP . 20.7 p-10 -77.87 -18.03 56.68 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.745 -178.712 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.579 HG13 ' HA3' ' A' ' 62' ' ' GLY . 0.7 OUTLIER 45.28 91.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-O 120.823 0.344 . . . . 0.0 111.255 -179.779 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.0 49.66 2.25 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -179.108 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.476 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 1.1 ttt 57.01 51.01 4.99 Favored Pre-proline 0 N--CA 1.466 0.364 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 178.715 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 62' ' ' GLY . 42.8 Cg_endo -69.26 -78.87 0.01 OUTLIER 'Trans proline' 0 CA--C 1.533 0.428 0 C-N-CA 122.75 2.3 . . . . 0.0 112.102 178.685 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -112.2 -20.81 6.51 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 121.262 -0.494 . . . . 0.0 112.09 179.603 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 1.001 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 0.8 OUTLIER -159.99 66.38 0.36 Allowed 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.084 0.469 . . . . 0.0 110.266 179.725 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.476 ' HA ' ' HA ' ' A' ' 57' ' ' MET . 0.9 OUTLIER 68.29 -23.56 0.13 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.321 179.746 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.607 ' N ' ' HD2' ' A' ' 58' ' ' PRO . . . 140.21 -31.67 2.24 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 111.286 -0.726 . . . . 0.0 111.286 -179.604 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.657 HD12 ' H ' ' A' ' 63' ' ' LEU . 2.4 mp -66.74 -28.23 68.25 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 178.92 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 1.001 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -53.79 -28.72 36.67 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.352 0.596 . . . . 0.0 109.791 178.074 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.705 ' CD2' HD11 ' A' ' 69' ' ' ILE . 4.9 tt -51.67 -57.06 10.27 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.343 179.243 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.726 HD13 ' CB ' ' A' ' 93' ' ' ALA . 1.9 mt -55.76 -40.99 73.34 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.746 -1.116 . . . . 0.0 110.692 179.91 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.531 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -47.72 -49.11 28.97 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 120.792 0.33 . . . . 0.0 111.039 179.197 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -69.22 -32.21 71.3 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.028 0.442 . . . . 0.0 110.831 -179.948 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.705 HD11 ' CD2' ' A' ' 65' ' ' LEU . 81.3 mt -60.75 -40.85 86.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.535 -179.222 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.531 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -74.61 -27.9 60.67 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.767 -179.666 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.0 -41.95 67.02 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.674 -178.925 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 72' ' ' ARG . 1.0 OUTLIER -94.84 -26.42 16.21 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.377 -0.374 . . . . 0.0 112.007 -179.15 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.585 ' HD2' HG23 ' A' ' 69' ' ' ILE . 1.3 m-70 -124.52 168.45 13.08 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-O 120.749 0.309 . . . . 0.0 111.173 -179.421 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.492 ' HD2' ' HB3' ' A' ' 73' ' ' HIS . 35.5 Cg_endo -69.6 -83.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.339 2.026 . . . . 0.0 112.723 -179.373 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.435 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 8.0 mtm -146.71 55.44 1.13 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.734 0.302 . . . . 0.0 111.406 -179.626 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.622 ' CD2' HG23 ' A' ' 47' ' ' THR . 0.1 OUTLIER -57.22 111.09 2.96 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.427 179.811 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.615 ' HD2' HD13 ' A' ' 76' ' ' LEU . 38.6 Cg_exo -58.68 115.62 2.67 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.264 1.976 . . . . 0.0 112.593 179.841 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.962 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 5.0 t -117.59 145.96 22.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.951 179.622 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.602 ' HB ' ' HG ' ' A' ' 52' ' ' LEU . 1.6 mp -117.52 112.61 39.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 179.147 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.785 HG13 ' CZ ' ' A' ' 101' ' ' TYR . 16.5 mm -93.7 130.65 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -178.205 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.667 ' HB2' ' CD2' ' A' ' 106' ' ' PHE . 6.7 ptm -72.43 -29.8 64.03 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.693 -179.968 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.568 ' H ' HG21 ' A' ' 55' ' ' ILE . 5.3 m -135.6 138.3 42.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.386 -179.433 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.571 ' HA ' ' CE2' ' A' ' 101' ' ' TYR . . . -89.71 -27.05 20.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.574 179.957 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.534 ' CE1' HG21 ' A' ' 82' ' ' THR . 3.2 m-70 44.72 -159.74 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.286 179.609 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.423 ' H ' ' HB3' ' A' ' 84' ' ' HIS . 2.6 t -81.41 164.31 22.18 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.937 0.399 . . . . 0.0 111.415 -179.529 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.406 ' O ' HD22 ' A' ' 63' ' ' LEU . 0.2 OUTLIER 72.07 31.24 2.01 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.746 179.99 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.607 HD23 ' CB ' ' A' ' 90' ' ' ALA . 1.1 mt -45.8 -21.84 0.15 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.793 -0.639 . . . . 0.0 112.502 -179.812 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -48.11 -44.23 31.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.617 0.246 . . . . 0.0 111.042 -179.657 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.505 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -67.25 -20.55 65.68 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.191 179.902 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.61 ' O ' ' HB3' ' A' ' 93' ' ' ALA . . . -62.35 -50.5 71.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.886 -179.777 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.587 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 6.3 t -67.72 -45.47 84.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.41 179.587 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.678 ' O ' ' HG3' ' A' ' 95' ' ' GLN . 9.8 m -61.56 -14.07 26.83 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.088 0.471 . . . . 0.0 109.835 178.24 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.726 ' CB ' HD13 ' A' ' 66' ' ' LEU . . . -75.66 -53.25 8.86 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.399 179.724 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.667 ' CE1' ' HA ' ' A' ' 100' ' ' ASP . 4.8 m-85 -55.81 -34.78 65.66 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.142 -178.805 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.678 ' HG3' ' O ' ' A' ' 92' ' ' SER . 1.8 pp0? -74.37 -34.14 63.26 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.242 -179.755 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.507 ' HG2' ' HA ' ' A' ' 93' ' ' ALA . 9.3 pt20 -100.29 11.29 39.75 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.141 -179.344 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 119.43 78.26 0.56 Allowed Glycine 0 C--N 1.334 0.441 0 C-N-CA 120.314 -0.946 . . . . 0.0 113.474 179.79 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.962 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -169.04 134.89 1.66 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.08 0.467 . . . . 0.0 111.623 178.966 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.724 ' CD2' ' HB2' ' A' ' 118' ' ' ALA . 3.5 t80 -74.96 -52.53 10.94 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.237 -179.673 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.667 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 0.9 OUTLIER 179.15 -167.71 0.08 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.247 0.546 . . . . 0.0 111.955 -179.831 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.785 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 4.9 m-85 -136.04 153.17 51.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.275 -179.685 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.602 HD23 ' HA ' ' A' ' 81' ' ' MET . 1.7 mm? -102.82 120.7 51.81 Favored Pre-proline 0 C--N 1.329 -0.299 0 C-N-CA 121.081 -0.247 . . . . 0.0 110.83 179.51 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -66.26 -78.7 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.318 2.012 . . . . 0.0 112.395 -179.838 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.648 ' HB3' ' HD3' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -108.81 -58.18 0.05 OUTLIER Pre-proline 0 C--O 1.232 0.175 0 C-N-CA 121.185 -0.206 . . . . 0.0 111.425 179.949 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.648 ' HD3' ' HB3' ' A' ' 104' ' ' LYS . 77.0 Cg_endo -79.07 163.03 25.79 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 121.693 1.595 . . . . 0.0 110.726 178.933 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.717 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 0.9 OUTLIER 177.58 -91.38 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 121.3 -0.16 . . . . 0.0 111.262 179.936 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.511 ' O ' ' CB ' ' A' ' 111' ' ' ALA . 2.7 p30 44.04 -165.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 -179.442 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.534 HG12 HG12 ' A' ' 18' ' ' VAL . 1.0 OUTLIER -66.67 -43.83 90.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 120.744 -0.383 . . . . 0.0 111.528 -179.727 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.471 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 8.6 t70 -48.84 -58.33 4.98 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.192 -179.684 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.717 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 5.2 mm-40 -78.23 -32.61 49.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.552 -179.68 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.511 ' CB ' ' O ' ' A' ' 107' ' ' ASP . . . -65.92 -59.58 3.7 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 179.398 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.709 ' O ' HG12 ' A' ' 115' ' ' VAL . 56.0 t -59.58 -29.85 43.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.452 0.644 . . . . 0.0 110.195 178.877 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.471 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -66.49 -46.76 75.23 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.566 178.759 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.521 HD23 ' CG2' ' A' ' 79' ' ' ILE . 15.2 tp -74.81 -20.76 59.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.205 179.859 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.709 HG12 ' O ' ' A' ' 112' ' ' VAL . 5.5 p -79.31 -48.43 21.17 Favored 'Isoleucine or valine' 0 C--O 1.231 0.088 0 CA-C-O 120.841 0.353 . . . . 0.0 111.44 179.985 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.629 ' HA ' HD12 ' A' ' 119' ' ' ILE . 35.6 mt-10 -63.5 -38.13 89.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.938 -179.967 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 13.6 mmt180 -65.24 -24.88 67.45 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.901 179.761 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.724 ' HB2' ' CD2' ' A' ' 99' ' ' PHE . . . -74.42 -39.63 62.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.222 179.935 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.633 HG12 ' OD2' ' A' ' 49' ' ' ASP . 4.9 mt -71.74 -30.67 38.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.135 0.493 . . . . 0.0 110.72 179.873 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 24.3 t -67.71 -35.77 79.38 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.02 179.823 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 25.9 m80 . . . . . 0 C--N 1.33 -0.263 0 CA-C-O 120.897 0.38 . . . . 0.0 111.161 -179.804 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.408 ' HG3' HD11 ' A' ' 5' ' ' ILE . 10.2 ptt-85 . . . . . 0 C--O 1.231 0.121 0 CA-C-O 121.039 0.447 . . . . 0.0 111.828 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.416 ' C ' HD13 ' A' ' 5' ' ' ILE . . . 98.85 102.12 2.31 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.964 -0.636 . . . . 0.0 111.879 -179.301 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.439 ' HB ' ' HA ' ' A' ' 48' ' ' PRO . 8.4 mm -111.12 112.78 42.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.887 0.375 . . . . 0.0 111.351 -179.393 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.92 HG23 HG13 ' A' ' 50' ' ' VAL . 7.7 p -109.06 123.47 64.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.818 179.459 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.955 ' CD1' HG22 ' A' ' 31' ' ' THR . 40.5 m0 -113.68 133.7 55.17 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.686 -179.798 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.567 HG13 ' HB3' ' A' ' 52' ' ' LEU . 0.6 OUTLIER -119.43 145.79 25.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.997 0.427 . . . . 0.0 111.965 -179.106 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.806 HG11 ' HA2' ' A' ' 36' ' ' GLY . 0.0 OUTLIER -123.96 110.63 26.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.095 0.474 . . . . 0.0 110.985 178.999 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.418 ' CB ' HG21 ' A' ' 15' ' ' ILE . 5.0 t0 -161.17 -163.45 1.02 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.78 -179.549 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -66.66 -1.73 4.08 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -178.788 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.529 ' O ' ' N ' ' A' ' 14' ' ' SER . 1.2 t70 65.24 -141.85 0.21 Allowed 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 121.027 -0.269 . . . . 0.0 110.61 179.338 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.486 ' HA ' ' HE ' ' A' ' 16' ' ' ARG . 1.0 OUTLIER 35.29 -82.21 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 179.07 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.758 ' O ' HG23 ' A' ' 18' ' ' VAL . 1.8 m -80.17 -44.4 19.91 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -178.71 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.418 HG21 ' CB ' ' A' ' 10' ' ' ASP . 27.3 mm -65.24 -33.74 65.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 -178.773 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.809 ' HA ' HG21 ' A' ' 32' ' ' THR . 2.4 ppt_? -72.42 -55.27 7.32 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.881 -179.279 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.422 ' N ' ' HD2' ' A' ' 16' ' ' ARG . 81.4 t90 -48.12 -41.95 27.89 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -178.9 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.943 HG12 HD13 ' A' ' 108' ' ' ILE . 0.8 OUTLIER -73.11 -57.48 6.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.137 0.494 . . . . 0.0 112.252 -178.557 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 1.046 HD12 HD12 ' A' ' 108' ' ' ILE . 7.3 mp -65.02 -30.94 71.95 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.573 -0.739 . . . . 0.0 112.567 -177.912 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.523 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 19.9 pt-20 -67.77 -59.18 3.51 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.877 0.37 . . . . 0.0 111.484 -179.63 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.473 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 6.2 mmm180 -56.9 -51.45 69.06 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.586 -179.623 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.567 ' HB3' HD11 ' A' ' 108' ' ' ILE . . . -59.47 -43.56 93.23 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 120.876 0.37 . . . . 0.0 111.589 -179.355 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.855 ' CD2' HG11 ' A' ' 6' ' ' VAL . 2.1 tp -74.09 -24.58 59.5 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.214 179.634 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.47 -35.16 75.34 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.357 178.374 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.9 -26.09 69.81 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.522 -0.847 . . . . 0.0 111.283 178.656 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.595 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -76.68 -16.15 59.6 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 120.677 0.275 . . . . 0.0 111.246 179.636 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.46 26.65 8.05 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 120.45 -0.881 . . . . 0.0 114.374 178.748 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.783 HD13 ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -125.72 170.83 11.16 Favored 'General case' 0 C--O 1.231 0.079 0 CA-C-N 118.28 1.04 . . . . 0.0 112.018 179.943 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 31.5 m -99.25 105.96 18.05 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.807 179.954 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.618 ' HA ' HG13 ' A' ' 6' ' ' VAL . 4.7 t -98.29 117.1 31.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.583 -179.675 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.955 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.2 t -126.66 130.92 51.37 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 178.401 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.809 HG21 ' HA ' ' A' ' 16' ' ' ARG . 60.4 p -103.26 164.51 11.59 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -177.713 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.718 ' CE1' HG23 ' A' ' 31' ' ' THR . 3.4 m-85 -135.92 174.48 10.56 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.936 -178.057 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.75 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 2.9 pp20? -61.36 -40.13 93.16 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -177.561 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.408 ' O ' ' HB ' ' A' ' 9' ' ' VAL . 1.4 t-20 -168.31 -46.66 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -179.165 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.833 ' CA ' HD21 ' A' ' 65' ' ' LEU . . . -176.73 -47.48 0.06 OUTLIER Glycine 0 C--N 1.32 -0.318 0 C-N-CA 120.178 -1.011 . . . . 0.0 113.628 -178.907 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -65.77 -27.94 68.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.896 0.379 . . . . 0.0 111.168 -179.2 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.75 ' HB2' ' HG3' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -58.62 -53.39 58.84 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.052 179.997 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.743 HG12 ' CD1' ' A' ' 43' ' ' LEU . 8.2 t -51.94 -49.01 39.38 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.145 0 C-N-CA 120.39 -0.524 . . . . 0.0 109.925 179.683 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.802 HD13 ' HB3' ' A' ' 68' ' ' GLN . 22.3 mt -48.18 -42.55 30.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.08 179.879 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.62 -49.57 62.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.232 0.539 . . . . 0.0 110.862 179.576 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.14 -26.41 68.8 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.712 179.552 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.774 HD13 ' NE2' ' A' ' 73' ' ' HIS . 1.3 mt -69.7 -27.12 64.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.465 -178.918 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.46 -21.04 1.31 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.84 -179.556 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 29.9 t -126.09 6.56 7.2 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -179.435 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.54 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.3 OUTLIER -166.44 156.44 11.9 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.974 0.416 . . . . 0.0 111.451 179.969 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 1.023 HG23 HD12 ' A' ' 76' ' ' LEU . 98.2 m -139.09 112.51 8.1 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.22 179.616 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.613 ' CD ' HD11 ' A' ' 76' ' ' LEU . 57.7 Cg_endo -71.82 165.13 33.48 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 121.873 1.716 . . . . 0.0 111.027 178.974 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -76.43 -22.66 54.38 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.691 -0.403 . . . . 0.0 111.232 -179.795 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.92 HG13 HG23 ' A' ' 6' ' ' VAL . 9.1 p -145.55 165.48 10.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 116.679 -0.237 . . . . 0.0 111.222 -179.666 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.764 HD12 ' O ' ' A' ' 7' ' ' TRP . 12.1 tp -152.69 136.31 16.07 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.999 0.428 . . . . 0.0 111.561 -179.353 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.567 ' HB3' HG13 ' A' ' 8' ' ' VAL . 0.6 OUTLIER -122.85 117.29 25.28 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.509 -179.991 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.481 ' OG ' HD13 ' A' ' 65' ' ' LEU . 3.3 m -105.76 134.53 48.73 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.232 0.539 . . . . 0.0 111.705 -179.667 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -83.08 16.04 2.55 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -178.938 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.774 HG22 ' HG2' ' A' ' 81' ' ' MET . 1.1 tt 31.53 -107.75 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 179.434 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.478 ' N ' ' CG1' ' A' ' 55' ' ' ILE . 3.5 ttt180 54.16 43.42 30.67 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 179.618 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.524 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 1.0 OUTLIER 48.25 63.78 9.73 Favored Pre-proline 0 N--CA 1.468 0.44 0 N-CA-C 113.472 0.915 . . . . 0.0 113.472 178.694 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.604 ' HD2' ' N ' ' A' ' 62' ' ' GLY . 55.9 Cg_endo -73.86 -78.23 0.01 OUTLIER 'Trans proline' 0 CA--C 1.533 0.434 0 C-N-CA 122.419 2.079 . . . . 0.0 111.248 177.948 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -109.61 -28.55 4.23 Favored Glycine 0 C--N 1.335 0.477 0 C-N-CA 121.127 -0.559 . . . . 0.0 112.16 179.068 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 1.025 ' HB3' ' HB2' ' A' ' 64' ' ' ALA . 0.4 OUTLIER -152.42 65.19 0.82 Allowed 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.173 0.511 . . . . 0.0 110.048 179.544 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.654 ' O ' HG13 ' A' ' 55' ' ' ILE . 0.4 OUTLIER 68.07 -25.29 0.13 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.184 -0.917 . . . . 0.0 112.161 -179.788 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.604 ' N ' ' HD2' ' A' ' 58' ' ' PRO . . . 141.84 -31.92 2.06 Favored Glycine 0 CA--C 1.502 -0.728 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 179.981 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.842 HD11 ' HB2' ' A' ' 85' ' ' SER . 1.2 mp -70.61 -16.75 62.87 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 115.068 -0.566 . . . . 0.0 110.044 179.124 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 1.025 ' HB2' ' HB3' ' A' ' 60' ' ' MET . . . -53.5 -39.26 64.45 Favored 'General case' 0 CA--C 1.522 -0.098 0 CA-C-O 121.312 0.577 . . . . 0.0 109.768 178.115 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.833 HD21 ' CA ' ' A' ' 36' ' ' GLY . 6.8 mt -62.3 -39.18 92.13 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.885 179.755 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.789 HD23 ' HA ' ' A' ' 63' ' ' LEU . 1.2 mm? -59.02 -44.12 91.68 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.272 0.558 . . . . 0.0 109.804 179.165 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.639 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -57.98 -43.7 86.7 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.729 179.474 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.802 ' HB3' HD13 ' A' ' 40' ' ' LEU . 30.3 mm100 -73.93 -38.41 64.28 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.659 179.692 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.811 HG21 HG22 ' A' ' 78' ' ' VAL . 17.1 mt -63.5 -36.0 74.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.364 -179.247 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.639 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -75.41 -26.64 58.57 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.056 -179.57 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.518 ' NE2' ' HG3' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -86.21 -32.62 21.09 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.603 -179.351 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.518 ' HG3' ' NE2' ' A' ' 71' ' ' GLN . 0.6 OUTLIER -95.41 -23.44 17.15 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.154 0.428 . . . . 0.0 112.154 -179.692 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.802 ' CE1' HG23 ' A' ' 69' ' ' ILE . 0.2 OUTLIER -111.11 135.23 20.9 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-O 120.673 0.273 . . . . 0.0 111.667 -179.07 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -59.76 -54.41 2.43 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.41 2.073 . . . . 0.0 112.082 179.116 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.449 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 22.2 mtt -156.47 36.74 0.32 Allowed 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.227 -179.9 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 1.023 HD12 HG23 ' A' ' 47' ' ' THR . 0.7 OUTLIER -71.13 121.79 85.18 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.379 -179.891 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.448 ' HD2' HD23 ' A' ' 76' ' ' LEU . 15.7 Cg_exo -68.58 121.86 8.8 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.586 2.19 . . . . 0.0 112.762 -179.708 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.811 HG22 HG21 ' A' ' 69' ' ' ILE . 11.4 t -99.21 141.02 17.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.843 179.302 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.964 HD13 HG23 ' A' ' 115' ' ' VAL . 2.4 mt -127.07 110.67 23.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.945 179.853 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.545 ' HB ' ' CD2' ' A' ' 101' ' ' TYR . 5.4 mm -101.17 142.12 16.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.104 -179.926 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.774 ' HG2' HG22 ' A' ' 55' ' ' ILE . 26.5 ptm -66.66 -56.51 10.3 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.943 179.607 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.682 ' O ' HD13 ' A' ' 55' ' ' ILE . 2.8 m -131.06 152.21 50.6 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 121.771 -0.581 . . . . 0.0 112.152 -179.809 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.968 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -116.71 46.18 1.68 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.825 -179.796 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 17.1 p80 -77.23 56.65 1.33 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.666 0.269 . . . . 0.0 111.192 -179.98 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.842 ' HB2' HD11 ' A' ' 63' ' ' LEU . 0.7 OUTLIER -159.64 -160.63 0.84 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 121.046 0.45 . . . . 0.0 111.67 -179.642 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.79 90.05 0.17 Allowed 'General case' 0 CA--C 1.528 0.097 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.834 179.559 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.761 HD13 ' HB3' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -44.44 -21.29 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -179.965 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -48.12 -53.66 15.87 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -178.975 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.554 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -66.46 -22.04 66.2 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.642 0.258 . . . . 0.0 111.446 -179.648 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.761 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -76.97 -42.91 37.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.754 0.311 . . . . 0.0 110.965 -179.865 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.561 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 13.6 t -64.69 -41.17 91.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.234 179.79 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 19.8 m -61.06 -36.08 78.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.922 179.0 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.549 ' HB1' ' HB2' ' A' ' 98' ' ' ALA . . . -55.76 -45.44 78.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.644 179.622 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.561 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 7.4 m-85 -55.16 -25.02 29.53 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.525 179.507 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.61 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -72.19 -40.77 67.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.337 179.688 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.61 ' N ' ' HG2' ' A' ' 95' ' ' GLN . 1.6 pt20 -76.03 -18.13 59.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.547 -179.6 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 134.32 -8.78 4.71 Favored Glycine 0 CA--C 1.521 0.45 0 C-N-CA 120.318 -0.944 . . . . 0.0 113.508 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.805 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -43.67 143.92 0.91 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 117.268 0.534 . . . . 0.0 111.505 -179.817 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.434 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 39.5 t80 -80.73 -54.63 5.46 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 121.049 -0.26 . . . . 0.0 111.232 -179.59 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 166.71 -168.23 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.06 0.457 . . . . 0.0 111.546 179.582 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.968 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 9.2 m-85 -118.3 152.63 35.41 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.654 178.948 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.909 HD13 HD22 ' A' ' 114' ' ' LEU . 19.6 tp -102.58 144.63 29.01 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-O 120.926 0.394 . . . . 0.0 111.5 -178.411 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.504 ' HD2' ' CD1' ' A' ' 102' ' ' LEU . 79.2 Cg_endo -80.22 -160.56 0.13 Allowed 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.513 2.142 . . . . 0.0 113.01 -179.399 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.503 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -42.15 -54.03 7.96 Favored Pre-proline 0 CA--C 1.534 0.347 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -179.165 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.503 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 18.2 Cg_endo -59.19 156.71 33.42 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.033 1.822 . . . . 0.0 112.39 -179.287 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.853 ' CD1' HD23 ' A' ' 102' ' ' LEU . 60.2 m-85 -157.36 -109.45 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.156 -179.924 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.505 ' O ' ' O ' ' A' ' 106' ' ' PHE . 2.6 p30 44.75 -179.48 0.0 OUTLIER 'General case' 0 C--O 1.227 -0.119 0 CA-C-O 121.336 0.588 . . . . 0.0 111.248 -179.579 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 1.046 HD12 HD12 ' A' ' 19' ' ' LEU . 0.5 OUTLIER -64.06 -53.64 41.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-O 121.473 0.654 . . . . 0.0 112.324 -179.788 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.629 ' N ' HG23 ' A' ' 108' ' ' ILE . 1.0 OUTLIER -49.16 -52.91 23.54 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 114.947 -1.024 . . . . 0.0 111.961 -178.014 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.682 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 2.0 mm-40 -81.51 -27.78 34.32 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -179.13 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.44 ' CB ' ' O ' ' A' ' 107' ' ' ASP . . . -76.39 -55.39 5.59 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.252 179.933 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.619 ' O ' HG12 ' A' ' 115' ' ' VAL . 61.8 t -59.01 -30.47 43.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.502 0.668 . . . . 0.0 110.061 178.55 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.491 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -62.04 -46.61 88.4 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.492 -0.777 . . . . 0.0 110.587 179.345 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.909 HD22 HD13 ' A' ' 102' ' ' LEU . 21.5 tp -71.36 -26.71 62.92 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.108 -0.951 . . . . 0.0 112.127 -178.764 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.964 HG23 HD13 ' A' ' 79' ' ' ILE . 4.3 p -79.35 -40.04 21.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.886 0.374 . . . . 0.0 111.57 -179.805 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -67.31 -43.97 80.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.282 -179.448 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.643 ' HD3' ' HA ' ' A' ' 114' ' ' LEU . 6.7 ptm180 -60.09 -23.64 63.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.64 0.257 . . . . 0.0 110.827 179.807 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.434 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -72.16 -50.11 30.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.763 179.203 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.751 HD11 HG11 ' A' ' 50' ' ' VAL . 3.9 mt -69.65 -34.52 61.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.274 0.559 . . . . 0.0 110.649 179.554 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.3 t -63.49 -38.93 93.04 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.002 -179.958 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.075 -179.907 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.616 ' HB3' HD11 ' A' ' 5' ' ' ILE . 0.8 OUTLIER . . . . . 0 N--CA 1.456 -0.154 0 CA-C-O 120.95 0.405 . . . . 0.0 110.942 . . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.509 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . 56.54 85.94 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.05 -179.534 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.616 HD11 ' HB3' ' A' ' 3' ' ' ARG . 3.5 mp -116.81 117.62 56.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.74 0.305 . . . . 0.0 111.565 -179.292 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.833 HG23 HG13 ' A' ' 50' ' ' VAL . 5.4 p -104.95 129.22 57.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.722 179.414 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.925 ' CD1' HG22 ' A' ' 31' ' ' THR . 28.2 m0 -116.38 130.49 56.8 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.789 179.248 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.545 HG11 HD23 ' A' ' 19' ' ' LEU . 1.6 t -114.43 135.71 53.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.503 -177.919 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.853 HG13 HG23 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -121.0 106.39 18.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.329 -0.396 . . . . 0.0 109.999 179.43 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.414 ' OD2' HG21 ' A' ' 15' ' ' ILE . 2.9 p30 -161.17 -160.85 0.76 Allowed 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.215 -177.887 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -66.3 -2.77 4.76 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -178.663 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 67.69 -150.12 0.16 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 121.199 -0.201 . . . . 0.0 111.177 179.268 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.438 ' OG ' ' N ' ' A' ' 14' ' ' SER . 60.1 p 34.78 -97.72 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 179.205 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.789 ' O ' HG23 ' A' ' 18' ' ' VAL . 12.5 t -53.17 -57.43 10.49 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.686 -0.234 . . . . 0.0 111.598 -179.069 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.414 HG21 ' OD2' ' A' ' 10' ' ' ASP . 17.6 mm -61.37 -25.1 35.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.78 0.324 . . . . 0.0 111.546 -179.854 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.952 ' HA ' HG21 ' A' ' 32' ' ' THR . 5.8 ttm180 -70.89 -54.54 11.07 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.103 179.919 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.427 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 84.7 t90 -60.79 -43.57 97.95 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -179.03 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.789 HG23 ' O ' ' A' ' 14' ' ' SER . 4.6 t -64.73 -46.15 93.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.67 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.545 HD23 HG11 ' A' ' 8' ' ' VAL . 11.9 tp -84.13 -23.16 30.8 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -178.198 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.508 ' HG3' ' N ' ' A' ' 21' ' ' ARG . 15.1 pt-20 -67.46 -58.85 4.01 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.194 -0.602 . . . . 0.0 111.321 -179.277 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.508 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 3.1 mmm180 -59.73 -50.42 73.9 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.689 -179.396 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.29 -48.48 71.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.881 0.372 . . . . 0.0 111.713 -179.343 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.805 ' HG ' HG11 ' A' ' 6' ' ' VAL . 2.4 tm? -70.06 -30.27 67.48 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.393 0.616 . . . . 0.0 110.516 179.972 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.09 -31.94 72.77 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 178.298 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.31 -28.34 70.78 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 178.029 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.595 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -77.26 -15.67 59.35 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 120.82 0.343 . . . . 0.0 110.711 179.159 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 94.71 26.4 13.24 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.729 -0.748 . . . . 0.0 114.373 178.552 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.626 ' HB2' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -126.12 166.32 17.23 Favored 'General case' 0 C--N 1.334 -0.066 0 CA-C-N 118.27 1.035 . . . . 0.0 112.379 179.892 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.599 ' O ' HG12 ' A' ' 6' ' ' VAL . 93.4 m -81.34 127.47 32.78 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.591 -179.745 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 2.4 p -123.61 116.75 23.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.935 -178.947 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.925 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.4 t -129.12 133.46 47.65 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.396 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.952 HG21 ' HA ' ' A' ' 16' ' ' ARG . 44.1 p -105.92 162.73 13.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.209 0.528 . . . . 0.0 112.114 -178.393 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.795 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 1.2 m-85 -131.56 172.22 12.49 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.775 -178.017 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.737 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 2.9 pp20? -63.55 -42.57 98.36 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -178.786 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -166.3 -59.76 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.224 0.535 . . . . 0.0 111.707 -178.983 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.782 ' HA3' HD22 ' A' ' 65' ' ' LEU . . . -162.98 -53.34 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.463 -0.79 . . . . 0.0 112.501 -179.485 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.706 ' HA ' HD12 ' A' ' 40' ' ' LEU . 0.8 OUTLIER -49.39 -28.4 5.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.996 0.427 . . . . 0.0 111.299 -179.817 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.795 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 2.1 tp10 -62.0 -56.74 15.94 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.253 179.919 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.853 HG23 HG13 ' A' ' 9' ' ' VAL . 38.6 t -60.52 -31.89 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.102 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.542 179.398 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.724 HD13 ' HB3' ' A' ' 68' ' ' GLN . 46.2 mt -55.21 -43.85 74.82 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.305 179.183 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -80.79 -48.71 12.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.142 -179.892 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.422 ' HB3' ' HE2' ' A' ' 33' ' ' PHE . . . -56.73 -30.94 64.05 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.317 -179.762 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.554 ' HG ' HG12 ' A' ' 39' ' ' VAL . 27.4 mt -64.26 -23.56 67.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.909 0.385 . . . . 0.0 111.323 179.986 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.95 -15.5 32.05 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.587 -179.911 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 31.4 t -119.47 -7.51 10.16 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.519 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.455 ' HB3' ' CH2' ' A' ' 7' ' ' TRP . 0.0 OUTLIER -164.61 163.17 21.83 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.891 0.377 . . . . 0.0 111.413 -179.866 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 51.8 m -138.48 113.61 8.71 Favored Pre-proline 0 N--CA 1.452 -0.331 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.264 179.855 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.741 ' HD2' HD11 ' A' ' 76' ' ' LEU . 57.1 Cg_endo -71.14 149.06 57.5 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.546 2.164 . . . . 0.0 111.672 179.228 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -74.07 -22.88 59.34 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.185 -179.743 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.835 HG11 HD11 ' A' ' 119' ' ' ILE . 6.3 p -149.02 98.23 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.751 -179.349 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.555 HD12 ' O ' ' A' ' 7' ' ' TRP . 38.9 tp -87.13 144.48 26.84 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.902 0.382 . . . . 0.0 111.863 -179.276 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.602 ' O ' HG23 ' A' ' 9' ' ' VAL . 1.0 OUTLIER -124.29 115.06 20.41 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.69 179.65 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.696 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 0.6 OUTLIER -115.23 134.03 55.5 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 121.567 0.699 . . . . 0.0 112.02 -179.337 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.08 -176.91 6.57 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.756 179.695 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.852 HG12 ' HA3' ' A' ' 62' ' ' GLY . 0.0 OUTLIER -149.17 108.62 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.492 179.623 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.467 ' O ' ' HG3' ' A' ' 57' ' ' MET . 0.1 OUTLIER -161.3 73.62 0.45 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.827 -179.463 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.467 ' HG3' ' O ' ' A' ' 56' ' ' ARG . 1.8 ptt? 38.85 51.45 3.14 Favored Pre-proline 0 CA--C 1.535 0.382 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 178.536 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.531 ' CG ' ' HA2' ' A' ' 62' ' ' GLY . 54.4 Cg_endo -76.4 -73.04 0.01 OUTLIER 'Trans proline' 0 CA--C 1.529 0.243 0 C-N-CA 122.215 1.944 . . . . 0.0 111.658 178.365 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -117.7 -27.06 2.65 Favored Glycine 0 CA--C 1.52 0.385 0 N-CA-C 111.835 -0.506 . . . . 0.0 111.835 179.172 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 1.059 ' HB3' ' HB2' ' A' ' 64' ' ' ALA . 4.4 tpt -159.44 69.6 0.45 Allowed 'General case' 0 C--O 1.236 0.358 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.318 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.445 ' O ' HG12 ' A' ' 55' ' ' ILE . 0.2 OUTLIER 68.82 -25.76 0.14 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.406 -0.816 . . . . 0.0 112.327 -179.951 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.852 ' HA3' HG12 ' A' ' 55' ' ' ILE . . . 142.13 -30.7 2.12 Favored Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -179.723 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.558 ' H ' HD12 ' A' ' 63' ' ' LEU . 3.3 mp -71.76 -21.36 61.75 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.456 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 1.059 ' HB2' ' HB3' ' A' ' 60' ' ' MET . . . -53.68 -42.38 67.88 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.008 0.433 . . . . 0.0 110.461 179.007 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.782 HD22 ' HA3' ' A' ' 36' ' ' GLY . 15.9 mt -51.54 -50.28 60.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.134 179.5 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.736 HD11 HG13 ' A' ' 80' ' ' ILE . 17.2 mt -52.12 -56.78 12.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.542 179.632 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.562 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 28.4 mttp -41.19 -47.68 3.34 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.669 -179.277 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.724 ' HB3' HD13 ' A' ' 40' ' ' LEU . 60.1 mm-40 -69.27 -35.9 76.54 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.278 -179.547 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.832 HG22 ' CD2' ' A' ' 73' ' ' HIS . 59.0 mt -54.07 -46.45 66.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.08 179.881 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.594 ' HA ' ' CE1' ' A' ' 73' ' ' HIS . 0.0 OUTLIER -70.96 -26.72 63.29 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -179.619 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -61.87 -30.23 70.72 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.218 -178.839 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.438 ' HD3' ' HB3' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -90.2 -59.73 2.11 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.405 0.621 . . . . 0.0 111.409 179.669 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.832 ' CD2' HG22 ' A' ' 69' ' ' ILE . 3.8 p80 -81.22 172.52 9.55 Favored Pre-proline 0 C--N 1.318 -0.779 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.557 -179.183 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.499 ' HD2' ' HB2' ' A' ' 73' ' ' HIS . 73.4 Cg_endo -87.33 -52.8 0.03 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.948 2.432 . . . . 0.0 112.073 179.015 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.638 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 28.7 mtt -157.48 49.51 0.43 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.071 179.213 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.741 HD11 ' HD2' ' A' ' 48' ' ' PRO . 2.1 tt -64.94 114.0 13.21 Favored Pre-proline 0 N--CA 1.454 -0.247 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.978 179.886 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -64.71 115.45 3.24 Favored 'Trans proline' 0 CA--C 1.528 0.206 0 C-N-CA 122.389 2.06 . . . . 0.0 112.635 -179.796 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 1.007 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 5.3 t -115.51 154.45 16.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.104 179.909 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.562 HD11 HG23 ' A' ' 50' ' ' VAL . 1.9 mp -120.86 117.38 52.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.492 178.972 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.736 HG13 HD11 ' A' ' 66' ' ' LEU . 9.4 mm -99.04 150.21 5.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.098 0.475 . . . . 0.0 111.841 -179.409 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.556 ' HB3' HG22 ' A' ' 55' ' ' ILE . 53.5 ttp -67.59 -52.75 34.83 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.835 -179.129 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.436 ' H ' HG21 ' A' ' 55' ' ' ILE . 3.0 m -143.91 146.85 33.28 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 122.306 -0.246 . . . . 0.0 111.584 -179.234 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.91 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -113.98 57.86 0.69 Allowed 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.37 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.471 ' CE1' ' CD1' ' A' ' 55' ' ' ILE . 10.6 p-80 -99.21 -176.6 3.35 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.946 -0.302 . . . . 0.0 110.952 179.392 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.406 ' OG ' ' O ' ' A' ' 84' ' ' HIS . 20.8 p 71.09 -61.16 0.49 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.603 -179.709 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.458 ' OD2' HD13 ' A' ' 63' ' ' LEU . 4.0 p-10 -154.01 85.64 1.16 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -179.096 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.878 HD23 ' HB3' ' A' ' 90' ' ' ALA . 0.7 OUTLIER -52.73 -20.8 3.42 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.487 179.33 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -47.83 -57.09 6.07 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.607 -0.269 . . . . 0.0 111.664 -178.972 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.466 ' HB3' HD22 ' A' ' 63' ' ' LEU . . . -64.21 -19.94 65.69 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.725 0.297 . . . . 0.0 111.209 -179.968 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.878 ' HB3' HD23 ' A' ' 87' ' ' LEU . . . -77.26 -46.4 23.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.696 -179.696 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.63 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 6.6 t -62.64 -49.14 84.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 120.985 -0.286 . . . . 0.0 111.141 -179.7 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 52.5 p -56.51 -25.6 51.97 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.216 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.589 ' HB3' ' O ' ' A' ' 90' ' ' ALA . . . -60.08 -52.89 63.43 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.924 179.791 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.63 ' CE2' ' HA ' ' A' ' 91' ' ' VAL . 2.8 m-85 -55.78 -31.2 62.4 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.459 0.647 . . . . 0.0 109.917 179.771 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.12 -42.07 39.43 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.922 -1.036 . . . . 0.0 110.995 -179.967 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.638 ' O ' ' HA ' ' A' ' 75' ' ' MET . 7.3 pt20 -85.2 -18.15 34.94 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.785 -179.421 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 93' ' ' ALA . . . 140.29 85.32 0.1 Allowed Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.114 -179.101 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 1.007 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -168.26 123.81 0.99 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.157 0.503 . . . . 0.0 111.918 179.946 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -58.16 -52.77 64.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.773 -179.931 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.584 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 0.2 OUTLIER 170.12 -172.53 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 121.197 0.522 . . . . 0.0 111.675 -179.873 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.91 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 7.9 m-85 -113.38 153.57 28.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.263 179.621 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.576 HD21 ' HA ' ' A' ' 106' ' ' PHE . 7.9 tp -102.3 144.97 29.66 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.827 -179.195 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.563 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 18.5 Cg_exo -66.69 -157.06 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.739 2.293 . . . . 0.0 112.838 -179.043 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.504 ' HB3' ' HD3' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -56.13 -55.08 45.62 Favored Pre-proline 0 CA--C 1.531 0.218 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.859 -179.246 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.563 ' HD2' ' HB2' ' A' ' 103' ' ' PRO . 54.1 Cg_exo -52.31 164.23 1.37 Allowed 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.349 2.032 . . . . 0.0 111.923 179.695 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.616 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 57.6 t80 -158.2 -106.93 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.707 -0.224 . . . . 0.0 110.588 179.865 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.541 ' O ' ' O ' ' A' ' 106' ' ' PHE . 3.1 p30 42.37 -176.82 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.937 0.398 . . . . 0.0 111.041 -179.791 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.628 HG12 HG12 ' A' ' 18' ' ' VAL . 0.7 OUTLIER -68.0 -40.73 83.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.224 0.535 . . . . 0.0 111.155 -179.969 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.44 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 8.3 t0 -50.62 -58.88 4.79 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.919 -179.316 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.616 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 9.6 mm-40 -76.41 -30.36 57.42 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 111.725 0.268 . . . . 0.0 111.725 -179.366 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -69.77 -55.63 9.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.928 0.394 . . . . 0.0 110.322 179.332 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.676 ' O ' HG12 ' A' ' 115' ' ' VAL . 48.1 t -61.2 -33.61 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-O 121.357 0.598 . . . . 0.0 110.364 179.332 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.44 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -61.63 -47.14 86.75 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.618 179.723 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.472 HD23 ' CG2' ' A' ' 79' ' ' ILE . 55.4 tp -75.6 -21.43 57.8 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.632 -179.58 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.676 HG12 ' O ' ' A' ' 112' ' ' VAL . 2.9 p -79.4 -38.8 20.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.776 -0.37 . . . . 0.0 111.836 -179.639 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.533 ' OE2' HG12 ' A' ' 112' ' ' VAL . 36.7 mt-10 -68.44 -38.5 81.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.846 0.355 . . . . 0.0 110.773 179.997 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -64.21 -24.91 67.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.951 0.405 . . . . 0.0 110.367 179.531 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -70.62 -49.54 46.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.717 179.544 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.835 HD11 HG11 ' A' ' 50' ' ' VAL . 4.7 mt -70.36 -32.66 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-O 121.271 0.558 . . . . 0.0 110.965 179.759 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 15.1 m -70.01 -44.06 70.07 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.262 -179.786 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 11.2 m80 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.181 -179.841 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.796 ' CG ' HD11 ' A' ' 5' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.802 0.335 . . . . 0.0 111.093 . . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.761 ' C ' HD13 ' A' ' 5' ' ' ILE . . . 88.46 97.78 0.97 Allowed Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.426 -0.892 . . . . 0.0 111.074 -179.257 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.796 HD11 ' CG ' ' A' ' 3' ' ' ARG . 4.9 mm -121.77 112.49 35.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 120.689 0.28 . . . . 0.0 111.361 -179.032 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.782 HG11 ' HG ' ' A' ' 23' ' ' LEU . 10.6 p -105.56 127.0 60.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.229 0.538 . . . . 0.0 110.657 179.101 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.944 ' CD1' HG22 ' A' ' 31' ' ' THR . 34.3 m0 -114.53 125.6 53.98 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.868 179.746 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.73 ' HB ' HG22 ' A' ' 32' ' ' THR . 0.2 OUTLIER -115.65 136.55 52.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.691 -177.956 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.698 HG12 ' HB2' ' A' ' 33' ' ' PHE . 18.0 m -115.25 110.68 32.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.224 0.535 . . . . 0.0 110.746 179.062 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.471 ' CB ' HG21 ' A' ' 15' ' ' ILE . 3.9 t0 -162.22 -158.6 0.53 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.381 -179.166 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -67.83 -0.19 3.97 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.614 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 68.78 -154.07 0.16 Allowed 'General case' 0 CA--C 1.532 0.265 0 O-C-N 122.313 -0.242 . . . . 0.0 111.02 179.553 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.438 ' OG ' ' N ' ' A' ' 14' ' ' SER . 74.8 p 33.01 -96.37 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 179.219 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.76 ' O ' HG23 ' A' ' 18' ' ' VAL . 4.4 t -53.06 -57.27 10.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.629 0.252 . . . . 0.0 111.599 -179.197 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.471 HG21 ' CB ' ' A' ' 10' ' ' ASP . 31.0 mm -61.41 -26.15 38.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.849 0.357 . . . . 0.0 111.078 179.931 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.706 ' HA ' HG21 ' A' ' 32' ' ' THR . 53.8 ttt180 -77.06 -44.27 31.31 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.708 179.803 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.447 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 70.2 t90 -64.23 -40.44 96.04 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.979 -179.275 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.76 HG23 ' O ' ' A' ' 14' ' ' SER . 3.5 t -70.48 -37.57 70.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.0 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.412 ' O ' HD13 ' A' ' 19' ' ' LEU . 0.2 OUTLIER -84.26 -29.32 26.56 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.969 -179.171 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.558 ' HA ' ' SG ' ' A' ' 30' ' ' CYS . 24.9 pt-20 -67.53 -60.36 2.62 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.913 -178.906 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.464 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 5.7 mmt85 -58.11 -54.09 50.85 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.189 -0.459 . . . . 0.0 112.008 -179.588 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.56 -53.96 47.65 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.108 0.48 . . . . 0.0 111.343 -179.574 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.782 ' HG ' HG11 ' A' ' 6' ' ' VAL . 2.5 tm? -66.32 -27.98 68.32 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.582 0.706 . . . . 0.0 110.451 179.52 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.428 ' HB2' ' O ' ' A' ' 20' ' ' GLU . . . -67.1 -34.55 77.86 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.527 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.53 -26.78 64.99 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.296 -0.954 . . . . 0.0 110.946 178.039 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.664 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -77.27 -16.22 59.09 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 120.701 0.286 . . . . 0.0 110.805 179.104 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.49 23.68 13.72 Favored Glycine 0 CA--C 1.521 0.419 0 C-N-CA 120.675 -0.774 . . . . 0.0 114.247 178.615 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.668 ' HB2' HD11 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -123.81 166.64 15.25 Favored 'General case' 0 CA--C 1.527 0.076 0 CA-C-N 118.107 0.954 . . . . 0.0 111.935 -179.802 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.736 ' O ' HG12 ' A' ' 6' ' ' VAL . 97.6 m -84.83 138.54 32.5 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.027 -179.777 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.558 ' SG ' ' HA ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -126.85 116.43 20.85 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.073 0.463 . . . . 0.0 111.694 -179.544 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.944 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.4 t -128.77 132.43 47.9 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.409 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.73 HG22 ' HB ' ' A' ' 8' ' ' VAL . 45.8 p -108.51 165.09 11.79 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.267 0.556 . . . . 0.0 111.749 -178.335 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.808 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 3.2 m-85 -135.06 172.09 13.51 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.196 -177.89 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.561 ' HG2' ' N ' ' A' ' 35' ' ' ASN . 0.0 OUTLIER -63.31 -32.67 74.15 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.797 -179.837 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.561 ' N ' ' HG2' ' A' ' 34' ' ' GLU . 50.1 p-10 -179.47 179.49 0.61 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.264 -179.434 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.603 ' O ' ' HG ' ' A' ' 40' ' ' LEU . . . -55.16 -10.2 2.48 Favored Glycine 0 CA--C 1.521 0.438 0 C-N-CA 120.709 -0.758 . . . . 0.0 114.011 -179.438 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.573 HD22 HD12 ' A' ' 40' ' ' LEU . 3.3 m120 -84.55 -44.57 13.44 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 117.727 0.763 . . . . 0.0 112.501 -179.315 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.808 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 6.6 tt0 -51.74 -58.72 5.6 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -179.271 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.615 HG22 ' CE1' ' A' ' 33' ' ' PHE . 55.1 t -47.55 -38.13 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 121.017 0.437 . . . . 0.0 111.173 -179.594 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.771 HD13 ' CB ' ' A' ' 68' ' ' GLN . 20.6 mt -57.03 -41.84 79.36 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.429 -179.956 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.87 -48.09 40.43 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.277 0.56 . . . . 0.0 110.177 178.911 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.48 -28.66 69.45 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.135 179.386 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.563 ' CD1' ' CE1' ' A' ' 73' ' ' HIS . 15.1 mt -65.56 -24.94 67.22 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.88 -179.412 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.64 -16.0 14.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.843 -179.471 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -125.68 -1.57 7.35 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.712 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.535 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -163.42 159.89 22.81 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.917 0.389 . . . . 0.0 111.419 179.822 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 83.1 m -139.08 116.03 8.7 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.297 -179.929 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.731 ' O ' HD21 ' A' ' 76' ' ' LEU . 77.3 Cg_endo -77.42 163.21 30.09 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.056 1.837 . . . . 0.0 111.511 179.084 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.472 ' HB3' HG23 ' A' ' 119' ' ' ILE . 1.5 m-20 -74.23 -22.17 59.46 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.973 -0.291 . . . . 0.0 111.33 -179.744 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.775 HG13 HG23 ' A' ' 6' ' ' VAL . 8.3 p -147.7 169.42 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.477 -179.562 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.785 HD12 ' O ' ' A' ' 7' ' ' TRP . 10.0 tp -152.93 129.85 11.0 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 120.958 0.409 . . . . 0.0 111.318 -179.075 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.577 ' HG ' ' HB ' ' A' ' 79' ' ' ILE . 0.2 OUTLIER -115.69 126.76 54.52 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.78 179.789 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.72 ' CB ' HD22 ' A' ' 65' ' ' LEU . 0.2 OUTLIER -119.3 126.43 51.43 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -178.727 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -83.21 101.9 11.54 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.643 177.803 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.683 ' CG2' ' HB ' ' A' ' 82' ' ' THR . 2.2 tt -68.79 93.03 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.665 -179.505 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.462 ' NH2' ' HB3' ' A' ' 35' ' ' ASN . 6.8 ptt85 -135.46 59.05 1.74 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.48 -179.446 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.529 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 24.6 ptm 41.04 48.94 2.98 Favored Pre-proline 0 N--CA 1.467 0.381 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 179.746 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 62' ' ' GLY . 43.5 Cg_endo -70.49 -80.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.267 1.978 . . . . 0.0 111.999 178.943 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -107.27 -23.72 6.85 Favored Glycine 0 N--CA 1.449 -0.441 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 179.359 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.941 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 8.8 tpt -162.88 69.1 0.23 Allowed 'General case' 0 C--O 1.236 0.36 0 CA-C-O 120.923 0.392 . . . . 0.0 110.447 179.816 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.529 ' HA ' ' HA ' ' A' ' 57' ' ' MET . 0.3 OUTLIER 68.56 -26.46 0.14 Allowed 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.246 179.834 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.652 ' HA3' HG13 ' A' ' 55' ' ' ILE . . . 140.62 -29.58 2.36 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -179.441 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.644 HD12 ' H ' ' A' ' 63' ' ' LEU . 2.2 mp -75.62 -12.19 60.16 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.649 -0.275 . . . . 0.0 110.428 179.088 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.941 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -53.67 -26.9 24.7 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-O 120.925 0.393 . . . . 0.0 110.455 179.155 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.832 ' CD2' HG11 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -59.11 -62.15 2.1 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.954 -0.567 . . . . 0.0 109.714 178.982 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.959 ' HA ' HD12 ' A' ' 69' ' ' ILE . 7.9 mt -43.56 -43.39 5.55 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.243 179.513 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.447 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 19.4 mttt -54.0 -58.0 8.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.004 0.43 . . . . 0.0 111.225 179.507 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.771 ' CB ' HD13 ' A' ' 40' ' ' LEU . 21.5 mm-40 -62.07 -28.73 69.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.035 -179.846 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.959 HD12 ' HA ' ' A' ' 66' ' ' LEU . 77.0 mt -63.11 -42.02 95.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.029 0.442 . . . . 0.0 111.294 -179.846 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.529 ' HA ' ' HA ' ' A' ' 74' ' ' PRO . 0.1 OUTLIER -67.64 -29.25 68.51 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.573 -179.773 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.453 ' NE2' ' HA ' ' A' ' 68' ' ' GLN . 9.8 mt-30 -68.51 -40.61 80.76 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.036 179.527 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.403 ' NE ' ' HB3' ' A' ' 40' ' ' LEU . 52.0 mtt-85 -93.26 -76.22 0.48 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.743 -179.963 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.893 ' CD2' HG23 ' A' ' 69' ' ' ILE . 0.5 OUTLIER -114.5 79.18 5.28 Favored Pre-proline 0 C--N 1.318 -0.781 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.88 179.707 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.553 ' O ' ' HG3' ' A' ' 75' ' ' MET . 56.9 Cg_endo -70.87 50.28 1.07 Allowed 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.734 2.289 . . . . 0.0 113.131 -179.708 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.553 ' HG3' ' O ' ' A' ' 74' ' ' PRO . 2.8 mtp -150.65 -36.88 0.14 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.145 0.497 . . . . 0.0 110.82 179.716 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.731 HD21 ' O ' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -48.7 117.46 6.17 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.629 -179.831 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.407 ' HA ' ' O ' ' A' ' 97' ' ' GLY . 31.5 Cg_endo -64.5 134.37 41.11 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.046 1.831 . . . . 0.0 111.627 179.051 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.882 HG21 HD13 ' A' ' 69' ' ' ILE . 5.8 t -122.15 143.62 34.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.932 0.396 . . . . 0.0 111.262 -179.56 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.643 ' CG2' HD23 ' A' ' 114' ' ' LEU . 1.6 mt -124.01 110.67 26.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.925 -180.0 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.674 HD12 ' HB3' ' A' ' 53' ' ' SER . 6.3 mm -99.01 148.28 6.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.586 -179.199 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.449 ' O ' ' HB2' ' A' ' 102' ' ' LEU . 62.2 ttp -76.21 -60.42 2.34 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.813 -0.631 . . . . 0.0 112.322 -179.211 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.878 HG23 ' HD2' ' A' ' 84' ' ' HIS . 40.9 m -109.76 151.57 26.78 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.31 -178.516 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.983 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -136.09 -3.7 2.21 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -179.377 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.878 ' HD2' HG23 ' A' ' 82' ' ' THR . 1.0 OUTLIER -71.49 35.41 0.06 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -178.982 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.503 ' O ' HD11 ' A' ' 63' ' ' LEU . 80.2 p -159.79 102.16 1.49 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.698 0.285 . . . . 0.0 111.184 179.447 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.534 ' HB3' HD13 ' A' ' 63' ' ' LEU . 0.7 OUTLIER 67.64 35.37 4.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.911 179.762 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.55 HD23 ' HB3' ' A' ' 90' ' ' ALA . 0.5 OUTLIER -46.52 -22.53 0.28 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.108 -0.496 . . . . 0.0 112.078 -179.931 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -47.98 -50.3 27.84 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 -179.498 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.481 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -60.77 -21.02 62.63 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.649 0.261 . . . . 0.0 111.661 -179.601 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.576 ' O ' ' HB3' ' A' ' 93' ' ' ALA . . . -70.29 -34.03 72.27 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.886 0.374 . . . . 0.0 110.711 179.625 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.593 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 4.5 t -61.75 -49.84 82.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.386 -179.961 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.444 ' O ' ' NE2' ' A' ' 95' ' ' GLN . 17.6 m -59.72 -22.51 62.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.063 0.459 . . . . 0.0 110.037 179.209 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.929 ' HB1' ' HB2' ' A' ' 98' ' ' ALA . . . -65.14 -50.85 64.43 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.526 179.419 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.593 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 9.8 m-85 -54.92 -24.48 23.82 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.089 179.146 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.474 HE22 ' HE2' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -76.51 -30.58 57.25 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.991 179.254 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.57 ' HG2' ' HA ' ' A' ' 93' ' ' ALA . 1.7 pt20 -91.14 -18.31 24.69 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.93 179.403 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 77' ' ' PRO . . . 127.85 14.72 2.49 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.059 -1.067 . . . . 0.0 114.016 179.283 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.929 ' HB2' ' HB1' ' A' ' 93' ' ' ALA . . . -55.46 144.52 25.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 117.457 0.629 . . . . 0.0 110.785 179.569 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.569 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 12.3 t80 -78.49 -54.46 6.13 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.337 -179.548 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.56 ' OD1' HD21 ' A' ' 114' ' ' LEU . 10.3 p-10 173.62 -165.26 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 121.065 0.46 . . . . 0.0 111.528 179.96 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.983 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 5.3 m-85 -138.78 153.8 48.45 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.097 -179.832 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.776 HD11 HD22 ' A' ' 114' ' ' LEU . 5.5 mp -103.0 127.9 28.87 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 120.662 0.267 . . . . 0.0 111.288 -179.918 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -77.84 -74.6 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 121.962 1.775 . . . . 0.0 112.252 179.593 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.704 ' H ' ' HD2' ' A' ' 105' ' ' PRO . 0.2 OUTLIER -107.77 -55.91 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 -179.661 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.704 ' HD2' ' H ' ' A' ' 104' ' ' LYS . 34.0 Cg_endo -64.44 160.01 41.42 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 121.909 1.739 . . . . 0.0 112.729 -179.5 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.681 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 47.5 t80 -166.21 -106.51 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.089 -179.929 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.566 ' O ' ' O ' ' A' ' 106' ' ' PHE . 2.4 p30 42.98 177.47 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.859 0.361 . . . . 0.0 111.414 -179.888 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.73 HG12 HG12 ' A' ' 18' ' ' VAL . 0.9 OUTLIER -68.06 -42.37 85.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.001 0.429 . . . . 0.0 111.401 -179.624 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.502 ' HB2' ' OD1' ' A' ' 107' ' ' ASP . 6.1 m-20 -49.08 -58.27 5.22 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.521 -179.826 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.681 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 8.1 mm-40 -74.76 -35.6 62.58 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.646 0.26 . . . . 0.0 111.602 -179.675 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.77 -56.15 13.51 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.692 179.693 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.627 ' O ' HG12 ' A' ' 115' ' ' VAL . 54.7 t -62.1 -33.92 60.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.341 0.591 . . . . 0.0 110.585 179.364 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.477 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -61.84 -46.45 89.44 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.427 179.19 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.776 HD22 HD11 ' A' ' 102' ' ' LEU . 36.3 tp -74.67 -23.66 58.68 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.837 -179.216 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.737 HG23 HG21 ' A' ' 50' ' ' VAL . 6.4 p -79.49 -43.12 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.586 -179.901 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -62.73 -47.31 84.15 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.056 -179.695 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.651 ' HD2' HD12 ' A' ' 114' ' ' LEU . 6.4 ptp180 -60.05 -23.6 63.87 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.735 179.507 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.569 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -74.63 -48.15 28.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.121 179.998 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.472 HG23 ' HB3' ' A' ' 49' ' ' ASP . 3.8 mt -68.76 -32.69 55.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.173 0.511 . . . . 0.0 110.738 179.697 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.5 t -68.95 -55.06 12.12 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.239 -179.763 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 6.4 m80 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.519 -179.612 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.316 0 CA-C-O 120.797 0.332 . . . . 0.0 111.319 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.459 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . 78.02 101.28 0.2 Allowed Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.809 -179.473 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.4 mp -118.72 113.24 41.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.913 0.387 . . . . 0.0 111.509 -179.419 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 1.02 HG11 ' HG ' ' A' ' 23' ' ' LEU . 11.6 p -105.97 128.33 60.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.675 179.297 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.914 ' CD1' HG22 ' A' ' 31' ' ' THR . 31.2 m0 -114.69 132.86 56.27 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.742 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.569 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -123.86 141.6 43.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.066 0.46 . . . . 0.0 111.594 -178.06 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.934 HG12 ' HB2' ' A' ' 33' ' ' PHE . 29.1 m -123.92 111.28 28.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.301 0.572 . . . . 0.0 111.005 179.474 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -161.38 -157.81 0.53 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.475 -179.557 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -72.0 9.12 1.01 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.987 0.365 . . . . 0.0 111.987 -179.929 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.532 ' O ' ' N ' ' A' ' 14' ' ' SER . 3.4 p30 47.8 -136.69 0.91 Allowed 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 179.662 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.53 ' N ' ' HG2' ' A' ' 16' ' ' ARG . 1.5 t 36.32 -84.44 0.0 OUTLIER 'General case' 0 C--O 1.236 0.348 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -179.584 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.715 ' O ' HG23 ' A' ' 18' ' ' VAL . 35.6 t -77.8 -43.82 29.37 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.205 -0.452 . . . . 0.0 112.135 -179.21 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 27.4 mm -63.97 -34.34 67.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -178.893 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.862 ' HA ' HG21 ' A' ' 32' ' ' THR . 6.1 ptp180 -67.85 -52.69 33.76 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.789 -179.44 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.586 ' H ' ' HG3' ' A' ' 16' ' ' ARG . 28.4 t90 -54.85 -41.92 71.36 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.326 -178.782 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.715 HG23 ' O ' ' A' ' 14' ' ' SER . 13.5 t -67.55 -49.16 73.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -178.542 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.683 ' HG ' HD11 ' A' ' 108' ' ' ILE . 6.7 mt -79.72 -26.9 40.7 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.777 -178.112 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.611 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 19.3 pt-20 -66.8 -57.99 5.95 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.506 -0.477 . . . . 0.0 111.411 -179.604 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.482 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 3.4 mmt-85 -60.79 -54.46 44.88 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.927 -179.463 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.86 -33.29 68.52 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -179.055 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 1.02 ' HG ' HG11 ' A' ' 6' ' ' VAL . 2.7 tm? -76.01 -30.36 58.47 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.494 0.664 . . . . 0.0 110.308 179.602 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.61 -33.3 75.61 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.28 178.401 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.18 -26.15 68.98 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.198 178.607 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.617 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -78.25 -15.57 58.65 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 120.752 0.311 . . . . 0.0 110.823 179.371 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.98 26.06 10.74 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.647 -0.787 . . . . 0.0 113.596 179.211 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.682 ' HB2' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -132.77 170.89 14.62 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 117.571 0.685 . . . . 0.0 111.742 179.854 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.779 ' O ' HG12 ' A' ' 6' ' ' VAL . 23.5 m -95.76 137.6 34.59 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.63 -179.438 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.611 ' HB3' ' HA ' ' A' ' 20' ' ' GLU . 10.9 t -125.38 119.86 29.47 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.088 0.471 . . . . 0.0 111.501 -179.569 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.914 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.5 t -125.95 132.27 52.11 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.833 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.862 HG21 ' HA ' ' A' ' 16' ' ' ARG . 69.9 p -103.4 164.11 11.85 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 -177.23 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.934 ' HB2' HG12 ' A' ' 9' ' ' VAL . 6.0 m-85 -134.41 172.96 12.18 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.59 -178.384 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.435 ' HG2' ' N ' ' A' ' 35' ' ' ASN . 0.5 OUTLIER -62.28 -34.83 77.32 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -177.175 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.613 ' C ' ' HB ' ' A' ' 9' ' ' VAL . 22.0 p30 -176.68 -26.44 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 179.622 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.614 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . 161.82 -56.64 0.3 Allowed Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.037 -1.077 . . . . 0.0 113.123 179.649 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.529 ' N ' HD11 ' A' ' 65' ' ' LEU . 0.7 OUTLIER -50.02 -34.03 19.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.12 0.486 . . . . 0.0 110.673 -179.764 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.659 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -54.22 -52.08 62.42 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.454 179.803 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.672 HG12 ' CD1' ' A' ' 43' ' ' LEU . 56.1 t -57.61 -40.98 78.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.036 -179.829 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.801 HD13 ' HB2' ' A' ' 68' ' ' GLN . 19.2 mt -53.12 -40.69 64.37 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.092 0.472 . . . . 0.0 110.426 179.459 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -77.25 -48.71 16.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.044 179.449 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.69 -25.15 67.22 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.763 179.67 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.77 HD21 ' HD2' ' A' ' 48' ' ' PRO . 9.3 mt -68.35 -22.05 64.7 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.036 -179.54 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.06 -17.09 36.84 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.737 -179.641 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.8 t -121.96 -3.48 9.12 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -179.611 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.647 ' O ' HD23 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -162.71 159.02 23.78 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.038 0.447 . . . . 0.0 111.34 179.643 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.696 HG23 HD13 ' A' ' 76' ' ' LEU . 98.2 m -139.23 113.96 8.22 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.442 179.703 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.77 ' HD2' HD21 ' A' ' 43' ' ' LEU . 72.0 Cg_endo -75.7 161.64 36.42 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.049 1.832 . . . . 0.0 111.291 178.92 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.45 ' O ' ' HG2' ' A' ' 77' ' ' PRO . 1.2 m-20 -73.69 -21.15 60.34 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.649 0.261 . . . . 0.0 110.956 -179.869 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.87 HG13 HG23 ' A' ' 6' ' ' VAL . 7.5 p -148.75 166.7 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.347 179.958 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.596 HD11 HG21 ' A' ' 39' ' ' VAL . 18.8 tp -153.02 130.78 11.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.736 0.303 . . . . 0.0 111.158 -179.467 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.31 121.44 44.9 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.531 -179.934 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.764 ' HB2' HD13 ' A' ' 80' ' ' ILE . 3.2 m -106.23 130.83 54.02 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.928 0.394 . . . . 0.0 111.488 -179.695 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.402 ' O ' ' CG2' ' A' ' 55' ' ' ILE . 35.4 t70 -73.78 -22.67 59.76 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.586 -179.803 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.813 HG12 ' HA3' ' A' ' 62' ' ' GLY . 0.0 OUTLIER 44.04 99.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 121.185 0.517 . . . . 0.0 111.832 -179.782 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -142.58 43.99 1.62 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.585 -179.57 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.555 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER 58.81 48.13 2.2 Favored Pre-proline 0 CA--C 1.532 0.264 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 179.296 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.556 ' HD2' ' N ' ' A' ' 62' ' ' GLY . 41.1 Cg_endo -68.06 -79.16 0.01 OUTLIER 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 122.327 2.018 . . . . 0.0 111.969 178.914 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -107.83 -25.15 6.04 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.331 179.478 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.966 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 0.3 OUTLIER -158.72 65.03 0.42 Allowed 'General case' 0 C--O 1.236 0.368 0 CA-C-O 120.962 0.41 . . . . 0.0 110.454 179.813 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.555 ' HA ' ' HA ' ' A' ' 57' ' ' MET . 0.2 OUTLIER 70.36 -21.24 0.19 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.961 179.998 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.813 ' HA3' HG12 ' A' ' 55' ' ' ILE . . . 130.76 -30.0 3.47 Favored Glycine 0 N--CA 1.446 -0.674 0 N-CA-C 110.146 -1.182 . . . . 0.0 110.146 -178.847 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.901 ' HA ' HD23 ' A' ' 66' ' ' LEU . 0.8 OUTLIER -70.54 -15.99 62.83 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.007 -0.596 . . . . 0.0 109.732 178.675 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.966 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -53.54 -32.08 49.15 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-O 120.906 0.384 . . . . 0.0 110.259 179.706 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.651 ' HG ' HD11 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -61.24 -43.38 98.97 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.311 179.027 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.901 HD23 ' HA ' ' A' ' 63' ' ' LEU . 3.1 mm? -57.69 -45.45 85.62 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.052 -179.493 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -55.55 -47.69 75.96 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.234 0.54 . . . . 0.0 110.361 179.15 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.801 ' HB2' HD13 ' A' ' 40' ' ' LEU . 34.7 mm-40 -60.04 -29.74 68.73 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.503 179.62 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.565 ' HA ' ' CD2' ' A' ' 73' ' ' HIS . 59.4 mt -57.19 -48.98 81.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.224 0.535 . . . . 0.0 111.155 -179.705 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.55 ' HB3' ' CG ' ' A' ' 96' ' ' GLN . 7.6 pttt -63.02 -33.57 75.7 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.004 -179.232 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.493 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 4.4 mt-30 -72.73 -32.94 66.08 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.913 -179.478 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.2 mtt180 -108.87 -65.71 1.11 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -178.627 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.565 ' CD2' ' HA ' ' A' ' 69' ' ' ILE . 0.8 OUTLIER -82.12 169.04 19.84 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.679 -178.677 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -84.67 -68.99 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.885 2.39 . . . . 0.0 113.116 -179.579 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.426 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 69.7 mtm -150.98 45.83 0.84 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.823 0.344 . . . . 0.0 110.786 -179.8 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.696 HD13 HG23 ' A' ' 47' ' ' THR . 25.3 tp -56.77 114.8 8.6 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.231 -179.589 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.45 ' HG2' ' O ' ' A' ' 49' ' ' ASP . 19.6 Cg_endo -59.87 123.14 12.62 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.236 1.957 . . . . 0.0 112.011 179.531 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.957 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 4.6 t -124.59 153.07 31.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.843 -179.743 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.884 HD13 HG23 ' A' ' 115' ' ' VAL . 1.7 mt -128.45 114.39 33.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.94 179.939 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.764 HD13 ' HB2' ' A' ' 53' ' ' SER . 13.7 mm -93.83 141.01 15.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.889 -179.865 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.593 ' HA ' ' HB3' ' A' ' 102' ' ' LEU . 0.3 OUTLIER -80.26 -33.04 38.17 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.573 -179.334 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.538 ' H ' HG21 ' A' ' 55' ' ' ILE . 19.8 m -147.83 144.92 28.5 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 120.96 0.41 . . . . 0.0 111.724 -179.244 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.474 ' HA ' ' CE2' ' A' ' 101' ' ' TYR . . . -86.92 -26.19 24.03 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.39 179.661 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.52 ' H ' HG22 ' A' ' 82' ' ' THR . 3.0 m-70 46.87 44.5 14.49 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.766 179.549 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 38.8 m 53.4 85.89 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.576 179.286 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 177.03 35.71 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.825 179.822 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.806 HD13 ' HB3' ' A' ' 90' ' ' ALA . 0.3 OUTLIER -49.12 -21.87 0.83 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.949 -179.509 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -47.7 -61.08 2.11 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.48 0.181 . . . . 0.0 111.422 -179.503 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.0 -20.03 60.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.824 0.345 . . . . 0.0 110.698 179.375 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.806 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -62.38 -47.57 83.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.345 -179.963 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.564 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 6.6 t -67.26 -41.05 86.16 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 C-N-CA 120.704 -0.399 . . . . 0.0 110.52 179.819 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.504 ' O ' ' HG3' ' A' ' 95' ' ' GLN . 39.7 m -62.19 -15.83 49.0 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.387 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.638 ' HB2' ' HG ' ' A' ' 66' ' ' LEU . . . -75.87 -64.0 1.18 Allowed 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 120.988 0.423 . . . . 0.0 111.625 179.904 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.636 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 3.9 m-85 -41.7 -44.35 3.14 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.782 -178.431 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.57 ' NE2' ' HG3' ' A' ' 96' ' ' GLN . 0.2 OUTLIER -69.97 -48.46 58.17 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.23 179.563 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.57 ' HG3' ' NE2' ' A' ' 95' ' ' GLN . 59.5 mt-30 -75.92 -9.83 58.93 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.292 -0.413 . . . . 0.0 112.106 -179.831 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 93' ' ' ALA . . . 133.48 80.64 0.16 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.063 -179.553 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.957 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -168.5 133.82 1.73 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.093 0.473 . . . . 0.0 111.309 -179.903 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.42 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 50.4 t80 -73.33 -53.37 10.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.773 -179.777 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.53 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 1.7 t0 175.84 -171.05 0.07 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.016 0.436 . . . . 0.0 111.404 -179.817 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.678 ' CE2' HG21 ' A' ' 80' ' ' ILE . 6.7 m-85 -114.35 152.88 30.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.233 179.328 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.702 HD21 ' HA ' ' A' ' 106' ' ' PHE . 5.9 tp -105.52 137.32 19.26 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.142 -179.032 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.23 -161.5 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.933 2.422 . . . . 0.0 112.726 -179.545 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.445 ' CB ' ' HD3' ' A' ' 105' ' ' PRO . 0.3 OUTLIER -48.89 -59.25 6.61 Favored Pre-proline 0 CA--C 1.531 0.223 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.819 -179.478 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.445 ' HD3' ' CB ' ' A' ' 104' ' ' LYS . 73.8 Cg_exo -48.49 164.27 0.22 Allowed 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.44 2.093 . . . . 0.0 111.868 179.776 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.702 ' HA ' HD21 ' A' ' 102' ' ' LEU . 64.8 t80 -161.74 -102.42 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.706 -0.224 . . . . 0.0 110.719 179.844 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.583 ' O ' ' O ' ' A' ' 106' ' ' PHE . 2.6 p-10 42.09 179.3 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.915 0.388 . . . . 0.0 111.318 -179.983 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.697 HG12 HG12 ' A' ' 18' ' ' VAL . 1.0 OUTLIER -67.66 -42.29 86.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.084 0.468 . . . . 0.0 111.346 179.863 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.52 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 3.4 t0 -51.86 -58.77 5.49 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.594 -179.36 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.63 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 3.3 mm-40 -75.62 -27.7 58.55 Favored 'General case' 0 C--N 1.333 -0.124 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -179.476 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.419 ' CB ' ' O ' ' A' ' 107' ' ' ASP . . . -73.82 -62.52 1.47 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.925 0.393 . . . . 0.0 110.256 179.519 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.62 ' O ' HG12 ' A' ' 115' ' ' VAL . 49.3 t -55.63 -29.86 25.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.484 0.659 . . . . 0.0 110.256 179.021 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.53 ' O ' ' HG3' ' A' ' 117' ' ' ARG . . . -63.46 -50.96 67.65 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.731 179.172 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 53.7 tp -72.4 -20.69 61.39 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.395 -0.82 . . . . 0.0 112.273 -179.705 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.884 HG23 HD13 ' A' ' 79' ' ' ILE . 2.9 p -79.36 -47.67 22.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.686 -179.338 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.416 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 26.0 mt-10 -64.24 -42.8 96.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.855 0.36 . . . . 0.0 110.652 179.98 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.53 ' HG3' ' O ' ' A' ' 113' ' ' ALA . 40.5 mtt85 -63.36 -23.68 67.52 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.924 0.392 . . . . 0.0 110.551 179.224 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.42 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -70.16 -48.76 55.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.663 179.446 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.687 HD11 HG11 ' A' ' 50' ' ' VAL . 4.9 mt -68.1 -31.95 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.039 179.892 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 9.2 p -74.04 -49.05 25.91 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.382 -179.725 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 1.6 m80 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.312 -179.551 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.639 ' CG ' HD11 ' A' ' 5' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.341 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 . . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.881 ' O ' HD13 ' A' ' 5' ' ' ILE . . . 104.84 103.46 2.86 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.444 179.41 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.881 HD13 ' O ' ' A' ' 4' ' ' GLY . 7.5 mm -127.56 112.7 28.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 120.904 0.383 . . . . 0.0 111.813 -179.546 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.953 HG23 HG13 ' A' ' 50' ' ' VAL . 7.9 p -107.07 135.16 46.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.144 179.642 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.908 ' CD1' HG22 ' A' ' 31' ' ' THR . 24.2 m0 -120.26 125.89 49.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.014 0.435 . . . . 0.0 110.657 179.447 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.734 ' HB ' HG22 ' A' ' 32' ' ' THR . 0.5 OUTLIER -114.56 146.64 18.79 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.288 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.46 -178.365 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.697 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -124.7 110.8 25.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.821 0.343 . . . . 0.0 110.582 179.243 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.503 ' OD2' HG21 ' A' ' 15' ' ' ILE . 3.8 t0 -161.49 -161.18 0.77 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.228 -179.231 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.24 -0.23 3.29 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -179.487 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.436 ' O ' ' N ' ' A' ' 14' ' ' SER . 0.8 OUTLIER 69.51 -157.72 0.16 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.5 0.19 . . . . 0.0 110.894 179.896 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.404 ' HB3' ' H ' ' A' ' 14' ' ' SER . 1.6 t 34.54 -88.61 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 113.002 0.741 . . . . 0.0 113.002 179.51 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.797 ' O ' HG23 ' A' ' 18' ' ' VAL . 28.4 t -56.07 -58.99 5.6 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.719 0.295 . . . . 0.0 111.235 -179.699 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.503 HG21 ' OD2' ' A' ' 10' ' ' ASP . 20.5 mm -65.77 -24.46 34.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.262 -179.821 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.76 ' HA ' HG21 ' A' ' 32' ' ' THR . 20.2 ttt-85 -78.39 -41.15 34.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.023 179.819 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.426 ' HA ' ' CD ' ' A' ' 20' ' ' GLU . 84.1 t90 -65.7 -40.17 91.99 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.541 -179.351 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.797 HG23 ' O ' ' A' ' 14' ' ' SER . 3.5 t -69.37 -38.17 76.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -178.93 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.652 ' CD2' HD11 ' A' ' 108' ' ' ILE . 0.2 OUTLIER -84.39 -29.29 26.33 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -178.962 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.766 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 24.4 pt-20 -67.87 -59.01 3.62 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -179.29 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.466 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 9.8 mmt180 -64.65 -51.69 61.23 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.885 -178.904 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.23 -44.43 79.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.103 0.478 . . . . 0.0 111.521 -179.384 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.909 ' HG ' HG11 ' A' ' 6' ' ' VAL . 2.1 tm? -72.04 -27.85 62.98 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.188 179.523 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.54 -33.63 76.11 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.29 178.397 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.18 -28.65 69.45 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.498 -0.858 . . . . 0.0 111.16 178.772 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.631 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -76.84 -15.35 59.74 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 120.717 0.294 . . . . 0.0 110.947 179.412 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.49 26.08 11.36 Favored Glycine 0 C--N 1.334 0.422 0 C-N-CA 120.7 -0.762 . . . . 0.0 113.657 179.001 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.631 ' CD1' ' HB3' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -131.5 172.65 11.96 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 117.528 0.664 . . . . 0.0 111.583 179.625 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.694 ' O ' HG12 ' A' ' 6' ' ' VAL . 16.6 m -96.62 138.08 34.73 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.43 -179.256 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.766 ' HB3' ' HA ' ' A' ' 20' ' ' GLU . 8.5 t -127.61 117.5 22.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.884 179.972 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.908 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.8 t -122.08 142.77 50.02 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.275 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.76 HG21 ' HA ' ' A' ' 16' ' ' ARG . 66.7 p -118.26 159.81 22.7 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.181 0.515 . . . . 0.0 112.165 -178.889 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.9 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 0.2 OUTLIER -135.1 171.92 13.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.823 -179.007 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.698 ' HG2' ' N ' ' A' ' 35' ' ' ASN . 0.0 OUTLIER -64.17 -43.53 94.84 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.212 -179.532 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.698 ' N ' ' HG2' ' A' ' 34' ' ' GLU . 29.3 p30 -173.1 178.89 2.37 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.104 0.478 . . . . 0.0 110.988 -179.018 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.637 ' HA3' ' HB3' ' A' ' 65' ' ' LEU . . . -43.05 -32.21 1.46 Allowed Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.46 -0.791 . . . . 0.0 113.825 -179.47 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.407 ' HA ' ' CD1' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -72.67 -45.68 57.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.945 0.373 . . . . 0.0 111.613 -178.966 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.9 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -52.2 -54.47 30.5 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 -179.836 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.544 HG12 ' CD1' ' A' ' 43' ' ' LEU . 3.5 t -48.86 -36.26 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.32 -179.438 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.673 HD11 HE21 ' A' ' 68' ' ' GLN . 7.0 mt -62.62 -49.6 74.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.838 0.351 . . . . 0.0 110.532 179.85 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -54.35 -50.39 67.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.32 -179.488 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.619 ' HB3' ' HE2' ' A' ' 33' ' ' PHE . . . -70.77 -33.46 70.78 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.258 179.953 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.623 HD13 ' NE2' ' A' ' 73' ' ' HIS . 16.0 mt -61.19 -27.12 68.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.307 -179.821 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.79 -17.99 4.2 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.618 -179.583 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 23.9 t -120.85 -3.39 9.7 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -179.635 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.608 ' NZ ' HG21 ' A' ' 5' ' ' ILE . 0.4 OUTLIER -167.66 165.38 14.37 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.883 0.373 . . . . 0.0 111.47 -179.73 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.464 ' HA ' HD23 ' A' ' 43' ' ' LEU . 59.3 m -139.18 128.14 13.94 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.221 179.585 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.643 ' HB3' ' CG ' ' A' ' 7' ' ' TRP . 74.1 Cg_endo -78.06 159.66 30.33 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.38 2.053 . . . . 0.0 111.904 179.195 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -75.42 -31.37 60.35 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.622 179.847 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.953 HG13 HG23 ' A' ' 6' ' ' VAL . 13.5 p -149.68 111.82 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.446 -179.435 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.709 HD12 ' O ' ' A' ' 7' ' ' TRP . 15.3 tp -87.13 150.2 24.14 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.925 0.393 . . . . 0.0 111.949 -179.656 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.696 ' HB3' HG13 ' A' ' 8' ' ' VAL . 1.4 tt -138.75 118.13 12.83 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.743 179.539 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.481 ' HB2' ' CD1' ' A' ' 80' ' ' ILE . 3.2 m -112.42 135.16 53.46 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 121.038 0.447 . . . . 0.0 111.286 179.756 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.411 ' O ' ' O ' ' A' ' 55' ' ' ILE . 25.7 t0 -77.36 -8.01 56.99 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -178.705 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 1.012 HG12 ' HA3' ' A' ' 62' ' ' GLY . 0.0 OUTLIER 37.61 100.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 179.908 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.401 HH21 ' HA ' ' A' ' 10' ' ' ASP . 1.3 ptt85 -146.03 44.0 1.24 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.501 179.68 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.524 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 37.7 ttp 65.27 49.37 0.72 Allowed Pre-proline 0 CA--C 1.532 0.285 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 178.894 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' A' ' 62' ' ' GLY . 57.5 Cg_endo -72.05 -84.54 0.0 OUTLIER 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 122.757 2.305 . . . . 0.0 112.116 178.711 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -100.33 -29.33 6.76 Favored Glycine 0 C--N 1.337 0.636 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.433 179.696 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.99 ' HB3' ' HB2' ' A' ' 64' ' ' ALA . 0.7 OUTLIER -157.23 69.4 0.57 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.907 0.384 . . . . 0.0 110.114 179.496 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.524 ' HA ' ' HA ' ' A' ' 57' ' ' MET . 0.2 OUTLIER 68.56 -22.96 0.13 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.964 -179.694 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 1.012 ' HA3' HG12 ' A' ' 55' ' ' ILE . . . 136.69 -26.63 3.01 Favored Glycine 0 CA--C 1.498 -0.997 0 C-N-CA 120.981 -0.628 . . . . 0.0 111.682 -179.838 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.638 HD12 ' H ' ' A' ' 63' ' ' LEU . 1.0 OUTLIER -75.95 -17.56 59.69 Favored 'General case' 0 N--CA 1.44 -0.971 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.157 179.221 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.99 ' HB2' ' HB3' ' A' ' 60' ' ' MET . . . -53.47 -38.34 63.51 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 121.002 0.429 . . . . 0.0 110.601 179.085 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.637 ' HB3' ' HA3' ' A' ' 36' ' ' GLY . 3.8 pp -58.76 -36.94 75.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.197 -179.795 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.792 HD13 ' HB2' ' A' ' 93' ' ' ALA . 9.6 mt -62.7 -43.73 98.04 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.835 0.35 . . . . 0.0 110.308 179.586 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.52 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 0.4 OUTLIER -52.9 -59.75 4.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.499 179.563 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.673 HE21 HD11 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -55.86 -38.19 69.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.023 0.44 . . . . 0.0 111.146 179.422 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.46 ' HA ' ' CD2' ' A' ' 73' ' ' HIS . 6.7 mm -61.56 -36.74 75.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.218 -178.738 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.623 ' HB2' ' HB2' ' A' ' 96' ' ' GLN . 1.1 pttt -78.44 -24.86 45.87 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.247 -0.433 . . . . 0.0 112.084 -179.613 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.513 ' NE2' ' HG3' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -80.57 -30.03 37.01 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.694 -178.251 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.513 ' HG3' ' NE2' ' A' ' 71' ' ' GLN . 27.5 mtt180 -103.9 -21.78 13.59 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -179.684 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.623 ' NE2' HD13 ' A' ' 43' ' ' LEU . 1.9 m-70 -128.67 156.24 77.77 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-O 120.776 0.322 . . . . 0.0 111.255 -178.935 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -95.25 100.88 0.11 Allowed 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 123.214 2.609 . . . . 0.0 113.687 -178.88 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.493 ' HA ' ' CA ' ' A' ' 97' ' ' GLY . 3.9 mtt 55.53 38.57 30.4 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.261 178.169 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.54 HD11 ' CD2' ' A' ' 43' ' ' LEU . 1.4 tt -60.52 114.19 9.51 Favored Pre-proline 0 C--N 1.325 -0.483 0 C-N-CA 121.143 -0.223 . . . . 0.0 110.867 179.602 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.453 ' HD2' HD23 ' A' ' 76' ' ' LEU . 50.7 Cg_exo -55.87 129.94 37.65 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.532 2.155 . . . . 0.0 112.848 -179.948 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.668 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 4.4 t -137.59 147.06 26.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.286 179.55 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.832 ' CG2' HD23 ' A' ' 114' ' ' LEU . 2.0 mt -122.47 111.07 28.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.212 179.563 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.549 HG13 ' CZ ' ' A' ' 101' ' ' TYR . 8.6 mm -99.2 142.13 15.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 120.996 0.426 . . . . 0.0 111.839 -178.903 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.642 ' O ' ' HB2' ' A' ' 102' ' ' LEU . 13.8 ttt -70.72 -75.73 0.12 Allowed 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.631 -179.42 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.526 ' H ' ' CG2' ' A' ' 55' ' ' ILE . 3.0 m -105.65 147.39 28.54 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.089 0.471 . . . . 0.0 111.542 -178.936 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.918 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -116.29 59.12 0.74 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.902 179.941 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 21.1 p80 -99.07 135.28 40.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.913 0.387 . . . . 0.0 111.561 -179.674 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.444 ' HB3' ' CG ' ' A' ' 61' ' ' ASP . 9.5 t 62.85 134.11 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.648 179.183 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.526 ' HB3' HD13 ' A' ' 63' ' ' LEU . 1.8 t70 55.49 36.65 27.57 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.128 179.65 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.72 HD21 ' HB1' ' A' ' 83' ' ' ALA . 0.5 OUTLIER -53.48 -24.27 12.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.566 -179.901 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -49.5 -47.46 48.63 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.96 0.41 . . . . 0.0 111.357 -179.782 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.478 ' O ' ' HB2' ' A' ' 93' ' ' ALA . . . -62.66 -19.74 64.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.258 -179.888 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.689 ' O ' ' HB3' ' A' ' 93' ' ' ALA . . . -72.09 -57.49 4.22 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.775 0.321 . . . . 0.0 110.972 179.527 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.694 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 3.5 t -59.95 -52.45 60.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.299 -179.55 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 89.9 p -58.44 -22.25 53.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.01 0.434 . . . . 0.0 109.98 178.975 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.792 ' HB2' HD13 ' A' ' 66' ' ' LEU . . . -59.92 -48.81 80.17 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.365 179.154 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.694 ' CE2' ' HA ' ' A' ' 91' ' ' VAL . 2.8 m-85 -57.62 -30.89 65.72 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.186 -180.0 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.77 -36.37 59.85 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.306 -179.911 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.623 ' HB2' ' HB2' ' A' ' 70' ' ' LYS . 11.8 pt20 -100.18 0.88 41.34 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.526 -178.98 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 93' ' ' ALA . . . 128.4 81.32 0.31 Allowed Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.347 -0.93 . . . . 0.0 113.323 179.955 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.668 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -169.7 136.04 1.56 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.778 0.323 . . . . 0.0 110.26 179.162 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.519 ' CZ ' ' HA ' ' A' ' 118' ' ' ALA . 32.0 t80 -74.97 -53.32 9.16 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.976 -0.29 . . . . 0.0 111.325 -179.449 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.634 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 2.4 t70 179.82 -172.76 0.2 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.265 0.555 . . . . 0.0 111.924 -179.756 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.918 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 3.1 m-85 -128.36 154.1 46.34 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.811 179.986 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.794 HD11 HD22 ' A' ' 114' ' ' LEU . 9.0 mp -102.04 123.58 43.07 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-O 120.719 0.295 . . . . 0.0 110.614 179.958 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -68.62 -66.8 0.03 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.19 1.927 . . . . 0.0 112.337 -179.753 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.755 ' H ' ' HD2' ' A' ' 105' ' ' PRO . 0.7 OUTLIER -119.4 -58.39 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.244 -0.434 . . . . 0.0 112.117 -179.535 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.755 ' HD2' ' H ' ' A' ' 104' ' ' LYS . 17.8 Cg_endo -59.5 163.1 13.43 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.255 1.97 . . . . 0.0 112.697 -179.501 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.616 ' HA ' HD23 ' A' ' 102' ' ' LEU . 38.9 t80 -166.86 -108.61 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.223 179.609 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.593 ' O ' ' O ' ' A' ' 106' ' ' PHE . 3.1 p30 43.04 176.57 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.896 0.379 . . . . 0.0 111.274 -179.975 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.652 HD11 ' CD2' ' A' ' 19' ' ' LEU . 1.0 OUTLIER -67.7 -39.41 82.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 121.903 -0.498 . . . . 0.0 111.278 -179.82 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.486 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 4.4 t70 -49.82 -58.47 5.3 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.246 -179.75 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.585 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 3.4 mm-40 -77.61 -34.32 53.42 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 111.709 0.263 . . . . 0.0 111.709 -179.76 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.39 -59.56 4.21 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 179.328 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.726 ' O ' HG12 ' A' ' 115' ' ' VAL . 55.8 t -59.54 -30.27 44.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.466 0.65 . . . . 0.0 110.506 178.86 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.486 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -65.37 -47.55 76.0 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.158 179.367 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.832 HD23 ' CG2' ' A' ' 79' ' ' ILE . 23.6 tp -73.51 -21.33 60.43 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.551 -179.627 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.726 HG12 ' O ' ' A' ' 112' ' ' VAL . 5.7 p -79.44 -47.08 22.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.779 0.323 . . . . 0.0 111.679 -179.838 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.642 ' HA ' HD12 ' A' ' 119' ' ' ILE . 31.8 mt-10 -67.88 -46.8 70.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.88 -179.786 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 55.8 mtp180 -61.01 -24.2 65.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.091 0.472 . . . . 0.0 110.567 179.392 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.519 ' HA ' ' CZ ' ' A' ' 99' ' ' PHE . . . -71.16 -47.4 57.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.97 179.625 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.642 HD12 ' HA ' ' A' ' 116' ' ' GLU . 4.6 mt -62.94 -31.17 51.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.127 -179.95 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.0 t -74.55 -51.0 15.86 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.422 -179.387 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 20.5 m80 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.394 -179.464 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.663 ' HG3' ' HE3' ' A' ' 1' ' ' MET 1.51 3.9 mtm . . . . . 3 N--CA 0.345 -55.692 2 N-CA-C 162.743 19.164 . . . . 0.0 162.743 . . . . . . . . . 4 2 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.586 2.3 mt-30 -124.41 111.4 15.7 Favored 'General case' 4 C--N 0.591 -32.401 5 O-C-N 76.631 -28.793 . . . . 0.0 122.754 179.739 . . . . . . . . 4 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.695 ' HG2' HD11 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -46.67 -29.08 1.7 Allowed 'General case' 3 C--N 0.87 -20.26 3 O-C-N 94.922 -17.361 . . . . 0.0 114.498 -179.438 . . . . . . . . 5 4 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.464 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . 79.76 87.59 0.54 Allowed Glycine 1 C--N 1.149 -9.831 1 O-C-N 113.565 -5.709 . . . . 0.0 112.665 -179.864 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 1.134 ' CD1' ' CB ' ' A' ' 5' ' ' ILE . 0.7 OUTLIER -112.7 113.3 43.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 O-C-N 122.59 -0.359 . . . . 0.0 111.365 -179.679 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.825 HG23 HG13 ' A' ' 50' ' ' VAL . 7.1 p -107.71 125.39 64.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.676 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.894 ' CD1' HG22 ' A' ' 31' ' ' THR . 31.4 m0 -114.44 134.13 55.23 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.03 0.443 . . . . 0.0 110.374 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.698 HG13 ' HB3' ' A' ' 52' ' ' LEU . 0.3 OUTLIER -122.29 143.83 33.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.653 -178.405 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.706 HG11 ' HA2' ' A' ' 36' ' ' GLY . 0.0 OUTLIER -123.81 109.65 23.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.038 0.447 . . . . 0.0 110.321 178.901 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.497 ' O ' ' N ' ' A' ' 12' ' ' ASP . 5.8 t0 -164.55 -177.24 4.72 Favored 'General case' 1 C--O 0.895 -17.579 0 CA-C-O 125.923 2.773 . . . . 0.0 111.103 -179.075 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 1.303 ' OD2' ' CB ' ' A' ' 11' ' ' ASP . 0.7 OUTLIER -44.89 -10.47 0.01 OUTLIER 'General case' 2 C--N 1.074 -11.412 3 O-C-N 104.073 -11.642 . . . . 0.0 112.854 -178.827 . . . . . . . . 5 4 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.497 ' N ' ' O ' ' A' ' 10' ' ' ASP . 2.6 t70 76.01 -147.53 0.03 OUTLIER 'General case' 1 C--O 1.13 -5.215 0 O-C-N 117.905 -2.997 . . . . 0.0 111.76 179.803 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 1.091 ' OG ' ' HB2' ' A' ' 13' ' ' SER . 8.2 t 22.05 -85.74 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.777 0 C-N-CA 126.371 1.868 . . . . 0.0 114.676 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.754 ' O ' HG23 ' A' ' 18' ' ' VAL . 0.3 OUTLIER -55.87 -56.92 14.9 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 120.925 0.393 . . . . 0.0 111.514 -179.447 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.0 mm -65.09 -24.99 36.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-O 120.823 0.344 . . . . 0.0 111.141 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 1.253 ' NH2' ' NE ' ' A' ' 16' ' ' ARG . 1.8 ttt180 -72.29 -50.2 28.84 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.291 0.567 . . . . 0.0 111.201 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 72.1 t90 -60.33 -43.24 96.6 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.754 HG23 ' O ' ' A' ' 14' ' ' SER . 3.2 t -65.84 -48.05 83.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -178.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 1.418 ' CD1' ' CB ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -81.15 -29.29 34.76 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -178.093 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 1.327 ' OE1' ' CG ' ' A' ' 20' ' ' GLU . 12.9 pt-20 -67.13 -59.33 3.54 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -178.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 1.202 ' NE ' ' CG ' ' A' ' 21' ' ' ARG . 11.8 mmt180 -59.2 -51.27 70.73 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.821 -179.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.64 -46.11 84.6 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.91 0.386 . . . . 0.0 111.83 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.479 ' CD1' ' CB ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -72.2 -26.46 62.06 Favored 'General case' 0 C--N 1.311 -1.109 0 CA-C-O 121.225 0.536 . . . . 0.0 110.408 179.577 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.09 -34.62 78.03 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.93 -26.14 68.63 Favored Glycine 0 N--CA 1.44 -1.073 0 C-N-CA 120.247 -0.978 . . . . 0.0 111.032 178.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.673 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -77.21 -15.71 59.37 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 120.802 0.334 . . . . 0.0 110.939 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.3 26.23 10.32 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.514 -0.851 . . . . 0.0 114.143 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.673 ' CD1' ' HB3' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -126.18 168.74 13.64 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 117.982 0.891 . . . . 0.0 112.238 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 53.7 m -91.85 115.3 27.95 Favored 'General case' 0 C--O 1.211 -0.953 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.627 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 1.223 ' SG ' ' CA ' ' A' ' 30' ' ' CYS . 49.1 t -110.81 113.55 26.23 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.008 0.433 . . . . 0.0 112.083 -179.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.894 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.7 t -122.48 146.22 47.59 Favored 'General case' 0 C--O 1.219 -0.509 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.816 HG21 ' HA ' ' A' ' 16' ' ' ARG . 60.3 p -119.52 162.57 18.68 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.315 0.579 . . . . 0.0 112.258 -178.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.816 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 3.0 m-85 -133.65 173.54 11.4 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.371 -0.832 . . . . 0.0 111.7 -178.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.676 ' HG3' ' N ' ' A' ' 35' ' ' ASN . 17.1 pt-20 -62.55 -47.03 85.66 Favored 'General case' 1 C--O 1.149 -4.211 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -177.98 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 1.103 ' CG ' ' CA ' ' A' ' 35' ' ' ASN . 0.0 OUTLIER -161.25 -61.73 0.05 Allowed 'General case' 1 C--O 0.886 -18.048 0 O-C-N 118.598 -2.564 . . . . 0.0 112.277 -179.252 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.968 ' HA3' HD23 ' A' ' 65' ' ' LEU . . . -163.39 -43.95 0.02 OUTLIER Glycine 1 C--N 1.066 -14.464 3 O-C-N 103.777 -11.827 . . . . 0.0 113.315 -179.399 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.451 ' HA ' HD12 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -60.43 -33.31 72.35 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 122.208 -0.584 . . . . 0.0 111.358 -179.359 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 1.103 ' CD ' ' HG2' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -57.1 -55.27 36.91 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.384 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.657 HG23 HG13 ' A' ' 9' ' ' VAL . 21.5 t -53.44 -37.62 30.42 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.289 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.816 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.68 HD13 ' HB3' ' A' ' 68' ' ' GLN . 18.5 mt -56.42 -44.72 80.66 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.681 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.39 -48.77 63.84 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.212 0.529 . . . . 0.0 111.218 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.64 -31.77 73.14 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.913 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 1.167 HD13 ' CE1' ' A' ' 73' ' ' HIS . 12.9 mt -64.4 -24.93 67.8 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.515 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.35 -18.72 18.65 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.66 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.39 0.11 8.84 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 1.256 ' NZ ' ' CD ' ' A' ' 46' ' ' LYS . 0.3 OUTLIER -162.4 160.38 26.36 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-O 120.779 0.323 . . . . 0.0 111.55 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 97.3 m -138.91 114.7 8.57 Favored Pre-proline 0 N--CA 1.448 -0.556 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.447 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.602 ' HD2' HD21 ' A' ' 43' ' ' LEU . 68.4 Cg_endo -75.29 159.58 40.15 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.441 2.094 . . . . 0.0 111.599 179.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -75.26 -26.53 58.88 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.803 0.335 . . . . 0.0 111.108 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.825 HG13 HG23 ' A' ' 6' ' ' VAL . 7.1 p -146.04 133.52 15.26 Favored 'Isoleucine or valine' 1 C--O 1.079 -7.92 0 CA-C-O 122.88 1.324 . . . . 0.0 110.861 -179.652 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.548 HD12 ' O ' ' A' ' 7' ' ' TRP . 18.2 tp -120.02 134.45 55.25 Favored 'General case' 1 C--N 1.203 -5.766 1 O-C-N 114.859 -4.901 . . . . 0.0 111.649 -179.262 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.698 ' HB3' HG13 ' A' ' 8' ' ' VAL . 0.6 OUTLIER -119.15 122.13 41.32 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 122.824 0.45 . . . . 0.0 110.232 179.676 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.452 ' HA ' HG23 ' A' ' 9' ' ' VAL . 0.5 OUTLIER -115.96 136.59 52.9 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.273 0.559 . . . . 0.0 112.169 -179.541 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 1.282 ' O ' ' CA ' ' A' ' 55' ' ' ILE . 10.3 t70 -80.96 -2.32 47.27 Favored 'General case' 1 C--O 0.48 -39.423 1 CA-C-O 162.772 20.32 . . . . 0.0 112.03 -179.978 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 1.282 ' CA ' ' O ' ' A' ' 54' ' ' ASP . 14.7 tt 32.72 97.83 0.0 OUTLIER 'Isoleucine or valine' 2 C--N 0.776 -24.364 3 O-C-N 28.812 -58.68 . . . . 0.0 111.483 -179.326 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 1.555 ' CB ' ' CD ' ' A' ' 56' ' ' ARG 0.266 0.3 OUTLIER -158.85 47.77 0.33 Allowed 'General case' 3 C--N 1.154 -7.898 1 O-C-N 112.899 -6.125 . . . . 0.0 117.447 -179.837 . . . . . . . . 6 4 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 1.532 ' CE ' ' CG ' ' A' ' 57' ' ' MET 0.684 11.2 ttt 88.93 28.48 0.0 OUTLIER Pre-proline 3 N--CA 1.257 -10.121 1 N-CA-C 139.177 10.436 . . . . 0.0 139.177 179.064 . . . . . . . . 5 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.421 ' HD2' ' O ' ' A' ' 61' ' ' ASP . 36.9 Cg_endo -65.36 -101.48 0.0 OUTLIER 'Trans proline' 3 C--O 0.983 -12.226 0 O-C-N 125.966 2.561 . . . . 0.0 112.862 178.977 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -98.25 -53.3 1.27 Allowed Glycine 4 C--O 0.965 -16.705 0 CA-C-N 125.744 3.884 . . . . 0.0 112.79 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 1.282 ' CE ' ' CG ' ' A' ' 60' ' ' MET . 0.0 OUTLIER -118.1 63.28 0.76 Allowed 'General case' 1 C--N 1.163 -7.537 2 O-C-N 113.5 -5.706 . . . . 0.0 109.958 178.763 . . . . . . . . 5 4 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 1.246 ' OD1' ' CB ' ' A' ' 61' ' ' ASP . 0.3 OUTLIER 62.99 -42.67 0.19 Allowed 'General case' 1 C--O 1.044 -9.721 0 CA-C-O 122.324 1.059 . . . . 0.0 112.137 -179.756 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 1.062 ' HA3' HG13 ' A' ' 55' ' ' ILE . . . 165.91 -30.87 0.21 Allowed Glycine 1 C--N 1.185 -7.814 1 O-C-N 114.55 -5.094 . . . . 0.0 111.417 -179.713 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.717 HD12 ' H ' ' A' ' 63' ' ' LEU . 2.2 mp -67.01 -19.19 65.66 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-O 120.852 0.358 . . . . 0.0 110.193 179.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.838 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -54.25 -37.49 64.74 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-O 121.183 0.516 . . . . 0.0 110.498 178.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 1.42 ' HG ' ' CA ' ' A' ' 65' ' ' LEU . 1.2 mt -58.33 -44.32 88.61 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.736 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 1.308 ' CD1' ' CB ' ' A' ' 66' ' ' LEU . 20.4 mt -55.88 -45.44 78.57 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.08 0.467 . . . . 0.0 110.619 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.2 mttt -53.34 -48.41 68.53 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.856 179.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 1.448 ' OE1' ' CG ' ' A' ' 68' ' ' GLN . 11.8 mm-40 -66.4 -34.55 78.21 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.963 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.576 HG13 ' O ' ' A' ' 65' ' ' LEU . 98.4 mt -61.34 -41.78 91.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.727 -179.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 1.25 ' NZ ' ' CD ' ' A' ' 70' ' ' LYS . 17.4 pttt -71.51 -28.1 63.66 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.669 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.772 ' NE2' ' HA ' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -72.84 -38.05 67.23 Favored 'General case' 0 C--O 1.213 -0.848 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.763 -179.441 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 70.7 mtt-85 -97.14 -41.65 8.22 Favored 'General case' 0 C--O 1.173 -2.949 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 1.415 ' NE2' ' CG ' ' A' ' 73' ' ' HIS . 0.0 OUTLIER -108.39 139.38 20.72 Favored Pre-proline 1 C--O 1.001 -11.985 0 CA-C-O 124.121 1.915 . . . . 0.0 112.683 -179.053 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.806 ' O ' ' HG3' ' A' ' 75' ' ' MET 0.337 8.3 Cg_endo -74.0 -36.37 3.51 Favored 'Trans proline' 4 C--O 0.774 -22.703 3 C-N-CA 128.145 5.896 . . . . 0.0 123.185 -179.942 . . . . . . . . 5 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 1.194 ' CE ' ' CG ' ' A' ' 75' ' ' MET . 47.5 mtt -159.83 31.21 0.18 Allowed 'General case' 2 C--N 0.983 -15.339 3 O-C-N 101.657 -13.152 . . . . 0.0 115.154 -179.923 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 1.306 ' CD1' ' CB ' ' A' ' 76' ' ' LEU . 1.5 tt -64.24 118.77 49.98 Favored Pre-proline 0 C--N 1.306 -1.316 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.621 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.49 ' HA ' ' O ' ' A' ' 97' ' ' GLY . 3.4 Cg_exo -63.44 125.1 14.94 Favored 'Trans proline' 0 C--O 1.212 -0.808 0 C-N-CA 122.809 2.339 . . . . 0.0 112.31 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.648 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 4.3 t -119.32 145.15 25.88 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-O 120.997 0.427 . . . . 0.0 111.321 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.664 ' CG2' HD23 ' A' ' 114' ' ' LEU . 2.0 mt -125.71 113.08 33.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.618 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.584 HD11 HD21 ' A' ' 66' ' ' LEU . 15.9 mm -98.69 141.77 15.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.604 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 1.0 ' SD ' ' CE ' ' A' ' 81' ' ' MET . 2.2 ptm -73.64 -41.0 63.33 Favored 'General case' 0 C--O 1.165 -3.381 0 CA-C-N 116.081 -0.509 . . . . 0.0 112.232 -179.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.567 ' H ' HG21 ' A' ' 55' ' ' ILE . 7.0 m -135.42 155.39 50.64 Favored 'General case' 0 C--N 1.29 -2.019 0 O-C-N 120.435 -1.416 . . . . 0.0 111.818 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.65 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -118.55 20.93 12.82 Favored 'General case' 1 C--O 0.955 -14.412 0 CA-C-O 121.331 0.586 . . . . 0.0 111.748 -179.667 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.559 ' O ' ' O ' ' A' ' 83' ' ' ALA 0.257 0.0 OUTLIER -25.71 -163.74 0.0 OUTLIER 'General case' 3 C--O 0.554 -35.513 2 O-C-N 111.277 -7.14 . . . . 0.0 118.378 -179.582 . . . . . . . . 6 4 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 1.147 ' O ' ' CA ' ' A' ' 86' ' ' ASP 0.46 0.2 OUTLIER -32.87 6.71 0.0 OUTLIER 'General case' 4 C--O 0.302 -48.796 5 O-C-N 90.034 -20.417 . . . . 0.0 127.013 -178.286 . . . . . . . . 6 4 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 1.354 ' OD2' ' CB ' ' A' ' 86' ' ' ASP . 0.5 OUTLIER -148.27 44.23 1.05 Allowed 'General case' 2 C--N 0.866 -20.424 3 O-C-N 41.666 -50.646 . . . . 0.0 115.159 178.086 . . . . . . . . 5 4 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.624 HD23 ' HB1' ' A' ' 83' ' ' ALA . 0.2 OUTLIER -48.95 -22.44 0.85 Allowed 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.967 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -48.11 -49.37 32.22 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -179.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.498 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -67.14 -21.19 65.84 Favored 'General case' 0 C--N 1.317 -0.807 0 O-C-N 122.371 -0.206 . . . . 0.0 111.081 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.55 ' O ' ' HB3' ' A' ' 93' ' ' ALA . . . -70.73 -42.14 70.94 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-O 121.282 0.563 . . . . 0.0 111.013 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.5 t -62.67 -46.06 97.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 CA-C-O 121.702 0.763 . . . . 0.0 111.725 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.37 -24.65 66.64 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.177 0.513 . . . . 0.0 110.267 178.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.55 ' HB3' ' O ' ' A' ' 90' ' ' ALA . . . -64.51 -47.81 77.5 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-O 121.809 0.814 . . . . 0.0 110.948 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 1.507 ' CZ ' ' CD1' ' A' ' 94' ' ' TYR . 12.3 m-85 -58.17 -28.33 64.66 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-O 122.211 1.005 . . . . 0.0 110.829 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.403 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -74.13 -38.11 63.89 Favored 'General case' 0 C--N 1.286 -2.188 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.523 179.91 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.914 ' OE1' ' HB3' ' A' ' 70' ' ' LYS . 7.6 pt20 -84.74 -12.44 53.75 Favored 'General case' 0 C--O 1.16 -3.634 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.263 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.49 ' O ' ' HA ' ' A' ' 77' ' ' PRO . . . 131.51 20.14 1.13 Allowed Glycine 2 C--O 0.905 -20.412 1 CA-C-O 128.143 4.19 . . . . 0.0 116.333 179.562 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.648 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -77.62 145.55 36.69 Favored 'General case' 1 C--N 1.022 -13.635 3 O-C-N 102.124 -12.398 . . . . 0.0 110.88 179.427 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.516 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 17.8 t80 -77.5 -53.7 7.3 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.707 -0.224 . . . . 0.0 111.433 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 1.14 ' CG ' ' CA ' ' A' ' 100' ' ' ASP . 2.9 t0 173.07 -167.3 0.03 OUTLIER 'General case' 0 C--O 1.221 -0.43 0 CA-C-O 120.882 0.372 . . . . 0.0 111.654 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.65 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 4.3 m-85 -132.42 152.82 51.33 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.365 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.573 ' CD1' HD22 ' A' ' 114' ' ' LEU . 0.9 OUTLIER -103.17 124.29 38.88 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-O 121.25 0.548 . . . . 0.0 110.903 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -68.19 -84.64 0.01 OUTLIER 'Trans proline' 1 C--O 1.101 -6.348 0 C-N-CA 122.104 1.869 . . . . 0.0 113.151 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.621 ' H ' ' HD2' ' A' ' 105' ' ' PRO . 14.1 mttt -106.62 -58.03 0.06 OUTLIER Pre-proline 1 C--N 1.184 -6.62 1 O-C-N 115.977 -4.202 . . . . 0.0 111.964 -179.604 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.621 ' HD2' ' H ' ' A' ' 104' ' ' LYS . 1.1 Cg_endo -57.49 160.29 14.38 Favored 'Trans proline' 0 CA--C 1.508 -0.81 0 C-N-CA 122.342 2.028 . . . . 0.0 112.748 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.666 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 3.0 t80 -166.73 -105.57 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.859 0 O-C-N 123.463 0.477 . . . . 0.0 111.131 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.564 ' O ' ' O ' ' A' ' 106' ' ' PHE . 2.9 p30 42.49 -179.44 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.861 0.362 . . . . 0.0 111.375 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.729 HG12 HG12 ' A' ' 18' ' ' VAL . 0.9 OUTLIER -67.63 -42.85 86.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.071 0.462 . . . . 0.0 111.594 -179.848 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 1.408 ' OD1' ' CB ' ' A' ' 109' ' ' ASP . 0.2 OUTLIER -49.76 -57.84 6.53 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.61 -179.407 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 1.097 ' OE1' ' CG ' ' A' ' 110' ' ' GLU . 5.2 mm-40 -76.99 -31.97 56.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.574 0.226 . . . . 0.0 111.542 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.4 ' CB ' ' O ' ' A' ' 107' ' ' ASP . . . -67.62 -59.52 3.28 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.845 0.355 . . . . 0.0 110.171 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.64 ' O ' HG12 ' A' ' 115' ' ' VAL . 48.2 t -59.3 -31.44 46.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.423 0.63 . . . . 0.0 110.473 178.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.502 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -63.43 -46.36 86.65 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.067 179.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.664 HD23 ' CG2' ' A' ' 79' ' ' ILE . 29.4 tp -75.37 -22.4 57.55 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.992 -1.004 . . . . 0.0 111.802 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.64 HG12 ' O ' ' A' ' 112' ' ' VAL . 4.2 p -79.26 -43.78 23.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.641 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 1.129 ' OE2' ' CG ' ' A' ' 116' ' ' GLU . 48.9 mt-10 -65.05 -44.69 88.22 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.949 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 1.514 ' CB ' ' CD ' ' A' ' 117' ' ' ARG . 0.0 OUTLIER -61.07 -24.73 66.44 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.859 179.772 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.516 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -71.27 -45.81 62.32 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.954 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.5 HD11 HG11 ' A' ' 50' ' ' VAL . 4.7 mt -69.67 -31.57 49.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.257 0.551 . . . . 0.0 111.034 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.4 t -70.33 -47.38 61.32 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.32 -0.854 . . . . 0.0 111.086 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 19.4 m80 -63.8 -25.92 68.4 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.059 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 1.637 ' CG ' ' CE2' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -74.39 -52.12 13.05 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.232 -179.98 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.736 ' O ' ' O ' ' A' ' 122' ' ' TYR 0.76 3.8 tt0 -34.99 -178.2 0.0 OUTLIER 'General case' 2 CA--C 0.881 -24.778 2 CA-C-O 89.335 -14.65 . . . . 0.0 126.055 179.967 . . . . . . . . 5 3 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . 1.541 5.7 tt0 . . . . . 4 C--O 0.216 -53.309 5 N-CA-C 172.136 22.643 . . . . 0.0 172.136 179.998 . . . . . . . . 3 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 ptt? . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.76 0.314 . . . . 0.0 111.238 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.464 ' O ' ' HB3' ' A' ' 3' ' ' ARG . 3.6 mt-30 -123.27 -34.75 3.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.781 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.765 ' HB3' HD11 ' A' ' 5' ' ' ILE . 0.1 OUTLIER 76.19 -20.05 0.38 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.702 -179.806 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 52.06 78.72 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.795 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.765 HD11 ' HB3' ' A' ' 3' ' ' ARG . 3.6 mp -110.88 112.35 40.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.75 0.31 . . . . 0.0 110.831 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 1.023 HG11 HD13 ' A' ' 23' ' ' LEU . 7.2 p -107.59 123.43 62.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.7 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.905 ' CD1' HG22 ' A' ' 31' ' ' THR . 30.7 m0 -114.35 131.71 56.45 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.995 0.426 . . . . 0.0 110.924 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.788 HG11 ' CD1' ' A' ' 19' ' ' LEU . 0.3 OUTLIER -113.95 146.88 17.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.909 -179.588 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.799 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -130.42 105.89 12.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.951 0.405 . . . . 0.0 110.099 179.377 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -161.33 -155.14 0.39 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.822 -179.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -69.58 12.15 0.21 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.7 p30 46.94 -152.4 0.08 Allowed 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.4 t 38.02 -91.51 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.869 ' O ' HG23 ' A' ' 18' ' ' VAL . 1.9 t -54.87 -60.15 3.76 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.727 0.299 . . . . 0.0 110.785 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.4 mm -63.28 -24.46 35.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.727 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 1.021 ' HA ' HG21 ' A' ' 32' ' ' THR . 0.0 OUTLIER -71.57 -55.16 8.34 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.618 -179.598 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.417 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 86.3 t90 -61.15 -41.49 96.84 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -179.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.869 HG23 ' O ' ' A' ' 14' ' ' SER . 6.3 t -65.35 -44.56 94.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -178.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.788 ' CD1' HG11 ' A' ' 8' ' ' VAL . 26.5 mt -83.8 -25.68 30.21 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -178.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.577 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 18.8 pt-20 -67.7 -57.96 5.46 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -179.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.531 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 1.9 mmt-85 -65.47 -47.78 74.91 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.857 -0.611 . . . . 0.0 112.044 -178.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.41 -60.08 3.82 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 120.901 0.381 . . . . 0.0 111.317 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.036 HD22 HD13 ' A' ' 28' ' ' LEU . 3.3 mt -63.25 -29.14 70.53 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.01 179.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.535 ' HB2' ' O ' ' A' ' 20' ' ' GLU . . . -63.26 -36.1 82.53 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.7 -24.9 71.48 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.247 -0.978 . . . . 0.0 111.086 178.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.726 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -77.48 -15.52 59.26 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 120.6 0.238 . . . . 0.0 111.241 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.5 25.88 8.46 Favored Glycine 0 CA--C 1.522 0.505 0 C-N-CA 120.791 -0.719 . . . . 0.0 113.887 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 1.036 HD13 HD22 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -124.64 171.13 10.3 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 117.691 0.745 . . . . 0.0 111.996 -179.83 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 32.4 m -99.12 106.45 18.66 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.371 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.577 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 48.7 t -103.15 113.39 26.82 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -178.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.905 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.6 t -120.73 149.04 43.14 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 1.021 HG21 ' HA ' ' A' ' 16' ' ' ARG . 32.7 p -119.8 166.12 13.68 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.318 0.58 . . . . 0.0 112.336 -178.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.799 ' HB2' HG13 ' A' ' 9' ' ' VAL . 3.9 m-85 -135.6 173.92 11.19 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.414 -178.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.666 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 2.6 pp20? -62.08 -43.21 99.34 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -177.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.462 ' C ' HG12 ' A' ' 9' ' ' VAL . 4.9 m120 -166.07 -62.99 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.549 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . -157.73 -48.87 0.01 OUTLIER Glycine 0 C--N 1.318 -0.466 0 C-N-CA 120.517 -0.849 . . . . 0.0 113.429 -178.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.444 ' HA ' ' CD1' ' A' ' 40' ' ' LEU . 0.4 OUTLIER -60.85 -24.51 65.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.975 0.417 . . . . 0.0 111.435 -179.072 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.676 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -60.25 -59.02 6.08 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.262 -179.866 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.756 HG12 ' CD1' ' A' ' 43' ' ' LEU . 4.7 t -52.49 -35.35 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 C-N-CA 120.431 -0.508 . . . . 0.0 111.135 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.559 HD13 ' CB ' ' A' ' 68' ' ' GLN . 19.5 mt -56.02 -42.37 76.37 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.03 0.443 . . . . 0.0 110.976 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.76 -47.47 21.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.2 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.405 ' CB ' ' HE2' ' A' ' 33' ' ' PHE . . . -63.16 -36.49 83.8 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.783 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.756 ' CD1' HG12 ' A' ' 39' ' ' VAL . 12.7 mt -59.81 -20.72 58.53 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.135 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.71 -16.79 52.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.501 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -120.68 -5.91 9.69 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -179.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.524 ' O ' HD23 ' A' ' 43' ' ' LEU . 0.1 OUTLIER -162.9 160.77 25.33 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.865 0.364 . . . . 0.0 111.325 -179.746 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.967 HG23 HD23 ' A' ' 76' ' ' LEU . 96.5 m -138.61 115.08 8.86 Favored Pre-proline 0 N--CA 1.453 -0.302 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.535 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.709 ' HD2' HD21 ' A' ' 43' ' ' LEU . 65.9 Cg_endo -73.46 157.02 49.72 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.595 2.197 . . . . 0.0 111.471 178.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.412 ' OD2' HD12 ' A' ' 5' ' ' ILE . 60.1 m-20 -77.0 -22.95 52.32 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.25 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.74 HG13 HG23 ' A' ' 6' ' ' VAL . 7.1 p -150.7 98.19 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-O 120.783 0.325 . . . . 0.0 111.46 -179.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.492 HD12 ' O ' ' A' ' 7' ' ' TRP . 29.1 tp -86.63 138.27 31.81 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.893 0.377 . . . . 0.0 111.435 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.531 ' HB3' HG13 ' A' ' 8' ' ' VAL . 0.4 OUTLIER -123.29 113.93 19.53 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.663 179.49 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.438 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -116.54 154.6 30.14 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.322 0.582 . . . . 0.0 112.132 -179.384 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.1 p30 -83.39 -169.7 2.68 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.738 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.66 HG21 ' O ' ' A' ' 82' ' ' THR . 0.9 OUTLIER -158.15 65.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.15 0.5 . . . . 0.0 111.307 178.988 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 29.4 ptt180 -177.18 65.07 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.232 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.627 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . 2.2 tpt -161.97 -64.44 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.696 179.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.627 ' HD3' ' HB3' ' A' ' 57' ' ' MET . 42.0 Cg_endo -65.99 -173.15 0.31 Allowed 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.265 1.977 . . . . 0.0 112.913 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.95 -67.03 2.41 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.233 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.558 ' O ' ' N ' ' A' ' 62' ' ' GLY . 0.0 OUTLIER -76.98 55.31 1.1 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.063 0.459 . . . . 0.0 110.344 179.457 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.448 ' O ' ' HD2' ' A' ' 58' ' ' PRO . 1.0 OUTLIER 42.41 -77.8 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.711 -179.739 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.723 ' O ' ' HG ' ' A' ' 65' ' ' LEU . . . -135.34 -30.6 0.34 Allowed Glycine 0 C--O 1.225 -0.419 0 C-N-CA 120.367 -0.92 . . . . 0.0 113.224 -179.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.76 ' HA ' HD12 ' A' ' 66' ' ' LEU . 0.2 OUTLIER -67.75 -12.54 60.77 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.619 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.487 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -56.34 -56.79 16.79 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-O 121.056 0.455 . . . . 0.0 110.116 178.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.859 HD12 ' N ' ' A' ' 66' ' ' LEU . 3.1 pp -54.78 -42.3 71.58 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.498 179.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.859 ' N ' HD12 ' A' ' 65' ' ' LEU . 28.8 mt -48.19 -52.62 20.05 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.005 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.773 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 34.5 tttp -54.58 -43.13 71.85 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.09 0.472 . . . . 0.0 110.711 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.559 ' CB ' HD13 ' A' ' 40' ' ' LEU . 34.4 mm-40 -64.75 -28.4 69.55 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.615 179.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.891 HD13 HG21 ' A' ' 78' ' ' VAL . 96.2 mt -63.83 -40.45 89.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.726 -179.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.773 ' HG2' ' O ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -75.22 -25.38 58.11 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.893 -179.187 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.22 -50.8 70.31 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.209 -0.45 . . . . 0.0 112.175 -179.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 14.2 mtt-85 -96.26 -45.32 6.88 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -178.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.454 ' HD2' HG23 ' A' ' 69' ' ' ILE . 1.8 m-70 -91.41 130.3 40.01 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.198 -178.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 73' ' ' HIS . 44.4 Cg_exo -56.76 -70.77 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.54 2.16 . . . . 0.0 113.099 -179.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.712 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 2.1 mpt? -133.74 46.88 2.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.932 0.396 . . . . 0.0 111.412 -179.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.967 HD23 HG23 ' A' ' 47' ' ' THR . 2.8 tm? -64.31 110.61 4.15 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.53 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.59 ' HD2' HD22 ' A' ' 76' ' ' LEU . 38.0 Cg_exo -58.49 131.58 43.46 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.624 2.216 . . . . 0.0 112.168 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.891 HG21 HD13 ' A' ' 69' ' ' ILE . 2.8 t -131.34 151.93 36.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.107 0.479 . . . . 0.0 111.431 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.624 HD11 ' CG2' ' A' ' 50' ' ' VAL . 4.0 mt -134.08 115.58 21.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.952 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.677 HG13 HD11 ' A' ' 66' ' ' LEU . 26.4 mm -93.68 141.95 14.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.525 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.635 ' HG3' HG22 ' A' ' 55' ' ' ILE . 7.7 ptm -71.99 -35.44 69.49 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -178.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.66 ' O ' HG21 ' A' ' 55' ' ' ILE . 4.1 m -147.31 149.4 32.76 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -179.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.717 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -108.64 83.31 1.75 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.798 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 -66.87 -159.34 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.669 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.469 ' O ' ' HB2' ' A' ' 86' ' ' ASP . 0.4 OUTLIER -80.46 78.98 7.13 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-O 121.079 0.466 . . . . 0.0 112.152 -178.455 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.483 ' HB3' HD13 ' A' ' 63' ' ' LEU . 13.7 t70 175.74 26.6 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.777 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.577 HD21 ' HB1' ' A' ' 83' ' ' ALA . 13.3 mt -45.73 -22.96 0.21 Allowed 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -179.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -47.98 -46.9 33.14 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.61 0.243 . . . . 0.0 111.325 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.05 -22.04 59.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.334 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.599 ' HB2' HD23 ' A' ' 63' ' ' LEU . . . -65.41 -40.89 93.94 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.182 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.63 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 6.6 t -65.26 -40.06 87.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.933 -179.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.463 ' O ' ' HG3' ' A' ' 95' ' ' GLN . 19.5 m -63.42 -16.49 60.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.124 0.488 . . . . 0.0 109.903 178.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.789 ' O ' ' HG3' ' A' ' 96' ' ' GLN . . . -75.94 -55.01 6.02 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 121.503 0.668 . . . . 0.0 111.062 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.63 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 3.6 m-85 -57.38 -34.69 69.11 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.291 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.463 ' HG3' ' O ' ' A' ' 92' ' ' SER . 2.3 pp0? -77.19 -35.2 55.97 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.119 -179.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.789 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 1.9 pp0? -77.65 -18.41 56.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.096 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 147.37 -27.61 1.52 Allowed Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.987 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.69 ' HB3' ' C ' ' A' ' 93' ' ' ALA . . . -41.95 152.7 0.07 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.563 0.181 . . . . 0.0 111.378 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.517 ' O ' ' HB2' ' A' ' 100' ' ' ASP . 59.6 t80 -85.63 -53.58 5.07 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 121.084 -0.246 . . . . 0.0 111.544 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.517 ' HB2' ' O ' ' A' ' 99' ' ' PHE . 1.0 OUTLIER 170.79 -176.19 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.009 0.433 . . . . 0.0 111.243 -179.717 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.717 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 3.9 m-85 -112.04 152.71 27.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.333 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.668 HD21 ' HA ' ' A' ' 106' ' ' PHE . 6.5 tp -104.64 139.62 20.28 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.09 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.513 ' HD2' HD12 ' A' ' 102' ' ' LEU . 38.7 Cg_endo -66.51 -164.29 0.08 OUTLIER 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.779 2.32 . . . . 0.0 113.1 -179.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.479 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 85.6 mttt -46.37 -59.71 4.61 Favored Pre-proline 0 CA--C 1.533 0.315 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.779 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 8.4 Cg_endo -50.74 164.4 0.57 Allowed 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.699 2.266 . . . . 0.0 112.157 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.668 ' HA ' HD21 ' A' ' 102' ' ' LEU . 86.7 t80 -162.16 -99.93 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.665 -0.243 . . . . 0.0 110.914 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.586 ' O ' ' O ' ' A' ' 106' ' ' PHE . 2.9 p-10 40.06 -177.2 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.977 0.418 . . . . 0.0 111.562 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.65 HG12 HG12 ' A' ' 18' ' ' VAL . 0.8 OUTLIER -67.76 -43.52 86.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.106 0.479 . . . . 0.0 111.024 179.474 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.497 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 8.1 t70 -49.42 -59.07 4.06 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.896 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.631 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 21.4 mm-40 -76.95 -27.51 54.83 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 111.841 0.312 . . . . 0.0 111.841 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.407 ' CB ' ' O ' ' A' ' 107' ' ' ASP . . . -71.01 -59.59 2.7 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 179.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.643 ' O ' HG12 ' A' ' 115' ' ' VAL . 53.6 t -59.61 -30.67 45.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.348 0.595 . . . . 0.0 110.271 178.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.497 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -63.61 -46.3 86.41 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.928 179.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.468 ' HA ' ' HG2' ' A' ' 117' ' ' ARG . 53.8 tp -74.86 -23.16 58.38 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.695 -179.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.643 HG12 ' O ' ' A' ' 112' ' ' VAL . 2.8 p -79.53 -42.38 22.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.997 -0.281 . . . . 0.0 111.547 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.583 ' HA ' HD12 ' A' ' 119' ' ' ILE . 47.6 mt-10 -63.71 -43.6 96.08 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.088 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.468 ' HG2' ' HA ' ' A' ' 114' ' ' LEU . 0.4 OUTLIER -64.35 -23.97 67.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.862 0.363 . . . . 0.0 110.739 179.638 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.458 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -71.35 -45.12 63.71 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.835 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.583 HD12 ' HA ' ' A' ' 116' ' ' GLU . 6.4 mt -62.71 -31.66 52.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.217 0.532 . . . . 0.0 110.709 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 9.2 m -71.19 -54.85 9.55 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.87 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -59.48 -27.2 65.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.912 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -75.64 -57.89 3.61 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.933 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 57.69 177.45 0.05 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.715 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.438 ' HB2' ' HG2' ' A' ' 2' ' ' GLN . 4.4 tm-20 . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.986 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 tpp . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.83 0.348 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.4 tp60 -67.51 -67.34 0.46 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.26 0.552 . . . . 0.0 111.066 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 57.57 58.71 3.62 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.399 -0.818 . . . . 0.0 111.173 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.691 ' C ' HD13 ' A' ' 5' ' ' ILE . . . -82.64 86.03 1.48 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.557 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.691 HD13 ' C ' ' A' ' 4' ' ' GLY . 2.6 mm -111.81 112.76 41.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.864 0.364 . . . . 0.0 111.157 -179.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.89 HG23 HG13 ' A' ' 50' ' ' VAL . 7.3 p -108.77 124.87 65.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.902 0.382 . . . . 0.0 110.521 179.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.942 ' CD1' HG22 ' A' ' 31' ' ' THR . 22.5 m0 -115.17 135.87 53.72 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.965 0.412 . . . . 0.0 110.637 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.856 HG13 ' HB3' ' A' ' 52' ' ' LEU . 1.3 t -126.22 146.04 32.69 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.332 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.431 -178.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.722 HG22 HG23 ' A' ' 39' ' ' VAL . 45.2 t -120.6 112.62 36.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 177.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -161.65 -158.21 0.54 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.96 -178.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -76.31 19.25 0.25 Allowed 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.6 p30 46.25 -156.2 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.433 ' OG ' ' N ' ' A' ' 14' ' ' SER . 76.7 p 35.83 -95.09 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.752 ' O ' HG23 ' A' ' 18' ' ' VAL . 0.3 OUTLIER -52.77 -62.04 1.91 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.911 -178.969 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 18.4 mm -63.93 -23.88 34.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.977 0.418 . . . . 0.0 111.063 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.565 ' HA ' HG21 ' A' ' 32' ' ' THR . 3.0 ttt-85 -75.95 -50.84 13.81 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.906 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.466 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 44.8 t90 -58.91 -37.41 76.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.188 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.752 HG23 ' O ' ' A' ' 14' ' ' SER . 11.2 t -69.39 -43.92 80.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.733 HD23 HG21 ' A' ' 8' ' ' VAL . 2.3 tp -84.03 -27.34 28.42 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.416 -178.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.661 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 12.8 pt-20 -67.82 -60.98 2.1 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.624 -0.431 . . . . 0.0 111.845 -179.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.479 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 3.9 mmt-85 -59.65 -52.19 66.59 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.805 -179.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.07 -52.36 64.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.982 0.42 . . . . 0.0 111.316 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.754 ' CD2' HG11 ' A' ' 6' ' ' VAL . 1.8 tp -68.06 -24.98 65.13 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.342 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.13 -35.61 78.38 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.87 -25.98 68.35 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.411 -0.9 . . . . 0.0 111.244 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.658 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -77.15 -15.78 59.39 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 120.675 0.274 . . . . 0.0 111.07 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.96 26.59 8.33 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.457 -0.878 . . . . 0.0 114.28 178.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.726 HD12 ' O ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -126.51 170.85 11.59 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 117.938 0.869 . . . . 0.0 111.897 -179.913 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 35.2 m -99.8 104.95 16.67 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.091 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.833 ' HA ' HG13 ' A' ' 6' ' ' VAL . 51.5 t -100.1 111.52 23.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.582 -179.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.942 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.6 t -124.06 147.39 47.9 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.77 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 65.7 p -116.95 166.11 12.55 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -178.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.88 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 5.0 m-85 -135.66 170.3 16.18 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.002 -178.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.927 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 2.1 pp20? -68.96 -54.13 16.99 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -179.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.7 ' C ' HG11 ' A' ' 9' ' ' VAL . 14.0 m120 -155.81 -178.65 7.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.898 0.38 . . . . 0.0 110.8 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.52 ' O ' ' HG ' ' A' ' 40' ' ' LEU . . . -50.98 -16.39 1.81 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.89 -0.671 . . . . 0.0 114.1 -178.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -85.54 -36.33 20.54 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 117.766 0.783 . . . . 0.0 112.131 -179.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.927 ' HB2' ' HG3' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -55.37 -62.07 1.92 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -178.444 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.722 HG23 HG22 ' A' ' 9' ' ' VAL . 48.6 t -49.06 -32.23 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.999 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' A' ' 36' ' ' GLY . 30.5 mt -59.9 -41.03 90.77 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.031 0.443 . . . . 0.0 110.209 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.53 -48.32 78.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.185 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.11 -29.65 64.29 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.829 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.727 HD13 ' NE2' ' A' ' 73' ' ' HIS . 5.9 mt -61.51 -33.52 73.94 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.017 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.56 -19.45 15.85 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.617 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.8 m -125.47 2.58 7.67 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.532 ' O ' HD23 ' A' ' 43' ' ' LEU . 0.1 OUTLIER -161.9 166.18 26.6 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 120.832 0.349 . . . . 0.0 111.165 179.966 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.788 HG23 HD23 ' A' ' 76' ' ' LEU . 85.1 m -138.41 114.78 8.96 Favored Pre-proline 0 N--CA 1.453 -0.289 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.999 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.625 ' HD2' HD21 ' A' ' 43' ' ' LEU . 61.2 Cg_endo -71.09 148.16 55.89 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.283 1.989 . . . . 0.0 111.886 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -74.21 -30.34 62.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.758 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.89 HG13 HG23 ' A' ' 6' ' ' VAL . 7.3 p -146.88 101.36 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.841 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.61 HD11 HG21 ' A' ' 39' ' ' VAL . 13.8 tp -85.46 125.6 33.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.08 0.467 . . . . 0.0 111.343 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.856 ' HB3' HG13 ' A' ' 8' ' ' VAL . 1.2 tt -120.64 120.26 35.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.823 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.502 ' CB ' HD23 ' A' ' 65' ' ' LEU . 8.1 t -118.38 130.2 55.86 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.067 0.461 . . . . 0.0 111.106 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.415 ' HA ' ' HG2' ' A' ' 81' ' ' MET . 24.5 t70 -83.24 15.19 3.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.805 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.696 HG13 ' O ' ' A' ' 61' ' ' ASP . 3.5 tt 33.51 93.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 120.766 0.317 . . . . 0.0 111.813 -179.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.9 tpt180 -104.7 34.1 3.3 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.356 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.534 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER 53.14 47.35 4.04 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.674 179.08 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.747 ' HD2' ' O ' ' A' ' 61' ' ' ASP . 21.0 Cg_endo -61.26 -74.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.096 1.864 . . . . 0.0 111.272 178.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -117.01 -80.94 0.81 Allowed Glycine 0 C--N 1.332 0.306 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 178.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.747 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -85.6 56.27 3.89 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 177.781 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.747 ' O ' ' HD2' ' A' ' 58' ' ' PRO . 4.1 p30 55.92 -62.88 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.224 -0.898 . . . . 0.0 112.106 -178.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 60' ' ' MET . . . -155.47 -35.97 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 121.147 -0.549 . . . . 0.0 112.276 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.763 HD21 ' HA ' ' A' ' 87' ' ' LEU . 0.3 OUTLIER -61.38 -22.0 64.57 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.73 0.3 . . . . 0.0 111.085 -179.802 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.747 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -54.91 -42.76 72.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.092 0.473 . . . . 0.0 111.135 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.546 ' HG ' HD11 ' A' ' 69' ' ' ILE . 7.4 tp -52.96 -43.85 66.69 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.252 -179.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 1.0 HD22 ' HB1' ' A' ' 93' ' ' ALA . 2.9 mt -59.93 -43.83 94.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.912 0.387 . . . . 0.0 110.862 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.439 ' HG3' ' HE3' ' A' ' 70' ' ' LYS . 4.1 tttt -53.07 -54.92 28.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.775 -179.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.519 ' HB3' HD13 ' A' ' 40' ' ' LEU . 66.2 mm-40 -61.18 -44.66 96.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.911 -179.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.59 ' CG2' ' HB3' ' A' ' 76' ' ' LEU . 22.7 mt -56.92 -54.18 33.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.287 0.565 . . . . 0.0 111.409 -178.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.473 ' HB3' ' CB ' ' A' ' 96' ' ' GLN . 11.0 pttt -57.45 -23.7 51.32 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.496 -179.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.65 -51.96 50.32 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.722 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 75.0 mtt-85 -100.37 -7.19 24.68 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.379 -178.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.727 ' NE2' HD13 ' A' ' 43' ' ' LEU . 71.6 m-70 -125.52 139.09 33.14 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-O 120.896 0.379 . . . . 0.0 112.015 -179.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -68.86 -62.33 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.95 2.433 . . . . 0.0 113.417 -179.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.739 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 1.8 mtt -136.06 49.0 2.14 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.788 HD23 HG23 ' A' ' 47' ' ' THR . 0.9 OUTLIER -68.26 108.49 2.85 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.014 178.916 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.525 ' O ' ' HB3' ' A' ' 51' ' ' LEU . 18.1 Cg_endo -59.42 132.32 45.6 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.419 2.079 . . . . 0.0 112.336 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.422 ' CG2' HD13 ' A' ' 69' ' ' ILE . 3.3 t -129.48 136.24 59.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.738 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.616 HD11 HG23 ' A' ' 50' ' ' VAL . 1.9 mt -127.61 110.89 23.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.934 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.633 HG13 ' CZ ' ' A' ' 101' ' ' TYR . 15.2 mm -99.79 147.53 7.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.538 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.489 ' HG3' ' N ' ' A' ' 82' ' ' THR . 0.3 OUTLIER -81.66 -34.58 30.69 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.261 -179.767 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.489 ' N ' ' HG3' ' A' ' 81' ' ' MET . 21.6 m -133.79 148.28 51.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.517 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.535 ' HA ' ' CE2' ' A' ' 101' ' ' TYR . . . -99.94 -25.82 14.2 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.417 ' HB3' ' H ' ' A' ' 85' ' ' SER . 3.3 m-70 46.77 -158.87 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.764 -0.198 . . . . 0.0 110.913 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.417 ' H ' ' HB3' ' A' ' 84' ' ' HIS . 94.0 p -80.25 175.44 10.64 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.977 0.417 . . . . 0.0 111.469 -179.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.657 ' O ' HD22 ' A' ' 63' ' ' LEU . 0.7 OUTLIER 62.89 32.46 15.72 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.989 -179.897 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.763 ' HA ' HD21 ' A' ' 63' ' ' LEU . 1.9 mt -49.05 -21.66 0.75 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.414 -179.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -48.39 -41.36 28.75 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.806 0.298 . . . . 0.0 111.806 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.638 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -66.16 -23.79 66.53 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.733 ' HB2' HD23 ' A' ' 63' ' ' LEU . . . -77.3 -26.86 52.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.819 0.342 . . . . 0.0 110.726 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.511 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 6.3 t -68.22 -39.21 80.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.936 0.398 . . . . 0.0 110.073 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 30.9 m -68.55 -20.54 64.55 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.742 178.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 1.0 ' HB1' HD22 ' A' ' 66' ' ' LEU . . . -67.41 -42.99 82.33 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.668 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.511 ' CE2' ' HA ' ' A' ' 91' ' ' VAL . 12.5 m-85 -62.39 -25.79 68.12 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.18 -41.13 42.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.282 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.739 ' O ' ' HA ' ' A' ' 75' ' ' MET . 0.0 OUTLIER -76.06 -16.91 59.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.206 -179.876 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 119.16 17.63 4.87 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.461 -0.876 . . . . 0.0 113.652 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.58 ' HB2' ' HB1' ' A' ' 93' ' ' ALA . . . -64.43 165.05 10.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 117.141 0.47 . . . . 0.0 110.811 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.481 ' HZ ' ' HG3' ' A' ' 117' ' ' ARG . 13.9 t80 -87.16 -54.42 4.32 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.497 ' OD2' HD11 ' A' ' 114' ' ' LEU . 9.5 p30 167.77 -164.55 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.782 0.325 . . . . 0.0 110.887 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.633 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 5.6 m-85 -138.63 153.19 48.6 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.755 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.404 ' CD1' HD22 ' A' ' 114' ' ' LEU . 0.8 OUTLIER -103.25 122.34 45.57 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.074 179.863 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -70.13 -69.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.078 1.852 . . . . 0.0 112.501 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.692 ' H ' ' HD2' ' A' ' 105' ' ' PRO . 0.9 OUTLIER -119.07 -60.42 0.03 OUTLIER Pre-proline 0 CA--C 1.533 0.301 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.901 -179.637 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.692 ' HD2' ' H ' ' A' ' 104' ' ' LYS . 11.7 Cg_endo -54.12 160.53 6.17 Favored 'Trans proline' 0 C--N 1.35 0.605 0 C-N-CA 122.214 1.943 . . . . 0.0 112.513 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.639 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 50.5 t80 -170.8 -102.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.551 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.566 ' O ' ' O ' ' A' ' 106' ' ' PHE . 2.3 p-10 43.26 178.46 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.558 0.218 . . . . 0.0 111.052 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.713 HG12 HG12 ' A' ' 18' ' ' VAL . 0.8 OUTLIER -67.82 -44.13 85.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.231 0.539 . . . . 0.0 111.217 179.852 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.492 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 1.5 t70 -49.42 -58.78 4.52 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.703 -179.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.639 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 6.4 mm-40 -74.17 -30.41 62.23 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 111.771 0.285 . . . . 0.0 111.771 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -68.76 -62.05 1.55 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.817 0.341 . . . . 0.0 110.331 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.641 ' HA ' HG12 ' A' ' 115' ' ' VAL . 44.0 t -57.84 -31.56 40.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.477 0.656 . . . . 0.0 110.716 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.492 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -64.0 -44.3 93.06 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.848 179.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.768 ' HA ' ' HD3' ' A' ' 117' ' ' ARG . 10.0 tp -78.33 -23.01 47.23 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.778 -179.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.641 HG12 ' HA ' ' A' ' 112' ' ' VAL . 4.8 p -79.45 -41.77 22.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.026 0.441 . . . . 0.0 111.47 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.495 ' HA ' HD12 ' A' ' 119' ' ' ILE . 20.8 mt-10 -59.65 -47.76 84.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.274 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.768 ' HD3' ' HA ' ' A' ' 114' ' ' LEU . 0.8 OUTLIER -59.24 -23.96 62.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.44 -179.531 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.479 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -71.03 -39.34 72.39 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.105 0.478 . . . . 0.0 111.0 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.696 HD13 ' CD2' ' A' ' 28' ' ' LEU . 4.6 mt -76.95 -30.95 18.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.728 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.4 t -67.44 -41.15 85.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.602 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 17.5 m80 -73.67 -23.43 59.84 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.979 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.42 ' O ' ' HG2' ' A' ' 123' ' ' GLN . 7.2 t80 -69.94 -60.69 2.15 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.695 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.42 ' HG2' ' O ' ' A' ' 122' ' ' TYR . 14.2 pt20 42.44 -169.14 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.805 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.806 -179.581 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.453 0 CA-C-O 120.78 0.324 . . . . 0.0 111.099 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.432 ' NE2' ' HB3' ' A' ' 123' ' ' GLN . 0.0 OUTLIER -82.42 148.4 28.23 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.93 0.395 . . . . 0.0 110.852 -179.958 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.634 ' HB3' HD11 ' A' ' 5' ' ' ILE . 0.3 OUTLIER -89.44 -26.99 20.69 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.079 -179.968 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.44 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . 53.65 82.76 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.536 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.634 HD11 ' HB3' ' A' ' 3' ' ' ARG . 3.8 mp -108.4 112.38 40.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.713 0.292 . . . . 0.0 111.545 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 1.003 HG11 ' CD2' ' A' ' 23' ' ' LEU . 7.5 p -106.64 123.37 61.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.974 0.416 . . . . 0.0 110.911 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.795 ' CD1' HG22 ' A' ' 31' ' ' THR . 28.6 m0 -114.53 136.94 52.47 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.363 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.693 HG21 ' OE1' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -129.68 141.49 46.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.478 -178.408 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 1.085 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -119.45 104.83 16.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 178.673 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.707 ' HB3' HG21 ' A' ' 15' ' ' ILE . 8.3 t0 -172.42 114.98 0.31 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.387 0.613 . . . . 0.0 111.401 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.672 ' O ' ' HB2' ' A' ' 12' ' ' ASP . 0.4 OUTLIER 49.75 -87.46 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.761 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.672 ' HB2' ' O ' ' A' ' 11' ' ' ASP . 22.9 t0 168.01 -125.72 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.51 0 O-C-N 123.041 0.213 . . . . 0.0 110.842 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.521 ' HA ' ' HB3' ' A' ' 16' ' ' ARG . 72.7 m -41.36 -43.58 2.54 Favored 'General case' 0 C--N 1.342 0.275 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.0 m -52.9 -62.4 1.67 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.65 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.707 HG21 ' HB3' ' A' ' 10' ' ' ASP . 21.8 mm -72.33 -20.08 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.617 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.85 ' HA ' HG21 ' A' ' 32' ' ' THR . 3.0 tmm_? -72.38 -30.97 65.16 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-O 121.529 0.681 . . . . 0.0 110.244 178.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.622 ' O ' ' HB2' ' A' ' 21' ' ' ARG . 41.2 t90 -72.16 -58.07 3.73 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.886 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.449 HG12 HG12 ' A' ' 108' ' ' ILE . 0.8 OUTLIER -60.68 -62.24 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 -177.467 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.53 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -68.81 -49.52 57.84 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 114.29 1.218 . . . . 0.0 114.29 -176.818 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.755 ' HG3' ' HG2' ' A' ' 16' ' ' ARG . 1.5 mm-40 -67.87 -61.23 1.97 Allowed 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -177.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.622 ' HB2' ' O ' ' A' ' 17' ' ' TRP . 8.5 mmt180 -48.61 -44.22 36.92 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.327 -177.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.22 -28.6 62.26 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.878 0.37 . . . . 0.0 110.887 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.003 ' CD2' HG11 ' A' ' 6' ' ' VAL . 5.0 tp -80.93 -23.35 38.93 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.406 179.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' A' ' 20' ' ' GLU . . . -69.31 -35.14 75.68 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.87 -27.08 66.22 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.202 -0.999 . . . . 0.0 110.84 178.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.671 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -77.68 -15.86 58.89 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.623 0.249 . . . . 0.0 111.071 179.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.75 26.71 11.31 Favored Glycine 0 CA--C 1.522 0.47 0 C-N-CA 120.548 -0.834 . . . . 0.0 114.732 178.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.769 HD13 ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -117.77 166.36 12.54 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 118.548 1.174 . . . . 0.0 112.007 -179.887 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.493 ' HB ' HG23 ' A' ' 5' ' ' ILE . 88.5 m -84.73 104.66 14.89 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.776 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.474 ' HA ' HG13 ' A' ' 6' ' ' VAL . 2.8 p -106.29 109.31 21.2 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.956 -178.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.795 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.7 t -125.26 152.46 44.58 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.85 HG21 ' HA ' ' A' ' 16' ' ' ARG . 64.7 p -122.9 164.16 18.97 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.392 0.615 . . . . 0.0 112.597 -178.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 1.085 ' HB2' HG13 ' A' ' 9' ' ' VAL . 26.3 m-85 -135.93 172.95 12.26 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.025 -0.989 . . . . 0.0 112.033 -177.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.435 ' HG2' ' H ' ' A' ' 35' ' ' ASN . 5.3 pt-20 -63.26 -50.92 68.27 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.318 0.858 . . . . 0.0 113.318 -177.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.435 ' H ' ' HG2' ' A' ' 34' ' ' GLU . 10.5 m-20 -168.75 -26.06 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -179.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.609 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . 174.29 -61.62 0.12 Allowed Glycine 0 N--CA 1.453 -0.191 0 C-N-CA 120.115 -1.041 . . . . 0.0 113.029 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.516 ' HA ' ' CD1' ' A' ' 40' ' ' LEU . 0.5 OUTLIER -51.93 -28.38 16.3 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.69 0.281 . . . . 0.0 111.24 -179.536 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.908 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.7 OUTLIER -58.83 -58.34 9.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.67 179.245 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.694 HG12 ' HG ' ' A' ' 43' ' ' LEU . 7.7 t -50.74 -38.16 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 120.619 -0.433 . . . . 0.0 111.339 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.715 HD13 ' HB3' ' A' ' 68' ' ' GLN . 17.5 mt -53.81 -43.88 69.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.394 -179.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.89 -48.94 62.13 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.546 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.63 -35.28 78.63 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.37 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.694 ' HG ' HG12 ' A' ' 39' ' ' VAL . 14.2 mt -60.2 -26.31 66.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.076 0.465 . . . . 0.0 110.909 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.06 -20.46 25.01 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.302 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.3 m -123.08 4.67 9.28 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 112.146 0.425 . . . . 0.0 112.146 -179.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.543 ' HB3' ' CH2' ' A' ' 7' ' ' TRP . 0.0 OUTLIER -164.51 158.99 18.83 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.893 0.378 . . . . 0.0 111.273 -179.768 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.982 HG23 HD23 ' A' ' 76' ' ' LEU . 90.8 m -138.23 112.14 8.64 Favored Pre-proline 0 N--CA 1.452 -0.347 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.688 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.588 ' HD2' HD21 ' A' ' 43' ' ' LEU . 73.9 Cg_endo -73.58 156.21 49.57 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.703 2.268 . . . . 0.0 111.477 178.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -78.47 -22.92 46.8 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.174 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.641 ' O ' HG13 ' A' ' 50' ' ' VAL . 7.3 p -150.58 96.66 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-O 120.663 0.268 . . . . 0.0 111.542 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 27.7 tp -87.09 145.8 26.31 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 121.123 0.487 . . . . 0.0 111.367 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.769 HD23 ' O ' ' A' ' 79' ' ' ILE . 0.6 OUTLIER -131.36 114.18 14.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.323 179.637 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.685 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 35.3 t -115.32 144.52 43.64 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.62 0.724 . . . . 0.0 112.126 -179.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -83.14 168.36 16.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.395 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.558 HG13 ' O ' ' A' ' 61' ' ' ASP . 3.6 tt -142.58 87.6 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.721 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.5 ptm85 -118.51 36.22 4.48 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.541 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.687 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 1.2 ttt 64.46 46.3 0.59 Allowed Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.099 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.58 ' HD2' ' O ' ' A' ' 61' ' ' ASP . 27.0 Cg_endo -64.23 -74.81 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.024 1.816 . . . . 0.0 110.769 178.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -111.84 -85.58 1.53 Allowed Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 109.981 -1.247 . . . . 0.0 109.981 177.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.881 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 0.5 OUTLIER -87.72 58.65 5.0 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 177.408 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.687 ' HA ' ' HA ' ' A' ' 57' ' ' MET . 0.2 OUTLIER 62.54 -42.69 0.18 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.993 -179.5 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.514 ' HA3' HD12 ' A' ' 55' ' ' ILE . . . 171.31 -29.52 0.12 Allowed Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 111.494 -0.642 . . . . 0.0 111.494 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.661 HD11 ' O ' ' A' ' 84' ' ' HIS . 0.5 OUTLIER -72.46 -17.48 61.77 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 120.992 -0.283 . . . . 0.0 110.452 179.427 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.881 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -53.94 -29.25 41.65 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 121.103 0.478 . . . . 0.0 110.54 178.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.451 ' HA ' ' OE1' ' A' ' 68' ' ' GLN . 1.4 mm? -66.77 -24.22 66.18 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.24 -179.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.96 HD13 ' HB2' ' A' ' 93' ' ' ALA . 3.7 mt -77.73 -46.5 21.59 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.696 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 1.7 mtpt -46.09 -51.92 12.99 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.501 178.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.715 ' HB3' HD13 ' A' ' 40' ' ' LEU . 2.6 mp0 -64.42 -48.44 75.35 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.241 0.543 . . . . 0.0 110.335 178.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.533 ' HA ' ' CD2' ' A' ' 73' ' ' HIS . 4.2 mm -54.71 -39.05 45.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.665 -179.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.696 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -78.14 -30.58 49.34 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.199 -178.97 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.35 -40.93 57.69 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.825 -178.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.88 -46.31 9.52 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -179.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.559 ' CD2' HD13 ' A' ' 43' ' ' LEU . 1.2 m-70 -103.69 142.87 25.49 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.95 -178.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.29 -71.17 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.733 2.289 . . . . 0.0 113.272 -179.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 13.8 mtt -140.28 47.08 1.8 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.884 0.373 . . . . 0.0 110.805 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.982 HD23 HG23 ' A' ' 47' ' ' THR . 3.1 tm? -59.31 110.31 2.6 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.684 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.489 ' HD2' HD22 ' A' ' 76' ' ' LEU . 28.9 Cg_exo -63.02 116.51 3.62 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 123.086 2.524 . . . . 0.0 113.427 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.968 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 3.3 t -118.56 152.43 20.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.652 179.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.769 ' O ' HD23 ' A' ' 52' ' ' LEU . 3.6 mt -132.25 114.28 23.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.548 -0.297 . . . . 0.0 110.572 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.685 ' HA ' ' O ' ' A' ' 53' ' ' SER . 11.6 mm -95.59 142.5 13.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.133 0.492 . . . . 0.0 111.788 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.457 ' HB2' ' CE1' ' A' ' 106' ' ' PHE . 2.8 ptt? -66.65 -28.74 68.71 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.308 -179.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.611 HG21 ' CE1' ' A' ' 84' ' ' HIS . 5.0 m -147.07 167.78 23.21 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.43 0.157 . . . . 0.0 111.293 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.501 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -122.3 61.94 0.97 Allowed 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -179.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.661 ' O ' HD11 ' A' ' 63' ' ' LEU . 4.2 m-70 -73.16 162.87 28.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.824 0.345 . . . . 0.0 110.851 179.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.434 ' HB2' ' CB ' ' A' ' 61' ' ' ASP . 8.3 t 63.8 -167.41 0.21 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.124 0.488 . . . . 0.0 112.151 178.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -56.06 92.44 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.493 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.774 HD23 ' HB3' ' A' ' 90' ' ' ALA . 0.6 OUTLIER -47.76 -20.46 0.29 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.997 179.343 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -47.45 -45.98 26.28 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -178.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.402 ' HB3' HD22 ' A' ' 63' ' ' LEU . . . -63.93 -25.73 68.27 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.786 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.774 ' HB3' HD23 ' A' ' 87' ' ' LEU . . . -72.54 -48.79 37.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.768 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.653 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 3.4 t -63.48 -53.62 42.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.086 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 92.4 p -57.28 -23.94 51.65 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 178.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.96 ' HB2' HD13 ' A' ' 66' ' ' LEU . . . -57.57 -53.77 54.37 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.438 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.702 ' CE1' ' HA ' ' A' ' 100' ' ' ASP . 5.9 m-85 -51.13 -33.16 25.41 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.764 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.91 -39.37 56.43 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.447 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.597 ' HB2' ' HB2' ' A' ' 70' ' ' LYS . 6.5 pt20 -94.39 5.8 50.67 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.063 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 93' ' ' ALA . . . 123.1 80.32 0.5 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.55 -0.834 . . . . 0.0 113.019 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.968 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -168.57 135.82 2.0 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.979 0.418 . . . . 0.0 111.27 179.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.511 ' HB3' HG12 ' A' ' 79' ' ' ILE . 38.5 t80 -75.84 -53.44 8.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.534 -179.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.702 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 1.0 OUTLIER 177.7 -172.84 0.12 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.177 0.513 . . . . 0.0 112.005 -179.535 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.661 ' OH ' HD11 ' A' ' 66' ' ' LEU . 3.2 m-85 -130.19 153.46 48.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.387 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.639 HD23 ' HA ' ' A' ' 106' ' ' PHE . 1.9 mp -103.97 118.38 57.3 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.62 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -73.24 -71.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 121.93 1.753 . . . . 0.0 111.895 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.691 ' H ' ' HD2' ' A' ' 105' ' ' PRO . 9.6 tttm -108.55 -58.66 0.05 OUTLIER Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.623 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.691 ' HD2' ' H ' ' A' ' 104' ' ' LYS . 15.6 Cg_endo -57.51 152.53 47.05 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.3 2.0 . . . . 0.0 113.014 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.639 ' HA ' HD23 ' A' ' 102' ' ' LEU . 14.9 t80 -163.22 -118.38 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.176 179.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.558 ' O ' ' O ' ' A' ' 106' ' ' PHE . 2.9 p30 42.5 -179.46 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 118.164 0.438 . . . . 0.0 111.486 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.449 HG12 HG12 ' A' ' 18' ' ' VAL . 1.0 OUTLIER -67.86 -40.92 84.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.516 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.539 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 30.8 t0 -49.18 -58.64 4.65 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.495 -179.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.545 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 74.9 mm-40 -77.87 -32.17 51.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.694 0.283 . . . . 0.0 111.371 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.409 ' CB ' ' O ' ' A' ' 107' ' ' ASP . . . -64.88 -62.5 1.52 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.931 0.396 . . . . 0.0 109.978 179.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.564 ' O ' HG12 ' A' ' 115' ' ' VAL . 47.0 t -58.4 -31.32 42.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.496 0.665 . . . . 0.0 110.802 179.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.539 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -63.46 -45.97 88.38 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.196 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.742 HD23 HG21 ' A' ' 79' ' ' ILE . 5.5 tp -76.76 -22.47 53.74 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.786 -1.097 . . . . 0.0 112.169 -179.052 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.564 HG12 ' O ' ' A' ' 112' ' ' VAL . 4.7 p -79.28 -46.44 23.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.321 -0.552 . . . . 0.0 111.595 -179.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.415 ' HA ' HD12 ' A' ' 119' ' ' ILE . 38.4 mt-10 -64.35 -47.89 77.62 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.746 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.54 ' HG2' ' HA ' ' A' ' 114' ' ' LEU . 2.8 ptp180 -60.46 -27.93 67.92 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.14 0.495 . . . . 0.0 110.404 179.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.471 ' HB2' ' CE2' ' A' ' 99' ' ' PHE . . . -66.77 -47.02 73.47 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.792 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.429 HD11 HG11 ' A' ' 50' ' ' VAL . 4.4 mt -70.26 -30.69 44.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.689 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 10.5 t -66.72 -43.83 83.23 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.21 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 13.0 m80 -68.09 -25.87 65.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.147 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -82.27 -43.23 17.81 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.873 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.432 ' HB3' ' NE2' ' A' ' 2' ' ' GLN . 9.0 pt20 -75.43 -175.66 2.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.01 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.805 -179.725 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.727 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.734 ' O ' ' HG2' ' A' ' 3' ' ' ARG . 0.0 OUTLIER -137.71 -176.23 4.35 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.509 0.195 . . . . 0.0 110.749 179.968 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.825 ' HG2' HD11 ' A' ' 5' ' ' ILE . 0.3 OUTLIER 66.08 -15.52 0.13 Allowed 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 179.834 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.864 ' O ' HD13 ' A' ' 5' ' ' ILE . . . 98.49 92.92 1.99 Allowed Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.242 179.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.864 HD13 ' O ' ' A' ' 4' ' ' GLY . 5.0 mm -126.04 112.48 30.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.074 0.464 . . . . 0.0 111.754 -179.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.951 HG11 ' HG ' ' A' ' 23' ' ' LEU . 14.3 p -109.93 128.69 65.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.684 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.877 ' CD1' HG22 ' A' ' 31' ' ' THR . 26.4 m0 -117.32 126.31 52.49 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.962 0.41 . . . . 0.0 110.112 179.09 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.743 HG11 ' CD1' ' A' ' 19' ' ' LEU . 0.5 OUTLIER -116.66 145.82 21.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.814 -178.105 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.813 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -124.52 111.1 27.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.919 0.39 . . . . 0.0 110.649 179.24 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -161.32 -159.15 0.62 Allowed 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.976 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -66.99 -0.64 3.29 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.474 ' O ' ' N ' ' A' ' 14' ' ' SER . 0.4 OUTLIER 68.08 -158.51 0.2 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 121.415 -0.114 . . . . 0.0 111.033 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.418 ' HB3' ' H ' ' A' ' 14' ' ' SER . 1.4 t 33.52 -86.46 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.758 ' O ' HG23 ' A' ' 18' ' ' VAL . 37.6 t -54.21 -63.9 1.0 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.741 0.305 . . . . 0.0 111.324 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.0 mm -61.44 -28.15 43.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.012 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.871 ' HA ' HG21 ' A' ' 32' ' ' THR . 2.7 ttm180 -73.29 -43.58 60.69 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.211 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 55.1 t90 -67.77 -40.75 84.0 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.965 -179.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.758 HG23 ' O ' ' A' ' 14' ' ' SER . 4.4 t -70.01 -39.27 77.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -178.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.743 ' CD1' HG11 ' A' ' 8' ' ' VAL . 16.2 mt -84.38 -27.72 27.47 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -178.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.604 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 24.5 pt-20 -67.44 -57.65 6.16 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.032 0.444 . . . . 0.0 111.655 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.472 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 0.7 OUTLIER -60.85 -52.49 64.85 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.937 -179.284 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.57 -43.85 84.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.866 0.365 . . . . 0.0 111.4 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.951 ' HG ' HG11 ' A' ' 6' ' ' VAL . 2.5 tm? -70.69 -31.78 68.79 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.331 0.586 . . . . 0.0 110.306 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.38 -34.22 77.67 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.16 -26.08 68.89 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.391 -0.909 . . . . 0.0 111.111 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.567 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -77.62 -15.56 59.13 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 120.751 0.31 . . . . 0.0 110.74 179.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.36 26.2 10.3 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.822 -0.704 . . . . 0.0 113.903 179.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.626 ' HB2' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -133.37 171.28 14.27 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 117.752 0.776 . . . . 0.0 111.902 179.705 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.649 ' O ' HG12 ' A' ' 6' ' ' VAL . 16.0 m -94.13 128.22 40.42 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.95 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.667 ' HA ' HG13 ' A' ' 6' ' ' VAL . 50.9 t -121.96 113.65 19.89 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 121.331 0.586 . . . . 0.0 111.477 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.877 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.7 t -117.8 151.86 36.49 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.594 178.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.871 HG21 ' HA ' ' A' ' 16' ' ' ARG . 40.2 p -124.35 164.46 19.58 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.219 0.533 . . . . 0.0 111.773 -179.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.859 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 2.3 m-85 -133.06 174.43 10.37 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.505 -178.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.402 ' HG2' ' N ' ' A' ' 35' ' ' ASN . 1.7 pt-20 -61.49 -40.7 95.54 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 -176.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.402 ' N ' ' HG2' ' A' ' 34' ' ' GLU . 1.4 m120 -170.96 -38.39 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 119.073 0.851 . . . . 0.0 112.589 -179.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.731 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . -178.77 -61.12 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.841 -179.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.635 HD22 HD12 ' A' ' 40' ' ' LEU . 13.0 m120 -50.74 -33.39 22.91 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 111.621 0.23 . . . . 0.0 111.621 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.859 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -57.7 -50.05 74.48 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.639 -0.425 . . . . 0.0 111.182 -179.98 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.869 HG11 HD11 ' A' ' 51' ' ' LEU . 5.5 t -62.44 -38.68 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 C-N-CA 119.93 -0.708 . . . . 0.0 110.442 179.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.798 HD13 ' CB ' ' A' ' 68' ' ' GLN . 12.9 mt -56.78 -42.16 78.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.524 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.35 -48.15 36.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.31 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.81 -28.41 69.84 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.364 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.664 HD21 ' HD2' ' A' ' 48' ' ' PRO . 8.4 mt -69.38 -24.12 63.83 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.083 -179.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.36 -17.69 5.32 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.266 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -123.97 0.61 8.57 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.657 ' O ' HD23 ' A' ' 43' ' ' LEU . 0.1 OUTLIER -161.96 155.57 21.2 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.912 0.387 . . . . 0.0 111.348 179.913 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.5 HG23 HD13 ' A' ' 76' ' ' LEU . 91.0 m -139.05 114.7 8.46 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.212 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.664 ' HD2' HD21 ' A' ' 43' ' ' LEU . 73.8 Cg_endo -76.19 166.1 28.36 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.41 2.073 . . . . 0.0 110.965 178.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -74.14 -21.92 59.66 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.681 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.711 HG13 HG23 ' A' ' 6' ' ' VAL . 7.4 p -146.7 168.45 5.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.23 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.869 HD11 HG11 ' A' ' 39' ' ' VAL . 13.5 tp -152.92 120.43 5.97 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.0 0.429 . . . . 0.0 111.53 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.682 ' HB3' HG13 ' A' ' 8' ' ' VAL . 0.3 OUTLIER -105.89 122.19 45.62 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.217 179.815 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.442 ' HB2' ' CD1' ' A' ' 80' ' ' ILE . 36.4 m -113.68 138.13 50.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.089 0.471 . . . . 0.0 112.021 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.526 ' O ' HG22 ' A' ' 55' ' ' ILE . 45.8 p-10 -78.23 -12.77 60.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.594 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.613 ' HB ' HG23 ' A' ' 80' ' ' ILE . 5.3 tt 50.62 82.31 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-O 121.387 0.613 . . . . 0.0 111.867 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.786 ' C ' ' HD2' ' A' ' 58' ' ' PRO . 1.0 OUTLIER 175.93 145.8 0.08 Allowed 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.708 179.273 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.529 ' CB ' ' O ' ' A' ' 56' ' ' ARG . 14.1 ttt 96.52 -52.12 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.766 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 178.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.786 ' HD2' ' C ' ' A' ' 56' ' ' ARG . 20.4 Cg_endo -58.58 175.83 0.51 Allowed 'Trans proline' 0 C--N 1.35 0.643 0 CA-C-N 121.147 1.445 . . . . 0.0 112.286 -178.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -42.17 -74.46 0.17 Allowed Glycine 0 C--N 1.335 0.522 0 C-N-CA 121.126 -0.559 . . . . 0.0 112.501 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.618 ' H ' ' HB2' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -69.46 56.22 0.12 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.773 0.32 . . . . 0.0 110.597 179.221 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 56.75 -80.37 0.01 OUTLIER 'General case' 0 C--O 1.231 0.111 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.735 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.508 ' HA3' ' C ' ' A' ' 55' ' ' ILE . . . -137.1 -34.46 0.2 Allowed Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.655 -0.783 . . . . 0.0 113.007 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.699 ' HA ' HD13 ' A' ' 66' ' ' LEU . 5.2 mp -63.28 -15.76 58.2 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.864 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.69 ' HB3' ' HB2' ' A' ' 58' ' ' PRO . . . -53.82 -48.61 69.72 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 120.929 0.395 . . . . 0.0 111.355 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.507 HD12 ' N ' ' A' ' 66' ' ' LEU . 4.0 pp -51.42 -39.36 57.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.065 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.851 ' HA ' HD12 ' A' ' 69' ' ' ILE . 5.1 mp -57.65 -47.98 80.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.912 0.387 . . . . 0.0 110.216 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.741 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 0.2 OUTLIER -49.98 -44.43 50.93 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.192 0.52 . . . . 0.0 110.097 178.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.798 ' CB ' HD13 ' A' ' 40' ' ' LEU . 11.6 mm100 -65.6 -26.42 67.83 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.262 179.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.879 HG12 ' CE1' ' A' ' 73' ' ' HIS . 94.0 mt -64.02 -39.62 86.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.486 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.741 ' HG2' ' O ' ' A' ' 67' ' ' LYS . 12.1 pttp -74.1 -27.22 60.78 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.893 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -85.85 -33.66 21.24 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.044 -179.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -106.54 -35.11 7.16 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -178.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.879 ' CE1' HG12 ' A' ' 69' ' ' ILE . 0.3 OUTLIER -99.44 136.07 20.49 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.891 -179.326 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 73' ' ' HIS . 91.4 Cg_endo -92.94 100.6 0.16 Allowed 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.953 2.435 . . . . 0.0 112.537 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.549 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 1.8 mtt 52.44 26.22 4.04 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.662 179.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.5 HD13 HG23 ' A' ' 47' ' ' THR . 12.9 tp -69.79 112.66 13.01 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.815 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.4 125.41 18.82 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.353 2.035 . . . . 0.0 112.09 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.832 HG21 HD13 ' A' ' 69' ' ' ILE . 3.7 t -118.25 148.52 21.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.934 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.894 ' CG2' HD23 ' A' ' 114' ' ' LEU . 2.0 mt -127.82 114.14 34.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.617 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.641 HG21 ' CE2' ' A' ' 101' ' ' TYR . 13.2 mm -99.54 143.49 13.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.984 0.421 . . . . 0.0 111.804 -179.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.437 ' HA ' ' HB2' ' A' ' 102' ' ' LEU . 18.6 ptm -86.56 -39.71 15.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.067 -178.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.431 ' H ' HG21 ' A' ' 55' ' ' ILE . 2.7 m -122.65 166.53 14.74 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.209 -179.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -138.99 -28.33 0.8 Allowed 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.458 ' CE1' ' CD1' ' A' ' 55' ' ' ILE . 3.5 p-80 38.19 -160.97 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 122.928 0.491 . . . . 0.0 111.863 -179.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.446 ' H ' ' HB2' ' A' ' 84' ' ' HIS . 27.4 t -82.66 42.05 0.75 Allowed 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -178.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.503 ' CB ' HD13 ' A' ' 63' ' ' LEU . 6.7 m-20 -132.84 15.98 4.28 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.718 0.294 . . . . 0.0 110.773 179.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.754 HD23 ' CB ' ' A' ' 90' ' ' ALA . 1.4 mt -44.74 -21.78 0.06 Allowed 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.291 -0.413 . . . . 0.0 112.006 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -47.94 -50.35 27.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.771 0.319 . . . . 0.0 111.028 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.403 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -70.7 -21.19 62.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.986 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.754 ' CB ' HD23 ' A' ' 87' ' ' LEU . . . -64.38 -33.22 75.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.861 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.631 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 3.1 t -66.15 -42.89 92.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.428 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.599 ' O ' ' HG3' ' A' ' 95' ' ' GLN . 14.9 m -60.43 -19.42 56.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.035 0.445 . . . . 0.0 110.073 178.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.742 ' O ' ' HG3' ' A' ' 96' ' ' GLN . . . -75.76 -53.93 7.73 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.62 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.631 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 5.6 m-85 -57.01 -33.19 66.91 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.148 0.499 . . . . 0.0 110.838 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.599 ' HG3' ' O ' ' A' ' 92' ' ' SER . 2.2 pp0? -76.95 -31.25 56.48 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.031 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.742 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 2.0 pp0? -83.09 -18.5 39.36 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.829 -0.349 . . . . 0.0 111.032 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 133.06 4.71 3.24 Favored Glycine 0 C--N 1.335 0.501 0 C-N-CA 120.231 -0.985 . . . . 0.0 114.315 178.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.68 ' HB2' ' HB1' ' A' ' 93' ' ' ALA . . . -58.03 158.34 6.87 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 117.85 0.825 . . . . 0.0 111.278 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.478 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 10.4 t80 -85.11 -53.73 5.08 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.481 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 177.02 -163.69 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.807 0.337 . . . . 0.0 111.297 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.641 ' CE2' HG21 ' A' ' 80' ' ' ILE . 5.9 m-85 -138.82 152.65 48.04 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.464 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.727 ' CD1' HD22 ' A' ' 114' ' ' LEU . 2.7 mp -104.25 122.19 44.9 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.939 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -66.38 -74.68 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.168 1.912 . . . . 0.0 112.395 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.698 ' H ' ' HD2' ' A' ' 105' ' ' PRO . 1.1 mtpm? -114.88 -60.81 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.808 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.698 ' HD2' ' H ' ' A' ' 104' ' ' LYS . 14.4 Cg_endo -56.55 163.22 7.15 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.368 2.046 . . . . 0.0 112.574 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.674 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 41.9 t80 -170.2 -99.94 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.562 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.541 ' O ' ' O ' ' A' ' 106' ' ' PHE . 1.0 OUTLIER 41.47 -175.67 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.812 0.339 . . . . 0.0 111.096 -179.575 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.693 HD11 ' HG ' ' A' ' 19' ' ' LEU . 1.0 OUTLIER -68.01 -40.3 82.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.011 0.434 . . . . 0.0 111.62 179.909 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.494 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 55.2 m-20 -51.85 -58.83 5.31 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.573 -179.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.674 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 6.8 mm-40 -75.08 -31.42 61.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.646 0.26 . . . . 0.0 111.417 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -69.91 -61.73 1.66 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.47 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.664 ' O ' HG12 ' A' ' 115' ' ' VAL . 54.4 t -57.31 -30.61 35.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.444 0.64 . . . . 0.0 110.298 178.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.494 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -65.12 -49.22 70.79 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.727 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.894 HD23 ' CG2' ' A' ' 79' ' ' ILE . 13.0 tp -71.71 -21.23 61.8 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.958 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.664 HG12 ' O ' ' A' ' 112' ' ' VAL . 4.3 p -79.43 -47.53 22.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 C-N-CA 120.446 -0.501 . . . . 0.0 111.497 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.427 ' N ' HG13 ' A' ' 115' ' ' VAL . 45.3 mt-10 -66.15 -45.08 82.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.578 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' A' ' 113' ' ' ALA . 0.0 OUTLIER -60.65 -24.41 65.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.583 179.501 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.478 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -71.26 -48.8 48.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.968 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 4.3 mt -68.49 -31.07 49.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.233 0.54 . . . . 0.0 110.755 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -75.7 -54.38 7.06 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.155 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 17.9 m80 -59.33 -28.0 66.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.112 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -71.46 -60.34 2.29 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.752 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 55.52 175.89 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.977 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.843 179.958 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.0 mtt . . . . . 0 N--CA 1.487 1.415 0 CA-C-O 120.918 0.39 . . . . 0.0 111.009 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.446 ' O ' ' HB3' ' A' ' 3' ' ' ARG . 0.0 OUTLIER -116.7 -32.57 5.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.579 179.655 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.744 ' HB3' HD11 ' A' ' 5' ' ' ILE . 15.1 ttt180 70.62 -9.64 0.78 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.955 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 51.39 73.83 0.35 Allowed Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.992 -0.623 . . . . 0.0 113.444 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.744 HD11 ' HB3' ' A' ' 3' ' ' ARG . 2.9 mp -105.17 112.76 40.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.749 0.309 . . . . 0.0 111.055 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.817 HG23 HG13 ' A' ' 50' ' ' VAL . 6.9 p -105.6 125.61 60.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.251 178.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.916 ' CD1' HG22 ' A' ' 31' ' ' THR . 31.4 m0 -115.74 132.01 56.76 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.09 0.472 . . . . 0.0 110.282 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.847 ' HB ' HG22 ' A' ' 32' ' ' THR . 46.6 t -118.8 145.86 24.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.664 -178.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.699 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -127.35 118.01 48.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.806 0.336 . . . . 0.0 110.559 179.782 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.554 ' CB ' HG21 ' A' ' 15' ' ' ILE . 2.1 t0 -163.48 -159.43 0.52 Allowed 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.775 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.94 -0.09 4.0 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 65.61 -158.33 0.27 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.495 0.188 . . . . 0.0 110.904 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.432 ' HB3' ' H ' ' A' ' 14' ' ' SER . 1.3 t 35.43 -90.93 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.845 ' O ' HG23 ' A' ' 18' ' ' VAL . 2.1 t -58.39 -54.87 42.17 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.708 0.289 . . . . 0.0 111.321 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.554 HG21 ' CB ' ' A' ' 10' ' ' ASP . 24.7 mm -64.83 -25.14 37.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.941 0.4 . . . . 0.0 111.15 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.551 ' HA ' HG21 ' A' ' 32' ' ' THR . 4.1 ttp180 -75.65 -53.27 8.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.257 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.588 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 86.7 t90 -57.25 -40.45 77.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.84 0.352 . . . . 0.0 111.51 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.845 HG23 ' O ' ' A' ' 14' ' ' SER . 18.9 t -66.43 -47.95 82.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 112.154 0.428 . . . . 0.0 112.154 -178.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.683 HD23 HG21 ' A' ' 8' ' ' VAL . 2.1 tp -80.54 -29.16 37.15 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -178.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.588 ' HG2' ' HA ' ' A' ' 17' ' ' TRP . 1.3 pp20? -62.46 -60.31 3.73 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.468 -0.493 . . . . 0.0 112.026 -179.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.422 ' HG2' ' CD ' ' A' ' 20' ' ' GLU . 3.0 mmm180 -58.93 -47.51 84.81 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.696 0.284 . . . . 0.0 111.679 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.87 -34.37 77.24 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -178.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.789 HD22 HG11 ' A' ' 6' ' ' VAL . 0.4 OUTLIER -81.82 -26.74 34.07 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.627 179.553 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.41 -34.25 74.21 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 177.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.68 -24.15 69.47 Favored Glycine 0 N--CA 1.443 -0.897 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 177.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.488 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -76.95 -15.3 59.7 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.589 -0.306 . . . . 0.0 110.275 178.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 94.1 26.65 13.79 Favored Glycine 0 C--N 1.337 0.633 0 C-N-CA 120.812 -0.709 . . . . 0.0 114.293 178.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.764 HD13 ' CD2' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -133.87 166.67 22.13 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-N 118.215 1.007 . . . . 0.0 112.784 -179.609 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.46 ' O ' HG12 ' A' ' 6' ' ' VAL . 60.1 m -85.65 118.17 24.99 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.051 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.589 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 1.7 p -116.68 117.13 28.97 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.967 -0.56 . . . . 0.0 112.208 -178.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.916 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.8 t -125.11 133.24 52.93 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.847 HG22 ' HB ' ' A' ' 8' ' ' VAL . 77.1 p -107.64 164.28 12.36 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.159 0.504 . . . . 0.0 111.659 -178.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.858 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 2.9 m-85 -134.94 174.33 10.71 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.879 -177.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.66 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 2.5 pp20? -63.18 -34.76 78.32 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -176.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -171.04 -55.83 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 118.947 0.794 . . . . 0.0 112.799 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.663 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . -170.43 -43.77 0.03 OUTLIER Glycine 0 C--N 1.316 -0.58 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.57 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.695 ' HA ' ' CD1' ' A' ' 40' ' ' LEU . 1.5 t-20 -62.98 -26.07 68.67 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 120.985 0.421 . . . . 0.0 110.714 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.858 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -62.02 -57.64 10.88 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.269 179.819 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.713 HG22 ' CD1' ' A' ' 33' ' ' PHE . 21.2 t -55.51 -32.22 29.71 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 C-N-CA 120.116 -0.634 . . . . 0.0 111.233 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.695 ' CD1' ' HA ' ' A' ' 37' ' ' ASN . 11.2 mt -58.83 -46.47 87.6 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.773 0.32 . . . . 0.0 110.652 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.27 -48.93 63.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.177 0.513 . . . . 0.0 110.794 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.55 -33.61 75.28 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.716 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.671 ' HB3' ' NE2' ' A' ' 73' ' ' HIS . 15.0 mt -63.23 -27.68 69.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.531 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.99 -18.41 45.68 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.299 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.2 m -115.06 -4.77 12.49 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.1 OUTLIER -165.64 161.98 18.62 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.885 0.374 . . . . 0.0 111.081 179.951 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.583 HG23 HD12 ' A' ' 76' ' ' LEU . 54.0 m -138.86 111.77 8.14 Favored Pre-proline 0 N--CA 1.45 -0.43 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.354 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.855 ' HD2' HD11 ' A' ' 76' ' ' LEU . 66.1 Cg_endo -73.3 164.37 35.41 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.162 1.908 . . . . 0.0 111.329 178.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -77.76 -22.1 50.74 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.151 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.817 HG13 HG23 ' A' ' 6' ' ' VAL . 9.8 p -145.15 164.41 12.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.782 HD12 ' O ' ' A' ' 7' ' ' TRP . 11.6 tp -152.67 111.37 3.76 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 121.139 0.495 . . . . 0.0 112.008 -178.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.48 HD13 HD21 ' A' ' 19' ' ' LEU . 1.4 tt -97.7 119.98 37.25 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.759 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.718 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 0.3 OUTLIER -125.47 137.96 53.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.435 0.636 . . . . 0.0 112.63 -178.758 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.505 ' HA ' ' HG2' ' A' ' 81' ' ' MET . 0.8 OUTLIER -83.14 177.37 8.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.172 179.319 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.876 HG21 ' O ' ' A' ' 82' ' ' THR . 0.0 OUTLIER -154.73 105.41 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.195 0.522 . . . . 0.0 110.807 178.978 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.433 ' H ' ' HD3' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -133.56 36.77 3.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.152 -179.508 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.499 ' N ' ' CD ' ' A' ' 58' ' ' PRO . 0.5 OUTLIER 66.42 41.55 0.27 Allowed Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 179.042 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.499 ' CD ' ' N ' ' A' ' 57' ' ' MET . 58.1 Cg_endo -68.81 -90.57 0.0 OUTLIER 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 122.042 1.828 . . . . 0.0 111.0 178.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -87.66 -91.46 1.03 Allowed Glycine 0 C--N 1.335 0.488 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 1.018 ' HB3' ' HB2' ' A' ' 64' ' ' ALA . 34.6 tpp -87.56 64.85 8.31 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 177.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.482 ' HA ' ' HA ' ' A' ' 57' ' ' MET . 0.2 OUTLIER 67.61 -20.71 0.12 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.695 -179.291 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.82 ' HA3' HG12 ' A' ' 55' ' ' ILE . . . 133.01 -32.33 2.77 Favored Glycine 0 N--CA 1.446 -0.69 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 -179.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.874 HD13 ' HB3' ' A' ' 86' ' ' ASP . 5.4 mp -68.27 -13.86 62.57 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 120.862 0.363 . . . . 0.0 110.332 179.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 1.018 ' HB2' ' HB3' ' A' ' 60' ' ' MET . . . -53.17 -36.22 60.67 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.558 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.6 HD11 HD11 ' A' ' 80' ' ' ILE . 3.8 pp -59.73 -40.68 88.86 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 121.1 -0.24 . . . . 0.0 111.222 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.617 ' CD1' ' HA ' ' A' ' 63' ' ' LEU . 4.8 mp -60.38 -43.01 97.02 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-O 121.124 0.488 . . . . 0.0 110.226 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.6 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -54.62 -44.23 72.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.202 -179.749 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.602 ' HB3' HD13 ' A' ' 40' ' ' LEU . 8.6 mm-40 -71.92 -43.51 65.19 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.44 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.428 HD12 ' HA ' ' A' ' 66' ' ' LEU . 16.8 mt -60.95 -35.38 64.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-O 121.033 0.444 . . . . 0.0 110.973 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.6 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -72.75 -29.81 63.63 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.013 -179.826 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.452 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -76.37 -36.68 58.02 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.631 -179.67 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.16 -26.14 21.44 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.926 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.671 ' NE2' ' HB3' ' A' ' 43' ' ' LEU . 31.9 m-70 -153.35 82.9 4.65 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.733 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.797 ' HA ' ' HB2' ' A' ' 96' ' ' GLN . 59.2 Cg_endo -73.47 39.08 0.46 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.583 2.189 . . . . 0.0 112.869 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.406 ' HG2' ' C ' ' A' ' 74' ' ' PRO . 1.5 mmm -141.92 -32.09 0.53 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.971 0.415 . . . . 0.0 111.689 -179.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.855 HD11 ' HD2' ' A' ' 48' ' ' PRO . 0.3 OUTLIER -61.29 124.37 80.28 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.805 -179.44 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.712 ' HD2' HD23 ' A' ' 76' ' ' LEU . 57.6 Cg_endo -71.2 126.31 12.25 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.32 2.013 . . . . 0.0 112.239 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.605 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 9.5 t -106.93 140.21 25.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.301 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.518 ' CG2' HD23 ' A' ' 114' ' ' LEU . 2.6 mt -127.13 110.08 22.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.614 179.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.718 ' HA ' ' O ' ' A' ' 53' ' ' SER . 13.5 mm -103.88 148.04 9.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.923 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.763 ' HG3' HG22 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -69.83 -73.3 0.16 Allowed 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.715 179.647 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.876 ' O ' HG21 ' A' ' 55' ' ' ILE . 3.9 m -105.31 162.8 13.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.949 0.404 . . . . 0.0 110.996 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.8 ' HB1' ' HG ' ' A' ' 87' ' ' LEU . . . -111.93 -22.22 11.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.621 -179.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.45 ' H ' HG22 ' A' ' 82' ' ' THR . 2.8 m-70 44.39 -163.0 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 120.605 0.241 . . . . 0.0 111.359 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 47.9 t -81.54 29.2 0.38 Allowed 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.874 ' HB3' HD13 ' A' ' 63' ' ' LEU . 0.4 OUTLIER -128.51 24.77 5.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.708 0.29 . . . . 0.0 110.865 179.624 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.8 ' HG ' ' HB1' ' A' ' 83' ' ' ALA . 1.7 mt -50.32 -23.77 2.53 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.456 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -48.09 -56.95 6.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.71 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.482 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -59.57 -22.18 61.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.582 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.459 ' HB2' ' CD2' ' A' ' 63' ' ' LEU . . . -71.02 -35.57 72.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.998 0.428 . . . . 0.0 110.143 179.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.65 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 13.7 t -60.03 -44.65 95.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.464 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 49.0 m -60.97 -34.69 75.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.005 0.431 . . . . 0.0 110.491 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.884 ' HB1' ' HB2' ' A' ' 98' ' ' ALA . . . -59.63 -42.28 92.37 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.019 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.65 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 11.0 m-85 -55.49 -24.24 30.4 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.317 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.605 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -75.74 -40.78 54.86 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.912 179.336 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.797 ' HB2' ' HA ' ' A' ' 74' ' ' PRO . 5.3 pp0? -77.1 -17.87 58.38 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.903 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.421 ' O ' ' HA ' ' A' ' 77' ' ' PRO . . . 123.36 18.09 3.13 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.761 -0.733 . . . . 0.0 113.335 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.884 ' HB2' ' HB1' ' A' ' 93' ' ' ALA . . . -48.92 141.03 8.11 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 117.283 0.541 . . . . 0.0 110.911 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.556 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 27.1 t80 -75.72 -53.43 8.53 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.965 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.625 ' OD1' HD21 ' A' ' 114' ' ' LEU . 1.7 p30 167.57 -171.27 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.953 0.406 . . . . 0.0 111.502 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.513 ' CE2' ' HB ' ' A' ' 80' ' ' ILE . 5.3 m-85 -131.0 153.71 48.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.583 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.78 HD23 ' CD1' ' A' ' 106' ' ' PHE . 1.6 tp -102.27 123.4 43.32 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.663 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -72.82 -78.08 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 121.981 1.788 . . . . 0.0 112.766 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.424 ' O ' ' CD2' ' A' ' 106' ' ' PHE . 2.4 tmtm? -108.28 -54.19 0.06 OUTLIER Pre-proline 0 CA--C 1.531 0.247 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.437 ' O ' ' CG ' ' A' ' 106' ' ' PHE . 52.6 Cg_exo -55.49 154.54 24.22 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.275 1.983 . . . . 0.0 112.508 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.78 ' CD1' HD23 ' A' ' 102' ' ' LEU . 59.9 m-85 -160.43 -119.14 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.9 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.494 ' O ' ' O ' ' A' ' 106' ' ' PHE . 2.6 p30 47.71 174.94 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 120.835 0.35 . . . . 0.0 111.142 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.621 HG12 HG12 ' A' ' 18' ' ' VAL . 1.1 mp -67.11 -44.5 87.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.027 0.442 . . . . 0.0 111.461 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.609 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 0.8 OUTLIER -49.23 -53.92 19.19 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.554 -179.384 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.606 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 3.2 mm-40 -82.47 -34.61 28.01 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 -179.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.42 ' CB ' ' O ' ' A' ' 107' ' ' ASP . . . -69.4 -57.35 5.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.807 0.337 . . . . 0.0 110.2 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.684 HG12 ' OE2' ' A' ' 116' ' ' GLU . 46.4 t -59.92 -30.84 46.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.294 0.569 . . . . 0.0 110.481 178.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.609 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -62.07 -46.16 90.32 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.522 0.677 . . . . 0.0 109.997 178.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.655 HD22 HD13 ' A' ' 102' ' ' LEU . 13.9 tp -72.8 -26.69 61.6 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 114.691 -1.14 . . . . 0.0 111.585 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.634 HG12 ' HA ' ' A' ' 112' ' ' VAL . 4.7 p -79.21 -43.03 23.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.833 0.349 . . . . 0.0 111.895 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.684 ' OE2' HG12 ' A' ' 112' ' ' VAL . 44.1 mt-10 -65.84 -45.68 81.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.786 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.511 ' HG2' ' HA ' ' A' ' 114' ' ' LEU . 6.6 ptp180 -59.19 -26.2 64.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.67 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.556 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -68.72 -42.17 78.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.978 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.727 HD13 HD22 ' A' ' 28' ' ' LEU . 5.0 mt -75.68 -30.94 22.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.88 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 10.3 t -70.6 -51.31 29.11 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.903 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 17.1 m80 -62.02 -22.89 66.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.073 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -68.65 -57.39 5.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.79 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.78 -170.25 1.27 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.04 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.862 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 ttp . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 120.766 0.317 . . . . 0.0 111.44 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.508 ' HG2' ' HB2' ' A' ' 124' ' ' GLU . 0.0 OUTLIER -127.01 174.53 8.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.11 -179.738 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.814 ' HG2' HD11 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -63.8 -60.04 3.78 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.406 -179.62 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 55.93 85.57 0.03 OUTLIER Glycine 0 C--N 1.319 -0.405 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.386 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.814 HD11 ' HG2' ' A' ' 3' ' ' ARG . 3.1 mp -108.5 114.87 47.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.668 0.271 . . . . 0.0 111.115 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.958 HG11 ' CD2' ' A' ' 23' ' ' LEU . 7.4 p -107.33 114.8 47.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.051 0.453 . . . . 0.0 111.067 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.801 ' CD1' HG22 ' A' ' 31' ' ' THR . 38.7 m0 -107.95 147.39 31.11 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.009 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.747 HG21 ' OE2' ' A' ' 20' ' ' GLU . 0.1 OUTLIER -137.42 146.1 28.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.353 -178.752 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.882 HG11 ' HA2' ' A' ' 36' ' ' GLY . 0.0 OUTLIER -120.61 104.78 15.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.035 0.445 . . . . 0.0 110.786 179.1 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.815 ' HB3' HG21 ' A' ' 15' ' ' ILE . 0.8 OUTLIER -174.1 118.05 0.24 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.812 -179.801 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.591 ' O ' ' HB2' ' A' ' 12' ' ' ASP . 0.2 OUTLIER 41.96 -87.28 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.232 -0.895 . . . . 0.0 112.033 -179.541 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.591 ' HB2' ' O ' ' A' ' 11' ' ' ASP . 24.4 t70 160.07 -100.79 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 122.734 0.414 . . . . 0.0 111.048 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.6 p -36.77 -76.51 0.02 OUTLIER 'General case' 0 C--O 1.231 0.096 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -179.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.654 ' O ' HG23 ' A' ' 18' ' ' VAL . 44.0 t -52.76 -37.97 60.29 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.322 -177.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.815 HG21 ' HB3' ' A' ' 10' ' ' ASP . 19.3 mm -78.72 -22.88 13.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.163 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.643 ' HA ' HG21 ' A' ' 32' ' ' THR . 3.8 ttm-85 -77.18 -31.37 55.39 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.243 0.544 . . . . 0.0 110.277 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.617 ' HA ' ' HG3' ' A' ' 21' ' ' ARG . 79.7 t90 -72.12 -60.49 2.21 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.683 HG12 HG12 ' A' ' 108' ' ' ILE . 0.8 OUTLIER -54.59 -62.04 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -176.816 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.516 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -77.11 -46.49 23.37 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 -176.177 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.747 ' OE2' HG21 ' A' ' 8' ' ' VAL . 4.7 mm-40 -68.01 -61.38 1.89 Allowed 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 113.456 0.909 . . . . 0.0 113.456 -177.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.617 ' HG3' ' HA ' ' A' ' 17' ' ' TRP . 2.4 mmt180 -48.74 -43.96 38.02 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.098 -177.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.41 -26.98 61.2 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.781 0.324 . . . . 0.0 111.045 179.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.958 ' CD2' HG11 ' A' ' 6' ' ' VAL . 5.9 tp -82.27 -24.66 34.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.288 0.566 . . . . 0.0 110.198 179.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.495 ' HB2' ' SG ' ' A' ' 30' ' ' CYS . . . -68.36 -36.11 78.73 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.29 -25.17 68.13 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.256 -0.973 . . . . 0.0 110.749 178.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.675 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -76.76 -15.83 59.65 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 120.627 0.251 . . . . 0.0 110.885 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.06 26.58 9.46 Favored Glycine 0 CA--C 1.523 0.547 0 C-N-CA 120.482 -0.866 . . . . 0.0 114.559 178.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.737 HD13 ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -120.76 166.98 12.98 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 118.227 1.014 . . . . 0.0 111.93 -179.93 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.646 ' HB ' HG23 ' A' ' 5' ' ' ILE . 87.2 m -86.52 104.27 15.82 Favored 'General case' 0 CA--C 1.522 -0.097 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 4.2 p -105.31 110.33 22.65 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.914 -178.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.801 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.8 t -127.16 153.4 46.09 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.643 HG21 ' HA ' ' A' ' 16' ' ' ARG . 58.8 p -125.77 163.76 22.16 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.145 0.498 . . . . 0.0 111.923 -179.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.841 ' HB2' HG13 ' A' ' 9' ' ' VAL . 9.4 m-85 -136.09 173.4 11.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.482 -178.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.418 ' HG3' ' OD1' ' A' ' 35' ' ' ASN . 0.9 OUTLIER -63.0 -42.51 99.87 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -177.562 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.418 ' OD1' ' HG3' ' A' ' 34' ' ' GLU . 1.0 OUTLIER -170.92 -35.05 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 118.66 0.664 . . . . 0.0 112.343 -179.653 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.91 ' HA3' HD22 ' A' ' 65' ' ' LEU . . . 176.71 -54.12 0.11 Allowed Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.231 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.455 ' HA ' HD12 ' A' ' 40' ' ' LEU . 27.5 m120 -51.31 -31.34 21.23 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.688 0.28 . . . . 0.0 111.328 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.814 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -65.15 -51.6 60.21 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.951 -0.3 . . . . 0.0 111.084 179.471 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.732 HG22 ' CD1' ' A' ' 33' ' ' PHE . 21.5 t -55.34 -33.95 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 120.277 -0.569 . . . . 0.0 111.722 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.455 HD12 ' HA ' ' A' ' 37' ' ' ASN . 13.3 mt -59.79 -47.85 84.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.692 0.282 . . . . 0.0 111.402 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.23 -47.36 79.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.268 0.556 . . . . 0.0 111.03 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.52 -40.06 96.04 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.025 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.55 HD13 ' CD2' ' A' ' 73' ' ' HIS . 17.9 mt -59.44 -26.12 64.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.433 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.74 -21.55 7.44 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.337 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.2 m -126.15 4.72 7.13 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -161.36 155.68 22.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.772 0.32 . . . . 0.0 110.968 179.946 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.93 HG23 HD23 ' A' ' 76' ' ' LEU . 89.8 m -138.56 112.05 8.39 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.448 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.661 ' HD2' HD21 ' A' ' 76' ' ' LEU . 71.7 Cg_endo -77.34 163.25 30.24 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.007 1.805 . . . . 0.0 111.444 178.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.462 ' O ' ' HG2' ' A' ' 77' ' ' PRO . 1.7 m-20 -75.74 -23.17 56.0 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.361 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.741 HG13 HG23 ' A' ' 6' ' ' VAL . 7.3 p -145.83 158.59 12.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 C-N-CA 121.16 -0.216 . . . . 0.0 110.83 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.562 ' HA ' ' O ' ' A' ' 7' ' ' TRP . 12.8 tp -152.86 115.69 4.55 Favored 'General case' 0 C--N 1.333 -0.115 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.574 ' HG ' ' HB ' ' A' ' 79' ' ' ILE . 0.8 OUTLIER -101.77 117.14 34.24 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.593 178.446 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.603 ' HB3' HD12 ' A' ' 65' ' ' LEU . 71.9 m -114.22 151.75 32.31 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.95 0.405 . . . . 0.0 112.022 -178.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -82.66 175.5 10.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.435 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.841 HG22 ' HG3' ' A' ' 81' ' ' MET . 3.2 tt -151.38 67.69 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.136 0 CA-C-O 121.343 0.592 . . . . 0.0 111.705 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 177.6 51.66 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.283 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.599 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . 3.1 ttt -159.8 -62.48 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.3 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.503 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.599 ' HD3' ' HB3' ' A' ' 57' ' ' MET . 33.3 Cg_endo -61.64 -165.41 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.307 2.005 . . . . 0.0 112.546 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.45 -80.97 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.976 -0.63 . . . . 0.0 112.909 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.94 ' HB2' ' HB2' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -77.03 55.57 1.14 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.794 0.33 . . . . 0.0 111.277 -179.629 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.589 ' HB3' HG13 ' A' ' 55' ' ' ILE . 0.8 OUTLIER 56.77 -68.93 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.574 179.4 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.637 ' O ' ' HG ' ' A' ' 65' ' ' LEU . . . -153.05 -34.34 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.817 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.6 HD23 ' HB2' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -62.17 -19.8 63.46 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 122.56 -0.377 . . . . 0.0 110.05 179.732 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.94 ' HB2' ' HB2' ' A' ' 60' ' ' MET . . . -54.3 -36.7 63.97 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 121.437 0.636 . . . . 0.0 109.975 178.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.91 HD22 ' HA3' ' A' ' 36' ' ' GLY . 10.9 mt -60.14 -56.79 17.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.034 -0.984 . . . . 0.0 110.605 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.705 HD22 ' HB1' ' A' ' 93' ' ' ALA . 9.6 mt -46.17 -43.77 15.41 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.552 179.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.428 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 0.6 OUTLIER -52.07 -55.45 20.66 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.252 178.68 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.445 ' HB3' HD13 ' A' ' 40' ' ' LEU . 42.5 mm-40 -68.49 -34.74 76.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.863 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.564 HG23 ' HD2' ' A' ' 73' ' ' HIS . 96.8 mt -65.53 -36.7 78.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.562 -179.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.442 ' HB2' ' HB3' ' A' ' 96' ' ' GLN . 11.9 pttt -78.19 -26.82 47.72 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.06 -0.518 . . . . 0.0 112.338 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -67.77 -48.67 65.71 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -178.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.8 mmm180 -91.68 -42.55 10.1 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -178.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.564 ' HD2' HG23 ' A' ' 69' ' ' ILE . 3.3 m-70 -90.98 149.24 39.74 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.442 -178.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -73.6 -77.51 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.599 2.199 . . . . 0.0 113.187 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.721 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 1.3 mtt -125.76 44.56 2.8 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.743 0.306 . . . . 0.0 111.711 -179.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.93 HD23 HG23 ' A' ' 47' ' ' THR . 1.0 OUTLIER -60.27 109.51 2.08 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.414 179.414 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.462 ' HG2' ' O ' ' A' ' 49' ' ' ASP . 32.9 Cg_exo -60.74 115.37 2.64 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.525 2.15 . . . . 0.0 112.051 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 5.0 t -115.47 151.91 17.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.14 0 CA-C-O 121.075 0.464 . . . . 0.0 111.345 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.585 HD11 HG23 ' A' ' 50' ' ' VAL . 2.1 mt -138.41 112.82 8.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.569 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.633 ' CG2' ' HB ' ' A' ' 55' ' ' ILE . 16.6 mm -95.03 142.07 14.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.018 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.841 ' HG3' HG22 ' A' ' 55' ' ' ILE . 1.4 ppp? -71.59 -27.24 63.0 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -178.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.547 ' O ' HD13 ' A' ' 55' ' ' ILE . 5.4 m -147.22 164.45 33.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.652 0.263 . . . . 0.0 110.77 179.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.883 ' HB1' ' HG ' ' A' ' 87' ' ' LEU . . . -129.18 37.26 4.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.769 0.318 . . . . 0.0 111.65 -179.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.438 ' O ' ' HB3' ' A' ' 85' ' ' SER . 0.6 OUTLIER -85.83 -172.91 4.34 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.72 179.794 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.438 ' HB3' ' O ' ' A' ' 84' ' ' HIS . 29.7 t 68.7 -79.6 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.384 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.535 ' O ' HD22 ' A' ' 63' ' ' LEU . 0.1 OUTLIER -141.49 80.2 1.72 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.928 0.394 . . . . 0.0 111.268 -179.568 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.883 ' HG ' ' HB1' ' A' ' 83' ' ' ALA . 0.5 OUTLIER -55.94 -21.82 22.83 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.604 179.912 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -48.29 -50.32 30.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.67 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.595 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -57.6 -20.1 30.38 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.731 0.3 . . . . 0.0 111.741 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.633 ' HB3' HD23 ' A' ' 87' ' ' LEU . . . -73.75 -26.02 60.46 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.964 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.595 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 12.2 t -64.84 -50.64 74.27 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.485 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.428 ' O ' ' HB3' ' A' ' 95' ' ' GLN . 3.8 m -62.44 -23.63 66.98 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.97 0.414 . . . . 0.0 110.149 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.705 ' HB1' HD22 ' A' ' 66' ' ' LEU . . . -62.27 -38.37 89.03 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 121.291 0.567 . . . . 0.0 109.935 178.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.595 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 9.1 m-85 -68.15 -23.06 64.83 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.547 178.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.428 ' HB3' ' O ' ' A' ' 92' ' ' SER . 0.0 OUTLIER -77.25 -38.37 51.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.855 179.38 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.721 ' O ' ' HA ' ' A' ' 75' ' ' MET . 1.5 pp0? -80.61 -19.01 46.39 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 120.949 -0.301 . . . . 0.0 111.31 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 117.99 31.42 1.59 Allowed Glycine 0 CA--C 1.52 0.388 0 C-N-CA 120.584 -0.817 . . . . 0.0 113.344 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.633 ' HB2' ' HB1' ' A' ' 93' ' ' ALA . . . -67.33 151.34 47.64 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 122.833 -0.216 . . . . 0.0 110.774 179.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.536 ' CZ ' ' HB2' ' A' ' 118' ' ' ALA . 14.2 t80 -76.84 -53.83 7.39 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 121.094 -0.242 . . . . 0.0 111.324 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.473 ' HB2' ' O ' ' A' ' 99' ' ' PHE . 4.4 t0 171.08 -168.7 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.312 0.577 . . . . 0.0 111.39 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.788 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 3.7 m-85 -133.79 152.36 51.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.016 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.596 HD11 HD22 ' A' ' 114' ' ' LEU . 1.5 mp -105.22 118.97 54.55 Favored Pre-proline 0 C--N 1.329 -0.314 0 C-N-CA 121.11 -0.236 . . . . 0.0 111.11 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -81.18 -76.31 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.399 2.066 . . . . 0.0 112.508 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.579 ' H ' ' HD2' ' A' ' 105' ' ' PRO . 1.3 mtpp -99.31 -62.07 0.1 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.603 -0.272 . . . . 0.0 111.682 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.579 ' HD2' ' H ' ' A' ' 104' ' ' LYS . 19.5 Cg_endo -59.03 149.56 78.87 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.186 1.924 . . . . 0.0 112.361 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.658 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 48.4 t80 -160.35 -111.79 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.89 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.629 ' O ' ' O ' ' A' ' 106' ' ' PHE . 2.8 p30 39.07 179.4 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.99 0.424 . . . . 0.0 111.921 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.683 HG12 HG12 ' A' ' 18' ' ' VAL . 0.7 OUTLIER -67.6 -42.57 86.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.85 0.357 . . . . 0.0 111.776 -179.403 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.447 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 3.9 m-20 -49.55 -58.42 5.24 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.364 -179.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.658 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 13.8 mm-40 -73.96 -35.35 64.52 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.771 0.319 . . . . 0.0 111.08 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.54 -56.18 15.74 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.924 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.637 ' HA ' HG12 ' A' ' 115' ' ' VAL . 52.8 t -63.89 -31.92 55.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.494 0.664 . . . . 0.0 110.598 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.447 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -62.7 -45.46 92.66 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.281 179.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.596 HD22 HD11 ' A' ' 102' ' ' LEU . 13.8 tp -78.15 -22.43 48.76 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.727 -1.124 . . . . 0.0 111.995 -178.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.637 HG12 ' HA ' ' A' ' 112' ' ' VAL . 6.2 p -79.6 -47.34 22.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 C-N-CA 120.351 -0.54 . . . . 0.0 111.348 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.418 ' N ' HG13 ' A' ' 115' ' ' VAL . 45.5 mt-10 -63.22 -43.43 98.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.762 0.315 . . . . 0.0 110.775 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 68.4 mtt180 -60.38 -24.99 65.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.008 0.432 . . . . 0.0 110.505 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.536 ' HB2' ' CZ ' ' A' ' 99' ' ' PHE . . . -68.9 -45.4 71.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.739 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 4.9 mt -73.86 -32.02 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-O 121.16 0.505 . . . . 0.0 110.706 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 29.6 t -75.47 -48.51 22.34 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.247 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -58.57 -28.72 65.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.027 0.441 . . . . 0.0 111.125 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -83.95 -50.74 7.75 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.267 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 57.48 171.63 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.408 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.508 ' HB2' ' HG2' ' A' ' 2' ' ' GLN . 5.1 mm-40 . . . . . 0 C--N 1.328 -0.365 0 CA-C-O 120.789 0.328 . . . . 0.0 111.004 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.827 0.346 . . . . 0.0 111.147 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -62.69 158.35 18.7 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.736 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.709 ' HB3' HD11 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -58.19 -23.63 56.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.044 -179.888 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 67.32 73.02 0.7 Allowed Glycine 0 CA--C 1.517 0.179 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.067 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.709 HD11 ' HB3' ' A' ' 3' ' ' ARG . 3.4 mp -112.03 112.91 42.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.747 0.308 . . . . 0.0 111.447 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.886 HG11 ' CD2' ' A' ' 23' ' ' LEU . 5.6 p -107.54 130.51 59.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.074 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.822 ' CD1' HG22 ' A' ' 31' ' ' THR . 36.7 m0 -114.61 140.48 48.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.46 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.658 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.9 OUTLIER -123.34 134.99 64.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.806 0.336 . . . . 0.0 111.683 -178.636 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.696 HG13 HG23 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -119.82 109.19 25.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 120.881 0.372 . . . . 0.0 110.729 179.557 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -162.29 -157.94 0.49 Allowed 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.855 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -66.1 -2.13 3.85 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -179.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.409 ' O ' ' N ' ' A' ' 14' ' ' SER . 0.6 OUTLIER 66.81 -153.33 0.22 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 121.235 -0.186 . . . . 0.0 111.05 179.253 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.7 t 33.94 -89.83 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.806 ' O ' HG23 ' A' ' 18' ' ' VAL . 3.6 m -55.18 -55.91 25.86 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.827 0.346 . . . . 0.0 111.125 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 27.6 mm -65.83 -25.58 36.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.372 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 1.15 ' HA ' HG21 ' A' ' 32' ' ' THR . 14.0 ttp180 -69.84 -55.64 9.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.467 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.446 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 71.2 t90 -58.39 -39.62 80.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.763 -179.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.806 HG23 ' O ' ' A' ' 14' ' ' SER . 12.3 t -65.67 -49.28 78.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.621 HD23 HD11 ' A' ' 108' ' ' ILE . 0.3 OUTLIER -82.99 -25.21 32.47 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -178.109 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.663 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 23.1 pt-20 -67.41 -59.94 2.98 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.607 -0.437 . . . . 0.0 112.061 -179.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.511 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 3.6 mmt85 -67.7 -49.71 61.31 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -179.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.0 -57.33 10.74 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 120.905 0.383 . . . . 0.0 111.657 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.886 ' CD2' HG11 ' A' ' 6' ' ' VAL . 2.1 tp -65.34 -22.94 66.88 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.363 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.407 ' HB2' ' O ' ' A' ' 20' ' ' GLU . . . -69.4 -37.32 77.44 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.44 -24.73 66.11 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.456 -0.878 . . . . 0.0 111.404 178.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.636 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -77.45 -15.43 59.33 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 120.668 0.27 . . . . 0.0 111.01 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.65 26.58 8.0 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 120.6 -0.809 . . . . 0.0 114.069 178.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.737 HD13 ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -128.97 171.85 11.94 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 117.764 0.782 . . . . 0.0 111.852 179.931 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.7 m -99.78 105.56 17.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.333 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.709 ' HA ' HG13 ' A' ' 6' ' ' VAL . 7.2 t -102.68 114.68 29.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.856 -179.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.822 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.5 t -115.01 156.95 24.15 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 1.15 HG21 ' HA ' ' A' ' 16' ' ' ARG . 28.3 p -131.15 163.43 27.72 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.918 0.39 . . . . 0.0 111.894 -179.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.559 ' CE1' HG23 ' A' ' 31' ' ' THR . 35.4 m-85 -136.02 174.7 10.32 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -178.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.734 ' HG2' ' CD ' ' A' ' 38' ' ' GLU . 1.6 pt-20 -59.31 -39.56 83.46 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -176.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.558 ' N ' ' HG2' ' A' ' 34' ' ' GLU . 44.8 m-20 -168.22 -67.04 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.992 0.425 . . . . 0.0 111.352 -178.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.762 ' CA ' HD21 ' A' ' 65' ' ' LEU . . . -160.82 -35.22 0.02 OUTLIER Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.327 -0.939 . . . . 0.0 114.165 -179.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.653 HD22 HD12 ' A' ' 40' ' ' LEU . 4.7 m120 -61.45 -35.35 77.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 117.34 0.57 . . . . 0.0 112.088 -178.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.734 ' CD ' ' HG2' ' A' ' 34' ' ' GLU . 1.4 mp0 -51.79 -61.73 2.07 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.762 HG12 ' CD1' ' A' ' 43' ' ' LEU . 94.2 t -45.84 -31.05 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-O 121.286 0.565 . . . . 0.0 110.745 -179.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.852 HD13 ' CB ' ' A' ' 68' ' ' GLN . 10.1 mt -64.52 -43.87 92.66 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.039 179.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -82.5 -47.94 11.61 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.337 0.589 . . . . 0.0 110.703 178.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.34 -37.78 65.3 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.568 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.762 ' CD1' HG12 ' A' ' 39' ' ' VAL . 37.3 mt -67.39 -22.99 65.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.843 0.354 . . . . 0.0 111.523 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.35 -18.07 3.69 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.752 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.7 m -119.92 -5.9 10.07 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.539 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.1 OUTLIER -165.71 162.65 18.85 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.041 0.448 . . . . 0.0 111.702 -179.889 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 100.0 m -139.38 119.5 9.37 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.139 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.777 ' HD2' HD11 ' A' ' 76' ' ' LEU . 91.1 Cg_endo -80.41 165.62 20.72 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.403 2.069 . . . . 0.0 111.101 178.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -74.25 -25.37 59.59 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.967 -0.293 . . . . 0.0 110.992 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.813 HG13 HG23 ' A' ' 6' ' ' VAL . 8.9 p -145.02 162.46 13.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.177 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.758 ' CD2' HG11 ' A' ' 39' ' ' VAL . 20.5 tp -152.91 126.67 8.88 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.177 0.513 . . . . 0.0 111.913 -179.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.606 ' O ' HG23 ' A' ' 9' ' ' VAL . 0.4 OUTLIER -104.49 114.66 29.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.27 179.275 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.68 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 1.7 t -110.79 139.03 46.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.167 0.508 . . . . 0.0 111.627 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 32.1 p-10 -82.8 -173.65 4.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.639 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.57 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 16.3 tt -161.46 170.7 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.175 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.53 ' N ' HG12 ' A' ' 55' ' ' ILE . 13.9 ptt85 58.55 43.25 19.53 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-O 121.526 0.679 . . . . 0.0 110.246 -178.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.497 ' CB ' ' CD ' ' A' ' 58' ' ' PRO . 6.3 mtm -151.67 -67.89 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.393 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.497 ' CD ' ' CB ' ' A' ' 57' ' ' MET . 27.2 Cg_endo -59.76 -163.29 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.87 2.38 . . . . 0.0 112.847 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -52.8 -87.52 0.01 OUTLIER Glycine 0 C--N 1.332 0.352 0 CA-C-N 115.964 -0.562 . . . . 0.0 113.258 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.664 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -76.39 61.17 1.66 Allowed 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.093 0.473 . . . . 0.0 110.466 -179.934 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.464 ' O ' ' HD2' ' A' ' 58' ' ' PRO . 6.9 m-20 60.8 -65.67 0.06 Allowed 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.944 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.57 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -165.05 -32.88 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.654 ' H ' HD12 ' A' ' 63' ' ' LEU . 0.9 OUTLIER -64.06 -13.25 45.86 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 120.54 0.21 . . . . 0.0 110.481 179.398 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.664 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -53.68 -31.55 48.19 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 121.054 0.455 . . . . 0.0 110.164 179.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.762 HD21 ' CA ' ' A' ' 36' ' ' GLY . 7.0 mp -62.64 -53.11 59.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.914 178.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.6 ' HA ' HD12 ' A' ' 69' ' ' ILE . 3.5 mm? -45.71 -45.82 14.56 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.861 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.715 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 27.1 mttt -59.15 -54.3 48.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.993 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.852 ' CB ' HD13 ' A' ' 40' ' ' LEU . 28.4 mm100 -64.34 -27.78 69.26 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.903 0.382 . . . . 0.0 110.34 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.602 HD13 HG21 ' A' ' 78' ' ' VAL . 41.4 mt -65.0 -36.74 78.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.853 -179.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.715 ' HG2' ' O ' ' A' ' 67' ' ' LYS . 6.5 pttt -75.72 -28.83 58.72 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.546 -179.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -69.14 -30.57 68.84 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.797 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.22 -56.96 2.31 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -179.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.58 ' CE1' ' HB2' ' A' ' 43' ' ' LEU . 1.3 m-70 -81.31 151.81 69.79 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-O 120.983 0.421 . . . . 0.0 111.817 -178.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -74.07 -80.99 0.01 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.377 2.051 . . . . 0.0 112.823 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.453 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 4.7 mtt -135.71 49.01 2.17 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 120.936 0.398 . . . . 0.0 111.73 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.777 HD11 ' HD2' ' A' ' 48' ' ' PRO . 0.7 OUTLIER -64.76 115.94 24.96 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.007 179.605 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.564 ' HD2' HD23 ' A' ' 76' ' ' LEU . 46.6 Cg_exo -55.61 116.95 3.52 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.376 2.051 . . . . 0.0 112.214 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.602 HG21 HD13 ' A' ' 69' ' ' ILE . 4.1 t -110.68 144.23 19.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.089 0.471 . . . . 0.0 111.365 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.585 ' CG2' HD23 ' A' ' 114' ' ' LEU . 1.7 mt -128.59 111.36 23.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.427 179.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.68 ' HA ' ' O ' ' A' ' 53' ' ' SER . 31.1 mm -96.89 141.6 15.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.929 0.395 . . . . 0.0 111.611 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.504 ' CG ' HG22 ' A' ' 55' ' ' ILE . 21.8 ptm -72.67 -31.25 64.92 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -178.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.587 ' HA ' ' O ' ' A' ' 102' ' ' LEU . 7.1 m -146.36 169.17 19.4 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.511 -179.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.815 ' HB1' ' HG ' ' A' ' 87' ' ' LEU . . . -141.86 -22.31 0.71 Allowed 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.476 ' HE1' HG12 ' A' ' 55' ' ' ILE . 1.9 p-80 35.6 -102.74 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.1 p -120.99 -11.95 8.83 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -178.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.507 ' HB3' HD13 ' A' ' 63' ' ' LEU . 5.8 m-20 -82.09 18.25 1.41 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.839 0.352 . . . . 0.0 111.265 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.815 ' HG ' ' HB1' ' A' ' 83' ' ' ALA . 3.0 mt -50.69 -20.47 1.24 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.961 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -46.88 -53.79 11.37 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -178.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.483 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -65.7 -20.59 66.34 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.737 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.6 ' HB3' ' O ' ' A' ' 87' ' ' LEU . . . -68.16 -40.47 82.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.225 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.687 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 4.3 t -57.31 -46.34 85.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.183 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.625 ' O ' ' NE2' ' A' ' 95' ' ' GLN . 12.8 m -62.23 -44.64 96.1 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.232 0.539 . . . . 0.0 109.827 179.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.695 ' HB1' ' HB2' ' A' ' 98' ' ' ALA . . . -47.48 -42.37 22.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.02 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.687 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 16.4 m-85 -56.19 -25.96 49.03 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.24 179.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.625 ' NE2' ' O ' ' A' ' 92' ' ' SER . 0.0 OUTLIER -71.35 -45.54 62.68 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.287 -179.916 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.679 ' HG3' ' HB3' ' A' ' 70' ' ' LYS . 75.5 mm-40 -74.23 -18.08 60.79 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.11 -179.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 119.86 32.56 1.18 Allowed Glycine 0 N--CA 1.453 -0.186 0 C-N-CA 120.311 -0.947 . . . . 0.0 113.163 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.695 ' HB2' ' HB1' ' A' ' 93' ' ' ALA . . . -64.43 145.81 55.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.819 0.309 . . . . 0.0 110.225 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.527 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 10.9 t80 -77.17 -53.93 7.13 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.197 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 173.18 -166.86 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.208 0.528 . . . . 0.0 111.728 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.66 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 5.3 m-85 -142.43 150.59 40.8 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.119 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.712 HD23 ' HA ' ' A' ' 106' ' ' PHE . 2.4 mp -104.87 119.53 53.08 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.234 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -69.25 -75.24 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.02 1.813 . . . . 0.0 112.194 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.65 ' H ' ' HD2' ' A' ' 105' ' ' PRO . 1.8 tttm -106.44 -60.0 0.05 OUTLIER Pre-proline 0 CA--C 1.533 0.293 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.65 ' HD2' ' H ' ' A' ' 104' ' ' LYS . 18.0 Cg_endo -59.72 156.73 36.02 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.263 1.975 . . . . 0.0 112.735 -179.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.712 ' HA ' HD23 ' A' ' 102' ' ' LEU . 24.0 t80 -166.94 -105.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.123 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.54 ' O ' ' O ' ' A' ' 106' ' ' PHE . 3.3 p30 42.79 -178.03 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.86 0.362 . . . . 0.0 111.155 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.621 HD11 HD23 ' A' ' 19' ' ' LEU . 0.9 OUTLIER -67.88 -40.89 84.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.137 0.494 . . . . 0.0 111.583 179.922 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.488 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 1.1 t70 -49.98 -58.62 5.08 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.721 -179.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.615 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 5.0 mm-40 -76.61 -31.59 57.54 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.74 0.305 . . . . 0.0 111.241 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.96 -61.58 1.97 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.901 0.381 . . . . 0.0 110.127 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.623 ' O ' HG12 ' A' ' 115' ' ' VAL . 46.5 t -59.1 -30.71 44.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.483 0.659 . . . . 0.0 110.792 179.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.488 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -64.53 -45.33 87.68 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.799 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.585 HD23 ' CG2' ' A' ' 79' ' ' ILE . 33.5 tp -77.38 -20.98 53.91 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.689 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.623 HG12 ' O ' ' A' ' 112' ' ' VAL . 4.1 p -79.4 -44.31 23.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.659 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.531 ' HA ' HD12 ' A' ' 119' ' ' ILE . 58.4 mt-10 -60.35 -44.91 95.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.894 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 21.8 mmm180 -62.26 -23.86 66.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.248 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.527 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -74.48 -42.69 58.57 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.63 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.531 HD12 ' HA ' ' A' ' 116' ' ' GLU . 6.3 mt -65.09 -31.29 53.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.13 0.49 . . . . 0.0 110.922 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 2.8 m -68.83 -49.34 59.29 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.995 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 31.8 m80 -62.95 -24.12 67.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.143 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -67.63 -59.35 3.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.797 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 45.99 -170.58 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.461 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 . . . . . 0 C--N 1.33 -0.264 0 CA-C-O 121.039 0.447 . . . . 0.0 110.849 -179.996 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.3 ptm . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 120.949 0.404 . . . . 0.0 111.44 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -122.69 140.48 52.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.496 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.729 ' HG2' HD11 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -75.43 -62.5 1.55 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.447 -179.615 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.43 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . 71.11 76.7 0.55 Allowed Glycine 0 C--N 1.317 -0.5 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.704 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.729 HD11 ' HG2' ' A' ' 3' ' ' ARG . 2.4 mp -111.27 114.48 47.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.795 0.331 . . . . 0.0 111.267 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.878 HG11 HD23 ' A' ' 23' ' ' LEU . 9.0 p -108.07 121.46 61.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.322 179.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.84 ' CD1' HG22 ' A' ' 31' ' ' THR . 27.4 m0 -111.55 133.32 53.9 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.912 0.387 . . . . 0.0 110.547 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.715 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.0 OUTLIER -124.89 149.15 29.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.149 -178.598 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 1.042 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -127.91 105.25 13.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 177.824 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.658 ' HB3' HG21 ' A' ' 15' ' ' ILE . 36.3 t0 -166.6 67.69 0.1 Allowed 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 120.952 0.406 . . . . 0.0 111.955 -179.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 20.6 t70 61.15 6.52 1.32 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.474 ' HA ' ' OG1' ' A' ' 32' ' ' THR . 4.5 p-10 44.28 -147.83 0.08 Allowed 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.7 t 36.05 -93.56 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.445 ' O ' HG23 ' A' ' 18' ' ' VAL . 29.1 t -53.83 -65.66 0.53 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.652 0.263 . . . . 0.0 110.974 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.658 HG21 ' HB3' ' A' ' 10' ' ' ASP . 17.2 mm -60.57 -20.63 21.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.301 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.947 ' HA ' HG21 ' A' ' 32' ' ' THR . 23.8 ttm-85 -69.74 -58.33 4.03 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 120.862 0.363 . . . . 0.0 110.848 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.479 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 49.8 t90 -51.5 -39.62 57.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.093 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.596 HG12 HG12 ' A' ' 108' ' ' ILE . 11.7 t -63.64 -51.59 68.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -178.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.746 HD11 HG22 ' A' ' 112' ' ' VAL . 6.2 tp -84.37 -24.97 29.46 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 -178.006 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.623 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 11.9 pt-20 -66.45 -59.86 3.27 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.416 -0.514 . . . . 0.0 111.565 -178.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.529 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 5.7 mmm180 -58.54 -52.78 64.19 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.848 -179.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.07 -47.92 77.05 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.81 0.338 . . . . 0.0 111.805 -179.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.878 HD23 HG11 ' A' ' 6' ' ' VAL . 1.7 tp -72.97 -24.65 60.81 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.126 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.96 -34.27 75.05 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.37 -27.76 69.91 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.324 -0.941 . . . . 0.0 111.107 178.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.671 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -76.87 -16.0 59.54 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 120.605 0.241 . . . . 0.0 111.07 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.07 26.54 8.81 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 120.461 -0.876 . . . . 0.0 114.281 178.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.72 HD13 ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -123.27 169.27 11.47 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 117.946 0.873 . . . . 0.0 111.653 179.756 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 54.0 m -96.42 105.69 17.8 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.004 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.694 ' HA ' HG13 ' A' ' 6' ' ' VAL . 41.8 t -103.6 110.37 22.4 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.979 -179.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.84 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.6 t -117.37 154.16 31.78 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.947 HG21 ' HA ' ' A' ' 16' ' ' ARG . 29.1 p -126.11 165.56 18.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.301 0.572 . . . . 0.0 112.071 -179.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 1.042 ' HB2' HG13 ' A' ' 9' ' ' VAL . 16.2 m-85 -136.04 174.76 10.26 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.863 -178.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.794 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 2.3 pp20? -60.6 -49.19 78.53 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -176.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -165.56 -29.29 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -179.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.565 ' CA ' HG11 ' A' ' 9' ' ' VAL . . . 174.92 -56.85 0.12 Allowed Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.448 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.45 ' HA ' HD12 ' A' ' 40' ' ' LEU . 1.2 t-20 -55.07 -30.59 59.96 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.674 0.273 . . . . 0.0 111.283 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.825 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -60.16 -55.66 31.11 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.709 179.796 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.784 HG12 ' CD1' ' A' ' 43' ' ' LEU . 5.5 t -50.9 -45.08 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.097 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.759 ' HB3' ' HD2' ' A' ' 72' ' ' ARG . 29.2 mt -52.1 -42.97 63.67 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.246 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.86 -50.78 67.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.202 0.525 . . . . 0.0 111.441 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.44 -29.36 65.93 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.766 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.868 HD13 ' NE2' ' A' ' 73' ' ' HIS . 5.6 mt -64.28 -25.44 68.05 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.8 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.9 -18.28 31.81 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.168 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 41.1 t -124.4 3.38 8.42 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 112.143 0.424 . . . . 0.0 112.143 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.64 ' O ' HD23 ' A' ' 43' ' ' LEU . 0.4 OUTLIER -162.74 159.01 23.68 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-O 120.958 0.409 . . . . 0.0 111.497 179.924 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.898 HG23 HD13 ' A' ' 76' ' ' LEU . 98.4 m -138.62 115.48 8.94 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.459 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.642 ' HD2' HD21 ' A' ' 43' ' ' LEU . 72.7 Cg_endo -73.75 165.7 31.6 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.486 2.124 . . . . 0.0 111.363 178.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -76.72 -29.23 56.14 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 121.033 -0.267 . . . . 0.0 110.712 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.748 HG13 HG23 ' A' ' 6' ' ' VAL . 8.4 p -148.35 108.34 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.587 ' CD1' HG11 ' A' ' 39' ' ' VAL . 15.0 tp -86.99 136.92 32.75 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.889 0.376 . . . . 0.0 111.241 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.721 ' O ' HG23 ' A' ' 9' ' ' VAL . 1.8 tt -124.2 124.17 41.88 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.099 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.872 ' HB2' HD13 ' A' ' 80' ' ' ILE . 67.0 m -110.94 136.61 49.7 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.045 0.45 . . . . 0.0 111.999 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.467 ' O ' ' HG2' ' A' ' 81' ' ' MET . 33.7 t70 -82.88 -12.91 57.02 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.209 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.995 HD11 ' CE1' ' A' ' 84' ' ' HIS . 6.5 tt 42.25 69.59 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-O 120.732 0.301 . . . . 0.0 111.502 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -112.06 44.85 1.34 Allowed 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.492 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 0.5 OUTLIER 59.75 44.91 1.02 Allowed Pre-proline 0 N--CA 1.465 0.321 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 178.663 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' ' 62' ' ' GLY . 36.3 Cg_endo -65.08 -75.6 0.02 OUTLIER 'Trans proline' 0 CA--C 1.532 0.391 0 C-N-CA 122.579 2.186 . . . . 0.0 112.391 178.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -112.37 -27.67 3.81 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.074 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.807 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 7.9 tpt -156.11 68.49 0.62 Allowed 'General case' 0 C--O 1.236 0.387 0 CA-C-O 120.981 0.419 . . . . 0.0 109.955 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.638 ' O ' HG13 ' A' ' 55' ' ' ILE . 0.4 OUTLIER 69.22 -26.43 0.15 Allowed 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.931 -179.709 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.843 ' HA3' HG13 ' A' ' 55' ' ' ILE . . . 139.32 -26.09 2.71 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -179.024 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.741 HD13 ' HB3' ' A' ' 86' ' ' ASP . 3.1 mp -74.23 -15.14 61.0 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.807 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -53.74 -44.88 70.3 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.838 178.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.704 ' HG ' ' O ' ' A' ' 62' ' ' GLY . 4.0 pp -58.6 -36.64 74.33 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.289 179.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.907 HD13 ' HB2' ' A' ' 93' ' ' ALA . 14.8 mt -55.75 -48.59 74.99 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.019 0.438 . . . . 0.0 110.402 179.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.571 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 12.6 tptt -53.23 -44.05 67.78 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.936 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.662 ' CB ' HD13 ' A' ' 40' ' ' LEU . 9.2 mm100 -67.08 -27.72 67.59 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.963 0.411 . . . . 0.0 110.704 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 1.043 HD13 HG21 ' A' ' 78' ' ' VAL . 96.8 mt -64.55 -38.13 81.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.527 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.571 ' HG2' ' O ' ' A' ' 67' ' ' LYS . 2.7 ptmt -74.97 -29.42 60.91 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.915 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.458 ' NE2' ' HG3' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -86.25 -30.61 22.21 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.735 -179.939 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.759 ' HD2' ' HB3' ' A' ' 40' ' ' LEU . 28.6 mtt85 -90.45 -68.01 0.81 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.856 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 1.024 ' ND1' HG23 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -88.04 144.63 34.86 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.629 -179.722 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -55.79 -67.49 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.603 2.202 . . . . 0.0 112.893 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.413 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 0.2 OUTLIER -146.89 40.13 1.06 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.934 0.397 . . . . 0.0 111.089 -179.554 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.898 HD13 HG23 ' A' ' 47' ' ' THR . 22.7 tp -63.75 129.43 93.77 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.037 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.534 ' HD2' HD12 ' A' ' 76' ' ' LEU . 58.2 Cg_endo -71.58 134.91 25.15 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.413 2.075 . . . . 0.0 112.278 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 1.043 HG21 HD13 ' A' ' 69' ' ' ILE . 5.5 t -123.95 148.57 28.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.944 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.687 ' CG2' HD23 ' A' ' 114' ' ' LEU . 2.2 mt -126.63 114.49 38.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.201 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.872 HD13 ' HB2' ' A' ' 53' ' ' SER . 9.7 mm -97.87 139.38 20.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.957 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.467 ' HG2' ' O ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -75.94 -30.76 58.8 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 112.357 0.502 . . . . 0.0 112.357 -178.882 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.81 ' O ' HD13 ' A' ' 55' ' ' ILE . 16.8 m -147.59 157.22 43.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.753 0.311 . . . . 0.0 111.574 -179.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.785 ' HB1' ' HG ' ' A' ' 87' ' ' LEU . . . -118.99 0.22 11.28 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.611 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.995 ' CE1' HD11 ' A' ' 55' ' ' ILE . 0.1 OUTLIER 25.75 -94.85 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 -179.168 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 16.1 m -136.89 -23.09 1.19 Allowed 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -178.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.741 ' HB3' HD13 ' A' ' 63' ' ' LEU . 0.3 OUTLIER -78.66 28.39 0.2 Allowed 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -179.285 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.813 HD23 ' HB3' ' A' ' 90' ' ' ALA . 0.5 OUTLIER -46.84 -21.95 0.26 Allowed 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.887 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -48.11 -53.17 17.48 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.886 0.374 . . . . 0.0 111.264 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.643 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -64.05 -20.31 65.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.331 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.813 ' HB3' HD23 ' A' ' 87' ' ' LEU . . . -68.87 -33.89 74.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.837 0.351 . . . . 0.0 110.514 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.64 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 2.8 t -63.94 -46.61 93.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.81 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.604 ' O ' ' HG3' ' A' ' 95' ' ' GLN . 52.5 p -62.04 -16.89 55.19 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 178.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.907 ' HB2' HD13 ' A' ' 66' ' ' LEU . . . -75.57 -52.14 11.29 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.408 0.623 . . . . 0.0 111.827 179.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.64 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 7.3 m-85 -57.9 -32.66 67.95 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.839 -179.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.604 ' HG3' ' O ' ' A' ' 92' ' ' SER . 2.1 pp0? -77.28 -32.06 55.23 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.247 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.739 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 3.3 pp0? -83.02 -15.95 49.05 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 121.13 -0.228 . . . . 0.0 111.295 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.503 ' O ' ' HA ' ' A' ' 77' ' ' PRO . . . 130.27 7.73 3.49 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.357 -0.925 . . . . 0.0 114.015 178.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.741 ' HB2' ' HB1' ' A' ' 93' ' ' ALA . . . -56.96 153.22 11.55 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 117.475 0.638 . . . . 0.0 111.138 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.553 ' CZ ' ' HA ' ' A' ' 118' ' ' ALA . 23.9 t80 -82.12 -53.65 5.92 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.336 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.548 ' HB3' ' O ' ' A' ' 99' ' ' PHE . 13.6 p-10 172.67 -161.49 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.311 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.706 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 4.6 m-85 -141.89 153.67 44.57 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.564 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.657 ' CD1' HD22 ' A' ' 114' ' ' LEU . 1.3 mp -102.32 120.01 54.62 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.71 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_exo -55.98 -69.19 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.478 2.118 . . . . 0.0 112.593 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.717 ' HB2' ' HD3' ' A' ' 105' ' ' PRO . 7.0 mmtt -128.42 -59.57 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.421 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.717 ' HD3' ' HB2' ' A' ' 104' ' ' LYS . 51.1 Cg_exo -54.16 161.56 5.04 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 121.74 1.627 . . . . 0.0 112.012 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.659 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 23.1 t80 -166.95 -105.6 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.653 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.484 ' O ' ' O ' ' A' ' 106' ' ' PHE . 2.8 p30 43.89 -175.57 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.778 0.323 . . . . 0.0 110.967 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.596 HG12 HG12 ' A' ' 18' ' ' VAL . 1.0 OUTLIER -67.86 -42.39 85.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 120.994 0.426 . . . . 0.0 111.416 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.469 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 26.3 t70 -49.12 -59.04 3.98 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.697 -179.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.659 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 7.0 mm-40 -76.16 -32.96 59.34 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.682 0.277 . . . . 0.0 111.376 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.419 ' CB ' ' O ' ' A' ' 107' ' ' ASP . . . -66.54 -59.37 3.7 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.486 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.746 HG22 HD11 ' A' ' 19' ' ' LEU . 35.9 t -59.53 -31.37 46.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.444 0.64 . . . . 0.0 110.715 178.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.469 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -63.1 -44.8 94.69 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.096 179.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.687 HD23 ' CG2' ' A' ' 79' ' ' ILE . 36.0 tp -79.33 -21.26 46.13 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.86 -1.064 . . . . 0.0 112.072 -179.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.648 HG12 ' HA ' ' A' ' 112' ' ' VAL . 6.0 p -79.2 -45.15 24.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.548 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.414 ' HA ' HD12 ' A' ' 119' ' ' ILE . 53.8 mt-10 -65.72 -45.4 82.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.693 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 42.8 mtp180 -60.03 -24.8 64.81 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.668 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.553 ' HA ' ' CZ ' ' A' ' 99' ' ' PHE . . . -72.27 -48.91 38.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.918 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.428 HD11 HG11 ' A' ' 50' ' ' VAL . 4.8 mt -65.27 -31.2 52.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.137 0.494 . . . . 0.0 110.75 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.3 t -72.24 -58.39 3.45 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.855 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 26.5 m80 -60.67 -26.72 67.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.885 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.412 ' HB2' ' O ' ' A' ' 118' ' ' ALA . 36.3 t80 -73.62 -58.04 3.58 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.639 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 56.79 169.81 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.022 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.913 179.945 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.289 0 CA-C-O 120.757 0.313 . . . . 0.0 111.115 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 63.35 144.17 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.82 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 21.0 ptt180 -70.9 -13.35 61.99 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.001 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.561 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . 89.33 88.77 1.23 Allowed Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.097 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.8 mp -99.3 113.14 33.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 120.819 0.342 . . . . 0.0 111.297 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.819 HG23 HG13 ' A' ' 50' ' ' VAL . 6.2 p -105.69 123.41 60.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.061 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.898 ' CD1' HG22 ' A' ' 31' ' ' THR . 31.4 m0 -115.08 127.91 55.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.633 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.687 HG13 ' HB3' ' A' ' 52' ' ' LEU . 0.2 OUTLIER -112.86 143.02 23.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.401 -178.977 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.757 HG11 ' HA2' ' A' ' 36' ' ' GLY . 0.1 OUTLIER -122.98 111.14 28.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.194 0.521 . . . . 0.0 110.633 179.367 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.423 ' HA ' ' OD2' ' A' ' 54' ' ' ASP . 3.9 t0 -161.43 -158.87 0.59 Allowed 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.188 -178.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.51 -2.25 4.49 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' A' ' 14' ' ' SER . 1.4 t0 67.76 -156.77 0.21 Allowed 'General case' 0 CA--C 1.531 0.233 0 O-C-N 122.381 -0.2 . . . . 0.0 110.833 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.4 ' HB3' ' H ' ' A' ' 14' ' ' SER . 3.3 t 34.66 -90.6 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.884 ' O ' HG23 ' A' ' 18' ' ' VAL . 26.8 t -54.36 -61.15 2.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.741 0.305 . . . . 0.0 111.089 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 30.4 mm -61.75 -22.84 29.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.96 0.41 . . . . 0.0 110.754 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.918 ' HA ' HG21 ' A' ' 32' ' ' THR . 41.6 ttt180 -75.64 -54.85 6.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.634 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.412 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 83.4 t90 -58.65 -38.39 78.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.691 0.282 . . . . 0.0 111.595 -179.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.884 HG23 ' O ' ' A' ' 14' ' ' SER . 3.6 t -69.52 -45.03 79.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -178.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.66 -26.69 29.67 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -178.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.555 ' HG3' ' N ' ' A' ' 21' ' ' ARG . 10.9 pt-20 -67.74 -60.43 2.54 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -179.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.555 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 2.3 mmt-85 -60.71 -52.89 63.2 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -178.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.49 -50.4 65.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.948 0.404 . . . . 0.0 111.567 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.796 ' CD2' HG11 ' A' ' 6' ' ' VAL . 1.0 OUTLIER -70.4 -27.67 64.48 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.352 179.807 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.56 -34.75 77.68 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.16 -26.45 69.26 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.417 -0.897 . . . . 0.0 111.038 178.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.649 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -77.26 -15.39 59.48 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.655 -0.273 . . . . 0.0 111.039 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.21 26.41 10.22 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.606 -0.807 . . . . 0.0 114.217 178.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.738 HD13 ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -124.68 170.68 10.74 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 117.87 0.835 . . . . 0.0 111.775 179.722 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 50.6 m -94.3 105.8 17.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.078 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.694 ' HA ' HG13 ' A' ' 6' ' ' VAL . 46.7 t -106.29 110.33 22.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.992 -178.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.898 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.8 t -118.73 153.05 35.03 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.918 HG21 ' HA ' ' A' ' 16' ' ' ARG . 20.5 p -126.43 157.12 39.42 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.558 0.694 . . . . 0.0 112.134 -179.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.807 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 1.0 OUTLIER -127.0 174.29 8.98 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.707 -1.133 . . . . 0.0 111.184 -178.73 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.684 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 3.0 pp20? -61.37 -34.23 74.97 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -177.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -176.92 -37.52 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.757 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . 173.47 -47.02 0.16 Allowed Glycine 0 C--N 1.318 -0.438 0 C-N-CA 120.32 -0.943 . . . . 0.0 112.884 -179.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.454 ' HA ' ' CD1' ' A' ' 40' ' ' LEU . 0.8 OUTLIER -59.62 -29.66 68.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.154 0.502 . . . . 0.0 111.071 -179.765 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.807 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -62.97 -53.58 51.86 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.708 -179.525 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.689 HG23 ' CG1' ' A' ' 9' ' ' VAL . 21.3 t -50.08 -37.2 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 C-N-CA 120.349 -0.54 . . . . 0.0 110.661 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.653 HD13 ' HB3' ' A' ' 68' ' ' GLN . 12.6 mt -55.65 -48.13 75.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.479 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.01 -50.17 69.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.107 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.4 -34.6 77.07 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.726 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.569 ' HA ' ' O ' ' A' ' 46' ' ' LYS . 21.1 mt -59.23 -23.5 62.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.421 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.02 -17.8 28.6 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.826 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.5 t -128.52 3.08 5.59 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.569 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.2 OUTLIER -167.44 161.25 13.87 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.909 0.385 . . . . 0.0 111.216 179.895 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.405 HG23 HD12 ' A' ' 76' ' ' LEU . 90.4 m -138.96 111.74 8.06 Favored Pre-proline 0 N--CA 1.45 -0.457 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.201 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.894 ' HD2' HD11 ' A' ' 76' ' ' LEU . 43.3 Cg_endo -71.38 158.68 53.66 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.084 1.856 . . . . 0.0 111.276 179.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.442 ' O ' ' HG2' ' A' ' 77' ' ' PRO . 1.7 m-20 -74.24 -24.15 59.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.466 -179.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.819 HG13 HG23 ' A' ' 6' ' ' VAL . 7.6 p -145.98 166.47 8.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.582 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.852 HD12 ' O ' ' A' ' 7' ' ' TRP . 10.0 tp -152.96 137.36 16.68 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.985 0.422 . . . . 0.0 111.43 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.687 ' HB3' HG13 ' A' ' 8' ' ' VAL . 1.1 tt -121.9 119.21 30.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.713 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.44 ' HB2' ' CD1' ' A' ' 80' ' ' ILE . 0.6 OUTLIER -115.08 138.21 51.13 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.905 0.383 . . . . 0.0 111.408 -179.723 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.64 ' O ' HG22 ' A' ' 55' ' ' ILE . 2.9 p30 -82.27 -4.04 56.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 0.0 112.058 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.931 HG13 ' HA3' ' A' ' 62' ' ' GLY . 7.1 tt 50.47 169.4 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-O 120.953 0.406 . . . . 0.0 111.923 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.484 ' H ' ' HA3' ' A' ' 62' ' ' GLY . 8.2 ttt85 67.43 77.93 0.25 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.901 0.382 . . . . 0.0 110.696 -179.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.608 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . 7.5 tpt -163.14 -61.24 0.01 OUTLIER Pre-proline 0 CA--C 1.537 0.479 0 CA-C-N 116.081 -0.509 . . . . 0.0 112.063 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.716 ' HG3' ' HG ' ' A' ' 65' ' ' LEU . 94.3 Cg_endo -71.96 -164.58 0.17 Allowed 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.975 2.45 . . . . 0.0 113.47 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.64 -65.48 3.13 Favored Glycine 0 C--N 1.335 0.525 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.241 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.467 ' O ' ' N ' ' A' ' 62' ' ' GLY . 5.2 ttt -70.19 60.42 0.19 Allowed 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.082 0.468 . . . . 0.0 110.013 179.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 58.3 -81.79 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.558 -0.747 . . . . 0.0 109.812 -179.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.931 ' HA3' HG13 ' A' ' 55' ' ' ILE . . . -145.38 -28.96 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.593 179.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.854 HD13 ' HB3' ' A' ' 86' ' ' ASP . 4.0 mp -59.75 -18.85 46.27 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.503 ' HB3' ' CG ' ' A' ' 58' ' ' PRO . . . -55.63 -37.1 67.75 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 178.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.716 ' HG ' ' HG3' ' A' ' 58' ' ' PRO . 32.4 mt -60.76 -49.14 78.69 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.738 HD11 HD11 ' A' ' 80' ' ' ILE . 9.4 mp -51.1 -51.47 53.06 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.98 179.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.564 ' HA ' ' CE ' ' A' ' 70' ' ' LYS . 6.4 mtpm? -44.63 -49.43 10.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.851 179.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.653 ' HB3' HD13 ' A' ' 40' ' ' LEU . 60.8 mm-40 -68.22 -26.51 65.75 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.375 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 1.069 HG22 ' CD2' ' A' ' 73' ' ' HIS . 63.3 mt -63.89 -54.18 34.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.012 0.434 . . . . 0.0 111.119 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.799 ' HA ' ' CD2' ' A' ' 73' ' ' HIS . 0.0 OUTLIER -62.43 -28.35 69.74 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.16 -178.94 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -64.82 -22.48 67.0 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.179 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.72 -11.68 9.36 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.005 0.742 . . . . 0.0 113.005 -179.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 1.069 ' CD2' HG22 ' A' ' 69' ' ' ILE . 1.6 p80 -109.55 160.61 27.19 Favored Pre-proline 0 N--CA 1.465 0.321 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -179.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.455 ' O ' ' HG2' ' A' ' 75' ' ' MET . 60.6 Cg_endo -87.71 -59.45 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.976 2.451 . . . . 0.0 111.42 178.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.566 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 5.8 mmt -151.24 51.33 0.84 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.9 178.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.894 HD11 ' HD2' ' A' ' 48' ' ' PRO . 0.4 OUTLIER -76.66 123.25 87.58 Favored Pre-proline 0 N--CA 1.456 -0.135 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -179.147 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.663 ' HD2' HD23 ' A' ' 76' ' ' LEU . 20.2 Cg_exo -64.72 138.07 56.88 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.189 1.926 . . . . 0.0 111.729 178.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.64 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 3.0 t -126.13 119.69 54.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.482 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.82 ' CG2' HD23 ' A' ' 114' ' ' LEU . 1.5 mp -109.83 110.22 31.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.863 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.738 HD11 HD11 ' A' ' 66' ' ' LEU . 37.0 mm -100.53 148.49 6.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.296 -178.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.515 ' HB3' ' CE1' ' A' ' 106' ' ' PHE . 13.0 ptm -81.98 -35.32 29.07 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.61 -179.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.826 ' O ' HD13 ' A' ' 55' ' ' ILE . 8.2 m -146.59 151.84 37.96 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.626 0.251 . . . . 0.0 111.138 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.833 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -117.03 10.24 13.9 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 111.803 0.297 . . . . 0.0 111.803 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.675 ' H ' HG22 ' A' ' 82' ' ' THR . 0.1 OUTLIER 25.84 -92.38 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -179.385 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 55.3 m -149.64 39.62 0.8 Allowed 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.854 ' HB3' HD13 ' A' ' 63' ' ' LEU . 0.4 OUTLIER -137.72 36.68 2.42 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.125 0.488 . . . . 0.0 110.349 179.236 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.45 ' O ' ' HB3' ' A' ' 90' ' ' ALA . 7.9 mt -50.33 -20.86 1.19 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.993 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -47.69 -58.76 3.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.624 0.25 . . . . 0.0 111.434 -179.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.58 ' O ' ' HB2' ' A' ' 93' ' ' ALA . . . -69.74 -19.64 63.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.892 0.377 . . . . 0.0 110.651 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 87' ' ' LEU . . . -69.25 -46.42 67.35 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.878 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.646 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 3.5 t -67.0 -52.92 38.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 C-N-CA 120.474 -0.491 . . . . 0.0 111.297 -179.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.595 ' O ' ' HB3' ' A' ' 95' ' ' GLN . 24.4 m -60.21 -27.08 66.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.137 0.494 . . . . 0.0 109.786 178.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.587 ' HA ' ' OE1' ' A' ' 96' ' ' GLN . . . -60.72 -41.81 96.01 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.056 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.646 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 3.9 m-85 -67.73 -27.33 66.7 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.967 179.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.595 ' HB3' ' O ' ' A' ' 92' ' ' SER . 0.2 OUTLIER -60.92 -40.89 94.88 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.807 -179.192 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.587 ' OE1' ' HA ' ' A' ' 93' ' ' ALA . 0.0 OUTLIER -100.37 -19.3 16.35 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -179.565 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.441 ' O ' ' C ' ' A' ' 98' ' ' ALA . . . -176.01 -57.67 0.06 OUTLIER Glycine 0 C--N 1.335 0.474 0 C-N-CA 119.22 -1.467 . . . . 0.0 114.824 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.64 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -29.1 139.37 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 117.32 0.56 . . . . 0.0 112.36 -178.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -84.78 -53.38 5.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.45 -179.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.67 ' OD1' HD21 ' A' ' 114' ' ' LEU . 7.9 p-10 -177.8 -164.65 0.09 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.747 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.833 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 4.1 m-85 -138.3 153.02 49.03 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.081 0.467 . . . . 0.0 111.004 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.816 ' CD1' HD22 ' A' ' 114' ' ' LEU . 3.2 mp -102.98 119.08 56.54 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.714 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 102' ' ' LEU . 21.1 Cg_exo -64.69 -66.84 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.537 2.158 . . . . 0.0 112.272 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.735 ' H ' ' HD2' ' A' ' 105' ' ' PRO . 5.6 mttp -119.81 -58.85 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.135 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.735 ' HD2' ' H ' ' A' ' 104' ' ' LYS . 11.9 Cg_endo -55.02 163.5 4.22 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.127 1.885 . . . . 0.0 112.347 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.665 ' HA ' HD23 ' A' ' 102' ' ' LEU . 39.9 t80 -172.08 -106.34 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.659 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.551 ' O ' ' O ' ' A' ' 106' ' ' PHE . 4.7 p-10 43.09 -179.94 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.744 0.307 . . . . 0.0 111.089 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.66 HG12 HG12 ' A' ' 18' ' ' VAL . 0.9 OUTLIER -67.87 -43.44 85.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -179.355 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.503 ' HB2' ' OD2' ' A' ' 107' ' ' ASP . 7.0 m-20 -49.82 -58.68 4.88 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.45 -179.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.612 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 6.1 mm-40 -74.46 -31.79 62.36 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.759 0.314 . . . . 0.0 111.318 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.419 ' CB ' ' O ' ' A' ' 107' ' ' ASP . . . -66.48 -61.18 2.13 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.336 179.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.608 ' O ' HG12 ' A' ' 115' ' ' VAL . 50.2 t -59.07 -31.51 45.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.5 0.667 . . . . 0.0 110.332 179.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.49 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -64.24 -45.27 88.88 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.722 179.088 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.82 HD23 ' CG2' ' A' ' 79' ' ' ILE . 23.5 tp -74.89 -24.14 58.49 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.835 -1.075 . . . . 0.0 111.901 -179.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.697 HG23 HD13 ' A' ' 79' ' ' ILE . 4.0 p -79.29 -43.83 23.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.668 -179.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.41 ' HA ' HD12 ' A' ' 119' ' ' ILE . 50.8 mt-10 -65.65 -43.76 88.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.114 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.769 ' HD3' HD12 ' A' ' 114' ' ' LEU . 7.8 ptm180 -63.27 -23.72 67.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.787 0.327 . . . . 0.0 110.844 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.38 -46.64 59.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.693 179.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.541 HD11 HG11 ' A' ' 50' ' ' VAL . 4.5 mt -68.62 -32.09 53.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.878 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 36.8 t -65.44 -41.89 93.0 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.492 -0.777 . . . . 0.0 110.819 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 2.4 m80 -62.38 -29.61 70.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.785 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.518 ' HH ' ' HB3' ' A' ' 75' ' ' MET . 0.1 OUTLIER -81.55 -50.86 8.87 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.663 179.605 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.59 170.86 15.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.709 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.873 179.986 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 mtt . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.842 0.353 . . . . 0.0 111.084 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -100.02 147.76 25.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.822 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.25 -13.75 20.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.222 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 89.3 94.39 1.11 Allowed Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.576 -0.821 . . . . 0.0 111.728 -179.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.8 mp -105.71 116.27 49.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.018 0.437 . . . . 0.0 111.451 -179.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.788 HG23 HG13 ' A' ' 50' ' ' VAL . 7.6 p -107.19 131.32 57.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.77 179.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.933 ' CD1' HG22 ' A' ' 31' ' ' THR . 39.5 m0 -117.44 142.2 47.43 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.132 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.732 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -134.18 145.37 33.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.011 0.434 . . . . 0.0 111.558 -178.421 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.992 HG12 ' HB2' ' A' ' 33' ' ' PHE . 3.1 m -131.39 105.93 11.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.262 178.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.767 ' HB3' HG21 ' A' ' 15' ' ' ILE . 53.7 t0 -166.46 66.98 0.1 Allowed 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 121.148 0.499 . . . . 0.0 111.845 -179.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.2 t70 74.85 -9.11 1.41 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 178.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.7 t70 59.45 -154.36 0.37 Allowed 'General case' 0 CA--C 1.534 0.357 0 O-C-N 122.275 -0.266 . . . . 0.0 110.955 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 t 34.83 -91.01 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.538 ' O ' HG23 ' A' ' 18' ' ' VAL . 1.5 m -54.57 -65.98 0.48 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.513 0.197 . . . . 0.0 111.234 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.767 HG21 ' HB3' ' A' ' 10' ' ' ASP . 40.2 mm -60.44 -20.58 21.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.771 0.319 . . . . 0.0 111.089 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.987 ' HA ' HG21 ' A' ' 32' ' ' THR . 27.1 ttt180 -70.32 -57.81 4.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.238 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.475 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 50.1 t90 -53.9 -39.68 66.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.69 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.66 HG12 HG12 ' A' ' 108' ' ' ILE . 14.5 t -62.28 -54.82 29.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 113.018 0.748 . . . . 0.0 113.018 -178.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.613 HD11 HG22 ' A' ' 112' ' ' VAL . 7.8 tp -82.84 -22.4 34.1 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -177.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.594 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 22.8 pt-20 -67.75 -57.69 5.9 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.499 -178.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.536 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 0.1 OUTLIER -63.34 -49.83 72.37 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.93 -179.48 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.15 -47.5 83.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.84 0.353 . . . . 0.0 111.675 -179.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.778 ' CD2' HG11 ' A' ' 6' ' ' VAL . 2.4 tp -71.04 -25.28 62.59 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.259 179.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.08 -33.71 75.04 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.34 -25.04 71.06 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.475 -0.869 . . . . 0.0 111.028 178.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.733 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -76.68 -15.66 59.74 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 120.585 0.231 . . . . 0.0 110.78 179.197 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.14 26.41 9.55 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.68 -0.771 . . . . 0.0 113.825 179.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.733 ' CD1' ' HB3' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -123.94 168.12 13.22 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 117.848 0.824 . . . . 0.0 111.689 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 73.5 m -94.75 105.66 17.61 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.627 179.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.72 ' HA ' HG13 ' A' ' 6' ' ' VAL . 10.8 t -100.77 112.44 24.85 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -178.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.933 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.5 t -120.21 144.75 47.56 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.987 HG21 ' HA ' ' A' ' 16' ' ' ARG . 43.6 p -121.53 157.96 29.54 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -178.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.992 ' HB2' HG12 ' A' ' 9' ' ' VAL . 0.4 OUTLIER -136.16 174.24 10.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.893 -1.049 . . . . 0.0 111.304 -179.882 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.575 ' HG2' ' N ' ' A' ' 35' ' ' ASN . 0.0 OUTLIER -63.19 -32.97 74.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.658 -179.294 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.575 ' N ' ' HG2' ' A' ' 34' ' ' GLU . 1.7 t-20 -178.61 179.0 0.77 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.356 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.708 ' HA3' HD13 ' A' ' 65' ' ' LEU . . . -52.03 -19.93 5.94 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.646 -0.788 . . . . 0.0 113.058 -179.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -69.12 -50.9 43.85 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -179.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.673 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 3.9 tt0 -51.98 -51.7 55.5 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.055 -179.329 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.714 HG23 ' CG1' ' A' ' 9' ' ' VAL . 82.8 t -51.42 -32.7 13.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.133 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.551 HD13 ' CB ' ' A' ' 68' ' ' GLN . 18.9 mt -58.3 -47.26 84.24 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.121 0.486 . . . . 0.0 110.065 179.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.47 -49.47 48.21 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.938 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.89 -32.08 71.55 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.206 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.584 ' HA ' ' O ' ' A' ' 46' ' ' LYS . 18.7 mt -68.78 -25.12 64.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.989 -179.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.31 -20.45 7.19 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.905 -179.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 28.6 t -124.8 4.92 8.1 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.584 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -167.69 155.73 9.02 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.972 0.415 . . . . 0.0 111.173 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.454 ' HA ' ' CD2' ' A' ' 43' ' ' LEU . 93.9 m -138.95 116.58 8.91 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.902 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.578 ' HD2' HD21 ' A' ' 43' ' ' LEU . 73.2 Cg_endo -77.92 163.0 28.95 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 121.988 1.792 . . . . 0.0 111.313 179.221 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -73.79 -21.0 60.31 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.818 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.788 HG13 HG23 ' A' ' 6' ' ' VAL . 5.5 p -147.63 161.42 7.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.715 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.745 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 26.8 tp -152.93 131.15 11.98 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 121.196 0.522 . . . . 0.0 111.947 -179.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.67 ' HB3' HG13 ' A' ' 8' ' ' VAL . 1.0 OUTLIER -114.45 118.18 33.07 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.447 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.852 ' HA ' HG23 ' A' ' 9' ' ' VAL . 3.8 m -117.26 144.37 44.91 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -178.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -82.98 179.15 7.85 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.559 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.737 HG13 ' HA3' ' A' ' 62' ' ' GLY . 9.0 tt -154.61 67.47 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.398 179.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.74 38.51 2.24 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.729 -179.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.547 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER 65.35 47.14 0.56 Allowed Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 178.947 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.511 ' HD2' ' N ' ' A' ' 62' ' ' GLY . 40.9 Cg_endo -68.18 -78.16 0.01 OUTLIER 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 122.387 2.058 . . . . 0.0 111.967 178.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -106.45 -27.71 5.43 Favored Glycine 0 C--N 1.335 0.496 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.126 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 1.024 ' HB3' ' HB2' ' A' ' 64' ' ' ALA . 2.2 tpt -159.51 67.97 0.41 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.885 0.374 . . . . 0.0 109.997 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.547 ' HA ' ' HA ' ' A' ' 57' ' ' MET . 0.2 OUTLIER 71.42 -29.12 0.19 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.338 -179.561 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.737 ' HA3' HG13 ' A' ' 55' ' ' ILE . . . 140.07 -28.45 2.49 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 -179.376 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.999 ' HA ' HD23 ' A' ' 66' ' ' LEU . 0.9 OUTLIER -72.74 -14.01 61.46 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 115.425 -0.387 . . . . 0.0 109.991 178.452 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 1.024 ' HB2' ' HB3' ' A' ' 60' ' ' MET . . . -53.38 -52.45 59.26 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-O 121.118 0.485 . . . . 0.0 110.428 178.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.708 HD13 ' HA3' ' A' ' 36' ' ' GLY . 3.5 pp -57.36 -33.23 67.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.121 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.999 HD23 ' HA ' ' A' ' 63' ' ' LEU . 3.9 mm? -59.36 -50.43 74.0 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.925 0.393 . . . . 0.0 110.766 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.543 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 6.9 mttt -54.54 -40.87 69.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.985 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.551 ' CB ' HD13 ' A' ' 40' ' ' LEU . 11.0 mm100 -65.84 -27.96 68.63 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.066 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.836 HD12 ' HA ' ' A' ' 66' ' ' LEU . 87.9 mt -64.76 -53.94 36.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.8 -179.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.543 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.5 OUTLIER -64.7 -24.93 67.73 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.847 -179.099 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.86 -51.7 63.42 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -178.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.94 -26.4 15.59 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.201 -0.454 . . . . 0.0 112.176 -178.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.54 ' CE1' ' HB3' ' A' ' 43' ' ' LEU . 3.6 m-70 -110.3 139.34 21.37 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-O 120.706 0.289 . . . . 0.0 111.039 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.452 ' C ' ' HG3' ' A' ' 75' ' ' MET . 48.6 Cg_exo -54.24 -76.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.639 2.226 . . . . 0.0 112.937 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.566 ' HB3' ' HA2' ' A' ' 97' ' ' GLY . 2.8 mtm -144.14 54.34 1.29 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.845 0.355 . . . . 0.0 110.743 -179.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.528 ' O ' HG23 ' A' ' 78' ' ' VAL . 1.9 tt -63.83 115.68 20.78 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.725 -179.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -56.72 118.04 4.81 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.497 2.131 . . . . 0.0 112.546 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.918 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 2.8 t -124.99 146.58 30.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.126 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.67 ' HB ' ' HG ' ' A' ' 52' ' ' LEU . 2.3 mp -128.07 116.23 41.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 179.271 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.798 ' HA ' ' O ' ' A' ' 53' ' ' SER . 18.0 mm -95.34 142.59 13.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.979 0.419 . . . . 0.0 112.086 -178.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.544 ' HG3' HG22 ' A' ' 55' ' ' ILE . 1.7 ptt? -66.46 -32.38 73.71 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.609 -178.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.565 ' HA ' ' O ' ' A' ' 102' ' ' LEU . 4.3 m -148.1 169.99 18.78 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.581 0.229 . . . . 0.0 111.362 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 1.008 ' HB1' HD23 ' A' ' 87' ' ' LEU . . . -144.69 56.06 1.27 Allowed 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 14.8 p80 -99.17 176.36 5.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.092 0.472 . . . . 0.0 111.897 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.4 t 67.44 -78.68 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.972 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.547 ' O ' HD22 ' A' ' 63' ' ' LEU . 0.8 OUTLIER -120.4 70.18 0.88 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.894 0.378 . . . . 0.0 111.277 -179.358 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 1.008 HD23 ' HB1' ' A' ' 83' ' ' ALA . 3.0 tm? -54.93 -22.37 14.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.985 179.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -51.46 -56.26 14.28 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.756 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.47 -20.51 55.8 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.715 0.293 . . . . 0.0 111.147 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.841 ' HB3' HD22 ' A' ' 87' ' ' LEU . . . -69.13 -62.17 1.49 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.973 0.416 . . . . 0.0 110.776 179.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.465 ' HA ' ' HD2' ' A' ' 94' ' ' TYR . 8.4 t -53.62 -44.48 57.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.831 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.594 ' HA ' ' CG ' ' A' ' 95' ' ' GLN . 1.7 m -60.25 -25.24 65.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.17 0.51 . . . . 0.0 109.686 178.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.575 ' HB3' ' O ' ' A' ' 90' ' ' ALA . . . -75.88 -49.5 17.74 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.573 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.71 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -73.31 -29.25 62.57 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.038 -179.139 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.594 ' CG ' ' HA ' ' A' ' 92' ' ' SER . 2.1 pp0? -77.27 -37.61 52.58 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.547 178.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.57 ' HG2' ' O ' ' A' ' 93' ' ' ALA . 10.3 pt20 -73.47 -17.23 61.26 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.053 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.566 ' HA2' ' HB3' ' A' ' 75' ' ' MET . . . 165.16 -33.08 0.25 Allowed Glycine 0 C--N 1.335 0.473 0 C-N-CA 120.047 -1.073 . . . . 0.0 113.762 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.918 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -58.4 155.64 11.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 117.549 0.674 . . . . 0.0 111.218 -179.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.507 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 23.8 t80 -69.2 -53.88 17.7 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.735 -178.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.439 ' HB3' ' O ' ' A' ' 99' ' ' PHE . 17.1 p-10 178.99 -160.25 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 120.922 0.391 . . . . 0.0 111.084 -179.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.923 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 3.5 m-85 -135.98 153.36 51.42 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.986 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.601 HD13 HD22 ' A' ' 114' ' ' LEU . 1.4 tp -103.74 118.98 56.06 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.826 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -71.68 -75.38 0.01 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.034 1.823 . . . . 0.0 112.278 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.441 ' CB ' ' HD3' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -108.94 -57.03 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.503 -179.962 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.497 ' HB3' ' HG3' ' A' ' 110' ' ' GLU . 56.0 Cg_exo -52.31 154.15 11.8 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.295 1.996 . . . . 0.0 112.61 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.59 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 31.2 t80 -164.44 -116.52 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.197 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.55 ' O ' ' O ' ' A' ' 106' ' ' PHE . 2.9 p30 43.22 179.48 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.967 0.413 . . . . 0.0 111.449 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.66 HG12 HG12 ' A' ' 18' ' ' VAL . 0.8 OUTLIER -67.99 -43.75 85.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.892 0.377 . . . . 0.0 111.803 -179.617 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.491 ' HB2' ' OD1' ' A' ' 107' ' ' ASP . 4.2 m-20 -49.23 -58.28 5.31 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.567 -179.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.59 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 6.7 mm-40 -76.01 -32.02 59.2 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.591 0.234 . . . . 0.0 111.231 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.433 ' CB ' ' O ' ' A' ' 107' ' ' ASP . . . -66.21 -57.46 7.53 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.336 179.295 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.653 ' O ' HG12 ' A' ' 115' ' ' VAL . 47.8 t -62.01 -33.52 58.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.362 0.601 . . . . 0.0 110.653 179.129 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.477 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -62.24 -46.26 89.63 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.551 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.601 HD22 HD13 ' A' ' 102' ' ' LEU . 37.9 tp -75.83 -21.98 56.75 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.96 -1.018 . . . . 0.0 112.205 -179.107 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.653 HG12 ' O ' ' A' ' 112' ' ' VAL . 7.2 p -79.18 -41.44 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 C-N-CA 120.447 -0.501 . . . . 0.0 111.994 -179.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -66.35 -42.95 87.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.825 0.345 . . . . 0.0 110.736 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.9 mtt180 -61.0 -23.86 65.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.385 179.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.507 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -72.17 -48.45 43.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.079 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.481 HD11 HG11 ' A' ' 50' ' ' VAL . 4.5 mt -69.63 -31.31 48.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.076 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 36.3 t -71.96 -50.84 25.52 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.165 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -60.27 -23.57 64.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.134 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -66.94 -44.84 79.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.08 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.17 170.38 16.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.152 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.892 -179.941 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.438 ' O ' ' HB3' ' A' ' 2' ' ' GLN . 13.7 mtm . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 120.619 0.247 . . . . 0.0 110.908 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.438 ' HB3' ' O ' ' A' ' 1' ' ' MET . 1.9 tp60 78.72 -20.69 0.37 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.436 -179.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.804 ' HB3' HD11 ' A' ' 5' ' ' ILE . 10.2 tpt85 -63.94 -10.01 18.78 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.776 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.528 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . 68.16 63.06 3.8 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.773 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.804 HD11 ' HB3' ' A' ' 3' ' ' ARG . 3.8 mp -101.73 115.02 42.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.767 0.318 . . . . 0.0 110.839 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.849 HG11 ' CD2' ' A' ' 23' ' ' LEU . 7.3 p -105.66 126.41 60.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.327 179.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.799 ' CD1' HG22 ' A' ' 31' ' ' THR . 21.6 m0 -116.63 126.31 53.05 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.669 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.711 HG13 ' HB3' ' A' ' 52' ' ' LEU . 0.2 OUTLIER -112.02 148.26 15.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.236 -179.056 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 1.098 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -130.79 113.36 24.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 120.885 0.374 . . . . 0.0 110.379 178.736 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -161.4 -156.63 0.45 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.798 -179.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -67.24 0.78 2.52 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.411 ' O ' ' N ' ' A' ' 14' ' ' SER . 0.1 OUTLIER 65.38 -158.68 0.28 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.509 0.195 . . . . 0.0 110.783 179.717 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.436 ' HB3' ' H ' ' A' ' 14' ' ' SER . 1.3 t 34.62 -90.51 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 179.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.813 ' O ' HG23 ' A' ' 18' ' ' VAL . 0.4 OUTLIER -53.87 -57.56 10.5 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.824 0.345 . . . . 0.0 111.114 -179.702 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 22.4 mm -65.2 -24.5 35.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.89 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 1.097 ' HA ' HG21 ' A' ' 32' ' ' THR . 14.7 ttm-85 -71.1 -58.18 3.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.165 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.475 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 57.9 t90 -54.43 -37.3 64.96 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -179.141 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.813 HG23 ' O ' ' A' ' 14' ' ' SER . 8.2 t -67.84 -47.08 80.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -178.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.749 HD23 HD11 ' A' ' 108' ' ' ILE . 0.2 OUTLIER -84.25 -27.63 27.78 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -178.636 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.542 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 12.1 pt-20 -66.75 -59.77 3.27 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.846 -179.138 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.504 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 4.0 mmm180 -67.0 -47.7 70.68 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.846 -179.156 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.67 -54.53 45.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.917 0.389 . . . . 0.0 111.456 -179.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.849 ' CD2' HG11 ' A' ' 6' ' ' VAL . 2.2 tp -67.68 -23.49 65.31 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.065 179.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.542 ' HB2' ' O ' ' A' ' 20' ' ' GLU . . . -69.22 -36.31 77.1 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.336 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.89 -25.73 68.1 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.427 -0.892 . . . . 0.0 110.982 178.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.611 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -76.81 -16.11 59.54 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 120.665 0.269 . . . . 0.0 111.067 179.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.71 26.59 8.46 Favored Glycine 0 CA--C 1.522 0.514 0 C-N-CA 120.289 -0.958 . . . . 0.0 114.158 178.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.718 HD12 ' O ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -127.21 170.38 12.49 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 117.994 0.897 . . . . 0.0 111.805 179.942 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 52.9 m -95.46 105.51 17.48 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.432 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.719 ' HA ' HG13 ' A' ' 6' ' ' VAL . 40.7 t -106.34 113.36 26.83 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.221 0.534 . . . . 0.0 111.948 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.799 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.8 t -116.85 156.43 27.31 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 1.097 HG21 ' HA ' ' A' ' 16' ' ' ARG . 28.9 p -127.04 158.44 36.95 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.358 0.599 . . . . 0.0 111.684 -179.347 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 1.098 ' HB2' HG13 ' A' ' 9' ' ' VAL . 17.0 m-85 -128.44 174.24 9.51 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.735 -178.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.488 ' HG3' ' ND2' ' A' ' 35' ' ' ASN . 1.6 pt-20 -63.3 -37.6 87.87 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.577 0.955 . . . . 0.0 113.577 -177.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.488 ' ND2' ' HG3' ' A' ' 34' ' ' GLU . 18.0 p30 -174.92 -41.02 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 118.766 0.712 . . . . 0.0 112.696 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.754 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . -178.57 -47.07 0.07 OUTLIER Glycine 0 C--N 1.321 -0.271 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.738 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.418 ' HA ' ' CD1' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -61.25 -29.94 70.15 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.616 0.246 . . . . 0.0 111.353 -179.525 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.836 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 3.1 tt0 -59.98 -51.34 70.07 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 121.089 -0.245 . . . . 0.0 111.597 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.621 HG21 ' CG2' ' A' ' 9' ' ' VAL . 19.5 t -52.37 -41.13 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 C-N-CA 120.584 -0.446 . . . . 0.0 111.461 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.74 HD13 ' HB3' ' A' ' 68' ' ' GLN . 7.1 mt -54.7 -46.74 74.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.97 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.91 -49.17 71.48 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.425 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.31 -32.7 74.26 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.881 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.642 HD21 ' HD2' ' A' ' 48' ' ' PRO . 8.3 mt -60.7 -25.02 66.11 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.086 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.4 -16.84 50.57 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.779 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.3 m -125.72 -0.97 7.37 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.515 ' O ' HD23 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -160.95 162.07 31.83 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.905 0.383 . . . . 0.0 111.024 179.834 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.443 HG23 HD23 ' A' ' 76' ' ' LEU . 57.8 m -138.42 116.0 9.21 Favored Pre-proline 0 N--CA 1.451 -0.414 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.134 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.642 ' HD2' HD21 ' A' ' 43' ' ' LEU . 70.9 Cg_endo -74.76 149.24 37.59 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 121.97 1.78 . . . . 0.0 111.881 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -73.73 -24.89 59.96 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.706 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.788 ' CG2' HD11 ' A' ' 79' ' ' ILE . 7.6 p -147.53 101.83 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.983 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.495 HD12 ' O ' ' A' ' 7' ' ' TRP . 18.0 tp -87.13 134.48 33.51 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.116 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.711 ' HB3' HG13 ' A' ' 8' ' ' VAL . 1.3 tt -121.73 122.54 39.77 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.333 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.55 ' OG ' HD13 ' A' ' 65' ' ' LEU . 2.2 m -123.67 125.51 44.92 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.416 0.627 . . . . 0.0 112.473 -178.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.649 ' HA ' ' HG2' ' A' ' 81' ' ' MET . 1.2 m-20 -83.18 107.14 15.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.78 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.985 HG13 ' HA3' ' A' ' 62' ' ' GLY . 4.9 tt -69.99 116.41 11.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.955 179.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.473 ' H ' ' HD3' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -158.22 58.13 0.46 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.036 0.446 . . . . 0.0 111.883 -179.783 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.456 ' N ' ' CD ' ' A' ' 58' ' ' PRO . 9.6 ptp 47.07 46.17 3.27 Favored Pre-proline 0 CA--C 1.537 0.473 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 178.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.608 ' CG ' ' HA2' ' A' ' 62' ' ' GLY . 50.3 Cg_endo -69.81 -81.94 0.01 OUTLIER 'Trans proline' 0 CA--C 1.533 0.475 0 C-N-CA 122.89 2.393 . . . . 0.0 111.885 178.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -105.85 -25.68 6.41 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.088 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.971 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -161.57 71.75 0.38 Allowed 'General case' 0 C--O 1.235 0.321 0 CA-C-O 120.985 0.421 . . . . 0.0 110.126 179.498 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.55 ' O ' HG13 ' A' ' 55' ' ' ILE . 0.2 OUTLIER 69.49 -25.77 0.15 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.886 -179.805 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.985 ' HA3' HG13 ' A' ' 55' ' ' ILE . . . 136.68 -26.34 3.04 Favored Glycine 0 CA--C 1.502 -0.737 0 N-CA-C 111.639 -0.584 . . . . 0.0 111.639 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.857 ' HA ' HD13 ' A' ' 66' ' ' LEU . 4.0 mp -78.26 -14.0 59.62 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-O 121.051 0.453 . . . . 0.0 109.977 178.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.971 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -53.83 -44.51 70.31 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.031 179.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.758 ' CD1' HD12 ' A' ' 66' ' ' LEU . 3.1 pp -57.98 -32.35 67.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.041 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.857 HD13 ' HA ' ' A' ' 63' ' ' LEU . 7.1 mp -62.93 -44.99 94.58 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.365 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.551 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 30.2 tttt -56.16 -44.62 79.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.756 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.74 ' HB3' HD13 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -66.26 -39.96 89.83 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.662 -179.869 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.667 HD12 ' HA ' ' A' ' 66' ' ' LEU . 10.4 mt -65.03 -32.65 59.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.816 -179.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.551 ' HG2' ' O ' ' A' ' 67' ' ' LYS . 16.0 pttt -76.16 -29.04 57.57 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.966 0.413 . . . . 0.0 111.108 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.18 -44.01 89.82 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.382 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 79.3 mtt-85 -87.57 -23.09 24.43 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.735 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.736 ' CB ' ' HB2' ' A' ' 76' ' ' LEU . 88.7 m-70 -143.28 92.57 6.67 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.972 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.465 ' O ' ' O ' ' A' ' 96' ' ' GLN . 23.0 Cg_exo -64.86 6.11 0.39 Allowed 'Trans proline' 0 CA--C 1.531 0.343 0 C-N-CA 122.657 2.238 . . . . 0.0 113.123 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.609 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -143.35 14.08 1.81 Allowed 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.666 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.736 ' HB2' ' CB ' ' A' ' 73' ' ' HIS . 0.8 OUTLIER -75.53 113.06 22.64 Favored Pre-proline 0 C--N 1.332 -0.188 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -179.512 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.861 ' HB2' ' HD1' ' A' ' 99' ' ' PHE . 37.9 Cg_endo -67.5 116.66 4.35 Favored 'Trans proline' 0 CA--C 1.533 0.458 0 C-N-CA 122.546 2.164 . . . . 0.0 112.423 179.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.461 ' C ' ' HB2' ' A' ' 99' ' ' PHE . 3.6 t -115.05 136.61 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 120.921 0.391 . . . . 0.0 111.719 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.788 HD11 ' CG2' ' A' ' 50' ' ' VAL . 2.3 mt -110.37 116.54 52.62 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.207 0 CA-C-O 121.143 0.497 . . . . 0.0 110.956 179.04 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.847 HD11 HD21 ' A' ' 66' ' ' LEU . 1.6 mp -98.77 134.26 38.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.385 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.964 ' HG3' HG22 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -73.61 -24.93 60.1 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -178.089 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.521 ' HB ' HG21 ' A' ' 55' ' ' ILE . 3.9 m -147.38 159.21 43.95 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.154 0.502 . . . . 0.0 112.327 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.911 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -138.03 68.58 1.4 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.61 179.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -68.2 -141.87 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.067 -179.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.2 p -80.44 79.23 7.07 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-O 120.927 0.394 . . . . 0.0 111.558 -179.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.624 ' HB3' HD13 ' A' ' 63' ' ' LEU . 2.1 t70 179.53 29.06 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.926 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.893 HD13 ' HB3' ' A' ' 90' ' ' ALA . 0.3 OUTLIER -54.15 -21.41 8.66 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.653 -179.966 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -47.25 -54.45 10.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.741 0.305 . . . . 0.0 111.59 -179.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.518 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -69.6 -22.3 63.51 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.145 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.893 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -75.11 -42.14 57.07 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.792 0.329 . . . . 0.0 110.34 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.691 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 19.5 t -62.56 -52.8 55.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.034 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.3 p -57.39 -33.55 67.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.62 0.724 . . . . 0.0 109.833 179.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.644 ' HA ' ' CD ' ' A' ' 96' ' ' GLN . . . -57.56 -39.95 77.84 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.482 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.691 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 18.8 m-85 -60.67 -21.12 62.49 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.237 179.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.65 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -74.01 -43.83 56.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.312 179.715 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.65 ' N ' ' HG2' ' A' ' 95' ' ' GLN . 3.8 pm0 -80.33 -12.4 59.6 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.48 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.525 ' O ' ' HA ' ' A' ' 77' ' ' PRO . . . 117.17 38.38 0.87 Allowed Glycine 0 C--O 1.228 -0.25 0 C-N-CA 119.972 -1.109 . . . . 0.0 114.045 178.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.544 ' HB2' ' HB1' ' A' ' 93' ' ' ALA . . . -63.04 146.36 53.4 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 117.319 0.559 . . . . 0.0 110.772 179.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.861 ' HD1' ' HB2' ' A' ' 77' ' ' PRO . 1.3 t80 -71.75 -54.35 10.51 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.167 179.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.539 ' HB3' ' O ' ' A' ' 99' ' ' PHE . 2.9 p30 166.79 -166.87 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.711 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.911 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 4.8 m-85 -143.21 145.95 33.24 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.38 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.67 HD23 ' O ' ' A' ' 105' ' ' PRO . 6.4 mp -102.26 119.76 55.45 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.625 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -58.53 -66.27 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.343 2.029 . . . . 0.0 112.593 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.727 ' H ' ' HD2' ' A' ' 105' ' ' PRO . 8.8 mtpp -124.5 -60.68 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.465 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.727 ' HD2' ' H ' ' A' ' 104' ' ' LYS . 16.7 Cg_endo -57.13 159.24 15.65 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.077 1.851 . . . . 0.0 112.422 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.62 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 29.1 t80 -170.62 -104.34 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.382 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.538 ' O ' ' O ' ' A' ' 106' ' ' PHE . 3.3 p30 42.85 -177.58 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.542 0.211 . . . . 0.0 110.833 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.749 HD11 HD23 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -67.93 -42.67 85.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.994 0.426 . . . . 0.0 111.681 -179.716 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.551 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 1.7 m-20 -49.03 -57.46 6.51 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.54 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.62 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 5.5 mm-40 -77.0 -32.28 57.09 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 121.047 -0.261 . . . . 0.0 111.699 -179.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.6 -62.59 1.38 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.713 ' O ' HG12 ' A' ' 115' ' ' VAL . 42.6 t -57.64 -30.37 36.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 121.31 0.576 . . . . 0.0 110.816 178.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.551 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -63.94 -47.04 82.06 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.412 0.625 . . . . 0.0 110.203 179.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.571 HD23 HG21 ' A' ' 79' ' ' ILE . 4.8 tp -72.63 -22.38 60.95 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.487 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.778 HG23 HG21 ' A' ' 50' ' ' VAL . 9.9 p -79.56 -49.57 19.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 120.437 -0.505 . . . . 0.0 111.843 -179.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.493 ' N ' HG13 ' A' ' 115' ' ' VAL . 7.5 mt-10 -65.47 -54.74 24.05 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.766 0.317 . . . . 0.0 111.092 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 27.7 mtp85 -57.21 -26.47 60.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.188 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.531 ' HB1' ' CZ ' ' A' ' 99' ' ' PHE . . . -73.3 -48.99 29.98 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.479 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.2 mt -63.52 -30.88 50.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.218 0.533 . . . . 0.0 110.469 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 46.4 t -73.13 -48.92 31.42 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.099 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 25.4 m80 -71.4 -23.37 61.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.271 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -68.63 -46.82 68.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.813 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 24.7 pt20 -75.62 -174.32 2.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.952 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 60.8 mt-10 . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.929 -179.88 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.9 mtp . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 120.775 0.322 . . . . 0.0 111.236 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 66.46 148.88 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.767 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.44 ' CG ' ' H ' ' A' ' 4' ' ' GLY . 0.0 OUTLIER -63.33 -69.71 0.25 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.285 -179.789 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.59 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . 167.93 89.78 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.701 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 23.0 mm -117.74 112.76 40.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.768 0.318 . . . . 0.0 111.496 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.969 HG23 HG13 ' A' ' 50' ' ' VAL . 12.2 p -105.26 128.36 59.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.054 178.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.814 ' CD1' HG22 ' A' ' 31' ' ' THR . 24.9 m0 -116.89 129.9 56.36 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.119 0.485 . . . . 0.0 110.009 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.81 HG13 ' HB3' ' A' ' 52' ' ' LEU . 0.9 OUTLIER -121.72 149.43 24.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.341 -177.681 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.955 HG11 ' HA2' ' A' ' 36' ' ' GLY . 0.0 OUTLIER -125.31 113.41 35.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.555 178.973 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.444 ' OD2' ' OD2' ' A' ' 54' ' ' ASP . 2.3 t0 -164.78 -159.15 0.44 Allowed 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.14 -179.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -67.29 1.1 2.34 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -179.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.406 ' O ' ' N ' ' A' ' 14' ' ' SER . 14.7 t0 65.89 -158.33 0.27 Allowed 'General case' 0 CA--C 1.534 0.33 0 O-C-N 122.233 -0.292 . . . . 0.0 110.995 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.1 t 31.92 -89.84 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 179.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.866 ' O ' HG23 ' A' ' 18' ' ' VAL . 3.5 t -53.72 -56.14 20.01 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.656 0.265 . . . . 0.0 111.468 -179.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.5 mm -66.51 -25.0 34.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.923 0.392 . . . . 0.0 111.048 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.741 ' HA ' HG21 ' A' ' 32' ' ' THR . 3.2 tmm_? -77.99 -44.48 26.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.777 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.452 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 82.3 t90 -64.49 -39.79 94.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.67 -179.128 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.866 HG23 ' O ' ' A' ' 14' ' ' SER . 6.3 t -69.14 -43.12 81.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 112.748 0.648 . . . . 0.0 112.748 -179.024 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.665 HD23 HG21 ' A' ' 8' ' ' VAL . 1.5 tp -84.53 -22.62 30.09 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -178.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.634 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 17.6 pt-20 -67.71 -57.11 6.93 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.099 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.495 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 5.8 mmt180 -63.22 -49.91 72.32 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.597 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.41 -56.3 20.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.154 0.502 . . . . 0.0 111.147 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.778 ' HG ' HG11 ' A' ' 6' ' ' VAL . 2.0 tm? -66.01 -28.21 68.7 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.537 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.45 ' HB2' ' O ' ' A' ' 20' ' ' GLU . . . -67.26 -34.23 76.98 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.24 -26.73 66.43 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.379 -0.915 . . . . 0.0 111.366 178.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.621 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -76.84 -15.76 59.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.822 0.344 . . . . 0.0 110.919 179.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.25 25.5 10.21 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.797 -0.716 . . . . 0.0 113.596 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.621 ' CD1' ' HB3' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -130.74 171.67 12.84 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 117.762 0.781 . . . . 0.0 111.648 179.689 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.677 ' O ' HG12 ' A' ' 6' ' ' VAL . 32.1 m -94.35 130.71 40.55 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.175 -179.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.634 ' HB3' ' HA ' ' A' ' 20' ' ' GLU . 48.9 t -123.69 115.65 21.78 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 121.272 0.558 . . . . 0.0 111.83 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.814 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.9 t -117.44 156.5 27.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.597 178.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.741 HG21 ' HA ' ' A' ' 16' ' ' ARG . 55.5 p -132.53 151.41 51.93 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.142 0.496 . . . . 0.0 112.054 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.899 ' HB2' HG13 ' A' ' 9' ' ' VAL . 2.0 m-85 -125.46 174.42 8.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.228 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.655 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -61.66 -107.63 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.652 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.464 ' H ' ' CD ' ' A' ' 34' ' ' GLU . 0.6 OUTLIER -80.35 -69.84 0.57 Allowed 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.029 0.442 . . . . 0.0 112.038 -178.545 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.955 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . -167.42 -36.56 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.484 -0.865 . . . . 0.0 113.543 -179.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.588 HD22 HD12 ' A' ' 40' ' ' LEU . 12.4 m120 -61.91 -30.0 70.59 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 116.999 0.399 . . . . 0.0 110.594 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.844 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -53.64 -56.86 13.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.624 179.225 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.825 HG21 HG22 ' A' ' 9' ' ' VAL . 2.9 t -51.75 -46.74 39.51 Favored 'Isoleucine or valine' 0 C--N 1.342 0.254 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.44 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.689 HD13 ' CB ' ' A' ' 68' ' ' GLN . 23.6 mt -55.23 -42.87 73.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.008 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.47 -49.65 72.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.159 0.504 . . . . 0.0 111.231 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.44 -26.4 63.63 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.05 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.846 HD13 ' NE2' ' A' ' 73' ' ' HIS . 6.5 mt -63.99 -21.3 66.43 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.445 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.72 -16.83 29.98 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.111 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.5 m -121.58 1.25 10.04 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.478 ' O ' HD23 ' A' ' 43' ' ' LEU . 0.7 OUTLIER -165.9 159.74 16.15 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.888 0.375 . . . . 0.0 111.367 179.764 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.642 HG23 HD12 ' A' ' 76' ' ' LEU . 90.8 m -138.58 111.84 8.34 Favored Pre-proline 0 N--CA 1.45 -0.441 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.422 179.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.713 ' HD2' HD11 ' A' ' 76' ' ' LEU . 51.8 Cg_endo -67.94 154.12 73.62 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.688 2.258 . . . . 0.0 111.891 179.041 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -74.66 -26.07 59.62 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.466 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.969 HG13 HG23 ' A' ' 6' ' ' VAL . 7.2 p -146.28 101.66 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.229 -178.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.69 HD12 ' O ' ' A' ' 7' ' ' TRP . 19.5 tp -86.85 137.11 32.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.985 0.421 . . . . 0.0 111.427 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.81 ' HB3' HG13 ' A' ' 8' ' ' VAL . 1.9 tt -126.85 127.55 45.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.145 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.517 ' N ' HD23 ' A' ' 52' ' ' LEU . 0.5 OUTLIER -126.22 129.21 48.51 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.343 0.592 . . . . 0.0 111.474 179.96 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.444 ' OD2' ' OD2' ' A' ' 10' ' ' ASP . 0.5 OUTLIER -79.02 -0.24 30.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.324 -179.212 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.705 HG13 ' HA3' ' A' ' 62' ' ' GLY . 11.9 tt 36.82 94.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-O 120.89 0.376 . . . . 0.0 111.579 -179.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.8 mtt180 -118.84 40.51 3.25 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.775 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.595 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER 59.59 46.19 1.33 Allowed Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 179.239 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.467 ' CG ' ' HA2' ' A' ' 62' ' ' GLY . 27.5 Cg_endo -61.9 -79.76 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.162 1.908 . . . . 0.0 111.23 178.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -106.35 -82.68 1.55 Allowed Glycine 0 C--N 1.332 0.343 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 178.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.82 ' HB3' ' HB2' ' A' ' 64' ' ' ALA . 17.0 tpp -87.57 59.36 5.42 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 177.18 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.595 ' HA ' ' HA ' ' A' ' 57' ' ' MET . 0.1 OUTLIER 63.54 -16.05 0.07 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.021 -0.99 . . . . 0.0 111.851 -178.656 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.705 ' HA3' HG13 ' A' ' 55' ' ' ILE . . . 135.98 -30.95 2.69 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 -178.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.803 HD11 ' HB2' ' A' ' 90' ' ' ALA . 1.9 tp -56.33 -30.17 62.26 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 178.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.82 ' HB2' ' HB3' ' A' ' 60' ' ' MET . . . -53.69 -38.32 64.1 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.213 178.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.638 ' O ' HG13 ' A' ' 69' ' ' ILE . 1.7 tp -51.41 -50.04 60.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.368 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 1.035 ' HA ' HD12 ' A' ' 69' ' ' ILE . 81.3 mt -52.8 -42.87 65.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.141 179.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 31.3 mttm -58.47 -46.88 85.72 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.4 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.689 ' CB ' HD13 ' A' ' 40' ' ' LEU . 16.7 mm100 -65.0 -31.68 73.03 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.778 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 1.035 HD12 ' HA ' ' A' ' 66' ' ' LEU . 88.7 mt -60.06 -45.72 95.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.728 -179.373 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.455 ' HG3' ' N ' ' A' ' 71' ' ' GLN . 0.4 OUTLIER -68.94 -29.5 67.75 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.536 -179.864 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.455 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 7.6 mt-30 -83.98 -33.21 24.63 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.565 -179.251 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.472 ' HB2' ' CD2' ' A' ' 73' ' ' HIS . 3.2 mtp85 -90.5 -65.26 1.03 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.18 -178.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.948 ' CE1' HG23 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -96.31 159.62 31.58 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.394 -178.956 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -96.44 101.2 0.09 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 123.489 2.793 . . . . 0.0 113.619 -179.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 6.8 mtt 57.04 24.2 9.29 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 177.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.713 HD11 ' HD2' ' A' ' 48' ' ' PRO . 2.2 tt -60.22 112.31 5.29 Favored Pre-proline 0 C--N 1.325 -0.487 0 C-N-CA 120.934 -0.307 . . . . 0.0 111.327 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.61 116.0 2.99 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.432 2.088 . . . . 0.0 112.153 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.989 HG21 HD13 ' A' ' 69' ' ' ILE . 19.0 t -115.06 145.14 21.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.985 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.631 ' CG2' HD23 ' A' ' 114' ' ' LEU . 1.8 mp -118.79 110.99 31.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.982 0.42 . . . . 0.0 111.031 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.55 ' HB ' ' CZ ' ' A' ' 101' ' ' TYR . 21.6 mm -103.3 146.72 10.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.578 -179.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.445 ' O ' ' HB2' ' A' ' 102' ' ' LEU . 7.2 ttt -69.06 -78.61 0.07 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.967 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.601 ' O ' HD13 ' A' ' 55' ' ' ILE . 4.0 m -106.62 159.08 16.47 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.118 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.487 ' HA ' ' CE2' ' A' ' 101' ' ' TYR . . . -87.52 -17.59 31.72 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.895 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.477 ' CD2' HG12 ' A' ' 55' ' ' ILE . 3.8 m-70 48.33 -89.63 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.409 ' N ' ' O ' ' A' ' 83' ' ' ALA . 4.7 m -81.83 -169.97 2.61 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.834 0.35 . . . . 0.0 111.087 -179.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.524 ' O ' HD21 ' A' ' 63' ' ' LEU . 24.7 m-20 -40.86 108.62 0.09 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.166 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.76 HD23 ' HB3' ' A' ' 90' ' ' ALA . 1.3 mt -48.15 -20.99 0.41 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.398 178.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -47.74 -43.58 27.24 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -178.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.617 ' HB3' ' HG ' ' A' ' 63' ' ' LEU . . . -74.1 -21.33 59.94 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 120.243 -0.583 . . . . 0.0 109.912 179.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.803 ' HB2' HD11 ' A' ' 63' ' ' LEU . . . -77.55 -58.91 3.01 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.615 178.239 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.757 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 18.3 t -58.25 -56.75 14.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.561 -179.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 57.6 p -52.79 -27.58 18.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.069 0.462 . . . . 0.0 110.696 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.656 ' CB ' HD13 ' A' ' 66' ' ' LEU . . . -58.36 -46.08 86.97 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.003 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.757 ' CE2' ' HA ' ' A' ' 91' ' ' VAL . 5.5 m-85 -48.68 -27.95 3.22 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.767 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.622 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -76.91 -39.61 50.27 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.704 -179.903 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.622 ' N ' ' HG2' ' A' ' 95' ' ' GLN . 7.7 pt20 -100.14 5.33 44.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.979 -178.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 127.98 79.25 0.26 Allowed Glycine 0 CA--C 1.519 0.323 0 C-N-CA 120.101 -1.047 . . . . 0.0 113.178 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.964 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -171.62 127.04 0.63 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.008 0.432 . . . . 0.0 110.477 179.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.568 ' CE2' ' HB2' ' A' ' 118' ' ' ALA . 13.6 t80 -70.14 -53.73 16.0 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -178.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.702 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 0.1 OUTLIER 179.04 -170.48 0.12 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.011 0.434 . . . . 0.0 111.729 -179.291 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.638 ' CE1' HD11 ' A' ' 66' ' ' LEU . 3.0 m-85 -135.01 153.6 52.02 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.476 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.78 HD11 HD22 ' A' ' 114' ' ' LEU . 7.4 mp -102.19 123.76 42.21 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-O 120.768 0.318 . . . . 0.0 111.09 -179.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -69.71 -56.62 0.14 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.434 2.089 . . . . 0.0 112.475 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.681 ' HB3' ' HD3' ' A' ' 105' ' ' PRO . 1.8 ttmp? -133.52 -56.14 0.02 OUTLIER Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.474 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.681 ' HD3' ' HB3' ' A' ' 104' ' ' LYS . 45.1 Cg_exo -57.52 160.03 15.12 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 121.765 1.644 . . . . 0.0 111.758 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.645 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 62.9 t80 -165.85 -105.52 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.186 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.6 ' O ' ' O ' ' A' ' 106' ' ' PHE . 3.1 p30 41.65 178.63 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.959 0.409 . . . . 0.0 111.321 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.665 HD11 HD13 ' A' ' 19' ' ' LEU . 0.9 OUTLIER -67.89 -41.04 84.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.124 179.659 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.477 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 33.7 t0 -49.18 -58.54 4.83 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.602 -179.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.645 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 10.3 mm-40 -76.33 -32.6 58.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.711 0.291 . . . . 0.0 111.402 -179.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.85 -60.07 3.23 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.815 0.34 . . . . 0.0 110.407 179.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.65 ' HA ' HG12 ' A' ' 115' ' ' VAL . 47.1 t -59.63 -30.79 45.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.576 0.703 . . . . 0.0 110.468 178.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.477 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -63.66 -45.51 89.83 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.011 178.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.78 HD22 HD11 ' A' ' 102' ' ' LEU . 34.1 tp -77.35 -22.7 51.42 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.604 -179.344 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.65 HG12 ' HA ' ' A' ' 112' ' ' VAL . 5.3 p -79.39 -40.98 22.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 120.467 -0.493 . . . . 0.0 111.412 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -67.19 -48.59 67.47 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.963 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.454 ' NH2' ' HB1' ' A' ' 113' ' ' ALA . 0.9 OUTLIER -58.93 -23.28 61.19 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.808 179.948 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.568 ' HB2' ' CE2' ' A' ' 99' ' ' PHE . . . -72.43 -44.39 62.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.169 179.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.653 HD11 HG11 ' A' ' 50' ' ' VAL . 4.8 mt -72.18 -32.05 41.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.283 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 2.3 t -71.9 -47.2 54.33 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.805 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -65.45 -24.34 67.15 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.08 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -71.38 -49.89 37.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.956 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -75.16 176.76 7.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.105 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.908 179.95 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 ttp . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 120.738 0.304 . . . . 0.0 110.92 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -102.96 143.19 32.87 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.211 0.529 . . . . 0.0 111.31 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.522 ' HD2' HD11 ' A' ' 5' ' ' ILE . 15.2 ptt180 -60.4 -49.6 76.95 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.691 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.701 ' O ' HD13 ' A' ' 5' ' ' ILE . . . 101.45 112.79 3.59 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.836 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.701 HD13 ' O ' ' A' ' 4' ' ' GLY . 8.7 mm -124.97 112.89 33.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.809 0.338 . . . . 0.0 111.576 -178.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.859 HG23 HG13 ' A' ' 50' ' ' VAL . 8.0 p -106.47 125.52 62.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.17 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.875 ' CD1' HG22 ' A' ' 31' ' ' THR . 29.1 m0 -117.13 123.46 46.81 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.897 HG11 HD13 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -116.97 137.83 49.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.329 -177.237 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.845 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -121.25 104.98 15.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.967 178.695 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.806 ' HB3' HG21 ' A' ' 15' ' ' ILE . 3.7 t70 -168.1 72.49 0.1 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.984 0.421 . . . . 0.0 111.87 -179.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 63.95 2.59 1.42 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 179.015 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.7 p30 44.83 -149.63 0.07 Allowed 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.436 ' O ' ' HB3' ' A' ' 16' ' ' ARG . 1.4 t 34.85 -92.17 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 179.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.694 ' O ' HG23 ' A' ' 18' ' ' VAL . 2.9 t -53.81 -66.06 0.46 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.776 0.322 . . . . 0.0 110.56 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.806 HG21 ' HB3' ' A' ' 10' ' ' ASP . 35.0 mm -60.98 -20.51 22.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.924 179.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.95 ' HA ' HG21 ' A' ' 32' ' ' THR . 2.0 ttt180 -69.86 -58.03 4.36 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.255 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.492 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 36.8 t90 -59.43 -41.24 89.11 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.048 -0.523 . . . . 0.0 112.273 -179.117 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.896 HG12 HG12 ' A' ' 108' ' ' ILE . 2.7 t -67.14 -42.19 87.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -178.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.897 HD13 HG11 ' A' ' 8' ' ' VAL . 24.0 mt -84.13 -26.85 28.58 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -178.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.555 ' HG3' ' N ' ' A' ' 21' ' ' ARG . 21.2 pt-20 -67.5 -58.71 4.25 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.036 0.446 . . . . 0.0 112.029 -178.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.555 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 0.9 OUTLIER -50.71 -53.53 30.59 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.168 -179.154 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.01 -50.25 67.04 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -179.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.834 ' HG ' HG11 ' A' ' 6' ' ' VAL . 3.0 tm? -70.09 -30.62 67.89 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.421 0.629 . . . . 0.0 110.336 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.77 -32.53 73.88 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.64 -27.94 70.64 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 110.701 -0.959 . . . . 0.0 110.701 177.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.606 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -76.66 -15.75 59.73 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 120.625 0.25 . . . . 0.0 110.5 179.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.51 26.33 12.19 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.533 -0.842 . . . . 0.0 114.271 178.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.703 ' HB2' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -125.41 165.78 17.78 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 118.257 1.028 . . . . 0.0 112.3 179.729 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.727 ' O ' HG12 ' A' ' 6' ' ' VAL . 91.8 m -75.06 125.95 30.01 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.783 -179.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.443 ' HA ' HG13 ' A' ' 6' ' ' VAL . 4.2 p -125.77 110.4 13.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.697 -179.447 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.875 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.6 t -125.46 149.71 47.98 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.95 HG21 ' HA ' ' A' ' 16' ' ' ARG . 53.1 p -126.95 161.36 28.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.529 0.68 . . . . 0.0 112.734 -179.254 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.845 ' HB2' HG13 ' A' ' 9' ' ' VAL . 0.7 OUTLIER -135.23 173.37 11.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.595 -179.714 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.61 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -59.3 -103.11 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.885 -178.234 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.498 ' OD1' ' HD3' ' A' ' 58' ' ' PRO . 0.2 OUTLIER -88.93 -71.44 0.6 Allowed 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.103 0.478 . . . . 0.0 111.814 -179.076 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.772 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . -163.45 -34.74 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.638 -0.71 . . . . 0.0 113.069 -178.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.448 HD22 HD12 ' A' ' 40' ' ' LEU . 28.1 m120 -58.43 -32.51 68.76 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 121.223 0.535 . . . . 0.0 110.11 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.753 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -54.67 -61.79 2.08 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.24 179.542 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.831 HG11 HD11 ' A' ' 51' ' ' LEU . 4.4 t -50.05 -32.51 8.56 Favored 'Isoleucine or valine' 0 C--N 1.342 0.282 0 C-N-CA 120.329 -0.549 . . . . 0.0 110.926 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.533 HD13 ' HB3' ' A' ' 68' ' ' GLN . 22.6 mt -58.49 -44.73 89.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.839 0.352 . . . . 0.0 110.56 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.33 -49.39 77.79 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.228 0.537 . . . . 0.0 110.348 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.69 -31.79 72.0 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.156 178.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.608 HD22 ' CD2' ' A' ' 73' ' ' HIS . 10.2 mt -63.65 -25.82 68.39 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.706 179.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.527 ' HA ' ' HD3' ' A' ' 72' ' ' ARG . . . -59.34 -24.25 63.19 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.155 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -128.61 9.35 5.97 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.643 ' HG2' ' CH2' ' A' ' 7' ' ' TRP . 25.2 tptt -146.02 162.46 37.81 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 121.365 0.602 . . . . 0.0 111.878 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.515 HG23 HD23 ' A' ' 76' ' ' LEU . 95.2 m -138.92 110.47 7.89 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.072 177.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.912 ' HG2' HD11 ' A' ' 76' ' ' LEU . 87.2 Cg_endo -80.65 148.38 17.94 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 122.433 2.089 . . . . 0.0 111.735 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -74.46 -30.79 62.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.946 0.403 . . . . 0.0 110.966 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.859 HG13 HG23 ' A' ' 6' ' ' VAL . 6.7 p -149.84 94.12 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.554 -179.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.831 HD11 HG11 ' A' ' 39' ' ' VAL . 27.0 tp -86.79 141.02 29.14 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.627 -179.218 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.868 ' HG ' ' HB ' ' A' ' 79' ' ' ILE . 0.2 OUTLIER -122.01 114.77 21.41 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.193 179.951 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.651 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -107.71 143.58 36.02 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.405 0.621 . . . . 0.0 112.086 -179.599 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 30.2 p30 -83.06 -177.66 6.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.02 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.795 HG22 ' HG3' ' A' ' 81' ' ' MET . 3.5 tt -159.13 160.85 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.885 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.466 ' H ' HG13 ' A' ' 55' ' ' ILE . 0.1 OUTLIER 78.01 51.95 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.007 0.432 . . . . 0.0 110.499 -179.207 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.493 ' CB ' ' CD ' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -163.39 -65.24 0.01 OUTLIER Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.95 179.892 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.795 ' HG3' HD21 ' A' ' 65' ' ' LEU . 37.6 Cg_endo -65.44 -163.46 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.115 2.544 . . . . 0.0 112.933 -179.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -52.81 -89.89 0.01 OUTLIER Glycine 0 C--N 1.332 0.315 0 CA-C-N 115.974 -0.557 . . . . 0.0 113.0 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.913 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 2.6 tpp -72.52 57.38 0.39 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.774 0.321 . . . . 0.0 110.77 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.585 ' O ' ' HD2' ' A' ' 58' ' ' PRO . 0.1 OUTLIER 59.67 -74.34 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.067 179.948 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 60' ' ' MET . . . -152.65 -30.1 0.04 OUTLIER Glycine 0 C--N 1.321 -0.264 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.502 -179.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.638 ' H ' HD12 ' A' ' 63' ' ' LEU . 0.3 OUTLIER -66.14 -22.17 66.37 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.742 0.306 . . . . 0.0 110.874 179.912 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.913 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -54.95 -30.21 58.41 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.349 0.595 . . . . 0.0 109.923 179.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.795 HD21 ' HG3' ' A' ' 58' ' ' PRO . 2.7 mm? -66.07 -45.29 81.83 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.998 179.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.871 HD21 HD11 ' A' ' 80' ' ' ILE . 10.2 mt -51.81 -44.22 63.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.509 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.455 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 2.8 ttmm -55.14 -44.54 75.17 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.474 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.533 ' HB3' HD13 ' A' ' 40' ' ' LEU . 51.0 mm-40 -70.6 -43.91 68.38 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.191 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.476 HD13 HD23 ' A' ' 51' ' ' LEU . 56.2 mt -60.68 -36.2 69.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 121.057 0.456 . . . . 0.0 111.431 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.549 ' HB3' ' CD ' ' A' ' 96' ' ' GLN . 16.2 pttp -73.07 -27.0 61.47 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.285 -179.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -65.08 -39.07 92.67 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.237 0.541 . . . . 0.0 110.663 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.527 ' HD3' ' HA ' ' A' ' 44' ' ' ALA . 15.4 mtt-85 -94.42 -24.76 17.21 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.21 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.608 ' CD2' HD22 ' A' ' 43' ' ' LEU . 83.1 m-70 -140.47 101.59 6.7 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.138 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.403 ' O ' ' HG3' ' A' ' 75' ' ' MET . 88.7 Cg_endo -77.03 11.48 2.02 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.596 2.198 . . . . 0.0 113.702 -179.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.693 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 5.9 mtt -147.64 12.95 1.03 Allowed 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.912 HD11 ' HG2' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -76.24 110.53 11.49 Favored Pre-proline 0 N--CA 1.462 0.164 0 CA-C-O 120.583 0.23 . . . . 0.0 111.576 179.881 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.402 ' HD3' ' O ' ' A' ' 75' ' ' MET . 35.4 Cg_exo -62.57 128.22 22.89 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.478 2.119 . . . . 0.0 111.906 179.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.57 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 4.3 t -125.1 152.66 31.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.059 0.456 . . . . 0.0 111.48 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.868 ' HB ' ' HG ' ' A' ' 52' ' ' LEU . 1.9 mt -134.17 112.09 15.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.483 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.871 HD11 HD21 ' A' ' 66' ' ' LEU . 16.6 mm -94.83 138.03 21.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.383 -179.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.795 ' HG3' HG22 ' A' ' 55' ' ' ILE . 0.2 OUTLIER -68.43 -31.41 70.72 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -178.936 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.667 ' O ' HD13 ' A' ' 55' ' ' ILE . 91.4 m -146.83 153.93 40.76 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.607 0.241 . . . . 0.0 110.713 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.712 ' HB1' ' CD2' ' A' ' 87' ' ' LEU . . . -106.23 -33.1 7.92 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -179.219 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 45.88 -166.64 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.727 0.298 . . . . 0.0 111.52 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -80.32 79.51 6.89 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.725 -179.066 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.561 ' HB3' HD13 ' A' ' 63' ' ' LEU . 0.1 OUTLIER -179.22 28.61 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.831 179.197 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.712 ' CD2' ' HB1' ' A' ' 83' ' ' ALA . 0.5 OUTLIER -49.23 -20.8 0.67 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 112.088 -179.985 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -47.68 -54.94 10.59 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 -179.103 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.481 ' HB3' ' HB2' ' A' ' 63' ' ' LEU . . . -70.68 -21.49 62.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.851 0.358 . . . . 0.0 111.247 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.697 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -69.69 -41.95 74.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.654 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.64 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 3.4 t -62.07 -46.24 96.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.898 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.47 ' O ' ' HB3' ' A' ' 95' ' ' GLN . 38.5 m -65.14 -21.96 66.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.039 0.447 . . . . 0.0 109.834 179.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.796 ' HB2' HD13 ' A' ' 66' ' ' LEU . . . -66.0 -39.33 90.2 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.296 0.57 . . . . 0.0 109.687 179.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.64 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 8.9 m-85 -69.89 -22.7 63.21 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.639 178.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.47 ' HB3' ' O ' ' A' ' 92' ' ' SER . 0.3 OUTLIER -69.39 -44.31 71.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.906 179.555 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.693 ' O ' ' HA ' ' A' ' 75' ' ' MET . 2.3 pt20 -75.68 -17.95 59.79 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.668 179.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 125.24 16.87 2.8 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.368 -0.92 . . . . 0.0 113.939 178.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.57 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -55.47 151.23 10.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 117.413 0.607 . . . . 0.0 110.79 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.553 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 14.3 t80 -77.07 -53.55 7.66 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.269 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 169.92 -166.0 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.0 0.428 . . . . 0.0 111.656 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.663 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 3.4 m-85 -133.4 153.35 51.68 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.086 -179.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.581 ' CD1' HD22 ' A' ' 114' ' ' LEU . 1.0 OUTLIER -103.42 118.64 57.19 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.887 179.943 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -73.7 -72.94 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.089 1.859 . . . . 0.0 112.444 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.474 ' CB ' ' HD3' ' A' ' 105' ' ' PRO . 2.2 tttt -111.38 -57.98 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.663 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.474 ' HD3' ' CB ' ' A' ' 104' ' ' LYS . 51.8 Cg_exo -54.45 153.35 23.18 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.165 1.91 . . . . 0.0 112.524 -179.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.653 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 41.1 t80 -163.54 -113.15 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.431 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.573 ' O ' ' O ' ' A' ' 106' ' ' PHE . 3.1 p30 42.6 178.3 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 118.122 0.419 . . . . 0.0 111.591 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.896 HG12 HG12 ' A' ' 18' ' ' VAL . 0.8 OUTLIER -67.78 -43.1 86.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.113 0.482 . . . . 0.0 111.272 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.501 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 0.4 OUTLIER -49.04 -58.11 5.46 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.594 -179.548 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.653 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 36.5 mm-40 -76.98 -33.29 57.64 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.757 0.313 . . . . 0.0 111.371 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.428 ' CB ' ' O ' ' A' ' 107' ' ' ASP . . . -64.41 -59.13 4.72 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.116 179.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.688 ' O ' HG12 ' A' ' 115' ' ' VAL . 48.3 t -60.74 -32.0 50.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.514 179.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.501 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -62.51 -46.08 90.07 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.09 179.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.581 HD22 ' CD1' ' A' ' 102' ' ' LEU . 20.6 tp -76.09 -21.12 57.06 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.835 -1.075 . . . . 0.0 111.907 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.688 HG12 ' O ' ' A' ' 112' ' ' VAL . 3.7 p -78.92 -37.98 20.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.477 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.602 ' HA ' HD12 ' A' ' 119' ' ' ILE . 35.7 mt-10 -68.67 -38.73 80.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.966 0.413 . . . . 0.0 110.735 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.1 mmm180 -63.54 -27.52 69.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.091 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.553 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -69.42 -44.57 71.08 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.064 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.602 HD12 ' HA ' ' A' ' 116' ' ' GLU . 6.5 mt -62.81 -31.95 54.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.16 0.505 . . . . 0.0 110.699 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 9.1 t -75.13 -49.54 19.25 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.868 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 18.1 m80 -64.44 -28.9 69.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.137 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -67.49 -57.19 6.96 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.105 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.07 171.66 14.69 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.393 -179.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.677 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 120.909 0.385 . . . . 0.0 111.13 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.493 ' O ' ' HB3' ' A' ' 3' ' ' ARG . 8.4 tt0 -122.7 -29.69 3.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.871 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.729 ' HB3' HD11 ' A' ' 5' ' ' ILE . 0.0 OUTLIER 74.47 -21.1 0.29 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.594 -179.771 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.515 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . 56.7 79.9 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.653 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.729 HD11 ' HB3' ' A' ' 3' ' ' ARG . 3.1 mp -116.71 112.18 38.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.697 0.285 . . . . 0.0 110.654 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.857 HG11 HD13 ' A' ' 23' ' ' LEU . 6.5 p -108.79 129.35 63.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.826 0.346 . . . . 0.0 110.929 179.242 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.859 ' CD1' HG22 ' A' ' 31' ' ' THR . 33.5 m0 -116.27 139.27 50.56 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.391 179.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.726 HG13 ' HB3' ' A' ' 52' ' ' LEU . 0.4 OUTLIER -122.59 146.96 27.02 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.303 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.51 -178.352 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.928 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -129.12 109.33 18.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 120.92 0.391 . . . . 0.0 110.973 179.368 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.439 ' OD1' ' HB3' ' A' ' 54' ' ' ASP . 6.5 t0 -162.16 -158.19 0.51 Allowed 'General case' 0 CA--C 1.53 0.212 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.693 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -66.37 -2.73 4.81 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -179.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.6 t0 66.87 -144.31 0.15 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 121.296 -0.162 . . . . 0.0 110.628 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.465 ' OG ' ' N ' ' A' ' 14' ' ' SER . 53.1 p 33.48 -101.83 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 179.262 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.784 ' O ' HG23 ' A' ' 18' ' ' VAL . 1.5 m -54.4 -49.5 69.77 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.675 0.274 . . . . 0.0 111.312 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.9 mm -62.97 -24.6 36.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.929 0.395 . . . . 0.0 111.11 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.867 ' HA ' HG21 ' A' ' 32' ' ' THR . 25.2 ttt180 -74.71 -55.09 6.23 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.022 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.452 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 14.6 t90 -56.3 -42.46 77.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.881 -0.6 . . . . 0.0 112.444 -178.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.784 HG23 ' O ' ' A' ' 14' ' ' SER . 5.3 t -66.53 -45.3 89.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -178.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.645 HD13 HD11 ' A' ' 108' ' ' ILE . 1.2 mp -83.77 -25.24 30.65 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -178.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.541 ' HG3' ' N ' ' A' ' 21' ' ' ARG . 14.8 pt-20 -66.58 -58.87 4.29 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.422 -0.511 . . . . 0.0 111.546 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.541 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -65.76 -51.23 60.88 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.121 -179.073 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.25 -45.27 80.1 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -178.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.857 HD13 HG11 ' A' ' 6' ' ' VAL . 0.4 OUTLIER -74.88 -25.25 58.82 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.95 0.405 . . . . 0.0 110.63 179.688 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.87 -34.22 75.08 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 177.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.69 -23.49 68.98 Favored Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 178.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.462 ' HB3' HD12 ' A' ' 28' ' ' LEU . . . -77.67 -15.73 58.98 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 120.805 0.336 . . . . 0.0 110.6 179.115 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.52 25.08 11.22 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.832 -0.699 . . . . 0.0 113.982 178.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.843 HD13 ' CD2' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -132.07 165.18 24.59 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 117.811 0.805 . . . . 0.0 112.562 179.694 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 29.5 m -87.67 108.86 19.29 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.004 -179.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.622 ' HA ' HG13 ' A' ' 6' ' ' VAL . 42.2 t -106.63 111.71 24.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.031 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.859 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.4 t -118.04 154.99 31.11 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.04 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.867 HG21 ' HA ' ' A' ' 16' ' ' ARG . 38.5 p -124.37 164.51 19.51 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.123 0.487 . . . . 0.0 111.879 -179.129 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.928 ' HB2' HG13 ' A' ' 9' ' ' VAL . 2.3 m-85 -130.19 172.31 11.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.592 -178.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.68 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 3.0 pp20? -63.53 -44.87 92.98 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -177.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.458 ' C ' HG12 ' A' ' 9' ' ' VAL . 1.4 t30 -160.78 -58.2 0.05 Allowed 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -179.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.73 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . -164.99 -43.47 0.02 OUTLIER Glycine 0 C--N 1.319 -0.382 0 C-N-CA 120.371 -0.919 . . . . 0.0 113.431 -179.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.616 HD22 HD12 ' A' ' 40' ' ' LEU . 11.2 m120 -67.4 -26.87 66.65 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -178.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.732 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 12.2 tt0 -58.92 -50.51 73.77 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.744 -0.382 . . . . 0.0 111.411 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.766 HG22 ' CG ' ' A' ' 33' ' ' PHE . 10.1 t -61.15 -35.46 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 C-N-CA 120.122 -0.631 . . . . 0.0 111.236 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.622 HD13 ' HB3' ' A' ' 68' ' ' GLN . 31.0 mt -56.94 -41.11 77.66 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.027 0.442 . . . . 0.0 110.728 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -77.53 -47.53 19.29 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.025 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.425 ' HB3' ' HE2' ' A' ' 33' ' ' PHE . . . -61.71 -36.38 80.77 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.069 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.6 HD21 ' HD2' ' A' ' 48' ' ' PRO . 16.0 mt -63.34 -22.98 67.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.031 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.17 -19.61 14.29 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.677 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -124.21 2.59 8.54 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.538 ' O ' HD23 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -162.41 155.26 19.78 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.801 0.334 . . . . 0.0 110.862 179.965 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.615 HG23 ' CD2' ' A' ' 76' ' ' LEU . 98.6 m -138.97 112.84 8.23 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.573 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.6 ' HD2' HD21 ' A' ' 43' ' ' LEU . 72.4 Cg_endo -79.1 161.82 26.26 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.085 1.857 . . . . 0.0 111.436 178.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -73.98 -22.57 59.57 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.701 0.286 . . . . 0.0 111.294 -179.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.81 HG13 HG23 ' A' ' 6' ' ' VAL . 7.1 p -144.97 161.34 13.7 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.231 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.622 HD12 ' O ' ' A' ' 7' ' ' TRP . 22.6 tp -152.87 133.19 13.59 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.164 0.507 . . . . 0.0 111.913 -178.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.726 ' HB3' HG13 ' A' ' 8' ' ' VAL . 0.5 OUTLIER -111.86 115.54 29.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.265 179.983 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.58 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 2.1 m -110.98 138.57 47.22 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.124 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.439 ' HB3' ' OD1' ' A' ' 10' ' ' ASP . 15.4 p-10 -83.03 179.68 7.69 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.781 179.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.678 HG13 ' O ' ' A' ' 61' ' ' ASP . 1.0 OUTLIER -154.06 96.85 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.153 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -138.96 40.17 2.14 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.797 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.471 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER 67.52 47.29 0.41 Allowed Pre-proline 0 CA--C 1.533 0.304 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 179.018 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.507 ' HD2' ' N ' ' A' ' 62' ' ' GLY . 37.5 Cg_endo -69.27 -76.45 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.309 2.006 . . . . 0.0 111.86 178.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -112.39 -25.25 4.74 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 121.069 -0.586 . . . . 0.0 111.928 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.9 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 1.0 OUTLIER -159.62 68.02 0.4 Allowed 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.261 0.553 . . . . 0.0 109.991 179.517 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.678 ' O ' HG13 ' A' ' 55' ' ' ILE . 0.1 OUTLIER 69.9 -29.21 0.18 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.862 -179.719 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.507 ' N ' ' HD2' ' A' ' 58' ' ' PRO . . . 142.58 -29.25 2.14 Favored Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.692 ' H ' HD12 ' A' ' 63' ' ' LEU . 1.1 mp -70.24 -19.17 63.15 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 178.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.9 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -53.59 -32.18 49.93 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.532 179.068 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.635 HD11 ' HA2' ' A' ' 36' ' ' GLY . 1.1 tt -57.79 -46.14 85.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.315 179.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.804 HD21 HD11 ' A' ' 80' ' ' ILE . 6.5 mt -57.82 -44.68 86.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.948 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.411 ' O ' ' CG ' ' A' ' 70' ' ' LYS . 20.8 ttmt -52.76 -53.23 51.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.371 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.622 ' HB3' HD13 ' A' ' 40' ' ' LEU . 86.5 mm-40 -59.64 -34.6 73.01 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.923 0.392 . . . . 0.0 111.483 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.627 HG23 ' HD2' ' A' ' 73' ' ' HIS . 86.5 mt -61.57 -33.36 56.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.773 -178.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.548 ' HB3' ' CB ' ' A' ' 96' ' ' GLN . 0.2 OUTLIER -78.01 -29.44 49.55 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.999 0.428 . . . . 0.0 111.718 179.932 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.468 ' NE2' ' HA ' ' A' ' 68' ' ' GLN . 2.6 mt-30 -65.63 -48.23 72.91 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.152 -178.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.3 mtp85 -93.38 -55.94 3.11 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.97 -178.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.627 ' HD2' HG23 ' A' ' 69' ' ' ILE . 1.6 m-70 -84.25 152.82 62.04 Favored Pre-proline 0 C--N 1.319 -0.76 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.543 -178.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -69.85 -76.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.618 2.212 . . . . 0.0 112.882 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.664 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 6.6 mtm -138.71 53.49 1.77 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.185 0.517 . . . . 0.0 111.338 -179.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.615 ' CD2' HG23 ' A' ' 47' ' ' THR . 0.2 OUTLIER -63.7 112.23 6.84 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.081 179.576 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.574 ' HG2' ' HA ' ' A' ' 50' ' ' VAL . 17.3 Cg_endo -57.19 122.73 12.32 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.188 1.925 . . . . 0.0 111.377 179.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.5 HG21 HD13 ' A' ' 69' ' ' ILE . 3.9 t -119.54 152.03 22.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.167 0.508 . . . . 0.0 111.894 -178.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.653 ' O ' HD23 ' A' ' 52' ' ' LEU . 3.3 mt -131.6 113.74 23.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.363 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.804 HD11 HD21 ' A' ' 66' ' ' LEU . 2.4 mp -96.26 132.48 40.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.952 0.406 . . . . 0.0 110.829 -179.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.518 ' HB2' ' CE1' ' A' ' 106' ' ' PHE . 3.7 ptp -70.2 -24.65 63.15 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -177.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.43 ' H ' HG21 ' A' ' 55' ' ' ILE . 12.0 m -146.96 160.16 42.69 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.974 0.416 . . . . 0.0 111.753 -179.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.827 ' HB1' HD21 ' A' ' 87' ' ' LEU . . . -142.32 57.84 1.46 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.56 -179.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.556 ' H ' ' CD2' ' A' ' 84' ' ' HIS . 0.1 OUTLIER -75.34 -95.73 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.364 -179.896 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 6.9 t -89.87 173.01 8.47 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-O 121.109 0.48 . . . . 0.0 111.914 -179.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.42 ' CB ' HD13 ' A' ' 63' ' ' LEU . 8.0 m-20 58.01 17.77 4.64 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.653 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.827 HD21 ' HB1' ' A' ' 83' ' ' ALA . 1.9 mt -48.8 -24.12 1.31 Allowed 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -48.01 -45.64 32.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.8 0.333 . . . . 0.0 111.062 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.547 ' HB3' ' HB2' ' A' ' 63' ' ' LEU . . . -65.99 -20.27 66.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.426 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.608 ' HB2' HD23 ' A' ' 63' ' ' LEU . . . -63.25 -44.86 93.97 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.845 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.566 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 5.6 t -59.41 -46.24 92.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.307 -179.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 98.4 p -62.87 -20.09 64.78 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.232 179.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.685 ' HB1' HD22 ' A' ' 66' ' ' LEU . . . -65.05 -44.49 88.85 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 121.147 0.499 . . . . 0.0 110.367 179.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.566 ' CE2' ' HA ' ' A' ' 91' ' ' VAL . 8.5 m-85 -61.82 -25.13 67.32 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.696 178.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -76.55 -38.81 54.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.324 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.674 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 1.6 pp0? -78.85 -18.22 54.36 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.42 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 125.92 1.92 7.37 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 120.444 -0.884 . . . . 0.0 113.663 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.603 ' CB ' ' HB1' ' A' ' 93' ' ' ALA . . . -53.43 151.59 5.48 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 117.419 0.61 . . . . 0.0 110.699 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.575 ' CE2' ' HB2' ' A' ' 118' ' ' ALA . 11.4 t80 -79.63 -53.9 6.4 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 121.018 -0.273 . . . . 0.0 111.303 -179.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 175.04 -166.95 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.036 0.446 . . . . 0.0 111.594 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.818 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 3.0 m-85 -133.95 153.53 51.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.034 -178.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.614 ' CD1' HD22 ' A' ' 114' ' ' LEU . 1.8 mp -103.62 118.83 56.54 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.197 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 102' ' ' LEU . 8.0 Cg_exo -70.63 -68.43 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.436 2.091 . . . . 0.0 111.97 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.731 ' H ' ' HD2' ' A' ' 105' ' ' PRO . 0.5 OUTLIER -117.92 -59.24 0.03 OUTLIER Pre-proline 0 CA--C 1.531 0.239 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -179.858 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.731 ' HD2' ' H ' ' A' ' 104' ' ' LYS . 13.0 Cg_endo -55.42 157.57 14.5 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.113 1.875 . . . . 0.0 112.44 -179.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.571 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 22.4 t80 -165.6 -111.01 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.434 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.548 ' O ' ' O ' ' A' ' 106' ' ' PHE . 3.0 p30 43.74 178.74 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.907 0.384 . . . . 0.0 111.257 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.71 HG12 HG12 ' A' ' 18' ' ' VAL . 0.9 OUTLIER -68.02 -42.88 85.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.979 0.418 . . . . 0.0 111.575 -179.643 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.492 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 78.8 m-20 -49.26 -58.35 5.2 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.413 -179.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.571 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 62.9 mm-40 -76.4 -32.26 58.43 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.678 0.275 . . . . 0.0 111.43 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.401 ' CB ' ' O ' ' A' ' 107' ' ' ASP . . . -64.92 -60.8 2.65 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.001 0.429 . . . . 0.0 109.946 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.608 ' O ' HG12 ' A' ' 115' ' ' VAL . 48.3 t -59.46 -31.27 46.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.413 0.625 . . . . 0.0 110.537 178.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.492 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -63.23 -45.07 93.35 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.01 179.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.658 HD12 ' HD2' ' A' ' 117' ' ' ARG . 55.7 tp -76.28 -23.44 54.41 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.703 -1.135 . . . . 0.0 111.782 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.608 HG12 ' O ' ' A' ' 112' ' ' VAL . 4.0 p -79.2 -41.25 22.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.801 0.334 . . . . 0.0 111.548 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.475 ' HA ' HD12 ' A' ' 119' ' ' ILE . 95.1 mt-10 -65.33 -44.48 87.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.181 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.658 ' HD2' HD12 ' A' ' 114' ' ' LEU . 6.5 ptp180 -62.29 -25.42 67.84 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.933 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.575 ' HB2' ' CE2' ' A' ' 99' ' ' PHE . . . -71.28 -44.56 64.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.088 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.489 HD11 HG11 ' A' ' 50' ' ' VAL . 4.8 mt -68.6 -30.8 48.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.252 0.548 . . . . 0.0 110.688 179.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 21.7 t -71.24 -45.03 64.16 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.212 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 30.1 m80 -67.44 -24.36 65.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.024 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -67.86 -50.05 58.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.651 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 3.0 tm0? -75.13 172.22 12.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.821 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.821 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.467 0 CA-C-O 120.807 0.336 . . . . 0.0 111.311 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 61.5 176.25 0.12 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.452 -179.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -76.39 1.96 14.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.561 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 84.4 86.33 0.9 Allowed Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.833 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.469 ' HB ' ' HA ' ' A' ' 48' ' ' PRO . 3.6 mp -110.56 112.75 41.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.102 0.477 . . . . 0.0 111.245 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.687 HG23 HG13 ' A' ' 50' ' ' VAL . 5.6 p -108.82 120.96 61.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.913 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.885 ' CD1' HG22 ' A' ' 31' ' ' THR . 31.4 m0 -112.32 141.74 45.67 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.117 0.484 . . . . 0.0 111.484 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.808 ' HB ' HG22 ' A' ' 32' ' ' THR . 1.6 t -128.3 143.01 42.31 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.306 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.975 -178.261 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.871 HG11 ' HA2' ' A' ' 36' ' ' GLY . 0.0 OUTLIER -120.95 110.69 28.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.456 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.548 ' HA ' ' HB3' ' A' ' 54' ' ' ASP . 4.5 p30 -161.3 -160.75 0.75 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.904 0.383 . . . . 0.0 111.67 -178.463 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -66.23 -3.28 5.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.681 -179.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 65.31 -155.91 0.28 Allowed 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 120.511 0.196 . . . . 0.0 110.927 179.439 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.444 ' OG ' ' N ' ' A' ' 14' ' ' SER . 64.0 p 33.56 -96.89 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 179.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.909 ' O ' HG23 ' A' ' 18' ' ' VAL . 40.4 t -52.93 -57.41 10.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.535 -179.516 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.4 mm -64.61 -26.36 40.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.937 0.398 . . . . 0.0 111.182 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.694 ' HA ' HG21 ' A' ' 32' ' ' THR . 9.8 ttt180 -73.43 -49.29 27.7 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.447 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.427 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 87.0 t90 -63.4 -39.83 95.57 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -179.087 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.909 HG23 ' O ' ' A' ' 14' ' ' SER . 3.2 t -67.03 -42.87 89.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 112.133 0.419 . . . . 0.0 112.133 -178.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.752 ' CD1' HD12 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -84.12 -30.52 25.87 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -178.696 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.553 ' HG3' ' N ' ' A' ' 21' ' ' ARG . 17.2 pt-20 -64.09 -60.03 3.73 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -178.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.553 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 5.5 mmm180 -53.76 -52.59 59.72 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -178.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.17 -29.23 70.21 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -178.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.88 ' CD2' HD13 ' A' ' 28' ' ' LEU . 0.4 OUTLIER -85.32 -29.88 24.16 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.146 0.498 . . . . 0.0 110.088 179.175 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.38 -32.06 73.5 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 177.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.55 -25.16 72.7 Favored Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 177.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.622 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -77.11 -15.18 59.65 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.572 -0.314 . . . . 0.0 110.588 179.007 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.96 26.48 14.49 Favored Glycine 0 C--N 1.336 0.577 0 C-N-CA 120.959 -0.639 . . . . 0.0 114.28 178.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.88 HD13 ' CD2' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -127.25 161.28 28.94 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 117.889 0.845 . . . . 0.0 112.874 -179.303 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 99.4 m -75.98 116.85 17.1 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.973 179.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 2.0 p -111.18 109.31 19.3 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -178.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.885 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.8 t -130.21 138.23 50.46 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 178.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.808 HG22 ' HB ' ' A' ' 8' ' ' VAL . 81.5 p -115.32 160.59 19.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.498 0.666 . . . . 0.0 112.652 -178.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.874 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 1.4 m-85 -135.84 173.87 11.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.179 -179.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.698 ' HG2' ' HG3' ' A' ' 38' ' ' GLU . 0.1 OUTLIER -62.27 -105.45 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.939 -179.028 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.423 ' H ' ' CG ' ' A' ' 34' ' ' GLU . 14.2 m120 -86.45 -71.7 0.53 Allowed 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.319 0.581 . . . . 0.0 111.257 -179.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.871 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . -159.76 -40.71 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.222 -0.899 . . . . 0.0 112.548 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.696 ' HA ' HD12 ' A' ' 40' ' ' LEU . 7.4 m120 -52.46 -30.08 27.97 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.726 0.298 . . . . 0.0 111.173 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.874 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -58.79 -58.0 10.52 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.417 179.526 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.778 HG23 HG13 ' A' ' 9' ' ' VAL . 6.0 t -54.58 -43.49 65.05 Favored 'Isoleucine or valine' 0 C--N 1.341 0.207 0 C-N-CA 120.24 -0.584 . . . . 0.0 111.295 -179.385 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.716 HD13 ' HB3' ' A' ' 68' ' ' GLN . 7.6 mt -53.37 -49.01 68.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.975 0.417 . . . . 0.0 110.564 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.73 -49.89 73.84 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.98 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.77 -28.05 67.28 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.838 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.847 HD13 ' NE2' ' A' ' 73' ' ' HIS . 5.9 mt -69.77 -26.11 64.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.631 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.22 -20.15 10.04 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.562 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 29.6 t -125.61 -0.27 7.47 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -154.3 155.66 35.56 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 120.761 0.315 . . . . 0.0 110.589 179.893 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.431 HG23 HD13 ' A' ' 76' ' ' LEU . 53.2 m -138.54 112.39 8.46 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.011 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.838 ' O ' HD11 ' A' ' 76' ' ' LEU . 59.2 Cg_endo -77.98 161.77 29.62 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.031 1.82 . . . . 0.0 111.511 179.333 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -73.72 -23.76 59.82 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.175 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.687 HG13 HG23 ' A' ' 6' ' ' VAL . 7.8 p -145.35 167.32 9.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.914 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.67 HD11 HG11 ' A' ' 39' ' ' VAL . 11.3 tp -152.84 131.01 11.94 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.003 0.43 . . . . 0.0 111.833 -179.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.666 ' O ' HG23 ' A' ' 9' ' ' VAL . 0.4 OUTLIER -113.84 128.21 56.31 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.243 179.695 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.2 m -105.69 134.23 49.15 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.835 0.35 . . . . 0.0 111.262 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.587 ' O ' HG22 ' A' ' 55' ' ' ILE . 16.5 p-10 -72.75 -29.79 63.61 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.683 -179.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 1.022 HG12 ' HA3' ' A' ' 62' ' ' GLY . 0.0 OUTLIER 49.08 97.22 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.549 179.572 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 39.8 tpt85 -157.36 57.16 0.51 Allowed 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.452 ' N ' ' CD ' ' A' ' 58' ' ' PRO . 0.0 OUTLIER 61.21 46.59 1.08 Allowed Pre-proline 0 N--CA 1.47 0.54 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 178.476 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.628 ' CD ' ' HA2' ' A' ' 62' ' ' GLY . 39.0 Cg_endo -70.37 -75.46 0.01 OUTLIER 'Trans proline' 0 CA--C 1.53 0.301 0 C-N-CA 122.458 2.105 . . . . 0.0 111.522 178.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -119.19 -21.23 3.8 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.216 -0.516 . . . . 0.0 112.101 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.979 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -159.95 67.78 0.38 Allowed 'General case' 0 C--O 1.236 0.393 0 CA-C-O 120.981 0.419 . . . . 0.0 110.177 179.748 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 72.93 -30.9 0.22 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.309 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 1.022 ' HA3' HG12 ' A' ' 55' ' ' ILE . . . 140.74 -24.2 2.61 Favored Glycine 0 CA--C 1.503 -0.679 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -179.124 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.828 HD23 ' HB2' ' A' ' 90' ' ' ALA . 3.1 mp -74.34 -23.67 59.07 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.979 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -53.96 -30.01 45.11 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.3 178.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.655 HD22 ' HA3' ' A' ' 36' ' ' GLY . 10.4 mt -58.48 -40.47 82.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.198 179.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.736 HD23 HG11 ' A' ' 78' ' ' VAL . 28.5 mt -63.51 -42.11 98.49 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.319 179.492 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.755 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 15.9 mttm -52.89 -42.2 65.07 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.152 179.088 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.716 ' HB3' HD13 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -71.54 -44.99 63.59 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.911 179.777 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.685 HD12 ' HA ' ' A' ' 66' ' ' LEU . 21.8 mt -56.1 -37.35 48.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.197 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.755 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -74.85 -28.17 60.57 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.892 179.885 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.56 -31.78 67.38 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.401 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.5 mtt-85 -91.73 -64.46 1.11 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.331 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.847 ' NE2' HD13 ' A' ' 43' ' ' LEU . 0.4 OUTLIER -125.06 76.22 67.34 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.996 179.718 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.419 ' HB3' ' O ' ' A' ' 70' ' ' LYS . 51.2 Cg_endo -69.59 60.82 1.62 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.528 2.152 . . . . 0.0 112.422 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 33.1 mtt -157.28 -35.45 0.08 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.534 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.838 HD11 ' O ' ' A' ' 48' ' ' PRO . 0.6 OUTLIER -61.52 145.98 90.43 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.877 -179.44 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.607 ' HD2' ' HG ' ' A' ' 76' ' ' LEU . 94.9 Cg_endo -82.88 115.43 2.4 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.739 2.292 . . . . 0.0 112.697 179.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.736 HG11 HD23 ' A' ' 66' ' ' LEU . 3.2 t -98.92 139.16 21.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.685 179.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.732 ' CG2' HD23 ' A' ' 114' ' ' LEU . 2.0 mp -122.15 112.13 33.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.698 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.752 HD13 ' CE1' ' A' ' 101' ' ' TYR . 2.2 mp -98.32 134.6 36.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.135 0.493 . . . . 0.0 111.279 -179.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.58 ' HA ' ' HB2' ' A' ' 102' ' ' LEU . 4.7 ptm -87.23 -9.13 55.89 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -178.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.875 ' HB ' HD12 ' A' ' 55' ' ' ILE . 19.0 m -149.02 136.78 20.51 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.642 0.258 . . . . 0.0 111.566 -179.197 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.694 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -123.0 82.27 1.97 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.834 0.35 . . . . 0.0 111.275 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -67.34 -166.32 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.574 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.35 80.53 6.78 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.022 0.439 . . . . 0.0 111.91 -179.06 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.68 ' HB3' HD13 ' A' ' 63' ' ' LEU . 27.0 t0 -178.15 28.38 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.945 179.2 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.869 HD13 ' HB3' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -44.99 -23.1 0.12 Allowed 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -179.687 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -47.94 -44.04 29.76 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.514 ' HB3' ' HB2' ' A' ' 63' ' ' LEU . . . -73.38 -22.23 60.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.674 0.273 . . . . 0.0 111.595 -179.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.869 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -68.88 -39.66 79.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.972 0.415 . . . . 0.0 110.169 179.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.645 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 2.4 t -54.15 -39.93 44.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.207 -179.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.544 ' O ' ' HG3' ' A' ' 95' ' ' GLN . 85.5 p -63.09 -19.74 64.71 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.257 0.551 . . . . 0.0 109.745 178.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.771 ' O ' ' HG3' ' A' ' 96' ' ' GLN . . . -75.9 -55.43 5.62 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.204 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.645 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 4.4 m-85 -56.82 -33.61 66.91 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.921 -179.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.544 ' HG3' ' O ' ' A' ' 92' ' ' SER . 2.1 pp0? -75.46 -28.94 59.47 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.863 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.771 ' HG3' ' O ' ' A' ' 93' ' ' ALA . 0.7 OUTLIER -87.03 -9.1 56.35 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 116.695 -0.23 . . . . 0.0 110.888 178.9 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 121.58 6.7 8.56 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 120.407 -0.902 . . . . 0.0 113.774 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.744 ' HB2' ' HB1' ' A' ' 93' ' ' ALA . . . -55.3 157.38 3.67 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 117.213 0.507 . . . . 0.0 111.466 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.471 ' CZ ' ' HA ' ' A' ' 118' ' ' ALA . 5.2 t80 -86.25 -53.89 4.77 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.584 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 170.19 -162.43 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.876 0.37 . . . . 0.0 111.867 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.752 ' CE1' HD13 ' A' ' 80' ' ' ILE . 2.2 m-85 -134.61 153.26 52.05 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.567 -178.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.62 ' CD1' HD22 ' A' ' 114' ' ' LEU . 1.0 OUTLIER -102.65 119.52 55.64 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.168 -179.905 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -65.18 -70.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.474 2.116 . . . . 0.0 112.553 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.682 ' H ' ' HD2' ' A' ' 105' ' ' PRO . 0.5 OUTLIER -123.63 -62.1 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.908 -179.611 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.682 ' HD2' ' H ' ' A' ' 104' ' ' LYS . 9.2 Cg_endo -50.12 163.56 0.57 Allowed 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.314 2.009 . . . . 0.0 112.367 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.594 ' O ' ' O ' ' A' ' 107' ' ' ASP . 58.9 t80 -171.71 -102.44 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.257 179.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.594 ' O ' ' O ' ' A' ' 106' ' ' PHE . 3.4 p30 43.14 178.39 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 117.792 0.269 . . . . 0.0 110.865 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.539 HD11 HD23 ' A' ' 19' ' ' LEU . 0.9 OUTLIER -67.91 -43.1 86.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 120.432 -0.507 . . . . 0.0 111.792 -179.738 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.485 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 32.7 t70 -49.62 -58.65 4.84 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.913 -179.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.589 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 3.7 mm-40 -74.81 -30.37 61.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.635 0.255 . . . . 0.0 111.6 -179.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -68.61 -62.53 1.35 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.279 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.546 ' HA ' HG12 ' A' ' 115' ' ' VAL . 49.0 t -55.96 -31.35 30.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.559 0.695 . . . . 0.0 110.163 178.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.485 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -64.38 -46.68 82.29 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.327 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.732 HD23 ' CG2' ' A' ' 79' ' ' ILE . 19.6 tp -76.96 -21.2 55.12 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.996 -179.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.546 HG12 ' HA ' ' A' ' 112' ' ' VAL . 4.7 p -79.4 -47.98 21.62 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 C-N-CA 120.401 -0.519 . . . . 0.0 111.715 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.415 ' N ' HG13 ' A' ' 115' ' ' VAL . 79.3 mt-10 -64.38 -41.89 96.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.871 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.451 ' HG2' ' O ' ' A' ' 113' ' ' ALA . 20.1 mmm180 -61.77 -23.71 66.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.768 179.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.471 ' HA ' ' CZ ' ' A' ' 99' ' ' PHE . . . -72.02 -49.34 37.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.941 179.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.447 HD11 HG11 ' A' ' 50' ' ' VAL . 3.9 mt -71.11 -31.66 45.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.16 0.505 . . . . 0.0 110.696 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.91 -48.63 52.59 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.122 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -57.48 -26.99 62.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.297 -179.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -80.36 -55.72 4.7 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.182 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 60.51 173.47 0.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.824 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 69.9 mt-10 . . . . . 0 C--N 1.326 -0.417 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.781 179.853 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.3 ptt? . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 120.836 0.351 . . . . 0.0 111.301 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.687 ' O ' ' HG2' ' A' ' 3' ' ' ARG . 7.8 mt-30 -120.33 -35.4 3.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.044 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.687 ' HG2' ' O ' ' A' ' 2' ' ' GLN . 2.9 ptm180 69.24 -28.14 0.16 Allowed 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.3 0.64 . . . . 0.0 112.672 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.667 ' C ' HD13 ' A' ' 5' ' ' ILE . . . 104.24 91.14 2.2 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.616 179.001 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.684 HD11 ' CG ' ' A' ' 3' ' ' ARG . 5.9 mm -118.73 112.23 37.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.908 0.385 . . . . 0.0 111.188 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.997 HG11 HD13 ' A' ' 23' ' ' LEU . 4.4 p -114.98 117.17 54.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.428 179.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.849 ' CD1' HG22 ' A' ' 31' ' ' THR . 25.7 m0 -107.31 133.89 51.19 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.031 0.443 . . . . 0.0 110.442 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.854 HG21 HD23 ' A' ' 19' ' ' LEU . 1.8 t -122.01 148.8 25.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.382 -177.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.792 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -126.16 112.0 28.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.991 178.037 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.469 ' OD2' HG21 ' A' ' 15' ' ' ILE . 8.7 t0 -161.42 -161.79 0.83 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.648 -178.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -66.36 -2.22 4.27 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -179.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 68.77 -153.23 0.16 Allowed 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 120.566 0.222 . . . . 0.0 110.711 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.462 ' OG ' ' N ' ' A' ' 14' ' ' SER . 62.5 p 33.66 -97.87 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 179.301 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.786 ' O ' HG23 ' A' ' 18' ' ' VAL . 0.3 OUTLIER -52.85 -52.1 58.5 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 111.608 0.225 . . . . 0.0 111.608 -179.417 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.469 HG21 ' OD2' ' A' ' 10' ' ' ASP . 20.1 mm -64.24 -30.56 50.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.866 0.365 . . . . 0.0 111.215 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.686 ' HA ' HG21 ' A' ' 32' ' ' THR . 47.3 ttp180 -72.83 -41.77 64.49 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.961 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.566 ' O ' ' HD2' ' A' ' 21' ' ' ARG . 57.3 t90 -65.11 -53.51 44.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.999 -179.229 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.786 HG23 ' O ' ' A' ' 14' ' ' SER . 2.1 t -60.24 -43.16 92.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -178.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.854 HD23 HG21 ' A' ' 8' ' ' VAL . 12.0 tp -82.44 -27.64 31.8 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -177.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.646 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 12.2 pt-20 -67.1 -62.3 1.5 Allowed 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 119.917 -0.713 . . . . 0.0 112.062 -178.461 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.733 ' HD2' ' H ' ' A' ' 21' ' ' ARG . 1.3 mpt_? -54.83 -49.16 71.73 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -179.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.87 -60.11 3.68 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.52 -179.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.057 HD22 HD13 ' A' ' 28' ' ' LEU . 2.6 mt -64.82 -27.36 68.83 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.081 0.467 . . . . 0.0 109.78 179.317 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.34 -34.92 79.26 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.78 -25.34 71.76 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.302 -0.952 . . . . 0.0 111.225 178.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.735 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -76.8 -15.42 59.74 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 120.681 0.277 . . . . 0.0 111.076 179.426 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.81 26.4 8.53 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.547 -0.835 . . . . 0.0 114.023 178.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 1.057 HD13 HD22 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -125.83 172.45 9.85 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 117.73 0.765 . . . . 0.0 112.158 -179.632 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.5 m -99.01 105.77 17.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.193 179.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.685 ' HA ' HG13 ' A' ' 6' ' ' VAL . 11.4 t -100.86 111.31 23.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.066 -179.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.849 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.9 t -120.18 156.52 30.94 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.686 HG21 ' HA ' ' A' ' 16' ' ' ARG . 64.3 p -129.97 161.83 30.04 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.278 0.561 . . . . 0.0 112.04 -179.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.792 ' HB2' HG13 ' A' ' 9' ' ' VAL . 3.8 m-85 -129.42 173.99 10.04 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.572 -178.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.719 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 2.3 pp20? -60.04 -51.59 68.98 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -177.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.502 ' OD1' ' HB3' ' A' ' 58' ' ' PRO . 0.7 OUTLIER -150.59 -71.74 0.17 Allowed 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -178.454 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.615 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . -153.39 -42.41 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.4 -0.905 . . . . 0.0 113.709 -178.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.405 ' HA ' ' HG ' ' A' ' 40' ' ' LEU . 0.5 OUTLIER -67.59 -30.77 70.46 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-O 120.852 0.358 . . . . 0.0 111.361 -178.956 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.767 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -51.87 -59.85 3.85 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.751 179.86 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.785 HG21 HG22 ' A' ' 9' ' ' VAL . 0.8 OUTLIER -55.4 -41.51 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 C-N-CA 119.804 -0.759 . . . . 0.0 110.083 -179.637 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.694 HD13 ' CB ' ' A' ' 68' ' ' GLN . 6.7 mt -53.32 -41.56 65.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.308 0.575 . . . . 0.0 109.845 179.078 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.48 -48.15 76.3 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.711 179.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.95 -26.75 63.31 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.894 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.952 HD13 ' CE1' ' A' ' 73' ' ' HIS . 1.1 mt -69.94 -22.46 63.18 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.564 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.48 -22.12 11.9 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.981 0.419 . . . . 0.0 110.847 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -130.48 2.45 4.58 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.612 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.68 ' HG2' ' CH2' ' A' ' 7' ' ' TRP . 1.3 tptp -138.05 161.48 36.63 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 121.523 0.678 . . . . 0.0 111.962 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.499 ' H ' ' HG3' ' A' ' 46' ' ' LYS . 51.1 m -139.38 111.25 7.7 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.674 178.06 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.797 ' HG2' HD21 ' A' ' 76' ' ' LEU . 73.2 Cg_endo -80.84 153.31 19.61 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.301 2.001 . . . . 0.0 111.305 179.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -74.44 -30.93 62.09 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.057 -179.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.868 HG13 HG23 ' A' ' 6' ' ' VAL . 9.0 p -150.95 103.71 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-O 120.892 0.377 . . . . 0.0 111.534 -179.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.703 HD11 HG11 ' A' ' 39' ' ' VAL . 11.1 tp -87.63 131.23 34.5 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -179.14 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.731 ' HB3' HG13 ' A' ' 8' ' ' VAL . 0.4 OUTLIER -115.17 127.42 55.54 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.446 179.524 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.699 ' OG ' HD23 ' A' ' 65' ' ' LEU . 0.6 OUTLIER -108.48 136.55 47.92 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 120.846 0.355 . . . . 0.0 110.972 179.969 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.424 ' O ' ' CG2' ' A' ' 55' ' ' ILE . 25.5 p-10 -79.54 -21.33 45.32 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -178.385 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.604 HG21 HG22 ' A' ' 80' ' ' ILE . 0.7 OUTLIER 44.81 86.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -179.666 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.408 ' O ' ' HG3' ' A' ' 56' ' ' ARG . 4.9 ptt85 -147.83 56.54 1.08 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 120.925 0.393 . . . . 0.0 111.832 179.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.475 ' N ' ' HD3' ' A' ' 58' ' ' PRO . 6.0 ttt 62.55 50.26 1.43 Allowed Pre-proline 0 N--CA 1.465 0.315 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 178.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.592 ' HD2' ' N ' ' A' ' 62' ' ' GLY . 45.2 Cg_endo -77.09 -77.01 0.01 OUTLIER 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 122.421 2.081 . . . . 0.0 111.749 178.397 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -118.04 -21.15 4.25 Favored Glycine 0 C--N 1.332 0.359 0 N-CA-C 111.798 -0.521 . . . . 0.0 111.798 179.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.993 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 5.1 ttt -161.3 67.61 0.3 Allowed 'General case' 0 C--O 1.236 0.351 0 CA-C-O 120.978 0.418 . . . . 0.0 110.415 179.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.419 ' OD1' ' CE1' ' A' ' 84' ' ' HIS . 0.2 OUTLIER 69.79 -23.07 0.16 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.484 179.543 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.592 ' N ' ' HD2' ' A' ' 58' ' ' PRO . . . 136.36 -29.58 2.79 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 -178.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.73 HD13 ' HB3' ' A' ' 86' ' ' ASP . 4.1 mp -71.56 -21.93 61.82 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.465 -0.368 . . . . 0.0 110.225 179.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.993 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -53.74 -33.48 55.83 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.952 179.054 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.699 HD23 ' OG ' ' A' ' 53' ' ' SER . 6.4 mp -56.99 -48.44 78.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.106 0.479 . . . . 0.0 110.76 179.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.96 ' HA ' HD12 ' A' ' 69' ' ' ILE . 4.9 mp -55.69 -40.3 72.18 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.763 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.687 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 0.1 OUTLIER -53.85 -48.07 70.34 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.9 179.286 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.694 ' CB ' HD13 ' A' ' 40' ' ' LEU . 13.1 mm-40 -71.39 -29.88 65.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.698 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.96 HD12 ' HA ' ' A' ' 66' ' ' LEU . 37.6 mt -62.72 -40.76 89.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.665 -179.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.687 ' HG2' ' O ' ' A' ' 67' ' ' LYS . 23.9 pttt -74.68 -29.58 61.27 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.475 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -85.88 -38.17 18.36 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -178.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 22.0 mtt-85 -95.33 -27.24 15.56 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -178.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.952 ' CE1' HD13 ' A' ' 43' ' ' LEU . 0.2 OUTLIER -107.52 134.85 19.83 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.699 -0.228 . . . . 0.0 111.131 -179.107 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.561 ' O ' ' HG2' ' A' ' 75' ' ' MET . 23.6 Cg_exo -63.66 79.88 0.14 Allowed 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.657 2.238 . . . . 0.0 112.587 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.561 ' HG2' ' O ' ' A' ' 74' ' ' PRO . 0.0 OUTLIER 50.69 43.19 27.93 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 121.558 0.694 . . . . 0.0 110.795 179.742 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.797 HD21 ' HG2' ' A' ' 48' ' ' PRO . 5.8 tp -68.24 137.08 91.47 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.678 -179.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.547 ' HD2' ' HG ' ' A' ' 76' ' ' LEU . 47.3 Cg_endo -67.34 125.09 12.92 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.495 2.13 . . . . 0.0 111.951 179.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.863 HG22 HG21 ' A' ' 69' ' ' ILE . 3.8 t -110.92 143.53 20.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.09 0.472 . . . . 0.0 111.614 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.564 HG21 HD23 ' A' ' 114' ' ' LEU . 2.3 mp -132.97 113.19 19.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.338 179.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.66 HD13 ' HB2' ' A' ' 53' ' ' SER . 13.0 mm -101.22 142.21 16.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.326 -179.211 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.503 ' O ' ' HB3' ' A' ' 102' ' ' LEU . 11.4 ptm -82.79 -21.23 34.64 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -178.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.557 ' H ' HG21 ' A' ' 55' ' ' ILE . 3.0 m -147.65 158.05 43.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.637 0.256 . . . . 0.0 111.22 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.851 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -138.53 66.43 1.43 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.571 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.419 ' CE1' ' OD1' ' A' ' 61' ' ' ASP . 16.1 p80 -99.24 120.62 39.84 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 120.898 0.38 . . . . 0.0 111.578 -179.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 55.77 165.83 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.752 179.385 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.73 ' HB3' HD13 ' A' ' 63' ' ' LEU . 1.0 OUTLIER 52.89 26.86 4.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.079 -179.817 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.765 HD21 ' HB1' ' A' ' 83' ' ' ALA . 0.1 OUTLIER -54.82 -23.72 19.62 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.352 -179.961 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -50.63 -35.93 32.85 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.829 -179.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.599 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -69.56 -23.32 63.55 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.798 0.333 . . . . 0.0 111.447 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.605 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -72.12 -30.63 65.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.209 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.659 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 5.5 t -66.67 -46.72 85.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.365 -179.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.6 m -58.12 -37.81 75.3 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.482 0.658 . . . . 0.0 110.093 179.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.591 ' HB1' ' HB2' ' A' ' 98' ' ' ALA . . . -56.89 -41.53 78.25 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.319 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.659 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 12.4 m-85 -59.03 -22.31 60.48 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.212 179.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.561 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -74.76 -39.76 61.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.518 -179.999 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.561 ' N ' ' HG2' ' A' ' 95' ' ' GLN . 4.8 pt20 -79.18 -11.12 59.97 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.376 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 108.05 32.15 3.37 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.336 -0.935 . . . . 0.0 112.91 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.591 ' HB2' ' HB1' ' A' ' 93' ' ' ALA . . . -61.07 145.76 49.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.756 0.278 . . . . 0.0 110.566 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.619 ' CZ ' ' HB2' ' A' ' 118' ' ' ALA . 9.2 t80 -71.08 -53.87 13.11 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.548 -179.387 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.559 ' OD2' HD11 ' A' ' 114' ' ' LEU . 2.8 p30 166.82 -166.4 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.185 0.517 . . . . 0.0 111.498 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.851 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 4.8 m-85 -133.95 152.42 51.85 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.99 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.503 ' HB3' ' O ' ' A' ' 81' ' ' MET . 1.0 OUTLIER -104.72 119.02 54.94 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.258 179.584 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -67.84 -67.52 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.306 2.004 . . . . 0.0 112.448 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.685 ' H ' ' HD2' ' A' ' 105' ' ' PRO . 4.9 mttt -121.76 -61.95 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.969 -179.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.685 ' HD2' ' H ' ' A' ' 104' ' ' LYS . 9.7 Cg_endo -50.29 159.76 1.81 Allowed 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.42 2.08 . . . . 0.0 112.279 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.605 ' O ' ' O ' ' A' ' 107' ' ' ASP . 47.8 t80 -169.74 -105.83 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.414 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.605 ' O ' ' O ' ' A' ' 106' ' ' PHE . 2.7 p30 43.1 175.38 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.033 0.444 . . . . 0.0 111.447 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.455 HG12 ' O ' ' A' ' 18' ' ' VAL . 0.9 OUTLIER -67.62 -41.07 85.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.09 0.472 . . . . 0.0 111.288 179.956 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.511 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 0.3 OUTLIER -50.01 -58.21 5.96 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.596 -179.707 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.587 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 58.4 mm-40 -77.32 -32.05 55.01 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -179.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -67.33 -58.44 4.79 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.858 0.361 . . . . 0.0 110.237 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.666 ' O ' HG12 ' A' ' 115' ' ' VAL . 51.8 t -60.89 -32.46 52.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.488 0.661 . . . . 0.0 110.189 179.176 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.511 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -62.07 -44.8 95.9 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.567 0.699 . . . . 0.0 109.911 178.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.656 HD12 ' HE ' ' A' ' 117' ' ' ARG . 6.1 tp -74.97 -23.7 58.32 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.588 -179.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.666 HG12 ' O ' ' A' ' 112' ' ' VAL . 2.7 p -79.57 -42.75 23.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.832 0.348 . . . . 0.0 111.736 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.448 ' HG3' ' O ' ' A' ' 112' ' ' VAL . 31.6 mt-10 -60.31 -51.92 67.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.298 -179.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.656 ' HE ' HD12 ' A' ' 114' ' ' LEU . 0.1 OUTLIER -57.25 -23.88 51.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.852 0.358 . . . . 0.0 110.979 -179.993 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.619 ' HB2' ' CZ ' ' A' ' 99' ' ' PHE . . . -70.39 -45.58 65.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.814 179.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.641 HD13 ' CD2' ' A' ' 28' ' ' LEU . 4.7 mt -77.22 -34.11 20.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.464 -179.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.9 m -65.18 -47.06 78.29 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.969 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 11.1 m80 -70.54 -29.67 66.21 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.986 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -78.81 -41.3 30.66 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.677 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -75.4 -179.49 4.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.647 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.768 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.8 mmm . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 120.78 0.324 . . . . 0.0 111.255 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.1 mp0 -86.66 155.61 20.33 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.43 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.29 -3.21 16.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.387 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.479 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . 84.89 85.81 0.95 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.79 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.7 mp -101.01 113.11 36.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.933 0.397 . . . . 0.0 111.218 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 1.013 HG11 HD13 ' A' ' 23' ' ' LEU . 5.9 p -105.44 120.18 55.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.281 179.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.856 ' CD1' HG22 ' A' ' 31' ' ' THR . 26.3 m0 -112.21 139.8 47.45 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.915 0.388 . . . . 0.0 110.512 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.957 HG11 HD13 ' A' ' 19' ' ' LEU . 0.2 OUTLIER -126.94 148.83 31.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.749 -178.765 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.818 HG23 ' O ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -127.01 114.61 38.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.002 0.429 . . . . 0.0 109.995 179.023 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.982 ' HB3' HG13 ' A' ' 15' ' ' ILE . 9.1 t0 -171.05 -150.24 0.07 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.426 -178.306 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -66.49 -3.37 6.08 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.511 ' O ' ' N ' ' A' ' 16' ' ' ARG . 2.3 t0 69.19 -79.52 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 178.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -40.83 -78.35 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -178.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.78 ' O ' HG23 ' A' ' 18' ' ' VAL . 1.7 t -52.61 -32.6 42.44 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.669 -178.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.982 HG13 ' HB3' ' A' ' 10' ' ' ASP . 23.2 mm -77.53 -28.69 16.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.892 -179.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.61 ' HA ' ' HG3' ' A' ' 20' ' ' GLU . 14.1 ttt180 -58.35 -44.69 88.89 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.307 0.575 . . . . 0.0 110.176 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.734 ' O ' ' HB2' ' A' ' 21' ' ' ARG . 38.4 t90 -71.95 -62.22 1.5 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.766 -179.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.78 HG23 ' O ' ' A' ' 14' ' ' SER . 0.5 OUTLIER -59.17 -60.89 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 -177.056 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.957 HD13 HG11 ' A' ' 8' ' ' VAL . 13.9 mt -70.67 -51.49 27.42 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -175.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.61 ' HG3' ' HA ' ' A' ' 16' ' ' ARG . 5.1 mt-10 -67.62 -61.66 1.79 Allowed 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -178.316 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.734 ' HB2' ' O ' ' A' ' 17' ' ' TRP . 0.0 OUTLIER -49.99 -44.45 50.97 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.058 -178.202 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.82 -37.37 76.2 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.672 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.013 HD13 HG11 ' A' ' 6' ' ' VAL . 3.0 mt -75.22 -27.1 59.42 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 178.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.409 ' N ' ' O ' ' A' ' 20' ' ' GLU . . . -63.72 -35.65 81.28 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.94 -26.2 69.97 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.171 -1.014 . . . . 0.0 110.993 178.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.764 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -76.85 -15.53 59.68 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 120.565 0.221 . . . . 0.0 110.923 179.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.13 26.71 9.97 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 120.636 -0.792 . . . . 0.0 113.955 179.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 1.001 HD13 HD22 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -123.72 168.87 12.12 Favored 'General case' 0 N--CA 1.456 -0.125 0 CA-C-N 117.707 0.754 . . . . 0.0 111.788 -179.983 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 58.2 m -96.44 113.52 25.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.918 179.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.682 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 3.1 t -112.05 117.51 32.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.093 0.473 . . . . 0.0 112.195 -179.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.856 HG22 ' CD1' ' A' ' 7' ' ' TRP . 3.3 t -123.57 139.85 53.59 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.169 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.487 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 76.8 p -112.5 161.42 16.76 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.129 0.49 . . . . 0.0 111.388 -178.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.775 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 3.7 m-85 -131.28 174.08 10.41 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.806 -177.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.728 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 3.2 pp20? -63.19 -39.04 93.5 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -177.219 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -164.2 -57.61 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.301 0 C-N-CA 119.755 -0.778 . . . . 0.0 113.049 -178.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.816 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . -169.07 -44.42 0.03 OUTLIER Glycine 0 C--N 1.318 -0.471 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.64 -178.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.503 ' N ' HD21 ' A' ' 65' ' ' LEU . 0.5 OUTLIER -64.88 -30.43 71.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.995 0.426 . . . . 0.0 110.96 -179.329 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.775 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -54.34 -52.84 60.29 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.551 -179.945 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.772 HG12 ' CD1' ' A' ' 43' ' ' LEU . 11.5 t -48.76 -38.77 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-O 121.017 0.437 . . . . 0.0 111.1 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.811 HD21 ' CD1' ' A' ' 65' ' ' LEU . 15.9 mt -61.82 -42.14 98.65 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.564 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.41 -49.45 73.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.19 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.86 -31.86 66.89 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.542 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.772 ' CD1' HG12 ' A' ' 39' ' ' VAL . 5.7 mt -59.88 -24.02 63.93 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.297 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.36 -19.32 34.53 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.439 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.5 t -121.52 0.88 10.03 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.557 ' O ' HD23 ' A' ' 43' ' ' LEU . 3.6 tttt -165.37 164.39 19.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.944 0.402 . . . . 0.0 111.367 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.523 ' HA ' HD23 ' A' ' 43' ' ' LEU . 85.9 m -138.79 116.83 9.09 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.948 179.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.741 ' HD2' HD21 ' A' ' 43' ' ' LEU . 40.0 Cg_endo -74.82 156.06 43.8 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 121.796 1.664 . . . . 0.0 111.466 179.25 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -74.05 -30.84 62.6 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.079 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.689 ' O ' HG13 ' A' ' 50' ' ' VAL . 14.9 p -149.49 106.27 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 CA-C-O 120.737 0.303 . . . . 0.0 111.699 -179.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.709 ' O ' HD12 ' A' ' 79' ' ' ILE . 20.5 tp -87.07 155.32 20.19 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.937 0.399 . . . . 0.0 111.201 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.818 ' O ' HG23 ' A' ' 9' ' ' VAL . 2.4 tt -137.16 119.6 15.85 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.197 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.528 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 0.6 OUTLIER -111.86 128.44 56.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.781 0.324 . . . . 0.0 111.378 -179.662 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.06 -2.9 56.55 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.514 HD11 ' CE1' ' A' ' 84' ' ' HIS . 3.0 tt 41.97 91.13 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-O 120.805 0.336 . . . . 0.0 111.698 179.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.4 ttt85 -117.56 40.17 3.14 Favored 'General case' 0 N--CA 1.461 0.111 0 N-CA-C 111.96 0.355 . . . . 0.0 111.96 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.624 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER 56.81 44.11 1.3 Allowed Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 179.042 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.478 ' CD ' ' N ' ' A' ' 57' ' ' MET . 30.1 Cg_endo -63.29 -80.81 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 121.959 1.773 . . . . 0.0 111.02 178.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -102.42 -86.6 1.95 Allowed Glycine 0 C--N 1.334 0.43 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 178.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.802 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 0.0 OUTLIER -87.82 60.97 6.18 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 177.228 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.624 ' HA ' ' HA ' ' A' ' 57' ' ' MET . 0.1 OUTLIER 65.57 -28.2 0.11 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.65 -1.159 . . . . 0.0 112.447 -179.494 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.533 ' H ' ' C ' ' A' ' 60' ' ' MET . . . 152.15 -35.19 0.84 Allowed Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 110.946 -0.861 . . . . 0.0 110.946 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.586 ' H ' HD12 ' A' ' 63' ' ' LEU . 1.0 OUTLIER -64.07 -21.43 66.52 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 178.878 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.802 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -53.56 -38.43 63.86 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 120.969 0.414 . . . . 0.0 110.389 179.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.811 ' CD1' HD21 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -55.03 -44.99 75.14 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.781 179.836 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.851 ' HA ' HD12 ' A' ' 69' ' ' ILE . 5.8 mt -54.5 -42.5 70.85 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.503 179.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.637 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 21.6 tttt -57.77 -43.47 85.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.704 179.451 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 8.2 mm100 -69.51 -27.78 65.47 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.851 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.851 HD12 ' HA ' ' A' ' 66' ' ' LEU . 96.7 mt -64.58 -36.85 78.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.96 -179.083 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.637 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -78.15 -31.62 49.84 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.512 -179.52 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -63.72 -44.53 93.32 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.076 -178.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.2 mtt85 -96.42 -50.93 4.56 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.857 -179.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.651 ' NE2' HD13 ' A' ' 43' ' ' LEU . 0.3 OUTLIER -95.77 156.38 37.4 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.834 -179.326 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -66.28 -73.29 0.02 OUTLIER 'Trans proline' 0 CA--C 1.528 0.209 0 C-N-CA 122.538 2.159 . . . . 0.0 112.682 -179.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 7.3 mtt -145.16 55.52 1.22 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.7 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.455 HD13 HG23 ' A' ' 47' ' ' THR . 22.5 tp -61.9 111.21 4.11 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.111 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -60.35 134.25 54.2 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.379 2.053 . . . . 0.0 112.387 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.791 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 5.1 t -131.43 152.93 38.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.25 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.709 HD12 ' O ' ' A' ' 51' ' ' LEU . 1.1 mt -126.8 113.2 31.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.721 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.528 ' HA ' ' O ' ' A' ' 53' ' ' SER . 9.5 mm -101.86 134.9 41.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -178.051 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.557 ' HB2' ' CD1' ' A' ' 106' ' ' PHE . 2.4 ptt? -69.16 -34.01 74.3 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.271 -0.877 . . . . 0.0 112.216 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 7.3 m -139.16 150.72 45.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.752 0.311 . . . . 0.0 111.348 -179.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.916 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -121.06 70.58 0.92 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.731 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.514 ' CE1' HD11 ' A' ' 55' ' ' ILE . 2.6 p80 -98.94 -179.27 4.22 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.193 179.174 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.4 ' HB2' ' CB ' ' A' ' 61' ' ' ASP . 0.1 OUTLIER 63.99 -161.42 0.29 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.769 -179.892 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.41 88.74 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.924 0.392 . . . . 0.0 111.377 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.859 HD21 ' HB1' ' A' ' 83' ' ' ALA . 0.3 OUTLIER -51.85 -24.0 5.56 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.465 179.804 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -48.84 -36.36 16.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.008 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.429 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -72.84 -19.84 61.24 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.219 -179.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.747 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -68.93 -52.37 29.97 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.984 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.62 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 9.4 t -66.33 -44.94 90.72 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.19 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.845 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.685 ' O ' ' HG3' ' A' ' 95' ' ' GLN . 3.3 m -61.08 -14.54 24.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.889 0.376 . . . . 0.0 110.035 178.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.699 ' HB2' HD13 ' A' ' 66' ' ' LEU . . . -75.15 -61.74 1.79 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.113 0.482 . . . . 0.0 111.066 179.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.66 ' N ' ' HB3' ' A' ' 98' ' ' ALA . 4.7 m-85 -44.84 -36.14 3.12 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.384 -178.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.685 ' HG3' ' O ' ' A' ' 92' ' ' SER . 1.7 pp0? -76.25 -37.01 58.21 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.959 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.526 ' HB2' ' HB3' ' A' ' 70' ' ' LYS . 10.3 pt20 -100.12 11.19 39.93 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -179.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 93' ' ' ALA . . . 122.21 79.0 0.48 Allowed Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.187 -1.006 . . . . 0.0 113.449 179.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.791 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -169.14 142.49 2.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.731 0.301 . . . . 0.0 110.637 178.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.502 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 3.3 t80 -84.49 -53.15 5.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.585 -178.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.591 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 0.4 OUTLIER 178.83 -165.58 0.05 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.139 0.495 . . . . 0.0 111.61 179.984 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.916 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 3.5 m-85 -136.38 153.73 51.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.458 -179.209 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.531 ' HG ' ' HB3' ' A' ' 106' ' ' PHE . 0.4 OUTLIER -101.9 118.85 58.5 Favored Pre-proline 0 C--N 1.327 -0.372 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 179.059 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.417 ' C ' ' HG3' ' A' ' 104' ' ' LYS . 61.5 Cg_exo -51.28 -42.49 53.97 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.58 2.187 . . . . 0.0 112.466 -179.211 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.642 ' HB2' ' HD3' ' A' ' 105' ' ' PRO . 40.3 mttp -156.07 -54.11 0.02 OUTLIER Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.173 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.642 ' HD3' ' HB2' ' A' ' 104' ' ' LYS . 98.1 Cg_endo -80.97 163.78 20.31 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.262 1.975 . . . . 0.0 112.229 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.677 ' HA ' ' HB2' ' A' ' 110' ' ' GLU . 0.5 OUTLIER -169.89 -75.88 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.487 178.928 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.554 ' O ' ' HB3' ' A' ' 111' ' ' ALA . 3.1 p30 37.32 -166.49 0.0 OUTLIER 'General case' 0 C--O 1.225 -0.189 0 CA-C-N 116.682 -0.235 . . . . 0.0 110.41 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.842 HD11 ' HG ' ' A' ' 19' ' ' LEU . 1.1 mp -67.85 -44.8 85.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 C-N-CA 120.11 -0.636 . . . . 0.0 111.366 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.521 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 2.6 m-20 -53.58 -58.06 8.52 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.666 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.677 ' HB2' ' HA ' ' A' ' 106' ' ' PHE . 3.1 mm-40 -79.2 -28.04 42.58 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -178.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.583 ' HB1' HD11 ' A' ' 52' ' ' LEU . . . -78.31 -55.09 5.52 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.349 -0.541 . . . . 0.0 110.084 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.783 ' O ' HG12 ' A' ' 115' ' ' VAL . 60.4 t -58.57 -29.51 39.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-O 121.549 0.69 . . . . 0.0 109.881 178.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.521 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -64.82 -47.97 76.09 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.718 178.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.605 HD23 ' CG2' ' A' ' 79' ' ' ILE . 10.6 tp -73.83 -20.66 60.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.455 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.783 HG12 ' O ' ' A' ' 112' ' ' VAL . 2.6 p -78.52 -43.42 26.27 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-O 120.735 0.302 . . . . 0.0 111.526 -179.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.48 ' HA ' HD12 ' A' ' 119' ' ' ILE . 35.7 mt-10 -66.2 -41.92 89.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.209 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.505 HH11 HD12 ' A' ' 114' ' ' LEU . 28.4 mtp-105 -61.18 -25.64 67.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.646 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.523 ' HB3' HG21 ' A' ' 50' ' ' VAL . . . -73.01 -40.44 65.18 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.305 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.48 HD12 ' HA ' ' A' ' 116' ' ' GLU . 3.8 mt -75.42 -30.51 22.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 121.125 0.488 . . . . 0.0 110.658 179.117 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 91.5 p -67.35 -43.32 81.78 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.567 -179.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 17.8 m80 -66.76 -23.76 66.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.006 0.431 . . . . 0.0 110.943 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -77.88 -50.59 11.95 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.734 179.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.551 ' HG3' ' HG2' ' A' ' 124' ' ' GLU . 19.7 pt20 -75.9 -173.59 2.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.89 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.551 ' HG2' ' HG3' ' A' ' 123' ' ' GLN . 6.9 mm-40 . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.859 -179.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 120.92 0.39 . . . . 0.0 111.22 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -120.98 161.39 21.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.546 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.23 -4.97 19.88 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.475 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 90.27 81.57 1.37 Allowed Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.942 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.6 mp -103.3 112.32 36.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.96 0.41 . . . . 0.0 111.26 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.852 HG21 HD21 ' A' ' 23' ' ' LEU . 4.3 p -106.92 126.64 62.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.1 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.919 ' CD1' HG22 ' A' ' 31' ' ' THR . 40.6 m0 -112.82 136.46 52.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.896 0.379 . . . . 0.0 110.444 179.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.681 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.1 OUTLIER -125.95 138.81 53.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.336 -178.658 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.952 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -115.6 105.59 18.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.988 0.423 . . . . 0.0 110.217 178.58 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.681 ' HB3' HG21 ' A' ' 15' ' ' ILE . 10.2 t0 -173.09 117.12 0.29 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.226 -179.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.599 ' O ' ' HB2' ' A' ' 12' ' ' ASP . 0.1 OUTLIER 47.67 -86.4 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.787 179.826 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.599 ' HB2' ' O ' ' A' ' 11' ' ' ASP . 15.4 t0 170.91 -133.31 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.676 -0.238 . . . . 0.0 110.824 -179.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.437 ' HA ' ' HB3' ' A' ' 16' ' ' ARG . 75.0 m -40.89 -42.03 1.74 Allowed 'General case' 0 C--N 1.341 0.234 0 CA-C-O 121.072 0.463 . . . . 0.0 112.117 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.602 ' O ' HG23 ' A' ' 18' ' ' VAL . 27.6 m -53.18 -63.51 1.12 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.675 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.681 HG21 ' HB3' ' A' ' 10' ' ' ASP . 15.1 mm -70.46 -20.61 22.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.871 0.367 . . . . 0.0 110.667 179.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.709 ' HA ' HG21 ' A' ' 32' ' ' THR . 3.4 ttt180 -69.77 -55.56 9.53 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.846 179.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.505 ' O ' ' HG3' ' A' ' 20' ' ' GLU . 89.6 t90 -53.58 -45.09 69.84 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.708 -179.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.852 HG12 HG12 ' A' ' 108' ' ' ILE . 3.1 t -65.58 -45.13 93.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -178.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.52 ' O ' HD13 ' A' ' 19' ' ' LEU . 0.2 OUTLIER -83.66 -26.93 29.45 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -177.786 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.505 ' HG3' ' O ' ' A' ' 17' ' ' TRP . 1.0 OUTLIER -66.61 -60.92 2.28 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -179.063 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.577 ' O ' ' HB3' ' A' ' 24' ' ' ALA . 31.1 mmm-85 -52.77 -63.21 1.22 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.734 0.302 . . . . 0.0 111.802 -179.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -49.75 -54.69 17.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.046 0.45 . . . . 0.0 111.554 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.852 HD21 HG21 ' A' ' 6' ' ' VAL . 9.3 tp -66.36 -19.43 65.8 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.183 179.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.577 ' HB3' ' O ' ' A' ' 21' ' ' ARG . . . -70.32 -35.85 73.91 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.13 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -57.59 -27.83 59.09 Favored Glycine 0 C--N 1.335 0.527 0 C-N-CA 120.51 -0.852 . . . . 0.0 111.035 178.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.746 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -77.98 -15.8 58.66 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 120.716 0.293 . . . . 0.0 110.495 178.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.94 26.61 14.17 Favored Glycine 0 C--N 1.337 0.609 0 C-N-CA 120.637 -0.792 . . . . 0.0 114.501 178.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.799 HD13 ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -116.06 164.94 13.71 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 118.32 1.06 . . . . 0.0 112.23 -179.779 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 27.0 m -94.4 118.56 31.81 Favored 'General case' 0 CA--C 1.521 -0.149 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.484 179.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.552 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 3.0 m -108.46 118.61 37.23 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -178.323 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.919 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.7 t -122.79 139.76 53.65 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.047 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.709 HG21 ' HA ' ' A' ' 16' ' ' ARG . 69.0 p -115.01 161.63 18.08 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -177.496 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.952 ' HB2' HG13 ' A' ' 9' ' ' VAL . 12.1 m-85 -136.27 174.88 10.13 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 114.868 -1.06 . . . . 0.0 111.834 -178.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.422 ' HG2' ' H ' ' A' ' 35' ' ' ASN . 3.6 pt-20 -62.0 -46.94 87.02 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -177.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.422 ' H ' ' HG2' ' A' ' 34' ' ' GLU . 0.5 OUTLIER -168.41 -27.97 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 118.58 0.627 . . . . 0.0 112.687 -179.573 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.7 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . 171.91 -59.66 0.16 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.402 -0.904 . . . . 0.0 112.754 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.587 ' HA ' HD12 ' A' ' 40' ' ' LEU . 6.5 m120 -48.1 -34.52 9.86 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 120.845 0.355 . . . . 0.0 110.979 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.913 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 5.2 tt0 -60.25 -55.65 31.12 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.382 179.082 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.919 HG11 HD11 ' A' ' 51' ' ' LEU . 6.2 t -53.93 -44.22 60.56 Favored 'Isoleucine or valine' 0 C--N 1.345 0.401 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.459 179.126 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.826 HD13 ' CB ' ' A' ' 68' ' ' GLN . 21.0 mt -57.51 -42.68 83.27 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.877 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.53 -50.13 40.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.075 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.55 -27.58 69.35 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.639 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.747 HD13 ' NE2' ' A' ' 73' ' ' HIS . 6.1 mt -67.71 -23.53 65.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.556 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.39 -16.71 15.83 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.182 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -117.43 -3.39 11.4 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.824 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.501 ' O ' HD23 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -167.33 163.06 15.16 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.984 0.421 . . . . 0.0 111.73 -179.917 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.979 HG23 HD12 ' A' ' 76' ' ' LEU . 66.3 m -139.11 112.47 8.08 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.522 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.713 ' HD2' HD21 ' A' ' 43' ' ' LEU . 66.6 Cg_endo -72.52 165.49 32.56 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.179 1.92 . . . . 0.0 111.548 178.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -74.09 -24.34 59.47 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 121.132 -0.227 . . . . 0.0 111.26 -179.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.832 HG13 HG23 ' A' ' 6' ' ' VAL . 7.2 p -145.15 166.45 11.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.919 HD11 HG11 ' A' ' 39' ' ' VAL . 19.6 tp -152.91 132.55 13.07 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 121.06 0.457 . . . . 0.0 111.368 -179.036 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.741 ' O ' HG23 ' A' ' 9' ' ' VAL . 0.9 OUTLIER -116.52 139.33 50.6 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.795 -179.878 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.555 ' HB2' HD13 ' A' ' 80' ' ' ILE . 8.1 m -127.1 128.44 46.23 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.978 0.418 . . . . 0.0 111.384 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.402 ' C ' HG22 ' A' ' 55' ' ' ILE . 44.6 t0 -69.48 -16.65 63.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.587 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.706 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 2.5 tt 43.79 72.58 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.109 -0.496 . . . . 0.0 112.262 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 177.46 61.82 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.695 179.245 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.61 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -162.0 -64.25 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.698 179.964 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.61 ' HD3' ' HB3' ' A' ' 57' ' ' MET . 36.4 Cg_endo -63.02 -165.6 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.694 2.263 . . . . 0.0 113.228 -179.496 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.79 -67.32 2.13 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.656 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.734 ' HB2' ' HB2' ' A' ' 64' ' ' ALA . 0.2 OUTLIER -79.95 51.23 1.31 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.941 0.4 . . . . 0.0 110.762 179.809 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.462 ' O ' ' HD2' ' A' ' 58' ' ' PRO . 0.1 OUTLIER 54.42 -74.56 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.407 179.643 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.706 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -144.14 -34.84 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.456 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.687 ' CB ' ' HB3' ' A' ' 89' ' ' ALA . 0.5 OUTLIER -54.05 -23.55 14.07 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.654 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.734 ' HB2' ' HB2' ' A' ' 60' ' ' MET . . . -54.22 -36.48 63.54 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.795 178.183 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.538 ' CD1' ' HG3' ' A' ' 58' ' ' PRO . 9.9 mp -59.47 -55.54 33.34 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.306 179.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.9 ' HA ' HD12 ' A' ' 69' ' ' ILE . 17.0 mt -44.24 -42.53 6.63 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.666 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.501 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 11.3 mttp -57.93 -47.19 83.59 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.037 179.159 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.826 ' CB ' HD13 ' A' ' 40' ' ' LEU . 10.6 mm100 -68.02 -30.33 69.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.375 179.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.9 HD12 ' HA ' ' A' ' 66' ' ' LEU . 77.9 mt -65.21 -45.11 94.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.222 -179.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.501 ' HG2' ' O ' ' A' ' 67' ' ' LYS . 8.9 ptmt -64.81 -29.31 70.27 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.961 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -72.72 -36.51 67.8 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.093 0.473 . . . . 0.0 110.928 179.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.44 -70.96 0.7 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.556 -179.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.747 ' NE2' HD13 ' A' ' 43' ' ' LEU . 2.2 p80 -117.83 78.0 12.11 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.59 -179.197 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.494 ' HA ' ' OE1' ' A' ' 96' ' ' GLN . 72.4 Cg_endo -76.46 56.27 5.02 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.536 2.157 . . . . 0.0 112.563 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 38.2 mtt -154.8 -43.02 0.09 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.093 0.473 . . . . 0.0 111.457 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.979 HD12 HG23 ' A' ' 47' ' ' THR . 1.0 OUTLIER -53.08 125.11 40.2 Favored Pre-proline 0 C--N 1.32 -0.679 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.614 -179.941 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.632 ' HD2' HD23 ' A' ' 76' ' ' LEU . 24.8 Cg_exo -61.82 129.65 28.37 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.428 2.085 . . . . 0.0 112.871 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.576 HG11 ' CD2' ' A' ' 66' ' ' LEU . 5.2 t -110.2 138.87 36.1 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.78 179.157 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.74 ' CG2' HD23 ' A' ' 114' ' ' LEU . 1.7 mt -123.8 113.2 36.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.545 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.585 HG22 HG21 ' A' ' 55' ' ' ILE . 15.1 mm -101.08 145.87 10.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.299 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.597 ' HG3' ' CG2' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -80.5 -30.11 37.33 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.242 -0.435 . . . . 0.0 112.029 -179.038 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.538 ' O ' HD13 ' A' ' 55' ' ' ILE . 4.8 m -147.44 146.48 29.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.836 0.35 . . . . 0.0 111.354 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.828 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -112.67 47.94 1.05 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.351 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.407 ' O ' ' HB2' ' A' ' 85' ' ' SER . 0.7 OUTLIER -98.49 -175.19 3.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.721 0.296 . . . . 0.0 110.743 179.816 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.407 ' HB2' ' O ' ' A' ' 84' ' ' HIS . 45.9 m 71.6 -78.39 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.793 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.567 ' O ' HD22 ' A' ' 63' ' ' LEU . 7.6 m-20 -138.99 68.1 1.38 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.64 0.257 . . . . 0.0 111.633 -179.327 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.723 ' HG ' ' HB1' ' A' ' 83' ' ' ALA . 0.4 OUTLIER -45.69 -23.82 0.29 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.898 179.467 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -48.54 -46.13 38.42 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -179.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.687 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -65.07 -20.04 66.29 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.809 0.338 . . . . 0.0 111.622 -179.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.571 ' HB2' HD23 ' A' ' 63' ' ' LEU . . . -68.84 -36.11 77.77 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.055 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.651 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 8.2 t -63.07 -41.2 91.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.063 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 44.5 m -63.31 -35.26 79.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.224 0.535 . . . . 0.0 110.306 179.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.805 ' HB2' HD13 ' A' ' 66' ' ' LEU . . . -57.78 -39.57 77.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.998 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.651 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 10.7 m-85 -63.24 -20.95 65.9 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.379 179.249 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.621 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -74.23 -41.37 61.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.723 -179.808 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.621 ' N ' ' HG2' ' A' ' 95' ' ' GLN . 1.0 OUTLIER -78.59 -18.47 54.53 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.494 -179.332 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 122.01 29.47 1.36 Allowed Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.789 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.605 ' HB2' ' HB1' ' A' ' 93' ' ' ALA . . . -64.1 143.32 57.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.762 0.281 . . . . 0.0 110.809 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.55 ' CE2' ' HB2' ' A' ' 118' ' ' ALA . 18.9 t80 -71.49 -53.96 12.19 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.249 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 168.21 -164.96 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.16 0.505 . . . . 0.0 111.124 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.828 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 3.3 m-85 -130.67 150.96 51.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.259 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.961 HD13 HD22 ' A' ' 114' ' ' LEU . 5.6 tp -102.87 135.56 19.42 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.986 -179.427 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.411 ' HG2' ' HG2' ' A' ' 105' ' ' PRO . 93.7 Cg_endo -78.96 -152.87 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.426 2.084 . . . . 0.0 111.904 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.515 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 5.7 mtpt -43.05 -56.55 6.2 Favored Pre-proline 0 CA--C 1.533 0.322 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.515 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 13.2 Cg_endo -56.71 163.39 7.21 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.565 2.177 . . . . 0.0 112.282 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.6 ' HD1' HD23 ' A' ' 102' ' ' LEU . 45.5 t80 -171.92 -105.03 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.892 179.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.521 ' O ' ' O ' ' A' ' 106' ' ' PHE . 4.6 p-10 43.75 -179.08 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.98 0.419 . . . . 0.0 111.039 -179.421 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.852 HG12 HG12 ' A' ' 18' ' ' VAL . 0.9 OUTLIER -67.84 -41.13 84.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 120.969 0.414 . . . . 0.0 111.533 -179.852 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.524 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 12.7 t70 -50.6 -58.56 5.54 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.623 -179.496 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.591 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 36.3 mm-40 -77.1 -30.89 55.51 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.663 0.268 . . . . 0.0 111.64 -179.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.403 ' CB ' ' O ' ' A' ' 107' ' ' ASP . . . -68.46 -61.13 1.97 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.018 0.437 . . . . 0.0 110.283 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.613 ' O ' HG12 ' A' ' 115' ' ' VAL . 58.1 t -57.63 -30.51 37.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.587 0.708 . . . . 0.0 110.25 178.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.524 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -63.86 -46.33 85.48 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.191 179.207 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.961 HD22 HD13 ' A' ' 102' ' ' LEU . 35.6 tp -74.66 -22.87 58.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.085 -179.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.613 HG12 ' O ' ' A' ' 112' ' ' VAL . 4.8 p -79.39 -46.44 23.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 120.442 -0.503 . . . . 0.0 111.639 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.412 ' N ' HG13 ' A' ' 115' ' ' VAL . 8.6 mt-10 -63.82 -45.29 90.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.963 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.577 ' HG2' ' HA ' ' A' ' 114' ' ' LEU . 0.0 OUTLIER -59.09 -27.06 65.19 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.956 0.408 . . . . 0.0 110.796 179.741 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.55 ' HB2' ' CE2' ' A' ' 99' ' ' PHE . . . -67.93 -47.64 68.17 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.629 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.671 HD13 ' CD2' ' A' ' 28' ' ' LEU . 4.5 mt -74.15 -31.17 28.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.819 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.0 t -69.64 -42.05 74.77 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.974 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -65.78 -22.81 66.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.976 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.439 ' OH ' ' HG3' ' A' ' 77' ' ' PRO . 5.4 m-85 -73.74 -48.24 33.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.89 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.404 ' H ' ' HG3' ' A' ' 123' ' ' GLN . 0.0 OUTLIER -75.39 -53.74 8.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.119 0.485 . . . . 0.0 110.527 179.911 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 . . . . . 0 C--N 1.319 -0.745 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.872 179.695 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.861 0.362 . . . . 0.0 111.174 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -58.71 174.52 0.33 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.047 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.05 -43.91 90.77 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.225 0.536 . . . . 0.0 110.764 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.524 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . 61.74 87.99 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.507 -0.769 . . . . 0.0 112.49 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.7 mp -111.0 112.34 40.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.848 0.356 . . . . 0.0 111.514 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.859 HG11 HD22 ' A' ' 23' ' ' LEU . 2.8 p -107.83 126.21 64.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.309 178.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.879 ' CD1' HG22 ' A' ' 31' ' ' THR . 27.2 m0 -114.11 140.21 48.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.846 0.355 . . . . 0.0 110.181 179.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.673 HG13 ' HB3' ' A' ' 52' ' ' LEU . 1.1 t -123.73 147.71 28.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.36 -178.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.773 HG13 HG23 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -130.93 112.03 21.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.094 0.473 . . . . 0.0 110.446 179.146 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -161.64 -158.64 0.57 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.711 -178.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -66.87 -1.85 4.47 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.349 0.499 . . . . 0.0 112.349 -179.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.424 ' O ' ' N ' ' A' ' 14' ' ' SER . 0.2 OUTLIER 69.43 -157.97 0.16 Allowed 'General case' 0 CA--C 1.532 0.254 0 O-C-N 122.443 -0.16 . . . . 0.0 110.875 179.912 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.6 t 34.06 -88.96 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 179.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.882 ' O ' HG23 ' A' ' 18' ' ' VAL . 3.6 m -53.02 -63.38 1.16 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.809 0.338 . . . . 0.0 111.216 -179.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.8 mm -61.46 -25.67 37.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.984 0.421 . . . . 0.0 110.89 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.971 ' HA ' HG21 ' A' ' 32' ' ' THR . 30.8 ttt180 -71.42 -55.64 7.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.591 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.445 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 30.1 t90 -58.63 -41.1 85.17 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -179.193 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.895 HG12 HG12 ' A' ' 108' ' ' ILE . 2.5 t -65.26 -49.12 80.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -178.297 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.621 HD23 HG11 ' A' ' 8' ' ' VAL . 9.7 tp -82.64 -24.79 33.63 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -178.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.555 ' HG3' ' N ' ' A' ' 21' ' ' ARG . 10.7 pt-20 -65.75 -57.6 7.63 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.721 -179.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.555 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 1.2 mmt-85 -67.12 -48.99 66.44 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.063 -179.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.11 -40.57 81.54 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -178.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.904 ' CD2' HD13 ' A' ' 28' ' ' LEU . 0.2 OUTLIER -77.37 -25.13 50.68 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.225 0.536 . . . . 0.0 110.053 179.217 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.03 -34.24 77.63 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.97 -23.61 71.21 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 177.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.624 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -76.71 -15.4 59.79 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 120.87 0.366 . . . . 0.0 110.471 179.032 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.87 26.27 11.86 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 120.945 -0.645 . . . . 0.0 113.815 178.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.904 HD13 ' CD2' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -132.78 169.09 17.22 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 117.534 0.667 . . . . 0.0 112.384 -179.371 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 32.9 m -89.84 109.1 20.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.75 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.585 ' HA ' HG13 ' A' ' 6' ' ' VAL . 47.3 t -107.48 110.55 22.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.076 0.465 . . . . 0.0 111.585 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.879 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.7 t -118.96 153.45 34.61 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.971 HG21 ' HA ' ' A' ' 16' ' ' ARG . 34.5 p -125.35 162.79 24.0 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.301 0.572 . . . . 0.0 111.945 -179.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.732 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 1.1 m-85 -129.3 174.22 9.8 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.431 -178.264 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.46 ' HG2' ' N ' ' A' ' 35' ' ' ASN . 0.6 OUTLIER -61.6 -37.14 82.81 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 -177.299 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.46 ' N ' ' HG2' ' A' ' 34' ' ' GLU . 5.1 m120 -169.85 -56.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 118.443 0.565 . . . . 0.0 112.133 -179.474 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.947 ' CA ' HD21 ' A' ' 65' ' ' LEU . . . -164.7 -58.53 0.02 OUTLIER Glycine 0 C--N 1.318 -0.432 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.951 -179.175 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.429 ' HA ' ' CD1' ' A' ' 40' ' ' LEU . 0.4 OUTLIER -48.79 -34.98 13.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.687 0.28 . . . . 0.0 111.742 -179.456 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.732 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -55.33 -54.05 48.4 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.509 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.834 HG12 ' CD1' ' A' ' 43' ' ' LEU . 39.0 t -58.65 -42.53 85.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.569 179.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.785 HD13 ' CB ' ' A' ' 68' ' ' GLN . 4.0 mt -51.24 -45.47 62.01 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.794 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.64 -47.31 40.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.301 0.572 . . . . 0.0 110.867 179.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.81 -31.04 70.45 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.132 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.834 ' CD1' HG12 ' A' ' 39' ' ' VAL . 11.7 mt -68.68 -20.67 64.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.763 -179.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.77 -18.4 12.55 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.511 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.7 t -122.69 -0.46 9.13 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.688 ' O ' HD23 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -164.22 157.15 17.56 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.064 0.459 . . . . 0.0 111.603 179.918 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.773 ' CG2' HD13 ' A' ' 76' ' ' LEU . 96.2 m -139.03 115.99 8.72 Favored Pre-proline 0 N--CA 1.45 -0.433 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.143 179.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.659 ' HG3' ' HB2' ' A' ' 7' ' ' TRP . 58.5 Cg_endo -72.24 165.08 33.68 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.267 1.978 . . . . 0.0 111.167 178.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -75.28 -27.09 59.23 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.966 -0.294 . . . . 0.0 111.267 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.703 HG11 HG22 ' A' ' 115' ' ' VAL . 7.2 p -148.79 104.9 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.553 -179.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.619 HD11 HG11 ' A' ' 39' ' ' VAL . 21.2 tp -86.52 132.04 34.02 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -179.125 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.75 ' O ' HG23 ' A' ' 9' ' ' VAL . 0.3 OUTLIER -114.82 123.19 48.56 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.289 179.044 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.699 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 0.5 OUTLIER -125.76 139.65 53.34 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 121.447 0.641 . . . . 0.0 112.254 -179.238 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.22 -170.05 2.84 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.231 178.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.617 ' HA ' ' HA3' ' A' ' 62' ' ' GLY . 3.6 tt -155.02 91.13 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.932 0.396 . . . . 0.0 111.048 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.421 ' HB3' ' O ' ' A' ' 55' ' ' ILE . 9.7 ptm180 172.73 47.02 0.0 OUTLIER 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.133 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.597 ' HB3' ' CD ' ' A' ' 58' ' ' PRO . 2.8 tpt -158.41 -64.29 0.02 OUTLIER Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.597 ' CD ' ' HB3' ' A' ' 57' ' ' MET . 11.9 Cg_endo -54.66 176.05 0.13 Allowed 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.368 2.045 . . . . 0.0 112.643 -179.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -52.37 -59.62 8.78 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.21 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.591 ' O ' ' N ' ' A' ' 62' ' ' GLY . 0.0 OUTLIER -82.55 52.26 2.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.552 0.215 . . . . 0.0 110.51 179.369 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 56.3 -71.81 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.143 0.497 . . . . 0.0 111.17 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.617 ' HA3' ' HA ' ' A' ' 55' ' ' ILE . . . -148.01 -36.16 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.641 -0.708 . . . . 0.0 111.753 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.91 ' HA ' HD23 ' A' ' 66' ' ' LEU . 3.0 mp -53.17 -24.16 10.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.779 0.324 . . . . 0.0 110.408 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.542 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -56.92 -33.89 67.42 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.003 178.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.947 HD21 ' CA ' ' A' ' 36' ' ' GLY . 0.2 OUTLIER -59.79 -35.86 75.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.429 179.39 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.986 ' HA ' HD12 ' A' ' 69' ' ' ILE . 3.3 mm? -63.67 -43.52 96.44 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.056 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.412 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 5.2 mmpt? -52.9 -50.62 63.55 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.325 179.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.785 ' CB ' HD13 ' A' ' 40' ' ' LEU . 12.2 mm100 -62.7 -38.46 90.49 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.517 179.16 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.986 HD12 ' HA ' ' A' ' 66' ' ' LEU . 18.5 mt -54.74 -46.09 73.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.645 -179.062 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.428 ' HB3' ' CD ' ' A' ' 96' ' ' GLN . 0.3 OUTLIER -69.61 -25.94 64.2 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.793 -179.27 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -85.62 -39.73 17.01 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -179.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.478 HH21 ' HB2' ' A' ' 40' ' ' LEU . 2.1 mtm180 -102.32 -40.9 6.54 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -178.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.696 ' CE1' HG12 ' A' ' 69' ' ' ILE . 0.5 OUTLIER -85.64 136.87 36.56 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.214 -178.962 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.602 ' O ' ' HG2' ' A' ' 75' ' ' MET . 17.2 Cg_exo -67.08 70.41 0.55 Allowed 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.509 2.139 . . . . 0.0 112.219 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.627 ' HB2' ' O ' ' A' ' 96' ' ' GLN . 0.2 OUTLIER 50.5 33.9 8.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.062 0.458 . . . . 0.0 111.114 179.843 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.773 HD13 ' CG2' ' A' ' 47' ' ' THR . 20.7 tp -67.23 131.79 93.47 Favored Pre-proline 0 C--O 1.233 0.216 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.299 -179.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.737 ' HD2' HD12 ' A' ' 76' ' ' LEU . 27.9 Cg_endo -63.66 127.32 19.45 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.383 2.055 . . . . 0.0 112.052 179.562 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.958 HG21 HD13 ' A' ' 69' ' ' ILE . 5.7 t -118.28 147.79 21.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.428 -179.423 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.674 HG21 HD23 ' A' ' 114' ' ' LEU . 2.0 mp -122.78 113.22 37.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.161 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.699 ' HA ' ' O ' ' A' ' 53' ' ' SER . 22.3 mm -99.31 144.22 12.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.568 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.561 ' O ' ' HB2' ' A' ' 102' ' ' LEU . 7.7 ttt -67.73 -67.22 0.48 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.47 -179.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.603 ' H ' ' CG2' ' A' ' 55' ' ' ILE . 3.7 m -106.45 169.65 8.39 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.524 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 1.036 ' HB1' HD23 ' A' ' 87' ' ' LEU . . . -124.22 -2.84 8.05 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -179.135 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.464 ' O ' ' O ' ' A' ' 83' ' ' ALA . 33.1 m170 31.23 -160.63 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 179.064 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 24.9 m -81.09 -22.58 39.05 Favored 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -178.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.489 ' HB2' HD13 ' A' ' 63' ' ' LEU . 67.4 m-20 -79.81 21.6 0.53 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 120.549 0.214 . . . . 0.0 111.324 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 1.036 HD23 ' HB1' ' A' ' 83' ' ' ALA . 3.1 tm? -43.68 -24.37 0.12 Allowed 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -49.03 -38.2 22.93 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.647 ' HB3' ' HB3' ' A' ' 63' ' ' LEU . . . -71.4 -22.94 61.8 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -179.034 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.676 ' HB2' HD23 ' A' ' 63' ' ' LEU . . . -73.45 -29.82 62.8 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.878 0.37 . . . . 0.0 110.476 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.623 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 3.0 t -61.74 -45.6 98.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.177 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.515 ' O ' ' HB3' ' A' ' 95' ' ' GLN . 83.7 p -67.46 -22.25 65.49 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 178.299 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' A' ' 90' ' ' ALA . . . -64.49 -39.73 94.34 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.306 0.574 . . . . 0.0 109.793 178.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.623 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 9.6 m-85 -69.19 -23.93 63.98 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.719 178.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.515 ' HB3' ' O ' ' A' ' 92' ' ' SER . 0.3 OUTLIER -67.59 -46.45 72.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.388 -179.949 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.627 ' O ' ' HB2' ' A' ' 75' ' ' MET . 4.5 pm0 -76.17 -18.14 59.24 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.751 179.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 117.7 33.9 1.24 Allowed Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.387 -0.911 . . . . 0.0 113.601 178.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.436 ' HB2' ' HB1' ' A' ' 93' ' ' ALA . . . -62.6 155.92 24.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.957 0.379 . . . . 0.0 110.553 179.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.597 ' CZ ' ' HB2' ' A' ' 118' ' ' ALA . 15.4 t80 -76.45 -53.69 7.77 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.032 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 168.46 -166.99 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.241 0.543 . . . . 0.0 111.799 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.525 ' CE2' ' HB ' ' A' ' 80' ' ' ILE . 3.2 m-85 -136.07 153.23 51.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.888 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.631 HD11 HD22 ' A' ' 114' ' ' LEU . 5.8 mp -102.22 120.26 54.05 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 120.595 0.236 . . . . 0.0 110.565 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -61.71 -67.33 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.116 1.877 . . . . 0.0 112.334 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.697 ' HB3' ' HD3' ' A' ' 105' ' ' PRO . 3.1 tttm -126.57 -53.04 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.074 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.697 ' HD3' ' HB3' ' A' ' 104' ' ' LYS . 31.8 Cg_exo -58.85 164.02 10.43 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.293 1.995 . . . . 0.0 112.311 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.681 ' O ' ' O ' ' A' ' 107' ' ' ASP . 74.2 t80 -169.38 -97.45 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.943 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.681 ' O ' ' O ' ' A' ' 106' ' ' PHE . 0.3 OUTLIER 37.53 177.3 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.26 0.553 . . . . 0.0 112.356 179.344 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.895 HG12 HG12 ' A' ' 18' ' ' VAL . 0.5 OUTLIER -68.18 -48.22 74.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.899 0.38 . . . . 0.0 111.998 -179.75 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -49.52 -58.7 4.71 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.913 -179.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.616 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 6.2 mm-40 -70.15 -30.75 67.99 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.811 0.339 . . . . 0.0 111.079 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -68.12 -62.17 1.52 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.063 179.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.635 ' O ' HG12 ' A' ' 115' ' ' VAL . 38.7 t -56.01 -34.24 37.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.36 0.6 . . . . 0.0 110.682 178.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.12 -45.9 91.43 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.389 179.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.674 HD23 HG21 ' A' ' 79' ' ' ILE . 5.2 tp -78.5 -21.52 48.82 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.56 -179.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.703 HG22 HG11 ' A' ' 50' ' ' VAL . 1.3 p -77.98 -36.34 21.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.613 -179.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -68.39 -41.08 81.03 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.098 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 5.6 mmt85 -60.47 -24.85 65.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.273 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.597 ' HB2' ' CZ ' ' A' ' 99' ' ' PHE . . . -71.3 -43.33 67.3 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.937 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.621 HD13 ' CD2' ' A' ' 28' ' ' LEU . 4.9 mt -73.57 -31.98 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.175 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 33.5 t -64.57 -42.32 95.72 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.947 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 14.5 m80 -63.49 -27.56 69.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.92 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -81.95 -54.65 5.15 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.989 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 59.65 -177.78 0.09 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.92 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.935 179.912 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 ptt? . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.744 0.307 . . . . 0.0 111.254 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.437 ' OE1' ' HG2' ' A' ' 3' ' ' ARG . 0.0 OUTLIER -82.79 158.2 22.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.52 179.686 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.732 ' HG3' HD11 ' A' ' 5' ' ' ILE . 0.3 OUTLIER -64.17 -54.56 31.71 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.955 0.407 . . . . 0.0 111.231 -179.682 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.473 ' C ' HD13 ' A' ' 5' ' ' ILE . . . 96.22 102.27 1.99 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.012 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.732 HD11 ' HG3' ' A' ' 3' ' ' ARG . 7.4 mm -114.13 114.14 45.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.956 0.408 . . . . 0.0 111.737 -179.382 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 1.025 HG11 HD13 ' A' ' 23' ' ' LEU . 3.5 p -114.07 119.81 62.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.128 178.751 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.952 ' CD1' HG22 ' A' ' 31' ' ' THR . 39.0 m0 -112.46 143.74 43.09 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.009 0.433 . . . . 0.0 110.698 -179.806 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.655 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -129.3 136.91 58.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.539 -178.807 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.897 HG11 ' HA2' ' A' ' 36' ' ' GLY . 3.0 m -115.64 110.09 30.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.625 178.947 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.531 ' OD1' ' HB ' ' A' ' 15' ' ' ILE . 1.9 p30 -164.05 -159.11 0.47 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.186 -178.052 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -66.45 -3.02 5.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.832 -179.619 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 66.41 -152.09 0.22 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.473 0.177 . . . . 0.0 111.271 179.359 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.456 ' OG ' ' N ' ' A' ' 14' ' ' SER . 72.0 p 34.89 -95.33 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 178.831 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.71 ' O ' HG23 ' A' ' 18' ' ' VAL . 8.2 t -52.79 -60.57 3.1 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.748 -178.984 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.531 ' HB ' ' OD1' ' A' ' 10' ' ' ASP . 9.9 mm -60.54 -24.99 33.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.684 0.278 . . . . 0.0 110.955 -179.781 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.699 ' HA ' HG21 ' A' ' 32' ' ' THR . 3.2 ttm-85 -71.48 -51.89 21.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.794 0.331 . . . . 0.0 110.594 179.494 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.402 ' HA ' ' CD ' ' A' ' 20' ' ' GLU . 40.8 t90 -59.3 -38.44 80.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.824 -179.516 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.71 HG23 ' O ' ' A' ' 14' ' ' SER . 18.1 t -65.65 -54.18 30.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -178.717 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.748 HD12 HD12 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -76.18 -26.43 56.19 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -178.235 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.631 ' HA ' ' CB ' ' A' ' 30' ' ' CYS . 10.7 pt-20 -67.82 -60.69 2.32 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.56 -0.456 . . . . 0.0 112.109 -178.874 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.501 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 4.5 mmm180 -57.89 -55.94 28.44 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.921 -179.098 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.44 -50.09 65.99 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -179.198 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.04 HD22 HD13 ' A' ' 28' ' ' LEU . 5.2 mt -69.44 -29.0 66.6 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.131 0.491 . . . . 0.0 110.16 179.532 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.1 -35.01 75.86 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.422 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.04 -28.09 69.92 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.048 -1.073 . . . . 0.0 110.462 177.762 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.72 ' HB3' HD11 ' A' ' 28' ' ' LEU . . . -78.53 -15.99 57.96 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 120.578 0.228 . . . . 0.0 110.88 179.173 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.86 27.11 13.09 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 120.482 -0.866 . . . . 0.0 114.491 178.665 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 1.04 HD13 HD22 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -118.04 167.53 11.37 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 118.407 1.104 . . . . 0.0 112.105 -179.921 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 98.7 m -88.28 117.23 27.04 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.941 179.223 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.631 ' CB ' ' HA ' ' A' ' 20' ' ' GLU . 3.1 m -108.96 110.19 21.43 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.661 -178.907 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.952 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.7 t -130.22 135.61 48.33 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 178.484 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.699 HG21 ' HA ' ' A' ' 16' ' ' ARG . 29.8 p -111.09 164.8 12.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.262 0.553 . . . . 0.0 111.915 -179.054 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.793 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 3.7 m-85 -136.39 172.17 13.41 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.302 -178.204 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.584 ' HG2' ' N ' ' A' ' 35' ' ' ASN . 0.1 OUTLIER -63.4 -32.63 74.12 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 121.445 0.64 . . . . 0.0 109.917 179.202 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.584 ' N ' ' HG2' ' A' ' 34' ' ' GLU . 8.1 t-20 179.81 170.2 1.14 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.994 -179.81 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.897 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . -43.43 -29.9 1.23 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.788 -0.72 . . . . 0.0 113.629 -179.238 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.47 ' HA ' ' HG ' ' A' ' 40' ' ' LEU . 0.4 OUTLIER -58.88 -51.48 69.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.737 0.304 . . . . 0.0 111.525 -179.48 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.793 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -51.91 -48.72 64.04 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.909 -0.316 . . . . 0.0 111.289 -179.531 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.621 HG22 ' CE1' ' A' ' 33' ' ' PHE . 79.5 t -60.7 -27.4 40.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.113 179.808 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.541 ' HG ' ' O ' ' A' ' 36' ' ' GLY . 33.9 mt -57.39 -46.88 82.96 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.222 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.31 -48.69 49.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.098 179.569 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.67 -31.6 68.34 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.832 179.818 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.695 HD21 ' HD2' ' A' ' 48' ' ' PRO . 16.1 mt -70.02 -25.03 63.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.485 -179.936 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.24 -19.6 14.68 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.913 -179.36 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.8 2.13 8.13 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -179.663 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.58 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -163.65 155.6 17.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.793 0.33 . . . . 0.0 110.733 179.712 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.622 HG23 ' CD2' ' A' ' 76' ' ' LEU . 87.4 m -139.09 112.71 8.12 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.466 179.92 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.695 ' HD2' HD21 ' A' ' 43' ' ' LEU . 94.7 Cg_endo -78.22 165.59 25.57 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.063 1.842 . . . . 0.0 110.914 178.538 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.633 ' OD2' HG12 ' A' ' 119' ' ' ILE . 4.8 p-10 -74.59 -59.58 2.67 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.659 -179.733 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.746 HG13 HG23 ' A' ' 6' ' ' VAL . 10.0 p -101.91 164.85 2.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.926 179.558 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.638 HD23 HG22 ' A' ' 78' ' ' VAL . 14.5 tp -153.45 143.04 21.82 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 120.733 0.301 . . . . 0.0 111.072 -179.765 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.602 ' HG ' ' HB ' ' A' ' 79' ' ' ILE . 0.2 OUTLIER -129.17 142.15 50.96 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.631 -0.258 . . . . 0.0 110.783 -179.922 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.798 ' HA ' HG23 ' A' ' 9' ' ' VAL . 3.0 m -129.48 137.05 50.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.005 0.431 . . . . 0.0 111.494 -179.864 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.471 ' HB3' ' HB3' ' A' ' 10' ' ' ASP . 20.7 p-10 -77.87 -18.03 56.68 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.745 -178.712 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.579 HG13 ' HA3' ' A' ' 62' ' ' GLY . 0.7 OUTLIER 45.28 91.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-O 120.823 0.344 . . . . 0.0 111.255 -179.779 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.0 49.66 2.25 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -179.108 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.476 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 1.1 ttt 57.01 51.01 4.99 Favored Pre-proline 0 N--CA 1.466 0.364 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 178.715 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 62' ' ' GLY . 42.8 Cg_endo -69.26 -78.87 0.01 OUTLIER 'Trans proline' 0 CA--C 1.533 0.428 0 C-N-CA 122.75 2.3 . . . . 0.0 112.102 178.685 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -112.2 -20.81 6.51 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 121.262 -0.494 . . . . 0.0 112.09 179.603 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 1.001 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 0.8 OUTLIER -159.99 66.38 0.36 Allowed 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.084 0.469 . . . . 0.0 110.266 179.725 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.476 ' HA ' ' HA ' ' A' ' 57' ' ' MET . 0.9 OUTLIER 68.29 -23.56 0.13 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.321 179.746 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.607 ' N ' ' HD2' ' A' ' 58' ' ' PRO . . . 140.21 -31.67 2.24 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 111.286 -0.726 . . . . 0.0 111.286 -179.604 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.657 HD12 ' H ' ' A' ' 63' ' ' LEU . 2.4 mp -66.74 -28.23 68.25 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 178.92 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 1.001 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -53.79 -28.72 36.67 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.352 0.596 . . . . 0.0 109.791 178.074 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.705 ' CD2' HD11 ' A' ' 69' ' ' ILE . 4.9 tt -51.67 -57.06 10.27 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.343 179.243 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.726 HD13 ' CB ' ' A' ' 93' ' ' ALA . 1.9 mt -55.76 -40.99 73.34 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.746 -1.116 . . . . 0.0 110.692 179.91 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.531 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -47.72 -49.11 28.97 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 120.792 0.33 . . . . 0.0 111.039 179.197 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -69.22 -32.21 71.3 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.028 0.442 . . . . 0.0 110.831 -179.948 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.705 HD11 ' CD2' ' A' ' 65' ' ' LEU . 81.3 mt -60.75 -40.85 86.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.535 -179.222 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.531 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -74.61 -27.9 60.67 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.767 -179.666 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.0 -41.95 67.02 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.674 -178.925 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 72' ' ' ARG . 1.0 OUTLIER -94.84 -26.42 16.21 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.377 -0.374 . . . . 0.0 112.007 -179.15 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.585 ' HD2' HG23 ' A' ' 69' ' ' ILE . 1.3 m-70 -124.52 168.45 13.08 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-O 120.749 0.309 . . . . 0.0 111.173 -179.421 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.492 ' HD2' ' HB3' ' A' ' 73' ' ' HIS . 35.5 Cg_endo -69.6 -83.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.339 2.026 . . . . 0.0 112.723 -179.373 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.435 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 8.0 mtm -146.71 55.44 1.13 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.734 0.302 . . . . 0.0 111.406 -179.626 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.622 ' CD2' HG23 ' A' ' 47' ' ' THR . 0.1 OUTLIER -57.22 111.09 2.96 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.427 179.811 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.615 ' HD2' HD13 ' A' ' 76' ' ' LEU . 38.6 Cg_exo -58.68 115.62 2.67 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.264 1.976 . . . . 0.0 112.593 179.841 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.962 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 5.0 t -117.59 145.96 22.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.951 179.622 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.602 ' HB ' ' HG ' ' A' ' 52' ' ' LEU . 1.6 mp -117.52 112.61 39.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 179.147 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.785 HG13 ' CZ ' ' A' ' 101' ' ' TYR . 16.5 mm -93.7 130.65 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -178.205 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.667 ' HB2' ' CD2' ' A' ' 106' ' ' PHE . 6.7 ptm -72.43 -29.8 64.03 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.693 -179.968 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.568 ' H ' HG21 ' A' ' 55' ' ' ILE . 5.3 m -135.6 138.3 42.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.386 -179.433 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.571 ' HA ' ' CE2' ' A' ' 101' ' ' TYR . . . -89.71 -27.05 20.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.574 179.957 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.534 ' CE1' HG21 ' A' ' 82' ' ' THR . 3.2 m-70 44.72 -159.74 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.286 179.609 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.423 ' H ' ' HB3' ' A' ' 84' ' ' HIS . 2.6 t -81.41 164.31 22.18 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.937 0.399 . . . . 0.0 111.415 -179.529 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.406 ' O ' HD22 ' A' ' 63' ' ' LEU . 0.2 OUTLIER 72.07 31.24 2.01 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.746 179.99 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.607 HD23 ' CB ' ' A' ' 90' ' ' ALA . 1.1 mt -45.8 -21.84 0.15 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.793 -0.639 . . . . 0.0 112.502 -179.812 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -48.11 -44.23 31.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.617 0.246 . . . . 0.0 111.042 -179.657 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.505 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -67.25 -20.55 65.68 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.191 179.902 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.61 ' O ' ' HB3' ' A' ' 93' ' ' ALA . . . -62.35 -50.5 71.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.886 -179.777 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.587 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 6.3 t -67.72 -45.47 84.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.41 179.587 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.678 ' O ' ' HG3' ' A' ' 95' ' ' GLN . 9.8 m -61.56 -14.07 26.83 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.088 0.471 . . . . 0.0 109.835 178.24 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.726 ' CB ' HD13 ' A' ' 66' ' ' LEU . . . -75.66 -53.25 8.86 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.399 179.724 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.667 ' CE1' ' HA ' ' A' ' 100' ' ' ASP . 4.8 m-85 -55.81 -34.78 65.66 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.142 -178.805 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.678 ' HG3' ' O ' ' A' ' 92' ' ' SER . 1.8 pp0? -74.37 -34.14 63.26 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.242 -179.755 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.507 ' HG2' ' HA ' ' A' ' 93' ' ' ALA . 9.3 pt20 -100.29 11.29 39.75 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.141 -179.344 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 119.43 78.26 0.56 Allowed Glycine 0 C--N 1.334 0.441 0 C-N-CA 120.314 -0.946 . . . . 0.0 113.474 179.79 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.962 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -169.04 134.89 1.66 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.08 0.467 . . . . 0.0 111.623 178.966 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.724 ' CD2' ' HB2' ' A' ' 118' ' ' ALA . 3.5 t80 -74.96 -52.53 10.94 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.237 -179.673 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.667 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 0.9 OUTLIER 179.15 -167.71 0.08 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.247 0.546 . . . . 0.0 111.955 -179.831 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.785 ' CZ ' HG13 ' A' ' 80' ' ' ILE . 4.9 m-85 -136.04 153.17 51.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.275 -179.685 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.602 HD23 ' HA ' ' A' ' 81' ' ' MET . 1.7 mm? -102.82 120.7 51.81 Favored Pre-proline 0 C--N 1.329 -0.299 0 C-N-CA 121.081 -0.247 . . . . 0.0 110.83 179.51 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -66.26 -78.7 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.318 2.012 . . . . 0.0 112.395 -179.838 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.648 ' HB3' ' HD3' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -108.81 -58.18 0.05 OUTLIER Pre-proline 0 C--O 1.232 0.175 0 C-N-CA 121.185 -0.206 . . . . 0.0 111.425 179.949 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.648 ' HD3' ' HB3' ' A' ' 104' ' ' LYS . 77.0 Cg_endo -79.07 163.03 25.79 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 121.693 1.595 . . . . 0.0 110.726 178.933 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.717 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 0.9 OUTLIER 177.58 -91.38 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 121.3 -0.16 . . . . 0.0 111.262 179.936 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.511 ' O ' ' CB ' ' A' ' 111' ' ' ALA . 2.7 p30 44.04 -165.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 -179.442 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.534 HG12 HG12 ' A' ' 18' ' ' VAL . 1.0 OUTLIER -66.67 -43.83 90.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 120.744 -0.383 . . . . 0.0 111.528 -179.727 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.471 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 8.6 t70 -48.84 -58.33 4.98 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.192 -179.684 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.717 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 5.2 mm-40 -78.23 -32.61 49.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.552 -179.68 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.511 ' CB ' ' O ' ' A' ' 107' ' ' ASP . . . -65.92 -59.58 3.7 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 179.398 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.709 ' O ' HG12 ' A' ' 115' ' ' VAL . 56.0 t -59.58 -29.85 43.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.452 0.644 . . . . 0.0 110.195 178.877 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.471 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -66.49 -46.76 75.23 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.566 178.759 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.521 HD23 ' CG2' ' A' ' 79' ' ' ILE . 15.2 tp -74.81 -20.76 59.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.205 179.859 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.709 HG12 ' O ' ' A' ' 112' ' ' VAL . 5.5 p -79.31 -48.43 21.17 Favored 'Isoleucine or valine' 0 C--O 1.231 0.088 0 CA-C-O 120.841 0.353 . . . . 0.0 111.44 179.985 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.629 ' HA ' HD12 ' A' ' 119' ' ' ILE . 35.6 mt-10 -63.5 -38.13 89.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.938 -179.967 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 13.6 mmt180 -65.24 -24.88 67.45 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.901 179.761 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.724 ' HB2' ' CD2' ' A' ' 99' ' ' PHE . . . -74.42 -39.63 62.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.222 179.935 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.633 HG12 ' OD2' ' A' ' 49' ' ' ASP . 4.9 mt -71.74 -30.67 38.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.135 0.493 . . . . 0.0 110.72 179.873 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 24.3 t -67.71 -35.77 79.38 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.02 179.823 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 25.9 m80 -69.46 -26.63 64.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.897 0.38 . . . . 0.0 111.161 -179.804 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -73.6 -53.71 9.86 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.825 179.972 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -77.71 -172.91 2.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.147 -179.994 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.2 tm-20 . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.947 179.988 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.1 mmt . . . . . 0 N--CA 1.488 1.45 0 CA-C-O 120.757 0.313 . . . . 0.0 111.255 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 62.61 152.73 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.228 179.899 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.408 ' HG3' HD11 ' A' ' 5' ' ' ILE . 10.2 ptt-85 -69.96 -60.63 2.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.828 -179.575 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.416 ' C ' HD13 ' A' ' 5' ' ' ILE . . . 98.85 102.12 2.31 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.964 -0.636 . . . . 0.0 111.879 -179.301 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.439 ' HB ' ' HA ' ' A' ' 48' ' ' PRO . 8.4 mm -111.12 112.78 42.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.887 0.375 . . . . 0.0 111.351 -179.393 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.92 HG23 HG13 ' A' ' 50' ' ' VAL . 7.7 p -109.06 123.47 64.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.818 179.459 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.955 ' CD1' HG22 ' A' ' 31' ' ' THR . 40.5 m0 -113.68 133.7 55.17 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.686 -179.798 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.567 HG13 ' HB3' ' A' ' 52' ' ' LEU . 0.6 OUTLIER -119.43 145.79 25.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.997 0.427 . . . . 0.0 111.965 -179.106 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.806 HG11 ' HA2' ' A' ' 36' ' ' GLY . 0.0 OUTLIER -123.96 110.63 26.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.095 0.474 . . . . 0.0 110.985 178.999 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.418 ' CB ' HG21 ' A' ' 15' ' ' ILE . 5.0 t0 -161.17 -163.45 1.02 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.78 -179.549 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -66.66 -1.73 4.08 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -178.788 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.529 ' O ' ' N ' ' A' ' 14' ' ' SER . 1.2 t70 65.24 -141.85 0.21 Allowed 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 121.027 -0.269 . . . . 0.0 110.61 179.338 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.486 ' HA ' ' HE ' ' A' ' 16' ' ' ARG . 1.0 OUTLIER 35.29 -82.21 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 179.07 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.758 ' O ' HG23 ' A' ' 18' ' ' VAL . 1.8 m -80.17 -44.4 19.91 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -178.71 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.418 HG21 ' CB ' ' A' ' 10' ' ' ASP . 27.3 mm -65.24 -33.74 65.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 -178.773 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.809 ' HA ' HG21 ' A' ' 32' ' ' THR . 2.4 ppt_? -72.42 -55.27 7.32 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.881 -179.279 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.422 ' N ' ' HD2' ' A' ' 16' ' ' ARG . 81.4 t90 -48.12 -41.95 27.89 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -178.9 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.943 HG12 HD13 ' A' ' 108' ' ' ILE . 0.8 OUTLIER -73.11 -57.48 6.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.137 0.494 . . . . 0.0 112.252 -178.557 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 1.046 HD12 HD12 ' A' ' 108' ' ' ILE . 7.3 mp -65.02 -30.94 71.95 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.573 -0.739 . . . . 0.0 112.567 -177.912 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.523 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 19.9 pt-20 -67.77 -59.18 3.51 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.877 0.37 . . . . 0.0 111.484 -179.63 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.473 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 6.2 mmm180 -56.9 -51.45 69.06 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.586 -179.623 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.567 ' HB3' HD11 ' A' ' 108' ' ' ILE . . . -59.47 -43.56 93.23 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 120.876 0.37 . . . . 0.0 111.589 -179.355 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.855 ' CD2' HG11 ' A' ' 6' ' ' VAL . 2.1 tp -74.09 -24.58 59.5 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.214 179.634 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.47 -35.16 75.34 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.357 178.374 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.9 -26.09 69.81 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.522 -0.847 . . . . 0.0 111.283 178.656 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.595 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -76.68 -16.15 59.6 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 120.677 0.275 . . . . 0.0 111.246 179.636 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.46 26.65 8.05 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 120.45 -0.881 . . . . 0.0 114.374 178.748 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.783 HD13 ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -125.72 170.83 11.16 Favored 'General case' 0 C--O 1.231 0.079 0 CA-C-N 118.28 1.04 . . . . 0.0 112.018 179.943 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 31.5 m -99.25 105.96 18.05 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.807 179.954 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.618 ' HA ' HG13 ' A' ' 6' ' ' VAL . 4.7 t -98.29 117.1 31.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.583 -179.675 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.955 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.2 t -126.66 130.92 51.37 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 178.401 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.809 HG21 ' HA ' ' A' ' 16' ' ' ARG . 60.4 p -103.26 164.51 11.59 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -177.713 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.718 ' CE1' HG23 ' A' ' 31' ' ' THR . 3.4 m-85 -135.92 174.48 10.56 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.936 -178.057 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.75 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 2.9 pp20? -61.36 -40.13 93.16 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -177.561 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.408 ' O ' ' HB ' ' A' ' 9' ' ' VAL . 1.4 t-20 -168.31 -46.66 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -179.165 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.833 ' CA ' HD21 ' A' ' 65' ' ' LEU . . . -176.73 -47.48 0.06 OUTLIER Glycine 0 C--N 1.32 -0.318 0 C-N-CA 120.178 -1.011 . . . . 0.0 113.628 -178.907 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -65.77 -27.94 68.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.896 0.379 . . . . 0.0 111.168 -179.2 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.75 ' HB2' ' HG3' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -58.62 -53.39 58.84 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.052 179.997 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.743 HG12 ' CD1' ' A' ' 43' ' ' LEU . 8.2 t -51.94 -49.01 39.38 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.145 0 C-N-CA 120.39 -0.524 . . . . 0.0 109.925 179.683 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.802 HD13 ' HB3' ' A' ' 68' ' ' GLN . 22.3 mt -48.18 -42.55 30.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.08 179.879 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.62 -49.57 62.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.232 0.539 . . . . 0.0 110.862 179.576 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.14 -26.41 68.8 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.712 179.552 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.774 HD13 ' NE2' ' A' ' 73' ' ' HIS . 1.3 mt -69.7 -27.12 64.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.465 -178.918 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.46 -21.04 1.31 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.84 -179.556 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 29.9 t -126.09 6.56 7.2 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -179.435 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.54 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.3 OUTLIER -166.44 156.44 11.9 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.974 0.416 . . . . 0.0 111.451 179.969 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 1.023 HG23 HD12 ' A' ' 76' ' ' LEU . 98.2 m -139.09 112.51 8.1 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.22 179.616 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.613 ' CD ' HD11 ' A' ' 76' ' ' LEU . 57.7 Cg_endo -71.82 165.13 33.48 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 121.873 1.716 . . . . 0.0 111.027 178.974 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -76.43 -22.66 54.38 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.691 -0.403 . . . . 0.0 111.232 -179.795 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.92 HG13 HG23 ' A' ' 6' ' ' VAL . 9.1 p -145.55 165.48 10.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 116.679 -0.237 . . . . 0.0 111.222 -179.666 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.764 HD12 ' O ' ' A' ' 7' ' ' TRP . 12.1 tp -152.69 136.31 16.07 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.999 0.428 . . . . 0.0 111.561 -179.353 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.567 ' HB3' HG13 ' A' ' 8' ' ' VAL . 0.6 OUTLIER -122.85 117.29 25.28 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.509 -179.991 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.481 ' OG ' HD13 ' A' ' 65' ' ' LEU . 3.3 m -105.76 134.53 48.73 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.232 0.539 . . . . 0.0 111.705 -179.667 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -83.08 16.04 2.55 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -178.938 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.774 HG22 ' HG2' ' A' ' 81' ' ' MET . 1.1 tt 31.53 -107.75 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 179.434 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.478 ' N ' ' CG1' ' A' ' 55' ' ' ILE . 3.5 ttt180 54.16 43.42 30.67 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 179.618 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.524 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 1.0 OUTLIER 48.25 63.78 9.73 Favored Pre-proline 0 N--CA 1.468 0.44 0 N-CA-C 113.472 0.915 . . . . 0.0 113.472 178.694 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.604 ' HD2' ' N ' ' A' ' 62' ' ' GLY . 55.9 Cg_endo -73.86 -78.23 0.01 OUTLIER 'Trans proline' 0 CA--C 1.533 0.434 0 C-N-CA 122.419 2.079 . . . . 0.0 111.248 177.948 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -109.61 -28.55 4.23 Favored Glycine 0 C--N 1.335 0.477 0 C-N-CA 121.127 -0.559 . . . . 0.0 112.16 179.068 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 1.025 ' HB3' ' HB2' ' A' ' 64' ' ' ALA . 0.4 OUTLIER -152.42 65.19 0.82 Allowed 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.173 0.511 . . . . 0.0 110.048 179.544 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.654 ' O ' HG13 ' A' ' 55' ' ' ILE . 0.4 OUTLIER 68.07 -25.29 0.13 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.184 -0.917 . . . . 0.0 112.161 -179.788 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.604 ' N ' ' HD2' ' A' ' 58' ' ' PRO . . . 141.84 -31.92 2.06 Favored Glycine 0 CA--C 1.502 -0.728 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 179.981 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.842 HD11 ' HB2' ' A' ' 85' ' ' SER . 1.2 mp -70.61 -16.75 62.87 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 115.068 -0.566 . . . . 0.0 110.044 179.124 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 1.025 ' HB2' ' HB3' ' A' ' 60' ' ' MET . . . -53.5 -39.26 64.45 Favored 'General case' 0 CA--C 1.522 -0.098 0 CA-C-O 121.312 0.577 . . . . 0.0 109.768 178.115 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.833 HD21 ' CA ' ' A' ' 36' ' ' GLY . 6.8 mt -62.3 -39.18 92.13 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.885 179.755 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.789 HD23 ' HA ' ' A' ' 63' ' ' LEU . 1.2 mm? -59.02 -44.12 91.68 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.272 0.558 . . . . 0.0 109.804 179.165 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.639 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -57.98 -43.7 86.7 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.729 179.474 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.802 ' HB3' HD13 ' A' ' 40' ' ' LEU . 30.3 mm100 -73.93 -38.41 64.28 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.659 179.692 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.811 HG21 HG22 ' A' ' 78' ' ' VAL . 17.1 mt -63.5 -36.0 74.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.364 -179.247 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.639 ' HG3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -75.41 -26.64 58.57 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.056 -179.57 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.518 ' NE2' ' HG3' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -86.21 -32.62 21.09 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.603 -179.351 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.518 ' HG3' ' NE2' ' A' ' 71' ' ' GLN . 0.6 OUTLIER -95.41 -23.44 17.15 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.154 0.428 . . . . 0.0 112.154 -179.692 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.802 ' CE1' HG23 ' A' ' 69' ' ' ILE . 0.2 OUTLIER -111.11 135.23 20.9 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-O 120.673 0.273 . . . . 0.0 111.667 -179.07 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -59.76 -54.41 2.43 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.41 2.073 . . . . 0.0 112.082 179.116 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.449 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 22.2 mtt -156.47 36.74 0.32 Allowed 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.227 -179.9 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 1.023 HD12 HG23 ' A' ' 47' ' ' THR . 0.7 OUTLIER -71.13 121.79 85.18 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.379 -179.891 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.448 ' HD2' HD23 ' A' ' 76' ' ' LEU . 15.7 Cg_exo -68.58 121.86 8.8 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.586 2.19 . . . . 0.0 112.762 -179.708 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.811 HG22 HG21 ' A' ' 69' ' ' ILE . 11.4 t -99.21 141.02 17.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.843 179.302 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.964 HD13 HG23 ' A' ' 115' ' ' VAL . 2.4 mt -127.07 110.67 23.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.945 179.853 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.545 ' HB ' ' CD2' ' A' ' 101' ' ' TYR . 5.4 mm -101.17 142.12 16.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.104 -179.926 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.774 ' HG2' HG22 ' A' ' 55' ' ' ILE . 26.5 ptm -66.66 -56.51 10.3 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.943 179.607 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.682 ' O ' HD13 ' A' ' 55' ' ' ILE . 2.8 m -131.06 152.21 50.6 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 121.771 -0.581 . . . . 0.0 112.152 -179.809 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.968 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -116.71 46.18 1.68 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.825 -179.796 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 17.1 p80 -77.23 56.65 1.33 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.666 0.269 . . . . 0.0 111.192 -179.98 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.842 ' HB2' HD11 ' A' ' 63' ' ' LEU . 0.7 OUTLIER -159.64 -160.63 0.84 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 121.046 0.45 . . . . 0.0 111.67 -179.642 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.79 90.05 0.17 Allowed 'General case' 0 CA--C 1.528 0.097 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.834 179.559 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.761 HD13 ' HB3' ' A' ' 90' ' ' ALA . 0.2 OUTLIER -44.44 -21.29 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -179.965 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -48.12 -53.66 15.87 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -178.975 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.554 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -66.46 -22.04 66.2 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.642 0.258 . . . . 0.0 111.446 -179.648 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.761 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -76.97 -42.91 37.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.754 0.311 . . . . 0.0 110.965 -179.865 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.561 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 13.6 t -64.69 -41.17 91.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.234 179.79 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 19.8 m -61.06 -36.08 78.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.922 179.0 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.549 ' HB1' ' HB2' ' A' ' 98' ' ' ALA . . . -55.76 -45.44 78.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.644 179.622 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.561 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 7.4 m-85 -55.16 -25.02 29.53 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.525 179.507 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.61 ' HG2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -72.19 -40.77 67.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.337 179.688 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.61 ' N ' ' HG2' ' A' ' 95' ' ' GLN . 1.6 pt20 -76.03 -18.13 59.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.547 -179.6 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 134.32 -8.78 4.71 Favored Glycine 0 CA--C 1.521 0.45 0 C-N-CA 120.318 -0.944 . . . . 0.0 113.508 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.805 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -43.67 143.92 0.91 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 117.268 0.534 . . . . 0.0 111.505 -179.817 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.434 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 39.5 t80 -80.73 -54.63 5.46 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 121.049 -0.26 . . . . 0.0 111.232 -179.59 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 166.71 -168.23 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.06 0.457 . . . . 0.0 111.546 179.582 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.968 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 9.2 m-85 -118.3 152.63 35.41 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.654 178.948 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.909 HD13 HD22 ' A' ' 114' ' ' LEU . 19.6 tp -102.58 144.63 29.01 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-O 120.926 0.394 . . . . 0.0 111.5 -178.411 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.504 ' HD2' ' CD1' ' A' ' 102' ' ' LEU . 79.2 Cg_endo -80.22 -160.56 0.13 Allowed 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.513 2.142 . . . . 0.0 113.01 -179.399 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.503 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -42.15 -54.03 7.96 Favored Pre-proline 0 CA--C 1.534 0.347 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -179.165 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.503 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 18.2 Cg_endo -59.19 156.71 33.42 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.033 1.822 . . . . 0.0 112.39 -179.287 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.853 ' CD1' HD23 ' A' ' 102' ' ' LEU . 60.2 m-85 -157.36 -109.45 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.156 -179.924 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.505 ' O ' ' O ' ' A' ' 106' ' ' PHE . 2.6 p30 44.75 -179.48 0.0 OUTLIER 'General case' 0 C--O 1.227 -0.119 0 CA-C-O 121.336 0.588 . . . . 0.0 111.248 -179.579 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 1.046 HD12 HD12 ' A' ' 19' ' ' LEU . 0.5 OUTLIER -64.06 -53.64 41.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-O 121.473 0.654 . . . . 0.0 112.324 -179.788 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.629 ' N ' HG23 ' A' ' 108' ' ' ILE . 1.0 OUTLIER -49.16 -52.91 23.54 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 114.947 -1.024 . . . . 0.0 111.961 -178.014 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.682 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 2.0 mm-40 -81.51 -27.78 34.32 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -179.13 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.44 ' CB ' ' O ' ' A' ' 107' ' ' ASP . . . -76.39 -55.39 5.59 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.252 179.933 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.619 ' O ' HG12 ' A' ' 115' ' ' VAL . 61.8 t -59.01 -30.47 43.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.502 0.668 . . . . 0.0 110.061 178.55 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.491 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -62.04 -46.61 88.4 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.492 -0.777 . . . . 0.0 110.587 179.345 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.909 HD22 HD13 ' A' ' 102' ' ' LEU . 21.5 tp -71.36 -26.71 62.92 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.108 -0.951 . . . . 0.0 112.127 -178.764 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.964 HG23 HD13 ' A' ' 79' ' ' ILE . 4.3 p -79.35 -40.04 21.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.886 0.374 . . . . 0.0 111.57 -179.805 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -67.31 -43.97 80.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.282 -179.448 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.643 ' HD3' ' HA ' ' A' ' 114' ' ' LEU . 6.7 ptm180 -60.09 -23.64 63.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.64 0.257 . . . . 0.0 110.827 179.807 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.434 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -72.16 -50.11 30.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.763 179.203 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.751 HD11 HG11 ' A' ' 50' ' ' VAL . 3.9 mt -69.65 -34.52 61.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.274 0.559 . . . . 0.0 110.649 179.554 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.3 t -63.49 -38.93 93.04 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.002 -179.958 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -62.08 -29.72 70.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.075 -179.907 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -75.89 -53.25 8.72 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.926 179.828 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.3 170.12 16.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.8 0.333 . . . . 0.0 110.964 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.857 179.891 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.471 0 CA-C-O 120.787 0.327 . . . . 0.0 111.187 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -112.41 175.06 5.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.956 179.929 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.616 ' HB3' HD11 ' A' ' 5' ' ' ILE . 0.8 OUTLIER -66.2 -27.79 68.26 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.95 0.405 . . . . 0.0 110.942 179.948 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.509 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . 56.54 85.94 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.05 -179.534 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.616 HD11 ' HB3' ' A' ' 3' ' ' ARG . 3.5 mp -116.81 117.62 56.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.74 0.305 . . . . 0.0 111.565 -179.292 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.833 HG23 HG13 ' A' ' 50' ' ' VAL . 5.4 p -104.95 129.22 57.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.722 179.414 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.925 ' CD1' HG22 ' A' ' 31' ' ' THR . 28.2 m0 -116.38 130.49 56.8 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.789 179.248 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.545 HG11 HD23 ' A' ' 19' ' ' LEU . 1.6 t -114.43 135.71 53.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.503 -177.919 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.853 HG13 HG23 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -121.0 106.39 18.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.329 -0.396 . . . . 0.0 109.999 179.43 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.414 ' OD2' HG21 ' A' ' 15' ' ' ILE . 2.9 p30 -161.17 -160.85 0.76 Allowed 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.215 -177.887 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -66.3 -2.77 4.76 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -178.663 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 67.69 -150.12 0.16 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 121.199 -0.201 . . . . 0.0 111.177 179.268 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.438 ' OG ' ' N ' ' A' ' 14' ' ' SER . 60.1 p 34.78 -97.72 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 179.205 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.789 ' O ' HG23 ' A' ' 18' ' ' VAL . 12.5 t -53.17 -57.43 10.49 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.686 -0.234 . . . . 0.0 111.598 -179.069 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.414 HG21 ' OD2' ' A' ' 10' ' ' ASP . 17.6 mm -61.37 -25.1 35.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.78 0.324 . . . . 0.0 111.546 -179.854 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.952 ' HA ' HG21 ' A' ' 32' ' ' THR . 5.8 ttm180 -70.89 -54.54 11.07 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.103 179.919 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.427 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 84.7 t90 -60.79 -43.57 97.95 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -179.03 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.789 HG23 ' O ' ' A' ' 14' ' ' SER . 4.6 t -64.73 -46.15 93.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.67 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.545 HD23 HG11 ' A' ' 8' ' ' VAL . 11.9 tp -84.13 -23.16 30.8 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -178.198 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.508 ' HG3' ' N ' ' A' ' 21' ' ' ARG . 15.1 pt-20 -67.46 -58.85 4.01 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.194 -0.602 . . . . 0.0 111.321 -179.277 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.508 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 3.1 mmm180 -59.73 -50.42 73.9 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.689 -179.396 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.29 -48.48 71.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.881 0.372 . . . . 0.0 111.713 -179.343 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.805 ' HG ' HG11 ' A' ' 6' ' ' VAL . 2.4 tm? -70.06 -30.27 67.48 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.393 0.616 . . . . 0.0 110.516 179.972 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.09 -31.94 72.77 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 178.298 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -62.31 -28.34 70.78 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 178.029 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.595 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -77.26 -15.67 59.35 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 120.82 0.343 . . . . 0.0 110.711 179.159 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 94.71 26.4 13.24 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.729 -0.748 . . . . 0.0 114.373 178.552 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.626 ' HB2' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -126.12 166.32 17.23 Favored 'General case' 0 C--N 1.334 -0.066 0 CA-C-N 118.27 1.035 . . . . 0.0 112.379 179.892 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.599 ' O ' HG12 ' A' ' 6' ' ' VAL . 93.4 m -81.34 127.47 32.78 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.591 -179.745 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 2.4 p -123.61 116.75 23.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.935 -178.947 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.925 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.4 t -129.12 133.46 47.65 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.396 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.952 HG21 ' HA ' ' A' ' 16' ' ' ARG . 44.1 p -105.92 162.73 13.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.209 0.528 . . . . 0.0 112.114 -178.393 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.795 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 1.2 m-85 -131.56 172.22 12.49 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.775 -178.017 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.737 ' HG3' ' HB2' ' A' ' 38' ' ' GLU . 2.9 pp20? -63.55 -42.57 98.36 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -178.786 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -166.3 -59.76 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.224 0.535 . . . . 0.0 111.707 -178.983 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.782 ' HA3' HD22 ' A' ' 65' ' ' LEU . . . -162.98 -53.34 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.463 -0.79 . . . . 0.0 112.501 -179.485 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.706 ' HA ' HD12 ' A' ' 40' ' ' LEU . 0.8 OUTLIER -49.39 -28.4 5.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.996 0.427 . . . . 0.0 111.299 -179.817 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.795 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 2.1 tp10 -62.0 -56.74 15.94 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.253 179.919 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.853 HG23 HG13 ' A' ' 9' ' ' VAL . 38.6 t -60.52 -31.89 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.102 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.542 179.398 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.724 HD13 ' HB3' ' A' ' 68' ' ' GLN . 46.2 mt -55.21 -43.85 74.82 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.305 179.183 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -80.79 -48.71 12.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.142 -179.892 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.422 ' HB3' ' HE2' ' A' ' 33' ' ' PHE . . . -56.73 -30.94 64.05 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.317 -179.762 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.554 ' HG ' HG12 ' A' ' 39' ' ' VAL . 27.4 mt -64.26 -23.56 67.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.909 0.385 . . . . 0.0 111.323 179.986 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.95 -15.5 32.05 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.587 -179.911 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 31.4 t -119.47 -7.51 10.16 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.519 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.455 ' HB3' ' CH2' ' A' ' 7' ' ' TRP . 0.0 OUTLIER -164.61 163.17 21.83 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.891 0.377 . . . . 0.0 111.413 -179.866 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 51.8 m -138.48 113.61 8.71 Favored Pre-proline 0 N--CA 1.452 -0.331 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.264 179.855 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.741 ' HD2' HD11 ' A' ' 76' ' ' LEU . 57.1 Cg_endo -71.14 149.06 57.5 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.546 2.164 . . . . 0.0 111.672 179.228 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -74.07 -22.88 59.34 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.185 -179.743 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.835 HG11 HD11 ' A' ' 119' ' ' ILE . 6.3 p -149.02 98.23 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.751 -179.349 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.555 HD12 ' O ' ' A' ' 7' ' ' TRP . 38.9 tp -87.13 144.48 26.84 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.902 0.382 . . . . 0.0 111.863 -179.276 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.602 ' O ' HG23 ' A' ' 9' ' ' VAL . 1.0 OUTLIER -124.29 115.06 20.41 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.69 179.65 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.696 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 0.6 OUTLIER -115.23 134.03 55.5 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 121.567 0.699 . . . . 0.0 112.02 -179.337 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.08 -176.91 6.57 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.756 179.695 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.852 HG12 ' HA3' ' A' ' 62' ' ' GLY . 0.0 OUTLIER -149.17 108.62 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.492 179.623 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.467 ' O ' ' HG3' ' A' ' 57' ' ' MET . 0.1 OUTLIER -161.3 73.62 0.45 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.827 -179.463 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.467 ' HG3' ' O ' ' A' ' 56' ' ' ARG . 1.8 ptt? 38.85 51.45 3.14 Favored Pre-proline 0 CA--C 1.535 0.382 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 178.536 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.531 ' CG ' ' HA2' ' A' ' 62' ' ' GLY . 54.4 Cg_endo -76.4 -73.04 0.01 OUTLIER 'Trans proline' 0 CA--C 1.529 0.243 0 C-N-CA 122.215 1.944 . . . . 0.0 111.658 178.365 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -117.7 -27.06 2.65 Favored Glycine 0 CA--C 1.52 0.385 0 N-CA-C 111.835 -0.506 . . . . 0.0 111.835 179.172 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 1.059 ' HB3' ' HB2' ' A' ' 64' ' ' ALA . 4.4 tpt -159.44 69.6 0.45 Allowed 'General case' 0 C--O 1.236 0.358 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.318 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.445 ' O ' HG12 ' A' ' 55' ' ' ILE . 0.2 OUTLIER 68.82 -25.76 0.14 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.406 -0.816 . . . . 0.0 112.327 -179.951 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.852 ' HA3' HG12 ' A' ' 55' ' ' ILE . . . 142.13 -30.7 2.12 Favored Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -179.723 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.558 ' H ' HD12 ' A' ' 63' ' ' LEU . 3.3 mp -71.76 -21.36 61.75 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.456 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 1.059 ' HB2' ' HB3' ' A' ' 60' ' ' MET . . . -53.68 -42.38 67.88 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.008 0.433 . . . . 0.0 110.461 179.007 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.782 HD22 ' HA3' ' A' ' 36' ' ' GLY . 15.9 mt -51.54 -50.28 60.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.134 179.5 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.736 HD11 HG13 ' A' ' 80' ' ' ILE . 17.2 mt -52.12 -56.78 12.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.542 179.632 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.562 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 28.4 mttp -41.19 -47.68 3.34 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.669 -179.277 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.724 ' HB3' HD13 ' A' ' 40' ' ' LEU . 60.1 mm-40 -69.27 -35.9 76.54 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.278 -179.547 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.832 HG22 ' CD2' ' A' ' 73' ' ' HIS . 59.0 mt -54.07 -46.45 66.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.08 179.881 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.594 ' HA ' ' CE1' ' A' ' 73' ' ' HIS . 0.0 OUTLIER -70.96 -26.72 63.29 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -179.619 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -61.87 -30.23 70.72 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.218 -178.839 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.438 ' HD3' ' HB3' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -90.2 -59.73 2.11 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.405 0.621 . . . . 0.0 111.409 179.669 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.832 ' CD2' HG22 ' A' ' 69' ' ' ILE . 3.8 p80 -81.22 172.52 9.55 Favored Pre-proline 0 C--N 1.318 -0.779 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.557 -179.183 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.499 ' HD2' ' HB2' ' A' ' 73' ' ' HIS . 73.4 Cg_endo -87.33 -52.8 0.03 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.948 2.432 . . . . 0.0 112.073 179.015 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.638 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 28.7 mtt -157.48 49.51 0.43 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.071 179.213 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.741 HD11 ' HD2' ' A' ' 48' ' ' PRO . 2.1 tt -64.94 114.0 13.21 Favored Pre-proline 0 N--CA 1.454 -0.247 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.978 179.886 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.556 ' HG3' ' CE2' ' A' ' 122' ' ' TYR . 29.3 Cg_endo -64.71 115.45 3.24 Favored 'Trans proline' 0 CA--C 1.528 0.206 0 C-N-CA 122.389 2.06 . . . . 0.0 112.635 -179.796 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 1.007 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 5.3 t -115.51 154.45 16.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.104 179.909 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.562 HD11 HG23 ' A' ' 50' ' ' VAL . 1.9 mp -120.86 117.38 52.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.492 178.972 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.736 HG13 HD11 ' A' ' 66' ' ' LEU . 9.4 mm -99.04 150.21 5.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.098 0.475 . . . . 0.0 111.841 -179.409 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.556 ' HB3' HG22 ' A' ' 55' ' ' ILE . 53.5 ttp -67.59 -52.75 34.83 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.835 -179.129 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.436 ' H ' HG21 ' A' ' 55' ' ' ILE . 3.0 m -143.91 146.85 33.28 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 122.306 -0.246 . . . . 0.0 111.584 -179.234 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.91 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -113.98 57.86 0.69 Allowed 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.37 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.471 ' CE1' ' CD1' ' A' ' 55' ' ' ILE . 10.6 p-80 -99.21 -176.6 3.35 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.946 -0.302 . . . . 0.0 110.952 179.392 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.406 ' OG ' ' O ' ' A' ' 84' ' ' HIS . 20.8 p 71.09 -61.16 0.49 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.603 -179.709 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.458 ' OD2' HD13 ' A' ' 63' ' ' LEU . 4.0 p-10 -154.01 85.64 1.16 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -179.096 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.878 HD23 ' HB3' ' A' ' 90' ' ' ALA . 0.7 OUTLIER -52.73 -20.8 3.42 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.487 179.33 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -47.83 -57.09 6.07 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.607 -0.269 . . . . 0.0 111.664 -178.972 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.466 ' HB3' HD22 ' A' ' 63' ' ' LEU . . . -64.21 -19.94 65.69 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.725 0.297 . . . . 0.0 111.209 -179.968 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.878 ' HB3' HD23 ' A' ' 87' ' ' LEU . . . -77.26 -46.4 23.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.696 -179.696 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.63 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 6.6 t -62.64 -49.14 84.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 120.985 -0.286 . . . . 0.0 111.141 -179.7 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 52.5 p -56.51 -25.6 51.97 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.216 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.589 ' HB3' ' O ' ' A' ' 90' ' ' ALA . . . -60.08 -52.89 63.43 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.924 179.791 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.63 ' CE2' ' HA ' ' A' ' 91' ' ' VAL . 2.8 m-85 -55.78 -31.2 62.4 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.459 0.647 . . . . 0.0 109.917 179.771 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.12 -42.07 39.43 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.922 -1.036 . . . . 0.0 110.995 -179.967 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.638 ' O ' ' HA ' ' A' ' 75' ' ' MET . 7.3 pt20 -85.2 -18.15 34.94 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.785 -179.421 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 93' ' ' ALA . . . 140.29 85.32 0.1 Allowed Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.114 -179.101 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 1.007 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -168.26 123.81 0.99 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.157 0.503 . . . . 0.0 111.918 179.946 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -58.16 -52.77 64.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.773 -179.931 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.584 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 0.2 OUTLIER 170.12 -172.53 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 121.197 0.522 . . . . 0.0 111.675 -179.873 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.91 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 7.9 m-85 -113.38 153.57 28.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.263 179.621 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.576 HD21 ' HA ' ' A' ' 106' ' ' PHE . 7.9 tp -102.3 144.97 29.66 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.827 -179.195 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.563 ' HB2' ' HD2' ' A' ' 105' ' ' PRO . 18.5 Cg_exo -66.69 -157.06 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.739 2.293 . . . . 0.0 112.838 -179.043 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.504 ' HB3' ' HD3' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -56.13 -55.08 45.62 Favored Pre-proline 0 CA--C 1.531 0.218 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.859 -179.246 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.563 ' HD2' ' HB2' ' A' ' 103' ' ' PRO . 54.1 Cg_exo -52.31 164.23 1.37 Allowed 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.349 2.032 . . . . 0.0 111.923 179.695 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.616 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 57.6 t80 -158.2 -106.93 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.707 -0.224 . . . . 0.0 110.588 179.865 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.541 ' O ' ' O ' ' A' ' 106' ' ' PHE . 3.1 p30 42.37 -176.82 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.937 0.398 . . . . 0.0 111.041 -179.791 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.628 HG12 HG12 ' A' ' 18' ' ' VAL . 0.7 OUTLIER -68.0 -40.73 83.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.224 0.535 . . . . 0.0 111.155 -179.969 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.44 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 8.3 t0 -50.62 -58.88 4.79 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.919 -179.316 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.616 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 9.6 mm-40 -76.41 -30.36 57.42 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 111.725 0.268 . . . . 0.0 111.725 -179.366 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -69.77 -55.63 9.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.928 0.394 . . . . 0.0 110.322 179.332 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.676 ' O ' HG12 ' A' ' 115' ' ' VAL . 48.1 t -61.2 -33.61 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-O 121.357 0.598 . . . . 0.0 110.364 179.332 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.44 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -61.63 -47.14 86.75 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.618 179.723 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.472 HD23 ' CG2' ' A' ' 79' ' ' ILE . 55.4 tp -75.6 -21.43 57.8 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.632 -179.58 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.676 HG12 ' O ' ' A' ' 112' ' ' VAL . 2.9 p -79.4 -38.8 20.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.776 -0.37 . . . . 0.0 111.836 -179.639 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.533 ' OE2' HG12 ' A' ' 112' ' ' VAL . 36.7 mt-10 -68.44 -38.5 81.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.846 0.355 . . . . 0.0 110.773 179.997 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -64.21 -24.91 67.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.951 0.405 . . . . 0.0 110.367 179.531 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -70.62 -49.54 46.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.717 179.544 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.835 HD11 HG11 ' A' ' 50' ' ' VAL . 4.7 mt -70.36 -32.66 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-O 121.271 0.558 . . . . 0.0 110.965 179.759 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 15.1 m -70.01 -44.06 70.07 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.262 -179.786 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 11.2 m80 -60.19 -24.27 64.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.181 -179.841 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.556 ' CE2' ' HG3' ' A' ' 77' ' ' PRO . 0.5 OUTLIER -72.07 -53.07 13.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.075 0.464 . . . . 0.0 111.245 -179.71 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.515 ' O ' ' HG3' ' A' ' 124' ' ' GLU . 11.5 pt20 -75.59 -168.25 0.81 Allowed 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.284 179.999 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.515 ' HG3' ' O ' ' A' ' 123' ' ' GLN . 0.4 OUTLIER . . . . . 0 N--CA 1.463 0.201 0 CA-C-O 120.888 0.375 . . . . 0.0 111.577 -179.924 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.472 0 CA-C-O 120.701 0.286 . . . . 0.0 111.278 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -119.55 -22.39 6.98 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.797 -179.958 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.796 ' CG ' HD11 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -59.74 -11.58 5.44 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.802 0.335 . . . . 0.0 111.093 179.698 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.761 ' C ' HD13 ' A' ' 5' ' ' ILE . . . 88.46 97.78 0.97 Allowed Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.426 -0.892 . . . . 0.0 111.074 -179.257 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.796 HD11 ' CG ' ' A' ' 3' ' ' ARG . 4.9 mm -121.77 112.49 35.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 120.689 0.28 . . . . 0.0 111.361 -179.032 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.782 HG11 ' HG ' ' A' ' 23' ' ' LEU . 10.6 p -105.56 127.0 60.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.229 0.538 . . . . 0.0 110.657 179.101 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.944 ' CD1' HG22 ' A' ' 31' ' ' THR . 34.3 m0 -114.53 125.6 53.98 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.868 179.746 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.73 ' HB ' HG22 ' A' ' 32' ' ' THR . 0.2 OUTLIER -115.65 136.55 52.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.691 -177.956 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.698 HG12 ' HB2' ' A' ' 33' ' ' PHE . 18.0 m -115.25 110.68 32.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.224 0.535 . . . . 0.0 110.746 179.062 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.471 ' CB ' HG21 ' A' ' 15' ' ' ILE . 3.9 t0 -162.22 -158.6 0.53 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.381 -179.166 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -67.83 -0.19 3.97 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.614 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 68.78 -154.07 0.16 Allowed 'General case' 0 CA--C 1.532 0.265 0 O-C-N 122.313 -0.242 . . . . 0.0 111.02 179.553 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.438 ' OG ' ' N ' ' A' ' 14' ' ' SER . 74.8 p 33.01 -96.37 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 179.219 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.76 ' O ' HG23 ' A' ' 18' ' ' VAL . 4.4 t -53.06 -57.27 10.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.629 0.252 . . . . 0.0 111.599 -179.197 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.471 HG21 ' CB ' ' A' ' 10' ' ' ASP . 31.0 mm -61.41 -26.15 38.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.849 0.357 . . . . 0.0 111.078 179.931 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.706 ' HA ' HG21 ' A' ' 32' ' ' THR . 53.8 ttt180 -77.06 -44.27 31.31 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.708 179.803 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.447 ' HA ' ' HG2' ' A' ' 20' ' ' GLU . 70.2 t90 -64.23 -40.44 96.04 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.979 -179.275 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.76 HG23 ' O ' ' A' ' 14' ' ' SER . 3.5 t -70.48 -37.57 70.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.0 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.412 ' O ' HD13 ' A' ' 19' ' ' LEU . 0.2 OUTLIER -84.26 -29.32 26.56 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.969 -179.171 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.558 ' HA ' ' SG ' ' A' ' 30' ' ' CYS . 24.9 pt-20 -67.53 -60.36 2.62 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.913 -178.906 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.464 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 5.7 mmt85 -58.11 -54.09 50.85 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.189 -0.459 . . . . 0.0 112.008 -179.588 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.56 -53.96 47.65 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.108 0.48 . . . . 0.0 111.343 -179.574 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.782 ' HG ' HG11 ' A' ' 6' ' ' VAL . 2.5 tm? -66.32 -27.98 68.32 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.582 0.706 . . . . 0.0 110.451 179.52 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.428 ' HB2' ' O ' ' A' ' 20' ' ' GLU . . . -67.1 -34.55 77.86 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.527 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.53 -26.78 64.99 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.296 -0.954 . . . . 0.0 110.946 178.039 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.664 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -77.27 -16.22 59.09 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 120.701 0.286 . . . . 0.0 110.805 179.104 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.49 23.68 13.72 Favored Glycine 0 CA--C 1.521 0.419 0 C-N-CA 120.675 -0.774 . . . . 0.0 114.247 178.615 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.668 ' HB2' HD11 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -123.81 166.64 15.25 Favored 'General case' 0 CA--C 1.527 0.076 0 CA-C-N 118.107 0.954 . . . . 0.0 111.935 -179.802 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.736 ' O ' HG12 ' A' ' 6' ' ' VAL . 97.6 m -84.83 138.54 32.5 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.027 -179.777 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.558 ' SG ' ' HA ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -126.85 116.43 20.85 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.073 0.463 . . . . 0.0 111.694 -179.544 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.944 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.4 t -128.77 132.43 47.9 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.409 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.73 HG22 ' HB ' ' A' ' 8' ' ' VAL . 45.8 p -108.51 165.09 11.79 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.267 0.556 . . . . 0.0 111.749 -178.335 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.808 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 3.2 m-85 -135.06 172.09 13.51 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.196 -177.89 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.561 ' HG2' ' N ' ' A' ' 35' ' ' ASN . 0.0 OUTLIER -63.31 -32.67 74.15 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.797 -179.837 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.561 ' N ' ' HG2' ' A' ' 34' ' ' GLU . 50.1 p-10 -179.47 179.49 0.61 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.264 -179.434 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.603 ' O ' ' HG ' ' A' ' 40' ' ' LEU . . . -55.16 -10.2 2.48 Favored Glycine 0 CA--C 1.521 0.438 0 C-N-CA 120.709 -0.758 . . . . 0.0 114.011 -179.438 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.573 HD22 HD12 ' A' ' 40' ' ' LEU . 3.3 m120 -84.55 -44.57 13.44 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 117.727 0.763 . . . . 0.0 112.501 -179.315 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.808 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 6.6 tt0 -51.74 -58.72 5.6 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -179.271 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.615 HG22 ' CE1' ' A' ' 33' ' ' PHE . 55.1 t -47.55 -38.13 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 121.017 0.437 . . . . 0.0 111.173 -179.594 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.771 HD13 ' CB ' ' A' ' 68' ' ' GLN . 20.6 mt -57.03 -41.84 79.36 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.429 -179.956 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.87 -48.09 40.43 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.277 0.56 . . . . 0.0 110.177 178.911 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.48 -28.66 69.45 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.135 179.386 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.563 ' CD1' ' CE1' ' A' ' 73' ' ' HIS . 15.1 mt -65.56 -24.94 67.22 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.88 -179.412 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.64 -16.0 14.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.843 -179.471 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -125.68 -1.57 7.35 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.712 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.535 ' O ' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -163.42 159.89 22.81 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.917 0.389 . . . . 0.0 111.419 179.822 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 83.1 m -139.08 116.03 8.7 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.297 -179.929 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.731 ' O ' HD21 ' A' ' 76' ' ' LEU . 77.3 Cg_endo -77.42 163.21 30.09 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.056 1.837 . . . . 0.0 111.511 179.084 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.472 ' HB3' HG23 ' A' ' 119' ' ' ILE . 1.5 m-20 -74.23 -22.17 59.46 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.973 -0.291 . . . . 0.0 111.33 -179.744 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.775 HG13 HG23 ' A' ' 6' ' ' VAL . 8.3 p -147.7 169.42 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.477 -179.562 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.785 HD12 ' O ' ' A' ' 7' ' ' TRP . 10.0 tp -152.93 129.85 11.0 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 120.958 0.409 . . . . 0.0 111.318 -179.075 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.577 ' HG ' ' HB ' ' A' ' 79' ' ' ILE . 0.2 OUTLIER -115.69 126.76 54.52 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.78 179.789 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.72 ' CB ' HD22 ' A' ' 65' ' ' LEU . 0.2 OUTLIER -119.3 126.43 51.43 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -178.727 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -83.21 101.9 11.54 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.643 177.803 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.683 ' CG2' ' HB ' ' A' ' 82' ' ' THR . 2.2 tt -68.79 93.03 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.665 -179.505 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.462 ' NH2' ' HB3' ' A' ' 35' ' ' ASN . 6.8 ptt85 -135.46 59.05 1.74 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.48 -179.446 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.529 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 24.6 ptm 41.04 48.94 2.98 Favored Pre-proline 0 N--CA 1.467 0.381 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 179.746 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 62' ' ' GLY . 43.5 Cg_endo -70.49 -80.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.267 1.978 . . . . 0.0 111.999 178.943 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -107.27 -23.72 6.85 Favored Glycine 0 N--CA 1.449 -0.441 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 179.359 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.941 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 8.8 tpt -162.88 69.1 0.23 Allowed 'General case' 0 C--O 1.236 0.36 0 CA-C-O 120.923 0.392 . . . . 0.0 110.447 179.816 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.529 ' HA ' ' HA ' ' A' ' 57' ' ' MET . 0.3 OUTLIER 68.56 -26.46 0.14 Allowed 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.246 179.834 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.652 ' HA3' HG13 ' A' ' 55' ' ' ILE . . . 140.62 -29.58 2.36 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -179.441 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.644 HD12 ' H ' ' A' ' 63' ' ' LEU . 2.2 mp -75.62 -12.19 60.16 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.649 -0.275 . . . . 0.0 110.428 179.088 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.941 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -53.67 -26.9 24.7 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-O 120.925 0.393 . . . . 0.0 110.455 179.155 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.832 ' CD2' HG11 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -59.11 -62.15 2.1 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.954 -0.567 . . . . 0.0 109.714 178.982 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.959 ' HA ' HD12 ' A' ' 69' ' ' ILE . 7.9 mt -43.56 -43.39 5.55 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.243 179.513 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.447 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 19.4 mttt -54.0 -58.0 8.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.004 0.43 . . . . 0.0 111.225 179.507 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.771 ' CB ' HD13 ' A' ' 40' ' ' LEU . 21.5 mm-40 -62.07 -28.73 69.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.035 -179.846 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.959 HD12 ' HA ' ' A' ' 66' ' ' LEU . 77.0 mt -63.11 -42.02 95.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.029 0.442 . . . . 0.0 111.294 -179.846 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.529 ' HA ' ' HA ' ' A' ' 74' ' ' PRO . 0.1 OUTLIER -67.64 -29.25 68.51 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.573 -179.773 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.453 ' NE2' ' HA ' ' A' ' 68' ' ' GLN . 9.8 mt-30 -68.51 -40.61 80.76 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.036 179.527 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.403 ' NE ' ' HB3' ' A' ' 40' ' ' LEU . 52.0 mtt-85 -93.26 -76.22 0.48 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.743 -179.963 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.893 ' CD2' HG23 ' A' ' 69' ' ' ILE . 0.5 OUTLIER -114.5 79.18 5.28 Favored Pre-proline 0 C--N 1.318 -0.781 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.88 179.707 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.553 ' O ' ' HG3' ' A' ' 75' ' ' MET . 56.9 Cg_endo -70.87 50.28 1.07 Allowed 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.734 2.289 . . . . 0.0 113.131 -179.708 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.553 ' HG3' ' O ' ' A' ' 74' ' ' PRO . 2.8 mtp -150.65 -36.88 0.14 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.145 0.497 . . . . 0.0 110.82 179.716 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.731 HD21 ' O ' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -48.7 117.46 6.17 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.629 -179.831 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.493 ' HB3' ' HE2' ' A' ' 122' ' ' TYR . 31.5 Cg_endo -64.5 134.37 41.11 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.046 1.831 . . . . 0.0 111.627 179.051 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.882 HG21 HD13 ' A' ' 69' ' ' ILE . 5.8 t -122.15 143.62 34.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.932 0.396 . . . . 0.0 111.262 -179.56 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.643 ' CG2' HD23 ' A' ' 114' ' ' LEU . 1.6 mt -124.01 110.67 26.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.925 -180.0 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.674 HD12 ' HB3' ' A' ' 53' ' ' SER . 6.3 mm -99.01 148.28 6.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.586 -179.199 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.449 ' O ' ' HB2' ' A' ' 102' ' ' LEU . 62.2 ttp -76.21 -60.42 2.34 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.813 -0.631 . . . . 0.0 112.322 -179.211 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.878 HG23 ' HD2' ' A' ' 84' ' ' HIS . 40.9 m -109.76 151.57 26.78 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.31 -178.516 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.983 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -136.09 -3.7 2.21 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -179.377 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.878 ' HD2' HG23 ' A' ' 82' ' ' THR . 1.0 OUTLIER -71.49 35.41 0.06 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -178.982 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.503 ' O ' HD11 ' A' ' 63' ' ' LEU . 80.2 p -159.79 102.16 1.49 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.698 0.285 . . . . 0.0 111.184 179.447 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.534 ' HB3' HD13 ' A' ' 63' ' ' LEU . 0.7 OUTLIER 67.64 35.37 4.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.911 179.762 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.55 HD23 ' HB3' ' A' ' 90' ' ' ALA . 0.5 OUTLIER -46.52 -22.53 0.28 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.108 -0.496 . . . . 0.0 112.078 -179.931 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -47.98 -50.3 27.84 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 -179.498 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.481 ' HB3' ' CB ' ' A' ' 63' ' ' LEU . . . -60.77 -21.02 62.63 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.649 0.261 . . . . 0.0 111.661 -179.601 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.576 ' O ' ' HB3' ' A' ' 93' ' ' ALA . . . -70.29 -34.03 72.27 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.886 0.374 . . . . 0.0 110.711 179.625 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.593 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 4.5 t -61.75 -49.84 82.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.386 -179.961 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.444 ' O ' ' NE2' ' A' ' 95' ' ' GLN . 17.6 m -59.72 -22.51 62.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.063 0.459 . . . . 0.0 110.037 179.209 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.929 ' HB1' ' HB2' ' A' ' 98' ' ' ALA . . . -65.14 -50.85 64.43 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.526 179.419 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.593 ' CD2' ' HA ' ' A' ' 91' ' ' VAL . 9.8 m-85 -54.92 -24.48 23.82 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.089 179.146 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.474 HE22 ' HE2' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -76.51 -30.58 57.25 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.991 179.254 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.57 ' HG2' ' HA ' ' A' ' 93' ' ' ALA . 1.7 pt20 -91.14 -18.31 24.69 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.93 179.403 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 77' ' ' PRO . . . 127.85 14.72 2.49 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.059 -1.067 . . . . 0.0 114.016 179.283 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.929 ' HB2' ' HB1' ' A' ' 93' ' ' ALA . . . -55.46 144.52 25.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 117.457 0.629 . . . . 0.0 110.785 179.569 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.569 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 12.3 t80 -78.49 -54.46 6.13 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.337 -179.548 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.56 ' OD1' HD21 ' A' ' 114' ' ' LEU . 10.3 p-10 173.62 -165.26 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 121.065 0.46 . . . . 0.0 111.528 179.96 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.983 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 5.3 m-85 -138.78 153.8 48.45 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.097 -179.832 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.776 HD11 HD22 ' A' ' 114' ' ' LEU . 5.5 mp -103.0 127.9 28.87 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 120.662 0.267 . . . . 0.0 111.288 -179.918 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -77.84 -74.6 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 121.962 1.775 . . . . 0.0 112.252 179.593 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.704 ' H ' ' HD2' ' A' ' 105' ' ' PRO . 0.2 OUTLIER -107.77 -55.91 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 -179.661 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.704 ' HD2' ' H ' ' A' ' 104' ' ' LYS . 34.0 Cg_endo -64.44 160.01 41.42 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 121.909 1.739 . . . . 0.0 112.729 -179.5 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.681 ' O ' ' HB2' ' A' ' 110' ' ' GLU . 47.5 t80 -166.21 -106.51 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.089 -179.929 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.566 ' O ' ' O ' ' A' ' 106' ' ' PHE . 2.4 p30 42.98 177.47 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.859 0.361 . . . . 0.0 111.414 -179.888 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.73 HG12 HG12 ' A' ' 18' ' ' VAL . 0.9 OUTLIER -68.06 -42.37 85.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.001 0.429 . . . . 0.0 111.401 -179.624 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.502 ' HB2' ' OD1' ' A' ' 107' ' ' ASP . 6.1 m-20 -49.08 -58.27 5.22 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.521 -179.826 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.681 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 8.1 mm-40 -74.76 -35.6 62.58 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.646 0.26 . . . . 0.0 111.602 -179.675 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.77 -56.15 13.51 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.692 179.693 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.627 ' O ' HG12 ' A' ' 115' ' ' VAL . 54.7 t -62.1 -33.92 60.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.341 0.591 . . . . 0.0 110.585 179.364 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.477 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -61.84 -46.45 89.44 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.427 179.19 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.776 HD22 HD11 ' A' ' 102' ' ' LEU . 36.3 tp -74.67 -23.66 58.68 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.837 -179.216 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.737 HG23 HG21 ' A' ' 50' ' ' VAL . 6.4 p -79.49 -43.12 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.586 -179.901 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -62.73 -47.31 84.15 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.056 -179.695 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.651 ' HD2' HD12 ' A' ' 114' ' ' LEU . 6.4 ptp180 -60.05 -23.6 63.87 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.735 179.507 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.569 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -74.63 -48.15 28.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.121 179.998 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.472 HG23 ' HB3' ' A' ' 49' ' ' ASP . 3.8 mt -68.76 -32.69 55.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.173 0.511 . . . . 0.0 110.738 179.697 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.5 t -68.95 -55.06 12.12 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.239 -179.763 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 6.4 m80 -59.35 -25.89 64.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.519 -179.612 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.493 ' HE2' ' HB3' ' A' ' 77' ' ' PRO . 2.2 m-85 -81.42 -34.11 31.75 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.094 -179.772 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.24 177.51 6.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.707 179.688 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.024 179.996 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.488 1.45 0 CA-C-O 120.944 0.402 . . . . 0.0 111.281 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 63.18 135.91 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.036 -179.779 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.45 -21.84 21.69 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.319 -179.84 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.459 ' O ' ' HB3' ' A' ' 28' ' ' LEU . . . 78.02 101.28 0.2 Allowed Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.809 -179.473 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.4 mp -118.72 113.24 41.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.913 0.387 . . . . 0.0 111.509 -179.419 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 1.02 HG11 ' HG ' ' A' ' 23' ' ' LEU . 11.6 p -105.97 128.33 60.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.675 179.297 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.914 ' CD1' HG22 ' A' ' 31' ' ' THR . 31.2 m0 -114.69 132.86 56.27 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.742 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.569 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -123.86 141.6 43.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.066 0.46 . . . . 0.0 111.594 -178.06 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.934 HG12 ' HB2' ' A' ' 33' ' ' PHE . 29.1 m -123.92 111.28 28.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.301 0.572 . . . . 0.0 111.005 179.474 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -161.38 -157.81 0.53 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.475 -179.557 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -72.0 9.12 1.01 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.987 0.365 . . . . 0.0 111.987 -179.929 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.532 ' O ' ' N ' ' A' ' 14' ' ' SER . 3.4 p30 47.8 -136.69 0.91 Allowed 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 179.662 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.53 ' N ' ' HG2' ' A' ' 16' ' ' ARG . 1.5 t 36.32 -84.44 0.0 OUTLIER 'General case' 0 C--O 1.236 0.348 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -179.584 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.715 ' O ' HG23 ' A' ' 18' ' ' VAL . 35.6 t -77.8 -43.82 29.37 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.205 -0.452 . . . . 0.0 112.135 -179.21 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 27.4 mm -63.97 -34.34 67.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -178.893 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.862 ' HA ' HG21 ' A' ' 32' ' ' THR . 6.1 ptp180 -67.85 -52.69 33.76 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.789 -179.44 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.586 ' H ' ' HG3' ' A' ' 16' ' ' ARG . 28.4 t90 -54.85 -41.92 71.36 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.326 -178.782 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.715 HG23 ' O ' ' A' ' 14' ' ' SER . 13.5 t -67.55 -49.16 73.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -178.542 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.683 ' HG ' HD11 ' A' ' 108' ' ' ILE . 6.7 mt -79.72 -26.9 40.7 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.777 -178.112 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.611 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 19.3 pt-20 -66.8 -57.99 5.95 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.506 -0.477 . . . . 0.0 111.411 -179.604 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.482 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 3.4 mmt-85 -60.79 -54.46 44.88 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.927 -179.463 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.86 -33.29 68.52 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -179.055 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.02 ' HG ' HG11 ' A' ' 6' ' ' VAL . 2.7 tm? -76.01 -30.36 58.47 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.494 0.664 . . . . 0.0 110.308 179.602 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.61 -33.3 75.61 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.28 178.401 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.18 -26.15 68.98 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.198 178.607 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.617 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -78.25 -15.57 58.65 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 120.752 0.311 . . . . 0.0 110.823 179.371 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.98 26.06 10.74 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.647 -0.787 . . . . 0.0 113.596 179.211 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.682 ' HB2' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -132.77 170.89 14.62 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 117.571 0.685 . . . . 0.0 111.742 179.854 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.779 ' O ' HG12 ' A' ' 6' ' ' VAL . 23.5 m -95.76 137.6 34.59 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.63 -179.438 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.611 ' HB3' ' HA ' ' A' ' 20' ' ' GLU . 10.9 t -125.38 119.86 29.47 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.088 0.471 . . . . 0.0 111.501 -179.569 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.914 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.5 t -125.95 132.27 52.11 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.833 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.862 HG21 ' HA ' ' A' ' 16' ' ' ARG . 69.9 p -103.4 164.11 11.85 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 -177.23 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.934 ' HB2' HG12 ' A' ' 9' ' ' VAL . 6.0 m-85 -134.41 172.96 12.18 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.59 -178.384 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.435 ' HG2' ' N ' ' A' ' 35' ' ' ASN . 0.5 OUTLIER -62.28 -34.83 77.32 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -177.175 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.613 ' C ' ' HB ' ' A' ' 9' ' ' VAL . 22.0 p30 -176.68 -26.44 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 179.622 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.614 ' HA2' HG11 ' A' ' 9' ' ' VAL . . . 161.82 -56.64 0.3 Allowed Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.037 -1.077 . . . . 0.0 113.123 179.649 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.529 ' N ' HD11 ' A' ' 65' ' ' LEU . 0.7 OUTLIER -50.02 -34.03 19.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.12 0.486 . . . . 0.0 110.673 -179.764 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.659 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -54.22 -52.08 62.42 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.454 179.803 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.672 HG12 ' CD1' ' A' ' 43' ' ' LEU . 56.1 t -57.61 -40.98 78.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.036 -179.829 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.801 HD13 ' HB2' ' A' ' 68' ' ' GLN . 19.2 mt -53.12 -40.69 64.37 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.092 0.472 . . . . 0.0 110.426 179.459 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -77.25 -48.71 16.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.044 179.449 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.69 -25.15 67.22 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.763 179.67 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.77 HD21 ' HD2' ' A' ' 48' ' ' PRO . 9.3 mt -68.35 -22.05 64.7 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.036 -179.54 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.06 -17.09 36.84 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.737 -179.641 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.8 t -121.96 -3.48 9.12 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -179.611 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.647 ' O ' HD23 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -162.71 159.02 23.78 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.038 0.447 . . . . 0.0 111.34 179.643 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.696 HG23 HD13 ' A' ' 76' ' ' LEU . 98.2 m -139.23 113.96 8.22 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.442 179.703 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.77 ' HD2' HD21 ' A' ' 43' ' ' LEU . 72.0 Cg_endo -75.7 161.64 36.42 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.049 1.832 . . . . 0.0 111.291 178.92 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.45 ' O ' ' HG2' ' A' ' 77' ' ' PRO . 1.2 m-20 -73.69 -21.15 60.34 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.649 0.261 . . . . 0.0 110.956 -179.869 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.87 HG13 HG23 ' A' ' 6' ' ' VAL . 7.5 p -148.75 166.7 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.347 179.958 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.596 HD11 HG21 ' A' ' 39' ' ' VAL . 18.8 tp -153.02 130.78 11.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.736 0.303 . . . . 0.0 111.158 -179.467 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.31 121.44 44.9 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.531 -179.934 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.764 ' HB2' HD13 ' A' ' 80' ' ' ILE . 3.2 m -106.23 130.83 54.02 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.928 0.394 . . . . 0.0 111.488 -179.695 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.402 ' O ' ' CG2' ' A' ' 55' ' ' ILE . 35.4 t70 -73.78 -22.67 59.76 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.586 -179.803 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.813 HG12 ' HA3' ' A' ' 62' ' ' GLY . 0.0 OUTLIER 44.04 99.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 121.185 0.517 . . . . 0.0 111.832 -179.782 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -142.58 43.99 1.62 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.585 -179.57 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.555 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER 58.81 48.13 2.2 Favored Pre-proline 0 CA--C 1.532 0.264 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 179.296 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.556 ' HD2' ' N ' ' A' ' 62' ' ' GLY . 41.1 Cg_endo -68.06 -79.16 0.01 OUTLIER 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 122.327 2.018 . . . . 0.0 111.969 178.914 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -107.83 -25.15 6.04 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.331 179.478 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.966 ' CB ' ' HB2' ' A' ' 64' ' ' ALA . 0.3 OUTLIER -158.72 65.03 0.42 Allowed 'General case' 0 C--O 1.236 0.368 0 CA-C-O 120.962 0.41 . . . . 0.0 110.454 179.813 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.555 ' HA ' ' HA ' ' A' ' 57' ' ' MET . 0.2 OUTLIER 70.36 -21.24 0.19 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.961 179.998 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.813 ' HA3' HG12 ' A' ' 55' ' ' ILE . . . 130.76 -30.0 3.47 Favored Glycine 0 N--CA 1.446 -0.674 0 N-CA-C 110.146 -1.182 . . . . 0.0 110.146 -178.847 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.901 ' HA ' HD23 ' A' ' 66' ' ' LEU . 0.8 OUTLIER -70.54 -15.99 62.83 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.007 -0.596 . . . . 0.0 109.732 178.675 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.966 ' HB2' ' CB ' ' A' ' 60' ' ' MET . . . -53.54 -32.08 49.15 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-O 120.906 0.384 . . . . 0.0 110.259 179.706 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.651 ' HG ' HD11 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -61.24 -43.38 98.97 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.311 179.027 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.901 HD23 ' HA ' ' A' ' 63' ' ' LEU . 3.1 mm? -57.69 -45.45 85.62 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.052 -179.493 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -55.55 -47.69 75.96 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.234 0.54 . . . . 0.0 110.361 179.15 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.801 ' HB2' HD13 ' A' ' 40' ' ' LEU . 34.7 mm-40 -60.04 -29.74 68.73 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.503 179.62 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.565 ' HA ' ' CD2' ' A' ' 73' ' ' HIS . 59.4 mt -57.19 -48.98 81.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.224 0.535 . . . . 0.0 111.155 -179.705 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.55 ' HB3' ' CG ' ' A' ' 96' ' ' GLN . 7.6 pttt -63.02 -33.57 75.7 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.004 -179.232 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.493 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 4.4 mt-30 -72.73 -32.94 66.08 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.913 -179.478 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.2 mtt180 -108.87 -65.71 1.11 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -178.627 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.565 ' CD2' ' HA ' ' A' ' 69' ' ' ILE . 0.8 OUTLIER -82.12 169.04 19.84 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.679 -178.677 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -84.67 -68.99 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.885 2.39 . . . . 0.0 113.116 -179.579 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.426 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 69.7 mtm -150.98 45.83 0.84 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.823 0.344 . . . . 0.0 110.786 -179.8 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.696 HD13 HG23 ' A' ' 47' ' ' THR . 25.3 tp -56.77 114.8 8.6 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.231 -179.589 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.45 ' HG2' ' O ' ' A' ' 49' ' ' ASP . 19.6 Cg_endo -59.87 123.14 12.62 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.236 1.957 . . . . 0.0 112.011 179.531 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.957 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 4.6 t -124.59 153.07 31.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.843 -179.743 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.884 HD13 HG23 ' A' ' 115' ' ' VAL . 1.7 mt -128.45 114.39 33.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.94 179.939 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.764 HD13 ' HB2' ' A' ' 53' ' ' SER . 13.7 mm -93.83 141.01 15.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.889 -179.865 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.593 ' HA ' ' HB3' ' A' ' 102' ' ' LEU . 0.3 OUTLIER -80.26 -33.04 38.17 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.573 -179.334 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.538 ' H ' HG21 ' A' ' 55' ' ' ILE . 19.8 m -147.83 144.92 28.5 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 120.96 0.41 . . . . 0.0 111.724 -179.244 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.474 ' HA ' ' CE2' ' A' ' 101' ' ' TYR . . . -86.92 -26.19 24.03 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.39 179.661 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.52 ' H ' HG22 ' A' ' 82' ' ' THR . 3.0 m-70 46.87 44.5 14.49 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.766 179.549 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 38.8 m 53.4 85.89 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.576 179.286 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 177.03 35.71 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.825 179.822 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.806 HD13 ' HB3' ' A' ' 90' ' ' ALA . 0.3 OUTLIER -49.12 -21.87 0.83 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.949 -179.509 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -47.7 -61.08 2.11 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.48 0.181 . . . . 0.0 111.422 -179.503 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.0 -20.03 60.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.824 0.345 . . . . 0.0 110.698 179.375 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.806 ' HB3' HD13 ' A' ' 87' ' ' LEU . . . -62.38 -47.57 83.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.345 -179.963 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.564 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 6.6 t -67.26 -41.05 86.16 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 C-N-CA 120.704 -0.399 . . . . 0.0 110.52 179.819 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.504 ' O ' ' HG3' ' A' ' 95' ' ' GLN . 39.7 m -62.19 -15.83 49.0 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.387 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.638 ' HB2' ' HG ' ' A' ' 66' ' ' LEU . . . -75.87 -64.0 1.18 Allowed 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 120.988 0.423 . . . . 0.0 111.625 179.904 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.636 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 3.9 m-85 -41.7 -44.35 3.14 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.782 -178.431 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.57 ' NE2' ' HG3' ' A' ' 96' ' ' GLN . 0.2 OUTLIER -69.97 -48.46 58.17 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.23 179.563 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.57 ' HG3' ' NE2' ' A' ' 95' ' ' GLN . 59.5 mt-30 -75.92 -9.83 58.93 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.292 -0.413 . . . . 0.0 112.106 -179.831 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 93' ' ' ALA . . . 133.48 80.64 0.16 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.063 -179.553 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.957 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -168.5 133.82 1.73 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.093 0.473 . . . . 0.0 111.309 -179.903 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.42 ' CE1' ' HA ' ' A' ' 118' ' ' ALA . 50.4 t80 -73.33 -53.37 10.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.773 -179.777 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.53 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 1.7 t0 175.84 -171.05 0.07 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.016 0.436 . . . . 0.0 111.404 -179.817 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.678 ' CE2' HG21 ' A' ' 80' ' ' ILE . 6.7 m-85 -114.35 152.88 30.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.233 179.328 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.702 HD21 ' HA ' ' A' ' 106' ' ' PHE . 5.9 tp -105.52 137.32 19.26 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.142 -179.032 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.23 -161.5 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.933 2.422 . . . . 0.0 112.726 -179.545 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.445 ' CB ' ' HD3' ' A' ' 105' ' ' PRO . 0.3 OUTLIER -48.89 -59.25 6.61 Favored Pre-proline 0 CA--C 1.531 0.223 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.819 -179.478 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.445 ' HD3' ' CB ' ' A' ' 104' ' ' LYS . 73.8 Cg_exo -48.49 164.27 0.22 Allowed 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.44 2.093 . . . . 0.0 111.868 179.776 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.702 ' HA ' HD21 ' A' ' 102' ' ' LEU . 64.8 t80 -161.74 -102.42 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.706 -0.224 . . . . 0.0 110.719 179.844 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.583 ' O ' ' O ' ' A' ' 106' ' ' PHE . 2.6 p-10 42.09 179.3 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.915 0.388 . . . . 0.0 111.318 -179.983 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.697 HG12 HG12 ' A' ' 18' ' ' VAL . 1.0 OUTLIER -67.66 -42.29 86.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.084 0.468 . . . . 0.0 111.346 179.863 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.52 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 3.4 t0 -51.86 -58.77 5.49 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.594 -179.36 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.63 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 3.3 mm-40 -75.62 -27.7 58.55 Favored 'General case' 0 C--N 1.333 -0.124 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -179.476 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.419 ' CB ' ' O ' ' A' ' 107' ' ' ASP . . . -73.82 -62.52 1.47 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.925 0.393 . . . . 0.0 110.256 179.519 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.62 ' O ' HG12 ' A' ' 115' ' ' VAL . 49.3 t -55.63 -29.86 25.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.484 0.659 . . . . 0.0 110.256 179.021 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.53 ' O ' ' HG3' ' A' ' 117' ' ' ARG . . . -63.46 -50.96 67.65 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.731 179.172 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 53.7 tp -72.4 -20.69 61.39 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.395 -0.82 . . . . 0.0 112.273 -179.705 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.884 HG23 HD13 ' A' ' 79' ' ' ILE . 2.9 p -79.36 -47.67 22.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.686 -179.338 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.416 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 26.0 mt-10 -64.24 -42.8 96.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.855 0.36 . . . . 0.0 110.652 179.98 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.53 ' HG3' ' O ' ' A' ' 113' ' ' ALA . 40.5 mtt85 -63.36 -23.68 67.52 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.924 0.392 . . . . 0.0 110.551 179.224 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.42 ' HA ' ' CE1' ' A' ' 99' ' ' PHE . . . -70.16 -48.76 55.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.663 179.446 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.687 HD11 HG11 ' A' ' 50' ' ' VAL . 4.9 mt -68.1 -31.95 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.039 179.892 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 9.2 p -74.04 -49.05 25.91 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.382 -179.725 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -59.61 -28.21 66.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.312 -179.551 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.443 ' CE2' ' HB3' ' A' ' 77' ' ' PRO . 6.2 m-85 -83.06 -54.14 5.28 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.164 -179.87 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? 59.65 -179.38 0.09 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.953 179.898 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 6.4 pm0 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.876 -179.995 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.5 tpp . . . . . 0 N--CA 1.487 1.424 0 CA-C-O 120.762 0.315 . . . . 0.0 111.104 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.639 ' O ' ' HG2' ' A' ' 3' ' ' ARG . 1.1 mt-30 -84.85 -68.45 0.72 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.295 179.61 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.639 ' HG2' ' O ' ' A' ' 2' ' ' GLN . 0.0 OUTLIER 71.04 -34.01 0.29 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.487 -0.779 . . . . 0.0 112.046 179.758 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.881 ' O ' HD13 ' A' ' 5' ' ' ILE . . . 104.84 103.46 2.86 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.444 179.41 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.881 HD13 ' O ' ' A' ' 4' ' ' GLY . 7.5 mm -127.56 112.7 28.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 120.904 0.383 . . . . 0.0 111.813 -179.546 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.953 HG23 HG13 ' A' ' 50' ' ' VAL . 7.9 p -107.07 135.16 46.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.144 179.642 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.908 ' CD1' HG22 ' A' ' 31' ' ' THR . 24.2 m0 -120.26 125.89 49.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.014 0.435 . . . . 0.0 110.657 179.447 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.734 ' HB ' HG22 ' A' ' 32' ' ' THR . 0.5 OUTLIER -114.56 146.64 18.79 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.288 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.46 -178.365 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.697 HG13 ' HB2' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -124.7 110.8 25.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.821 0.343 . . . . 0.0 110.582 179.243 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.503 ' OD2' HG21 ' A' ' 15' ' ' ILE . 3.8 t0 -161.49 -161.18 0.77 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.228 -179.231 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.24 -0.23 3.29 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -179.487 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.436 ' O ' ' N ' ' A' ' 14' ' ' SER . 0.8 OUTLIER 69.51 -157.72 0.16 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.5 0.19 . . . . 0.0 110.894 179.896 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.404 ' HB3' ' H ' ' A' ' 14' ' ' SER . 1.6 t 34.54 -88.61 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 113.002 0.741 . . . . 0.0 113.002 179.51 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.797 ' O ' HG23 ' A' ' 18' ' ' VAL . 28.4 t -56.07 -58.99 5.6 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.719 0.295 . . . . 0.0 111.235 -179.699 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.503 HG21 ' OD2' ' A' ' 10' ' ' ASP . 20.5 mm -65.77 -24.46 34.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.262 -179.821 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.76 ' HA ' HG21 ' A' ' 32' ' ' THR . 20.2 ttt-85 -78.39 -41.15 34.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.023 179.819 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.426 ' HA ' ' CD ' ' A' ' 20' ' ' GLU . 84.1 t90 -65.7 -40.17 91.99 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.541 -179.351 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.797 HG23 ' O ' ' A' ' 14' ' ' SER . 3.5 t -69.37 -38.17 76.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -178.93 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.652 ' CD2' HD11 ' A' ' 108' ' ' ILE . 0.2 OUTLIER -84.39 -29.29 26.33 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -178.962 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.766 ' HA ' ' HB3' ' A' ' 30' ' ' CYS . 24.4 pt-20 -67.87 -59.01 3.62 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -179.29 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.466 ' N ' ' HG3' ' A' ' 20' ' ' GLU . 9.8 mmt180 -64.65 -51.69 61.23 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.885 -178.904 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.23 -44.43 79.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.103 0.478 . . . . 0.0 111.521 -179.384 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.909 ' HG ' HG11 ' A' ' 6' ' ' VAL . 2.1 tm? -72.04 -27.85 62.98 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.188 179.523 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.54 -33.63 76.11 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.29 178.397 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.18 -28.65 69.45 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.498 -0.858 . . . . 0.0 111.16 178.772 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.631 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . . . -76.84 -15.35 59.74 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 120.717 0.294 . . . . 0.0 110.947 179.412 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.49 26.08 11.36 Favored Glycine 0 C--N 1.334 0.422 0 C-N-CA 120.7 -0.762 . . . . 0.0 113.657 179.001 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.631 ' CD1' ' HB3' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -131.5 172.65 11.96 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 117.528 0.664 . . . . 0.0 111.583 179.625 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.694 ' O ' HG12 ' A' ' 6' ' ' VAL . 16.6 m -96.62 138.08 34.73 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.43 -179.256 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.766 ' HB3' ' HA ' ' A' ' 20' ' ' GLU . 8.5 t -127.61 117.5 22.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.884 179.972 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.908 HG22 ' CD1' ' A' ' 7' ' ' TRP . 2.8 t -122.08 142.77 50.02 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.275 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.76 HG21 ' HA ' ' A' ' 16' ' ' ARG . 66.7 p -118.26 159.81 22.7 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.181 0.515 . . . . 0.0 112.165 -178.889 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.9 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 0.2 OUTLIER -135.1 171.92 13.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.823 -179.007 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.698 ' HG2' ' N ' ' A' ' 35' ' ' ASN . 0.0 OUTLIER -64.17 -43.53 94.84 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.212 -179.532 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.698 ' N ' ' HG2' ' A' ' 34' ' ' GLU . 29.3 p30 -173.1 178.89 2.37 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.104 0.478 . . . . 0.0 110.988 -179.018 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.637 ' HA3' ' HB3' ' A' ' 65' ' ' LEU . . . -43.05 -32.21 1.46 Allowed Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.46 -0.791 . . . . 0.0 113.825 -179.47 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.407 ' HA ' ' CD1' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -72.67 -45.68 57.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.945 0.373 . . . . 0.0 111.613 -178.966 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.9 ' HB3' ' HB3' ' A' ' 33' ' ' PHE . 0.0 OUTLIER -52.2 -54.47 30.5 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 -179.836 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.544 HG12 ' CD1' ' A' ' 43' ' ' LEU . 3.5 t -48.86 -36.26 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.32 -179.438 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.673 HD11 HE21 ' A' ' 68' ' ' GLN . 7.0 mt -62.62 -49.6 74.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.838 0.351 . . . . 0.0 110.532 179.85 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -54.35 -50.39 67.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.32 -179.488 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.619 ' HB3' ' HE2' ' A' ' 33' ' ' PHE . . . -70.77 -33.46 70.78 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.258 179.953 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.623 HD13 ' NE2' ' A' ' 73' ' ' HIS . 16.0 mt -61.19 -27.12 68.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.307 -179.821 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.79 -17.99 4.2 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.618 -179.583 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 23.9 t -120.85 -3.39 9.7 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -179.635 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.608 ' NZ ' HG21 ' A' ' 5' ' ' ILE . 0.4 OUTLIER -167.66 165.38 14.37 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.883 0.373 . . . . 0.0 111.47 -179.73 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.464 ' HA ' HD23 ' A' ' 43' ' ' LEU . 59.3 m -139.18 128.14 13.94 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.221 179.585 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.643 ' HB3' ' CG ' ' A' ' 7' ' ' TRP . 74.1 Cg_endo -78.06 159.66 30.33 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.38 2.053 . . . . 0.0 111.904 179.195 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -75.42 -31.37 60.35 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.622 179.847 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.953 HG13 HG23 ' A' ' 6' ' ' VAL . 13.5 p -149.68 111.82 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.446 -179.435 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.709 HD12 ' O ' ' A' ' 7' ' ' TRP . 15.3 tp -87.13 150.2 24.14 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.925 0.393 . . . . 0.0 111.949 -179.656 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.696 ' HB3' HG13 ' A' ' 8' ' ' VAL . 1.4 tt -138.75 118.13 12.83 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.743 179.539 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.481 ' HB2' ' CD1' ' A' ' 80' ' ' ILE . 3.2 m -112.42 135.16 53.46 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 121.038 0.447 . . . . 0.0 111.286 179.756 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.411 ' O ' ' O ' ' A' ' 55' ' ' ILE . 25.7 t0 -77.36 -8.01 56.99 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -178.705 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 1.012 HG12 ' HA3' ' A' ' 62' ' ' GLY . 0.0 OUTLIER 37.61 100.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 179.908 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.401 HH21 ' HA ' ' A' ' 10' ' ' ASP . 1.3 ptt85 -146.03 44.0 1.24 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.501 179.68 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.524 ' HA ' ' HA ' ' A' ' 61' ' ' ASP . 37.7 ttp 65.27 49.37 0.72 Allowed Pre-proline 0 CA--C 1.532 0.285 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 178.894 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' A' ' 62' ' ' GLY . 57.5 Cg_endo -72.05 -84.54 0.0 OUTLIER 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 122.757 2.305 . . . . 0.0 112.116 178.711 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -100.33 -29.33 6.76 Favored Glycine 0 C--N 1.337 0.636 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.433 179.696 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.99 ' HB3' ' HB2' ' A' ' 64' ' ' ALA . 0.7 OUTLIER -157.23 69.4 0.57 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.907 0.384 . . . . 0.0 110.114 179.496 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.524 ' HA ' ' HA ' ' A' ' 57' ' ' MET . 0.2 OUTLIER 68.56 -22.96 0.13 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.964 -179.694 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 1.012 ' HA3' HG12 ' A' ' 55' ' ' ILE . . . 136.69 -26.63 3.01 Favored Glycine 0 CA--C 1.498 -0.997 0 C-N-CA 120.981 -0.628 . . . . 0.0 111.682 -179.838 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.638 HD12 ' H ' ' A' ' 63' ' ' LEU . 1.0 OUTLIER -75.95 -17.56 59.69 Favored 'General case' 0 N--CA 1.44 -0.971 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.157 179.221 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.99 ' HB2' ' HB3' ' A' ' 60' ' ' MET . . . -53.47 -38.34 63.51 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 121.002 0.429 . . . . 0.0 110.601 179.085 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.637 ' HB3' ' HA3' ' A' ' 36' ' ' GLY . 3.8 pp -58.76 -36.94 75.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.197 -179.795 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.792 HD13 ' HB2' ' A' ' 93' ' ' ALA . 9.6 mt -62.7 -43.73 98.04 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.835 0.35 . . . . 0.0 110.308 179.586 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.52 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 0.4 OUTLIER -52.9 -59.75 4.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.499 179.563 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.673 HE21 HD11 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -55.86 -38.19 69.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.023 0.44 . . . . 0.0 111.146 179.422 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.46 ' HA ' ' CD2' ' A' ' 73' ' ' HIS . 6.7 mm -61.56 -36.74 75.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.218 -178.738 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.623 ' HB2' ' HB2' ' A' ' 96' ' ' GLN . 1.1 pttt -78.44 -24.86 45.87 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.247 -0.433 . . . . 0.0 112.084 -179.613 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.513 ' NE2' ' HG3' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -80.57 -30.03 37.01 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.694 -178.251 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.513 ' HG3' ' NE2' ' A' ' 71' ' ' GLN . 27.5 mtt180 -103.9 -21.78 13.59 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -179.684 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.623 ' NE2' HD13 ' A' ' 43' ' ' LEU . 1.9 m-70 -128.67 156.24 77.77 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-O 120.776 0.322 . . . . 0.0 111.255 -178.935 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -95.25 100.88 0.11 Allowed 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 123.214 2.609 . . . . 0.0 113.687 -178.88 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.493 ' HA ' ' CA ' ' A' ' 97' ' ' GLY . 3.9 mtt 55.53 38.57 30.4 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.261 178.169 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.54 HD11 ' CD2' ' A' ' 43' ' ' LEU . 1.4 tt -60.52 114.19 9.51 Favored Pre-proline 0 C--N 1.325 -0.483 0 C-N-CA 121.143 -0.223 . . . . 0.0 110.867 179.602 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.542 ' HB3' ' CE2' ' A' ' 122' ' ' TYR . 50.7 Cg_exo -55.87 129.94 37.65 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.532 2.155 . . . . 0.0 112.848 -179.948 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.668 ' H ' ' HA ' ' A' ' 98' ' ' ALA . 4.4 t -137.59 147.06 26.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.286 179.55 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.832 ' CG2' HD23 ' A' ' 114' ' ' LEU . 2.0 mt -122.47 111.07 28.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.212 179.563 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.549 HG13 ' CZ ' ' A' ' 101' ' ' TYR . 8.6 mm -99.2 142.13 15.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 120.996 0.426 . . . . 0.0 111.839 -178.903 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.642 ' O ' ' HB2' ' A' ' 102' ' ' LEU . 13.8 ttt -70.72 -75.73 0.12 Allowed 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.631 -179.42 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.526 ' H ' ' CG2' ' A' ' 55' ' ' ILE . 3.0 m -105.65 147.39 28.54 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.089 0.471 . . . . 0.0 111.542 -178.936 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.918 ' HB2' ' CD2' ' A' ' 101' ' ' TYR . . . -116.29 59.12 0.74 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.902 179.941 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 21.1 p80 -99.07 135.28 40.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.913 0.387 . . . . 0.0 111.561 -179.674 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.444 ' HB3' ' CG ' ' A' ' 61' ' ' ASP . 9.5 t 62.85 134.11 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.648 179.183 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.526 ' HB3' HD13 ' A' ' 63' ' ' LEU . 1.8 t70 55.49 36.65 27.57 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.128 179.65 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.72 HD21 ' HB1' ' A' ' 83' ' ' ALA . 0.5 OUTLIER -53.48 -24.27 12.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.566 -179.901 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -49.5 -47.46 48.63 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.96 0.41 . . . . 0.0 111.357 -179.782 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.478 ' O ' ' HB2' ' A' ' 93' ' ' ALA . . . -62.66 -19.74 64.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.258 -179.888 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.689 ' O ' ' HB3' ' A' ' 93' ' ' ALA . . . -72.09 -57.49 4.22 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.775 0.321 . . . . 0.0 110.972 179.527 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.694 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 3.5 t -59.95 -52.45 60.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.299 -179.55 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 89.9 p -58.44 -22.25 53.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.01 0.434 . . . . 0.0 109.98 178.975 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.792 ' HB2' HD13 ' A' ' 66' ' ' LEU . . . -59.92 -48.81 80.17 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.365 179.154 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.694 ' CE2' ' HA ' ' A' ' 91' ' ' VAL . 2.8 m-85 -57.62 -30.89 65.72 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.186 -180.0 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.77 -36.37 59.85 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.306 -179.911 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.623 ' HB2' ' HB2' ' A' ' 70' ' ' LYS . 11.8 pt20 -100.18 0.88 41.34 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.526 -178.98 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 93' ' ' ALA . . . 128.4 81.32 0.31 Allowed Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.347 -0.93 . . . . 0.0 113.323 179.955 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.668 ' HA ' ' H ' ' A' ' 78' ' ' VAL . . . -169.7 136.04 1.56 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.778 0.323 . . . . 0.0 110.26 179.162 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.519 ' CZ ' ' HA ' ' A' ' 118' ' ' ALA . 32.0 t80 -74.97 -53.32 9.16 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.976 -0.29 . . . . 0.0 111.325 -179.449 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.634 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 2.4 t70 179.82 -172.76 0.2 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.265 0.555 . . . . 0.0 111.924 -179.756 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.918 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 3.1 m-85 -128.36 154.1 46.34 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.811 179.986 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.794 HD11 HD22 ' A' ' 114' ' ' LEU . 9.0 mp -102.04 123.58 43.07 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-O 120.719 0.295 . . . . 0.0 110.614 179.958 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -68.62 -66.8 0.03 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.19 1.927 . . . . 0.0 112.337 -179.753 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.755 ' H ' ' HD2' ' A' ' 105' ' ' PRO . 0.7 OUTLIER -119.4 -58.39 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.244 -0.434 . . . . 0.0 112.117 -179.535 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.755 ' HD2' ' H ' ' A' ' 104' ' ' LYS . 17.8 Cg_endo -59.5 163.1 13.43 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.255 1.97 . . . . 0.0 112.697 -179.501 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.616 ' HA ' HD23 ' A' ' 102' ' ' LEU . 38.9 t80 -166.86 -108.61 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.223 179.609 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.593 ' O ' ' O ' ' A' ' 106' ' ' PHE . 3.1 p30 43.04 176.57 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.896 0.379 . . . . 0.0 111.274 -179.975 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.652 HD11 ' CD2' ' A' ' 19' ' ' LEU . 1.0 OUTLIER -67.7 -39.41 82.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 121.903 -0.498 . . . . 0.0 111.278 -179.82 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.486 ' O ' ' HB2' ' A' ' 113' ' ' ALA . 4.4 t70 -49.82 -58.47 5.3 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.246 -179.75 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.585 ' HB2' ' O ' ' A' ' 106' ' ' PHE . 3.4 mm-40 -77.61 -34.32 53.42 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 111.709 0.263 . . . . 0.0 111.709 -179.76 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.39 -59.56 4.21 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 179.328 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.726 ' O ' HG12 ' A' ' 115' ' ' VAL . 55.8 t -59.54 -30.27 44.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.466 0.65 . . . . 0.0 110.506 178.86 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.486 ' HB2' ' O ' ' A' ' 109' ' ' ASP . . . -65.37 -47.55 76.0 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.158 179.367 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.832 HD23 ' CG2' ' A' ' 79' ' ' ILE . 23.6 tp -73.51 -21.33 60.43 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.551 -179.627 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.726 HG12 ' O ' ' A' ' 112' ' ' VAL . 5.7 p -79.44 -47.08 22.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.779 0.323 . . . . 0.0 111.679 -179.838 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.642 ' HA ' HD12 ' A' ' 119' ' ' ILE . 31.8 mt-10 -67.88 -46.8 70.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.88 -179.786 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 55.8 mtp180 -61.01 -24.2 65.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.091 0.472 . . . . 0.0 110.567 179.392 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.519 ' HA ' ' CZ ' ' A' ' 99' ' ' PHE . . . -71.16 -47.4 57.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.97 179.625 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.642 HD12 ' HA ' ' A' ' 116' ' ' GLU . 4.6 mt -62.94 -31.17 51.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.127 -179.95 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.0 t -74.55 -51.0 15.86 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.422 -179.387 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 20.5 m80 -68.89 -24.95 64.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.394 -179.464 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.542 ' CE2' ' HB3' ' A' ' 77' ' ' PRO . 1.1 m-85 -67.93 -55.62 12.11 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.959 -179.816 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -75.62 -176.1 3.14 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.972 179.987 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.819 179.913 . . . . . . . . 0 0 . 1 stop_ save_